Citrus Sinensis ID: 021306
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 314 | 2.2.26 [Sep-21-2011] | |||||||
| Q39011 | 380 | Shaggy-related protein ki | yes | no | 0.923 | 0.763 | 0.941 | 1e-163 | |
| Q39012 | 407 | Shaggy-related protein ki | no | no | 0.923 | 0.712 | 0.897 | 1e-158 | |
| Q39010 | 412 | Shaggy-related protein ki | no | no | 0.917 | 0.699 | 0.896 | 1e-158 | |
| Q8VZD5 | 410 | Shaggy-related protein ki | no | no | 0.923 | 0.707 | 0.835 | 1e-147 | |
| P43288 | 405 | Shaggy-related protein ki | no | no | 0.917 | 0.711 | 0.827 | 1e-145 | |
| P43289 | 409 | Shaggy-related protein ki | no | no | 0.923 | 0.709 | 0.811 | 1e-144 | |
| P51137 | 411 | Glycogen synthase kinase- | N/A | no | 0.923 | 0.705 | 0.811 | 1e-143 | |
| P51139 | 411 | Glycogen synthase kinase- | N/A | no | 0.917 | 0.700 | 0.814 | 1e-142 | |
| Q40518 | 409 | Shaggy-related protein ki | N/A | no | 0.923 | 0.709 | 0.797 | 1e-142 | |
| P51138 | 411 | Glycogen synthase kinase- | N/A | no | 0.917 | 0.700 | 0.788 | 1e-140 |
| >sp|Q39011|KSG7_ARATH Shaggy-related protein kinase eta OS=Arabidopsis thaliana GN=ASK7 PE=1 SV=2 | Back alignment and function desciption |
|---|
Score = 573 bits (1478), Expect = e-163, Method: Compositional matrix adjust.
Identities = 275/292 (94%), Positives = 281/292 (96%), Gaps = 2/292 (0%)
Query: 1 MADDKEMSAAVVDGSDHVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCL 60
MADDKEM AAVVDG D VTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCL
Sbjct: 1 MADDKEMPAAVVDGHDQVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCL 60
Query: 61 ETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE 120
ETGETVAIKKVLQDRRYKNRELQLMRVMDHPNV+ LKHCFFSTTSK+ELFLNLVMEYVPE
Sbjct: 61 ETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVVCLKHCFFSTTSKDELFLNLVMEYVPE 120
Query: 121 SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQV 180
S+YRVLKHYSSANQRMPL+YVKLY YQIFRGLAYIH V VCHRDLKPQNLLVDPLTHQV
Sbjct: 121 SLYRVLKHYSSANQRMPLVYVKLYMYQIFRGLAYIHNVAGVCHRDLKPQNLLVDPLTHQV 180
Query: 181 KICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL 240
KICDFGSAKQL+ GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL
Sbjct: 181 KICDFGSAKQLVKGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL 240
Query: 241 FPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVCIFH 292
FPGENAVDQLVEIIKVLGTPTREEIRCMNP+YTDFRFPQIKAHPWHK IFH
Sbjct: 241 FPGENAVDQLVEIIKVLGTPTREEIRCMNPHYTDFRFPQIKAHPWHK--IFH 290
|
Negative regulator in brassinosteroid signal transduction pathway important for plant growth. May be also involved in auxin signaling pathway. Phosphorylates and increases the degradation of BZR1 and BZR2/BES1 by the proteasome. Phosphorylates BHLH150, beet curly top virus C4 and tomato golden mosaic virus AC4 on threonine and serine residues. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q39012|KSG9_ARATH Shaggy-related protein kinase iota OS=Arabidopsis thaliana GN=ASK9 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 558 bits (1437), Expect = e-158, Method: Compositional matrix adjust.
Identities = 262/292 (89%), Positives = 280/292 (95%), Gaps = 2/292 (0%)
Query: 1 MADDKEMSAAVVDGSDHVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCL 60
+ DKEMSAAV++G+D VTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCL
Sbjct: 31 LDSDKEMSAAVIEGNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCL 90
Query: 61 ETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE 120
ETGE+VAIKKVLQDRRYKNRELQLMR MDHPNVISLKHCFFSTTS++ELFLNLVMEYVPE
Sbjct: 91 ETGESVAIKKVLQDRRYKNRELQLMRPMDHPNVISLKHCFFSTTSRDELFLNLVMEYVPE 150
Query: 121 SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQV 180
++YRVL+HY+S+NQRMP+ YVKLYTYQIFRGLAYIHTVP VCHRD+KPQNLLVDPLTHQV
Sbjct: 151 TLYRVLRHYTSSNQRMPIFYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQV 210
Query: 181 KICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL 240
K+CDFGSAK L+ GE NISYICSR+YRAPELIFGATEYT SIDIWSAGCVLAELLLGQPL
Sbjct: 211 KLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTASIDIWSAGCVLAELLLGQPL 270
Query: 241 FPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVCIFH 292
FPGEN+VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKV FH
Sbjct: 271 FPGENSVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKV--FH 320
|
May mediate extracellular signals to regulate transcription in differentiating cells. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q39010|KSG6_ARATH Shaggy-related protein kinase zeta OS=Arabidopsis thaliana GN=ASK6 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 556 bits (1433), Expect = e-158, Method: Compositional matrix adjust.
Identities = 260/290 (89%), Positives = 281/290 (96%), Gaps = 2/290 (0%)
Query: 3 DDKEMSAAVVDGSDHVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLET 62
+DKEMSAAV++G+D VTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLET
Sbjct: 35 NDKEMSAAVIEGNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLET 94
Query: 63 GETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESM 122
GE+VAIKKVLQDRRYKNRELQLMR+MDHPNV+SLKHCFFSTT+++ELFLNLVMEYVPE++
Sbjct: 95 GESVAIKKVLQDRRYKNRELQLMRLMDHPNVVSLKHCFFSTTTRDELFLNLVMEYVPETL 154
Query: 123 YRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKI 182
YRVLKHY+S+NQRMP+ YVKLYTYQIFRGLAYIHT P VCHRD+KPQNLLVDPLTHQ K+
Sbjct: 155 YRVLKHYTSSNQRMPIFYVKLYTYQIFRGLAYIHTAPGVCHRDVKPQNLLVDPLTHQCKL 214
Query: 183 CDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFP 242
CDFGSAK L+ GEANISYICSR+YRAPELIFGATEYT+SIDIWSAGCVLAELLLGQPLFP
Sbjct: 215 CDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTSSIDIWSAGCVLAELLLGQPLFP 274
Query: 243 GENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVCIFH 292
GEN+VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKV FH
Sbjct: 275 GENSVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKV--FH 322
|
May mediate extracellular signals to regulate transcription in differentiating cells. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8VZD5|KSG5_ARATH Shaggy-related protein kinase epsilon OS=Arabidopsis thaliana GN=ASK5 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 520 bits (1338), Expect = e-147, Method: Compositional matrix adjust.
Identities = 244/292 (83%), Positives = 268/292 (91%), Gaps = 2/292 (0%)
Query: 1 MADDKEMSAAVVDGSDHVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCL 60
+ DDKEM AAVVDG+ TGHII TTIGGKNG+PKQTISYMAER+VG GSFGIVFQAKCL
Sbjct: 35 IKDDKEMEAAVVDGNGTETGHIIVTTIGGKNGQPKQTISYMAERIVGQGSFGIVFQAKCL 94
Query: 61 ETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE 120
ETGETVAIKKVLQD+RYKNRELQ MR++DHPNV+SLKHCFFSTT K+EL+LNLV+EYVPE
Sbjct: 95 ETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE 154
Query: 121 SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQV 180
++YRV KHYS ANQRMP+IYVKLYTYQI R LAYIH VCHRD+KPQNLLV+P THQV
Sbjct: 155 TVYRVSKHYSRANQRMPIIYVKLYTYQICRALAYIHGGVGVCHRDIKPQNLLVNPHTHQV 214
Query: 181 KICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL 240
K+CDFGSAK L+ GE NISYICSR+YRAPELIFGATEYTT+IDIWSAGCVLAELLLGQPL
Sbjct: 215 KLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTTIDIWSAGCVLAELLLGQPL 274
Query: 241 FPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVCIFH 292
FPGE+ VDQLVEIIKVLGTPTREEI+CMNPNYT+F+FPQIKAHPWHK IFH
Sbjct: 275 FPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHK--IFH 324
|
May mediate extracellular signals to regulate transcription in differentiating cells. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P43288|KSG1_ARATH Shaggy-related protein kinase alpha OS=Arabidopsis thaliana GN=ASK1 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 513 bits (1321), Expect = e-145, Method: Compositional matrix adjust.
Identities = 240/290 (82%), Positives = 267/290 (92%), Gaps = 2/290 (0%)
Query: 3 DDKEMSAAVVDGSDHVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLET 62
DDKEM A VVDG+ TGHII TTIGG+NG+PKQTISYMAERVVG GSFG+VFQAKCLET
Sbjct: 32 DDKEMEATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAERVVGHGSFGVVFQAKCLET 91
Query: 63 GETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESM 122
GETVAIKKVLQDRRYKNRELQ MR++DHPNV+SLKHCFFSTT K+EL+LNLV+EYVPE++
Sbjct: 92 GETVAIKKVLQDRRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETV 151
Query: 123 YRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKI 182
+RV+KHY+ NQRMPLIYVKLYTYQIFR L+YIH VCHRD+KPQNLLV+P THQVK+
Sbjct: 152 HRVIKHYNKLNQRMPLIYVKLYTYQIFRALSYIHRCIGVCHRDIKPQNLLVNPHTHQVKL 211
Query: 183 CDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFP 242
CDFGSAK L+ GE NISYICSR+YRAPELIFGATEYTT+ID+WSAGCVLAELLLGQPLFP
Sbjct: 212 CDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDVWSAGCVLAELLLGQPLFP 271
Query: 243 GENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVCIFH 292
GE+ VDQLVEIIKVLGTPTREEI+CMNPNYT+F+FPQIKAHPWHK IFH
Sbjct: 272 GESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHK--IFH 319
|
May mediate extracellular signals to regulate transcription in differentiating cells. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P43289|KSG3_ARATH Shaggy-related protein kinase gamma OS=Arabidopsis thaliana GN=ASK3 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 511 bits (1315), Expect = e-144, Method: Compositional matrix adjust.
Identities = 237/292 (81%), Positives = 268/292 (91%), Gaps = 2/292 (0%)
Query: 1 MADDKEMSAAVVDGSDHVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCL 60
+ DDKEM A +V+G+ TGHII TTIGG+NG+PKQTISYMAERVVG GSFG+VFQAKCL
Sbjct: 34 IQDDKEMEATIVNGNVTETGHIIVTTIGGRNGQPKQTISYMAERVVGHGSFGVVFQAKCL 93
Query: 61 ETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE 120
ETGETVAIKKVLQDRRYKNRELQ MR++DHPNV+SLKHCFFSTT K+EL+LNLV+EYVPE
Sbjct: 94 ETGETVAIKKVLQDRRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE 153
Query: 121 SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQV 180
+++RV+KHY+ NQRMPL+YVKLYTYQIFR L+YIH VCHRD+KPQNLLV+P THQV
Sbjct: 154 TVHRVIKHYNKLNQRMPLVYVKLYTYQIFRSLSYIHRCIGVCHRDIKPQNLLVNPHTHQV 213
Query: 181 KICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL 240
K+CDFGSAK L+ GE NISYICSR+YRAPELIFGATEYTT+ID+WSAGCVLAELLLGQPL
Sbjct: 214 KLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDVWSAGCVLAELLLGQPL 273
Query: 241 FPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVCIFH 292
FPGE+ VDQLVEIIKVLGTPTREEI+CMNPNYT+F+FPQIKAHPWHK IFH
Sbjct: 274 FPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHK--IFH 323
|
May mediate extracellular signals to regulate transcription in differentiating cells. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P51137|MSK1_MEDSA Glycogen synthase kinase-3 homolog MsK-1 OS=Medicago sativa GN=MSK-1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 509 bits (1310), Expect = e-143, Method: Compositional matrix adjust.
Identities = 237/292 (81%), Positives = 266/292 (91%), Gaps = 2/292 (0%)
Query: 1 MADDKEMSAAVVDGSDHVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCL 60
+ DD+EM A VVDG+ TGHII TTIGG+NG+PKQTISYMAERVVG GSFG+VFQAKCL
Sbjct: 36 IRDDREMEATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAERVVGHGSFGVVFQAKCL 95
Query: 61 ETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE 120
ETGETVAIKKVLQD+RYKNRELQ MR++DHPNV+SLKHCFFSTT K+EL+LNLV+EYVPE
Sbjct: 96 ETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE 155
Query: 121 SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQV 180
+++RV+KHYS NQRMP+IYVKLYTYQIFR L+YIH VCHRD+KPQNLLV+P THQV
Sbjct: 156 TVHRVIKHYSKLNQRMPMIYVKLYTYQIFRALSYIHRCIGVCHRDIKPQNLLVNPHTHQV 215
Query: 181 KICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL 240
K+CDFGSAK L+ GE NISYICSR+YRAPELIFGATEYTT+ID+WS GCVLAELLLGQPL
Sbjct: 216 KLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDVWSVGCVLAELLLGQPL 275
Query: 241 FPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVCIFH 292
FPGE VDQLVEIIKVLGTPTREEI+CMNPNYT+F+FPQIKAHPWHK IFH
Sbjct: 276 FPGERGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHK--IFH 325
|
Medicago sativa (taxid: 3879) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P51139|MSK3_MEDSA Glycogen synthase kinase-3 homolog MsK-3 OS=Medicago sativa GN=MSK-3 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 505 bits (1300), Expect = e-142, Method: Compositional matrix adjust.
Identities = 237/291 (81%), Positives = 265/291 (91%), Gaps = 3/291 (1%)
Query: 3 DDKEMSAA-VVDGSDHVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLE 61
DDKEM AA +VDG+ TGHII TTIGGKNG+PKQTISYMAERVVG GSFG+VFQAKCLE
Sbjct: 36 DDKEMEAATIVDGNGTETGHIIVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLE 95
Query: 62 TGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPES 121
TGETVAIKKVLQD+RYKNRELQ MR++DHPNV+SLKHCFFSTT K+EL+LNLV+EYVPE+
Sbjct: 96 TGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPET 155
Query: 122 MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVK 181
+ RV++HY+ NQRMP+IYVKLY+YQI R LAYIH VCHRD+KPQNLLV+P THQ+K
Sbjct: 156 VSRVIRHYNKMNQRMPMIYVKLYSYQICRALAYIHNSIGVCHRDIKPQNLLVNPHTHQLK 215
Query: 182 ICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLF 241
ICDFGSAK L+ GE NISYICSR+YRAPELIFGATEYTT+IDIWSAGCVL ELLLGQPLF
Sbjct: 216 ICDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVLGELLLGQPLF 275
Query: 242 PGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVCIFH 292
PGE+ VDQLVEIIKVLGTPTREEI+CMNPNYT+F+FPQIKAHPWHK IFH
Sbjct: 276 PGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHK--IFH 324
|
Medicago sativa (taxid: 3879) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q40518|MSK1_TOBAC Shaggy-related protein kinase NtK-1 OS=Nicotiana tabacum GN=NTK-1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 503 bits (1296), Expect = e-142, Method: Compositional matrix adjust.
Identities = 233/292 (79%), Positives = 266/292 (91%), Gaps = 2/292 (0%)
Query: 1 MADDKEMSAAVVDGSDHVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCL 60
+ DDKE+ AA+VDG+ TGHII TTIGG++G+PKQTISYMAER+VG GSFG+VFQAKCL
Sbjct: 34 IRDDKEIEAAIVDGNGTETGHIIVTTIGGRHGQPKQTISYMAERIVGQGSFGVVFQAKCL 93
Query: 61 ETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE 120
ETGETVAIKKVLQD+RYKNRELQ MR++DHPNV+ LKHCFFSTT K+E++LNLV+EYVPE
Sbjct: 94 ETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVCLKHCFFSTTEKDEVYLNLVLEYVPE 153
Query: 121 SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQV 180
+++RV+KHY+ NQRMPLI VKLYTYQIFR L+YIH VCHRD+KPQNLLV+P THQV
Sbjct: 154 TVHRVIKHYNKLNQRMPLILVKLYTYQIFRALSYIHHTIGVCHRDIKPQNLLVNPHTHQV 213
Query: 181 KICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL 240
K+CDFGSAK L+ GE NISYICSR+YRAPELIFGATEYTT+IDIWSAGCVLAELLLGQPL
Sbjct: 214 KLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVLAELLLGQPL 273
Query: 241 FPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVCIFH 292
FPGE+ VDQLVEIIKVLGTPTREEI+CMNPNY +F+FPQIKAHPWHK IFH
Sbjct: 274 FPGESGVDQLVEIIKVLGTPTREEIKCMNPNYNEFKFPQIKAHPWHK--IFH 323
|
May mediate extracellular signals to regulate transcription in differentiating cells. Nicotiana tabacum (taxid: 4097) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P51138|MSK2_MEDSA Glycogen synthase kinase-3 homolog MsK-2 OS=Medicago sativa GN=MSK-2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 498 bits (1282), Expect = e-140, Method: Compositional matrix adjust.
Identities = 227/288 (78%), Positives = 260/288 (90%)
Query: 1 MADDKEMSAAVVDGSDHVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCL 60
+ DDKEM A VVDG+ GH+I TTIGGKNG+PKQTISYMAER VG GSFG+VFQAKCL
Sbjct: 35 IKDDKEMEAHVVDGNSTEAGHVIVTTIGGKNGQPKQTISYMAERAVGQGSFGVVFQAKCL 94
Query: 61 ETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE 120
ETGETVAIKKVLQD+RYKNRELQ MR++DHPNV++LKHCFFSTT K+EL+LNLV+E+VPE
Sbjct: 95 ETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVTLKHCFFSTTEKDELYLNLVLEFVPE 154
Query: 121 SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQV 180
+++RV++HYS NQRMPLIYVKLY+YQI R LAYIH V HRD+KPQNLLV+P THQ+
Sbjct: 155 TVHRVIRHYSKMNQRMPLIYVKLYSYQICRSLAYIHNCVGVSHRDIKPQNLLVNPHTHQL 214
Query: 181 KICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL 240
K+CDFGSAK L+ GE NISYICSR+YRAPELIFGATEYT++IDIWSAGCVL ELLLGQPL
Sbjct: 215 KLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTSAIDIWSAGCVLGELLLGQPL 274
Query: 241 FPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKV 288
FPG + VDQLVEIIKVLGTPTREEI+CMNPNYT+F+FPQIKAHPWHK+
Sbjct: 275 FPGASGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKI 322
|
Medicago sativa (taxid: 3879) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 314 | ||||||
| 297804284 | 380 | hypothetical protein ARALYDRAFT_914806 [ | 0.923 | 0.763 | 0.941 | 1e-161 | |
| 312281491 | 380 | unnamed protein product [Thellungiella h | 0.923 | 0.763 | 0.941 | 1e-161 | |
| 15233984 | 380 | Shaggy-related protein kinase eta [Arabi | 0.923 | 0.763 | 0.941 | 1e-161 | |
| 18700188 | 380 | AT4g18710/F28A21_120 [Arabidopsis thalia | 0.923 | 0.763 | 0.941 | 1e-161 | |
| 1161512 | 380 | shaggy-like kinase etha [Arabidopsis tha | 0.923 | 0.763 | 0.931 | 1e-161 | |
| 224116828 | 380 | predicted protein [Populus trichocarpa] | 0.923 | 0.763 | 0.938 | 1e-160 | |
| 359483773 | 380 | PREDICTED: shaggy-related protein kinase | 0.923 | 0.763 | 0.931 | 1e-160 | |
| 255562450 | 380 | Glycogen synthase kinase-3 beta, putativ | 0.923 | 0.763 | 0.928 | 1e-159 | |
| 356507479 | 380 | PREDICTED: shaggy-related protein kinase | 0.923 | 0.763 | 0.910 | 1e-159 | |
| 224079065 | 380 | predicted protein [Populus trichocarpa] | 0.923 | 0.763 | 0.921 | 1e-158 |
| >gi|297804284|ref|XP_002870026.1| hypothetical protein ARALYDRAFT_914806 [Arabidopsis lyrata subsp. lyrata] gi|297315862|gb|EFH46285.1| hypothetical protein ARALYDRAFT_914806 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 573 bits (1478), Expect = e-161, Method: Compositional matrix adjust.
Identities = 275/292 (94%), Positives = 281/292 (96%), Gaps = 2/292 (0%)
Query: 1 MADDKEMSAAVVDGSDHVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCL 60
MADDKEM AAVVDG D VTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCL
Sbjct: 1 MADDKEMPAAVVDGHDQVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCL 60
Query: 61 ETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE 120
ETGETVAIKKVLQDRRYKNRELQLMRVMDHPNV+ LKHCFFSTTSK+ELFLNLVMEYVPE
Sbjct: 61 ETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVVCLKHCFFSTTSKDELFLNLVMEYVPE 120
Query: 121 SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQV 180
S+YRVLKHYSSANQRMPL+YVKLY YQIFRGLAYIH V VCHRDLKPQNLLVDPLTHQV
Sbjct: 121 SLYRVLKHYSSANQRMPLVYVKLYMYQIFRGLAYIHNVAGVCHRDLKPQNLLVDPLTHQV 180
Query: 181 KICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL 240
KICDFGSAKQL+ GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL
Sbjct: 181 KICDFGSAKQLVKGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL 240
Query: 241 FPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVCIFH 292
FPGENAVDQLVEIIKVLGTPTREEIRCMNP+YTDFRFPQIKAHPWHK IFH
Sbjct: 241 FPGENAVDQLVEIIKVLGTPTREEIRCMNPHYTDFRFPQIKAHPWHK--IFH 290
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|312281491|dbj|BAJ33611.1| unnamed protein product [Thellungiella halophila] | Back alignment and taxonomy information |
|---|
Score = 573 bits (1478), Expect = e-161, Method: Compositional matrix adjust.
Identities = 275/292 (94%), Positives = 281/292 (96%), Gaps = 2/292 (0%)
Query: 1 MADDKEMSAAVVDGSDHVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCL 60
MADDKEM AAVVDG D VTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCL
Sbjct: 1 MADDKEMPAAVVDGHDQVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCL 60
Query: 61 ETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE 120
ETGETVAIKKVLQDRRYKNRELQLMRVMDHPNV+ LKHCFFSTTSK+ELFLNLVMEYVPE
Sbjct: 61 ETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVVCLKHCFFSTTSKDELFLNLVMEYVPE 120
Query: 121 SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQV 180
S+YRVLKHYSSANQRMPL+YVKLY YQIFRGLAYIH V VCHRDLKPQNLLVDPLTHQV
Sbjct: 121 SLYRVLKHYSSANQRMPLVYVKLYMYQIFRGLAYIHNVAGVCHRDLKPQNLLVDPLTHQV 180
Query: 181 KICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL 240
KICDFGSAKQL+ GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL
Sbjct: 181 KICDFGSAKQLVRGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL 240
Query: 241 FPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVCIFH 292
FPGENAVDQLVEIIKVLGTPTREEIRCMNP+YTDFRFPQIKAHPWHK IFH
Sbjct: 241 FPGENAVDQLVEIIKVLGTPTREEIRCMNPHYTDFRFPQIKAHPWHK--IFH 290
|
Source: Thellungiella halophila Species: Eutrema halophilum Genus: Eutrema Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15233984|ref|NP_193606.1| Shaggy-related protein kinase eta [Arabidopsis thaliana] gi|47117893|sp|Q39011.2|KSG7_ARATH RecName: Full=Shaggy-related protein kinase eta; AltName: Full=ASK-eta; AltName: Full=Protein BRASSINOSTEROID INSENSITIVE 2; AltName: Full=Protein ULTRACURVATA 1 gi|4539390|emb|CAB37456.1| shaggy-like protein kinase etha (EC 2.7.1.-) [Arabidopsis thaliana] gi|7268665|emb|CAB78873.1| shaggy-like protein kinase etha (EC 2.7.1.-) [Arabidopsis thaliana] gi|21554512|gb|AAM63594.1| shaggy-like protein kinase etha (EC 2.7.1.-) [Arabidopsis thaliana] gi|25140476|gb|AAN71719.1| glycogen synthase kinase 3 beta protein kinase DWARF12 [Arabidopsis thaliana] gi|109946417|gb|ABG48387.1| At4g18710 [Arabidopsis thaliana] gi|332658679|gb|AEE84079.1| Shaggy-related protein kinase eta [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 573 bits (1478), Expect = e-161, Method: Compositional matrix adjust.
Identities = 275/292 (94%), Positives = 281/292 (96%), Gaps = 2/292 (0%)
Query: 1 MADDKEMSAAVVDGSDHVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCL 60
MADDKEM AAVVDG D VTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCL
Sbjct: 1 MADDKEMPAAVVDGHDQVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCL 60
Query: 61 ETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE 120
ETGETVAIKKVLQDRRYKNRELQLMRVMDHPNV+ LKHCFFSTTSK+ELFLNLVMEYVPE
Sbjct: 61 ETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVVCLKHCFFSTTSKDELFLNLVMEYVPE 120
Query: 121 SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQV 180
S+YRVLKHYSSANQRMPL+YVKLY YQIFRGLAYIH V VCHRDLKPQNLLVDPLTHQV
Sbjct: 121 SLYRVLKHYSSANQRMPLVYVKLYMYQIFRGLAYIHNVAGVCHRDLKPQNLLVDPLTHQV 180
Query: 181 KICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL 240
KICDFGSAKQL+ GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL
Sbjct: 181 KICDFGSAKQLVKGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL 240
Query: 241 FPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVCIFH 292
FPGENAVDQLVEIIKVLGTPTREEIRCMNP+YTDFRFPQIKAHPWHK IFH
Sbjct: 241 FPGENAVDQLVEIIKVLGTPTREEIRCMNPHYTDFRFPQIKAHPWHK--IFH 290
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|18700188|gb|AAL77705.1| AT4g18710/F28A21_120 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 573 bits (1476), Expect = e-161, Method: Compositional matrix adjust.
Identities = 275/292 (94%), Positives = 281/292 (96%), Gaps = 2/292 (0%)
Query: 1 MADDKEMSAAVVDGSDHVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCL 60
MADDKEM AAVVDG D VTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCL
Sbjct: 1 MADDKEMPAAVVDGHDQVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCL 60
Query: 61 ETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE 120
ETGETVAIKKVLQDRRYKNRELQLMRVMDHPNV+ LKHCFFSTTSK+ELFLNLVMEYVPE
Sbjct: 61 ETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVVCLKHCFFSTTSKDELFLNLVMEYVPE 120
Query: 121 SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQV 180
S+YRVLKHYSSANQRMPL+YVKLY YQIFRGLAYIH V VCHRDLKPQNLLVDPLTHQV
Sbjct: 121 SLYRVLKHYSSANQRMPLVYVKLYMYQIFRGLAYIHNVAGVCHRDLKPQNLLVDPLTHQV 180
Query: 181 KICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL 240
KICDFGSAKQL+ GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL
Sbjct: 181 KICDFGSAKQLVKGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL 240
Query: 241 FPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVCIFH 292
FPGENAVDQLVEIIKVLGTPTREEIRCMNP+YTDFRFPQIKAHPWHK IFH
Sbjct: 241 FPGENAVDQLVEIIKVLGTPTREEIRCMNPHYTDFRFPQIKAHPWHK--IFH 290
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|1161512|emb|CAA64409.1| shaggy-like kinase etha [Arabidopsis thaliana] gi|1627516|emb|CAA70144.1| shaggy-like kinase etha [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 572 bits (1474), Expect = e-161, Method: Compositional matrix adjust.
Identities = 272/292 (93%), Positives = 281/292 (96%), Gaps = 2/292 (0%)
Query: 1 MADDKEMSAAVVDGSDHVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCL 60
MADDKEM AAVVDG D VTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCL
Sbjct: 1 MADDKEMPAAVVDGHDQVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCL 60
Query: 61 ETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE 120
ETGETVAIKKVLQDRRYKNRELQLMRVMDHPNV+ LKHCFFSTT K+ELFLNLVMEYVPE
Sbjct: 61 ETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVVCLKHCFFSTTEKDELFLNLVMEYVPE 120
Query: 121 SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQV 180
++YRVLKHYSSANQRMPL+YVKLY+YQIFRGLAYIH+ P VCHRDLKPQNLLVDPLTHQV
Sbjct: 121 TLYRVLKHYSSANQRMPLVYVKLYSYQIFRGLAYIHSCPGVCHRDLKPQNLLVDPLTHQV 180
Query: 181 KICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL 240
KICDFGSAKQL+ GE NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL
Sbjct: 181 KICDFGSAKQLVKGEPNISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL 240
Query: 241 FPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVCIFH 292
FPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF+FPQIKAHPWHK IFH
Sbjct: 241 FPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFKFPQIKAHPWHK--IFH 290
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224116828|ref|XP_002317404.1| predicted protein [Populus trichocarpa] gi|222860469|gb|EEE98016.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 572 bits (1473), Expect = e-160, Method: Compositional matrix adjust.
Identities = 274/292 (93%), Positives = 280/292 (95%), Gaps = 2/292 (0%)
Query: 1 MADDKEMSAAVVDGSDHVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCL 60
MA+DKEM+A V DG+D VTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCL
Sbjct: 1 MAEDKEMNARVADGNDPVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCL 60
Query: 61 ETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE 120
ETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTT NELFLNLVMEYVPE
Sbjct: 61 ETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTDNNELFLNLVMEYVPE 120
Query: 121 SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQV 180
SMYRVLKHYS+A Q MPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQV
Sbjct: 121 SMYRVLKHYSNAKQAMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQV 180
Query: 181 KICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL 240
K+CDFGSAK L+ GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL
Sbjct: 181 KLCDFGSAKVLVKGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL 240
Query: 241 FPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVCIFH 292
F GENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKV FH
Sbjct: 241 FSGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKV--FH 290
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359483773|ref|XP_003633016.1| PREDICTED: shaggy-related protein kinase eta-like [Vitis vinifera] gi|297740523|emb|CBI30705.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 570 bits (1469), Expect = e-160, Method: Compositional matrix adjust.
Identities = 272/292 (93%), Positives = 283/292 (96%), Gaps = 2/292 (0%)
Query: 1 MADDKEMSAAVVDGSDHVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCL 60
M+DDKE+SA VVDG+D VTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCL
Sbjct: 1 MSDDKEISAPVVDGNDPVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCL 60
Query: 61 ETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE 120
ETGETVAIKKVLQDRRYKNRELQLMR MDHPNVISLKHCFFSTTS++ELFLNLVMEYVPE
Sbjct: 61 ETGETVAIKKVLQDRRYKNRELQLMRTMDHPNVISLKHCFFSTTSRDELFLNLVMEYVPE 120
Query: 121 SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQV 180
+MYRVLKHYS+A QRMPLIYVKLYTYQIFRGLAYIH+VP VCHRDLKPQNLLVDPLTHQV
Sbjct: 121 TMYRVLKHYSNAKQRMPLIYVKLYTYQIFRGLAYIHSVPGVCHRDLKPQNLLVDPLTHQV 180
Query: 181 KICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL 240
K+CDFGSAK L+ GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL
Sbjct: 181 KLCDFGSAKVLVKGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL 240
Query: 241 FPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVCIFH 292
FPGENAVDQLVEIIKVLGTPTREEIRCMNP+YTDFRFPQIKAHPWHKV FH
Sbjct: 241 FPGENAVDQLVEIIKVLGTPTREEIRCMNPSYTDFRFPQIKAHPWHKV--FH 290
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255562450|ref|XP_002522231.1| Glycogen synthase kinase-3 beta, putative [Ricinus communis] gi|223538484|gb|EEF40089.1| Glycogen synthase kinase-3 beta, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 568 bits (1463), Expect = e-159, Method: Compositional matrix adjust.
Identities = 271/292 (92%), Positives = 280/292 (95%), Gaps = 2/292 (0%)
Query: 1 MADDKEMSAAVVDGSDHVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCL 60
MADDKEM+A VVD +D VTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCL
Sbjct: 1 MADDKEMAARVVDSNDPVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCL 60
Query: 61 ETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE 120
ETGETVAIKKVLQD+RYKNRELQLMRVMDHPNVISLKHCFFSTT+ NELFLNLVMEYVPE
Sbjct: 61 ETGETVAIKKVLQDKRYKNRELQLMRVMDHPNVISLKHCFFSTTNNNELFLNLVMEYVPE 120
Query: 121 SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQV 180
SMYRVLKHYS+A Q MPL+YVKLY YQIFRGLAYIHTVP VCHRDLKPQN+LVDPLTHQV
Sbjct: 121 SMYRVLKHYSNAKQTMPLVYVKLYMYQIFRGLAYIHTVPGVCHRDLKPQNILVDPLTHQV 180
Query: 181 KICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL 240
K+CDFGSAK L+ GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL
Sbjct: 181 KLCDFGSAKVLVKGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL 240
Query: 241 FPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVCIFH 292
FPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKV FH
Sbjct: 241 FPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKV--FH 290
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356507479|ref|XP_003522493.1| PREDICTED: shaggy-related protein kinase eta-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 565 bits (1456), Expect = e-159, Method: Compositional matrix adjust.
Identities = 266/292 (91%), Positives = 281/292 (96%), Gaps = 2/292 (0%)
Query: 1 MADDKEMSAAVVDGSDHVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCL 60
MA+DKEMS +V++G+D +TGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCL
Sbjct: 1 MAEDKEMSTSVINGNDSLTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCL 60
Query: 61 ETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE 120
ETGE VAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTS +ELFLNLVMEYVPE
Sbjct: 61 ETGEAVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSTDELFLNLVMEYVPE 120
Query: 121 SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQV 180
SMYRVLKHYS+ANQRMP+IYVKLY YQIFRGLAYIHTVP+VCHRDLKPQN+LVDPLTHQV
Sbjct: 121 SMYRVLKHYSNANQRMPIIYVKLYMYQIFRGLAYIHTVPKVCHRDLKPQNILVDPLTHQV 180
Query: 181 KICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL 240
K+CDFGSAK L+ GEANISYICSRFYRAPELIFGATEYT+SIDIWSAGCVLAELLLGQPL
Sbjct: 181 KLCDFGSAKVLVKGEANISYICSRFYRAPELIFGATEYTSSIDIWSAGCVLAELLLGQPL 240
Query: 241 FPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVCIFH 292
FPGENAVDQLV IIKVLGTPTREE+RCMNPNY DFRFPQIKAHPWHK IFH
Sbjct: 241 FPGENAVDQLVHIIKVLGTPTREEVRCMNPNYNDFRFPQIKAHPWHK--IFH 290
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224079065|ref|XP_002305736.1| predicted protein [Populus trichocarpa] gi|222848700|gb|EEE86247.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 564 bits (1454), Expect = e-158, Method: Compositional matrix adjust.
Identities = 269/292 (92%), Positives = 278/292 (95%), Gaps = 2/292 (0%)
Query: 1 MADDKEMSAAVVDGSDHVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCL 60
MA+DKEM+ V DG+D VTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFG+VFQAKCL
Sbjct: 1 MAEDKEMTTRVADGNDPVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGVVFQAKCL 60
Query: 61 ETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE 120
ETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTT+ NELFLNLVMEYVPE
Sbjct: 61 ETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTNNNELFLNLVMEYVPE 120
Query: 121 SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQV 180
SMYRVLKHYS+A Q MPLIYVKLY YQIFRGLAYIH VP VCHRDLKPQNLLVDPLTHQV
Sbjct: 121 SMYRVLKHYSNAKQTMPLIYVKLYMYQIFRGLAYIHAVPGVCHRDLKPQNLLVDPLTHQV 180
Query: 181 KICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL 240
K+CDFGSAK L+ GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL
Sbjct: 181 KLCDFGSAKVLVKGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL 240
Query: 241 FPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVCIFH 292
FPGENAVDQLV+IIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKV FH
Sbjct: 241 FPGENAVDQLVDIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKV--FH 290
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 314 | ||||||
| TAIR|locus:2124082 | 380 | BIN2 "BRASSINOSTEROID-INSENSIT | 0.977 | 0.807 | 0.894 | 1.3e-148 | |
| TAIR|locus:2202255 | 407 | GSK1 "GSK3/SHAGGY-like protein | 0.914 | 0.705 | 0.906 | 1.2e-143 | |
| TAIR|locus:2052861 | 412 | SKdZeta "SHAGGY-related protei | 0.917 | 0.699 | 0.896 | 1.2e-143 | |
| TAIR|locus:2222642 | 410 | SK13 "shaggy-like kinase 13" [ | 0.917 | 0.702 | 0.841 | 1.4e-133 | |
| TAIR|locus:2832141 | 405 | SK 11 "AT5G26751" [Arabidopsis | 0.917 | 0.711 | 0.827 | 4.8e-133 | |
| TAIR|locus:2074464 | 409 | ATSK12 [Arabidopsis thaliana ( | 0.917 | 0.704 | 0.817 | 4.4e-132 | |
| TAIR|locus:2126993 | 472 | SK32 "shaggy-like protein kina | 0.917 | 0.610 | 0.755 | 3.4e-126 | |
| TAIR|locus:2024341 | 421 | SK41 "shaggy-like protein kina | 0.910 | 0.679 | 0.713 | 7.1e-116 | |
| TAIR|locus:2098896 | 438 | AT3G61160 [Arabidopsis thalian | 0.917 | 0.657 | 0.690 | 9.7e-112 | |
| ZFIN|ZDB-GENE-090312-2 | 419 | si:dkeyp-80c12.7 "si:dkeyp-80c | 0.863 | 0.646 | 0.667 | 1.7e-100 |
| TAIR|locus:2124082 BIN2 "BRASSINOSTEROID-INSENSITIVE 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1451 (515.8 bits), Expect = 1.3e-148, P = 1.3e-148
Identities = 279/312 (89%), Positives = 289/312 (92%)
Query: 1 MADDKEMSAAVVDGSDHVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCL 60
MADDKEM AAVVDG D VTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCL
Sbjct: 1 MADDKEMPAAVVDGHDQVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCL 60
Query: 61 ETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE 120
ETGETVAIKKVLQDRRYKNRELQLMRVMDHPNV+ LKHCFFSTTSK+ELFLNLVMEYVPE
Sbjct: 61 ETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVVCLKHCFFSTTSKDELFLNLVMEYVPE 120
Query: 121 SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQV 180
S+YRVLKHYSSANQRMPL+YVKLY YQIFRGLAYIH V VCHRDLKPQNLLVDPLTHQV
Sbjct: 121 SLYRVLKHYSSANQRMPLVYVKLYMYQIFRGLAYIHNVAGVCHRDLKPQNLLVDPLTHQV 180
Query: 181 KICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL 240
KICDFGSAKQL+ GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL
Sbjct: 181 KICDFGSAKQLVKGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL 240
Query: 241 FPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVCIFH--FPKHWL 298
FPGENAVDQLVEIIKVLGTPTREEIRCMNP+YTDFRFPQIKAHPWHK IFH P
Sbjct: 241 FPGENAVDQLVEIIKVLGTPTREEIRCMNPHYTDFRFPQIKAHPWHK--IFHKRMPPE-A 297
Query: 299 LEYGSHINAISP 310
+++ S + SP
Sbjct: 298 IDFASRLLQYSP 309
|
|
| TAIR|locus:2202255 GSK1 "GSK3/SHAGGY-like protein kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1404 (499.3 bits), Expect = 1.2e-143, P = 1.2e-143
Identities = 262/289 (90%), Positives = 279/289 (96%)
Query: 4 DKEMSAAVVDGSDHVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETG 63
DKEMSAAV++G+D VTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETG
Sbjct: 34 DKEMSAAVIEGNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETG 93
Query: 64 ETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMY 123
E+VAIKKVLQDRRYKNRELQLMR MDHPNVISLKHCFFSTTS++ELFLNLVMEYVPE++Y
Sbjct: 94 ESVAIKKVLQDRRYKNRELQLMRPMDHPNVISLKHCFFSTTSRDELFLNLVMEYVPETLY 153
Query: 124 RVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKIC 183
RVL+HY+S+NQRMP+ YVKLYTYQIFRGLAYIHTVP VCHRD+KPQNLLVDPLTHQVK+C
Sbjct: 154 RVLRHYTSSNQRMPIFYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLC 213
Query: 184 DFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 243
DFGSAK L+ GE NISYICSR+YRAPELIFGATEYT SIDIWSAGCVLAELLLGQPLFPG
Sbjct: 214 DFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTASIDIWSAGCVLAELLLGQPLFPG 273
Query: 244 ENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVCIFH 292
EN+VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKV FH
Sbjct: 274 ENSVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKV--FH 320
|
|
| TAIR|locus:2052861 SKdZeta "SHAGGY-related protein kinase dZeta" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1404 (499.3 bits), Expect = 1.2e-143, P = 1.2e-143
Identities = 260/290 (89%), Positives = 281/290 (96%)
Query: 3 DDKEMSAAVVDGSDHVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLET 62
+DKEMSAAV++G+D VTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLET
Sbjct: 35 NDKEMSAAVIEGNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLET 94
Query: 63 GETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESM 122
GE+VAIKKVLQDRRYKNRELQLMR+MDHPNV+SLKHCFFSTT+++ELFLNLVMEYVPE++
Sbjct: 95 GESVAIKKVLQDRRYKNRELQLMRLMDHPNVVSLKHCFFSTTTRDELFLNLVMEYVPETL 154
Query: 123 YRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKI 182
YRVLKHY+S+NQRMP+ YVKLYTYQIFRGLAYIHT P VCHRD+KPQNLLVDPLTHQ K+
Sbjct: 155 YRVLKHYTSSNQRMPIFYVKLYTYQIFRGLAYIHTAPGVCHRDVKPQNLLVDPLTHQCKL 214
Query: 183 CDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFP 242
CDFGSAK L+ GEANISYICSR+YRAPELIFGATEYT+SIDIWSAGCVLAELLLGQPLFP
Sbjct: 215 CDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTSSIDIWSAGCVLAELLLGQPLFP 274
Query: 243 GENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVCIFH 292
GEN+VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKV FH
Sbjct: 275 GENSVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKV--FH 322
|
|
| TAIR|locus:2222642 SK13 "shaggy-like kinase 13" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1309 (465.8 bits), Expect = 1.4e-133, P = 1.4e-133
Identities = 244/290 (84%), Positives = 267/290 (92%)
Query: 3 DDKEMSAAVVDGSDHVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLET 62
DDKEM AAVVDG+ TGHII TTIGGKNG+PKQTISYMAER+VG GSFGIVFQAKCLET
Sbjct: 37 DDKEMEAAVVDGNGTETGHIIVTTIGGKNGQPKQTISYMAERIVGQGSFGIVFQAKCLET 96
Query: 63 GETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESM 122
GETVAIKKVLQD+RYKNRELQ MR++DHPNV+SLKHCFFSTT K+EL+LNLV+EYVPE++
Sbjct: 97 GETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETV 156
Query: 123 YRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKI 182
YRV KHYS ANQRMP+IYVKLYTYQI R LAYIH VCHRD+KPQNLLV+P THQVK+
Sbjct: 157 YRVSKHYSRANQRMPIIYVKLYTYQICRALAYIHGGVGVCHRDIKPQNLLVNPHTHQVKL 216
Query: 183 CDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFP 242
CDFGSAK L+ GE NISYICSR+YRAPELIFGATEYTT+IDIWSAGCVLAELLLGQPLFP
Sbjct: 217 CDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTTIDIWSAGCVLAELLLGQPLFP 276
Query: 243 GENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVCIFH 292
GE+ VDQLVEIIKVLGTPTREEI+CMNPNYT+F+FPQIKAHPWHK IFH
Sbjct: 277 GESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHK--IFH 324
|
|
| TAIR|locus:2832141 SK 11 "AT5G26751" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1304 (464.1 bits), Expect = 4.8e-133, P = 4.8e-133
Identities = 240/290 (82%), Positives = 267/290 (92%)
Query: 3 DDKEMSAAVVDGSDHVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLET 62
DDKEM A VVDG+ TGHII TTIGG+NG+PKQTISYMAERVVG GSFG+VFQAKCLET
Sbjct: 32 DDKEMEATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAERVVGHGSFGVVFQAKCLET 91
Query: 63 GETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESM 122
GETVAIKKVLQDRRYKNRELQ MR++DHPNV+SLKHCFFSTT K+EL+LNLV+EYVPE++
Sbjct: 92 GETVAIKKVLQDRRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETV 151
Query: 123 YRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKI 182
+RV+KHY+ NQRMPLIYVKLYTYQIFR L+YIH VCHRD+KPQNLLV+P THQVK+
Sbjct: 152 HRVIKHYNKLNQRMPLIYVKLYTYQIFRALSYIHRCIGVCHRDIKPQNLLVNPHTHQVKL 211
Query: 183 CDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFP 242
CDFGSAK L+ GE NISYICSR+YRAPELIFGATEYTT+ID+WSAGCVLAELLLGQPLFP
Sbjct: 212 CDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDVWSAGCVLAELLLGQPLFP 271
Query: 243 GENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVCIFH 292
GE+ VDQLVEIIKVLGTPTREEI+CMNPNYT+F+FPQIKAHPWHK IFH
Sbjct: 272 GESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHK--IFH 319
|
|
| TAIR|locus:2074464 ATSK12 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1295 (460.9 bits), Expect = 4.4e-132, P = 4.4e-132
Identities = 237/290 (81%), Positives = 267/290 (92%)
Query: 3 DDKEMSAAVVDGSDHVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLET 62
DDKEM A +V+G+ TGHII TTIGG+NG+PKQTISYMAERVVG GSFG+VFQAKCLET
Sbjct: 36 DDKEMEATIVNGNVTETGHIIVTTIGGRNGQPKQTISYMAERVVGHGSFGVVFQAKCLET 95
Query: 63 GETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESM 122
GETVAIKKVLQDRRYKNRELQ MR++DHPNV+SLKHCFFSTT K+EL+LNLV+EYVPE++
Sbjct: 96 GETVAIKKVLQDRRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETV 155
Query: 123 YRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKI 182
+RV+KHY+ NQRMPL+YVKLYTYQIFR L+YIH VCHRD+KPQNLLV+P THQVK+
Sbjct: 156 HRVIKHYNKLNQRMPLVYVKLYTYQIFRSLSYIHRCIGVCHRDIKPQNLLVNPHTHQVKL 215
Query: 183 CDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFP 242
CDFGSAK L+ GE NISYICSR+YRAPELIFGATEYTT+ID+WSAGCVLAELLLGQPLFP
Sbjct: 216 CDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDVWSAGCVLAELLLGQPLFP 275
Query: 243 GENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVCIFH 292
GE+ VDQLVEIIKVLGTPTREEI+CMNPNYT+F+FPQIKAHPWHK IFH
Sbjct: 276 GESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHK--IFH 323
|
|
| TAIR|locus:2126993 SK32 "shaggy-like protein kinase 32" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1221 (434.9 bits), Expect = 3.4e-126, Sum P(2) = 3.4e-126
Identities = 219/290 (75%), Positives = 258/290 (88%)
Query: 3 DDKEMSAAVVDGSDHVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLET 62
+DK+M VV+GS TG +I+TT+GG++G+PKQTISYMA+RVVGTGSFG+VFQAKCLET
Sbjct: 101 EDKDMETTVVNGSGTETGQVITTTVGGRDGKPKQTISYMAQRVVGTGSFGVVFQAKCLET 160
Query: 63 GETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESM 122
GE VAIKKVLQD+RYKNRELQ+MR+ DHPNV+ L+H FFSTT K+EL+LNLV+EYVPE++
Sbjct: 161 GEQVAIKKVLQDKRYKNRELQIMRLQDHPNVVRLRHSFFSTTDKDELYLNLVLEYVPETV 220
Query: 123 YRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKI 182
YR KHY+ NQ MP+I+V+LYTYQI R L Y+H V VCHRD+KPQNLLV+P THQ+KI
Sbjct: 221 YRASKHYTKMNQHMPIIFVQLYTYQICRALNYLHRVVGVCHRDIKPQNLLVNPQTHQLKI 280
Query: 183 CDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFP 242
CDFGSAK L+ GE NISYICSR+YRAPELIFGATEYT +ID+WS GCV+AELLLGQPLFP
Sbjct: 281 CDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTNAIDMWSGGCVMAELLLGQPLFP 340
Query: 243 GENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVCIFH 292
GE+ +DQLVEIIK+LGTPTREEIRCMNPNYT+F+FPQIKAHPWHK IFH
Sbjct: 341 GESGIDQLVEIIKILGTPTREEIRCMNPNYTEFKFPQIKAHPWHK--IFH 388
|
|
| TAIR|locus:2024341 SK41 "shaggy-like protein kinase 41" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1142 (407.1 bits), Expect = 7.1e-116, P = 7.1e-116
Identities = 204/286 (71%), Positives = 247/286 (86%)
Query: 3 DDKEMSAAVVDGSDHVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLET 62
D+++ ++DG+ GH+I TT+ G+NG+ +QT+SY++E VVGTGSFG+VFQAKC ET
Sbjct: 46 DERDSEPDIIDGAGAEPGHVIRTTLRGRNGQSRQTVSYISEHVVGTGSFGMVFQAKCRET 105
Query: 63 GETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESM 122
GE VAIKKVLQD+RYKNRELQ+M+++DHPN ++LKH FFS T E++LNLV+E+VPE++
Sbjct: 106 GEVVAIKKVLQDKRYKNRELQIMQMLDHPNAVALKHSFFSRTDNEEVYLNLVLEFVPETV 165
Query: 123 YRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKI 182
RV + YS NQ MPLIYVKLYTYQI R LAYIH +CHRD+KPQNLLV+P THQ+KI
Sbjct: 166 NRVARSYSRTNQLMPLIYVKLYTYQICRALAYIHNSFGLCHRDIKPQNLLVNPHTHQLKI 225
Query: 183 CDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFP 242
CDFGSAK L+ GE N+SYICSR+YRAPELIFGA+EYTT+IDIWS GCV+AELLLGQPLFP
Sbjct: 226 CDFGSAKVLVKGEPNVSYICSRYYRAPELIFGASEYTTAIDIWSTGCVMAELLLGQPLFP 285
Query: 243 GENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKV 288
GE+ VDQLVEIIKVLGTPTREEI+CMNPNYT+F+FPQIK HPWHKV
Sbjct: 286 GESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKV 331
|
|
| TAIR|locus:2098896 AT3G61160 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1103 (393.3 bits), Expect = 9.7e-112, P = 9.7e-112
Identities = 199/288 (69%), Positives = 240/288 (83%)
Query: 1 MADDKEMSAAVVDGSDHVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCL 60
+ DDK+M ++ G+ +G II+T G N + +TISY AE V+GTGSFG+VFQAKCL
Sbjct: 70 LGDDKDMDCGIIKGNGTESGRIITTKKKGLNDQKDKTISYRAEHVIGTGSFGVVFQAKCL 129
Query: 61 ETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE 120
ET E VAIKKVLQD+RYKNRELQ+MR++DHPNV+ LKH FFSTT K+EL+LNLV+EYVPE
Sbjct: 130 ETEEKVAIKKVLQDKRYKNRELQIMRMLDHPNVVELKHSFFSTTEKDELYLNLVLEYVPE 189
Query: 121 SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQV 180
++YR + Y+ NQ MPLIY++LYTYQI R + Y+H V VCHRD+KPQNLLV+ +TH+V
Sbjct: 190 TIYRASRSYTKMNQHMPLIYIQLYTYQICRAMNYLHQVVGVCHRDIKPQNLLVNNVTHEV 249
Query: 181 KICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL 240
KICDFGSAK LI GE NISYICSR+YRAPELIFGATEYT++ID+WS GCV+AEL LG PL
Sbjct: 250 KICDFGSAKMLIPGEPNISYICSRYYRAPELIFGATEYTSAIDMWSVGCVMAELFLGHPL 309
Query: 241 FPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKV 288
FPGE +VDQLVEIIK+LGTP REEI+ MNP Y DF+FPQIKA PWHK+
Sbjct: 310 FPGETSVDQLVEIIKILGTPAREEIKNMNPRYNDFKFPQIKAQPWHKI 357
|
|
| ZFIN|ZDB-GENE-090312-2 si:dkeyp-80c12.7 "si:dkeyp-80c12.7" [Danio rerio (taxid:7955)] | Back alignment and assigned GO terms |
|---|
Score = 997 (356.0 bits), Expect = 1.7e-100, P = 1.7e-100
Identities = 185/277 (66%), Positives = 231/277 (83%)
Query: 13 DGSDHVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVL 72
DGS T ++ T G P Q +SY +V+G GSFG+V+QAK +TGE VAIKKVL
Sbjct: 33 DGSKVTT---VAATPGQGPDRP-QEVSYTDTKVIGNGSFGVVYQAKLCDTGELVAIKKVL 88
Query: 73 QDRRYKNRELQLMRVMDHPNVISLKHCFFST-TSKNELFLNLVMEYVPESMYRVLKHYSS 131
QD+R+KNRELQ+MR +DH N++ L++ F+S+ K+E++LNLVM+YVPE++YRV +HYS
Sbjct: 89 QDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGDKKDEVYLNLVMDYVPENVYRVARHYSK 148
Query: 132 ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 191
A Q +P++YVKLY YQ+FR LAYIH+ +CHRD+KPQNLL+DP T +K+CDFGSAKQL
Sbjct: 149 AKQNLPMVYVKLYMYQLFRSLAYIHSYG-ICHRDIKPQNLLLDPETAVLKLCDFGSAKQL 207
Query: 192 IAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLV 251
+ GE N+SYICSR+YRAPELIFGAT+YT+SIDIWSAGCVLAELLLGQP+FPG++ VDQLV
Sbjct: 208 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDIWSAGCVLAELLLGQPIFPGDSGVDQLV 267
Query: 252 EIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKV 288
EIIKVLGTPTRE+IR MNPNYT+F+FPQIKAHPW KV
Sbjct: 268 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKV 304
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q10452 | GSK3_SCHPO | 2, ., 7, ., 1, 1, ., 1 | 0.5820 | 0.8439 | 0.6847 | yes | no |
| A8X5H5 | GSK3_CAEBR | 2, ., 7, ., 1, 1, ., 2, 6 | 0.6061 | 0.9171 | 0.8022 | N/A | no |
| Q39011 | KSG7_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.9417 | 0.9235 | 0.7631 | yes | no |
| P38615 | RIM11_YEAST | 2, ., 7, ., 1, 1, ., 1 | 0.5896 | 0.7993 | 0.6783 | yes | no |
| Q9U2Q9 | GSK3_CAEEL | 2, ., 7, ., 1, 1, ., 2, 6 | 0.6027 | 0.9171 | 0.7955 | yes | no |
| Q40518 | MSK1_TOBAC | 2, ., 7, ., 1, 1, ., 1 | 0.7979 | 0.9235 | 0.7090 | N/A | no |
| Q9WV60 | GSK3B_MOUSE | 2, ., 7, ., 1, 1, ., 1 | 0.6580 | 0.8535 | 0.6380 | yes | no |
| P51137 | MSK1_MEDSA | 2, ., 7, ., 1, 1, ., 1 | 0.8116 | 0.9235 | 0.7055 | N/A | no |
| P51138 | MSK2_MEDSA | 2, ., 7, ., 1, 1, ., 1 | 0.7881 | 0.9171 | 0.7007 | N/A | no |
| P51139 | MSK3_MEDSA | 2, ., 7, ., 1, 1, ., 1 | 0.8144 | 0.9171 | 0.7007 | N/A | no |
| O04160 | KSGT_BRANA | 2, ., 7, ., 1, 1, ., 1 | 0.7448 | 0.9171 | 0.6153 | N/A | no |
| P18266 | GSK3B_RAT | 2, ., 7, ., 1, 1, ., 1 | 0.6580 | 0.8535 | 0.6380 | yes | no |
| P49841 | GSK3B_HUMAN | 2, ., 7, ., 1, 1, ., 1 | 0.6580 | 0.8535 | 0.6380 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.979 |
| 3rd Layer | 2.7.11 | 0.983 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 314 | |||
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-115 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-74 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 8e-74 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 4e-73 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 4e-72 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 6e-72 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 3e-69 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 4e-68 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 4e-65 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-62 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-61 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 3e-61 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-59 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 4e-57 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 4e-56 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-55 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-55 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 6e-55 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 3e-52 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 3e-52 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-51 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 3e-51 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 4e-51 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 5e-51 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 7e-51 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-50 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-50 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-50 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 4e-50 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-49 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-49 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-49 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 7e-49 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-48 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 3e-48 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 6e-48 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 9e-48 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-47 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 3e-47 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 5e-46 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 3e-45 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-43 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 4e-43 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 4e-43 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 5e-43 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 6e-42 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-41 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 4e-41 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 6e-41 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-40 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 5e-40 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 7e-40 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 4e-39 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 3e-38 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 3e-37 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 7e-37 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 9e-35 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-34 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-34 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-34 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 4e-34 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 3e-33 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 5e-33 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 6e-33 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 1e-32 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 3e-32 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-31 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-31 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 3e-31 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 5e-31 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-30 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-30 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 6e-30 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-29 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-29 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-28 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-28 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-28 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 6e-28 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 3e-27 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 3e-27 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 3e-27 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 4e-27 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 5e-27 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-26 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 9e-26 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-25 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 3e-25 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-24 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-24 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 4e-24 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 4e-24 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 6e-24 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-23 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-23 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-23 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 3e-23 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 4e-23 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 6e-23 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 8e-23 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-22 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 3e-22 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 5e-22 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 5e-22 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 8e-22 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-21 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-21 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-21 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-21 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-21 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-21 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 3e-21 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 4e-21 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 5e-21 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-20 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-20 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-20 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-20 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-20 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-20 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-20 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 5e-20 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 7e-20 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 9e-20 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-19 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-19 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 4e-19 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 4e-19 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-18 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-18 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 3e-18 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 4e-18 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 5e-18 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 9e-18 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 9e-18 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 9e-18 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 1e-17 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-17 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-17 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 3e-17 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 5e-17 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 9e-17 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-16 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-16 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-16 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-16 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-16 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-16 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-16 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 3e-16 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 4e-16 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 4e-16 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 5e-16 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 5e-16 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 5e-16 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 7e-16 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-15 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-15 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-15 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-15 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-15 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-15 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 4e-15 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 4e-15 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 5e-15 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 6e-15 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 7e-15 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 7e-15 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 8e-15 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 8e-15 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 1e-14 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-14 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-14 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 1e-14 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 1e-14 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-14 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-14 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-14 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 3e-14 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 3e-14 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 3e-14 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 3e-14 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 4e-14 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 5e-14 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 8e-14 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 9e-14 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 9e-14 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-13 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-13 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-13 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-13 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 3e-13 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 3e-13 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 3e-13 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 4e-13 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 6e-13 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 6e-13 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 6e-13 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 8e-13 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 9e-13 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-12 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-12 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-12 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 3e-12 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 5e-12 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 5e-12 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 6e-12 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 9e-12 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-11 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 1e-11 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-11 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-11 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-11 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-11 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 3e-11 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 3e-11 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 3e-11 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 4e-11 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 6e-11 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 7e-11 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 7e-11 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 9e-11 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-10 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-10 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-10 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-10 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-10 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 3e-10 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 3e-10 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 3e-10 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 4e-10 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 4e-10 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 7e-10 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 1e-09 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-09 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-09 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-09 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 3e-09 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 4e-09 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 5e-09 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 5e-09 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 5e-09 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 6e-09 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 7e-09 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 7e-09 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 9e-09 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-08 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-08 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-08 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-08 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 2e-08 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 3e-08 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 3e-08 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 4e-08 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 5e-08 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 6e-08 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-07 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 1e-07 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-07 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-07 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 2e-07 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 2e-07 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 3e-07 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 3e-07 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 4e-07 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 4e-07 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 5e-07 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 5e-07 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 5e-07 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 6e-07 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 6e-07 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 8e-07 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 9e-07 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-06 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 1e-06 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-06 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-06 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 3e-06 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 5e-06 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 5e-06 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 7e-06 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 8e-06 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 8e-06 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 9e-06 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 9e-06 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 1e-05 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 1e-05 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-05 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 3e-05 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 5e-05 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 5e-05 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 7e-05 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 8e-05 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-04 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 4e-04 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 4e-04 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 8e-04 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 0.001 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 0.002 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 340 bits (872), Expect = e-115
Identities = 146/260 (56%), Positives = 202/260 (77%), Gaps = 8/260 (3%)
Query: 39 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKH 98
SY ++G GSFG+V++A C++T E VAIKKVLQD +YKNREL +M+ ++H N+I LK
Sbjct: 67 SYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKNLNHINIIFLKD 126
Query: 99 CFFSTT-SKNE--LFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 155
+++ KNE +FLN+VME++P+++++ +KHY+ N +PL VKLY+YQ+ R LAYI
Sbjct: 127 YYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYI 186
Query: 156 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGA 215
H+ +CHRDLKPQNLL+DP TH +K+CDFGSAK L+AG+ ++SYICSRFYRAPEL+ GA
Sbjct: 187 HS-KFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLGA 245
Query: 216 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 275
T YTT ID+WS GC++AE++LG P+F G+++VDQLV II+VLGTPT ++++ MNPNY D
Sbjct: 246 TNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADI 305
Query: 276 RFPQIKAHPWHKVCIFHFPK 295
+FP +K KV FPK
Sbjct: 306 KFPDVKPKDLKKV----FPK 321
|
Length = 440 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 229 bits (587), Expect = 2e-74
Identities = 101/264 (38%), Positives = 144/264 (54%), Gaps = 28/264 (10%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISLK 97
+G G+ GIVF+AK ETGETVA+KKV R RE++ ++ HP V+ L
Sbjct: 6 GRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLL 65
Query: 98 HCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT 157
F + LVMEY+P + VL+ + +P VK Y + +G+AY+H
Sbjct: 66 DVFPHGSG-----FVLVMEYMPSDLSEVLRDEE---RPLPEAQVKSYMRMLLKGVAYMHA 117
Query: 158 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISY---ICSRFYRAPELIFG 214
+ HRDLKP NLL+ +KI DFG A+ L + E Y + +R+YRAPEL++G
Sbjct: 118 N-GIMHRDLKPANLLISA-DGVLKIADFGLAR-LFSEEEPRLYSHQVATRWYRAPELLYG 174
Query: 215 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE---EIRCMNPN 271
A +Y +D+W+ GC+ AELL G PLFPGEN ++QL + + LGTP E + + P+
Sbjct: 175 ARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSL-PD 233
Query: 272 YTDFRFPQIKAHPWHKVCIFHFPK 295
Y FP+ K P + FP
Sbjct: 234 YNKITFPESKPIPLEE----IFPD 253
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 228 bits (583), Expect = 8e-74
Identities = 92/258 (35%), Positives = 142/258 (55%), Gaps = 19/258 (7%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR---YKN---RELQLMRVMDHPNV 93
Y +G G++G+V++A+ TGE VAIKK+ RE++L++ ++HPN+
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNI 60
Query: 94 ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 153
I L F L LV E++ +Y+++K + +P +K Y YQ+ +GLA
Sbjct: 61 IKLLDVFRHKGD-----LYLVFEFMDTDLYKLIKDR---QRGLPESLIKSYLYQLLQGLA 112
Query: 154 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL-IAGEANISYICSRFYRAPELI 212
+ H+ + HRDLKP+NLL++ +K+ DFG A+ Y+ +R+YRAPEL+
Sbjct: 113 FCHS-HGILHRDLKPENLLINT-EGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELL 170
Query: 213 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN- 271
G Y+T +DIWS GC+ AELL +PLFPG++ +DQL +I + LGTP E
Sbjct: 171 LGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLA 230
Query: 272 -YTDFRFPQIKAHPWHKV 288
F FP+ P K+
Sbjct: 231 RNYKFSFPKKAGMPLPKL 248
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 226 bits (578), Expect = 4e-73
Identities = 90/257 (35%), Positives = 146/257 (56%), Gaps = 28/257 (10%)
Query: 46 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--------RELQLMRVMDHPNVISLK 97
+G G++G+V++A+ +TGE VA+KK+ D + RE+ L++ + HPN++ L
Sbjct: 7 LGEGTYGVVYKARDKKTGEIVALKKIRLD--NEEEGIPSTALREISLLKELKHPNIVKLL 64
Query: 98 HCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT 157
++ +L+L V EY + + L + +K YQ+ RGLAY H+
Sbjct: 65 DVI---HTERKLYL--VFEYCDMDLKKYLDKRPGP---LSPNLIKSIMYQLLRGLAYCHS 116
Query: 158 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISY---ICSRFYRAPELIFG 214
R+ HRDLKPQN+L++ +K+ DFG A+ G +Y + + +YRAPE++ G
Sbjct: 117 H-RILHRDLKPQNILINR-DGVLKLADFGLARAF--GIPLRTYTHEVVTLWYRAPEILLG 172
Query: 215 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR--CMNPNY 272
+ Y+T++DIWS GC+ AE++ G+PLFPG++ +DQL +I ++LGTPT E P+Y
Sbjct: 173 SKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDY 232
Query: 273 TDFRFPQIKAHPWHKVC 289
FP+ KV
Sbjct: 233 KP-TFPKFPPKDLEKVL 248
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 225 bits (576), Expect = 4e-72
Identities = 95/265 (35%), Positives = 152/265 (57%), Gaps = 23/265 (8%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV------LQDRRYKNRELQLMRVMDHPNV 93
Y + +G+G++G+V A TG VAIKK+ L D + RE++L+R + H N+
Sbjct: 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENI 61
Query: 94 ISLKHCF--FSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 151
I L S N++++ V E + +++V+K Q + +++ + YQI RG
Sbjct: 62 IGLLDILRPPSPEDFNDVYI--VTELMETDLHKVIKS----PQPLTDDHIQYFLYQILRG 115
Query: 152 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS----YICSRFYR 207
L Y+H+ V HRDLKP N+LV+ +KICDFG A+ + E Y+ +R+YR
Sbjct: 116 LKYLHSA-NVIHRDLKPSNILVN-SNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYR 173
Query: 208 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 267
APEL+ ++ YT +IDIWS GC+ AELL +PLFPG + +DQL I++VLGTP+ E+++
Sbjct: 174 APELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKF 233
Query: 268 M-NPNYTDF--RFPQIKAHPWHKVC 289
+ + ++ P+ P K+
Sbjct: 234 ITSEKARNYLKSLPKKPKKPLSKLF 258
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 222 bits (568), Expect = 6e-72
Identities = 85/268 (31%), Positives = 133/268 (49%), Gaps = 37/268 (13%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV-----LQDRRYKNRELQLMRVMDHPNVI 94
Y +G GSFG V+ A+ +TG+ VAIK + +DR RE+++++ + HPN++
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 95 SLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 153
L F L LVMEY ++ +LK R+ + Y QI L
Sbjct: 61 RLYDVFEDED-----KLYLVMEYCEGGDLFDLLKK----RGRLSEDEARFYLRQILSALE 111
Query: 154 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIF 213
Y+H+ + HRDLKP+N+L+D VK+ DFG A+QL GE +++ + Y APE++
Sbjct: 112 YLHSK-GIVHRDLKPENILLDE-DGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLL 169
Query: 214 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI-------- 265
G Y ++DIWS G +L ELL G+P FPG++ QL+E+ K +G P
Sbjct: 170 G-KGYGKAVDIWSLGVILYELLTGKPPFPGDD---QLLELFKKIGKPKPPFPPPEWDISP 225
Query: 266 -------RCMNPNYTD-FRFPQIKAHPW 285
+ + + + HP+
Sbjct: 226 EAKDLIRKLLVKDPEKRLTAEEALQHPF 253
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 215 bits (550), Expect = 3e-69
Identities = 88/266 (33%), Positives = 133/266 (50%), Gaps = 33/266 (12%)
Query: 43 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISL 96
R +G+GSFG V++AK TG+ VA+K + + RE++++R + HPN++ L
Sbjct: 4 LRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRL 63
Query: 97 KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 156
F + L LVMEY L Y S + K QI RGL Y+H
Sbjct: 64 IDAF--EDKDH---LYLVMEYCEGG---DLFDYLSRGGPLSEDEAKKIALQILRGLEYLH 115
Query: 157 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA-GEANISYICSRFYRAPELIFGA 215
+ + HRDLKP+N+L+D VKI DFG AK+L+ + +++ + +Y APE++ G
Sbjct: 116 SN-GIIHRDLKPENILLDE-NGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGG 173
Query: 216 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 275
Y +D+WS G +L ELL G+P F GEN +DQL I ++LG P + + +
Sbjct: 174 NGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEA 233
Query: 276 R----------------FPQIKAHPW 285
+ +I HPW
Sbjct: 234 KDLIKKCLNKDPSKRPTAEEILQHPW 259
|
Length = 260 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 214 bits (546), Expect = 4e-68
Identities = 92/247 (37%), Positives = 147/247 (59%), Gaps = 20/247 (8%)
Query: 45 VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISLKH 98
VVG G++G+V + + TGE VAIKK + ++ RE++++R + H N+++LK
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKE 67
Query: 99 CFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV 158
F K L+L V EYV ++ +L+ +P V+ Y +Q+ + +AY H+
Sbjct: 68 AF---RRKGRLYL--VFEYVERTLLELLEASPGG---LPPDAVRSYIWQLLQAIAYCHSH 119
Query: 159 PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN--ISYICSRFYRAPELIFGAT 216
+ HRD+KP+N+LV + +K+CDFG A+ L A A+ Y+ +R+YRAPEL+ G T
Sbjct: 120 -NIIHRDIKPENILVSE-SGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDT 177
Query: 217 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLG--TPTREEIRCMNPNYTD 274
Y +D+W+ GC++AELL G+PLFPG++ +DQL I K LG P+ +E+ NP +
Sbjct: 178 NYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAG 237
Query: 275 FRFPQIK 281
FP+
Sbjct: 238 VAFPEPS 244
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 206 bits (526), Expect = 4e-65
Identities = 90/252 (35%), Positives = 137/252 (54%), Gaps = 26/252 (10%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---------RELQLMRVMDH 90
Y + +G G++ +V++A+ ETG VAIKK+ R + RE++L++ + H
Sbjct: 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKH 61
Query: 91 PNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 150
PN+I L F K+ +NLV E++ + +V+K + + +K Y R
Sbjct: 62 PNIIGLLDVF---GHKS--NINLVFEFMETDLEKVIK---DKSIVLTPADIKSYMLMTLR 113
Query: 151 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC---SRFYR 207
GL Y+H + HRDLKP NLL+ +K+ DFG A+ G N +R+YR
Sbjct: 114 GLEYLH-SNWILHRDLKPNNLLIAS-DGVLKLADFGLARSF--GSPNRKMTHQVVTRWYR 169
Query: 208 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 267
APEL+FGA Y +D+WS GC+ AELLL P PG++ +DQL +I + LGTPT E
Sbjct: 170 APELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPG 229
Query: 268 MN--PNYTDFRF 277
+ P+Y +F+
Sbjct: 230 VTSLPDYVEFKP 241
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 199 bits (508), Expect = 2e-62
Identities = 94/260 (36%), Positives = 151/260 (58%), Gaps = 31/260 (11%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-------RELQ-LMRVMDHPNVIS 95
+ +G G+FG V+ A+ ETGE VAIKK+ + ++ + RE++ L ++ +HPN++
Sbjct: 5 KQLGDGTFGSVYLARNKETGELVAIKKMKK--KFYSWEECMNLREVKSLRKLNEHPNIVK 62
Query: 96 LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 155
LK F +EL+ V EY+ ++Y+++K + ++ YQI +GLA+I
Sbjct: 63 LKEVF---RENDELYF--VFEYMEGNLYQLMKDR--KGKPFSESVIRSIIYQILQGLAHI 115
Query: 156 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGA 215
H HRDLKP+NLLV VKI DFG A+++ + Y+ +R+YRAPE++ +
Sbjct: 116 HKHGFF-HRDLKPENLLVSGPE-VVKIADFGLAREIRSRPPYTDYVSTRWYRAPEILLRS 173
Query: 216 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE-------IRCM 268
T Y++ +DIW+ GC++AEL +PLFPG + +DQL +I VLGTPT+++ +
Sbjct: 174 TSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKL 233
Query: 269 NPNYTDFRFPQIKAHPWHKV 288
FRFPQ H++
Sbjct: 234 G-----FRFPQFAPTSLHQL 248
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 198 bits (506), Expect = 2e-61
Identities = 87/233 (37%), Positives = 131/233 (56%), Gaps = 20/233 (8%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQ--------DRRYKNRELQLMRVMDHP 91
Y VG+G++G V A +TG VAIKK+ + R Y REL+L++ MDH
Sbjct: 17 YQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTY--RELRLLKHMDHE 74
Query: 92 NVISLKHCFFSTTSKNELF-LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 150
NVI L F +S + + LV + + ++K Q++ +++ YQI R
Sbjct: 75 NVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKC-----QKLSDDHIQFLVYQILR 129
Query: 151 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPE 210
GL YIH+ + HRDLKP N+ V+ ++KI DFG A+ + Y+ +R+YRAPE
Sbjct: 130 GLKYIHSA-GIIHRDLKPSNIAVNE-DCELKILDFGLARH--TDDEMTGYVATRWYRAPE 185
Query: 211 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 263
++ Y ++DIWS GC++AELL G+ LFPG + +DQL I+ ++GTP E
Sbjct: 186 IMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEE 238
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 196 bits (500), Expect = 3e-61
Identities = 76/248 (30%), Positives = 136/248 (54%), Gaps = 26/248 (10%)
Query: 46 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISLKHC 99
+G G++G V++A+ +TGE VA+KK+ + + RE++L++ + HPN++ LK
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEI 66
Query: 100 FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 159
S K +++ V EY+ + +L + +K Y Q+ GL Y+H+
Sbjct: 67 VTSKG-KGSIYM--VFEYMDHDLTGLLDS---PEVKFTESQIKCYMKQLLEGLQYLHSN- 119
Query: 160 RVCHRDLKPQNLLVDPLTHQ--VKICDFGSAKQLIAGEANISY---ICSRFYRAPELIFG 214
+ HRD+K N+L++ + +K+ DFG A+ + Y + + +YR PEL+ G
Sbjct: 120 GILHRDIKGSNILIN---NDGVLKLADFGLARP-YTKRNSADYTNRVITLWYRPPELLLG 175
Query: 215 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE---EIRCMNPN 271
AT Y +D+WS GC+LAEL LG+P+F G ++QL +I ++ G+PT E + + P
Sbjct: 176 ATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKL-PW 234
Query: 272 YTDFRFPQ 279
+ + + +
Sbjct: 235 FENLKPKK 242
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 193 bits (493), Expect = 1e-59
Identities = 94/273 (34%), Positives = 150/273 (54%), Gaps = 31/273 (11%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV-------LQDRRYKNRELQLMRVMDHPN 92
Y +G G++G+V A TG VAIKK+ R RE++++R H N
Sbjct: 7 YQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTL--REIKILRRFKHEN 64
Query: 93 VISLKHCFFSTT--SKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 150
+I + + S N++++ V E + +Y+++K +N +++ + YQI R
Sbjct: 65 IIGILDIIRPPSFESFNDVYI--VQELMETDLYKLIKTQHLSND-----HIQYFLYQILR 117
Query: 151 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS----YICSRFY 206
GL YIH+ V HRDLKP NLL++ +KICDFG A+ + Y+ +R+Y
Sbjct: 118 GLKYIHSA-NVLHRDLKPSNLLLNT-NCDLKICDFGLARIADPEHDHTGFLTEYVATRWY 175
Query: 207 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 266
RAPE++ + YT +IDIWS GC+LAE+L +PLFPG++ + QL I+ VLGTP++E++
Sbjct: 176 RAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLN 235
Query: 267 CM-NPNYTDF--RFPQIKAHPWHKVCIFHFPKH 296
C+ + ++ P PW+K+ FP
Sbjct: 236 CIISLRARNYIKSLPFKPKVPWNKL----FPNA 264
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 187 bits (477), Expect = 4e-57
Identities = 89/249 (35%), Positives = 146/249 (58%), Gaps = 27/249 (10%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVL------QD--RRYKNRELQLMRVM-DH 90
Y + +G G++GIV++A T E VA+KK+ D R + RE+ ++ + DH
Sbjct: 9 YEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTF--REIMFLQELGDH 66
Query: 91 PNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 150
PN++ L + ++N+ + LV EY+ ++ V++ AN ++ + YQ+ +
Sbjct: 67 PNIVKLLNVI---KAENDKDIYLVFEYMETDLHAVIR----ANILED-VHKRYIMYQLLK 118
Query: 151 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS------YICSR 204
L YIH+ V HRDLKP N+L++ VK+ DFG A+ L E N Y+ +R
Sbjct: 119 ALKYIHS-GNVIHRDLKPSNILLNSDCR-VKLADFGLARSLSELEENPENPVLTDYVATR 176
Query: 205 FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 264
+YRAPE++ G+T YT +D+WS GC+L E+LLG+PLFPG + ++QL +II+V+G P+ E+
Sbjct: 177 WYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAED 236
Query: 265 IRCMNPNYT 273
I + +
Sbjct: 237 IESIKSPFA 245
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 182 bits (465), Expect = 4e-56
Identities = 91/256 (35%), Positives = 144/256 (56%), Gaps = 25/256 (9%)
Query: 46 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISLKHC 99
+G G++G+V++A+ TGE VA+KK+ + + RE+ L++ ++HPN++ L
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDV 66
Query: 100 FFSTTSKNELFLNLVMEYVPESMYRVLKHY--SSANQRMPLIYVKLYTYQIFRGLAYIHT 157
S E L LV E++ LK Y SS + +K Y YQ+ +G+AY H+
Sbjct: 67 VHS-----ENKLYLVFEFLDLD----LKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHS 117
Query: 158 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL-IAGEANISYICSRFYRAPELIFGAT 216
RV HRDLKPQNLL+D +K+ DFG A+ + + + +YRAPE++ G+
Sbjct: 118 -HRVLHRDLKPQNLLIDR-EGALKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGSR 175
Query: 217 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE---EIRCMNPNYT 273
+Y+T +DIWS GC+ AE++ +PLFPG++ +DQL I + LGTP + + + P+Y
Sbjct: 176 QYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSL-PDYK 234
Query: 274 DFRFPQIKAHPWHKVC 289
FP+ KV
Sbjct: 235 P-TFPKWARQDLSKVV 249
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 183 bits (467), Expect = 1e-55
Identities = 95/274 (34%), Positives = 145/274 (52%), Gaps = 31/274 (11%)
Query: 39 SYMAERVVGTGSFGIVFQAKCLETGETVAIKK------VLQDRRYKNRELQLMRVMDHPN 92
Y +G+G++G+V A +G+ VAIKK V + REL+++R H N
Sbjct: 6 RYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDN 65
Query: 93 VISLKHCFFSTTSKNELFLN--LVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 150
+I+++ F + +VM+ M L H ++Q + +++ + YQ+ R
Sbjct: 66 IIAIRDIL---RPPGADFKDVYVVMDL----MESDLHHIIHSDQPLTEEHIRYFLYQLLR 118
Query: 151 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN-----ISYICSRF 205
GL YIH+ V HRDLKP NLLV+ ++I DFG A+ L + Y+ +R+
Sbjct: 119 GLKYIHSA-NVIHRDLKPSNLLVNEDCE-LRIGDFGMARGLSSSPTEHKYFMTEYVATRW 176
Query: 206 YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 265
YRAPEL+ EYTT+ID+WS GC+ AE+L + LFPG+N V QL I+ VLG+P+ E +
Sbjct: 177 YRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVL 236
Query: 266 RCMNP----NYTDFRFPQIKAHPWHKVCIFHFPK 295
+ Y P+ + PW K+ FPK
Sbjct: 237 NRIGSDRVRKYIQ-NLPRKQPVPWSKI----FPK 265
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 182 bits (465), Expect = 2e-55
Identities = 91/233 (39%), Positives = 144/233 (61%), Gaps = 13/233 (5%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV------LQDRRYKNRELQLMRVMDHPNV 93
Y+ + +G G++GIV AK ET E VAIKK+ D + RE++L+R +DH NV
Sbjct: 7 YVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENV 66
Query: 94 ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 153
I++K + + +V E + ++++++ ++Q + + + + YQ+ RGL
Sbjct: 67 IAIKDIMPPPHREAFNDVYIVYELMDTDLHQIIR----SSQTLSDDHCQYFLYQLLRGLK 122
Query: 154 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK-QLIAGEANISYICSRFYRAPELI 212
YIH+ V HRDLKP NLL++ +KICDFG A+ G+ Y+ +R+YRAPEL+
Sbjct: 123 YIHSA-NVLHRDLKPSNLLLNA-NCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELL 180
Query: 213 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 265
+EYTT+ID+WS GC+ AELL +PLFPG++ V QL I ++LG+P+ E++
Sbjct: 181 LNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDL 233
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 179 bits (457), Expect = 6e-55
Identities = 101/262 (38%), Positives = 156/262 (59%), Gaps = 24/262 (9%)
Query: 45 VVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRVMDHPNVISLKH 98
+VG GS+G+V + K ETG+ VAIKK L+ ++ RE+++++ + H N+++L
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67
Query: 99 CFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV 158
F K L+L V E+V ++ L+ Y + + V+ Y +QI RG+ + H+
Sbjct: 68 VF---RRKKRLYL--VFEFVDHTVLDDLEKYPNG---LDESRVRKYLFQILRGIEFCHS- 118
Query: 159 PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA-GEANISYICSRFYRAPELIFGATE 217
+ HRD+KP+N+LV + VK+CDFG A+ L A GE Y+ +R+YRAPEL+ G T+
Sbjct: 119 HNIIHRDIKPENILVSQ-SGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTK 177
Query: 218 YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT--PTREEIRCMNPNYTDF 275
Y ++DIW+ GC++ E+L G+PLFPG++ +DQL IIK LG P +EI NP +
Sbjct: 178 YGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGM 237
Query: 276 RFPQIK-AHPWHKVCIFHFPKH 296
R P++K P K FPK
Sbjct: 238 RLPEVKEIEPLEK----RFPKL 255
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 173 bits (440), Expect = 3e-52
Identities = 84/232 (36%), Positives = 127/232 (54%), Gaps = 22/232 (9%)
Query: 46 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN----------RELQLMRVMD---HPN 92
+G G++G V++A+ L TG VA+KKV R RE+ L++ ++ HPN
Sbjct: 7 IGEGAYGTVYKARDLNTGRFVALKKV----RVPLSEEGIPLSTLREIALLKQLESFEHPN 62
Query: 93 VISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 152
++ L + EL L LV E+V + + L +P +K Q+ RG+
Sbjct: 63 IVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPG--LPPETIKDLMRQLLRGV 120
Query: 153 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELI 212
++H+ R+ HRDLKPQN+LV QVKI DFG A+ A S + + +YRAPE++
Sbjct: 121 DFLHS-HRIVHRDLKPQNILVTS-DGQVKIADFGLARIYSFEMALTSVVVTLWYRAPEVL 178
Query: 213 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 264
++ Y T +D+WS GC+ AEL +PLF G + DQL +I V+G P+ EE
Sbjct: 179 LQSS-YATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEE 229
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 174 bits (443), Expect = 3e-52
Identities = 93/238 (39%), Positives = 141/238 (59%), Gaps = 19/238 (7%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV------LQDRRYKNRELQLMRVMDHPNV 93
Y + V+G GS+G+V A TGE VAIKK+ + D RE++L+R++ HP++
Sbjct: 2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDI 61
Query: 94 ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 153
+ +KH + + + +V E + +++V+K AN + + + + YQ+ R L
Sbjct: 62 VEIKHIMLPPSRREFKDIYVVFELMESDLHQVIK----ANDDLTPEHHQFFLYQLLRALK 117
Query: 154 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN----ISYICSRFYRAP 209
YIHT V HRDLKP+N+L + ++KICDFG A+ Y+ +R+YRAP
Sbjct: 118 YIHTA-NVFHRDLKPKNILANA-DCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAP 175
Query: 210 ELIFGA--TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 265
EL G+ ++YT +IDIWS GC+ AE+L G+PLFPG+N V QL I +LGTP+ E I
Sbjct: 176 ELC-GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETI 232
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 171 bits (436), Expect = 1e-51
Identities = 83/226 (36%), Positives = 137/226 (60%), Gaps = 23/226 (10%)
Query: 49 GSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISLKHCFFS 102
G++G+V++A+ +TGE VA+KK+ ++ + RE+ ++ + HPN++++K
Sbjct: 16 GTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVG 75
Query: 103 TTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVC 162
+ +++++ VMEYV + +++ Q VK Q+ G+A++H +
Sbjct: 76 SNL-DKIYM--VMEYVEHDLKSLMETMK---QPFLQSEVKCLMLQLLSGVAHLHD-NWIL 128
Query: 163 HRDLKPQNLLVDPLTH--QVKICDFGSAKQLIAGEANISY---ICSRFYRAPELIFGATE 217
HRDLK NLL L + +KICDFG A++ G Y + + +YRAPEL+ GA E
Sbjct: 129 HRDLKTSNLL---LNNRGILKICDFGLAREY--GSPLKPYTQLVVTLWYRAPELLLGAKE 183
Query: 218 YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 263
Y+T+ID+WS GC+ AELL +PLFPG++ +DQL +I K+LGTPT +
Sbjct: 184 YSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEK 229
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 170 bits (432), Expect = 3e-51
Identities = 90/236 (38%), Positives = 140/236 (59%), Gaps = 25/236 (10%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNV 93
Y +G G++G+V++A+ T ET+A+KK+ ++ + RE+ L++ M H N+
Sbjct: 4 YEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNI 63
Query: 94 ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSA-----NQRMPLIYVKLYTYQI 148
+ L+ S E L LV EY+ + KH S+ N R+ +K Y YQI
Sbjct: 64 VRLQDVVHS-----EKRLYLVFEYLDLDLK---KHMDSSPDFAKNPRL----IKTYLYQI 111
Query: 149 FRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL-IAGEANISYICSRFYR 207
RG+AY H+ RV HRDLKPQNLL+D T+ +K+ DFG A+ I + + +YR
Sbjct: 112 LRGIAYCHS-HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYR 170
Query: 208 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 263
APE++ G+ Y+T +DIWS GC+ AE++ +PLFPG++ +D+L +I ++LGTP E
Sbjct: 171 APEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEE 226
|
Length = 294 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 170 bits (433), Expect = 4e-51
Identities = 91/254 (35%), Positives = 133/254 (52%), Gaps = 39/254 (15%)
Query: 46 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISLKHC 99
+G G++GIV++A+ +GE VA+KKV D RE+ L+ + HPN++ LK
Sbjct: 15 IGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEV 74
Query: 100 FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 159
+ +FL VMEY + + +L + + VK Q+ RGL Y+H
Sbjct: 75 VVGK-HLDSIFL--VMEYCEQDLASLLDNMPTP---FSESQVKCLMLQLLRGLQYLHE-N 127
Query: 160 RVCHRDLKPQNLLVDPLTHQ--VKICDFGSAKQLIAGEANISYIC--------SRFYRAP 209
+ HRDLK NLL LT + +KI DFG A+ + +YRAP
Sbjct: 128 FIIHRDLKVSNLL---LTDKGCLKIADFGLAR-------TYGLPAKPMTPKVVTLWYRAP 177
Query: 210 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI---- 265
EL+ G T YTT+ID+W+ GC+LAELL +PL PG++ ++QL II++LGTP E I
Sbjct: 178 ELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPN-ESIWPGF 236
Query: 266 RCMNPNYTDFRFPQ 279
+ P F P+
Sbjct: 237 SDL-PLVGKFTLPK 249
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 171 bits (434), Expect = 5e-51
Identities = 93/237 (39%), Positives = 135/237 (56%), Gaps = 23/237 (9%)
Query: 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKK--------VLQDRRYKNRELQLMRVM 88
T Y+ + VG G+FG+V A+ TG+ VAIKK VL R Y REL+L++ +
Sbjct: 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTY--RELKLLKHL 66
Query: 89 DHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQI 148
H N+ISL F S + V E + ++R+L Q +++ + YQI
Sbjct: 67 RHENIISLSDIFISPLED----IYFVTELLGTDLHRLLTSRPLEKQ-----FIQYFLYQI 117
Query: 149 FRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRA 208
RGL Y+H+ V HRDLKP N+L++ +KICDFG A+ I Y+ +R+YRA
Sbjct: 118 LRGLKYVHSAG-VVHRDLKPSNILINE-NCDLKICDFGLAR--IQDPQMTGYVSTRYYRA 173
Query: 209 PELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 265
PE++ +Y +DIWSAGC+ AE+L G+PLFPG++ V+Q I +LGTP + I
Sbjct: 174 PEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVI 230
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 167 bits (424), Expect = 7e-51
Identities = 70/247 (28%), Positives = 120/247 (48%), Gaps = 40/247 (16%)
Query: 46 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----RELQLMRVMDHPNVISLKHCF 100
+G G FG V+ A+ +TG+ VAIK + ++ RE+++++ ++HPN++ L F
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 101 FSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 159
++E L LVMEY S+ +LK ++ + QI GL Y+H+
Sbjct: 61 -----EDENHLYLVMEYCEGGSLKDLLKEN---EGKLSEDEILRILLQILEGLEYLHSNG 112
Query: 160 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPELIFGATEY 218
+ HRDLKP+N+L+D +VK+ DFG +K L + ++ + I + Y APE++ G Y
Sbjct: 113 -IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYY 171
Query: 219 TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD-FRF 277
+ DIWS G +L EL +L ++I+ + + +
Sbjct: 172 SEKSDIWSLGVILYEL-------------PELKDLIR----------KMLQKDPEKRPSA 208
Query: 278 PQIKAHP 284
+I H
Sbjct: 209 KEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 168 bits (428), Expect = 2e-50
Identities = 80/220 (36%), Positives = 132/220 (60%), Gaps = 17/220 (7%)
Query: 46 VGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRVMDHPNVISLKHC 99
+G GS+G+VF+ + ETG+ VAIKK ++ ++ RE+++++ + HPN+++L
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEV 68
Query: 100 FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 159
F + + L+LV EY ++ L+ + +P +K +Q + + + H
Sbjct: 69 F-----RRKRKLHLVFEYCDHTVLNELEKNP---RGVPEHLIKKIIWQTLQAVNFCHK-H 119
Query: 160 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS-YICSRFYRAPELIFGATEY 218
HRD+KP+N+L+ Q+K+CDFG A+ L + + Y+ +R+YRAPEL+ G T+Y
Sbjct: 120 NCIHRDVKPENILITK-QGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQY 178
Query: 219 TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLG 258
+D+W+ GCV AELL GQPL+PG++ VDQL I K LG
Sbjct: 179 GPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLG 218
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 168 bits (427), Expect = 2e-50
Identities = 84/227 (37%), Positives = 140/227 (61%), Gaps = 24/227 (10%)
Query: 46 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISLKHC 99
+G G++G+V++A+ TGE VA+KK+ D + RE+ L++ ++HPN++ L
Sbjct: 8 IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 67
Query: 100 FFSTTSKNELFLNLVMEYVPESMYRVLKHY--SSANQRMPLIYVKLYTYQIFRGLAYIHT 157
+ +N+L+L V E+ +++ LK + +S +PL +K Y +Q+ +GLA+ H+
Sbjct: 68 IHT---ENKLYL--VFEF----LHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHS 118
Query: 158 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISY---ICSRFYRAPELIFG 214
RV HRDLKPQNLL++ +K+ DFG A+ G +Y + + +YRAPE++ G
Sbjct: 119 -HRVLHRDLKPQNLLINTEGA-IKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLG 174
Query: 215 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 261
Y+T++DIWS GC+ AE++ + LFPG++ +DQL I + LGTP
Sbjct: 175 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD 221
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 168 bits (427), Expect = 2e-50
Identities = 82/247 (33%), Positives = 132/247 (53%), Gaps = 24/247 (9%)
Query: 47 GTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-------RELQLMRVM-DHPNVISLKH 98
G G+F V +A+ +TG+ AIK + + +K+ RE+Q +R + HPN++ L
Sbjct: 8 GEGTFSEVLKAQSRKTGKYYAIKCMKK--HFKSLEQVNNLREIQALRRLSPHPNILRLIE 65
Query: 99 CFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPL--IYVKLYTYQIFRGLAYIH 156
F + L LV E + ++Y ++K ++ PL VK Y YQ+ + L ++H
Sbjct: 66 VLFDRKTGR---LALVFELMDMNLYELIK-----GRKRPLPEKRVKSYMYQLLKSLDHMH 117
Query: 157 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGAT 216
+ HRD+KP+N+L+ +K+ DFGS + + + YI +R+YRAPE +
Sbjct: 118 R-NGIFHRDIKPENILIKDDI--LKLADFGSCRGIYSKPPYTEYISTRWYRAPECLLTDG 174
Query: 217 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP-NYTDF 275
Y +DIW+ GCV E+L PLFPG N +DQ+ +I VLGTP E ++ + ++
Sbjct: 175 YYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNY 234
Query: 276 RFPQIKA 282
FP K
Sbjct: 235 NFPSKKG 241
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 167 bits (425), Expect = 4e-50
Identities = 91/240 (37%), Positives = 140/240 (58%), Gaps = 20/240 (8%)
Query: 46 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISLKHC 99
+G G++G VF+AK ET E VA+K+V D + RE+ L++ + H N++ L
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67
Query: 100 FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 159
S + L LV EY + + K++ S N + VK + +Q+ +GLA+ H+
Sbjct: 68 LHS-----DKKLTLVFEYCDQDLK---KYFDSCNGDIDPEIVKSFMFQLLKGLAFCHS-H 118
Query: 160 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL-IAGEANISYICSRFYRAPELIFGATEY 218
V HRDLKPQNLL++ ++K+ DFG A+ I + + + +YR P+++FGA Y
Sbjct: 119 NVLHRDLKPQNLLINK-NGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLY 177
Query: 219 TTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN--PNYTDF 275
+TSID+WSAGC+ AEL G+PLFPG + DQL I ++LGTPT E ++ P+Y +
Sbjct: 178 STSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPY 237
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 166 bits (421), Expect = 1e-49
Identities = 96/250 (38%), Positives = 146/250 (58%), Gaps = 22/250 (8%)
Query: 45 VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISLKH 98
VVG G++G+V + + ET E VAIKK + REL+++R + N++ LK
Sbjct: 8 VVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKE 67
Query: 99 CFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV 158
F + +L+L V EYV ++M +L+ + +P V+ Y YQ+ + + + H
Sbjct: 68 AF---RRRGKLYL--VFEYVEKNMLELLEEMPNG---VPPEKVRSYIYQLIKAIHWCHK- 118
Query: 159 PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG-EANIS-YICSRFYRAPELIFGAT 216
+ HRD+KP+NLL+ +K+CDFG A+ L G AN + Y+ +R+YR+PEL+ GA
Sbjct: 119 NDIVHRDIKPENLLISH-NDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAP 177
Query: 217 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM--NPNYTD 274
Y ++D+WS GC+L EL GQPLFPGE+ +DQL I KVLG E+++ NP +
Sbjct: 178 -YGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHG 236
Query: 275 FRFPQIKAHP 284
RFP + HP
Sbjct: 237 LRFPAV-NHP 245
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 167 bits (425), Expect = 1e-49
Identities = 91/238 (38%), Positives = 134/238 (56%), Gaps = 27/238 (11%)
Query: 46 VGTGSFGIVFQAKCLET--GETVAIKKV--------LQDRRYKNRELQLMR-VMDHPNVI 94
+G G++GIV A+ ET ETVAIKK+ L R REL+L+R H N+
Sbjct: 8 LGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRAL--RELKLLRHFRGHKNIT 65
Query: 95 SLKHCFFSTTSK-NELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 153
L NEL+L E + ++++++ + Q + + + + YQI GL
Sbjct: 66 CLYDMDIVFPGNFNELYL--YEELMEADLHQIIR----SGQPLTDAHFQSFIYQILCGLK 119
Query: 154 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS-----YICSRFYRA 208
YIH+ V HRDLKP NLLV+ ++KICDFG A+ + Y+ +R+YRA
Sbjct: 120 YIHSA-NVLHRDLKPGNLLVN-ADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRA 177
Query: 209 PELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 266
PE++ YT +ID+WS GC+LAELL +P+F G++ VDQL +I++VLGTP E +
Sbjct: 178 PEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLS 235
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 167 bits (424), Expect = 2e-49
Identities = 91/227 (40%), Positives = 131/227 (57%), Gaps = 20/227 (8%)
Query: 46 VGTGSFGIVFQAKCLETGETVAIKKV--------LQDRRYKNRELQLMRVMDHPNVISLK 97
VG+G++G V A TG VAIKK+ R Y REL+L++ M H NVI L
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAY--RELRLLKHMKHENVIGLL 80
Query: 98 HCFFSTTSKNELF-LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 156
F S + LVM ++ + +++KH + R ++ YQ+ +GL YIH
Sbjct: 81 DVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDR-----IQFLVYQMLKGLKYIH 135
Query: 157 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGAT 216
+ HRDLKP NL V+ ++KI DFG A+Q Y+ +R+YRAPE+I
Sbjct: 136 AAG-IIHRDLKPGNLAVNE-DCELKILDFGLARQ--TDSEMTGYVVTRWYRAPEVILNWM 191
Query: 217 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 263
YT ++DIWS GC++AE+L G+PLF G + +DQL+EI+KV GTP++E
Sbjct: 192 HYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKE 238
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 165 bits (419), Expect = 7e-49
Identities = 94/280 (33%), Positives = 135/280 (48%), Gaps = 48/280 (17%)
Query: 46 VGTGSFGIVFQAKCLE--TGETVAIKKVLQDRRYKN-------RELQLMRVMDHPNVISL 96
+G G++G V++AK G+ AIKK D+ RE+ L+R + H NV+SL
Sbjct: 8 IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSL 67
Query: 97 KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRM-PLIYVKLYTYQIFRGLAYI 155
F K+ + L+ +Y +++++K + A + P VK +QI G+ Y+
Sbjct: 68 VEVFLEHADKS---VYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYL 124
Query: 156 HTVPRVCHRDLKPQNLLV---DPLTHQVKICDFGSA-------KQLIAGEANISYICSRF 205
H+ V HRDLKP N+LV P VKI D G A K L + + I +
Sbjct: 125 HS-NWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTI---W 180
Query: 206 YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA---------VDQLVEIIKV 256
YRAPEL+ GA YT +IDIW+ GC+ AELL +P+F G A DQL I +V
Sbjct: 181 YRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEV 240
Query: 257 LGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVCIFHFPKH 296
LGTPT + +P IK P + + F
Sbjct: 241 LGTPTEK------------DWPDIKKMPEYDTLMKDFKTK 268
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 163 bits (414), Expect = 1e-48
Identities = 87/225 (38%), Positives = 136/225 (60%), Gaps = 20/225 (8%)
Query: 46 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----RELQLMRVMDHPNVISLKHCF 100
+G G++ V++ + TGE VA+K++ D RE+ LM+ + H N++ L H
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRL-HDV 66
Query: 101 FSTTSKNELFLNLVMEYVPESMYRVLKHY--SSANQR-MPLIYVKLYTYQIFRGLAYIHT 157
T +K L LV EY M + LK Y + + + VK +TYQ+ +G+A+ H
Sbjct: 67 IHTENK----LMLVFEY----MDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHE 118
Query: 158 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL-IAGEANISYICSRFYRAPELIFGAT 216
RV HRDLKPQNLL++ ++K+ DFG A+ I + + + +YRAP+++ G+
Sbjct: 119 -NRVLHRDLKPQNLLINK-RGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSR 176
Query: 217 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 261
Y+TSIDIWS GC++AE++ G+PLFPG N DQL++I +++GTPT
Sbjct: 177 TYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPT 221
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 162 bits (413), Expect = 3e-48
Identities = 90/277 (32%), Positives = 147/277 (53%), Gaps = 25/277 (9%)
Query: 39 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKV-LQDRR----YKNRELQLMRVMDHPNV 93
+Y +G GS+ V++ + TG+ VA+K++ L+ RE L++ + H N+
Sbjct: 6 TYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANI 65
Query: 94 ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHY-SSANQRMPLIYVKLYTYQIFRGL 152
++L + + L LV EY + LK Y + + V+L+ +Q+ RGL
Sbjct: 66 VTLHDIIHTKKT-----LTLVFEY----LDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGL 116
Query: 153 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK-QLIAGEANISYICSRFYRAPEL 211
AY H RV HRDLKPQNLL+ ++K+ DFG A+ + + + + + + +YR P++
Sbjct: 117 AYCHQ-RRVLHRDLKPQNLLISERG-ELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDV 174
Query: 212 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPG-ENAVDQLVEIIKVLGTPTREEIR--CM 268
+ G+TEY+TS+D+W GC+ E+ G+PLFPG + DQL +I +VLGTPT E
Sbjct: 175 LLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSS 234
Query: 269 NPNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGSHI 305
NP + + FP P H P+ + +G +
Sbjct: 235 NPEFKPYSFPFYPPRPLIN----HAPRLDRIPHGEEL 267
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 161 bits (409), Expect = 6e-48
Identities = 72/218 (33%), Positives = 112/218 (51%), Gaps = 20/218 (9%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIKKV-LQDRRYKN-----RELQLMRVMDHPNVISLK 97
++G GSFG V+ A +TGE +A+K V L + RE++++ + HPN++
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIV--- 62
Query: 98 HCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 156
+ S + + LN+ +EYV S L ++P ++ YT QI GLAY+H
Sbjct: 63 RYYGSERDEEKNTLNIFLEYVSGGS----LSSLLKKFGKLPEPVIRKYTRQILEGLAYLH 118
Query: 157 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL---IAGEANISYICSRFYRAPELIF 213
+ + HRD+K N+LVD VK+ DFG AK+L GE S + ++ APE+I
Sbjct: 119 S-NGIVHRDIKGANILVDS-DGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIR 176
Query: 214 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLV 251
G EY + DIWS GC + E+ G+P + +
Sbjct: 177 G-EEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAAL 213
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 161 bits (410), Expect = 9e-48
Identities = 85/247 (34%), Positives = 134/247 (54%), Gaps = 18/247 (7%)
Query: 46 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISLKHC 99
+G G++G V++A+ TG+ VA+KK + + RE+ L++++ I
Sbjct: 9 IGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLD 68
Query: 100 FFSTTSKN-ELFLNLVMEYVPESMYRVL-KHYSSANQRMPLIYVKLYTYQIFRGLAYIHT 157
KN + L LV EY+ + + + + + +P +K + YQ+ +G+A+ H
Sbjct: 69 VEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK 128
Query: 158 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL-IAGEANISYICSRFYRAPELIFGAT 216
V HRDLKPQNLLVD +KI D G + I ++ I + +YRAPE++ G+T
Sbjct: 129 HG-VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLGST 187
Query: 217 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR 276
Y+T +DIWS GC+ AE+ QPLFPG++ + QL+ I K+LGTPT + P + R
Sbjct: 188 HYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVW----PGVSKLR 243
Query: 277 ----FPQ 279
FPQ
Sbjct: 244 DWHEFPQ 250
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 162 bits (411), Expect = 2e-47
Identities = 92/239 (38%), Positives = 134/239 (56%), Gaps = 21/239 (8%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKK--------VLQDRRYKNRELQLMRVMDHP 91
Y + + VG+G++G V A TGE VAIKK + R Y REL L++ M H
Sbjct: 17 YTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAY--RELTLLKHMQHE 74
Query: 92 NVISLKHCFFSTTSKNELF-LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 150
NVI L F S S +E LVM Y+ + +++ H S ++ V+ YQ+
Sbjct: 75 NVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDK------VQYLVYQMLC 128
Query: 151 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPE 210
GL YIH+ + HRDLKP NL V+ ++KI DFG A+ A Y+ +R+YRAPE
Sbjct: 129 GLKYIHSAG-IIHRDLKPGNLAVNE-DCELKILDFGLARH--ADAEMTGYVVTRWYRAPE 184
Query: 211 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 269
+I Y ++DIWS GC++AE+L G+ LF G++ +DQL +I+KV G P E ++ +
Sbjct: 185 VILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLE 243
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 159 bits (405), Expect = 3e-47
Identities = 83/233 (35%), Positives = 134/233 (57%), Gaps = 29/233 (12%)
Query: 46 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN----------RELQLMRVMDHPNVIS 95
+G G++G+V++ + +TG+ VA+KK+ R ++ RE+ L++ + HPN++
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKI----RLESEEEGVPSTAIREISLLKELQHPNIVC 63
Query: 96 LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSS---ANQRMPLIYVKLYTYQIFRGL 152
L+ ++ L+L + E++ SM LK Y Q M VK Y YQI +G+
Sbjct: 64 LQDVLMQ---ESRLYL--IFEFL--SMD--LKKYLDSLPKGQYMDAELVKSYLYQILQGI 114
Query: 153 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL-IAGEANISYICSRFYRAPEL 211
+ H+ RV HRDLKPQNLL+D +K+ DFG A+ I + + +YRAPE+
Sbjct: 115 LFCHS-RRVLHRDLKPQNLLIDN-KGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEV 172
Query: 212 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 264
+ G+ Y+T +DIWS G + AE+ +PLF G++ +DQL I ++LGTPT +
Sbjct: 173 LLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDV 225
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 158 bits (401), Expect = 5e-46
Identities = 77/253 (30%), Positives = 137/253 (54%), Gaps = 26/253 (10%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVL--QDRRYKN--RELQLMRVMDHPNVIS 95
YM R +G GS G+VF A + + VA+KK++ + K+ RE++++R +DH N++
Sbjct: 7 YMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVK 66
Query: 96 LKHCFFSTTSKNELFLN---------LVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTY 146
+ + S + +V EY+ + VL+ + + +L+ Y
Sbjct: 67 VYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQ-----GPLSEEHARLFMY 121
Query: 147 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYI----C 202
Q+ RGL YIH+ V HRDLKP N+ ++ +KI DFG A+ + ++ Y+
Sbjct: 122 QLLRGLKYIHSA-NVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLV 180
Query: 203 SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQL---VEIIKVLGT 259
+++YR+P L+ YT +ID+W+AGC+ AE+L G+PLF G + ++Q+ +E + V+
Sbjct: 181 TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVRE 240
Query: 260 PTREEIRCMNPNY 272
R E+ + P++
Sbjct: 241 EDRNELLNVIPSF 253
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 156 bits (396), Expect = 3e-45
Identities = 90/272 (33%), Positives = 131/272 (48%), Gaps = 48/272 (17%)
Query: 46 VGTGSFGIVFQAKCLETGETVAIKKV---------LQDRRYKN---------RELQLMRV 87
+G G++G V +A TG+ VAIKKV +DR+ REL++M
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 88 MDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQ 147
+ H N++ L + F+NLVM+ M LK R+ VK Q
Sbjct: 77 IKHENIMGLVDVYVE-----GDFINLVMDI----MASDLKKVVDRKIRLTESQVKCILLQ 127
Query: 148 IFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ-----LIAGEANISYIC 202
I GL +H HRDL P N+ ++ KI DFG A++ + +
Sbjct: 128 ILNGLNVLHKW-YFMHRDLSPANIFINS-KGICKIADFGLARRYGYPPYSDTLSKDETMQ 185
Query: 203 SR----------FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVE 252
R +YRAPEL+ GA +Y ++D+WS GC+ AELL G+PLFPGEN +DQL
Sbjct: 186 RREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGR 245
Query: 253 IIKVLGTPTRE---EIRCMNPNYTDFRFPQIK 281
I ++LGTP + + + + P YT+F + K
Sbjct: 246 IFELLGTPNEDNWPQAKKL-PLYTEFTPRKPK 276
|
Length = 335 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 151 bits (383), Expect = 2e-43
Identities = 88/233 (37%), Positives = 133/233 (57%), Gaps = 20/233 (8%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV------LQDRRYKNRELQLMRVMDHPNV 93
Y VG+G++G V A + VA+KK+ L R REL+L++ M H NV
Sbjct: 17 YQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENV 76
Query: 94 ISLKHCFFSTTSK---NELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 150
I L F TS NE++L V + + ++K Q++ +V+ YQ+ R
Sbjct: 77 IGLLDVFTPATSIENFNEVYL--VTNLMGADLNNIVKC-----QKLSDEHVQFLIYQLLR 129
Query: 151 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPE 210
GL YIH+ + HRDLKP N+ V+ +++I DFG A+Q A + Y+ +R+YRAPE
Sbjct: 130 GLKYIHSAG-IIHRDLKPSNVAVNE-DCELRILDFGLARQ--ADDEMTGYVATRWYRAPE 185
Query: 211 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 263
++ Y ++DIWS GC++AELL G+ LFPG + +DQL I++V+GTP+ E
Sbjct: 186 IMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPE 238
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 152 bits (383), Expect = 4e-43
Identities = 78/241 (32%), Positives = 113/241 (46%), Gaps = 27/241 (11%)
Query: 39 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRVMDHP 91
SY R +G GSFG V+ A+ + VA+K + + RE+Q++ ++HP
Sbjct: 1 SYRILRKLGEGSFGEVYLARDRKL---VALKVLAKKLESKSKEVERFLREIQILASLNHP 57
Query: 92 NVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 151
I + FF ++E L LVMEYV L + QI
Sbjct: 58 PNIVKLYDFF----QDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSA 113
Query: 152 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI-------SYICSR 204
L Y+H+ + HRD+KP+N+L+D VK+ DFG AK L + + + +
Sbjct: 114 LEYLHSK-GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTP 172
Query: 205 FYRAPELIFGATE--YTTSIDIWSAGCVLAELLLGQPLFPGEN---AVDQLVEIIKVLGT 259
Y APE++ G + ++S DIWS G L ELL G P F GE A Q ++II L T
Sbjct: 173 GYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPT 232
Query: 260 P 260
P
Sbjct: 233 P 233
|
Length = 384 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 150 bits (380), Expect = 4e-43
Identities = 78/253 (30%), Positives = 125/253 (49%), Gaps = 56/253 (22%)
Query: 47 GTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN----------RELQLMRVMDHPNVISL 96
G G+FG V++A+ ++TG VA+KK+L N RE+++++ + HPNV+ L
Sbjct: 17 GEGTFGEVYKARQIKTGRVVALKKILM----HNEKDGFPITALREIKILKKLKHPNVVPL 72
Query: 97 KHCFFSTTSKNELFLNLVMEYVPE------SMYRVLKHYSS------ANQRMPLIY--VK 142
+++ +E + S+Y V + N + L +K
Sbjct: 73 --------------IDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIK 118
Query: 143 LYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK---------QLIA 193
Y Q+ G+ Y+H + HRD+K N+L+D +KI DFG A+ +
Sbjct: 119 CYMLQLLEGINYLHE-NHILHRDIKAANILIDN-QGILKIADFGLARPYDGPPPNPKGGG 176
Query: 194 GEANISY---ICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQL 250
G Y + +R+YR PEL+ G YTT++DIW GCV AE+ +P+ G++ +DQL
Sbjct: 177 GGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQL 236
Query: 251 VEIIKVLGTPTRE 263
I K+ GTPT E
Sbjct: 237 HLIFKLCGTPTEE 249
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 151 bits (382), Expect = 5e-43
Identities = 92/268 (34%), Positives = 148/268 (55%), Gaps = 30/268 (11%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--------RELQLMRVMDHP 91
Y + +G+G+ GIV A TG+ VAIKK+ R ++N REL LM++++H
Sbjct: 18 YQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKL--SRPFQNVTHAKRAYRELVLMKLVNHK 75
Query: 92 NVISLKHCFFSTTSKNELF-LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 150
N+I L + F S E + LVME + ++ +V+ ++RM + YQ+
Sbjct: 76 NIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVI-QMDLDHERMSYL-----LYQMLC 129
Query: 151 GLAYIHTVPRVCHRDLKPQNLLV-DPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAP 209
G+ ++H+ + HRDLKP N++V T +KI DFG A+ Y+ +R+YRAP
Sbjct: 130 GIKHLHSAG-IIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAP 186
Query: 210 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 269
E+I G Y ++DIWS GC++ E++ G LFPG + +DQ +II+ LGTP+ E + +
Sbjct: 187 EVILGMG-YKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQ 245
Query: 270 P---NYTDFRFPQIKAHPWHKVCIFHFP 294
P NY + R P+ + + ++ FP
Sbjct: 246 PTVRNYVENR-PKYAGYSFEEL----FP 268
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 148 bits (375), Expect = 6e-42
Identities = 84/242 (34%), Positives = 131/242 (54%), Gaps = 34/242 (14%)
Query: 43 ERVVGTGSFGIVFQAKCLETGETVAIKK---VLQD-----RRYKNRELQLMRVMDHPNVI 94
+R +G G+FG+V+ G+ VA+KK V Q+ R + REL+++ H NV+
Sbjct: 5 DRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVF--RELKMLCFFKHDNVL 62
Query: 95 S--------LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTY 146
S F E+++ V E M L + Q + +VK++ Y
Sbjct: 63 SALDILQPPHIDPF------EEIYV------VTELMQSDLHKIIVSPQPLSSDHVKVFLY 110
Query: 147 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI--SYICSR 204
QI RGL Y+H+ + HRD+KP NLLV+ +KICDFG A+ E+ + ++
Sbjct: 111 QILRGLKYLHSA-GILHRDIKPGNLLVNS-NCVLKICDFGLARVEEPDESKHMTQEVVTQ 168
Query: 205 FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 264
+YRAPE++ G+ YT+++DIWS GC+ AELL + LF ++ + QL I +LGTP+ E
Sbjct: 169 YYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEA 228
Query: 265 IR 266
+R
Sbjct: 229 MR 230
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 143 bits (364), Expect = 2e-41
Identities = 71/239 (29%), Positives = 118/239 (49%), Gaps = 21/239 (8%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIKKV-LQDRRYKN---RELQLMRVMDHPNVISLKHC 99
+G G FG V++A+ TG+ VAIK + L+ + K E+Q+++ HPN++
Sbjct: 6 EKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGS 65
Query: 100 FFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV 158
+ K+EL++ VME+ S+ +LK NQ + + ++ +GL Y+H+
Sbjct: 66 YLK---KDELWI--VMEFCSGGSLKDLLKST---NQTLTESQIAYVCKELLKGLEYLHSN 117
Query: 159 PRVCHRDLKPQNLLVDPLTH--QVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGAT 216
+ HRD+K N+L LT +VK+ DFG + QL +A + + + ++ APE+I G
Sbjct: 118 -GIIHRDIKAANIL---LTSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVING-K 172
Query: 217 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 275
Y DIWS G EL G+P + + L +I G P + + DF
Sbjct: 173 PYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATN-GPPGLRNPEKWSDEFKDF 230
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 144 bits (363), Expect = 4e-41
Identities = 87/266 (32%), Positives = 146/266 (54%), Gaps = 24/266 (9%)
Query: 39 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----RELQLMRVMDHPNV 93
+Y+ +G G++ VF+ + T VA+K++ + RE+ L++ + H N+
Sbjct: 6 TYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANI 65
Query: 94 ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHY-SSANQRMPLIYVKLYTYQIFRGL 152
++L H T E L LV EY+ LK Y + M + VK++ +Q+ RGL
Sbjct: 66 VTL-HDIIHT----ERCLTLVFEYLDSD----LKQYLDNCGNLMSMHNVKIFMFQLLRGL 116
Query: 153 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK-QLIAGEANISYICSRFYRAPEL 211
+Y H ++ HRDLKPQNLL++ ++K+ DFG A+ + + + + + + +YR P++
Sbjct: 117 SYCHK-RKILHRDLKPQNLLINE-KGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDV 174
Query: 212 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR--CMN 269
+ G+TEY+T ID+W GC+L E+ G+P+FPG ++L I ++LGTPT E N
Sbjct: 175 LLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSN 234
Query: 270 PNYTDFRFPQIKAHPWHKVCIFHFPK 295
+ + FPQ +A P I H P+
Sbjct: 235 EEFRSYLFPQYRAQP----LINHAPR 256
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 144 bits (364), Expect = 6e-41
Identities = 88/266 (33%), Positives = 146/266 (54%), Gaps = 24/266 (9%)
Query: 39 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----RELQLMRVMDHPNV 93
+Y+ +G G++ VF+ + T VA+K++ + RE+ L++ + H N+
Sbjct: 7 TYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANI 66
Query: 94 ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHY-SSANQRMPLIYVKLYTYQIFRGL 152
++L + S L LV EY+ + LK Y M + VK++ YQI RGL
Sbjct: 67 VTLHDIVHTDKS-----LTLVFEYLDKD----LKQYMDDCGNIMSMHNVKIFLYQILRGL 117
Query: 153 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK-QLIAGEANISYICSRFYRAPEL 211
AY H +V HRDLKPQNLL++ ++K+ DFG A+ + + + + + + +YR P++
Sbjct: 118 AYCHR-RKVLHRDLKPQNLLINE-RGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDV 175
Query: 212 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 271
+ G++EY+T ID+W GC+ E+ G+PLFPG D+L I ++LGTPT E ++ N
Sbjct: 176 LLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSN 235
Query: 272 --YTDFRFPQIKAHPWHKVCIFHFPK 295
+ ++ FP+ K P I H P+
Sbjct: 236 DEFKNYNFPKYKPQPL----INHAPR 257
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 144 bits (365), Expect = 1e-40
Identities = 87/232 (37%), Positives = 132/232 (56%), Gaps = 20/232 (8%)
Query: 46 VGTGSFGIVFQAKCLETGETVAIKKVLQ--------DRRYKNRELQLMRVMDHPNVISLK 97
VG+G++G V A +TG VA+KK+ + R Y REL+L++ M H NVI L
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY--RELRLLKHMKHENVIGLL 82
Query: 98 HCFFSTTSKNELF-LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 156
F S E + LV + + ++K Q++ +V+ YQI RGL YIH
Sbjct: 83 DVFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH 137
Query: 157 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGAT 216
+ + HRDLKP NL V+ ++KI DFG A+ + Y+ +R+YRAPE++
Sbjct: 138 SAD-IIHRDLKPSNLAVNE-DCELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWM 193
Query: 217 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 268
Y ++DIWS GC++AELL G+ LFPG + +DQL I++++GTP E ++ +
Sbjct: 194 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 245
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 141 bits (357), Expect = 5e-40
Identities = 81/258 (31%), Positives = 140/258 (54%), Gaps = 20/258 (7%)
Query: 39 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----RELQLMRVMDHPNV 93
+Y+ +G G++ V++ + T VA+K++ + RE+ L++ + H N+
Sbjct: 7 TYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANI 66
Query: 94 ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHY-SSANQRMPLIYVKLYTYQIFRGL 152
++L + S L LV EY+ + LK Y + + VKL+ +Q+ RGL
Sbjct: 67 VTLHDIIHTEKS-----LTLVFEYLDKD----LKQYLDDCGNSINMHNVKLFLFQLLRGL 117
Query: 153 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK-QLIAGEANISYICSRFYRAPEL 211
Y H +V HRDLKPQNLL++ ++K+ DFG A+ + I + + + + +YR P++
Sbjct: 118 NYCHR-RKVLHRDLKPQNLLINE-RGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDI 175
Query: 212 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM--N 269
+ G+T+Y+T ID+W GC+ E+ G+PLFPG +QL I ++LGTPT E + N
Sbjct: 176 LLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSN 235
Query: 270 PNYTDFRFPQIKAHPWHK 287
+ + +P+ +A H
Sbjct: 236 EEFKSYNYPKYRADCLHN 253
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 139 bits (354), Expect = 7e-40
Identities = 60/214 (28%), Positives = 102/214 (47%), Gaps = 16/214 (7%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV------LQDRRYKNRELQLMRVMDHPNV 93
Y + +G GSFG V+ + G+ +K++ ++R E+++++ ++HPN+
Sbjct: 2 YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNI 61
Query: 94 ISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 152
I F L +VMEY + + +K + P + + Q+ L
Sbjct: 62 IKYYESFEEKGK-----LCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLAL 116
Query: 153 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI-AGEANISYICSRFYRAPEL 211
Y+H+ ++ HRD+KPQN+ + VK+ DFG +K L + + + + +Y +PEL
Sbjct: 117 KYLHS-RKILHRDIKPQNIFLTS-NGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPEL 174
Query: 212 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 245
Y DIWS GCVL EL + F GEN
Sbjct: 175 CQNK-PYNYKSDIWSLGCVLYELCTLKHPFEGEN 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 139 bits (351), Expect = 4e-39
Identities = 83/260 (31%), Positives = 135/260 (51%), Gaps = 19/260 (7%)
Query: 39 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNRELQLMRVMDHPNV 93
SY+ +G GS+ V++ G+ VA+K + RE L++ + H N+
Sbjct: 6 SYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANI 65
Query: 94 ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 153
+ L + + L V EY+ + + + + + V+L+ +Q+ RGLA
Sbjct: 66 VLLHDIIHTKET-----LTFVFEYMHTDLAQYMIQHPGG---LHPYNVRLFMFQLLRGLA 117
Query: 154 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK-QLIAGEANISYICSRFYRAPELI 212
YIH + HRDLKPQNLL+ L ++K+ DFG A+ + I + S + + +YR P+++
Sbjct: 118 YIHG-QHILHRDLKPQNLLISYLG-ELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVL 175
Query: 213 FGATEYTTSIDIWSAGCVLAELLLGQPLFPG-ENAVDQLVEIIKVLGTPTREEIRCMN-- 269
GAT+Y++++DIW AGC+ E+L GQP FPG + +QL +I VLG PT + ++
Sbjct: 176 LGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKL 235
Query: 270 PNYTDFRFPQIKAHPWHKVC 289
PNY F K V
Sbjct: 236 PNYKPEWFLPCKPQQLRVVW 255
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 3e-38
Identities = 81/263 (30%), Positives = 129/263 (49%), Gaps = 37/263 (14%)
Query: 46 VGTGSFGIVFQAKCLETGETVAI----KKVLQDRR---YKNRELQLMRVMDHPNVISLKH 98
+G GSFG V + +TG+ A+ KK + R+ + E ++ ++HP ++ L H
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKL-H 59
Query: 99 CFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 156
F T K L LV+EY P E L + S R + Y +I L Y+H
Sbjct: 60 YAFQTEEK----LYLVLEYAPGGE-----LFSHLSKEGRFSEERARFYAAEIVLALEYLH 110
Query: 157 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPELIFGA 215
++ + +RDLKP+N+L+D H +K+ DFG AK+L + + + C + Y APE++ G
Sbjct: 111 SL-GIIYRDLKPENILLDADGH-IKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGK 168
Query: 216 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII--KVLGTP------TREEIRC 267
Y ++D WS G +L E+L G+P F E+ ++ E I L P R+ I
Sbjct: 169 -GYGKAVDWWSLGVLLYEMLTGKPPFYAED-RKEIYEKILKDPLRFPEFLSPEARDLISG 226
Query: 268 M---NPN--YTDFRFPQIKAHPW 285
+ +P +IKAHP+
Sbjct: 227 LLQKDPTKRLGSGGAEEIKAHPF 249
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 3e-37
Identities = 74/232 (31%), Positives = 122/232 (52%), Gaps = 22/232 (9%)
Query: 46 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN----------RELQLMRVM---DHPN 92
+G G++G V++A+ +G VA+K V R + RE+ L++ + DHPN
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSV----RVQTNEDGLPLSTVREVALLKRLEAFDHPN 63
Query: 93 VISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 152
++ L ++ + E + LV E+V + + L +P +K Q RGL
Sbjct: 64 IVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPG--LPAETIKDLMRQFLRGL 121
Query: 153 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELI 212
++H + HRDLKP+N+LV QVK+ DFG A+ A + + +YRAPE++
Sbjct: 122 DFLHA-NCIVHRDLKPENILVTS-GGQVKLADFGLARIYSCQMALTPVVVTLWYRAPEVL 179
Query: 213 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 264
+T Y T +D+WS GC+ AE+ +PLF G + DQL +I ++G P ++
Sbjct: 180 LQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDD 230
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 133 bits (335), Expect = 7e-37
Identities = 84/230 (36%), Positives = 132/230 (57%), Gaps = 17/230 (7%)
Query: 46 VGTGSFGIVFQAKCLETG-ETVAIKKVLQDRRYKN------RELQLMRVMD---HPNVIS 95
+G G++G VF+A+ L+ G VA+K+V + RE+ ++R ++ HPNV+
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 96 L-KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 154
L C S T + E L LV E+V + + L +P +K +Q+ RGL +
Sbjct: 69 LFDVCTVSRTDR-ETKLTLVFEHVDQDLTTYLD--KVPEPGVPTETIKDMMFQLLRGLDF 125
Query: 155 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFG 214
+H+ RV HRDLKPQN+LV + Q+K+ DFG A+ A S + + +YRAPE++
Sbjct: 126 LHS-HRVVHRDLKPQNILVTS-SGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQ 183
Query: 215 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 264
++ Y T +D+WS GC+ AE+ +PLF G + VDQL +I+ V+G P E+
Sbjct: 184 SS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 232
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 126 bits (320), Expect = 9e-35
Identities = 76/244 (31%), Positives = 119/244 (48%), Gaps = 29/244 (11%)
Query: 45 VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR-----ELQLMRVMDHPNVISLKHC 99
V+G GS G+V++ + TG+ A+KK+ D + R EL+ +R + P V+
Sbjct: 8 VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGA 67
Query: 100 FFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV 158
F+ +++V+EY+ S+ +LK ++P + QI +GL Y+HT
Sbjct: 68 FYKEGE-----ISIVLEYMDGGSLADLLK----KVGKIPEPVLAYIARQILKGLDYLHTK 118
Query: 159 PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF-----YRAPELIF 213
+ HRD+KP NLL++ +VKI DFG +K L N C+ F Y +PE I
Sbjct: 119 RHIIHRDIKPSNLLIN-SKGEVKIADFGISKVL----ENTLDQCNTFVGTVTYMSPERIQ 173
Query: 214 GATEYTTSIDIWSAGCVLAELLLGQ-PLFPGENAVD-QLVEIIKVLGTPTREEIRCMNPN 271
G + Y+ + DIWS G L E LG+ P P +L++ I G P +P
Sbjct: 174 GES-YSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAI-CDGPPPSLPAEEFSPE 231
Query: 272 YTDF 275
+ DF
Sbjct: 232 FRDF 235
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 1e-34
Identities = 82/245 (33%), Positives = 135/245 (55%), Gaps = 20/245 (8%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--------RELQLMRVMDHP 91
Y + +G+G+ GIV A G VA+KK+ R ++N REL L++ ++H
Sbjct: 23 YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKL--SRPFQNQTHAKRAYRELVLLKCVNHK 80
Query: 92 NVISLKHCFFSTTSKNELF-LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 150
N+ISL + F S E + LVME + ++ +V+ H ++RM + YQ+
Sbjct: 81 NIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVI-HMELDHERMSYLL-----YQMLC 134
Query: 151 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPE 210
G+ ++H+ + HRDLKP N++V +KI DFG A+ Y+ +R+YRAPE
Sbjct: 135 GIKHLHSAG-IIHRDLKPSNIVVKS-DCTLKILDFGLARTACTNFMMTPYVVTRYYRAPE 192
Query: 211 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 270
+I G Y ++DIWS GC++ EL+ G +F G + +DQ ++I+ LGTP+ E + + P
Sbjct: 193 VILG-MGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQP 251
Query: 271 NYTDF 275
++
Sbjct: 252 TVRNY 256
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 125 bits (317), Expect = 2e-34
Identities = 64/203 (31%), Positives = 112/203 (55%), Gaps = 20/203 (9%)
Query: 45 VVGTGSFGIVFQAKCLETGETVAIKKV-LQDRRYKN-----RELQLMRVMDHPNVISLKH 98
++G G+FG+V++ LETG+ VAIK++ L+ + + +E+ L++ + HPN++
Sbjct: 7 LIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIG 66
Query: 99 CFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT 157
+ L +++EY S+ +++K + + + V +Y YQ+ +GLAY+H
Sbjct: 67 SI-----ETSDSLYIILEYAENGSLRQIIKKFGPFPESL----VAVYVYQVLQGLAYLHE 117
Query: 158 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI-SYICSRFYRAPELIFGAT 216
V HRD+K N+L VK+ DFG A +L + S + + ++ APE+I +
Sbjct: 118 -QGVIHRDIKAANILTTKDGV-VKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEM-S 174
Query: 217 EYTTSIDIWSAGCVLAELLLGQP 239
+T+ DIWS GC + ELL G P
Sbjct: 175 GASTASDIWSLGCTVIELLTGNP 197
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 2e-34
Identities = 69/206 (33%), Positives = 108/206 (52%), Gaps = 21/206 (10%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK---------NRELQLMRVMDHPNVI 94
++G+GSFG V++ L+ G+ A+K+V + +E+ L+ + HPN++
Sbjct: 6 ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIV 65
Query: 95 SLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 153
+ T + E L + +E VP S+ ++LK Y S P ++LYT QI GL
Sbjct: 66 Q-----YLGTEREEDNLYIFLELVPGGSLAKLLKKYGS----FPEPVIRLYTRQILLGLE 116
Query: 154 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIF 213
Y+H HRD+K N+LVD VK+ DFG AKQ++ S+ S ++ APE+I
Sbjct: 117 YLHD-RNTVHRDIKGANILVDT-NGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIA 174
Query: 214 GATEYTTSIDIWSAGCVLAELLLGQP 239
Y + DIWS GC + E+ G+P
Sbjct: 175 QQGGYGLAADIWSLGCTVLEMATGKP 200
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 4e-34
Identities = 70/232 (30%), Positives = 121/232 (52%), Gaps = 19/232 (8%)
Query: 46 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISLKH- 98
+G G+FG VF+A+ +T + VA+KKVL + + RE+++++++ H NV++L
Sbjct: 20 IGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 79
Query: 99 CFFSTT--SKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 156
C T ++ + LV E+ + +L S+ N + L +K + GL YIH
Sbjct: 80 CRTKATPYNRYKGSFYLVFEFCEHDLAGLL---SNKNVKFTLSEIKKVMKMLLNGLYYIH 136
Query: 157 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK---QLIAGEAN--ISYICSRFYRAPEL 211
++ HRD+K N+L+ +K+ DFG A+ + N + + + +YR PEL
Sbjct: 137 R-NKILHRDMKAANILITK-DGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPEL 194
Query: 212 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 263
+ G +Y ID+W AGC++AE+ P+ G QL I ++ G+ T E
Sbjct: 195 LLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPE 246
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 3e-33
Identities = 71/234 (30%), Positives = 123/234 (52%), Gaps = 26/234 (11%)
Query: 45 VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISLKH 98
+G G++G V++A+ +TGE VA+KKV D + RE++++R ++H N+++LK
Sbjct: 14 QIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKE 73
Query: 99 CFFSTTS-----KNELFLNLVMEYVPESMYRVLK----HYSSANQRMPLIYVKLYTYQIF 149
K++ LV EY+ + +L+ H+S + +K + Q+
Sbjct: 74 IVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDH-------IKSFMKQLL 126
Query: 150 RGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN--ISYICSRFYR 207
GL Y H HRD+K N+L++ Q+K+ DFG A+ + E+ + + + +YR
Sbjct: 127 EGLNYCHK-KNFLHRDIKCSNILLNN-KGQIKLADFGLARLYNSEESRPYTNKVITLWYR 184
Query: 208 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 261
PEL+ G Y +ID+WS GC+L EL +P+F + QL I ++ G+P
Sbjct: 185 PPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPC 238
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 123 bits (309), Expect = 5e-33
Identities = 77/232 (33%), Positives = 125/232 (53%), Gaps = 17/232 (7%)
Query: 39 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKV-LQDRR----YKNRELQLMRVMDHPNV 93
SY +G GS+ V++ K G+ VA+K + LQ+ RE L++ + H N+
Sbjct: 6 SYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANI 65
Query: 94 ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 153
+ L + + L LV EYV + + + + + VKL+ +Q+ RGL+
Sbjct: 66 VLLHDIIHTKET-----LTLVFEYVHTDLCQYMDKHPGG---LHPENVKLFLFQLLRGLS 117
Query: 154 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK-QLIAGEANISYICSRFYRAPELI 212
YIH + HRDLKPQNLL+ T ++K+ DFG A+ + + + + + +YR P+++
Sbjct: 118 YIHQ-RYILHRDLKPQNLLISD-TGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVL 175
Query: 213 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV-DQLVEIIKVLGTPTRE 263
G+TEY+T +D+W GC+ E++ G FPG + DQL I VLGTP +
Sbjct: 176 LGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNED 227
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 6e-33
Identities = 69/237 (29%), Positives = 108/237 (45%), Gaps = 44/237 (18%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR--------YKNRE-LQLMRVMDH 90
+ +++G GSF V AK ET + AI K+L R+ Y E L R+ H
Sbjct: 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAI-KILDKRQLIKEKKVKYVKIEKEVLTRLNGH 61
Query: 91 PNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIF 149
P +I L + F ++E L V+EY P + + ++ Y S +++ + Y +I
Sbjct: 62 PGIIKLYYTF-----QDEENLYFVLEYAPNGELLQYIRKYGSLDEKC----TRFYAAEIL 112
Query: 150 RGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL----IAGEANISYICSRF 205
L Y+H+ + HRDLKP+N+L+D H +KI DFG+AK L
Sbjct: 113 LALEYLHSK-GIIHRDLKPENILLDKDMH-IKITDFGTAKVLDPNSSPESNKGDATNIDS 170
Query: 206 -----------------YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 245
Y +PEL+ S D+W+ GC++ ++L G+P F G N
Sbjct: 171 QIEKNRRRFASFVGTAEYVSPELL-NEKPAGKSSDLWALGCIIYQMLTGKPPFRGSN 226
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 123 bits (309), Expect = 1e-32
Identities = 85/249 (34%), Positives = 137/249 (55%), Gaps = 23/249 (9%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--------RELQLMRVMDHP 91
Y + +G+G+ GIV A VAIKK+ R ++N REL LM+ ++H
Sbjct: 19 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKL--SRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 92 NVISLKHCFFSTTSKNELF-LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 150
N+ISL + F S E + LVME + ++ +V++ ++RM + YQ+
Sbjct: 77 NIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQ-MELDHERMSYLL-----YQMLC 130
Query: 151 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPE 210
G+ ++H+ + HRDLKP N++V +KI DFG A+ Y+ +R+YRAPE
Sbjct: 131 GIKHLHSAG-IIHRDLKPSNIVVKS-DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPE 188
Query: 211 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 270
+I G Y ++DIWS GC++ E++ + LFPG + +DQ ++I+ LGTP E ++ + P
Sbjct: 189 VILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 247
Query: 271 ---NYTDFR 276
NY + R
Sbjct: 248 TVRNYVENR 256
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 3e-32
Identities = 81/240 (33%), Positives = 132/240 (55%), Gaps = 20/240 (8%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--------RELQLMRVMDHP 91
Y + +G+G+ GIV A VAIKK+ R ++N REL LM+ ++H
Sbjct: 26 YQNLKPIGSGAQGIVCAAYDAILERNVAIKKL--SRPFQNQTHAKRAYRELVLMKCVNHK 83
Query: 92 NVISLKHCFFSTTSKNELF-LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 150
N+I L + F S E + +VME + ++ +V++ ++RM + YQ+
Sbjct: 84 NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ-MELDHERMSYLL-----YQMLC 137
Query: 151 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPE 210
G+ ++H+ + HRDLKP N++V +KI DFG A+ Y+ +R+YRAPE
Sbjct: 138 GIKHLHSAG-IIHRDLKPSNIVVKS-DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPE 195
Query: 211 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 270
+I G Y ++DIWS GC++ E++ G LFPG + +DQ ++I+ LGTP E ++ + P
Sbjct: 196 VILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQP 254
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 1e-31
Identities = 93/263 (35%), Positives = 137/263 (52%), Gaps = 37/263 (14%)
Query: 46 VGTGSFGIVFQAKCLETGET--VAIKKVLQD--RRYKNRELQLMRVMDHPNVISLKHCFF 101
VG G++G V++AK + + A+K++ RE+ L+R + HPNVI+L+ F
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFL 68
Query: 102 STTSKNELFLNLVMEYVPESMYRVLKHY--SSANQR---MPLIYVKLYTYQIFRGLAYIH 156
S + + + L+ +Y ++ ++K + S AN++ +P VK YQI G+ Y+H
Sbjct: 69 SHSDRK---VWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH 125
Query: 157 TVPRVCHRDLKPQNLLV---DPLTHQVKICDFGSAKQL---IAGEANISYICSRF-YRAP 209
V HRDLKP N+LV P +VKI D G A+ + A++ + F YRAP
Sbjct: 126 A-NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 184
Query: 210 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA---------VDQLVEIIKVLGTP 260
EL+ GA YT +IDIW+ GC+ AELL +P+F DQL I V+G P
Sbjct: 185 ELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGFP 244
Query: 261 TR---EEIRCMNPNY----TDFR 276
E+IR M P Y DFR
Sbjct: 245 ADKDWEDIRKM-PEYPTLQKDFR 266
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 2e-31
Identities = 65/231 (28%), Positives = 109/231 (47%), Gaps = 34/231 (14%)
Query: 43 ERVVGTGSFGIVFQAKCL----ETGETVAIKKVLQDRRYKN-----RELQLMRVMDHPNV 93
+ +G G+FG V++ VA+K + +D + RE ++MR +DHPN+
Sbjct: 4 GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNI 63
Query: 94 ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHY--SSANQRMPLIYVKLYTYQIFRG 151
+ L T + L +VMEY+P L Y + + + L + + QI RG
Sbjct: 64 VKLLGV---CTEEEPLM--IVMEYMP---GGDLLDYLRKNRPKELSLSDLLSFALQIARG 115
Query: 152 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF----YR 207
+ Y+ + HRDL +N LV VKI DFG ++ L + Y + R
Sbjct: 116 MEYLESK-NFIHRDLAARNCLVG-ENLVVKISDFGLSRDL----YDDDYYKVKGGKLPIR 169
Query: 208 --APELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIK 255
APE + ++T+ D+WS G +L E+ LG+ +PG + +++E +K
Sbjct: 170 WMAPESLK-EGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSN-AEVLEYLK 218
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 119 bits (298), Expect = 3e-31
Identities = 92/262 (35%), Positives = 136/262 (51%), Gaps = 35/262 (13%)
Query: 46 VGTGSFGIVFQAKCLETGET--VAIKKVLQD--RRYKNRELQLMRVMDHPNVISLKHCFF 101
VG G++G V++AK + + A+K++ RE+ L+R + HPNVISL+ F
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 68
Query: 102 STTSKNELFLNLVMEYVPESMYRVLKHY--SSANQR---MPLIYVKLYTYQIFRGLAYIH 156
S + + L+ +Y ++ ++K + S AN++ +P VK YQI G+ Y+H
Sbjct: 69 SHADRK---VWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 125
Query: 157 TVPRVCHRDLKPQNLLV---DPLTHQVKICDFGSAKQL---IAGEANISYICSRF-YRAP 209
V HRDLKP N+LV P +VKI D G A+ + A++ + F YRAP
Sbjct: 126 A-NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 184
Query: 210 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA---------VDQLVEIIKVLGTP 260
EL+ GA YT +IDIW+ GC+ AELL +P+F DQL I V+G P
Sbjct: 185 ELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFP 244
Query: 261 TR---EEIRCMNPNYT---DFR 276
E+I+ M + T DFR
Sbjct: 245 ADKDWEDIKKMPEHSTLMKDFR 266
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 5e-31
Identities = 63/212 (29%), Positives = 112/212 (52%), Gaps = 25/212 (11%)
Query: 46 VGTGSFGIVFQAKCLETGETVAIKKV-LQDRRYKN-----RELQLMRVMDHPNVISLKHC 99
+G G+FG V+ A L+TGE +A+K++ +QD K E++++ ++ HPN++
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVK---Y 64
Query: 100 FFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV 158
+ + ++ + MEY ++ +L+H + + +++YT Q+ GLAY+H+
Sbjct: 65 YGVEVHREKV--YIFMEYCSGGTLEELLEH----GRILDEHVIRVYTLQLLEGLAYLHS- 117
Query: 159 PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL-----IAGEANISYICSRFYRAPELIF 213
+ HRD+KP N+ +D +K+ DFG A +L GE S + Y APE+I
Sbjct: 118 HGIVHRDIKPANIFLDHNG-VIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVIT 176
Query: 214 GAT--EYTTSIDIWSAGCVLAELLLGQPLFPG 243
G + + DIWS GCV+ E+ G+ +
Sbjct: 177 GGKGKGHGRAADIWSLGCVVLEMATGKRPWSE 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 116 bits (291), Expect = 1e-30
Identities = 73/260 (28%), Positives = 132/260 (50%), Gaps = 32/260 (12%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN----------RELQLMRVMDHPNV 93
+ +GTG+F +QA+ ++TG +A+K+V R + +E++LM ++HP++
Sbjct: 6 QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65
Query: 94 ISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 152
I +T + NL +E++ S+ +L Y + + + + YT Q+ RGL
Sbjct: 66 I---RMLGATCEDSHF--NLFVEWMAGGSVSHLLSKYGAFKEA---VIIN-YTEQLLRGL 116
Query: 153 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI-----AGEANISYICSRFYR 207
+Y+H ++ HRD+K NLL+D +++I DFG+A +L AGE + + +
Sbjct: 117 SYLHE-NQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFM 175
Query: 208 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV---LGTPTREE 264
APE++ G +Y S D+WS GCV+ E+ +P + E + L I K+ P+ E
Sbjct: 176 APEVLRG-EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPE 234
Query: 265 IRCMNPNYTDFRFPQIKAHP 284
++P D ++ P
Sbjct: 235 --HLSPGLRDVTLRCLELQP 252
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 2e-30
Identities = 78/271 (28%), Positives = 129/271 (47%), Gaps = 45/271 (16%)
Query: 49 GSFGIVFQAKCLETGETVAIKKV-LQDRRYKNR------ELQLMRVMDHPNVISLKHCFF 101
G++G VF AK TG+ AIK + D KN+ E ++ P V+ L ++
Sbjct: 4 GAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKL---YY 60
Query: 102 STTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR 160
S K L+L VMEY+P + +L++ S ++ + ++Y +I L Y+H+
Sbjct: 61 SFQGKKNLYL--VMEYLPGGDLASLLENVGSLDEDV----ARIYIAEIVLALEYLHSN-G 113
Query: 161 VCHRDLKPQNLLVDPLTHQVKICDFGSAK----QLIAGEANISYICSRF-----YRAPEL 211
+ HRDLKP N+L+D H +K+ DFG +K + + R Y APE+
Sbjct: 114 IIHRDLKPDNILIDSNGH-LKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEV 172
Query: 212 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII--KVLGTPTREEI---- 265
I G ++ ++D WS GC+L E L+G P F GE +++ + I + P E+
Sbjct: 173 ILGQG-HSKTVDWWSLGCILYEFLVGIPPFHGET-PEEIFQNILNGKIEWPEDVEVSDEA 230
Query: 266 -----RCMNPNYT---DFR-FPQIKAHPWHK 287
+ + P+ + +IK HP+ K
Sbjct: 231 IDLISKLLVPDPEKRLGAKSIEEIKNHPFFK 261
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 113 bits (286), Expect = 6e-30
Identities = 66/226 (29%), Positives = 112/226 (49%), Gaps = 25/226 (11%)
Query: 43 ERVVGTGSFGIVFQAK----CLETGETVAIKKVLQDRRYKN-----RELQLMRVMDHPNV 93
+ +G G+FG V++ K + VA+K + +D + RE ++MR +DHPNV
Sbjct: 4 GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63
Query: 94 ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQ-RMPLIYVKLYTYQIFRGL 152
+ L T + L+ +VMEY+ L Y N+ ++ L + + QI RG+
Sbjct: 64 VKLLGV---CTEEEPLY--IVMEYME---GGDLLSYLRKNRPKLSLSDLLSFALQIARGM 115
Query: 153 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYR--APE 210
Y+ + + HRDL +N LV VKI DFG ++ L + R APE
Sbjct: 116 EYLESKNFI-HRDLAARNCLVGE-NLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPE 173
Query: 211 LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIK 255
+ ++T+ D+WS G +L E+ LG+ +PG + ++++E +K
Sbjct: 174 SLK-EGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSN-EEVLEYLK 217
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 2e-29
Identities = 65/208 (31%), Positives = 112/208 (53%), Gaps = 26/208 (12%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYK--NRELQLMRVMDHPNVISL 96
+ +GTGSFG V + +G+ A+K K+++ ++ + E ++++ + HP +++L
Sbjct: 7 KTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNL 66
Query: 97 KHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 154
F +++ L LVMEYVP E L + + R P + Y Q+ L Y
Sbjct: 67 YGSF-----QDDSNLYLVMEYVPGGE-----LFSHLRKSGRFPEPVARFYAAQVVLALEY 116
Query: 155 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPELIF 213
+H++ V +RDLKP+NLL+D + +KI DFG AK++ + +C + Y APE+I
Sbjct: 117 LHSLDIV-YRDLKPENLLLDSDGY-IKITDFGFAKRV---KGRTYTLCGTPEYLAPEIIL 171
Query: 214 GATEYTTSIDIWSAGCVLAELLLGQPLF 241
Y ++D W+ G ++ E+L G P F
Sbjct: 172 S-KGYGKAVDWWALGILIYEMLAGYPPF 198
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 2e-29
Identities = 77/241 (31%), Positives = 122/241 (50%), Gaps = 42/241 (17%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVL--------QDRRYK-----NRELQLMR 86
++ ++G+GSFG V+ +GE +A+K+V +DR+ RE+ L++
Sbjct: 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLK 61
Query: 87 VMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYT 145
+ H N++ S + LN+ +EYVP S+ +L +Y + + + V+ +
Sbjct: 62 ELQHENIVQYLGS-----SLDADHLNIFLEYVPGGSVAALLNNYGAFEETL----VRNFV 112
Query: 146 YQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI------- 198
QI +GL Y+H + HRD+K N+LVD +KI DFG +K+L EAN
Sbjct: 113 RQILKGLNYLHN-RGIIHRDIKGANILVDN-KGGIKISDFGISKKL---EANSLSTKTNG 167
Query: 199 ---SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 255
S S F+ APE++ T YT DIWS GC++ E+L G+ FP QL I K
Sbjct: 168 ARPSLQGSVFWMAPEVV-KQTSYTRKADIWSLGCLVVEMLTGKHPFPD---CTQLQAIFK 223
Query: 256 V 256
+
Sbjct: 224 I 224
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 1e-28
Identities = 63/223 (28%), Positives = 112/223 (50%), Gaps = 22/223 (9%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQD-----RRYKNRELQLMRVMDHPNVISLKH 98
+G G+ G+V + TG+ +A+K + + ++ REL ++ + P ++
Sbjct: 7 GELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYG 66
Query: 99 CFFSTTSKNELFLNLVMEYV-PESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT 157
F++ ++ + MEY+ S+ ++LK R+P + + +GL Y+H
Sbjct: 67 AFYN---NGDISI--CMEYMDGGSLDKILKEVQ---GRIPERILGKIAVAVLKGLTYLHE 118
Query: 158 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATE 217
++ HRD+KP N+LV+ Q+K+CDFG + QL+ A +++ + Y APE I G +
Sbjct: 119 KHKIIHRDVKPSNILVNSRG-QIKLCDFGVSGQLVNSLAK-TFVGTSSYMAPERIQG-ND 175
Query: 218 YTTSIDIWSAGCVLAELLLGQPLFPGENA-----VDQLVEIIK 255
Y+ DIWS G L EL G+ +P EN + L I+
Sbjct: 176 YSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVN 218
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 1e-28
Identities = 69/233 (29%), Positives = 121/233 (51%), Gaps = 30/233 (12%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR--------------ELQLM 85
++ ++G G++G V+ A + TGE +A+K+V R E++ +
Sbjct: 3 WVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETL 62
Query: 86 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLY 144
+ +DH N++ E +L++ +EYVP S+ L+ Y +++ V+ +
Sbjct: 63 KDLDHLNIVQYLGF-----ETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQL----VRFF 113
Query: 145 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ---LIAGEANISYI 201
T Q+ GLAY+H+ + HRDLK NLLVD KI DFG +K+ + + N+S
Sbjct: 114 TEQVLEGLAYLHS-KGILHRDLKADNLLVD-ADGICKISDFGISKKSDDIYDNDQNMSMQ 171
Query: 202 CSRFYRAPELIFGATE-YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEI 253
S F+ APE+I ++ Y+ +DIWS GCV+ E+ G+ + E A+ + ++
Sbjct: 172 GSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKL 224
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 2e-28
Identities = 67/240 (27%), Positives = 108/240 (45%), Gaps = 22/240 (9%)
Query: 45 VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----RELQLM---RVMDHPNVISL 96
++G G++G V++ K + TG VA+K + D + RE+ L+ R PN+
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67
Query: 97 KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 156
+ L ++MEY R L ++ Y+ + ++ L YIH
Sbjct: 68 YGSYLKGPR-----LWIIMEYAEGGSVRTLMKAGPIAEK----YISVIIREVLVALKYIH 118
Query: 157 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN-ISYICSRFYRAPELIFGA 215
V V HRD+K N+LV T VK+CDFG A L + +++ + ++ APE+I
Sbjct: 119 KVG-VIHRDIKAANILVT-NTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEG 176
Query: 216 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 275
Y T DIWS G + E+ G P + +A ++ I K P R E + +F
Sbjct: 177 KYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPK--SKPPRLEDNGYSKLLREF 234
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 6e-28
Identities = 68/216 (31%), Positives = 109/216 (50%), Gaps = 17/216 (7%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV----LQDRRYKNR---ELQLMRVMDHPN 92
+ E+ +G G F +V++A CL G VA+KKV + D + + E+ L++ +DHPN
Sbjct: 4 FKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPN 63
Query: 93 VISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 151
VI F NE LN+V+E + R++KH+ + +P + Y Q+
Sbjct: 64 VIKYLASFI---ENNE--LNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSA 118
Query: 152 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE-ANISYICSRFYRAPE 210
L ++H+ R+ HRD+KP N+ + T VK+ D G + + A S + + +Y +PE
Sbjct: 119 LEHMHS-KRIMHRDIKPANVFITA-TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE 176
Query: 211 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA 246
I Y DIWS GC+L E+ Q F G+
Sbjct: 177 RIHENG-YNFKSDIWSLGCLLYEMAALQSPFYGDKM 211
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 3e-27
Identities = 78/266 (29%), Positives = 121/266 (45%), Gaps = 37/266 (13%)
Query: 46 VGTGSFGIVFQAKCLETGETVAIKKV-------LQDRRYKNRELQLMRVMDHPNVISLKH 98
VG G +G VF AK +TGE VA+K++ L + R+ E ++ ++ L +
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68
Query: 99 CFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV 158
F L+L MEYVP +R L + + + + Y ++F + +H +
Sbjct: 69 AF---QDDEYLYL--AMEYVPGGDFRTLL---NNLGVLSEDHARFYMAEMFEAVDALHEL 120
Query: 159 PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEY 218
HRDLKP+N L+D H +K+ DFG +K ++ AN S + S Y APE++ G Y
Sbjct: 121 G-YIHRDLKPENFLIDASGH-IKLTDFGLSKGIVT-YAN-SVVGSPDYMAPEVLRG-KGY 175
Query: 219 TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII---KVLGTPTREEIR--------- 266
++D WS GC+L E L G P F G + + + L P ++ R
Sbjct: 176 DFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWD 235
Query: 267 ----CMNPNYTDFR-FPQIKAHPWHK 287
+N F IK HP+ K
Sbjct: 236 LITKLINDPSRRFGSLEDIKNHPFFK 261
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 106 bits (268), Expect = 3e-27
Identities = 59/225 (26%), Positives = 104/225 (46%), Gaps = 22/225 (9%)
Query: 45 VVGTGSFGIVFQAKCLETGETVAIKKV------LQDRRYKNRELQLMRVMDHPNVISLKH 98
+G GSFG V + + G+ + K++ ++++ E+ ++R + HPN++
Sbjct: 7 TIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYD 66
Query: 99 CFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT 157
+++ L +VMEY + ++++ + + ++ Q+ L H
Sbjct: 67 RIIDRSNQT---LYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHN 123
Query: 158 V----PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI---SYICSRFYRAPE 210
V HRDLKP N+ +D + VK+ DFG AK L G + +Y+ + +Y +PE
Sbjct: 124 RSDPGNTVLHRDLKPANIFLDA-NNNVKLGDFGLAKIL--GHDSSFAKTYVGTPYYMSPE 180
Query: 211 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 255
+ + Y DIWS GC++ EL P F N QL IK
Sbjct: 181 QLNHMS-YDEKSDIWSLGCLIYELCALSPPFTARNQ-LQLASKIK 223
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 3e-27
Identities = 70/241 (29%), Positives = 119/241 (49%), Gaps = 27/241 (11%)
Query: 45 VVGTGSFGIVFQAKCLETGETVAIKKVL---QDRRYKNRELQLMRVMDHPNVISLKHCFF 101
+G G+ G V++A TG+ VAIKK+ Q++ E+ +M+ HPN++ +
Sbjct: 26 KIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYL 85
Query: 102 STTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMP---LIYVKLYTYQIFRGLAYIHT 157
+EL++ VMEY+ S+ ++ RM + YV ++ +GL Y+H+
Sbjct: 86 V---GDELWV--VMEYMDGGSLTDIITQNFV---RMNEPQIAYVCR---EVLQGLEYLHS 134
Query: 158 VPRVCHRDLKPQNLLVDPLTHQ--VKICDFGSAKQLIAGEAN-ISYICSRFYRAPELIFG 214
+ HRD+K N+L L+ VK+ DFG A QL ++ S + + ++ APE+I
Sbjct: 135 QNVI-HRDIKSDNIL---LSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKR 190
Query: 215 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 274
+Y +DIWS G + E+ G+P + E + L I G P + +P + D
Sbjct: 191 -KDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITT-KGIPPLKNPEKWSPEFKD 248
Query: 275 F 275
F
Sbjct: 249 F 249
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 4e-27
Identities = 62/215 (28%), Positives = 106/215 (49%), Gaps = 15/215 (6%)
Query: 45 VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--RELQLMRVMDHPNVISLKHCFFS 102
+G GS+G V++A ETG+ VAIK V + + +E+ +++ D P ++ +F
Sbjct: 10 KLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVKYYGSYF- 68
Query: 103 TTSKNELFLNLVMEY-VPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRV 161
+L+ +VMEY S+ ++K N+ + + YQ +GL Y+H+ +
Sbjct: 69 --KNTDLW--IVMEYCGAGSVSDIMK---ITNKTLTEEEIAAILYQTLKGLEYLHSN-KK 120
Query: 162 CHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI-SYICSRFYRAPELIFGATEYTT 220
HRD+K N+L++ Q K+ DFG + QL A + I + F+ APE+I Y
Sbjct: 121 IHRDIKAGNILLNE-EGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQE-IGYNN 178
Query: 221 SIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 255
DIWS G E+ G+P + + + + I
Sbjct: 179 KADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPN 213
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 5e-27
Identities = 73/233 (31%), Positives = 117/233 (50%), Gaps = 26/233 (11%)
Query: 31 NGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-------RELQ 83
+P++ + + E +G GSFG V+ A+ + T E VAIKK+ + N +E++
Sbjct: 10 KDDPEKLFTDLRE--IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVR 67
Query: 84 LMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKL 143
++ + HPN I K C+ + LVMEY S +L+ + Q + + +
Sbjct: 68 FLQQLRHPNTIEYKGCYLREHTA-----WLVMEYCLGSASDILEVHKKPLQEVEIAAI-- 120
Query: 144 YTYQIFRGLAYIHTVPRVCHRDLKPQN-LLVDPLTHQVKICDFGSAKQLIAGEANISYIC 202
+ +GLAY+H+ R+ HRD+K N LL +P VK+ DFGSA + AN S++
Sbjct: 121 -CHGALQGLAYLHSHERI-HRDIKAGNILLTEP--GTVKLADFGSAS--LVSPAN-SFVG 173
Query: 203 SRFYRAPELIFGATE--YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEI 253
+ ++ APE+I E Y +D+WS G EL +P NA+ L I
Sbjct: 174 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI 226
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 1e-26
Identities = 78/271 (28%), Positives = 125/271 (46%), Gaps = 54/271 (19%)
Query: 49 GSFGIVFQAKCLETGETVAIK-----KVLQDRRYKNRELQ---LMRVMDHPNVISLKHCF 100
G+FG V+ AK TG+ AIK ++ + N + + +M + P V L +
Sbjct: 7 GAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKL---Y 63
Query: 101 FSTTSKNELFLNLVMEYVP----ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 156
+S SK+ L+L VMEY+ S+ + L +P + K Y ++ G+ +H
Sbjct: 64 YSFQSKDYLYL--VMEYLNGGDCASLIKTLGG-------LPEDWAKQYIAEVVLGVEDLH 114
Query: 157 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGAT 216
+ HRD+KP+NLL+D H +K+ DFG ++ G N ++ + Y APE I G
Sbjct: 115 Q-RGIIHRDIKPENLLIDQTGH-LKLTDFGLSR---NGLENKKFVGTPDYLAPETILGVG 169
Query: 217 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII--KVLGTPTREE---------- 264
+ D WS GCV+ E L G P F E D + + I + + P +
Sbjct: 170 D-DKMSDWWSLGCVIFEFLFGYPPFHAE-TPDAVFDNILSRRINWPEEVKEFCSPEAVDL 227
Query: 265 ---IRCMNPNYTDFR-----FPQIKAHPWHK 287
+ CM+P R + +IK+HP+ K
Sbjct: 228 INRLLCMDPAK---RLGANGYQEIKSHPFFK 255
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 9e-26
Identities = 61/210 (29%), Positives = 108/210 (51%), Gaps = 26/210 (12%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---------RELQLMRVMDHPNVI 94
+++G G+FG V+ ++TG +A+K+V D E+QL++ + H ++
Sbjct: 8 KLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIV 67
Query: 95 SLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 153
C +++ L++ MEY+P S+ LK Y + + + + YT QI G+
Sbjct: 68 QYYGCL-----RDDETLSIFMEYMPGGSVKDQLKAYGALTETV----TRKYTRQILEGVE 118
Query: 154 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL----IAGEANISYICSRFYRAP 209
Y+H+ + HRD+K N+L D VK+ DFG++K+L +G S + ++ +P
Sbjct: 119 YLHS-NMIVHRDIKGANILRD-SAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSP 176
Query: 210 ELIFGATEYTTSIDIWSAGCVLAELLLGQP 239
E+I G Y D+WS GC + E+L +P
Sbjct: 177 EVISGEG-YGRKADVWSVGCTVVEMLTEKP 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 1e-25
Identities = 67/217 (30%), Positives = 103/217 (47%), Gaps = 18/217 (8%)
Query: 47 GTGSFGIVFQAKCLETGETVAIKKV-LQDRRYKNR-----ELQLMRVMDHPNVISLKHCF 100
G GS+G V++ K L + A+K+V L K R E++++ ++HPN+IS K F
Sbjct: 9 GKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAF 68
Query: 101 FSTTSKNELFLNLVMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 159
L +VMEY P + + + + +P + Q+ RGL +H
Sbjct: 69 LDGNK-----LCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ- 122
Query: 160 RVCHRDLKPQN-LLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEY 218
++ HRDLK N LLV VKI D G +K L A + I + Y APE ++ Y
Sbjct: 123 KILHRDLKSANILLVAN--DLVKIGDLGISKVLKKNMAK-TQIGTPHYMAPE-VWKGRPY 178
Query: 219 TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 255
+ DIWS GC+L E+ P F + D ++ +
Sbjct: 179 SYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQR 215
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 3e-25
Identities = 56/214 (26%), Positives = 98/214 (45%), Gaps = 25/214 (11%)
Query: 44 RVVGTGSFGIVFQAKCLETGE----TVAIKKVLQDRRYKN-----RELQLMRVMDHPNVI 94
+ +G G+FG V++ GE VA+K + + + E +M+ + HPN++
Sbjct: 5 KKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIV 64
Query: 95 SLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHY-SSANQRMPLIYVKLYTYQIFRGLA 153
L T L+ +V EY+P L + +++ L + QI +G+
Sbjct: 65 RLLGVC---TQGEPLY--IVTEYMP---GGDLLDFLRKHGEKLTLKDLLQMALQIAKGME 116
Query: 154 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF---YRAPE 210
Y+ + V HRDL +N LV VKI DFG ++ + + + + APE
Sbjct: 117 YLESKNFV-HRDLAARNCLVT-ENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPE 174
Query: 211 LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 243
+ ++T+ D+WS G +L E+ LG+ +PG
Sbjct: 175 SLK-DGKFTSKSDVWSFGVLLWEIFTLGEQPYPG 207
|
Length = 258 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 1e-24
Identities = 75/225 (33%), Positives = 110/225 (48%), Gaps = 29/225 (12%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIKK-----VLQDRRY-----KNRELQLMRVMDHPNV 93
+V+G GSFG V A+ T E A+K +LQD + R L L HP +
Sbjct: 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAG--KHPFL 58
Query: 94 ISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 151
L H F T K+ LF VMEYV + M+ + + + R + Y +I G
Sbjct: 59 TQL-HSCFQT--KDRLFF--VMEYVNGGDLMFHIQR-----SGRFDEPRARFYAAEIVLG 108
Query: 152 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPE 210
L ++H + +RDLK N+L+D H +KI DFG K+ I G S C + Y APE
Sbjct: 109 LQFLHE-RGIIYRDLKLDNVLLDSEGH-IKIADFGMCKEGILGGVTTSTFCGTPDYIAPE 166
Query: 211 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 255
++ Y ++D W+ G +L E+L GQ F G++ D+L + I
Sbjct: 167 ILSY-QPYGPAVDWWALGVLLYEMLAGQSPFEGDDE-DELFQSIL 209
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 98.8 bits (246), Expect = 2e-24
Identities = 67/213 (31%), Positives = 101/213 (47%), Gaps = 16/213 (7%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV------LQDRRYKNRELQLMRVMDHPNV 93
Y RVVG G+FGIV + + V IK++ +R E Q+++++ HPN+
Sbjct: 2 YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNI 61
Query: 94 ISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 152
I F + L +VMEY P ++ ++ N + + + QI L
Sbjct: 62 IEYYENFLEDKA-----LMIVMEYAPGGTLAEYIQ--KRCNSLLDEDTILHFFVQILLAL 114
Query: 153 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELI 212
++HT + HRDLK QN+L+D VKI DFG +K L + + + + Y +PEL
Sbjct: 115 HHVHT-KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELC 173
Query: 213 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 245
G Y DIW+ GCVL EL + F N
Sbjct: 174 EG-KPYNQKSDIWALGCVLYELASLKRAFEAAN 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 98.6 bits (246), Expect = 4e-24
Identities = 61/210 (29%), Positives = 102/210 (48%), Gaps = 23/210 (10%)
Query: 45 VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----RELQLMRVMDHPNVISLKHC 99
V+G G+ +V+ A CL E VAIK++ ++ + +E+Q M +HPNV+ +
Sbjct: 8 VIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKY-YT 66
Query: 100 FFSTTSKNELFLNLVMEYVPE-SMYRVLKH-YSSANQRMPLIYVKLYTYQIFRGLAYIHT 157
F +EL+ LVM Y+ S+ ++K Y +I L ++ +GL Y+H+
Sbjct: 67 SF--VVGDELW--LVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVL--KEVLKGLEYLHS 120
Query: 158 VPRVCHRDLKPQNLLVDPLTH-QVKICDFGSAKQLIAG-----EANISYICSRFYRAPEL 211
++ HRD+K N+L+ VKI DFG + L G + +++ + + APE+
Sbjct: 121 NGQI-HRDIKAGNILLG--EDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEV 177
Query: 212 IFGATEYTTSIDIWSAGCVLAELLLGQPLF 241
+ Y DIWS G EL G +
Sbjct: 178 MEQVHGYDFKADIWSFGITAIELATGAAPY 207
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 98.4 bits (245), Expect = 4e-24
Identities = 75/218 (34%), Positives = 109/218 (50%), Gaps = 37/218 (16%)
Query: 43 ERVV-GTGSFGIVFQAKCLETGETVAIKKV-LQDRRYK---NRELQLMRVMDHPNVISLK 97
ERVV G G++GIV+ A+ L T +AIK++ +D RY + E+ L + H N++
Sbjct: 12 ERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQ-- 69
Query: 98 HCFFSTTSKNELFLNLVMEYVP--------ESMYRVLKHYSSANQRMPLIYVKLYTYQIF 149
+ + S+N F + ME VP S + LK + YT QI
Sbjct: 70 --YLGSDSENGFFK-IFMEQVPGGSLSALLRSKWGPLKDNEQT--------IIFYTKQIL 118
Query: 150 RGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF---- 205
GL Y+H ++ HRD+K N+LV+ + VKI DFG++K+L A I+ F
Sbjct: 119 EGLKYLHDN-QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL----AGINPCTETFTGTL 173
Query: 206 -YRAPELI-FGATEYTTSIDIWSAGCVLAELLLGQPLF 241
Y APE+I G Y DIWS GC + E+ G+P F
Sbjct: 174 QYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPF 211
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 98.2 bits (245), Expect = 6e-24
Identities = 70/244 (28%), Positives = 113/244 (46%), Gaps = 45/244 (18%)
Query: 44 RVVGTGSFGIVFQAKCLE-----TGETVAIKK-----VLQDRRYKNRELQLMRVMDHPNV 93
+ +G G FG V + TGE VA+K Q R RE++++R +DH N+
Sbjct: 10 KQLGEGHFGKVELC-RYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENI 68
Query: 94 ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQ-RMPLIYVKLYTYQIFRGL 152
+ K ++ L L+MEY+P L+ Y ++ ++ L + L++ QI +G+
Sbjct: 69 VKYKGVCEKPGGRS---LRLIMEYLP---SGSLRDYLQRHRDQINLKRLLLFSSQICKGM 122
Query: 153 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR-------F 205
Y+ + R HRDL +N+LV+ VKI DFG AK L + Y + F
Sbjct: 123 DYLGSQ-RYIHRDLAARNILVES-EDLVKISDFGLAKVLPEDK---DYYYVKEPGESPIF 177
Query: 206 YRAPELIFGATEYTTSIDIWSAGCVLAELL---------LGQPL-----FPGENAVDQLV 251
+ APE + + + S D+WS G L EL + L G+ V +L+
Sbjct: 178 WYAPECLRTSKFSSAS-DVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLL 236
Query: 252 EIIK 255
E++K
Sbjct: 237 ELLK 240
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 97.2 bits (243), Expect = 1e-23
Identities = 61/230 (26%), Positives = 100/230 (43%), Gaps = 50/230 (21%)
Query: 44 RVVGTGSFGIVFQAKCLETGET---VAIKKVLQDRRYKNR-----ELQLMRVMDHPNVIS 95
+ +G G+FG V++ K VA+K + +D + R E ++M+ + HPNV+
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 96 LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHY---------SSANQRMPLIYVKLYTY 146
L T + L+ LV+EY+ L Y S + L + +
Sbjct: 61 LLGV---CTEEEPLY--LVLEYME---GGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAI 112
Query: 147 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFY 206
QI +G+ Y+ + + HRDL +N LV VKI DFG ++ + + +Y
Sbjct: 113 QIAKGMEYLASK-KFVHRDLAARNCLVGE-DLVVKISDFGLSRDVYDDD---------YY 161
Query: 207 R------------APELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 243
R APE + +T+ D+WS G +L E+ LG +PG
Sbjct: 162 RKKTGGKLPIRWMAPESLKDGI-FTSKSDVWSFGVLLWEIFTLGATPYPG 210
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 97.7 bits (243), Expect = 2e-23
Identities = 69/213 (32%), Positives = 112/213 (52%), Gaps = 24/213 (11%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLM----RVM----DHPNVIS 95
+++G GSFG VF A+ T + AIK + +D + +++ RV+ +HP
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP---F 57
Query: 96 LKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 153
L H + + +K LF VMEY+ + M+ + + + L Y +I GL
Sbjct: 58 LTHLYCTFQTKENLFF--VMEYLNGGDLMFHI-----QSCHKFDLPRATFYAAEIICGLQ 110
Query: 154 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPELI 212
++H+ + +RDLK N+L+D H +KI DFG K+ + G+A C + Y APE++
Sbjct: 111 FLHS-KGIVYRDLKLDNILLDTDGH-IKIADFGMCKENMLGDAKTCTFCGTPDYIAPEIL 168
Query: 213 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 245
G +Y TS+D WS G +L E+L+GQ F G +
Sbjct: 169 LG-QKYNTSVDWWSFGVLLYEMLIGQSPFHGHD 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 97.5 bits (242), Expect = 2e-23
Identities = 76/220 (34%), Positives = 113/220 (51%), Gaps = 24/220 (10%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-------RELQLMRVMDHPNVISL 96
R +G GSFG V+ A+ + T E VAIKK+ + N +E++ ++ + HPN I
Sbjct: 31 REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEY 90
Query: 97 KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 156
K C+ E LVMEY S +L+ + Q + + + T+ +GLAY+H
Sbjct: 91 KGCYL-----REHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAI---THGALQGLAYLH 142
Query: 157 TVPRVCHRDLKPQN-LLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGA 215
+ + HRD+K N LL +P QVK+ DFGSA IA AN S++ + ++ APE+I
Sbjct: 143 S-HNMIHRDIKAGNILLTEP--GQVKLADFGSAS--IASPAN-SFVGTPYWMAPEVILAM 196
Query: 216 TE--YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEI 253
E Y +D+WS G EL +P NA+ L I
Sbjct: 197 DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI 236
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 3e-23
Identities = 71/218 (32%), Positives = 109/218 (50%), Gaps = 24/218 (11%)
Query: 46 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-------RELQLMRVMDHPNVISLKH 98
+G GSFG V+ A T E VA+KK+ + N +E++ ++ + HPN I K
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 99 CFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV 158
C+ + LVMEY S +L+ + Q + + + T+ +GLAY+H+
Sbjct: 89 CYLKEHTA-----WLVMEYCLGSASDLLEVHKKPLQEVEIAAI---THGALQGLAYLHSH 140
Query: 159 PRVCHRDLKPQN-LLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATE 217
+ HRD+K N LL +P QVK+ DFGSA + AN S++ + ++ APE+I E
Sbjct: 141 NMI-HRDIKAGNILLTEP--GQVKLADFGSAS--KSSPAN-SFVGTPYWMAPEVILAMDE 194
Query: 218 --YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEI 253
Y +D+WS G EL +P NA+ L I
Sbjct: 195 GQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI 232
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.1 bits (240), Expect = 4e-23
Identities = 57/210 (27%), Positives = 92/210 (43%), Gaps = 26/210 (12%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV-----LQDRRYKNRELQLMRVMDHPNVI 94
+ +G GSFG V++A T + VAIK + + +E+Q + P +
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62
Query: 95 SLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 153
F + L ++MEY S +LK ++ Y+ ++ GL
Sbjct: 63 KYYGSFLKGSK-----LWIIMEYCGGGSCLDLLKPG-----KLDETYIAFILREVLLGLE 112
Query: 154 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS----YICSRFYRAP 209
Y+H HRD+K N+L+ VK+ DFG + QL + +S ++ + F+ AP
Sbjct: 113 YLHE-EGKIHRDIKAANILLSE-EGDVKLADFGVSGQL---TSTMSKRNTFVGTPFWMAP 167
Query: 210 ELIFGATEYTTSIDIWSAGCVLAELLLGQP 239
E+I + Y DIWS G EL G+P
Sbjct: 168 EVIKQ-SGYDEKADIWSLGITAIELAKGEP 196
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 96.4 bits (240), Expect = 6e-23
Identities = 75/222 (33%), Positives = 115/222 (51%), Gaps = 21/222 (9%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLM----RVM----DHPNVIS 95
+V+G GSFG V A+ T E AIK + +D ++ +++ RV+ +HP
Sbjct: 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHP---F 57
Query: 96 LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 155
L H F + +K LF VMEY+ L + ++ R + Y +I GL ++
Sbjct: 58 LTHLFCTFQTKEHLFF--VMEYLNGGD---LMFHIQSSGRFDEARARFYAAEIICGLQFL 112
Query: 156 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPELIFG 214
H + +RDLK N+L+D H +KI DFG K+ + GE S C + Y APE++ G
Sbjct: 113 HK-KGIIYRDLKLDNVLLDKDGH-IKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKG 170
Query: 215 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 256
+Y S+D WS G +L E+L+GQ F GE+ D+L + I
Sbjct: 171 -QKYNESVDWWSFGVLLYEMLIGQSPFHGEDE-DELFDSILN 210
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 95.9 bits (238), Expect = 8e-23
Identities = 72/220 (32%), Positives = 109/220 (49%), Gaps = 24/220 (10%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-------RELQLMRVMDHPNVISL 96
R +G GSFG V+ A+ + E VAIKK+ + N +E++ ++ + HPN I
Sbjct: 21 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80
Query: 97 KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 156
+ C+ E LVMEY S +L+ + Q + + V T+ +GLAY+H
Sbjct: 81 RGCYL-----REHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAV---THGALQGLAYLH 132
Query: 157 TVPRVCHRDLKPQN-LLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGA 215
+ + HRD+K N LL +P VK+ DFGSA I AN ++ + ++ APE+I
Sbjct: 133 S-HNMIHRDVKAGNILLSEP--GLVKLGDFGSAS--IMAPAN-XFVGTPYWMAPEVILAM 186
Query: 216 TE--YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEI 253
E Y +D+WS G EL +P NA+ L I
Sbjct: 187 DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI 226
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 95.4 bits (237), Expect = 1e-22
Identities = 74/224 (33%), Positives = 119/224 (53%), Gaps = 25/224 (11%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLM----RVM----DHPNVIS 95
+V+G GSFG V A+ GE A+K + +D + +++ RV+ ++P +
Sbjct: 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60
Query: 96 LKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 153
L +C F T K LF VME++ + M+ + R L Y +I GL
Sbjct: 61 L-YCTFQT--KEHLFF--VMEFLNGGDLMFHI-----QDKGRFDLYRATFYAAEIVCGLQ 110
Query: 154 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPELI 212
++H+ + +RDLK N+++D H +KI DFG K+ + G+ S C + Y APE++
Sbjct: 111 FLHS-KGIIYRDLKLDNVMLDRDGH-IKIADFGMCKENVFGDNRASTFCGTPDYIAPEIL 168
Query: 213 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 256
G +YT S+D WS G +L E+L+GQ F G++ D+L E I+V
Sbjct: 169 QG-LKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE-DELFESIRV 210
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 93.1 bits (232), Expect = 3e-22
Identities = 56/207 (27%), Positives = 104/207 (50%), Gaps = 18/207 (8%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKN--RELQLMRVMDHPNVISL 96
RV+G G+FG V + +T + A+K K ++ +N E ++++ ++HP +++L
Sbjct: 6 RVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNL 65
Query: 97 KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 156
+ F ++E + LV++ + + L+++ S + VK + +I L Y+H
Sbjct: 66 WYSF-----QDEENMYLVVDLL---LGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLH 117
Query: 157 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGAT 216
+ + HRD+KP N+L+D H V I DF A ++ S + Y APE++
Sbjct: 118 S-KGIIHRDIKPDNILLDEQGH-VHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCRQG 175
Query: 217 EYTTSIDIWSAGCVLAELLLGQPLFPG 243
Y+ ++D WS G E L G+ + G
Sbjct: 176 -YSVAVDWWSLGVTAYECLRGKRPYRG 201
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 92.7 bits (231), Expect = 5e-22
Identities = 71/268 (26%), Positives = 113/268 (42%), Gaps = 42/268 (15%)
Query: 46 VGTGSFGIVFQAKCLETGETVAIKKV----LQDRRYKN---RELQLMRVMDHPNVISLKH 98
+G G FG V K T A+K V + + + E +++ +HP ++ L +
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKL-Y 59
Query: 99 CFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 156
F K++ ++ ++MEY E L + Y + Y+H
Sbjct: 60 RTF----KDKKYIYMLMEYCLGGE-----LWTILRDRGLFDEYTARFYIACVVLAFEYLH 110
Query: 157 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGAT 216
+ +RDLKP+NLL+D VK+ DFG AK+L +G+ ++ + Y APE+I
Sbjct: 111 NR-GIIYRDLKPENLLLD-SNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKG 168
Query: 217 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQL------VEIIKVLGTP---TREEIRC 267
Y S+D WS G +L ELL G+P F GE+ D + ++ L P +
Sbjct: 169 -YDFSVDYWSLGILLYELLTGRPPF-GEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDL 226
Query: 268 M------NP----NYTDFRFPQIKAHPW 285
+ NP IK H W
Sbjct: 227 IKQLLRRNPEERLGNLKGGIKDIKKHKW 254
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 5e-22
Identities = 67/266 (25%), Positives = 119/266 (44%), Gaps = 41/266 (15%)
Query: 47 GTGSFGIVFQAKCLETGETVAIKKV---LQDRRYKNRELQLMRVMDHPNVISLK--HCFF 101
G G++G+V + + + TG +A+K++ + + K +L+ +D IS++ C +
Sbjct: 10 GRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQK----RLLMDLD----ISMRSVDCPY 61
Query: 102 STTSKNELFLN----LVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT 157
+ T LF + ME + S+ + K +P + I + L Y+H+
Sbjct: 62 TVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS 121
Query: 158 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATE 217
V HRD+KP N+L++ QVK+CDFG + L+ A + Y APE I
Sbjct: 122 KLSVIHRDVKPSNVLINRNG-QVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELN 180
Query: 218 ---YTTSIDIWSAGCVLAELLLGQPLFPGEN---AVDQLVEIIKVLGTPTR-------EE 264
Y D+WS G + EL G+ FP ++ QL ++++ + E
Sbjct: 181 QKGYDVKSDVWSLGITMIELATGR--FPYDSWKTPFQQLKQVVE--EPSPQLPAEKFSPE 236
Query: 265 I-----RCMNPNYTDF-RFPQIKAHP 284
+C+ NY + +P++ HP
Sbjct: 237 FQDFVNKCLKKNYKERPNYPELLQHP 262
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 8e-22
Identities = 65/219 (29%), Positives = 105/219 (47%), Gaps = 20/219 (9%)
Query: 46 VGTGSFGIVFQAKCLETGETVAIKKV-LQ--DRRYKN---RELQLMRVMDHPNVISLKHC 99
+G GSFG+VF+ A+K++ L +RR + E +++ +D +I
Sbjct: 8 IGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYES 67
Query: 100 FFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV 158
F LN+VMEY ++++LK + +P V + QI GLA++H+
Sbjct: 68 FLDKGK-----LNIVMEYAENGDLHKLLKMQRG--RPLPEDQVWRFFIQILLGLAHLHS- 119
Query: 159 PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE--ANISYICSRFYRAPELIFGAT 216
++ HRD+K NL +D VKI D G AK L AN + + + +Y +PEL
Sbjct: 120 KKILHRDIKSLNLFLDA-YDNVKIGDLGVAKLLSDNTNFAN-TIVGTPYYLSPELC-EDK 176
Query: 217 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 255
Y D+W+ G VL E G+ F N +++II+
Sbjct: 177 PYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIR 215
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 91.9 bits (228), Expect = 1e-21
Identities = 58/213 (27%), Positives = 106/213 (49%), Gaps = 31/213 (14%)
Query: 45 VVGTGSFGIVFQAKCLETGETVAIKKVLQD--------RRYK--NRELQLMRVMDHPNVI 94
V+G G++G V+ G+ +A+K+V D + Y+ E+ L++ + H N++
Sbjct: 7 VLGKGAYGTVY-CGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 95 SLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 153
+ T ++ +++ ME+VP S+ +L + +P YT QI G+A
Sbjct: 66 Q-----YLGTCLDDNTISIFMEFVPGGSISSILNRFGP----LPEPVFCKYTKQILDGVA 116
Query: 154 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYI-------CSRFY 206
Y+H V HRD+K N+++ P +K+ DFG A++L + ++ + ++
Sbjct: 117 YLHN-NCVVHRDIKGNNVMLMP-NGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYW 174
Query: 207 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQP 239
APE+I + Y DIWS GC + E+ G+P
Sbjct: 175 MAPEVI-NESGYGRKSDIWSIGCTVFEMATGKP 206
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 1e-21
Identities = 66/203 (32%), Positives = 105/203 (51%), Gaps = 20/203 (9%)
Query: 46 VGTGSFGIVFQAKCLETGETVAIKKVLQD-----RRYKNRELQLMRVMDHPNVISLKHCF 100
+G G+ G V + K + TG +A K V R+ RELQ+M P ++S F
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72
Query: 101 FSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 159
NE + + ME++ S+ R+ K +P+ + + GL Y++ V
Sbjct: 73 L-----NENNICMCMEFMDCGSLDRIYKKGGP----IPVEILGKIAVAVVEGLTYLYNVH 123
Query: 160 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYT 219
R+ HRD+KP N+LV+ Q+K+CDFG + +LI A+ +++ + Y +PE I G +YT
Sbjct: 124 RIMHRDIKPSNILVNS-RGQIKLCDFGVSGELINSIAD-TFVGTSTYMSPERIQGG-KYT 180
Query: 220 TSIDIWSAGCVLAELLLGQPLFP 242
D+WS G + EL LG+ FP
Sbjct: 181 VKSDVWSLGISIIELALGK--FP 201
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 2e-21
Identities = 64/208 (30%), Positives = 109/208 (52%), Gaps = 18/208 (8%)
Query: 45 VVGTGSFGIVFQAKCLETGETVAIKKVLQD-----RRYKNRELQLMRVMDHPNVISLKHC 99
+G G+ G+V + +G +A K + + R REL+++ + P ++
Sbjct: 8 ELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGA 67
Query: 100 FFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV 158
F+S E+ ++ ME++ S+ +VLK R+P + + + RGL Y+
Sbjct: 68 FYS---DGEI--SICMEHMDGGSLDQVLKKAG----RIPENILGKISIAVLRGLTYLREK 118
Query: 159 PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEY 218
++ HRD+KP N+LV+ ++K+CDFG + QLI AN S++ +R Y +PE + G T Y
Sbjct: 119 HKIMHRDVKPSNILVNS-RGEIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-THY 175
Query: 219 TTSIDIWSAGCVLAELLLGQPLFPGENA 246
T DIWS G L E+ +G+ P +A
Sbjct: 176 TVQSDIWSLGLSLVEMAIGRYPIPPPDA 203
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.2 bits (227), Expect = 2e-21
Identities = 68/209 (32%), Positives = 109/209 (52%), Gaps = 32/209 (15%)
Query: 46 VGTGSFGIVFQAKCLETGETVAIKKVL----QDRRYKNRELQLMRVMDHPNVISLKHCFF 101
+G+G++G V++A+ + TGE VAIK + D +E+ +++ HPN++ F
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIV---AYFG 67
Query: 102 STTSKNELFLNLVMEYVP----ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT 157
S +++L+ +VMEY + +Y+V + S Q + YV + +GLAY+H
Sbjct: 68 SYLRRDKLW--IVMEYCGGGSLQDIYQVTRGPLSELQ---IAYV---CRETLKGLAYLHE 119
Query: 158 VPRVCHRDLKPQNLLVDPLTHQ--VKICDFGSAKQLIAGEAN-ISYICSRFYRAPELIFG 214
++ HRD+K N+L LT VK+ DFG + QL A A S+I + ++ APE+
Sbjct: 120 TGKI-HRDIKGANIL---LTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVA-- 173
Query: 215 ATE----YTTSIDIWSAGCVLAELLLGQP 239
A E Y DIW+ G EL QP
Sbjct: 174 AVERKGGYDGKCDIWALGITAIELAELQP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 2e-21
Identities = 67/210 (31%), Positives = 103/210 (49%), Gaps = 26/210 (12%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ---------LMRVMDHPNVI 94
+V+G GSFG V AK G+ A+ KVLQ + ++ Q L++ + HP ++
Sbjct: 1 KVIGKGSFGKVLLAKHKADGKFYAV-KVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLV 59
Query: 95 SLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 152
L H F T K L V++YV E + + + + P + Y +I L
Sbjct: 60 GL-HYSFQTADK----LYFVLDYVNGGELFFHLQRE-----RSFPEPRARFYAAEIASAL 109
Query: 153 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPEL 211
Y+H++ + +RDLKP+N+L+D H V + DFG K+ I S C + Y APE+
Sbjct: 110 GYLHSL-NIIYRDLKPENILLDSQGH-VVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEV 167
Query: 212 IFGATEYTTSIDIWSAGCVLAELLLGQPLF 241
+ Y ++D W G VL E+L G P F
Sbjct: 168 LR-KQPYDRTVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 90.9 bits (225), Expect = 2e-21
Identities = 65/236 (27%), Positives = 116/236 (49%), Gaps = 27/236 (11%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR---------ELQLMRVMDHPNVI 94
+++G G+FG V+ +TG +A+K+V D E+QL++ + H ++
Sbjct: 8 KLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIV 67
Query: 95 SLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 153
C + L++ ME++P S+ LK Y + + + + YT QI G++
Sbjct: 68 QYYGCLRDPMERT---LSIFMEHMPGGSIKDQLKSYGALTENV----TRKYTRQILEGVS 120
Query: 154 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL----IAGEANISYICSRFYRAP 209
Y+H+ + HRD+K N+L D VK+ DFG++K+L ++G S + ++ +P
Sbjct: 121 YLHS-NMIVHRDIKGANILRDS-VGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSP 178
Query: 210 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 265
E+I G Y DIWS GC + E+L +P + + + I K+ PT +
Sbjct: 179 EVISGEG-YGRKADIWSVGCTVVEMLTEKPPWA---EFEAMAAIFKIATQPTNPVL 230
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 90.9 bits (226), Expect = 3e-21
Identities = 60/208 (28%), Positives = 104/208 (50%), Gaps = 21/208 (10%)
Query: 47 GTGSFGIVFQAKCLETGETVAIKKVLQD-----RRYKNRELQLMRVMDHPNVISLKHCFF 101
G G+ G V + + TG A+K + D ++ REL++ + P ++ F
Sbjct: 10 GEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFL 69
Query: 102 STTSKNELFLNLVMEYVP----ESMY-RVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 156
+S + + + MEY +S+Y +V K ++ L + + +GL+Y+H
Sbjct: 70 DESSSS---IGIAMEYCEGGSLDSIYKKVKKRGGRIGEK-VLGKI---AESVLKGLSYLH 122
Query: 157 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGAT 216
+ ++ HRD+KP N+L+ QVK+CDFG + +L+ A ++ + FY APE I G
Sbjct: 123 S-RKIIHRDIKPSNILLT-RKGQVKLCDFGVSGELVNSLAG-TFTGTSFYMAPERIQGKP 179
Query: 217 EYTTSIDIWSAGCVLAELLLGQPLFPGE 244
Y+ + D+WS G L E+ + FP E
Sbjct: 180 -YSITSDVWSLGLTLLEVAQNRFPFPPE 206
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 4e-21
Identities = 61/209 (29%), Positives = 109/209 (52%), Gaps = 24/209 (11%)
Query: 46 VGTGSFGIVFQAKCLETGETVAIKKV-------LQDRRYKNRELQLMRVMDHPNVISLKH 98
VGTG+FG V + + A+K + L+ ++ + E ++++ + HP +I L
Sbjct: 9 VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLF- 67
Query: 99 CFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT 157
T ++ FL ++MEYVP ++ L++ + L Y +I L Y+H+
Sbjct: 68 ----WTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGL----FYASEIVCALEYLHS 119
Query: 158 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPELIFGAT 216
+ +RDLKP+N+L+D H +K+ DFG AK+L +C + Y APE+I +
Sbjct: 120 K-EIVYRDLKPENILLDKEGH-IKLTDFGFAKKLRD---RTWTLCGTPEYLAPEVI-QSK 173
Query: 217 EYTTSIDIWSAGCVLAELLLGQPLFPGEN 245
+ ++D W+ G ++ E+L+G P F +N
Sbjct: 174 GHNKAVDWWALGILIYEMLVGYPPFFDDN 202
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.6 bits (228), Expect = 5e-21
Identities = 73/297 (24%), Positives = 122/297 (41%), Gaps = 69/297 (23%)
Query: 45 VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMR----VM---DHPNVISLK 97
V+G G+FG V+ + +TG+ A+K + + K ++ +R ++ D P ++ L
Sbjct: 8 VIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKL- 66
Query: 98 HCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 156
+ F ++E L LVMEY+P + +L P + Y ++ L +H
Sbjct: 67 YYSF----QDEEHLYLVMEYMPGGDLMNLLIRK----DVFPEETARFYIAELVLALDSVH 118
Query: 157 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF----------- 205
+ + HRD+KP N+L+D H +K+ DFG K++ + Y+
Sbjct: 119 KLGFI-HRDIKPDNILIDADGH-IKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVR 176
Query: 206 -------------------YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA 246
Y APE++ G T Y D WS G +L E+L G P F +
Sbjct: 177 RRDHKQRRVRANSTVGTPDYIAPEVLRG-TPYGLECDWWSLGVILYEMLYGFPPFYSDTL 235
Query: 247 VDQLVEII---KVLGTPTREEIRCMNPNYTDF-------------RFPQIKAHPWHK 287
+ +II + L P + P D F +IK+HP+ K
Sbjct: 236 QETYNKIINWKESLRFPPDPPVS---PEAIDLICRLLCDPEDRLGSFEEIKSHPFFK 289
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 1e-20
Identities = 68/221 (30%), Positives = 116/221 (52%), Gaps = 22/221 (9%)
Query: 46 VGTGSFGIVFQAKCLETGETVAIKKVLQD-----RRYKNRELQLMRVMDHPNVISLKHCF 100
+G G+ G+V + + +G +A K + + R RELQ++ + P ++ F
Sbjct: 13 LGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 72
Query: 101 FSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 159
+S +++ ME++ S+ +VLK +R+P + + + RGLAY+
Sbjct: 73 YSDGE-----ISICMEHMDGGSLDQVLKE----AKRIPEEILGKVSIAVLRGLAYLREKH 123
Query: 160 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYT 219
++ HRD+KP N+LV+ ++K+CDFG + QLI AN S++ +R Y +PE + G T Y+
Sbjct: 124 QIMHRDVKPSNILVNS-RGEIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-THYS 180
Query: 220 TSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 260
DIWS G L EL +G+ P +A E+ + G P
Sbjct: 181 VQSDIWSMGLSLVELAIGRYPIPPPDA----KELEAIFGRP 217
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 1e-20
Identities = 70/215 (32%), Positives = 110/215 (51%), Gaps = 17/215 (7%)
Query: 39 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKV----LQDRRYKN---RELQLMRVMDHP 91
++ E+ +G G F V++A CL G VA+KKV L D + + +E+ L++ ++HP
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 92 NVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFR 150
NVI F NE LN+V+E + R++KH+ + +P V Y Q+
Sbjct: 63 NVIKYYASFI---EDNE--LNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCS 117
Query: 151 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG-EANISYICSRFYRAP 209
L ++H+ RV HRD+KP N+ + T VK+ D G + + A S + + +Y +P
Sbjct: 118 ALEHMHS-RRVMHRDIKPANVFITA-TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSP 175
Query: 210 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE 244
E I Y DIWS GC+L E+ Q F G+
Sbjct: 176 ERIH-ENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 1e-20
Identities = 71/210 (33%), Positives = 106/210 (50%), Gaps = 26/210 (12%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ---------LMRVMDHPNVI 94
+V+G GSFG V AK G+ A+K VLQ + NR+ Q L++ + HP ++
Sbjct: 1 KVIGKGSFGKVLLAKRKLDGKCYAVK-VLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLV 59
Query: 95 SLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 152
L H F TT K L V+++V E + + + S R + Y +I L
Sbjct: 60 GL-HYSFQTTEK----LYFVLDFVNGGELFFHLQRERSFPEPR-----ARFYAAEIASAL 109
Query: 153 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPEL 211
Y+H++ + +RDLKP+N+L+D H V + DFG K+ IA + C + Y APE+
Sbjct: 110 GYLHSI-NIVYRDLKPENILLDSQGHVV-LTDFGLCKEGIAQSDTTTTFCGTPEYLAPEV 167
Query: 212 IFGATEYTTSIDIWSAGCVLAELLLGQPLF 241
I Y ++D W G VL E+L G P F
Sbjct: 168 I-RKQPYDNTVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 88.6 bits (219), Expect = 2e-20
Identities = 68/242 (28%), Positives = 120/242 (49%), Gaps = 27/242 (11%)
Query: 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR---------ELQLMRVM 88
I++ +++G G+FG V+ ++TG +A K+V D E+QL++ +
Sbjct: 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNL 61
Query: 89 DHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQ 147
H ++ C + E L + MEY+P S+ LK Y + + + + YT Q
Sbjct: 62 QHERIVQYYGCL---RDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESV----TRKYTRQ 114
Query: 148 IFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL----IAGEANISYICS 203
I G++Y+H+ + HRD+K N+L D VK+ DFG++K+L ++G S +
Sbjct: 115 ILEGMSYLHS-NMIVHRDIKGANILRDS-AGNVKLGDFGASKRLQTICMSGTGIRSVTGT 172
Query: 204 RFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 263
++ +PE+I G Y D+WS GC + E+L +P + A + I K+ PT
Sbjct: 173 PYWMSPEVISGEG-YGRKADVWSLGCTVVEMLTEKPPWAEYEA---MAAIFKIATQPTNP 228
Query: 264 EI 265
++
Sbjct: 229 QL 230
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 88.8 bits (220), Expect = 2e-20
Identities = 73/270 (27%), Positives = 117/270 (43%), Gaps = 44/270 (16%)
Query: 46 VGTGSFGIVFQAKCLETGETVAIKKV---LQDRRYKN--RELQLMRVMDHPNVISLKHCF 100
+G G++G V++ TG T+A+K++ L + ++ EL ++ P ++ F
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF 68
Query: 101 FSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR 160
F + + + MEY+ L A + +P ++ TY + +GL ++
Sbjct: 69 FIEGA-----VYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN 123
Query: 161 VCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELI-----FGA 215
+ HRD+KP N+LV+ QVK+CDFG + L+A A + C Y APE I
Sbjct: 124 IIHRDVKPTNVLVNG-NGQVKLCDFGVSGNLVASLAKTNIGCQS-YMAPERIKSGGPNQN 181
Query: 216 TEYTTSIDIWSAGCVLAELLLGQPLFPGE---NAVDQLVEIIKVLGTPTR---------- 262
YT D+WS G + E+ LG+ +P E N QL I+ G P
Sbjct: 182 PTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVD--GDPPTLPSGYSDDAQ 239
Query: 263 -------EEIRCMNPNYTDFRFPQIKAHPW 285
+I P Y Q+ HPW
Sbjct: 240 DFVAKCLNKIPNRRPTY-----AQLLEHPW 264
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 2e-20
Identities = 69/210 (32%), Positives = 104/210 (49%), Gaps = 38/210 (18%)
Query: 46 VGTGSFGIVFQAKCL------ETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVIS 95
+G G+FG V C TGE VA+KK+ R RE+++++ + H N++
Sbjct: 12 LGKGNFGSV--ELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVK 69
Query: 96 LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQ-RMPLIYVKLYTYQIFRGLAY 154
K +S +N L LVMEY+P Y L+ Y ++ R+ + LY QI +G+ Y
Sbjct: 70 YKGVCYSAGRRN---LRLVMEYLP---YGSLRDYLQKHRERLDHRKLLLYASQICKGMEY 123
Query: 155 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI----------AGEANISYICSR 204
+ R HRDL +N+LV+ VKI DFG K L GE+ I
Sbjct: 124 L-GSKRYVHRDLATRNILVESENR-VKIGDFGLTKVLPQDKEYYKVREPGESPI------ 175
Query: 205 FYRAPELIFGATEYTTSIDIWSAGCVLAEL 234
F+ APE + ++++ + D+WS G VL EL
Sbjct: 176 FWYAPESL-TESKFSVASDVWSFGVVLYEL 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 2e-20
Identities = 76/224 (33%), Positives = 108/224 (48%), Gaps = 29/224 (12%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIK-----KVLQD-----RRYKNRELQLMRVMDHPNV 93
+V+G GSFG V A+ T E AIK +LQD + R L L HP +
Sbjct: 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAA--KHPFL 58
Query: 94 ISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 151
+L HC F T K+ LF VMEYV + M+++ + R + Y ++
Sbjct: 59 TAL-HCCFQT--KDRLFF--VMEYVNGGDLMFQIQRSRKFDEPR-----SRFYAAEVTLA 108
Query: 152 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPE 210
L ++H V +RDLK N+L+D H K+ DFG K+ I + C + Y APE
Sbjct: 109 LMFLHR-HGVIYRDLKLDNILLDAEGH-CKLADFGMCKEGILNGVTTTTFCGTPDYIAPE 166
Query: 211 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 254
I EY S+D W+ G ++ E++ GQP F +N D L E I
Sbjct: 167 -ILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNE-DDLFESI 208
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.3 bits (217), Expect = 5e-20
Identities = 67/213 (31%), Positives = 114/213 (53%), Gaps = 27/213 (12%)
Query: 45 VVGTGSFGIVFQAKCLETGETVAIK--KVLQDRRYKNR-ELQLMRVM-DHPNVISLKHCF 100
V+G G++G V++A+ +TG+ VAIK +++D + + E ++R +HPN+ + F
Sbjct: 13 VIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAF 72
Query: 101 F---STTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 156
+ ++L+ LVME S+ ++K +R+ ++ + RGLAY+H
Sbjct: 73 IKKNPPGNDDQLW--LVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLH 130
Query: 157 TVPRVCHRDLKPQNLLVDPLTH--QVKICDFGSAKQLIA--GEANISYICSRFYRAPELI 212
+V HRD+K QN+L LT +VK+ DFG + QL + G N ++I + ++ APE+I
Sbjct: 131 E-NKVIHRDIKGQNIL---LTKNAEVKLVDFGVSAQLDSTLGRRN-TFIGTPYWMAPEVI 185
Query: 213 FGATE------YTTSIDIWSAGCVLAELLLGQP 239
A + Y D+WS G EL G+P
Sbjct: 186 --ACDEQPDASYDARSDVWSLGITAIELADGKP 216
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 7e-20
Identities = 60/205 (29%), Positives = 96/205 (46%), Gaps = 20/205 (9%)
Query: 46 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR--------ELQLMRVMDHPNVISLK 97
+G G FG V + TG+ A KK L +R K R E +++ + ++SL
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKK-LDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLA 59
Query: 98 HCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQR-MPLIYVKLYTYQIFRGLAYIH 156
+ F + L LVM + + H + + P Y QI GL ++H
Sbjct: 60 YAFETKDD-----LCLVMTLMNGGDLKY--HIYNVGEPGFPEARAIFYAAQIICGLEHLH 112
Query: 157 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGAT 216
R+ +RDLKP+N+L+D + V+I D G A +L G+ + Y APE++ G
Sbjct: 113 QR-RIVYRDLKPENVLLDDHGN-VRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGE- 169
Query: 217 EYTTSIDIWSAGCVLAELLLGQPLF 241
Y S+D ++ GC L E++ G+ F
Sbjct: 170 VYDFSVDWFALGCTLYEMIAGRSPF 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 9e-20
Identities = 65/215 (30%), Positives = 110/215 (51%), Gaps = 17/215 (7%)
Query: 39 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKV----LQDRRYKN---RELQLMRVMDHP 91
++ E+ +G G F V++A CL + VA+KKV + D + + +E+ L++ ++HP
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 92 NVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFR 150
NVI F NE LN+V+E + +++K++ + +P V Y Q+
Sbjct: 63 NVIKYLDSFI---EDNE--LNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCS 117
Query: 151 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA-GEANISYICSRFYRAP 209
+ ++H+ RV HRD+KP N+ + T VK+ D G + + A S + + +Y +P
Sbjct: 118 AVEHMHS-RRVMHRDIKPANVFITA-TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSP 175
Query: 210 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE 244
E I Y DIWS GC+L E+ Q F G+
Sbjct: 176 ERIH-ENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 1e-19
Identities = 63/207 (30%), Positives = 109/207 (52%), Gaps = 18/207 (8%)
Query: 46 VGTGSFGIVFQAKCLETGETVAIKKVLQD-----RRYKNRELQLMRVMDHPNVISLKHCF 100
+G G+ G+VF+ +G +A K + + R RELQ++ + P ++ F
Sbjct: 13 LGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 72
Query: 101 FSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 159
+S +++ ME++ S+ +VLK R+P + + + +GL Y+
Sbjct: 73 YSDGE-----ISICMEHMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTYLREKH 123
Query: 160 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYT 219
++ HRD+KP N+LV+ ++K+CDFG + QLI AN S++ +R Y +PE + G T Y+
Sbjct: 124 KIMHRDVKPSNILVNS-RGEIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-THYS 180
Query: 220 TSIDIWSAGCVLAELLLGQPLFPGENA 246
DIWS G L E+ +G+ P +A
Sbjct: 181 VQSDIWSMGLSLVEMAIGRYPIPPPDA 207
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 2e-19
Identities = 64/236 (27%), Positives = 118/236 (50%), Gaps = 27/236 (11%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR---------ELQLMRVMDHPNVI 94
+++G G+FG V+ +TG +A+K+V D + E+QL++ + H ++
Sbjct: 8 KLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIV 67
Query: 95 SLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 153
C K L++ +EY+P S+ LK Y + + + + YT QI +G++
Sbjct: 68 QYYGCLRDPEEKK---LSIFVEYMPGGSIKDQLKAYGALTENV----TRRYTRQILQGVS 120
Query: 154 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL----IAGEANISYICSRFYRAP 209
Y+H+ + HRD+K N+L D VK+ DFG++K++ ++G S + ++ +P
Sbjct: 121 YLHS-NMIVHRDIKGANILRDS-AGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSP 178
Query: 210 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 265
E+I G Y D+WS C + E+L +P + A + I K+ PT+ +
Sbjct: 179 EVISGEG-YGRKADVWSVACTVVEMLTEKPPWAEYEA---MAAIFKIATQPTKPML 230
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 4e-19
Identities = 70/221 (31%), Positives = 108/221 (48%), Gaps = 28/221 (12%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIKKV------LQDRRYKNRELQLMRVMDHPNVISLK 97
+ +G GSFG ++ AK E IK++ ++++ +E+ L+ M HPN+++
Sbjct: 6 KKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTF- 64
Query: 98 HCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYS---SANQRMPLIYVKLYTYQIFRGL 152
F S LF+ VMEY + M R+ + S +Q + + QI GL
Sbjct: 65 --FASFQENGRLFI--VMEYCDGGDLMKRINRQRGVLFSEDQ------ILSWFVQISLGL 114
Query: 153 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC--SRFYRAPE 210
+IH ++ HRD+K QN+ + K+ DFG A+QL ++Y C + +Y +PE
Sbjct: 115 KHIHD-RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQL-NDSMELAYTCVGTPYYLSPE 172
Query: 211 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLV 251
I Y DIWS GCVL EL + F G N + QLV
Sbjct: 173 -ICQNRPYNNKTDIWSLGCVLYELCTLKHPFEG-NNLHQLV 211
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 4e-19
Identities = 67/230 (29%), Positives = 110/230 (47%), Gaps = 20/230 (8%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV-LQD-----RRYKNRELQLMRVMDHPNV 93
Y+ RV+G G+FG + E V K+V L RR E+ ++ ++ HPN+
Sbjct: 2 YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNI 61
Query: 94 ISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 152
I+ + F + L + MEY ++Y + Q V Y +QI +
Sbjct: 62 IAYYNHFMDDNT-----LLIEMEYANGGTLYDKIVR--QKGQLFEEEMVLWYLFQIVSAV 114
Query: 153 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC--SRFYRAPE 210
+YIH + HRD+K N+ + +K+ DFG +K L E +++ + +Y +PE
Sbjct: 115 SYIHKA-GILHRDIKTLNIFLTK-AGLIKLGDFGISKIL-GSEYSMAETVVGTPYYMSPE 171
Query: 211 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 260
L G +Y DIW+ GCVL ELL + F N ++ +V+I++ TP
Sbjct: 172 LCQGV-KYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTP 220
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 1e-18
Identities = 72/220 (32%), Positives = 110/220 (50%), Gaps = 23/220 (10%)
Query: 45 VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLM----RVM---DHPNVISLK 97
V+G GSFG V A+ T E AIK + +D ++ +++ RV+ P ++
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQL 66
Query: 98 HCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 155
H F T + L VMEYV + MY + + + P + Y +I GL ++
Sbjct: 67 HSCFQTMDR----LYFVMEYVNGGDLMYHIQQ---VGKFKEP--HAVFYAAEIAIGLFFL 117
Query: 156 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPELIFG 214
H+ + +RDLK N+++D H +KI DFG K+ I G C + Y APE+I
Sbjct: 118 HS-KGIIYRDLKLDNVMLDAEGH-IKIADFGMCKENIFGGKTTRTFCGTPDYIAPEII-A 174
Query: 215 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 254
Y S+D W+ G +L E+L GQP F GE+ D+L + I
Sbjct: 175 YQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE-DELFQSI 213
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 2e-18
Identities = 71/250 (28%), Positives = 127/250 (50%), Gaps = 22/250 (8%)
Query: 32 GEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKV-LQDRRYKN---RELQLMRV 87
G+PK+ Y +G G+ G VF A + TG+ VAIK++ LQ + K E+ +M+
Sbjct: 15 GDPKK--KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKE 72
Query: 88 MDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTY 146
+ +PN+++ F +ELF+ VMEY+ S+ V+ ++ +
Sbjct: 73 LKNPNIVNFLDSFLV---GDELFV--VMEYLAGGSLTDVVTETCMDEAQIAAV-----CR 122
Query: 147 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS-YICSRF 205
+ + L ++H +V HRD+K N+L+ + VK+ DFG Q+ ++ S + + +
Sbjct: 123 ECLQALEFLHA-NQVIHRDIKSDNVLLG-MDGSVKLTDFGFCAQITPEQSKRSTMVGTPY 180
Query: 206 YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 265
+ APE++ Y +DIWS G + E++ G+P + EN + L +I GTP +
Sbjct: 181 WMAPEVV-TRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-LIATNGTPELQNP 238
Query: 266 RCMNPNYTDF 275
++P + DF
Sbjct: 239 EKLSPIFRDF 248
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.0 bits (205), Expect = 3e-18
Identities = 62/206 (30%), Positives = 101/206 (49%), Gaps = 18/206 (8%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR--------ELQLMRVMDHPNVIS 95
RV+G G FG V + TG+ A KK L+ +R K R E Q++ ++ V+S
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKK-LEKKRIKKRKGEAMALNEKQILEKVNSRFVVS 64
Query: 96 LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 155
L + + +K+ L L L + + + + Y+ N Y +I GL +
Sbjct: 65 LAYAY---ETKDALCLVLTLMNGGDLKFHI---YNMGNPGFDEERAVFYAAEITCGLEDL 118
Query: 156 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGA 215
H R+ +RDLKP+N+L+D H ++I D G A ++ GE + + Y APE++
Sbjct: 119 HR-ERIVYRDLKPENILLDDYGH-IRISDLGLAVEIPEGETIRGRVGTVGYMAPEVV-KN 175
Query: 216 TEYTTSIDIWSAGCVLAELLLGQPLF 241
YT S D W GC++ E++ G+ F
Sbjct: 176 ERYTFSPDWWGLGCLIYEMIEGKSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 4e-18
Identities = 66/209 (31%), Positives = 97/209 (46%), Gaps = 31/209 (14%)
Query: 44 RVVGTGSFGIV----FQAKCLETGETVAIKKVLQDRRYKNR-----ELQLMRVMDHPNVI 94
RV+G G FG V + TGE VA+K + ++ +N E+ +++ + H N++
Sbjct: 10 RVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIV 69
Query: 95 SLKHCFFSTTSKNELFLNLVMEYVPESMYR--VLKHYSSANQRMPLIYVKLYTYQIFRGL 152
K C + + L L+MEYVP R + KH + Q + L+ QI G+
Sbjct: 70 KYKGC---CSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLL------LFAQQICEGM 120
Query: 153 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR------FY 206
AY+H+ HRDL +N+L+D VKI DFG AK + G Y F+
Sbjct: 121 AYLHS-QHYIHRDLAARNVLLDN-DRLVKIGDFGLAKAVPEGH--EYYRVREDGDSPVFW 176
Query: 207 RAPELIFGATEYTTSIDIWSAGCVLAELL 235
A E + S D+WS G L ELL
Sbjct: 177 YAVECLKENKFSYAS-DVWSFGVTLYELL 204
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 5e-18
Identities = 71/226 (31%), Positives = 109/226 (48%), Gaps = 24/226 (10%)
Query: 46 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ--------LMRVMDHPNVISLK 97
+G GSFG V Q + +T A+K + + E+ L +V + P ++ LK
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQV-NCPFIVPLK 59
Query: 98 HCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT 157
FS S +L+L L E L H+ R L + YT ++ L +H
Sbjct: 60 ---FSFQSPEKLYLVLAFINGGE-----LFHHLQREGRFDLSRARFYTAELLCALENLHK 111
Query: 158 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPELIFGAT 216
V +RDLKP+N+L+D H + +CDFG K + + + C + Y APEL+ G
Sbjct: 112 F-NVIYRDLKPENILLDYQGH-IALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHG 169
Query: 217 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 262
YT ++D W+ G +L E+L G P F EN V+++ K+L P R
Sbjct: 170 -YTKAVDWWTLGVLLYEMLTGLPPFYDEN-VNEMYR--KILQEPLR 211
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 9e-18
Identities = 63/204 (30%), Positives = 103/204 (50%), Gaps = 22/204 (10%)
Query: 46 VGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYK-----NRELQLMRVMDHPNVISLK 97
+GTGSFG V AK TGE AI K L+ R + K +E ++ + HP ++++
Sbjct: 26 LGTGSFGRVRIAKHKGTGEYYAI-KCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMM 84
Query: 98 HCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT 157
F +N ++ ++E+V + H A R P K Y ++ Y+H+
Sbjct: 85 CSF---QDENRVY--FLLEFVVGG--ELFTHLRKAG-RFPNDVAKFYHAELVLAFEYLHS 136
Query: 158 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATE 217
+ +RDLKP+NLL+D H VK+ DFG AK++ + + + Y APE+I +
Sbjct: 137 K-DIIYRDLKPENLLLDNKGH-VKVTDFGFAKKVP--DRTFTLCGTPEYLAPEVI-QSKG 191
Query: 218 YTTSIDIWSAGCVLAELLLGQPLF 241
+ ++D W+ G +L E + G P F
Sbjct: 192 HGKAVDWWTMGVLLYEFIAGYPPF 215
|
Length = 329 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 9e-18
Identities = 69/223 (30%), Positives = 111/223 (49%), Gaps = 29/223 (13%)
Query: 45 VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ-------LMRVMDHPNVISLK 97
V+G GSFG V A+ T E AIK + +D ++ +++ ++ + D P ++
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQL 66
Query: 98 HCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLI---YVKLYTYQIFRGL 152
H F T + L VMEYV + MY + Q++ Y +I GL
Sbjct: 67 HSCFQTVDR----LYFVMEYVNGGDLMYHI--------QQVGKFKEPQAVFYAAEISVGL 114
Query: 153 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ-LIAGEANISYICSRFYRAPEL 211
++H + +RDLK N+++D H +KI DFG K+ ++ G ++ + Y APE+
Sbjct: 115 FFLHR-RGIIYRDLKLDNVMLDSEGH-IKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEI 172
Query: 212 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 254
I Y S+D W+ G +L E+L GQP F GE+ D+L + I
Sbjct: 173 I-AYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE-DELFQSI 213
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 9e-18
Identities = 69/250 (27%), Positives = 126/250 (50%), Gaps = 22/250 (8%)
Query: 32 GEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKV-LQDRRYKN---RELQLMRV 87
G+PK+ Y +G G+ G V+ A + TG+ VAIK++ LQ + K E+ +MR
Sbjct: 15 GDPKK--KYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRE 72
Query: 88 MDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTY 146
HPN+++ + +EL++ VMEY+ S+ V+ ++ +
Sbjct: 73 NKHPNIVNYLDSYLVG---DELWV--VMEYLAGGSLTDVVTETCMDEGQIAAV-----CR 122
Query: 147 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS-YICSRF 205
+ + L ++H+ +V HRD+K N+L+ + VK+ DFG Q+ ++ S + + +
Sbjct: 123 ECLQALEFLHS-NQVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSTMVGTPY 180
Query: 206 YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 265
+ APE++ Y +DIWS G + E++ G+P + EN + L +I GTP +
Sbjct: 181 WMAPEVV-TRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-LIATNGTPELQNP 238
Query: 266 RCMNPNYTDF 275
++ + DF
Sbjct: 239 EKLSAIFRDF 248
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 1e-17
Identities = 67/214 (31%), Positives = 103/214 (48%), Gaps = 27/214 (12%)
Query: 45 VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ-LM---RV------MDHPNVI 94
V+G G FG V A+ +TGE AIK + + E++ LM R+ HP ++
Sbjct: 6 VLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLV 65
Query: 95 SLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 152
+L CF T + F VMEY + M + S + Y + GL
Sbjct: 66 NLFACF--QTEDHVCF---VMEYAAGGDLMMHIHTDVFSEPR------AVFYAACVVLGL 114
Query: 153 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPEL 211
Y+H ++ +RDLK NLL+D VKI DFG K+ + S C + + APE+
Sbjct: 115 QYLHE-NKIVYRDLKLDNLLLDTEGF-VKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEV 172
Query: 212 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 245
+ T YT ++D W G ++ E+L+G+ FPG++
Sbjct: 173 LTE-TSYTRAVDWWGLGVLIYEMLVGESPFPGDD 205
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 1e-17
Identities = 75/224 (33%), Positives = 106/224 (47%), Gaps = 29/224 (12%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIKK-----VLQD-----RRYKNRELQLMRVMDHPNV 93
RV+G GSFG V A+ E+G A+K +LQD + R L L R +HP +
Sbjct: 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLAR--NHPFL 58
Query: 94 ISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 151
L CF + + LF VME+V + M+ + K ++R + Y +I
Sbjct: 59 TQLYCCFQTP---DRLF--FVMEFVNGGDLMFHIQK-----SRRFDEARARFYAAEITSA 108
Query: 152 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPE 210
L ++H + +RDLK N+L+D H K+ DFG K+ I S C + Y APE
Sbjct: 109 LMFLHD-KGIIYRDLKLDNVLLDHEGH-CKLADFGMCKEGIFNGKTTSTFCGTPDYIAPE 166
Query: 211 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 254
I Y S+D W+ G +L E+L G F EN D L E I
Sbjct: 167 -ILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENE-DDLFEAI 208
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 80.1 bits (198), Expect = 2e-17
Identities = 64/226 (28%), Positives = 102/226 (45%), Gaps = 16/226 (7%)
Query: 46 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRV-MDHPNVISLKHCFFSTT 104
+G G+FG V + +G +A+K++ R E + R+ MD V+ C +
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRI----RSTVDEKEQKRLLMDLDVVMRSSDCPYIVK 67
Query: 105 SKNELFLN----LVMEYVPESMYRVLKH-YSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 159
LF + ME + S+ + K+ Y +P + + L Y+
Sbjct: 68 FYGALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL 127
Query: 160 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELI--FGATE 217
++ HRD+KP N+L+D +K+CDFG + QL+ A R Y APE I
Sbjct: 128 KIIHRDVKPSNILLD-RNGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSARDG 186
Query: 218 YTTSIDIWSAGCVLAELLLGQPLFPGENAV-DQLVEIIKVLGTPTR 262
Y D+WS G L E+ G+ +P N+V DQL +++K G P
Sbjct: 187 YDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVK--GDPPI 230
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 3e-17
Identities = 59/203 (29%), Positives = 102/203 (50%), Gaps = 21/203 (10%)
Query: 45 VVGTGSFGIVFQAKCLETGETVAIKKVLQD-----RRYKNRELQLMRVMDHPNVISLKHC 99
++G G+ G V++A L T +A+K + D ++ EL+++ D P +I
Sbjct: 8 ILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGA 67
Query: 100 FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 159
FF E +++ E++ V + ++P + + +GL Y+ ++
Sbjct: 68 FFV-----ENRISICTEFMDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSL- 114
Query: 160 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYT 219
++ HRD+KP N+LV+ QVK+CDFG + QL+ A +Y+ + Y APE I G +Y
Sbjct: 115 KILHRDVKPSNMLVNT-RGQVKLCDFGVSTQLVNSIAK-TYVGTNAYMAPERISG-EQYG 171
Query: 220 TSIDIWSAGCVLAELLLGQPLFP 242
D+WS G EL LG+ +P
Sbjct: 172 IHSDVWSLGISFMELALGRFPYP 194
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 5e-17
Identities = 68/223 (30%), Positives = 105/223 (47%), Gaps = 26/223 (11%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-YKNRELQ--------LMRVMDHPNVI 94
+V+G GSFG V A+ + E KVLQ + K +E + L++ + HP ++
Sbjct: 1 KVIGKGSFGKVLLAR-HKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLV 59
Query: 95 SLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 152
L H F T K L V++Y+ E Y + + R + Y +I L
Sbjct: 60 GL-HFSFQTADK----LYFVLDYINGGELFYHLQRERCFLEPR-----ARFYAAEIASAL 109
Query: 153 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPEL 211
Y+H++ + +RDLKP+N+L+D H V + DFG K+ I S C + Y APE+
Sbjct: 110 GYLHSL-NIVYRDLKPENILLDSQGHIV-LTDFGLCKENIEHNGTTSTFCGTPEYLAPEV 167
Query: 212 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 254
+ Y ++D W G VL E+L G P F N + I+
Sbjct: 168 LH-KQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNIL 209
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 9e-17
Identities = 69/241 (28%), Positives = 121/241 (50%), Gaps = 30/241 (12%)
Query: 46 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR------ELQLMRVMDHPNVISLKHC 99
+G GS GIV A TG VA+KK+ D R + R E+ +MR HPN++ +
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKM--DLRKQQRRELLFNEVVIMRDYQHPNIVEM--- 81
Query: 100 FFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV 158
+ S +EL++ VME++ ++ ++ H RM + + + L+++H
Sbjct: 82 YSSYLVGDELWV--VMEFLEGGALTDIVTH-----TRMNEEQIATVCLAVLKALSFLHA- 133
Query: 159 PRVCHRDLKPQNLLVDPLTH--QVKICDFGSAKQLIAGEA--NISYICSRFYRAPELIFG 214
V HRD+K ++L LT +VK+ DFG Q ++ E S + + ++ APE+I
Sbjct: 134 QGVIHRDIKSDSIL---LTSDGRVKLSDFGFCAQ-VSKEVPRRKSLVGTPYWMAPEVI-S 188
Query: 215 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 274
Y T +DIWS G ++ E++ G+P + E + Q ++ I+ P + + ++P
Sbjct: 189 RLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL-QAMKRIRDNLPPKLKNLHKVSPRLRS 247
Query: 275 F 275
F
Sbjct: 248 F 248
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 2e-16
Identities = 65/211 (30%), Positives = 100/211 (47%), Gaps = 35/211 (16%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----RELQLMRVMDHPNVI 94
Y RVVG GSFG + + + + A+K++ + +E L+ M HPN++
Sbjct: 2 YNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIV 61
Query: 95 SLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYT--------Y 146
+ K F + + L +VMEY Q++ L KL+
Sbjct: 62 AFKESF-----EADGHLYIVMEYCDGG---------DLMQKIKLQRGKLFPEDTILQWFV 107
Query: 147 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH--QVKICDFGSAKQLIA-GEANISYICS 203
Q+ G+ +IH RV HRD+K +N+ LT +VK+ DFGSA+ L + G +Y+ +
Sbjct: 108 QMCLGVQHIHE-KRVLHRDIKSKNIF---LTQNGKVKLGDFGSARLLTSPGAYACTYVGT 163
Query: 204 RFYRAPELIFGATEYTTSIDIWSAGCVLAEL 234
+Y PE I+ Y DIWS GC+L EL
Sbjct: 164 PYYVPPE-IWENMPYNNKSDIWSLGCILYEL 193
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 2e-16
Identities = 67/253 (26%), Positives = 119/253 (47%), Gaps = 29/253 (11%)
Query: 46 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR-----ELQLMRVMDHPNVISLKHCF 100
+G G+FG V++AK ETG +A KV++ + + E++++ +HP ++ L F
Sbjct: 20 LGDGAFGKVYKAKNKETG-ALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78
Query: 101 FSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR 160
+ L +++E+ P + P I ++ Q+ L Y+H++ +
Sbjct: 79 YWDGK-----LWIMIEFCPGGAVDAIMLELDRGLTEPQI--QVICRQMLEALQYLHSM-K 130
Query: 161 VCHRDLKPQNLLVDPLTHQVKICDFG-SAKQLIAGEANISYICSRFYRAPELIFGAT--- 216
+ HRDLK N+L+ L +K+ DFG SAK + + S+I + ++ APE++ T
Sbjct: 131 IIHRDLKAGNVLLT-LDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKD 189
Query: 217 -EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK----VLGTPTREEIRCMNPN 271
Y DIWS G L E+ +P N + L++I K L P++ +
Sbjct: 190 TPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSK-----WSME 244
Query: 272 YTDFRFPQIKAHP 284
+ DF + HP
Sbjct: 245 FRDFLKTALDKHP 257
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 2e-16
Identities = 69/231 (29%), Positives = 117/231 (50%), Gaps = 28/231 (12%)
Query: 44 RVVGTGSFGIVFQAKCL---ETGETVAIK-------KVLQDRRYKNRELQLMRVMDHPNV 93
+V+G GSFG VF + + + G+ A+K KV +DR E ++ ++HP +
Sbjct: 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKV-RDRVRTKMERDILAEVNHPFI 60
Query: 94 ISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 151
+ L H F T K L L+++++ + R+ K + VK Y ++
Sbjct: 61 VKL-HYAFQTEGK----LYLILDFLRGGDLFTRLSKEVMFTEED-----VKFYLAELALA 110
Query: 152 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF-YRAPE 210
L ++H++ + +RDLKP+N+L+D H +K+ DFG +K+ I E C Y APE
Sbjct: 111 LDHLHSLG-IIYRDLKPENILLDEEGH-IKLTDFGLSKESIDHEKKAYSFCGTVEYMAPE 168
Query: 211 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV-LGTP 260
++ +T S D WS G ++ E+L G F G++ + + I+K LG P
Sbjct: 169 VV-NRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMP 218
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 2e-16
Identities = 61/255 (23%), Positives = 120/255 (47%), Gaps = 38/255 (14%)
Query: 46 VGTGSFGIVFQAKCLETGET-VAIKKVL-------QDRRYKNR-------ELQLMR-VMD 89
+G+G+FG V++ + G+ +A+K++ +D+R +++ E+ +++ +
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 90 HPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSS---ANQRMPLIYVKLYTY 146
HPN++ ++ T +N+ L +VM+ + + +H++S QR +
Sbjct: 68 HPNIVR----YYKTFLENDR-LYIVMDLIEGAPLG--EHFNSLKEKKQRFTEERIWNIFV 120
Query: 147 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFY 206
Q+ L Y+H R+ HRDL P N+++ +V I DFG AKQ S + + Y
Sbjct: 121 QMVLALRYLHKEKRIVHRDLTPNNIMLGE-DDKVTITDFGLAKQKQPESKLTSVVGTILY 179
Query: 207 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI- 265
PE++ Y D+W+ GC+L ++ QP F N + +I++ + P E +
Sbjct: 180 SCPEIVKN-EPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGMY 238
Query: 266 ---------RCMNPN 271
C+ P+
Sbjct: 239 SEDVTDVITSCLTPD 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 2e-16
Identities = 76/311 (24%), Positives = 121/311 (38%), Gaps = 84/311 (27%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQ-DRRYKNR------ELQLMRVMDHPNVISL 96
+V+G G+FG V + +TG A+KK+ + + K + E ++ D+P V+ L
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKL 66
Query: 97 KHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVK--LYTYQIFRGLA 153
+ F ++E +L L+MEY+P M +L + + Y+ + L
Sbjct: 67 YYSF-----QDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLG 121
Query: 154 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL--------------IAGEANIS 199
YIH RD+KP NLL+D H +K+ DFG L +
Sbjct: 122 YIH-------RDIKPDNLLLDAKGH-IKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLD 173
Query: 200 YICSRF-------------------------YRAPELIFGATEYTTSIDIWSAGCVLAEL 234
+I Y APE +F T Y D WS G ++ E+
Sbjct: 174 FISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPE-VFLQTGYNKECDWWSLGVIMYEM 232
Query: 235 LLGQPLFPGENAVDQLVEII---KVLGTPTREEIRCMNPNYTDF--RF------------ 277
L+G P F +N + +II + L P + +P D R
Sbjct: 233 LVGYPPFCSDNPQETYRKIINWKETLQFPDEVPL---SPEAKDLIKRLCCEAERRLGNNG 289
Query: 278 -PQIKAHPWHK 287
+IK+HP+ K
Sbjct: 290 VNEIKSHPFFK 300
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 77.0 bits (190), Expect = 2e-16
Identities = 64/217 (29%), Positives = 95/217 (43%), Gaps = 45/217 (20%)
Query: 46 VGTGSFGIVFQAKCLETGE---TVAIKKVLQDRRYKN-----RELQLMRVMDHPNVISLK 97
+G G+FG V + L VA+K + Q+ RE +M +DHP ++ L
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRL- 61
Query: 98 HCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 156
K E + LVME P + + LK + +P+ +K +Q+ G+AY+
Sbjct: 62 ----IGVCKGEPLM-LVMELAPLGPLLKYLKK----RREIPVSDLKELAHQVAMGMAYLE 112
Query: 157 TVPRVCHRDLKPQN-LLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYR-------- 207
+ HRDL +N LLV+ HQ KI DFG ++ L AG S +YR
Sbjct: 113 SK-HFVHRDLAARNVLLVN--RHQAKISDFGMSRALGAG--------SDYYRATTAGRWP 161
Query: 208 ----APELIFGATEYTTSIDIWSAGCVLAELL-LGQP 239
APE I +++ D+WS G L E G
Sbjct: 162 LKWYAPECINYGK-FSSKSDVWSYGVTLWEAFSYGAK 197
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 2e-16
Identities = 64/206 (31%), Positives = 103/206 (50%), Gaps = 18/206 (8%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLM-----RVMDHPN---VIS 95
RV+G G FG V + TG+ A KK L+ +R K R+ + M R+++ N V+S
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKK-LEKKRIKKRKGEAMALNEKRILEKVNSRFVVS 64
Query: 96 LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 155
L + + +K+ L L L + + + + Y+ N Y ++ GL +
Sbjct: 65 LAYAY---ETKDALCLVLTIMNGGDLKFHI---YNMGNPGFDEQRAIFYAAELCCGLEDL 118
Query: 156 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGA 215
R+ +RDLKP+N+L+D H ++I D G A Q+ GE + + Y APE+I
Sbjct: 119 QR-ERIVYRDLKPENILLDDRGH-IRISDLGLAVQIPEGETVRGRVGTVGYMAPEVI-NN 175
Query: 216 TEYTTSIDIWSAGCVLAELLLGQPLF 241
+YT S D W GC++ E++ GQ F
Sbjct: 176 EKYTFSPDWWGLGCLIYEMIQGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 3e-16
Identities = 65/227 (28%), Positives = 114/227 (50%), Gaps = 25/227 (11%)
Query: 44 RVVGTGSFGIVFQAKCL---ETGETVAIK-----KVLQDRR---YKNRELQ-LMRVMDHP 91
RV+GTG++G VF + + + G+ A+K ++Q + + E Q L V P
Sbjct: 6 RVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCP 65
Query: 92 NVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 151
+++L H F T +K L+L+++YV + + H + V++Y +I
Sbjct: 66 FLVTL-HYAFQTDTK----LHLILDYV--NGGELFTHLYQ-REHFTESEVRVYIAEIVLA 117
Query: 152 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISY-ICSRF-YRAP 209
L ++H + + +RD+K +N+L+D H V + DFG +K+ +A E +Y C Y AP
Sbjct: 118 LDHLHQL-GIIYRDIKLENILLDSEGH-VVLTDFGLSKEFLAEEEERAYSFCGTIEYMAP 175
Query: 210 ELIFGATE-YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 255
E+I G + + ++D WS G + ELL G F + + EI +
Sbjct: 176 EVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISR 222
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 77.1 bits (189), Expect = 4e-16
Identities = 68/250 (27%), Positives = 126/250 (50%), Gaps = 22/250 (8%)
Query: 32 GEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKV-LQDRRYKN---RELQLMRV 87
G+PK+ Y +G G+ G V+ A + TG+ VAIK++ LQ + K E+ +MR
Sbjct: 15 GDPKK--KYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRE 72
Query: 88 MDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTY 146
+PN+++ + +EL++ VMEY+ S+ V+ ++ +
Sbjct: 73 NKNPNIVNYLDSYLV---GDELWV--VMEYLAGGSLTDVVTETCMDEGQIAAV-----CR 122
Query: 147 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS-YICSRF 205
+ + L ++H+ +V HRD+K N+L+ + VK+ DFG Q+ ++ S + + +
Sbjct: 123 ECLQALDFLHS-NQVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSTMVGTPY 180
Query: 206 YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 265
+ APE++ Y +DIWS G + E++ G+P + EN + L +I GTP +
Sbjct: 181 WMAPEVV-TRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-LIATNGTPELQNP 238
Query: 266 RCMNPNYTDF 275
++ + DF
Sbjct: 239 ERLSAVFRDF 248
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 4e-16
Identities = 62/206 (30%), Positives = 106/206 (51%), Gaps = 22/206 (10%)
Query: 46 VGTGSFGIVFQAKCLETGETVAIKKVL----QDRRYKNRELQLMRVMDHPNVISLKHCFF 101
+G+G++G V++A+ + TGE AIK + +D +E+ +M+ H N+++ F
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAY---FG 73
Query: 102 STTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRV 161
S +++L++ ME+ + + H + + YV T Q GL Y+H+ ++
Sbjct: 74 SYLRRDKLWIC--MEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQ---GLYYLHSKGKM 128
Query: 162 CHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN-ISYICSRFYRAPELIFGATE--- 217
HRD+K N+L+ H VK+ DFG + Q+ A A S+I + ++ APE+ A E
Sbjct: 129 -HRDIKGANILLTDNGH-VKLADFGVSAQITATIAKRKSFIGTPYWMAPEV--AAVERKG 184
Query: 218 -YTTSIDIWSAGCVLAELL-LGQPLF 241
Y DIW+ G EL L P+F
Sbjct: 185 GYNQLCDIWAVGITAIELAELQPPMF 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 76.7 bits (188), Expect = 5e-16
Identities = 67/250 (26%), Positives = 126/250 (50%), Gaps = 22/250 (8%)
Query: 32 GEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKV-LQDRRYKN---RELQLMRV 87
G+PK+ Y +G G+ G V+ A + TG+ VAI+++ LQ + K E+ +MR
Sbjct: 16 GDPKK--KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 73
Query: 88 MDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTY 146
+PN+++ + +EL++ VMEY+ S+ V+ ++ +
Sbjct: 74 NKNPNIVNYLDSYLV---GDELWV--VMEYLAGGSLTDVVTETCMDEGQIAAV-----CR 123
Query: 147 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS-YICSRF 205
+ + L ++H+ +V HRD+K N+L+ + VK+ DFG Q+ ++ S + + +
Sbjct: 124 ECLQALEFLHS-NQVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSTMVGTPY 181
Query: 206 YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 265
+ APE++ Y +DIWS G + E++ G+P + EN + L +I GTP +
Sbjct: 182 WMAPEVV-TRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-LIATNGTPELQNP 239
Query: 266 RCMNPNYTDF 275
++ + DF
Sbjct: 240 EKLSAIFRDF 249
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 5e-16
Identities = 61/208 (29%), Positives = 101/208 (48%), Gaps = 18/208 (8%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR--------ELQLMRVMDHPNVIS 95
RV+G G FG V + TG+ A K+ L+ +R K R E Q++ ++ V++
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKR-LEKKRIKKRKGESMALNEKQILEKVNSQFVVN 64
Query: 96 LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 155
L + + +K+ L L L + + + + Y+ N Y +I GL +
Sbjct: 65 LAYAY---ETKDALCLVLTIMNGGDLKFHI---YNMGNPGFEEERALFYAAEILCGLEDL 118
Query: 156 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGA 215
H +RDLKP+N+L+D H ++I D G A ++ GE+ + + Y APE++
Sbjct: 119 HR-ENTVYRDLKPENILLDDYGH-IRISDLGLAVKIPEGESIRGRVGTVGYMAPEVL-NN 175
Query: 216 TEYTTSIDIWSAGCVLAELLLGQPLFPG 243
YT S D W GC++ E++ GQ F G
Sbjct: 176 QRYTLSPDYWGLGCLIYEMIEGQSPFRG 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 5e-16
Identities = 62/206 (30%), Positives = 99/206 (48%), Gaps = 18/206 (8%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR--------ELQLMRVMDHPNVIS 95
RV+G G FG V + TG+ A KK L+ +R K R E Q++ ++ V+S
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKK-LEKKRIKKRKGESMALNEKQILEKVNSRFVVS 64
Query: 96 LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 155
L + + +K+ L L L + + + + Y Y +I GL +
Sbjct: 65 LAYAY---ETKDALCLVLTLMNGGDLKFHI---YHMGEAGFEEGRAVFYAAEICCGLEDL 118
Query: 156 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGA 215
H R+ +RDLKP+N+L+D H ++I D G A + G+ + + Y APE++
Sbjct: 119 HQ-ERIVYRDLKPENILLDDHGH-IRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVV-KN 175
Query: 216 TEYTTSIDIWSAGCVLAELLLGQPLF 241
YT S D W+ GC+L E++ GQ F
Sbjct: 176 ERYTFSPDWWALGCLLYEMIAGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 7e-16
Identities = 56/213 (26%), Positives = 100/213 (46%), Gaps = 25/213 (11%)
Query: 46 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRE----------LQLMRVMDHPNVIS 95
+G G+FG V+Q + +T A+K + + +E L + + P ++
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 96 LKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 153
LK FS + ++L+L V +Y+ E + + K + R K Y ++ L
Sbjct: 61 LK---FSFQTDSDLYL--VTDYMSGGELFWHLQKEGRFSEDR-----AKFYIAELVLALE 110
Query: 154 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPELI 212
++H + +RDLKP+N+L+D H + +CDFG +K + + C + Y APE++
Sbjct: 111 HLHKY-DIVYRDLKPENILLDATGH-IALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVL 168
Query: 213 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 245
YT +D WS G ++ E+ G F E+
Sbjct: 169 LDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAED 201
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 1e-15
Identities = 64/225 (28%), Positives = 106/225 (47%), Gaps = 36/225 (16%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIKKV-LQDRRYKNR------ELQLMRVMDHPNVISL 96
+++ G++G V+ + ET + A+KK+ Q+ +N+ E ++ ++P V+S+
Sbjct: 7 KLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSM 66
Query: 97 KHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 155
C F T L +VMEYV +LK+ + +P+ ++Y + L Y+
Sbjct: 67 -FCSFETKR----HLCMVMEYVEGGDCATLLKNIGA----LPVDMARMYFAETVLALEYL 117
Query: 156 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG------EANISYICSRF---- 205
H V HRDLKP NLL+ + H +K+ DFG +K + E +I F
Sbjct: 118 HNYGIV-HRDLKPDNLLITSMGH-IKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQ 175
Query: 206 ------YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE 244
Y APE+I Y +D W+ G +L E L+G F G+
Sbjct: 176 VCGTPEYIAPEVIL-RQGYGKPVDWWAMGIILYEFLVGCVPFFGD 219
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 1e-15
Identities = 60/230 (26%), Positives = 114/230 (49%), Gaps = 32/230 (13%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRV--------MDHPNVIS 95
RV+G GS+ V + +T A+K + ++ + ++ ++ +HP ++
Sbjct: 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVG 60
Query: 96 LKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 153
L CF T S+ LF V+E+V + M+ + + +++P + + Y+ +I L
Sbjct: 61 LHSCF-QTESR--LFF--VIEFVSGGDLMFHMQRQ-----RKLPEEHARFYSAEISLALN 110
Query: 154 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPELI 212
++H + +RDLK N+L+D H +K+ D+G K+ I S C + Y APE++
Sbjct: 111 FLHE-RGIIYRDLKLDNVLLDAEGH-IKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEIL 168
Query: 213 FGATEYTTSIDIWSAGCVLAELLLGQPLF--------PGENAVDQLVEII 254
G +Y S+D W+ G ++ E++ G+ F P +N D L ++I
Sbjct: 169 RG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVI 217
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 1e-15
Identities = 65/225 (28%), Positives = 105/225 (46%), Gaps = 25/225 (11%)
Query: 44 RVVGTGSFGIVFQAKCL---ETGETVAIKKVLQ---------DRRYKNRELQLMRVMDHP 91
+V+G G +G VFQ + + +TG+ A+K VL+ D + E ++ + HP
Sbjct: 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMK-VLKKATIVRNQKDTAHTKAERNILEAVKHP 60
Query: 92 NVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 151
++ L F T K L L++EY+ + H M Y +I
Sbjct: 61 FIVDL-IYAFQTGGK----LYLILEYLSGG--ELFMHLEREGIFMEDT-ACFYLSEISLA 112
Query: 152 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF-YRAPE 210
L ++H + +RDLKP+N+L+D H VK+ DFG K+ I C Y APE
Sbjct: 113 LEHLHQQG-IIYRDLKPENILLDAQGH-VKLTDFGLCKESIHEGTVTHTFCGTIEYMAPE 170
Query: 211 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 255
I + + ++D WS G ++ ++L G P F EN + +I+K
Sbjct: 171 -ILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILK 214
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 1e-15
Identities = 65/224 (29%), Positives = 106/224 (47%), Gaps = 26/224 (11%)
Query: 44 RVVGTGSFGIVFQAKCLETGET----VAIKKVLQDRRYKN-----RELQLMRVMDHPNVI 94
+V+G+G+FG V++ + GE VAIK + ++ K E +M +DHP+V+
Sbjct: 13 KVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVV 72
Query: 95 SLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 154
L S+ + L+ + +P + +L + + + Y+ + QI +G++Y
Sbjct: 73 RLLGICLSSQ------VQLITQLMP--LGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSY 124
Query: 155 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF---YRAPEL 211
+ R+ HRDL +N+LV H VKI DFG AK L E + + A E
Sbjct: 125 LEEK-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALES 182
Query: 212 IFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVD--QLVE 252
I YT D+WS G + EL+ G + G AV+ L+E
Sbjct: 183 IL-HRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLE 225
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 2e-15
Identities = 65/210 (30%), Positives = 101/210 (48%), Gaps = 26/210 (12%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ---------LMRVMDHPNVI 94
+V+G GSFG V AK G A+K VLQ + ++ Q L++ + HP ++
Sbjct: 1 KVIGKGSFGKVLLAKRKSDGSFYAVK-VLQKKTILKKKEQNHIMAERNVLLKNLKHPFLV 59
Query: 95 SLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 152
L H F T K L V++YV E + + + R + Y ++ +
Sbjct: 60 GL-HYSFQTAEK----LYFVLDYVNGGELFFHLQRERCFLEPR-----ARFYAAEVASAI 109
Query: 153 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPEL 211
Y+H++ + +RDLKP+N+L+D H V + DFG K+ + E S C + Y APE
Sbjct: 110 GYLHSL-NIIYRDLKPENILLDSQGHVV-LTDFGLCKEGVEPEETTSTFCGTPEYLAPE- 166
Query: 212 IFGATEYTTSIDIWSAGCVLAELLLGQPLF 241
+ Y ++D W G VL E+L G P F
Sbjct: 167 VLRKEPYDRTVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 2e-15
Identities = 60/230 (26%), Positives = 116/230 (50%), Gaps = 32/230 (13%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRV--------MDHPNVIS 95
RV+G GS+ V + +T A+K V ++ + ++ ++ +HP ++
Sbjct: 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 60
Query: 96 LKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 153
L CF +++ LF V+EYV + M+ + + +++P + + Y+ +I L
Sbjct: 61 LHSCF---QTESRLFF--VIEYVNGGDLMFHMQRQ-----RKLPEEHARFYSAEISLALN 110
Query: 154 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ-LIAGEANISYICSRFYRAPELI 212
Y+H + +RDLK N+L+D H +K+ D+G K+ L G+ ++ + Y APE++
Sbjct: 111 YLHE-RGIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEIL 168
Query: 213 FGATEYTTSIDIWSAGCVLAELLLGQPLF--------PGENAVDQLVEII 254
G +Y S+D W+ G ++ E++ G+ F P +N D L ++I
Sbjct: 169 RGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI 217
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 4e-15
Identities = 63/203 (31%), Positives = 104/203 (51%), Gaps = 21/203 (10%)
Query: 46 VGTGSFGIVFQAKCLETGETVAIKKVL----QDRRYKNRELQLMRVMDHPNVISLKHCFF 101
VG+G++G V++A+ L TGE A+K + D +E+ +++ H N+++ F
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAY---FG 73
Query: 102 STTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRV 161
S S+ +L+ + MEY + + H + + + YV T Q GLAY+H+ ++
Sbjct: 74 SYLSREKLW--ICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQ---GLAYLHSKGKM 128
Query: 162 CHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN-ISYICSRFYRAPELIFGATE--- 217
HRD+K N+L+ VK+ DFG A ++ A A S+I + ++ APE+ A E
Sbjct: 129 -HRDIKGANILLTD-NGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEV--AAVEKNG 184
Query: 218 -YTTSIDIWSAGCVLAELLLGQP 239
Y DIW+ G EL QP
Sbjct: 185 GYNQLCDIWAVGITAIELAELQP 207
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 4e-15
Identities = 67/220 (30%), Positives = 108/220 (49%), Gaps = 23/220 (10%)
Query: 45 VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ-------LMRVMDHPNVISLK 97
V+G GSFG V A+ T E AIK + +D ++ +++ ++ + P ++
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQL 66
Query: 98 HCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 155
H F T + L VMEYV + MY++ + R + Y +I GL ++
Sbjct: 67 HSCFQTMDR----LYFVMEYVNGGDLMYQIQQ-----VGRFKEPHAVFYAAEIAIGLFFL 117
Query: 156 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPELIFG 214
H+ + +RDLK N+++D H +KI DFG K+ + C + Y APE+I
Sbjct: 118 HS-KGIIYRDLKLDNVMLDSEGH-IKIADFGMCKENMWDGVTTKTFCGTPDYIAPEII-A 174
Query: 215 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 254
Y S+D W+ G +L E+L GQ F GE+ D+L + I
Sbjct: 175 YQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE-DELFQSI 213
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 5e-15
Identities = 63/211 (29%), Positives = 107/211 (50%), Gaps = 24/211 (11%)
Query: 46 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKH------- 98
+G+G+ G V++ + +TG +A+K++ RR N+E + R++ +V+ H
Sbjct: 23 IGSGTCGQVYKMRFKKTGHVMAVKQM---RRTGNKE-ENKRILMDLDVVLKSHDCPYIVK 78
Query: 99 CFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV 158
C+ + +++F+ ME + + ++LK +P + T I + L Y+
Sbjct: 79 CYGYFITDSDVFI--CMELMSTCLDKLLKR---IQGPIPEDILGKMTVAIVKALHYLKEK 133
Query: 159 PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI-SYICSRFYRAPELIFGAT- 216
V HRD+KP N+L+D + VK+CDFG + +L+ +A S C+ Y APE I
Sbjct: 134 HGVIHRDVKPSNILLD-ASGNVKLCDFGISGRLVDSKAKTRSAGCAA-YMAPERIDPPDP 191
Query: 217 --EYTTSIDIWSAGCVLAELLLGQPLFPGEN 245
+Y D+WS G L EL GQ FP +N
Sbjct: 192 NPKYDIRADVWSLGISLVELATGQ--FPYKN 220
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 6e-15
Identities = 67/236 (28%), Positives = 114/236 (48%), Gaps = 36/236 (15%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQD----------RRYKNRELQLMRVMDHPNV 93
+++G G+FG V + TG+ A+K + ++ ++R LQ R HP +
Sbjct: 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTR---HPFL 57
Query: 94 ISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 151
+LK+ F + L VMEY E + + + + R + Y +I
Sbjct: 58 TALKYSFQTHD-----RLCFVMEYANGGELFFHLSRERVFSEDR-----ARFYGAEIVSA 107
Query: 152 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPE 210
L Y+H+ V +RDLK +NL++D H +KI DFG K+ I+ A + C + Y APE
Sbjct: 108 LGYLHSC-DVVYRDLKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFCGTPEYLAPE 165
Query: 211 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 266
+ +Y ++D W G V+ E++ G+ F ++ ++L E+I + EEIR
Sbjct: 166 -VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELILM------EEIR 213
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 7e-15
Identities = 64/236 (27%), Positives = 118/236 (50%), Gaps = 32/236 (13%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDH--------PNVIS 95
RV+G GS+ V + + + A+K V ++ + + ++ ++ H P ++
Sbjct: 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVG 60
Query: 96 LKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 153
L CF TTS+ L LV+EYV + M+ + + +++P + + Y +I L
Sbjct: 61 LHSCF-QTTSR----LFLVIEYVNGGDLMFHMQRQ-----RKLPEEHARFYAAEICIALN 110
Query: 154 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA-GEANISYICSRFYRAPELI 212
++H + +RDLK N+L+D H +K+ D+G K+ + G+ ++ + Y APE++
Sbjct: 111 FLHE-RGIIYRDLKLDNVLLDADGH-IKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEIL 168
Query: 213 FGATEYTTSIDIWSAGCVLAELLLGQPLF------PGENAVDQLVEIIKVLGTPTR 262
G EY S+D W+ G ++ E++ G+ F P N D L ++I L P R
Sbjct: 169 RGE-EYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVI--LEKPIR 221
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.7 bits (179), Expect = 7e-15
Identities = 63/220 (28%), Positives = 107/220 (48%), Gaps = 26/220 (11%)
Query: 34 PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRVMDH 90
P++++ ER +G G FG V+ T + VA+K + +E Q+M+ + H
Sbjct: 4 PRESLKL--ERKLGAGQFGEVWMGTWNGTTK-VAVKTLKPGTMSPEAFLQEAQIMKKLRH 60
Query: 91 PNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMP-LIYVKLYTYQI 148
++ L ++ S+ E +V EY+ + S+ LK R+P L+ + QI
Sbjct: 61 DKLVQL----YAVCSEEEPIY-IVTEYMSKGSLLDFLKSGEGKKLRLPQLVDM---AAQI 112
Query: 149 FRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF--- 205
G+AY+ + HRDL +N+LV KI DFG A+ LI + + ++F
Sbjct: 113 AEGMAYLESR-NYIHRDLAARNILVGE-NLVCKIADFGLAR-LIEDDEYTAREGAKFPIK 169
Query: 206 YRAPELI-FGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 243
+ APE +G +T D+WS G +L E++ G+ +PG
Sbjct: 170 WTAPEAANYG--RFTIKSDVWSFGILLTEIVTYGRVPYPG 207
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 8e-15
Identities = 64/229 (27%), Positives = 115/229 (50%), Gaps = 23/229 (10%)
Query: 32 GEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ-----LMR 86
G+P++ + + +G GS GIV A TG+ VA+KK + R+ + REL +MR
Sbjct: 18 GDPREYLDSFIK--IGEGSTGIVCIATEKHTGKQVAVKK-MDLRKQQRRELLFNEVVIMR 74
Query: 87 VMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTY 146
H NV+ + + S +EL++ VME++ + ++ N+ +
Sbjct: 75 DYHHENVVDM---YNSYLVGDELWV--VMEFLEGGALTDIVTHTRMNEEQ----IATVCL 125
Query: 147 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA--NISYICSR 204
+ R L+Y+H V HRD+K ++L+ ++K+ DFG Q ++ E S + +
Sbjct: 126 SVLRALSYLHN-QGVIHRDIKSDSILLTS-DGRIKLSDFGFCAQ-VSKEVPKRKSLVGTP 182
Query: 205 FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEI 253
++ APE+I Y T +DIWS G ++ E++ G+P + E + + I
Sbjct: 183 YWMAPEVI-SRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRI 230
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 8e-15
Identities = 59/225 (26%), Positives = 100/225 (44%), Gaps = 23/225 (10%)
Query: 49 GSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 108
GS G VF A + V +K + + E L++ ++HP+VI +K S
Sbjct: 77 GSEGRVFVATKPGQPDPVVLK--IGQKGTTLIEAMLLQNVNHPSVIRMKDTLVSGAITC- 133
Query: 109 LFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKP 168
+V+ + +Y L + ++ +P+ + QI GL Y+H R+ HRD+K
Sbjct: 134 ----MVLPHYSSDLYTYL---TKRSRPLPIDQALIIEKQILEGLRYLHAQ-RIIHRDVKT 185
Query: 169 QNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAG 228
+N+ ++ + QV I D G+A+ + A + + APE + +Y + DIWSAG
Sbjct: 186 ENIFINDVD-QVCIGDLGAAQFPVVAPAFLGLAGTVETNAPE-VLARDKYNSKADIWSAG 243
Query: 229 CVLAELLL----------GQPLFPGENAVDQLVEIIKVLGTPTRE 263
VL E+L P ++ L++II L E
Sbjct: 244 IVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEE 288
|
Length = 357 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 1e-14
Identities = 69/248 (27%), Positives = 117/248 (47%), Gaps = 36/248 (14%)
Query: 45 VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR---ELQLM---RVMDHPNVISLKH 98
++G G+FG V +A + E A+K V +Y E+Q M R D + L
Sbjct: 136 LLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMK 195
Query: 99 C--FFSTTSKNELFLNLVM-EYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 155
+F + + + +VM +Y P + ++KH +++ + I +Q L Y
Sbjct: 196 IQRYFQNETGH---MCIVMPKYGPCLLDWIMKHGPFSHRHLAQI-----IFQTGVALDYF 247
Query: 156 HTVPRVCHRDLKPQNLL-------VDPLTHQ--------VKICDFGSAKQLIAGEANISY 200
HT + H DLKP+N+L VDP+T++ V+ICD G + +
Sbjct: 248 HTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCD--ERHSRTAI 305
Query: 201 ICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT- 259
+ +R YR+PE++ G + S D+WS GC++ EL G+ L+ + ++ L + K LG
Sbjct: 306 VSTRHYRSPEVVLGLG-WMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRL 364
Query: 260 PTREEIRC 267
P+ RC
Sbjct: 365 PSEWAGRC 372
|
Length = 467 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 1e-14
Identities = 69/236 (29%), Positives = 110/236 (46%), Gaps = 35/236 (14%)
Query: 44 RVVGTGSFGIVFQAKCLETG----------ETVAIKKVLQDRRYKNRELQLMRVMDHPNV 93
+++G G+FG V K TG E + K + +NR LQ R HP +
Sbjct: 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR---HPFL 57
Query: 94 ISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 151
+LK+ F + L VMEY E + + + + R + Y +I
Sbjct: 58 TALKYSFQTHDR-----LCFVMEYANGGELFFHLSRERVFSEDR-----ARFYGAEIVSA 107
Query: 152 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPE 210
L Y+H+ V +RDLK +NL++D H +KI DFG K+ I A + C + Y APE
Sbjct: 108 LDYLHSEKNVVYRDLKLENLMLDKDGH-IKITDFGLCKEGIKDGATMKTFCGTPEYLAPE 166
Query: 211 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 266
+ +Y ++D W G V+ E++ G+ F ++ ++L E+I + EEIR
Sbjct: 167 -VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELILM------EEIR 214
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 1e-14
Identities = 56/227 (24%), Positives = 110/227 (48%), Gaps = 20/227 (8%)
Query: 40 YMAERVVGTGSFGIVF--QAKCLETGETVAIKKVL-------QDRRYKNRELQLMRVMDH 90
Y+ ++ +G GSFG V+ + K E + + K + + N+E QL+ +DH
Sbjct: 2 YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDH 61
Query: 91 PNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIF 149
P ++ F ++ + + F ++ EY + L+ + + V + Q+
Sbjct: 62 PAIVK----FHASFLERDAFC-IITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLL 116
Query: 150 RGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG-EANISYICSRFYRA 208
G+ Y+H R+ HRDLK +N+ + + +KI DFG ++ L+ + ++ + +Y +
Sbjct: 117 LGVHYMH-QRRILHRDLKAKNIFLK--NNLLKIGDFGVSRLLMGSCDLATTFTGTPYYMS 173
Query: 209 PELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 255
PE + Y + DIWS GC+L E+ F G+N + ++ I++
Sbjct: 174 PEAL-KHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVE 219
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 74.4 bits (182), Expect = 1e-14
Identities = 67/252 (26%), Positives = 113/252 (44%), Gaps = 45/252 (17%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV----LQDRRYKNR--ELQLMRVMDHPNV 93
Y + +G G FG VF K T E K + L++R E+ +MR + H N+
Sbjct: 15 YEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNI 74
Query: 94 ISLKHCFFSTTSKNELFLNLVMEY-----VPESMYRVLKHYSSANQRMPLIYVKLYTYQI 148
+ F + ++ L ++ME+ + ++ + K + + + T Q+
Sbjct: 75 VRYIDRFLNKANQK---LYILMEFCDAGDLSRNIQKCYKMFGKIEEHA----IVDITRQL 127
Query: 149 FRGLAYIHTVP------RVCHRDLKPQNLL-------VDPLTHQV---------KICDFG 186
LAY H + RV HRDLKPQN+ + +T Q KI DFG
Sbjct: 128 LHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFG 187
Query: 187 SAKQLIAGEANISYIC--SRFYRAPELIFGATE-YTTSIDIWSAGCVLAELLLGQPLFPG 243
+K + G ++++ C + +Y +PEL+ T+ Y D+W+ GC++ EL G+ F
Sbjct: 188 LSKNI--GIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK 245
Query: 244 ENAVDQLVEIIK 255
N QL+ +K
Sbjct: 246 ANNFSQLISELK 257
|
Length = 1021 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 1e-14
Identities = 60/211 (28%), Positives = 98/211 (46%), Gaps = 36/211 (17%)
Query: 47 GTGSFGIVFQAKCLETGETVAIKKV-------LQDRRYKNRELQLMRVMDHPNVISLKHC 99
G G+FG V++A+ ETG A K + L+D E+ ++ HPN++ L
Sbjct: 14 GDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMV---EIDILSECKHPNIVGLYEA 70
Query: 100 FFSTTSKNELFLNLVMEYVP----ESMYRVLKHYSSANQRMPLI--YVKLYTYQIFRGLA 153
+F E L +++E+ +S+ L+ L ++ Q+ L
Sbjct: 71 YF-----YENKLWILIEFCDGGALDSIMLELER--------GLTEPQIRYVCRQMLEALN 117
Query: 154 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG-SAKQLIAGEANISYICSRFYRAPELI 212
++H+ +V HRDLK N+L+ L VK+ DFG SAK + ++I + ++ APE++
Sbjct: 118 FLHS-HKVIHRDLKAGNILL-TLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVV 175
Query: 213 ----FGATEYTTSIDIWSAGCVLAELLLGQP 239
F Y DIWS G L EL +P
Sbjct: 176 ACETFKDNPYDYKADIWSLGITLIELAQMEP 206
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 2e-14
Identities = 55/206 (26%), Positives = 101/206 (49%), Gaps = 22/206 (10%)
Query: 46 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR--------ELQLMRVMDHPNVISLK 97
+G G FG V + TG+ A KK L +R K + E +++ ++ P +++L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKK-LDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLA 59
Query: 98 HCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 155
+ F S T L LVM + + Y + Y+ + + + V Y+ QI G+ ++
Sbjct: 60 YAFESKTH-----LCLVMSLMNGGDLKYHI---YNVGERGLEMERVIHYSAQITCGILHL 111
Query: 156 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGA 215
H++ + +RD+KP+N+L+D ++ D G A +L G+ + Y APE I
Sbjct: 112 HSM-DIVYRDMKPENVLLDDQG-NCRLSDLGLAVELKDGKTITQRAGTNGYMAPE-ILKE 168
Query: 216 TEYTTSIDIWSAGCVLAELLLGQPLF 241
Y+ +D ++ GC + E++ G+ F
Sbjct: 169 EPYSYPVDWFAMGCSIYEMVAGRTPF 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-14
Identities = 66/249 (26%), Positives = 115/249 (46%), Gaps = 39/249 (15%)
Query: 46 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR-----ELQLMRVMDHPNVISLKHCF 100
+G G+FG V++A+ ETG +A KV+ + + E+ ++ DHPN++ L F
Sbjct: 13 LGDGAFGKVYKAQNKETG-VLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71
Query: 101 FSTTSKNELFLNLVMEY-----VPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 155
+ +N L+ +++E+ V M + + + +++ Q L Y+
Sbjct: 72 Y---YENNLW--ILIEFCAGGAVDAVMLELERPLTEPQ-------IRVVCKQTLEALNYL 119
Query: 156 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFG-SAKQLIAGEANISYICSRFYRAPELIFG 214
H ++ HRDLK N+L L +K+ DFG SAK + S+I + ++ APE++
Sbjct: 120 HE-NKIIHRDLKAGNILFT-LDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMC 177
Query: 215 ATE----YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK----VLGTPTREEIR 266
T Y D+WS G L E+ +P N + L++I K L P+R
Sbjct: 178 ETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSR---- 233
Query: 267 CMNPNYTDF 275
+ + DF
Sbjct: 234 -WSSEFKDF 241
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 2e-14
Identities = 65/209 (31%), Positives = 101/209 (48%), Gaps = 29/209 (13%)
Query: 44 RVVGTGSFGIV----FQAKCLETGETVAIKKVLQDRRYKN-----RELQLMRVMDHPNVI 94
R +G G FG V + + TGE VA+K + + + +E++++R + H N++
Sbjct: 10 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 69
Query: 95 SLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQ-RMPLIYVKLYTYQIFRGLA 153
K T + L+ME++P LK Y N+ ++ L Y QI +G+
Sbjct: 70 KYKGI---CTEDGGNGIKLIMEFLPSGS---LKEYLPRNKNKINLKQQLKYAVQICKGMD 123
Query: 154 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR-------FY 206
Y+ + V HRDL +N+LV+ HQVKI DFG K + E + Y + F+
Sbjct: 124 YLGSRQYV-HRDLAARNVLVES-EHQVKIGDFGLTKAI---ETDKEYYTVKDDLDSPVFW 178
Query: 207 RAPELIFGATEYTTSIDIWSAGCVLAELL 235
APE + + Y S D+WS G L ELL
Sbjct: 179 YAPECLIQSKFYIAS-DVWSFGVTLYELL 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 3e-14
Identities = 58/204 (28%), Positives = 98/204 (48%), Gaps = 17/204 (8%)
Query: 39 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKV------LQDRRYKNRELQLMRVMDHPN 92
+Y RVVG GS+G V + G+ IKK+ ++R+ +E QL+ + HPN
Sbjct: 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPN 60
Query: 93 VISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 151
+++ + + + L +VM + +Y LK + +P V + QI
Sbjct: 61 IVAYRESW----EGEDGLLYIVMGFCEGGDLYHKLKE--QKGKLLPENQVVEWFVQIAMA 114
Query: 152 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG-EANISYICSRFYRAPE 210
L Y+H + HRDLK QN+ + T+ +K+ D G A+ L + + I + +Y +PE
Sbjct: 115 LQYLHE-KHILHRDLKTQNVFLTR-TNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPE 172
Query: 211 LIFGATEYTTSIDIWSAGCVLAEL 234
L F Y D+W+ GC + E+
Sbjct: 173 L-FSNKPYNYKSDVWALGCCVYEM 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 3e-14
Identities = 64/232 (27%), Positives = 112/232 (48%), Gaps = 36/232 (15%)
Query: 44 RVVGTGSFGIVF--------------QAKCLETGETVAIKKVLQDRRYKNRELQLMRVMD 89
+V+GTG++G VF K L+ V K ++ R + L+ +R
Sbjct: 6 KVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVR--Q 63
Query: 90 HPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVL---KHYSSANQRMPLIYVKLYT 145
P +++L H F T +K L+L+++YV M+ L ++S V+ Y+
Sbjct: 64 SPFLVTL-HYAFQTEAK----LHLILDYVSGGEMFTHLYQRDNFSEDE-------VRFYS 111
Query: 146 YQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISY-ICSR 204
+I L ++H + + +RD+K +N+L+D H V + DFG +K+ ++ E +Y C
Sbjct: 112 GEIILALEHLHKLG-IVYRDIKLENILLDSEGHVV-LTDFGLSKEFLSEEKERTYSFCGT 169
Query: 205 F-YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 255
Y APE+I G + ++D WS G ++ ELL G F E + E+ +
Sbjct: 170 IEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSR 221
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 3e-14
Identities = 66/267 (24%), Positives = 117/267 (43%), Gaps = 68/267 (25%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRV-------MDHPNVISL 96
+V+G G+FG V + +TG+ A+K +L+ +K +L ++ D P V+SL
Sbjct: 7 KVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSL 66
Query: 97 KHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 155
+ F ++ +L L+ME++P + +L Y + ++ + + Y + + +
Sbjct: 67 YYSF-----QDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDV----TRFYMAECVLAIEAV 117
Query: 156 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFG------------SAKQLIAGEANISYICS 203
H + + HRD+KP N+L+D H +K+ DFG ++L+ G++N + I +
Sbjct: 118 HKLGFI-HRDIKPDNILIDRGGH-IKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDN 175
Query: 204 RF------------------------------------YRAPELIFGATEYTTSIDIWSA 227
R Y APE IF Y D WS
Sbjct: 176 RNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPE-IFLQQGYGQECDWWSL 234
Query: 228 GCVLAELLLGQPLFPGENAVDQLVEII 254
G ++ E L+G P F EN+ + +II
Sbjct: 235 GAIMFECLIGWPPFCSENSHETYRKII 261
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 3e-14
Identities = 61/221 (27%), Positives = 112/221 (50%), Gaps = 24/221 (10%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNREL-------QLMRVMDHPNVISL 96
+++G G+FG V + +G+ A+K + ++ E+ ++++ HP + SL
Sbjct: 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60
Query: 97 KHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 154
K+ F +K+ L VMEYV E + + + + R + Y +I L Y
Sbjct: 61 KYSF---QTKDRLCF--VMEYVNGGELFFHLSRERVFSEDR-----TRFYGAEIVSALDY 110
Query: 155 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPELIF 213
+H+ ++ +RDLK +NL++D H +KI DFG K+ I A + C + Y APE +
Sbjct: 111 LHS-GKIVYRDLKLENLMLDKDGH-IKITDFGLCKEGITDAATMKTFCGTPEYLAPE-VL 167
Query: 214 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 254
+Y ++D W G V+ E++ G+ F ++ ++L E+I
Sbjct: 168 EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELI 207
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 4e-14
Identities = 62/207 (29%), Positives = 102/207 (49%), Gaps = 15/207 (7%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIK--KVLQDRRYK-NRELQLMRVMDHPNVISLKHCF 100
VVG G++G V++ + ++TG+ AIK V +D + E+ +++ H I+ +
Sbjct: 22 EVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGA 81
Query: 101 FSTTSK--NELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV 158
F S ++ L LVME+ L + N + ++ +I RGLA++H
Sbjct: 82 FIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNA-LKEDWIAYICREILRGLAHLH-A 139
Query: 159 PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL--IAGEANISYICSRFYRAPELIF--- 213
+V HRD+K QN+L+ +VK+ DFG + QL G N ++I + ++ APE+I
Sbjct: 140 HKVIHRDIKGQNVLLTE-NAEVKLVDFGVSAQLDRTVGRRN-TFIGTPYWMAPEVIACDE 197
Query: 214 -GATEYTTSIDIWSAGCVLAELLLGQP 239
Y DIWS G E+ G P
Sbjct: 198 NPDATYDYRSDIWSLGITAIEMAEGAP 224
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 5e-14
Identities = 58/213 (27%), Positives = 110/213 (51%), Gaps = 25/213 (11%)
Query: 44 RVVGTGSFGIVFQAKCL---ETGETVAIK-----KVLQDRRYKNRELQLMRVMDH----P 91
+V+GTG++G VF + + ++G+ A+K ++Q + +V++H P
Sbjct: 6 KVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 65
Query: 92 NVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 151
+++L H F T +K L+L+++Y+ + H S +R V++Y+ +I
Sbjct: 66 FLVTL-HYAFQTDTK----LHLILDYINGG--ELFTHLSQ-RERFKEQEVQIYSGEIVLA 117
Query: 152 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISY-ICSRF-YRAP 209
L ++H + + +RD+K +N+L+D H V + DFG +K+ E +Y C Y AP
Sbjct: 118 LEHLHKLG-IIYRDIKLENILLDSNGHVV-LTDFGLSKEFHEDEVERAYSFCGTIEYMAP 175
Query: 210 ELIFGA-TEYTTSIDIWSAGCVLAELLLGQPLF 241
+++ G + ++D WS G ++ ELL G F
Sbjct: 176 DIVRGGDGGHDKAVDWWSMGVLMYELLTGASPF 208
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 8e-14
Identities = 58/226 (25%), Positives = 105/226 (46%), Gaps = 27/226 (11%)
Query: 45 VVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLK 97
+VG G FG V + TG+ A+K + + + E ++ + + P + L+
Sbjct: 8 LVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQ 67
Query: 98 HCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 155
+ F K+ L+L VMEY P + + + ++ ++ M + Y ++ + +
Sbjct: 68 YAF---QDKDNLYL--VMEYQPGGDLLSLLNRYEDQFDEDM----AQFYLAELVLAIHSV 118
Query: 156 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISY--ICSRFYRAPELI- 212
H + V HRD+KP+N+L+D H +K+ DFGSA +L A + S + + Y APE++
Sbjct: 119 HQMGYV-HRDIKPENVLIDRTGH-IKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLT 176
Query: 213 ----FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 254
G Y D WS G + E++ G+ F + I+
Sbjct: 177 TMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIM 222
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 9e-14
Identities = 68/249 (27%), Positives = 122/249 (48%), Gaps = 26/249 (10%)
Query: 46 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ-----LMRVMDHPNVISLKHCF 100
+G GS GIV A+ +G VA+K ++ R+ + REL +MR H NV+ + +
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVK-MMDLRKQQRRELLFNEVVIMRDYQHQNVVEM---Y 84
Query: 101 FSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR 160
S EL++ +ME++ + + N+ + + + L Y+H+
Sbjct: 85 KSYLVGEELWV--LMEFLQGGALTDIVSQTRLNEEQ----IATVCESVLQALCYLHS-QG 137
Query: 161 VCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG-EANISYICSRFYRAPELIFGATEYT 219
V HRD+K ++L+ L +VK+ DFG Q+ S + + ++ APE+I T Y
Sbjct: 138 VIHRDIKSDSILLT-LDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVI-SRTPYG 195
Query: 220 TSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF---- 275
T +DIWS G ++ E++ G+P + ++ V Q ++ ++ P + ++P DF
Sbjct: 196 TEVDIWSLGIMVIEMVDGEPPYFSDSPV-QAMKRLRDSPPPKLKNAHKISPVLRDFLERM 254
Query: 276 --RFPQIKA 282
R PQ +A
Sbjct: 255 LTREPQERA 263
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 9e-14
Identities = 60/199 (30%), Positives = 94/199 (47%), Gaps = 17/199 (8%)
Query: 46 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ--------LMRVMDHPNVISLK 97
+G G FG V + TG+ A KK+ + R K + + L +V H I
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKV--HSRFIVSL 58
Query: 98 HCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT 157
F T K +L L + + + Y + + N P YT QI GL ++H
Sbjct: 59 AYAFQT--KTDLCLVMTIMNGGDLRYHIY-NVDEENPGFPEPRACFYTAQIISGLEHLHQ 115
Query: 158 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI-SYICSRFYRAPELIFGAT 216
R+ +RDLKP+N+L+D + V+I D G A +L G++ Y + + APEL+ G
Sbjct: 116 -RRIIYRDLKPENVLLDNDGN-VRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQG-E 172
Query: 217 EYTTSIDIWSAGCVLAELL 235
EY S+D ++ G L E++
Sbjct: 173 EYDFSVDYFALGVTLYEMI 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 1e-13
Identities = 67/249 (26%), Positives = 113/249 (45%), Gaps = 32/249 (12%)
Query: 45 VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRE-----------LQLMRVMDHPNV 93
++G G FG V+ + +TG+ A+K L +R K ++ L L+ D P +
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMK-CLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 59
Query: 94 ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 153
+ + + F T K L+L+ + Y + +H + M + Y +I GL
Sbjct: 60 VCMSYAF-HTPDKLSFILDLMNG--GDLHYHLSQHGVFSEAEM-----RFYAAEIILGLE 111
Query: 154 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIF 213
++H V +RDLKP N+L+D H V+I D G A + + S + + Y APE++
Sbjct: 112 HMH-NRFVVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPHAS-VGTHGYMAPEVLQ 168
Query: 214 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 273
Y +S D +S GC+L +LL G F D+ EI ++ T M
Sbjct: 169 KGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EIDRMTLT--------MAVELP 219
Query: 274 DFRFPQIKA 282
D P++++
Sbjct: 220 DSFSPELRS 228
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 1e-13
Identities = 61/229 (26%), Positives = 107/229 (46%), Gaps = 28/229 (12%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV------LQDRRYKNRELQLMRVMDHPNV 93
Y+ + +G GSFG K E G+ IK++ ++R +E+ ++ M HPN+
Sbjct: 2 YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNI 61
Query: 94 ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIY----VKLYTYQIF 149
+ + F + L +VM+Y Y N + +++ + + QI
Sbjct: 62 VQYQESFEENGN-----LYIVMDYCEGG-----DLYKKINAQRGVLFPEDQILDWFVQIC 111
Query: 150 RGLAYIHTVPRVCHRDLKPQNLLVDPLTHQ--VKICDFGSAKQLIAG-EANISYICSRFY 206
L ++H ++ HRD+K QN+ LT +K+ DFG A+ L + E + I + +Y
Sbjct: 112 LALKHVHD-RKILHRDIKSQNIF---LTKDGTIKLGDFGIARVLNSTVELARTCIGTPYY 167
Query: 207 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 255
+PE I Y DIW+ GCVL E+ + F N + +++II+
Sbjct: 168 LSPE-ICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIR 215
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 2e-13
Identities = 64/233 (27%), Positives = 114/233 (48%), Gaps = 30/233 (12%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNREL-------QLMRVMDHPNVISL 96
+++G G+FG V + TG A+K + ++ E+ ++++ HP + +L
Sbjct: 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 60
Query: 97 KHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 154
K+ F T + L VMEY E + + + +R + Y +I L Y
Sbjct: 61 KYAF-QTHDR----LCFVMEYANGGELFFHLSRERVFTEER-----ARFYGAEIVSALEY 110
Query: 155 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPELIF 213
+H+ V +RD+K +NL++D H +KI DFG K+ I+ A + C + Y APE +
Sbjct: 111 LHS-RDVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFCGTPEYLAPE-VL 167
Query: 214 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 266
+Y ++D W G V+ E++ G+ F ++ ++L E+I + EEIR
Sbjct: 168 EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-ERLFELILM------EEIR 213
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 2e-13
Identities = 62/216 (28%), Positives = 103/216 (47%), Gaps = 23/216 (10%)
Query: 45 VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRE-----------LQLMRVMDHPNV 93
++G G FG V+ + +TG+ A+K L +R K ++ L L+ D P +
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMK-CLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 59
Query: 94 ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 153
+ + + F T K L+L+ + Y + +H + + M + Y +I GL
Sbjct: 60 VCMTYAF-HTPDKLCFILDLMNG--GDLHYHLSQHGVFSEKEM-----RFYATEIILGLE 111
Query: 154 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIF 213
++H V +RDLKP N+L+D H V+I D G A + + S + + Y APE++
Sbjct: 112 HMHN-RFVVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPHAS-VGTHGYMAPEVLQ 168
Query: 214 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQ 249
T Y +S D +S GC+L +LL G F D+
Sbjct: 169 KGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK 204
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 3e-13
Identities = 66/223 (29%), Positives = 113/223 (50%), Gaps = 29/223 (13%)
Query: 32 GEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ-----LMR 86
G+P+ + + +G GS GIV A +G+ VA+KK + R+ + REL +MR
Sbjct: 16 GDPRTYLDNFIK--IGEGSTGIVCIATVKSSGKLVAVKK-MDLRKQQRRELLFNEVVIMR 72
Query: 87 VMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYT 145
H NV+ + + S +EL++ VME++ ++ ++ H RM +
Sbjct: 73 DYQHENVVEM---YNSYLVGDELWV--VMEFLEGGALTDIVTH-----TRMNEEQIAAVC 122
Query: 146 YQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH--QVKICDFGSAKQLIAGEA--NISYI 201
+ + L+ +H V HRD+K ++L LTH +VK+ DFG Q ++ E S +
Sbjct: 123 LAVLKALSVLHA-QGVIHRDIKSDSIL---LTHDGRVKLSDFGFCAQ-VSKEVPRRKSLV 177
Query: 202 CSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE 244
+ ++ APELI Y +DIWS G ++ E++ G+P + E
Sbjct: 178 GTPYWMAPELI-SRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE 219
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 3e-13
Identities = 67/248 (27%), Positives = 114/248 (45%), Gaps = 57/248 (22%)
Query: 46 VGTGSFGIVFQAKCLETGE-----TVAIKKVLQDRRYKN-----RELQLMRVM-DHPNVI 94
+G G+FG V +A+ + TVA+K + D K+ E+++M+++ H N+I
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNII 79
Query: 95 SLKHCFFSTTSKNELFLNLVMEYV-------------PESMYRVLKHYSSANQRMPLIYV 141
+L T + L++ V+EY P Y + + +
Sbjct: 80 NLLGV---CTQEGPLYV--VVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDL 134
Query: 142 KLYTYQIFRGLAYIHTVPRVC-HRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISY 200
+ YQ+ RG+ ++ + + C HRDL +N+LV H +KI DFG A+ +I +
Sbjct: 135 VSFAYQVARGMEFLAS--KKCIHRDLAARNVLVTE-DHVMKIADFGLAR-------DIHH 184
Query: 201 ICSRFYR------------APELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAV 247
I +YR APE +F YT D+WS G +L E+ LG +PG V
Sbjct: 185 I--DYYRKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLLWEIFTLGGSPYPGI-PV 240
Query: 248 DQLVEIIK 255
++L +++K
Sbjct: 241 EELFKLLK 248
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 3e-13
Identities = 60/219 (27%), Positives = 104/219 (47%), Gaps = 29/219 (13%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLM----RVMDHPN---VISL 96
+V+G G+FG V + + + A+K + + K + +M H N ++ L
Sbjct: 49 KVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQL 108
Query: 97 KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 156
H F +++ +L +VMEY+P L +N +P + + YT ++ L IH
Sbjct: 109 -HYAF----QDDKYLYMVMEYMPGGDLVNL----MSNYDIPEKWARFYTAEVVLALDAIH 159
Query: 157 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF-----YRAPEL 211
++ + HRD+KP N+L+D H +K+ DFG+ ++ +AN C Y +PE+
Sbjct: 160 SMGFI-HRDVKPDNMLLDKSGH-LKLADFGTCMKM---DANGMVRCDTAVGTPDYISPEV 214
Query: 212 IF---GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV 247
+ G Y D WS G L E+L+G F ++ V
Sbjct: 215 LKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV 253
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 4e-13
Identities = 60/229 (26%), Positives = 112/229 (48%), Gaps = 27/229 (11%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQ-------DRRYKNRELQLMRVMDHPN 92
Y +V+G G+FG V + T + A+K + + D + E +M + P
Sbjct: 45 YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 104
Query: 93 VISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 151
V+ L + F +++ +L +VMEY+P + ++ +Y +P + + YT ++
Sbjct: 105 VVQLFYAF-----QDDRYLYMVMEYMPGGDLVNLMSNYD-----VPEKWARFYTAEVVLA 154
Query: 152 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI---SYICSRFYRA 208
L IH++ + HRD+KP N+L+D H +K+ DFG+ ++ E + + + + Y +
Sbjct: 155 LDAIHSMGFI-HRDVKPDNMLLDKSGH-LKLADFGTCMKM-NKEGMVRCDTAVGTPDYIS 211
Query: 209 PELIF---GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 254
PE++ G Y D WS G L E+L+G F ++ V +I+
Sbjct: 212 PEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM 260
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 6e-13
Identities = 61/230 (26%), Positives = 112/230 (48%), Gaps = 29/230 (12%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQ-------DRRYKNRELQLMRVMDHPN 92
Y +V+G G+FG V + + + A+K + + D + E +M + P
Sbjct: 45 YDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 104
Query: 93 VISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 151
V+ L C F +++ +L +VMEY+P + ++ +Y +P + K YT ++
Sbjct: 105 VVQL-FCAF----QDDKYLYMVMEYMPGGDLVNLMSNYD-----VPEKWAKFYTAEVVLA 154
Query: 152 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI----SYICSRFYR 207
L IH++ + HRD+KP N+L+D H +K+ DFG+ ++ E + + + + Y
Sbjct: 155 LDAIHSMGLI-HRDVKPDNMLLDKHGH-LKLADFGTCMKM--DETGMVRCDTAVGTPDYI 210
Query: 208 APELIF---GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 254
+PE++ G Y D WS G L E+L+G F ++ V +I+
Sbjct: 211 SPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIM 260
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 6e-13
Identities = 62/207 (29%), Positives = 102/207 (49%), Gaps = 23/207 (11%)
Query: 44 RVVGTGSFGIVFQAKCL-ETGETVAIKKVLQDRRYKNR-------ELQLMRVMDHPNVIS 95
R +GTGSFG V A E VAIK+ + + K + E +++ ++HP ++
Sbjct: 36 RTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVN 95
Query: 96 LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 155
L F K+E +L LV+E+V + + N+R P Y QI Y+
Sbjct: 96 LYGSF-----KDESYLYLVLEFVIGGEFFT---FLRRNKRFPNDVGCFYAAQIVLIFEYL 147
Query: 156 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPELIFG 214
++ + +RDLKP+NLL+D +K+ DFG AK + + +C + Y APE++
Sbjct: 148 QSL-NIVYRDLKPENLLLDK-DGFIKMTDFGFAKVV---DTRTYTLCGTPEYIAPEILLN 202
Query: 215 ATEYTTSIDIWSAGCVLAELLLGQPLF 241
+ + D W+ G + E+L+G P F
Sbjct: 203 VG-HGKAADWWTLGIFIYEILVGCPPF 228
|
Length = 340 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 6e-13
Identities = 59/215 (27%), Positives = 96/215 (44%), Gaps = 32/215 (14%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIKK-----VLQDRRYKNRELQLMRVMDHPNVISLKH 98
+G G+FG V++ L+ VA+K +R +E ++++ DHPN++ L
Sbjct: 1 EKIGKGNFGDVYKGV-LKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKL-- 57
Query: 99 CFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV 158
K +++ VME VP L R+ + + + G+ Y+ +
Sbjct: 58 -IGVCVQKQPIYI--VMELVPGGSL--LTFLRKKKNRLTVKKLLQMSLDAAAGMEYLES- 111
Query: 159 PRVC-HRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYR-------APE 210
+ C HRDL +N LV + +KI DFG +++ E Y S + APE
Sbjct: 112 -KNCIHRDLAARNCLVG-ENNVLKISDFGMSRE----EEGGIYTVSDGLKQIPIKWTAPE 165
Query: 211 -LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 243
L +G YT+ D+WS G +L E LG +PG
Sbjct: 166 ALNYG--RYTSESDVWSYGILLWETFSLGDTPYPG 198
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 8e-13
Identities = 67/234 (28%), Positives = 111/234 (47%), Gaps = 33/234 (14%)
Query: 24 STTIGGKNGEPKQTISYMA-ERV--VGTGSFGIVFQAKCLETGETVAIKKVLQD-----R 75
S++ P S ERV +G+G+ G V++ TG A+K + + R
Sbjct: 57 SSSSSASGSAPSAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVR 116
Query: 76 RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQR 135
R RE++++R ++HPNV+ H F + + +++E++ L+ A+++
Sbjct: 117 RQICREIEILRDVNHPNVVKC-HDMFDHNGE----IQVLLEFMDGGS---LEGTHIADEQ 168
Query: 136 MPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL--IA 193
++ QI G+AY+H + HRD+KP NLL++ VKI DFG ++ L
Sbjct: 169 ----FLADVARQILSGIAYLHR-RHIVHRDIKPSNLLINS-AKNVKIADFGVSRILAQTM 222
Query: 194 GEANISYICSRFYRAPELI-----FGATEYTTSIDIWSAGCVLAELLLGQPLFP 242
N S + + Y +PE I GA + DIWS G + E LG+ FP
Sbjct: 223 DPCN-SSVGTIAYMSPERINTDLNHGAYDGYAG-DIWSLGVSILEFYLGR--FP 272
|
Length = 353 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 9e-13
Identities = 58/200 (29%), Positives = 96/200 (48%), Gaps = 18/200 (9%)
Query: 46 VGTGSFGIVFQAKCLETGETVAIKKV-LQDRRYK----NRELQLMRVMDHPNVISLKHCF 100
+G GSFG VF+ T + VAIK + L++ + +E+ ++ D P V +
Sbjct: 12 IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71
Query: 101 FSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR 160
T L ++MEY+ L ++ +K +I +GL Y+H+ +
Sbjct: 72 LKGTK-----LWIIMEYLGGGSALDLLRAGPFDEFQIATMLK----EILKGLDYLHSEKK 122
Query: 161 VCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE-ANISYICSRFYRAPELIFGATEYT 219
+ HRD+K N+L+ VK+ DFG A QL + +++ + F+ APE+I + Y
Sbjct: 123 I-HRDIKAANVLLSE-QGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI-QQSAYD 179
Query: 220 TSIDIWSAGCVLAELLLGQP 239
+ DIWS G EL G+P
Sbjct: 180 SKADIWSLGITAIELAKGEP 199
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 1e-12
Identities = 61/203 (30%), Positives = 101/203 (49%), Gaps = 24/203 (11%)
Query: 46 VGTGSFGIVFQAKCLETGETVAIKKV-LQDRRYK----NRELQLMRVMDHPNVISLKHCF 100
+G GSFG VF+ T + VAIK + L++ + +E+ ++ D P V +
Sbjct: 12 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71
Query: 101 FSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTY--QIFRGLAYIHT 157
T L ++MEY+ S +L + PL ++ T +I +GL Y+H+
Sbjct: 72 LKDTK-----LWIIMEYLGGGSALDLL-------EPGPLDETQIATILREILKGLDYLHS 119
Query: 158 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS-YICSRFYRAPELIFGAT 216
++ HRD+K N+L+ +VK+ DFG A QL + + ++ + F+ APE+I +
Sbjct: 120 EKKI-HRDIKAANVLLSE-HGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI-KQS 176
Query: 217 EYTTSIDIWSAGCVLAELLLGQP 239
Y + DIWS G EL G+P
Sbjct: 177 AYDSKADIWSLGITAIELAKGEP 199
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-12
Identities = 64/205 (31%), Positives = 99/205 (48%), Gaps = 28/205 (13%)
Query: 46 VGTGSFGIVFQAKCLETGETVAIKKV-LQDRRYK----NRELQLMRVMDHPNVISLKHCF 100
+G GSFG V++ T E VAIK + L++ + +E+ ++ D P + +
Sbjct: 12 IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSY 71
Query: 101 FSTTSKNELFLNLVMEYV-PESMYRVLKHYSSANQRMPL--IYVKLYTYQIFRGLAYIHT 157
T L ++MEY+ S +LK PL Y+ +I +GL Y+H+
Sbjct: 72 LKGTK-----LWIIMEYLGGGSALDLLK-------PGPLEETYIATILREILKGLDYLHS 119
Query: 158 VPRVCHRDLKPQNLLVDPLTHQ--VKICDFGSAKQLIAGE-ANISYICSRFYRAPELIFG 214
R HRD+K N+L L+ Q VK+ DFG A QL + +++ + F+ APE+I
Sbjct: 120 -ERKIHRDIKAANVL---LSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI-K 174
Query: 215 ATEYTTSIDIWSAGCVLAELLLGQP 239
+ Y DIWS G EL G+P
Sbjct: 175 QSAYDFKADIWSLGITAIELAKGEP 199
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 2e-12
Identities = 58/225 (25%), Positives = 97/225 (43%), Gaps = 31/225 (13%)
Query: 46 VGTGSFGIVFQAKCLETGET---VAIKKVLQDRRYKN-----RELQLMRVMDHPNVISLK 97
+G GSFG+V + + +G VA+K + D+ +E +M +DH N+I L
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLY 62
Query: 98 HCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 156
+ +V E P S+ L+ A + + Y QI G+ Y+
Sbjct: 63 GVVLTHPLM------MVTELAPLGSLLDRLR--KDALGHFLISTLCDYAVQIANGMRYLE 114
Query: 157 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYR-------AP 209
+ R HRDL +N+L+ +VKI DFG + L E + Y+ + AP
Sbjct: 115 S-KRFIHRDLAARNILL-ASDDKVKIGDFGLMRALPQNEDH--YV-MEEHLKVPFAWCAP 169
Query: 210 ELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEI 253
E + T ++ + D+W G L E+ G+ + G + L +I
Sbjct: 170 ESLRTRT-FSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKI 213
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 3e-12
Identities = 62/220 (28%), Positives = 103/220 (46%), Gaps = 20/220 (9%)
Query: 34 PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ-----LMRVM 88
P + ++ +G G++G VF+ + G A+K +L + E++ L +
Sbjct: 14 PDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVK-ILDPIHDIDEEIEAEYNILKALS 72
Query: 89 DHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQ 147
DHPNV+ ++ KN L LV+E S+ ++K + +RM + ++
Sbjct: 73 DHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHE 132
Query: 148 IFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQ--VKICDFGSAKQLIAG--EANISYICS 203
GL ++H V + HRD+K N+L LT + VK+ DFG + QL + N S + +
Sbjct: 133 ALMGLQHLH-VNKTIHRDVKGNNIL---LTTEGGVKLVDFGVSAQLTSTRLRRNTS-VGT 187
Query: 204 RFYRAPELIFGA----TEYTTSIDIWSAGCVLAELLLGQP 239
F+ APE+I + Y D+WS G EL G P
Sbjct: 188 PFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDP 227
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 5e-12
Identities = 63/222 (28%), Positives = 101/222 (45%), Gaps = 20/222 (9%)
Query: 46 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ-----LMRVMDHPNVISLKHCF 100
+G G++G V++ + G A+K +L + E++ L + +HPNV+ F
Sbjct: 30 IGKGTYGKVYKVTNKKDGSLAAVK-ILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMF 88
Query: 101 FSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 159
+ L LV+E S+ ++K QR+ + Y GL ++H
Sbjct: 89 YKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHN-N 147
Query: 160 RVCHRDLKPQNLLVDPLTHQ--VKICDFGSAKQLIAGE--ANISYICSRFYRAPELIFGA 215
R+ HRD+K N+L LT + VK+ DFG + QL + N S + + F+ APE+I
Sbjct: 148 RIIHRDVKGNNIL---LTTEGGVKLVDFGVSAQLTSTRLRRNTS-VGTPFWMAPEVIACE 203
Query: 216 TEYTTS----IDIWSAGCVLAELLLGQPLFPGENAVDQLVEI 253
+Y S D+WS G EL G P + V L +I
Sbjct: 204 QQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKI 245
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 5e-12
Identities = 59/208 (28%), Positives = 102/208 (49%), Gaps = 19/208 (9%)
Query: 45 VVGTGSFGIVFQAKCLETGETVAIK--KVLQDRRYK-NRELQLMRVMDHPNVISLKHCFF 101
+VG G++G V++ + ++TG+ AIK V D + +E+ +++ H I+ + F
Sbjct: 13 LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAF 72
Query: 102 STTSKNELFLN----LVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT 157
KN ++ LVME+ L + N + ++ +I RGL+++H
Sbjct: 73 --IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNT-LKEEWIAYICREILRGLSHLHQ 129
Query: 158 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL--IAGEANISYICSRFYRAPELIF-- 213
+V HRD+K QN+L+ +VK+ DFG + QL G N ++I + ++ APE+I
Sbjct: 130 -HKVIHRDIKGQNVLLTE-NAEVKLVDFGVSAQLDRTVGRRN-TFIGTPYWMAPEVIACD 186
Query: 214 --GATEYTTSIDIWSAGCVLAELLLGQP 239
Y D+WS G E+ G P
Sbjct: 187 ENPDATYDFKSDLWSLGITAIEMAEGAP 214
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 6e-12
Identities = 60/218 (27%), Positives = 104/218 (47%), Gaps = 30/218 (13%)
Query: 44 RVVGTGSFGIVFQAKCLETGET-----VAIKKVLQDRRYKNR-----ELQLMRVM-DHPN 92
+ +G G+FG V +A ++ VA+K + R EL++M + +H N
Sbjct: 41 KTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHEN 100
Query: 93 VISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKL--YTYQIFR 150
+++L + T + + + EY Y L ++ + L L ++YQ+ +
Sbjct: 101 IVNL---LGACTIGGPILV--ITEYC---CYGDLLNFLRRKRESFLTLEDLLSFSYQVAK 152
Query: 151 GLAYIHTVPRVC-HRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF---Y 206
G+A++ + + C HRDL +N+L+ VKICDFG A+ ++ + +R +
Sbjct: 153 GMAFLAS--KNCIHRDLAARNVLLTH-GKIVKICDFGLARDIMNDSNYVVKGNARLPVKW 209
Query: 207 RAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 243
APE IF YT D+WS G +L E+ LG +PG
Sbjct: 210 MAPESIFNCV-YTFESDVWSYGILLWEIFSLGSNPYPG 246
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 9e-12
Identities = 61/206 (29%), Positives = 98/206 (47%), Gaps = 27/206 (13%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-----NREL----QLMRVMDHPNVI 94
+V+G+G+FG V++ + GE V I +++ R N+E+ +M +D+P+V
Sbjct: 13 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 72
Query: 95 SLKH-CFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQ-RMPLIYVKLYTYQIFRGL 152
L C ST + L+ + +P + L Y ++ + Y+ + QI +G+
Sbjct: 73 RLLGICLTST-------VQLITQLMP---FGCLLDYVREHKDNIGSQYLLNWCVQIAKGM 122
Query: 153 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF---YRAP 209
Y+ R+ HRDL +N+LV H VKI DFG AK L A E + + A
Sbjct: 123 NYLEE-RRLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGADEKEYHAEGGKVPIKWMAL 180
Query: 210 ELIFGATEYTTSIDIWSAGCVLAELL 235
E I YT D+WS G + EL+
Sbjct: 181 ESILHRI-YTHQSDVWSYGVTVWELM 205
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 1e-11
Identities = 66/219 (30%), Positives = 102/219 (46%), Gaps = 33/219 (15%)
Query: 44 RVVGTGSFGIVFQAK-CLETGE--TVAIKKVLQDRRYKNREL-----QLMRVMDHPNVIS 95
R +G G FG V+Q E VA+K RE +MR DHP+++
Sbjct: 12 RCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVK 71
Query: 96 LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQ-RMPLIYVKLYTYQIFRGLAY 154
L ++N ++ +VME P L+ Y N+ + L + LY+YQ+ LAY
Sbjct: 72 L----IGVITENPVW--IVMELAP---LGELRSYLQVNKYSLDLASLILYSYQLSTALAY 122
Query: 155 IHTVPRVCHRDLKPQNLLV-DPLTHQVKICDFGSAKQLIAGEANISYICSRF-----YRA 208
+ + R HRD+ +N+LV P VK+ DFG ++ L E Y S+ + A
Sbjct: 123 LESK-RFVHRDIAARNVLVSSP--DCVKLGDFGLSRYL---EDESYYKASKGKLPIKWMA 176
Query: 209 PELIFGATEYTTSIDIWSAG-CVLAELLLG-QPLFPGEN 245
PE I +T++ D+W G C+ L+LG +P +N
Sbjct: 177 PESI-NFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKN 214
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 1e-11
Identities = 56/200 (28%), Positives = 91/200 (45%), Gaps = 32/200 (16%)
Query: 49 GSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 108
G+ G F +T E V IK R E ++R ++HP++I LK F T +K
Sbjct: 103 GAEGFAFACIDNKTCEHVVIKA--GQRGGTATEAHILRAINHPSIIQLKGTF--TYNK-- 156
Query: 109 LFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKP 168
F L++ +Y Y +A + + + + + R + Y+H R+ HRD+K
Sbjct: 157 -FTCLILPRYKTDLY----CYLAAKRNIAICDILAIERSVLRAIQYLHE-NRIIHRDIKA 210
Query: 169 QNLLVDPLTHQVKIC--DFGSAKQLIAGEANISYICSRFY--------RAPELIFGATEY 218
+N+ ++ H +C DFG+A + AN ++Y APEL+ Y
Sbjct: 211 ENIFIN---HPGDVCLGDFGAACFPVDINAN------KYYGWAGTIATNAPELL-ARDPY 260
Query: 219 TTSIDIWSAGCVLAELLLGQ 238
++DIWSAG VL E+
Sbjct: 261 GPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 1e-11
Identities = 61/238 (25%), Positives = 108/238 (45%), Gaps = 49/238 (20%)
Query: 44 RVVGTGSFGIVFQAKCLETG-----ETVAIKKVLQ-----DRRYKNRELQLMRVMDHPNV 93
+ +G G FG V +A TVA+K + + + R E L++ ++HP+V
Sbjct: 6 KTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHV 65
Query: 94 ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKL---------- 143
I L + S++ L L++EY + Y L+ + ++++ Y+
Sbjct: 66 IKL----YGACSQDGPLL-LIVEY---AKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLD 117
Query: 144 --------------YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 189
+ +QI RG+ Y+ + V HRDL +N+LV ++KI DFG ++
Sbjct: 118 NPDERALTMGDLISFAWQISRGMQYLAEMKLV-HRDLAARNVLVAE-GRKMKISDFGLSR 175
Query: 190 QLIAGEANISYICSRF---YRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 243
+ ++ + R + A E +F YTT D+WS G +L E++ LG +PG
Sbjct: 176 DVYEEDSYVKRSKGRIPVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIVTLGGNPYPG 232
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 2e-11
Identities = 61/210 (29%), Positives = 97/210 (46%), Gaps = 25/210 (11%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIK---KVLQDRRYKNRELQ------LMRVMDHPNVI 94
+V+G+G+FG V++ + GETV I K+L + ++ +M MDHP+++
Sbjct: 13 KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 72
Query: 95 SLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 154
L S T + LV + +P H N L+ + QI +G+ Y
Sbjct: 73 RLLGVCLSPT------IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLN--WCVQIAKGMMY 124
Query: 155 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF---YRAPEL 211
+ R+ HRDL +N+LV H VKI DFG A+ L E + + + A E
Sbjct: 125 LEE-RRLVHRDLAARNVLVKSPNH-VKITDFGLARLLEGDEKEYNADGGKMPIKWMALEC 182
Query: 212 IFGATEYTTSIDIWSAGCVLAELLL--GQP 239
I ++T D+WS G + EL+ G+P
Sbjct: 183 IH-YRKFTHQSDVWSYGVTIWELMTFGGKP 211
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 2e-11
Identities = 61/240 (25%), Positives = 107/240 (44%), Gaps = 48/240 (20%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIK----KVLQDRRYKNR---ELQLMRVMDHPNVISL 96
+++G G G VF + TG+ A+K K + R R E +++ +DHP + +L
Sbjct: 7 KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTL 66
Query: 97 KHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 155
F + T +L LVM+Y P ++R+L+ + + + Y ++ L Y+
Sbjct: 67 YASFQTET-----YLCLVMDYCPGGELFRLLQ--RQPGKCLSEEVARFYAAEVLLALEYL 119
Query: 156 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL------------------------ 191
H + V +RDLKP+N+L+ H + + DF +KQ
Sbjct: 120 HLLGIV-YRDLKPENILLHESGH-IMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIP 177
Query: 192 ------IAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 245
+ S++ + Y APE+I G + +++D W+ G +L E+L G F G N
Sbjct: 178 SETFSEEPSFRSNSFVGTEEYIAPEVISGDG-HGSAVDWWTLGILLYEMLYGTTPFKGSN 236
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 2e-11
Identities = 63/221 (28%), Positives = 102/221 (46%), Gaps = 16/221 (7%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFST 103
+V+G G+FG V K T A+K + + K E R + NV+ C + T
Sbjct: 7 KVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFR--EERNVLVNGDCQWIT 64
Query: 104 T----SKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 159
T ++E +L LVM+Y +L S R+P + Y ++ + IH +
Sbjct: 65 TLHYAFQDENYLYLVMDYYVGG--DLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQL- 121
Query: 160 RVCHRDLKPQNLLVDPLTHQVKICDFGSA-KQLIAGEANISY-ICSRFYRAPELIF---- 213
HRD+KP N+L+D H +++ DFGS K G S + + Y +PE++
Sbjct: 122 HYVHRDIKPDNVLLDMNGH-IRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMED 180
Query: 214 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 254
G +Y D WS G + E+L G+ F E+ V+ +I+
Sbjct: 181 GMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 221
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 3e-11
Identities = 64/221 (28%), Positives = 105/221 (47%), Gaps = 28/221 (12%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMR----VM---DHPNVISL 96
+V+G G+FG V K TG+ A+K + + K E R V+ D + +L
Sbjct: 7 KVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNL 66
Query: 97 KHCFFSTTSKNELFLNLVMEY-VPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 155
+ F ++E L LVM+Y V + +L S R+P + Y ++ + +
Sbjct: 67 HYAF-----QDENNLYLVMDYYVGGDLLTLL---SKFEDRLPEDMARFYLAEMVLAIDSV 118
Query: 156 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG---EANIS-----YICSRFYR 207
H + V HRD+KP N+L+D H +++ DFGS +L+A ++N++ YI +
Sbjct: 119 HQLGYV-HRDIKPDNVLLDKNGH-IRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQ 176
Query: 208 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVD 248
A E G Y D WS G + E+L G+ F E+ V+
Sbjct: 177 AME--DGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE 215
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 3e-11
Identities = 63/226 (27%), Positives = 104/226 (46%), Gaps = 33/226 (14%)
Query: 43 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR----ELQLMRVMDHPNVISLKH 98
ER +G+G FG V++ VAIK + D K + E+Q ++ + H ++ISL
Sbjct: 11 ERKLGSGYFGEVWEGLWKNRVR-VAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL-- 67
Query: 99 CFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMP-LIYVKLYTYQIFRGLAYIH 156
F+ S E ++ E + + S+ L+ + LI + Q+ G+AY+
Sbjct: 68 --FAVCSVGEPVY-IITELMEKGSLLAFLRSPEGQVLPVASLIDM---ACQVAEGMAYLE 121
Query: 157 TVPRVCHRDLKPQNLLV-DPLTHQVKICDFGSAKQL-----IAGEANISYICSRFYRAPE 210
HRDL +N+LV + L K+ DFG A+ + ++ + I Y + APE
Sbjct: 122 E-QNSIHRDLAARNILVGEDLV--CKVADFGLARLIKEDVYLSSDKKIPYK----WTAPE 174
Query: 211 LIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGEN---AVDQLVE 252
++T D+WS G +L E+ GQ +PG N DQ+
Sbjct: 175 AA-SHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITA 219
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 3e-11
Identities = 47/148 (31%), Positives = 72/148 (48%), Gaps = 16/148 (10%)
Query: 144 YTYQIFRGLAYIHTVPRVC-HRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC 202
Y++Q+ +G+ ++ + R C HRDL +N+L+ + VKICDFG A+ + +
Sbjct: 184 YSFQVAKGMEFLAS--RKCIHRDLAARNILLSE-NNVVKICDFGLARDIYKDPDYVRKGD 240
Query: 203 SRF---YRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLG 258
+R + APE IF YT D+WS G +L E+ LG +PG V+I +
Sbjct: 241 ARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------VKIDEEFC 292
Query: 259 TPTREEIRCMNPNYTDFRFPQIKAHPWH 286
+E R P+YT Q WH
Sbjct: 293 RRLKEGTRMRAPDYTTPEMYQTMLDCWH 320
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 4e-11
Identities = 45/148 (30%), Positives = 70/148 (47%), Gaps = 16/148 (10%)
Query: 144 YTYQIFRGLAYIHTVPRVC-HRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC 202
Y++Q+ RG+ ++ + R C HRDL +N+L+ + VKICDFG A+ + +
Sbjct: 179 YSFQVARGMEFLAS--RKCIHRDLAARNILLSE-NNVVKICDFGLARDIYKDPDYVRKGS 235
Query: 203 SRF---YRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLG 258
+R + APE IF YTT D+WS G +L E+ LG +PG V+I +
Sbjct: 236 ARLPLKWMAPESIFDKV-YTTQSDVWSFGVLLWEIFSLGASPYPG-------VQINEEFC 287
Query: 259 TPTREEIRCMNPNYTDFRFPQIKAHPWH 286
++ R P +I W
Sbjct: 288 QRLKDGTRMRAPENATPEIYRIMLACWQ 315
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 6e-11
Identities = 72/270 (26%), Positives = 112/270 (41%), Gaps = 65/270 (24%)
Query: 33 EPKQTISYMAERVVGTGSFGIVFQAKCL-----ETGETVAIK--------KVLQDRRYKN 79
P + ++ E +G G+FG V++ + + +VAIK KV Q+ R
Sbjct: 2 IPLSAVRFLEE--LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFR--- 56
Query: 80 RELQLMRVMDHPNVISL--------KHC-FFSTTSKNELFLNLVMEYVPESMYRVLKHYS 130
+E +LM + HPN++ L C F + +L LV P S V
Sbjct: 57 QEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRN-SPHS--DVGAESG 113
Query: 131 SANQRMPLIYVKLY--TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 188
+ L QI G+ Y+ + HRDL +N LV VKI DFG +
Sbjct: 114 DETVKSSLDCSDFLHIAIQIAAGMEYLSS-HHFVHRDLAARNCLVGE-GLTVKISDFGLS 171
Query: 189 KQLIAGEANISYICSRFYR------------APELI-FGATEYTTSIDIWSAGCVLAELL 235
+ + + + +YR PE I +G ++TT DIWS G VL E+
Sbjct: 172 RDIYSAD---------YYRVQSKSLLPVRWMPPEAILYG--KFTTESDIWSFGVVLWEIF 220
Query: 236 -LG-QPLFPGENAVDQLVEIIK---VLGTP 260
G QP + N +++E+I+ +L P
Sbjct: 221 SYGLQPYYGFSN--QEVIEMIRSRQLLPCP 248
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 7e-11
Identities = 64/242 (26%), Positives = 100/242 (41%), Gaps = 43/242 (17%)
Query: 61 ETGETVAIKKVLQD-----RRYK--NRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 113
TG VAIK + D + RE L + HPN+++L + L
Sbjct: 1 MTGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVAL----LDSGEAPPGLLFA 56
Query: 114 VMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLV 173
V EYVP R L+ +A+ +P Q+ LA H + HRDLKPQN++V
Sbjct: 57 VFEYVPG---RTLREVLAADGALPAGETGRLMLQVLDALACAHN-QGIVHRDLKPQNIMV 112
Query: 174 DP--LTHQVKICDFGSAKQLI-AGEANIS-------YICSRFYRAPELIFGATEYTTSID 223
+ K+ DFG L +A+++ + + Y APE + G T + D
Sbjct: 113 SQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPV-TPNSD 171
Query: 224 IWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQ-IKA 282
+++ G + E L GQ + G + + EI+ + ++P D P I
Sbjct: 172 LYAWGLIFLECLTGQRVVQGAS----VAEILY----------QQLSPV--DVSLPPWIAG 215
Query: 283 HP 284
HP
Sbjct: 216 HP 217
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 7e-11
Identities = 66/235 (28%), Positives = 101/235 (42%), Gaps = 55/235 (23%)
Query: 43 ERVVGTGSFGIVFQ--AKCLETGE---TVAIKKV-----LQDRRYKNRELQLMRVMDHPN 92
R +G GSFG+V++ AK + GE VAIK V +++R E +M+ + +
Sbjct: 11 IRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHH 70
Query: 93 VISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHY--------SSANQRMPLIYVKLY 144
V+ L S + L +VME + + LK Y + P K
Sbjct: 71 VVRL----LGVVSTGQPTL-VVMELMAKGD---LKSYLRSRRPEAENNPGLGPPTLQKFI 122
Query: 145 TY--QIFRGLAYIHTVPRVCHRDLKPQNLLV-DPLTHQVKICDFGSAKQLIAGEANISYI 201
+I G+AY+ + HRDL +N +V + LT VKI DFG + +I
Sbjct: 123 QMAAEIADGMAYLAAK-KFVHRDLAARNCMVAEDLT--VKIGDFGMTR-------DIYE- 171
Query: 202 CSRFYR------------APELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 243
+ +YR APE + +TT D+WS G VL E+ L + + G
Sbjct: 172 -TDYYRKGGKGLLPVRWMAPESLKDGV-FTTKSDVWSFGVVLWEMATLAEQPYQG 224
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 9e-11
Identities = 69/267 (25%), Positives = 101/267 (37%), Gaps = 63/267 (23%)
Query: 34 PKQTISYMAERVVGTGSFGIVFQAKC--LETGET---VAIKKVLQD------RRYKNREL 82
+ TI R +G G+FG VF +C LE VA+ K L++ R+ RE
Sbjct: 3 QRDTIVLK--RELGEGAFGKVFLGECYHLEPENDKELVAV-KTLKETASNDARKDFEREA 59
Query: 83 QLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPES-----------MYRVLKHYSS 131
+L+ H N++ +V EY+ LK S
Sbjct: 60 ELLTNFQHENIVKFYGVCTEGDP-----PIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDS 114
Query: 132 ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLV-DPLTHQVKICDFGSAKQ 190
+ L + QI G+ Y+ HRDL +N LV L VKI DFG ++
Sbjct: 115 PMGELTLSQLLQIAVQIASGMVYL-ASQHFVHRDLATRNCLVGYDLV--VKIGDFGMSRD 171
Query: 191 LIAGEANISYICSRFYR------------APELIFGATEYTTSIDIWSAGCVLAELLL-- 236
+ Y +YR PE I +TT D+WS G VL E+
Sbjct: 172 V--------YTTD-YYRVGGHTMLPIRWMPPESIMYRK-FTTESDVWSFGVVLWEIFTYG 221
Query: 237 GQPLFPGENAVDQLVEIIK---VLGTP 260
QP + N ++++E I +L P
Sbjct: 222 KQPWYGLSN--EEVIECITQGRLLQRP 246
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 1e-10
Identities = 67/219 (30%), Positives = 102/219 (46%), Gaps = 29/219 (13%)
Query: 40 YMAERVVGTGSFGIVFQA-KCLETGETVAIKKV-LQDRR---YKNRELQLMRVMDHPNVI 94
Y+ +VG F A + + E V K V L D R Y EL + DH ++
Sbjct: 69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIV 128
Query: 95 SLKHCFFSTTSKNELFLNLVMEY-----VPESMYRVLKHYSSANQRMPL--IYVKLYTYQ 147
KH F S ++L L +MEY + + + + LK + +P V L YQ
Sbjct: 129 --KH-FDDFKSDDKLLL--IMEYGSGGDLNKQIKQRLK------EHLPFQEYEVGLLFYQ 177
Query: 148 IFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL---IAGEANISYICSR 204
I L +H+ ++ HRDLK N+ + P T +K+ DFG +KQ ++ + S+ +
Sbjct: 178 IVLALDEVHS-RKMMHRDLKSANIFLMP-TGIIKLGDFGFSKQYSDSVSLDVASSFCGTP 235
Query: 205 FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 243
+Y APEL + Y+ D+WS G +L ELL F G
Sbjct: 236 YYLAPEL-WERKRYSKKADMWSLGVILYELLTLHRPFKG 273
|
Length = 478 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 1e-10
Identities = 76/277 (27%), Positives = 124/277 (44%), Gaps = 54/277 (19%)
Query: 46 VGTGSFGIVFQAKCL-------ETGETVAIKKVLQDRRYKN-----RELQLMRVM-DHPN 92
+G G FG V A+ L + TVA+K + D K+ E+++M+++ H N
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 93 VISLKHCFFSTTSKNELFLNLVMEYVPESMYRVL--------KHYSSANQRMP---LIYV 141
+I+L + T L++ ++EY + R YS R+P + +
Sbjct: 83 IINL---LGACTQDGPLYV--IVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFK 137
Query: 142 KLY--TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS 199
L TYQ+ RG+ Y+ + + HRDL +N+LV + +KI DFG A+ + NI
Sbjct: 138 DLVSCTYQVARGMEYLAS-QKCIHRDLAARNVLVTE-NNVMKIADFGLARDV----NNID 191
Query: 200 YICSRF-------YRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLV 251
Y + APE +F YT D+WS G ++ E+ LG +PG V++L
Sbjct: 192 YYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPGI-PVEELF 249
Query: 252 EIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKV 288
+++K G + C N Y R WH +
Sbjct: 250 KLLKE-GHRMDKPANCTNELYMMMR------DCWHAI 279
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 2e-10
Identities = 48/148 (32%), Positives = 71/148 (47%), Gaps = 16/148 (10%)
Query: 144 YTYQIFRGLAYIHTVPRVC-HRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC 202
Y++Q+ RG+ ++ + R C HRDL +N+L+ + VKICDFG A+ + +
Sbjct: 178 YSFQVARGMEFLAS--RKCIHRDLAARNILLSE-NNVVKICDFGLARDIYKDPDYVRKGD 234
Query: 203 SRF---YRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLG 258
+R + APE IF YTT D+WS G +L E+ LG +PG V+I +
Sbjct: 235 ARLPLKWMAPESIFDKV-YTTQSDVWSFGVLLWEIFSLGASPYPG-------VQIDEEFC 286
Query: 259 TPTREEIRCMNPNYTDFRFPQIKAHPWH 286
+E R P Y I WH
Sbjct: 287 RRLKEGTRMRAPEYATPEIYSIMLDCWH 314
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 2e-10
Identities = 57/209 (27%), Positives = 90/209 (43%), Gaps = 28/209 (13%)
Query: 45 VVGTGSFGIVFQAK----CLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVI 94
+G G FG VF AK E GET+ + K LQ + +N REL + R + H NV+
Sbjct: 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVV 71
Query: 95 SLKHCFFSTTSKNELFLNLVMEYVP----ESMYRVLKHYSSANQRMPLIYVKLYT--YQI 148
L + E +++EY + R K + PL + QI
Sbjct: 72 RL----LGLCREAEPHY-MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQI 126
Query: 149 FRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE---ANISYICSRF 205
G+ ++ R HRDL +N LV +VK+ +K + E + I R
Sbjct: 127 ALGMDHLSNA-RFVHRDLAARNCLVSS-QREVKVSLLSLSKDVYNSEYYKLRNALIPLR- 183
Query: 206 YRAPELIFGATEYTTSIDIWSAGCVLAEL 234
+ APE + +++T D+WS G ++ E+
Sbjct: 184 WLAPEAVQ-EDDFSTKSDVWSFGVLMWEV 211
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 2e-10
Identities = 62/228 (27%), Positives = 92/228 (40%), Gaps = 32/228 (14%)
Query: 34 PKQTISYMAERVVGTGSFGIVFQAKCL-----ETGETVAIKKV-----LQDRRYKNRELQ 83
P+ I Y R +G G+FG VFQA+ E VA+K + + RE
Sbjct: 3 PRNNIEY--VRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAA 60
Query: 84 LMRVMDHPNVISL--------KHC----FFSTTSKNELFLNLVMEYVPESMYRVLKHYSS 131
LM DHPN++ L C + + NE + +
Sbjct: 61 LMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKC 120
Query: 132 ANQRMPLIYVKLY--TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 189
+PL + Q+ G+AY+ V HRDL +N LV VKI DFG ++
Sbjct: 121 GLNPLPLSCTEQLCIAKQVAAGMAYLSERKFV-HRDLATRNCLVGE-NMVVKIADFGLSR 178
Query: 190 QLIAGE---ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAEL 234
+ + + A+ + + PE IF YTT D+W+ G VL E+
Sbjct: 179 NIYSADYYKASENDAIPIRWMPPESIFYN-RYTTESDVWAYGVVLWEI 225
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 3e-10
Identities = 63/206 (30%), Positives = 97/206 (47%), Gaps = 27/206 (13%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIK---KVLQDRRY--KNREL----QLMRVMDHPNVI 94
+V+G+G+FG V++ + GE V I KVL++ N+E+ +M + P V
Sbjct: 13 KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVC 72
Query: 95 SLKH-CFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQ-RMPLIYVKLYTYQIFRGL 152
L C ST + LV + +P Y L Y N+ R+ + + QI +G+
Sbjct: 73 RLLGICLTST-------VQLVTQLMP---YGCLLDYVRENKDRIGSQDLLNWCVQIAKGM 122
Query: 153 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF---YRAP 209
+Y+ V R+ HRDL +N+LV H VKI DFG A+ L E + + A
Sbjct: 123 SYLEEV-RLVHRDLAARNVLVKSPNH-VKITDFGLARLLDIDETEYHADGGKVPIKWMAL 180
Query: 210 ELIFGATEYTTSIDIWSAGCVLAELL 235
E I +T D+WS G + EL+
Sbjct: 181 ESIL-HRRFTHQSDVWSYGVTVWELM 205
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 3e-10
Identities = 66/246 (26%), Positives = 119/246 (48%), Gaps = 38/246 (15%)
Query: 34 PKQTISYMAERVVGTGSFGIVFQA----------KCLETGETVAIKKVLQDRRYKNRELQ 83
P+++I + + +G G FG V+ K L+ G T++++ L+ E
Sbjct: 4 PRESIKLV--KKLGAGQFGEVWMGYYNNSTKVAVKTLKPG-TMSVQAFLE-------EAN 53
Query: 84 LMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVK 142
LM+ + H ++ L ++ +K E + ++ EY+ + S+ LK S ++ L +
Sbjct: 54 LMKTLQHDKLVRL----YAVVTKEEP-IYIITEYMAKGSLLDFLK--SDEGGKVLLPKLI 106
Query: 143 LYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC 202
++ QI G+AYI + HRDL+ N+LV KI DFG A+ +I +
Sbjct: 107 DFSAQIAEGMAYIERKNYI-HRDLRAANVLVSESL-MCKIADFGLAR-VIEDNEYTAREG 163
Query: 203 SRF---YRAPELI-FGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVL 257
++F + APE I FG+ +T D+WS G +L E++ G+ +PG + D + + +
Sbjct: 164 AKFPIKWTAPEAINFGS--FTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGY 221
Query: 258 GTPTRE 263
P E
Sbjct: 222 RMPRME 227
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 3e-10
Identities = 64/250 (25%), Positives = 113/250 (45%), Gaps = 39/250 (15%)
Query: 44 RVVGTGSFGIVFQAKCLETGET---VAIKKV-----LQDRRYKNRELQLMRVMDHPNVIS 95
RV+G G FG V+ +++ A+K + L++ +E +M+ HPNV+S
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 96 LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMP----LIYVKLYTYQIFRG 151
L + LV+ +P + L+++ + P LI L Q+ +G
Sbjct: 61 LLGICLPSEG-----SPLVV--LPYMKHGDLRNFIRSETHNPTVKDLIGFGL---QVAKG 110
Query: 152 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPEL 211
+ Y+ + + HRDL +N ++D + VK+ DFG A+ + E Y + +L
Sbjct: 111 MEYLAS-KKFVHRDLAARNCMLDE-SFTVKVADFGLARDIYDKE----YYSVHNHTGAKL 164
Query: 212 --IFGATE------YTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTR 262
+ A E +TT D+WS G +L EL+ G P +P ++ D V +++ G
Sbjct: 165 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQ--GRRLL 222
Query: 263 EEIRCMNPNY 272
+ C +P Y
Sbjct: 223 QPEYCPDPLY 232
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 59.1 bits (144), Expect = 4e-10
Identities = 58/220 (26%), Positives = 99/220 (45%), Gaps = 35/220 (15%)
Query: 83 QLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYV 141
QLM+ D+PN I L ++S T+ L +M+Y+ + ++ +LK ++ V
Sbjct: 63 QLMK--DNPNFIKL---YYSVTTLKGHVL--IMDYIKDGDLFDLLKK----EGKLSEAEV 111
Query: 142 KLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYI 201
K Q+ L +H + H D+K +N+L D ++ +CD+G K I G Y
Sbjct: 112 KKIIRQLVEALNDLH-KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCK--IIG-TPSCYD 167
Query: 202 CSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEI-------- 253
+ Y +PE I G Y S D W+ G + ELL G+ P + D+ +++
Sbjct: 168 GTLDYFSPEKIKGHN-YDVSFDWWAVGVLTYELLTGK--HPFKEDEDEELDLESLLKRQQ 224
Query: 254 -----IKVLGTPTREEIRCM---NPNYTDFRFPQIKAHPW 285
IK + + ++ M N NY + +I HP+
Sbjct: 225 KKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPF 264
|
Length = 267 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 4e-10
Identities = 61/240 (25%), Positives = 100/240 (41%), Gaps = 50/240 (20%)
Query: 44 RVVGTGSFGIVFQAKCLE-----TGET-VAIKK-----VLQDRRYKNRELQLMRVMDHPN 92
+G+G+FG V++ + +G VA+K Q+++ +E LM +HPN
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60
Query: 93 VISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVK---LYTYQI 148
++ L ++ME + + L+ PL+ +K +
Sbjct: 61 IVKLLGVCLLNEP-----QYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDV 115
Query: 149 FRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQ----VKICDFGSAKQLIAGEANISYICSR 204
+G Y+ + HRDL +N LV + VKI DFG A+ + S
Sbjct: 116 AKGCVYLEQM-HFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYK---------SD 165
Query: 205 FYR------------APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQL 250
+YR APE L+ G +TT D+WS G ++ E+L LGQ +P N + L
Sbjct: 166 YYRKEGEGLLPVRWMAPESLLDGK--FTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVL 223
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 7e-10
Identities = 59/225 (26%), Positives = 104/225 (46%), Gaps = 24/225 (10%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR--------ELQLMRVMDHPNVIS 95
+V+G G+FG V K L+ + V K+L R E ++ D+ + +
Sbjct: 7 KVIGRGAFGEVAVVK-LKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITT 65
Query: 96 LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 155
L + F +N L+L VM+Y +L S R+P + Y ++ + +
Sbjct: 66 LHYAF---QDENNLYL--VMDYYVGG--DLLTLLSKFEDRLPEDMARFYLAEMVIAIDSV 118
Query: 156 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC--SRFYRAPELIF 213
H + V HRD+KP N+L+D + +++ DFGS +L+ S + + Y +PE++
Sbjct: 119 HQLHYV-HRDIKPDNILMD-MNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQ 176
Query: 214 ----GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 254
G +Y D WS G + E+L G+ F E+ V+ +I+
Sbjct: 177 AMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 221
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 1e-09
Identities = 42/107 (39%), Positives = 58/107 (54%), Gaps = 13/107 (12%)
Query: 144 YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQ--VKICDFGSAKQLIAGEANISYI 201
+TYQ+ RG+ ++ + HRDL +N+L L VKICDFG A+ I ++N
Sbjct: 242 FTYQVARGMEFLAS-KNCVHRDLAARNVL---LAQGKIVKICDFGLARD-IMHDSNYVSK 296
Query: 202 CSRF----YRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 243
S F + APE IF YTT D+WS G +L E+ LG +PG
Sbjct: 297 GSTFLPVKWMAPESIFDNL-YTTLSDVWSYGILLWEIFSLGGTPYPG 342
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 57.3 bits (139), Expect = 1e-09
Identities = 58/209 (27%), Positives = 103/209 (49%), Gaps = 31/209 (14%)
Query: 43 ERVVGTGSFGIVFQAKCLETGE---TVAIKKVL-----QDRRYKNRELQLMRVMDHPNVI 94
E+V+G G FG V + + G+ VAIK + + R E +M DHPN+I
Sbjct: 9 EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNII 68
Query: 95 SLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 153
L+ +K+ + ++ EY+ S+ + L+ + V + I G+
Sbjct: 69 RLE----GVVTKSRPVM-IITEYMENGSLDKFLRENDG--KFTVGQLVGM-LRGIASGMK 120
Query: 154 YIHTVPRVCHRDLKPQNLLVDPLTHQV-KICDFGSAKQLIAGEANISY------ICSRFY 206
Y+ + V HRDL +N+LV+ ++ V K+ DFG +++L ++ +Y I R +
Sbjct: 121 YLSEMNYV-HRDLAARNILVN--SNLVCKVSDFGLSRRL--EDSEATYTTKGGKIPIR-W 174
Query: 207 RAPELIFGATEYTTSIDIWSAGCVLAELL 235
APE I ++T++ D+WS G V+ E++
Sbjct: 175 TAPEAI-AYRKFTSASDVWSFGIVMWEVM 202
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 2e-09
Identities = 58/219 (26%), Positives = 100/219 (45%), Gaps = 16/219 (7%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV------LQDRRYKNRELQLMRVMDHPNV 93
Y RV+G+G+ G V AK + GE A+K V D+ E+ + D ++
Sbjct: 34 YWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSI 93
Query: 94 ISLKHCFFSTTSKNE---LFLNLVMEYVPESMYRV-LKHYSSANQRMPLIYVKLYTYQIF 149
+ F +N L + LV++Y R +K + N+ L Q+
Sbjct: 94 VKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVL 153
Query: 150 RGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL---IAGEANISYICSRFY 206
+ ++H+ + HRD+K N+L+ VK+ DFG +K ++ + ++ + +Y
Sbjct: 154 LAVHHVHS-KHMIHRDIKSANILLCS-NGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYY 211
Query: 207 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 245
APE I+ Y+ D++S G +L ELL + F GEN
Sbjct: 212 VAPE-IWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN 249
|
Length = 496 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 2e-09
Identities = 61/231 (26%), Positives = 112/231 (48%), Gaps = 41/231 (17%)
Query: 43 ERVVGTGSFGIVFQA----------KCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPN 92
E+ +G G FG V+ A K ++ G +++++ L E +M+ + H
Sbjct: 11 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLA-------EANVMKTLQHDK 62
Query: 93 VISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 151
++ L + +K +++ + E++ + S+ LK S + PL + ++ QI G
Sbjct: 63 LVKLH----AVVTKEPIYI--ITEFMAKGSLLDFLK--SDEGSKQPLPKLIDFSAQIAEG 114
Query: 152 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF---YRA 208
+A+I + HRDL+ N+LV KI DFG A+ +I + ++F + A
Sbjct: 115 MAFIEQRNYI-HRDLRAANILVSASL-VCKIADFGLAR-VIEDNEYTAREGAKFPIKWTA 171
Query: 209 PELI-FGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVL 257
PE I FG+ +T D+WS G +L E++ G+ +PG + E+I+ L
Sbjct: 172 PEAINFGS--FTIKSDVWSFGILLMEIVTYGRIPYPGMSN----PEVIRAL 216
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 3e-09
Identities = 60/209 (28%), Positives = 99/209 (47%), Gaps = 23/209 (11%)
Query: 45 VVGTGSFGIVFQAKCLETGETVAIKKVLQD--RRYKNRELQLMRVM---DHPNVISLKHC 99
++G G+FG VF+ L+ VA+K +D + K + L R++ DHPN++ L
Sbjct: 2 LLGKGNFGEVFKGT-LKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKL--- 57
Query: 100 FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 159
T + ++ +VME VP + L + + + G+AY+ +
Sbjct: 58 IGVCTQRQPIY--IVMELVPGGDF--LSFLRKKKDELKTKQLVKFALDAAAGMAYLES-K 112
Query: 160 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL---IAGEANISYICSRFYRAPE-LIFGA 215
HRDL +N LV + +KI DFG ++Q I + + I + + APE L +G
Sbjct: 113 NCIHRDLAARNCLVGE-NNVLKISDFGMSRQEDDGIYSSSGLKQIPIK-WTAPEALNYG- 169
Query: 216 TEYTTSIDIWSAGCVLAELL-LGQPLFPG 243
Y++ D+WS G +L E LG +PG
Sbjct: 170 -RYSSESDVWSYGILLWETFSLGVCPYPG 197
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 4e-09
Identities = 66/244 (27%), Positives = 115/244 (47%), Gaps = 47/244 (19%)
Query: 46 VGTGSFGIVFQAKCL-------ETGETVAIKKVLQDRRYKN-----RELQLMRVMD-HPN 92
+G G FG V +A+ + TVA+K + + K+ E++LM+++ H N
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 93 VISLKHCFFSTTSKNELFLNLVMEYVPESMYRVL--------KHYSSANQRMP---LIYV 141
+I+L T + L++ ++EY + R Y+ ++P L +
Sbjct: 80 IINL---LGVCTQEGPLYV--IVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFK 134
Query: 142 KLYT--YQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS 199
L + YQ+ RG+ Y+ + R HRDL +N+LV + +KI DFG A+ G +I
Sbjct: 135 DLVSCAYQVARGMEYLES-RRCIHRDLAARNVLVTE-DNVMKIADFGLAR----GVHDID 188
Query: 200 YICSRF-------YRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLV 251
Y + APE +F YT D+WS G ++ E+ LG +PG V++L
Sbjct: 189 YYKKTSNGRLPVKWMAPEALFDRV-YTHQSDVWSFGILMWEIFTLGGSPYPGI-PVEELF 246
Query: 252 EIIK 255
++++
Sbjct: 247 KLLR 250
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 5e-09
Identities = 58/208 (27%), Positives = 96/208 (46%), Gaps = 26/208 (12%)
Query: 43 ERVVGTGSFGIVFQAKCLETGE---TVAIKKVL-----QDRRYKNRELQLMRVMDHPNVI 94
E V+G G FG V + + G+ VAIK + + RR E +M DHPN+I
Sbjct: 9 EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNII 68
Query: 95 SLKHCFFSTTSKNELFLNLVMEY-VPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 153
L+ T S+ + + ME +S R + + +I + I G+
Sbjct: 69 HLEGVV--TKSRPVMIITEFMENGALDSFLRQ------NDGQFTVIQLVGMLRGIAAGMK 120
Query: 154 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR------FYR 207
Y+ + V HRDL +N+LV+ K+ DFG ++ L ++ +Y S +
Sbjct: 121 YLSEMNYV-HRDLAARNILVNS-NLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWT 178
Query: 208 APELIFGATEYTTSIDIWSAGCVLAELL 235
APE I ++T++ D+WS G V+ E++
Sbjct: 179 APEAI-AYRKFTSASDVWSYGIVMWEVM 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 5e-09
Identities = 47/151 (31%), Positives = 70/151 (46%), Gaps = 24/151 (15%)
Query: 144 YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQ--VKICDFGSAKQLIAGEANISYI 201
++YQ+ +G++++ HRDL +N+L LTH KICDFG A+ I ++N Y+
Sbjct: 219 FSYQVAKGMSFL-ASKNCIHRDLAARNIL---LTHGRITKICDFGLARD-IRNDSN--YV 271
Query: 202 CSRFYR------APELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEII 254
R APE IF YT D+WS G +L E+ LG +PG + ++I
Sbjct: 272 VKGNARLPVKWMAPESIFNCV-YTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMI 330
Query: 255 KVLGTPTREEIRCMNPNYTDFRFPQIKAHPW 285
K E R ++P I W
Sbjct: 331 K-------EGYRMLSPECAPSEMYDIMKSCW 354
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 5e-09
Identities = 61/240 (25%), Positives = 102/240 (42%), Gaps = 36/240 (15%)
Query: 49 GSFGIVFQAKCLETGE---TVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTS 105
GS G VF C + G+ I K + + RE+ +++ + H +I+L H +
Sbjct: 103 GSEGEVFV--CTKHGDEQRKKVIVKAVTGGKTPGREIDILKTISHRAIINLIHAY----- 155
Query: 106 KNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRD 165
+ + + +VM ++ Y + +PL ++ LAY+H + HRD
Sbjct: 156 RWKSTVCMVMPKYKCDLFT----YVDRSGPLPLEQAITIQRRLLEALAYLHG-RGIIHRD 210
Query: 166 LKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF-----YRAPELIFGATEYTT 220
+K +N+ +D + V + DFG+A +L + C + +PEL+ Y
Sbjct: 211 VKTENIFLDEPENAV-LGDFGAACKL--DAHPDTPQCYGWSGTLETNSPELL-ALDPYCA 266
Query: 221 SIDIWSAGCVLAELLLGQ-PLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQ 279
DIWSAG VL E+ + LF + K + R IRCM + FPQ
Sbjct: 267 KTDIWSAGLVLFEMSVKNVTLFGKQV---------KSSSSQLRSIIRCMQVH--PLEFPQ 315
|
Length = 392 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 6e-09
Identities = 55/211 (26%), Positives = 98/211 (46%), Gaps = 26/211 (12%)
Query: 44 RVVGTGSFGIVFQAKCLETGET-VAIKKVLQDRRYKN---RELQLMRVMDHPNVISLKHC 99
R +G G FG V++ L T VA+K + E Q+M+ + HP +I L
Sbjct: 12 RKLGAGQFGEVWEG--LWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQL--- 66
Query: 100 FFSTTSKNE--LFLNLVMEYVPESMYRVLKHYSSANQRMP-LIYVKLYTYQIFRGLAYIH 156
++ + E + +M+Y S+ L+ + ++P LI + Q+ G+AY+
Sbjct: 67 -YAVCTLEEPIYIVTELMKY--GSLLEYLQGGAGRALKLPQLIDM---AAQVASGMAYLE 120
Query: 157 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF---YRAPELIF 213
+ HRDL +N+LV + K+ DFG A+ + + ++F + APE
Sbjct: 121 AQNYI-HRDLAARNVLVGE-NNICKVADFGLARVIKEDIYE-AREGAKFPIKWTAPEAAL 177
Query: 214 GATEYTTSIDIWSAGCVLAELL-LGQPLFPG 243
++ D+WS G +L E++ G+ +PG
Sbjct: 178 -YNRFSIKSDVWSFGILLTEIVTYGRMPYPG 207
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 7e-09
Identities = 51/197 (25%), Positives = 80/197 (40%), Gaps = 26/197 (13%)
Query: 46 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR---ELQLMRVMDHPNVISLKHCFFS 102
+G G FG V G+ VA+K + D E +M + HPN++ L
Sbjct: 14 IGKGEFGDVMLG--DYRGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQL--LGVV 69
Query: 103 TTSKNELFLNLVMEYVPESMYRVLKHY--SSANQRMPLIYVKLYTYQIFRGLAYIHTVPR 160
L +V EY+ + L Y S + L + + G+ Y+
Sbjct: 70 LQGNP---LYIVTEYMAKG---SLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEE-KN 122
Query: 161 VCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF---YRAPELIFGATE 217
HRDL +N+LV K+ DFG AK EA+ + + APE + +
Sbjct: 123 FVHRDLAARNVLVSE-DLVAKVSDFGLAK-----EASQGQDSGKLPVKWTAPEAL-REKK 175
Query: 218 YTTSIDIWSAGCVLAEL 234
++T D+WS G +L E+
Sbjct: 176 FSTKSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 7e-09
Identities = 61/220 (27%), Positives = 105/220 (47%), Gaps = 27/220 (12%)
Query: 34 PKQTISYMAERVVGTGSFGIVFQAKCLETGET-VAIKKVLQDRRYKN---RELQLMRVMD 89
P++T+ + +G G FG V+ G T VAIK + Q E LM+ +
Sbjct: 4 PRETLKL--VKKLGAGQFGEVWMG--YYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQ 59
Query: 90 HPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQI 148
HP ++ L ++ ++ +++ + EY+ S+ LK + ++ + + QI
Sbjct: 60 HPRLVRL----YAVVTQEPIYI--ITEYMENGSLVDFLK--TPEGIKLTINKLIDMAAQI 111
Query: 149 FRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF--- 205
G+A+I + HRDL+ N+LV KI DFG A+ LI + ++F
Sbjct: 112 AEGMAFIERKNYI-HRDLRAANILVSETLC-CKIADFGLAR-LIEDNEYTAREGAKFPIK 168
Query: 206 YRAPELI-FGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 243
+ APE I +G +T D+WS G +L E++ G+ +PG
Sbjct: 169 WTAPEAINYGT--FTIKSDVWSFGILLTEIVTYGRIPYPG 206
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 9e-09
Identities = 65/226 (28%), Positives = 110/226 (48%), Gaps = 27/226 (11%)
Query: 39 SYMAERVVGTGSFGIVFQAKCLETGET-VAIKKVLQDRRYKN---RELQLMRVMDHPNVI 94
S + +G G FG V+ G T VA+K + E Q+M+ + H ++
Sbjct: 7 SLQLIKKLGNGQFGEVWMG--TWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLV 64
Query: 95 SLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 153
L ++ S+ +++ V EY+ + S+ LK ++P + V + Q+ G+A
Sbjct: 65 QL----YAVVSEEPIYI--VTEYMSKGSLLDFLKDGEGRALKLPNL-VDMAA-QVAAGMA 116
Query: 154 YIHTVPRVCHRDLKPQNLLV-DPLTHQVKICDFGSAKQLIAGEANISYICSRF---YRAP 209
YI + + HRDL+ N+LV D L KI DFG A+ LI + ++F + AP
Sbjct: 117 YIERMNYI-HRDLRSANILVGDGLV--CKIADFGLAR-LIEDNEYTARQGAKFPIKWTAP 172
Query: 210 EL-IFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEI 253
E ++G +T D+WS G +L EL+ G+ +PG N + L ++
Sbjct: 173 EAALYG--RFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQV 216
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 1e-08
Identities = 69/244 (28%), Positives = 116/244 (47%), Gaps = 47/244 (19%)
Query: 46 VGTGSFGIVFQAKCLETGE-------TVAIKKVLQDRRYKN-----RELQLMRVM-DHPN 92
+G G FG V A+ + + TVA+K + D K+ E+++M+++ H N
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 93 VISLKHCFFSTTSKNELFLNLVMEYVPESMYRVL--------KHYSSANQRMP---LIYV 141
+I+L + T L++ ++EY + R YS ++P L +
Sbjct: 80 IINL---LGACTQDGPLYV--LVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFK 134
Query: 142 KLYT--YQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS 199
L + YQ+ RG+ Y+ + + HRDL +N+LV + +KI DFG A+ + NI
Sbjct: 135 DLVSCAYQVARGMEYLAS-QKCIHRDLAARNVLVTE-DNVMKIADFGLARDV----HNID 188
Query: 200 Y----ICSRF---YRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLV 251
Y R + APE +F YT D+WS G +L E+ LG +PG V++L
Sbjct: 189 YYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLLWEIFTLGGSPYPGI-PVEELF 246
Query: 252 EIIK 255
+++K
Sbjct: 247 KLLK 250
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 2e-08
Identities = 36/108 (33%), Positives = 58/108 (53%), Gaps = 15/108 (13%)
Query: 144 YTYQIFRGLAYIHTVPRVC-HRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC 202
++ Q+ +G+ ++ + + C HRD+ +N+L+ KICDFG A+ I ++N Y+
Sbjct: 217 FSSQVAQGMDFLAS--KNCIHRDVAARNVLLTDG-RVAKICDFGLARD-IMNDSN--YVV 270
Query: 203 SRFYR------APELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 243
R APE IF YT D+WS G +L E+ LG+ +PG
Sbjct: 271 KGNARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGKSPYPG 317
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 2e-08
Identities = 53/225 (23%), Positives = 100/225 (44%), Gaps = 29/225 (12%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIK---KVLQDRRYKNRELQ-------LMRVMDHPNV 93
+++G G FG V + + L + +K K ++ + E++ M+ DHPNV
Sbjct: 5 KILGEGEFGSVMEGQ-LSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNV 63
Query: 94 ISLKHCFFSTTSKNELFLNLV----MEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIF 149
+ L F +S ++ +V M++ + + +++PL + + I
Sbjct: 64 MKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIA 123
Query: 150 RGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAP 209
G+ Y+ HRDL +N ++ V + DFG +K++ +G+ Y R + P
Sbjct: 124 LGMEYLSN-RNFIHRDLAARNCMLRE-DMTVCVADFGLSKKIYSGD---YYRQGRIAKMP 178
Query: 210 ELIFGATE------YTTSIDIWSAGCVLAELL-LGQPLFPG-ENA 246
+ + A E YT+ D+W+ G + E+ GQ +PG EN
Sbjct: 179 -VKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH 222
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 2e-08
Identities = 63/220 (28%), Positives = 106/220 (48%), Gaps = 27/220 (12%)
Query: 34 PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRVMDH 90
P++++ E +G G FG V+ T VAIK + +E Q+M+ + H
Sbjct: 4 PRESLRL--EVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRH 60
Query: 91 PNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIF 149
++ L ++ S+ +++ V EY+ + S+ LK R+P + QI
Sbjct: 61 EKLVQL----YAVVSEEPIYI--VTEYMSKGSLLDFLKGEMGKYLRLPQLVD--MAAQIA 112
Query: 150 RGLAYIHTVPRVCHRDLKPQNLLV-DPLTHQVKICDFGSAKQLIAGEANISYICSRF--- 205
G+AY+ + V HRDL+ N+LV + L K+ DFG A+ LI + ++F
Sbjct: 113 SGMAYVERMNYV-HRDLRAANILVGENLV--CKVADFGLAR-LIEDNEYTARQGAKFPIK 168
Query: 206 YRAPE-LIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPG 243
+ APE ++G +T D+WS G +L EL G+ +PG
Sbjct: 169 WTAPEAALYG--RFTIKSDVWSFGILLTELTTKGRVPYPG 206
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 2e-08
Identities = 61/246 (24%), Positives = 104/246 (42%), Gaps = 58/246 (23%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRV-------MDHPNVISL 96
+V+G G+FG V + +TG A+K + + + ++ +R D V+ +
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKM 66
Query: 97 KHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 154
F+S K L+L +ME++P + M ++K + + + + Y + +
Sbjct: 67 ---FYSFQDKRNLYL--IMEFLPGGDMMTLLMKKDTLSEEA-----TQFYIAETVLAIDA 116
Query: 155 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG---------------------------- 186
IH + + HRD+KP NLL+D H VK+ DFG
Sbjct: 117 IHQLGFI-HRDIKPDNLLLDAKGH-VKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQ 174
Query: 187 ---SAKQLIAGEAN-----ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQ 238
S ++ + N S + + Y APE +F T Y D WS G ++ E+L+G
Sbjct: 175 NMNSKRKAETWKKNRRQLAYSTVGTPDYIAPE-VFMQTGYNKLCDWWSLGVIMYEMLIGY 233
Query: 239 PLFPGE 244
P F E
Sbjct: 234 PPFCSE 239
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 3e-08
Identities = 50/206 (24%), Positives = 98/206 (47%), Gaps = 19/206 (9%)
Query: 46 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRVMDHPNVISLKHCFFS 102
+G G +G V++ + TVA+K + +D +E +M+ + HPN++ L
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQL----LG 69
Query: 103 TTSKNELFLNLVMEYVPESMYRVLKHYSSAN-QRMPLIYVKLYTYQIFRGLAYIHTVPRV 161
++ F ++ E++ +L + N Q + + + QI + Y+ +
Sbjct: 70 VCTREPPFY-IITEFMTYG--NLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFI 126
Query: 162 CHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF---YRAPELIFGATEY 218
HRDL +N LV H VK+ DFG ++ L+ G+ ++ ++F + APE + ++
Sbjct: 127 -HRDLAARNCLVGE-NHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESL-AYNKF 182
Query: 219 TTSIDIWSAGCVLAEL-LLGQPLFPG 243
+ D+W+ G +L E+ G +PG
Sbjct: 183 SIKSDVWAFGVLLWEIATYGMSPYPG 208
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 3e-08
Identities = 59/243 (24%), Positives = 104/243 (42%), Gaps = 52/243 (21%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMR----VMDHPNVISLKHC 99
+V+G G+FG V + +TG A+K + + + ++ +R ++ + + +
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKM 66
Query: 100 FFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT 157
F+S K L+L +ME++P + M ++K + + + Y + + IH
Sbjct: 67 FYSFQDKLNLYL--IMEFLPGGDMMTLLMKKDTLTEEE-----TQFYIAETVLAIDSIHQ 119
Query: 158 VPRVCHRDLKPQNLLVDPLTHQVKICDFG------------------------------- 186
+ + HRD+KP NLL+D H VK+ DFG
Sbjct: 120 LGFI-HRDIKPDNLLLDSKGH-VKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMN 177
Query: 187 SAKQLIAGEAN-----ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLF 241
S ++ + N S + + Y APE +F T Y D WS G ++ E+L+G P F
Sbjct: 178 SKRKAETWKRNRRQLAFSTVGTPDYIAPE-VFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236
Query: 242 PGE 244
E
Sbjct: 237 CSE 239
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 4e-08
Identities = 66/255 (25%), Positives = 106/255 (41%), Gaps = 54/255 (21%)
Query: 43 ERVVGTGSFGIVFQAKCLETGET-----VAIKKV----LQDRRYKNRELQLMRVMDHPNV 93
+R +G G+FG VF A+C T VA+K + L R+ RE +L+ + H ++
Sbjct: 10 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 69
Query: 94 ISLKHCFFSTTSKNELFLNLVMEYV-------------PESMYRVLKHYSSANQRMPLIY 140
+ F+ + + +V EY+ P++M V A + L
Sbjct: 70 VK----FYGVCGDGDPLI-MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQ 124
Query: 141 VKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISY 200
+ QI G+ Y+ + V HRDL +N LV VKI DFG ++ + +
Sbjct: 125 MLHIASQIASGMVYLASQHFV-HRDLATRNCLVGA-NLLVKIGDFGMSRDVYS------- 175
Query: 201 ICSRFYRA------------PELIFGATEYTTSIDIWSAGCVLAELLL--GQPLFP-GEN 245
+ +YR PE I ++TT D+WS G +L E+ QP F
Sbjct: 176 --TDYYRVGGHTMLPIRWMPPESIM-YRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT 232
Query: 246 AVDQLVEIIKVLGTP 260
V + + +VL P
Sbjct: 233 EVIECITQGRVLERP 247
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 53.1 bits (128), Expect = 5e-08
Identities = 53/236 (22%), Positives = 85/236 (36%), Gaps = 31/236 (13%)
Query: 44 RVVGTGSFG--IVFQAKCLETGETVAIKKVLQDRRYKNR------ELQLMRVMDHPNVIS 95
++G IV AK T VA+KK+ D K E+ R + HPN++
Sbjct: 4 TLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILP 63
Query: 96 LKHCFFSTTSKNELFLNLVMEYVPESMYRVL--KHYSSANQRMPLIYVKLYTYQIFRGLA 153
F +EL+ +V + L H+ +P + + + L
Sbjct: 64 YVTSF---IVDSELY--VVSPLMAYGSCEDLLKTHFPEG---LPELAIAFILKDVLNALD 115
Query: 154 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA-GEANISYICSRFYRAPELI 212
YIH+ + HR +K ++L+ +V + + +I G+ L
Sbjct: 116 YIHSKGFI-HRSVKASHILLSG-DGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLP 173
Query: 213 FGATE--------YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 260
+ + E Y DI+S G EL G F A L+E KV GT
Sbjct: 174 WLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLE--KVRGTV 227
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 6e-08
Identities = 58/207 (28%), Positives = 98/207 (47%), Gaps = 26/207 (12%)
Query: 43 ERVVGTGSFGIVFQAKCLETGE---TVAIKKVL-----QDRRYKNRELQLMRVMDHPNVI 94
E+V+G G FG V + G+ VAIK + + RR E +M DHPN+I
Sbjct: 9 EKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNII 68
Query: 95 SLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 153
L+ T SK + +V EY+ S+ L+ + + +I + I G+
Sbjct: 69 HLEGVV--TKSKPVM---IVTEYMENGSLDAFLRKHDG---QFTVIQLVGMLRGIASGMK 120
Query: 154 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR-----FYRA 208
Y+ + V HRDL +N+LV+ K+ DFG ++ ++ + +Y + A
Sbjct: 121 YLSDMGYV-HRDLAARNILVNS-NLVCKVSDFGLSR-VLEDDPEAAYTTRGGKIPIRWTA 177
Query: 209 PELIFGATEYTTSIDIWSAGCVLAELL 235
PE I ++T++ D+WS G V+ E++
Sbjct: 178 PEAI-AYRKFTSASDVWSYGIVMWEVM 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 1e-07
Identities = 58/223 (26%), Positives = 97/223 (43%), Gaps = 50/223 (22%)
Query: 46 VGTGSFGIVFQAKCL----ETGETVAIKKVLQD-----RRYKNRELQLMRVMDHPNVISL 96
+G G+FG VF A+C E + + K L++ R+ RE +L+ V+ H +++
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR- 71
Query: 97 KHCFFSTTSKNELFLNLVMEYVPE-SMYRVLK------HYSSANQRMPLIYVKL-----Y 144
F+ ++ L +V EY+ + R L+ + + + + L
Sbjct: 72 ---FYGVCTEGRPLL-MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAI 127
Query: 145 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR 204
QI G+ Y+ ++ V HRDL +N LV VKI DFG ++ + + +
Sbjct: 128 ASQIASGMVYLASLHFV-HRDLATRNCLVGQ-GLVVKIGDFGMSRDIYSTD--------- 176
Query: 205 FYRA------------PELIFGATEYTTSIDIWSAGCVLAELL 235
+YR PE I ++TT DIWS G VL E+
Sbjct: 177 YYRVGGRTMLPIRWMPPESIL-YRKFTTESDIWSFGVVLWEIF 218
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 1e-07
Identities = 61/240 (25%), Positives = 108/240 (45%), Gaps = 39/240 (16%)
Query: 46 VGTGSFGIVFQAKCLETGE-------TVAIKKVLQDRRYKN-----RELQLMRVM-DHPN 92
+G G FG V A+ + + VA+K + D K+ E+++M+++ H N
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 93 VISLKHCFFSTTSKNELFLNLVMEYV-------------PESMYRVLKHYSSANQRMPLI 139
+I+L + T L++ ++EY P M +++
Sbjct: 86 IINL---LGACTQDGPLYV--IVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFK 140
Query: 140 YVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS 199
+ YQ+ RG+ Y+ + + HRDL +N+LV + +KI DFG A+ + +
Sbjct: 141 DLVSCAYQVARGMEYLAS-KKCIHRDLAARNVLVTE-DNVMKIADFGLARDIHHIDYYKK 198
Query: 200 YICSRF---YRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIK 255
R + APE +F YT D+WS G +L E+ LG +PG V++L +++K
Sbjct: 199 TTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPYPGV-PVEELFKLLK 256
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 1e-07
Identities = 58/215 (26%), Positives = 103/215 (47%), Gaps = 31/215 (14%)
Query: 43 ERVVGTGSFGIVFQAKCLETG--ETVAIKKVLQ-----DRRYKNRELQLM-RVMDHPNVI 94
+ V+G G+FG V +A+ + G AIK++ + D R EL+++ ++ HPN+I
Sbjct: 12 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 71
Query: 95 SLKHCFFSTTSKNELFLNLVMEYVPES-------MYRVLK---HYSSANQRMPLIYVK-- 142
+L ++ +L L +EY P RVL+ ++ AN + +
Sbjct: 72 NLL-----GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 126
Query: 143 -LYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG-SAKQLIAGEANISY 200
+ + RG+ Y+ + + HRDL +N+LV + KI DFG S Q + + +
Sbjct: 127 LHFAADVARGMDYL-SQKQFIHRDLAARNILVGE-NYVAKIADFGLSRGQEVYVKKTMGR 184
Query: 201 ICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELL 235
+ R+ L + YTT+ D+WS G +L E++
Sbjct: 185 LPVRWMAIESLNYSV--YTTNSDVWSYGVLLWEIV 217
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 2e-07
Identities = 56/221 (25%), Positives = 101/221 (45%), Gaps = 21/221 (9%)
Query: 44 RVVGTGSFGIVFQAKCLE---TGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVI 94
R++G G FG V +A+ + + VA+K + D + RE M+ DHPNVI
Sbjct: 5 RMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVI 64
Query: 95 SLKHCFFSTTSKNELFLNLV----MEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 150
L + +K L + +V M++ + ++ +PL + + I
Sbjct: 65 KLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIAS 124
Query: 151 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF---YR 207
G+ Y+ + HRDL +N +++ V + DFG +K++ +G+ S+ +
Sbjct: 125 GMEYLSS-KNFIHRDLAARNCMLNE-NMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWL 182
Query: 208 APELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG-ENA 246
A E + YTT D+W+ G + E++ GQ + G EN+
Sbjct: 183 ALESL-ADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS 222
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 2e-07
Identities = 43/117 (36%), Positives = 63/117 (53%), Gaps = 11/117 (9%)
Query: 133 NQRMPLIYVKL--YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 190
N+ L Y+ L ++YQ+ G+ ++ + V HRDL +N+L+ VKICDFG A+
Sbjct: 231 NESPALSYMDLVGFSYQVANGMEFLASKNCV-HRDLAARNVLICE-GKLVKICDFGLARD 288
Query: 191 LIAGEANISYICSRF----YRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFP 242
++ IS S F + APE IF YTT D+WS G +L E+ LG +P
Sbjct: 289 IMRDSNYISK-GSTFLPLKWMAPESIFNNL-YTTLSDVWSFGILLWEIFTLGGTPYP 343
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 2e-07
Identities = 41/132 (31%), Positives = 63/132 (47%), Gaps = 19/132 (14%)
Query: 120 ESMYRVLKH--------YSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNL 171
+S++ VL+H + S +P VK + ++ L +H VC RDL P N+
Sbjct: 58 DSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVC-RDLNPNNI 116
Query: 172 LVDPLTHQVKICDFGSAKQL---IAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAG 228
L+D H +++ F ++ GEA Y APE + G +E T + D WS G
Sbjct: 117 LLDDRGH-IQLTYFSRWSEVEDSCDGEA-----VENMYCAPE-VGGISEETEACDWWSLG 169
Query: 229 CVLAELLLGQPL 240
+L ELL G+ L
Sbjct: 170 AILFELLTGKTL 181
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 50.8 bits (122), Expect = 3e-07
Identities = 43/199 (21%), Positives = 77/199 (38%), Gaps = 60/199 (30%)
Query: 67 AIKKVLQDRRYKNRELQLMRVMDHPNVISL-------KHCFFSTTSKNELFLNLVMEYVP 119
A +D +E++++ + PN+ L ++MEY+
Sbjct: 58 ASDNAREDFL---KEVKILSRLSDPNIARLLGVCTVDPPLC------------MIMEYME 102
Query: 120 E-------SMYRVLKHYSSANQRMP----LIYVKLYTYQIFRGLAYIHTVPRVCHRDLKP 168
+ + N + L+Y+ QI G+ Y+ ++ V HRDL
Sbjct: 103 NGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMAT---QIASGMRYLESLNFV-HRDLAT 158
Query: 169 QNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFY----RAP--------ELIFGAT 216
+N LV + +KI DFG ++ L + + +Y RAP E +
Sbjct: 159 RNCLVGKN-YTIKIADFGMSRNLYSSD---------YYRVQGRAPLPIRWMAWESVLL-G 207
Query: 217 EYTTSIDIWSAGCVLAELL 235
++TT D+W+ G L E+L
Sbjct: 208 KFTTKSDVWAFGVTLWEIL 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 3e-07
Identities = 50/197 (25%), Positives = 94/197 (47%), Gaps = 22/197 (11%)
Query: 46 VGTGSFGIVFQAKCLETGETVAIKKV----LQDRRYKNRELQLMRVMDHPNVISLKHCFF 101
+G+G FG+V+ LE + VAIK + + + + E Q+M + HP ++ L
Sbjct: 12 IGSGQFGLVWLGYWLEKRK-VAIKTIREGAMSEEDFI-EEAQVMMKLSHPKLVQLYGVCT 69
Query: 102 STTSKNELFLNLVMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR 160
+ + LV E++ + L+ + L+ + L + G+AY+ +
Sbjct: 70 ERSP-----ICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCL---DVCEGMAYLES-SN 120
Query: 161 VCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF---YRAPELIFGATE 217
V HRDL +N LV VK+ DFG + + + S ++F + +PE +F ++
Sbjct: 121 VIHRDLAARNCLVGE-NQVVKVSDFGMTR-FVLDDQYTSSTGTKFPVKWSSPE-VFSFSK 177
Query: 218 YTTSIDIWSAGCVLAEL 234
Y++ D+WS G ++ E+
Sbjct: 178 YSSKSDVWSFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 4e-07
Identities = 65/237 (27%), Positives = 105/237 (44%), Gaps = 50/237 (21%)
Query: 34 PKQTISYMAERVVGTGSFGIVFQ--AKCLETGET---VAIKKVLQDRRYKNR-----ELQ 83
++ I+ + E +G GSFG+V++ A+ + GE VA+K V + + R E
Sbjct: 4 SREKITLLRE--LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEAS 61
Query: 84 LMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP----ESMYRVLKHYSSANQRMPLI 139
+M+ +V+ L SK + L +VME + +S R L+ + N P
Sbjct: 62 VMKGFTCHHVVRL----LGVVSKGQPTL-VVMELMAHGDLKSYLRSLRPEAENNPGRPPP 116
Query: 140 YVK---LYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA 196
++ +I G+AY++ + HRDL +N +V VKI DFG + + +
Sbjct: 117 TLQEMIQMAAEIADGMAYLNA-KKFVHRDLAARNCMVAH-DFTVKIGDFGMTRDIYETD- 173
Query: 197 NISYICSRFYR------------APELIFGATEYTTSIDIWSAGCVLAEL--LLGQP 239
+YR APE + +TTS D+WS G VL E+ L QP
Sbjct: 174 --------YYRKGGKGLLPVRWMAPESLKDGV-FTTSSDMWSFGVVLWEITSLAEQP 221
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 4e-07
Identities = 47/180 (26%), Positives = 80/180 (44%), Gaps = 20/180 (11%)
Query: 80 RELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLV-----MEYVPESMYRVLKHYSSANQ 134
E M+ DHPNV+ L T ++E + + V M++ + + Q
Sbjct: 49 SEAVCMKEFDHPNVMRLIGVCLQTV-ESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQ 107
Query: 135 RMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG 194
+P + + I G+ Y+ + HRDL +N +++ V + DFG +K++ G
Sbjct: 108 YLPTQMLVKFMTDIASGMEYLSS-KSFIHRDLAARNCMLNE-NMNVCVADFGLSKKIYNG 165
Query: 195 EANISYICSRFYRAPELIFGATE------YTTSIDIWSAGCVLAELLL-GQPLFPG-ENA 246
+ Y R + P + + A E YTT D+WS G + E+ GQ +PG EN+
Sbjct: 166 D---YYRQGRIAKMP-VKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS 221
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 5e-07
Identities = 51/211 (24%), Positives = 92/211 (43%), Gaps = 37/211 (17%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIK---KVLQDRRYKNR------ELQLMRVMDHPNVI 94
+++G+G FG V + + G+++ I K +QDR + + M +DH ++
Sbjct: 13 KLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIV 72
Query: 95 SLKH-CFFSTTSKNELFLNLVMEYVPES--MYRVLKHYSSANQRMPLIYVKLYTYQIFRG 151
L C ++ L LV + P + V +H S + + L + QI +G
Sbjct: 73 RLLGICPGAS-------LQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNW----CVQIAKG 121
Query: 152 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA-------KQLIAGEANISYICSR 204
+ Y+ R+ HR+L +N+L+ V+I DFG A K+ E +
Sbjct: 122 MYYLEE-HRMVHRNLAARNILLKS-DSIVQIADFGVADLLYPDDKKYFYSEHKTPI---K 176
Query: 205 FYRAPELIFGATEYTTSIDIWSAGCVLAELL 235
+ ++FG YT D+WS G + E++
Sbjct: 177 WMALESILFG--RYTHQSDVWSYGVTVWEMM 205
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 5e-07
Identities = 47/161 (29%), Positives = 77/161 (47%), Gaps = 19/161 (11%)
Query: 49 GSFGIVFQAKCLETGETVAIKKVLQ-DRRYKNRELQLMRVMDHPNVISLK------HCFF 101
G+FG V+ + + A+K V + D KN Q V + ++L H ++
Sbjct: 15 GAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQ---VQAERDALALSKSPFIVHLYY 71
Query: 102 STTSKNELFLNLVMEYVPESMYRVLKH-YSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR 160
S S N ++L VMEY+ + L H Y ++ M + Y+ ++ L Y+H
Sbjct: 72 SLQSANNVYL--VMEYLIGGDVKSLLHIYGYFDEEMAVKYIS----EVALALDYLHR-HG 124
Query: 161 VCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYI 201
+ HRDLKP N+L+ H +K+ DFG +K + E N+ I
Sbjct: 125 IIHRDLKPDNMLISNEGH-IKLTDFGLSKVTLNRELNMMDI 164
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 5e-07
Identities = 52/205 (25%), Positives = 98/205 (47%), Gaps = 25/205 (12%)
Query: 45 VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--RELQLMRVMDHPNVISLKHCFFS 102
++G G FG V Q + TG+ VA+K + D + E +M + H N++ L
Sbjct: 13 IIGEGEFGAVLQGE--YTGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRL----LG 66
Query: 103 TTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRV 161
N L++ VME + + ++ L+ + + +I + ++ + G+ Y+ + ++
Sbjct: 67 VILHNGLYI--VMELMSKGNLVNFLR--TRGRALVSVIQLLQFSLDVAEGMEYLES-KKL 121
Query: 162 CHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF---YRAPELIFGATEY 218
HRDL +N+LV K+ DFG A+ G N S+ + APE + ++
Sbjct: 122 VHRDLAARNILVSE-DGVAKVSDFGLARVGSMGVDN-----SKLPVKWTAPEAL-KHKKF 174
Query: 219 TTSIDIWSAGCVLAELL-LGQPLFP 242
++ D+WS G +L E+ G+ +P
Sbjct: 175 SSKSDVWSYGVLLWEVFSYGRAPYP 199
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 6e-07
Identities = 59/206 (28%), Positives = 93/206 (45%), Gaps = 32/206 (15%)
Query: 46 VGTGSFGIVFQA--KCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISLK 97
+G+G+FG V + K + VAIK VL++ K+ RE ++M +D+P ++ +
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIK-VLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61
Query: 98 HCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT 157
+ L LVME K S + + V +Q+ G+ Y+
Sbjct: 62 GVCEAEA------LMLVMEMASGGPLN--KFLSGKKDEITVSNVVELMHQVSMGMKYLEG 113
Query: 158 VPRVCHRDLKPQN-LLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF-------YRAP 209
V HRDL +N LLV+ H KI DFG +K L A + SY +R + AP
Sbjct: 114 KNFV-HRDLAARNVLLVN--QHYAKISDFGLSKALGADD---SYYKARSAGKWPLKWYAP 167
Query: 210 ELIFGATEYTTSIDIWSAGCVLAELL 235
E I ++++ D+WS G + E
Sbjct: 168 ECI-NFRKFSSRSDVWSYGITMWEAF 192
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 6e-07
Identities = 58/232 (25%), Positives = 98/232 (42%), Gaps = 54/232 (23%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQD----RRYKNRELQLMRV---MDHPNVISL 96
R++G G G V+ A VA+KK+ +D K R L+ ++ + HP ++ +
Sbjct: 8 RLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPV 67
Query: 97 KHCFFSTTSKNELFLNLVMEYVP--------------ESMYRVLKHYSSANQRMPLIYVK 142
+S S + + M Y+ ES+ + L +S + I+ K
Sbjct: 68 ----YSICSDGDP-VYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLS-IFHK 121
Query: 143 LYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK-------QLIAGE 195
I + Y+H+ V HRDLKP N+L+ L +V I D+G+A L+ +
Sbjct: 122 -----ICATIEYVHS-KGVLHRDLKPDNILLG-LFGEVVILDWGAAIFKKLEEEDLLDID 174
Query: 196 ANISYICSRF------------YRAPELIFGATEYTTSIDIWSAGCVLAELL 235
+ IC Y APE + G + S DI++ G +L ++L
Sbjct: 175 VDERNICYSSMTIPGKIVGTPDYMAPERLLG-VPASESTDIYALGVILYQML 225
|
Length = 932 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 8e-07
Identities = 62/208 (29%), Positives = 104/208 (50%), Gaps = 25/208 (12%)
Query: 46 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRVMDHPNVISLKHCFFS 102
+G G FG V+ T + VAIK + +E Q+M+ + H ++ L ++
Sbjct: 14 LGQGCFGEVWMGTWNGTTK-VAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPL----YA 68
Query: 103 TTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRV 161
S+ +++ V E++ + S+ LK ++P + V + QI G+AYI + +
Sbjct: 69 VVSEEPIYI--VTEFMGKGSLLDFLKEGDGKYLKLPQL-VDMAA-QIADGMAYIERMNYI 124
Query: 162 CHRDLKPQNLLV-DPLTHQVKICDFGSAKQLIAGEANISYICSRF---YRAPEL-IFGAT 216
HRDL+ N+LV D L KI DFG A+ LI + ++F + APE ++G
Sbjct: 125 -HRDLRAANILVGDNLV--CKIADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALYG-- 178
Query: 217 EYTTSIDIWSAGCVLAELLL-GQPLFPG 243
+T D+WS G +L EL+ G+ +PG
Sbjct: 179 RFTIKSDVWSFGILLTELVTKGRVPYPG 206
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 9e-07
Identities = 60/224 (26%), Positives = 101/224 (45%), Gaps = 34/224 (15%)
Query: 37 TISYMAERVVGTGSFGIVFQAKCL-----ETGETVAIKKVLQDR-----RYKNRELQLMR 86
T+ +M E +G FG V++ E + VAIK L+D+ R + + +MR
Sbjct: 6 TVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIK-TLKDKAEGPLREEFKHEAMMR 62
Query: 87 V-MDHPNVISL---------KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRM 136
+ HPN++ L FS S ++L LVM + + +
Sbjct: 63 SRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLE 122
Query: 137 PLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLV-DPLTHQVKICDFGSAKQLIAGE 195
P +V + T QI G+ ++ + V H+DL +N+LV D L VKI D G +++ A +
Sbjct: 123 PADFVHIVT-QIAAGMEFLSS-HHVVHKDLATRNVLVFDKLN--VKISDLGLFREVYAAD 178
Query: 196 ----ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELL 235
S + R+ +++G +++ DIWS G VL E+
Sbjct: 179 YYKLMGNSLLPIRWMSPEAIMYG--KFSIDSDIWSYGVVLWEVF 220
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 1e-06
Identities = 54/205 (26%), Positives = 95/205 (46%), Gaps = 24/205 (11%)
Query: 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRVMDHPNVI 94
+++M E +G+G FG+V K VAIK + + + E ++M + HP ++
Sbjct: 6 LTFMKE--LGSGQFGVVHLGK-WRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLV 62
Query: 95 SLKHCFFSTTSKNELFLNLVMEYVPESMYR-VLKHYSSANQRMPLIYVKLYTYQ-IFRGL 152
L + T + L++ V E M L +Y Q + L Q + G+
Sbjct: 63 QL---YGVCTQQKPLYI------VTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGM 113
Query: 153 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF---YRAP 209
Y+ + HRDL +N LV T VK+ DFG + ++ E S ++F + P
Sbjct: 114 EYLERNSFI-HRDLAARNCLVSS-TGVVKVSDFGMTRYVLDDEY-TSSSGAKFPVKWSPP 170
Query: 210 ELIFGATEYTTSIDIWSAGCVLAEL 234
E +F ++Y++ D+WS G ++ E+
Sbjct: 171 E-VFNFSKYSSKSDVWSFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 1e-06
Identities = 27/69 (39%), Positives = 35/69 (50%), Gaps = 9/69 (13%)
Query: 147 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF- 205
QI L +H+ V HRD+KPQN++ + KI D G+A L G I+YI F
Sbjct: 263 QILFALDGLHSTGIV-HRDVKPQNIIFSEGSGSFKIIDLGAAADLRVG---INYIPKEFL 318
Query: 206 ----YRAPE 210
Y APE
Sbjct: 319 LDPRYAAPE 327
|
Length = 566 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 2e-06
Identities = 47/195 (24%), Positives = 93/195 (47%), Gaps = 18/195 (9%)
Query: 46 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRVMDHPNVISLKHCFFS 102
+GTG FG+V K VAIK + + ++ E ++M + H ++ L +
Sbjct: 12 LGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQL---YGV 67
Query: 103 TTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVC 162
T + +++ V EY+ +L + +R + + G+AY+ + +
Sbjct: 68 CTKQRPIYI--VTEYMSNGC--LLNYLREHGKRFQPSQLLEMCKDVCEGMAYLES-KQFI 122
Query: 163 HRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF---YRAPELIFGATEYT 219
HRDL +N LVD VK+ DFG ++ ++ E S + S+F + PE + ++++
Sbjct: 123 HRDLAARNCLVDD-QGCVKVSDFGLSRYVLDDEY-TSSVGSKFPVRWSPPE-VLLYSKFS 179
Query: 220 TSIDIWSAGCVLAEL 234
+ D+W+ G ++ E+
Sbjct: 180 SKSDVWAFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 2e-06
Identities = 52/219 (23%), Positives = 90/219 (41%), Gaps = 39/219 (17%)
Query: 45 VVGTGSFGIVFQAKCLETG----ETVAIKKVLQ-----DRRYKNRELQLMRVMDHPNVIS 95
++ G+FG +F ++ E V +K V +E L+ + H N++
Sbjct: 13 LLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILP 72
Query: 96 LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHY------SSAN--QRMPLIYVKLYTYQ 147
+ H + P + LK + AN Q + + Q
Sbjct: 73 ILHVCIEDGEPPFVLY-------PYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQ 125
Query: 148 IFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC----- 202
I G++Y+H V H+D+ +N ++D QVKI D ++ L + Y C
Sbjct: 126 IACGMSYLHKR-GVIHKDIAARNCVIDE-ELQVKITDNALSRDLFPMD----YHCLGDNE 179
Query: 203 SRFYR--APELIFGATEYTTSIDIWSAGCVLAELL-LGQ 238
+R + A E + EY+++ D+WS G +L EL+ LGQ
Sbjct: 180 NRPVKWMALESLVN-KEYSSASDVWSFGVLLWELMTLGQ 217
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 3e-06
Identities = 54/197 (27%), Positives = 81/197 (41%), Gaps = 45/197 (22%)
Query: 81 ELQLMRVMDHPNVISL--KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPL 138
E +L+R + HP V++L T LV+ +Y L + + + L
Sbjct: 210 EARLLRRLSHPAVLALLDVRVVGGLTC-------LVLPKYRSDLYTYL---GARLRPLGL 259
Query: 139 IYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKIC--DFGSA-------- 188
V Q+ + YIH + HRD+K +N+LV+ IC DFG+A
Sbjct: 260 AQVTAVARQLLSAIDYIHG-EGIIHRDIKTENVLVNG---PEDICLGDFGAACFARGSWS 315
Query: 189 ---KQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAEL------LLGQP 239
IAG + + APE++ G YT S+DIWSAG V+ E L
Sbjct: 316 TPFHYGIAGTVDTN--------APEVLAG-DPYTPSVDIWSAGLVIFEAAVHTASLFSAS 366
Query: 240 LFPGENAVD-QLVEIIK 255
D Q++ II+
Sbjct: 367 RGDERRPYDAQILRIIR 383
|
Length = 461 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 5e-06
Identities = 54/206 (26%), Positives = 94/206 (45%), Gaps = 24/206 (11%)
Query: 43 ERVVGTGSFGIVFQAKCLETGE---TVAIKKVLQDRRYKNR-----ELQLMRVMDHPNVI 94
++V+G G FG VF+ G VAIK + K R E +M H N+I
Sbjct: 10 QKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNII 69
Query: 95 SLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 154
L+ T K + + ME ++ + L+ + L+ + I G+ Y
Sbjct: 70 RLEGVV--TKFKPAMIITEYME--NGALDKYLRDHDGEFSSYQLVGM---LRGIAAGMKY 122
Query: 155 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR-----FYRAP 209
+ + V HRDL +N+LV+ + K+ DFG ++ ++ + +Y S + AP
Sbjct: 123 LSDMNYV-HRDLAARNILVNS-NLECKVSDFGLSR-VLEDDPEGTYTTSGGKIPIRWTAP 179
Query: 210 ELIFGATEYTTSIDIWSAGCVLAELL 235
E I ++T++ D+WS G V+ E++
Sbjct: 180 EAI-AYRKFTSASDVWSFGIVMWEVM 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 5e-06
Identities = 64/254 (25%), Positives = 113/254 (44%), Gaps = 55/254 (21%)
Query: 43 ERVVGTGSFGIVFQAKCL----ETGETVAIKKVLQD-----RRYKNRELQLMRVMDHPNV 93
+R +G G+FG VF A+C E + + K L+D R+ +RE +L+ + H ++
Sbjct: 10 KRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHI 69
Query: 94 ISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHY-------SSANQRMPLIYVKLY- 144
+ F+ + + + +V EY+ + + L+ + + N+ L ++
Sbjct: 70 VK----FYGVCVEGDPLI-MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLH 124
Query: 145 -TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICS 203
QI G+ Y+ + HRDL +N LV VKI DFG ++ + + +
Sbjct: 125 IAQQIAAGMVYLAS-QHFVHRDLATRNCLVGE-NLLVKIGDFGMSRDVYSTD-------- 174
Query: 204 RFYRA------------PELIFGATEYTTSIDIWSAGCVLAELLL--GQPLFPGENAVDQ 249
+YR PE I ++TT D+WS G VL E+ QP + N ++
Sbjct: 175 -YYRVGGHTMLPIRWMPPESIM-YRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN--NE 230
Query: 250 LVEII---KVLGTP 260
++E I +VL P
Sbjct: 231 VIECITQGRVLQRP 244
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 7e-06
Identities = 63/236 (26%), Positives = 114/236 (48%), Gaps = 35/236 (14%)
Query: 46 VGTGSFGIVFQA--KCLETGETVAIKKVLQ----DRRYKN---RELQLMRVMDHPNVISL 96
+G+G+FG V + K ++ +TVA+K +L+ D K+ RE +M+ +D+P ++ +
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVK-ILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 97 KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 156
+ E ++ LVME + L + N+ + + +Q+ G+ Y+
Sbjct: 62 -----IGICEAESWM-LVMEL---AELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLE 112
Query: 157 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF-------YRAP 209
V HRDL +N+L+ H KI DFG +K L A E +Y ++ + AP
Sbjct: 113 ETNFV-HRDLAARNVLL-VTQHYAKISDFGLSKALGADE---NYYKAKTHGKWPVKWYAP 167
Query: 210 ELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGE--NAVDQLVEIIKVLGTPTR 262
E + ++++ D+WS G ++ E GQ + G N V Q++E + + P R
Sbjct: 168 ECM-NYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQR 222
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 8e-06
Identities = 48/191 (25%), Positives = 87/191 (45%), Gaps = 33/191 (17%)
Query: 66 VAIKKVLQDRRYKNR-----ELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE 120
VA+K + D R E+++M + +PN+I L S L ++ EY+
Sbjct: 47 VAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDP-----LCMITEYMEN 101
Query: 121 -------SMYRVLKHYSSANQ-----RMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKP 168
S + ++ AN L+Y+ + QI G+ Y+ ++ V HRDL
Sbjct: 102 GDLNQFLSQREIESTFTHANNIPSVSIANLLYMAV---QIASGMKYLASLNFV-HRDLAT 157
Query: 169 QNLLVDPLTHQVKICDFGSAKQLIAGE----ANISYICSRFYRAPELIFGATEYTTSIDI 224
+N LV + +KI DFG ++ L +G+ + + R+ ++ G ++TT+ D+
Sbjct: 158 RNCLVGN-HYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLG--KFTTASDV 214
Query: 225 WSAGCVLAELL 235
W+ G L E+
Sbjct: 215 WAFGVTLWEMF 225
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 8e-06
Identities = 37/152 (24%), Positives = 74/152 (48%), Gaps = 21/152 (13%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQ-DRRYKNR------ELQLMRVMDHPNVISL 96
+ +G G+FG V + ++T A+K + + D +N+ E ++ D+ V+ L
Sbjct: 7 KTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKL 66
Query: 97 KHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 154
++S K+ L+ VM+Y+P + M +++ + Y ++ +
Sbjct: 67 ---YYSFQDKDNLYF--VMDYIPGGDMMSLLIRL-----GIFEEDLARFYIAELTCAIES 116
Query: 155 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 186
+H + + HRD+KP N+L+D H +K+ DFG
Sbjct: 117 VHKMGFI-HRDIKPDNILIDRDGH-IKLTDFG 146
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 9e-06
Identities = 54/200 (27%), Positives = 90/200 (45%), Gaps = 26/200 (13%)
Query: 46 VGTGSFGIVFQAKCLETGETVAIKKVLQD--RRYKNRELQLMRVM---DHPNVISLKHCF 100
+G G+FG VF + VA+K + K + LQ R++ HPN++ L
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRL---I 59
Query: 101 FSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMP-LIYVKLYTYQIFRGLAYIHTVP 159
T K ++ +VME V + ++ LI + G+ Y+ +
Sbjct: 60 GVCTQKQPIY--IVMELVQGGDFLTFLRTEGPRLKVKELIQM---VENAAAGMEYLES-- 112
Query: 160 RVC-HRDLKPQNLLVDPLTHQVKICDFGSAKQ----LIAGEANISYICSRFYRAPE-LIF 213
+ C HRDL +N LV + +KI DFG +++ + A + I + + APE L +
Sbjct: 113 KHCIHRDLAARNCLVTE-KNVLKISDFGMSREEEDGVYASTGGMKQIPVK-WTAPEALNY 170
Query: 214 GATEYTTSIDIWSAGCVLAE 233
G Y++ D+WS G +L E
Sbjct: 171 G--RYSSESDVWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 9e-06
Identities = 59/217 (27%), Positives = 99/217 (45%), Gaps = 35/217 (16%)
Query: 43 ERVVGTGSFGIVFQAKCLETGE--TVAIKKVLQ-----DRRYKNRELQLM-RVMDHPNVI 94
E V+G G+FG V +A + G AIK + + D R EL+++ ++ HPN+I
Sbjct: 7 EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNII 66
Query: 95 SLKHCFFSTTSKNELFLNLVMEYVPES-------MYRVLKHYSSANQRMPLIYVKLYTYQ 147
+L +N +L + +EY P RVL+ A + L + Q
Sbjct: 67 NL-----LGACENRGYLYIAIEYAPYGNLLDFLRKSRVLE-TDPAFAKEHGTASTLTSQQ 120
Query: 148 IFR-------GLAYIHTVPRVCHRDLKPQNLLV-DPLTHQVKICDFG-SAKQLIAGEANI 198
+ + G+ Y+ + + HRDL +N+LV + L KI DFG S + + + +
Sbjct: 121 LLQFASDVATGMQYL-SEKQFIHRDLAARNVLVGENLA--SKIADFGLSRGEEVYVKKTM 177
Query: 199 SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELL 235
+ R+ L + YTT D+WS G +L E++
Sbjct: 178 GRLPVRWMAIESLNYSV--YTTKSDVWSFGVLLWEIV 212
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 1e-05
Identities = 57/214 (26%), Positives = 91/214 (42%), Gaps = 39/214 (18%)
Query: 46 VGTGSFGIVFQAKCLETGETVA--IKKVLQDRRYKNRELQLM------RVMDHPNVIS-L 96
+G G FG V + G + A + K L+ + +L + R ++HPNV+ L
Sbjct: 3 IGNGWFGKVLLGE-AHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCL 61
Query: 97 KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRM------PLIYVKLYTYQIFR 150
C S LV+E+ P LK+Y +N+ M + ++ ++
Sbjct: 62 GQCIESIP------YLLVLEFCP---LGDLKNYLRSNRGMVAQMAQKDVLQRM-ACEVAS 111
Query: 151 GLAYIHTVPRVCHRDLKPQN-LLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF---Y 206
GL ++H + H DL +N L L+ VKI D+G A + + I+ C +
Sbjct: 112 GLLWLHQADFI-HSDLALRNCQLTADLS--VKIGDYGLALEQYPEDYYITKDCHAVPLRW 168
Query: 207 RAPEL--IFGA----TEYTTSIDIWSAGCVLAEL 234
APEL I G + T +IWS G + EL
Sbjct: 169 LAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 1e-05
Identities = 42/152 (27%), Positives = 72/152 (47%), Gaps = 21/152 (13%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR--------ELQLMRVMDHPNVIS 95
+ +G G+FG V A ++T A+K L+ + NR E ++ D+ V+
Sbjct: 7 KTLGIGAFGEVCLACKVDTHALYAMK-TLRKKDVLNRNQVAHVKAERDILAEADNEWVVK 65
Query: 96 LKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 154
L ++S K+ L+ VM+Y+P M +L + + Y+ T I
Sbjct: 66 L---YYSFQDKDNLYF--VMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAI----ES 116
Query: 155 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 186
+H + + HRD+KP N+L+D L +K+ DFG
Sbjct: 117 VHKMGFI-HRDIKPDNILID-LDGHIKLTDFG 146
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 2e-05
Identities = 47/199 (23%), Positives = 91/199 (45%), Gaps = 26/199 (13%)
Query: 46 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRVMDHPNVISLKHCFFS 102
+G+G FG+V K + VAIK + + ++ E ++M + HPN++ L +
Sbjct: 12 LGSGQFGVVHLGKWRGKID-VAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQL----YG 66
Query: 103 TTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRV 161
+K + +V EY+ + L+ L+ + + + Y+ +
Sbjct: 67 VCTKQRP-IFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCS---DVCEAMEYLES-NGF 121
Query: 162 CHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICS---RF---YRAPELIFGA 215
HRDL +N LV + VK+ DFG A+ ++ + Y S +F + PE +F
Sbjct: 122 IHRDLAARNCLVGE-DNVVKVSDFGLARYVLDDQ----YTSSQGTKFPVKWAPPE-VFDY 175
Query: 216 TEYTTSIDIWSAGCVLAEL 234
+ +++ D+WS G ++ E+
Sbjct: 176 SRFSSKSDVWSFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 3e-05
Identities = 39/121 (32%), Positives = 59/121 (48%), Gaps = 29/121 (23%)
Query: 147 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFY 206
QI G+ Y+ ++ V HRDL +N LV +KI DFG ++ L AG+ +Y
Sbjct: 146 QIASGMKYLSSLNFV-HRDLATRNCLVGENLT-IKIADFGMSRNLYAGD---------YY 194
Query: 207 R------------APELIFGATEYTTSIDIWSAGCVLAELLL---GQPLFPGENAVDQLV 251
R A E I ++TT+ D+W+ G L E+L+ QP GE +Q++
Sbjct: 195 RIQGRAVLPIRWMAWECIL-MGKFTTASDVWAFGVTLWEILMLCKEQPY--GELTDEQVI 251
Query: 252 E 252
E
Sbjct: 252 E 252
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 5e-05
Identities = 58/214 (27%), Positives = 98/214 (45%), Gaps = 33/214 (15%)
Query: 45 VVGTGSFGIVFQAKCLETG--ETVAIKKVLQ-----DRRYKNRELQLM-RVMDHPNVISL 96
V+G G+FG V +A+ + G AIK++ + D R EL+++ ++ HPN+I+L
Sbjct: 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 61
Query: 97 KHCFFSTTSKNELFLNLVMEYVPES-------MYRVLKHYSSANQRMPLIYVKLYTYQIF 149
++ +L L +EY P RVL+ A L + Q+
Sbjct: 62 L-----GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLE-TDPAFAIANSTASTLSSQQLL 115
Query: 150 R-------GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG-SAKQLIAGEANISYI 201
G+ Y+ + + HRDL +N+LV + KI DFG S Q + + + +
Sbjct: 116 HFAADVARGMDYL-SQKQFIHRDLAARNILVGE-NYVAKIADFGLSRGQEVYVKKTMGRL 173
Query: 202 CSRFYRAPELIFGATEYTTSIDIWSAGCVLAELL 235
R+ L + YTT+ D+WS G +L E++
Sbjct: 174 PVRWMAIESLNYSV--YTTNSDVWSYGVLLWEIV 205
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 5e-05
Identities = 23/54 (42%), Positives = 33/54 (61%), Gaps = 2/54 (3%)
Query: 141 VKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG 194
+K Q+ GL +H + + HRD+KP+NLLV + QVKI DFG+A + G
Sbjct: 311 IKGVMRQVLTGLRKLHRIG-IVHRDIKPENLLVT-VDGQVKIIDFGAAVDMCTG 362
|
Length = 507 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 7e-05
Identities = 32/104 (30%), Positives = 50/104 (48%), Gaps = 22/104 (21%)
Query: 206 YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK---VLGTPTR 262
Y APE++ T YT D WS G +L E+L+GQP F + ++ +++I L P +
Sbjct: 214 YIAPEVLL-RTGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQ 272
Query: 263 EEIRCMNPNYTDF-----RFP----------QIKAHPWHKVCIF 291
+ ++P +D R P +IKAHP+ K F
Sbjct: 273 AK---LSPEASDLIIKLCRGPEDRLGKNGADEIKAHPFFKTIDF 313
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 8e-05
Identities = 42/153 (27%), Positives = 75/153 (49%), Gaps = 23/153 (15%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQ-DRRYKNR------ELQLMRVMDHPNVISL 96
+ +G G+FG V A+ ++T A+K + + D +N+ E ++ D+ V+ L
Sbjct: 7 KTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRL 66
Query: 97 KHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 155
++S K+ L+ VM+Y+P M +L RM + L + I +
Sbjct: 67 ---YYSFQDKDNLYF--VMDYIPGGDMMSLLI-------RMGIFPEDLARFYIAELTCAV 114
Query: 156 HTVPRV--CHRDLKPQNLLVDPLTHQVKICDFG 186
+V ++ HRD+KP N+L+D H +K+ DFG
Sbjct: 115 ESVHKMGFIHRDIKPDNILIDRDGH-IKLTDFG 146
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 2e-04
Identities = 60/219 (27%), Positives = 95/219 (43%), Gaps = 32/219 (14%)
Query: 44 RVVGTGSFGIVFQ--AKCL---ETGETVAIKKVLQDRRYKNR-----ELQLMRVMDHPNV 93
R +G GSFG+V++ AK + E VAIK V + + R E +M+ + +V
Sbjct: 12 RELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 71
Query: 94 ISLKHCFFSTTSKNELFLNLVMEYVP----ESMYRVLKHYSSANQRM---PLIYVKLYTY 146
+ L S+ + L ++ME + +S R L+ N L +
Sbjct: 72 VRL----LGVVSQGQPTL-VIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAG 126
Query: 147 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE----ANISYIC 202
+I G+AY++ + HRDL +N +V VKI DFG + + + +
Sbjct: 127 EIADGMAYLNA-NKFVHRDLAARNCMVAE-DFTVKIGDFGMTRDIYETDYYRKGGKGLLP 184
Query: 203 SRFYRAPELIFGATEYTTSIDIWSAGCVLAEL--LLGQP 239
R+ L G +TT D+WS G VL E+ L QP
Sbjct: 185 VRWMSPESLKDGV--FTTYSDVWSFGVVLWEIATLAEQP 221
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 4e-04
Identities = 28/100 (28%), Positives = 46/100 (46%), Gaps = 22/100 (22%)
Query: 206 YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII---KVLGTPTR 262
Y APE++ T YT D WS G +L E+L+GQP F + + +++I L P++
Sbjct: 210 YIAPEVLL-RTGYTQLCDWWSVGVILYEMLVGQPPFLADTPAETQLKVINWETTLHIPSQ 268
Query: 263 EEIRCMNPNYTDF---------------RFPQIKAHPWHK 287
+ ++ +D +IKAHP+ K
Sbjct: 269 AK---LSREASDLILRLCCGAEDRLGKNGADEIKAHPFFK 305
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 4e-04
Identities = 36/158 (22%), Positives = 56/158 (35%), Gaps = 16/158 (10%)
Query: 160 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYT 219
R HR K N+L LT + GS E + ++ APE+I G YT
Sbjct: 31 RELHRQAKSGNIL---LTWDGLLKLDGSVAF-KTPEQSRP---DPYFMAPEVIQG-QSYT 82
Query: 220 TSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR-FP 278
DI+S G L E L + + E + ++EI+ R + R F
Sbjct: 83 EKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLEGVSAARSFE 142
Query: 279 QIKAHPWHKVCIFHFPKHWLL--EYGSHINAISPRHCD 314
++C P+ Y +H A+ +
Sbjct: 143 DFM-----RLCASRLPQRREAANHYLAHCRALFAETLE 175
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 8e-04
Identities = 43/222 (19%), Positives = 91/222 (40%), Gaps = 35/222 (15%)
Query: 31 NGEPKQTIS---YMAERVVGTGSFGIVFQAKCLE---------------TGETVAIKKVL 72
G P I+ + ++++G G FG V++ +C ET+ ++ ++
Sbjct: 2 EGIPLIDITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLV 61
Query: 73 QDRRY-KNRELQLMRV--MDHPNVISLKHCFFSTTSKNELFLNLVM-EYVPESMYRVLKH 128
+ Y ++ + +DH + C + + ++ ++ E + E+ + K
Sbjct: 62 YNNIYDIDKIALWKNIHNIDHLGIPKYYGC--GSFKRCRMYYRFILLEKLVENTKEIFKR 119
Query: 129 YSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 188
N+++ +K + L YIH + H D+KP+N++VD ++ I D+G A
Sbjct: 120 IKCKNKKL----IKNIMKDMLTTLEYIHEHG-ISHGDIKPENIMVDG-NNRGYIIDYGIA 173
Query: 189 KQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCV 230
I +I Y + + + T Y +D + CV
Sbjct: 174 SHFIIHGKHIEY-----SKEQKDLHRGTLYYAGLDAHNGACV 210
|
Length = 294 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.001
Identities = 29/93 (31%), Positives = 51/93 (54%), Gaps = 8/93 (8%)
Query: 147 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE----ANISYIC 202
QI G+ Y+ ++ V HRDL +N LV + +KI DFG ++ L +G+ + +
Sbjct: 138 QIASGMKYLSSLNFV-HRDLATRNCLVG-KNYTIKIADFGMSRNLYSGDYYRIQGRAVLP 195
Query: 203 SRFYRAPELIFGATEYTTSIDIWSAGCVLAELL 235
R+ ++ G ++TT+ D+W+ G L E+L
Sbjct: 196 IRWMSWESILLG--KFTTASDVWAFGVTLWEIL 226
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.002
Identities = 26/79 (32%), Positives = 37/79 (46%), Gaps = 15/79 (18%)
Query: 206 YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 265
Y APE++ YT D WS G +L E+L+GQP F + TPT ++
Sbjct: 214 YIAPEVLL-RKGYTQLCDWWSVGVILFEMLVGQPPF--------------LAPTPTETQL 258
Query: 266 RCMNPNYTDFRFPQIKAHP 284
+ +N T PQ+K P
Sbjct: 259 KVINWENTLHIPPQVKLSP 277
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 314 | |||
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.98 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.97 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.97 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.97 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.97 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.97 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.96 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.96 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.96 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.95 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.95 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.94 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.94 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.94 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.93 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.92 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.92 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.91 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.89 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.89 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.86 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.86 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.86 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.86 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.85 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.84 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.84 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.83 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.82 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.79 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.78 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.78 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.77 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.73 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.71 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.7 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.7 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.68 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.66 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.64 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.61 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.59 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.57 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.52 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.43 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.38 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.37 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.35 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.34 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.33 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.32 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.28 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.2 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.15 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.14 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.12 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.08 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.03 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.01 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.98 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.91 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.88 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.82 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.79 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.75 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.54 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.44 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.28 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.25 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.21 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.2 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.19 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.99 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.98 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.94 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.92 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.91 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.88 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.83 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.76 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.63 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.45 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.41 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 97.33 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.33 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.27 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.25 | |
| PLN02236 | 344 | choline kinase | 97.22 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.17 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.16 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.1 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.8 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.59 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.47 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.45 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.4 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.18 | |
| PTZ00384 | 383 | choline kinase; Provisional | 96.12 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 96.12 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 96.07 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 95.82 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 95.65 | |
| PTZ00296 | 442 | choline kinase; Provisional | 95.05 | |
| COG0510 | 269 | ycfN Thiamine kinase and related kinases [Coenzyme | 94.45 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 94.29 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 94.01 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 93.66 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 93.0 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 92.18 | |
| smart00587 | 196 | CHK ZnF_C4 abd HLH domain containing kinases domai | 91.29 |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-53 Score=357.06 Aligned_cols=285 Identities=68% Similarity=1.154 Sum_probs=258.6
Q ss_pred eeeeeccccCCCCCCccCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHhCCCCceeeecee
Q 021306 20 GHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHC 99 (314)
Q Consensus 20 ~~~~~~~~~~~~~~~~~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 99 (314)
..+..+...+.+..+...-.|+-.+.+|+|+||.||+++...+++.+|+|++-.+.+...+|+.+++.+.|||||++.-+
T Consensus 6 ~~~~~~~~~~~~~~~~~~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~knrEl~im~~l~HpNIV~L~~~ 85 (364)
T KOG0658|consen 6 GHVIQTVAEGRNDGKKVEISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYKNRELQIMRKLDHPNIVRLLYF 85 (364)
T ss_pred eeEEEEEeecCCCCcceEEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcCcHHHHHHHhcCCcCeeeEEEE
Confidence 33445555666666666668999999999999999999999999999999999999999999999999999999999888
Q ss_pred eeecCCCCceeEEEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCc
Q 021306 100 FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQ 179 (314)
Q Consensus 100 ~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~ 179 (314)
|....+.+..+..+||||++.+|.+.+.++...+..++...++-+..||.+||.|||+ .||+||||||.|+|+|..++.
T Consensus 86 f~~~~~~d~~~lnlVleymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~-~~IcHRDIKPqNlLvD~~tg~ 164 (364)
T KOG0658|consen 86 FSSSTESDEVYLNLVLEYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHS-HGICHRDIKPQNLLVDPDTGV 164 (364)
T ss_pred EEecCCCchhHHHHHHHhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHh-cCcccCCCChheEEEcCCCCe
Confidence 8776666566788999999999999999988888999999999999999999999999 899999999999999998899
Q ss_pred EEEeecCcccccccCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCC
Q 021306 180 VKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT 259 (314)
Q Consensus 180 ~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~ 259 (314)
+||||||.|+.........++.+|..|+|||.+.|...|+.+.||||.||++.||+-|++.|.|.+..+++..|++.++.
T Consensus 165 LKicDFGSAK~L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~ 244 (364)
T KOG0658|consen 165 LKICDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGT 244 (364)
T ss_pred EEeccCCcceeeccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCC
Confidence 99999999999988888899999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCcccccccCChhhhhcccCChHHHHHhcchhh
Q 021306 260 PTREEIRCMNPNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGSHIN 306 (314)
Q Consensus 260 ~~~~~~~~~~p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~~~~ 306 (314)
|..+.+.+++|........++..+||.+......+++++ +.++++.
T Consensus 245 Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~-dll~~~L 290 (364)
T KOG0658|consen 245 PTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDAL-DLLSKLL 290 (364)
T ss_pred CCHHHHhhcCcccccccCcccccccceeecccCCCHHHH-HHHHHHh
Confidence 999999999999889999999999999977776666544 3433333
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-50 Score=341.12 Aligned_cols=248 Identities=29% Similarity=0.425 Sum_probs=201.8
Q ss_pred cCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc-----------cchHHHHHHHHhCCCCceeeeceeeeecC
Q 021306 36 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----------RYKNRELQLMRVMDHPNVISLKHCFFSTT 104 (314)
Q Consensus 36 ~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~-----------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 104 (314)
..+.|.+.+.||+|+||.|-+|..+.+|+.||+|++++.. ...++|+++|++++|||||+++++|...
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~- 248 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVP- 248 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecC-
Confidence 4467999999999999999999999999999999996432 1236999999999999999999999443
Q ss_pred CCCceeEEEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCC--CCcEEE
Q 021306 105 SKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPL--THQVKI 182 (314)
Q Consensus 105 ~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~--~~~~~l 182 (314)
.+.|+|+||++|+ .|......++.+.+...+.+++||+.|+.|||+ +||+||||||+|||+..+ +..+||
T Consensus 249 ----ds~YmVlE~v~GG---eLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~-~GI~HRDiKPeNILl~~~~e~~llKI 320 (475)
T KOG0615|consen 249 ----DSSYMVLEYVEGG---ELFDKVVANKYLREDLGKLLFKQLLTAVKYLHS-QGIIHRDIKPENILLSNDAEDCLLKI 320 (475)
T ss_pred ----CceEEEEEEecCc---cHHHHHHhccccccchhHHHHHHHHHHHHHHHH-cCcccccCCcceEEeccCCcceEEEe
Confidence 3478999999975 333334457889999999999999999999999 899999999999999762 357999
Q ss_pred eecCcccccccCCccccccccccccccccccCCC--CCCcchhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHc--
Q 021306 183 CDFGSAKQLIAGEANISYICSRFYRAPELIFGAT--EYTTSIDIWSAGCVLAELLLGQPLFPGENAVD-QLVEIIKVL-- 257 (314)
Q Consensus 183 ~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~-~~~~i~~~~-- 257 (314)
.|||+|+...........+|||.|.|||++.+.. .+..+.|+|||||+||-+++|.+||.+..... ...+|.++.
T Consensus 321 tDFGlAK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~ 400 (475)
T KOG0615|consen 321 TDFGLAKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYA 400 (475)
T ss_pred cccchhhccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCccc
Confidence 9999999887777777899999999999996543 23458899999999999999999998876555 344444331
Q ss_pred ---------CCCCHHH---HhccCCCCCCCcccccccCChhhhhcccC
Q 021306 258 ---------GTPTREE---IRCMNPNYTDFRFPQIKAHPWHKVCIFHF 293 (314)
Q Consensus 258 ---------~~~~~~~---~~~~~p~~~~~~~~~l~~~p~~~~~~~~~ 293 (314)
.....++ +..++|+ +|+++.++++|||++..+...
T Consensus 401 f~p~~w~~Iseea~dlI~~mL~VdP~-~R~s~~eaL~hpW~~~~~~~s 447 (475)
T KOG0615|consen 401 FGPLQWDRISEEALDLINWMLVVDPE-NRPSADEALNHPWFKDAPCLS 447 (475)
T ss_pred ccChhhhhhhHHHHHHHHHhhEeCcc-cCcCHHHHhcChhhhcccccc
Confidence 1111222 3345899 899999999999999887654
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-48 Score=348.04 Aligned_cols=246 Identities=30% Similarity=0.509 Sum_probs=208.9
Q ss_pred CCccCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeecc-------ccchHHHHHHHHhCCCCceeeeceeeeecCC
Q 021306 33 EPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRVMDHPNVISLKHCFFSTTS 105 (314)
Q Consensus 33 ~~~~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~-------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 105 (314)
.|+. ..|..++.||+|+|+.||.+++..+|+.||+|.+.+. +....+|+++-++|+|||||+++++|
T Consensus 14 D~~~-~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~F----- 87 (592)
T KOG0575|consen 14 DPRS-KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFF----- 87 (592)
T ss_pred cCCc-ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEe-----
Confidence 3444 5799999999999999999999999999999998652 33346899999999999999999999
Q ss_pred CCceeEEEEeeccccc-HHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEee
Q 021306 106 KNELFLNLVMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICD 184 (314)
Q Consensus 106 ~~~~~~~lv~e~~~~~-l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~d 184 (314)
++..++|+|.|+|..+ |...+. ..++++|.+++.+++||+.||.|||+ ++|+|||||..|+|++. +.++||+|
T Consensus 88 EDs~nVYivLELC~~~sL~el~K----rrk~ltEpEary~l~QIv~GlkYLH~-~~IiHRDLKLGNlfL~~-~~~VKIgD 161 (592)
T KOG0575|consen 88 EDSNNVYIVLELCHRGSLMELLK----RRKPLTEPEARYFLRQIVEGLKYLHS-LGIIHRDLKLGNLFLNE-NMNVKIGD 161 (592)
T ss_pred ecCCceEEEEEecCCccHHHHHH----hcCCCCcHHHHHHHHHHHHHHHHHHh-cCceecccchhheeecC-cCcEEecc
Confidence 5555599999999964 444333 46899999999999999999999999 89999999999999998 88999999
Q ss_pred cCcccccccC-CccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH-------
Q 021306 185 FGSAKQLIAG-EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV------- 256 (314)
Q Consensus 185 fg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~------- 256 (314)
||+|..+..+ ....+.+|||.|.|||++. ....+..+||||+||+||.|++|++||...+-.+.+..|...
T Consensus 162 FGLAt~le~~~Erk~TlCGTPNYIAPEVl~-k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~~ 240 (592)
T KOG0575|consen 162 FGLATQLEYDGERKKTLCGTPNYIAPEVLN-KSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPSH 240 (592)
T ss_pred cceeeeecCcccccceecCCCcccChhHhc-cCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCcccccc
Confidence 9999988755 5567789999999999996 445899999999999999999999999999888888877754
Q ss_pred cCCCCHHHHhc---cCCCCCCCcccccccCChh-hhhccc
Q 021306 257 LGTPTREEIRC---MNPNYTDFRFPQIKAHPWH-KVCIFH 292 (314)
Q Consensus 257 ~~~~~~~~~~~---~~p~~~~~~~~~l~~~p~~-~~~~~~ 292 (314)
+..++.+++.. .+|. +|+++++++.|+|+ +.+-+.
T Consensus 241 ls~~A~dLI~~lL~~~P~-~Rpsl~~vL~h~Ff~~g~~p~ 279 (592)
T KOG0575|consen 241 LSAEAKDLIRKLLRPNPS-ERPSLDEVLDHPFFKSGFTPA 279 (592)
T ss_pred cCHHHHHHHHHHhcCCcc-cCCCHHHHhcCHhhhCCCcCC
Confidence 33344455554 3777 89999999999999 444433
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-49 Score=322.05 Aligned_cols=243 Identities=37% Similarity=0.690 Sum_probs=211.2
Q ss_pred CCceeeeeEeecCceEEEEEEECCCCcEEEEEEeecccc------chHHHHHHHHhCCCCceeeeceeeeecCCCCceeE
Q 021306 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR------YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 111 (314)
Q Consensus 38 ~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~~------~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 111 (314)
++|+....+|+|+||+||+|+++.||+.||+|+|..... ..-+|+++|++++|+|+|.++++| .....+
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVF-----rrkrkl 76 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVF-----RRKRKL 76 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHH-----Hhccee
Confidence 579999999999999999999999999999999964432 234899999999999999999999 555558
Q ss_pred EEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCccccc
Q 021306 112 NLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 191 (314)
Q Consensus 112 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~ 191 (314)
++|+|||+.++++.+..+ ...++.+.++.+++|++.|+.|+|+ ++++||||||+|||++. ++.+||||||+|+..
T Consensus 77 hLVFE~~dhTvL~eLe~~---p~G~~~~~vk~~l~Q~l~ai~~cHk-~n~IHRDIKPENILit~-~gvvKLCDFGFAR~L 151 (396)
T KOG0593|consen 77 HLVFEYCDHTVLHELERY---PNGVPSELVKKYLYQLLKAIHFCHK-NNCIHRDIKPENILITQ-NGVVKLCDFGFARTL 151 (396)
T ss_pred EEEeeecchHHHHHHHhc---cCCCCHHHHHHHHHHHHHHhhhhhh-cCeecccCChhheEEec-CCcEEeccchhhHhh
Confidence 899999999988888864 4668999999999999999999999 99999999999999998 999999999999988
Q ss_pred ccCC-ccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCHHH------
Q 021306 192 IAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE------ 264 (314)
Q Consensus 192 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~------ 264 (314)
..+. ....+..|..|+|||.+.+..+|....||||+||++.||++|.+.|++.++.+++..|++.++.-.+..
T Consensus 152 ~~pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~ 231 (396)
T KOG0593|consen 152 SAPGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSS 231 (396)
T ss_pred cCCcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhcc
Confidence 7433 334577799999999999988899999999999999999999999999999999999998866544321
Q ss_pred -----------------------------------HhccCCCCCCCcccccccCChhhhhcc
Q 021306 265 -----------------------------------IRCMNPNYTDFRFPQIKAHPWHKVCIF 291 (314)
Q Consensus 265 -----------------------------------~~~~~p~~~~~~~~~l~~~p~~~~~~~ 291 (314)
...++|. +|++-++|+.||+|.....
T Consensus 232 N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~-~R~sc~qll~H~yFd~~~e 292 (396)
T KOG0593|consen 232 NPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPD-DRLSCEQLLHHPYFDGFIE 292 (396)
T ss_pred CCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCcc-ccccHHHHhcChHHHHHHH
Confidence 1235777 8999999999999855443
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-48 Score=328.07 Aligned_cols=246 Identities=29% Similarity=0.508 Sum_probs=206.2
Q ss_pred CccCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCC
Q 021306 34 PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSK 106 (314)
Q Consensus 34 ~~~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 106 (314)
....+.|++.+.||+|+||+||+|+.+.+++.||+|.+++.. .....|..+|.+++||+||+++-.| +
T Consensus 21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysF-----Q 95 (357)
T KOG0598|consen 21 MVGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSF-----Q 95 (357)
T ss_pred cCChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEec-----c
Confidence 344678999999999999999999999999999999886542 3335899999999999999998888 4
Q ss_pred CceeEEEEeeccccc-HHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeec
Q 021306 107 NELFLNLVMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF 185 (314)
Q Consensus 107 ~~~~~~lv~e~~~~~-l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~df 185 (314)
....+|+|+||+.|+ |...|+ .++.+++..++.++.+|+.||.|||+ +||+||||||+|||+|. +++++|+||
T Consensus 96 t~~kLylVld~~~GGeLf~hL~----~eg~F~E~~arfYlaEi~lAL~~LH~-~gIiyRDlKPENILLd~-~GHi~LtDF 169 (357)
T KOG0598|consen 96 TEEKLYLVLDYLNGGELFYHLQ----REGRFSEDRARFYLAEIVLALGYLHS-KGIIYRDLKPENILLDE-QGHIKLTDF 169 (357)
T ss_pred cCCeEEEEEeccCCccHHHHHH----hcCCcchhHHHHHHHHHHHHHHHHHh-CCeeeccCCHHHeeecC-CCcEEEecc
Confidence 444599999999984 554444 57899999999999999999999999 99999999999999999 999999999
Q ss_pred Ccccccc-cCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCC---
Q 021306 186 GSAKQLI-AGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT--- 261 (314)
Q Consensus 186 g~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~--- 261 (314)
|+++... ....+.+.+||+.|||||++.+.. ++.++|+||||+++|+|++|..||.+.+....+.+|.+.-...+
T Consensus 170 gL~k~~~~~~~~t~tfcGT~eYmAPEil~~~g-y~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p~~ 248 (357)
T KOG0598|consen 170 GLCKEDLKDGDATRTFCGTPEYMAPEILLGKG-YDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPPGY 248 (357)
T ss_pred ccchhcccCCCccccccCCccccChHHHhcCC-CCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCCcc
Confidence 9998543 345566689999999999998765 99999999999999999999999999998888888877642222
Q ss_pred -----HHH---HhccCCCCCCC----cccccccCChhhhhccc
Q 021306 262 -----REE---IRCMNPNYTDF----RFPQIKAHPWHKVCIFH 292 (314)
Q Consensus 262 -----~~~---~~~~~p~~~~~----~~~~l~~~p~~~~~~~~ 292 (314)
++. +...+|. .|+ .+.+|.+|||++.-+.+
T Consensus 249 ls~~ardll~~LL~rdp~-~RLg~~~d~~~ik~HpfF~~inW~ 290 (357)
T KOG0598|consen 249 LSEEARDLLKKLLKRDPR-QRLGGPGDAEEIKRHPFFKGINWE 290 (357)
T ss_pred CCHHHHHHHHHHhccCHH-HhcCCCCChHHhhcCcccccCCHH
Confidence 222 2345777 554 67889999998877654
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-48 Score=329.93 Aligned_cols=210 Identities=31% Similarity=0.596 Sum_probs=182.5
Q ss_pred ccCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCCc
Q 021306 35 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 108 (314)
Q Consensus 35 ~~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 108 (314)
...++|.+.+.||.|+|++||+|+++.++..||||.+.+.. .....|+.+|+.++|||||.+++++ ...
T Consensus 7 ~~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~-----~~~ 81 (429)
T KOG0595|consen 7 RVVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCI-----EDD 81 (429)
T ss_pred cccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEE-----ecC
Confidence 34568999999999999999999999999999999986553 2235799999999999999999998 444
Q ss_pred eeEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCC--C---CcEEE
Q 021306 109 LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPL--T---HQVKI 182 (314)
Q Consensus 109 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~--~---~~~~l 182 (314)
+++|+|||||.| +|...++ ..+.+++..++.++.||+.|+++||+ ++|+||||||.|||++.. + -.+||
T Consensus 82 ~~i~lVMEyC~gGDLs~yi~----~~~~l~e~t~r~Fm~QLA~alq~L~~-~~IiHRDLKPQNiLLs~~~~~~~~~~LKI 156 (429)
T KOG0595|consen 82 DFIYLVMEYCNGGDLSDYIR----RRGRLPEATARHFMQQLASALQFLHE-NNIIHRDLKPQNILLSTTARNDTSPVLKI 156 (429)
T ss_pred CeEEEEEEeCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeccCCcceEEeccCCCCCCCceEEe
Confidence 469999999996 5555554 45799999999999999999999999 999999999999999873 1 46999
Q ss_pred eecCcccccccCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 021306 183 CDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 255 (314)
Q Consensus 183 ~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~ 255 (314)
.|||+|+.+.........+|+|.|||||++...+ |+.|+|+||+|+++|+|++|+.||...+..+.+..+.+
T Consensus 157 ADFGfAR~L~~~~~a~tlcGSplYMAPEV~~~~~-YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k 228 (429)
T KOG0595|consen 157 ADFGFARFLQPGSMAETLCGSPLYMAPEVIMSQQ-YDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKK 228 (429)
T ss_pred cccchhhhCCchhHHHHhhCCccccCHHHHHhcc-ccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhc
Confidence 9999999888777777889999999999996544 99999999999999999999999999998877765544
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-48 Score=336.77 Aligned_cols=245 Identities=36% Similarity=0.649 Sum_probs=219.7
Q ss_pred CCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccccch-----HHHHHHHHhCC-CCceeeeceeeeecCCCCcee
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-----NRELQLMRVMD-HPNVISLKHCFFSTTSKNELF 110 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~~~~-----~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~ 110 (314)
.++|.+++.||.|.||.||+|+.+.+|+.||+|++++.-... .+|+.-|++|+ ||||+++.+++.+.+. .
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~----~ 84 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDR----I 84 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCc----e
Confidence 468999999999999999999999999999999987654333 48999999998 9999999999865442 5
Q ss_pred EEEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcccc
Q 021306 111 LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 190 (314)
Q Consensus 111 ~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~ 190 (314)
+++|||||+.+|+..+..+ +..|++..++.|+.||++||+|+|+ +|++|||+||+|||+.. ...+||+|||+|+.
T Consensus 85 L~fVfE~Md~NLYqLmK~R---~r~fse~~irnim~QilqGL~hiHk-~GfFHRDlKPENiLi~~-~~~iKiaDFGLARe 159 (538)
T KOG0661|consen 85 LYFVFEFMDCNLYQLMKDR---NRLFSESDIRNIMYQILQGLAHIHK-HGFFHRDLKPENILISG-NDVIKIADFGLARE 159 (538)
T ss_pred EeeeHHhhhhhHHHHHhhc---CCcCCHHHHHHHHHHHHHHHHHHHh-cCcccccCChhheEecc-cceeEecccccccc
Confidence 8999999999999998874 7899999999999999999999999 99999999999999997 77899999999998
Q ss_pred cccCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCHHH------
Q 021306 191 LIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE------ 264 (314)
Q Consensus 191 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~------ 264 (314)
.........++-|..|+|||++.....|+.+.|+||+|||++|+.+-++.|.|.+..+++.+|++-++.|..+.
T Consensus 160 v~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~ 239 (538)
T KOG0661|consen 160 VRSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYN 239 (538)
T ss_pred cccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHH
Confidence 88877778888899999999998888899999999999999999999999999999999999999887775422
Q ss_pred ----------------------------------HhccCCCCCCCcccccccCChhhhhcc
Q 021306 265 ----------------------------------IRCMNPNYTDFRFPQIKAHPWHKVCIF 291 (314)
Q Consensus 265 ----------------------------------~~~~~p~~~~~~~~~l~~~p~~~~~~~ 291 (314)
+..++|+ +|+++.++++|||+++...
T Consensus 240 La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~-kRpTA~~al~~pffq~~~~ 299 (538)
T KOG0661|consen 240 LASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPD-KRPTASQALQHPFFQVGRA 299 (538)
T ss_pred HHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCc-cCccHHHHhcCcccccccc
Confidence 2235787 9999999999999998764
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-47 Score=311.09 Aligned_cols=248 Identities=28% Similarity=0.462 Sum_probs=206.4
Q ss_pred ccCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCC
Q 021306 35 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKN 107 (314)
Q Consensus 35 ~~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 107 (314)
-..++|++.+.||.|+||+|.+++.+.+|..||+|.+.+.. ....+|..+|+.+.||+++++.+.+ .+
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~-----~d 115 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTF-----KD 115 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEee-----cc
Confidence 44579999999999999999999999999999999987543 2234899999999999999999988 44
Q ss_pred ceeEEEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCc
Q 021306 108 ELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 187 (314)
Q Consensus 108 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~ 187 (314)
..++++||||++|+ .+..+.+..+++++..++.++.|++.|++|||+ .+|++|||||+|||+|. ++.+||+|||+
T Consensus 116 ~~~lymvmeyv~GG---ElFS~Lrk~~rF~e~~arFYAAeivlAleylH~-~~iiYRDLKPENiLlD~-~G~iKitDFGF 190 (355)
T KOG0616|consen 116 NSNLYMVMEYVPGG---ELFSYLRKSGRFSEPHARFYAAEIVLALEYLHS-LDIIYRDLKPENLLLDQ-NGHIKITDFGF 190 (355)
T ss_pred CCeEEEEEeccCCc---cHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHh-cCeeeccCChHHeeecc-CCcEEEEeccc
Confidence 45599999999986 334444456899999999999999999999999 89999999999999999 99999999999
Q ss_pred ccccccCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCC-------
Q 021306 188 AKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP------- 260 (314)
Q Consensus 188 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~------- 260 (314)
|+..... +...+|||.|+|||.++... ++.++|.||||+++|||+.|.+||.+.++...+.+|+++--..
T Consensus 191 AK~v~~r--T~TlCGTPeYLAPEii~sk~-ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP~~fs~~ 267 (355)
T KOG0616|consen 191 AKRVSGR--TWTLCGTPEYLAPEIIQSKG-YNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFPSYFSSD 267 (355)
T ss_pred eEEecCc--EEEecCCccccChHHhhcCC-CCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCCcccCHH
Confidence 9876543 66789999999999997655 9999999999999999999999999999999999998763222
Q ss_pred CHHHHhc---cCCCCCC-----CcccccccCChhhhhcccCChH
Q 021306 261 TREEIRC---MNPNYTD-----FRFPQIKAHPWHKVCIFHFPKH 296 (314)
Q Consensus 261 ~~~~~~~---~~p~~~~-----~~~~~l~~~p~~~~~~~~~~~~ 296 (314)
..+++.. .+.. +| -..++|+.|||++....+....
T Consensus 268 ~kdLl~~LL~vD~t-~R~gnlknG~~dIk~H~wF~~v~W~~i~~ 310 (355)
T KOG0616|consen 268 AKDLLKKLLQVDLT-KRFGNLKNGVEDIKNHPWFKGVDWEAILQ 310 (355)
T ss_pred HHHHHHHHHhhhhH-hhhcCcCCCccccccCcccccccHHHHhh
Confidence 2333332 2222 23 2578999999999776654433
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-47 Score=330.33 Aligned_cols=245 Identities=35% Similarity=0.622 Sum_probs=212.4
Q ss_pred CCccCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCC
Q 021306 33 EPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSK 106 (314)
Q Consensus 33 ~~~~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 106 (314)
.|...+.|+..+.||+|.||.||++++..+|+.||+|++..+. ....+|+.+|++|.||||+++.+++.+..
T Consensus 112 ~~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~-- 189 (560)
T KOG0600|consen 112 GPRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKL-- 189 (560)
T ss_pred cccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecC--
Confidence 3455678999999999999999999999999999999997554 22369999999999999999999887652
Q ss_pred CceeEEEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecC
Q 021306 107 NELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 186 (314)
Q Consensus 107 ~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg 186 (314)
...+|+|+|||+.+|.-.+.. .+..|++.+++.++.||+.||.|||. +||.|||||.+|||+|. ++.+||+|||
T Consensus 190 -~~siYlVFeYMdhDL~GLl~~---p~vkft~~qIKc~mkQLl~Gl~~cH~-~gvlHRDIK~SNiLidn-~G~LKiaDFG 263 (560)
T KOG0600|consen 190 -SGSIYLVFEYMDHDLSGLLSS---PGVKFTEPQIKCYMKQLLEGLEYCHS-RGVLHRDIKGSNILIDN-NGVLKIADFG 263 (560)
T ss_pred -CceEEEEEecccchhhhhhcC---CCcccChHHHHHHHHHHHHHHHHHhh-cCeeeccccccceEEcC-CCCEEecccc
Confidence 234889999999988877764 45689999999999999999999999 99999999999999999 8999999999
Q ss_pred cccccccCC--ccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCHHH
Q 021306 187 SAKQLIAGE--ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 264 (314)
Q Consensus 187 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 264 (314)
+|+.+.... ...+.+.|..|.|||.+.|...|+.+.|+||+||||.||++|++.|.+.+..+++..|.+.++.|..+.
T Consensus 264 LAr~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~ 343 (560)
T KOG0600|consen 264 LARFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDY 343 (560)
T ss_pred ceeeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhc
Confidence 999665433 334566789999999999999999999999999999999999999999999999999999888776543
Q ss_pred Hh---------------------------------------ccCCCCCCCcccccccCChh
Q 021306 265 IR---------------------------------------CMNPNYTDFRFPQIKAHPWH 286 (314)
Q Consensus 265 ~~---------------------------------------~~~p~~~~~~~~~l~~~p~~ 286 (314)
+. +++|+ +|.++.+.++++||
T Consensus 344 W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~-kR~tA~~aL~seyF 403 (560)
T KOG0600|consen 344 WPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPD-KRGTASSALQSEYF 403 (560)
T ss_pred cccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCcc-ccccHHHHhcCccc
Confidence 32 34566 78888888888888
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-47 Score=331.48 Aligned_cols=245 Identities=31% Similarity=0.551 Sum_probs=207.0
Q ss_pred ccCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeecc-------ccchHHHHHHHHhC-CCCceeeeceeeeecCCC
Q 021306 35 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRVM-DHPNVISLKHCFFSTTSK 106 (314)
Q Consensus 35 ~~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~-------~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~ 106 (314)
+..++|.+++.||.|+|++|++|+++.+++.||+|++.+. ......|.+.|.+| .||.|++++-.|++...
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s- 148 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES- 148 (604)
T ss_pred CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc-
Confidence 3346899999999999999999999999999999988543 23345888999999 89999999998855444
Q ss_pred CceeEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeec
Q 021306 107 NELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF 185 (314)
Q Consensus 107 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~df 185 (314)
+|+|+||+++ .|++.+.++ +.|++..++.++.||+.||+|||+ +||+||||||+|||+|. +++++|.||
T Consensus 149 ----LYFvLe~A~nGdll~~i~K~----Gsfde~caR~YAAeIldAleylH~-~GIIHRDlKPENILLd~-dmhikITDF 218 (604)
T KOG0592|consen 149 ----LYFVLEYAPNGDLLDLIKKY----GSFDETCARFYAAEILDALEYLHS-NGIIHRDLKPENILLDK-DGHIKITDF 218 (604)
T ss_pred ----eEEEEEecCCCcHHHHHHHh----CcchHHHHHHHHHHHHHHHHHHHh-cCceeccCChhheeEcC-CCcEEEeec
Confidence 8999999995 777777764 899999999999999999999999 99999999999999999 999999999
Q ss_pred CcccccccCCc------------c--ccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 021306 186 GSAKQLIAGEA------------N--ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLV 251 (314)
Q Consensus 186 g~~~~~~~~~~------------~--~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~ 251 (314)
|.|+.+..... . .+++||..|.+||.+... ..++.+|+|+||||+|+|+.|++||.+.+..-.++
T Consensus 219 GsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~-~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFq 297 (604)
T KOG0592|consen 219 GSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDS-PAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQ 297 (604)
T ss_pred cccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCC-CCCcccchHHHHHHHHHHhcCCCCCccccHHHHHH
Confidence 99986643211 1 457899999999999654 48999999999999999999999999999999999
Q ss_pred HHHHHcCC-------CCHHHHh---ccCCCCCCCcccccccCChhhhhccc
Q 021306 252 EIIKVLGT-------PTREEIR---CMNPNYTDFRFPQIKAHPWHKVCIFH 292 (314)
Q Consensus 252 ~i~~~~~~-------~~~~~~~---~~~p~~~~~~~~~l~~~p~~~~~~~~ 292 (314)
+|++..-. ...+++. -++|. +|++.++|+.||||.....+
T Consensus 298 kI~~l~y~fp~~fp~~a~dLv~KLLv~dp~-~Rlt~~qIk~HpFF~~Vdw~ 347 (604)
T KOG0592|consen 298 KIQALDYEFPEGFPEDARDLIKKLLVRDPS-DRLTSQQIKAHPFFEGVDWE 347 (604)
T ss_pred HHHHhcccCCCCCCHHHHHHHHHHHccCcc-ccccHHHHhhCcccccCChh
Confidence 99876322 1223333 45888 89999999999999876653
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-46 Score=312.08 Aligned_cols=253 Identities=31% Similarity=0.553 Sum_probs=218.2
Q ss_pred CCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccccc------hHHHHHHHHhCCCCceeeeceeeeecCCCCcee
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY------KNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 110 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~~~------~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 110 (314)
.++|+.++.|++|.||.||+|+++.|++.||+|+++.+... ..+|+.+|.+++|||||.+.+++....-..
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~--- 151 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDK--- 151 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccce---
Confidence 46899999999999999999999999999999999765422 259999999999999999999876544333
Q ss_pred EEEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcccc
Q 021306 111 LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 190 (314)
Q Consensus 111 ~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~ 190 (314)
+|+|||||+.+|.+.+.. ...+|...+++.++.|++.|++|||. ..|+||||||+|+|++. .+.+|++|||+|+.
T Consensus 152 iy~VMe~~EhDLksl~d~---m~q~F~~~evK~L~~QlL~glk~lH~-~wilHRDLK~SNLLm~~-~G~lKiaDFGLAR~ 226 (419)
T KOG0663|consen 152 IYIVMEYVEHDLKSLMET---MKQPFLPGEVKTLMLQLLRGLKHLHD-NWILHRDLKTSNLLLSH-KGILKIADFGLARE 226 (419)
T ss_pred eeeeHHHHHhhHHHHHHh---ccCCCchHHHHHHHHHHHHHHHHHhh-ceeEecccchhheeecc-CCcEEecccchhhh
Confidence 889999999998888775 34789999999999999999999999 89999999999999998 89999999999998
Q ss_pred cccCCccc-cccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCHHHH----
Q 021306 191 LIAGEANI-SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI---- 265 (314)
Q Consensus 191 ~~~~~~~~-~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~---- 265 (314)
+..+.... ....|..|.|||.+.+...|+.+.|+||+|||+.||+++++.|.+.+..+++.+|.+.++.|....+
T Consensus 227 ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~ 306 (419)
T KOG0663|consen 227 YGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYS 306 (419)
T ss_pred hcCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCcc
Confidence 87764433 3456888999999999999999999999999999999999999999999999999998777654221
Q ss_pred --------------------------------------hccCCCCCCCcccccccCChhhhhcccCChHHH
Q 021306 266 --------------------------------------RCMNPNYTDFRFPQIKAHPWHKVCIFHFPKHWL 298 (314)
Q Consensus 266 --------------------------------------~~~~p~~~~~~~~~l~~~p~~~~~~~~~~~~~~ 298 (314)
...+|. +|+++.+.++|.||+..+....+.-+
T Consensus 307 ~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~-kR~tA~~~L~h~~F~e~P~p~~P~~~ 376 (419)
T KOG0663|consen 307 ELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPG-KRITAEDGLKHEYFRETPLPIDPSMF 376 (419)
T ss_pred ccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCcc-ccccHHHhhcccccccCCCCCChhhc
Confidence 123566 89999999999999987766555433
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-47 Score=322.60 Aligned_cols=242 Identities=29% Similarity=0.524 Sum_probs=201.9
Q ss_pred CCceeeeeEeecCceEEEEEEECCCCcEEEEEEeecc-----ccchHHHHHHHHhCCCCceeeeceeeeecCCCCceeEE
Q 021306 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-----RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 112 (314)
Q Consensus 38 ~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~-----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 112 (314)
.+.+.++.||+|+.|+||+|+++.|++.+|+|.+..+ ++...+|+++++..+||+||.++++|+.... .+.
T Consensus 79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~----~is 154 (364)
T KOG0581|consen 79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGE----EIS 154 (364)
T ss_pred HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCc----eEE
Confidence 3788899999999999999999999999999999432 2344589999999999999999999987553 278
Q ss_pred EEeeccccc-HHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCccccc
Q 021306 113 LVMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 191 (314)
Q Consensus 113 lv~e~~~~~-l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~ 191 (314)
|+||||+|+ |...+.. .+.+++..+..++.++++||.|||+.++|+||||||+|||++. .+.+||||||.++..
T Consensus 155 I~mEYMDgGSLd~~~k~----~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNs-kGeVKicDFGVS~~l 229 (364)
T KOG0581|consen 155 ICMEYMDGGSLDDILKR----VGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNS-KGEVKICDFGVSGIL 229 (364)
T ss_pred eehhhcCCCCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeecc-CCCEEeccccccHHh
Confidence 999999975 4444433 4789999999999999999999995489999999999999999 999999999999877
Q ss_pred ccCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCC-----ChHHHHHHHHHHcCCCCHHH--
Q 021306 192 IAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE-----NAVDQLVEIIKVLGTPTREE-- 264 (314)
Q Consensus 192 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~-----~~~~~~~~i~~~~~~~~~~~-- 264 (314)
.+. ...++.||..|||||.+.+.. |+.++||||||++++||++|+.||... +..+.+..|+..-.+..+..
T Consensus 230 vnS-~a~tfvGT~~YMsPERi~g~~-Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~~f 307 (364)
T KOG0581|consen 230 VNS-IANTFVGTSAYMSPERISGES-YSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEGEF 307 (364)
T ss_pred hhh-hcccccccccccChhhhcCCc-CCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcccC
Confidence 665 556789999999999998765 999999999999999999999999774 55666666666444433332
Q ss_pred -------Hh-c--cCCCCCCCcccccccCChhhhhcc
Q 021306 265 -------IR-C--MNPNYTDFRFPQIKAHPWHKVCIF 291 (314)
Q Consensus 265 -------~~-~--~~p~~~~~~~~~l~~~p~~~~~~~ 291 (314)
+. | .+|. +|.++.+|+.|||.+....
T Consensus 308 S~ef~~FV~~CL~Kdp~-~R~s~~qLl~Hpfi~~~~~ 343 (364)
T KOG0581|consen 308 SPEFRSFVSCCLRKDPS-ERPSAKQLLQHPFIKKFED 343 (364)
T ss_pred CHHHHHHHHHHhcCCcc-cCCCHHHHhcCHHHhhccc
Confidence 11 2 2666 8999999999999986654
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-46 Score=327.71 Aligned_cols=247 Identities=28% Similarity=0.478 Sum_probs=202.8
Q ss_pred cCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeecccc-------chHHHHHHHHhCCCCceeeeceeeeecCCCCc
Q 021306 36 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 108 (314)
Q Consensus 36 ~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~~-------~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 108 (314)
..++|++++.||+|+||.||+|+-+.||+.||+|++++..- ....|..+|..-.++.||+++-.| ++.
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsF-----QD~ 213 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSF-----QDK 213 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEe-----cCC
Confidence 45789999999999999999999999999999999976532 234688889989999999999888 556
Q ss_pred eeEEEEeeccccc-HHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCc
Q 021306 109 LFLNLVMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 187 (314)
Q Consensus 109 ~~~~lv~e~~~~~-l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~ 187 (314)
.++|+||||++|+ +...|. ....|++.+++.++.+++.||..+|+ .|++||||||+|+|+|. .|++||+|||+
T Consensus 214 ~~LYLiMEylPGGD~mTLL~----~~~~L~e~~arfYiaE~vlAI~~iH~-~gyIHRDIKPdNlLiD~-~GHiKLSDFGL 287 (550)
T KOG0605|consen 214 EYLYLIMEYLPGGDMMTLLM----RKDTLTEDWARFYIAETVLAIESIHQ-LGYIHRDIKPDNLLIDA-KGHIKLSDFGL 287 (550)
T ss_pred CeeEEEEEecCCccHHHHHH----hcCcCchHHHHHHHHHHHHHHHHHHH-cCcccccCChhheeecC-CCCEeeccccc
Confidence 6699999999985 443333 46899999999999999999999999 89999999999999999 99999999999
Q ss_pred cccccc-----------------------CCc-------------------------cccccccccccccccccCCCCCC
Q 021306 188 AKQLIA-----------------------GEA-------------------------NISYICSRFYRAPELIFGATEYT 219 (314)
Q Consensus 188 ~~~~~~-----------------------~~~-------------------------~~~~~~~~~y~aPE~~~~~~~~~ 219 (314)
+..+.. ... ..+.+|||.|+|||++.+.. ++
T Consensus 288 s~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kg-Y~ 366 (550)
T KOG0605|consen 288 STGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKG-YG 366 (550)
T ss_pred cchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCC-CC
Confidence 742210 000 01356799999999998766 99
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHc---CC--------CCHHHHh--ccCCCCCCC---cccccccC
Q 021306 220 TSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVL---GT--------PTREEIR--CMNPNYTDF---RFPQIKAH 283 (314)
Q Consensus 220 ~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~---~~--------~~~~~~~--~~~p~~~~~---~~~~l~~~ 283 (314)
..+|+||||||+|||+.|-+||.+.++.+.+.+|+..- .. .+.+++. ..+|+ .|+ ++++|++|
T Consensus 367 ~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~d~~-~RLG~~G~~EIK~H 445 (550)
T KOG0605|consen 367 KECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLCDPE-NRLGSKGAEEIKKH 445 (550)
T ss_pred ccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhcCHH-HhcCcccHHHHhcC
Confidence 99999999999999999999999999999999988652 22 2233333 22565 455 58999999
Q ss_pred ChhhhhcccCCh
Q 021306 284 PWHKVCIFHFPK 295 (314)
Q Consensus 284 p~~~~~~~~~~~ 295 (314)
|||+....+-+.
T Consensus 446 PfF~~v~W~~l~ 457 (550)
T KOG0605|consen 446 PFFKGVDWDHLR 457 (550)
T ss_pred CccccCCcchhh
Confidence 999988765433
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-45 Score=297.71 Aligned_cols=240 Identities=39% Similarity=0.711 Sum_probs=210.5
Q ss_pred CCceeeeeEeecCceEEEEEEECCCCcEEEEEEeecccc------chHHHHHHHHhCCCCceeeeceeeeecCCCCceeE
Q 021306 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR------YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 111 (314)
Q Consensus 38 ~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~~------~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 111 (314)
.+|...+.||+|.||.||+|++..+|+.||+|+++.... ...+|++.|+.++|+||+.++++|.+... +
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~-----l 76 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSN-----L 76 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCc-----e
Confidence 479999999999999999999999999999999975432 23599999999999999999999955444 7
Q ss_pred EEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCccccc
Q 021306 112 NLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 191 (314)
Q Consensus 112 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~ 191 (314)
-+|+||++.+|...+.+ ....++..+++.|+.++++|++|||+ +.|.||||||.|+|+++ ++.+||.|||+++..
T Consensus 77 ~lVfEfm~tdLe~vIkd---~~i~l~pa~iK~y~~m~LkGl~y~H~-~~IlHRDlKPnNLLis~-~g~lKiADFGLAr~f 151 (318)
T KOG0659|consen 77 SLVFEFMPTDLEVVIKD---KNIILSPADIKSYMLMTLKGLAYCHS-KWILHRDLKPNNLLISS-DGQLKIADFGLARFF 151 (318)
T ss_pred EEEEEeccccHHHHhcc---cccccCHHHHHHHHHHHHHHHHHHHh-hhhhcccCCccceEEcC-CCcEEeecccchhcc
Confidence 89999999999988875 46789999999999999999999999 99999999999999999 999999999999987
Q ss_pred ccCCcccc-ccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCHHHHhcc--
Q 021306 192 IAGEANIS-YICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM-- 268 (314)
Q Consensus 192 ~~~~~~~~-~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~-- 268 (314)
........ ...|..|.|||.+.|...|+...|+||.|||+.||+.|.+-|.|.++.+++..|.+.++.|.++.++.+
T Consensus 152 ~~p~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~ 231 (318)
T KOG0659|consen 152 GSPNRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTS 231 (318)
T ss_pred CCCCcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccc
Confidence 65544333 356888999999999999999999999999999999999999999999999999999999887665532
Q ss_pred ------------------------------------CCCCCCCcccccccCChhhh
Q 021306 269 ------------------------------------NPNYTDFRFPQIKAHPWHKV 288 (314)
Q Consensus 269 ------------------------------------~p~~~~~~~~~l~~~p~~~~ 288 (314)
+|- +|+++.+.++|+|+..
T Consensus 232 lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~-~Rita~qaL~~~yf~~ 286 (318)
T KOG0659|consen 232 LPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPK-KRITASQALKHPYFKS 286 (318)
T ss_pred cccHHHHhcCCCCccccccccccHHHHHHHHhhhccCch-hcccHHHHhcchhhhc
Confidence 232 7888888888888874
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-45 Score=323.67 Aligned_cols=243 Identities=31% Similarity=0.474 Sum_probs=201.6
Q ss_pred ccCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeecc---------ccchHHHHHHHHhCC-CCceeeeceeeeecC
Q 021306 35 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD---------RRYKNRELQLMRVMD-HPNVISLKHCFFSTT 104 (314)
Q Consensus 35 ~~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~---------~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~ 104 (314)
...++|.+++.||+|+||+|+.+.+..++..||+|.+.+. .....+|+.++++++ ||||+++++++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 3456899999999999999999999999999999976553 122347999999999 999999999984433
Q ss_pred CCCceeEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEe
Q 021306 105 SKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKIC 183 (314)
Q Consensus 105 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~ 183 (314)
.+++||||+.| .|++.+.. .+++.+.+++.+++|++.|+.|||+ +||+||||||+||+++...+.+||+
T Consensus 94 -----~~~ivmEy~~gGdL~~~i~~----~g~l~E~~ar~~F~Qlisav~y~H~-~gi~HRDLK~ENilld~~~~~~Kl~ 163 (370)
T KOG0583|consen 94 -----KIYIVMEYCSGGDLFDYIVN----KGRLKEDEARKYFRQLISAVAYCHS-RGIVHRDLKPENILLDGNEGNLKLS 163 (370)
T ss_pred -----eEEEEEEecCCccHHHHHHH----cCCCChHHHHHHHHHHHHHHHHHHh-CCEeeCCCCHHHEEecCCCCCEEEe
Confidence 38899999997 66665553 6899999999999999999999999 8999999999999999833899999
Q ss_pred ecCccccc-ccCCccccccccccccccccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHc----
Q 021306 184 DFGSAKQL-IAGEANISYICSRFYRAPELIFGAT-EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVL---- 257 (314)
Q Consensus 184 dfg~~~~~-~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~---- 257 (314)
|||++... .........+||+.|+|||.+.+.. ....++||||+|++||.|++|..||...+....+..|.+..
T Consensus 164 DFG~s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~p 243 (370)
T KOG0583|consen 164 DFGLSAISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKIP 243 (370)
T ss_pred ccccccccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccCC
Confidence 99999877 3445556788999999999998766 34589999999999999999999999988877777766541
Q ss_pred ----CCCCHHHHh---ccCCCCCCCcccccccCChhhh
Q 021306 258 ----GTPTREEIR---CMNPNYTDFRFPQIKAHPWHKV 288 (314)
Q Consensus 258 ----~~~~~~~~~---~~~p~~~~~~~~~l~~~p~~~~ 288 (314)
+......+. ..+|. +|+++.+|+.|||++.
T Consensus 244 ~~~~S~~~~~Li~~mL~~~P~-~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 244 SYLLSPEARSLIEKMLVPDPS-TRITLLEILEHPWFQK 280 (370)
T ss_pred CCcCCHHHHHHHHHHcCCCcc-cCCCHHHHhhChhhcc
Confidence 111122233 23666 7999999999999997
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-45 Score=329.84 Aligned_cols=245 Identities=32% Similarity=0.503 Sum_probs=209.4
Q ss_pred CCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeecc-------ccchHHHHHHHHhCCCCceeeeceeeeecCCCCce
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL 109 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~-------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 109 (314)
.+.|++++.||.|+.|.|-+|++..||+..|||.+.+. .....+|+.+++.+.|||++++++.| ....
T Consensus 11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVw-----e~~~ 85 (786)
T KOG0588|consen 11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVW-----ENKQ 85 (786)
T ss_pred ccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeee-----ccCc
Confidence 34799999999999999999999999999999999766 34457999999999999999999999 4444
Q ss_pred eEEEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCccc
Q 021306 110 FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 189 (314)
Q Consensus 110 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~ 189 (314)
++|+|.||++|+ .+.++....+++++.++.++++||+.|+.|||. .+|+||||||+|++++. .+++||+|||.|.
T Consensus 86 ~lylvlEyv~gG---ELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~-~~icHRDLKpENlLLd~-~~nIKIADFGMAs 160 (786)
T KOG0588|consen 86 HLYLVLEYVPGG---ELFDYLVRKGPLPEREAAHFFRQILDGVSYCHA-FNICHRDLKPENLLLDV-KNNIKIADFGMAS 160 (786)
T ss_pred eEEEEEEecCCc---hhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhh-hcceeccCCchhhhhhc-ccCEeeeccceee
Confidence 599999999975 344444567999999999999999999999999 89999999999999999 5559999999998
Q ss_pred ccccCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHc-------CCCCH
Q 021306 190 QLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVL-------GTPTR 262 (314)
Q Consensus 190 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~-------~~~~~ 262 (314)
.-..+..-.+.+|+|.|.|||++.|.+....++||||+|+|||.|+||+.||.+.+....+.++.++. ...+.
T Consensus 161 Le~~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MPs~Is~eaQ 240 (786)
T KOG0588|consen 161 LEVPGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMPSNISSEAQ 240 (786)
T ss_pred cccCCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCCCcCCHHHH
Confidence 76666667778999999999999998877899999999999999999999999888776666665542 22233
Q ss_pred HHHh---ccCCCCCCCcccccccCChhhhhccc
Q 021306 263 EEIR---CMNPNYTDFRFPQIKAHPWHKVCIFH 292 (314)
Q Consensus 263 ~~~~---~~~p~~~~~~~~~l~~~p~~~~~~~~ 292 (314)
+++. .++|+ +|++.++|.+|||..-+...
T Consensus 241 dLLr~ml~VDp~-~RiT~~eI~kHP~l~g~~~~ 272 (786)
T KOG0588|consen 241 DLLRRMLDVDPS-TRITTEEILKHPFLSGYTSL 272 (786)
T ss_pred HHHHHHhccCcc-ccccHHHHhhCchhhcCCCC
Confidence 4444 45888 99999999999998876653
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-46 Score=303.15 Aligned_cols=220 Identities=31% Similarity=0.505 Sum_probs=186.8
Q ss_pred CCceeeeeEeecCceEEEEEEECCCCcEEEEEEeecc------ccchHHHHHHHHhCCCCceeeeceeeeecCCCCceeE
Q 021306 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 111 (314)
Q Consensus 38 ~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 111 (314)
.+|++.+.||+|+||.||++.+..+|..+|+|.++-+ +...-.|+.+|++|+|||||++++.-+..+ ...+
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~---~evl 95 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIED---NEVL 95 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhcc---chhh
Confidence 3699999999999999999999999999999998632 333458999999999999999988433222 2227
Q ss_pred EEEeeccc-ccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhc--C-CCceecCCCCCcEEEcCCCCcEEEeecCc
Q 021306 112 NLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT--V-PRVCHRDLKPQNLLVDPLTHQVKICDFGS 187 (314)
Q Consensus 112 ~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~--~-~~i~h~dl~p~Nil~~~~~~~~~l~dfg~ 187 (314)
+|+||+|+ |+|...++++......+++..+|.++.|++.||..+|. . ..++||||||.|||++. ++.+||+|||+
T Consensus 96 nivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~-~gvvKLGDfGL 174 (375)
T KOG0591|consen 96 NIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTA-NGVVKLGDFGL 174 (375)
T ss_pred HHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcC-CCceeeccchh
Confidence 79999999 58999999999999999999999999999999999998 2 23899999999999998 89999999999
Q ss_pred ccccccCCc-cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCH
Q 021306 188 AKQLIAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 262 (314)
Q Consensus 188 ~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~ 262 (314)
++....... ..+.+|||.||+||.+.+.+ |+++|||||+||++|||+.-++||.+.+-.+...+|.++--++.+
T Consensus 175 ~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~-Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p 249 (375)
T KOG0591|consen 175 GRFLSSKTTFAHSLVGTPYYMSPERIHESG-YNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLP 249 (375)
T ss_pred HhHhcchhHHHHhhcCCCcccCHHHHhcCC-CCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCc
Confidence 987765433 45688999999999997655 999999999999999999999999999766666666665443333
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-43 Score=321.93 Aligned_cols=252 Identities=53% Similarity=0.977 Sum_probs=210.3
Q ss_pred CCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHhCCCCceeeeceeeeecC---CCCceeEEE
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTT---SKNELFLNL 113 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~---~~~~~~~~l 113 (314)
..+|++++.||+|+||.||+|.+..+++.||+|++........+|+.+++.++|+||++++++++... .....++++
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~l 144 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNV 144 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCcchHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEE
Confidence 35799999999999999999999999999999999777666778999999999999999988765432 123346789
Q ss_pred EeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCccccccc
Q 021306 114 VMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA 193 (314)
Q Consensus 114 v~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~~ 193 (314)
||||+++++.+.+..+...+..+++..++.++.||+.||.|||+ +||+||||||+||+++..++.++|+|||+++....
T Consensus 145 vmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~-~~IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~ 223 (440)
T PTZ00036 145 VMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHS-KFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLA 223 (440)
T ss_pred EEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCcCHHHEEEcCCCCceeeeccccchhccC
Confidence 99999999888887766667889999999999999999999999 89999999999999997456799999999987655
Q ss_pred CCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCHH----------
Q 021306 194 GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE---------- 263 (314)
Q Consensus 194 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~---------- 263 (314)
........+++.|+|||.+.+...++.++|||||||++|+|++|.+||.+.+..+.+..+++..+.+..+
T Consensus 224 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~ 303 (440)
T PTZ00036 224 GQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYA 303 (440)
T ss_pred CCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhchhhh
Confidence 4444556789999999998776668999999999999999999999999988888888777655443221
Q ss_pred --------------------------HHh---ccCCCCCCCcccccccCChhhhhc
Q 021306 264 --------------------------EIR---CMNPNYTDFRFPQIKAHPWHKVCI 290 (314)
Q Consensus 264 --------------------------~~~---~~~p~~~~~~~~~l~~~p~~~~~~ 290 (314)
.+. ..+|. +|+++.++++|||++...
T Consensus 304 ~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~-~R~ta~e~l~hp~f~~~~ 358 (440)
T PTZ00036 304 DIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPL-KRLNPIEALADPFFDDLR 358 (440)
T ss_pred cccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChh-HCcCHHHHhCChhHHhhh
Confidence 111 22566 788999999999987643
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-45 Score=321.39 Aligned_cols=244 Identities=30% Similarity=0.544 Sum_probs=205.8
Q ss_pred CCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccccc------hHHHHHHHHhCCCCceeeeceeeeecCCCCceeE
Q 021306 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY------KNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 111 (314)
Q Consensus 38 ~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~~~------~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 111 (314)
++|.+.+.||+|+||+||+|+.+.+.+.||+|.+.+..+. .++|+++++.++||||+.++++|. ....+
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfE-----t~~~~ 76 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFE-----TSAHL 76 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhc-----ccceE
Confidence 5899999999999999999999999999999998654332 468999999999999999999994 44449
Q ss_pred EEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCccccc
Q 021306 112 NLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 191 (314)
Q Consensus 112 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~ 191 (314)
|+|+||+.|+|...+. .++.+++++++.++.+++.||.|||+ .+|.|+|+||.||+++. ++.+|+||||+++..
T Consensus 77 ~vVte~a~g~L~~il~----~d~~lpEe~v~~~a~~LVsaL~yLhs-~rilhrd~kPqniLl~~-~~~~KlcdFg~Ar~m 150 (808)
T KOG0597|consen 77 WVVTEYAVGDLFTILE----QDGKLPEEQVRAIAYDLVSALYYLHS-NRILHRDMKPQNILLEK-GGTLKLCDFGLARAM 150 (808)
T ss_pred EEEehhhhhhHHHHHH----hccCCCHHHHHHHHHHHHHHHHHHHh-cCcccccCCcceeeecC-CCceeechhhhhhhc
Confidence 9999999998777766 47999999999999999999999999 89999999999999998 889999999999876
Q ss_pred ccCCc-cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCHH-------
Q 021306 192 IAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE------- 263 (314)
Q Consensus 192 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~------- 263 (314)
..... ..+..|||.|||||.+.++. ++..+|+|||||++|||++|++||...+..+....|...-..++..
T Consensus 151 ~~~t~vltsikGtPlYmAPElv~e~p-yd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p~~~S~~f~n 229 (808)
T KOG0597|consen 151 STNTSVLTSIKGTPLYMAPELVEEQP-YDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPPSTASSSFVN 229 (808)
T ss_pred ccCceeeeeccCcccccCHHHHcCCC-ccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCcccccHHHHH
Confidence 54332 23467899999999997655 9999999999999999999999999888877777776554333321
Q ss_pred ---HHhccCCCCCCCcccccccCChhhhhcccCC
Q 021306 264 ---EIRCMNPNYTDFRFPQIKAHPWHKVCIFHFP 294 (314)
Q Consensus 264 ---~~~~~~p~~~~~~~~~l~~~p~~~~~~~~~~ 294 (314)
.+...+|. .|++..+|+.|||.......+.
T Consensus 230 fl~gLL~kdP~-~RltW~~Ll~HpF~k~~~~~~~ 262 (808)
T KOG0597|consen 230 FLQGLLIKDPA-QRLTWTDLLGHPFWKGKINIAE 262 (808)
T ss_pred HHHHHhhcChh-hcccHHHHhcChHHhhhhhhhc
Confidence 12234777 8999999999999776554433
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-44 Score=322.13 Aligned_cols=246 Identities=29% Similarity=0.479 Sum_probs=204.6
Q ss_pred CccCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccccch-------HHHHHHHHhC-CCCceeeeceeeeecCC
Q 021306 34 PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-------NRELQLMRVM-DHPNVISLKHCFFSTTS 105 (314)
Q Consensus 34 ~~~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~~~~-------~~e~~~l~~l-~h~~iv~~~~~~~~~~~ 105 (314)
+...++|++.++||+|+||+|+++..+.+++.||||.++++.... ..|..++... +||+++.++.+|
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~f----- 438 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCF----- 438 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeeccccc-----
Confidence 445679999999999999999999999999999999998764322 3566666655 599999999999
Q ss_pred CCceeEEEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeec
Q 021306 106 KNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF 185 (314)
Q Consensus 106 ~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~df 185 (314)
+...++|+||||+.|+. +.. ......|++..++.++.+++.||+|||+ +||++||||.+|||+|. .+.+||+||
T Consensus 439 QT~~~l~fvmey~~Ggd---m~~-~~~~~~F~e~rarfyaAev~l~L~fLH~-~~IIYRDlKLdNiLLD~-eGh~kiADF 512 (694)
T KOG0694|consen 439 QTKEHLFFVMEYVAGGD---LMH-HIHTDVFSEPRARFYAAEVVLGLQFLHE-NGIIYRDLKLDNLLLDT-EGHVKIADF 512 (694)
T ss_pred ccCCeEEEEEEecCCCc---EEE-EEecccccHHHHHHHHHHHHHHHHHHHh-cCceeeecchhheEEcc-cCcEEeccc
Confidence 44455999999999974 222 2235789999999999999999999999 99999999999999999 899999999
Q ss_pred Ccccccc-cCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCH--
Q 021306 186 GSAKQLI-AGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR-- 262 (314)
Q Consensus 186 g~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~-- 262 (314)
|+++..- ....+.+.+|||.|+|||++.+.. |+.+.|+||||++||||+.|+.||.+.+.++....|+..-...+.
T Consensus 513 GlcKe~m~~g~~TsTfCGTpey~aPEil~e~~-Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~yP~~l 591 (694)
T KOG0694|consen 513 GLCKEGMGQGDRTSTFCGTPEFLAPEVLTEQS-YTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFL 591 (694)
T ss_pred ccccccCCCCCccccccCChhhcChhhhccCc-ccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCcc
Confidence 9998654 445567789999999999997655 999999999999999999999999999999999988865333221
Q ss_pred --------HHHhccCCCCCCCc-----ccccccCChhhhhccc
Q 021306 263 --------EEIRCMNPNYTDFR-----FPQIKAHPWHKVCIFH 292 (314)
Q Consensus 263 --------~~~~~~~p~~~~~~-----~~~l~~~p~~~~~~~~ 292 (314)
+.+...+|+ +|+. +++|+.|||||.-..+
T Consensus 592 s~ea~~il~~ll~k~p~-kRLG~~e~d~~~i~~hpFFr~i~w~ 633 (694)
T KOG0694|consen 592 SKEAIAIMRRLLRKNPE-KRLGSGERDAEDIKKHPFFRSIDWD 633 (694)
T ss_pred cHHHHHHHHHHhccCcc-cccCCCCCCchhhhhCCccccCCHH
Confidence 122344777 6765 5789999999987753
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=299.87 Aligned_cols=214 Identities=34% Similarity=0.687 Sum_probs=179.2
Q ss_pred CCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeE
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 111 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 111 (314)
.++|++.+.||.|+||.||+|++..+++.|++|.++... ....+|+.++++++|+||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-----~~~~ 78 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHT-----ERCL 78 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcC-----CCeE
Confidence 467999999999999999999999999999999886432 233589999999999999999998743 3358
Q ss_pred EEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCccccc
Q 021306 112 NLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 191 (314)
Q Consensus 112 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~ 191 (314)
++||||+++++.+.+.. ....+++..++.++.||+.||.|||+ +||+||||||+||+++. ++.++|+|||++...
T Consensus 79 ~lv~e~~~~~l~~~l~~---~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivH~dlkp~Nil~~~-~~~~kl~DfG~~~~~ 153 (288)
T cd07871 79 TLVFEYLDSDLKQYLDN---CGNLMSMHNVKIFMFQLLRGLSYCHK-RKILHRDLKPQNLLINE-KGELKLADFGLARAK 153 (288)
T ss_pred EEEEeCCCcCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEECC-CCCEEECcCcceeec
Confidence 89999999988776653 24568999999999999999999999 89999999999999998 788999999998754
Q ss_pred ccCC-ccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCC
Q 021306 192 IAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 260 (314)
Q Consensus 192 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~ 260 (314)
.... ......+++.|+|||.+.+...++.++||||||+++|+|++|+.||.+.+..+.+..+.+..+.+
T Consensus 154 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 223 (288)
T cd07871 154 SVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTP 223 (288)
T ss_pred cCCCccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 3222 22234568889999998766668999999999999999999999999988877777776655443
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=306.87 Aligned_cols=245 Identities=28% Similarity=0.449 Sum_probs=200.1
Q ss_pred ccCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc------------------cchHHHHHHHHhCCCCceeee
Q 021306 35 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------------------RYKNRELQLMRVMDHPNVISL 96 (314)
Q Consensus 35 ~~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~------------------~~~~~e~~~l~~l~h~~iv~~ 96 (314)
...|+|++.+.||+|.||.|-+|++..+++.||+|++.+.. ...++|+.+++++.|+|||++
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 34579999999999999999999999999999999985431 123589999999999999999
Q ss_pred ceeeeecCCCCceeEEEEeecccccHHHHHHhhhhcCCC-CCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcC
Q 021306 97 KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQR-MPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP 175 (314)
Q Consensus 97 ~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~-l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~ 175 (314)
+++.- ++....+|+|+|||..+- +. ......+ +++.+++.++++++.||+|||. +||+||||||+|+|++.
T Consensus 174 iEvLD---DP~s~~~YlVley~s~G~---v~-w~p~d~~els~~~Ar~ylrDvv~GLEYLH~-QgiiHRDIKPsNLLl~~ 245 (576)
T KOG0585|consen 174 IEVLD---DPESDKLYLVLEYCSKGE---VK-WCPPDKPELSEQQARKYLRDVVLGLEYLHY-QGIIHRDIKPSNLLLSS 245 (576)
T ss_pred EEeec---CcccCceEEEEEeccCCc---cc-cCCCCcccccHHHHHHHHHHHHHHHHHHHh-cCeeccccchhheEEcC
Confidence 98873 344556999999999752 22 2234566 9999999999999999999999 99999999999999999
Q ss_pred CCCcEEEeecCcccccccC------CccccccccccccccccccCC---CCCCcchhHHHHHHHHHHHHhCCCCCCCCCh
Q 021306 176 LTHQVKICDFGSAKQLIAG------EANISYICSRFYRAPELIFGA---TEYTTSIDIWSAGCVLAELLLGQPLFPGENA 246 (314)
Q Consensus 176 ~~~~~~l~dfg~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~---~~~~~~~Dv~slG~il~el~tg~~pf~~~~~ 246 (314)
++++||+|||.+...... .......|||.|+|||.+.+. ...+.+.||||+|++||.|+.|+.||-+...
T Consensus 246 -~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~ 324 (576)
T KOG0585|consen 246 -DGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFE 324 (576)
T ss_pred -CCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchH
Confidence 799999999998755221 122347789999999999763 3346789999999999999999999999999
Q ss_pred HHHHHHHHHHcCCC---------CHHH---HhccCCCCCCCcccccccCChhhhh
Q 021306 247 VDQLVEIIKVLGTP---------TREE---IRCMNPNYTDFRFPQIKAHPWHKVC 289 (314)
Q Consensus 247 ~~~~~~i~~~~~~~---------~~~~---~~~~~p~~~~~~~~~l~~~p~~~~~ 289 (314)
.+.+.+|+..--.. ..+. +.+.+|+ .|+++.+|..|||-...
T Consensus 325 ~~l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~-~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 325 LELFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPE-QRITLPDIKLHPWVTRD 378 (576)
T ss_pred HHHHHHHhcCcccCCCcccccHHHHHHHHHHhhcChh-heeehhhheecceeccC
Confidence 98888888652111 1122 3355888 89999999999997665
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=295.22 Aligned_cols=246 Identities=28% Similarity=0.416 Sum_probs=205.4
Q ss_pred ccCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeec------cccchHHHHHHHHhCCCCceeeeceeeeecCCCCc
Q 021306 35 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQ------DRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 108 (314)
Q Consensus 35 ~~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 108 (314)
...++|++.++||+|.|+.|+++.+..+|+.+++|.+.. +.....+|+.+-+.|+||||+++++.+ ...
T Consensus 8 ~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti-----~~~ 82 (355)
T KOG0033|consen 8 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI-----QEE 82 (355)
T ss_pred ccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhh-----ccc
Confidence 345789999999999999999999999999999987742 334457899999999999999999987 555
Q ss_pred eeEEEEeeccccc-HHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCC--CCcEEEeec
Q 021306 109 LFLNLVMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPL--THQVKICDF 185 (314)
Q Consensus 109 ~~~~lv~e~~~~~-l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~--~~~~~l~df 185 (314)
.+.++|+|++.|+ +...+- ....+++..+..+++||+.||.|+|. +||+|||+||+|+++-+. ..-+||+||
T Consensus 83 ~~~ylvFe~m~G~dl~~eIV----~R~~ySEa~aSH~~rQiLeal~yCH~-n~IvHRDvkP~nllLASK~~~A~vKL~~F 157 (355)
T KOG0033|consen 83 SFHYLVFDLVTGGELFEDIV----AREFYSEADASHCIQQILEALAYCHS-NGIVHRDLKPENLLLASKAKGAAVKLADF 157 (355)
T ss_pred ceeEEEEecccchHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHHHh-cCceeccCChhheeeeeccCCCceeeccc
Confidence 5688999999985 322222 22678999999999999999999999 999999999999999653 346999999
Q ss_pred CcccccccCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCC----
Q 021306 186 GSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT---- 261 (314)
Q Consensus 186 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~---- 261 (314)
|++........-....|||.|+|||+++..+ ++..+|||+.|++||-++.|.+||.+.+....+++|+++--..+
T Consensus 158 GvAi~l~~g~~~~G~~GtP~fmaPEvvrkdp-y~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w 236 (355)
T KOG0033|consen 158 GLAIEVNDGEAWHGFAGTPGYLSPEVLKKDP-YSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEW 236 (355)
T ss_pred ceEEEeCCccccccccCCCcccCHHHhhcCC-CCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCccc
Confidence 9998887555566788999999999997655 89999999999999999999999999999999999988743322
Q ss_pred -------HHHH---hccCCCCCCCcccccccCChhhhhccc
Q 021306 262 -------REEI---RCMNPNYTDFRFPQIKAHPWHKVCIFH 292 (314)
Q Consensus 262 -------~~~~---~~~~p~~~~~~~~~l~~~p~~~~~~~~ 292 (314)
.+++ ..++|. +|+++.+.++|||.+.-..-
T Consensus 237 ~~is~~Ak~LvrrML~~dP~-kRIta~EAL~HpWi~~r~~~ 276 (355)
T KOG0033|consen 237 DTVTPEAKSLIRRMLTVNPK-KRITADEALKHPWICNRERV 276 (355)
T ss_pred CcCCHHHHHHHHHHhccChh-hhccHHHHhCCchhcchHHH
Confidence 2222 245888 99999999999998876543
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-42 Score=300.31 Aligned_cols=244 Identities=32% Similarity=0.552 Sum_probs=194.2
Q ss_pred CCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeE
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 111 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 111 (314)
.++|++.+.||+|+||.||+|++..+++.+|+|.+.... ....+|+.+++.++|+||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-----~~~~ 78 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHT-----KETL 78 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEec-----CCeE
Confidence 468999999999999999999999999999999886432 233579999999999999999998843 3348
Q ss_pred EEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCccccc
Q 021306 112 NLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 191 (314)
Q Consensus 112 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~ 191 (314)
++||||+++++.+.+.. ....+++..++.++.|++.||.|||+ +||+|+||||+||+++. ++.++|+|||++...
T Consensus 79 ~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~dlkp~Nill~~-~~~~kl~Dfg~~~~~ 153 (303)
T cd07869 79 TLVFEYVHTDLCQYMDK---HPGGLHPENVKLFLFQLLRGLSYIHQ-RYILHRDLKPQNLLISD-TGELKLADFGLARAK 153 (303)
T ss_pred EEEEECCCcCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEECC-CCCEEECCCCcceec
Confidence 89999999998777654 34678999999999999999999999 89999999999999998 788999999998644
Q ss_pred ccCC-ccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHcCCC---------
Q 021306 192 IAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA-VDQLVEIIKVLGTP--------- 260 (314)
Q Consensus 192 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~-~~~~~~i~~~~~~~--------- 260 (314)
.... ......+++.|+|||.+.+...++.++||||||+++|+|++|..||.+... .+.+..+....+.+
T Consensus 154 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (303)
T cd07869 154 SVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVH 233 (303)
T ss_pred cCCCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchh
Confidence 3222 223345688899999987666678899999999999999999999987543 33333333221111
Q ss_pred ------------------------------CHHHH---hccCCCCCCCcccccccCChhhhhcc
Q 021306 261 ------------------------------TREEI---RCMNPNYTDFRFPQIKAHPWHKVCIF 291 (314)
Q Consensus 261 ------------------------------~~~~~---~~~~p~~~~~~~~~l~~~p~~~~~~~ 291 (314)
..+.+ ...+|. +|+++.++++|||++....
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~-~R~s~~~~l~h~~f~~~~~ 296 (303)
T cd07869 234 SLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPK-NRLSAQAALSHEYFSDLPP 296 (303)
T ss_pred hccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCch-hccCHHHHhcCcccccCCh
Confidence 11222 234677 8999999999999987654
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-43 Score=298.22 Aligned_cols=246 Identities=25% Similarity=0.431 Sum_probs=204.0
Q ss_pred CCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCCce
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL 109 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 109 (314)
.+.|++.+.||+|.-|+||+|+.+.++..+|+|.+.++. ...+.|.+||..+.||.++.++..| +...
T Consensus 76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~f-----et~~ 150 (459)
T KOG0610|consen 76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASF-----ETDK 150 (459)
T ss_pred HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhhee-----eccc
Confidence 357999999999999999999999999999999986542 3345789999999999999999998 5556
Q ss_pred eEEEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCccc
Q 021306 110 FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 189 (314)
Q Consensus 110 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~ 189 (314)
+.|++||||+|+-+..+.. .+.++.|++..++.++.+++.||+|||. .|||+|||||+|||+.+ ++++.|+||.++.
T Consensus 151 ~~cl~meyCpGGdL~~Lrq-kQp~~~fse~~aRFYaAEvl~ALEYLHm-lGivYRDLKPENILvre-dGHIMLsDFDLS~ 227 (459)
T KOG0610|consen 151 YSCLVMEYCPGGDLHSLRQ-KQPGKRFSESAARFYAAEVLLALEYLHM-LGIVYRDLKPENILVRE-DGHIMLSDFDLSL 227 (459)
T ss_pred eeEEEEecCCCccHHHHHh-hCCCCccchhhHHHHHHHHHHHHHHHHh-hceeeccCCcceeEEec-CCcEEeeeccccc
Confidence 7999999999854444443 3567889999999999999999999999 89999999999999998 9999999999864
Q ss_pred cccc-----------------------------------C----------------------Cccccccccccccccccc
Q 021306 190 QLIA-----------------------------------G----------------------EANISYICSRFYRAPELI 212 (314)
Q Consensus 190 ~~~~-----------------------------------~----------------------~~~~~~~~~~~y~aPE~~ 212 (314)
.+.. . ....+++||-.|+|||++
T Consensus 228 ~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI 307 (459)
T KOG0610|consen 228 RCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVI 307 (459)
T ss_pred cCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceee
Confidence 3310 0 001235567889999999
Q ss_pred cCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCC---------CHHHHhc---cCCCCCCCc----
Q 021306 213 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP---------TREEIRC---MNPNYTDFR---- 276 (314)
Q Consensus 213 ~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~---------~~~~~~~---~~p~~~~~~---- 276 (314)
.|.. .+.++|+|+|||.+|||+.|..||.+.+..+.+.+++.+-... ..+++.. .+|. +|+.
T Consensus 308 ~G~G-HgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~-kRlg~~rG 385 (459)
T KOG0610|consen 308 RGEG-HGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPS-KRLGSKRG 385 (459)
T ss_pred ecCC-CCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChh-hhhccccc
Confidence 8876 8999999999999999999999999999999999998653221 2344443 3777 7887
Q ss_pred ccccccCChhhhhccc
Q 021306 277 FPQIKAHPWHKVCIFH 292 (314)
Q Consensus 277 ~~~l~~~p~~~~~~~~ 292 (314)
+.+|.+||||+...++
T Consensus 386 A~eIK~HpFF~gVnWa 401 (459)
T KOG0610|consen 386 AAEIKRHPFFEGVNWA 401 (459)
T ss_pred hHHhhcCccccCCChh
Confidence 9999999999988765
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-43 Score=293.86 Aligned_cols=245 Identities=40% Similarity=0.703 Sum_probs=206.8
Q ss_pred CCceeeeeEeecCceEEEEEEECCCCcEEEEEEeecc------ccchHHHHHHHHhCCCCceeeeceeeeecCCCCceeE
Q 021306 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 111 (314)
Q Consensus 38 ~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 111 (314)
..|...+.||+|+||.|..+.++.+|+.||+|++... .+..-+|+++++.++|+||+.+.+++.......-..+
T Consensus 22 ~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~Dv 101 (359)
T KOG0660|consen 22 RYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDV 101 (359)
T ss_pred ceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccccee
Confidence 3566689999999999999999999999999998632 2333589999999999999999998865333445558
Q ss_pred EEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCccccc
Q 021306 112 NLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 191 (314)
Q Consensus 112 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~ 191 (314)
|+|+|+|+.+|...+.. +..+++..+..++.|+++||+|+|+ .+++||||||+|++++. +..+|++|||+|+..
T Consensus 102 YiV~elMetDL~~iik~----~~~L~d~H~q~f~YQiLrgLKyiHS-AnViHRDLKPsNll~n~-~c~lKI~DFGLAR~~ 175 (359)
T KOG0660|consen 102 YLVFELMETDLHQIIKS----QQDLTDDHAQYFLYQILRGLKYIHS-ANVIHRDLKPSNLLLNA-DCDLKICDFGLARYL 175 (359)
T ss_pred EEehhHHhhHHHHHHHc----CccccHHHHHHHHHHHHHhcchhhc-ccccccccchhheeecc-CCCEEeccccceeec
Confidence 89999998887777764 5569999999999999999999999 89999999999999998 888999999999977
Q ss_pred ccC---CccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCHHHHhc-
Q 021306 192 IAG---EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC- 267 (314)
Q Consensus 192 ~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~- 267 (314)
... ..-..++.|..|.|||.+.....|+.+.||||+|||+.||++|++.|.|.+..+++..|+..++.|..+.+.+
T Consensus 176 ~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i 255 (359)
T KOG0660|consen 176 DKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKI 255 (359)
T ss_pred cccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHh
Confidence 542 2224567789999999998888899999999999999999999999999999999999998888876544322
Q ss_pred ----------------------------------------cCCCCCCCcccccccCChhhhh
Q 021306 268 ----------------------------------------MNPNYTDFRFPQIKAHPWHKVC 289 (314)
Q Consensus 268 ----------------------------------------~~p~~~~~~~~~l~~~p~~~~~ 289 (314)
++|. +|+++++.+.||++...
T Consensus 256 ~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~-kRita~eAL~hPYl~~~ 316 (359)
T KOG0660|consen 256 RSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPK-KRITAEEALAHPYLAPY 316 (359)
T ss_pred ccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCcc-ccCCHHHHhcChhhhhh
Confidence 2455 78888888888886554
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=310.42 Aligned_cols=242 Identities=26% Similarity=0.396 Sum_probs=192.3
Q ss_pred CCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCCcee
Q 021306 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 110 (314)
Q Consensus 38 ~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 110 (314)
++|++.+.||+|+||.||+|++..+++.||+|.+.+.. ....+|..+++.++|++|+++++.+.. ...
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~-----~~~ 75 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQD-----KLN 75 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEec-----CCe
Confidence 47999999999999999999999999999999986532 233578899999999999999998843 345
Q ss_pred EEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCccc
Q 021306 111 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 189 (314)
Q Consensus 111 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~ 189 (314)
+++||||++| +|.+.+. ....+++.+++.++.|++.||.|||+ +||+||||||+||+++. ++.++|+|||++.
T Consensus 76 ~~lv~E~~~gg~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~lH~-~givHrDlKp~NILi~~-~~~vkL~DFGla~ 149 (363)
T cd05628 76 LYLIMEFLPGGDMMTLLM----KKDTLTEEETQFYIAETVLAIDSIHQ-LGFIHRDIKPDNLLLDS-KGHVKLSDFGLCT 149 (363)
T ss_pred EEEEEcCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHh-CCeEecCCCHHHeEECC-CCCEEEeeccCcc
Confidence 8899999987 5555554 35789999999999999999999999 89999999999999998 7899999999986
Q ss_pred ccccCC------------------------------------ccccccccccccccccccCCCCCCcchhHHHHHHHHHH
Q 021306 190 QLIAGE------------------------------------ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAE 233 (314)
Q Consensus 190 ~~~~~~------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e 233 (314)
...... ......||+.|+|||.+.+.. ++.++|||||||++|+
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~-~~~~~DvwSlGvil~e 228 (363)
T cd05628 150 GLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTG-YNKLCDWWSLGVIMYE 228 (363)
T ss_pred cccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCC-CCCchhhhhhHHHHHH
Confidence 432110 012346899999999997654 8899999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHHHHHcCC---C--------CHHHHhc--cCC--CCCCCcccccccCChhhhhcc
Q 021306 234 LLLGQPLFPGENAVDQLVEIIKVLGT---P--------TREEIRC--MNP--NYTDFRFPQIKAHPWHKVCIF 291 (314)
Q Consensus 234 l~tg~~pf~~~~~~~~~~~i~~~~~~---~--------~~~~~~~--~~p--~~~~~~~~~l~~~p~~~~~~~ 291 (314)
|++|+.||.+.+..+....+++.... + ..+.+.. ..| ...|+++++|++|||++....
T Consensus 229 ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~hp~f~~~~~ 301 (363)
T cd05628 229 MLIGYPPFCSETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTNPFFEGVDW 301 (363)
T ss_pred HHhCCCCCCCCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCCCCCCCCCH
Confidence 99999999998887777776642111 1 1122221 222 235678999999999976543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=302.99 Aligned_cols=246 Identities=37% Similarity=0.666 Sum_probs=193.8
Q ss_pred CceeeeeEeecCceEEEEEEECCCCcEEEEEEeecc------ccchHHHHHHHHhCCCCceeeeceeeeecCCCCceeEE
Q 021306 39 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 112 (314)
Q Consensus 39 ~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 112 (314)
+|++.+.||+|+||.||+|++..+++.|++|.+... .....+|+.++++++||||+++++++..........++
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 599999999999999999999999999999988642 12245799999999999999999987655444444578
Q ss_pred EEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcccccc
Q 021306 113 LVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 192 (314)
Q Consensus 113 lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~ 192 (314)
++|||++++|.+.+.. ...+++..++.++.||+.||.|||+ +||+|+||||+||+++. ++.++|+|||++....
T Consensus 81 lv~e~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~dlkp~NIll~~-~~~~kL~Dfg~~~~~~ 154 (338)
T cd07859 81 VVFELMESDLHQVIKA----NDDLTPEHHQFFLYQLLRALKYIHT-ANVFHRDLKPKNILANA-DCKLKICDFGLARVAF 154 (338)
T ss_pred EEEecCCCCHHHHHHh----cccCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEECC-CCcEEEccCccccccc
Confidence 9999999888776653 4679999999999999999999999 89999999999999998 8899999999987543
Q ss_pred cCCc----cccccccccccccccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCC------
Q 021306 193 AGEA----NISYICSRFYRAPELIFGA-TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT------ 261 (314)
Q Consensus 193 ~~~~----~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~------ 261 (314)
.... .....+++.|+|||.+.+. ..++.++||||||+++|+|++|+.||.+.+....+..+....+.+.
T Consensus 155 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (338)
T cd07859 155 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISR 234 (338)
T ss_pred cccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence 2211 1234678899999998542 3478999999999999999999999988765444332222111111
Q ss_pred --------------------------------HHHHh---ccCCCCCCCcccccccCChhhhhcc
Q 021306 262 --------------------------------REEIR---CMNPNYTDFRFPQIKAHPWHKVCIF 291 (314)
Q Consensus 262 --------------------------------~~~~~---~~~p~~~~~~~~~l~~~p~~~~~~~ 291 (314)
.+.+. ..+|+ +|+++.++++|||++....
T Consensus 235 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~-~Rpt~~e~l~hp~f~~~~~ 298 (338)
T cd07859 235 VRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPK-DRPTAEEALADPYFKGLAK 298 (338)
T ss_pred hhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcc-cCCCHHHHhcCchhhhcCc
Confidence 11222 23677 8999999999999976544
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-43 Score=298.54 Aligned_cols=247 Identities=32% Similarity=0.541 Sum_probs=194.9
Q ss_pred CCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeecc----ccchHHHHHHHHhCCCCceeeeceeeeecCCCCceeEE
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD----RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 112 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 112 (314)
..+|..++.||+|+||.||++.+..+|...|+|.+... .....+|+.+|.+++|||||++++....... ..++
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~---~~~~ 92 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSREN---DEYN 92 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccC---eeeE
Confidence 45799999999999999999999999999999998766 3445899999999999999999986322111 3478
Q ss_pred EEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCccccc
Q 021306 113 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 191 (314)
Q Consensus 113 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~ 191 (314)
++|||+++ ++.+.+..+ ++.+++..++.+.+|++.||.|||+ +||+|+||||+|||++..++.+||+|||+++..
T Consensus 93 i~mEy~~~GsL~~~~~~~---g~~l~E~~v~~ytr~iL~GL~ylHs-~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~ 168 (313)
T KOG0198|consen 93 IFMEYAPGGSLSDLIKRY---GGKLPEPLVRRYTRQILEGLAYLHS-KGIVHCDIKPANILLDPSNGDVKLADFGLAKKL 168 (313)
T ss_pred eeeeccCCCcHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHh-CCEeccCcccceEEEeCCCCeEEeccCcccccc
Confidence 99999996 666655542 2279999999999999999999999 999999999999999985578999999998866
Q ss_pred cc----CCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCC-CChHHHHHHHHHHcCCC-C----
Q 021306 192 IA----GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG-ENAVDQLVEIIKVLGTP-T---- 261 (314)
Q Consensus 192 ~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~-~~~~~~~~~i~~~~~~~-~---- 261 (314)
.. ........||+.|||||++.+......++|||||||++.||+||+.||.. ....+.+..+......| .
T Consensus 169 ~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~l 248 (313)
T KOG0198|consen 169 ESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPDSL 248 (313)
T ss_pred ccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCCccc
Confidence 53 22234577899999999997533234599999999999999999999988 45444444444333222 1
Q ss_pred ----HHHHh---ccCCCCCCCcccccccCChhhhhcc
Q 021306 262 ----REEIR---CMNPNYTDFRFPQIKAHPWHKVCIF 291 (314)
Q Consensus 262 ----~~~~~---~~~p~~~~~~~~~l~~~p~~~~~~~ 291 (314)
.+.+. ..+|. .|+++.+|+.|||.+....
T Consensus 249 s~~a~~Fl~~C~~~~p~-~Rpta~eLL~hpf~~~~~~ 284 (313)
T KOG0198|consen 249 SDEAKDFLRKCFKRDPE-KRPTAEELLEHPFLKQNSI 284 (313)
T ss_pred CHHHHHHHHHHhhcCcc-cCcCHHHHhhChhhhcccc
Confidence 22222 23666 7999999999999877554
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-42 Score=289.79 Aligned_cols=228 Identities=34% Similarity=0.681 Sum_probs=195.8
Q ss_pred CCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeecccc------chHHHHHHHHhCCCCc-eeeeceeeeecCC-CCc
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR------YKNRELQLMRVMDHPN-VISLKHCFFSTTS-KNE 108 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~~------~~~~e~~~l~~l~h~~-iv~~~~~~~~~~~-~~~ 108 (314)
...|+.++.||+|.||+||+|+.+.+|+.||+|++..+.. ...+|+.+++.++|+| |+++++++..... ...
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 4569999999999999999999999999999999975533 2259999999999999 9999998865441 223
Q ss_pred eeEEEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcc
Q 021306 109 LFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 188 (314)
Q Consensus 109 ~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~ 188 (314)
..+++|+||++-+|...+.........++...++.+++||+.||.|||+ ++|+||||||.||++++ ++.+||+|||+|
T Consensus 90 ~~l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~-~~IlHRDLKPQNlLi~~-~G~lKlaDFGlA 167 (323)
T KOG0594|consen 90 GKLYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHS-HGILHRDLKPQNLLISS-SGVLKLADFGLA 167 (323)
T ss_pred ceEEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHh-CCeecccCCcceEEECC-CCcEeeeccchH
Confidence 3578999999999888887654333567889999999999999999999 99999999999999999 999999999999
Q ss_pred cccccC-CccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCHHHHh
Q 021306 189 KQLIAG-EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 266 (314)
Q Consensus 189 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 266 (314)
+...-+ ........|..|.|||.+.+...|+...|+||+|||+.||++++..|.+....+++..|.+.++.|..+.++
T Consensus 168 ra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp 246 (323)
T KOG0594|consen 168 RAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWP 246 (323)
T ss_pred HHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCC
Confidence 866533 334456678889999999998889999999999999999999999999999999999999998887654433
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-42 Score=295.37 Aligned_cols=256 Identities=25% Similarity=0.452 Sum_probs=209.1
Q ss_pred cccCCCCCCccCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceee
Q 021306 26 TIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCF 100 (314)
Q Consensus 26 ~~~~~~~~~~~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~ 100 (314)
+...+..-|...+.|++.++||.|..++||+|+...+++.||||++..+. ...++|+..++.+.||||++++.+|
T Consensus 14 ~~~~~~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sF 93 (516)
T KOG0582|consen 14 ASSSEKEFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSF 93 (516)
T ss_pred cccccccCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEE
Confidence 33444556777789999999999999999999999999999999997543 3456899999999999999999998
Q ss_pred eecCCCCceeEEEEeeccc-ccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCc
Q 021306 101 FSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQ 179 (314)
Q Consensus 101 ~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~ 179 (314)
....+ +|+||+||. |++++.+..+... .+.+..+..+++++++||.|||. +|.+|||||+.|||++. ++.
T Consensus 94 vv~~~-----LWvVmpfMa~GS~ldIik~~~~~--Gl~E~~Ia~iLre~LkaL~YLH~-~G~IHRdvKAgnILi~~-dG~ 164 (516)
T KOG0582|consen 94 VVDSE-----LWVVMPFMAGGSLLDIIKTYYPD--GLEEASIATILREVLKALDYLHQ-NGHIHRDVKAGNILIDS-DGT 164 (516)
T ss_pred Eecce-----eEEeehhhcCCcHHHHHHHHccc--cccHHHHHHHHHHHHHHHHHHHh-cCceecccccccEEEcC-CCc
Confidence 66655 999999999 4788888776543 39999999999999999999999 99999999999999999 899
Q ss_pred EEEeecCcccccccCCcc-----ccccccccccccccc-cCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 021306 180 VKICDFGSAKQLIAGEAN-----ISYICSRFYRAPELI-FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEI 253 (314)
Q Consensus 180 ~~l~dfg~~~~~~~~~~~-----~~~~~~~~y~aPE~~-~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i 253 (314)
|+|+|||.+......... ....++++|||||.+ .+-..|+.|+|||||||+..||++|..||....+..++-..
T Consensus 165 VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~t 244 (516)
T KOG0582|consen 165 VKLADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLT 244 (516)
T ss_pred EEEcCceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHH
Confidence 999999987654332211 345789999999994 44456999999999999999999999999999998877766
Q ss_pred HHHcCCC------CHH-----------HHh-c--cCCCCCCCcccccccCChhhhhcc
Q 021306 254 IKVLGTP------TRE-----------EIR-C--MNPNYTDFRFPQIKAHPWHKVCIF 291 (314)
Q Consensus 254 ~~~~~~~------~~~-----------~~~-~--~~p~~~~~~~~~l~~~p~~~~~~~ 291 (314)
+++-.+. ..+ .+. | .+|. +|+++.+|++|+||.....
T Consensus 245 Lqn~pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~-kRptAskLlkh~FFk~~k~ 301 (516)
T KOG0582|consen 245 LQNDPPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPS-KRPTASKLLKHAFFKKAKS 301 (516)
T ss_pred hcCCCCCcccccCChHHhhhhcHHHHHHHHHHhhcCcc-cCCCHHHHhccHHHhhccc
Confidence 6653321 111 111 2 2676 8999999999999876543
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-42 Score=301.32 Aligned_cols=254 Identities=28% Similarity=0.388 Sum_probs=203.3
Q ss_pred CCCceeeeeEeecCceEEEEEEECCCCcE-EEEEEeecc------ccchHHHHHHHHhCCCCceeeeceeeeecCCCCce
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCLETGET-VAIKKVLQD------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL 109 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~-~~vK~~~~~------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 109 (314)
..+..+.+.||+|+||+||++.+ .|+. +|+|++... ...+.+|+.++.+++|||||++++++.....
T Consensus 40 ~~~l~~~~~iG~G~~g~V~~~~~--~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~---- 113 (362)
T KOG0192|consen 40 PDELPIEEVLGSGSFGTVYKGKW--RGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPG---- 113 (362)
T ss_pred hHHhhhhhhcccCCceeEEEEEe--CCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC----
Confidence 34567778899999999999998 4556 999998653 2356799999999999999999999854431
Q ss_pred eEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCC-ceecCCCCCcEEEcCCCC-cEEEeecC
Q 021306 110 FLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR-VCHRDLKPQNLLVDPLTH-QVKICDFG 186 (314)
Q Consensus 110 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~-i~h~dl~p~Nil~~~~~~-~~~l~dfg 186 (314)
.+++||||+++ +|.+.+... ....+++..+..|+.||+.|+.|||+ ++ |+||||||+|||++. +. ++||+|||
T Consensus 114 ~~~iVtEy~~~GsL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~-~~~iIHrDLK~~NiLv~~-~~~~~KI~DFG 189 (362)
T KOG0192|consen 114 SLCIVTEYMPGGSLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHS-EGPIIHRDLKSDNILVDL-KGKTLKIADFG 189 (362)
T ss_pred ceEEEEEeCCCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhc-CCCeeecccChhhEEEcC-CCCEEEECCCc
Confidence 37899999996 555555432 46889999999999999999999999 89 999999999999998 65 99999999
Q ss_pred cccccccC-CccccccccccccccccccC-CCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCHHH
Q 021306 187 SAKQLIAG-EANISYICSRFYRAPELIFG-ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 264 (314)
Q Consensus 187 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 264 (314)
+++..... .......||+.|||||.+.+ ...++.++||||||+++|||+||+.||.+....+....+......+....
T Consensus 190 lsr~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~ 269 (362)
T KOG0192|consen 190 LSREKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPK 269 (362)
T ss_pred cceeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCc
Confidence 99866543 22333678999999999985 35599999999999999999999999999998665555554433332111
Q ss_pred HhccCCCCCCCcccccccCChhhhhcccCChHHHHHhcchhhh
Q 021306 265 IRCMNPNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGSHINA 307 (314)
Q Consensus 265 ~~~~~p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~~~~~ 307 (314)
- ....+..|+..||...+..+.....+...+..+..
T Consensus 270 ~-------~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~ 305 (362)
T KOG0192|consen 270 E-------CPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMS 305 (362)
T ss_pred c-------CCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHH
Confidence 1 34457788888999999998888888877765543
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=293.40 Aligned_cols=207 Identities=40% Similarity=0.753 Sum_probs=173.4
Q ss_pred CCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeE
Q 021306 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 111 (314)
Q Consensus 38 ~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 111 (314)
++|++.+.||+|+||.||+|+++.+++.+++|.+.... ....+|+.+++.++|+||+++++++.. ....
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~ 75 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRR-----RGKL 75 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEec-----CCEE
Confidence 47999999999999999999999999999999986432 223579999999999999999998843 3358
Q ss_pred EEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCccccc
Q 021306 112 NLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 191 (314)
Q Consensus 112 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~ 191 (314)
++||||+++++++.+.. ....+++..++.++.|++.||.|||+ .|++|+||||+||+++. ++.++|+|||++...
T Consensus 76 ~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~-~~i~H~dlkp~Nill~~-~~~~kl~Dfg~~~~~ 150 (287)
T cd07848 76 YLVFEYVEKNMLELLEE---MPNGVPPEKVRSYIYQLIKAIHWCHK-NDIVHRDIKPENLLISH-NDVLKLCDFGFARNL 150 (287)
T ss_pred EEEEecCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEEcC-CCcEEEeeccCcccc
Confidence 89999999987766543 34679999999999999999999999 89999999999999998 788999999998765
Q ss_pred ccCC--ccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 021306 192 IAGE--ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 255 (314)
Q Consensus 192 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~ 255 (314)
.... ......+++.|+|||.+.+.. ++.++|+||||+++|+|++|+.||.+.+..+....+.+
T Consensus 151 ~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~ 215 (287)
T cd07848 151 SEGSNANYTEYVATRWYRSPELLLGAP-YGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQK 215 (287)
T ss_pred cccccccccccccccccCCcHHHcCCC-CCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 3322 122345788999999997655 78999999999999999999999998776665554443
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=301.58 Aligned_cols=212 Identities=33% Similarity=0.581 Sum_probs=175.1
Q ss_pred cCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeecc------ccchHHHHHHHHhCCCCceeeeceeeeecCC-CCc
Q 021306 36 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRVMDHPNVISLKHCFFSTTS-KNE 108 (314)
Q Consensus 36 ~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~~~ 108 (314)
..++|++.+.||+|+||.||++++..+++.+|+|.+... .....+|+.+++.++|+||+++++++..... ...
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 346899999999999999999999999999999998643 1223578999999999999999998754322 122
Q ss_pred eeEEEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcc
Q 021306 109 LFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 188 (314)
Q Consensus 109 ~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~ 188 (314)
..++++|||+++++...+. ..+++..+..++.|++.||.|||+ +||+||||||+||+++. ++.++|+|||++
T Consensus 99 ~~~~lv~e~~~~~l~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~-~~ivHrDlkp~NIl~~~-~~~~kl~Dfg~a 170 (359)
T cd07876 99 QDVYLVMELMDANLCQVIH------MELDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKS-DCTLKILDFGLA 170 (359)
T ss_pred ceeEEEEeCCCcCHHHHHh------ccCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEECC-CCCEEEecCCCc
Confidence 3478999999998776653 458899999999999999999999 89999999999999998 889999999998
Q ss_pred cccccCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q 021306 189 KQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 256 (314)
Q Consensus 189 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~ 256 (314)
.............+++.|+|||.+.+.. ++.++||||||+++|+|++|+.||.+.+..+.+..+++.
T Consensus 171 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~ 237 (359)
T cd07876 171 RTACTNFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQ 237 (359)
T ss_pred cccccCccCCCCcccCCCCCchhccCCC-CCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 7554333334456788999999996654 889999999999999999999999988766555544443
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-41 Score=291.82 Aligned_cols=216 Identities=37% Similarity=0.653 Sum_probs=175.9
Q ss_pred CCceeeeeEeecCceEEEEEEECC-CCcEEEEEEeeccc------cchHHHHHHHHhC---CCCceeeeceeeeecCCCC
Q 021306 38 ISYMAERVVGTGSFGIVFQAKCLE-TGETVAIKKVLQDR------RYKNRELQLMRVM---DHPNVISLKHCFFSTTSKN 107 (314)
Q Consensus 38 ~~y~~~~~Lg~g~~g~Vy~~~~~~-~~~~~~vK~~~~~~------~~~~~e~~~l~~l---~h~~iv~~~~~~~~~~~~~ 107 (314)
.+|++.+.||+|+||.||+|++.. +++.+|+|.+.... ....+|..+++.+ .||||+++++++.......
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 379999999999999999999865 46889999886432 1234566666665 6999999999875443334
Q ss_pred ceeEEEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCc
Q 021306 108 ELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 187 (314)
Q Consensus 108 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~ 187 (314)
...+++++||+.+++.+.+... ....+++..++.++.|++.||.|||+ +|++|+||||+||+++. ++.++|+|||+
T Consensus 81 ~~~~~lv~e~~~~~l~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~-~~iiH~dlkp~Nil~~~-~~~~kl~Dfg~ 156 (290)
T cd07862 81 ETKLTLVFEHVDQDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHS-HRVVHRDLKPQNILVTS-SGQIKLADFGL 156 (290)
T ss_pred CCcEEEEEccCCCCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCCHHHEEEcC-CCCEEEccccc
Confidence 4558899999999888777542 23568999999999999999999999 89999999999999998 78899999999
Q ss_pred ccccccCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcC
Q 021306 188 AKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLG 258 (314)
Q Consensus 188 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~ 258 (314)
+.............+++.|+|||.+.+.. ++.++||||||+++|+|++|+.||.+.+..+.+..++...+
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~ 226 (290)
T cd07862 157 ARIYSFQMALTSVVVTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIG 226 (290)
T ss_pred eEeccCCcccccccccccccChHHHhCCC-CCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhC
Confidence 87654443344456789999999986544 88999999999999999999999999888777777765543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=295.93 Aligned_cols=238 Identities=26% Similarity=0.431 Sum_probs=193.0
Q ss_pred CCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCCcee
Q 021306 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 110 (314)
Q Consensus 38 ~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 110 (314)
++|++.+.||+|+||.||+|++..+++.+|+|.+.... ....+|+.++++++||||+++++++. +...
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~~~ 75 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEH-----DQRF 75 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhc-----cCCe
Confidence 47999999999999999999999999999999986432 23457999999999999999988873 3345
Q ss_pred EEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCccc
Q 021306 111 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 189 (314)
Q Consensus 111 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~ 189 (314)
+++||||+++ +|.+.+. ....+++..++.++.|++.||.|||+ +|++||||||+||+++. ++.++|+|||++.
T Consensus 76 ~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~NIli~~-~~~~kl~Dfg~~~ 149 (291)
T cd05612 76 LYMLMEYVPGGELFSYLR----NSGRFSNSTGLFYASEIVCALEYLHS-KEIVYRDLKPENILLDK-EGHIKLTDFGFAK 149 (291)
T ss_pred EEEEEeCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCHHHeEECC-CCCEEEEecCcch
Confidence 8899999986 5655554 34679999999999999999999999 89999999999999998 8899999999987
Q ss_pred ccccCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCC-------CH
Q 021306 190 QLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP-------TR 262 (314)
Q Consensus 190 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~-------~~ 262 (314)
..... .....+++.|+|||.+.+.. ++.++||||||+++|+|++|+.||.+.+..+....+....... ..
T Consensus 150 ~~~~~--~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 226 (291)
T cd05612 150 KLRDR--TWTLCGTPEYLAPEVIQSKG-HNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHLDLYAK 226 (291)
T ss_pred hccCC--cccccCChhhcCHHHHcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcCCCccCCHHHH
Confidence 65332 22346789999999986654 7899999999999999999999999988777666665542211 11
Q ss_pred HHHh---ccCCCCCCC-----cccccccCChhhhhc
Q 021306 263 EEIR---CMNPNYTDF-----RFPQIKAHPWHKVCI 290 (314)
Q Consensus 263 ~~~~---~~~p~~~~~-----~~~~l~~~p~~~~~~ 290 (314)
+.+. ..+|. +|+ ++++++.|||++...
T Consensus 227 ~li~~~l~~dp~-~R~~~~~~~~~~~l~h~~~~~~~ 261 (291)
T cd05612 227 DLIKKLLVVDRT-RRLGNMKNGADDVKNHRWFKSVD 261 (291)
T ss_pred HHHHHHcCCCHH-HccCCccCCHHHHhcCccccCCC
Confidence 2222 33666 788 499999999997543
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=300.40 Aligned_cols=238 Identities=26% Similarity=0.432 Sum_probs=193.0
Q ss_pred CCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCCce
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL 109 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 109 (314)
.++|++.+.||+|+||.||+|+++.+++.|++|.+.... ....+|+.++++++||||+++++++.. ..
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~~ 91 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQD-----EN 91 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEc-----CC
Confidence 468999999999999999999999999999999986432 224578999999999999999998843 33
Q ss_pred eEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcc
Q 021306 110 FLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 188 (314)
Q Consensus 110 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~ 188 (314)
..+++|||+.+ +|.+.+.. ...+++..++.++.|++.||.|||+ +||+||||||+||+++. ++.++|+|||++
T Consensus 92 ~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivH~dlkp~NIll~~-~~~~kl~Dfg~~ 165 (329)
T PTZ00263 92 RVYFLLEFVVGGELFTHLRK----AGRFPNDVAKFYHAELVLAFEYLHS-KDIIYRDLKPENLLLDN-KGHVKVTDFGFA 165 (329)
T ss_pred EEEEEEcCCCCChHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCHHHEEECC-CCCEEEeeccCc
Confidence 48899999986 55555543 5678999999999999999999999 89999999999999998 889999999998
Q ss_pred cccccCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCC-------C
Q 021306 189 KQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP-------T 261 (314)
Q Consensus 189 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~-------~ 261 (314)
...... .....+++.|+|||.+.+.. ++.++||||||+++|+|++|..||.+.+..+....+.+..... .
T Consensus 166 ~~~~~~--~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~ 242 (329)
T PTZ00263 166 KKVPDR--TFTLCGTPEYLAPEVIQSKG-HGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFDGRA 242 (329)
T ss_pred eEcCCC--cceecCChhhcCHHHHcCCC-CCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcCCCCCCCHHH
Confidence 765332 23456789999999996654 7899999999999999999999999888776666555432111 1
Q ss_pred HHHHh---ccCCCCCCCc-----ccccccCChhhhh
Q 021306 262 REEIR---CMNPNYTDFR-----FPQIKAHPWHKVC 289 (314)
Q Consensus 262 ~~~~~---~~~p~~~~~~-----~~~l~~~p~~~~~ 289 (314)
.+.+. ..+|. +|++ +++|+.|||++..
T Consensus 243 ~~li~~~L~~dP~-~R~~~~~~~~~~ll~hp~f~~~ 277 (329)
T PTZ00263 243 RDLVKGLLQTDHT-KRLGTLKGGVADVKNHPYFHGA 277 (329)
T ss_pred HHHHHHHhhcCHH-HcCCCCCCCHHHHhcCCccCCC
Confidence 12222 33666 6775 7999999999864
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=306.01 Aligned_cols=239 Identities=26% Similarity=0.448 Sum_probs=200.5
Q ss_pred CceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeEEEE
Q 021306 39 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLV 114 (314)
Q Consensus 39 ~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 114 (314)
.|...+.||+|+.|.||.++...+++.||+|.+.... ...-+|+.+++..+|+|||.+++.|...+. +|+|
T Consensus 274 ~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~de-----LWVV 348 (550)
T KOG0578|consen 274 KYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDE-----LWVV 348 (550)
T ss_pred hhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccce-----eEEE
Confidence 6999999999999999999999999999999986543 333589999999999999999998866544 9999
Q ss_pred eecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCccccccc
Q 021306 115 MEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA 193 (314)
Q Consensus 115 ~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~~ 193 (314)
|||++| +|.+.+. ...+++.++..++++++.||+|||. +||+|||||.+||+++. ++.+||+|||++..+..
T Consensus 349 MEym~ggsLTDvVt-----~~~~~E~qIA~Icre~l~aL~fLH~-~gIiHrDIKSDnILL~~-~g~vKltDFGFcaqi~~ 421 (550)
T KOG0578|consen 349 MEYMEGGSLTDVVT-----KTRMTEGQIAAICREILQGLKFLHA-RGIIHRDIKSDNILLTM-DGSVKLTDFGFCAQISE 421 (550)
T ss_pred EeecCCCchhhhhh-----cccccHHHHHHHHHHHHHHHHHHHh-cceeeeccccceeEecc-CCcEEEeeeeeeecccc
Confidence 999997 4544444 3669999999999999999999999 99999999999999998 88899999999987766
Q ss_pred CC-ccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCH----------
Q 021306 194 GE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR---------- 262 (314)
Q Consensus 194 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~---------- 262 (314)
.. ......|||.|||||.+. +..|.++.||||||++++||+-|++||-..++...++.|.....+...
T Consensus 422 ~~~KR~TmVGTPYWMAPEVvt-rk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~k 500 (550)
T KOG0578|consen 422 EQSKRSTMVGTPYWMAPEVVT-RKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPELK 500 (550)
T ss_pred ccCccccccCCCCccchhhhh-hcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHHH
Confidence 54 445678999999999995 455999999999999999999999999998888878777665443321
Q ss_pred HHH---hccCCCCCCCcccccccCChhhhhcc
Q 021306 263 EEI---RCMNPNYTDFRFPQIKAHPWHKVCIF 291 (314)
Q Consensus 263 ~~~---~~~~p~~~~~~~~~l~~~p~~~~~~~ 291 (314)
+.+ .+++++ +|.++.+|+.|||+.....
T Consensus 501 dFL~~cL~~dv~-~RasA~eLL~HpFl~~a~p 531 (550)
T KOG0578|consen 501 DFLDRCLVVDVE-QRASAKELLEHPFLKMAKP 531 (550)
T ss_pred HHHHHHhhcchh-cCCCHHHHhcChhhhhcCC
Confidence 222 233565 7889999999999965554
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=299.59 Aligned_cols=214 Identities=34% Similarity=0.589 Sum_probs=178.7
Q ss_pred cCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCC-CCc
Q 021306 36 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTS-KNE 108 (314)
Q Consensus 36 ~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~~~ 108 (314)
..++|++.+.||+|+||.||++.+..+++.+++|++.... ....+|+.+++.++|+||+++++++..... ...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 3568999999999999999999999999999999986432 223478899999999999999987743322 122
Q ss_pred eeEEEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcc
Q 021306 109 LFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 188 (314)
Q Consensus 109 ~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~ 188 (314)
..+++||||+++++...+. ..+++..++.++.|++.||.|||+ +||+||||||+||+++. ++.++|+|||++
T Consensus 102 ~~~~lv~e~~~~~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~-~~~~kL~DfG~a 173 (364)
T cd07875 102 QDVYIVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKS-DCTLKILDFGLA 173 (364)
T ss_pred CeEEEEEeCCCCCHHHHHH------hcCCHHHHHHHHHHHHHHHHHHhh-CCeecCCCCHHHEEECC-CCcEEEEeCCCc
Confidence 3478999999998877664 358889999999999999999999 89999999999999998 889999999999
Q ss_pred cccccCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcC
Q 021306 189 KQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLG 258 (314)
Q Consensus 189 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~ 258 (314)
.............+++.|+|||.+.+.. ++.++||||||+++|+|++|+.||.+.+..+.+..+++..+
T Consensus 174 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~ 242 (364)
T cd07875 174 RTAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLG 242 (364)
T ss_pred cccCCCCcccCCcccCCcCCHHHHhCCC-CCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence 7654433334456789999999997654 89999999999999999999999999888777776665444
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=305.09 Aligned_cols=240 Identities=29% Similarity=0.473 Sum_probs=190.9
Q ss_pred CCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCCcee
Q 021306 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 110 (314)
Q Consensus 38 ~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 110 (314)
++|++.+.||+|+||.||+|++..+++.||+|.+.... ....+|+.+++.++|+||+++++++.. ..+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~-----~~~ 75 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQD-----ENY 75 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEc-----CCe
Confidence 47999999999999999999999999999999986532 223579999999999999999998843 345
Q ss_pred EEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCccc
Q 021306 111 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 189 (314)
Q Consensus 111 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~ 189 (314)
+++||||++| +|.+.+. ....+++..++.++.|++.||.|||+ +||+||||||+||+++. ++.++|+|||++.
T Consensus 76 ~~lv~E~~~~g~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~lH~-~~ivH~Dlkp~NIl~~~-~~~~kl~Dfg~~~ 149 (364)
T cd05599 76 LYLIMEYLPGGDMMTLLM----KKDTFTEEETRFYIAETILAIDSIHK-LGYIHRDIKPDNLLLDA-KGHIKLSDFGLCT 149 (364)
T ss_pred EEEEECCCCCcHHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeccCCHHHeEECC-CCCEEEeecccce
Confidence 8999999986 4554443 35679999999999999999999999 89999999999999998 8899999999886
Q ss_pred ccccCCc---------------------------------------cccccccccccccccccCCCCCCcchhHHHHHHH
Q 021306 190 QLIAGEA---------------------------------------NISYICSRFYRAPELIFGATEYTTSIDIWSAGCV 230 (314)
Q Consensus 190 ~~~~~~~---------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~i 230 (314)
....... .....||+.|+|||.+.+.. ++.++|||||||+
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~i 228 (364)
T cd05599 150 GLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTG-YNKECDWWSLGVI 228 (364)
T ss_pred eccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCC-CCCeeeeecchhH
Confidence 4321110 01235789999999986544 8999999999999
Q ss_pred HHHHHhCCCCCCCCChHHHHHHHHHHcCC---C--------CHHHHhc--cCCCCCCCc---ccccccCChhhhhc
Q 021306 231 LAELLLGQPLFPGENAVDQLVEIIKVLGT---P--------TREEIRC--MNPNYTDFR---FPQIKAHPWHKVCI 290 (314)
Q Consensus 231 l~el~tg~~pf~~~~~~~~~~~i~~~~~~---~--------~~~~~~~--~~p~~~~~~---~~~l~~~p~~~~~~ 290 (314)
+|+|++|..||.+.+..+....+++.... + ..+.+.. .+|. +|++ +.+++.|||++...
T Consensus 229 l~el~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~~p~-~R~~~~~~~~ll~h~~~~~~~ 303 (364)
T cd05599 229 MYEMLVGYPPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCCEAE-RRLGNNGVNEIKSHPFFKGVD 303 (364)
T ss_pred HHHhhcCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHccCHh-hcCCCCCHHHHhcCCCcCCCC
Confidence 99999999999998887776666542111 0 1122222 1555 5665 99999999997654
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=288.09 Aligned_cols=242 Identities=32% Similarity=0.585 Sum_probs=192.9
Q ss_pred CceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhC---CCCceeeeceeeeecCCCCce
Q 021306 39 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVM---DHPNVISLKHCFFSTTSKNEL 109 (314)
Q Consensus 39 ~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~------~~~~~e~~~l~~l---~h~~iv~~~~~~~~~~~~~~~ 109 (314)
+|++.+.||+|++|.||+|+++.+++.+++|.++... ....+|..+++.+ +|+||+++++++.........
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 5899999999999999999999999999999886432 1234567666655 799999999987655444455
Q ss_pred eEEEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCccc
Q 021306 110 FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 189 (314)
Q Consensus 110 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~ 189 (314)
..++++||+.+++.+.+... ....+++.+++.++.|++.||.|||+ +|++|+||||+||+++. ++.++|+|||++.
T Consensus 81 ~~~lv~e~~~~~l~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~dikp~Nili~~-~~~~kl~dfg~~~ 156 (288)
T cd07863 81 KVTLVFEHVDQDLRTYLDKV--PPPGLPAETIKDLMRQFLRGLDFLHA-NCIVHRDLKPENILVTS-GGQVKLADFGLAR 156 (288)
T ss_pred eEEEEEcccccCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEECC-CCCEEECccCccc
Confidence 68899999999887776542 23458999999999999999999999 89999999999999998 7889999999987
Q ss_pred ccccCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCC--------
Q 021306 190 QLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT-------- 261 (314)
Q Consensus 190 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~-------- 261 (314)
............++..|+|||.+.+.. ++.++||||||+++|+|++|+.||.+....+.+.++....+.+.
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T cd07863 157 IYSCQMALTPVVVTLWYRAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDV 235 (288)
T ss_pred cccCcccCCCccccccccCchHhhCCC-CCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccc
Confidence 654433333456688899999986554 89999999999999999999999988877766666655332111
Q ss_pred --------------------------HHHH---hccCCCCCCCcccccccCChh
Q 021306 262 --------------------------REEI---RCMNPNYTDFRFPQIKAHPWH 286 (314)
Q Consensus 262 --------------------------~~~~---~~~~p~~~~~~~~~l~~~p~~ 286 (314)
.+.+ ...+|. +|+++.+++.||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~-~R~t~~~~l~hp~f 288 (288)
T cd07863 236 TLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPH-KRISAFRALQHPFF 288 (288)
T ss_pred cccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcc-cCCCHHHHhcCCCC
Confidence 0111 233676 89999999999996
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=290.52 Aligned_cols=245 Identities=31% Similarity=0.605 Sum_probs=197.7
Q ss_pred CCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeE
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 111 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 111 (314)
.++|++.+.||+|+||.||++++..+++.+++|.++... ....+|+.++++++|+||+++++++... ...
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~ 79 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTD-----KSL 79 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeC-----CeE
Confidence 467999999999999999999999999999999886432 2335799999999999999999988443 348
Q ss_pred EEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCccccc
Q 021306 112 NLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 191 (314)
Q Consensus 112 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~ 191 (314)
+++|||+++++.+.+.. ....+++..++.++.|++.||.|||+ +||+||||||+||+++. ++.++|+|||++...
T Consensus 80 ~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~aL~~lH~-~~ivH~dlkp~Nill~~-~~~~kl~Dfg~~~~~ 154 (309)
T cd07872 80 TLVFEYLDKDLKQYMDD---CGNIMSMHNVKIFLYQILRGLAYCHR-RKVLHRDLKPQNLLINE-RGELKLADFGLARAK 154 (309)
T ss_pred EEEEeCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEECC-CCCEEECccccceec
Confidence 89999999988776654 24568999999999999999999999 89999999999999998 788999999998754
Q ss_pred ccCCc-cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCH--------
Q 021306 192 IAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR-------- 262 (314)
Q Consensus 192 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~-------- 262 (314)
..... .....+++.|+|||.+.+...++.++||||||+++|+|+||+.||.+.+..+.+..+.+..+.+..
T Consensus 155 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (309)
T cd07872 155 SVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISS 234 (309)
T ss_pred CCCccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcc
Confidence 32222 223456888999999876666889999999999999999999999988876666655544332211
Q ss_pred -----------------------------HHHh---ccCCCCCCCcccccccCChhhhhccc
Q 021306 263 -----------------------------EEIR---CMNPNYTDFRFPQIKAHPWHKVCIFH 292 (314)
Q Consensus 263 -----------------------------~~~~---~~~p~~~~~~~~~l~~~p~~~~~~~~ 292 (314)
+.+. ..+|. +|+++.++++|||++....+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~-~R~t~~e~l~h~~~~~~~~~ 295 (309)
T cd07872 235 NDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESK-KRISAEEAMKHAYFRSLGTR 295 (309)
T ss_pred hhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChh-hCCCHHHHhcChhhhhcccc
Confidence 1111 23566 89999999999999976544
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-42 Score=273.46 Aligned_cols=244 Identities=27% Similarity=0.465 Sum_probs=204.5
Q ss_pred CCccCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeecc-------ccchHHHHHHHHhCCCCceeeeceeeeecCC
Q 021306 33 EPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRVMDHPNVISLKHCFFSTTS 105 (314)
Q Consensus 33 ~~~~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~-------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 105 (314)
..-..++|++++.||+|-||.||+++.+.++..+|+|.+.+. .....+|+++...|+||||++++++|.+...
T Consensus 17 ~~~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~r 96 (281)
T KOG0580|consen 17 KTWTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKR 96 (281)
T ss_pred cccchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccce
Confidence 334567899999999999999999999999999999988543 3445689999999999999999999965554
Q ss_pred CCceeEEEEeeccc-ccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEee
Q 021306 106 KNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICD 184 (314)
Q Consensus 106 ~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~d 184 (314)
.|+++||.+ |.++..|.. +...++++...+.++.|++.|+.|+|. ++++||||||+|+|++. .+.+++.|
T Consensus 97 -----iyLilEya~~gel~k~L~~--~~~~~f~e~~~a~Yi~q~A~Al~y~h~-k~VIhRdiKpenlLlg~-~~~lkiAd 167 (281)
T KOG0580|consen 97 -----IYLILEYAPRGELYKDLQE--GRMKRFDEQRAATYIKQLANALLYCHL-KRVIHRDIKPENLLLGS-AGELKIAD 167 (281)
T ss_pred -----eEEEEEecCCchHHHHHHh--cccccccccchhHHHHHHHHHHHHhcc-CCcccCCCCHHHhccCC-CCCeeccC
Confidence 899999998 577777764 245789999999999999999999999 99999999999999998 88999999
Q ss_pred cCcccccccCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHc-------
Q 021306 185 FGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVL------- 257 (314)
Q Consensus 185 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~------- 257 (314)
||.+...+ .......+||..|++||...+.. .+...|+|++|++.||++.|.+||.+.+..+.+.+|.+.-
T Consensus 168 fGwsV~~p-~~kR~tlcgt~dyl~pEmv~~~~-hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p~~i 245 (281)
T KOG0580|consen 168 FGWSVHAP-SNKRKTLCGTLDYLPPEMVEGRG-HDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFPSTI 245 (281)
T ss_pred CCceeecC-CCCceeeecccccCCHhhcCCCC-ccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCCccc
Confidence 99987554 44555678899999999997765 8999999999999999999999999998777777766532
Q ss_pred CCCCHHHHh---ccCCCCCCCcccccccCChhhh
Q 021306 258 GTPTREEIR---CMNPNYTDFRFPQIKAHPWHKV 288 (314)
Q Consensus 258 ~~~~~~~~~---~~~p~~~~~~~~~l~~~p~~~~ 288 (314)
+....+.+. ..+|. .|+.+.+++.|||...
T Consensus 246 s~~a~dlI~~ll~~~p~-~r~~l~~v~~hpwI~a 278 (281)
T KOG0580|consen 246 SGGAADLISRLLVKNPI-ERLALTEVMDHPWIVA 278 (281)
T ss_pred ChhHHHHHHHHhccCcc-ccccHHHHhhhHHHHh
Confidence 112234444 33676 7999999999999753
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=297.69 Aligned_cols=212 Identities=33% Similarity=0.572 Sum_probs=175.8
Q ss_pred cCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCC-CCc
Q 021306 36 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTS-KNE 108 (314)
Q Consensus 36 ~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~~~ 108 (314)
..++|++.+.||+|+||.||++.+..+++.+++|.+.... ....+|+.+++.++|+||+++++++..... ...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 3568999999999999999999999899999999886432 223478899999999999999998754332 122
Q ss_pred eeEEEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcc
Q 021306 109 LFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 188 (314)
Q Consensus 109 ~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~ 188 (314)
...+++|||+++++...+. ..+++..++.++.|++.||.|||+ +||+||||||+||+++. ++.++|+|||++
T Consensus 95 ~~~~lv~e~~~~~l~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~-~givHrDikp~Nill~~-~~~~kl~Dfg~~ 166 (355)
T cd07874 95 QDVYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKS-DCTLKILDFGLA 166 (355)
T ss_pred ceeEEEhhhhcccHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCChHHEEECC-CCCEEEeeCccc
Confidence 3468999999998776654 358899999999999999999999 89999999999999998 889999999999
Q ss_pred cccccCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q 021306 189 KQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 256 (314)
Q Consensus 189 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~ 256 (314)
+............+++.|+|||.+.+.. ++.++||||||+++|+|++|+.||.+.+..+.+..++..
T Consensus 167 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~ 233 (355)
T cd07874 167 RTAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 233 (355)
T ss_pred ccCCCccccCCccccCCccCHHHHcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 7654433334456789999999996654 889999999999999999999999988766665555443
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=299.52 Aligned_cols=239 Identities=30% Similarity=0.481 Sum_probs=192.6
Q ss_pred CCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCCcee
Q 021306 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 110 (314)
Q Consensus 38 ~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 110 (314)
++|++.+.||+|+||.||+|++..+++.||+|.+++.. ....+|+.+++.++|+||+++++++.. ..+
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~-----~~~ 75 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQD-----DEY 75 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEc-----CCE
Confidence 47999999999999999999999999999999987532 223478899999999999999988843 345
Q ss_pred EEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCccc
Q 021306 111 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 189 (314)
Q Consensus 111 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~ 189 (314)
.++||||++| +|.+.+. ....+++.+++.++.||+.||.|||+ +|++||||||+||+++. ++.++|+|||++.
T Consensus 76 ~~lv~e~~~g~~L~~~l~----~~~~l~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nil~~~-~~~~kL~Dfg~a~ 149 (333)
T cd05600 76 LYLAMEYVPGGDFRTLLN----NLGVLSEDHARFYMAEMFEAVDALHE-LGYIHRDLKPENFLIDA-SGHIKLTDFGLSK 149 (333)
T ss_pred EEEEEeCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEECC-CCCEEEEeCcCCc
Confidence 8899999986 5655554 34679999999999999999999999 89999999999999998 8899999999987
Q ss_pred ccccCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHc---CCC------
Q 021306 190 QLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVL---GTP------ 260 (314)
Q Consensus 190 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~---~~~------ 260 (314)
.... ......+++.|+|||.+.+. .++.++||||||+++|+|++|..||.+.+..+....+.... ..+
T Consensus 150 ~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 226 (333)
T cd05600 150 GIVT--YANSVVGSPDYMAPEVLRGK-GYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPR 226 (333)
T ss_pred cccc--ccCCcccCccccChhHhcCC-CCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccc
Confidence 5533 23345678999999999765 48999999999999999999999999888776665554321 111
Q ss_pred ------CHHHHh-cc-CCCCCCCcccccccCChhhhhc
Q 021306 261 ------TREEIR-CM-NPNYTDFRFPQIKAHPWHKVCI 290 (314)
Q Consensus 261 ------~~~~~~-~~-~p~~~~~~~~~l~~~p~~~~~~ 290 (314)
..+.+. ++ .+.-+|+++.++++|||++...
T Consensus 227 ~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~~ 264 (333)
T cd05600 227 FNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEVD 264 (333)
T ss_pred cccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccCCCC
Confidence 111222 22 3334899999999999998643
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-41 Score=296.35 Aligned_cols=243 Identities=30% Similarity=0.489 Sum_probs=204.2
Q ss_pred CccCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeecccc-------chHHHHHHHHhCC-CCceeeeceeeeecCC
Q 021306 34 PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YKNRELQLMRVMD-HPNVISLKHCFFSTTS 105 (314)
Q Consensus 34 ~~~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~~-------~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~ 105 (314)
......|++.+.||+|.||.||+++.+.+|+.+|+|.+++... ...+|+.+++++. ||||+.+++.|....
T Consensus 31 ~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~- 109 (382)
T KOG0032|consen 31 EDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPD- 109 (382)
T ss_pred ccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCC-
Confidence 3445689999999999999999999999999999999965432 5579999999998 999999999995444
Q ss_pred CCceeEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCC---CcEE
Q 021306 106 KNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLT---HQVK 181 (314)
Q Consensus 106 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~---~~~~ 181 (314)
.+++|||++.| .|.+.+... .+++..+..++.|++.++.|||+ .|++|+||||+|+|+.... +.++
T Consensus 110 ----~~~lvmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~-~gvvHrDlKpEN~L~~~~~~~~~~ik 179 (382)
T KOG0032|consen 110 ----SVYLVMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHS-LGVVHRDLKPENLLLASKDEGSGRIK 179 (382)
T ss_pred ----eEEEEEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCHHHeeeccccCCCCcEE
Confidence 48999999996 566666542 39999999999999999999999 8999999999999997642 3799
Q ss_pred EeecCcccccccCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCC
Q 021306 182 ICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 261 (314)
Q Consensus 182 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~ 261 (314)
++|||++............+||+.|+|||.+.... ++..+|+||+|+++|.|++|..||.+.+.......+.+.--...
T Consensus 180 ~~DFGla~~~~~~~~~~~~~Gtp~y~APEvl~~~~-y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~ 258 (382)
T KOG0032|consen 180 LIDFGLAKFIKPGERLHTIVGTPEYVAPEVLGGRP-YGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFT 258 (382)
T ss_pred EeeCCCceEccCCceEeeecCCccccCchhhcCCC-CCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCC
Confidence 99999999877655566788999999999996544 99999999999999999999999999998888887776532221
Q ss_pred -----------HHHHh---ccCCCCCCCcccccccCChhhhh
Q 021306 262 -----------REEIR---CMNPNYTDFRFPQIKAHPWHKVC 289 (314)
Q Consensus 262 -----------~~~~~---~~~p~~~~~~~~~l~~~p~~~~~ 289 (314)
.+.+. ..+|. +|+++.++++|||.+..
T Consensus 259 ~~~w~~is~~akd~i~~ll~~dp~-~R~ta~~~L~HpWi~~~ 299 (382)
T KOG0032|consen 259 SEPWDDISESAKDFIRKLLEFDPR-KRLTAAQALQHPWIKSI 299 (382)
T ss_pred CCCccccCHHHHHHHHHhcccCcc-cCCCHHHHhcCccccCC
Confidence 12222 34675 89999999999998875
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-41 Score=298.09 Aligned_cols=241 Identities=27% Similarity=0.409 Sum_probs=192.3
Q ss_pred ccCCCceeeeeEeecCceEEEEEEECCCC-cEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCC
Q 021306 35 KQTISYMAERVVGTGSFGIVFQAKCLETG-ETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSK 106 (314)
Q Consensus 35 ~~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~-~~~~vK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 106 (314)
...++|++.+.||+|+||.||+|.+..++ ..+++|.+.... ....+|+.+++.++||||+++++++..
T Consensus 27 ~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~---- 102 (340)
T PTZ00426 27 MKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKD---- 102 (340)
T ss_pred CChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEe----
Confidence 44568999999999999999999876654 689999886432 223478999999999999999998843
Q ss_pred CceeEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeec
Q 021306 107 NELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF 185 (314)
Q Consensus 107 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~df 185 (314)
...++++|||+.+ +|.+.+. .+..+++..++.++.||+.||.|||+ +||+||||||+||+++. ++.++|+||
T Consensus 103 -~~~~~lv~Ey~~~g~L~~~i~----~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDLkp~NILl~~-~~~ikL~DF 175 (340)
T PTZ00426 103 -ESYLYLVLEFVIGGEFFTFLR----RNKRFPNDVGCFYAAQIVLIFEYLQS-LNIVYRDLKPENLLLDK-DGFIKMTDF 175 (340)
T ss_pred -CCEEEEEEeCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEccCCCHHHEEECC-CCCEEEecC
Confidence 3348899999986 5555554 35689999999999999999999999 89999999999999997 889999999
Q ss_pred CcccccccCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCC-----
Q 021306 186 GSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP----- 260 (314)
Q Consensus 186 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~----- 260 (314)
|++..... ......+|+.|+|||.+.+.. ++.++|+|||||++|+|++|..||.+.+.......+.+.....
T Consensus 176 G~a~~~~~--~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~ 252 (340)
T PTZ00426 176 GFAKVVDT--RTYTLCGTPEYIAPEILLNVG-HGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKFLD 252 (340)
T ss_pred CCCeecCC--CcceecCChhhcCHHHHhCCC-CCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCC
Confidence 99875432 223456899999999996654 7899999999999999999999999888776666665543211
Q ss_pred --CHHHHh---ccCCCCCC-----CcccccccCChhhhhc
Q 021306 261 --TREEIR---CMNPNYTD-----FRFPQIKAHPWHKVCI 290 (314)
Q Consensus 261 --~~~~~~---~~~p~~~~-----~~~~~l~~~p~~~~~~ 290 (314)
..+.+. ..+|. +| .+++++++|||++...
T Consensus 253 ~~~~~li~~~l~~dp~-~R~~~~~~~~~~~~~hp~f~~~~ 291 (340)
T PTZ00426 253 NNCKHLMKKLLSHDLT-KRYGNLKKGAQNVKEHPWFGNID 291 (340)
T ss_pred HHHHHHHHHHcccCHH-HcCCCCCCCHHHHHcCCCcCCCC
Confidence 112222 22455 55 4899999999998754
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=305.18 Aligned_cols=241 Identities=27% Similarity=0.438 Sum_probs=189.4
Q ss_pred CCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCCcee
Q 021306 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 110 (314)
Q Consensus 38 ~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 110 (314)
++|++.+.||+|+||.||++++..+++.||+|.+.+.. ....+|..++++++|+||+++++++. ...+
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~-----~~~~ 75 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQ-----DAQY 75 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEE-----cCCe
Confidence 47999999999999999999999999999999886432 22357899999999999999999884 3345
Q ss_pred EEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCccc
Q 021306 111 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 189 (314)
Q Consensus 111 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~ 189 (314)
+++||||++| +|.+.+. ....+++..++.++.|++.||.|||+ +||+||||||+||+++. ++.++|+|||+++
T Consensus 76 ~~lv~E~~~gg~L~~~l~----~~~~~~~~~~~~~~~ql~~aL~~LH~-~givHrDlkp~NIll~~-~~~~kl~DfGla~ 149 (377)
T cd05629 76 LYLIMEFLPGGDLMTMLI----KYDTFSEDVTRFYMAECVLAIEAVHK-LGFIHRDIKPDNILIDR-GGHIKLSDFGLST 149 (377)
T ss_pred eEEEEeCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHEEECC-CCCEEEeeccccc
Confidence 8999999986 5655554 34679999999999999999999999 89999999999999998 8889999999985
Q ss_pred ccccCCc------------------------------------------------cccccccccccccccccCCCCCCcc
Q 021306 190 QLIAGEA------------------------------------------------NISYICSRFYRAPELIFGATEYTTS 221 (314)
Q Consensus 190 ~~~~~~~------------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~ 221 (314)
....... .....||+.|+|||.+.+.. ++.+
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~ 228 (377)
T cd05629 150 GFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQG-YGQE 228 (377)
T ss_pred ccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCC-CCCc
Confidence 3211000 00235788999999996544 8999
Q ss_pred hhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHc---CCC--------CHHHHhcc--CCC--CCCCcccccccCChh
Q 021306 222 IDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVL---GTP--------TREEIRCM--NPN--YTDFRFPQIKAHPWH 286 (314)
Q Consensus 222 ~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~---~~~--------~~~~~~~~--~p~--~~~~~~~~l~~~p~~ 286 (314)
+|||||||++|+|++|..||.+.+..+.+..+.... ..+ ..+.+..+ +|. +.|.++.+++.|||+
T Consensus 229 ~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~~~~~r~~r~~~~~~l~hp~~ 308 (377)
T cd05629 229 CDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLITNAENRLGRGGAHEIKSHPFF 308 (377)
T ss_pred eeeEecchhhhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhcCHhhcCCCCCHHHHhcCCCc
Confidence 999999999999999999999888777666665421 111 11222211 333 236799999999999
Q ss_pred hhhc
Q 021306 287 KVCI 290 (314)
Q Consensus 287 ~~~~ 290 (314)
+...
T Consensus 309 ~~~~ 312 (377)
T cd05629 309 RGVD 312 (377)
T ss_pred CCCC
Confidence 8543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=299.06 Aligned_cols=244 Identities=33% Similarity=0.575 Sum_probs=197.0
Q ss_pred CceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeEE
Q 021306 39 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 112 (314)
Q Consensus 39 ~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 112 (314)
+|++.+.||+|+||.||++.+..+++.||+|.+.... ....+|+.+++.++|+||+++++++...........+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4789999999999999999999999999999885421 2345799999999999999999988544322223578
Q ss_pred EEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcccccc
Q 021306 113 LVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 192 (314)
Q Consensus 113 lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~ 192 (314)
+++||+.+++...+. ....+++..++.++.||+.||.|||+ +|++||||||+||+++. ++.++|+|||++....
T Consensus 81 lv~e~~~~~l~~~~~----~~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivH~dlkp~Nili~~-~~~~kL~Dfg~a~~~~ 154 (372)
T cd07853 81 VVTELMQSDLHKIIV----SPQPLSSDHVKVFLYQILRGLKYLHS-AGILHRDIKPGNLLVNS-NCVLKICDFGLARVEE 154 (372)
T ss_pred EEeeccccCHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCChHHEEECC-CCCEEeccccceeecc
Confidence 999999988776664 35679999999999999999999999 89999999999999998 8899999999987543
Q ss_pred cCC--ccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCHH-------
Q 021306 193 AGE--ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE------- 263 (314)
Q Consensus 193 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~------- 263 (314)
... ......+++.|+|||.+.+...++.++|||||||++|+|++|+.||.+.+..+.+..+.+..+.+...
T Consensus 155 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 234 (372)
T cd07853 155 PDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACE 234 (372)
T ss_pred cCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhH
Confidence 221 12234568889999998776657899999999999999999999999988877776665543332211
Q ss_pred --------------------------------HH---hccCCCCCCCcccccccCChhhhh
Q 021306 264 --------------------------------EI---RCMNPNYTDFRFPQIKAHPWHKVC 289 (314)
Q Consensus 264 --------------------------------~~---~~~~p~~~~~~~~~l~~~p~~~~~ 289 (314)
.+ ...+|. +|+++.++++|||++..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~-~R~t~~e~l~hp~~~~~ 294 (372)
T cd07853 235 GARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPD-KRISAADALAHPYLDEG 294 (372)
T ss_pred HHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChh-hCcCHHHHhcCHhhCCC
Confidence 11 123677 89999999999998763
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=304.79 Aligned_cols=239 Identities=26% Similarity=0.409 Sum_probs=188.7
Q ss_pred CceeeeeEeecCceEEEEEEECCCCcEEEEEEeecc-------ccchHHHHHHHHhCCCCceeeeceeeeecCCCCceeE
Q 021306 39 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 111 (314)
Q Consensus 39 ~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~-------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 111 (314)
+|++.+.||+|+||.||++++..+++.||+|.+.+. .....+|+.++++++|+||+++++.+.. ...+
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~-----~~~~ 76 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQD-----KDNL 76 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEc-----CCEE
Confidence 699999999999999999999999999999998642 1234579999999999999999988843 3458
Q ss_pred EEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcccc
Q 021306 112 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 190 (314)
Q Consensus 112 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~ 190 (314)
++||||+++ +|.+.+.. .+.+++..++.++.||+.||.|||+ +||+||||||+||+++. ++.++|+|||++..
T Consensus 77 ~lv~E~~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~-~~ivHrDlkp~Nill~~-~~~ikL~DFG~a~~ 150 (376)
T cd05598 77 YFVMDYIPGGDMMSLLIR----LGIFEEDLARFYIAELTCAIESVHK-MGFIHRDIKPDNILIDR-DGHIKLTDFGLCTG 150 (376)
T ss_pred EEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeCCCCHHHEEECC-CCCEEEEeCCCCcc
Confidence 899999986 56555543 4678999999999999999999999 89999999999999998 88999999998742
Q ss_pred cccC--------------------------------------------CccccccccccccccccccCCCCCCcchhHHH
Q 021306 191 LIAG--------------------------------------------EANISYICSRFYRAPELIFGATEYTTSIDIWS 226 (314)
Q Consensus 191 ~~~~--------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~s 226 (314)
.... .......||+.|+|||.+.+.. ++.++||||
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwS 229 (376)
T cd05598 151 FRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTG-YTQLCDWWS 229 (376)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCC-CCcceeeee
Confidence 2100 0001235789999999996544 899999999
Q ss_pred HHHHHHHHHhCCCCCCCCChHHHHHHHHHHcC---CC--------CHHHHhc--cCCCCCCC---cccccccCChhhhhc
Q 021306 227 AGCVLAELLLGQPLFPGENAVDQLVEIIKVLG---TP--------TREEIRC--MNPNYTDF---RFPQIKAHPWHKVCI 290 (314)
Q Consensus 227 lG~il~el~tg~~pf~~~~~~~~~~~i~~~~~---~~--------~~~~~~~--~~p~~~~~---~~~~l~~~p~~~~~~ 290 (314)
|||++|+|++|+.||.+.+..+....+..... .+ ..+.+.. .+|. +|+ ++.++++|||++...
T Consensus 230 lGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~~~p~-~R~~~~t~~ell~h~~~~~~~ 308 (376)
T cd05598 230 VGVILYEMLVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLCCGAE-DRLGKNGADEIKAHPFFKGID 308 (376)
T ss_pred ccceeeehhhCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHhcCHh-hcCCCCCHHHHhCCCCcCCCC
Confidence 99999999999999998887666555543211 01 1112222 3565 788 899999999998643
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=301.99 Aligned_cols=241 Identities=29% Similarity=0.499 Sum_probs=194.8
Q ss_pred CCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCCcee
Q 021306 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 110 (314)
Q Consensus 38 ~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 110 (314)
++|++.+.||+|+||.||+|++..+++.||+|.++... ....+|..++..++|+||+++++++. ...+
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~ 75 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQ-----DEEH 75 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhhee-----cCCe
Confidence 47999999999999999999999999999999986432 23457899999999999999998874 3345
Q ss_pred EEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCccc
Q 021306 111 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 189 (314)
Q Consensus 111 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~ 189 (314)
+++||||+++ +|.+.+.. ...+++..++.++.|++.||.|||+ +||+||||||+||+++. ++.++|+|||++.
T Consensus 76 ~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~-~giiH~Dlkp~NIll~~-~~~~kL~Dfg~~~ 149 (350)
T cd05573 76 LYLVMEYMPGGDLMNLLIR----KDVFPEETARFYIAELVLALDSVHK-LGFIHRDIKPDNILIDA-DGHIKLADFGLCK 149 (350)
T ss_pred EEEEEcCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHeEECC-CCCEEeecCCCCc
Confidence 8899999986 66665543 3689999999999999999999999 99999999999999998 8899999999987
Q ss_pred ccccCC------------------------------ccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCC
Q 021306 190 QLIAGE------------------------------ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQP 239 (314)
Q Consensus 190 ~~~~~~------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~ 239 (314)
...... ......+++.|+|||.+.+. .++.++|||||||++|+|++|+.
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~ 228 (350)
T cd05573 150 KMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGT-PYGLECDWWSLGVILYEMLYGFP 228 (350)
T ss_pred cCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCC-CCCCceeeEecchhhhhhccCCC
Confidence 654332 12235678999999999765 48999999999999999999999
Q ss_pred CCCCCChHHHHHHHHHH---cCCC-----C---HHHHh-cc-CCCCCCCc-ccccccCChhhhhcc
Q 021306 240 LFPGENAVDQLVEIIKV---LGTP-----T---REEIR-CM-NPNYTDFR-FPQIKAHPWHKVCIF 291 (314)
Q Consensus 240 pf~~~~~~~~~~~i~~~---~~~~-----~---~~~~~-~~-~p~~~~~~-~~~l~~~p~~~~~~~ 291 (314)
||...+..+....+.+. ...+ . .+.+. ++ +|. +|++ +.++++|||++....
T Consensus 229 Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~dp~-~R~~s~~~ll~hp~~~~~~~ 293 (350)
T cd05573 229 PFYSDTLQETYNKIINWKESLRFPPDPPVSPEAIDLICRLLCDPE-DRLGSFEEIKSHPFFKGIDW 293 (350)
T ss_pred CCCCCCHHHHHHHHhccCCcccCCCCCCCCHHHHHHHHHHccChh-hcCCCHHHHhcCCCcCCCCH
Confidence 99988877766666651 1111 1 11222 12 566 7888 999999999976543
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=298.70 Aligned_cols=253 Identities=26% Similarity=0.334 Sum_probs=209.3
Q ss_pred CCceeeeeEeecCceEEEEEEECCCCcEEEEEEeecc---ccchHHHHHHHHhCCCCceeeeceeeeecCCCCceeEEEE
Q 021306 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD---RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLV 114 (314)
Q Consensus 38 ~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 114 (314)
..+++.+.||+|.||.||.|..+. ...|++|.++.. ...+.+|+.++++|+|++||++++++.... .++||
T Consensus 206 ~~l~l~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~-----piyIV 279 (468)
T KOG0197|consen 206 EELKLIRELGSGQFGEVWLGKWNG-STKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQE-----PIYIV 279 (468)
T ss_pred HHHHHHHHhcCCccceEEEEEEcC-CCcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecCC-----ceEEE
Confidence 357788999999999999999843 347899988653 344568999999999999999999985433 38899
Q ss_pred eeccc-ccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCccccccc
Q 021306 115 MEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA 193 (314)
Q Consensus 115 ~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~~ 193 (314)
|||++ |+|++.|+. ..+..+...+...++.|||.|++||++ +++|||||...||||+. +..+||+|||+++....
T Consensus 280 tE~m~~GsLl~yLr~--~~~~~l~~~~Ll~~a~qIaeGM~YLes-~~~IHRDLAARNiLV~~-~~~vKIsDFGLAr~~~d 355 (468)
T KOG0197|consen 280 TEYMPKGSLLDYLRT--REGGLLNLPQLLDFAAQIAEGMAYLES-KNYIHRDLAARNILVDE-DLVVKISDFGLARLIGD 355 (468)
T ss_pred EEecccCcHHHHhhh--cCCCccchHHHHHHHHHHHHHHHHHHh-CCccchhhhhhheeecc-CceEEEcccccccccCC
Confidence 99999 678888875 346789999999999999999999999 99999999999999998 88999999999994433
Q ss_pred CCcccc--ccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCHHHHhccCC
Q 021306 194 GEANIS--YICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 270 (314)
Q Consensus 194 ~~~~~~--~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~p 270 (314)
...... .....-|.|||.+... .++.+|||||||++||||+| |+.||.+.+..+.+..+.++..-+. |
T Consensus 356 ~~Y~~~~~~kfPIkWtAPEa~~~~-~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~--------P 426 (468)
T KOG0197|consen 356 DEYTASEGGKFPIKWTAPEALNYG-KFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPR--------P 426 (468)
T ss_pred CceeecCCCCCCceecCHHHHhhC-CcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCC--------C
Confidence 322221 2225569999999654 49999999999999999999 9999999999998888876644433 3
Q ss_pred CCCCCcccccccCChhhhhcccCChHHHHHhcchhhhcC
Q 021306 271 NYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGSHINAIS 309 (314)
Q Consensus 271 ~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (314)
..+...+.+||+.||...+..+.+...+...+..+....
T Consensus 427 ~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~~ 465 (468)
T KOG0197|consen 427 EGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTST 465 (468)
T ss_pred CCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhcc
Confidence 335567889999999999999999999988888776644
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-41 Score=302.53 Aligned_cols=240 Identities=26% Similarity=0.427 Sum_probs=188.9
Q ss_pred CceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeE
Q 021306 39 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 111 (314)
Q Consensus 39 ~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 111 (314)
.|++++.||+|+||.||+|++..+++.||+|.+.+.. ....+|..++++++|+||+++++++.. ...+
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~-----~~~~ 76 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQD-----KDNL 76 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEec-----CCEE
Confidence 5899999999999999999999999999999986532 223578999999999999999998843 3348
Q ss_pred EEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcccc
Q 021306 112 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 190 (314)
Q Consensus 112 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~ 190 (314)
++||||++| +|.+.+. ....+++..++.++.||+.||.|||+ .||+||||||+||+++. ++.++|+|||++..
T Consensus 77 ~lv~E~~~gg~L~~~l~----~~~~~~e~~~~~~~~qi~~aL~~LH~-~givHrDlKp~Nili~~-~~~~kL~DFGl~~~ 150 (381)
T cd05626 77 YFVMDYIPGGDMMSLLI----RMEVFPEVLARFYIAELTLAIESVHK-MGFIHRDIKPDNILIDL-DGHIKLTDFGLCTG 150 (381)
T ss_pred EEEEecCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCcHHHEEECC-CCCEEEeeCcCCcc
Confidence 899999986 5555544 34679999999999999999999999 89999999999999998 78999999998753
Q ss_pred cccCC------------------------------------------------ccccccccccccccccccCCCCCCcch
Q 021306 191 LIAGE------------------------------------------------ANISYICSRFYRAPELIFGATEYTTSI 222 (314)
Q Consensus 191 ~~~~~------------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~ 222 (314)
..... ......||+.|+|||.+.+.. ++.++
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~~~~~ 229 (381)
T cd05626 151 FRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKG-YTQLC 229 (381)
T ss_pred cccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCC-CCCcc
Confidence 21000 011245789999999996544 88999
Q ss_pred hHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHc---CCC--------CHHHHh---ccCCC-CCCCcccccccCChhh
Q 021306 223 DIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVL---GTP--------TREEIR---CMNPN-YTDFRFPQIKAHPWHK 287 (314)
Q Consensus 223 Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~---~~~--------~~~~~~---~~~p~-~~~~~~~~l~~~p~~~ 287 (314)
|||||||++|+|++|..||...+..+....++... ..+ ..+.+. +..++ ..|+++.+++.|||++
T Consensus 230 DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~ 309 (381)
T cd05626 230 DWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFS 309 (381)
T ss_pred ceeehhhHHHHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccC
Confidence 99999999999999999998887766655555321 111 112222 22333 3589999999999997
Q ss_pred hhc
Q 021306 288 VCI 290 (314)
Q Consensus 288 ~~~ 290 (314)
...
T Consensus 310 ~~~ 312 (381)
T cd05626 310 EVD 312 (381)
T ss_pred CCC
Confidence 643
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-41 Score=303.60 Aligned_cols=239 Identities=27% Similarity=0.454 Sum_probs=188.7
Q ss_pred CceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeE
Q 021306 39 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 111 (314)
Q Consensus 39 ~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 111 (314)
.|++++.||+|+||.||+|++..+++.+|+|.+.+.. ....+|+.++++++|+||+++++.+... ..+
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~-----~~~ 76 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDK-----DNL 76 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeC-----CEE
Confidence 5899999999999999999999999999999986532 2345789999999999999999988543 348
Q ss_pred EEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcccc
Q 021306 112 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 190 (314)
Q Consensus 112 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~ 190 (314)
++||||+++ +|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+||+++. ++.++|+|||++..
T Consensus 77 ~lv~E~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~al~~lH~-~~ivHrDlKp~NILl~~-~g~~kL~DFGla~~ 150 (382)
T cd05625 77 YFVMDYIPGGDMMSLLIR----MGIFPEDLARFYIAELTCAVESVHK-MGFIHRDIKPDNILIDR-DGHIKLTDFGLCTG 150 (382)
T ss_pred EEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEECC-CCCEEEeECCCCcc
Confidence 899999986 55555543 4678999999999999999999999 89999999999999998 88999999998642
Q ss_pred cccC------------------------------------------------CccccccccccccccccccCCCCCCcch
Q 021306 191 LIAG------------------------------------------------EANISYICSRFYRAPELIFGATEYTTSI 222 (314)
Q Consensus 191 ~~~~------------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~ 222 (314)
.... .......||+.|+|||.+.+.. ++.++
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~~~~~ 229 (382)
T cd05625 151 FRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTG-YTQLC 229 (382)
T ss_pred ccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCC-CCCee
Confidence 2100 0011235788999999996654 89999
Q ss_pred hHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcC---CC--------CHHHHh--ccCCCCCCCc---ccccccCChh
Q 021306 223 DIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLG---TP--------TREEIR--CMNPNYTDFR---FPQIKAHPWH 286 (314)
Q Consensus 223 Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~---~~--------~~~~~~--~~~p~~~~~~---~~~l~~~p~~ 286 (314)
|||||||++|+|++|+.||.+.++.+....+..... .+ ..+.+. +.+|. +|++ ++++++|||+
T Consensus 230 DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~p~-~R~~~~~~~ei~~hp~f 308 (382)
T cd05625 230 DWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLCRGPE-DRLGKNGADEIKAHPFF 308 (382)
T ss_pred eEEechHHHHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHccCHh-HcCCCCCHHHHhcCCCc
Confidence 999999999999999999998887766666554211 11 112222 23555 5665 9999999999
Q ss_pred hhhc
Q 021306 287 KVCI 290 (314)
Q Consensus 287 ~~~~ 290 (314)
+...
T Consensus 309 ~~~~ 312 (382)
T cd05625 309 KTID 312 (382)
T ss_pred CCcC
Confidence 7654
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-41 Score=300.89 Aligned_cols=244 Identities=26% Similarity=0.437 Sum_probs=193.5
Q ss_pred ccCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeecc-------ccchHHHHHHHHhCCCCceeeeceeeeecCCCC
Q 021306 35 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKN 107 (314)
Q Consensus 35 ~~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~-------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 107 (314)
...++|++.+.||+|+||.||++++..+++.+|+|.+.+. .....+|..+++.++||||+++++++. .
T Consensus 40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~-----~ 114 (370)
T cd05621 40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQ-----D 114 (370)
T ss_pred CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEE-----c
Confidence 3456899999999999999999999999999999988642 123457899999999999999999884 3
Q ss_pred ceeEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecC
Q 021306 108 ELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 186 (314)
Q Consensus 108 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg 186 (314)
..++++||||++| +|.+.+. ...+++.+++.++.||+.||.|||+ +||+||||||+||+++. ++.++|+|||
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~l~-----~~~~~~~~~~~~~~qil~aL~~LH~-~~IvHrDLKp~NILl~~-~~~~kL~DFG 187 (370)
T cd05621 115 DKYLYMVMEYMPGGDLVNLMS-----NYDVPEKWAKFYTAEVVLALDAIHS-MGLIHRDVKPDNMLLDK-HGHLKLADFG 187 (370)
T ss_pred CCEEEEEEcCCCCCcHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHEEECC-CCCEEEEecc
Confidence 3458899999986 5665554 2468999999999999999999999 89999999999999998 8899999999
Q ss_pred cccccccCCc--cccccccccccccccccCCC---CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCC--
Q 021306 187 SAKQLIAGEA--NISYICSRFYRAPELIFGAT---EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT-- 259 (314)
Q Consensus 187 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~---~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~-- 259 (314)
++........ .....+|+.|+|||.+.+.. .++.++|+||||+++|+|++|+.||.+.+....+..++.....
T Consensus 188 ~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~ 267 (370)
T cd05621 188 TCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLN 267 (370)
T ss_pred cceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccC
Confidence 9876533221 22456899999999986432 3678999999999999999999999988877777777653211
Q ss_pred -C--------CHHHHhcc--CCC--CCCCcccccccCChhhhhc
Q 021306 260 -P--------TREEIRCM--NPN--YTDFRFPQIKAHPWHKVCI 290 (314)
Q Consensus 260 -~--------~~~~~~~~--~p~--~~~~~~~~l~~~p~~~~~~ 290 (314)
+ ..+.+.++ ++. ..|+++.++++|||++...
T Consensus 268 ~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~~ 311 (370)
T cd05621 268 FPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKNDQ 311 (370)
T ss_pred CCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCCC
Confidence 1 11222221 222 2478999999999998643
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=289.00 Aligned_cols=238 Identities=27% Similarity=0.448 Sum_probs=204.9
Q ss_pred CCceeeeeEeecCceEEEEEEECCCCcEEEEEEeecccc-------chHHHHHHHHhCCCCceeeeceeeeecCCCCcee
Q 021306 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 110 (314)
Q Consensus 38 ~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~~-------~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 110 (314)
.+|++.+.||+|.||.|-++.....|+.||+|.++++.. ..++|++++..|+||||+.++++|. ....
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFE-----NkdK 127 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFE-----NKDK 127 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhc-----CCce
Confidence 489999999999999999999989999999999876532 2368999999999999999999994 3344
Q ss_pred EEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCccc
Q 021306 111 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 189 (314)
Q Consensus 111 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~ 189 (314)
+.|||||.++ .|++.+.. .+.+++.+++.+++||+.|+.|||+ ++++|||||.+|||+|. ++.+||.|||++.
T Consensus 128 IvivMEYaS~GeLYDYiSe----r~~LsErEaRhfFRQIvSAVhYCHk-nrVvHRDLKLENILLD~-N~NiKIADFGLSN 201 (668)
T KOG0611|consen 128 IVIVMEYASGGELYDYISE----RGSLSEREARHFFRQIVSAVHYCHK-NRVVHRDLKLENILLDQ-NNNIKIADFGLSN 201 (668)
T ss_pred EEEEEEecCCccHHHHHHH----hccccHHHHHHHHHHHHHHHHHHhh-ccceecccchhheeecC-CCCeeeeccchhh
Confidence 8899999996 67776664 5889999999999999999999999 99999999999999999 8899999999999
Q ss_pred ccccCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCC--------
Q 021306 190 QLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT-------- 261 (314)
Q Consensus 190 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~-------- 261 (314)
.+........++|+|.|.+||++.|.+.-.+..|-||||++||.++.|..||.+.+-...+.+|.++--..+
T Consensus 202 ly~~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP~~PSdA~g 281 (668)
T KOG0611|consen 202 LYADKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREPETPSDASG 281 (668)
T ss_pred hhccccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCCCCCchHHH
Confidence 888877888899999999999998877567899999999999999999999999887766666665422111
Q ss_pred -HHHHhccCCCCCCCcccccccCChhh
Q 021306 262 -REEIRCMNPNYTDFRFPQIKAHPWHK 287 (314)
Q Consensus 262 -~~~~~~~~p~~~~~~~~~l~~~p~~~ 287 (314)
..++..++|+ +|-++++|-.|=|..
T Consensus 282 LIRwmLmVNP~-RRATieDiAsHWWvN 307 (668)
T KOG0611|consen 282 LIRWMLMVNPE-RRATIEDIASHWWVN 307 (668)
T ss_pred HHHHHHhcCcc-cchhHHHHhhhheee
Confidence 1334466898 899999999888843
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=299.35 Aligned_cols=217 Identities=39% Similarity=0.704 Sum_probs=191.0
Q ss_pred CceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccccch---HHHHHHHHhCC------CCceeeeceeeeecCCCCce
Q 021306 39 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK---NRELQLMRVMD------HPNVISLKHCFFSTTSKNEL 109 (314)
Q Consensus 39 ~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~~~~---~~e~~~l~~l~------h~~iv~~~~~~~~~~~~~~~ 109 (314)
+|++.+.||+|.||.|.+|.+..|++.||||+++...... ..|+.+|..++ .-|+|+++++|...+.
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~H---- 262 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNH---- 262 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccc----
Confidence 7899999999999999999999999999999998776544 47888888885 3579999999955444
Q ss_pred eEEEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcC-CCCcEEEeecCcc
Q 021306 110 FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP-LTHQVKICDFGSA 188 (314)
Q Consensus 110 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~-~~~~~~l~dfg~~ 188 (314)
+|||+|.++.+|++.+... ....++...++.++.||+.||.+||+ .||+|+||||+|||+.. ....+|++|||.+
T Consensus 263 -lciVfELL~~NLYellK~n--~f~Glsl~~ir~~~~Qil~~L~~L~~-l~IIHcDLKPENILL~~~~r~~vKVIDFGSS 338 (586)
T KOG0667|consen 263 -LCIVFELLSTNLYELLKNN--KFRGLSLPLVRKFAQQILTALLFLHE-LGIIHCDLKPENILLKDPKRSRIKVIDFGSS 338 (586)
T ss_pred -eeeeehhhhhhHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccCChhheeeccCCcCceeEEecccc
Confidence 9999999999999998863 23568999999999999999999999 89999999999999965 3457999999999
Q ss_pred cccccCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCHHHHh
Q 021306 189 KQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 266 (314)
Q Consensus 189 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 266 (314)
+..... ...+..+..|+|||++.|.+ |+.+.|+||||||+.||++|.+.|.|.+..+++..|++.++.|+...+.
T Consensus 339 c~~~q~--vytYiQSRfYRAPEVILGlp-Y~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~ 413 (586)
T KOG0667|consen 339 CFESQR--VYTYIQSRFYRAPEVILGLP-YDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLD 413 (586)
T ss_pred cccCCc--ceeeeeccccccchhhccCC-CCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 765433 33788899999999999876 9999999999999999999999999999999999999999988876655
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-42 Score=301.16 Aligned_cols=245 Identities=27% Similarity=0.442 Sum_probs=206.0
Q ss_pred cCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeecc------ccchHHHHHHHHhCCCCceeeeceeeeecCCCCce
Q 021306 36 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL 109 (314)
Q Consensus 36 ~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 109 (314)
..++|..++++|+|+||.+++++++.+++.|++|++.-. ++...+|..+++++.|||||.+.+.|. .+..
T Consensus 2 ~m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~----~~~~ 77 (426)
T KOG0589|consen 2 EMDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFE----EDGQ 77 (426)
T ss_pred ccchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchh----cCCc
Confidence 357899999999999999999999999999999998643 334468999999999999999999985 3334
Q ss_pred eEEEEeeccccc-HHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcc
Q 021306 110 FLNLVMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 188 (314)
Q Consensus 110 ~~~lv~e~~~~~-l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~ 188 (314)
+++|+|+||+|+ +.+.+... .+..++++.+..|+.|++.|+.|||+ ++|.|||||+.|||++. ++.++|+|||++
T Consensus 78 ~l~Ivm~Y~eGg~l~~~i~~~--k~~~f~E~~i~~~~~Q~~~av~ylH~-~~iLHRDlK~~Nifltk-~~~VkLgDfGla 153 (426)
T KOG0589|consen 78 LLCIVMEYCEGGDLAQLIKEQ--KGVLFPEERILKWFVQILLAVNYLHE-NRVLHRDLKCANIFLTK-DKKVKLGDFGLA 153 (426)
T ss_pred eEEEEEeecCCCCHHHHHHHH--hhccccHHHHHHHHHHHHHHHHHHHh-hhhhcccchhhhhhccc-cCceeecchhhh
Confidence 589999999974 55544432 25789999999999999999999999 99999999999999999 777899999999
Q ss_pred cccccCC-ccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCHHH---
Q 021306 189 KQLIAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE--- 264 (314)
Q Consensus 189 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~--- 264 (314)
+...... ...+..||+.|++||.+.+.+ |..++|||||||++|||++-+++|.+.+......+|++....|.+..
T Consensus 154 K~l~~~~~~a~tvvGTp~YmcPEil~d~p-Yn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp~~ys~ 232 (426)
T KOG0589|consen 154 KILNPEDSLASTVVGTPYYMCPEILSDIP-YNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLPSMYSS 232 (426)
T ss_pred hhcCCchhhhheecCCCcccCHHHhCCCC-CCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCCccccH
Confidence 9887665 566788999999999997655 99999999999999999999999999999999999998876665432
Q ss_pred --------HhccCCCCCCCcccccccCChhhhhc
Q 021306 265 --------IRCMNPNYTDFRFPQIKAHPWHKVCI 290 (314)
Q Consensus 265 --------~~~~~p~~~~~~~~~l~~~p~~~~~~ 290 (314)
....+|. .|+++.+|+.+|...+..
T Consensus 233 el~~lv~~~l~~~P~-~RPsa~~LL~~P~l~~~~ 265 (426)
T KOG0589|consen 233 ELRSLVKSMLRKNPE-HRPSALELLRRPHLLRYL 265 (426)
T ss_pred HHHHHHHHHhhcCCc-cCCCHHHHhhChhhhhHH
Confidence 1123566 677777877777665444
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-41 Score=295.42 Aligned_cols=233 Identities=24% Similarity=0.380 Sum_probs=185.1
Q ss_pred eeEeecCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeEEEEee
Q 021306 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVME 116 (314)
Q Consensus 44 ~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e 116 (314)
+.||+|+||.||+|+++.+|+.||+|.+++.. ....+|..++++++||||+++++++.. ...+++|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~-----~~~~~lv~e 75 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQT-----HDRLCFVME 75 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEc-----CCEEEEEEe
Confidence 46999999999999999999999999987532 223468899999999999999988743 335889999
Q ss_pred cccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcccccccC-
Q 021306 117 YVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG- 194 (314)
Q Consensus 117 ~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~~~- 194 (314)
|+++ +|...+. ....+++.+++.++.||+.||.|||+ +||+||||||+||+++. ++.++|+|||++......
T Consensus 76 ~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~L~~lH~-~~ivHrDlkp~NIll~~-~~~~kl~DfG~a~~~~~~~ 149 (323)
T cd05571 76 YANGGELFFHLS----RERVFSEDRARFYGAEIVSALGYLHS-CDVVYRDLKLENLMLDK-DGHIKITDFGLCKEGISDG 149 (323)
T ss_pred CCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHh-CCeEeCCCCHHHEEECC-CCCEEEeeCCCCcccccCC
Confidence 9997 4544443 35789999999999999999999999 89999999999999998 788999999998753222
Q ss_pred CccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCC-------CHHHHh-
Q 021306 195 EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP-------TREEIR- 266 (314)
Q Consensus 195 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~-------~~~~~~- 266 (314)
.......+++.|+|||.+.+.. ++.++|||||||++|+|++|+.||.+.+.......+....... ..+.+.
T Consensus 150 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~ 228 (323)
T cd05571 150 ATMKTFCGTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLAG 228 (323)
T ss_pred CcccceecCccccChhhhcCCC-CCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 2233456899999999996554 8999999999999999999999998877665555544322111 112222
Q ss_pred --ccCCCCCCC-----cccccccCChhhhh
Q 021306 267 --CMNPNYTDF-----RFPQIKAHPWHKVC 289 (314)
Q Consensus 267 --~~~p~~~~~-----~~~~l~~~p~~~~~ 289 (314)
..+|. +|+ ++.+|++|||++..
T Consensus 229 ~L~~dP~-~R~~~~~~~~~~ll~h~~f~~~ 257 (323)
T cd05571 229 LLKKDPK-QRLGGGPEDAKEIMEHRFFASI 257 (323)
T ss_pred HccCCHH-HcCCCCCCCHHHHHcCCCcCCC
Confidence 33677 788 79999999999764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-40 Score=295.49 Aligned_cols=193 Identities=25% Similarity=0.397 Sum_probs=164.3
Q ss_pred CCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHhCCCCceeeeceeeeecCCCCceeEEEEee
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVME 116 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e 116 (314)
.++|++.+.||+|+||.||+|.+..+++.||+|.... ....+|+.++++++||||+++++++... ...++++|
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~--~~~~~E~~il~~l~HpnIv~~~~~~~~~-----~~~~lv~e 163 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR--GGTATEAHILRAINHPSIIQLKGTFTYN-----KFTCLILP 163 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh--hhhHHHHHHHHhCCCCCCCCEeEEEEEC-----CeeEEEEe
Confidence 3579999999999999999999999999999997543 3356899999999999999999988443 34789999
Q ss_pred cccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcccccccC--
Q 021306 117 YVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG-- 194 (314)
Q Consensus 117 ~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~~~-- 194 (314)
++.+++...+.. ...+++..++.++.|++.||.|||+ +||+||||||+||+++. .+.++|+|||++......
T Consensus 164 ~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~ylH~-~~IvHrDiKP~NIll~~-~~~vkL~DFG~a~~~~~~~~ 237 (391)
T PHA03212 164 RYKTDLYCYLAA----KRNIAICDILAIERSVLRAIQYLHE-NRIIHRDIKAENIFINH-PGDVCLGDFGAACFPVDINA 237 (391)
T ss_pred cCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCChHhEEEcC-CCCEEEEeCCcccccccccc
Confidence 999887776653 4678999999999999999999999 89999999999999998 788999999998643221
Q ss_pred CccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 021306 195 EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 243 (314)
Q Consensus 195 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~ 243 (314)
.......+|+.|+|||.+.+.. ++.++||||||+++|+|++|+.||..
T Consensus 238 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvil~elltg~~p~~~ 285 (391)
T PHA03212 238 NKYYGWAGTIATNAPELLARDP-YGPAVDIWSAGIVLFEMATCHDSLFE 285 (391)
T ss_pred cccccccCccCCCChhhhcCCC-CCcHHHHHHHHHHHHHHHHCCCCcCC
Confidence 1223456899999999996544 89999999999999999999988744
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-42 Score=276.96 Aligned_cols=244 Identities=27% Similarity=0.458 Sum_probs=205.8
Q ss_pred ccCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc------------cchHHHHHHHHhC-CCCceeeeceeee
Q 021306 35 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------------RYKNRELQLMRVM-DHPNVISLKHCFF 101 (314)
Q Consensus 35 ~~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~------------~~~~~e~~~l~~l-~h~~iv~~~~~~~ 101 (314)
...++|.-.+.||+|..+.|-++.++.+|+.+++|++.... ....+|+.+|+++ .||+|+++.+.+
T Consensus 14 ~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y- 92 (411)
T KOG0599|consen 14 GFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY- 92 (411)
T ss_pred hHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec-
Confidence 34568999999999999999999999999999999884221 1113688899887 799999999998
Q ss_pred ecCCCCceeEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcE
Q 021306 102 STTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQV 180 (314)
Q Consensus 102 ~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~ 180 (314)
+...++|+|+|.|+. .|.+.|. ....+++...+.+++|+..++.|||. ++||||||||+||++++ +.++
T Consensus 93 ----es~sF~FlVFdl~prGELFDyLt----s~VtlSEK~tR~iMrqlfegVeylHa-~~IVHRDLKpENILldd-n~~i 162 (411)
T KOG0599|consen 93 ----ESDAFVFLVFDLMPRGELFDYLT----SKVTLSEKETRRIMRQLFEGVEYLHA-RNIVHRDLKPENILLDD-NMNI 162 (411)
T ss_pred ----cCcchhhhhhhhcccchHHHHhh----hheeecHHHHHHHHHHHHHHHHHHHH-hhhhhcccChhheeecc-ccce
Confidence 555569999999995 5555554 46889999999999999999999999 89999999999999998 8899
Q ss_pred EEeecCcccccccCCcccccccccccccccccc-----CCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 021306 181 KICDFGSAKQLIAGEANISYICSRFYRAPELIF-----GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 255 (314)
Q Consensus 181 ~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~ 255 (314)
+|+|||+++.+.........+|||+|+|||.+. +.+.|+...|+||+|+|+|.++.|.+||.-....-++..|++
T Consensus 163 ~isDFGFa~~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~Ime 242 (411)
T KOG0599|consen 163 KISDFGFACQLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIME 242 (411)
T ss_pred EEeccceeeccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHh
Confidence 999999999988887778889999999999984 344578899999999999999999999988888888888887
Q ss_pred Hc-----------CCCCHHHHh---ccCCCCCCCcccccccCChhhhhc
Q 021306 256 VL-----------GTPTREEIR---CMNPNYTDFRFPQIKAHPWHKVCI 290 (314)
Q Consensus 256 ~~-----------~~~~~~~~~---~~~p~~~~~~~~~l~~~p~~~~~~ 290 (314)
+. +....+.+. ..+|. +|+++.+.+.|||+.+..
T Consensus 243 GkyqF~speWadis~~~KdLIsrlLqVdp~-~Ritake~LaHpff~q~~ 290 (411)
T KOG0599|consen 243 GKYQFRSPEWADISATVKDLISRLLQVDPT-KRITAKEALAHPFFIQIA 290 (411)
T ss_pred cccccCCcchhhccccHHHHHHHHHeeCch-hcccHHHHhcChHHHHHH
Confidence 63 222233333 45888 899999999999995544
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=284.87 Aligned_cols=246 Identities=31% Similarity=0.603 Sum_probs=197.2
Q ss_pred cCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCcee
Q 021306 36 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 110 (314)
Q Consensus 36 ~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 110 (314)
..++|++.+.||+|++|.||++++..+++.|++|.+.... ....+|+.+++.++|+||+++++++.. ...
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~-----~~~ 78 (301)
T cd07873 4 KLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHT-----EKS 78 (301)
T ss_pred cccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEec-----CCe
Confidence 3568999999999999999999999999999999886432 234579999999999999999999843 334
Q ss_pred EEEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcccc
Q 021306 111 LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 190 (314)
Q Consensus 111 ~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~ 190 (314)
.++++||+++++...+.. ....+++..++.++.|++.||.+||+ .|++|+||+|+||+++. ++.++|+|||.+..
T Consensus 79 ~~lv~e~~~~~l~~~l~~---~~~~~~~~~~~~~~~qi~~aL~~lH~-~~i~H~dlkp~Nil~~~-~~~~kl~dfg~~~~ 153 (301)
T cd07873 79 LTLVFEYLDKDLKQYLDD---CGNSINMHNVKLFLFQLLRGLNYCHR-RKVLHRDLKPQNLLINE-RGELKLADFGLARA 153 (301)
T ss_pred EEEEEeccccCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCCHHHEEECC-CCcEEECcCcchhc
Confidence 889999999988777654 24568999999999999999999999 89999999999999998 78899999999875
Q ss_pred cccCCc-cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCC--------
Q 021306 191 LIAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT-------- 261 (314)
Q Consensus 191 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~-------- 261 (314)
...... .....+++.|+|||.+.+...++.++||||||+++|+|++|+.||.+.+..+....+.+..+.+.
T Consensus 154 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (301)
T cd07873 154 KSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGIL 233 (301)
T ss_pred cCCCCCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhh
Confidence 433222 22345678899999987666678899999999999999999999998887666655544332211
Q ss_pred -----------------------------HHHHh---ccCCCCCCCcccccccCChhhhhccc
Q 021306 262 -----------------------------REEIR---CMNPNYTDFRFPQIKAHPWHKVCIFH 292 (314)
Q Consensus 262 -----------------------------~~~~~---~~~p~~~~~~~~~l~~~p~~~~~~~~ 292 (314)
.+.+. ..+|. +|+++.++++|||++-...+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~-~R~t~~eil~h~~f~~~~~~ 295 (301)
T cd07873 234 SNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGR-KRISAEEAMKHPYFHCLGER 295 (301)
T ss_pred ccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcc-cCcCHHHHhcCcccccccch
Confidence 11222 23566 89999999999999765543
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-41 Score=299.54 Aligned_cols=240 Identities=26% Similarity=0.433 Sum_probs=190.2
Q ss_pred CCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCCcee
Q 021306 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 110 (314)
Q Consensus 38 ~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 110 (314)
++|++.+.||+|+||.||++++..+++.||+|.+.... ....+|..++..++|++|+++++.+. ....
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~-----~~~~ 75 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQ-----DKRN 75 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEE-----cCCE
Confidence 47999999999999999999999999999999986432 22357888999999999999998884 3345
Q ss_pred EEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCccc
Q 021306 111 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 189 (314)
Q Consensus 111 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~ 189 (314)
+++||||++| +|.+.+. ....+++..++.++.|++.||.|||+ +||+||||||+||+++. ++.++|+|||++.
T Consensus 76 ~~lv~E~~~gg~L~~~l~----~~~~l~~~~~~~~~~qi~~~L~~lH~-~givHrDLkp~NIli~~-~~~vkL~DfG~~~ 149 (360)
T cd05627 76 LYLIMEFLPGGDMMTLLM----KKDTLSEEATQFYIAETVLAIDAIHQ-LGFIHRDIKPDNLLLDA-KGHVKLSDFGLCT 149 (360)
T ss_pred EEEEEeCCCCccHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEccCCCHHHEEECC-CCCEEEeeccCCc
Confidence 8999999986 5555554 35679999999999999999999999 89999999999999998 8899999999876
Q ss_pred ccccCC------------------------------------ccccccccccccccccccCCCCCCcchhHHHHHHHHHH
Q 021306 190 QLIAGE------------------------------------ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAE 233 (314)
Q Consensus 190 ~~~~~~------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e 233 (314)
...... ......||+.|+|||.+.+.. ++.++|+|||||++|+
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~-~~~~~DiwSlGvilye 228 (360)
T cd05627 150 GLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTG-YNKLCDWWSLGVIMYE 228 (360)
T ss_pred ccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCC-CCCcceeccccceeee
Confidence 432110 011245789999999996654 8899999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHHHHHcCC---C--------CHHHHh--ccCCCCCCC---cccccccCChhhhhc
Q 021306 234 LLLGQPLFPGENAVDQLVEIIKVLGT---P--------TREEIR--CMNPNYTDF---RFPQIKAHPWHKVCI 290 (314)
Q Consensus 234 l~tg~~pf~~~~~~~~~~~i~~~~~~---~--------~~~~~~--~~~p~~~~~---~~~~l~~~p~~~~~~ 290 (314)
|++|+.||.+.+.......++..... + ..+.+. +.+|. .|+ +++++++|||++...
T Consensus 229 l~tG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~p~-~R~~~~~~~ei~~hp~f~~~~ 300 (360)
T cd05627 229 MLIGYPPFCSETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCTDSE-NRIGSNGVEEIKSHPFFEGVD 300 (360)
T ss_pred cccCCCCCCCCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhccChh-hcCCCCCHHHHhcCCCCCCCC
Confidence 99999999998887776666542110 1 112222 22555 455 578999999998654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=295.95 Aligned_cols=244 Identities=25% Similarity=0.427 Sum_probs=193.3
Q ss_pred ccCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCC
Q 021306 35 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKN 107 (314)
Q Consensus 35 ~~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 107 (314)
...++|++.+.||+|+||.||++++..+++.||+|.+.+.. ....+|+.+++.++||||+++++++. .
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~-----~ 114 (370)
T cd05596 40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQ-----D 114 (370)
T ss_pred CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEe-----c
Confidence 44578999999999999999999999999999999986421 22357899999999999999998874 3
Q ss_pred ceeEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecC
Q 021306 108 ELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 186 (314)
Q Consensus 108 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg 186 (314)
..++++||||++| +|.+.+. +..+++.++..++.||+.||.|||+ +||+||||||+||+++. ++.++|+|||
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~l~-----~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivHrDLkp~NILl~~-~~~~kL~DfG 187 (370)
T cd05596 115 DKYLYMVMEYMPGGDLVNLMS-----NYDIPEKWARFYTAEVVLALDAIHS-MGFIHRDVKPDNMLLDK-SGHLKLADFG 187 (370)
T ss_pred CCEEEEEEcCCCCCcHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHEEEcC-CCCEEEEecc
Confidence 3458899999986 5555443 2568999999999999999999999 89999999999999998 8899999999
Q ss_pred cccccccCC--ccccccccccccccccccCCC---CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCC--
Q 021306 187 SAKQLIAGE--ANISYICSRFYRAPELIFGAT---EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT-- 259 (314)
Q Consensus 187 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~---~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~-- 259 (314)
++....... ......+++.|+|||.+.+.. .++.++|||||||++|+|++|+.||.+.+....+..++.....
T Consensus 188 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~ 267 (370)
T cd05596 188 TCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLT 267 (370)
T ss_pred ceeeccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCC
Confidence 987653322 122356799999999986432 3678999999999999999999999998877777776643211
Q ss_pred -CC--------HHHHh-cc--CCC-CCCCcccccccCChhhhhc
Q 021306 260 -PT--------REEIR-CM--NPN-YTDFRFPQIKAHPWHKVCI 290 (314)
Q Consensus 260 -~~--------~~~~~-~~--~p~-~~~~~~~~l~~~p~~~~~~ 290 (314)
+. .+.+. ++ +|. ..|+++.++++|||++...
T Consensus 268 ~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~~ 311 (370)
T cd05596 268 FPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKNDQ 311 (370)
T ss_pred CCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCCCC
Confidence 11 11122 12 344 2388999999999998643
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=298.66 Aligned_cols=258 Identities=26% Similarity=0.393 Sum_probs=205.5
Q ss_pred CCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeE
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 111 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 111 (314)
...|+..+.||+|+||.||+|.+..+++.||+|.+..+. ...++|+.++.+++++||.++++.++.... +
T Consensus 12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~-----L 86 (467)
T KOG0201|consen 12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTK-----L 86 (467)
T ss_pred ccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeeccc-----H
Confidence 346899999999999999999999999999999986543 344689999999999999999999965554 8
Q ss_pred EEEeeccccc-HHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcccc
Q 021306 112 NLVMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 190 (314)
Q Consensus 112 ~lv~e~~~~~-l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~ 190 (314)
|++||||.|+ +.+.+. .+..+.+..+..++++++.|+.|||. ++.+|+|||+.||++.. .+.++|+|||.+..
T Consensus 87 wiiMey~~gGsv~~lL~----~~~~~~E~~i~~ilre~l~~l~ylH~-~~kiHrDIKaanil~s~-~g~vkl~DfgVa~q 160 (467)
T KOG0201|consen 87 WIIMEYCGGGSVLDLLK----SGNILDEFEIAVILREVLKGLDYLHS-EKKIHRDIKAANILLSE-SGDVKLADFGVAGQ 160 (467)
T ss_pred HHHHHHhcCcchhhhhc----cCCCCccceeeeehHHHHHHhhhhhh-cceecccccccceeEec-cCcEEEEecceeee
Confidence 9999999975 444443 45666999999999999999999999 89999999999999998 68999999999876
Q ss_pred cccCCc-cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCC--------
Q 021306 191 LIAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT-------- 261 (314)
Q Consensus 191 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~-------- 261 (314)
...... ...+.|||.|||||++.+.. |+.++||||||++++||++|.+|+...++...+..|-+...+..
T Consensus 161 l~~~~~rr~tfvGTPfwMAPEVI~~~~-Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L~~~~S~~~ 239 (467)
T KOG0201|consen 161 LTNTVKRRKTFVGTPFWMAPEVIKQSG-YDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRLDGDFSPPF 239 (467)
T ss_pred eechhhccccccccccccchhhhcccc-ccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCccccccCHHH
Confidence 655433 36788999999999997544 99999999999999999999999999999776666655422211
Q ss_pred HHHHh---ccCCCCCCCcccccccCChhhhhcccCChHHHHHhcchhhh
Q 021306 262 REEIR---CMNPNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGSHINA 307 (314)
Q Consensus 262 ~~~~~---~~~p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~~~~~ 307 (314)
.+.+. ..+|+ .|+++.+|++|+|.+..........+++..+..++
T Consensus 240 kEFV~~CL~k~P~-~RpsA~~LLKh~FIk~a~k~s~L~~~i~r~~~~~~ 287 (467)
T KOG0201|consen 240 KEFVEACLDKNPE-FRPSAKELLKHKFIKRAKKTSELKELIDRYKRWRV 287 (467)
T ss_pred HHHHHHHhhcCcc-cCcCHHHHhhhHHHHhcCCchHHHHHHHHHHHHhh
Confidence 12221 23666 57788888888887775544444444444444443
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-40 Score=291.99 Aligned_cols=245 Identities=36% Similarity=0.613 Sum_probs=196.3
Q ss_pred cCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCC-CCc
Q 021306 36 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTS-KNE 108 (314)
Q Consensus 36 ~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~~~ 108 (314)
..++|++.+.||+|+||.||+|.+..+++.||+|.+.... ....+|+.++++++|+||+++++++..... ...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 3468999999999999999999999999999999986432 223479999999999999999988743221 122
Q ss_pred eeEEEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcc
Q 021306 109 LFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 188 (314)
Q Consensus 109 ~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~ 188 (314)
...+++++++.+++...+. ...+++..++.++.||+.||.|||+ +||+|+||||+||+++. ++.++|+|||++
T Consensus 93 ~~~~~~~~~~~~~l~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivHrdikp~Nil~~~-~~~~kl~Dfg~~ 165 (343)
T cd07878 93 NEVYLVTNLMGADLNNIVK-----CQKLSDEHVQFLIYQLLRGLKYIHS-AGIIHRDLKPSNVAVNE-DCELRILDFGLA 165 (343)
T ss_pred CcEEEEeecCCCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeecccCChhhEEECC-CCCEEEcCCccc
Confidence 3468999999888766554 3679999999999999999999999 89999999999999998 888999999998
Q ss_pred cccccCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCH------
Q 021306 189 KQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR------ 262 (314)
Q Consensus 189 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~------ 262 (314)
...... .....+++.|+|||.+.+...++.++||||||+++|+|++|+.||.+.+..+.+..+....+.+..
T Consensus 166 ~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd07878 166 RQADDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKI 243 (343)
T ss_pred eecCCC--cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence 765432 234567889999999877556889999999999999999999999887766666555543322211
Q ss_pred --------------------------------HHH---hccCCCCCCCcccccccCChhhhhc
Q 021306 263 --------------------------------EEI---RCMNPNYTDFRFPQIKAHPWHKVCI 290 (314)
Q Consensus 263 --------------------------------~~~---~~~~p~~~~~~~~~l~~~p~~~~~~ 290 (314)
+.+ ...+|. +|+++.+++.|||+....
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~-~R~s~~ell~hp~~~~~~ 305 (343)
T cd07878 244 SSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSD-KRISASEALAHPYFSQYH 305 (343)
T ss_pred chhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChh-hCCCHHHHhcCcchhccC
Confidence 111 123666 899999999999997643
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=297.88 Aligned_cols=245 Identities=25% Similarity=0.423 Sum_probs=193.4
Q ss_pred CccCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCC
Q 021306 34 PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSK 106 (314)
Q Consensus 34 ~~~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 106 (314)
....++|++.+.||+|+||.||+++++.+++.+|+|.+.+.. ....+|..+++.++||||+++++++.
T Consensus 39 ~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~----- 113 (371)
T cd05622 39 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQ----- 113 (371)
T ss_pred CcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEE-----
Confidence 344579999999999999999999999999999999986421 22357889999999999999998884
Q ss_pred CceeEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeec
Q 021306 107 NELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF 185 (314)
Q Consensus 107 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~df 185 (314)
...++++||||++| +|.+.+. ...+++.+++.++.||+.||.|||+ +||+||||||+||+++. ++.++|+||
T Consensus 114 ~~~~~~lv~Ey~~gg~L~~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDLkp~NIll~~-~~~ikL~Df 186 (371)
T cd05622 114 DDRYLYMVMEYMPGGDLVNLMS-----NYDVPEKWARFYTAEVVLALDAIHS-MGFIHRDVKPDNMLLDK-SGHLKLADF 186 (371)
T ss_pred cCCEEEEEEcCCCCCcHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHH-CCEEeCCCCHHHEEECC-CCCEEEEeC
Confidence 33458899999986 5555443 2568999999999999999999999 89999999999999998 889999999
Q ss_pred CcccccccCCc--cccccccccccccccccCCC---CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCC-
Q 021306 186 GSAKQLIAGEA--NISYICSRFYRAPELIFGAT---EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT- 259 (314)
Q Consensus 186 g~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~---~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~- 259 (314)
|++........ .....+|+.|+|||.+.+.. .++.++|||||||++|+|++|+.||.+.+....+..++.....
T Consensus 187 G~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~ 266 (371)
T cd05622 187 GTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSL 266 (371)
T ss_pred CceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcc
Confidence 99876543221 22456899999999986432 3678999999999999999999999998877777776643211
Q ss_pred --CC--------HHHHhcc--CCC--CCCCcccccccCChhhhhc
Q 021306 260 --PT--------REEIRCM--NPN--YTDFRFPQIKAHPWHKVCI 290 (314)
Q Consensus 260 --~~--------~~~~~~~--~p~--~~~~~~~~l~~~p~~~~~~ 290 (314)
+. ...+..+ +|. ..|+++.++++|||++...
T Consensus 267 ~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~~ 311 (371)
T cd05622 267 TFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQ 311 (371)
T ss_pred cCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCCC
Confidence 11 1122221 222 2477999999999997643
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-40 Score=284.10 Aligned_cols=243 Identities=27% Similarity=0.395 Sum_probs=188.2
Q ss_pred CceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeE
Q 021306 39 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 111 (314)
Q Consensus 39 ~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 111 (314)
.|++.+.||+|+||.||++.+..+++.||+|.+.... ....+|+.++++++|++|+++.+++.. ...+
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~-----~~~~ 75 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYET-----KDAL 75 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEcc-----CCeE
Confidence 4889999999999999999999999999999886432 123478999999999999999888733 3358
Q ss_pred EEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcccc
Q 021306 112 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 190 (314)
Q Consensus 112 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~ 190 (314)
++++||+++ +|...+.. .....+++..++.++.|++.||.|||+ +||+||||||+||+++. ++.++|+|||++..
T Consensus 76 ~lv~e~~~~g~L~~~~~~--~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~iiH~dikp~Nill~~-~~~~kl~Dfg~~~~ 151 (285)
T cd05631 76 CLVLTIMNGGDLKFHIYN--MGNPGFDEQRAIFYAAELCCGLEDLQR-ERIVYRDLKPENILLDD-RGHIRISDLGLAVQ 151 (285)
T ss_pred EEEEEecCCCcHHHHHHh--hCCCCCCHHHHHHHHHHHHHHHHHHHh-CCEEeCCCCHHHEEECC-CCCEEEeeCCCcEE
Confidence 899999996 45444432 123568999999999999999999999 89999999999999998 78899999999876
Q ss_pred cccCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCC----------
Q 021306 191 LIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP---------- 260 (314)
Q Consensus 191 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~---------- 260 (314)
...........+++.|+|||.+.+.. ++.++||||||+++|+|++|+.||.+.........+.+.....
T Consensus 152 ~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 230 (285)
T cd05631 152 IPEGETVRGRVGTVGYMAPEVINNEK-YTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSE 230 (285)
T ss_pred cCCCCeecCCCCCCCccCHhhhcCCC-CCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCH
Confidence 54333334456789999999997654 8999999999999999999999998765433222222211110
Q ss_pred -CHHHHh---ccCCCCCCCc-----ccccccCChhhhhccc
Q 021306 261 -TREEIR---CMNPNYTDFR-----FPQIKAHPWHKVCIFH 292 (314)
Q Consensus 261 -~~~~~~---~~~p~~~~~~-----~~~l~~~p~~~~~~~~ 292 (314)
..+.+. ..+|. +|++ +.++++|||+.....+
T Consensus 231 ~~~~li~~~l~~~P~-~R~~~~~~~~~~~~~h~~~~~~~~~ 270 (285)
T cd05631 231 DAKSICRMLLTKNPK-ERLGCRGNGAAGVKQHPIFKNINFK 270 (285)
T ss_pred HHHHHHHHHhhcCHH-HhcCCCCCCHHHHhcCHhhcCCCHH
Confidence 111222 33566 6775 8999999999876644
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=300.06 Aligned_cols=243 Identities=24% Similarity=0.409 Sum_probs=188.5
Q ss_pred CCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHhCCCC------ceeeeceeeeecCCCC
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMDHP------NVISLKHCFFSTTSKN 107 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~---~~~~~e~~~l~~l~h~------~iv~~~~~~~~~~~~~ 107 (314)
.++|++.+.||+|+||.||+|.+..+++.||+|+++... .....|+.+++.++|. +++++++++.. .
T Consensus 128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~----~ 203 (467)
T PTZ00284 128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN----E 203 (467)
T ss_pred CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc----C
Confidence 468999999999999999999999999999999986432 2234677777777554 47777777642 2
Q ss_pred ceeEEEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCC---------
Q 021306 108 ELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH--------- 178 (314)
Q Consensus 108 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~--------- 178 (314)
..++++|+|++.+++.+.+.. .+.+++..++.++.||+.||.|||+..||+||||||+||+++..+.
T Consensus 204 ~~~~~iv~~~~g~~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~ 279 (467)
T PTZ00284 204 TGHMCIVMPKYGPCLLDWIMK----HGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRA 279 (467)
T ss_pred CceEEEEEeccCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccc
Confidence 235789999998888877654 4679999999999999999999997139999999999999986321
Q ss_pred ------cEEEeecCcccccccCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 021306 179 ------QVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVE 252 (314)
Q Consensus 179 ------~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~ 252 (314)
.+||+|||.+.... .......+|+.|+|||.+.+.. ++.++|||||||++|||++|+.||.+.+..+.+..
T Consensus 280 ~~~~~~~vkl~DfG~~~~~~--~~~~~~~gt~~Y~APE~~~~~~-~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~ 356 (467)
T PTZ00284 280 LPPDPCRVRICDLGGCCDER--HSRTAIVSTRHYRSPEVVLGLG-WMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHL 356 (467)
T ss_pred cCCCCceEEECCCCccccCc--cccccccCCccccCcHHhhcCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence 59999999875432 2233457799999999997655 89999999999999999999999988776665554
Q ss_pred HHHHcCCCCH-------------------------------------------------HHH---hccCCCCCCCccccc
Q 021306 253 IIKVLGTPTR-------------------------------------------------EEI---RCMNPNYTDFRFPQI 280 (314)
Q Consensus 253 i~~~~~~~~~-------------------------------------------------~~~---~~~~p~~~~~~~~~l 280 (314)
+.+..+..+. +.+ ...+|. +|+++.++
T Consensus 357 i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~-~R~ta~e~ 435 (467)
T PTZ00284 357 MEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQ-KRLNARQM 435 (467)
T ss_pred HHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChh-hCCCHHHH
Confidence 4443322111 111 234777 89999999
Q ss_pred ccCChhhhhcc
Q 021306 281 KAHPWHKVCIF 291 (314)
Q Consensus 281 ~~~p~~~~~~~ 291 (314)
++|||++....
T Consensus 436 L~Hp~~~~~~~ 446 (467)
T PTZ00284 436 TTHPYVLKYYP 446 (467)
T ss_pred hcCccccccCC
Confidence 99999987543
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=289.39 Aligned_cols=192 Identities=28% Similarity=0.442 Sum_probs=163.2
Q ss_pred CCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHhCCCCceeeeceeeeecCCCCceeEEEEee
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVME 116 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e 116 (314)
..+|++.+.||+|+||.||+|++..+++.|++|..... ....|+.++++++|+||+++++++.... ..++|+|
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~--~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~~lv~e 137 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG--TTLIEAMLLQNVNHPSVIRMKDTLVSGA-----ITCMVLP 137 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc--ccHHHHHHHHhCCCCCCcChhheEEeCC-----eeEEEEE
Confidence 35799999999999999999999999999999975433 3357899999999999999999885433 3789999
Q ss_pred cccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcccccccCCc
Q 021306 117 YVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA 196 (314)
Q Consensus 117 ~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~~~~~ 196 (314)
++.+++.+.+.. ....+++.+++.++.||+.||.|||+ +||+||||||+||+++. .+.++|+|||++........
T Consensus 138 ~~~~~l~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~Nill~~-~~~~kl~DfG~a~~~~~~~~ 212 (357)
T PHA03209 138 HYSSDLYTYLTK---RSRPLPIDQALIIEKQILEGLRYLHA-QRIIHRDVKTENIFIND-VDQVCIGDLGAAQFPVVAPA 212 (357)
T ss_pred ccCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEECC-CCCEEEecCccccccccCcc
Confidence 999988877754 34679999999999999999999999 89999999999999998 78899999999875433333
Q ss_pred cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCC
Q 021306 197 NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLF 241 (314)
Q Consensus 197 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf 241 (314)
.....+++.|+|||.+.+.. ++.++||||||+++|+|+++..|+
T Consensus 213 ~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 213 FLGLAGTVETNAPEVLARDK-YNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred cccccccccccCCeecCCCC-CCchhhHHHHHHHHHHHHHcCCcc
Confidence 34456889999999996654 899999999999999999865444
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=294.97 Aligned_cols=242 Identities=24% Similarity=0.416 Sum_probs=193.2
Q ss_pred CCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCCcee
Q 021306 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 110 (314)
Q Consensus 38 ~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 110 (314)
++|++.+.||+|+||.||++++..+++.||+|.++... ....+|..+++.++|+||+++++++.. ...
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~-----~~~ 75 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQD-----KDN 75 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEec-----CCe
Confidence 47999999999999999999999999999999987532 234578889999999999999888743 334
Q ss_pred EEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCccc
Q 021306 111 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 189 (314)
Q Consensus 111 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~ 189 (314)
.++||||+++ +|.+.+.. ....+++..++.++.|++.||.|||+ .||+||||||+||+++. ++.++|+|||++.
T Consensus 76 ~~lv~e~~~~~~L~~~l~~---~~~~l~~~~~~~~~~qi~~aL~~lH~-~~i~H~Dlkp~NIll~~-~~~~kL~Dfg~a~ 150 (330)
T cd05601 76 LYLVMEYQPGGDLLSLLNR---YEDQFDEDMAQFYLAELVLAIHSVHQ-MGYVHRDIKPENVLIDR-TGHIKLADFGSAA 150 (330)
T ss_pred EEEEECCCCCCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEcccCchHheEECC-CCCEEeccCCCCe
Confidence 8899999986 66655543 23679999999999999999999999 89999999999999998 8899999999987
Q ss_pred ccccCCc--cccccccccccccccccC-----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCC---
Q 021306 190 QLIAGEA--NISYICSRFYRAPELIFG-----ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT--- 259 (314)
Q Consensus 190 ~~~~~~~--~~~~~~~~~y~aPE~~~~-----~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~--- 259 (314)
....... .....+++.|+|||.+.. ...++.++||||||+++|+|++|+.||...+....+..++.....
T Consensus 151 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~ 230 (330)
T cd05601 151 RLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKF 230 (330)
T ss_pred ECCCCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCC
Confidence 6543322 123457889999999853 334678999999999999999999999988877766666543210
Q ss_pred C-----C---HHHHhcc--CCCCCCCcccccccCChhhhhc
Q 021306 260 P-----T---REEIRCM--NPNYTDFRFPQIKAHPWHKVCI 290 (314)
Q Consensus 260 ~-----~---~~~~~~~--~p~~~~~~~~~l~~~p~~~~~~ 290 (314)
+ . .+.+..+ +|. +|+++.+++.|||++...
T Consensus 231 ~~~~~~~~~~~~li~~ll~~p~-~R~t~~~l~~h~~~~~~~ 270 (330)
T cd05601 231 PEDPKVSSDFLDLIQSLLCGQK-ERLGYEGLCCHPFFSKID 270 (330)
T ss_pred CCCCCCCHHHHHHHHHHccChh-hCCCHHHHhCCCCcCCCC
Confidence 1 1 1122211 666 899999999999997643
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-40 Score=289.81 Aligned_cols=234 Identities=24% Similarity=0.370 Sum_probs=184.1
Q ss_pred eeEeecCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeEEEEee
Q 021306 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVME 116 (314)
Q Consensus 44 ~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e 116 (314)
+.||+|+||.||++++..+|+.||+|.+.... ....+|..+++.++||||+++++++... ..+++|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~-----~~~~lv~E 75 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTH-----DRLCFVME 75 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecC-----CEEEEEEe
Confidence 46999999999999999999999999986532 1224688999999999999999888433 34889999
Q ss_pred cccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcccccccCC
Q 021306 117 YVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE 195 (314)
Q Consensus 117 ~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~~~~ 195 (314)
|+++ +|...+. ....+++..++.++.||+.||.|||+ +|++||||||+||+++. ++.++|+|||++.......
T Consensus 76 ~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~-~~~~kL~Dfg~~~~~~~~~ 149 (323)
T cd05595 76 YANGGELFFHLS----RERVFTEERARFYGAEIVSALEYLHS-RDVVYRDIKLENLMLDK-DGHIKITDFGLCKEGISDG 149 (323)
T ss_pred CCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHEEEcC-CCCEEecccHHhccccCCC
Confidence 9997 4444433 35679999999999999999999999 89999999999999998 7889999999886532222
Q ss_pred -ccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCC-------CHHHHh-
Q 021306 196 -ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP-------TREEIR- 266 (314)
Q Consensus 196 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~-------~~~~~~- 266 (314)
......+++.|+|||.+.+.. ++.++||||||+++|+|++|+.||.+.+.......+....... ..+.+.
T Consensus 150 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~ 228 (323)
T cd05595 150 ATMKTFCGTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAG 228 (323)
T ss_pred CccccccCCcCcCCcccccCCC-CCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHH
Confidence 223356789999999996654 7999999999999999999999998887766655554322111 112222
Q ss_pred --ccCCCCCCC-----cccccccCChhhhhc
Q 021306 267 --CMNPNYTDF-----RFPQIKAHPWHKVCI 290 (314)
Q Consensus 267 --~~~p~~~~~-----~~~~l~~~p~~~~~~ 290 (314)
..+|. +|+ ++.++++|||+....
T Consensus 229 ~L~~dP~-~R~~~~~~~~~~~l~h~~~~~~~ 258 (323)
T cd05595 229 LLKKDPK-QRLGGGPSDAKEVMEHRFFLSIN 258 (323)
T ss_pred HccCCHH-HhCCCCCCCHHHHHcCCCcCCCC
Confidence 23566 666 899999999987543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=286.95 Aligned_cols=239 Identities=28% Similarity=0.421 Sum_probs=187.2
Q ss_pred CceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCC-ceeeeceeeeecCCCCcee
Q 021306 39 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHP-NVISLKHCFFSTTSKNELF 110 (314)
Q Consensus 39 ~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~-------~~~~~e~~~l~~l~h~-~iv~~~~~~~~~~~~~~~~ 110 (314)
+|++.+.||+|+||.||+|++..+++.||+|.+.+.. .....|..++..+.|+ +|+++++++... ..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~-----~~ 75 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM-----DR 75 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcC-----CE
Confidence 5899999999999999999999999999999987532 1234677788888765 577787777432 34
Q ss_pred EEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCccc
Q 021306 111 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 189 (314)
Q Consensus 111 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~ 189 (314)
+++||||+++ +|...+. ....+++.+++.++.||+.||.|||+ +||+||||||+||+++. ++.++|+|||++.
T Consensus 76 ~~lv~E~~~~g~L~~~~~----~~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~dlkp~Nill~~-~~~~kL~Dfg~~~ 149 (324)
T cd05587 76 LYFVMEYVNGGDLMYHIQ----QVGKFKEPHAVFYAAEIAIGLFFLHS-KGIIYRDLKLDNVMLDA-EGHIKIADFGMCK 149 (324)
T ss_pred EEEEEcCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHeEEcC-CCCEEEeecCcce
Confidence 8899999986 5554443 34678999999999999999999999 89999999999999998 7889999999986
Q ss_pred cccc-CCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCC-------
Q 021306 190 QLIA-GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT------- 261 (314)
Q Consensus 190 ~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~------- 261 (314)
.... ........+++.|+|||.+.+.. ++.++|+||||+++|+|++|+.||.+.+..+.+..+.+.....+
T Consensus 150 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 228 (324)
T cd05587 150 ENIFGGKTTRTFCGTPDYIAPEIIAYQP-YGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEA 228 (324)
T ss_pred ecCCCCCceeeecCCccccChhhhcCCC-CCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHH
Confidence 4322 22233456789999999997654 78999999999999999999999998887777766655432211
Q ss_pred HHHHh---ccCCCCCCCcc-----cccccCChhhhhc
Q 021306 262 REEIR---CMNPNYTDFRF-----PQIKAHPWHKVCI 290 (314)
Q Consensus 262 ~~~~~---~~~p~~~~~~~-----~~l~~~p~~~~~~ 290 (314)
.+.+. ..+|. +|++. +++++|||++...
T Consensus 229 ~~li~~~l~~~P~-~R~~~~~~~~~~~~~hp~~~~~~ 264 (324)
T cd05587 229 VSICKGLLTKHPA-KRLGCGPTGERDIREHAFFRRID 264 (324)
T ss_pred HHHHHHHhhcCHH-HcCCCCCCCHHHHhcCCCcCCCC
Confidence 11222 23666 77765 7999999987643
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-40 Score=289.60 Aligned_cols=234 Identities=25% Similarity=0.397 Sum_probs=183.4
Q ss_pred eeEeecCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeEEEEee
Q 021306 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVME 116 (314)
Q Consensus 44 ~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e 116 (314)
+.||+|+||.||++++..+++.||+|.+.+.. ....+|+.+++.+.||||+++.+++.. ...+++|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~~~~~lv~E 75 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQT-----KDRLCFVME 75 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEc-----CCEEEEEEe
Confidence 46899999999999999999999999987532 223468889999999999999888743 334889999
Q ss_pred cccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcccccccC-
Q 021306 117 YVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG- 194 (314)
Q Consensus 117 ~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~~~- 194 (314)
|+++ +|...+. ....+++.+++.++.||+.||.|||+ +||+||||||+||+++. ++.++|+|||++......
T Consensus 76 y~~~g~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivHrDikp~NIll~~-~~~~kL~DfG~~~~~~~~~ 149 (328)
T cd05593 76 YVNGGELFFHLS----RERVFSEDRTRFYGAEIVSALDYLHS-GKIVYRDLKLENLMLDK-DGHIKITDFGLCKEGITDA 149 (328)
T ss_pred CCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHh-CCeEecccCHHHeEECC-CCcEEEecCcCCccCCCcc
Confidence 9987 4544443 35679999999999999999999999 89999999999999998 888999999998753222
Q ss_pred CccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCC-------CCHHHHh-
Q 021306 195 EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT-------PTREEIR- 266 (314)
Q Consensus 195 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~-------~~~~~~~- 266 (314)
.......+++.|+|||.+.+.. ++.++||||||+++|+|++|+.||.+.+..+....+...... ...+.+.
T Consensus 150 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~ 228 (328)
T cd05593 150 ATMKTFCGTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSADAKSLLSG 228 (328)
T ss_pred cccccccCCcCccChhhhcCCC-CCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCccCCCCCCHHHHHHHHH
Confidence 2223356789999999996554 789999999999999999999999887766555544322111 1112222
Q ss_pred --ccCCCCCCC-----cccccccCChhhhhc
Q 021306 267 --CMNPNYTDF-----RFPQIKAHPWHKVCI 290 (314)
Q Consensus 267 --~~~p~~~~~-----~~~~l~~~p~~~~~~ 290 (314)
..+|. +|+ ++.++++|||+....
T Consensus 229 ~L~~dP~-~R~~~~~~~~~~il~h~~~~~~~ 258 (328)
T cd05593 229 LLIKDPN-KRLGGGPDDAKEIMRHSFFTGVN 258 (328)
T ss_pred HcCCCHH-HcCCCCCCCHHHHhcCCCcCCCC
Confidence 33666 675 899999999986543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-39 Score=278.11 Aligned_cols=209 Identities=35% Similarity=0.675 Sum_probs=172.7
Q ss_pred CceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeEE
Q 021306 39 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 112 (314)
Q Consensus 39 ~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 112 (314)
+|++.+.||+|++|.||+|++..+++.|++|.+.... ....+|+.++++++|+|++++++++... ...+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~ 75 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQE-----SRLY 75 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeC-----CeEE
Confidence 5899999999999999999999999999999886432 2346799999999999999999988543 3488
Q ss_pred EEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcccccc
Q 021306 113 LVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 192 (314)
Q Consensus 113 lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~ 192 (314)
+|+||+.+++.+.+... ..+..+++.+++.++.|++.||.|||+ +|++|+||+|+||+++. ++.++|+|||++....
T Consensus 76 ~v~e~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~qi~~~L~~lH~-~~i~H~dl~p~nil~~~-~~~~~l~dfg~~~~~~ 152 (285)
T cd07861 76 LIFEFLSMDLKKYLDSL-PKGQYMDAELVKSYLYQILQGILFCHS-RRVLHRDLKPQNLLIDN-KGVIKLADFGLARAFG 152 (285)
T ss_pred EEEecCCCCHHHHHhcC-CCCCcCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCCHHHEEEcC-CCcEEECcccceeecC
Confidence 99999998877766542 234679999999999999999999999 89999999999999998 8899999999987543
Q ss_pred cCCc-cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 021306 193 AGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 255 (314)
Q Consensus 193 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~ 255 (314)
.... .....+++.|+|||.+.+...++.++|+||||+++|+|+||+.||.+....+....+.+
T Consensus 153 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~ 216 (285)
T cd07861 153 IPVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFR 216 (285)
T ss_pred CCcccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHH
Confidence 2211 12234578899999987666678999999999999999999999988776555544443
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-40 Score=287.36 Aligned_cols=231 Identities=28% Similarity=0.490 Sum_probs=183.4
Q ss_pred EeecCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeEEEEeecc
Q 021306 46 VGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYV 118 (314)
Q Consensus 46 Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~ 118 (314)
||+|+||.||+|++..+++.||+|.+.... ....+|..++++++||||+++++++.. ....++||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~lv~e~~ 75 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQS-----PEKLYLVLAFI 75 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEec-----CCeEEEEEcCC
Confidence 699999999999999999999999986432 223468899999999999999888743 33488999999
Q ss_pred cc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcccccccC-Cc
Q 021306 119 PE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG-EA 196 (314)
Q Consensus 119 ~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~~~-~~ 196 (314)
++ +|.+.+. ....+++..++.++.|++.||.|||+ +||+||||||+||+++. ++.++|+|||++...... ..
T Consensus 76 ~~g~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~HrDlkp~Nili~~-~~~~kl~Dfg~~~~~~~~~~~ 149 (312)
T cd05585 76 NGGELFHHLQ----REGRFDLSRARFYTAELLCALENLHK-FNVIYRDLKPENILLDY-QGHIALCDFGLCKLNMKDDDK 149 (312)
T ss_pred CCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHh-CCeEeCCCCHHHeEECC-CCcEEEEECcccccCccCCCc
Confidence 97 5555544 35679999999999999999999999 89999999999999998 888999999998743222 22
Q ss_pred cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCC-------CHHHHh---
Q 021306 197 NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP-------TREEIR--- 266 (314)
Q Consensus 197 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~-------~~~~~~--- 266 (314)
.....+++.|+|||.+.+.. ++.++||||||+++|+|++|+.||.+.+..+....+.+..... ..+.+.
T Consensus 150 ~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 228 (312)
T cd05585 150 TNTFCGTPEYLAPELLLGHG-YTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFDRDAKDLLIGLL 228 (312)
T ss_pred cccccCCcccCCHHHHcCCC-CCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHc
Confidence 23356799999999996654 8999999999999999999999999888776666655432111 112222
Q ss_pred ccCCCCCCC---cccccccCChhhhh
Q 021306 267 CMNPNYTDF---RFPQIKAHPWHKVC 289 (314)
Q Consensus 267 ~~~p~~~~~---~~~~l~~~p~~~~~ 289 (314)
..+|. +|+ ++.+++.|||++..
T Consensus 229 ~~dp~-~R~~~~~~~e~l~hp~~~~~ 253 (312)
T cd05585 229 SRDPT-RRLGYNGAQEIKNHPFFSQL 253 (312)
T ss_pred CCCHH-HcCCCCCHHHHHcCCCcCCC
Confidence 23566 676 46899999999865
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=285.90 Aligned_cols=236 Identities=27% Similarity=0.451 Sum_probs=184.7
Q ss_pred ceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHH---HHhCCCCceeeeceeeeecCCCCce
Q 021306 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQL---MRVMDHPNVISLKHCFFSTTSKNEL 109 (314)
Q Consensus 40 y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~-------~~~~~e~~~---l~~l~h~~iv~~~~~~~~~~~~~~~ 109 (314)
|++.+.||+|++|.||+|.+..+++.|++|.+++.. ....+|..+ ++.++||||+++++++.. ..
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~-----~~ 75 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQT-----ED 75 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEc-----CC
Confidence 789999999999999999999999999999987432 112344444 456689999999998843 33
Q ss_pred eEEEEeeccccc-HHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcc
Q 021306 110 FLNLVMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 188 (314)
Q Consensus 110 ~~~lv~e~~~~~-l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~ 188 (314)
..++||||++++ |...+. ...+++.+++.++.||+.||.|||+ +|++||||||+||+++. ++.++|+|||++
T Consensus 76 ~~~lv~E~~~~~~L~~~~~-----~~~l~~~~~~~~~~qi~~al~~lH~-~~ivHrdlkp~Nill~~-~~~~kL~Dfg~~ 148 (324)
T cd05589 76 HVCFVMEYAAGGDLMMHIH-----TDVFSEPRAVFYAACVVLGLQYLHE-NKIVYRDLKLDNLLLDT-EGFVKIADFGLC 148 (324)
T ss_pred EEEEEEcCCCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeEecCCCHHHeEECC-CCcEEeCcccCC
Confidence 488999999975 433332 3679999999999999999999999 89999999999999998 789999999988
Q ss_pred cccccC-CccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCC------
Q 021306 189 KQLIAG-EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT------ 261 (314)
Q Consensus 189 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~------ 261 (314)
...... .......+++.|+|||.+.+.. ++.++||||||+++|+|++|+.||.+.+..+....+.......+
T Consensus 149 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~ 227 (324)
T cd05589 149 KEGMGFGDRTSTFCGTPEFLAPEVLTETS-YTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSRE 227 (324)
T ss_pred ccCCCCCCcccccccCccccCHhHhcCCC-CCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHH
Confidence 643222 2223456789999999996654 78999999999999999999999998887776666655422211
Q ss_pred -HHHHh---ccCCCCCCC-----cccccccCChhhhh
Q 021306 262 -REEIR---CMNPNYTDF-----RFPQIKAHPWHKVC 289 (314)
Q Consensus 262 -~~~~~---~~~p~~~~~-----~~~~l~~~p~~~~~ 289 (314)
.+.+. ..+|. +|+ ++.++++|||++..
T Consensus 228 ~~~li~~~L~~dP~-~R~~~~~~~~~~l~~~~~f~~~ 263 (324)
T cd05589 228 AISIMRRLLRRNPE-RRLGSGEKDAEDVKKQPFFRDI 263 (324)
T ss_pred HHHHHHHHhhcCHh-HcCCCCCCCHHHHhhCCCcCCC
Confidence 11222 33666 676 68899999998764
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=286.08 Aligned_cols=242 Identities=26% Similarity=0.421 Sum_probs=189.7
Q ss_pred CCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCCcee
Q 021306 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 110 (314)
Q Consensus 38 ~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 110 (314)
++|++.+.||+|+||.||++++..+++.||+|.+.+.. ....+|..+++.++|+||+++++++.. ..+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~ 75 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQD-----ENN 75 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEec-----CCe
Confidence 47999999999999999999999999999999986421 224578889999999999999988843 345
Q ss_pred EEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCccc
Q 021306 111 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 189 (314)
Q Consensus 111 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~ 189 (314)
+++||||+.| +|.+.+.. ....+++..++.++.||+.||.|||+ +||+||||||+||+++. ++.++|+|||++.
T Consensus 76 ~~lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nill~~-~~~~kl~Dfg~~~ 150 (331)
T cd05597 76 LYLVMDYYVGGDLLTLLSK---FEDRLPEDMARFYLAEMVLAIDSVHQ-LGYVHRDIKPDNVLLDK-NGHIRLADFGSCL 150 (331)
T ss_pred EEEEEecCCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHh-CCeEECCCCHHHEEECC-CCCEEEEECCcee
Confidence 8999999986 66555543 24679999999999999999999999 89999999999999988 8889999999986
Q ss_pred ccccCCc--cccccccccccccccccC----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCC---C
Q 021306 190 QLIAGEA--NISYICSRFYRAPELIFG----ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT---P 260 (314)
Q Consensus 190 ~~~~~~~--~~~~~~~~~y~aPE~~~~----~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~---~ 260 (314)
....... .....+++.|+|||.+.+ ...++.++|||||||++|+|++|+.||.+.+..+....++..... +
T Consensus 151 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~ 230 (331)
T cd05597 151 RLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFP 230 (331)
T ss_pred ecCCCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCC
Confidence 5433222 122457899999999853 234678999999999999999999999988777666666543210 0
Q ss_pred ---------CHHHHh---ccCCC-CCCCcccccccCChhhhh
Q 021306 261 ---------TREEIR---CMNPN-YTDFRFPQIKAHPWHKVC 289 (314)
Q Consensus 261 ---------~~~~~~---~~~p~-~~~~~~~~l~~~p~~~~~ 289 (314)
..+.+. +.++. ..|++++++++|||++..
T Consensus 231 ~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~ 272 (331)
T cd05597 231 PDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGI 272 (331)
T ss_pred CccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCC
Confidence 112222 22222 247899999999998654
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=284.64 Aligned_cols=199 Identities=31% Similarity=0.526 Sum_probs=167.0
Q ss_pred CCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeE
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 111 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 111 (314)
.++|++.+.||+|+||.||++++..++..+++|.+..+. ....+|+.++++++|+||+++++++.... ..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~ 78 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG-----EI 78 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECC-----EE
Confidence 468999999999999999999999999999999886542 23468999999999999999999885433 38
Q ss_pred EEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcccc
Q 021306 112 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 190 (314)
Q Consensus 112 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~ 190 (314)
+++|||+++ +|.+.+.. ...+++..+..++.|++.||.|||+..+|+|+||||+||+++. ++.++|+|||++..
T Consensus 79 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~-~~~~kl~Dfg~~~~ 153 (331)
T cd06649 79 SICMEHMDGGSLDQVLKE----AKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNS-RGEIKLCDFGVSGQ 153 (331)
T ss_pred EEEeecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcC-CCcEEEccCccccc
Confidence 899999997 55555543 4678999999999999999999998236999999999999998 78899999999875
Q ss_pred cccCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChH
Q 021306 191 LIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV 247 (314)
Q Consensus 191 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~ 247 (314)
.... ......+++.|+|||.+.+.. ++.++||||||+++|+|++|+.||...+..
T Consensus 154 ~~~~-~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwslG~il~el~tg~~p~~~~~~~ 208 (331)
T cd06649 154 LIDS-MANSFVGTRSYMSPERLQGTH-YSVQSDIWSMGLSLVELAIGRYPIPPPDAK 208 (331)
T ss_pred cccc-ccccCCCCcCcCCHhHhcCCC-CCchHhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 5332 223456788999999997654 899999999999999999999999766543
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=285.50 Aligned_cols=233 Identities=29% Similarity=0.465 Sum_probs=183.1
Q ss_pred eeEeecCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhC-CCCceeeeceeeeecCCCCceeEEEEe
Q 021306 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVM-DHPNVISLKHCFFSTTSKNELFLNLVM 115 (314)
Q Consensus 44 ~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~-------~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv~ 115 (314)
+.||+|+||.||+|+++.+++.||+|.+.+.. .....|..++..+ .||||+++++++.. ...+++||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~-----~~~~~iv~ 75 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQT-----PDRLFFVM 75 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEc-----CCEEEEEE
Confidence 46999999999999999999999999987532 1223566666665 79999999998843 33488999
Q ss_pred ecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCccccccc-
Q 021306 116 EYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA- 193 (314)
Q Consensus 116 e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~~- 193 (314)
||+++ +|...+. ....+++..++.++.|++.||.|||+ +|++||||||+||+++. ++.++|+|||++.....
T Consensus 76 Ey~~~g~L~~~i~----~~~~l~~~~~~~~~~ql~~~L~~lH~-~~ivH~dlkp~NIli~~-~~~~kL~DfG~~~~~~~~ 149 (320)
T cd05590 76 EFVNGGDLMFHIQ----KSRRFDEARARFYAAEITSALMFLHD-KGIIYRDLKLDNVLLDH-EGHCKLADFGMCKEGIFN 149 (320)
T ss_pred cCCCCchHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeCCCCHHHeEECC-CCcEEEeeCCCCeecCcC
Confidence 99997 4544443 35679999999999999999999999 89999999999999998 78899999999865322
Q ss_pred CCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCC-------HHHHh
Q 021306 194 GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT-------REEIR 266 (314)
Q Consensus 194 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~-------~~~~~ 266 (314)
........+++.|+|||.+.+.. ++.++||||||+++|+|++|+.||.+.+..+.+..+.+.....+ .+.+.
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~ 228 (320)
T cd05590 150 GKTTSTFCGTPDYIAPEILQEML-YGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLSQDAVDILK 228 (320)
T ss_pred CCcccccccCccccCHHHHcCCC-CCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Confidence 22223456799999999986544 78999999999999999999999998887776666654322111 12222
Q ss_pred ---ccCCCCCCCcc------cccccCChhhhh
Q 021306 267 ---CMNPNYTDFRF------PQIKAHPWHKVC 289 (314)
Q Consensus 267 ---~~~p~~~~~~~------~~l~~~p~~~~~ 289 (314)
..+|. +|++. +++++|||++..
T Consensus 229 ~~L~~dP~-~R~~~~~~~~~~~~~~h~~f~~~ 259 (320)
T cd05590 229 AFMTKNPT-MRLGSLTLGGEEAILRHPFFKEL 259 (320)
T ss_pred HHcccCHH-HCCCCCCCCCHHHHHcCCCcCCC
Confidence 34677 78887 889999999754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-39 Score=277.77 Aligned_cols=208 Identities=37% Similarity=0.646 Sum_probs=171.1
Q ss_pred CceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeEE
Q 021306 39 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 112 (314)
Q Consensus 39 ~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 112 (314)
+|++.+.||+|++|.||+|++..+|+.+++|.++... ....+|+.++++++|+||+++++++.. ...++
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~-----~~~~~ 75 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHS-----DKKLT 75 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhcc-----CCceE
Confidence 5899999999999999999999999999999886432 233579999999999999999998843 33488
Q ss_pred EEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcccccc
Q 021306 113 LVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 192 (314)
Q Consensus 113 lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~ 192 (314)
+++||+++++.+.+.. ....+++..++.++.||+.||.|||+ +|++|+||+|+||+++. ++.++|+|||++....
T Consensus 76 lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~al~~LH~-~~i~H~dl~~~nil~~~-~~~~~l~dfg~~~~~~ 150 (284)
T cd07839 76 LVFEYCDQDLKKYFDS---CNGDIDPEIVKSFMFQLLKGLAFCHS-HNVLHRDLKPQNLLINK-NGELKLADFGLARAFG 150 (284)
T ss_pred EEEecCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCCCHHHEEEcC-CCcEEECccchhhccC
Confidence 9999999988776653 24679999999999999999999999 89999999999999998 7889999999987543
Q ss_pred cCCc-cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCC-CCCChHHHHHHHHHH
Q 021306 193 AGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLF-PGENAVDQLVEIIKV 256 (314)
Q Consensus 193 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf-~~~~~~~~~~~i~~~ 256 (314)
.... .....++..|+|||.+.+...++.++||||||+++|+|++|..|+ .+.+..+.+..+.+.
T Consensus 151 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~ 216 (284)
T cd07839 151 IPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRL 216 (284)
T ss_pred CCCCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHH
Confidence 3221 223455788999999877665789999999999999999998885 555555555555443
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=284.81 Aligned_cols=239 Identities=28% Similarity=0.400 Sum_probs=186.3
Q ss_pred CceeeeeEeecCceEEEEEEECCCCcEEEEEEeecccc-------chHHHHHHHHhC-CCCceeeeceeeeecCCCCcee
Q 021306 39 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YKNRELQLMRVM-DHPNVISLKHCFFSTTSKNELF 110 (314)
Q Consensus 39 ~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~~-------~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~ 110 (314)
+|++.+.||+|+||.||+|++..+++.+|+|.+.+... ....|..++..+ .|++|+++++++... ..
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~-----~~ 75 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTM-----DR 75 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecC-----CE
Confidence 58999999999999999999999999999999875421 123455666665 588899998887433 34
Q ss_pred EEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCccc
Q 021306 111 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 189 (314)
Q Consensus 111 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~ 189 (314)
+++||||+++ +|...+. ....+++.+++.++.||+.||.|||+ +||+||||||+||+++. ++.++|+|||++.
T Consensus 76 ~~lv~E~~~~g~L~~~~~----~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~Nill~~-~~~~kL~DfG~~~ 149 (323)
T cd05616 76 LYFVMEYVNGGDLMYQIQ----QVGRFKEPHAVFYAAEIAIGLFFLHS-KGIIYRDLKLDNVMLDS-EGHIKIADFGMCK 149 (323)
T ss_pred EEEEEcCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCEEecCCCHHHeEECC-CCcEEEccCCCce
Confidence 8899999986 5554443 34679999999999999999999999 89999999999999998 8899999999987
Q ss_pred cccc-CCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCC-------
Q 021306 190 QLIA-GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT------- 261 (314)
Q Consensus 190 ~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~------- 261 (314)
.... ........+++.|+|||.+.+.. ++.++|||||||++|+|++|+.||.+.+..+....++......+
T Consensus 150 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~ 228 (323)
T cd05616 150 ENMWDGVTTKTFCGTPDYIAPEIIAYQP-YGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEA 228 (323)
T ss_pred ecCCCCCccccCCCChhhcCHHHhcCCC-CCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcCCHHH
Confidence 4332 22223456789999999997654 89999999999999999999999998887777766665422211
Q ss_pred HHHHh---ccCCCCCCCc-----ccccccCChhhhhc
Q 021306 262 REEIR---CMNPNYTDFR-----FPQIKAHPWHKVCI 290 (314)
Q Consensus 262 ~~~~~---~~~p~~~~~~-----~~~l~~~p~~~~~~ 290 (314)
.+.+. ..+|. +|++ ..+++.|||++...
T Consensus 229 ~~li~~~l~~~p~-~R~~~~~~~~~~i~~h~~~~~~~ 264 (323)
T cd05616 229 VAICKGLMTKHPG-KRLGCGPEGERDIKEHAFFRYID 264 (323)
T ss_pred HHHHHHHcccCHH-hcCCCCCCCHHHHhcCCCcCCCC
Confidence 11222 23666 6765 47899999987543
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-39 Score=281.75 Aligned_cols=198 Identities=37% Similarity=0.640 Sum_probs=160.7
Q ss_pred eeeEeecCceEEEEEEEC--CCCcEEEEEEeeccc--cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeEEEEeecc
Q 021306 43 ERVVGTGSFGIVFQAKCL--ETGETVAIKKVLQDR--RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYV 118 (314)
Q Consensus 43 ~~~Lg~g~~g~Vy~~~~~--~~~~~~~vK~~~~~~--~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~ 118 (314)
.+.||+|+||.||+|+++ .+++.+++|.+.... ....+|+.++++++||||+++++.+.... ...+++++||+
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~---~~~~~lv~e~~ 82 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHA---DRKVWLLFDYA 82 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCcHHHHHHHHHHHhcCCCCCcceeeeEecCC---CcEEEEEEecc
Confidence 568999999999999965 367899999886543 23468999999999999999998875432 23478999999
Q ss_pred cccHHHHHHhhhh-----cCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEc---CCCCcEEEeecCcccc
Q 021306 119 PESMYRVLKHYSS-----ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVD---PLTHQVKICDFGSAKQ 190 (314)
Q Consensus 119 ~~~l~~~l~~~~~-----~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~---~~~~~~~l~dfg~~~~ 190 (314)
++++...+..... ....+++..++.++.||+.||.|||+ +||+|+||||+||++. ..++.++|+|||++..
T Consensus 83 ~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~ 161 (317)
T cd07868 83 EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA-NWVLHRDLKPANILVMGEGPERGRVKIADMGFARL 161 (317)
T ss_pred CCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHh-CCEEcCCCCHHHEEEecCCCCcCcEEEeecCceec
Confidence 9988877653211 12368999999999999999999999 8999999999999994 2256899999999976
Q ss_pred cccCCc----cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 021306 191 LIAGEA----NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE 244 (314)
Q Consensus 191 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~ 244 (314)
...... .....+|+.|+|||.+.+...++.++|+||+||++|+|++|+.||.+.
T Consensus 162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 162 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred cCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 543221 123456889999999877666889999999999999999999999654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=285.01 Aligned_cols=233 Identities=29% Similarity=0.453 Sum_probs=183.6
Q ss_pred eeEeecCceEEEEEEECCCCcEEEEEEeecccc-------chHHHHHHHHhC-CCCceeeeceeeeecCCCCceeEEEEe
Q 021306 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YKNRELQLMRVM-DHPNVISLKHCFFSTTSKNELFLNLVM 115 (314)
Q Consensus 44 ~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~~-------~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv~ 115 (314)
+.||+|+||.||+|++..+++.||+|.+++... ....|..++..+ +||||+++++++... ..+++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~-----~~~~lv~ 75 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTK-----DRLFFVM 75 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcC-----CeEEEEE
Confidence 468999999999999999999999999875421 123567777755 799999999988433 3488999
Q ss_pred ecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcccccccC
Q 021306 116 EYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG 194 (314)
Q Consensus 116 e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~~~ 194 (314)
||+++ +|...+. ....+++..++.++.||+.||.|||+ +||+||||||+||+++. ++.++|+|||++......
T Consensus 76 E~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDikp~Nill~~-~~~~kL~Dfg~~~~~~~~ 149 (321)
T cd05591 76 EYVNGGDLMFQIQ----RSRKFDEPRSRFYAAEVTLALMFLHR-HGVIYRDLKLDNILLDA-EGHCKLADFGMCKEGILN 149 (321)
T ss_pred eCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHeEECC-CCCEEEeecccceecccC
Confidence 99987 5544443 34679999999999999999999999 89999999999999998 889999999998753322
Q ss_pred -CccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCC-------HHHHh
Q 021306 195 -EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT-------REEIR 266 (314)
Q Consensus 195 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~-------~~~~~ 266 (314)
.......+++.|+|||.+.+.. ++.++||||||+++|+|++|+.||.+.+..+.+..+.+.....+ .+.+.
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~ 228 (321)
T cd05591 150 GVTTTTFCGTPDYIAPEILQELE-YGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLSKEAVSILK 228 (321)
T ss_pred CccccccccCccccCHHHHcCCC-CCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 2223355789999999986544 88999999999999999999999999888777776665422111 12222
Q ss_pred ---ccCCCCCCC-------cccccccCChhhhh
Q 021306 267 ---CMNPNYTDF-------RFPQIKAHPWHKVC 289 (314)
Q Consensus 267 ---~~~p~~~~~-------~~~~l~~~p~~~~~ 289 (314)
..+|. +|+ +++++++|||++..
T Consensus 229 ~~L~~dp~-~R~~~~~~~~~~~~~~~hp~~~~~ 260 (321)
T cd05591 229 AFMTKNPN-KRLGCVASQGGEDAIKQHPFFKEI 260 (321)
T ss_pred HHhccCHH-HcCCCCCCCCCHHHHhcCCccCCC
Confidence 23666 687 88999999998654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=274.35 Aligned_cols=208 Identities=38% Similarity=0.727 Sum_probs=173.4
Q ss_pred CCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeE
Q 021306 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 111 (314)
Q Consensus 38 ~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 111 (314)
++|++.+.||+|++|.||+++++.+++.+++|.+.... ....+|+.++++++|+|++++++++... ...
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-----~~~ 75 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRK-----RKL 75 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeC-----CEE
Confidence 47999999999999999999999899999999885432 2235789999999999999999988433 347
Q ss_pred EEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCccccc
Q 021306 112 NLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 191 (314)
Q Consensus 112 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~ 191 (314)
++++||+++++++.+.. ....+++.+++.++.|++.+|.|||+ .|++|+||+|+||+++. ++.++|+|||++...
T Consensus 76 ~~v~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~ql~~~l~~LH~-~~i~H~dl~p~nil~~~-~~~~~l~dfg~~~~~ 150 (286)
T cd07847 76 HLVFEYCDHTVLNELEK---NPRGVPEHLIKKIIWQTLQAVNFCHK-HNCIHRDVKPENILITK-QGQIKLCDFGFARIL 150 (286)
T ss_pred EEEEeccCccHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCChhhEEEcC-CCcEEECccccceec
Confidence 89999999976665543 34579999999999999999999999 89999999999999998 788999999998765
Q ss_pred ccCC-ccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 021306 192 IAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 255 (314)
Q Consensus 192 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~ 255 (314)
.... ......++..|+|||.+.+...++.++|+||||+++|+|++|+.||.+.+..+....+.+
T Consensus 151 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~ 215 (286)
T cd07847 151 TGPGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRK 215 (286)
T ss_pred CCCcccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 4433 222344677899999987655578999999999999999999999998877666555443
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=274.39 Aligned_cols=218 Identities=33% Similarity=0.599 Sum_probs=177.5
Q ss_pred CCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhCC-CCceeeeceeeeecCCCCcee
Q 021306 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMD-HPNVISLKHCFFSTTSKNELF 110 (314)
Q Consensus 38 ~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~------~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~ 110 (314)
++|++.+.||+|++|.||++.+..+++.|++|.+.... ....+|+.+++++. |+||+++++++..........
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 47999999999999999999999999999999876432 23457899999995 699999998876544434445
Q ss_pred EEEEeecccccHHHHHHhhhhc-CCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCccc
Q 021306 111 LNLVMEYVPESMYRVLKHYSSA-NQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 189 (314)
Q Consensus 111 ~~lv~e~~~~~l~~~l~~~~~~-~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~ 189 (314)
.++++||+++++.+.+...... ...+++..++.++.||+.||.|||+ +|++|+||+|+||+++..++.++|+|||.+.
T Consensus 81 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~-~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~ 159 (295)
T cd07837 81 LYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK-HGVMHRDLKPQNLLVDKQKGLLKIADLGLGR 159 (295)
T ss_pred EEEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCChHHEEEecCCCeEEEeecccce
Confidence 7899999999888777653322 4578999999999999999999999 8999999999999999767789999999987
Q ss_pred ccccCC-ccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q 021306 190 QLIAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 256 (314)
Q Consensus 190 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~ 256 (314)
...... ......+++.|+|||.+.+...++.++|+||||+++|+|++|..||.+.+....+..+.+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~ 227 (295)
T cd07837 160 AFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKL 227 (295)
T ss_pred ecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH
Confidence 543221 1122345778999999866555789999999999999999999999988776666655543
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-39 Score=281.77 Aligned_cols=234 Identities=28% Similarity=0.468 Sum_probs=181.7
Q ss_pred eeEeecCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHh-CCCCceeeeceeeeecCCCCceeEEEEe
Q 021306 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRV-MDHPNVISLKHCFFSTTSKNELFLNLVM 115 (314)
Q Consensus 44 ~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~-------~~~~~e~~~l~~-l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 115 (314)
+.||+|+||.||+|+++.+++.||+|.++... .....|..++.. +.|++|+++++++.. ..++++||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~-----~~~~~lv~ 75 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQT-----KEHLFFVM 75 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEe-----CCEEEEEE
Confidence 47999999999999999999999999987532 122356666654 489999999998843 34588999
Q ss_pred ecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCccccccc-
Q 021306 116 EYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA- 193 (314)
Q Consensus 116 e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~~- 193 (314)
||+.+ +|...+. ....+++.++..++.|++.||.|||+ +||+||||||+||+++. ++.++|+|||++.....
T Consensus 76 E~~~~g~L~~~i~----~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivHrDlkp~Nil~~~-~~~~kl~Dfg~~~~~~~~ 149 (316)
T cd05620 76 EFLNGGDLMFHIQ----DKGRFDLYRATFYAAEIVCGLQFLHS-KGIIYRDLKLDNVMLDR-DGHIKIADFGMCKENVFG 149 (316)
T ss_pred CCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHeEECC-CCCEEeCccCCCeecccC
Confidence 99996 5554443 35679999999999999999999999 89999999999999998 78899999999864321
Q ss_pred CCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCC-------HHHHh
Q 021306 194 GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT-------REEIR 266 (314)
Q Consensus 194 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~-------~~~~~ 266 (314)
........+++.|+|||.+.+.. ++.++||||||+++|+|++|+.||.+.+..+....+.......+ .+.+.
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 228 (316)
T cd05620 150 DNRASTFCGTPDYIAPEILQGLK-YTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDILE 228 (316)
T ss_pred CCceeccCCCcCccCHHHHcCCC-CCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 12223456789999999996654 89999999999999999999999988877665555443322111 12222
Q ss_pred ---ccCCCCCCCcc-cccccCChhhhhc
Q 021306 267 ---CMNPNYTDFRF-PQIKAHPWHKVCI 290 (314)
Q Consensus 267 ---~~~p~~~~~~~-~~l~~~p~~~~~~ 290 (314)
..+|. +|+++ +++++|||++...
T Consensus 229 ~~l~~dP~-~R~~~~~~~~~h~~f~~~~ 255 (316)
T cd05620 229 KLFERDPT-RRLGVVGNIRGHPFFKTIN 255 (316)
T ss_pred HHccCCHH-HcCCChHHHHcCCCcCCCC
Confidence 33677 78887 5899999997653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=293.76 Aligned_cols=250 Identities=25% Similarity=0.363 Sum_probs=199.2
Q ss_pred CCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCC---CC
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTS---KN 107 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~---~~ 107 (314)
.++|++.+.||+|+||.||++++..+++.||+|.+.... ....+|+.++..++|+|+++++..+..... ..
T Consensus 31 ~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~ 110 (496)
T PTZ00283 31 AKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPEN 110 (496)
T ss_pred CCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCccc
Confidence 468999999999999999999999999999999986432 233578888999999999998877643322 12
Q ss_pred ceeEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecC
Q 021306 108 ELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 186 (314)
Q Consensus 108 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg 186 (314)
...+++||||+.+ +|.+.+.........+++..++.++.|++.||.|||+ ++|+||||||+||+++. ++.++|+|||
T Consensus 111 ~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~-~~IiHrDLKP~NILl~~-~~~vkL~DFG 188 (496)
T PTZ00283 111 VLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHS-KHMIHRDIKSANILLCS-NGLVKLGDFG 188 (496)
T ss_pred ceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEEeC-CCCEEEEecc
Confidence 2346799999985 7777776555556789999999999999999999999 89999999999999998 8899999999
Q ss_pred cccccccC---CccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCH-
Q 021306 187 SAKQLIAG---EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR- 262 (314)
Q Consensus 187 ~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~- 262 (314)
+++..... .......+|+.|+|||.+.+.. ++.++||||||+++|+|++|+.||.+.+..+.+..+......+.+
T Consensus 189 ls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~-~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~ 267 (496)
T PTZ00283 189 FSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKP-YSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDPLPP 267 (496)
T ss_pred cCeeccccccccccccccCCcceeCHHHhCCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCCCC
Confidence 98754322 1223456789999999997654 899999999999999999999999988877766666554322211
Q ss_pred -------HHH---hccCCCCCCCcccccccCChhhhhc
Q 021306 263 -------EEI---RCMNPNYTDFRFPQIKAHPWHKVCI 290 (314)
Q Consensus 263 -------~~~---~~~~p~~~~~~~~~l~~~p~~~~~~ 290 (314)
+.+ ...+|. +|+++.++++|||.+...
T Consensus 268 ~~~~~l~~li~~~L~~dP~-~RPs~~ell~~p~~~~~~ 304 (496)
T PTZ00283 268 SISPEMQEIVTALLSSDPK-RRPSSSKLLNMPICKLFI 304 (496)
T ss_pred CCCHHHHHHHHHHcccChh-hCcCHHHHHhCHHHHHhh
Confidence 111 123677 899999999999987644
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=284.94 Aligned_cols=234 Identities=27% Similarity=0.437 Sum_probs=181.0
Q ss_pred eeEeecCceEEEEEEECCCCcEEEEEEeecccc-------chHHH-HHHHHhCCCCceeeeceeeeecCCCCceeEEEEe
Q 021306 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YKNRE-LQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVM 115 (314)
Q Consensus 44 ~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~~-------~~~~e-~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 115 (314)
+.||+|+||.||++++..+|+.|++|.+..... ...+| ..+++.++||||+++++++.. ....++||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~-----~~~~~lv~ 75 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQT-----ADKLYFVL 75 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEe-----CCEEEEEE
Confidence 479999999999999999999999999865321 11223 335677899999999988743 33488999
Q ss_pred ecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcccccccC
Q 021306 116 EYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG 194 (314)
Q Consensus 116 e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~~~ 194 (314)
||+.+ +|...+. .+..+++..++.++.||+.||.|||+ +||+||||||+||+++. ++.++|+|||++......
T Consensus 76 e~~~~g~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH~-~givH~dikp~NIll~~-~~~~kl~Dfg~~~~~~~~ 149 (323)
T cd05575 76 DYVNGGELFFHLQ----RERSFPEPRARFYAAEIASALGYLHS-LNIIYRDLKPENILLDS-QGHVVLTDFGLCKEGIEH 149 (323)
T ss_pred cCCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeCCCCHHHeEECC-CCcEEEeccCCCcccccC
Confidence 99997 5544443 35789999999999999999999999 89999999999999998 889999999998653222
Q ss_pred -CccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCC----C---HHHHh
Q 021306 195 -EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP----T---REEIR 266 (314)
Q Consensus 195 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~----~---~~~~~ 266 (314)
.......+++.|+|||.+.+.. ++.++||||||+++|+|++|..||.+.+..+....+....... . .+.+.
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~ 228 (323)
T cd05575 150 SKTTSTFCGTPEYLAPEVLRKQP-YDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPNISVSARHLLE 228 (323)
T ss_pred CCccccccCChhhcChhhhcCCC-CCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 2223356789999999986654 8899999999999999999999999888776666665432111 1 11122
Q ss_pred ---ccCCCCCCCcc----cccccCChhhhhc
Q 021306 267 ---CMNPNYTDFRF----PQIKAHPWHKVCI 290 (314)
Q Consensus 267 ---~~~p~~~~~~~----~~l~~~p~~~~~~ 290 (314)
..+|. +|++. .+++.|||++...
T Consensus 229 ~~l~~~p~-~R~~~~~~~~~il~~~~~~~~~ 258 (323)
T cd05575 229 GLLQKDRT-KRLGAKDDFLEIKNHVFFSSIN 258 (323)
T ss_pred HHhhcCHH-hCCCCCCCHHHHHcCCCcCCCC
Confidence 23566 67766 5999999987644
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-39 Score=282.48 Aligned_cols=234 Identities=28% Similarity=0.478 Sum_probs=182.3
Q ss_pred eeEeecCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHh-CCCCceeeeceeeeecCCCCceeEEEEe
Q 021306 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRV-MDHPNVISLKHCFFSTTSKNELFLNLVM 115 (314)
Q Consensus 44 ~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~-------~~~~~e~~~l~~-l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 115 (314)
+.||+|+||.||+|++..+++.||+|.++... .....|..++.. +.||||+++++++... ..+++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~-----~~~~lv~ 75 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTK-----ENLFFVM 75 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeC-----CEEEEEE
Confidence 47999999999999999999999999987542 122356666665 5899999999988443 3488999
Q ss_pred ecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCccccccc-
Q 021306 116 EYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA- 193 (314)
Q Consensus 116 e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~~- 193 (314)
||+++ +|...+.. ...+++.++..++.|++.||.|||+ +|++|+||||+||+++. ++.++|+|||++.....
T Consensus 76 ey~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~LH~-~~ivHrdikp~Nil~~~-~~~~kl~Dfg~~~~~~~~ 149 (316)
T cd05619 76 EYLNGGDLMFHIQS----CHKFDLPRATFYAAEIICGLQFLHS-KGIVYRDLKLDNILLDT-DGHIKIADFGMCKENMLG 149 (316)
T ss_pred eCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeEeCCCCHHHEEECC-CCCEEEccCCcceECCCC
Confidence 99986 55555542 4678999999999999999999999 89999999999999998 78899999999864322
Q ss_pred CCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCC-------HHHHh
Q 021306 194 GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT-------REEIR 266 (314)
Q Consensus 194 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~-------~~~~~ 266 (314)
........+++.|+|||.+.+.. ++.++||||||+++|+|++|+.||.+.+..+....+.......+ .+.+.
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~ 228 (316)
T cd05619 150 DAKTCTFCGTPDYIAPEILLGQK-YNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKDILV 228 (316)
T ss_pred CCceeeecCCccccCHHHHcCCC-CCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHH
Confidence 12233456789999999986654 89999999999999999999999988877665554433221111 12222
Q ss_pred ---ccCCCCCCCccc-ccccCChhhhhc
Q 021306 267 ---CMNPNYTDFRFP-QIKAHPWHKVCI 290 (314)
Q Consensus 267 ---~~~p~~~~~~~~-~l~~~p~~~~~~ 290 (314)
..+|. +|+++. ++++|||++...
T Consensus 229 ~~l~~~P~-~R~~~~~~l~~h~~~~~~~ 255 (316)
T cd05619 229 KLFVREPE-RRLGVKGDIRQHPFFREID 255 (316)
T ss_pred HHhccCHh-hcCCChHHHHcCcccCCCC
Confidence 33677 899986 899999987754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=284.51 Aligned_cols=251 Identities=27% Similarity=0.420 Sum_probs=216.1
Q ss_pred CCCCccCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeecccc------chHHHHHHHHhCCCCceeeeceeeeecC
Q 021306 31 NGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR------YKNRELQLMRVMDHPNVISLKHCFFSTT 104 (314)
Q Consensus 31 ~~~~~~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~~------~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 104 (314)
....++.+-|.+-+.||+|-|.+|-++++..+|+.||||++.+..- ..-+|+..++..+|||||+++++.
T Consensus 11 i~DgkIAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEVi---- 86 (864)
T KOG4717|consen 11 IYDGKIAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVI---- 86 (864)
T ss_pred ccccceeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehh----
Confidence 3455666789999999999999999999999999999999976542 234899999999999999999987
Q ss_pred CCCceeEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEe
Q 021306 105 SKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKIC 183 (314)
Q Consensus 105 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~ 183 (314)
..+..+|+|+|.-++ +|.+.+... ...+.+..+++++.||+.|+.|+|+ -.+|||||||+|+.+...-+-+||.
T Consensus 87 -DTQTKlyLiLELGD~GDl~DyImKH---e~Gl~E~La~kYF~QI~~AI~YCHq-LHVVHRDLKPENVVFFEKlGlVKLT 161 (864)
T KOG4717|consen 87 -DTQTKLYLILELGDGGDLFDYIMKH---EEGLNEDLAKKYFAQIVHAISYCHQ-LHVVHRDLKPENVVFFEKLGLVKLT 161 (864)
T ss_pred -cccceEEEEEEecCCchHHHHHHhh---hccccHHHHHHHHHHHHHHHHHHhh-hhhhcccCCcceeEEeeecCceEee
Confidence 444458899999886 788877753 5779999999999999999999999 7999999999999998878899999
Q ss_pred ecCcccccccCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCC---
Q 021306 184 DFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP--- 260 (314)
Q Consensus 184 dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~--- 260 (314)
|||++..+.........+|+..|.|||++.|.....++.||||||+|||.+++|+.||...++.+.+..|+...-..
T Consensus 162 DFGFSNkf~PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvPsh 241 (864)
T KOG4717|consen 162 DFGFSNKFQPGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVPSH 241 (864)
T ss_pred eccccccCCCcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCchh
Confidence 99999988887777788999999999999998866789999999999999999999999999999999999753222
Q ss_pred ----CHHHHhc---cCCCCCCCcccccccCChhhhhcc
Q 021306 261 ----TREEIRC---MNPNYTDFRFPQIKAHPWHKVCIF 291 (314)
Q Consensus 261 ----~~~~~~~---~~p~~~~~~~~~l~~~p~~~~~~~ 291 (314)
.++++.. .+|. +|-++++|..++|.+....
T Consensus 242 vS~eCrdLI~sMLvRdPk-kRAslEeI~s~~Wlq~~D~ 278 (864)
T KOG4717|consen 242 VSKECRDLIQSMLVRDPK-KRASLEEIVSTSWLQAGDR 278 (864)
T ss_pred hhHHHHHHHHHHHhcCch-hhccHHHHhccccccCCCC
Confidence 2333332 3777 8999999999999887654
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-39 Score=273.83 Aligned_cols=235 Identities=34% Similarity=0.602 Sum_probs=187.8
Q ss_pred ceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccccch------HHHHHHHHhCCCCceeeeceeeeecCCCCceeEEE
Q 021306 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK------NRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 113 (314)
Q Consensus 40 y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~~~~------~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 113 (314)
|++++.||+|+||.||++++..+++.+++|.+....... .+|+.++++++|+||+++.+++.. ....++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-----~~~~~~ 75 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQD-----DNYLYI 75 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEE-----SSEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccc-----cccccc
Confidence 899999999999999999999999999999997654222 248889999999999999998865 334789
Q ss_pred Eeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCccccc-
Q 021306 114 VMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL- 191 (314)
Q Consensus 114 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~- 191 (314)
+||++.+ +|.+.+. ....+++.+++.++.||+.||.+||+ .|++|+||+|+||+++. ++.++|+|||.+...
T Consensus 76 v~~~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~L~~Lh~-~~i~H~dikp~NIl~~~-~~~~~l~Dfg~~~~~~ 149 (260)
T PF00069_consen 76 VMEYCPGGSLQDYLQ----KNKPLSEEEILKIAYQILEALAYLHS-KGIVHRDIKPENILLDE-NGEVKLIDFGSSVKLS 149 (260)
T ss_dssp EEEEETTEBHHHHHH----HHSSBBHHHHHHHHHHHHHHHHHHHH-TTEEESSBSGGGEEEST-TSEEEESSGTTTEEST
T ss_pred ccccccccccccccc----cccccccccccccccccccccccccc-ccccccccccccccccc-cccccccccccccccc
Confidence 9999998 7776666 34789999999999999999999999 89999999999999997 889999999998753
Q ss_pred ccCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCC------------
Q 021306 192 IAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT------------ 259 (314)
Q Consensus 192 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~------------ 259 (314)
..........++..|+|||.+......+.++|+||||+++|+|++|..||......+....+.+....
T Consensus 150 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (260)
T PF00069_consen 150 ENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREK 229 (260)
T ss_dssp STTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTS
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchh
Confidence 22233334566888999999863445899999999999999999999999987433333333222110
Q ss_pred --CCHHHHh---ccCCCCCCCcccccccCChh
Q 021306 260 --PTREEIR---CMNPNYTDFRFPQIKAHPWH 286 (314)
Q Consensus 260 --~~~~~~~---~~~p~~~~~~~~~l~~~p~~ 286 (314)
...+.+. ..+|. +|+++.++++|||+
T Consensus 230 ~~~l~~li~~~l~~~p~-~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 230 SEELRDLIKKMLSKDPE-QRPSAEELLKHPWF 260 (260)
T ss_dssp HHHHHHHHHHHSSSSGG-GSTTHHHHHTSGGG
T ss_pred HHHHHHHHHHHccCChh-HCcCHHHHhcCCCC
Confidence 1111122 23666 89999999999996
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-39 Score=282.90 Aligned_cols=234 Identities=26% Similarity=0.463 Sum_probs=184.2
Q ss_pred eeeEeecCceEEEEEEEC---CCCcEEEEEEeeccc--------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeE
Q 021306 43 ERVVGTGSFGIVFQAKCL---ETGETVAIKKVLQDR--------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 111 (314)
Q Consensus 43 ~~~Lg~g~~g~Vy~~~~~---~~~~~~~vK~~~~~~--------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 111 (314)
++.||+|+||.||++++. .+++.||+|.++... ....+|+.+++.++||||+++++++.. ...+
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~-----~~~~ 75 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQT-----GGKL 75 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEec-----CCeE
Confidence 368999999999999864 468899999986431 123478999999999999999988843 3348
Q ss_pred EEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcccc
Q 021306 112 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 190 (314)
Q Consensus 112 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~ 190 (314)
+++|||+++ +|.+.+. ..+.+++..++.++.|++.||.|||+ +||+|+||||+||+++. ++.++|+|||++..
T Consensus 76 ~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nil~~~-~~~~kl~Dfg~~~~ 149 (323)
T cd05584 76 YLILEYLSGGELFMHLE----REGIFMEDTACFYLSEISLALEHLHQ-QGIIYRDLKPENILLDA-QGHVKLTDFGLCKE 149 (323)
T ss_pred EEEEeCCCCchHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEECC-CCCEEEeeCcCCee
Confidence 899999997 5544443 35678999999999999999999999 89999999999999998 88999999999864
Q ss_pred cccC-CccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCC-------H
Q 021306 191 LIAG-EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT-------R 262 (314)
Q Consensus 191 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~-------~ 262 (314)
.... .......+++.|+|||.+.+.. ++.++||||||+++|+|++|+.||.+.+.......+.+.....+ .
T Consensus 150 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (323)
T cd05584 150 SIHEGTVTHTFCGTIEYMAPEILMRSG-HGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEAR 228 (323)
T ss_pred cccCCCcccccCCCccccChhhccCCC-CCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 3222 2223356789999999996544 78999999999999999999999998887766666654322111 1
Q ss_pred HHHh---ccCCCCCCC-----cccccccCChhhhh
Q 021306 263 EEIR---CMNPNYTDF-----RFPQIKAHPWHKVC 289 (314)
Q Consensus 263 ~~~~---~~~p~~~~~-----~~~~l~~~p~~~~~ 289 (314)
+.+. ..+|+ +|+ ++++++.|||++..
T Consensus 229 ~li~~~l~~~p~-~R~~~~~~~~~~l~~h~~~~~~ 262 (323)
T cd05584 229 DLLKKLLKRNPS-SRLGAGPGDAAEVQSHPFFRHV 262 (323)
T ss_pred HHHHHHcccCHh-HcCCCCCCCHHHHhcCCCcCCC
Confidence 2222 23666 787 89999999998764
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=275.98 Aligned_cols=236 Identities=26% Similarity=0.372 Sum_probs=180.3
Q ss_pred EeecCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeEEEEeecc
Q 021306 46 VGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYV 118 (314)
Q Consensus 46 Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~ 118 (314)
||+|+||.||++.+..+++.+++|.+.... .....|+.+++.+.|+||+++.+++.. ...++++|||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~-----~~~~~lv~e~~ 75 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQT-----KTDLCLVMTIM 75 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcC-----CCeEEEEEeCC
Confidence 689999999999999999999999986432 123468889999999999999887733 33488999999
Q ss_pred cc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcccccccCC-c
Q 021306 119 PE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE-A 196 (314)
Q Consensus 119 ~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~~~~-~ 196 (314)
++ +|...+......+..+++..++.++.||+.||.|||+ +||+|+||+|+||+++. ++.++|+|||.+....... .
T Consensus 76 ~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nili~~-~~~~~l~dfg~~~~~~~~~~~ 153 (280)
T cd05608 76 NGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ-RRIIYRDLKPENVLLDN-DGNVRISDLGLAVELKDGQSK 153 (280)
T ss_pred CCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECC-CCCEEEeeCccceecCCCCcc
Confidence 86 5554444333345679999999999999999999999 89999999999999998 7889999999987543322 2
Q ss_pred cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCC--------CC---HHHH
Q 021306 197 NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT--------PT---REEI 265 (314)
Q Consensus 197 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~--------~~---~~~~ 265 (314)
.....+++.|+|||.+.+.. ++.++|+||||+++|+|++|+.||...+.......+.+.... .. .+.+
T Consensus 154 ~~~~~g~~~y~aPE~~~~~~-~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 232 (280)
T cd05608 154 TKGYAGTPGFMAPELLQGEE-YDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFC 232 (280)
T ss_pred ccccCCCcCccCHHHhcCCC-CCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCCHHHHHHH
Confidence 22346788999999997654 889999999999999999999999765432222222211110 01 1122
Q ss_pred h---ccCCCCCCC-----cccccccCChhhhhc
Q 021306 266 R---CMNPNYTDF-----RFPQIKAHPWHKVCI 290 (314)
Q Consensus 266 ~---~~~p~~~~~-----~~~~l~~~p~~~~~~ 290 (314)
. ..+|. +|+ +++++++|||++...
T Consensus 233 ~~~l~~~P~-~R~~~~~~~~~~~l~h~~~~~~~ 264 (280)
T cd05608 233 EALLAKDPE-KRLGFRDGNCDGLRTHPLFRDLN 264 (280)
T ss_pred HHHhcCCHH-HhcCCCCCCHHHHhcChhhhcCC
Confidence 2 33666 677 778999999998744
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=273.93 Aligned_cols=247 Identities=24% Similarity=0.393 Sum_probs=192.4
Q ss_pred CCceeeeeEeecCceEEEEEEECCCCcEEEEEEeecccc-----chHHHHH-HHHhCCCCceeeeceeeeecCCCCceeE
Q 021306 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNRELQ-LMRVMDHPNVISLKHCFFSTTSKNELFL 111 (314)
Q Consensus 38 ~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~~-----~~~~e~~-~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 111 (314)
++|++.+.||+|+||.||++.+..+|+.||+|.++.... ....|.. .++.+.|+||+++++++.... ..
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~-----~~ 75 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREG-----DV 75 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCC-----cE
Confidence 479999999999999999999999999999998865421 1223444 466679999999999885432 38
Q ss_pred EEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCC-CceecCCCCCcEEEcCCCCcEEEeecCcccc
Q 021306 112 NLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP-RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 190 (314)
Q Consensus 112 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~-~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~ 190 (314)
++++||+++++.+.+.........+++..++.++.|++.||.|||+ + +++|+||+|+||+++. ++.++|+|||.+..
T Consensus 76 ~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~~i~h~dlkp~nil~~~-~~~~kl~dfg~~~~ 153 (283)
T cd06617 76 WICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS-KLSVIHRDVKPSNVLINR-NGQVKLCDFGISGY 153 (283)
T ss_pred EEEhhhhcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCeecCCCCHHHEEECC-CCCEEEeecccccc
Confidence 8999999998888877655555789999999999999999999998 7 9999999999999998 88899999999876
Q ss_pred cccCCccccccccccccccccccCC---CCCCcchhHHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHHHHcCCCC-----
Q 021306 191 LIAGEANISYICSRFYRAPELIFGA---TEYTTSIDIWSAGCVLAELLLGQPLFPGE-NAVDQLVEIIKVLGTPT----- 261 (314)
Q Consensus 191 ~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~~Dv~slG~il~el~tg~~pf~~~-~~~~~~~~i~~~~~~~~----- 261 (314)
...........++..|+|||.+.+. ..++.++|+||||+++|+|++|+.||... ...+.+..+.+......
T Consensus 154 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd06617 154 LVDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKF 233 (283)
T ss_pred cccccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCCcccc
Confidence 5433222334567889999988542 23678999999999999999999999754 33344444444322111
Q ss_pred -H---HHHh---ccCCCCCCCcccccccCChhhhhccc
Q 021306 262 -R---EEIR---CMNPNYTDFRFPQIKAHPWHKVCIFH 292 (314)
Q Consensus 262 -~---~~~~---~~~p~~~~~~~~~l~~~p~~~~~~~~ 292 (314)
. +.+. ..+|. .|+++.+++.|||++....+
T Consensus 234 ~~~l~~li~~~l~~~p~-~Rp~~~~il~~~~~~~~~~~ 270 (283)
T cd06617 234 SPEFQDFVNKCLKKNYK-ERPNYPELLQHPFFELHLSK 270 (283)
T ss_pred CHHHHHHHHHHccCChh-hCcCHHHHhcCchhhhcccc
Confidence 1 1121 23677 89999999999999998766
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=276.98 Aligned_cols=246 Identities=35% Similarity=0.576 Sum_probs=198.2
Q ss_pred CCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeecccc------chHHHHHHHHhCCCCceeeeceeeeecCCCCcee
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR------YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 110 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~~------~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 110 (314)
.++|++.+.||+|++|.||++.+..+|+.|++|.+..... ...+|+.++++++|+||+++++++.... ...
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~---~~~ 82 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKH---LDS 82 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCC---CCe
Confidence 5679999999999999999999999999999998864321 2347999999999999999999875422 234
Q ss_pred EEEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcccc
Q 021306 111 LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 190 (314)
Q Consensus 111 ~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~ 190 (314)
+++|+||+.+++.+.+... ...+++.+++.++.|++.||.+||+ .|++|+||+|+||+++. ++.++|+|||.+..
T Consensus 83 ~~lv~e~~~~~l~~~l~~~---~~~l~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~nil~~~-~~~~kL~dfg~~~~ 157 (309)
T cd07845 83 IFLVMEYCEQDLASLLDNM---PTPFSESQVKCLMLQLLRGLQYLHE-NFIIHRDLKVSNLLLTD-KGCLKIADFGLART 157 (309)
T ss_pred EEEEEecCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEECC-CCCEEECccceeee
Confidence 7899999999887777642 3679999999999999999999999 89999999999999998 78899999999876
Q ss_pred cccCCc-cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCC--------
Q 021306 191 LIAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT-------- 261 (314)
Q Consensus 191 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~-------- 261 (314)
...... ......++.|+|||.+.+...++.++|+||||+++|+|++|+.||.+.+..+.+..+.+..+.+.
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (309)
T cd07845 158 YGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFS 237 (309)
T ss_pred cCCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhh
Confidence 543321 12223467799999987656678999999999999999999999999888877777666433221
Q ss_pred -----------------------------HHHHh---ccCCCCCCCcccccccCChhhhhcc
Q 021306 262 -----------------------------REEIR---CMNPNYTDFRFPQIKAHPWHKVCIF 291 (314)
Q Consensus 262 -----------------------------~~~~~---~~~p~~~~~~~~~l~~~p~~~~~~~ 291 (314)
.+.+. ..+|. +|+++++++.|||++....
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~-~R~t~~~il~h~~f~~~~~ 298 (309)
T cd07845 238 DLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPK-KRATAEEALESSYFKEKPL 298 (309)
T ss_pred cccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChh-hCcCHHHHhcChhhccCCC
Confidence 11222 23666 8999999999999985554
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-39 Score=284.17 Aligned_cols=243 Identities=24% Similarity=0.388 Sum_probs=190.2
Q ss_pred CCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCCcee
Q 021306 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 110 (314)
Q Consensus 38 ~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 110 (314)
++|++.+.||+|+||.||+++++.+++.+++|.+.+.. ....+|..++..++|++|+++++++.. ...
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~ 75 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQD-----ENN 75 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEec-----CCE
Confidence 47999999999999999999999999999999986421 124578888999999999999988743 334
Q ss_pred EEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCccc
Q 021306 111 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 189 (314)
Q Consensus 111 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~ 189 (314)
+++||||+.+ +|.+.+.. ....+++..++.++.||+.||.|||+ +||+||||||+||+++. ++.++|+|||++.
T Consensus 76 ~~lv~ey~~~g~L~~~l~~---~~~~l~~~~~~~~~~qi~~al~~lH~-~~iiHrDlkp~Nili~~-~~~~kL~DfG~a~ 150 (332)
T cd05623 76 LYLVMDYYVGGDLLTLLSK---FEDRLPEDMARFYLAEMVIAIDSVHQ-LHYVHRDIKPDNILMDM-NGHIRLADFGSCL 150 (332)
T ss_pred EEEEEeccCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHEEECC-CCCEEEeecchhe
Confidence 8899999985 66666543 24678999999999999999999999 89999999999999997 8889999999986
Q ss_pred ccccCCc--cccccccccccccccccC----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCC---C
Q 021306 190 QLIAGEA--NISYICSRFYRAPELIFG----ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT---P 260 (314)
Q Consensus 190 ~~~~~~~--~~~~~~~~~y~aPE~~~~----~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~---~ 260 (314)
....... .....+++.|+|||.+.+ ...++.++||||||+++|+|++|+.||...+..+.+..+...... +
T Consensus 151 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p 230 (332)
T cd05623 151 KLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFP 230 (332)
T ss_pred ecccCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCC
Confidence 5432222 223467999999999852 334788999999999999999999999988877777666543211 0
Q ss_pred ---------CHHHHhc---cCCC-CCCCcccccccCChhhhhc
Q 021306 261 ---------TREEIRC---MNPN-YTDFRFPQIKAHPWHKVCI 290 (314)
Q Consensus 261 ---------~~~~~~~---~~p~-~~~~~~~~l~~~p~~~~~~ 290 (314)
..+.+.. ..+. ..|+++.++++|||++...
T Consensus 231 ~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~~ 273 (332)
T cd05623 231 AQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGID 273 (332)
T ss_pred CccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCCC
Confidence 1122222 1222 3467899999999987543
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-39 Score=283.99 Aligned_cols=233 Identities=26% Similarity=0.491 Sum_probs=177.9
Q ss_pred eeEeecCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhC-CCCceeeeceeeeecCCCCceeEEEEe
Q 021306 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVM-DHPNVISLKHCFFSTTSKNELFLNLVM 115 (314)
Q Consensus 44 ~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~-------~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv~ 115 (314)
+.||+|+||.||++++..+++.||+|.+++.. ....+|..++..+ +||||+++++++.. ...+++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~-----~~~~~lv~ 75 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQT-----ESRLFFVI 75 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEc-----CCEEEEEE
Confidence 46899999999999999999999999987532 1234678888888 79999999998843 33488999
Q ss_pred ecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCccccccc-
Q 021306 116 EYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA- 193 (314)
Q Consensus 116 e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~~- 193 (314)
||++| +|...+. ....+++..++.++.||+.||.|||+ +|++||||||+||+++. ++.++|+|||++.....
T Consensus 76 e~~~~g~L~~~~~----~~~~l~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nili~~-~~~~kL~Dfg~~~~~~~~ 149 (329)
T cd05588 76 EFVSGGDLMFHMQ----RQRKLPEEHARFYSAEISLALNFLHE-RGIIYRDLKLDNVLLDA-EGHIKLTDYGMCKEGIRP 149 (329)
T ss_pred eCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHeEECC-CCCEEECcCccccccccC
Confidence 99987 5544443 35789999999999999999999999 89999999999999998 78899999999864322
Q ss_pred CCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC--------hHHHHHHHHHHcCCCC----
Q 021306 194 GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN--------AVDQLVEIIKVLGTPT---- 261 (314)
Q Consensus 194 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~--------~~~~~~~i~~~~~~~~---- 261 (314)
........+++.|+|||.+.+.. ++.++|+||||+++|+|++|+.||.... ..+.....+.......
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~ 228 (329)
T cd05588 150 GDTTSTFCGTPNYIAPEILRGED-YGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSL 228 (329)
T ss_pred CCccccccCCccccCHHHHcCCC-CCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCCCC
Confidence 22233456789999999997654 8899999999999999999999996321 1122222222211111
Q ss_pred ----HHHHh---ccCCCCCCCc------ccccccCChhhhh
Q 021306 262 ----REEIR---CMNPNYTDFR------FPQIKAHPWHKVC 289 (314)
Q Consensus 262 ----~~~~~---~~~p~~~~~~------~~~l~~~p~~~~~ 289 (314)
.+.+. ..+|. +|++ ++++++|||++..
T Consensus 229 ~~~~~~li~~~L~~dP~-~R~~~~~~~~~~~i~~hp~~~~~ 268 (329)
T cd05588 229 SVKASSVLKGFLNKDPK-ERLGCHPQTGFRDIKSHPFFRNI 268 (329)
T ss_pred CHHHHHHHHHHhccCHH-HcCCCCCCCCHHHHhcCCCCCCC
Confidence 12222 33666 7876 6899999999753
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=285.75 Aligned_cols=235 Identities=25% Similarity=0.375 Sum_probs=182.8
Q ss_pred eeEeecCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeEEEEee
Q 021306 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVME 116 (314)
Q Consensus 44 ~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e 116 (314)
+.||+|+||.||++++..+++.|++|.+.... ....+|..+++.++|+||+++++++.. ...+++|||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~-----~~~~~lv~E 75 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQT-----HDRLCFVME 75 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEc-----CCEEEEEEe
Confidence 46999999999999999999999999987532 222467888999999999999888743 334889999
Q ss_pred ccccc-HHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcccccccC-
Q 021306 117 YVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG- 194 (314)
Q Consensus 117 ~~~~~-l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~~~- 194 (314)
|++++ |...+. ....+++..++.++.||+.||.|||+.+||+||||||+||+++. ++.++|+|||++......
T Consensus 76 ~~~~~~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~-~~~~kL~Dfg~~~~~~~~~ 150 (325)
T cd05594 76 YANGGELFFHLS----RERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDK-DGHIKITDFGLCKEGIKDG 150 (325)
T ss_pred CCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECC-CCCEEEecCCCCeecCCCC
Confidence 99974 443333 35679999999999999999999995259999999999999998 889999999998643222
Q ss_pred CccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCC-------CHHHHh-
Q 021306 195 EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP-------TREEIR- 266 (314)
Q Consensus 195 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~-------~~~~~~- 266 (314)
.......+++.|+|||.+.+.. ++.++||||||+++|+|++|+.||.+.+.......+....... ..+.+.
T Consensus 151 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~ 229 (325)
T cd05594 151 ATMKTFCGTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLSG 229 (325)
T ss_pred cccccccCCcccCCHHHHccCC-CCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHH
Confidence 2223356789999999996654 8899999999999999999999998877665555444321111 112222
Q ss_pred --ccCCCCCCC-----cccccccCChhhhhc
Q 021306 267 --CMNPNYTDF-----RFPQIKAHPWHKVCI 290 (314)
Q Consensus 267 --~~~p~~~~~-----~~~~l~~~p~~~~~~ 290 (314)
..+|. +|+ ++.++++|||++...
T Consensus 230 ~L~~dP~-~R~~~~~~~~~~il~h~~~~~~~ 259 (325)
T cd05594 230 LLKKDPK-QRLGGGPDDAKEIMQHKFFAGIV 259 (325)
T ss_pred HhhcCHH-HhCCCCCCCHHHHhcCCCcCCCC
Confidence 34666 675 899999999987643
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-39 Score=281.91 Aligned_cols=234 Identities=29% Similarity=0.480 Sum_probs=184.2
Q ss_pred eeEeecCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhC-CCCceeeeceeeeecCCCCceeEEEEe
Q 021306 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVM-DHPNVISLKHCFFSTTSKNELFLNLVM 115 (314)
Q Consensus 44 ~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~-------~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv~ 115 (314)
+.||+|+||.||+|++..+++.||+|.+++.. ....+|..+++.+ +|+||+++++++.. ...+++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~-----~~~~~lv~ 75 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQT-----KDRLFFVM 75 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEc-----CCEEEEEE
Confidence 47999999999999999999999999987532 1224677777777 79999999998843 33488999
Q ss_pred ecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCccccccc-
Q 021306 116 EYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA- 193 (314)
Q Consensus 116 e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~~- 193 (314)
||++| +|...+. ....+++.++..++.|++.||.|||+ +|++|+||||+||+++. ++.++|+|||++.....
T Consensus 76 e~~~~~~L~~~~~----~~~~l~~~~~~~~~~qi~~~l~~LH~-~~ivH~dlkp~Nill~~-~~~~kl~Dfg~~~~~~~~ 149 (318)
T cd05570 76 EYVNGGDLMFHIQ----RSGRFDEPRARFYAAEIVLGLQFLHE-RGIIYRDLKLDNVLLDS-EGHIKIADFGMCKEGILG 149 (318)
T ss_pred cCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHh-CCeEccCCCHHHeEECC-CCcEEecccCCCeecCcC
Confidence 99986 5544443 34679999999999999999999999 89999999999999998 78999999998864322
Q ss_pred CCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCC-------HHHHh
Q 021306 194 GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT-------REEIR 266 (314)
Q Consensus 194 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~-------~~~~~ 266 (314)
........+++.|+|||.+.+.. ++.++|+||||+++|+|++|+.||.+.+.......+.+.....+ .+.+.
T Consensus 150 ~~~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~ 228 (318)
T cd05570 150 GVTTSTFCGTPDYIAPEILSYQP-YGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWLSKEAKSILK 228 (318)
T ss_pred CCcccceecCccccCHHHhcCCC-CCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHH
Confidence 22223345788999999996654 88999999999999999999999988877666555543322111 12222
Q ss_pred ---ccCCCCCCCcc-----cccccCChhhhhc
Q 021306 267 ---CMNPNYTDFRF-----PQIKAHPWHKVCI 290 (314)
Q Consensus 267 ---~~~p~~~~~~~-----~~l~~~p~~~~~~ 290 (314)
..+|. +|+++ .+++.|||++...
T Consensus 229 ~~l~~dP~-~R~s~~~~~~~~ll~~~~~~~~~ 259 (318)
T cd05570 229 SFLTKNPE-KRLGCLPTGEQDIKGHPFFREID 259 (318)
T ss_pred HHccCCHH-HcCCCCCCCHHHHhcCCCcCCCC
Confidence 34677 89999 9999999997754
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=280.44 Aligned_cols=239 Identities=28% Similarity=0.411 Sum_probs=185.7
Q ss_pred CceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhCC-CCceeeeceeeeecCCCCcee
Q 021306 39 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMD-HPNVISLKHCFFSTTSKNELF 110 (314)
Q Consensus 39 ~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~-------~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~ 110 (314)
+|++.+.||+|+||.||+|+++.+++.||+|.+++.. .....|..+++.+. |++|+++++++.. ...
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~-----~~~ 75 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQT-----VDR 75 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEec-----CCE
Confidence 4789999999999999999999999999999987532 12235777777775 5677778777743 234
Q ss_pred EEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCccc
Q 021306 111 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 189 (314)
Q Consensus 111 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~ 189 (314)
+++||||++| +|...+. ....+++.+++.++.|++.||.|||+ +|++||||||+||+++. ++.++|+|||++.
T Consensus 76 ~~lv~Ey~~~g~L~~~i~----~~~~l~~~~~~~i~~qi~~al~~lH~-~~ivHrDikp~Nill~~-~~~ikL~Dfg~~~ 149 (323)
T cd05615 76 LYFVMEYVNGGDLMYHIQ----QVGKFKEPQAVFYAAEISVGLFFLHR-RGIIYRDLKLDNVMLDS-EGHIKIADFGMCK 149 (323)
T ss_pred EEEEEcCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHeEECC-CCCEEEecccccc
Confidence 8899999986 5544443 35679999999999999999999999 89999999999999998 7889999999987
Q ss_pred ccccCC-ccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCC-------
Q 021306 190 QLIAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT------- 261 (314)
Q Consensus 190 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~------- 261 (314)
...... ......+++.|+|||.+.+.. ++.++|+||||+++|+|++|+.||.+.+.......+++.....+
T Consensus 150 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~ 228 (323)
T cd05615 150 EHMVDGVTTRTFCGTPDYIAPEIIAYQP-YGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEA 228 (323)
T ss_pred ccCCCCccccCccCCccccCHHHHcCCC-CCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHH
Confidence 532222 223355789999999986544 88999999999999999999999998887777766665432211
Q ss_pred HHHHh---ccCCCCCCCc-----ccccccCChhhhhc
Q 021306 262 REEIR---CMNPNYTDFR-----FPQIKAHPWHKVCI 290 (314)
Q Consensus 262 ~~~~~---~~~p~~~~~~-----~~~l~~~p~~~~~~ 290 (314)
.+.+. ..+|. +|++ .+++++|||++...
T Consensus 229 ~~li~~~l~~~p~-~R~~~~~~~~~~i~~h~~f~~~~ 264 (323)
T cd05615 229 VSICKGLMTKHPS-KRLGCGPEGERDIREHAFFRRID 264 (323)
T ss_pred HHHHHHHcccCHh-hCCCCCCCCHHHHhcCcccCCCC
Confidence 11222 23566 6765 46899999998654
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=286.30 Aligned_cols=241 Identities=24% Similarity=0.340 Sum_probs=189.5
Q ss_pred CCceeeeeEeecCceEEEEEEEC--CCCcEEEEEEeeccccchHHHHHHHHhCCCCceeeeceeeeecCCCCceeEEEEe
Q 021306 38 ISYMAERVVGTGSFGIVFQAKCL--ETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVM 115 (314)
Q Consensus 38 ~~y~~~~~Lg~g~~g~Vy~~~~~--~~~~~~~vK~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 115 (314)
.+|++++.||+|+||.||++... .++..+++|.+... ....+|+.++++++|+||+++++.+.. ....+++|
T Consensus 92 ~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-~~~~~E~~il~~l~h~~iv~~~~~~~~-----~~~~~lv~ 165 (392)
T PHA03207 92 MQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-KTPGREIDILKTISHRAIINLIHAYRW-----KSTVCMVM 165 (392)
T ss_pred CceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-ccHHHHHHHHHhcCCCCccceeeeEee-----CCEEEEEe
Confidence 47999999999999999999754 35678999987654 345689999999999999999988743 33488999
Q ss_pred ecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcccccccCC
Q 021306 116 EYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE 195 (314)
Q Consensus 116 e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~~~~ 195 (314)
|++.+++...+. ....+++.+++.++.||+.||.|||+ +||+||||||+||+++. ++.++|+|||++.......
T Consensus 166 e~~~~~l~~~l~----~~~~l~~~~~~~i~~ql~~aL~~LH~-~givHrDlkp~Nill~~-~~~~~l~DfG~a~~~~~~~ 239 (392)
T PHA03207 166 PKYKCDLFTYVD----RSGPLPLEQAITIQRRLLEALAYLHG-RGIIHRDVKTENIFLDE-PENAVLGDFGAACKLDAHP 239 (392)
T ss_pred hhcCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEEcC-CCCEEEccCccccccCccc
Confidence 999998877663 34789999999999999999999999 89999999999999998 7889999999987554322
Q ss_pred c---cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHHcCCC---------
Q 021306 196 A---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA---VDQLVEIIKVLGTP--------- 260 (314)
Q Consensus 196 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~---~~~~~~i~~~~~~~--------- 260 (314)
. .....+|+.|+|||.+.+.. ++.++|||||||++|+|++|+.||.+... ...+..+++..+..
T Consensus 240 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~ 318 (392)
T PHA03207 240 DTPQCYGWSGTLETNSPELLALDP-YCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGS 318 (392)
T ss_pred ccccccccccccCccCHhHhcCCC-CCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccc
Confidence 1 22456799999999996544 88999999999999999999999976432 23333333321110
Q ss_pred --------------------------------CHHHH---hccCCCCCCCcccccccCChhhhhccc
Q 021306 261 --------------------------------TREEI---RCMNPNYTDFRFPQIKAHPWHKVCIFH 292 (314)
Q Consensus 261 --------------------------------~~~~~---~~~~p~~~~~~~~~l~~~p~~~~~~~~ 292 (314)
..+.+ ...+|. +|+++.+++.|||+...+.+
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~-~Rpsa~e~l~~p~f~~~~~~ 384 (392)
T PHA03207 319 TNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQE-FRPSAQDILSLPLFTKEPIN 384 (392)
T ss_pred hhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChh-hCCCHHHHhhCchhhccchh
Confidence 00112 233677 89999999999999775543
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=280.48 Aligned_cols=246 Identities=36% Similarity=0.650 Sum_probs=193.1
Q ss_pred CCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeE
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 111 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 111 (314)
+++|++.+.||+|++|.||+|.+..+|+.|++|.+.... ....+|+.++++++|+||+++++++...........
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 468999999999999999999999999999999886321 123468999999999999999987654443444557
Q ss_pred EEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCccccc
Q 021306 112 NLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 191 (314)
Q Consensus 112 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~ 191 (314)
++++||+++++.+.+. ...+++..++.++.|++.||.+||+ .|++|+||+|+||+++. ++.++|+|||++...
T Consensus 84 ~lv~e~~~~~l~~~~~-----~~~l~~~~~~~i~~ql~~aL~~LH~-~~ivH~dlkp~Nill~~-~~~~kl~dfg~~~~~ 156 (336)
T cd07849 84 YIVQELMETDLYKLIK-----TQHLSNDHIQYFLYQILRGLKYIHS-ANVLHRDLKPSNLLLNT-NCDLKICDFGLARIA 156 (336)
T ss_pred EEEehhcccCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHEEECC-CCCEEECcccceeec
Confidence 8999999998776654 3679999999999999999999999 89999999999999998 888999999998754
Q ss_pred ccCCcc----ccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCC-------
Q 021306 192 IAGEAN----ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP------- 260 (314)
Q Consensus 192 ~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~------- 260 (314)
...... ....+++.|+|||.+.+...++.++||||||+++|+|++|+.||.+.+.......+....+.+
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (336)
T cd07849 157 DPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNC 236 (336)
T ss_pred cccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHH
Confidence 332211 224567889999987665558899999999999999999999998766544333332222111
Q ss_pred -------------------------------CHHHHh---ccCCCCCCCcccccccCChhhhhc
Q 021306 261 -------------------------------TREEIR---CMNPNYTDFRFPQIKAHPWHKVCI 290 (314)
Q Consensus 261 -------------------------------~~~~~~---~~~p~~~~~~~~~l~~~p~~~~~~ 290 (314)
..+.+. ..+|. +|+++.+++.|||++...
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~-~Rpt~~e~l~hp~~~~~~ 299 (336)
T cd07849 237 IISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPH-KRITVEEALAHPYLEQYH 299 (336)
T ss_pred hhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChh-hCcCHHHHhcCccccccC
Confidence 111222 22566 899999999999987654
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=272.68 Aligned_cols=238 Identities=36% Similarity=0.699 Sum_probs=190.5
Q ss_pred CceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeEE
Q 021306 39 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 112 (314)
Q Consensus 39 ~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 112 (314)
+|++.+.||.|++|.||+|++..+++.+++|.+..+. ....+|+.++++++|+||+++++++.. ....+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~~~ 75 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT-----ENKLY 75 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhccc-----CCcEE
Confidence 5899999999999999999999999999999886432 234579999999999999999998743 33488
Q ss_pred EEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcccccc
Q 021306 113 LVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 192 (314)
Q Consensus 113 lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~ 192 (314)
++|||+.+++.+.+.. .....+++.+++.++.|++.|+.|||+ .+++|+||+|+||+++. ++.++|+|||.+....
T Consensus 76 ~v~e~~~~~l~~~~~~--~~~~~l~~~~~~~~~~~i~~~l~~lh~-~~i~H~~l~p~nill~~-~~~~~l~dfg~~~~~~ 151 (284)
T cd07860 76 LVFEFLHQDLKKFMDA--SPLSGIPLPLIKSYLFQLLQGLAFCHS-HRVLHRDLKPQNLLINT-EGAIKLADFGLARAFG 151 (284)
T ss_pred EEeeccccCHHHHHHh--CCCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEECC-CCCEEEeeccchhhcc
Confidence 9999999887766653 234678999999999999999999999 89999999999999998 7889999999986543
Q ss_pred cCCc-cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCH---------
Q 021306 193 AGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR--------- 262 (314)
Q Consensus 193 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~--------- 262 (314)
.... .....+++.|+|||.+.+...++.++|+||||+++|+|+||+.||.+.+..+....+.+..+.+..
T Consensus 152 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd07860 152 VPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSL 231 (284)
T ss_pred cCccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHH
Confidence 3221 222345778999999876555688999999999999999999999888776666655544333211
Q ss_pred ---------------------------HHHh---ccCCCCCCCcccccccCChh
Q 021306 263 ---------------------------EEIR---CMNPNYTDFRFPQIKAHPWH 286 (314)
Q Consensus 263 ---------------------------~~~~---~~~p~~~~~~~~~l~~~p~~ 286 (314)
+.+. ..+|. +|+++.++++|||+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~-~Rpt~~~~l~~~~f 284 (284)
T cd07860 232 PDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPN-KRISAKAALAHPFF 284 (284)
T ss_pred HHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcc-cCCCHHHHhcCCCC
Confidence 1122 23676 88999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=280.21 Aligned_cols=233 Identities=29% Similarity=0.484 Sum_probs=180.1
Q ss_pred eeEeecCceEEEEEEECCCCcEEEEEEeecccc-------chHHHHHHHHh-CCCCceeeeceeeeecCCCCceeEEEEe
Q 021306 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YKNRELQLMRV-MDHPNVISLKHCFFSTTSKNELFLNLVM 115 (314)
Q Consensus 44 ~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~~-------~~~~e~~~l~~-l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 115 (314)
+.||+|+||.||+|++..+++.||+|.++.... ....|..++.. ..||||+++++++.. ...+++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~-----~~~~~lv~ 75 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQT-----KEHLFFVM 75 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEc-----CCEEEEEE
Confidence 469999999999999999999999999875421 11245555554 489999999988743 33588999
Q ss_pred ecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcccccccC
Q 021306 116 EYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG 194 (314)
Q Consensus 116 e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~~~ 194 (314)
||++| +|...+. ....+++.+++.++.|++.||.|||+ +||+||||||+||+++. ++.++|+|||++......
T Consensus 76 e~~~gg~L~~~~~----~~~~~~~~~~~~~~~qi~~al~~LH~-~~ivH~dlkp~Nill~~-~~~~kL~Dfg~a~~~~~~ 149 (316)
T cd05592 76 EYLNGGDLMFHIQ----SSGRFDEARARFYAAEIICGLQFLHK-KGIIYRDLKLDNVLLDK-DGHIKIADFGMCKENMNG 149 (316)
T ss_pred cCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCEEeCCCCHHHeEECC-CCCEEEccCcCCeECCCC
Confidence 99986 5544443 34679999999999999999999999 89999999999999998 788999999998754322
Q ss_pred -CccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCC-------CHHHHh
Q 021306 195 -EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP-------TREEIR 266 (314)
Q Consensus 195 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~-------~~~~~~ 266 (314)
.......+++.|+|||.+.+.. ++.++||||||+++|+|++|+.||.+.+..+.+..+....... ..+.+.
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ll~ 228 (316)
T cd05592 150 EGKASTFCGTPDYIAPEILKGQK-YNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWISKEAKDCLS 228 (316)
T ss_pred CCccccccCCccccCHHHHcCCC-CCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 2223456799999999997654 8899999999999999999999999888766665554332111 112222
Q ss_pred ---ccCCCCCCCcc-cccccCChhhhh
Q 021306 267 ---CMNPNYTDFRF-PQIKAHPWHKVC 289 (314)
Q Consensus 267 ---~~~p~~~~~~~-~~l~~~p~~~~~ 289 (314)
..+|. +|++. .+++.|||++..
T Consensus 229 ~~l~~~P~-~R~~~~~~l~~h~~~~~~ 254 (316)
T cd05592 229 KLFERDPT-KRLGVDGDIRQHPFFRGI 254 (316)
T ss_pred HHccCCHH-HcCCChHHHHcCcccCCC
Confidence 23666 78875 589999998754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=283.71 Aligned_cols=233 Identities=27% Similarity=0.449 Sum_probs=179.5
Q ss_pred eeEeecCceEEEEEEECCCCcEEEEEEeecccc-------chHHHH-HHHHhCCCCceeeeceeeeecCCCCceeEEEEe
Q 021306 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YKNREL-QLMRVMDHPNVISLKHCFFSTTSKNELFLNLVM 115 (314)
Q Consensus 44 ~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~~-------~~~~e~-~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 115 (314)
+.||+|+||.||++++..+|+.+++|.+.+... ...+|. .+++.++||||+++++.+.. ...+++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~-----~~~~~lv~ 75 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQT-----TEKLYFVL 75 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEec-----CCEEEEEE
Confidence 469999999999999999999999999864321 112333 35677899999999988743 33488999
Q ss_pred eccccc-HHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCccccccc-
Q 021306 116 EYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA- 193 (314)
Q Consensus 116 e~~~~~-l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~~- 193 (314)
||++++ |...+. ....+++.+++.++.||+.||.|||+ +|++||||||+||+++. ++.++|+|||++.....
T Consensus 76 e~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~al~~lH~-~givH~Dlkp~NIll~~-~~~~kL~DfG~~~~~~~~ 149 (325)
T cd05604 76 DFVNGGELFFHLQ----RERSFPEPRARFYAAEIASALGYLHS-INIVYRDLKPENILLDS-QGHVVLTDFGLCKEGIAQ 149 (325)
T ss_pred cCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCHHHeEECC-CCCEEEeecCCcccCCCC
Confidence 999974 444433 35789999999999999999999999 89999999999999998 78999999999864322
Q ss_pred CCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCC----C---HHHHh
Q 021306 194 GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP----T---REEIR 266 (314)
Q Consensus 194 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~----~---~~~~~ 266 (314)
........+++.|+|||.+.+.. ++.++||||||+++|+|++|..||.+.+..+....++...... . .+.+.
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~ 228 (325)
T cd05604 150 SDTTTTFCGTPEYLAPEVIRKQP-YDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSILE 228 (325)
T ss_pred CCCcccccCChhhCCHHHHcCCC-CCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCccCCCCCCHHHHHHHH
Confidence 22233456789999999996654 7899999999999999999999999888776666665432111 1 11222
Q ss_pred ---ccCCCCCCCcc----cccccCChhhhh
Q 021306 267 ---CMNPNYTDFRF----PQIKAHPWHKVC 289 (314)
Q Consensus 267 ---~~~p~~~~~~~----~~l~~~p~~~~~ 289 (314)
..+|. +|++. .+++.|||+...
T Consensus 229 ~ll~~~p~-~R~~~~~~~~~i~~h~~f~~~ 257 (325)
T cd05604 229 ELLEKDRQ-RRLGAKEDFLEIQEHPFFESL 257 (325)
T ss_pred HHhccCHH-hcCCCCCCHHHHhcCCCcCCC
Confidence 23555 56655 589999999754
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=275.84 Aligned_cols=242 Identities=27% Similarity=0.399 Sum_probs=188.8
Q ss_pred CceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeE
Q 021306 39 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 111 (314)
Q Consensus 39 ~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 111 (314)
+|++.+.||+|+||.||++.+..+++.||+|.+.... ....+|+.+++.++|+||+++++++. ....+
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~ 75 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYE-----TKDAL 75 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeec-----CCCeE
Confidence 4899999999999999999999999999999886432 22346899999999999999988873 33358
Q ss_pred EEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcccc
Q 021306 112 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 190 (314)
Q Consensus 112 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~ 190 (314)
+++|||+.+ +|.+.+.. .....+++..+..++.|++.||.|||+ .|++|+||+|+||+++. ++.++|+|||++..
T Consensus 76 ~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nil~~~-~~~~~l~Dfg~~~~ 151 (285)
T cd05605 76 CLVLTLMNGGDLKFHIYN--MGNPGFDEERAVFYAAEITCGLEDLHR-ERIVYRDLKPENILLDD-YGHIRISDLGLAVE 151 (285)
T ss_pred EEEEeccCCCcHHHHHHh--cCcCCCCHHHHHHHHHHHHHHHHHHHH-CCcEecCCCHHHEEECC-CCCEEEeeCCCcee
Confidence 899999986 55444432 123569999999999999999999999 89999999999999998 78899999999876
Q ss_pred cccCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH---cCCC----C--
Q 021306 191 LIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV---LGTP----T-- 261 (314)
Q Consensus 191 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~---~~~~----~-- 261 (314)
...........+++.|+|||.+.+.. ++.++||||+|+++|+|++|+.||.+.+.......+... .... .
T Consensus 152 ~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (285)
T cd05605 152 IPEGETIRGRVGTVGYMAPEVVKNER-YTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSE 230 (285)
T ss_pred cCCCCccccccCCCCccCcHHhcCCC-CCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCH
Confidence 54333333456788999999996544 889999999999999999999999886654333332221 1111 1
Q ss_pred --HHHHh---ccCCCCCCC-----cccccccCChhhhhcc
Q 021306 262 --REEIR---CMNPNYTDF-----RFPQIKAHPWHKVCIF 291 (314)
Q Consensus 262 --~~~~~---~~~p~~~~~-----~~~~l~~~p~~~~~~~ 291 (314)
.+.+. ..+|. +|+ ++.+|++|||++....
T Consensus 231 ~~~~li~~~l~~~P~-~R~~~~~~~~~~l~~~~~~~~~~~ 269 (285)
T cd05605 231 AARSICRQLLTKDPG-FRLGCRGEGAEEVKAHPFFRTANF 269 (285)
T ss_pred HHHHHHHHHccCCHH-HhcCCCCCCHHHHhcCcCccCCCH
Confidence 11122 23666 788 8889999999987554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=285.04 Aligned_cols=243 Identities=24% Similarity=0.385 Sum_probs=188.9
Q ss_pred CCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCCcee
Q 021306 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 110 (314)
Q Consensus 38 ~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 110 (314)
++|++.+.||+|+||.||++++..+++.||+|.+.+.. ....+|..++..+.|++|+++++++. ...+
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~-----~~~~ 75 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQ-----DENY 75 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-----cCCE
Confidence 57999999999999999999999999999999886421 22357888899999999999998884 3345
Q ss_pred EEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCccc
Q 021306 111 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 189 (314)
Q Consensus 111 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~ 189 (314)
.++||||+.| +|.+.+.. ....+++..++.++.|++.||.|||+ +||+|+||||+||+++. ++.++|+|||++.
T Consensus 76 ~~lv~Ey~~gg~L~~~l~~---~~~~l~~~~~~~~~~qi~~~L~~lH~-~~iiHrDlkp~Nill~~-~~~~kl~DfG~a~ 150 (331)
T cd05624 76 LYLVMDYYVGGDLLTLLSK---FEDRLPEDMARFYIAEMVLAIHSIHQ-LHYVHRDIKPDNVLLDM-NGHIRLADFGSCL 150 (331)
T ss_pred EEEEEeCCCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeccCchHHEEEcC-CCCEEEEecccee
Confidence 8899999986 55555543 24678999999999999999999999 89999999999999998 7889999999987
Q ss_pred ccccCCcc--ccccccccccccccccCC----CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCC---C
Q 021306 190 QLIAGEAN--ISYICSRFYRAPELIFGA----TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT---P 260 (314)
Q Consensus 190 ~~~~~~~~--~~~~~~~~y~aPE~~~~~----~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~---~ 260 (314)
........ ....+++.|+|||.+.+. ..++.++|+||||+++|+|++|+.||...+..+.+..+...... +
T Consensus 151 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p 230 (331)
T cd05624 151 KMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFP 230 (331)
T ss_pred eccCCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCC
Confidence 55432221 224578999999998542 34678999999999999999999999988877666665542211 0
Q ss_pred ---------CHHHHh---ccCCC-CCCCcccccccCChhhhhc
Q 021306 261 ---------TREEIR---CMNPN-YTDFRFPQIKAHPWHKVCI 290 (314)
Q Consensus 261 ---------~~~~~~---~~~p~-~~~~~~~~l~~~p~~~~~~ 290 (314)
..+.+. +..+. ..+.+++++++|||++...
T Consensus 231 ~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~~ 273 (331)
T cd05624 231 SHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGID 273 (331)
T ss_pred CccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCCC
Confidence 111122 11221 2356899999999997643
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=271.65 Aligned_cols=210 Identities=42% Similarity=0.750 Sum_probs=175.8
Q ss_pred CceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeEE
Q 021306 39 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 112 (314)
Q Consensus 39 ~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 112 (314)
+|++.+.||+|++|.||+|.+..+|+.+++|.+.... ....+|+.++++++|+||+++++++.. ..+.+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~~~ 75 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPH-----GSGFV 75 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEec-----CCeeE
Confidence 5899999999999999999999899999999986543 234578999999999999999998843 34588
Q ss_pred EEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcccccc
Q 021306 113 LVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 192 (314)
Q Consensus 113 lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~ 192 (314)
+|+||+.++|.+.+... ...+++.+++.++.|++.||.+||+ .|++|+||+|+||+++. ++.++|+|||.+....
T Consensus 76 ~v~e~~~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~ni~~~~-~~~~~l~dfg~~~~~~ 150 (286)
T cd07832 76 LVMEYMPSDLSEVLRDE---ERPLPEAQVKSYMRMLLKGVAYMHA-NGIMHRDLKPANLLISA-DGVLKIADFGLARLFS 150 (286)
T ss_pred EEecccCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCcCHHHEEEcC-CCcEEEeeeeeccccc
Confidence 99999976887776542 3679999999999999999999999 89999999999999998 8889999999987654
Q ss_pred cCCc--cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcC
Q 021306 193 AGEA--NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLG 258 (314)
Q Consensus 193 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~ 258 (314)
.... .....++..|+|||.+.+...++.++||||||+++|+|++|..||.+......+..++...+
T Consensus 151 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~ 218 (286)
T cd07832 151 EEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLG 218 (286)
T ss_pred CCCCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcC
Confidence 3321 22345688899999987666578999999999999999999999988777666666655433
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=281.47 Aligned_cols=213 Identities=35% Similarity=0.608 Sum_probs=175.8
Q ss_pred cCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCC-CCc
Q 021306 36 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTS-KNE 108 (314)
Q Consensus 36 ~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~~~ 108 (314)
..++|++.+.||+|++|.||++.+..+++.+++|.+.+.. ....+|+.++++++|+||+++++++..... ...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 3568999999999999999999999999999999886432 123478999999999999999998754322 122
Q ss_pred eeEEEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcc
Q 021306 109 LFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 188 (314)
Q Consensus 109 ~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~ 188 (314)
...++|+||+.+++.+.+.. .+++..+..++.|++.||.+||+ +|++|+||||+||+++. ++.++|+|||.+
T Consensus 94 ~~~~lv~e~~~~~l~~~~~~------~l~~~~~~~~~~ql~~aL~~LH~-~gi~H~dlkp~Nil~~~-~~~~kL~Dfg~~ 165 (353)
T cd07850 94 QDVYLVMELMDANLCQVIQM------DLDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKS-DCTLKILDFGLA 165 (353)
T ss_pred CcEEEEEeccCCCHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCCHHHEEECC-CCCEEEccCccc
Confidence 34789999999988776652 38999999999999999999999 89999999999999998 788999999999
Q ss_pred cccccCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHc
Q 021306 189 KQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVL 257 (314)
Q Consensus 189 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~ 257 (314)
.............+++.|+|||.+.+.. ++.++||||||+++|+|++|+.||...+....+..+++..
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~ 233 (353)
T cd07850 166 RTAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQL 233 (353)
T ss_pred eeCCCCCCCCCCcccccccCHHHHhCCC-CCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhc
Confidence 7654433333445688899999997654 8999999999999999999999998887666665555433
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=310.81 Aligned_cols=243 Identities=26% Similarity=0.489 Sum_probs=204.3
Q ss_pred CCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeec-------cccchHHHHHHHHhCCCCceeeeceeeeecCCCCce
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQ-------DRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL 109 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~-------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 109 (314)
.++|.++++||+|+||.|.+++++.+++.||+|++++ +...+.+|..++.....+=|+.++-.| ++..
T Consensus 74 ~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAF-----QD~~ 148 (1317)
T KOG0612|consen 74 AEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAF-----QDER 148 (1317)
T ss_pred HHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHh-----cCcc
Confidence 4689999999999999999999999999999999865 344567888999888889999988788 6677
Q ss_pred eEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcc
Q 021306 110 FLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 188 (314)
Q Consensus 110 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~ 188 (314)
++|+||||++| +|+..+..+ .++++.+++.++.+|+.||.-||+ -|+|||||||+|||+|. .|+++|.|||.+
T Consensus 149 ~LYlVMdY~pGGDlltLlSk~----~~~pE~~ArFY~aEiVlAldslH~-mgyVHRDiKPDNvLld~-~GHikLADFGsC 222 (1317)
T KOG0612|consen 149 YLYLVMDYMPGGDLLTLLSKF----DRLPEDWARFYTAEIVLALDSLHS-MGYVHRDIKPDNVLLDK-SGHIKLADFGSC 222 (1317)
T ss_pred ceEEEEecccCchHHHHHhhc----CCChHHHHHHHHHHHHHHHHHHHh-ccceeccCCcceeEecc-cCcEeeccchhH
Confidence 79999999997 677666653 489999999999999999999999 89999999999999999 999999999998
Q ss_pred cccccCCc--cccccccccccccccccC---C-CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH---cCC
Q 021306 189 KQLIAGEA--NISYICSRFYRAPELIFG---A-TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV---LGT 259 (314)
Q Consensus 189 ~~~~~~~~--~~~~~~~~~y~aPE~~~~---~-~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~---~~~ 259 (314)
-.....+. ....+|||.|.|||+++. . ..|...+|+||+||++|||+.|..||...+-.+.+.+|+.. ++-
T Consensus 223 lkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~F 302 (1317)
T KOG0612|consen 223 LKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSF 302 (1317)
T ss_pred HhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCC
Confidence 77654443 345789999999999853 2 44789999999999999999999999999999999999976 233
Q ss_pred C--------CHHHHhcc--CCCCCCCc---ccccccCChhhhhcc
Q 021306 260 P--------TREEIRCM--NPNYTDFR---FPQIKAHPWHKVCIF 291 (314)
Q Consensus 260 ~--------~~~~~~~~--~p~~~~~~---~~~l~~~p~~~~~~~ 291 (314)
| ..+.+..+ +|+ .|+. ++++..||||....+
T Consensus 303 P~~~~VSeeakdLI~~ll~~~e-~RLgrngiedik~HpFF~g~~W 346 (1317)
T KOG0612|consen 303 PDETDVSEEAKDLIEALLCDRE-VRLGRNGIEDIKNHPFFEGIDW 346 (1317)
T ss_pred CcccccCHHHHHHHHHHhcChh-hhcccccHHHHHhCccccCCCh
Confidence 3 12233322 444 4555 999999999998876
|
|
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=303.42 Aligned_cols=252 Identities=25% Similarity=0.354 Sum_probs=198.3
Q ss_pred CCccCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeecc------ccchHHHHHHHHhCCCCceeeeceeeeecCCC
Q 021306 33 EPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSK 106 (314)
Q Consensus 33 ~~~~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 106 (314)
.+...++|++.+.||.|+||.||+|++..++..+++|.+... ...+..|+.++++++||||++++++|....
T Consensus 8 ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~-- 85 (1021)
T PTZ00266 8 GESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKA-- 85 (1021)
T ss_pred CccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecC--
Confidence 344557899999999999999999999999999999988643 223457999999999999999999886532
Q ss_pred CceeEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCC-------ceecCCCCCcEEEcCC--
Q 021306 107 NELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR-------VCHRDLKPQNLLVDPL-- 176 (314)
Q Consensus 107 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~-------i~h~dl~p~Nil~~~~-- 176 (314)
...+|+||||+++ +|.+.+.........+++..++.|+.||+.||.|||+ .+ |+|+||||+|||++..
T Consensus 86 -~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs-~g~~~~~k~IVHRDLKPeNILL~s~~~ 163 (1021)
T PTZ00266 86 -NQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHN-LKDGPNGERVLHRDLKPQNIFLSTGIR 163 (1021)
T ss_pred -CCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHh-cccccccCCceeccCcHHHeEeecCcc
Confidence 2347899999985 7877777655556789999999999999999999998 44 9999999999999641
Q ss_pred --------------CCcEEEeecCcccccccCCccccccccccccccccccCC-CCCCcchhHHHHHHHHHHHHhCCCCC
Q 021306 177 --------------THQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGA-TEYTTSIDIWSAGCVLAELLLGQPLF 241 (314)
Q Consensus 177 --------------~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~el~tg~~pf 241 (314)
...++|+|||++.............+++.|+|||.+.+. ..++.++|||||||++|+|+||..||
T Consensus 164 ~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF 243 (1021)
T PTZ00266 164 HIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPF 243 (1021)
T ss_pred ccccccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCC
Confidence 234899999999765443333445689999999998643 34788999999999999999999999
Q ss_pred CCCChHHHHHHHHHHcCCCC-----H---HH---HhccCCCCCCCcccccccCChhhhh
Q 021306 242 PGENAVDQLVEIIKVLGTPT-----R---EE---IRCMNPNYTDFRFPQIKAHPWHKVC 289 (314)
Q Consensus 242 ~~~~~~~~~~~i~~~~~~~~-----~---~~---~~~~~p~~~~~~~~~l~~~p~~~~~ 289 (314)
...+....+...+......+ . +. +...+|. .|+++.+++.|||+...
T Consensus 244 ~~~~~~~qli~~lk~~p~lpi~~~S~eL~dLI~~~L~~dPe-eRPSa~QlL~h~~ik~i 301 (1021)
T PTZ00266 244 HKANNFSQLISELKRGPDLPIKGKSKELNILIKNLLNLSAK-ERPSALQCLGYQIIKNV 301 (1021)
T ss_pred CcCCcHHHHHHHHhcCCCCCcCCCCHHHHHHHHHHhcCChh-HCcCHHHHhccHHHhhc
Confidence 87766555555554432221 1 11 2233677 89999999999999744
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=271.57 Aligned_cols=245 Identities=35% Similarity=0.625 Sum_probs=194.3
Q ss_pred CCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeE
Q 021306 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 111 (314)
Q Consensus 38 ~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 111 (314)
++|++.+.||+|++|.||+++++.+++.|++|.+.... ....+|+.++++++|+||+++++++... ...
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~ 76 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSE-----KRL 76 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecC-----CeE
Confidence 57999999999999999999999899999999885432 2345799999999999999999988433 348
Q ss_pred EEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCccccc
Q 021306 112 NLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 191 (314)
Q Consensus 112 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~ 191 (314)
++|+||+++++.+.+... ....+++..++.++.||+.||.+||+ ++++|+||+|+||+++..+..++|+|||++...
T Consensus 77 ~lv~e~~~~~l~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~LH~-~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~ 153 (294)
T PLN00009 77 YLVFEYLDLDLKKHMDSS--PDFAKNPRLIKTYLYQILRGIAYCHS-HRVLHRDLKPQNLLIDRRTNALKLADFGLARAF 153 (294)
T ss_pred EEEEecccccHHHHHHhC--CCCCcCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCCcceEEEECCCCEEEEccccccccc
Confidence 899999998877766532 23346888999999999999999999 899999999999999865678999999998754
Q ss_pred ccCCc-cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCC---------
Q 021306 192 IAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT--------- 261 (314)
Q Consensus 192 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~--------- 261 (314)
..... .....+++.|+|||.+.+...++.++|+||||+++|+|+||+.||...+..+.+.++....+.+.
T Consensus 154 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (294)
T PLN00009 154 GIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTS 233 (294)
T ss_pred CCCccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccc
Confidence 33221 22345578899999987655578999999999999999999999988877666665554322211
Q ss_pred ---------------------------HHHHh---ccCCCCCCCcccccccCChhhhhcc
Q 021306 262 ---------------------------REEIR---CMNPNYTDFRFPQIKAHPWHKVCIF 291 (314)
Q Consensus 262 ---------------------------~~~~~---~~~p~~~~~~~~~l~~~p~~~~~~~ 291 (314)
.+.+. ..+|. +|+++.+++.|||++....
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~-~Rps~~~~l~~~~~~~~~~ 292 (294)
T PLN00009 234 LPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPS-KRITARAALEHEYFKDLGD 292 (294)
T ss_pred chhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChh-hCcCHHHHhcCchHhHHhc
Confidence 11111 23666 7899999999999987654
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=292.68 Aligned_cols=242 Identities=27% Similarity=0.358 Sum_probs=195.2
Q ss_pred CceeeeeEeecCceEEEEEEECCC-CcEEEEEEeeccc----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeEEE
Q 021306 39 SYMAERVVGTGSFGIVFQAKCLET-GETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 113 (314)
Q Consensus 39 ~y~~~~~Lg~g~~g~Vy~~~~~~~-~~~~~vK~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 113 (314)
.|.+.+.||+|++|.||++....+ +..+++|.+.... ....+|+.+++.++||||+++++.+... ..+++
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~-----~~~~l 142 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSD-----DKLLL 142 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEEC-----CEEEE
Confidence 499999999999999999998877 7888888764332 2345799999999999999999988543 34889
Q ss_pred Eeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcccccc
Q 021306 114 VMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 192 (314)
Q Consensus 114 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~ 192 (314)
||||++| +|.+.+........++++.++..++.|++.||.|||+ ++|+||||||+||+++. ++.++|+|||++....
T Consensus 143 v~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~-~~ivHrDlkp~NIll~~-~~~~kL~DFgla~~~~ 220 (478)
T PTZ00267 143 IMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHS-RKMMHRDLKSANIFLMP-TGIIKLGDFGFSKQYS 220 (478)
T ss_pred EEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh-CCEEECCcCHHhEEECC-CCcEEEEeCcCceecC
Confidence 9999985 7777666555556789999999999999999999999 89999999999999998 8899999999997654
Q ss_pred cCCc---cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCC--------
Q 021306 193 AGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT-------- 261 (314)
Q Consensus 193 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~-------- 261 (314)
.... .....+|+.|+|||.+.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+......+.
T Consensus 221 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 299 (478)
T PTZ00267 221 DSVSLDVASSFCGTPYYLAPELWERK-RYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPCPVSSGM 299 (478)
T ss_pred CccccccccccCCCccccCHhHhCCC-CCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCccCCHHH
Confidence 3221 2334579999999998654 489999999999999999999999998887776666655432211
Q ss_pred HHHHh---ccCCCCCCCcccccccCChhhhh
Q 021306 262 REEIR---CMNPNYTDFRFPQIKAHPWHKVC 289 (314)
Q Consensus 262 ~~~~~---~~~p~~~~~~~~~l~~~p~~~~~ 289 (314)
.+.+. ..+|. +|+++.+++.|||++..
T Consensus 300 ~~li~~~L~~dP~-~Rps~~~~l~~~~~~~~ 329 (478)
T PTZ00267 300 KALLDPLLSKNPA-LRPTTQQLLHTEFLKYV 329 (478)
T ss_pred HHHHHHHhccChh-hCcCHHHHHhCHHHHHH
Confidence 11122 23677 89999999999998754
|
|
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=270.49 Aligned_cols=199 Identities=34% Similarity=0.671 Sum_probs=166.7
Q ss_pred CCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeE
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 111 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 111 (314)
.++|++.+.||+|++|.||++.++.+++.|++|.+.... ....+|+.++++++|+||+++++++.. ..+.
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~~ 78 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHT-----KKTL 78 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEec-----CCeE
Confidence 468999999999999999999998899999999886432 223579999999999999999998743 3358
Q ss_pred EEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCccccc
Q 021306 112 NLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 191 (314)
Q Consensus 112 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~ 191 (314)
++|+||+.++|.+.+.. ....+++..++.++.|++.||.|||+ .+++|+||+|+||+++. ++.++|+|||.+...
T Consensus 79 ~lv~e~~~~~L~~~~~~---~~~~~~~~~~~~~~~ql~~al~~lH~-~~i~H~dl~p~nil~~~-~~~~kl~dfg~~~~~ 153 (291)
T cd07844 79 TLVFEYLDTDLKQYMDD---CGGGLSMHNVRLFLFQLLRGLAYCHQ-RRVLHRDLKPQNLLISE-RGELKLADFGLARAK 153 (291)
T ss_pred EEEEecCCCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHh-CCeecccCCHHHEEEcC-CCCEEECcccccccc
Confidence 89999999988776653 23578999999999999999999999 89999999999999998 788999999998654
Q ss_pred ccCCc-cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 021306 192 IAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 245 (314)
Q Consensus 192 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~ 245 (314)
..... .....++..|+|||.+.+...++.++||||+|+++|+|++|+.||.+..
T Consensus 154 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~ 208 (291)
T cd07844 154 SVPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGST 208 (291)
T ss_pred CCCCccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCc
Confidence 32211 1123457789999998765557899999999999999999999997665
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=274.51 Aligned_cols=199 Identities=36% Similarity=0.643 Sum_probs=160.1
Q ss_pred eeeeEeecCceEEEEEEECC--CCcEEEEEEeeccc--cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeEEEEeec
Q 021306 42 AERVVGTGSFGIVFQAKCLE--TGETVAIKKVLQDR--RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEY 117 (314)
Q Consensus 42 ~~~~Lg~g~~g~Vy~~~~~~--~~~~~~vK~~~~~~--~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~ 117 (314)
....||+|+||.||+|+.+. ++..+++|.+.... ....+|+.++++++|+||+++++++.... ....++++||
T Consensus 5 ~g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~---~~~~~lv~e~ 81 (317)
T cd07867 5 EGCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFLSHS---DRKVWLLFDY 81 (317)
T ss_pred eceEeccCCCeeEEEEEecCCCccceEEEEEecCCCCcHHHHHHHHHHHhCCCCCeeeEEEEEeccC---CCeEEEEEee
Confidence 34689999999999999654 56889999886543 23468999999999999999999875432 2347899999
Q ss_pred ccccHHHHHHhhh-----hcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEc---CCCCcEEEeecCccc
Q 021306 118 VPESMYRVLKHYS-----SANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVD---PLTHQVKICDFGSAK 189 (314)
Q Consensus 118 ~~~~l~~~l~~~~-----~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~---~~~~~~~l~dfg~~~ 189 (314)
+++++.+.+.... .....+++..++.++.|++.||.|||+ +|++|+||||+||++. ..++.++|+|||+++
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~-~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 82 AEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA-NWVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred eCCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHh-CCEEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 9998887765321 122458999999999999999999999 8999999999999994 225689999999997
Q ss_pred ccccCCc----cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 021306 190 QLIAGEA----NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE 244 (314)
Q Consensus 190 ~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~ 244 (314)
....... .....+++.|+|||.+.+...++.++||||||+++|+|+||+.||...
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 6543221 123456888999999876565789999999999999999999999654
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-38 Score=272.27 Aligned_cols=213 Identities=36% Similarity=0.656 Sum_probs=176.7
Q ss_pred CCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeecccc------chHHHHHHHHhCCCCceeeeceeeeecCCCCcee
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR------YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 110 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~~------~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 110 (314)
.++|++.+.||+|++|.||+|.+..+++.+++|.++.... ...+|+.++++++|+||+++++++.... ...
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~---~~~ 80 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSN---LDK 80 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecC---CCc
Confidence 4689999999999999999999998999999999864321 2247899999999999999999875432 234
Q ss_pred EEEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcccc
Q 021306 111 LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 190 (314)
Q Consensus 111 ~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~ 190 (314)
.++++||++++|.+.+... ...+++.+++.++.|++.||.|||+ +|++|+||+|+||+++. ++.++|+|||.+..
T Consensus 81 ~~lv~e~~~~~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~-~~i~H~dl~p~nili~~-~~~~~l~d~g~~~~ 155 (293)
T cd07843 81 IYMVMEYVEHDLKSLMETM---KQPFLQSEVKCLMLQLLSGVAHLHD-NWILHRDLKTSNLLLNN-RGILKICDFGLARE 155 (293)
T ss_pred EEEEehhcCcCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeccCCHHHEEECC-CCcEEEeecCceee
Confidence 8899999999887776542 3469999999999999999999999 89999999999999998 78899999999876
Q ss_pred cccCC-ccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHc
Q 021306 191 LIAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVL 257 (314)
Q Consensus 191 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~ 257 (314)
..... ......+++.|+|||.+.+...++.++|+||||+++|+|++|..||......+.+..+....
T Consensus 156 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~ 223 (293)
T cd07843 156 YGSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLL 223 (293)
T ss_pred ccCCccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Confidence 54432 22234457789999998765557889999999999999999999999887776666665543
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=281.39 Aligned_cols=234 Identities=25% Similarity=0.424 Sum_probs=180.3
Q ss_pred eeEeecCceEEEEEEECCCCcEEEEEEeecccc-------ch-HHHHHHHHhCCCCceeeeceeeeecCCCCceeEEEEe
Q 021306 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YK-NRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVM 115 (314)
Q Consensus 44 ~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~~-------~~-~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 115 (314)
+.||+|+||.||+|++..+++.+++|.+.+... .. .++..+++.++|+||+++++++... ..+++||
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~-----~~~~lv~ 75 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTA-----DKLYFVL 75 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcC-----CeEEEEE
Confidence 479999999999999999999999999864321 11 1233456788999999999887433 3488999
Q ss_pred ecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCccccccc-
Q 021306 116 EYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA- 193 (314)
Q Consensus 116 e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~~- 193 (314)
||+++ +|...+. ....+++..++.++.||+.||.|||+ +||+||||||+||+++. ++.++|+|||++.....
T Consensus 76 e~~~~~~L~~~~~----~~~~~~~~~~~~~~~qi~~~L~~lH~-~giiHrDlkp~Nili~~-~~~~kl~DfG~a~~~~~~ 149 (325)
T cd05602 76 DYINGGELFYHLQ----RERCFLEPRARFYAAEIASALGYLHS-LNIVYRDLKPENILLDS-QGHIVLTDFGLCKENIEH 149 (325)
T ss_pred eCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHeEECC-CCCEEEccCCCCcccccC
Confidence 99997 5544443 35678999999999999999999999 89999999999999998 78899999999865322
Q ss_pred CCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCC-------HHHHh
Q 021306 194 GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT-------REEIR 266 (314)
Q Consensus 194 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~-------~~~~~ 266 (314)
........+++.|+|||.+.+.. ++.++||||||+++|+|++|..||.+.+..+.+..+........ .+.+.
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~ 228 (325)
T cd05602 150 NGTTSTFCGTPEYLAPEVLHKQP-YDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLE 228 (325)
T ss_pred CCCcccccCCccccCHHHHcCCC-CCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCcCCCCCCCHHHHHHHH
Confidence 22233456899999999996644 88999999999999999999999998887776666654321111 11222
Q ss_pred ---ccCCCCCCCccc----ccccCChhhhhc
Q 021306 267 ---CMNPNYTDFRFP----QIKAHPWHKVCI 290 (314)
Q Consensus 267 ---~~~p~~~~~~~~----~l~~~p~~~~~~ 290 (314)
..+|. +|++.. ++++|+|+....
T Consensus 229 ~~l~~~p~-~R~~~~~~~~~i~~~~~~~~~~ 258 (325)
T cd05602 229 GLLQKDRT-KRLGAKDDFMEIKNHIFFSPIN 258 (325)
T ss_pred HHcccCHH-HCCCCCCCHHHHhcCcccCCCC
Confidence 23555 677665 799999986643
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-39 Score=282.98 Aligned_cols=233 Identities=27% Similarity=0.457 Sum_probs=184.5
Q ss_pred eeEeecCceEEEEEEEC---CCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeEEEE
Q 021306 44 RVVGTGSFGIVFQAKCL---ETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLV 114 (314)
Q Consensus 44 ~~Lg~g~~g~Vy~~~~~---~~~~~~~vK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 114 (314)
+.||+|+||.||++++. .+|+.+++|.+.... ....+|+.++++++|+||+++++++.. ...+++|
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-----~~~~~lv 76 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQT-----EGKLYLI 76 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEc-----CCEEEEE
Confidence 67999999999999863 578999999987532 223478899999999999999998843 3348899
Q ss_pred eecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCccccccc
Q 021306 115 MEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA 193 (314)
Q Consensus 115 ~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~~ 193 (314)
|||+.+ +|.+.+. ....+++..++.++.||+.||.|||+ +|++|+||||+||+++. ++.++|+|||++.....
T Consensus 77 ~e~~~~~~L~~~l~----~~~~l~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nil~~~-~~~~kL~Dfg~~~~~~~ 150 (318)
T cd05582 77 LDFLRGGDLFTRLS----KEVMFTEEDVKFYLAELALALDHLHS-LGIIYRDLKPENILLDE-EGHIKLTDFGLSKESID 150 (318)
T ss_pred EcCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCCCHHHeEECC-CCcEEEeeccCCcccCC
Confidence 999986 5555543 35679999999999999999999999 89999999999999998 78899999999875443
Q ss_pred C-CccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCC-------HHHH
Q 021306 194 G-EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT-------REEI 265 (314)
Q Consensus 194 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~-------~~~~ 265 (314)
. .......+++.|+|||.+.+.. ++.++||||||+++|+|++|+.||...+..+....+.+.....+ .+.+
T Consensus 151 ~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li 229 (318)
T cd05582 151 HEKKAYSFCGTVEYMAPEVVNRRG-HTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLL 229 (318)
T ss_pred CCCceecccCChhhcCHHHHcCCC-CCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 3 2233456789999999986544 78999999999999999999999998887766666654322111 1222
Q ss_pred h---ccCCCCCCCc-----ccccccCChhhhh
Q 021306 266 R---CMNPNYTDFR-----FPQIKAHPWHKVC 289 (314)
Q Consensus 266 ~---~~~p~~~~~~-----~~~l~~~p~~~~~ 289 (314)
. ..+|. +|++ +++++.|||++..
T Consensus 230 ~~~l~~~P~-~R~~a~~~~~~~~~~~~~~~~~ 260 (318)
T cd05582 230 RALFKRNPA-NRLGAGPDGVEEIKRHPFFSTI 260 (318)
T ss_pred HHHhhcCHh-HcCCCCCCCHHHHhCCCCcCCC
Confidence 2 33666 7888 6669999998754
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-40 Score=271.45 Aligned_cols=249 Identities=25% Similarity=0.386 Sum_probs=197.7
Q ss_pred ccCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccccchH-------HHHHHHHhCCCCceeeeceeeeecCCCC
Q 021306 35 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-------RELQLMRVMDHPNVISLKHCFFSTTSKN 107 (314)
Q Consensus 35 ~~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~~~~~-------~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 107 (314)
...++|...++||+|.||+|-+|+.+.+++.||+|+++++....+ .|-.+|+..+||++..+.-.|+.
T Consensus 165 vTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt----- 239 (516)
T KOG0690|consen 165 VTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQT----- 239 (516)
T ss_pred eccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhcc-----
Confidence 356789999999999999999999999999999999987644332 56778999999999988766743
Q ss_pred ceeEEEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCc
Q 021306 108 ELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 187 (314)
Q Consensus 108 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~ 187 (314)
...+|+||||..|+ .|.-.+.....+++...+.+..+|+.||.|||+ ++||+||||.+|+++|. ++++||.|||+
T Consensus 240 ~drlCFVMeyanGG---eLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs-~~ivYRDlKLENLlLDk-DGHIKitDFGL 314 (516)
T KOG0690|consen 240 QDRLCFVMEYANGG---ELFFHLSRERVFSEDRTRFYGAEIVSALGYLHS-RNIVYRDLKLENLLLDK-DGHIKITDFGL 314 (516)
T ss_pred CceEEEEEEEccCc---eEeeehhhhhcccchhhhhhhHHHHHHhhhhhh-CCeeeeechhhhheecc-CCceEeeeccc
Confidence 33499999999975 222233346889999999999999999999999 99999999999999999 99999999999
Q ss_pred cccccc-CCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH-------cCC
Q 021306 188 AKQLIA-GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV-------LGT 259 (314)
Q Consensus 188 ~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~-------~~~ 259 (314)
++.-.. .......+|||.|+|||++.. ..|..+.|+|.+|+++|||++|+.||...+....+..|+-. +++
T Consensus 315 CKE~I~~g~t~kTFCGTPEYLAPEVleD-nDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFPr~ls~ 393 (516)
T KOG0690|consen 315 CKEEIKYGDTTKTFCGTPEYLAPEVLED-NDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFPRTLSP 393 (516)
T ss_pred chhcccccceeccccCChhhcCchhhcc-ccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCCccCCH
Confidence 875433 344567899999999999954 45999999999999999999999999888876655555532 222
Q ss_pred CCHHHHh---ccCCCCCCC-----cccccccCChhhhhcccCCh
Q 021306 260 PTREEIR---CMNPNYTDF-----RFPQIKAHPWHKVCIFHFPK 295 (314)
Q Consensus 260 ~~~~~~~---~~~p~~~~~-----~~~~l~~~p~~~~~~~~~~~ 295 (314)
.+..++. ..+|. +|+ .+.+|++|+|++....+...
T Consensus 394 eAktLLsGLL~kdP~-kRLGgGpdDakEi~~h~FF~~v~W~~~~ 436 (516)
T KOG0690|consen 394 EAKTLLSGLLKKDPK-KRLGGGPDDAKEIMRHRFFASVDWEATY 436 (516)
T ss_pred HHHHHHHHHhhcChH-hhcCCCchhHHHHHhhhhhccCCHHHHH
Confidence 2233333 22454 444 56789999998876654433
|
|
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=269.94 Aligned_cols=249 Identities=25% Similarity=0.393 Sum_probs=194.6
Q ss_pred cCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHhC-CCCceeeeceeeeecCCCCceeE
Q 021306 36 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVM-DHPNVISLKHCFFSTTSKNELFL 111 (314)
Q Consensus 36 ~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~---~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~ 111 (314)
..++|++.+.||+|++|.||++.+..+++.+++|.+.... ....+|+.+++++ +|+|++++++++...+.......
T Consensus 20 ~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~ 99 (291)
T cd06639 20 PTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQL 99 (291)
T ss_pred CCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCee
Confidence 3578999999999999999999999999999999886432 2335788888888 89999999998865544334557
Q ss_pred EEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcccc
Q 021306 112 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 190 (314)
Q Consensus 112 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~ 190 (314)
++|+||+++ +|.+.+.........+++..++.++.|++.||.+||+ ++++|+||+|+||+++. ++.++|+|||++..
T Consensus 100 ~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~dlkp~nili~~-~~~~kl~dfg~~~~ 177 (291)
T cd06639 100 WLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHN-NRIIHRDVKGNNILLTT-EGGVKLVDFGVSAQ 177 (291)
T ss_pred EEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHEEEcC-CCCEEEeecccchh
Confidence 899999986 6666555444455789999999999999999999999 89999999999999998 77899999999875
Q ss_pred cccCCc-cccccccccccccccccCCC----CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCC----
Q 021306 191 LIAGEA-NISYICSRFYRAPELIFGAT----EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT---- 261 (314)
Q Consensus 191 ~~~~~~-~~~~~~~~~y~aPE~~~~~~----~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~---- 261 (314)
...... .....++..|+|||.+.... .++.++|+||||+++|+|++|+.||...+....+..+.+......
T Consensus 178 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (291)
T cd06639 178 LTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPTLLHPE 257 (291)
T ss_pred cccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCCCCCCccc
Confidence 433221 22345678899999975432 257899999999999999999999988876666655543322110
Q ss_pred ------HHHHh-cc--CCCCCCCcccccccCChhh
Q 021306 262 ------REEIR-CM--NPNYTDFRFPQIKAHPWHK 287 (314)
Q Consensus 262 ------~~~~~-~~--~p~~~~~~~~~l~~~p~~~ 287 (314)
.+.+. ++ +|+ +|+++.+|+.|||++
T Consensus 258 ~~~~~l~~li~~~l~~~p~-~Rps~~~il~~~~~~ 291 (291)
T cd06639 258 KWCRSFNHFISQCLIKDFE-ARPSVTHLLEHPFIK 291 (291)
T ss_pred ccCHHHHHHHHHHhhcChh-hCcCHHHHhcCcccC
Confidence 11222 23 677 899999999999985
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=272.40 Aligned_cols=243 Identities=37% Similarity=0.664 Sum_probs=194.2
Q ss_pred CceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccccc---------hHHHHHHHHhCCCCceeeeceeeeecCCCCce
Q 021306 39 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY---------KNRELQLMRVMDHPNVISLKHCFFSTTSKNEL 109 (314)
Q Consensus 39 ~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~~~---------~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 109 (314)
+|++.+.||+|++|.||+|.+..+++.|++|.+...... ..+|+.++++++|+||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~ 75 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGH-----KS 75 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeec-----CC
Confidence 588999999999999999999989999999998654322 2468899999999999999998844 33
Q ss_pred eEEEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCccc
Q 021306 110 FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 189 (314)
Q Consensus 110 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~ 189 (314)
..++||||+.++|.+.+... ...+++..++.++.|++.||.+||+ +|++|+||+|+||+++. ++.++|+|||++.
T Consensus 76 ~~~lv~e~~~~~L~~~i~~~---~~~~~~~~~~~~~~qi~~al~~lH~-~~i~H~dl~p~nill~~-~~~~~l~dfg~~~ 150 (298)
T cd07841 76 NINLVFEFMETDLEKVIKDK---SIVLTPADIKSYMLMTLRGLEYLHS-NWILHRDLKPNNLLIAS-DGVLKLADFGLAR 150 (298)
T ss_pred EEEEEEcccCCCHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCChhhEEEcC-CCCEEEccceeee
Confidence 58899999977777766531 1379999999999999999999999 89999999999999998 8899999999987
Q ss_pred ccccCCc-cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCHH-----
Q 021306 190 QLIAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE----- 263 (314)
Q Consensus 190 ~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~----- 263 (314)
....... .....+++.|+|||.+.+...++.++|+||||+++|+|++|..||.+.+..+.+..+....+.+...
T Consensus 151 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (298)
T cd07841 151 SFGSPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGV 230 (298)
T ss_pred eccCCCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhc
Confidence 6544322 2223457789999998665557899999999999999999988898877766666665443322111
Q ss_pred ------------------------------H---HhccCCCCCCCcccccccCChhhhhccc
Q 021306 264 ------------------------------E---IRCMNPNYTDFRFPQIKAHPWHKVCIFH 292 (314)
Q Consensus 264 ------------------------------~---~~~~~p~~~~~~~~~l~~~p~~~~~~~~ 292 (314)
. ....+|. +|+++.+++.|||++.....
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~-~R~s~~e~l~~~~~~~~~~~ 291 (298)
T cd07841 231 TSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPN-KRITARQALEHPYFSNDPAP 291 (298)
T ss_pred ccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcc-cCcCHHHHhhCccccCCCCC
Confidence 1 1123566 89999999999999986643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=268.84 Aligned_cols=209 Identities=35% Similarity=0.647 Sum_probs=171.6
Q ss_pred ceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccccc-----hHHHHHHHHhCC-CCceeeeceeeeecCCCCceeEEE
Q 021306 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY-----KNRELQLMRVMD-HPNVISLKHCFFSTTSKNELFLNL 113 (314)
Q Consensus 40 y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~~~-----~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~l 113 (314)
|++.+.||+|++|.||++.+..+++.+++|.++..... ..+|+..+.++. |+|++++++++.... ...+++
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~---~~~~~l 77 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRK---TGRLAL 77 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCC---CCcEEE
Confidence 78899999999999999999999999999988653221 235777788775 999999999885431 134789
Q ss_pred EeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCccccccc
Q 021306 114 VMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA 193 (314)
Q Consensus 114 v~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~~ 193 (314)
|+||+.+++.+.+.. ....+++.+++.++.|++.||.+||+ .|++|+||+|+||+++. +.++|+|||.+.....
T Consensus 78 v~e~~~~~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~LH~-~~i~H~dl~p~ni~l~~--~~~kl~dfg~~~~~~~ 151 (282)
T cd07831 78 VFELMDMNLYELIKG---RKRPLPEKRVKSYMYQLLKSLDHMHR-NGIFHRDIKPENILIKD--DILKLADFGSCRGIYS 151 (282)
T ss_pred EEecCCccHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHH-CCceecccCHHHEEEcC--CCeEEEeccccccccc
Confidence 999999988877654 23578999999999999999999999 89999999999999997 7899999999876544
Q ss_pred CCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHc
Q 021306 194 GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVL 257 (314)
Q Consensus 194 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~ 257 (314)
........++..|+|||.+.+...++.++|+||||+++|+|++|..||.+.+..+.+..+....
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~ 215 (282)
T cd07831 152 KPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVL 215 (282)
T ss_pred CCCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHc
Confidence 4333344568889999987555557889999999999999999999999887766666555443
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=279.74 Aligned_cols=233 Identities=25% Similarity=0.412 Sum_probs=178.4
Q ss_pred eeEeecCceEEEEEEECCCCcEEEEEEeecccc-------chHHH-HHHHHhCCCCceeeeceeeeecCCCCceeEEEEe
Q 021306 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YKNRE-LQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVM 115 (314)
Q Consensus 44 ~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~~-------~~~~e-~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 115 (314)
+.||+|+||.||+|++..+++.|++|.+.+... ....| ..+++.++|+||+++++.+.. ....++||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~-----~~~~~lv~ 75 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQT-----AEKLYFVL 75 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEc-----CCEEEEEE
Confidence 479999999999999999999999999864321 11223 346788999999999988743 33488999
Q ss_pred ecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCccccccc-
Q 021306 116 EYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA- 193 (314)
Q Consensus 116 e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~~- 193 (314)
||+++ +|...+. ....+++.+++.++.||+.||.|||+ .||+||||||+||+++. ++.++|+|||++.....
T Consensus 76 e~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~L~~lH~-~~ivH~Dlkp~NIll~~-~~~~kl~Dfg~~~~~~~~ 149 (321)
T cd05603 76 DYVNGGELFFHLQ----RERCFLEPRARFYAAEVASAIGYLHS-LNIIYRDLKPENILLDS-QGHVVLTDFGLCKEGVEP 149 (321)
T ss_pred cCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeccCCHHHeEECC-CCCEEEccCCCCccCCCC
Confidence 99997 5544443 35679999999999999999999999 89999999999999998 88999999999864322
Q ss_pred CCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCC-------HHHHh
Q 021306 194 GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT-------REEIR 266 (314)
Q Consensus 194 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~-------~~~~~ 266 (314)
........+++.|+|||.+.+.. ++.++||||||+++|+|++|..||.+.+.......+.......+ .+.+.
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~ 228 (321)
T cd05603 150 EETTSTFCGTPEYLAPEVLRKEP-YDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGKTVAACDLLV 228 (321)
T ss_pred CCccccccCCcccCCHHHhcCCC-CCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Confidence 22223456789999999986544 88999999999999999999999998887666555554321111 11222
Q ss_pred ---ccCCCCCCCcc----cccccCChhhhh
Q 021306 267 ---CMNPNYTDFRF----PQIKAHPWHKVC 289 (314)
Q Consensus 267 ---~~~p~~~~~~~----~~l~~~p~~~~~ 289 (314)
..+|. +|++. .++++|||+...
T Consensus 229 ~~l~~~p~-~R~~~~~~~~~~~~~~~~~~~ 257 (321)
T cd05603 229 GLLHKDQR-RRLGAKADFLEIKNHVFFSPI 257 (321)
T ss_pred HHccCCHh-hcCCCCCCHHHHhCCCCcCCC
Confidence 23555 56654 489999998753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=280.02 Aligned_cols=234 Identities=26% Similarity=0.476 Sum_probs=176.7
Q ss_pred eeEeecCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhC-CCCceeeeceeeeecCCCCceeEEEEe
Q 021306 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVM-DHPNVISLKHCFFSTTSKNELFLNLVM 115 (314)
Q Consensus 44 ~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~-------~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv~ 115 (314)
+.||+|+||.||++++..+++.+|+|.+++.. ....+|..++.++ +||||+++++++... ..+++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~-----~~~~lv~ 75 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE-----SRLFFVI 75 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeC-----CEEEEEE
Confidence 47999999999999999999999999987532 1234677777666 899999999988443 3488999
Q ss_pred ecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcccccccC
Q 021306 116 EYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG 194 (314)
Q Consensus 116 e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~~~ 194 (314)
||+++ +|...+. ....+++..++.++.|++.||.|||+ +||+||||||+||+++. ++.++|+|||++......
T Consensus 76 E~~~~~~L~~~~~----~~~~l~~~~~~~i~~qi~~~l~~lH~-~~ivH~Dikp~Nili~~-~~~~kL~DfG~~~~~~~~ 149 (329)
T cd05618 76 EYVNGGDLMFHMQ----RQRKLPEEHARFYSAEISLALNYLHE-RGIIYRDLKLDNVLLDS-EGHIKLTDYGMCKEGLRP 149 (329)
T ss_pred eCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCCHHHEEECC-CCCEEEeeCCccccccCC
Confidence 99997 4444433 35689999999999999999999999 89999999999999998 788999999998653222
Q ss_pred -CccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCC--------ChHHHHHHHHHHcCCCC----
Q 021306 195 -EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE--------NAVDQLVEIIKVLGTPT---- 261 (314)
Q Consensus 195 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~--------~~~~~~~~i~~~~~~~~---- 261 (314)
.......+++.|+|||.+.+.. ++.++|+||||+++|+|++|+.||... .....+...+.......
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~ 228 (329)
T cd05618 150 GDTTSTFCGTPNYIAPEILRGED-YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSL 228 (329)
T ss_pred CCccccccCCccccCHHHHcCCC-CCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCCCC
Confidence 2223456789999999997654 789999999999999999999999531 11122222222211111
Q ss_pred ----HHHHh---ccCCCCCCCc------ccccccCChhhhhc
Q 021306 262 ----REEIR---CMNPNYTDFR------FPQIKAHPWHKVCI 290 (314)
Q Consensus 262 ----~~~~~---~~~p~~~~~~------~~~l~~~p~~~~~~ 290 (314)
.+.+. ..+|. +|++ +.+++.|||++...
T Consensus 229 ~~~~~~ll~~~L~~dP~-~R~~~~~~~~~~~i~~hp~f~~~~ 269 (329)
T cd05618 229 SVKAASVLKSFLNKDPK-ERLGCHPQTGFADIQGHPFFRNVD 269 (329)
T ss_pred CHHHHHHHHHHhcCCHH-HcCCCCCCCCHHHHhcCCCCCCCC
Confidence 12222 33666 7877 47999999997653
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-38 Score=285.87 Aligned_cols=192 Identities=27% Similarity=0.388 Sum_probs=162.4
Q ss_pred CCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHhCCCCceeeeceeeeecCCCCceeEEEEee
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVME 116 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e 116 (314)
+..|.+.+.||+|+||.||++.+..+++.|++|.... ....+|+.++++++|+||+++++++... ...++++|
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~--~~~~~E~~iL~~L~HpnIv~l~~~~~~~-----~~~~lv~e 240 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY--ASSVHEARLLRRLSHPAVLALLDVRVVG-----GLTCLVLP 240 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc--cCHHHHHHHHHHCCCCCCCcEEEEEEEC-----CEEEEEEE
Confidence 4579999999999999999999999999999996432 3346899999999999999999987443 23789999
Q ss_pred cccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcccccccCCc
Q 021306 117 YVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA 196 (314)
Q Consensus 117 ~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~~~~~ 196 (314)
++.+++...+.. ....+++.+++.++.|++.||.|||+ +||+|+||||+||+++. ++.++|+|||+++.......
T Consensus 241 ~~~~~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~yLH~-~gIvHrDLKP~NILl~~-~~~vkL~DFGla~~~~~~~~ 315 (461)
T PHA03211 241 KYRSDLYTYLGA---RLRPLGLAQVTAVARQLLSAIDYIHG-EGIIHRDIKTENVLVNG-PEDICLGDFGAACFARGSWS 315 (461)
T ss_pred ccCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCEEECcCCHHHEEECC-CCCEEEcccCCceecccccc
Confidence 999988877653 23579999999999999999999999 89999999999999998 78899999999875433211
Q ss_pred ---cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCC
Q 021306 197 ---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLF 241 (314)
Q Consensus 197 ---~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf 241 (314)
.....+|+.|+|||.+.+.. ++.++|||||||++|||++|..|+
T Consensus 316 ~~~~~~~~GT~~Y~APE~~~~~~-~~~~sDvwSlGviL~El~~g~~~l 362 (461)
T PHA03211 316 TPFHYGIAGTVDTNAPEVLAGDP-YTPSVDIWSAGLVIFEAAVHTASL 362 (461)
T ss_pred cccccccCCCcCCcCHHHHcCCC-CCchHHHHHHHHHHHHHHHcCCCc
Confidence 12345799999999997654 899999999999999999987654
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=267.91 Aligned_cols=200 Identities=34% Similarity=0.638 Sum_probs=166.5
Q ss_pred CCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeE
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 111 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 111 (314)
.++|++.+.||+|++|.||+|.+..+++.+++|.+.... ....+|+.+++.++|+||+++++++.. ....
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~-----~~~~ 78 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHT-----KETL 78 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEec-----CCeE
Confidence 467999999999999999999999999999999986432 123578999999999999999998743 2347
Q ss_pred EEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCccccc
Q 021306 112 NLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 191 (314)
Q Consensus 112 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~ 191 (314)
++++||+.+++.+.+.. ....+++.+++.++.|++.||.|||+ .|++|+||+|+||+++. ++.++|+|||++...
T Consensus 79 ~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~-~~i~H~dlkp~Nil~~~-~~~~~l~Dfg~~~~~ 153 (291)
T cd07870 79 TFVFEYMHTDLAQYMIQ---HPGGLHPYNVRLFMFQLLRGLAYIHG-QHILHRDLKPQNLLISY-LGELKLADFGLARAK 153 (291)
T ss_pred EEEEecccCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCChHHEEEcC-CCcEEEecccccccc
Confidence 89999999887776543 23568889999999999999999999 89999999999999998 788999999988754
Q ss_pred ccCC-ccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCh
Q 021306 192 IAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA 246 (314)
Q Consensus 192 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~ 246 (314)
.... ......+++.|+|||.+.+...++.++|+||||+++|+|++|..||.+.+.
T Consensus 154 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~ 209 (291)
T cd07870 154 SIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSD 209 (291)
T ss_pred CCCCCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchh
Confidence 3322 122334578899999987655578899999999999999999999976543
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=281.36 Aligned_cols=242 Identities=26% Similarity=0.366 Sum_probs=183.7
Q ss_pred CccCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCc
Q 021306 34 PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 108 (314)
Q Consensus 34 ~~~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 108 (314)
....++|++.+.||+|+||.||++++..+++.|++|.+.... ....+|+.+++.++|+||+++++++.. .
T Consensus 70 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~ 144 (353)
T PLN00034 70 AKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDH-----N 144 (353)
T ss_pred CCCHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEecc-----C
Confidence 334568999999999999999999999999999999985432 234589999999999999999998843 3
Q ss_pred eeEEEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcc
Q 021306 109 LFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 188 (314)
Q Consensus 109 ~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~ 188 (314)
..+++++||+.++.+. . .....+..+..++.||+.||.|||+ +||+|+||||+||+++. ++.++|+|||++
T Consensus 145 ~~~~lv~e~~~~~~L~---~----~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~-~~~~kL~DfG~~ 215 (353)
T PLN00034 145 GEIQVLLEFMDGGSLE---G----THIADEQFLADVARQILSGIAYLHR-RHIVHRDIKPSNLLINS-AKNVKIADFGVS 215 (353)
T ss_pred CeEEEEEecCCCCccc---c----cccCCHHHHHHHHHHHHHHHHHHHH-CCEeecCCCHHHEEEcC-CCCEEEcccccc
Confidence 3488999999975322 1 2346778889999999999999999 89999999999999998 788999999998
Q ss_pred cccccCC-ccccccccccccccccccCC----CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHcCCC
Q 021306 189 KQLIAGE-ANISYICSRFYRAPELIFGA----TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQ---LVEIIKVLGTP 260 (314)
Q Consensus 189 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~----~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~---~~~i~~~~~~~ 260 (314)
....... ......++..|+|||.+... ...+.++|||||||++|+|++|+.||......+. ...+.......
T Consensus 216 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 295 (353)
T PLN00034 216 RILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPE 295 (353)
T ss_pred eecccccccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCC
Confidence 7653322 12335678999999987432 2245689999999999999999999974332211 11111111111
Q ss_pred --------CHHHHh---ccCCCCCCCcccccccCChhhhhc
Q 021306 261 --------TREEIR---CMNPNYTDFRFPQIKAHPWHKVCI 290 (314)
Q Consensus 261 --------~~~~~~---~~~p~~~~~~~~~l~~~p~~~~~~ 290 (314)
..+.+. ..+|+ +|+++.++++|||+....
T Consensus 296 ~~~~~~~~l~~li~~~l~~~P~-~Rpt~~ell~hp~~~~~~ 335 (353)
T PLN00034 296 APATASREFRHFISCCLQREPA-KRWSAMQLLQHPFILRAQ 335 (353)
T ss_pred CCCccCHHHHHHHHHHccCChh-hCcCHHHHhcCcccccCC
Confidence 111222 23676 899999999999998864
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=271.24 Aligned_cols=216 Identities=30% Similarity=0.570 Sum_probs=174.4
Q ss_pred ccCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeecccc------chHHHHHHHHhCCCCceeeeceeeeecCC---
Q 021306 35 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR------YKNRELQLMRVMDHPNVISLKHCFFSTTS--- 105 (314)
Q Consensus 35 ~~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~~------~~~~e~~~l~~l~h~~iv~~~~~~~~~~~--- 105 (314)
...++|++.+.||+|++|.||++++..+++.|++|.+..... ...+|+.++++++||||+++++++.....
T Consensus 9 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (310)
T cd07865 9 DEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYN 88 (310)
T ss_pred chhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEeccccccc
Confidence 345689999999999999999999999999999998854321 22468999999999999999987754332
Q ss_pred CCceeEEEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeec
Q 021306 106 KNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF 185 (314)
Q Consensus 106 ~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~df 185 (314)
......++++||+++++.+.+.. ....+++.+++.++.|++.||.|||+ +|++|+||+|+||+++. ++.++|+||
T Consensus 89 ~~~~~~~lv~e~~~~~l~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~-~~i~H~dl~p~nil~~~-~~~~kl~df 163 (310)
T cd07865 89 RYKGSFYLVFEFCEHDLAGLLSN---KNVKFTLSEIKKVMKMLLNGLYYIHR-NKILHRDMKAANILITK-DGILKLADF 163 (310)
T ss_pred CCCceEEEEEcCCCcCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHEEECC-CCcEEECcC
Confidence 12345689999999988776653 33578999999999999999999999 89999999999999998 789999999
Q ss_pred CcccccccCCcc-----ccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 021306 186 GSAKQLIAGEAN-----ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 255 (314)
Q Consensus 186 g~~~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~ 255 (314)
|.+......... ....++..|+|||.+.+...++.++|+||||+++|+|++|..||.+.+.......+.+
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~ 238 (310)
T cd07865 164 GLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQ 238 (310)
T ss_pred CCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 998755332211 1234577899999986655578899999999999999999999988776555444443
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=281.74 Aligned_cols=239 Identities=27% Similarity=0.455 Sum_probs=183.0
Q ss_pred CceeeeeEeecCceEEEEEEEC---CCCcEEEEEEeeccc--------cchHHHHHHHHhC-CCCceeeeceeeeecCCC
Q 021306 39 SYMAERVVGTGSFGIVFQAKCL---ETGETVAIKKVLQDR--------RYKNRELQLMRVM-DHPNVISLKHCFFSTTSK 106 (314)
Q Consensus 39 ~y~~~~~Lg~g~~g~Vy~~~~~---~~~~~~~vK~~~~~~--------~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~ 106 (314)
+|++.+.||+|+||.||++++. .+++.|++|.+.+.. ....+|..+++.+ .|++|+++++++.
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~----- 75 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQ----- 75 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEe-----
Confidence 5899999999999999999864 478999999986431 1234688899998 5899999988873
Q ss_pred CceeEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeec
Q 021306 107 NELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF 185 (314)
Q Consensus 107 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~df 185 (314)
....++++|||+++ +|.+.+. ....+++.+++.++.||+.||.|||+ +||+||||||+||+++. ++.++|+||
T Consensus 76 ~~~~~~lv~e~~~~g~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivHrDlkp~Nili~~-~~~~kl~Df 149 (332)
T cd05614 76 TEAKLHLILDYVSGGEMFTHLY----QRDNFSEDEVRFYSGEIILALEHLHK-LGIVYRDIKLENILLDS-EGHVVLTDF 149 (332)
T ss_pred cCCEEEEEEeCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCcEecCCCHHHeEECC-CCCEEEeeC
Confidence 33448899999996 5555554 34679999999999999999999999 89999999999999998 789999999
Q ss_pred CcccccccCC--ccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC---hHHHHHHHHHHcCCC
Q 021306 186 GSAKQLIAGE--ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN---AVDQLVEIIKVLGTP 260 (314)
Q Consensus 186 g~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~---~~~~~~~i~~~~~~~ 260 (314)
|++....... ......+++.|+|||.+.+...++.++||||||+++|+|++|+.||.... ....+...+.....+
T Consensus 150 G~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 229 (332)
T cd05614 150 GLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPP 229 (332)
T ss_pred cCCccccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCC
Confidence 9987543222 22245679999999999765557889999999999999999999996532 222222222222111
Q ss_pred C--------HHHHh---ccCCCCCCC-----cccccccCChhhhh
Q 021306 261 T--------REEIR---CMNPNYTDF-----RFPQIKAHPWHKVC 289 (314)
Q Consensus 261 ~--------~~~~~---~~~p~~~~~-----~~~~l~~~p~~~~~ 289 (314)
. .+.+. ..+|. +|+ +++++++|||++..
T Consensus 230 ~~~~~~~~~~~li~~~l~~dp~-~R~~~~~~~~~~~l~h~~~~~~ 273 (332)
T cd05614 230 FPSFIGPEAQDLLHKLLRKDPK-KRLGAGPQGASEIKEHPFFKGL 273 (332)
T ss_pred CCCCCCHHHHHHHHHHcCCCHH-HcCCCCCCCHHHHHcCCCcCCC
Confidence 1 12222 23566 788 78899999998764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=277.90 Aligned_cols=234 Identities=25% Similarity=0.472 Sum_probs=178.6
Q ss_pred eeEeecCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhC-CCCceeeeceeeeecCCCCceeEEEEe
Q 021306 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVM-DHPNVISLKHCFFSTTSKNELFLNLVM 115 (314)
Q Consensus 44 ~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~-------~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv~ 115 (314)
+.||+|+||.||+|++..+++.+++|.+++.. ....+|..++.++ .|++|+++++++.. ...+++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~-----~~~~~lv~ 75 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQT-----TSRLFLVI 75 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEe-----CCEEEEEE
Confidence 47999999999999999999999999997542 2234677787777 69999999998843 33488999
Q ss_pred ecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCccccccc-
Q 021306 116 EYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA- 193 (314)
Q Consensus 116 e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~~- 193 (314)
||+++ +|...+. ....+++..++.++.||+.||.|||+ +|++||||||+||+++. ++.++|+|||++.....
T Consensus 76 e~~~~~~L~~~~~----~~~~l~~~~~~~~~~qi~~al~~lH~-~~ivHrDlkp~Nili~~-~~~~kl~Dfg~~~~~~~~ 149 (327)
T cd05617 76 EYVNGGDLMFHMQ----RQRKLPEEHARFYAAEICIALNFLHE-RGIIYRDLKLDNVLLDA-DGHIKLTDYGMCKEGLGP 149 (327)
T ss_pred eCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHEEEeC-CCCEEEeccccceeccCC
Confidence 99986 5544443 34679999999999999999999999 89999999999999998 78899999999874322
Q ss_pred CCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCC------ChHHHHHHHHHHcCCCC------
Q 021306 194 GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE------NAVDQLVEIIKVLGTPT------ 261 (314)
Q Consensus 194 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~------~~~~~~~~i~~~~~~~~------ 261 (314)
........+++.|+|||.+.+.. ++.++|+||||+++|+|++|+.||... ...+.....+.......
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~ 228 (327)
T cd05617 150 GDTTSTFCGTPNYIAPEILRGEE-YGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSV 228 (327)
T ss_pred CCceecccCCcccCCHHHHCCCC-CCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCCCCCCH
Confidence 22233456799999999996654 889999999999999999999999532 22223333332221111
Q ss_pred --HHHHh---ccCCCCCCCc------ccccccCChhhhhc
Q 021306 262 --REEIR---CMNPNYTDFR------FPQIKAHPWHKVCI 290 (314)
Q Consensus 262 --~~~~~---~~~p~~~~~~------~~~l~~~p~~~~~~ 290 (314)
.+.+. ..+|. +|++ +++++.|||++...
T Consensus 229 ~~~~li~~~L~~dP~-~R~~~~~~~~~~~i~~h~~f~~~~ 267 (327)
T cd05617 229 KASHVLKGFLNKDPK-ERLGCQPQTGFSDIKSHTFFRSID 267 (327)
T ss_pred HHHHHHHHHhccCHH-HcCCCCCCCCHHHHHcCCCCCCCC
Confidence 11122 33666 6776 46999999997654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=269.52 Aligned_cols=234 Identities=22% Similarity=0.375 Sum_probs=178.6
Q ss_pred EeecCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeEEEEeecc
Q 021306 46 VGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYV 118 (314)
Q Consensus 46 Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~ 118 (314)
||+|+||.||+++++.+|+.|++|.+.... .....|.+++++++||||+++++.+. ...+++++|||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~-----~~~~~~lv~e~~ 75 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFE-----SKTHLCLVMSLM 75 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEe-----cCCeEEEEEecC
Confidence 689999999999999999999999886422 12235889999999999999988873 334588999999
Q ss_pred cc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcccccccCCcc
Q 021306 119 PE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN 197 (314)
Q Consensus 119 ~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~~~~~~ 197 (314)
+| +|...+.. .....+++..+..++.|++.||.|||+ .|++|+||+|+||+++. ++.++|+|||++.........
T Consensus 76 ~g~~L~~~~~~--~~~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~dikp~Nili~~-~~~~~l~Dfg~~~~~~~~~~~ 151 (277)
T cd05607 76 NGGDLKYHIYN--VGERGLEMERVIHYSAQITCGILHLHS-MDIVYRDMKPENVLLDD-QGNCRLSDLGLAVELKDGKTI 151 (277)
T ss_pred CCCCHHHHHHh--ccccCCCHHHHHHHHHHHHHHHHHHHH-CCEEEccCChHhEEEcC-CCCEEEeeceeeeecCCCcee
Confidence 86 55444432 123468999999999999999999999 89999999999999998 788999999998765443333
Q ss_pred ccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChH----HHHHHHHHHc--------CCCCHHHH
Q 021306 198 ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV----DQLVEIIKVL--------GTPTREEI 265 (314)
Q Consensus 198 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~----~~~~~i~~~~--------~~~~~~~~ 265 (314)
....+++.|+|||.+.+.. ++.++|+||||+++|+|++|+.||...... +......... .....+.+
T Consensus 152 ~~~~~~~~y~aPE~~~~~~-~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 230 (277)
T cd05607 152 TQRAGTNGYMAPEILKEEP-YSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDIC 230 (277)
T ss_pred eccCCCCCccCHHHHccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccccccCCHHHHHHH
Confidence 3456788999999997655 899999999999999999999999765332 1122221111 01112222
Q ss_pred h---ccCCCCCCCcc----cccccCChhhhhc
Q 021306 266 R---CMNPNYTDFRF----PQIKAHPWHKVCI 290 (314)
Q Consensus 266 ~---~~~p~~~~~~~----~~l~~~p~~~~~~ 290 (314)
. ..+|. +|+++ +++++|||++...
T Consensus 231 ~~~L~~~P~-~R~~~~~~~~~~~~h~~f~~~~ 261 (277)
T cd05607 231 RLFLAKKPE-DRLGSREKNDDPRKHEFFKTIN 261 (277)
T ss_pred HHHhccCHh-hCCCCccchhhhhcChhhcCCC
Confidence 2 33677 78888 6677999997643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=266.00 Aligned_cols=236 Identities=28% Similarity=0.495 Sum_probs=186.5
Q ss_pred CCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc---------cchHHHHHHHHhCCCCceeeeceeeeecCCCCc
Q 021306 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 108 (314)
Q Consensus 38 ~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~---------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 108 (314)
++|++.+.||+|++|.||++.+..+++.+++|.+.... ....+|+.++++++|+||+++++++...
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~----- 76 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDD----- 76 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccC-----
Confidence 57999999999999999999998899999999875331 2345788999999999999999988433
Q ss_pred eeEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCc
Q 021306 109 LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 187 (314)
Q Consensus 109 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~ 187 (314)
...++++||+++ ++.+.+.. ...+++..++.++.|++.||.+||+ .|++|+||+|+||+++. ++.++|+|||.
T Consensus 77 ~~~~~v~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lH~-~~i~H~dl~p~nilv~~-~~~~~l~dfg~ 150 (263)
T cd06625 77 ETLSIFMEYMPGGSVKDQLKA----YGALTETVTRKYTRQILEGVEYLHS-NMIVHRDIKGANILRDS-AGNVKLGDFGA 150 (263)
T ss_pred CeEEEEEEECCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcC-CCCEEEeeccc
Confidence 358899999986 55555543 4678999999999999999999999 89999999999999997 88999999999
Q ss_pred ccccccCCcc----ccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCC---
Q 021306 188 AKQLIAGEAN----ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP--- 260 (314)
Q Consensus 188 ~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~--- 260 (314)
+......... ....++..|+|||.+.+.. ++.++||||||+++|+|++|+.||...+.......+......+
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 229 (263)
T cd06625 151 SKRLQTICSSGTGMKSVTGTPYWMSPEVISGEG-YGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLP 229 (263)
T ss_pred ceeccccccccccccCCCcCccccCcceeccCC-CCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCC
Confidence 8754322111 1234577899999997655 8899999999999999999999998877665555444331111
Q ss_pred --C----HHHHh---ccCCCCCCCcccccccCChh
Q 021306 261 --T----REEIR---CMNPNYTDFRFPQIKAHPWH 286 (314)
Q Consensus 261 --~----~~~~~---~~~p~~~~~~~~~l~~~p~~ 286 (314)
. .+.+. ..+|. +|+++.++++|||+
T Consensus 230 ~~~~~~~~~li~~~l~~~p~-~Rpt~~~ll~~~~~ 263 (263)
T cd06625 230 SHVSPDARNFLRRTFVENAK-KRPSAEELLRHFFV 263 (263)
T ss_pred ccCCHHHHHHHHHHhhcCcc-cCCCHHHHhhCCCC
Confidence 0 11222 22566 78999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=267.08 Aligned_cols=210 Identities=36% Similarity=0.687 Sum_probs=174.3
Q ss_pred CceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeEEE
Q 021306 39 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 113 (314)
Q Consensus 39 ~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 113 (314)
+|++.+.||.|++|.||+|++..+|+.+++|.++... ....+|+.++++++|+||+++++++.... ..++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-----~~~l 75 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTEN-----KLML 75 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCC-----cEEE
Confidence 5899999999999999999999999999999886532 23347899999999999999999885433 3789
Q ss_pred EeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCccccccc
Q 021306 114 VMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA 193 (314)
Q Consensus 114 v~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~~ 193 (314)
|+||+++++.+.+.... ....+++.++..++.|++.||.+||+ .|++|+||+|+||+++. ++.++|+|||.+.....
T Consensus 76 v~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~h~dl~p~ni~~~~-~~~~~l~d~g~~~~~~~ 152 (284)
T cd07836 76 VFEYMDKDLKKYMDTHG-VRGALDPNTVKSFTYQLLKGIAFCHE-NRVLHRDLKPQNLLINK-RGELKLADFGLARAFGI 152 (284)
T ss_pred EEecCCccHHHHHHhcC-CCCCcCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCCHHHEEECC-CCcEEEeecchhhhhcC
Confidence 99999998877765422 23569999999999999999999999 89999999999999997 78899999999865433
Q ss_pred CCc-cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q 021306 194 GEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 256 (314)
Q Consensus 194 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~ 256 (314)
... .....++..|++||.+.+...++.++|+||||+++|+|++|+.||.+.+..+....+.+.
T Consensus 153 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~ 216 (284)
T cd07836 153 PVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRI 216 (284)
T ss_pred CccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHH
Confidence 211 123445778999999866555788999999999999999999999988777666665543
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=276.24 Aligned_cols=247 Identities=37% Similarity=0.674 Sum_probs=193.9
Q ss_pred cCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeecc------ccchHHHHHHHHhCCCCceeeeceeeeecCCCCce
Q 021306 36 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL 109 (314)
Q Consensus 36 ~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 109 (314)
..++|++.+.||.|++|.||++++..+++.|++|.+... .....+|+.+++.++|+||+++++++.........
T Consensus 3 ~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (337)
T cd07858 3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFN 82 (337)
T ss_pred cccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccC
Confidence 346899999999999999999999999999999987642 12234788999999999999999987654433334
Q ss_pred eEEEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCccc
Q 021306 110 FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 189 (314)
Q Consensus 110 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~ 189 (314)
..++++||+.+++.+.+.. ...+++..+..++.|++.||.+||+ ++++|+||+|+||+++. ++.++|+|||++.
T Consensus 83 ~~~lv~e~~~~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~-~~i~H~dlkp~Nil~~~-~~~~kL~Dfg~~~ 156 (337)
T cd07858 83 DVYIVYELMDTDLHQIIRS----SQTLSDDHCQYFLYQLLRGLKYIHS-ANVLHRDLKPSNLLLNA-NCDLKICDFGLAR 156 (337)
T ss_pred cEEEEEeCCCCCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEEcC-CCCEEECcCcccc
Confidence 5789999999887766653 4679999999999999999999999 89999999999999998 7889999999987
Q ss_pred ccccC-CccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCC-------
Q 021306 190 QLIAG-EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT------- 261 (314)
Q Consensus 190 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~------- 261 (314)
..... .......++..|+|||.+.+...++.++|+||||+++|+|++|+.||.+.+.......+.+..+.+.
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (337)
T cd07858 157 TTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFI 236 (337)
T ss_pred ccCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhc
Confidence 65433 1222345678899999986544588999999999999999999999987665444433332211110
Q ss_pred -------------------------------HHHHh---ccCCCCCCCcccccccCChhhhh
Q 021306 262 -------------------------------REEIR---CMNPNYTDFRFPQIKAHPWHKVC 289 (314)
Q Consensus 262 -------------------------------~~~~~---~~~p~~~~~~~~~l~~~p~~~~~ 289 (314)
.+.+. ..+|. +|+++.++++|||++..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~-~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 237 RNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPS-KRITVEEALAHPYLASL 297 (337)
T ss_pred CchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChh-hccCHHHHHcCcchhhh
Confidence 11122 23566 89999999999999764
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=276.57 Aligned_cols=198 Identities=30% Similarity=0.529 Sum_probs=165.5
Q ss_pred CCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeE
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 111 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 111 (314)
.++|++.+.||+|+||.||++.+..++..+++|.+.... ....+|+.++++++|+||+++++++... ..+
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~ 78 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD-----GEI 78 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEEC-----CEE
Confidence 468999999999999999999999999999999876542 2345899999999999999999998543 348
Q ss_pred EEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcccc
Q 021306 112 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 190 (314)
Q Consensus 112 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~ 190 (314)
+++|||+.+ +|.+.+.. ...+++..+..++.|++.||.|||+..+++|+||||+||+++. ++.++|+|||++..
T Consensus 79 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~-~~~~kL~Dfg~~~~ 153 (333)
T cd06650 79 SICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNS-RGEIKLCDFGVSGQ 153 (333)
T ss_pred EEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcC-CCCEEEeeCCcchh
Confidence 899999986 66555543 4678999999999999999999997247999999999999998 78899999999875
Q ss_pred cccCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCh
Q 021306 191 LIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA 246 (314)
Q Consensus 191 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~ 246 (314)
.... ......++..|+|||.+.+.. ++.++|+||||+++|+|++|+.||.....
T Consensus 154 ~~~~-~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~~l~~g~~p~~~~~~ 207 (333)
T cd06650 154 LIDS-MANSFVGTRSYMSPERLQGTH-YSVQSDIWSMGLSLVEMAIGRYPIPPPDA 207 (333)
T ss_pred hhhh-ccccCCCCccccCHHHhcCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCcch
Confidence 4322 222345788999999996654 88999999999999999999999976544
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=268.92 Aligned_cols=256 Identities=24% Similarity=0.383 Sum_probs=198.1
Q ss_pred CCceeeeeEeecCceEEEEEEECCCCcEEEEEEeecccc----chHHHHHHHHhCCCCceeeeceeeeecCCCCceeEEE
Q 021306 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR----YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 113 (314)
Q Consensus 38 ~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~~----~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 113 (314)
+.|++.+.||.|++|.||++++..+++.+++|.+..... ...+|+.+++.++|+|++++++++... ..+++
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~l 86 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWD-----GKLWI 86 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeC-----CeEEE
Confidence 579999999999999999999999999999999865432 235688899999999999999987443 34889
Q ss_pred EeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCccccccc
Q 021306 114 VMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA 193 (314)
Q Consensus 114 v~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~~ 193 (314)
+|||++++.+..+.. .....+++..++.++.|++.++.+||+ .|++|+||+|+||+++. ++.++|+|||.+.....
T Consensus 87 v~e~~~~~~l~~~~~--~~~~~l~~~~~~~~~~ql~~~l~~lH~-~~i~H~dlkp~Nili~~-~~~~kl~dfg~~~~~~~ 162 (292)
T cd06644 87 MIEFCPGGAVDAIML--ELDRGLTEPQIQVICRQMLEALQYLHS-MKIIHRDLKAGNVLLTL-DGDIKLADFGVSAKNVK 162 (292)
T ss_pred EEecCCCCcHHHHHH--hhcCCCCHHHHHHHHHHHHHHHHHHhc-CCeeecCCCcceEEEcC-CCCEEEccCccceeccc
Confidence 999999864433321 224678999999999999999999999 89999999999999987 78899999998765432
Q ss_pred CC-ccccccccccccccccccC----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCC-------
Q 021306 194 GE-ANISYICSRFYRAPELIFG----ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT------- 261 (314)
Q Consensus 194 ~~-~~~~~~~~~~y~aPE~~~~----~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~------- 261 (314)
.. ......+++.|+|||.+.+ ...++.++|+||||+++|+|++|..||...+.......+.+......
T Consensus 163 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (292)
T cd06644 163 TLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWS 242 (292)
T ss_pred cccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCCCCcccC
Confidence 21 1223456788999999852 23367899999999999999999999988776555544443222110
Q ss_pred ---HHHHh---ccCCCCCCCcccccccCChhhhhcccCChHHHHHhcc
Q 021306 262 ---REEIR---CMNPNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGS 303 (314)
Q Consensus 262 ---~~~~~---~~~p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~ 303 (314)
.+.+. ..+|+ +|+++.++++|||++.........++....+
T Consensus 243 ~~~~~li~~~l~~~p~-~Rp~~~~il~~~~~~~~~~~~~~~~~~~~~~ 289 (292)
T cd06644 243 MEFRDFLKTALDKHPE-TRPSAAQLLEHPFVSSVTSNRPLRELVAEAK 289 (292)
T ss_pred HHHHHHHHHHhcCCcc-cCcCHHHHhcCccccccccchhHHHHHHHhh
Confidence 11122 23677 8999999999999998777766666655443
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=268.78 Aligned_cols=250 Identities=26% Similarity=0.383 Sum_probs=197.8
Q ss_pred CCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeEE
Q 021306 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 112 (314)
Q Consensus 38 ~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 112 (314)
++|++.+.||.|++|.||++++..+++.+++|.+.... ....+|+.+++.++|+|++++.+++... ...+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~ 75 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKG-----SKLW 75 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEEC-----CeEE
Confidence 47999999999999999999999999999999886543 2245788999999999999999987543 3588
Q ss_pred EEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCccccc
Q 021306 113 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 191 (314)
Q Consensus 113 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~ 191 (314)
+++||+++ ++.+.+.. .++++..++.++.|++.|+.+||+ ++++|+||+|+||+++. ++.++|+|||.+...
T Consensus 76 ~v~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lh~-~~i~h~dl~p~ni~i~~-~~~~~l~d~g~~~~~ 148 (274)
T cd06609 76 IIMEYCGGGSCLDLLKP-----GKLDETYIAFILREVLLGLEYLHE-EGKIHRDIKAANILLSE-EGDVKLADFGVSGQL 148 (274)
T ss_pred EEEEeeCCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEECC-CCCEEEcccccceee
Confidence 99999987 55554442 389999999999999999999999 89999999999999998 888999999998766
Q ss_pred ccC-CccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCC---------
Q 021306 192 IAG-EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT--------- 261 (314)
Q Consensus 192 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~--------- 261 (314)
... .......+++.|+|||.+.+.. ++.++|+||||+++|+|++|+.||...++......+.+...+..
T Consensus 149 ~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (274)
T cd06609 149 TSTMSKRNTFVGTPFWMAPEVIKQSG-YDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNKFSKPF 227 (274)
T ss_pred cccccccccccCCccccChhhhccCC-CCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCCcccccCHHH
Confidence 443 2223345678899999997655 89999999999999999999999988776655554444332211
Q ss_pred HHHHh---ccCCCCCCCcccccccCChhhhhcccCChHHHHHh
Q 021306 262 REEIR---CMNPNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEY 301 (314)
Q Consensus 262 ~~~~~---~~~p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~ 301 (314)
.+.+. ..+|+ .|++++++++|||++.....-.-..+.+.
T Consensus 228 ~~~l~~~l~~~p~-~Rpt~~~il~~~~~~~~~~~~~~~~~~~~ 269 (274)
T cd06609 228 KDFVSLCLNKDPK-ERPSAKELLKHKFIKKAKKTSYLTLLIER 269 (274)
T ss_pred HHHHHHHhhCChh-hCcCHHHHhhChhhcCCCcccHHHHHHHH
Confidence 11111 23677 79999999999999887665333333333
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=282.53 Aligned_cols=233 Identities=25% Similarity=0.429 Sum_probs=179.7
Q ss_pred EeecCceEEEEEEECCCCcEEEEEEeeccccc-------hHHHHHHHHhC---CCCceeeeceeeeecCCCCceeEEEEe
Q 021306 46 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRY-------KNRELQLMRVM---DHPNVISLKHCFFSTTSKNELFLNLVM 115 (314)
Q Consensus 46 Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~~~-------~~~e~~~l~~l---~h~~iv~~~~~~~~~~~~~~~~~~lv~ 115 (314)
||+|+||.||+|++..+++.||+|.+.+.... ...|..++... .||+|+++++++... ..+++||
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~-----~~~~lv~ 75 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTD-----SDLYLVT 75 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecC-----CeEEEEE
Confidence 69999999999999999999999998643211 12345555544 699999999888433 3488999
Q ss_pred ecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCccccccc-
Q 021306 116 EYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA- 193 (314)
Q Consensus 116 e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~~- 193 (314)
||+.+ +|...+. ....+++..++.++.||+.||.|||+ +||+||||||+||+++. ++.++|+|||++.....
T Consensus 76 e~~~~g~L~~~l~----~~~~~~~~~~~~~~~qil~al~~LH~-~~ivHrDlkp~Nili~~-~~~~kl~Dfg~a~~~~~~ 149 (330)
T cd05586 76 DYMSGGELFWHLQ----KEGRFSEDRAKFYIAELVLALEHLHK-YDIVYRDLKPENILLDA-TGHIALCDFGLSKANLTD 149 (330)
T ss_pred cCCCCChHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeccCCHHHeEECC-CCCEEEecCCcCcCCCCC
Confidence 99986 5554443 35789999999999999999999999 89999999999999998 78899999999865322
Q ss_pred CCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCC--------HHHH
Q 021306 194 GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT--------REEI 265 (314)
Q Consensus 194 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~--------~~~~ 265 (314)
........+++.|+|||.+.+...++.++||||||+++|+|++|+.||.+.+..+.+..+.......+ .+.+
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li 229 (330)
T cd05586 150 NKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFV 229 (330)
T ss_pred CCCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHH
Confidence 22233456799999999987655578999999999999999999999988877666555543211111 1122
Q ss_pred h---ccCCCCCCC----cccccccCChhhhhc
Q 021306 266 R---CMNPNYTDF----RFPQIKAHPWHKVCI 290 (314)
Q Consensus 266 ~---~~~p~~~~~----~~~~l~~~p~~~~~~ 290 (314)
. ..+|. +|+ ++.++++|||+....
T Consensus 230 ~~~L~~~P~-~R~~~~~~~~~ll~h~~~~~~~ 260 (330)
T cd05586 230 KGLLNRNPQ-HRLGAHRDAVELKEHPFFADID 260 (330)
T ss_pred HHHcCCCHH-HCCCCCCCHHHHhcCccccCCC
Confidence 2 33666 676 788999999997543
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=276.61 Aligned_cols=204 Identities=28% Similarity=0.462 Sum_probs=177.5
Q ss_pred CceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc--cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeEEEEee
Q 021306 39 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR--RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVME 116 (314)
Q Consensus 39 ~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~--~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e 116 (314)
-|.+++.||+|+||.||++.++.+|+.+|+|++..+. +..-+|+.++++++.+++|++++.++...+ +|+|||
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sD-----LWIVME 108 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSD-----LWIVME 108 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccchHHHHHHHHHHHHHcCCchhhhhhhhhccCCc-----eEeehh
Confidence 3889999999999999999999999999999997654 344589999999999999999999876665 999999
Q ss_pred cccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcccccccC-
Q 021306 117 YVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG- 194 (314)
Q Consensus 117 ~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~~~- 194 (314)
||+. +..+.++. ++.++++.++..+++..+++|+|||. ..-+|||||..|||++. ++..||.|||.+..+...
T Consensus 109 YCGAGSiSDI~R~---R~K~L~E~EIs~iL~~TLKGL~YLH~-~~KIHRDIKAGNILLNT-~G~AKLADFGVAGQLTDTM 183 (502)
T KOG0574|consen 109 YCGAGSISDIMRA---RRKPLSEQEISAVLRDTLKGLQYLHD-LKKIHRDIKAGNILLNT-DGIAKLADFGVAGQLTDTM 183 (502)
T ss_pred hcCCCcHHHHHHH---hcCCccHHHHHHHHHHHHhHHHHHHH-HHHHHhhcccccEEEcc-cchhhhhhccccchhhhhH
Confidence 9994 55555543 46899999999999999999999999 67899999999999999 899999999999765443
Q ss_pred CccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 021306 195 EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEI 253 (314)
Q Consensus 195 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i 253 (314)
.......|||.|||||++..-. |..++||||||++..||..|++||.+..+...+..|
T Consensus 184 AKRNTVIGTPFWMAPEVI~EIG-Y~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMI 241 (502)
T KOG0574|consen 184 AKRNTVIGTPFWMAPEVIEEIG-YDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMI 241 (502)
T ss_pred HhhCccccCcccccHHHHHHhc-cchhhhHhhhcchhhhhhcCCCCcccccccceeEec
Confidence 3344578999999999996544 899999999999999999999999999887665544
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-38 Score=277.64 Aligned_cols=256 Identities=24% Similarity=0.365 Sum_probs=188.7
Q ss_pred CCCceeeeeEeecCceEEEEEEEC-----CCCcEEEEEEeeccc-----cchHHHHHHHHhC-CCCceeeeceeeeecCC
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCL-----ETGETVAIKKVLQDR-----RYKNRELQLMRVM-DHPNVISLKHCFFSTTS 105 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~-----~~~~~~~vK~~~~~~-----~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~ 105 (314)
.++|++.+.||+|+||.||+|.+. .+++.||+|.++... ....+|+.++..+ +||||+++++++....
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~- 84 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN- 84 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC-
Confidence 468999999999999999999752 345789999886432 2345789999999 8999999999774322
Q ss_pred CCceeEEEEeecccc-cHHHHHHhhhh-----------------------------------------------------
Q 021306 106 KNELFLNLVMEYVPE-SMYRVLKHYSS----------------------------------------------------- 131 (314)
Q Consensus 106 ~~~~~~~lv~e~~~~-~l~~~l~~~~~----------------------------------------------------- 131 (314)
..++++|||+++ +|.+.+.....
T Consensus 85 ---~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (338)
T cd05102 85 ---GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQ 161 (338)
T ss_pred ---CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccch
Confidence 237899999996 66666543211
Q ss_pred -----cCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcccccccCCc---ccccccc
Q 021306 132 -----ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA---NISYICS 203 (314)
Q Consensus 132 -----~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~ 203 (314)
...++++..+..++.|++.||.|||+ +||+||||||+||+++. ++.++|+|||+++....... .....++
T Consensus 162 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivHrDiKp~Nil~~~-~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~ 239 (338)
T cd05102 162 ETDDLWKSPLTMEDLICYSFQVARGMEFLAS-RKCIHRDLAARNILLSE-NNVVKICDFGLARDIYKDPDYVRKGSARLP 239 (338)
T ss_pred hccccccCCCCHHHHHHHHHHHHHHHHHHHH-CCEECCCCccceEEEcC-CCcEEEeecccccccccCcchhcccCCCCC
Confidence 02358889999999999999999999 89999999999999998 78899999999875432211 1122345
Q ss_pred ccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCHHHHhccCCCCCCCccccccc
Q 021306 204 RFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKA 282 (314)
Q Consensus 204 ~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~p~~~~~~~~~l~~ 282 (314)
+.|+|||.+.+.. ++.++||||||+++|+|++ |..||.+....+.+...+....... .|......+.+|+.
T Consensus 240 ~~y~aPE~~~~~~-~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~l~~li~ 311 (338)
T cd05102 240 LKWMAPESIFDKV-YTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMR-------APENATPEIYRIML 311 (338)
T ss_pred ccccCcHHhhcCC-CCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCC-------CCCCCCHHHHHHHH
Confidence 6799999986554 8999999999999999997 9999988665444444433221111 11112234566777
Q ss_pred CChhhhhcccCChHHHHHhcchhh
Q 021306 283 HPWHKVCIFHFPKHWLLEYGSHIN 306 (314)
Q Consensus 283 ~p~~~~~~~~~~~~~~~~~~~~~~ 306 (314)
.||...+..+++...++..++.+.
T Consensus 312 ~cl~~dp~~RPs~~el~~~l~~~~ 335 (338)
T cd05102 312 ACWQGDPKERPTFSALVEILGDLL 335 (338)
T ss_pred HHccCChhhCcCHHHHHHHHHHHH
Confidence 777777777777777777766543
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=273.74 Aligned_cols=248 Identities=35% Similarity=0.573 Sum_probs=197.1
Q ss_pred ccCCCcee-eeeEeecCceEEEEEEECCCCcEEEEEEeecccc------------------chHHHHHHHHhCCCCceee
Q 021306 35 KQTISYMA-ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR------------------YKNRELQLMRVMDHPNVIS 95 (314)
Q Consensus 35 ~~~~~y~~-~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~~------------------~~~~e~~~l~~l~h~~iv~ 95 (314)
...++|.. .+.||.|++|.||++.+..+++.|++|.+..... ...+|+.+++.++|+||++
T Consensus 5 ~~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 84 (335)
T PTZ00024 5 SISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMG 84 (335)
T ss_pred ccccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceee
Confidence 34567865 5779999999999999999999999998864321 2347899999999999999
Q ss_pred eceeeeecCCCCceeEEEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcC
Q 021306 96 LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP 175 (314)
Q Consensus 96 ~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~ 175 (314)
+++++.. ..+.+++|||+.+++.+.+.. ...+++..+..++.|++.||.+||+ .|++|+||+|+||+++.
T Consensus 85 ~~~~~~~-----~~~~~lv~e~~~~~l~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~-~~i~H~dl~~~nill~~ 154 (335)
T PTZ00024 85 LVDVYVE-----GDFINLVMDIMASDLKKVVDR----KIRLTESQVKCILLQILNGLNVLHK-WYFMHRDLSPANIFINS 154 (335)
T ss_pred eeEEEec-----CCcEEEEEeccccCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeecccccHHHeEECC
Confidence 9998843 334889999999988777653 4679999999999999999999999 89999999999999998
Q ss_pred CCCcEEEeecCcccccccC---------------CccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCC
Q 021306 176 LTHQVKICDFGSAKQLIAG---------------EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL 240 (314)
Q Consensus 176 ~~~~~~l~dfg~~~~~~~~---------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~p 240 (314)
++.++|+|||.+...... .......+++.|+|||.+.+...++.++|+||||+++|+|++|+.|
T Consensus 155 -~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p 233 (335)
T PTZ00024 155 -KGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPL 233 (335)
T ss_pred -CCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence 788999999998754311 1111223467799999987665578999999999999999999999
Q ss_pred CCCCChHHHHHHHHHHcCCCCH-----------------------------------HHHh---ccCCCCCCCccccccc
Q 021306 241 FPGENAVDQLVEIIKVLGTPTR-----------------------------------EEIR---CMNPNYTDFRFPQIKA 282 (314)
Q Consensus 241 f~~~~~~~~~~~i~~~~~~~~~-----------------------------------~~~~---~~~p~~~~~~~~~l~~ 282 (314)
|.+.+..+.+..+....+.+.. +.+. ..+|+ +|+++++++.
T Consensus 234 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~-~R~s~~~~l~ 312 (335)
T PTZ00024 234 FPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPL-ERISAKEALK 312 (335)
T ss_pred CCCCCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCch-hccCHHHHhc
Confidence 9998887777666654332211 1111 23677 8999999999
Q ss_pred CChhhhhcccCC
Q 021306 283 HPWHKVCIFHFP 294 (314)
Q Consensus 283 ~p~~~~~~~~~~ 294 (314)
|||++.......
T Consensus 313 ~~~~~~~~~~~~ 324 (335)
T PTZ00024 313 HEYFKSDPLPCD 324 (335)
T ss_pred CcccCCCCCCCC
Confidence 999998766533
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=269.91 Aligned_cols=240 Identities=27% Similarity=0.436 Sum_probs=185.3
Q ss_pred CceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeE
Q 021306 39 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 111 (314)
Q Consensus 39 ~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 111 (314)
.|++.+.||+|+||.||++.+..+++.+++|.+.... ....+|+.++++++|++++++.+.+.. ....
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~-----~~~~ 75 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYET-----KDAL 75 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEec-----CCEE
Confidence 4788999999999999999999999999999886432 123468899999999999999888743 3348
Q ss_pred EEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcccc
Q 021306 112 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 190 (314)
Q Consensus 112 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~ 190 (314)
+++|||+.| +|.+.+.. .....+++..+..++.|++.||.|||+ .|++|+||+|+||+++. ++.++|+|||++..
T Consensus 76 ~lv~e~~~g~~L~~~l~~--~~~~~l~~~~~~~~~~qi~~~l~~lH~-~~iiH~dikp~Nil~~~-~~~~~l~Dfg~~~~ 151 (285)
T cd05630 76 CLVLTLMNGGDLKFHIYH--MGEAGFEEGRAVFYAAEICCGLEDLHQ-ERIVYRDLKPENILLDD-HGHIRISDLGLAVH 151 (285)
T ss_pred EEEEEecCCCcHHHHHHH--hcccCCCHHHHHHHHHHHHHHHHHHHh-CCEEeCCCCHHHEEECC-CCCEEEeeccceee
Confidence 899999986 55555432 223569999999999999999999999 89999999999999998 78899999999875
Q ss_pred cccCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHcCC-----C--
Q 021306 191 LIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV---DQLVEIIKVLGT-----P-- 260 (314)
Q Consensus 191 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~---~~~~~i~~~~~~-----~-- 260 (314)
...........++..|+|||.+.+.. ++.++|+||||+++|+|++|+.||...... +........... .
T Consensus 152 ~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (285)
T cd05630 152 VPEGQTIKGRVGTVGYMAPEVVKNER-YTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSP 230 (285)
T ss_pred cCCCccccCCCCCccccChHHHcCCC-CCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhhcCccCCH
Confidence 44333333456788999999996654 899999999999999999999999865432 122222211110 1
Q ss_pred -CHHHHh---ccCCCCCCCc-----ccccccCChhhhh
Q 021306 261 -TREEIR---CMNPNYTDFR-----FPQIKAHPWHKVC 289 (314)
Q Consensus 261 -~~~~~~---~~~p~~~~~~-----~~~l~~~p~~~~~ 289 (314)
..+.+. ..+|. +|++ ++++++|||++..
T Consensus 231 ~~~~li~~~l~~~p~-~R~s~~~~~~~~~~~h~~~~~~ 267 (285)
T cd05630 231 DARSLCKMLLCKDPK-ERLGCQGGGAREVKEHPLFKQI 267 (285)
T ss_pred HHHHHHHHHhhcCHH-HccCCCCCchHHHHcChhhhcc
Confidence 112222 33666 7888 8899999999764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=269.45 Aligned_cols=239 Identities=29% Similarity=0.501 Sum_probs=191.0
Q ss_pred CCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCCcee
Q 021306 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 110 (314)
Q Consensus 38 ~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 110 (314)
++|++.+.||+|++|.||++++..+++.+++|.+.... ....+|+++++++.|+||+++++++... ..
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~ 75 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDD-----SN 75 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcC-----Ce
Confidence 47999999999999999999999999999999886432 2245789999999999999999988433 34
Q ss_pred EEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCccc
Q 021306 111 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 189 (314)
Q Consensus 111 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~ 189 (314)
++++|||+++ +|.+.+.. ...+++..+..++.|++.||.+||+ .|++|+||+|+||+++. ++.++|+|||++.
T Consensus 76 ~~~v~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~qil~~l~~lH~-~~i~H~dl~p~nili~~-~~~~kl~dfg~~~ 149 (290)
T cd05580 76 LYLVMEYVPGGELFSHLRK----SGRFPEPVARFYAAQVVLALEYLHS-LDIVYRDLKPENLLLDS-DGYIKITDFGFAK 149 (290)
T ss_pred EEEEEecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCCCHHHEEECC-CCCEEEeeCCCcc
Confidence 8899999964 66655543 4789999999999999999999999 89999999999999998 7889999999987
Q ss_pred ccccCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCC-------H
Q 021306 190 QLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT-------R 262 (314)
Q Consensus 190 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~-------~ 262 (314)
..... .....+++.|+|||.+.+.. .+.++|+||||+++|+|++|+.||...+.......+.......+ .
T Consensus 150 ~~~~~--~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 226 (290)
T cd05580 150 RVKGR--TYTLCGTPEYLAPEIILSKG-YGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSFFSPDAK 226 (290)
T ss_pred ccCCC--CCCCCCCccccChhhhcCCC-CCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCccCCccCCHHHH
Confidence 65443 23345688899999986554 78899999999999999999999988776555555543211111 1
Q ss_pred HHHh---ccCCCCCCC-----cccccccCChhhhhcc
Q 021306 263 EEIR---CMNPNYTDF-----RFPQIKAHPWHKVCIF 291 (314)
Q Consensus 263 ~~~~---~~~p~~~~~-----~~~~l~~~p~~~~~~~ 291 (314)
+.+. ..+|. +|+ ++.++++|||++....
T Consensus 227 ~li~~~l~~~p~-~R~~~~~~~~~~l~~~~~~~~~~~ 262 (290)
T cd05580 227 DLIRNLLQVDLT-KRLGNLKNGVNDIKNHPWFAGIDW 262 (290)
T ss_pred HHHHHHccCCHH-HccCcccCCHHHHHcCcccccCCH
Confidence 1222 23565 666 8899999999977653
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=258.72 Aligned_cols=264 Identities=23% Similarity=0.407 Sum_probs=204.4
Q ss_pred cCCCCCCccCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccccchH-----HHHHH-HHhCCCCceeeeceeee
Q 021306 28 GGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----RELQL-MRVMDHPNVISLKHCFF 101 (314)
Q Consensus 28 ~~~~~~~~~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~~~~~-----~e~~~-l~~l~h~~iv~~~~~~~ 101 (314)
.+....+...++.+.+..||.|..|.|++++.+.+|...|||.+.+..+..+ ..+.+ ++.-.+|+||+.+++|.
T Consensus 82 ~~g~r~~~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi 161 (391)
T KOG0983|consen 82 GGGQRYQADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFI 161 (391)
T ss_pred cCCcccccChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEe
Confidence 3344555666788899999999999999999999999999999976544321 22222 22225899999999996
Q ss_pred ecCCCCceeEEEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEE
Q 021306 102 STTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVK 181 (314)
Q Consensus 102 ~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~ 181 (314)
...+ .++.||.|+.-+...+.. ..+++++..+-.+...+++||.||.+.+||+|||+||+|||+|. .+++|
T Consensus 162 ~n~d-----V~IcMelMs~C~ekLlkr---ik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe-~GniK 232 (391)
T KOG0983|consen 162 TNTD-----VFICMELMSTCAEKLLKR---IKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDE-RGNIK 232 (391)
T ss_pred eCch-----HHHHHHHHHHHHHHHHHH---hcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEcc-CCCEE
Confidence 6554 778999988655555543 34789999999999999999999998789999999999999998 89999
Q ss_pred EeecCcccccccCCccccccccccccccccccC--CCCCCcchhHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHHcC
Q 021306 182 ICDFGSAKQLIAGEANISYICSRFYRAPELIFG--ATEYTTSIDIWSAGCVLAELLLGQPLFPGEN-AVDQLVEIIKVLG 258 (314)
Q Consensus 182 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~Dv~slG~il~el~tg~~pf~~~~-~~~~~~~i~~~~~ 258 (314)
|||||++.............|.+.|||||.+-- ..+|..++||||||++++|++||+.||.+.+ ..+.+.++.+...
T Consensus 233 lCDFGIsGrlvdSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~eP 312 (391)
T KOG0983|consen 233 LCDFGISGRLVDSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEP 312 (391)
T ss_pred eecccccceeecccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCC
Confidence 999999998887777777889999999999842 3458889999999999999999999998854 4566676766433
Q ss_pred CCCH-------HHH----hcc--CCCCCCCcccccccCChhhhhcccCC--hHHHHHh
Q 021306 259 TPTR-------EEI----RCM--NPNYTDFRFPQIKAHPWHKVCIFHFP--KHWLLEY 301 (314)
Q Consensus 259 ~~~~-------~~~----~~~--~p~~~~~~~~~l~~~p~~~~~~~~~~--~~~~~~~ 301 (314)
+..+ +.+ .|+ ++. +|+...+|++|||.+...+... .+||.++
T Consensus 313 P~L~~~~gFSp~F~~fv~~CL~kd~r-~RP~Y~~Ll~h~Fi~~ye~a~~dVa~WF~dV 369 (391)
T KOG0983|consen 313 PLLPGHMGFSPDFQSFVKDCLTKDHR-KRPKYNKLLEHPFIKRYETAEVDVASWFKDV 369 (391)
T ss_pred CCCCcccCcCHHHHHHHHHHhhcCcc-cCcchHHHhcCcceeecchhhccHHHHHHHH
Confidence 2111 111 122 444 7999999999999887766432 3366665
|
|
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=267.14 Aligned_cols=252 Identities=24% Similarity=0.390 Sum_probs=193.9
Q ss_pred CCCccCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHhC-CCCceeeeceeeeecCCCC
Q 021306 32 GEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVM-DHPNVISLKHCFFSTTSKN 107 (314)
Q Consensus 32 ~~~~~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~---~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~ 107 (314)
.-+...++|++.+.||+|++|.||++++..+++.+++|.+.... ....+|..+++++ +|+||+++++++.....+.
T Consensus 12 ~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~ 91 (286)
T cd06638 12 SFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKN 91 (286)
T ss_pred cCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCC
Confidence 34455678999999999999999999999999999999875432 2345788889998 6999999999876554445
Q ss_pred ceeEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecC
Q 021306 108 ELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 186 (314)
Q Consensus 108 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg 186 (314)
...++++|||+++ +|.+.+.........+++..++.++.|++.||.|||+ ++++|+||+|+||+++. ++.++|+|||
T Consensus 92 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~nili~~-~~~~kl~dfg 169 (286)
T cd06638 92 GDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHV-NKTIHRDVKGNNILLTT-EGGVKLVDFG 169 (286)
T ss_pred CCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHh-CCccccCCCHHhEEECC-CCCEEEccCC
Confidence 5568899999986 6666555444455679999999999999999999999 89999999999999998 7789999999
Q ss_pred cccccccCC-ccccccccccccccccccCC----CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCC-
Q 021306 187 SAKQLIAGE-ANISYICSRFYRAPELIFGA----TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP- 260 (314)
Q Consensus 187 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~----~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~- 260 (314)
++....... ......+++.|+|||.+... ..++.++|+||||+++|+|++|+.||...+....+..+.+.....
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 249 (286)
T cd06638 170 VSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPPTL 249 (286)
T ss_pred ceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccCCCcc
Confidence 987553322 22234578889999997532 336889999999999999999999998877655444332221110
Q ss_pred ---------CHHHHh-c--cCCCCCCCcccccccCChh
Q 021306 261 ---------TREEIR-C--MNPNYTDFRFPQIKAHPWH 286 (314)
Q Consensus 261 ---------~~~~~~-~--~~p~~~~~~~~~l~~~p~~ 286 (314)
....+. + .+|+ +|+++.+++.|+|+
T Consensus 250 ~~~~~~~~~~~~li~~~l~~~p~-~Rps~~ell~~~~~ 286 (286)
T cd06638 250 HQPELWSNEFNDFIRKCLTKDYE-KRPTVSDLLQHVFI 286 (286)
T ss_pred cCCCCcCHHHHHHHHHHccCCcc-cCCCHHHHhhcccC
Confidence 011111 2 3566 78899999998885
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=240.33 Aligned_cols=218 Identities=38% Similarity=0.686 Sum_probs=189.5
Q ss_pred CceeeeeEeecCceEEEEEEECCCCcEEEEEEeecccc------chHHHHHHHHhCCCCceeeeceeeeecCCCCceeEE
Q 021306 39 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR------YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 112 (314)
Q Consensus 39 ~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~~------~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 112 (314)
+|.-.+.||+|.||+||++++..+++.||+|.+..+.. ...+|+-+++.++|.|||++++.... ...+.
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhs-----dkklt 77 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS-----DKKLT 77 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhcc-----CceeE
Confidence 57778899999999999999999999999999975432 23589999999999999999998733 22388
Q ss_pred EEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcccccc
Q 021306 113 LVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 192 (314)
Q Consensus 113 lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~ 192 (314)
+|+|||...|...+.. .++.++.+.++.++.|+++++.++|+ +++.|||+||.|++++. ++.+||.|||+++-..
T Consensus 78 lvfe~cdqdlkkyfds---lng~~d~~~~rsfmlqllrgl~fchs-hnvlhrdlkpqnllin~-ngelkladfglarafg 152 (292)
T KOG0662|consen 78 LVFEFCDQDLKKYFDS---LNGDLDPEIVRSFMLQLLRGLGFCHS-HNVLHRDLKPQNLLINR-NGELKLADFGLARAFG 152 (292)
T ss_pred EeHHHhhHHHHHHHHh---cCCcCCHHHHHHHHHHHHhhhhhhhh-hhhhhccCCcceEEecc-CCcEEecccchhhhcC
Confidence 9999999988877765 47889999999999999999999999 99999999999999998 9999999999998654
Q ss_pred cCCc-cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCHHHHh
Q 021306 193 AGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIR 266 (314)
Q Consensus 193 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 266 (314)
.+.. ......|..|.+|.++.+..-|+...|+||.|||+.|+.. |++.|.+.+..+++.+|...++.+..+.++
T Consensus 153 ipvrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wp 228 (292)
T KOG0662|consen 153 IPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWP 228 (292)
T ss_pred CceEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCC
Confidence 4432 2234558889999999999889999999999999999997 888999999999999999998887766544
|
|
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=265.49 Aligned_cols=239 Identities=28% Similarity=0.522 Sum_probs=187.2
Q ss_pred CCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc---------cchHHHHHHHHhCCCCceeeeceeeeecCCCCc
Q 021306 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 108 (314)
Q Consensus 38 ~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~---------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 108 (314)
.+|++.+.||+|++|.||++.+..++..+++|.+.... ....+|+.++++++|+||+++++++... ..
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~ 78 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDR---AE 78 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcC---CC
Confidence 47999999999999999999999999999999875321 2245788999999999999999887432 12
Q ss_pred eeEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCc
Q 021306 109 LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 187 (314)
Q Consensus 109 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~ 187 (314)
..+++++||+++ +|.+.+.. ...+++...+.++.|++.||.+||+ .+++|+||+|+||+++. ++.++|+|||+
T Consensus 79 ~~~~l~~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~LH~-~~i~H~~l~p~nil~~~-~~~~~l~dfg~ 152 (266)
T cd06651 79 KTLTIFMEYMPGGSVKDQLKA----YGALTESVTRKYTRQILEGMSYLHS-NMIVHRDIKGANILRDS-AGNVKLGDFGA 152 (266)
T ss_pred CEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCCHHHEEECC-CCCEEEccCCC
Confidence 347799999986 56555543 4568999999999999999999999 89999999999999997 78899999999
Q ss_pred ccccccCC----ccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCC---
Q 021306 188 AKQLIAGE----ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP--- 260 (314)
Q Consensus 188 ~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~--- 260 (314)
+....... ......++..|+|||.+.+.. ++.++|+||||+++|+|++|+.||...+.......+......+
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 231 (266)
T cd06651 153 SKRLQTICMSGTGIRSVTGTPYWMSPEVISGEG-YGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLP 231 (266)
T ss_pred ccccccccccCCccccCCccccccCHHHhCCCC-CCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCCc
Confidence 87543211 111234677899999986644 7899999999999999999999998876655554443222111
Q ss_pred ------CHHHHhcc--CCCCCCCcccccccCChhh
Q 021306 261 ------TREEIRCM--NPNYTDFRFPQIKAHPWHK 287 (314)
Q Consensus 261 ------~~~~~~~~--~p~~~~~~~~~l~~~p~~~ 287 (314)
....+.++ +|. +|++++++++|||++
T Consensus 232 ~~~~~~~~~li~~~~~~p~-~Rp~~~eil~hp~~~ 265 (266)
T cd06651 232 SHISEHARDFLGCIFVEAR-HRPSAEELLRHPFAQ 265 (266)
T ss_pred hhcCHHHHHHHHHhcCChh-hCcCHHHHhcCcccc
Confidence 11223333 666 899999999999986
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=264.31 Aligned_cols=250 Identities=28% Similarity=0.432 Sum_probs=195.5
Q ss_pred CccCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHhC-CCCceeeeceeeeecCC-CCc
Q 021306 34 PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVM-DHPNVISLKHCFFSTTS-KNE 108 (314)
Q Consensus 34 ~~~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~---~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~-~~~ 108 (314)
|...++|++.+.||+|++|.||+|.++.+++.+++|.+.... ....+|+.+++++ .|+||+++++++..... ...
T Consensus 2 ~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 2 PDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred CCchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 445689999999999999999999998899999999886543 3346788999998 79999999998865543 335
Q ss_pred eeEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCc
Q 021306 109 LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 187 (314)
Q Consensus 109 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~ 187 (314)
..+++++||+++ +|.+.+......+..+++..++.++.|++.||.|||+ .+++|+||+|+||+++. ++.++|+|||.
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~-~~i~H~~l~p~ni~~~~-~~~~~l~d~~~ 159 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHE-NKVIHRDIKGQNILLTK-NAEVKLVDFGV 159 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhc-CCcccCCCCHHHEEEcc-CCeEEECCCcc
Confidence 567899999997 5655555433345789999999999999999999999 89999999999999998 78899999998
Q ss_pred ccccccCC-ccccccccccccccccccC----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCC--
Q 021306 188 AKQLIAGE-ANISYICSRFYRAPELIFG----ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP-- 260 (314)
Q Consensus 188 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~----~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~-- 260 (314)
+....... ......++..|+|||.+.. ...++.++||||||+++|+|++|+.||...........+.......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 239 (275)
T cd06608 160 SAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPTLK 239 (275)
T ss_pred ceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCCCCC
Confidence 86543322 1223456888999998743 2336788999999999999999999998776655555554432111
Q ss_pred --------CHHHHh---ccCCCCCCCcccccccCChh
Q 021306 261 --------TREEIR---CMNPNYTDFRFPQIKAHPWH 286 (314)
Q Consensus 261 --------~~~~~~---~~~p~~~~~~~~~l~~~p~~ 286 (314)
..+.+. ..+|. +|+++.++++|||.
T Consensus 240 ~~~~~~~~~~~li~~~l~~dp~-~Rpt~~~ll~~~~~ 275 (275)
T cd06608 240 SPENWSKKFNDFISECLIKNYE-QRPFMEELLEHPFI 275 (275)
T ss_pred chhhcCHHHHHHHHHHhhcChh-hCcCHHHHhcCCCC
Confidence 012222 23677 89999999999995
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=267.37 Aligned_cols=242 Identities=25% Similarity=0.397 Sum_probs=188.7
Q ss_pred CceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeE
Q 021306 39 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 111 (314)
Q Consensus 39 ~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 111 (314)
.|+..+.||+|+||.||++.+..+++.+|+|.+.... ....+|+.++++++|++++++.+.+.. ....
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~-----~~~~ 75 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYET-----KDAL 75 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEec-----CCEE
Confidence 4788999999999999999999999999999886432 123578999999999999999888743 3348
Q ss_pred EEEeeccccc-HHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcccc
Q 021306 112 NLVMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 190 (314)
Q Consensus 112 ~lv~e~~~~~-l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~ 190 (314)
++++||+.++ +...+.. .....+++..+..++.|++.||.|||+ +||+|+||+|+||+++. ++.++|+|||++..
T Consensus 76 ~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~ql~~~l~~lH~-~~iiH~dikp~Nili~~-~~~~kl~Dfg~~~~ 151 (285)
T cd05632 76 CLVLTIMNGGDLKFHIYN--MGNPGFEEERALFYAAEILCGLEDLHR-ENTVYRDLKPENILLDD-YGHIRISDLGLAVK 151 (285)
T ss_pred EEEEEeccCccHHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCCHHHEEECC-CCCEEEecCCccee
Confidence 8999999974 4444432 223579999999999999999999999 89999999999999998 77899999999875
Q ss_pred cccCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCC--------C--
Q 021306 191 LIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT--------P-- 260 (314)
Q Consensus 191 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~--------~-- 260 (314)
...........++..|+|||.+.+.. ++.++|+||||+++|+|++|..||.+.........+...... .
T Consensus 152 ~~~~~~~~~~~g~~~~~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (285)
T cd05632 152 IPEGESIRGRVGTVGYMAPEVLNNQR-YTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSE 230 (285)
T ss_pred cCCCCcccCCCCCcCccChHHhcCCC-CCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCH
Confidence 54333333456788999999996654 889999999999999999999999887655443333322111 0
Q ss_pred -CHHHHh-c--cCCCCCCCc-----ccccccCChhhhhcc
Q 021306 261 -TREEIR-C--MNPNYTDFR-----FPQIKAHPWHKVCIF 291 (314)
Q Consensus 261 -~~~~~~-~--~~p~~~~~~-----~~~l~~~p~~~~~~~ 291 (314)
..+.+. + .+|. +|++ +.+++.|||++....
T Consensus 231 ~~~~li~~~l~~~P~-~R~~~~~~~~~~l~~~~~~~~~~~ 269 (285)
T cd05632 231 EAKSICKMLLTKDPK-QRLGCQEEGAGEVKRHPFFRNMNF 269 (285)
T ss_pred HHHHHHHHHccCCHh-HcCCCcccChHHHHcChhhhcCCH
Confidence 111222 2 2565 7888 789999999988754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=259.51 Aligned_cols=238 Identities=27% Similarity=0.441 Sum_probs=188.4
Q ss_pred CceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeEE
Q 021306 39 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 112 (314)
Q Consensus 39 ~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 112 (314)
.|++.+.||.|++|.||++.+..+++.+++|.+.... ....+|+.++++++|+|++++++.+.. ....++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~~~ 76 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEG----EDGLLY 76 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecC----CCCEEE
Confidence 4899999999999999999999899999999986432 234578899999999999999887632 233478
Q ss_pred EEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCccccc
Q 021306 113 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 191 (314)
Q Consensus 113 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~ 191 (314)
+++||+++ ++.+.+... ....+++.+++.++.|++.++.+||+ .|++|+||+|+||+++. ++.++|+|||++...
T Consensus 77 lv~e~~~~~~l~~~l~~~--~~~~l~~~~~~~~~~~l~~~l~~lH~-~~i~H~di~p~nil~~~-~~~~~l~df~~~~~~ 152 (257)
T cd08223 77 IVMGFCEGGDLYHKLKEQ--KGKLLPENQVVEWFVQIAMALQYLHE-KHILHRDLKTQNVFLTR-TNIIKVGDLGIARVL 152 (257)
T ss_pred EEecccCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCchhEEEec-CCcEEEecccceEEe
Confidence 99999986 566555531 24568999999999999999999999 89999999999999998 889999999998755
Q ss_pred ccCC-ccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCH--------
Q 021306 192 IAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR-------- 262 (314)
Q Consensus 192 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~-------- 262 (314)
.... ......+++.|+|||.+.+.. ++.++|+||||+++|+|++|+.||...+.......+........+
T Consensus 153 ~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (257)
T cd08223 153 ENQCDMASTLIGTPYYMSPELFSNKP-YNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELG 231 (257)
T ss_pred cccCCccccccCCcCccChhHhcCCC-CCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHH
Confidence 3322 222345678899999986654 788999999999999999999999887766665555554322211
Q ss_pred HHHh---ccCCCCCCCcccccccCChh
Q 021306 263 EEIR---CMNPNYTDFRFPQIKAHPWH 286 (314)
Q Consensus 263 ~~~~---~~~p~~~~~~~~~l~~~p~~ 286 (314)
+.+. ..+|. .|+++.++++|||+
T Consensus 232 ~li~~~l~~~p~-~Rp~~~~~l~~~~~ 257 (257)
T cd08223 232 ELIATMLSKRPE-KRPSVKSILRQPYI 257 (257)
T ss_pred HHHHHHhccCcc-cCCCHHHHhcCCCC
Confidence 1111 23676 89999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=269.67 Aligned_cols=204 Identities=38% Similarity=0.648 Sum_probs=168.3
Q ss_pred CceeeeeEeecCceEEEEEEECC--CCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCCce
Q 021306 39 SYMAERVVGTGSFGIVFQAKCLE--TGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL 109 (314)
Q Consensus 39 ~y~~~~~Lg~g~~g~Vy~~~~~~--~~~~~~vK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 109 (314)
+|++.+.||+|++|.||+|.+.. +++.|++|.+.... ....+|+.++++++||||+++++++... ...
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~ 77 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEH---ADK 77 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCC---CCc
Confidence 48999999999999999999988 89999999987632 2335789999999999999999988543 123
Q ss_pred eEEEEeecccccHHHHHHhhhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcC---CCCcEEEeec
Q 021306 110 FLNLVMEYVPESMYRVLKHYSSAN-QRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP---LTHQVKICDF 185 (314)
Q Consensus 110 ~~~lv~e~~~~~l~~~l~~~~~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~---~~~~~~l~df 185 (314)
.+++|+||+++++.+.+....... ..+++..++.++.|++.||.|||+ ++++|+||+|+||+++. .++.++|+||
T Consensus 78 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 78 SVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHS-NWVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred eEEEEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHh-CCEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 588999999998887776543333 379999999999999999999999 89999999999999986 2467999999
Q ss_pred CcccccccCCc----cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCh
Q 021306 186 GSAKQLIAGEA----NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA 246 (314)
Q Consensus 186 g~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~ 246 (314)
|++........ .....++..|+|||.+.+...++.++|+||||+++|+|++|+.||.+...
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~ 221 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREA 221 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcc
Confidence 99876533222 12234577899999887655578999999999999999999999976543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=267.15 Aligned_cols=207 Identities=40% Similarity=0.760 Sum_probs=170.8
Q ss_pred CCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeE
Q 021306 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 111 (314)
Q Consensus 38 ~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 111 (314)
++|++.+.||+|++|.||+|.+..+++.+++|.+.... ....+|+++++.++|+||+++++++. .....
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~ 75 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFR-----RKKRL 75 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcc-----cCCeE
Confidence 47999999999999999999998899999999875432 22357899999999999999999883 34458
Q ss_pred EEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCccccc
Q 021306 112 NLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 191 (314)
Q Consensus 112 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~ 191 (314)
++++||+.++++..+.. ....+++.+++.++.|++.|+.|||+ .|++|+||+|+||+++. ++.++|+|||++...
T Consensus 76 ~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~h~~l~p~ni~~~~-~~~~~l~dfg~~~~~ 150 (286)
T cd07846 76 YLVFEFVDHTVLDDLEK---YPNGLDESRVRKYLFQILRGIEFCHS-HNIIHRDIKPENILVSQ-SGVVKLCDFGFARTL 150 (286)
T ss_pred EEEEecCCccHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEECC-CCcEEEEeeeeeeec
Confidence 89999999876655443 24568999999999999999999999 89999999999999998 889999999998755
Q ss_pred ccCCc-cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 021306 192 IAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 254 (314)
Q Consensus 192 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~ 254 (314)
..... .....++..|+|||.+.+...++.++||||||+++|+|++|+.||.+.+..+....+.
T Consensus 151 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~ 214 (286)
T cd07846 151 AAPGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHII 214 (286)
T ss_pred cCCccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHH
Confidence 33322 1234567889999998765557889999999999999999999998777655554444
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=273.31 Aligned_cols=245 Identities=31% Similarity=0.567 Sum_probs=190.1
Q ss_pred CCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc----cchHHHHHHHHhCCCCceeeeceeeeecCCC------
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSK------ 106 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~------ 106 (314)
..+|++.+.||.|++|.||+|.+..+++.|++|.+.... ....+|+.++++++|+||+++++.+......
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 468999999999999999999999999999999885432 2345789999999999999998876432211
Q ss_pred ---CceeEEEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEe
Q 021306 107 ---NELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKIC 183 (314)
Q Consensus 107 ---~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~ 183 (314)
.....++++||+++++.+.+. ...+++..++.++.||+.||.|||+ .|++|+||+|+||+++..+..++|+
T Consensus 84 ~~~~~~~~~lv~e~~~~~L~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~-~givH~dikp~Nili~~~~~~~kl~ 157 (342)
T cd07854 84 SLTELNSVYIVQEYMETDLANVLE-----QGPLSEEHARLFMYQLLRGLKYIHS-ANVLHRDLKPANVFINTEDLVLKIG 157 (342)
T ss_pred cccccceEEEEeecccccHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEEcCCCceEEEC
Confidence 123578999999987766554 3579999999999999999999999 8999999999999998757789999
Q ss_pred ecCcccccccCCc----cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCC
Q 021306 184 DFGSAKQLIAGEA----NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT 259 (314)
Q Consensus 184 dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~ 259 (314)
|||.+........ .....++..|+|||.+.+...++.++||||||+++|+|++|+.||.+.++.+....+.+....
T Consensus 158 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~ 237 (342)
T cd07854 158 DFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPV 237 (342)
T ss_pred CcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence 9999875432211 112345778999998765555788999999999999999999999887765554444332110
Q ss_pred ----------------------------------CC---HHHHh---ccCCCCCCCcccccccCChhhh
Q 021306 260 ----------------------------------PT---REEIR---CMNPNYTDFRFPQIKAHPWHKV 288 (314)
Q Consensus 260 ----------------------------------~~---~~~~~---~~~p~~~~~~~~~l~~~p~~~~ 288 (314)
.. .+.+. ..+|. +|+++.+++.|||++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~-~R~t~~ell~h~~~~~ 305 (342)
T cd07854 238 VREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPM-DRLTAEEALMHPYMSC 305 (342)
T ss_pred CChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCch-hccCHHHHhCCCcccc
Confidence 00 11222 22666 8999999999999984
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=264.37 Aligned_cols=208 Identities=37% Similarity=0.701 Sum_probs=171.8
Q ss_pred ceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeEEE
Q 021306 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 113 (314)
Q Consensus 40 y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 113 (314)
|++.+.||.|++|.||++.++.+|+.|++|.+..+. ....+|+.+++.++|+|++++++++.. ....++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~-----~~~~~i 75 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHS-----ENKLYL 75 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheecc-----CCeEEE
Confidence 678999999999999999999999999999886432 234579999999999999999998743 345889
Q ss_pred EeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCccccccc
Q 021306 114 VMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA 193 (314)
Q Consensus 114 v~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~~ 193 (314)
++||+++++.+.+... ....+++..++.++.|++.||.+||+ ++++|+||+|+||+++. ++.++|+|||.+.....
T Consensus 76 v~e~~~~~l~~~~~~~--~~~~~~~~~~~~~~~~i~~~L~~lH~-~~~~H~dl~p~nil~~~-~~~~~l~df~~~~~~~~ 151 (283)
T cd07835 76 VFEFLDLDLKKYMDSS--PLTGLDPPLIKSYLYQLLQGIAYCHS-HRVLHRDLKPQNLLIDR-EGALKLADFGLARAFGV 151 (283)
T ss_pred EEeccCcCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeCCCCCHHHEEEcC-CCcEEEeecccccccCC
Confidence 9999988877766542 12468999999999999999999999 89999999999999998 88999999999875432
Q ss_pred CCc-cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q 021306 194 GEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 256 (314)
Q Consensus 194 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~ 256 (314)
... .....++..|+|||.+.+...++.++|+||||+++|+|++|+.||...+.......+.+.
T Consensus 152 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 215 (283)
T cd07835 152 PVRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRT 215 (283)
T ss_pred CccccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 221 122345778999998866555788999999999999999999999888776666655543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=267.41 Aligned_cols=215 Identities=32% Similarity=0.632 Sum_probs=175.8
Q ss_pred CCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCC---CC
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTS---KN 107 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~---~~ 107 (314)
.++|++.+.||+|++|.||+|.++.+++.+++|.+.... ....+|++++++++|+||+++++.+..... ..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 578999999999999999999999999999999885322 234579999999999999999987754332 22
Q ss_pred ceeEEEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCc
Q 021306 108 ELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 187 (314)
Q Consensus 108 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~ 187 (314)
...+++++||+.+++...+.. ....+++.+++.++.|++.||.|||+ +|++|+||+|+||+++. ++.++|+|||+
T Consensus 87 ~~~~~lv~~~~~~~l~~~~~~---~~~~~~~~~~~~i~~~l~~al~~lH~-~~i~H~dl~p~nil~~~-~~~~~l~dfg~ 161 (311)
T cd07866 87 RGSVYMVTPYMDHDLSGLLEN---PSVKLTESQIKCYMLQLLEGINYLHE-NHILHRDIKAANILIDN-QGILKIADFGL 161 (311)
T ss_pred CceEEEEEecCCcCHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEECC-CCCEEECcCcc
Confidence 345789999999887766653 34579999999999999999999999 89999999999999998 88999999999
Q ss_pred ccccccCCcc------------ccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 021306 188 AKQLIAGEAN------------ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 255 (314)
Q Consensus 188 ~~~~~~~~~~------------~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~ 255 (314)
+......... ....+++.|+|||.+.+...++.++||||||+++|+|++|+.||.+.+.......+..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~ 241 (311)
T cd07866 162 ARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFK 241 (311)
T ss_pred chhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 8754322211 1123467799999986655578999999999999999999999998877766665554
Q ss_pred H
Q 021306 256 V 256 (314)
Q Consensus 256 ~ 256 (314)
.
T Consensus 242 ~ 242 (311)
T cd07866 242 L 242 (311)
T ss_pred H
Confidence 4
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=280.11 Aligned_cols=250 Identities=29% Similarity=0.439 Sum_probs=208.8
Q ss_pred CCCccCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCC
Q 021306 32 GEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTS 105 (314)
Q Consensus 32 ~~~~~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 105 (314)
..+...+.|.+.+.||+|.|+.|.++++..++..||+|.+.+.. ....+|+.+++.++|||||+++.+......
T Consensus 50 ~~~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~ 129 (596)
T KOG0586|consen 50 DDSNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEAT 129 (596)
T ss_pred cccccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecce
Confidence 44555678999999999999999999999999999999986543 224589999999999999999999865555
Q ss_pred CCceeEEEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeec
Q 021306 106 KNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF 185 (314)
Q Consensus 106 ~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~df 185 (314)
+++||||+.++ .+.+|...++.+.+..++.++.|++.|++|||+ ++|+|||||++||+++. +..++|+||
T Consensus 130 -----lylV~eya~~g---e~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~-k~ivHrdLk~eNilL~~-~mnikIaDf 199 (596)
T KOG0586|consen 130 -----LYLVMEYASGG---ELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHS-KNIVHRDLKAENILLDE-NMNIKIADF 199 (596)
T ss_pred -----eEEEEEeccCc---hhHHHHHhcccchhhhhhhhhHHHHHHHHHHhh-cceeccccchhhccccc-ccceeeecc
Confidence 89999999985 455555667888899999999999999999999 99999999999999998 778999999
Q ss_pred CcccccccCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH-------cC
Q 021306 186 GSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV-------LG 258 (314)
Q Consensus 186 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~-------~~ 258 (314)
|++..+........++|++.|.|||.+.+.....+..|+||+|+++|.|+.|..||.+.+-.+.....+.+ ..
T Consensus 200 gfS~~~~~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp~~ms 279 (596)
T KOG0586|consen 200 GFSTFFDYGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIPFYMS 279 (596)
T ss_pred ccceeecccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeecccceee
Confidence 99998887777888999999999999988876789999999999999999999999987755443333322 11
Q ss_pred CCCHHHHh---ccCCCCCCCcccccccCChhhhhccc
Q 021306 259 TPTREEIR---CMNPNYTDFRFPQIKAHPWHKVCIFH 292 (314)
Q Consensus 259 ~~~~~~~~---~~~p~~~~~~~~~l~~~p~~~~~~~~ 292 (314)
......+. -++|. +|.+.+++++|+|...--.+
T Consensus 280 ~dce~lLrk~lvl~Ps-kr~~~dqim~~~W~n~~~~~ 315 (596)
T KOG0586|consen 280 CDCEDLLRKFLVLNPS-KRGPCDQIMKDRWRNDLLEA 315 (596)
T ss_pred chhHHHHHHhhccCcc-ccCCHHHhhhhcccchhhhh
Confidence 11223333 24777 89999999999998766554
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=271.77 Aligned_cols=246 Identities=37% Similarity=0.656 Sum_probs=200.3
Q ss_pred CceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeEE
Q 021306 39 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 112 (314)
Q Consensus 39 ~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 112 (314)
+|++.+.||+|++|.||+|++..+++.+++|.+.... ....+|+.+++.++|+||+++.+++..........++
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 5899999999999999999998889999999886532 2345799999999999999999987655433334578
Q ss_pred EEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcccccc
Q 021306 113 LVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 192 (314)
Q Consensus 113 lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~ 192 (314)
+++||+++++.+.+.. ..++++..++.++.||+.||.+||+ +|++|+||+|+||+++. ++.++|+|||.+....
T Consensus 81 lv~e~~~~~l~~~l~~----~~~l~~~~~~~i~~~l~~~l~~LH~-~gi~H~dlkp~nili~~-~~~~~L~dfg~~~~~~ 154 (330)
T cd07834 81 IVTELMETDLHKVIKS----PQPLTDDHIQYFLYQILRGLKYLHS-ANVIHRDLKPSNILVNS-NCDLKICDFGLARGVD 154 (330)
T ss_pred EEecchhhhHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcC-CCCEEEcccCceEeec
Confidence 9999999877666543 4589999999999999999999999 89999999999999998 7899999999998665
Q ss_pred cCC----ccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCHH-----
Q 021306 193 AGE----ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE----- 263 (314)
Q Consensus 193 ~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~----- 263 (314)
... ......++..|+|||.+.+...++.++|+||||+++|+|++|+.||.+.+..+.+..++...+.+...
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 234 (330)
T cd07834 155 PDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFI 234 (330)
T ss_pred ccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhc
Confidence 432 12234567889999999776468999999999999999999999999988777777666654433221
Q ss_pred ---------------------------------HHh---ccCCCCCCCcccccccCChhhhhcc
Q 021306 264 ---------------------------------EIR---CMNPNYTDFRFPQIKAHPWHKVCIF 291 (314)
Q Consensus 264 ---------------------------------~~~---~~~p~~~~~~~~~l~~~p~~~~~~~ 291 (314)
.+. ..+|+ +|+++.+++.|||++....
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~-~Rpt~~~ll~~~~~~~~~~ 297 (330)
T cd07834 235 TSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPK-KRITADEALAHPYLAQLHD 297 (330)
T ss_pred cccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChh-hCCCHHHHHhCccHHhhcc
Confidence 111 23566 8999999999999976554
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=274.82 Aligned_cols=251 Identities=26% Similarity=0.393 Sum_probs=199.3
Q ss_pred CCCccCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecC
Q 021306 32 GEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTT 104 (314)
Q Consensus 32 ~~~~~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 104 (314)
..|...+.|+..++||+|+||.|+-++.+.||+.||+|++.+.+ ....+|..+|.+...++||.+--.|...+
T Consensus 179 ~qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd 258 (591)
T KOG0986|consen 179 LQPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKD 258 (591)
T ss_pred hhhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCC
Confidence 35777788999999999999999999999999999999885443 22247899999999999999866663333
Q ss_pred CCCceeEEEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEee
Q 021306 105 SKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICD 184 (314)
Q Consensus 105 ~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~d 184 (314)
.+++|+..|.|+-+.. .-+...+..|++..++.++.+|+.||.+||+ ++||+||+||+|||+|+ .++++|+|
T Consensus 259 -----~LClVLtlMNGGDLkf-Hiyn~g~~gF~e~ra~FYAAEi~cGLehlH~-~~iVYRDLKPeNILLDd-~GhvRISD 330 (591)
T KOG0986|consen 259 -----ALCLVLTLMNGGDLKF-HIYNHGNPGFDEQRARFYAAEIICGLEHLHR-RRIVYRDLKPENILLDD-HGHVRISD 330 (591)
T ss_pred -----ceEEEEEeecCCceeE-EeeccCCCCCchHHHHHHHHHHHhhHHHHHh-cceeeccCChhheeecc-CCCeEeec
Confidence 3999999999863322 2223334579999999999999999999999 89999999999999998 89999999
Q ss_pred cCcccccccCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCH--
Q 021306 185 FGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR-- 262 (314)
Q Consensus 185 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~-- 262 (314)
+|+|..+..........||.+|||||++.+.. |+...|+|||||++|+|+.|+.||..-.......++-+.....+.
T Consensus 331 LGLAvei~~g~~~~~rvGT~GYMAPEvl~ne~-Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey 409 (591)
T KOG0986|consen 331 LGLAVEIPEGKPIRGRVGTVGYMAPEVLQNEV-YDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEY 409 (591)
T ss_pred cceEEecCCCCccccccCcccccCHHHHcCCc-ccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhc
Confidence 99999888887777789999999999997666 999999999999999999999999765444333333333222111
Q ss_pred ---------H---HHhccCCCCCC-----CcccccccCChhhhhccc
Q 021306 263 ---------E---EIRCMNPNYTD-----FRFPQIKAHPWHKVCIFH 292 (314)
Q Consensus 263 ---------~---~~~~~~p~~~~-----~~~~~l~~~p~~~~~~~~ 292 (314)
+ .+...+|. +| -..+++..||+|+.-+.+
T Consensus 410 ~~kFS~eakslc~~LL~Kdp~-~RLGcrg~ga~evk~HpfFk~lnw~ 455 (591)
T KOG0986|consen 410 SDKFSEEAKSLCEGLLTKDPE-KRLGCRGEGAQEVKEHPFFKDLNWR 455 (591)
T ss_pred ccccCHHHHHHHHHHHccCHH-HhccCCCcCcchhhhCcccccCCHh
Confidence 1 12233555 33 367799999999876654
|
|
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=263.76 Aligned_cols=207 Identities=40% Similarity=0.750 Sum_probs=173.1
Q ss_pred CCceeeeeEeecCceEEEEEEECCCCcEEEEEEeecc------ccchHHHHHHHHhCCCCceeeeceeeeecCCCCceeE
Q 021306 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 111 (314)
Q Consensus 38 ~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 111 (314)
++|++.+.||+|++|.||+|.+..+++.|++|.++.. .....+|+.++++++|+||+++++++... ...
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~ 75 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRK-----GRL 75 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEEC-----CEE
Confidence 4799999999999999999999999999999987542 12345899999999999999999998543 348
Q ss_pred EEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCccccc
Q 021306 112 NLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 191 (314)
Q Consensus 112 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~ 191 (314)
++++||++++++..+.. ....+++.+++.++.|++.|+.+||+ .+++|+||+|+||+++. ++.++|+|||.+...
T Consensus 76 ~iv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~H~dl~~~ni~~~~-~~~~kl~d~g~~~~~ 150 (288)
T cd07833 76 YLVFEYVERTLLELLEA---SPGGLPPDAVRSYIWQLLQAIAYCHS-HNIIHRDIKPENILVSE-SGVLKLCDFGFARAL 150 (288)
T ss_pred EEEEecCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEECC-CCCEEEEeeeccccc
Confidence 89999999987665543 34668999999999999999999999 89999999999999998 889999999998765
Q ss_pred ccCC--ccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 021306 192 IAGE--ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 254 (314)
Q Consensus 192 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~ 254 (314)
.... ......++..|+|||.+.+...++.++|+||||+++|+|++|+.||.+....+.+..+.
T Consensus 151 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~ 215 (288)
T cd07833 151 RARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQ 215 (288)
T ss_pred CCCccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 4433 22335567889999999776458899999999999999999999998776655544433
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=272.91 Aligned_cols=247 Identities=34% Similarity=0.635 Sum_probs=194.0
Q ss_pred CCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCCcee
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 110 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 110 (314)
.++|++.+.||.|++|.||++.++.+++.|++|.+.... ....+|+.++++++|+||+++++++.... .....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~~ 82 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPG-ADFKD 82 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccC-CCCce
Confidence 368999999999999999999999999999999886532 22347899999999999999998765433 33446
Q ss_pred EEEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcccc
Q 021306 111 LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 190 (314)
Q Consensus 111 ~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~ 190 (314)
.++|+||+.+++.+.+. ....+++..++.++.|++.||.|||+ +|++|+||+|+||+++. ++.++|+|||.+..
T Consensus 83 ~~lv~e~~~~~l~~~~~----~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~dlkp~Nil~~~-~~~~kl~dfg~~~~ 156 (334)
T cd07855 83 VYVVMDLMESDLHHIIH----SDQPLTEEHIRYFLYQLLRGLKYIHS-ANVIHRDLKPSNLLVNE-DCELRIGDFGMARG 156 (334)
T ss_pred EEEEEehhhhhHHHHhc----cCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEEcC-CCcEEeccccccee
Confidence 78999999987766654 34669999999999999999999999 89999999999999998 88999999999865
Q ss_pred cccCCcc-----ccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCH---
Q 021306 191 LIAGEAN-----ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR--- 262 (314)
Q Consensus 191 ~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~--- 262 (314)
....... ....++..|+|||.+.+...++.++|+||||+++|+|++|+.||.+.+....+..+....+.++.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~ 236 (334)
T cd07855 157 LSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVL 236 (334)
T ss_pred ecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhh
Confidence 4332211 12456788999999866555789999999999999999999999887765554444433222211
Q ss_pred -----------------------------------HHHh---ccCCCCCCCcccccccCChhhhhcc
Q 021306 263 -----------------------------------EEIR---CMNPNYTDFRFPQIKAHPWHKVCIF 291 (314)
Q Consensus 263 -----------------------------------~~~~---~~~p~~~~~~~~~l~~~p~~~~~~~ 291 (314)
+.+. ..+|. +|+++.+++.|||+.....
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~-~Rpt~~~~l~~~~~~~~~~ 302 (334)
T cd07855 237 NRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPE-ERITVEQALQHPFLAQYHD 302 (334)
T ss_pred hhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChh-hCcCHHHHHhChhhhhccC
Confidence 1111 23566 8999999999999865443
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=283.99 Aligned_cols=241 Identities=25% Similarity=0.414 Sum_probs=194.4
Q ss_pred ceeeeeEeecCceEEEEEEECCCCcEEEEEEeec------cc--cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeE
Q 021306 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQ------DR--RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 111 (314)
Q Consensus 40 y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~------~~--~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 111 (314)
.+..++||+|+|.+||+|.+..+|..||.-.++. .. ..+..|+.+|+.|+|+||++++.+|.+... ..+
T Consensus 42 ~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n---~~i 118 (632)
T KOG0584|consen 42 LKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDN---KTI 118 (632)
T ss_pred eehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCC---cee
Confidence 3567899999999999999999999998765532 22 455689999999999999999999977654 346
Q ss_pred EEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcC-CCceecCCCCCcEEEcCCCCcEEEeecCcccc
Q 021306 112 NLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV-PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 190 (314)
Q Consensus 112 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~-~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~ 190 (314)
-+|+|.+..+ .|..|....+.++...++.|++||++||.|||+. ..|+|||||.+|||++...+.|||+|+|+|..
T Consensus 119 n~iTEL~TSG---tLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl 195 (632)
T KOG0584|consen 119 NFITELFTSG---TLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATL 195 (632)
T ss_pred eeeeecccCC---cHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHH
Confidence 7899999965 3344445568899999999999999999999982 46999999999999998889999999999986
Q ss_pred cccCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHHHHcCCCCH-------
Q 021306 191 LIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE-NAVDQLVEIIKVLGTPTR------- 262 (314)
Q Consensus 191 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~-~~~~~~~~i~~~~~~~~~------- 262 (314)
...... ....|||.|||||... ..|+...||||||+++.||+|+..||..- ++.+.+.+++.+.++...
T Consensus 196 ~r~s~a-ksvIGTPEFMAPEmYE--E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~dPe 272 (632)
T KOG0584|consen 196 LRKSHA-KSVIGTPEFMAPEMYE--ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKDPE 272 (632)
T ss_pred hhcccc-ceeccCccccChHHHh--hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCCHH
Confidence 544333 3478999999999984 34999999999999999999999999764 555666666665444321
Q ss_pred --HHHh-ccCCCCCCCcccccccCChhhhh
Q 021306 263 --EEIR-CMNPNYTDFRFPQIKAHPWHKVC 289 (314)
Q Consensus 263 --~~~~-~~~p~~~~~~~~~l~~~p~~~~~ 289 (314)
+.+. |+-+.-.|+++.+|++|||++..
T Consensus 273 vr~fIekCl~~~~~R~sa~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 273 VREFIEKCLATKSERLSAKELLKDPFFDED 302 (632)
T ss_pred HHHHHHHHhcCchhccCHHHHhhChhhccc
Confidence 2222 45455589999999999999886
|
|
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=264.74 Aligned_cols=258 Identities=26% Similarity=0.409 Sum_probs=191.5
Q ss_pred CCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeEE
Q 021306 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 112 (314)
Q Consensus 38 ~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 112 (314)
++|++.+.||+|++|.||++++..+++.+++|.+.... ....+|+.++++++|+||+++++.+.. ...++
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~~~ 75 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFI-----EGAVY 75 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheec-----CCeEE
Confidence 47999999999999999999999899999999886432 234578999999999999999998743 33488
Q ss_pred EEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcccccc
Q 021306 113 LVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 192 (314)
Q Consensus 113 lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~ 192 (314)
+++||++++.+..+.........+++..+..++.|++.||.|||+..+++|+||+|+||+++. ++.++|+|||.+....
T Consensus 76 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~-~~~~~l~dfg~~~~~~ 154 (286)
T cd06622 76 MCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNG-NGQVKLCDFGVSGNLV 154 (286)
T ss_pred EEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECC-CCCEEEeecCCccccc
Confidence 999999974333333211123479999999999999999999996259999999999999998 8889999999987543
Q ss_pred cCCccccccccccccccccccCCC-----CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH---HHHcCCCC---
Q 021306 193 AGEANISYICSRFYRAPELIFGAT-----EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEI---IKVLGTPT--- 261 (314)
Q Consensus 193 ~~~~~~~~~~~~~y~aPE~~~~~~-----~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i---~~~~~~~~--- 261 (314)
.. ......+++.|+|||.+.+.. .++.++|+||||+++|+|++|+.||...........+ ........
T Consensus 155 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (286)
T cd06622 155 AS-LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSG 233 (286)
T ss_pred CC-ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCcc
Confidence 22 222345677899999985432 2478999999999999999999999776554433322 22111111
Q ss_pred -----HHHHh---ccCCCCCCCcccccccCChhhhhcccC--ChHHHHHhcc
Q 021306 262 -----REEIR---CMNPNYTDFRFPQIKAHPWHKVCIFHF--PKHWLLEYGS 303 (314)
Q Consensus 262 -----~~~~~---~~~p~~~~~~~~~l~~~p~~~~~~~~~--~~~~~~~~~~ 303 (314)
.+.+. ..+|+ +|+++.+++.|||+....... ...++.+.++
T Consensus 234 ~~~~~~~li~~~l~~~p~-~Rp~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (286)
T cd06622 234 YSDDAQDFVAKCLNKIPN-RRPTYAQLLEHPWLVKYKNADVDMAEWVTGALK 284 (286)
T ss_pred cCHHHHHHHHHHcccCcc-cCCCHHHHhcChhhhhccCCccchHHHHHHHHh
Confidence 11112 23677 899999999999987665432 2335554443
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=258.55 Aligned_cols=238 Identities=31% Similarity=0.472 Sum_probs=190.8
Q ss_pred CceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeEE
Q 021306 39 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 112 (314)
Q Consensus 39 ~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 112 (314)
+|++.+.||+|++|.||++.+..+++.+++|.+.... ....+|+.++++++|+|++++++.+.. ....+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~~~ 75 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLE-----DKALM 75 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEec-----CCEEE
Confidence 5999999999999999999999999999999886432 234578999999999999999988743 33488
Q ss_pred EEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCccccc
Q 021306 113 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 191 (314)
Q Consensus 113 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~ 191 (314)
+|+||+++ +|.+.+... ....+++..++.++.|++.++.+||+ +|++|+||+|+||+++..+..++|+|||.+...
T Consensus 76 lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lh~-~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~ 152 (256)
T cd08220 76 IVMEYAPGGTLAEYIQKR--CNSLLDEDTILHFFVQILLALHHVHT-KLILHRDLKTQNILLDKHKMVVKIGDFGISKIL 152 (256)
T ss_pred EEEecCCCCCHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcCCCCEEEEccCCCceec
Confidence 99999986 666666532 24568999999999999999999999 899999999999999875667899999998866
Q ss_pred ccCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCH--------H
Q 021306 192 IAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR--------E 263 (314)
Q Consensus 192 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~--------~ 263 (314)
..........++..|+|||.+.+.. ++.++|+||||+++|+|++|+.||...+.......+......+.+ +
T Consensus 153 ~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 231 (256)
T cd08220 153 SSKSKAYTVVGTPCYISPELCEGKP-YNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPDLRQ 231 (256)
T ss_pred CCCccccccccCCcccCchhccCCC-CCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCCCCCCcCHHHHH
Confidence 5444444456788899999986544 788999999999999999999999888776666555543322211 1
Q ss_pred HHh-cc--CCCCCCCcccccccCChh
Q 021306 264 EIR-CM--NPNYTDFRFPQIKAHPWH 286 (314)
Q Consensus 264 ~~~-~~--~p~~~~~~~~~l~~~p~~ 286 (314)
.+. ++ +|+ +|+++.++++|||+
T Consensus 232 li~~~l~~~p~-~Rpt~~~ll~~p~~ 256 (256)
T cd08220 232 LILSMLNLDPS-KRPQLSQIMAQPIC 256 (256)
T ss_pred HHHHHccCChh-hCCCHHHHhhCCCC
Confidence 111 23 566 79999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=263.35 Aligned_cols=240 Identities=26% Similarity=0.417 Sum_probs=186.1
Q ss_pred CCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeEE
Q 021306 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 112 (314)
Q Consensus 38 ~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 112 (314)
++|++.+.||+|++|.||+|++..+++.+++|.+..+. ....+|+.++++++||||+++++.+.... ..+
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~~ 75 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVEN-----RIS 75 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECC-----EEE
Confidence 36899999999999999999999999999999886542 22347899999999999999999885433 377
Q ss_pred EEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcccccc
Q 021306 113 LVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 192 (314)
Q Consensus 113 lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~ 192 (314)
+++||++++.+... ..+++..+..++.|++.|+.|||+ .|++|+||+|+||+++. ++.++|+|||++....
T Consensus 76 lv~e~~~~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nill~~-~~~~~l~dfg~~~~~~ 146 (279)
T cd06619 76 ICTEFMDGGSLDVY-------RKIPEHVLGRIAVAVVKGLTYLWS-LKILHRDVKPSNMLVNT-RGQVKLCDFGVSTQLV 146 (279)
T ss_pred EEEecCCCCChHHh-------hcCCHHHHHHHHHHHHHHHHHHHH-CCEeeCCCCHHHEEECC-CCCEEEeeCCcceecc
Confidence 99999998644322 357889999999999999999999 89999999999999998 8899999999987543
Q ss_pred cCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChH-------HHHHHHHHHcCC------
Q 021306 193 AGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV-------DQLVEIIKVLGT------ 259 (314)
Q Consensus 193 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~-------~~~~~i~~~~~~------ 259 (314)
.. ......++..|+|||.+.+.. ++.++|+||||+++|+|++|+.||...... .....+......
T Consensus 147 ~~-~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (279)
T cd06619 147 NS-IAKTYVGTNAYMAPERISGEQ-YGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQ 224 (279)
T ss_pred cc-cccCCCCChhhcCceeecCCC-CCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCc
Confidence 32 223356788999999996654 889999999999999999999999653221 111111111101
Q ss_pred CCH---HHHh---ccCCCCCCCcccccccCChhhhhcccCC
Q 021306 260 PTR---EEIR---CMNPNYTDFRFPQIKAHPWHKVCIFHFP 294 (314)
Q Consensus 260 ~~~---~~~~---~~~p~~~~~~~~~l~~~p~~~~~~~~~~ 294 (314)
... +.+. ..+|. +|+++++++.|||++.......
T Consensus 225 ~~~~~~~li~~~l~~~P~-~Rp~~~eil~~~~~~~~~~~~~ 264 (279)
T cd06619 225 FSEKFVHFITQCMRKQPK-ERPAPENLMDHPFIVQYNDGNA 264 (279)
T ss_pred CCHHHHHHHHHHhhCChh-hCCCHHHHhcCcccccccCccH
Confidence 011 1121 23677 8999999999999988765543
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=260.34 Aligned_cols=249 Identities=27% Similarity=0.396 Sum_probs=195.3
Q ss_pred cCCCceeee-eEeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHH-HhCCCCceeeeceeeeecCCCCceeEEE
Q 021306 36 QTISYMAER-VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLM-RVMDHPNVISLKHCFFSTTSKNELFLNL 113 (314)
Q Consensus 36 ~~~~y~~~~-~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~~~~~~e~~~l-~~l~h~~iv~~~~~~~~~~~~~~~~~~l 113 (314)
..++|++.. +||-|-.|.|..+.++.+|+.+|+|.+.. ....++|+++- +.-.|+|||.++++|...- ++..++.+
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D-s~KARrEVeLHw~~s~h~~iV~IidVyeNs~-~~rkcLLi 136 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD-SPKARREVELHWMASGHPHIVSIIDVYENSY-QGRKCLLI 136 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc-CHHHHhHhhhhhhhcCCCceEEeehhhhhhc-cCceeeEe
Confidence 456787764 78999999999999999999999996654 44456777763 3348999999999874332 44566889
Q ss_pred Eeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcC--CCCcEEEeecCcccc
Q 021306 114 VMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP--LTHQVKICDFGSAKQ 190 (314)
Q Consensus 114 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~--~~~~~~l~dfg~~~~ 190 (314)
|||.++| .|.+.++.. ....|++.++..|++||+.|+.|||+ .+|.||||||+|+|... .+..+||+|||+|+.
T Consensus 137 VmE~meGGeLfsriq~~--g~~afTErea~eI~~qI~~Av~~lH~-~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~ 213 (400)
T KOG0604|consen 137 VMECMEGGELFSRIQDR--GDQAFTEREASEIMKQIGLAVRYLHS-MNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKE 213 (400)
T ss_pred eeecccchHHHHHHHHc--ccccchHHHHHHHHHHHHHHHHHHHh-cchhhccCChhheeeecCCCCcceEecccccccc
Confidence 9999997 566655542 34679999999999999999999999 89999999999999965 245799999999998
Q ss_pred cccCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChH----HHHHHHHHHcCCCCHH---
Q 021306 191 LIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV----DQLVEIIKVLGTPTRE--- 263 (314)
Q Consensus 191 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~----~~~~~i~~~~~~~~~~--- 263 (314)
........+.+.||.|.|||++ +..++....|+||+|+++|-|++|-+||.+.... .+..+|..+.-..+.+
T Consensus 214 t~~~~~L~TPc~TPyYvaPevl-g~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~pEWs 292 (400)
T KOG0604|consen 214 TQEPGDLMTPCFTPYYVAPEVL-GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEPEWS 292 (400)
T ss_pred cCCCccccCCcccccccCHHHh-CchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCChhHh
Confidence 7665666677889999999998 5566999999999999999999999999876542 3334444332222222
Q ss_pred --------HHh---ccCCCCCCCcccccccCChhhhhcc
Q 021306 264 --------EIR---CMNPNYTDFRFPQIKAHPWHKVCIF 291 (314)
Q Consensus 264 --------~~~---~~~p~~~~~~~~~l~~~p~~~~~~~ 291 (314)
.++ ..+|. .|+++++++.|||......
T Consensus 293 ~VSe~aKdlIR~LLkt~Pt-eRlTI~~~m~hpwi~~~~~ 330 (400)
T KOG0604|consen 293 CVSEAAKDLIRKLLKTEPT-ERLTIEEVMDHPWINQYEA 330 (400)
T ss_pred HHHHHHHHHHHHHhcCCch-hheeHHHhhcCchhccccc
Confidence 222 33677 8999999999999876553
|
|
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=262.17 Aligned_cols=240 Identities=27% Similarity=0.424 Sum_probs=189.4
Q ss_pred CCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeEE
Q 021306 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 112 (314)
Q Consensus 38 ~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 112 (314)
++|++.+.||.|++|.||+|....++..+++|.+.... ....+|+.+++.++|+|++++++.+... ...+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~ 75 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVG-----DELW 75 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeC-----CEEE
Confidence 47999999999999999999988899999999886432 2345888999999999999999887433 3488
Q ss_pred EEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCccccc
Q 021306 113 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 191 (314)
Q Consensus 113 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~ 191 (314)
+++|++.+ ++.+.+.. ......+++..++.++.|++.|+.+||+ .|++|+||+|+||++++ ++.++|+|||.+...
T Consensus 76 iv~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~~~ql~~al~~lh~-~~i~h~~l~p~ni~~~~-~~~~~l~df~~~~~~ 152 (267)
T cd06610 76 LVMPYLSGGSLLDIMKS-SYPRGGLDEAIIATVLKEVLKGLEYLHS-NGQIHRDIKAGNILLGE-DGSVKIADFGVSASL 152 (267)
T ss_pred EEEeccCCCcHHHHHHH-hcccCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHhEEEcC-CCCEEEcccchHHHh
Confidence 99999987 55544433 1123568999999999999999999999 89999999999999998 788999999998755
Q ss_pred ccCCcc-----ccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCC------
Q 021306 192 IAGEAN-----ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP------ 260 (314)
Q Consensus 192 ~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~------ 260 (314)
...... ....++..|+|||.+.....++.++|+||||+++|+|++|+.||...+....+..+.+.....
T Consensus 153 ~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (267)
T cd06610 153 ADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGAD 232 (267)
T ss_pred ccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCccc
Confidence 433222 223567889999998766458899999999999999999999998877665555554432110
Q ss_pred -------CHHHHh---ccCCCCCCCcccccccCChh
Q 021306 261 -------TREEIR---CMNPNYTDFRFPQIKAHPWH 286 (314)
Q Consensus 261 -------~~~~~~---~~~p~~~~~~~~~l~~~p~~ 286 (314)
..+.+. ..+|+ +|+++.+|++|||+
T Consensus 233 ~~~~~~~~~~li~~~l~~~p~-~Rp~~~~ll~~p~~ 267 (267)
T cd06610 233 YKKYSKSFRKMISLCLQKDPS-KRPTAEELLKHKFF 267 (267)
T ss_pred cccccHHHHHHHHHHcCCChh-hCcCHHHHhhCCCC
Confidence 012222 23677 88999999999996
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=267.37 Aligned_cols=197 Identities=30% Similarity=0.513 Sum_probs=164.2
Q ss_pred CCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeEE
Q 021306 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 112 (314)
Q Consensus 38 ~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 112 (314)
++|++.+.||+|+||.||++.+..++..+++|.+..+. ....+|++++++++||||+++++++... ..++
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~ 75 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSD-----GEIS 75 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC-----CEEE
Confidence 47999999999999999999999999999999886442 2245799999999999999999998543 3488
Q ss_pred EEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCccccc
Q 021306 113 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 191 (314)
Q Consensus 113 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~ 191 (314)
+++||+++ +|.+.+.. ...+++..+..++.|++.||.|||+..+++|+||+|+||+++. ++.++|+|||.+...
T Consensus 76 lv~ey~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~-~~~~~l~dfg~~~~~ 150 (308)
T cd06615 76 ICMEHMDGGSLDQVLKK----AGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNS-RGEIKLCDFGVSGQL 150 (308)
T ss_pred EEeeccCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEec-CCcEEEccCCCcccc
Confidence 99999986 55555543 4678999999999999999999997248999999999999998 788999999988654
Q ss_pred ccCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCh
Q 021306 192 IAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA 246 (314)
Q Consensus 192 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~ 246 (314)
... ......+++.|+|||.+.+.. ++.++|+||||+++|+|++|+.||...+.
T Consensus 151 ~~~-~~~~~~~~~~~~aPE~~~~~~-~~~~~DiwslG~~l~~l~~g~~p~~~~~~ 203 (308)
T cd06615 151 IDS-MANSFVGTRSYMSPERLQGTH-YTVQSDIWSLGLSLVEMAIGRYPIPPPDA 203 (308)
T ss_pred ccc-ccccCCCCcCccChhHhcCCC-CCccchHHHHHHHHHHHHhCCCCCCCcch
Confidence 322 223346688899999986544 78999999999999999999999976553
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=260.88 Aligned_cols=239 Identities=27% Similarity=0.463 Sum_probs=185.0
Q ss_pred CCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc---------cchHHHHHHHHhCCCCceeeeceeeeecCCCCc
Q 021306 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 108 (314)
Q Consensus 38 ~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~---------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 108 (314)
++|++.+.||+|++|.||++++..++..|++|.+.... ....+|+.+++++.|+||+++++++.... .
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~---~ 78 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPM---E 78 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCC---C
Confidence 47999999999999999999999999999999875321 13356899999999999999999874322 2
Q ss_pred eeEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCc
Q 021306 109 LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 187 (314)
Q Consensus 109 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~ 187 (314)
..+++++||+++ +|.+.+. ....+++..+..++.|++.||.+||+ ++++|+||+|+||+++. ++.++|+|||.
T Consensus 79 ~~~~~v~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~~l~~~l~~lH~-~~i~H~dl~p~nil~~~-~~~~~l~Dfg~ 152 (265)
T cd06652 79 RTLSIFMEHMPGGSIKDQLK----SYGALTENVTRKYTRQILEGVSYLHS-NMIVHRDIKGANILRDS-VGNVKLGDFGA 152 (265)
T ss_pred ceEEEEEEecCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEecC-CCCEEECcCcc
Confidence 347799999986 5555544 23568999999999999999999999 89999999999999998 88999999998
Q ss_pred ccccccCC----ccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCC-H
Q 021306 188 AKQLIAGE----ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT-R 262 (314)
Q Consensus 188 ~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~-~ 262 (314)
+....... ......++..|+|||.+.+.. ++.++|+||||+++|+|++|+.||...........+......+. +
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 231 (265)
T cd06652 153 SKRLQTICLSGTGMKSVTGTPYWMSPEVISGEG-YGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLP 231 (265)
T ss_pred ccccccccccccccccCCCCccccChhhhcCCC-CCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCCCc
Confidence 87543211 112234677899999986644 78999999999999999999999987765555444332211110 1
Q ss_pred --------HHHh--ccCCCCCCCcccccccCChhh
Q 021306 263 --------EEIR--CMNPNYTDFRFPQIKAHPWHK 287 (314)
Q Consensus 263 --------~~~~--~~~p~~~~~~~~~l~~~p~~~ 287 (314)
+.+. ...|. .|+++++|++|||.+
T Consensus 232 ~~~~~~~~~~i~~~l~~p~-~Rp~~~~il~~~~~~ 265 (265)
T cd06652 232 PHVSDHCRDFLKRIFVEAK-LRPSADELLRHTFVH 265 (265)
T ss_pred hhhCHHHHHHHHHHhcChh-hCCCHHHHhcCcccC
Confidence 1111 12565 799999999999974
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=261.40 Aligned_cols=245 Identities=25% Similarity=0.425 Sum_probs=188.5
Q ss_pred CCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHhC-CCCceeeeceeeeecCCCC-ceeE
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVM-DHPNVISLKHCFFSTTSKN-ELFL 111 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~---~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~-~~~~ 111 (314)
.+.|++.+.||+|+||.||+|....+++.+++|.+.... .....|+.+++++ +|+|++++.+++....... ...+
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 84 (272)
T cd06637 5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQL 84 (272)
T ss_pred hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEE
Confidence 457999999999999999999999999999999986542 2345788888888 6999999999886543322 3457
Q ss_pred EEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcccc
Q 021306 112 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 190 (314)
Q Consensus 112 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~ 190 (314)
++++||+++ +|.+.+.. .....+++..++.++.|++.|+.|||+ ++++|+||+|+||+++. ++.++|+|||++..
T Consensus 85 ~iv~e~~~~~~L~~~l~~--~~~~~l~~~~~~~~~~qi~~~l~~LH~-~~ivh~dl~~~nili~~-~~~~~l~Dfg~~~~ 160 (272)
T cd06637 85 WLVMEFCGAGSVTDLIKN--TKGNTLKEEWIAYICREILRGLSHLHQ-HKVIHRDIKGQNVLLTE-NAEVKLVDFGVSAQ 160 (272)
T ss_pred EEEEEcCCCCcHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHHH-CCCccCCCCHHHEEECC-CCCEEEccCCCcee
Confidence 899999986 56555543 124578999999999999999999999 89999999999999998 78899999999875
Q ss_pred cccC-CccccccccccccccccccC----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCC-----
Q 021306 191 LIAG-EANISYICSRFYRAPELIFG----ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP----- 260 (314)
Q Consensus 191 ~~~~-~~~~~~~~~~~y~aPE~~~~----~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~----- 260 (314)
.... .......+++.|+|||.+.+ ...++.++|+||||+++|+|++|..||...........+.......
T Consensus 161 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (272)
T cd06637 161 LDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKK 240 (272)
T ss_pred cccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCCCCCCCC
Confidence 4322 12233457888999999853 2236789999999999999999999998776655444443321111
Q ss_pred ----CHHHHh-cc--CCCCCCCcccccccCChh
Q 021306 261 ----TREEIR-CM--NPNYTDFRFPQIKAHPWH 286 (314)
Q Consensus 261 ----~~~~~~-~~--~p~~~~~~~~~l~~~p~~ 286 (314)
..+.+. ++ +|. +|+++.+++.|||+
T Consensus 241 ~~~~~~~li~~~l~~~p~-~Rpt~~~il~~~~~ 272 (272)
T cd06637 241 WSKKFQSFIESCLVKNHS-QRPTTEQLMKHPFI 272 (272)
T ss_pred cCHHHHHHHHHHcCCChh-hCCCHHHHhhCCCC
Confidence 011122 22 566 89999999999996
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=262.87 Aligned_cols=240 Identities=25% Similarity=0.432 Sum_probs=189.9
Q ss_pred CCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeEE
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 112 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 112 (314)
..+|++.+.||.|++|.||++.+..+++.+++|.+.... ....+|..+++.++|+|++++++.+... ..++
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~ 92 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVG-----DELF 92 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecC-----ceEE
Confidence 357999999999999999999999999999999886432 2335788999999999999999988433 3488
Q ss_pred EEeeccccc-HHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCccccc
Q 021306 113 LVMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 191 (314)
Q Consensus 113 lv~e~~~~~-l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~ 191 (314)
+++||+.++ |...+. ...+++.++..++.|++.|+.+||+ .|++|+||+|+||+++. ++.++|+|||++...
T Consensus 93 lv~e~~~~~~L~~~~~-----~~~l~~~~~~~i~~~l~~al~~LH~-~~i~H~dL~p~Nili~~-~~~~kl~dfg~~~~~ 165 (296)
T cd06655 93 VVMEYLAGGSLTDVVT-----ETCMDEAQIAAVCRECLQALEFLHA-NQVIHRDIKSDNVLLGM-DGSVKLTDFGFCAQI 165 (296)
T ss_pred EEEEecCCCcHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECC-CCCEEEccCccchhc
Confidence 999999874 444333 3568999999999999999999999 89999999999999998 788999999988754
Q ss_pred ccCCc-cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCC----------
Q 021306 192 IAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP---------- 260 (314)
Q Consensus 192 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~---------- 260 (314)
..... .....++..|+|||.+.+.. ++.++|+||||+++|+|++|+.||...+.......+.......
T Consensus 166 ~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (296)
T cd06655 166 TPEQSKRSTMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPI 244 (296)
T ss_pred ccccccCCCcCCCccccCcchhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHH
Confidence 33222 22345678899999986544 7899999999999999999999998887765555444321111
Q ss_pred CHHHHh---ccCCCCCCCcccccccCChhhhhc
Q 021306 261 TREEIR---CMNPNYTDFRFPQIKAHPWHKVCI 290 (314)
Q Consensus 261 ~~~~~~---~~~p~~~~~~~~~l~~~p~~~~~~ 290 (314)
..+.+. ..+|. +|+++.+|+.|||++...
T Consensus 245 ~~~li~~~l~~dp~-~Rpt~~~il~~~~~~~~~ 276 (296)
T cd06655 245 FRDFLNRCLEMDVE-KRGSAKELLQHPFLKLAK 276 (296)
T ss_pred HHHHHHHHhhcChh-hCCCHHHHhhChHhhhcc
Confidence 111222 23676 799999999999998644
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=266.36 Aligned_cols=257 Identities=20% Similarity=0.287 Sum_probs=188.6
Q ss_pred CCceeeeeEeecCceEEEEEEECC----------------CCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeee
Q 021306 38 ISYMAERVVGTGSFGIVFQAKCLE----------------TGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISL 96 (314)
Q Consensus 38 ~~y~~~~~Lg~g~~g~Vy~~~~~~----------------~~~~~~vK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~ 96 (314)
++|++.+.||+|+||.||+|.+.. ++..||+|.+.... ....+|+.++++++|+||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 579999999999999999998532 34579999886532 234579999999999999999
Q ss_pred ceeeeecCCCCceeEEEEeecccc-cHHHHHHhhhh---------------cCCCCCHHHHHHHHHHHHHHHHHhhcCCC
Q 021306 97 KHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSS---------------ANQRMPLIYVKLYTYQIFRGLAYIHTVPR 160 (314)
Q Consensus 97 ~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~---------------~~~~l~~~~~~~i~~ql~~~l~~LH~~~~ 160 (314)
++++.... ..+++|||+.+ +|.+.+..... ....+++.+++.++.||+.||.|||+ .|
T Consensus 85 ~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~-~~ 158 (304)
T cd05096 85 LGVCVDED-----PLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS-LN 158 (304)
T ss_pred EEEEecCC-----ceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH-CC
Confidence 99885433 37899999986 66665543211 11347888999999999999999999 89
Q ss_pred ceecCCCCCcEEEcCCCCcEEEeecCcccccccCCc---cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-
Q 021306 161 VCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL- 236 (314)
Q Consensus 161 i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~t- 236 (314)
|+|+||||+||+++. ++.++|+|||++........ .....++..|+|||.+.+.. ++.++||||||+++|+|++
T Consensus 159 ivH~dlkp~Nill~~-~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~el~~~ 236 (304)
T cd05096 159 FVHRDLATRNCLVGE-NLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGK-FTTASDVWAFGVTLWEILML 236 (304)
T ss_pred ccccCcchhheEEcC-CccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCC-CCchhhhHHHHHHHHHHHHc
Confidence 999999999999998 78899999999875433221 11223467799999986554 8999999999999999986
Q ss_pred -CCCCCCCCChHHHHHHHHHHcCCCCHHHHhccCCCCCCCcccccccCChhhhhcccCChHHHHHhcc
Q 021306 237 -GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGS 303 (314)
Q Consensus 237 -g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~ 303 (314)
+..||.+.+..+.+..+.+............ .|......+.+++..||...+..+++...+...++
T Consensus 237 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 237 CKEQPYGELTDEQVIENAGEFFRDQGRQVYLF-RPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred cCCCCCCcCCHHHHHHHHHHHhhhcccccccc-CCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 6688988776665554443221111111111 11112335677888888888888877777766543
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=262.24 Aligned_cols=210 Identities=33% Similarity=0.654 Sum_probs=174.1
Q ss_pred ceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeEEE
Q 021306 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 113 (314)
Q Consensus 40 y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 113 (314)
|++.+.||+|++|.||+|.+..+++.+++|.+.... ....+|+.++++++|+|++++++.+.... ....++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---~~~~~l 77 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKG---KGSIYM 77 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCC---CCcEEE
Confidence 789999999999999999999899999999997552 22357899999999999999999875431 235889
Q ss_pred EeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCccccccc
Q 021306 114 VMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA 193 (314)
Q Consensus 114 v~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~~ 193 (314)
++||+++++.+.+.. ....+++.+++.++.|++.|+.+||+ .|++|+||+|+||+++. ++.++|+|||.+.....
T Consensus 78 v~e~~~~~l~~~~~~---~~~~~~~~~~~~i~~~i~~al~~LH~-~~~~h~dl~p~nil~~~-~~~~~l~d~g~~~~~~~ 152 (287)
T cd07840 78 VFEYMDHDLTGLLDS---PEVKFTESQIKCYMKQLLEGLQYLHS-NGILHRDIKGSNILINN-DGVLKLADFGLARPYTK 152 (287)
T ss_pred EeccccccHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCcHHHeEEcC-CCCEEEccccceeeccC
Confidence 999999887766653 23579999999999999999999999 89999999999999998 88999999999876644
Q ss_pred CCc--cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHc
Q 021306 194 GEA--NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVL 257 (314)
Q Consensus 194 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~ 257 (314)
... .....++..|+|||.+.+...++.++||||||+++|+|++|+.||...+....+..+.+..
T Consensus 153 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~ 218 (287)
T cd07840 153 RNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELC 218 (287)
T ss_pred CCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Confidence 321 2233457789999988665557899999999999999999999998887766666555443
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=264.54 Aligned_cols=242 Identities=23% Similarity=0.380 Sum_probs=190.4
Q ss_pred CCceeeeeEeecCceEEEEEEECCCCcEEEEEEeecccc----chHHHHHHHHhCCCCceeeeceeeeecCCCCceeEEE
Q 021306 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR----YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 113 (314)
Q Consensus 38 ~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~~----~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 113 (314)
++|++.+.||.|++|.||++.+..+++.+++|.+..... ...+|+.++++++|+||+++++.+... ...++
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~l 79 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYE-----NKLWI 79 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecC-----CeEEE
Confidence 579999999999999999999988999999998864322 245789999999999999999988533 34889
Q ss_pred Eeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcccccc
Q 021306 114 VMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 192 (314)
Q Consensus 114 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~ 192 (314)
+|||+++ ++.+.+.. .+..+++..++.++.|++.|+.|||+ +|++|+||+|+||+++. ++.++|+|||.+....
T Consensus 80 v~e~~~~~~L~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lh~-~~i~h~dl~p~nili~~-~~~~~l~d~g~~~~~~ 154 (280)
T cd06611 80 LIEFCDGGALDSIMLE---LERGLTEPQIRYVCRQMLEALNFLHS-HKVIHRDLKAGNILLTL-DGDVKLADFGVSAKNK 154 (280)
T ss_pred EeeccCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCChhhEEECC-CCCEEEccCccchhhc
Confidence 9999997 45444432 24579999999999999999999999 89999999999999998 8899999999876543
Q ss_pred cCC-ccccccccccccccccccC----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCC-------
Q 021306 193 AGE-ANISYICSRFYRAPELIFG----ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP------- 260 (314)
Q Consensus 193 ~~~-~~~~~~~~~~y~aPE~~~~----~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~------- 260 (314)
... ......+++.|+|||.+.. ...++.++|+||||+++|+|++|+.||...+.......+.+.....
T Consensus 155 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (280)
T cd06611 155 STLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKW 234 (280)
T ss_pred ccccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCCcccC
Confidence 222 2223456888999999742 2336779999999999999999999998887666555544332111
Q ss_pred ---CHHHHh---ccCCCCCCCcccccccCChhhhhc
Q 021306 261 ---TREEIR---CMNPNYTDFRFPQIKAHPWHKVCI 290 (314)
Q Consensus 261 ---~~~~~~---~~~p~~~~~~~~~l~~~p~~~~~~ 290 (314)
..+.+. ..+|. .|+++.++++|||++...
T Consensus 235 ~~~~~~li~~~l~~~p~-~Rps~~~il~~~~~~~~~ 269 (280)
T cd06611 235 SSSFNDFLKSCLVKDPD-DRPTAAELLKHPFVSDQS 269 (280)
T ss_pred CHHHHHHHHHHhccChh-hCcCHHHHhcChhhcccc
Confidence 011122 23676 899999999999998764
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=257.40 Aligned_cols=237 Identities=28% Similarity=0.421 Sum_probs=187.9
Q ss_pred CceeeeeEeecCceEEEEEEECCCCcEEEEEEeecc------ccchHHHHHHHHhCCCCceeeeceeeeecCCCCceeEE
Q 021306 39 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 112 (314)
Q Consensus 39 ~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 112 (314)
+|++.+.||+|++|.||++.+..+++.+++|.+... .....+|+.+++.++|+|++++++++.. ....+
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~ 75 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLD-----KGKLN 75 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeecc-----CCEEE
Confidence 488999999999999999999999999999988642 2233578889999999999999998843 33588
Q ss_pred EEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCccccc
Q 021306 113 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 191 (314)
Q Consensus 113 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~ 191 (314)
+++||+++ +|.+.+... ....+++..++.++.|++.||.|||+ .|++|+||+|+||+++. ++.++|+|||.+...
T Consensus 76 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~~l~~al~~lH~-~~i~h~dl~~~nili~~-~~~~~l~df~~~~~~ 151 (256)
T cd08529 76 IVMEYAENGDLHKLLKMQ--RGRPLPEDQVWRFFIQILLGLAHLHS-KKILHRDIKSLNLFLDA-YDNVKIGDLGVAKLL 151 (256)
T ss_pred EEEEeCCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCcceEEEeC-CCCEEEcccccceec
Confidence 99999986 666655532 24679999999999999999999999 89999999999999998 788999999988755
Q ss_pred ccCCc-cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCH--------
Q 021306 192 IAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR-------- 262 (314)
Q Consensus 192 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~-------- 262 (314)
..... .....+++.|+|||.+.+.. ++.++|+||||+++|+|++|+.||...+.......+.+....+..
T Consensus 152 ~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (256)
T cd08529 152 SDNTNFANTIVGTPYYLSPELCEDKP-YNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLA 230 (256)
T ss_pred cCccchhhccccCccccCHHHhcCCC-CCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHH
Confidence 43222 22345678899999986654 789999999999999999999999888766655555544322211
Q ss_pred HHHh-c--cCCCCCCCcccccccCChh
Q 021306 263 EEIR-C--MNPNYTDFRFPQIKAHPWH 286 (314)
Q Consensus 263 ~~~~-~--~~p~~~~~~~~~l~~~p~~ 286 (314)
+.+. + .+|+ +|+++.++++|||.
T Consensus 231 ~~i~~~l~~~p~-~Rp~~~~ll~~~~~ 256 (256)
T cd08529 231 QLIDQCLTKDYR-QRPDTFQLLRNPSL 256 (256)
T ss_pred HHHHHHccCCcc-cCcCHHHHhhCCCC
Confidence 1111 2 2566 78899999999884
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=271.32 Aligned_cols=246 Identities=36% Similarity=0.625 Sum_probs=196.9
Q ss_pred cCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCC-CCc
Q 021306 36 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTS-KNE 108 (314)
Q Consensus 36 ~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~~~ 108 (314)
..++|++.+.||+|++|.||+|++..+++.|++|.+.... ....+|+.++++++|+|++++.+++..... ...
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 4678999999999999999999999999999999876421 223468999999999999999887644332 223
Q ss_pred eeEEEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcc
Q 021306 109 LFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 188 (314)
Q Consensus 109 ~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~ 188 (314)
...++++||++++|.+.+.. .++++..++.++.|++.||.+||+ .|++|+||+|+||+++. ++.++|+|||.+
T Consensus 93 ~~~~lv~e~~~~~L~~~~~~-----~~l~~~~~~~~~~ql~~aL~~LH~-~gi~H~dlkp~Nill~~-~~~~kL~dfg~~ 165 (343)
T cd07851 93 QDVYLVTHLMGADLNNIVKC-----QKLSDDHIQFLVYQILRGLKYIHS-AGIIHRDLKPSNIAVNE-DCELKILDFGLA 165 (343)
T ss_pred ccEEEEEecCCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEECC-CCCEEEcccccc
Confidence 34789999998887776653 679999999999999999999999 89999999999999998 788999999998
Q ss_pred cccccCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCH------
Q 021306 189 KQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR------ 262 (314)
Q Consensus 189 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~------ 262 (314)
...... .....++..|+|||.+.+...++.++||||||+++|+|++|+.||.+....+.+..+++..+.+.+
T Consensus 166 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 243 (343)
T cd07851 166 RHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKI 243 (343)
T ss_pred cccccc--ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhc
Confidence 765332 223456788999999866545789999999999999999999999988877766666554332221
Q ss_pred --------------------------------HHHh-cc--CCCCCCCcccccccCChhhhhcc
Q 021306 263 --------------------------------EEIR-CM--NPNYTDFRFPQIKAHPWHKVCIF 291 (314)
Q Consensus 263 --------------------------------~~~~-~~--~p~~~~~~~~~l~~~p~~~~~~~ 291 (314)
+.+. ++ +|. +|+++.+|+.|||++....
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~-~Rpt~~ell~h~~~~~~~~ 306 (343)
T cd07851 244 SSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPD-KRITAAEALAHPYLAEYHD 306 (343)
T ss_pred cchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChh-hCCCHHHHhcCCCccccCC
Confidence 1122 22 566 8999999999999986554
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=269.72 Aligned_cols=199 Identities=21% Similarity=0.327 Sum_probs=158.4
Q ss_pred eeeeEeec--CceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeEEE
Q 021306 42 AERVVGTG--SFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 113 (314)
Q Consensus 42 ~~~~Lg~g--~~g~Vy~~~~~~~~~~~~vK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 113 (314)
+.++||+| +++.||++.++.+|+.||+|.+..+. ...++|+.+++.++||||+++++++.... ..++
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~-----~~~l 76 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADN-----ELWV 76 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECC-----EEEE
Confidence 57889999 68899999999999999999986532 23457899999999999999999885433 4889
Q ss_pred Eeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcccccc
Q 021306 114 VMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 192 (314)
Q Consensus 114 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~ 192 (314)
|+||+++ ++.+.+... ....+++..++.++.|++.||.|||+ ++++|+||||+||+++. ++.+++.||+......
T Consensus 77 v~e~~~~~~l~~~~~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~-~~iiH~dlkp~Nil~~~-~~~~~l~~~~~~~~~~ 152 (327)
T cd08227 77 VTSFMAYGSAKDLICTH--FMDGMSELAIAYILQGVLKALDYIHH-MGYVHRSVKASHILISV-DGKVYLSGLRSNLSMI 152 (327)
T ss_pred EEeccCCCcHHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCCChhhEEEec-CCcEEEcccchhhccc
Confidence 9999996 555555432 13458999999999999999999999 89999999999999998 7889999998654322
Q ss_pred cCCc--------cccccccccccccccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 021306 193 AGEA--------NISYICSRFYRAPELIFGA-TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQ 249 (314)
Q Consensus 193 ~~~~--------~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~ 249 (314)
.... .....++..|+|||.+.+. ..++.++||||||+++|+|++|+.||........
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~ 218 (327)
T cd08227 153 NHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM 218 (327)
T ss_pred cccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHH
Confidence 1111 1112346679999998653 3478999999999999999999999987654443
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=262.76 Aligned_cols=241 Identities=24% Similarity=0.417 Sum_probs=190.3
Q ss_pred CCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeEE
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 112 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 112 (314)
..+|++.+.||+|++|.||++++..+++.+++|.+.... ....+|+.+++.+.|+|++++++.+... ...+
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~-----~~~~ 93 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVG-----DELW 93 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeC-----CEEE
Confidence 358999999999999999999998999999999886533 2345788999999999999999988543 2488
Q ss_pred EEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCccccc
Q 021306 113 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 191 (314)
Q Consensus 113 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~ 191 (314)
+|+||+++ +|.+.+. +..+++.++..++.|++.||.|||+ .|++|+||+|+||+++. ++.++|+|||.+...
T Consensus 94 lv~e~~~~~~L~~~~~-----~~~~~~~~~~~i~~ql~~aL~~LH~-~gi~H~dLkp~Nill~~-~~~~kl~dfg~~~~~ 166 (296)
T cd06654 94 VVMEYLAGGSLTDVVT-----ETCMDEGQIAAVCRECLQALEFLHS-NQVIHRDIKSDNILLGM-DGSVKLTDFGFCAQI 166 (296)
T ss_pred EeecccCCCCHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEEcC-CCCEEECccccchhc
Confidence 99999986 5555443 3568999999999999999999999 89999999999999988 788999999988754
Q ss_pred ccCCc-cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCC----------
Q 021306 192 IAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP---------- 260 (314)
Q Consensus 192 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~---------- 260 (314)
..... .....+++.|+|||.+.+.. ++.++|+||||+++|+|++|+.||...++......+......+
T Consensus 167 ~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (296)
T cd06654 167 TPEQSKRSTMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAI 245 (296)
T ss_pred cccccccCcccCCccccCHHHHcCCC-CCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHH
Confidence 32221 22345678899999986544 7899999999999999999999998877655544443322111
Q ss_pred CHHHHh-cc--CCCCCCCcccccccCChhhhhcc
Q 021306 261 TREEIR-CM--NPNYTDFRFPQIKAHPWHKVCIF 291 (314)
Q Consensus 261 ~~~~~~-~~--~p~~~~~~~~~l~~~p~~~~~~~ 291 (314)
..+.+. ++ +|. .|+++.+++.|||+.....
T Consensus 246 l~~li~~~l~~~p~-~Rpt~~eil~~~~~~~~~~ 278 (296)
T cd06654 246 FRDFLNRCLDMDVE-KRGSAKELLQHQFLKIAKP 278 (296)
T ss_pred HHHHHHHHCcCCcc-cCcCHHHHhhChhhhccCC
Confidence 011121 33 566 7999999999999987654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=258.58 Aligned_cols=241 Identities=25% Similarity=0.411 Sum_probs=191.1
Q ss_pred CceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeEE
Q 021306 39 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 112 (314)
Q Consensus 39 ~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 112 (314)
+|++.+.||.|++|.||++.+..+++.+++|.+.... ....+|+.++++++|+||+++++++... .....+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---~~~~~~ 77 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDR---SNQTLY 77 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecC---CCCEEE
Confidence 5899999999999999999999999999999886432 2234688999999999999998876532 233478
Q ss_pred EEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhh-----cCCCceecCCCCCcEEEcCCCCcEEEeecC
Q 021306 113 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH-----TVPRVCHRDLKPQNLLVDPLTHQVKICDFG 186 (314)
Q Consensus 113 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH-----~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg 186 (314)
+++||+++ +|.+.+........++++..++.++.||+.||.+|| + .+++|+||+|+||+++. ++.++|+|||
T Consensus 78 ~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~-~~i~h~dl~p~nili~~-~~~~kl~d~g 155 (265)
T cd08217 78 IVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPG-NTVLHRDLKPANIFLDA-NNNVKLGDFG 155 (265)
T ss_pred EEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCcccc-CcceecCCCHHHEEEec-CCCEEEeccc
Confidence 99999986 677777665555678999999999999999999999 8 89999999999999998 7899999999
Q ss_pred cccccccCCc-cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCH---
Q 021306 187 SAKQLIAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR--- 262 (314)
Q Consensus 187 ~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~--- 262 (314)
.+........ .....+++.|+|||.+.+.. ++.++|+||||+++|+|++|+.||...+.......+........+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (265)
T cd08217 156 LAKILGHDSSFAKTYVGTPYYMSPEQLNHMS-YDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIPYRY 234 (265)
T ss_pred ccccccCCcccccccccCCCccChhhhcCCC-CCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCCCCcccc
Confidence 9886644332 33456788899999986544 789999999999999999999999887755444444332221111
Q ss_pred -----HHHh---ccCCCCCCCcccccccCChh
Q 021306 263 -----EEIR---CMNPNYTDFRFPQIKAHPWH 286 (314)
Q Consensus 263 -----~~~~---~~~p~~~~~~~~~l~~~p~~ 286 (314)
+.+. ..+|. .|+++.+|++|||.
T Consensus 235 ~~~~~~l~~~~l~~~p~-~Rp~~~~il~~~~~ 265 (265)
T cd08217 235 SSELNEVIKSMLNVDPD-KRPSTEELLQLPLI 265 (265)
T ss_pred CHHHHHHHHHHccCCcc-cCCCHHHHhhCCCC
Confidence 1111 23566 89999999999984
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=263.05 Aligned_cols=236 Identities=24% Similarity=0.395 Sum_probs=183.9
Q ss_pred CCceeeeeEeecCceEEEEEEECCCCcEEEEEEeecccc----chHHHHHHHHhCCCCceeeeceeeeecCCCCceeEEE
Q 021306 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR----YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 113 (314)
Q Consensus 38 ~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~~----~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 113 (314)
++|++.+.||+|++|.||+|++..+++.+++|.++.... ...+|+.+++.++|+||+++++.+... ..+++
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~-----~~~~l 83 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRR-----DKLWI 83 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeC-----CEEEE
Confidence 579999999999999999999999999999998865432 245788999999999999999987443 34889
Q ss_pred Eeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcccccc
Q 021306 114 VMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 192 (314)
Q Consensus 114 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~ 192 (314)
++||+++ +|.+.+. ..+.+++.+++.++.|++.|+.|||+ .|++|+||+|+||+++. ++.++|+|||.+....
T Consensus 84 v~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~nili~~-~~~~~l~dfg~~~~~~ 157 (267)
T cd06645 84 CMEFCGGGSLQDIYH----VTGPLSESQIAYVSRETLQGLYYLHS-KGKMHRDIKGANILLTD-NGHVKLADFGVSAQIT 157 (267)
T ss_pred EEeccCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEECC-CCCEEECcceeeeEcc
Confidence 9999997 5555443 35689999999999999999999999 89999999999999997 7889999999986543
Q ss_pred cCC-ccccccccccccccccccC--CCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCC--------
Q 021306 193 AGE-ANISYICSRFYRAPELIFG--ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT-------- 261 (314)
Q Consensus 193 ~~~-~~~~~~~~~~y~aPE~~~~--~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~-------- 261 (314)
... ......++..|+|||.+.. ...++.++|+||||+++|+|++|..||....+.............+.
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (267)
T cd06645 158 ATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKW 237 (267)
T ss_pred CcccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCC
Confidence 221 1233467889999998742 23378899999999999999999999977665444433322211110
Q ss_pred ----HHHHh---ccCCCCCCCcccccccCCh
Q 021306 262 ----REEIR---CMNPNYTDFRFPQIKAHPW 285 (314)
Q Consensus 262 ----~~~~~---~~~p~~~~~~~~~l~~~p~ 285 (314)
.+.+. ..+|+ +|+++.+|+.|||
T Consensus 238 ~~~~~~li~~~l~~~P~-~R~~~~~ll~~~~ 267 (267)
T cd06645 238 SNSFHHFVKMALTKNPK-KRPTAEKLLQHPF 267 (267)
T ss_pred CHHHHHHHHHHccCCch-hCcCHHHHhcCCC
Confidence 11222 23677 7899999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=266.56 Aligned_cols=242 Identities=28% Similarity=0.487 Sum_probs=191.9
Q ss_pred CCceeeeeEeecCceEEEEEEECCCCcEEEEEEeecccc-------chHHHHHHHHhCCCCceeeeceeeeecCCCCcee
Q 021306 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 110 (314)
Q Consensus 38 ~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~~-------~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 110 (314)
++|++.+.||+|++|.||+|.+..+++.+++|.+..... ...+|+.+++.++|+||+++++.+. ...+
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~ 75 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQ-----TETY 75 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeee-----cCCE
Confidence 379999999999999999999998999999999875432 2357889999999999999998873 3345
Q ss_pred EEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCccc
Q 021306 111 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 189 (314)
Q Consensus 111 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~ 189 (314)
.++++||+.+ +|.+.+.. ..+..+++..++.++.|++.||.|||+ .|++|+||||+||+++. ++.++|+|||++.
T Consensus 76 ~~lv~e~~~~~~L~~~~~~--~~~~~l~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nili~~-~~~~~l~dfg~~~ 151 (316)
T cd05574 76 LCLVMDYCPGGELFRLLQR--QPGKCLSEEVARFYAAEVLLALEYLHL-LGIVYRDLKPENILLHE-SGHIMLSDFDLSK 151 (316)
T ss_pred EEEEEEecCCCCHHHHHHh--CCCCccCHHHHHHHHHHHHHHHHHHHH-CCeeccCCChHHeEEcC-CCCEEEeecchhh
Confidence 8899999986 66655542 234679999999999999999999999 89999999999999998 7889999999876
Q ss_pred ccccCCc------------------------------cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCC
Q 021306 190 QLIAGEA------------------------------NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQP 239 (314)
Q Consensus 190 ~~~~~~~------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~ 239 (314)
....... .....++..|+|||.+.+.. ++.++||||||+++|+|++|+.
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~Di~slG~ll~~l~~g~~ 230 (316)
T cd05574 152 QSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDG-HGSAVDWWTLGILLYEMLYGTT 230 (316)
T ss_pred cccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCC-CCchHHHHHHHHHHHHHhhCCC
Confidence 5422111 01234677899999996654 7899999999999999999999
Q ss_pred CCCCCChHHHHHHHHHHcCCC---------CHHHHh---ccCCCCCCCc----ccccccCChhhhhc
Q 021306 240 LFPGENAVDQLVEIIKVLGTP---------TREEIR---CMNPNYTDFR----FPQIKAHPWHKVCI 290 (314)
Q Consensus 240 pf~~~~~~~~~~~i~~~~~~~---------~~~~~~---~~~p~~~~~~----~~~l~~~p~~~~~~ 290 (314)
||.+.+....+..+....... ..+.+. ..+|. +|++ +.+++.|||++...
T Consensus 231 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~-~R~s~~~~~~~ll~~~~~~~~~ 296 (316)
T cd05574 231 PFKGSNRDETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPS-KRLGSKRGAAEIKQHPFFRGVN 296 (316)
T ss_pred CCCCCchHHHHHHHhcCCccCCCccccCHHHHHHHHHHccCCHh-HCCCchhhHHHHHcCchhhcCC
Confidence 998888776666665432111 111222 23676 8999 99999999998754
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=262.62 Aligned_cols=235 Identities=26% Similarity=0.427 Sum_probs=185.1
Q ss_pred CceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeE
Q 021306 39 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 111 (314)
Q Consensus 39 ~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 111 (314)
+|++.+.||.|+||.||+|++..+++.+++|.+.+.. ....+|+.++++++||||+++++++ ......
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~ 75 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSF-----QDEENM 75 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhh-----cCCCeE
Confidence 5899999999999999999998899999999886432 2335788999999999999999887 334458
Q ss_pred EEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcccc
Q 021306 112 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 190 (314)
Q Consensus 112 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~ 190 (314)
++++||+.| +|...+.. ..++++..+..++.|++.||.+||+ .+++|+||+|+||+++. ++.++|+|||.+..
T Consensus 76 ~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lh~-~~i~h~dl~~~nil~~~-~~~~~l~d~~~~~~ 149 (258)
T cd05578 76 YLVVDLLLGGDLRYHLSQ----KVKFSEEQVKFWICEIVLALEYLHS-KGIIHRDIKPDNILLDE-QGHVHITDFNIATK 149 (258)
T ss_pred EEEEeCCCCCCHHHHHHh----cCCcCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHeEEcC-CCCEEEeecccccc
Confidence 899999987 55544432 3689999999999999999999999 89999999999999998 78899999999876
Q ss_pred cccCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHHHcCCC--------
Q 021306 191 LIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA--VDQLVEIIKVLGTP-------- 260 (314)
Q Consensus 191 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~--~~~~~~i~~~~~~~-------- 260 (314)
...........++..|+|||.+.+.. ++.++|+||||+++|+|++|..||...+. .+.+..........
T Consensus 150 ~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (258)
T cd05578 150 VTPDTLTTSTSGTPGYMAPEVLCRQG-YSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTE 228 (258)
T ss_pred cCCCccccccCCChhhcCHHHHcccC-CCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhccccccCcccCcHH
Confidence 65443334456778899999986544 88999999999999999999999987764 22232222211111
Q ss_pred CHHHHh---ccCCCCCCCcc--cccccCChh
Q 021306 261 TREEIR---CMNPNYTDFRF--PQIKAHPWH 286 (314)
Q Consensus 261 ~~~~~~---~~~p~~~~~~~--~~l~~~p~~ 286 (314)
..+.+. ..+|. +|+++ ++++.|||+
T Consensus 229 ~~~~i~~~l~~~p~-~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 229 AIDAINKLLERDPQ-KRLGDNLKDLKNHPYF 258 (258)
T ss_pred HHHHHHHHccCChh-HcCCccHHHHhcCCCC
Confidence 111121 23566 78888 899999986
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=261.55 Aligned_cols=248 Identities=23% Similarity=0.391 Sum_probs=193.0
Q ss_pred CceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeEEEE
Q 021306 39 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLV 114 (314)
Q Consensus 39 ~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 114 (314)
.|++.+.||+|+||.||++.+..++..+++|.+.... ....+|+.+++.++|+|++++++.+... ...+++
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~-----~~~~~v 80 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYE-----NNLWIL 80 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeC-----CEEEEE
Confidence 3789999999999999999999999999999885432 2335788999999999999999988543 347899
Q ss_pred eecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcccccccC
Q 021306 115 MEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG 194 (314)
Q Consensus 115 ~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~~~ 194 (314)
+||++++.+..+.. ....++++..+..++.|++.||.+||+ .|++|+||+|+||+++. ++.++|+|||++......
T Consensus 81 ~e~~~~~~l~~~~~--~~~~~l~~~~~~~~~~qi~~~L~~LH~-~~i~H~dlkp~nili~~-~~~~kl~dfg~~~~~~~~ 156 (282)
T cd06643 81 IEFCAGGAVDAVML--ELERPLTEPQIRVVCKQTLEALNYLHE-NKIIHRDLKAGNILFTL-DGDIKLADFGVSAKNTRT 156 (282)
T ss_pred EEecCCCcHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCcccEEEcc-CCCEEEcccccccccccc
Confidence 99999754433322 124679999999999999999999999 89999999999999998 888999999998654322
Q ss_pred C-ccccccccccccccccccC----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCC---------
Q 021306 195 E-ANISYICSRFYRAPELIFG----ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP--------- 260 (314)
Q Consensus 195 ~-~~~~~~~~~~y~aPE~~~~----~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~--------- 260 (314)
. ......+++.|+|||.+.. ...++.++|+||||+++|+|++|+.||...+..+....+.+.....
T Consensus 157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
T cd06643 157 IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSS 236 (282)
T ss_pred ccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCccccCH
Confidence 1 1223456888999999742 2336789999999999999999999998887766666655432211
Q ss_pred -CHHHHh-cc--CCCCCCCcccccccCChhhhhcccCChH
Q 021306 261 -TREEIR-CM--NPNYTDFRFPQIKAHPWHKVCIFHFPKH 296 (314)
Q Consensus 261 -~~~~~~-~~--~p~~~~~~~~~l~~~p~~~~~~~~~~~~ 296 (314)
..+.+. ++ +|. .|+++.++++|||++.........
T Consensus 237 ~~~~li~~~l~~~p~-~Rp~~~~il~~~~~~~~~~~~~~~ 275 (282)
T cd06643 237 EFKDFLKKCLEKNVD-ARWTTTQLLQHPFVTVNSNKPIRE 275 (282)
T ss_pred HHHHHHHHHccCChh-hCcCHHHHhcCCCEeccCCCCHHH
Confidence 112222 33 565 899999999999999877654433
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=258.03 Aligned_cols=237 Identities=27% Similarity=0.433 Sum_probs=186.1
Q ss_pred CCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeEEE
Q 021306 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 113 (314)
Q Consensus 38 ~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 113 (314)
++|++.+.||+|++|.||+|.+..+++.+++|.+.... ....+|+.++++++|+||+++++.+... ..+++
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-----~~~~l 77 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRR-----DKLWI 77 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeC-----CEEEE
Confidence 57999999999999999999998899999999987542 3346889999999999999999987443 34889
Q ss_pred Eeeccccc-HHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcccccc
Q 021306 114 VMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 192 (314)
Q Consensus 114 v~e~~~~~-l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~ 192 (314)
+|||++++ +.+.+.. ....+++.+++.++.|++.|+.+||+ ++++|+||+|+||+++. ++.++|+|||.+....
T Consensus 78 ~~e~~~~~~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lh~-~~i~h~dl~p~ni~i~~-~~~~~l~d~g~~~~~~ 152 (262)
T cd06613 78 VMEYCGGGSLQDIYQV---TRGPLSELQIAYVCRETLKGLAYLHE-TGKIHRDIKGANILLTE-DGDVKLADFGVSAQLT 152 (262)
T ss_pred EEeCCCCCcHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCChhhEEECC-CCCEEECccccchhhh
Confidence 99999974 4444332 23679999999999999999999999 89999999999999998 7889999999987554
Q ss_pred cCC-ccccccccccccccccccCC--CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCC-C-------
Q 021306 193 AGE-ANISYICSRFYRAPELIFGA--TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP-T------- 261 (314)
Q Consensus 193 ~~~-~~~~~~~~~~y~aPE~~~~~--~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~-~------- 261 (314)
... ......++..|+|||.+.+. ..++.++|+||||+++|+|++|+.||...+.......+.+....+ .
T Consensus 153 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (262)
T cd06613 153 ATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKW 232 (262)
T ss_pred hhhhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhh
Confidence 322 22234567789999998654 247889999999999999999999998887666555444331111 0
Q ss_pred ----HHHHh---ccCCCCCCCcccccccCCh
Q 021306 262 ----REEIR---CMNPNYTDFRFPQIKAHPW 285 (314)
Q Consensus 262 ----~~~~~---~~~p~~~~~~~~~l~~~p~ 285 (314)
.+.+. ..+|. .|+++.+++.|+|
T Consensus 233 ~~~~~~li~~~l~~~p~-~Rpt~~~il~~~~ 262 (262)
T cd06613 233 SPVFHDFIKKCLTKDPK-KRPTATKLLQHPF 262 (262)
T ss_pred hHHHHHHHHHHcCCChh-hCCCHHHHhcCCC
Confidence 11122 22566 7888888888887
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=267.62 Aligned_cols=242 Identities=36% Similarity=0.612 Sum_probs=190.3
Q ss_pred CCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCC-CCce
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTS-KNEL 109 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~~~~ 109 (314)
.++|++.+.||+|+||.||++.+..+++.|++|++.... ....+|+.++++++|+||+++++++..... ....
T Consensus 16 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (345)
T cd07877 16 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 95 (345)
T ss_pred cCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccc
Confidence 468999999999999999999999999999999886432 223478999999999999999987753322 1223
Q ss_pred eEEEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCccc
Q 021306 110 FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 189 (314)
Q Consensus 110 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~ 189 (314)
..+++++++.+++.+.+. ...+++..++.++.|++.||.|||+ .|++|+||+|+||+++. ++.++|+|||++.
T Consensus 96 ~~~lv~~~~~~~L~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~dlkp~NIll~~-~~~~kl~dfg~~~ 168 (345)
T cd07877 96 DVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHS-ADIIHRDLKPSNLAVNE-DCELKILDFGLAR 168 (345)
T ss_pred cEEEEehhcccCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCChHHEEEcC-CCCEEEecccccc
Confidence 467899998877766554 2569999999999999999999999 89999999999999998 7889999999987
Q ss_pred ccccCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCC--------
Q 021306 190 QLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT-------- 261 (314)
Q Consensus 190 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~-------- 261 (314)
.... ......++..|+|||.+.+...++.++||||||+++|+|++|+.||...+....+..+.+..+.+.
T Consensus 169 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (345)
T cd07877 169 HTDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 246 (345)
T ss_pred cccc--cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcc
Confidence 5432 223345688899999986655578899999999999999999999987776555554443322111
Q ss_pred ------------------------------HHHHh---ccCCCCCCCcccccccCChhhh
Q 021306 262 ------------------------------REEIR---CMNPNYTDFRFPQIKAHPWHKV 288 (314)
Q Consensus 262 ------------------------------~~~~~---~~~p~~~~~~~~~l~~~p~~~~ 288 (314)
.+.+. ..+|. +|+++.+++.|||++.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~-~R~t~~e~l~h~~f~~ 305 (345)
T cd07877 247 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSD-KRITAAQALAHAYFAQ 305 (345)
T ss_pred cHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChh-hcCCHHHHhcChhhhh
Confidence 11111 23555 8999999999999884
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=273.11 Aligned_cols=241 Identities=23% Similarity=0.377 Sum_probs=185.2
Q ss_pred CCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhC-CCCceeeeceeeeecCCCCce
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVM-DHPNVISLKHCFFSTTSKNEL 109 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~------~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~ 109 (314)
+..|++.+.||+||.+.||++. ..+.+.|++|++.... ....+|+.+|.+| .|.+|++++++-. ...
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~-~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv-----~d~ 433 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVL-NSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEV-----TDG 433 (677)
T ss_pred cchhhHHHhhcCCCcceeeeee-cCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeec-----cCc
Confidence 4589999999999999999999 4566778888775432 2235899999999 5899999999863 355
Q ss_pred eEEEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCccc
Q 021306 110 FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 189 (314)
Q Consensus 110 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~ 189 (314)
++|+||||-+.+|-..|... ...++...++.+..||+.|+.++|. +||||.||||.|+++- .|.+||+|||+|.
T Consensus 434 ~lYmvmE~Gd~DL~kiL~k~---~~~~~~~~lk~ywkqML~aV~~IH~-~gIVHSDLKPANFLlV--kG~LKLIDFGIA~ 507 (677)
T KOG0596|consen 434 YLYMVMECGDIDLNKILKKK---KSIDPDWFLKFYWKQMLLAVKTIHQ-HGIVHSDLKPANFLLV--KGRLKLIDFGIAN 507 (677)
T ss_pred eEEEEeecccccHHHHHHhc---cCCCchHHHHHHHHHHHHHHHHHHH-hceeecCCCcccEEEE--eeeEEeeeechhc
Confidence 79999999888998888863 3344445899999999999999999 9999999999999998 5789999999998
Q ss_pred ccccCCc---cccccccccccccccccCC----------CCCCcchhHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHH
Q 021306 190 QLIAGEA---NISYICSRFYRAPELIFGA----------TEYTTSIDIWSAGCVLAELLLGQPLFPGENA-VDQLVEIIK 255 (314)
Q Consensus 190 ~~~~~~~---~~~~~~~~~y~aPE~~~~~----------~~~~~~~Dv~slG~il~el~tg~~pf~~~~~-~~~~~~i~~ 255 (314)
.+..... ....+||+.||+||.+... -+.+.++||||||||||+|+.|+.||..... ...+..|+.
T Consensus 508 aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~ 587 (677)
T KOG0596|consen 508 AIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITD 587 (677)
T ss_pred ccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcC
Confidence 7655443 2357789999999998321 1256799999999999999999999976542 222222221
Q ss_pred HcC-----C---C--CHHH---HhccCCCCCCCcccccccCChhhhhc
Q 021306 256 VLG-----T---P--TREE---IRCMNPNYTDFRFPQIKAHPWHKVCI 290 (314)
Q Consensus 256 ~~~-----~---~--~~~~---~~~~~p~~~~~~~~~l~~~p~~~~~~ 290 (314)
-.. . . ..+. ...++|. +|++..+|++|||+.+..
T Consensus 588 P~~~Iefp~~~~~~~li~~mK~CL~rdPk-kR~si~eLLqhpFl~~~~ 634 (677)
T KOG0596|consen 588 PNHEIEFPDIPENDELIDVMKCCLARDPK-KRWSIPELLQHPFLQIQP 634 (677)
T ss_pred CCccccccCCCCchHHHHHHHHHHhcCcc-cCCCcHHHhcCccccccc
Confidence 100 0 0 0111 1234888 899999999999998843
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=262.71 Aligned_cols=218 Identities=31% Similarity=0.573 Sum_probs=176.9
Q ss_pred CCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCC-----
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTS----- 105 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~----- 105 (314)
.++|++.+.||.|++|.||+|.++.+++.+++|.++... ....+|+.+++.++|||++++++.+.....
T Consensus 6 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~ 85 (302)
T cd07864 6 VDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFK 85 (302)
T ss_pred hhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhcc
Confidence 468999999999999999999999999999999986432 123578899999999999999988754331
Q ss_pred CCceeEEEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeec
Q 021306 106 KNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF 185 (314)
Q Consensus 106 ~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~df 185 (314)
.....+++++||+++++...+.. ....+++.+++.++.|++.||.|||+ .||+|+||+|+||+++. ++.++|+||
T Consensus 86 ~~~~~~~lv~e~~~~~l~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~-~~i~H~dl~p~nili~~-~~~~kl~df 160 (302)
T cd07864 86 KDKGAFYLVFEYMDHDLMGLLES---GLVHFSEDHIKSFMKQLLEGLNYCHK-KNFLHRDIKCSNILLNN-KGQIKLADF 160 (302)
T ss_pred ccCCcEEEEEcccCccHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEECC-CCcEEeCcc
Confidence 11235889999999987776653 23579999999999999999999999 89999999999999998 888999999
Q ss_pred CcccccccCCc--cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCC
Q 021306 186 GSAKQLIAGEA--NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT 259 (314)
Q Consensus 186 g~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~ 259 (314)
|.+........ .....++..|+|||.+.+...++.++||||||+++|+|++|+.||...+..+.+..+.+..+.
T Consensus 161 g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~ 236 (302)
T cd07864 161 GLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGS 236 (302)
T ss_pred cccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Confidence 99875533221 112334677999998866555788999999999999999999999888777766666655433
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=261.85 Aligned_cols=237 Identities=30% Similarity=0.555 Sum_probs=183.6
Q ss_pred CceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc----------cchHHHHHHHHhCCCCceeeeceeeeecCCCCc
Q 021306 39 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 108 (314)
Q Consensus 39 ~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~----------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 108 (314)
+|+..+.||+|++|.||++++..+++.+++|.+.... ....+|+.++++++|+||+++++++.. .
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~ 75 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCE-----D 75 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceecc-----C
Confidence 5889999999999999999999999999999886432 234578999999999999999998843 3
Q ss_pred eeEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCc
Q 021306 109 LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 187 (314)
Q Consensus 109 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~ 187 (314)
..+++++||+.+ +|.+.+.. ..++++..++.++.|++.||.+||+ +|++|+||+|+||+++..+..++|+|||.
T Consensus 76 ~~~~~v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~ql~~al~~LH~-~~i~H~~i~~~nil~~~~~~~~~l~dfg~ 150 (268)
T cd06630 76 SHFNLFVEWMAGGSVSHLLSK----YGAFKEAVIINYTEQLLRGLSYLHE-NQIIHRDVKGANLLIDSTGQRLRIADFGA 150 (268)
T ss_pred CeEEEEEeccCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcCCCCEEEEccccc
Confidence 348899999997 55555442 4678999999999999999999999 89999999999999987455799999999
Q ss_pred ccccccCCc-----cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH---cCC
Q 021306 188 AKQLIAGEA-----NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV---LGT 259 (314)
Q Consensus 188 ~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~---~~~ 259 (314)
+........ .....++..|+|||.+.+. .++.++|+||||+++|+|++|..||...........+.+. ...
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 229 (268)
T cd06630 151 AARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGE-QYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTA 229 (268)
T ss_pred ccccccccccCCccccccccccceeCHhHhccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCC
Confidence 876543211 1123467789999998654 4789999999999999999999999765433322222221 111
Q ss_pred C---------CHHHHh-c--cCCCCCCCcccccccCChhh
Q 021306 260 P---------TREEIR-C--MNPNYTDFRFPQIKAHPWHK 287 (314)
Q Consensus 260 ~---------~~~~~~-~--~~p~~~~~~~~~l~~~p~~~ 287 (314)
+ ..+.+. + .+|+ .|+++.++++|||++
T Consensus 230 ~~~~~~~~~~~~~~i~~~l~~~p~-~R~~~~~ll~~~~~~ 268 (268)
T cd06630 230 PSIPEHLSPGLRDVTLRCLELQPE-DRPPSRELLKHPVFR 268 (268)
T ss_pred CCCchhhCHHHHHHHHHHcCCCcc-cCcCHHHHhcCcccC
Confidence 1 111222 2 3566 799999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=260.68 Aligned_cols=208 Identities=40% Similarity=0.763 Sum_probs=174.2
Q ss_pred ceeeeeEeecCceEEEEEEECCCCcEEEEEEeecccc------chHHHHHHHHhCCCCceeeeceeeeecCCCCceeEEE
Q 021306 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR------YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 113 (314)
Q Consensus 40 y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~~------~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 113 (314)
|++.+.||+|++|.||++.+..+++.+++|.+..... ...+|+.++++++|+||+++++.+... ...++
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~~ 75 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHK-----GDLYL 75 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccC-----CCEEE
Confidence 6788999999999999999988999999998865432 245788999999999999999987443 34889
Q ss_pred EeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCccccccc
Q 021306 114 VMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA 193 (314)
Q Consensus 114 v~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~~ 193 (314)
++||+++++.+.+.. ....+++..+..++.|++.||.+||+ ++++|+||+|+||+++. ++.++|+|||.+.....
T Consensus 76 v~e~~~~~l~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~H~dl~p~nili~~-~~~~~l~df~~~~~~~~ 150 (283)
T cd05118 76 VFEFMDTDLYKLIKD---RQRGLPESLIKSYLYQLLQGLAFCHS-HGILHRDLKPENLLINT-EGVLKLADFGLARSFGS 150 (283)
T ss_pred EEeccCCCHHHHHHh---hcccCCHHHHHHHHHHHHHHHHHHHH-CCeeecCcCHHHEEECC-CCcEEEeeeeeeEecCC
Confidence 999999988777664 23689999999999999999999999 89999999999999998 78899999999876544
Q ss_pred CC-ccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHc
Q 021306 194 GE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVL 257 (314)
Q Consensus 194 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~ 257 (314)
.. ......++..|+|||.+.+...++.++|+||||+++|+|++|+.||.+.+..+.+..+....
T Consensus 151 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~ 215 (283)
T cd05118 151 PVRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTL 215 (283)
T ss_pred CcccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHc
Confidence 33 22234467789999998766458999999999999999999999998888776666655443
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=258.10 Aligned_cols=212 Identities=38% Similarity=0.649 Sum_probs=173.9
Q ss_pred ceeeeeEeecCceEEEEEEECCCCcEEEEEEeecccc------chHHHHHHHHhC---CCCceeeeceeeeecCCCCcee
Q 021306 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR------YKNRELQLMRVM---DHPNVISLKHCFFSTTSKNELF 110 (314)
Q Consensus 40 y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~~------~~~~e~~~l~~l---~h~~iv~~~~~~~~~~~~~~~~ 110 (314)
|++.+.||+|++|.||+++++.+++.+++|.+..... ...+|+.+++++ .|+|++++++++..........
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 7899999999999999999988899999999864321 233566666555 6999999999987655444455
Q ss_pred EEEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcccc
Q 021306 111 LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 190 (314)
Q Consensus 111 ~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~ 190 (314)
+++++||+.+++.+.+... ....+++.+++.++.|++.||.+||+ .+++|+||+|+||+++. ++.++|+|||.+..
T Consensus 81 ~~l~~e~~~~~l~~~l~~~--~~~~l~~~~~~~~~~~i~~al~~LH~-~~i~h~~l~~~nili~~-~~~~~l~dfg~~~~ 156 (287)
T cd07838 81 LTLVFEHVDQDLATYLSKC--PKPGLPPETIKDLMRQLLRGVDFLHS-HRIVHRDLKPQNILVTS-DGQVKIADFGLARI 156 (287)
T ss_pred eEEEehhcccCHHHHHHHc--cCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeccCChhhEEEcc-CCCEEEeccCccee
Confidence 8899999998877766542 22468999999999999999999999 89999999999999998 78999999999876
Q ss_pred cccCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q 021306 191 LIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 256 (314)
Q Consensus 191 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~ 256 (314)
...........++..|+|||.+.+.. ++.++|+||||+++|+|++|..||.+....+.+.++.+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 221 (287)
T cd07838 157 YSFEMALTSVVVTLWYRAPEVLLQSS-YATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDV 221 (287)
T ss_pred ccCCcccccccccccccChHHhccCC-CCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHH
Confidence 64433333345678899999997654 789999999999999999999999988877777766654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=263.28 Aligned_cols=240 Identities=26% Similarity=0.436 Sum_probs=188.0
Q ss_pred CCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeEE
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 112 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 112 (314)
..+|++++.||+|++|.||++.+..+++.|++|.+.... ....+|..+++.++|+|++++++++.. ....+
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~~~~ 92 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV-----GDELW 92 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEec-----CCEEE
Confidence 357999999999999999999998999999999886432 223578889999999999999998843 33488
Q ss_pred EEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCccccc
Q 021306 113 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 191 (314)
Q Consensus 113 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~ 191 (314)
+|+||+++ ++.+.+. ...+++.++..++.|++.+|.+||+ .|++|+||+|+||+++. ++.++|+|||.+...
T Consensus 93 lv~e~~~~~~L~~~~~-----~~~~~~~~~~~~~~~l~~~L~~LH~-~~i~H~dL~p~Nili~~-~~~~~l~Dfg~~~~~ 165 (297)
T cd06656 93 VVMEYLAGGSLTDVVT-----ETCMDEGQIAAVCRECLQALDFLHS-NQVIHRDIKSDNILLGM-DGSVKLTDFGFCAQI 165 (297)
T ss_pred EeecccCCCCHHHHHH-----hCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECC-CCCEEECcCccceEc
Confidence 99999986 5555443 2568999999999999999999999 89999999999999998 788999999988754
Q ss_pred ccCCc-cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCC----------
Q 021306 192 IAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP---------- 260 (314)
Q Consensus 192 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~---------- 260 (314)
..... .....+++.|+|||.+.+.. ++.++|+||||+++|+|++|..||.+.++......+.......
T Consensus 166 ~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (297)
T cd06656 166 TPEQSKRSTMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAV 244 (297)
T ss_pred cCCccCcCcccCCccccCHHHHcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCHH
Confidence 33222 22345678899999986544 7899999999999999999999998776544433332221111
Q ss_pred CHHHHh-c--cCCCCCCCcccccccCChhhhhc
Q 021306 261 TREEIR-C--MNPNYTDFRFPQIKAHPWHKVCI 290 (314)
Q Consensus 261 ~~~~~~-~--~~p~~~~~~~~~l~~~p~~~~~~ 290 (314)
..+.+. + .+|. +|+++.++++|||++...
T Consensus 245 ~~~li~~~l~~~p~-~Rps~~~il~~~~~~~~~ 276 (297)
T cd06656 245 FRDFLNRCLEMDVD-RRGSAKELLQHPFLKLAK 276 (297)
T ss_pred HHHHHHHHccCChh-hCcCHHHHhcCchhcccc
Confidence 011222 2 3677 799999999999997444
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=268.00 Aligned_cols=247 Identities=35% Similarity=0.675 Sum_probs=195.3
Q ss_pred CccCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeecc------ccchHHHHHHHHhC-CCCceeeeceeeeecCCC
Q 021306 34 PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRVM-DHPNVISLKHCFFSTTSK 106 (314)
Q Consensus 34 ~~~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~------~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~ 106 (314)
+...++|++.+.||+|++|.||+|.+..+++.+++|.+... .....+|+.+++++ +|+||+++++++...
T Consensus 3 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~--- 79 (337)
T cd07852 3 KHILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAE--- 79 (337)
T ss_pred chhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccC---
Confidence 45567899999999999999999999889999999987532 12234789999999 999999999987432
Q ss_pred CceeEEEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecC
Q 021306 107 NELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 186 (314)
Q Consensus 107 ~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg 186 (314)
.....++|+||+.++|...+.. ..+++..++.++.|++.||.+||+ .|++|+||+|+||+++. ++.++|+|||
T Consensus 80 ~~~~~~lv~e~~~~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~-~~i~H~dl~p~nill~~-~~~~kl~d~g 152 (337)
T cd07852 80 NDKDIYLVFEYMETDLHAVIRA-----NILEDVHKRYIMYQLLKALKYIHS-GNVIHRDLKPSNILLNS-DCRVKLADFG 152 (337)
T ss_pred CCceEEEEecccccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEEcC-CCcEEEeecc
Confidence 2234789999999887766543 378899999999999999999999 89999999999999998 8899999999
Q ss_pred cccccccCC------ccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCC
Q 021306 187 SAKQLIAGE------ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 260 (314)
Q Consensus 187 ~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~ 260 (314)
.+....... ......++..|+|||.+.+...++.++|+||||+++|+|++|+.||.+....+....+....+.+
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~ 232 (337)
T cd07852 153 LARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPP 232 (337)
T ss_pred chhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence 987553322 11224567889999988665557889999999999999999999998877666655554443221
Q ss_pred C--------------------------------------HHHHh---ccCCCCCCCcccccccCChhhhhcc
Q 021306 261 T--------------------------------------REEIR---CMNPNYTDFRFPQIKAHPWHKVCIF 291 (314)
Q Consensus 261 ~--------------------------------------~~~~~---~~~p~~~~~~~~~l~~~p~~~~~~~ 291 (314)
. .+.+. ..+|+ +|+++.+++.|||++....
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~-~Rps~~~il~~~~~~~~~~ 303 (337)
T cd07852 233 SAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPN-KRLTAEEALEHPYVAQFHN 303 (337)
T ss_pred CHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcc-cccCHHHHhhChhhhhhcc
Confidence 1 11111 23666 7999999999999987644
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=263.65 Aligned_cols=243 Identities=28% Similarity=0.444 Sum_probs=198.4
Q ss_pred CCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccccch-------HHHHHHHHhC-CCCceeeeceeeeecCCCCc
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-------NRELQLMRVM-DHPNVISLKHCFFSTTSKNE 108 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~~~~-------~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~ 108 (314)
..+|..+.+||+|+||.|.++..+.+.+.||+|+++++.... -.|..+|... +-|.+++++.+|+..+.
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR--- 424 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR--- 424 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh---
Confidence 347999999999999999999999999999999988764332 1455666555 67899999999965554
Q ss_pred eeEEEEeeccccc-HHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCc
Q 021306 109 LFLNLVMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 187 (314)
Q Consensus 109 ~~~~lv~e~~~~~-l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~ 187 (314)
+|+||||+.|+ |.-.++ +-+.+.+..+..++.+|+.||-+||+ +||++||||.+||+++. .+++||.|||+
T Consensus 425 --LyFVMEyvnGGDLMyhiQ----Q~GkFKEp~AvFYAaEiaigLFFLh~-kgIiYRDLKLDNvmLd~-eGHiKi~DFGm 496 (683)
T KOG0696|consen 425 --LYFVMEYVNGGDLMYHIQ----QVGKFKEPVAVFYAAEIAIGLFFLHS-KGIIYRDLKLDNVMLDS-EGHIKIADFGM 496 (683)
T ss_pred --eeeEEEEecCchhhhHHH----HhcccCCchhhhhhHHHHHHhhhhhc-CCeeeeeccccceEecc-CCceEeeeccc
Confidence 89999999974 444443 45889999999999999999999999 99999999999999999 89999999999
Q ss_pred ccccc-cCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCHHH--
Q 021306 188 AKQLI-AGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE-- 264 (314)
Q Consensus 188 ~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~-- 264 (314)
++.-. ....+...+|||.|+|||++. .++|+.++|+||+|++||||+.|++||.+.+..+.+..|+......+...
T Consensus 497 cKEni~~~~TTkTFCGTPdYiAPEIi~-YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyPKslSk 575 (683)
T KOG0696|consen 497 CKENIFDGVTTKTFCGTPDYIAPEIIA-YQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYPKSLSK 575 (683)
T ss_pred ccccccCCcceeeecCCCcccccceEE-ecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCcccccH
Confidence 87433 334556789999999999995 45599999999999999999999999999999999999987754443321
Q ss_pred --------HhccCCCCCCC-----cccccccCChhhhhccc
Q 021306 265 --------IRCMNPNYTDF-----RFPQIKAHPWHKVCIFH 292 (314)
Q Consensus 265 --------~~~~~p~~~~~-----~~~~l~~~p~~~~~~~~ 292 (314)
+....|. +|+ .-++|..|||+|.-..+
T Consensus 576 EAv~ickg~ltK~P~-kRLGcg~~ge~di~~H~FFR~iDWe 615 (683)
T KOG0696|consen 576 EAVAICKGLLTKHPG-KRLGCGPEGERDIREHPFFRRIDWE 615 (683)
T ss_pred HHHHHHHHHhhcCCc-cccCCCCccccchhhCcchhhccHH
Confidence 1223555 454 34689999999987764
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=285.95 Aligned_cols=248 Identities=25% Similarity=0.402 Sum_probs=190.7
Q ss_pred CCceeeeeEeecCceEEEEEEECCCCcEEEEEEeecc-c---cchHHHHHHHHhCC-CCceeeece-eeeecCCCC-cee
Q 021306 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-R---RYKNRELQLMRVMD-HPNVISLKH-CFFSTTSKN-ELF 110 (314)
Q Consensus 38 ~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~-~---~~~~~e~~~l~~l~-h~~iv~~~~-~~~~~~~~~-~~~ 110 (314)
.+++|.+.|.+|||+.||+|.+...|..||+|++-.. . +...+|+.++++|+ |+|||.+++ ......... ..-
T Consensus 37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~E 116 (738)
T KOG1989|consen 37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWE 116 (738)
T ss_pred EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeE
Confidence 3789999999999999999999888899999987432 2 33469999999996 999999999 333332333 456
Q ss_pred EEEEeeccc-ccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCC--ceecCCCCCcEEEcCCCCcEEEeecCc
Q 021306 111 LNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR--VCHRDLKPQNLLVDPLTHQVKICDFGS 187 (314)
Q Consensus 111 ~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~--i~h~dl~p~Nil~~~~~~~~~l~dfg~ 187 (314)
+.|+||||. |+|.+++..+.. ..|++.++++|+.|++.|+.+||. .. |+|||||-+|||++. ++..||||||.
T Consensus 117 vllLmEyC~gg~Lvd~mn~Rlq--~~lte~eVLkIf~dv~~AVa~mH~-~~pPiIHRDLKiENvLls~-~g~~KLCDFGS 192 (738)
T KOG1989|consen 117 VLLLMEYCKGGSLVDFMNTRLQ--TRLTEDEVLKIFYDVCEAVAAMHY-LKPPIIHRDLKIENVLLSA-DGNYKLCDFGS 192 (738)
T ss_pred EEeehhhccCCcHHHHHHHHHh--ccCChHHHHHHHHHHHHHHHHHhc-CCCccchhhhhhhheEEcC-CCCEEeCcccc
Confidence 779999999 599999988765 349999999999999999999999 56 999999999999998 88999999999
Q ss_pred ccccccCCcc----------cccccccccccccccc--CCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 021306 188 AKQLIAGEAN----------ISYICSRFYRAPELIF--GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 255 (314)
Q Consensus 188 ~~~~~~~~~~----------~~~~~~~~y~aPE~~~--~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~ 255 (314)
+......... .....|+.|+|||.+- .+...+.|+|||||||+||.|+...+||....... |+.
T Consensus 193 att~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~la----Iln 268 (738)
T KOG1989|consen 193 ATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLA----ILN 268 (738)
T ss_pred cccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCccee----EEe
Confidence 8644332211 1233489999999972 33447899999999999999999999998775432 222
Q ss_pred H-cCCCCHHHHhccCCCCCCCcccccccCChhhhhcccCChH
Q 021306 256 V-LGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVCIFHFPKH 296 (314)
Q Consensus 256 ~-~~~~~~~~~~~~~p~~~~~~~~~l~~~p~~~~~~~~~~~~ 296 (314)
. ..-|+. ...+..+++++..+|...||+|+...+...+
T Consensus 269 g~Y~~P~~---p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~ 307 (738)
T KOG1989|consen 269 GNYSFPPF---PNYSDRLKDLIRTMLQPNPDERPNIYQVLEE 307 (738)
T ss_pred ccccCCCC---ccHHHHHHHHHHHHhccCcccCCCHHHHHHH
Confidence 1 112211 2223334677888888888888888764433
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=281.14 Aligned_cols=245 Identities=23% Similarity=0.313 Sum_probs=182.5
Q ss_pred CCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeE
Q 021306 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 111 (314)
Q Consensus 38 ~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 111 (314)
++..+.+.||+|+||+||+|++-. .||||+++.+. +.+++|+..+++-+|.||+-+-|++. ... +
T Consensus 392 ~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~-----~p~-~ 462 (678)
T KOG0193|consen 392 EEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACM-----NPP-L 462 (678)
T ss_pred HHhhccceeccccccceeeccccc---ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhc-----CCc-e
Confidence 367789999999999999999854 49999987543 44579999999999999999999883 222 3
Q ss_pred EEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcccc
Q 021306 112 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 190 (314)
Q Consensus 112 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~ 190 (314)
.||+-+|+| +|+..+.. ....|.....+.|++|+++|+.|||. ++|+|+|||..|||+.+ ++.|+|+|||++..
T Consensus 463 AIiTqwCeGsSLY~hlHv---~etkfdm~~~idIAqQiaqGM~YLHA-K~IIHrDLKSnNIFl~~-~~kVkIgDFGLatv 537 (678)
T KOG0193|consen 463 AIITQWCEGSSLYTHLHV---QETKFDMNTTIDIAQQIAQGMDYLHA-KNIIHRDLKSNNIFLHE-DLKVKIGDFGLATV 537 (678)
T ss_pred eeeehhccCchhhhhccc---hhhhhhHHHHHHHHHHHHHhhhhhhh-hhhhhhhccccceEEcc-CCcEEEecccceee
Confidence 799999999 56665543 45789999999999999999999999 99999999999999998 79999999999864
Q ss_pred ccc---CCccccccccccccccccccCC--CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCHHHH
Q 021306 191 LIA---GEANISYICSRFYRAPELIFGA--TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 265 (314)
Q Consensus 191 ~~~---~~~~~~~~~~~~y~aPE~~~~~--~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 265 (314)
... ........+...|||||+++.+ .++++.+||||||+++|||+||..||.....++.+..+=++...+....+
T Consensus 538 k~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~~ 617 (678)
T KOG0193|consen 538 KTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSKI 617 (678)
T ss_pred eeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchhh
Confidence 322 1222234457789999999643 35889999999999999999999999966655555544444333333333
Q ss_pred hccCCCCCCCcccccccCChhhhhcccCChHHHHH
Q 021306 266 RCMNPNYTDFRFPQIKAHPWHKVCIFHFPKHWLLE 300 (314)
Q Consensus 266 ~~~~p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~ 300 (314)
..--| -.+.+|+..||......+.+...+++
T Consensus 618 ~s~~p----k~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 618 RSNCP----KAMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred hccCH----HHHHHHHHHHHhcCcccCccHHHHHH
Confidence 32222 12444555555544444444444444
|
|
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=259.34 Aligned_cols=235 Identities=30% Similarity=0.517 Sum_probs=184.1
Q ss_pred CceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc-------------cchHHHHHHHHhCCCCceeeeceeeeecCC
Q 021306 39 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------------RYKNRELQLMRVMDHPNVISLKHCFFSTTS 105 (314)
Q Consensus 39 ~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~-------------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 105 (314)
+|.+...||+|++|.||+|.+..+++.+++|.+.... ....+|+.++++++|+||+++++++...
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-- 78 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDA-- 78 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC--
Confidence 4889999999999999999998899999999885432 1235788999999999999999987443
Q ss_pred CCceeEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEee
Q 021306 106 KNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICD 184 (314)
Q Consensus 106 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~d 184 (314)
.+.++++||+++ +|.+.+. ....+++..+..++.|++.||.+||+ .|++|+||+|+||++++ ++.++|+|
T Consensus 79 ---~~~~lv~e~~~~~~L~~~l~----~~~~l~~~~~~~~~~~l~~~l~~lH~-~~ivH~di~p~nil~~~-~~~~~l~d 149 (267)
T cd06628 79 ---DHLNIFLEYVPGGSVAALLN----NYGAFEETLVRNFVRQILKGLNYLHN-RGIIHRDIKGANILVDN-KGGIKISD 149 (267)
T ss_pred ---CccEEEEEecCCCCHHHHHH----hccCccHHHHHHHHHHHHHHHHHHHh-cCcccccCCHHHEEEcC-CCCEEecc
Confidence 347899999987 5555554 34678999999999999999999999 89999999999999998 88899999
Q ss_pred cCcccccccCCc-------cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHc
Q 021306 185 FGSAKQLIAGEA-------NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVL 257 (314)
Q Consensus 185 fg~~~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~ 257 (314)
||.+........ .....++..|+|||.+.+.. ++.++|+||||+++|+|++|+.||.+.+....+..+....
T Consensus 150 fg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~ 228 (267)
T cd06628 150 FGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTS-YTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENA 228 (267)
T ss_pred cCCCcccccccccCCccccccccCCCcCccChhHhccCC-CCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccC
Confidence 999876542111 11234577899999986544 7889999999999999999999998876655554444332
Q ss_pred CCCC--------HHHHh-cc--CCCCCCCcccccccCChh
Q 021306 258 GTPT--------REEIR-CM--NPNYTDFRFPQIKAHPWH 286 (314)
Q Consensus 258 ~~~~--------~~~~~-~~--~p~~~~~~~~~l~~~p~~ 286 (314)
.... .+.+. ++ +|. +|+++.++++|||+
T Consensus 229 ~~~~~~~~~~~~~~li~~~l~~~p~-~Rp~~~~il~~~~~ 267 (267)
T cd06628 229 SPEIPSNISSEAIDFLEKTFEIDHN-KRPTAAELLKHPFL 267 (267)
T ss_pred CCcCCcccCHHHHHHHHHHccCCch-hCcCHHHHhhCCCC
Confidence 2111 11222 23 565 79999999999995
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=278.51 Aligned_cols=193 Identities=31% Similarity=0.531 Sum_probs=167.9
Q ss_pred ceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHhCCCCceeeeceeeeecCCCCceeEEEEeeccc
Q 021306 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP 119 (314)
Q Consensus 40 y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~ 119 (314)
...++-||+|+.|.||+++. .++.||||+++.- .+.+++=|++|+|+||+.|.+++ ....++|||||||.
T Consensus 126 IsELeWlGSGaQGAVF~Grl--~netVAVKKV~el---kETdIKHLRkLkH~NII~FkGVC-----tqsPcyCIiMEfCa 195 (904)
T KOG4721|consen 126 ISELEWLGSGAQGAVFLGRL--HNETVAVKKVREL---KETDIKHLRKLKHPNIITFKGVC-----TQSPCYCIIMEFCA 195 (904)
T ss_pred hhhhhhhccCcccceeeeec--cCceehhHHHhhh---hhhhHHHHHhccCcceeeEeeee-----cCCceeEEeeeccc
Confidence 34466799999999999986 6789999977533 34677889999999999999998 34445899999999
Q ss_pred c-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcccccccCCccc
Q 021306 120 E-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI 198 (314)
Q Consensus 120 ~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~ 198 (314)
. -|...|. .+.+++......|..+|+.|+.|||. +.|+|||||.-|||+.. +..|||+|||.++.........
T Consensus 196 ~GqL~~VLk----a~~~itp~llv~Wsk~IA~GM~YLH~-hKIIHRDLKSPNiLIs~-~d~VKIsDFGTS~e~~~~STkM 269 (904)
T KOG4721|consen 196 QGQLYEVLK----AGRPITPSLLVDWSKGIAGGMNYLHL-HKIIHRDLKSPNILISY-DDVVKISDFGTSKELSDKSTKM 269 (904)
T ss_pred cccHHHHHh----ccCccCHHHHHHHHHHhhhhhHHHHH-hhHhhhccCCCceEeec-cceEEeccccchHhhhhhhhhh
Confidence 5 5666655 47899999999999999999999999 89999999999999998 7889999999999877777778
Q ss_pred cccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 021306 199 SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQ 249 (314)
Q Consensus 199 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~ 249 (314)
.+.||..|||||++++.+ .+.+.||||||++||||+||..||.+.+....
T Consensus 270 SFaGTVaWMAPEvIrneP-csEKVDIwSfGVVLWEmLT~EiPYkdVdssAI 319 (904)
T KOG4721|consen 270 SFAGTVAWMAPEVIRNEP-CSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAI 319 (904)
T ss_pred hhhhhHhhhCHHHhhcCC-cccccceehhHHHHHHHHhcCCCccccchhee
Confidence 899999999999998766 89999999999999999999999988776543
|
|
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=256.19 Aligned_cols=237 Identities=25% Similarity=0.425 Sum_probs=189.4
Q ss_pred CceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeEE
Q 021306 39 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 112 (314)
Q Consensus 39 ~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 112 (314)
+|++.+.||+|+||.+|++++..+++.+++|.+.... ....+|+.++++++|+||+++.+++. .....+
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~ 75 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFE-----ENGNLY 75 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeec-----CCCeEE
Confidence 5899999999999999999999999999999886431 23457889999999999999999873 334588
Q ss_pred EEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCccccc
Q 021306 113 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 191 (314)
Q Consensus 113 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~ 191 (314)
+++||+.+ ++.+.+... ....+++.++..++.|++.|+.+||+ ++++|+||+|+||+++. ++.++++|||.+...
T Consensus 76 lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~h~~l~~~nil~~~-~~~~~l~d~~~~~~~ 151 (256)
T cd08218 76 IVMDYCEGGDLYKKINAQ--RGVLFPEDQILDWFVQICLALKHVHD-RKILHRDIKSQNIFLTK-DGTIKLGDFGIARVL 151 (256)
T ss_pred EEEecCCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEEcC-CCCEEEeeccceeec
Confidence 99999986 666655431 23468899999999999999999999 89999999999999998 788999999998755
Q ss_pred ccCCcc-ccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCH--------
Q 021306 192 IAGEAN-ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR-------- 262 (314)
Q Consensus 192 ~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~-------- 262 (314)
...... ....+++.|+|||.+.+.. .+.++|+||||+++|+|++|+.||...+..+....++.....+.+
T Consensus 152 ~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (256)
T cd08218 152 NSTVELARTCIGTPYYLSPEICENRP-YNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLR 230 (256)
T ss_pred CcchhhhhhccCCccccCHHHhCCCC-CCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCCCcccCCHHHH
Confidence 332221 2234677899999986654 788999999999999999999999888777766666554332211
Q ss_pred HHHh---ccCCCCCCCcccccccCChh
Q 021306 263 EEIR---CMNPNYTDFRFPQIKAHPWH 286 (314)
Q Consensus 263 ~~~~---~~~p~~~~~~~~~l~~~p~~ 286 (314)
+.+. ..+|+ +|+++.++++|||+
T Consensus 231 ~li~~~l~~~p~-~Rp~~~~vl~~~~~ 256 (256)
T cd08218 231 NLVSQLFKRNPR-DRPSVNSILEKNFI 256 (256)
T ss_pred HHHHHHhhCChh-hCcCHHHHhhCcCC
Confidence 1122 23666 89999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=257.35 Aligned_cols=237 Identities=27% Similarity=0.449 Sum_probs=188.6
Q ss_pred CCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc--cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeEEEEe
Q 021306 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR--RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVM 115 (314)
Q Consensus 38 ~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~--~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 115 (314)
++|++.+.||+|++|.||++....+++.+++|.+.... ....+|+.++++++|+||+++++++... ..+++++
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-----~~~~l~~ 77 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVKYYGSYFKN-----TDLWIVM 77 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecC-----CcEEEEE
Confidence 57999999999999999999998889999999987553 3456899999999999999999988543 3488999
Q ss_pred ecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcccccccC
Q 021306 116 EYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG 194 (314)
Q Consensus 116 e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~~~ 194 (314)
||+++ +|.+.+.. ....+++..++.++.|++.|+.+||+ .+++|+||+|+||+++. ++.++|+|||.+......
T Consensus 78 e~~~~~~L~~~l~~---~~~~l~~~~~~~~~~~l~~~l~~lh~-~~i~H~dl~~~ni~~~~-~~~~~l~dfg~~~~~~~~ 152 (256)
T cd06612 78 EYCGAGSVSDIMKI---TNKTLTEEEIAAILYQTLKGLEYLHS-NKKIHRDIKAGNILLNE-EGQAKLADFGVSGQLTDT 152 (256)
T ss_pred ecCCCCcHHHHHHh---CccCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCcceEEECC-CCcEEEcccccchhcccC
Confidence 99997 55555432 34678999999999999999999999 89999999999999998 788999999998765443
Q ss_pred C-ccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCC----------CHH
Q 021306 195 E-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP----------TRE 263 (314)
Q Consensus 195 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~----------~~~ 263 (314)
. ......++..|+|||.+.+. .++.++||||||+++|+|++|+.||...+.......+....... ..+
T Consensus 153 ~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (256)
T cd06612 153 MAKRNTVIGTPFWMAPEVIQEI-GYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFND 231 (256)
T ss_pred ccccccccCCccccCHHHHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHHHHH
Confidence 3 22234467889999998655 47899999999999999999999998776654443332211110 011
Q ss_pred HHh---ccCCCCCCCcccccccCChh
Q 021306 264 EIR---CMNPNYTDFRFPQIKAHPWH 286 (314)
Q Consensus 264 ~~~---~~~p~~~~~~~~~l~~~p~~ 286 (314)
.+. ..+|. +|+++.+++.|||+
T Consensus 232 ~i~~~l~~~P~-~Rps~~~il~~~~~ 256 (256)
T cd06612 232 FVKKCLVKDPE-ERPSAIQLLQHPFI 256 (256)
T ss_pred HHHHHHhcChh-hCcCHHHHhcCCCC
Confidence 222 23677 79999999999996
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=258.54 Aligned_cols=255 Identities=25% Similarity=0.396 Sum_probs=194.9
Q ss_pred CCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCCcee
Q 021306 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 110 (314)
Q Consensus 38 ~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 110 (314)
++|++.+.||+|+||.||+|++..+++.+++|.++... ....+|+.+++.++||||+++++++.... .
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~ 76 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDN-----E 76 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECC-----e
Confidence 57999999999999999999999999999999875321 12357899999999999999999885433 3
Q ss_pred EEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCccc
Q 021306 111 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 189 (314)
Q Consensus 111 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~ 189 (314)
.++++||+++ ++.+.+.........+++..+..++.|++.||.|||+ +|++|+||+|+||+++. ++.++|+|||.+.
T Consensus 77 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~H~dl~~~nil~~~-~~~~~l~d~g~~~ 154 (267)
T cd08228 77 LNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHS-RRVMHRDIKPANVFITA-TGVVKLGDLGLGR 154 (267)
T ss_pred EEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhh-CCeeCCCCCHHHEEEcC-CCCEEECccccce
Confidence 7899999996 6666665444445668999999999999999999999 89999999999999998 7889999999887
Q ss_pred ccccCCc-cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHcCCCCHHHHhc
Q 021306 190 QLIAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV-DQLVEIIKVLGTPTREEIRC 267 (314)
Q Consensus 190 ~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~ 267 (314)
....... .....+++.|+|||.+.+.. ++.++|+||||+++|+|++|+.||...... ..+...+.....++.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~----- 228 (267)
T cd08228 155 FFSSKTTAAHSLVGTPYYMSPERIHENG-YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPL----- 228 (267)
T ss_pred eccchhHHHhcCCCCccccChhhhccCC-CCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCC-----
Confidence 5533221 11235677899999986554 789999999999999999999999665422 222222222221111
Q ss_pred cCCCCCCCcccccccCChhhhhcccCChHHHHHhcchhh
Q 021306 268 MNPNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGSHIN 306 (314)
Q Consensus 268 ~~p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~~~~ 306 (314)
.+.-....+.+++..||...+..++....+++.++.++
T Consensus 229 -~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 229 -PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred -ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 01101223677888888888888888888888877664
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=292.01 Aligned_cols=203 Identities=24% Similarity=0.313 Sum_probs=165.0
Q ss_pred CCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCCcee
Q 021306 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 110 (314)
Q Consensus 38 ~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 110 (314)
++|++.+.||+|+||.||+|.+..+++.||+|++..+. ....+|+.++++++||||+++++++... ..
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~-----~~ 76 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDG-----DP 76 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeC-----CE
Confidence 58999999999999999999999999999999986432 2345789999999999999999987433 34
Q ss_pred EEEEeecccc-cHHHHHHhhhh-------cCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEE
Q 021306 111 LNLVMEYVPE-SMYRVLKHYSS-------ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKI 182 (314)
Q Consensus 111 ~~lv~e~~~~-~l~~~l~~~~~-------~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l 182 (314)
.+++|||++| +|.+.+..... ....++...+..++.|++.||.|||+ +||+||||||+||+++. ++.++|
T Consensus 77 lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs-~GIIHRDLKPeNILLd~-dg~vKL 154 (932)
T PRK13184 77 VYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHS-KGVLHRDLKPDNILLGL-FGEVVI 154 (932)
T ss_pred EEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHH-CCccccCCchheEEEcC-CCCEEE
Confidence 7899999996 66665543211 12346677889999999999999999 89999999999999998 788999
Q ss_pred eecCcccccccCC-------------------ccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 021306 183 CDFGSAKQLIAGE-------------------ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 243 (314)
Q Consensus 183 ~dfg~~~~~~~~~-------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~ 243 (314)
+|||++....... ......||+.|+|||.+.+.. ++.++||||||+++|+|+||+.||..
T Consensus 155 iDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~-~S~kSDIWSLGVILyELLTG~~PF~~ 233 (932)
T PRK13184 155 LDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVP-ASESTDIYALGVILYQMLTLSFPYRR 233 (932)
T ss_pred EecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCC-CCcHhHHHHHHHHHHHHHHCCCCCCC
Confidence 9999987541110 001235789999999986655 79999999999999999999999987
Q ss_pred CChHH
Q 021306 244 ENAVD 248 (314)
Q Consensus 244 ~~~~~ 248 (314)
.+...
T Consensus 234 ~~~~k 238 (932)
T PRK13184 234 KKGRK 238 (932)
T ss_pred cchhh
Confidence 65443
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=263.23 Aligned_cols=241 Identities=37% Similarity=0.702 Sum_probs=189.4
Q ss_pred cCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeecc------ccchHHHHHHHHhCCCCceeeeceeeeecCCCCce
Q 021306 36 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL 109 (314)
Q Consensus 36 ~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 109 (314)
..++|++.+.||.|+||.||++.+..+++.+++|.+.+. .....+|+.++++++||||+++.+++.... .
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~----~ 83 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPL----E 83 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCC----C
Confidence 467899999999999999999999999999999987542 223457999999999999999999875322 2
Q ss_pred eEEEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCccc
Q 021306 110 FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 189 (314)
Q Consensus 110 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~ 189 (314)
..++++||+++++...+. ..++++..+..++.|++.||.+||+ .+++|+||+|+||+++. ++.++|+|||.+.
T Consensus 84 ~~~lv~e~~~~~L~~~~~-----~~~~~~~~~~~~~~ql~~aL~~LH~-~~iiH~dl~p~Nili~~-~~~~~l~dfg~~~ 156 (328)
T cd07856 84 DIYFVTELLGTDLHRLLT-----SRPLEKQFIQYFLYQILRGLKYVHS-AGVVHRDLKPSNILINE-NCDLKICDFGLAR 156 (328)
T ss_pred cEEEEeehhccCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEeECC-CCCEEeCcccccc
Confidence 377999999888766554 3578899999999999999999999 89999999999999998 8889999999987
Q ss_pred ccccCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCC--------
Q 021306 190 QLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT-------- 261 (314)
Q Consensus 190 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~-------- 261 (314)
.... ......++..|+|||.+.+...++.++|+||||+++|+|++|+.||...........+.+..+.++
T Consensus 157 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (328)
T cd07856 157 IQDP--QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTIC 234 (328)
T ss_pred ccCC--CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcc
Confidence 5422 222345677899999986645588999999999999999999999988765444333332222111
Q ss_pred ------------------------------HHHHh---ccCCCCCCCcccccccCChhhhhc
Q 021306 262 ------------------------------REEIR---CMNPNYTDFRFPQIKAHPWHKVCI 290 (314)
Q Consensus 262 ------------------------------~~~~~---~~~p~~~~~~~~~l~~~p~~~~~~ 290 (314)
.+.+. ..+|+ +|+++.+++.|||+....
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~-~R~t~~ell~~~~~~~~~ 295 (328)
T cd07856 235 SENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQ-KRISAAEALAHPYLAPYH 295 (328)
T ss_pred chhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChh-hCCCHHHHhcCCcccccc
Confidence 11111 23566 899999999999985444
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=264.78 Aligned_cols=245 Identities=37% Similarity=0.634 Sum_probs=193.0
Q ss_pred cCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCC-Cc
Q 021306 36 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSK-NE 108 (314)
Q Consensus 36 ~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~-~~ 108 (314)
..++|++.+.||+|++|.||++.+..++..|++|.+.... ....+|+.++++++|+||+++++++...... ..
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 3568999999999999999999999999999999885432 1235799999999999999999987543221 12
Q ss_pred eeEEEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcc
Q 021306 109 LFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 188 (314)
Q Consensus 109 ~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~ 188 (314)
..+++|+||+++++...+. ...+++..++.++.|++.||.+||+ .||+|+||+|+||+++. ++.++|+|||.+
T Consensus 93 ~~~~lv~e~~~~~l~~~~~-----~~~l~~~~~~~i~~qi~~al~~LH~-~gi~H~dlkp~Nill~~-~~~~kl~dfg~~ 165 (343)
T cd07880 93 HDFYLVMPFMGTDLGKLMK-----HEKLSEDRIQFLVYQMLKGLKYIHA-AGIIHRDLKPGNLAVNE-DCELKILDFGLA 165 (343)
T ss_pred ceEEEEEecCCCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcC-CCCEEEeecccc
Confidence 3468999999777765554 3679999999999999999999999 89999999999999998 788999999998
Q ss_pred cccccCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCC-------
Q 021306 189 KQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT------- 261 (314)
Q Consensus 189 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~------- 261 (314)
...... .....+++.|+|||.+.+...++.++|+||||+++|++++|+.||.+.+.......+++......
T Consensus 166 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd07880 166 RQTDSE--MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKL 243 (343)
T ss_pred cccccC--ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhh
Confidence 754332 22345678899999986644578999999999999999999999988776555555444222111
Q ss_pred -------------------------------HHHH---hccCCCCCCCcccccccCChhhhhc
Q 021306 262 -------------------------------REEI---RCMNPNYTDFRFPQIKAHPWHKVCI 290 (314)
Q Consensus 262 -------------------------------~~~~---~~~~p~~~~~~~~~l~~~p~~~~~~ 290 (314)
.+.+ ...+|. +|+++.+++.|||++...
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~-~R~t~~~~l~~~~~~~~~ 305 (343)
T cd07880 244 QSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAE-SRITAAEALAHPYFEEFH 305 (343)
T ss_pred cchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChh-hCCCHHHHhcCccHhhhc
Confidence 1111 123666 899999999999998763
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-36 Score=265.37 Aligned_cols=244 Identities=36% Similarity=0.609 Sum_probs=191.4
Q ss_pred CCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCC-CCce
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTS-KNEL 109 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~~~~ 109 (314)
.++|.+.+.||+|++|.||+|.+..+++.+++|.+.... ....+|+.++++++|+||+++++++..... ....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 358999999999999999999998899999999886431 123578999999999999999998754322 1223
Q ss_pred eEEEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCccc
Q 021306 110 FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 189 (314)
Q Consensus 110 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~ 189 (314)
.+++++||+..++.... +..+++..++.++.|++.||.+||+ .+++||||+|+||+++. ++.++|+|||++.
T Consensus 94 ~~~lv~e~~~~~l~~~~------~~~~~~~~~~~~~~qi~~aL~~LH~-~~i~H~dlkp~NIll~~-~~~~kL~dfg~~~ 165 (342)
T cd07879 94 DFYLVMPYMQTDLQKIM------GHPLSEDKVQYLVYQMLCGLKYIHS-AGIIHRDLKPGNLAVNE-DCELKILDFGLAR 165 (342)
T ss_pred eEEEEecccccCHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECC-CCCEEEeeCCCCc
Confidence 36799999987654432 2568999999999999999999999 89999999999999998 8899999999987
Q ss_pred ccccCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCC--------
Q 021306 190 QLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT-------- 261 (314)
Q Consensus 190 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~-------- 261 (314)
.... ......+++.|+|||.+.+...++.++|+||||+++|+|++|+.||.+.+....+..++...+.+.
T Consensus 166 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (342)
T cd07879 166 HADA--EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLE 243 (342)
T ss_pred CCCC--CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhc
Confidence 5422 222345678899999987655578999999999999999999999998776655555444322111
Q ss_pred ------------------------------HHHHh---ccCCCCCCCcccccccCChhhhhcc
Q 021306 262 ------------------------------REEIR---CMNPNYTDFRFPQIKAHPWHKVCIF 291 (314)
Q Consensus 262 ------------------------------~~~~~---~~~p~~~~~~~~~l~~~p~~~~~~~ 291 (314)
.+.+. ..+|. +|+++.+++.|||++....
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~-~R~~~~e~l~h~~f~~~~~ 305 (342)
T cd07879 244 DKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVD-KRLTATEALEHPYFDSFRD 305 (342)
T ss_pred ccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChh-hCcCHHHHhcCcchhhccc
Confidence 11222 23566 8999999999999887653
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=264.64 Aligned_cols=243 Identities=26% Similarity=0.409 Sum_probs=189.0
Q ss_pred CCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCCcee
Q 021306 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 110 (314)
Q Consensus 38 ~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 110 (314)
++|++.+.||+|++|.||++.+..+++.|++|.+.... ....+|+.+++.++|+||+++++.+. ...+
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~ 75 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFE-----TKRH 75 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEe-----cCCE
Confidence 47999999999999999999999999999999886542 12347888999999999999998873 3335
Q ss_pred EEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCccc
Q 021306 111 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 189 (314)
Q Consensus 111 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~ 189 (314)
++++|||++| +|.+.+.. ...+++..+..++.|++.|+.|||+ .+++|+||+|+||+++. ++.++|+|||.++
T Consensus 76 ~~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~NIll~~-~~~~~l~dfg~~~ 149 (305)
T cd05609 76 LCMVMEYVEGGDCATLLKN----IGALPVDMARMYFAETVLALEYLHN-YGIVHRDLKPDNLLITS-MGHIKLTDFGLSK 149 (305)
T ss_pred EEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCchHHEEECC-CCCEEEeeCCCcc
Confidence 8899999997 55555543 4679999999999999999999999 89999999999999998 8899999999876
Q ss_pred ccccCC----------------ccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 021306 190 QLIAGE----------------ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEI 253 (314)
Q Consensus 190 ~~~~~~----------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i 253 (314)
...... ......++..|+|||.+.+.. ++.++|+||||+++|+|++|..||.+.+..+....+
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~ 228 (305)
T cd05609 150 IGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQG-YGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQV 228 (305)
T ss_pred ccCcCccccccccccccchhhccccCCccCccccCchhccCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 321100 001124567899999986544 789999999999999999999999887776656555
Q ss_pred HHHcCC-C------C---HHHHh---ccCCCCCCCc---ccccccCChhhhhcccC
Q 021306 254 IKVLGT-P------T---REEIR---CMNPNYTDFR---FPQIKAHPWHKVCIFHF 293 (314)
Q Consensus 254 ~~~~~~-~------~---~~~~~---~~~p~~~~~~---~~~l~~~p~~~~~~~~~ 293 (314)
...... + + .+.+. ..+|+ .|++ +.+++.|||++....+.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~-~R~~~~~~~~ll~~~~~~~~~~~~ 283 (305)
T cd05609 229 ISDDIEWPEGDEALPADAQDLISRLLRQNPL-ERLGTGGAFEVKQHRFFLGLDWNG 283 (305)
T ss_pred HhcccCCCCccccCCHHHHHHHHHHhccChh-hccCccCHHHHHhCccccCCCHHH
Confidence 443211 0 1 11222 23677 7886 68899999997766543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=255.78 Aligned_cols=236 Identities=31% Similarity=0.534 Sum_probs=185.9
Q ss_pred CceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc---------cchHHHHHHHHhCCCCceeeeceeeeecCCCCce
Q 021306 39 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL 109 (314)
Q Consensus 39 ~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~---------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 109 (314)
+|+..+.||+|++|.||+|....+++.+++|.+.... ....+|+.+++.++|+||+++++++.. ..
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~ 75 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTERE-----ED 75 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEec-----CC
Confidence 4888999999999999999998899999999875432 234578899999999999999998743 23
Q ss_pred eEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcc
Q 021306 110 FLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 188 (314)
Q Consensus 110 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~ 188 (314)
.+++++||+++ +|.+.+. ....+++..++.++.|++.|+.+||+ .|++|+||+|+||+++. ++.++|+|||.+
T Consensus 76 ~~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~~~ni~~~~-~~~~kl~d~~~~ 149 (258)
T cd06632 76 NLYIFLELVPGGSLAKLLK----KYGSFPEPVIRLYTRQILLGLEYLHD-RNTVHRDIKGANILVDT-NGVVKLADFGMA 149 (258)
T ss_pred eEEEEEEecCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECC-CCCEEEccCccc
Confidence 48899999987 5555544 34568999999999999999999999 89999999999999998 789999999998
Q ss_pred cccccCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCC------H
Q 021306 189 KQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT------R 262 (314)
Q Consensus 189 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~------~ 262 (314)
.............++..|++||.+.....++.++|+||||+++|+|++|+.||...........+......+. .
T Consensus 150 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (258)
T cd06632 150 KQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSD 229 (258)
T ss_pred eeccccccccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCCcCH
Confidence 7654433333455788899999985544478999999999999999999999987775555544443111111 1
Q ss_pred ---HHHh-c--cCCCCCCCcccccccCChh
Q 021306 263 ---EEIR-C--MNPNYTDFRFPQIKAHPWH 286 (314)
Q Consensus 263 ---~~~~-~--~~p~~~~~~~~~l~~~p~~ 286 (314)
+.+. + .+|. +|+++.+++.|||+
T Consensus 230 ~~~~li~~~l~~~p~-~Rp~~~~~l~~~~~ 258 (258)
T cd06632 230 EAKDFILKCLQRDPS-LRPTAAELLEHPFV 258 (258)
T ss_pred HHHHHHHHHhhcCcc-cCcCHHHHhcCCCC
Confidence 1111 2 3666 78999999999985
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=259.00 Aligned_cols=249 Identities=20% Similarity=0.232 Sum_probs=189.2
Q ss_pred CCCceeeeeEeecCceEEEEEEEC---CCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCc
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCL---ETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 108 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~---~~~~~~~vK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 108 (314)
.++|++.+.||+|+||.||++.++ ..+..+++|.++... ....+|+..+++++||||+++++++...
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~----- 78 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRG----- 78 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecC-----
Confidence 457999999999999999999765 346789999886542 2335788999999999999999987433
Q ss_pred eeEEEEeeccccc-HHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCc
Q 021306 109 LFLNLVMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 187 (314)
Q Consensus 109 ~~~~lv~e~~~~~-l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~ 187 (314)
...++||||++++ |.+.+.. ....+++.+++.++.|++.||.|||+ +|++|+||+|+||+++. ++.++++|||.
T Consensus 79 ~~~~lv~e~~~~~~L~~~l~~---~~~~l~~~~~~~~~~~i~~al~~lH~-~~iiH~dikp~nili~~-~~~~~l~dfg~ 153 (266)
T cd05064 79 NTMMIVTEYMSNGALDSFLRK---HEGQLVAGQLMGMLPGLASGMKYLSE-MGYVHKGLAAHKVLVNS-DLVCKISGFRR 153 (266)
T ss_pred CCcEEEEEeCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHH-CCEeeccccHhhEEEcC-CCcEEECCCcc
Confidence 3488999999975 4434432 23578999999999999999999999 89999999999999998 88999999998
Q ss_pred ccccccCCcc--ccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCHHH
Q 021306 188 AKQLIAGEAN--ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREE 264 (314)
Q Consensus 188 ~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 264 (314)
+......... ....++..|+|||.+.+.. ++.++||||||+++|++++ |..||.+.+..+....+.+....+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~---- 228 (266)
T cd05064 154 LQEDKSEAIYTTMSGKSPVLWAAPEAIQYHH-FSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLP---- 228 (266)
T ss_pred cccccccchhcccCCCCceeecCHHHHhhCC-ccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCC----
Confidence 7543222111 1122356799999986544 8999999999999999775 999999888766555443322111
Q ss_pred HhccCCCCCCCcccccccCChhhhhcccCChHHHHHhcch
Q 021306 265 IRCMNPNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGSH 304 (314)
Q Consensus 265 ~~~~~p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~~ 304 (314)
.|......+.+++..||...+..++....+...+..
T Consensus 229 ----~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~ 264 (266)
T cd05064 229 ----APRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSK 264 (266)
T ss_pred ----CCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHh
Confidence 112133456778888888888888877777776543
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=260.27 Aligned_cols=202 Identities=27% Similarity=0.433 Sum_probs=165.9
Q ss_pred CCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeEE
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 112 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 112 (314)
.++|++.+.||+|+||.||++++..+++.+++|.+.... ....+|+.++++++|+||+++++.+... ..++
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~-----~~~~ 82 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSR-----EKLW 82 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeC-----CEEE
Confidence 347999999999999999999999999999999886432 2345789999999999999999987433 3478
Q ss_pred EEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCccccc
Q 021306 113 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 191 (314)
Q Consensus 113 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~ 191 (314)
+++||+++ +|.+.+. ...++++.++..++.|++.|+.|||+ .|++|+||+|+||+++. ++.++|+|||.+...
T Consensus 83 iv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~nill~~-~~~~~l~dfg~~~~~ 156 (267)
T cd06646 83 ICMEYCGGGSLQDIYH----VTGPLSELQIAYVCRETLQGLAYLHS-KGKMHRDIKGANILLTD-NGDVKLADFGVAAKI 156 (267)
T ss_pred EEEeCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEECC-CCCEEECcCccceee
Confidence 99999996 5555443 24678999999999999999999999 89999999999999987 778999999998765
Q ss_pred ccCC-ccccccccccccccccccC--CCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 021306 192 IAGE-ANISYICSRFYRAPELIFG--ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQ 249 (314)
Q Consensus 192 ~~~~-~~~~~~~~~~y~aPE~~~~--~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~ 249 (314)
.... ......+++.|+|||.+.+ ...++.++|+||||+++|+|++|+.||....+.+.
T Consensus 157 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~ 217 (267)
T cd06646 157 TATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA 217 (267)
T ss_pred cccccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhh
Confidence 3322 1223456788999998742 33367899999999999999999999976655443
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=256.57 Aligned_cols=234 Identities=26% Similarity=0.465 Sum_probs=181.9
Q ss_pred CceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc----------cchHHHHHHHHhCCCCceeeeceeeeecCCCCc
Q 021306 39 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 108 (314)
Q Consensus 39 ~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~----------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 108 (314)
+|++.+.||+|+||.||++.. .+++.+++|.+.... ....+|+.+++.++|+||+++++++.. .
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~ 74 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLD-----D 74 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeec-----C
Confidence 488999999999999999985 578899999876432 224578999999999999999998843 3
Q ss_pred eeEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCc
Q 021306 109 LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 187 (314)
Q Consensus 109 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~ 187 (314)
...++++||+++ +|.+.+. ...++++..++.++.|++.|+.+||+ .+++|+||+|+||+++. ++.++|+|||.
T Consensus 75 ~~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~nil~~~-~~~~~l~dfg~ 148 (265)
T cd06631 75 NTISIFMEFVPGGSISSILN----RFGPLPEPVFCKYTKQILDGVAYLHN-NCVVHRDIKGNNVMLMP-NGIIKLIDFGC 148 (265)
T ss_pred CeEEEEEecCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCcCHHhEEECC-CCeEEeccchh
Confidence 458899999987 5554443 34678999999999999999999999 89999999999999997 78899999998
Q ss_pred ccccccC-------CccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCC
Q 021306 188 AKQLIAG-------EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 260 (314)
Q Consensus 188 ~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~ 260 (314)
+...... .......++..|+|||.+.+.. ++.++|+||||+++|+|++|..||...+.......+.......
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 227 (265)
T cd06631 149 ARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESG-YGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLM 227 (265)
T ss_pred hHhhhhccccccccccccccCCCccccChhhhcCCC-CcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCC
Confidence 8654211 1112345678899999986544 7899999999999999999999998776555444433321111
Q ss_pred --C--------HHHHh-cc--CCCCCCCcccccccCChh
Q 021306 261 --T--------REEIR-CM--NPNYTDFRFPQIKAHPWH 286 (314)
Q Consensus 261 --~--------~~~~~-~~--~p~~~~~~~~~l~~~p~~ 286 (314)
. .+.+. ++ +|+ +|+++.+++.|||+
T Consensus 228 ~~~~~~~~~~~~~~i~~~l~~~p~-~Rp~~~~~l~~~~~ 265 (265)
T cd06631 228 PRLPDSFSAAAIDFVTSCLTRDQH-ERPSALQLLRHDFL 265 (265)
T ss_pred CCCCCCCCHHHHHHHHHHhcCCcc-cCCCHHHHhcCCCC
Confidence 1 11222 23 566 89999999999996
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=258.96 Aligned_cols=210 Identities=40% Similarity=0.729 Sum_probs=174.5
Q ss_pred ceeeeeEeecCceEEEEEEECCCCcEEEEEEeecccc-----chHHHHHHHHhCC-CCceeeeceeeeecCCCCceeEEE
Q 021306 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNRELQLMRVMD-HPNVISLKHCFFSTTSKNELFLNL 113 (314)
Q Consensus 40 y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~~-----~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~l 113 (314)
|++.+.||+|++|.||+|+...+++.+++|.+..... ...+|+..+++++ |+|++++++++.. ....++
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~-----~~~~~l 75 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRE-----NDELYF 75 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhc-----CCcEEE
Confidence 7889999999999999999988899999998865432 2246888899998 9999999998854 334889
Q ss_pred EeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCccccccc
Q 021306 114 VMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA 193 (314)
Q Consensus 114 v~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~~ 193 (314)
||||+.+++.+.+... ....+++.++..++.|++.+|.+||+ +|++|+||+|+||+++. ++.++|+|||.+.....
T Consensus 76 v~e~~~~~l~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~Lh~-~~i~H~dl~~~ni~i~~-~~~~~l~d~~~~~~~~~ 151 (283)
T cd07830 76 VFEYMEGNLYQLMKDR--KGKPFSESVIRSIIYQILQGLAHIHK-HGFFHRDLKPENLLVSG-PEVVKIADFGLAREIRS 151 (283)
T ss_pred EEecCCCCHHHHHHhc--ccccCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCChhhEEEcC-CCCEEEeecccceeccC
Confidence 9999988887777642 12478999999999999999999999 89999999999999998 88999999999876554
Q ss_pred CCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcC
Q 021306 194 GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLG 258 (314)
Q Consensus 194 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~ 258 (314)
........++..|+|||.+.+...++.++|+||||+++++|++|+.||......+.+..+....+
T Consensus 152 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~ 216 (283)
T cd07830 152 RPPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLG 216 (283)
T ss_pred CCCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcC
Confidence 33333455678899999886655678999999999999999999999988877766666554433
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-36 Score=264.21 Aligned_cols=244 Identities=37% Similarity=0.637 Sum_probs=190.2
Q ss_pred CceeeeeEeecCceEEEEEEECCC--CcEEEEEEeeccc------cchHHHHHHHHhC-CCCceeeeceeeeecCCCCce
Q 021306 39 SYMAERVVGTGSFGIVFQAKCLET--GETVAIKKVLQDR------RYKNRELQLMRVM-DHPNVISLKHCFFSTTSKNEL 109 (314)
Q Consensus 39 ~y~~~~~Lg~g~~g~Vy~~~~~~~--~~~~~vK~~~~~~------~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~ 109 (314)
+|++.+.||+|+||.||++++..+ +..+++|.+.... ....+|+.+++++ .|+||+++++...... ....
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~-~~~~ 79 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFP-GNFN 79 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeecc-ccCC
Confidence 589999999999999999999887 8999999886431 2234688889888 5999999988654321 2223
Q ss_pred eEEEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCccc
Q 021306 110 FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 189 (314)
Q Consensus 110 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~ 189 (314)
..++++++++++|.+.+.. ...+++..++.++.||+.||.+||+ +|++|+||||+||+++. ++.++|+|||.+.
T Consensus 80 ~~~~~~e~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~givH~dlkp~Nili~~-~~~~kl~Dfg~a~ 153 (332)
T cd07857 80 ELYLYEELMEADLHQIIRS----GQPLTDAHFQSFIYQILCGLKYIHS-ANVLHRDLKPGNLLVNA-DCELKICDFGLAR 153 (332)
T ss_pred cEEEEEecccCCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHeEEcC-CCCEEeCcCCCce
Confidence 4679999999887776653 5779999999999999999999999 89999999999999998 7889999999987
Q ss_pred ccccCCc-----cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCH--
Q 021306 190 QLIAGEA-----NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR-- 262 (314)
Q Consensus 190 ~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~-- 262 (314)
....... .....++..|+|||.+.+...++.++|+||||+++|+|++|+.||...+....+..++...+.+..
T Consensus 154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 233 (332)
T cd07857 154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEET 233 (332)
T ss_pred ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 5432211 122456888999998866555889999999999999999999999887765555554443322211
Q ss_pred ------------------------------------HHHh---ccCCCCCCCcccccccCChhhhhc
Q 021306 263 ------------------------------------EEIR---CMNPNYTDFRFPQIKAHPWHKVCI 290 (314)
Q Consensus 263 ------------------------------------~~~~---~~~p~~~~~~~~~l~~~p~~~~~~ 290 (314)
+.+. ..+|. +|+++.+++.|||++...
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~-~R~t~~~ll~~~~~~~~~ 299 (332)
T cd07857 234 LSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPT-KRISVEEALEHPYLAIWH 299 (332)
T ss_pred HHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcc-cCCCHHHHhcChhhhhhc
Confidence 1111 23566 799999999999987543
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=260.69 Aligned_cols=240 Identities=28% Similarity=0.443 Sum_probs=190.9
Q ss_pred CCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCCcee
Q 021306 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 110 (314)
Q Consensus 38 ~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 110 (314)
..|++.+.||+|++|.||++++..+++.|++|.+.... ....+|+.+++.++|+|++++.+++.... .
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~-----~ 89 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREH-----T 89 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCC-----e
Confidence 35999999999999999999998899999999886322 22357889999999999999999885433 3
Q ss_pred EEEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcccc
Q 021306 111 LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 190 (314)
Q Consensus 111 ~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~ 190 (314)
.++|+||+.|++.+.+.. ....+++..+..++.|++.||.|||+ .|++|+||+|+||+++. ++.++|+|||++..
T Consensus 90 ~~lv~e~~~g~l~~~~~~---~~~~l~~~~~~~~~~ql~~~L~~LH~-~~i~H~dl~p~nIl~~~-~~~~kL~dfg~~~~ 164 (307)
T cd06607 90 AWLVMEYCLGSASDILEV---HKKPLQEVEIAAICHGALQGLAYLHS-HERIHRDIKAGNILLTE-PGTVKLADFGSASL 164 (307)
T ss_pred EEEEHHhhCCCHHHHHHH---cccCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCcccEEECC-CCCEEEeecCccee
Confidence 789999999988776653 23579999999999999999999999 89999999999999998 78899999998865
Q ss_pred cccCCccccccccccccccccccC--CCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCC-------
Q 021306 191 LIAGEANISYICSRFYRAPELIFG--ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT------- 261 (314)
Q Consensus 191 ~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~------- 261 (314)
.... ....+++.|+|||.+.+ ...++.++||||||+++|+|++|+.||.+.+.......+........
T Consensus 165 ~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (307)
T cd06607 165 VSPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSD 241 (307)
T ss_pred cCCC---CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCchhhCH
Confidence 4322 23456778999998742 34478899999999999999999999988776655544433211111
Q ss_pred --HHHHh-c--cCCCCCCCcccccccCChhhhhcc
Q 021306 262 --REEIR-C--MNPNYTDFRFPQIKAHPWHKVCIF 291 (314)
Q Consensus 262 --~~~~~-~--~~p~~~~~~~~~l~~~p~~~~~~~ 291 (314)
.+.+. + .+|. +|+++.+|+.|||++....
T Consensus 242 ~~~~li~~~l~~~p~-~Rp~~~~il~~~~~~~~~~ 275 (307)
T cd06607 242 YFRNFVDSCLQKIPQ-DRPSSEELLKHRFVLRERP 275 (307)
T ss_pred HHHHHHHHHhcCChh-hCcCHHHHhcChhhcccCC
Confidence 11122 2 3666 8999999999999987553
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=281.54 Aligned_cols=246 Identities=18% Similarity=0.276 Sum_probs=178.9
Q ss_pred CCCceeeeeEeecCceEEEEEEECCCC-cEEEEE------------------Eeecc---ccchHHHHHHHHhCCCCcee
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCLETG-ETVAIK------------------KVLQD---RRYKNRELQLMRVMDHPNVI 94 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~~~~-~~~~vK------------------~~~~~---~~~~~~e~~~l~~l~h~~iv 94 (314)
.++|++.+.||+|+||.||+|..+... ...+.| .+... .....+|+.++++++|+||+
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 468999999999999999998764322 111111 11111 12345899999999999999
Q ss_pred eeceeeeecCCCCceeEEEEeecccccHHHHHHhhh-hcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEE
Q 021306 95 SLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYS-SANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLV 173 (314)
Q Consensus 95 ~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~-~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~ 173 (314)
++++++.... ..+++++++.+++...+.... .........+++.++.||+.||.|||+ +||+||||||+|||+
T Consensus 227 ~l~~~~~~~~-----~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~-~gIiHrDLKP~NILl 300 (501)
T PHA03210 227 KIEEILRSEA-----NTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHD-KKLIHRDIKLENIFL 300 (501)
T ss_pred cEeEEEEECC-----eeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEE
Confidence 9999885433 378999999988877664321 112334567788999999999999999 899999999999999
Q ss_pred cCCCCcEEEeecCcccccccCCc--cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCC-CCCCC--ChHH
Q 021306 174 DPLTHQVKICDFGSAKQLIAGEA--NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQP-LFPGE--NAVD 248 (314)
Q Consensus 174 ~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~-pf~~~--~~~~ 248 (314)
+. ++.++|+|||++........ .....++..|+|||.+.+.. ++.++|||||||++|||++|.. ||... ....
T Consensus 301 ~~-~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~ 378 (501)
T PHA03210 301 NC-DGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDG-YCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGK 378 (501)
T ss_pred CC-CCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCC-CCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHH
Confidence 98 78899999999976543322 22356899999999997654 8999999999999999999875 44332 2333
Q ss_pred HHHHHHHHcCCCC------------------------------------------HHHHhccCCCCCCCcccccccCChh
Q 021306 249 QLVEIIKVLGTPT------------------------------------------REEIRCMNPNYTDFRFPQIKAHPWH 286 (314)
Q Consensus 249 ~~~~i~~~~~~~~------------------------------------------~~~~~~~~p~~~~~~~~~l~~~p~~ 286 (314)
.+.+++....... ...+...+|. +|+++.+++.|||+
T Consensus 379 ~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~-~Rpsa~elL~hp~f 457 (501)
T PHA03210 379 QLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWH-LRPGAAELLALPLF 457 (501)
T ss_pred HHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcc-cCcCHHHHhhChhh
Confidence 4444333221100 0112245777 89999999999999
Q ss_pred hhhcc
Q 021306 287 KVCIF 291 (314)
Q Consensus 287 ~~~~~ 291 (314)
.....
T Consensus 458 ~~~~~ 462 (501)
T PHA03210 458 SAEEE 462 (501)
T ss_pred hcCCc
Confidence 77654
|
|
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=257.52 Aligned_cols=247 Identities=27% Similarity=0.487 Sum_probs=189.5
Q ss_pred CCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeEE
Q 021306 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 112 (314)
Q Consensus 38 ~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 112 (314)
++|+..+.||.|++|.||++.+..+++.+++|.+.... ....+|++++++++|+||+++++++.... ...++
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~---~~~~~ 77 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDES---SSSIG 77 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccC---CCeEE
Confidence 46899999999999999999999999999999887532 23458999999999999999999875432 23478
Q ss_pred EEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCccccc
Q 021306 113 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 191 (314)
Q Consensus 113 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~ 191 (314)
++|||+++ +|.+.+.........+++..+..++.||+.||.|||+ .|++|+||+|+||+++. ++.++|+|||++...
T Consensus 78 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~-~~i~H~dl~~~nil~~~-~~~~~l~dfg~~~~~ 155 (287)
T cd06621 78 IAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHS-RKIIHRDIKPSNILLTR-KGQVKLCDFGVSGEL 155 (287)
T ss_pred EEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEEec-CCeEEEeeccccccc
Confidence 99999986 6666555444445778999999999999999999999 89999999999999998 778999999998654
Q ss_pred ccCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC-----hHHHHHHHHHHcC----CCC-
Q 021306 192 IAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN-----AVDQLVEIIKVLG----TPT- 261 (314)
Q Consensus 192 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~-----~~~~~~~i~~~~~----~~~- 261 (314)
..... ....++..|+|||.+.+.. ++.++|+||||+++|+|++|+.||.... ..+....+..... ...
T Consensus 156 ~~~~~-~~~~~~~~y~~pE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd06621 156 VNSLA-GTFTGTSFYMAPERIQGKP-YSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPG 233 (287)
T ss_pred ccccc-ccccCCccccCHHHhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCC
Confidence 32221 2334577899999986544 8899999999999999999999997652 2222222221110 000
Q ss_pred ---------HHHHh-cc--CCCCCCCcccccccCChhhhhccc
Q 021306 262 ---------REEIR-CM--NPNYTDFRFPQIKAHPWHKVCIFH 292 (314)
Q Consensus 262 ---------~~~~~-~~--~p~~~~~~~~~l~~~p~~~~~~~~ 292 (314)
.+.+. ++ +|+ +|+++.++++|||++....+
T Consensus 234 ~~~~~~~~~~~li~~~l~~~p~-~Rpt~~eil~~~~~~~~~~~ 275 (287)
T cd06621 234 NGIKWSEEFKDFIKQCLEKDPT-RRPTPWDMLEHPWIKAQMKK 275 (287)
T ss_pred CCCchHHHHHHHHHHHcCCCcc-cCCCHHHHHhCccccccccc
Confidence 11222 23 566 89999999999999665544
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=262.16 Aligned_cols=248 Identities=24% Similarity=0.357 Sum_probs=189.0
Q ss_pred CCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHhCC-CCceeeeceeeeecCCCCceeE
Q 021306 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMD-HPNVISLKHCFFSTTSKNELFL 111 (314)
Q Consensus 38 ~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~-----~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~ 111 (314)
++|+..+.||+|+||.||++.+..+++.+++|.+.... ....+|+.++.++. |+||+++++++.... ..
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~-----~~ 78 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREG-----DC 78 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCC-----cE
Confidence 46888899999999999999999999999999886432 23357888888885 999999999875433 37
Q ss_pred EEEeecccccHHHHHHhh-hhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcccc
Q 021306 112 NLVMEYVPESMYRVLKHY-SSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 190 (314)
Q Consensus 112 ~lv~e~~~~~l~~~l~~~-~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~ 190 (314)
++++||+.+++.+..... ......+++..+..++.|++.||.|||+..+++|+||+|+||+++. ++.++|+|||++..
T Consensus 79 ~~~~e~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~-~~~~kl~dfg~~~~ 157 (288)
T cd06616 79 WICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDR-NGNIKLCDFGISGQ 157 (288)
T ss_pred EEEEecccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEcc-CCcEEEeecchhHH
Confidence 799999998765544322 1234679999999999999999999997249999999999999998 78899999999876
Q ss_pred cccCCccccccccccccccccccCC--CCCCcchhHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHcCCC-------
Q 021306 191 LIAGEANISYICSRFYRAPELIFGA--TEYTTSIDIWSAGCVLAELLLGQPLFPGENA-VDQLVEIIKVLGTP------- 260 (314)
Q Consensus 191 ~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~~Dv~slG~il~el~tg~~pf~~~~~-~~~~~~i~~~~~~~------- 260 (314)
...........++..|+|||.+.+. ..++.++||||||+++|+|++|+.||..... .+.+.++.....+.
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd06616 158 LVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEER 237 (288)
T ss_pred hccCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCCC
Confidence 5443333344568889999998665 3578999999999999999999999976652 12222222111100
Q ss_pred -----CHHHHh-c--cCCCCCCCcccccccCChhhhhccc
Q 021306 261 -----TREEIR-C--MNPNYTDFRFPQIKAHPWHKVCIFH 292 (314)
Q Consensus 261 -----~~~~~~-~--~~p~~~~~~~~~l~~~p~~~~~~~~ 292 (314)
..+.+. + .+|+ +|++++++++|||++....+
T Consensus 238 ~~~~~l~~li~~~l~~~p~-~Rpt~~~i~~~~~~~~~~~~ 276 (288)
T cd06616 238 EFSPSFVNFINLCLIKDES-KRPKYKELLEHPFIKDYEER 276 (288)
T ss_pred ccCHHHHHHHHHHccCChh-hCcCHHHHhcChhhhchhhc
Confidence 012222 2 2566 89999999999999886643
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-36 Score=258.50 Aligned_cols=245 Identities=27% Similarity=0.414 Sum_probs=188.7
Q ss_pred CCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHhC-CCCceeeeceeeeecCC-CCceeE
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVM-DHPNVISLKHCFFSTTS-KNELFL 111 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~---~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~-~~~~~~ 111 (314)
.+.|++.+.||.|+||.||++++..+++.+++|.+.... .....|+.+++++ .|+||+++++++..... ....++
T Consensus 15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 94 (282)
T cd06636 15 AGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQL 94 (282)
T ss_pred hhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEE
Confidence 468999999999999999999999999999999886543 2345678888888 69999999998754322 234568
Q ss_pred EEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcccc
Q 021306 112 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 190 (314)
Q Consensus 112 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~ 190 (314)
+++|||+++ ++.+.+.. .....+++.+++.++.|++.|+.|||+ +|++|+||+|+||+++. ++.++|+|||.+..
T Consensus 95 ~iv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~qi~~al~~LH~-~~ivH~dl~~~nili~~-~~~~~l~dfg~~~~ 170 (282)
T cd06636 95 WLVMEFCGAGSVTDLVKN--TKGNALKEDWIAYICREILRGLAHLHA-HKVIHRDIKGQNVLLTE-NAEVKLVDFGVSAQ 170 (282)
T ss_pred EEEEEeCCCCcHHHHHHH--ccCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECC-CCCEEEeeCcchhh
Confidence 899999986 56655543 224568899999999999999999999 89999999999999998 78899999999875
Q ss_pred cccC-CccccccccccccccccccC----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCC-----
Q 021306 191 LIAG-EANISYICSRFYRAPELIFG----ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP----- 260 (314)
Q Consensus 191 ~~~~-~~~~~~~~~~~y~aPE~~~~----~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~----- 260 (314)
.... .......+++.|+|||.+.. ...++.++|+||||+++|+|++|..||....+......+.......
T Consensus 171 ~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (282)
T cd06636 171 LDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKSKK 250 (282)
T ss_pred hhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCCCCCcccc
Confidence 4322 12233557888999999752 2346789999999999999999999998776655554443332211
Q ss_pred -C---HHHHh-c--cCCCCCCCcccccccCChh
Q 021306 261 -T---REEIR-C--MNPNYTDFRFPQIKAHPWH 286 (314)
Q Consensus 261 -~---~~~~~-~--~~p~~~~~~~~~l~~~p~~ 286 (314)
+ .+.+. + .+|. .|+++.+|++|||+
T Consensus 251 ~~~~~~~li~~cl~~~p~-~Rp~~~ell~~~~~ 282 (282)
T cd06636 251 WSKKFIDFIEGCLVKNYL-SRPSTEQLLKHPFI 282 (282)
T ss_pred cCHHHHHHHHHHhCCChh-hCcCHHHHhcCCCC
Confidence 1 12222 2 3566 89999999999996
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=258.13 Aligned_cols=240 Identities=26% Similarity=0.388 Sum_probs=190.6
Q ss_pred CceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeEEE
Q 021306 39 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 113 (314)
Q Consensus 39 ~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 113 (314)
.|+..+.||.|++|.||+|.+..+++.+++|.+.... ....+|+.+++.+.|+||+++++++... .+.++
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~l 79 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKG-----TKLWI 79 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC-----CEEEE
Confidence 5889999999999999999998899999999886442 2345788999999999999999988443 34889
Q ss_pred Eeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcccccc
Q 021306 114 VMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 192 (314)
Q Consensus 114 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~ 192 (314)
||||++| +|.+.+. ..++++.++..++.|++.|+.+||+ .+++|+||+|+||+++. ++.++++|||.+....
T Consensus 80 v~e~~~~~~L~~~i~-----~~~l~~~~~~~~~~~l~~~l~~lh~-~~ivH~dl~p~Nil~~~-~~~~~l~dfg~~~~~~ 152 (277)
T cd06640 80 IMEYLGGGSALDLLR-----AGPFDEFQIATMLKEILKGLDYLHS-EKKIHRDIKAANVLLSE-QGDVKLADFGVAGQLT 152 (277)
T ss_pred EEecCCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh-CCccCcCCChhhEEEcC-CCCEEEcccccceecc
Confidence 9999987 5555443 3578999999999999999999999 89999999999999998 7889999999987554
Q ss_pred cCCc-cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCC--------HH
Q 021306 193 AGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT--------RE 263 (314)
Q Consensus 193 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~--------~~ 263 (314)
.... .....++..|+|||.+.+.. ++.++|+||||+++|+|++|..||...++......+.....+.. .+
T Consensus 153 ~~~~~~~~~~~~~~y~apE~~~~~~-~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (277)
T cd06640 153 DTQIKRNTFVGTPFWMAPEVIQQSA-YDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKPFKE 231 (277)
T ss_pred CCccccccccCcccccCHhHhccCC-CccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCCCCCCchhhhHHHHH
Confidence 3221 22345677899999986554 78999999999999999999999988776555444332222111 11
Q ss_pred HHh---ccCCCCCCCcccccccCChhhhhccc
Q 021306 264 EIR---CMNPNYTDFRFPQIKAHPWHKVCIFH 292 (314)
Q Consensus 264 ~~~---~~~p~~~~~~~~~l~~~p~~~~~~~~ 292 (314)
.+. ..+|+ .|+++.++++|||+.....+
T Consensus 232 li~~~l~~~p~-~Rp~~~~il~~~~~~~~~~~ 262 (277)
T cd06640 232 FIDACLNKDPS-FRPTAKELLKHKFIVKNAKK 262 (277)
T ss_pred HHHHHcccCcc-cCcCHHHHHhChHhhhcchh
Confidence 111 23677 79999999999999877764
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=252.70 Aligned_cols=237 Identities=28% Similarity=0.458 Sum_probs=187.9
Q ss_pred CceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeEE
Q 021306 39 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 112 (314)
Q Consensus 39 ~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 112 (314)
+|++.+.||.|++|.||.+++..+++.+++|.+.... ....+|+.++++++|+||+++++++... ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-----~~~~ 75 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDD-----NTLL 75 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecC-----CeEE
Confidence 5999999999999999999999999999999876432 2345789999999999999999998543 3488
Q ss_pred EEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCccccc
Q 021306 113 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 191 (314)
Q Consensus 113 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~ 191 (314)
+++||+++ +|.+.+... ....+++.++..++.|++.++.+||+ .|++|+||+|+||+++. ++.++|+|||.+...
T Consensus 76 ~~~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~h~dl~p~ni~~~~-~~~~kl~d~~~~~~~ 151 (256)
T cd08221 76 IEMEYANGGTLYDKIVRQ--KGQLFEEEMVLWYLFQIVSAVSYIHK-AGILHRDIKTLNIFLTK-AGLIKLGDFGISKIL 151 (256)
T ss_pred EEEEecCCCcHHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCChHhEEEeC-CCCEEECcCcceEEc
Confidence 99999986 666655432 24578999999999999999999999 89999999999999998 788999999998755
Q ss_pred ccCC-ccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCH--------
Q 021306 192 IAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR-------- 262 (314)
Q Consensus 192 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~-------- 262 (314)
.... ......+++.|+|||.+.+.. ++.++|+||||+++|+|++|..||...+..+....+......+..
T Consensus 152 ~~~~~~~~~~~~~~~y~ape~~~~~~-~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (256)
T cd08221 152 GSEYSMAETVVGTPYYMSPELCQGVK-YNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELI 230 (256)
T ss_pred ccccccccccCCCccccCHhhcCCCC-CCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHH
Confidence 3332 223345688999999986654 788999999999999999999999888777766666543222211
Q ss_pred HHHh-c--cCCCCCCCcccccccCChh
Q 021306 263 EEIR-C--MNPNYTDFRFPQIKAHPWH 286 (314)
Q Consensus 263 ~~~~-~--~~p~~~~~~~~~l~~~p~~ 286 (314)
+.+. + .+|. .|+++.++++|||+
T Consensus 231 ~~i~~~l~~~p~-~R~s~~~ll~~~~l 256 (256)
T cd08221 231 SLVHSLLQQDPE-KRPTADEVLDQPLL 256 (256)
T ss_pred HHHHHHcccCcc-cCCCHHHHhhCcCC
Confidence 1111 2 2555 67888888888874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=244.47 Aligned_cols=204 Identities=29% Similarity=0.423 Sum_probs=172.6
Q ss_pred CCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeec----cccchHHHHHHHHhCCCCceeeeceeeeecCCCCceeEE
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQ----DRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 112 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 112 (314)
.++|++.+.||.|||+-||+++...+++.||+|++.- +.....+|++..++++|||+++++++............|
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~y 99 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAY 99 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEE
Confidence 4589999999999999999999999999999999842 234446899999999999999998876554444555688
Q ss_pred EEeeccc-ccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCC--ceecCCCCCcEEEcCCCCcEEEeecCccc
Q 021306 113 LVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR--VCHRDLKPQNLLVDPLTHQVKICDFGSAK 189 (314)
Q Consensus 113 lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~--i~h~dl~p~Nil~~~~~~~~~l~dfg~~~ 189 (314)
++++|.. |++++.+......+..+++.++..|+.++++||++||+ .. +.|+||||.||++.. .+.++|+|||.+.
T Consensus 100 ll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~-~~~~yAH~DiKP~NILls~-~~~~vl~D~GS~~ 177 (302)
T KOG2345|consen 100 LLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHE-KEPPYAHRDIKPANILLSD-SGLPVLMDLGSAT 177 (302)
T ss_pred EEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhc-cCCcccccCCCcceeEecC-CCceEEEeccCcc
Confidence 9999998 67999999887778899999999999999999999999 77 999999999999998 8899999999987
Q ss_pred ccccCCcc----------ccccccccccccccccC--CCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 021306 190 QLIAGEAN----------ISYICSRFYRAPELIFG--ATEYTTSIDIWSAGCVLAELLLGQPLFP 242 (314)
Q Consensus 190 ~~~~~~~~----------~~~~~~~~y~aPE~~~~--~~~~~~~~Dv~slG~il~el~tg~~pf~ 242 (314)
.....-.. ....+|..|+|||.+.- ....+.++|||||||+||.|+.|..||.
T Consensus 178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe 242 (302)
T KOG2345|consen 178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFE 242 (302)
T ss_pred ccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcch
Confidence 65332211 13456889999999732 2336789999999999999999999994
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=253.48 Aligned_cols=250 Identities=35% Similarity=0.589 Sum_probs=201.3
Q ss_pred ccCCCceeeeeEeecCceEEEEEEECCCC----cEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecC
Q 021306 35 KQTISYMAERVVGTGSFGIVFQAKCLETG----ETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTT 104 (314)
Q Consensus 35 ~~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~----~~~~vK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 104 (314)
+....|++...||+|.||.||++..+.++ +.+|+|+++.+. ...-+|+.+++.++|+|++.+..+|...+
T Consensus 21 e~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d 100 (438)
T KOG0666|consen 21 EDLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHD 100 (438)
T ss_pred HHHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccC
Confidence 34468999999999999999999655543 378999997552 22248999999999999999999886542
Q ss_pred CCCceeEEEEeecccccHHHHHHhhhhc-CCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCC---CCcE
Q 021306 105 SKNELFLNLVMEYVPESMYRVLKHYSSA-NQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPL---THQV 180 (314)
Q Consensus 105 ~~~~~~~~lv~e~~~~~l~~~l~~~~~~-~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~---~~~~ 180 (314)
..+++++||.+.+|+..+...... ...++...++.++.||+.|+.|||+ +-|.||||||.||++..+ .+.+
T Consensus 101 ----~~v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~-NWvlHRDLKPaNIlvmgdgperG~V 175 (438)
T KOG0666|consen 101 ----KKVWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHS-NWVLHRDLKPANILVMGDGPERGRV 175 (438)
T ss_pred ----ceEEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhh-hheeeccCCcceEEEeccCCccCee
Confidence 348999999999999998765433 3578999999999999999999999 899999999999999762 3899
Q ss_pred EEeecCcccccccCCcc----ccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC---------hH
Q 021306 181 KICDFGSAKQLIAGEAN----ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN---------AV 247 (314)
Q Consensus 181 ~l~dfg~~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~---------~~ 247 (314)
||+|+|+++.+.++-.. ...+.|..|.|||.+.|...|+.+.||||.|||+.||+|-++.|.+.. ..
T Consensus 176 KIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~ 255 (438)
T KOG0666|consen 176 KIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQH 255 (438)
T ss_pred EeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchH
Confidence 99999999987654332 234458889999999999889999999999999999999999997643 23
Q ss_pred HHHHHHHHHcCCCCHHHHh-----------------------------------------------ccCCCCCCCccccc
Q 021306 248 DQLVEIIKVLGTPTREEIR-----------------------------------------------CMNPNYTDFRFPQI 280 (314)
Q Consensus 248 ~~~~~i~~~~~~~~~~~~~-----------------------------------------------~~~p~~~~~~~~~l 280 (314)
+++.+|++-++.|....++ ..+|- +|+++++.
T Consensus 256 dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~-kRIta~qA 334 (438)
T KOG0666|consen 256 DQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPI-KRITAEQA 334 (438)
T ss_pred HHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCch-hhccHHHH
Confidence 5677777766665432211 22444 89999999
Q ss_pred ccCChhhhhc
Q 021306 281 KAHPWHKVCI 290 (314)
Q Consensus 281 ~~~p~~~~~~ 290 (314)
++|++|+..+
T Consensus 335 leh~yF~~d~ 344 (438)
T KOG0666|consen 335 LEHPYFTEDP 344 (438)
T ss_pred hcccccccCC
Confidence 9999998774
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=273.34 Aligned_cols=240 Identities=27% Similarity=0.452 Sum_probs=193.3
Q ss_pred eeeEeecCceEEEEEEECCCCcEEEEEEeecc------ccchHHHHHHHHhCCCCceeeeceeeeecCCCCceeEEEEee
Q 021306 43 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVME 116 (314)
Q Consensus 43 ~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e 116 (314)
-+.||+|.||+||-++++.+|+.||||.+.+. ....++|+.+|+++.||.||.+-..|...+ .+|+|||
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~e-----rvFVVME 643 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPE-----RVFVVME 643 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCc-----eEEEEeh
Confidence 36899999999999999999999999988543 345578999999999999999866553322 3899999
Q ss_pred cccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCC--CcEEEeecCcccccccC
Q 021306 117 YVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLT--HQVKICDFGSAKQLIAG 194 (314)
Q Consensus 117 ~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~--~~~~l~dfg~~~~~~~~ 194 (314)
-+.|+.++.+.. ...+++++...+.++.||+-||.|||. ++|+|+||||+|||+...+ -++||||||+++.+...
T Consensus 644 Kl~GDMLEMILS--sEkgRL~er~TkFlvtQIL~ALr~LH~-knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk 720 (888)
T KOG4236|consen 644 KLHGDMLEMILS--SEKGRLPERITKFLVTQILVALRYLHF-KNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK 720 (888)
T ss_pred hhcchHHHHHHH--hhcccchHHHHHHHHHHHHHHHHHhhh-cceeeccCCchheeeccCCCCCceeeccccceeecchh
Confidence 999998888764 456889999999999999999999999 9999999999999997633 38999999999988877
Q ss_pred CccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHc--------CCCCHHHH
Q 021306 195 EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA-VDQLVEIIKVL--------GTPTREEI 265 (314)
Q Consensus 195 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~-~~~~~~i~~~~--------~~~~~~~~ 265 (314)
....+..|||.|+|||+++++. |+..-|+||+|+|+|--+.|..||....+ .+++++..=.. ...+.+.+
T Consensus 721 sFRrsVVGTPAYLaPEVLrnkG-yNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNAaFMyPp~PW~eis~~AidlI 799 (888)
T KOG4236|consen 721 SFRRSVVGTPAYLAPEVLRNKG-YNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNAAFMYPPNPWSEISPEAIDLI 799 (888)
T ss_pred hhhhhhcCCccccCHHHHhhcc-ccccccceeeeEEEEEEecccccCCCccchhHHhhccccccCCCchhhcCHHHHHHH
Confidence 7777889999999999997765 89999999999999999999999976543 33333221111 11122333
Q ss_pred hcc--CCCCCCCcccccccCChhhhhcc
Q 021306 266 RCM--NPNYTDFRFPQIKAHPWHKVCIF 291 (314)
Q Consensus 266 ~~~--~p~~~~~~~~~l~~~p~~~~~~~ 291 (314)
+++ -..-+|.+.+..+.|||++....
T Consensus 800 n~LLqVkm~kRysvdk~lsh~Wlq~yq~ 827 (888)
T KOG4236|consen 800 NNLLQVKMRKRYSVDKSLSHPWLQDYQT 827 (888)
T ss_pred HHHHHHHHHHhcchHhhccchhhhcchH
Confidence 322 11127889999999999987764
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=255.95 Aligned_cols=232 Identities=30% Similarity=0.523 Sum_probs=183.0
Q ss_pred EeecCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeEEEEeecc
Q 021306 46 VGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYV 118 (314)
Q Consensus 46 Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~ 118 (314)
||.|++|.||++++..+++.+++|.+.+.. ....+|+.++++++|+||+++++.+... ..+++++||+
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~ 75 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDK-----KYIYMLMEYC 75 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcC-----CccEEEEecC
Confidence 689999999999999889999999986432 2345788999999999999999987433 3488999999
Q ss_pred cc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcccccccCCcc
Q 021306 119 PE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN 197 (314)
Q Consensus 119 ~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~~~~~~ 197 (314)
++ +|.+.+.. ...+++..+..++.|++.||.+||+ ++++|+||+|+||+++. ++.++|+|||.+.........
T Consensus 76 ~~~~L~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lH~-~~~~h~dl~~~nilv~~-~~~~~l~df~~~~~~~~~~~~ 149 (262)
T cd05572 76 LGGELWTILRD----RGLFDEYTARFYIACVVLAFEYLHN-RGIIYRDLKPENLLLDS-NGYVKLVDFGFAKKLKSGQKT 149 (262)
T ss_pred CCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhh-CCcccCCCCHHHEEEcC-CCCEEEeeCCcccccCccccc
Confidence 86 66555543 4568999999999999999999999 89999999999999998 788999999998766544333
Q ss_pred ccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC--hHHHHHHHHHHcCC---C------CHHHHh
Q 021306 198 ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN--AVDQLVEIIKVLGT---P------TREEIR 266 (314)
Q Consensus 198 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~--~~~~~~~i~~~~~~---~------~~~~~~ 266 (314)
....+++.|++||.+.+.. ++.++|+||||+++|+|++|..||.... ..+....+...... + ..+.+.
T Consensus 150 ~~~~~~~~~~~PE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 228 (262)
T cd05572 150 WTFCGTPEYVAPEIILNKG-YDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIK 228 (262)
T ss_pred ccccCCcCccChhHhcCCC-CCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHH
Confidence 3456788899999986544 7899999999999999999999998776 44444444421111 1 011222
Q ss_pred ---ccCCCCCCCc-----ccccccCChhhhhc
Q 021306 267 ---CMNPNYTDFR-----FPQIKAHPWHKVCI 290 (314)
Q Consensus 267 ---~~~p~~~~~~-----~~~l~~~p~~~~~~ 290 (314)
..+|+ +|++ +.++++|||+....
T Consensus 229 ~~l~~~p~-~R~~~~~~~~~~l~~~~~~~~~~ 259 (262)
T cd05572 229 QLLRRNPE-ERLGNLKGGIKDIKKHKWFNGFD 259 (262)
T ss_pred HHccCChh-hCcCCcccCHHHHhcChhhhCCC
Confidence 23666 7888 89999999998654
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=271.25 Aligned_cols=253 Identities=21% Similarity=0.313 Sum_probs=186.8
Q ss_pred CCCceeeeeEeecCceEEEEEEECCC-----CcEEEEEEeeccc-----cchHHHHHHHHhC-CCCceeeeceeeeecCC
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCLET-----GETVAIKKVLQDR-----RYKNRELQLMRVM-DHPNVISLKHCFFSTTS 105 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~~~-----~~~~~vK~~~~~~-----~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~ 105 (314)
.++|++++.||+|+||.||+|++... +..||+|.++... ....+|+.+++.+ +|+||+++++++...
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~-- 114 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHG-- 114 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCC--
Confidence 34799999999999999999986543 3579999886532 2245789999999 899999999988433
Q ss_pred CCceeEEEEeecccc-cHHHHHHhhhh-----------------------------------------------------
Q 021306 106 KNELFLNLVMEYVPE-SMYRVLKHYSS----------------------------------------------------- 131 (314)
Q Consensus 106 ~~~~~~~lv~e~~~~-~l~~~l~~~~~----------------------------------------------------- 131 (314)
...+++|||+++ +|.+.+.....
T Consensus 115 ---~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (374)
T cd05106 115 ---GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSS 191 (374)
T ss_pred ---CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccc
Confidence 348899999985 66666543110
Q ss_pred -------------cCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcccccccCCcc-
Q 021306 132 -------------ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN- 197 (314)
Q Consensus 132 -------------~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~~~~~~- 197 (314)
...++++.+++.++.||+.||.|||+ +|++||||||+||+++. +..++|+|||++.........
T Consensus 192 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~giiHrDLkp~Nil~~~-~~~~kL~DfGla~~~~~~~~~~ 269 (374)
T cd05106 192 SQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLAS-KNCIHRDVAARNVLLTD-GRVAKICDFGLARDIMNDSNYV 269 (374)
T ss_pred cccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHH-CCEEeccCchheEEEeC-CCeEEEeeceeeeeccCCccee
Confidence 12358889999999999999999999 89999999999999997 788999999998754332211
Q ss_pred --ccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCHHHHhccCCCCCC
Q 021306 198 --ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 274 (314)
Q Consensus 198 --~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~p~~~~ 274 (314)
....++..|+|||.+.+.. ++.++||||||+++|+|++ |+.||........+...++....+. .|....
T Consensus 270 ~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~-------~~~~~~ 341 (374)
T cd05106 270 VKGNARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMS-------RPDFAP 341 (374)
T ss_pred eccCCCCccceeCHHHhcCCC-CCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCcc-------CCCCCC
Confidence 1122345799999986544 8999999999999999997 9999988765544444443321111 111122
Q ss_pred CcccccccCChhhhhcccCChHHHHHhcch
Q 021306 275 FRFPQIKAHPWHKVCIFHFPKHWLLEYGSH 304 (314)
Q Consensus 275 ~~~~~l~~~p~~~~~~~~~~~~~~~~~~~~ 304 (314)
..+..++..||...+..+++.+.+.+.++.
T Consensus 342 ~~l~~li~~cl~~dp~~RPs~~~l~~~l~~ 371 (374)
T cd05106 342 PEIYSIMKMCWNLEPTERPTFSQISQLIQR 371 (374)
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 345566667777766777777777766654
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=261.97 Aligned_cols=241 Identities=26% Similarity=0.396 Sum_probs=188.4
Q ss_pred CCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeEEE
Q 021306 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 113 (314)
Q Consensus 38 ~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 113 (314)
+.|.....||+|++|.||++.+..++..+++|.+.... ....+|+.+++.++|+|++++++.+... .+.++
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~-----~~~~l 96 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVG-----DELWV 96 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecC-----CeEEE
Confidence 35777888999999999999998899999999885432 2345788999999999999999987433 34889
Q ss_pred EeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCccccccc
Q 021306 114 VMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA 193 (314)
Q Consensus 114 v~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~~ 193 (314)
++||++++.+..+.. ...+++.+++.++.||+.|+.|||+ +|++|+||+|+||+++. ++.++|+|||++.....
T Consensus 97 v~e~~~~~~L~~~~~----~~~l~~~~~~~~~~qi~~~l~~LH~-~~ivH~dlkp~Nill~~-~~~~kL~dfg~~~~~~~ 170 (292)
T cd06658 97 VMEFLEGGALTDIVT----HTRMNEEQIATVCLSVLRALSYLHN-QGVIHRDIKSDSILLTS-DGRIKLSDFGFCAQVSK 170 (292)
T ss_pred EEeCCCCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCEeecCCCHHHEEEcC-CCCEEEccCcchhhccc
Confidence 999999754333332 3568999999999999999999999 89999999999999998 78899999998865432
Q ss_pred CCc-cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCC----------H
Q 021306 194 GEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT----------R 262 (314)
Q Consensus 194 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~----------~ 262 (314)
... .....++..|+|||.+.+.. ++.++|+||||+++|+|++|+.||...+....+..+........ .
T Consensus 171 ~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (292)
T cd06658 171 EVPKRKSLVGTPYWMAPEVISRLP-YGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLR 249 (292)
T ss_pred ccccCceeecCccccCHHHHccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccccccccCHHHH
Confidence 221 22345688899999986544 78999999999999999999999988776655544433322211 1
Q ss_pred HHHh---ccCCCCCCCcccccccCChhhhhcc
Q 021306 263 EEIR---CMNPNYTDFRFPQIKAHPWHKVCIF 291 (314)
Q Consensus 263 ~~~~---~~~p~~~~~~~~~l~~~p~~~~~~~ 291 (314)
..+. ..+|. +|++++++++|||++....
T Consensus 250 ~li~~~l~~~P~-~Rpt~~~il~~~~~~~~~~ 280 (292)
T cd06658 250 GFLDLMLVREPS-QRATAQELLQHPFLKLAGP 280 (292)
T ss_pred HHHHHHccCChh-HCcCHHHHhhChhhhccCC
Confidence 1112 24677 8999999999999996554
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=279.91 Aligned_cols=239 Identities=28% Similarity=0.428 Sum_probs=200.5
Q ss_pred CceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeE
Q 021306 39 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 111 (314)
Q Consensus 39 ~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 111 (314)
-|.-.+.||.|+||.||-+++..+.+.||+|++.-.. ....+|+..|++++|||++.+.+||..... .
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~T-----a 101 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHT-----A 101 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccch-----H
Confidence 4788899999999999999999999999999986432 223489999999999999999999975554 7
Q ss_pred EEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCccccc
Q 021306 112 NLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 191 (314)
Q Consensus 112 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~ 191 (314)
|+|||||-|+..+.+... ..++.+-++..|+.+.+.||.|||+ .+.+|||||..|||++. .+.|||+|||.+...
T Consensus 102 WLVMEYClGSAsDlleVh---kKplqEvEIAAi~~gaL~gLaYLHS-~~~IHRDiKAGNILLse-~g~VKLaDFGSAsi~ 176 (948)
T KOG0577|consen 102 WLVMEYCLGSASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHS-HNRIHRDIKAGNILLSE-PGLVKLADFGSASIM 176 (948)
T ss_pred HHHHHHHhccHHHHHHHH---hccchHHHHHHHHHHHHHHHHHHHH-hhHHhhhccccceEecC-CCeeeeccccchhhc
Confidence 899999999877777653 4789999999999999999999999 89999999999999998 999999999998754
Q ss_pred ccCCcccccccccccccccccc--CCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCHH------
Q 021306 192 IAGEANISYICSRFYRAPELIF--GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE------ 263 (314)
Q Consensus 192 ~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~------ 263 (314)
.+..+++|||.|||||++. ....|+-++|||||||+..|+.-.++|+-+++....++-|.+.-++....
T Consensus 177 ---~PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~eWS~~ 253 (948)
T KOG0577|consen 177 ---APANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDY 253 (948)
T ss_pred ---CchhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCchhHHH
Confidence 3455789999999999985 34458999999999999999999999999999999999887764443211
Q ss_pred ------HHhccCCCCCCCcccccccCChhhhhcc
Q 021306 264 ------EIRCMNPNYTDFRFPQIKAHPWHKVCIF 291 (314)
Q Consensus 264 ------~~~~~~p~~~~~~~~~l~~~p~~~~~~~ 291 (314)
......|. .|++.+.|++|+|-...-+
T Consensus 254 F~~Fvd~CLqKipq-eRptse~ll~H~fv~R~Rp 286 (948)
T KOG0577|consen 254 FRNFVDSCLQKIPQ-ERPTSEELLKHRFVLRERP 286 (948)
T ss_pred HHHHHHHHHhhCcc-cCCcHHHHhhcchhccCCC
Confidence 11112444 7999999999999765543
|
|
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=254.48 Aligned_cols=241 Identities=30% Similarity=0.490 Sum_probs=190.1
Q ss_pred CCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeEE
Q 021306 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 112 (314)
Q Consensus 38 ~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 112 (314)
++|++.+.||.|++|.||++.+..+++.+++|.+.... ....+|+..+.+++|+|++++++++... ...+
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~ 75 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKE-----GEIS 75 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccC-----CeEE
Confidence 47999999999999999999999999999999986553 3345888999999999999999988443 4488
Q ss_pred EEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCccccc
Q 021306 113 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 191 (314)
Q Consensus 113 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~ 191 (314)
+++||+++ +|.+.+.. ..++++..++.++.|++.|+.+||+..+++|+||+|+||+++. ++.++|+|||.+...
T Consensus 76 lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~-~~~~~l~df~~~~~~ 150 (264)
T cd06623 76 IVLEYMDGGSLADLLKK----VGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINS-KGEVKIADFGISKVL 150 (264)
T ss_pred EEEEecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECC-CCCEEEccCccceec
Confidence 99999995 66655543 3789999999999999999999998349999999999999998 889999999998765
Q ss_pred ccCCccc-cccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC---hHHHHHHHHHHcCCC-------
Q 021306 192 IAGEANI-SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN---AVDQLVEIIKVLGTP------- 260 (314)
Q Consensus 192 ~~~~~~~-~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~---~~~~~~~i~~~~~~~------- 260 (314)
....... ...++..|+|||.+.+. .++.++|+||||+++|+|++|+.||.... ..+....+.......
T Consensus 151 ~~~~~~~~~~~~~~~y~~pE~~~~~-~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (264)
T cd06623 151 ENTLDQCNTFVGTVTYMSPERIQGE-SYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFS 229 (264)
T ss_pred ccCCCcccceeecccccCHhhhCCC-CCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCCCcccCC
Confidence 4333222 34567889999998665 48899999999999999999999998774 333333333221111
Q ss_pred --CHHHHh-cc--CCCCCCCcccccccCChhhhhc
Q 021306 261 --TREEIR-CM--NPNYTDFRFPQIKAHPWHKVCI 290 (314)
Q Consensus 261 --~~~~~~-~~--~p~~~~~~~~~l~~~p~~~~~~ 290 (314)
..+.+. ++ +|+ .|+++.+++.|||++...
T Consensus 230 ~~l~~li~~~l~~~p~-~R~~~~~ll~~~~~~~~~ 263 (264)
T cd06623 230 PEFRDFISACLQKDPK-KRPSAAELLQHPFIKKAD 263 (264)
T ss_pred HHHHHHHHHHccCChh-hCCCHHHHHhCHHHHhcc
Confidence 111122 23 455 799999999999998654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=259.54 Aligned_cols=245 Identities=17% Similarity=0.176 Sum_probs=190.3
Q ss_pred eeEeecCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeEEEEee
Q 021306 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVME 116 (314)
Q Consensus 44 ~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e 116 (314)
..|++|+++.||+|+. +|+.||+|.++... ....+|+.++++++||||+++++++.+.. ....+++++||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~-~~~~~~~lv~E 102 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIV-DDLPRLSLILE 102 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecc-cCCCceEEEEE
Confidence 6789999999999997 78999999986542 22348999999999999999999875521 12234789999
Q ss_pred ccccc-HHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcccccccCC
Q 021306 117 YVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE 195 (314)
Q Consensus 117 ~~~~~-l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~~~~ 195 (314)
|++++ |.+.+. ....+++.....++.|++.|+.+||+..+++||||+|+||+++. ++.++|+|||++......
T Consensus 103 y~~~g~L~~~l~----~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~-~~~~kl~dfg~~~~~~~~- 176 (283)
T PHA02988 103 YCTRGYLREVLD----KEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTE-NYKLKIICHGLEKILSSP- 176 (283)
T ss_pred eCCCCcHHHHHh----hCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECC-CCcEEEcccchHhhhccc-
Confidence 99974 555544 35678999999999999999999997248999999999999998 889999999998754332
Q ss_pred ccccccccccccccccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCHHHHhccCCCCCC
Q 021306 196 ANISYICSRFYRAPELIFGA-TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 274 (314)
Q Consensus 196 ~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~p~~~~ 274 (314)
.....++..|+|||.+.+. ..++.++||||||+++|+|++|+.||.+.+..+....+.+....+. .++. ..
T Consensus 177 -~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~------~~~~-~~ 248 (283)
T PHA02988 177 -PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLK------LPLD-CP 248 (283)
T ss_pred -cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCC------CCCc-Cc
Confidence 2234568889999998652 3489999999999999999999999998887666665554332221 1111 23
Q ss_pred CcccccccCChhhhhcccCChHHHHHhcchh
Q 021306 275 FRFPQIKAHPWHKVCIFHFPKHWLLEYGSHI 305 (314)
Q Consensus 275 ~~~~~l~~~p~~~~~~~~~~~~~~~~~~~~~ 305 (314)
..+.+++..||...+..+++...++..++.+
T Consensus 249 ~~l~~li~~cl~~dp~~Rps~~ell~~l~~~ 279 (283)
T PHA02988 249 LEIKCIVEACTSHDSIKRPNIKEILYNLSLY 279 (283)
T ss_pred HHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 3467788888888888888888777776543
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=254.65 Aligned_cols=238 Identities=26% Similarity=0.470 Sum_probs=182.4
Q ss_pred CCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc---------cchHHHHHHHHhCCCCceeeeceeeeecCCCCc
Q 021306 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 108 (314)
Q Consensus 38 ~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~---------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 108 (314)
.+|++.+.||+|++|.||++++..+++.+++|.+.... ....+|+.++++++|+||+++++++.... .
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~---~ 78 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPE---E 78 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCC---C
Confidence 47999999999999999999999999999999874321 23357899999999999999999874422 2
Q ss_pred eeEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCc
Q 021306 109 LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 187 (314)
Q Consensus 109 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~ 187 (314)
..+++++||+++ +|.+.+.. ...+++..++.++.|++.||.+||+ +|++|+||+|+||+++. ++.++|+|||+
T Consensus 79 ~~~~~v~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~al~~LH~-~~i~H~dl~p~ni~i~~-~~~~~l~dfg~ 152 (264)
T cd06653 79 KKLSIFVEYMPGGSIKDQLKA----YGALTENVTRRYTRQILQGVSYLHS-NMIVHRDIKGANILRDS-AGNVKLGDFGA 152 (264)
T ss_pred CEEEEEEEeCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEEcC-CCCEEECcccc
Confidence 346799999986 55555542 4568999999999999999999999 89999999999999998 78899999999
Q ss_pred ccccccCC----ccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCC-H
Q 021306 188 AKQLIAGE----ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT-R 262 (314)
Q Consensus 188 ~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~-~ 262 (314)
+....... ......++..|+|||.+.+.. ++.++|+||||+++|+|++|+.||...........+......+. +
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~p 231 (264)
T cd06653 153 SKRIQTICMSGTGIKSVTGTPYWMSPEVISGEG-YGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLP 231 (264)
T ss_pred ccccccccccCccccccCCcccccCHhhhcCCC-CCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCCC
Confidence 87543211 112345678899999986644 78999999999999999999999988766555544432211110 1
Q ss_pred --------HHHh-ccCCCCCCCcccccccCCh
Q 021306 263 --------EEIR-CMNPNYTDFRFPQIKAHPW 285 (314)
Q Consensus 263 --------~~~~-~~~p~~~~~~~~~l~~~p~ 285 (314)
+.+. ++....+|+++.+++.|||
T Consensus 232 ~~~~~~~~~~i~~~l~~~~~r~~~~~~~~~~~ 263 (264)
T cd06653 232 DGVSDACRDFLKQIFVEEKRRPTAEFLLRHPF 263 (264)
T ss_pred cccCHHHHHHHHHHhcCcccCccHHHHhcCCC
Confidence 1111 2222347888888888876
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=253.43 Aligned_cols=238 Identities=28% Similarity=0.431 Sum_probs=187.6
Q ss_pred CceeeeeEeecCceEEEEEEECCCCcEEEEEEeecc------ccchHHHHHHHHhCCCCceeeeceeeeecCCCCceeEE
Q 021306 39 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 112 (314)
Q Consensus 39 ~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 112 (314)
+|++.+.||+|++|.||++.++.+|..+++|.+... .....+|+.+++.++|+|++++++.+.. ....+
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~-----~~~~~ 75 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQE-----NGRLF 75 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheecc-----CCeEE
Confidence 589999999999999999999999999999998543 2334589999999999999999998743 33488
Q ss_pred EEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCccccc
Q 021306 113 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 191 (314)
Q Consensus 113 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~ 191 (314)
+++||+++ +|.+.+... ....+++..+..++.|++.|+.+||+ .+++|+||+|+||+++..+..++++|||.+...
T Consensus 76 lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~ 152 (257)
T cd08225 76 IVMEYCDGGDLMKRINRQ--RGVLFSEDQILSWFVQISLGLKHIHD-RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQL 152 (257)
T ss_pred EEEecCCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCCHHHEEEcCCCCeEEecccccchhc
Confidence 99999986 666655431 23468999999999999999999999 899999999999999984456899999988765
Q ss_pred ccCCcc-ccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCC--------H
Q 021306 192 IAGEAN-ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT--------R 262 (314)
Q Consensus 192 ~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~--------~ 262 (314)
...... ....+++.|+|||.+.+.. ++.++|+||||+++|+|++|..||...+..+....+.+....+. .
T Consensus 153 ~~~~~~~~~~~~~~~~~ape~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (257)
T cd08225 153 NDSMELAYTCVGTPYYLSPEICQNRP-YNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRDLR 231 (257)
T ss_pred cCCcccccccCCCccccCHHHHcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCCCCCCCCCHHHH
Confidence 432221 2235678899999986544 78999999999999999999999988776665555544322211 1
Q ss_pred HHHh---ccCCCCCCCcccccccCChh
Q 021306 263 EEIR---CMNPNYTDFRFPQIKAHPWH 286 (314)
Q Consensus 263 ~~~~---~~~p~~~~~~~~~l~~~p~~ 286 (314)
+.+. ..+|+ +|+++.++++|||+
T Consensus 232 ~~i~~~l~~~p~-~Rpt~~~ll~~~~~ 257 (257)
T cd08225 232 SLISQLFKVSPR-DRPSITSILKRPFL 257 (257)
T ss_pred HHHHHHhccChh-hCcCHHHHhhCCCC
Confidence 1111 23677 89999999999995
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=283.84 Aligned_cols=255 Identities=24% Similarity=0.323 Sum_probs=206.2
Q ss_pred CceeeeeEeecCceEEEEEEECC-----CCcEEEEEEeecc-----ccchHHHHHHHHhCCCCceeeeceeeeecCCCCc
Q 021306 39 SYMAERVVGTGSFGIVFQAKCLE-----TGETVAIKKVLQD-----RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 108 (314)
Q Consensus 39 ~y~~~~~Lg~g~~g~Vy~~~~~~-----~~~~~~vK~~~~~-----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 108 (314)
+-+..+.||+|.||+||+++... +...||||.++.. +..+++|++++..++|||||+++|.+...+.
T Consensus 487 ~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P--- 563 (774)
T KOG1026|consen 487 DIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDP--- 563 (774)
T ss_pred heeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCe---
Confidence 67788999999999999998652 2467999988754 3456899999999999999999999954443
Q ss_pred eeEEEEeeccc-ccHHHHHHhhhh------cCC----CCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCC
Q 021306 109 LFLNLVMEYVP-ESMYRVLKHYSS------ANQ----RMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLT 177 (314)
Q Consensus 109 ~~~~lv~e~~~-~~l~~~l~~~~~------~~~----~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~ 177 (314)
+++|+|||. |+|.++|..... .+. +++..+.+.|+.||+.|+.||-+ +.+|||||-.+|.||+. +
T Consensus 564 --~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~-~~FVHRDLATRNCLVge-~ 639 (774)
T KOG1026|consen 564 --LCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSS-HHFVHRDLATRNCLVGE-N 639 (774)
T ss_pred --eEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-Ccccccchhhhhceecc-c
Confidence 899999999 677777764321 123 38999999999999999999999 89999999999999998 8
Q ss_pred CcEEEeecCcccccccCCccc---cccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 021306 178 HQVKICDFGSAKQLIAGEANI---SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEI 253 (314)
Q Consensus 178 ~~~~l~dfg~~~~~~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~t-g~~pf~~~~~~~~~~~i 253 (314)
..|||+|||+++......... ...-..+|||||.+.-+. ++.+|||||+|++|||+++ |+.||.+.+.++.++.+
T Consensus 640 l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~k-FTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i 718 (774)
T KOG1026|consen 640 LVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGK-FTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECI 718 (774)
T ss_pred eEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCc-ccchhhhhhhhhhhhhhhccccCcccccchHHHHHHH
Confidence 999999999998665433221 223366899999997544 9999999999999999999 99999999999988888
Q ss_pred HHHcCCCCHHHHhccCCCCCCCcccccccCChhhhhcccCChHHHHHhcchhhhcC
Q 021306 254 IKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGSHINAIS 309 (314)
Q Consensus 254 ~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (314)
.++. .+. -|+-+...+..||..||.+.+..+.....+...+++.-...
T Consensus 719 ~~g~------lL~--~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s 766 (774)
T KOG1026|consen 719 RAGQ------LLS--CPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQAS 766 (774)
T ss_pred HcCC------ccc--CCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcC
Confidence 6642 111 23335667899999999999999888887777766544433
|
|
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=258.10 Aligned_cols=241 Identities=26% Similarity=0.424 Sum_probs=188.3
Q ss_pred cCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeE
Q 021306 36 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 111 (314)
Q Consensus 36 ~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 111 (314)
..++|++.+.||+|+||.||++.+..++..+++|.+.... ....+|+.+++.++|||++++++.+.... ..
T Consensus 17 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~-----~~ 91 (293)
T cd06647 17 PKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGD-----EL 91 (293)
T ss_pred chhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCC-----cE
Confidence 3468999999999999999999988899999999885432 22357888999999999999999885433 37
Q ss_pred EEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcccc
Q 021306 112 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 190 (314)
Q Consensus 112 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~ 190 (314)
++|+||+++ ++.+.+. ...+++.++..++.|++.|+.+||+ +|++|+||+|+||+++. ++.++|+|||++..
T Consensus 92 ~lv~e~~~~~~L~~~~~-----~~~l~~~~~~~i~~~l~~al~~LH~-~gi~H~dL~p~Nili~~-~~~~kL~dfg~~~~ 164 (293)
T cd06647 92 WVVMEYLAGGSLTDVVT-----ETCMDEGQIAAVCRECLQALEFLHS-NQVIHRDIKSDNILLGM-DGSVKLTDFGFCAQ 164 (293)
T ss_pred EEEEecCCCCcHHHHHh-----hcCCCHHHHHHHHHHHHHHHHHHHh-CCEeeccCCHHHEEEcC-CCCEEEccCcceec
Confidence 899999986 5555443 2468899999999999999999999 89999999999999998 78899999998764
Q ss_pred cccCCc-cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCC---------
Q 021306 191 LIAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP--------- 260 (314)
Q Consensus 191 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~--------- 260 (314)
...... .....+++.|++||.+.+. .++.++|+||||+++|++++|+.||...+.......+.......
T Consensus 165 ~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (293)
T cd06647 165 ITPEQSKRSTMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSA 243 (293)
T ss_pred ccccccccccccCChhhcCchhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCH
Confidence 433222 2223567789999998654 47899999999999999999999998776654443332211110
Q ss_pred -CHHHHh---ccCCCCCCCcccccccCChhhhhc
Q 021306 261 -TREEIR---CMNPNYTDFRFPQIKAHPWHKVCI 290 (314)
Q Consensus 261 -~~~~~~---~~~p~~~~~~~~~l~~~p~~~~~~ 290 (314)
..+.+. ..+|+ .|+++.+++.|||++..-
T Consensus 244 ~l~~li~~~l~~~p~-~Rp~~~~il~h~~~~~~~ 276 (293)
T cd06647 244 IFRDFLNRCLEMDVE-KRGSAKELLQHPFLKIAK 276 (293)
T ss_pred HHHHHHHHHccCChh-hCcCHHHHhcCHHHhcCc
Confidence 111222 23676 789999999999998766
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=276.63 Aligned_cols=210 Identities=26% Similarity=0.387 Sum_probs=173.6
Q ss_pred CCccCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecC-CC
Q 021306 33 EPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTT-SK 106 (314)
Q Consensus 33 ~~~~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~ 106 (314)
++.+...|...+.||+|+||.||+++++.+|+.||+|.++... ...-+|++++++++|+|||++.++-.... .-
T Consensus 8 ~~~~~y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~ 87 (732)
T KOG4250|consen 8 TSGENYLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGL 87 (732)
T ss_pred ccCCCcceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCc
Confidence 3344567899999999999999999999999999999987632 22348999999999999999987642211 00
Q ss_pred CceeEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCC---CCcEEE
Q 021306 107 NELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPL---THQVKI 182 (314)
Q Consensus 107 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~---~~~~~l 182 (314)
-.....++||||.| +|...+... .....+++.+++.++..+..|+.|||+ +||+||||||.||++..+ ....||
T Consensus 88 ~~~~~vlvmEyC~gGsL~~~L~~P-EN~~GLpE~e~l~lL~d~~~al~~LrE-n~IvHRDlKP~NIvl~~Gedgq~IyKL 165 (732)
T KOG4250|consen 88 VTRLPVLVMEYCSGGSLRKVLNSP-ENAYGLPESEFLDLLSDLVSALRHLRE-NGIVHRDLKPGNIVLQIGEDGQSIYKL 165 (732)
T ss_pred ccccceEEEeecCCCcHHHHhcCc-ccccCCCHHHHHHHHHHHHHHHHHHHH-cCceeccCCCCcEEEeecCCCceEEee
Confidence 02235699999996 666666542 234569999999999999999999999 999999999999999653 346999
Q ss_pred eecCcccccccCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 021306 183 CDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE 244 (314)
Q Consensus 183 ~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~ 244 (314)
+|||.|+..+.+....+..||..|++||....+..++..+|.||||+++|+++||..||...
T Consensus 166 tDfG~Arel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~ 227 (732)
T KOG4250|consen 166 TDFGAARELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPF 227 (732)
T ss_pred ecccccccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcC
Confidence 99999999988888888999999999999964566899999999999999999999999554
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-36 Score=259.00 Aligned_cols=262 Identities=22% Similarity=0.313 Sum_probs=199.1
Q ss_pred CCCceeeeeEeecCceEEEEEEEC-----CCCcEEEEEEeeccc----cchHHHHHHHHhCCCCceeeeceeeeecCCCC
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCL-----ETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKN 107 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~-----~~~~~~~vK~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 107 (314)
.++|.+.+.||+|+||.||++.+. .++..+++|.+.... ....+|+.++++++|+||+++++++..
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----- 78 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVE----- 78 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-----
Confidence 357999999999999999999853 345678999886432 234679999999999999999998743
Q ss_pred ceeEEEEeecccc-cHHHHHHhhh---------hcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCC
Q 021306 108 ELFLNLVMEYVPE-SMYRVLKHYS---------SANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLT 177 (314)
Q Consensus 108 ~~~~~lv~e~~~~-~l~~~l~~~~---------~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~ 177 (314)
....++++||+++ +|.+.+.... .....+++.+++.++.|++.||.+||+ +|++|+||||+||+++. +
T Consensus 79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~-~~i~H~dlkp~Nili~~-~ 156 (288)
T cd05093 79 GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLAS-QHFVHRDLATRNCLVGE-N 156 (288)
T ss_pred CCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecccCcceEEEcc-C
Confidence 3348899999985 6665554321 112358999999999999999999999 89999999999999998 8
Q ss_pred CcEEEeecCcccccccCCc---cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 021306 178 HQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEI 253 (314)
Q Consensus 178 ~~~~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~t-g~~pf~~~~~~~~~~~i 253 (314)
+.++|+|||.+........ .....++..|+|||.+.+.. ++.++|+||||+++|+|++ |..||......+....+
T Consensus 157 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i 235 (288)
T cd05093 157 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRK-FTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECI 235 (288)
T ss_pred CcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 8899999999875533221 11223356799999986544 8899999999999999998 99999888776666555
Q ss_pred HHHcCCCCHHHHhccCCCCCCCcccccccCChhhhhcccCChHHHHHhcchhhhcCCCCCC
Q 021306 254 IKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGSHINAISPRHCD 314 (314)
Q Consensus 254 ~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (314)
.+...... +......+.+++..+|...+..+++...+...++.+....+..+|
T Consensus 236 ~~~~~~~~--------~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~~~~~~~ 288 (288)
T cd05093 236 TQGRVLQR--------PRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKASPVYLD 288 (288)
T ss_pred HcCCcCCC--------CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHhcccccC
Confidence 44321111 111223467788888888888888888888888877766665554
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=259.74 Aligned_cols=240 Identities=27% Similarity=0.399 Sum_probs=189.3
Q ss_pred CceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeEEE
Q 021306 39 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 113 (314)
Q Consensus 39 ~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 113 (314)
.|++.+.||+|++|.||+|.+..+++.+++|.+.... ....+|+.++++++|+||+++++++.. ....++
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~l 79 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLK-----GTKLWI 79 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhccccc-----CCceEE
Confidence 5888999999999999999998899999999876432 234689999999999999999998843 334889
Q ss_pred Eeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcccccc
Q 021306 114 VMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 192 (314)
Q Consensus 114 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~ 192 (314)
|+||+++ ++.+.+. ...+++..++.++.|++.|+.|||+ +|++|+||+|+||+++. ++.++|+|||++....
T Consensus 80 v~e~~~~~~L~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~-~~ivH~dl~p~ni~i~~-~~~~~l~dfg~~~~~~ 152 (277)
T cd06642 80 IMEYLGGGSALDLLK-----PGPLEETYIATILREILKGLDYLHS-ERKIHRDIKAANVLLSE-QGDVKLADFGVAGQLT 152 (277)
T ss_pred EEEccCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHhc-CCeeccCCChheEEEeC-CCCEEEcccccccccc
Confidence 9999997 4444433 3678999999999999999999999 89999999999999998 7889999999987554
Q ss_pred cCCc-cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCC--------CHH
Q 021306 193 AGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP--------TRE 263 (314)
Q Consensus 193 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~--------~~~ 263 (314)
.... .....++..|+|||.+.+.. ++.++|+||||+++|+|++|+.||....+......+....... ..+
T Consensus 153 ~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (277)
T cd06642 153 DTQIKRNTFVGTPFWMAPEVIKQSA-YDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSKPFKE 231 (277)
T ss_pred CcchhhhcccCcccccCHHHhCcCC-CchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCCCCCCcccCHHHHH
Confidence 3221 12234677899999986554 7899999999999999999999998776655444333222111 111
Q ss_pred HHh---ccCCCCCCCcccccccCChhhhhccc
Q 021306 264 EIR---CMNPNYTDFRFPQIKAHPWHKVCIFH 292 (314)
Q Consensus 264 ~~~---~~~p~~~~~~~~~l~~~p~~~~~~~~ 292 (314)
.+. ..+|+ +|+++.++++|||++.....
T Consensus 232 li~~~l~~~p~-~Rp~~~~il~~~~~~~~~~~ 262 (277)
T cd06642 232 FVEACLNKDPR-FRPTAKELLKHKFITRYTKK 262 (277)
T ss_pred HHHHHccCCcc-cCcCHHHHHHhHHHHHHhhh
Confidence 222 23677 79999999999999887653
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=256.11 Aligned_cols=240 Identities=28% Similarity=0.517 Sum_probs=187.2
Q ss_pred CCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeEE
Q 021306 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 112 (314)
Q Consensus 38 ~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 112 (314)
++|++.+.||+|++|.||++.++.+++.+++|.+.... ....+|+++++++.|+||+++++.+... ..++
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-----~~~~ 75 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNN-----GDIS 75 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecC-----CEEE
Confidence 46899999999999999999999999999999886542 2345788999999999999999987443 4488
Q ss_pred EEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCccccc
Q 021306 113 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 191 (314)
Q Consensus 113 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~ 191 (314)
+++||+++ +|.+.+... ...+++..+..++.|++.|+.+||+..|++|+||+|+||+++. ++.++|+|||.+...
T Consensus 76 lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~-~~~~~l~d~g~~~~~ 151 (265)
T cd06605 76 ICMEYMDGGSLDKILKEV---QGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNS-RGQIKLCDFGVSGQL 151 (265)
T ss_pred EEEEecCCCcHHHHHHHc---cCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECC-CCCEEEeecccchhh
Confidence 99999995 666555431 2688999999999999999999998459999999999999998 888999999998655
Q ss_pred ccCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC-----hHHHHHHHHHHcCCC------
Q 021306 192 IAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN-----AVDQLVEIIKVLGTP------ 260 (314)
Q Consensus 192 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~-----~~~~~~~i~~~~~~~------ 260 (314)
...... ...++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...+ ..+....+.+.....
T Consensus 152 ~~~~~~-~~~~~~~y~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (265)
T cd06605 152 VNSLAK-TFVGTSSYMAPERIQGN-DYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKF 229 (265)
T ss_pred HHHHhh-cccCChhccCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCChhhc
Confidence 332222 25667889999998665 48899999999999999999999997652 222233332221111
Q ss_pred ---CHHHHh-c--cCCCCCCCcccccccCChhhhh
Q 021306 261 ---TREEIR-C--MNPNYTDFRFPQIKAHPWHKVC 289 (314)
Q Consensus 261 ---~~~~~~-~--~~p~~~~~~~~~l~~~p~~~~~ 289 (314)
..+.+. + .+|. +|+++.+++.|||++..
T Consensus 230 ~~~~~~li~~~l~~~p~-~Rpt~~~ll~~~~~~~~ 263 (265)
T cd06605 230 SPDFQDFVNLCLIKDPR-ERPSYKELLEHPFIKKY 263 (265)
T ss_pred CHHHHHHHHHHcCCCch-hCcCHHHHhhCchhhcc
Confidence 111222 2 3566 89999999999999764
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=251.83 Aligned_cols=239 Identities=28% Similarity=0.459 Sum_probs=191.9
Q ss_pred CceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeEE
Q 021306 39 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 112 (314)
Q Consensus 39 ~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 112 (314)
+|++.+.||.|++|.||++.+..+++.+++|.+.... ....+|+++++.++|+|++++.+.+... ...+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~-----~~~~ 75 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEK-----GKLC 75 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecC-----CEEE
Confidence 5899999999999999999999899999999986542 2345789999999999999999988543 4588
Q ss_pred EEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCccccc
Q 021306 113 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 191 (314)
Q Consensus 113 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~ 191 (314)
+++||+++ +|.+.+......+..+++..+..++.|++.|+.+||+ .|++|+||+|+||+++. ++.++|+|||.+...
T Consensus 76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~~~H~dl~~~nil~~~-~~~~~l~d~~~~~~~ 153 (258)
T cd08215 76 IVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHS-RKILHRDIKPQNIFLTS-NGLVKLGDFGISKVL 153 (258)
T ss_pred EEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHh-CCEecccCChHHeEEcC-CCcEEECCccceeec
Confidence 99999986 6777666543335789999999999999999999999 89999999999999998 788999999998765
Q ss_pred ccCC-ccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCH--------
Q 021306 192 IAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR-------- 262 (314)
Q Consensus 192 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~-------- 262 (314)
.... ......+++.|+|||...+.. ++.++|+||+|+++++|++|+.||...+.........+....+.+
T Consensus 154 ~~~~~~~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (258)
T cd08215 154 SSTVDLAKTVVGTPYYLSPELCQNKP-YNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSSELR 232 (258)
T ss_pred ccCcceecceeeeecccChhHhccCC-CCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCCCCCCCCHHHH
Confidence 4432 222345678899999986554 789999999999999999999999887766555555443222111
Q ss_pred HHHh---ccCCCCCCCcccccccCChh
Q 021306 263 EEIR---CMNPNYTDFRFPQIKAHPWH 286 (314)
Q Consensus 263 ~~~~---~~~p~~~~~~~~~l~~~p~~ 286 (314)
+.+. ..+|+ +|+++.+++.|||+
T Consensus 233 ~~i~~~l~~~p~-~Rp~~~~ll~~~~~ 258 (258)
T cd08215 233 NLVSSLLQKDPE-ERPSIAQILQSPFI 258 (258)
T ss_pred HHHHHHcCCChh-hCcCHHHHhcCCCC
Confidence 1111 23666 89999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=266.48 Aligned_cols=200 Identities=28% Similarity=0.401 Sum_probs=165.8
Q ss_pred cCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeE
Q 021306 36 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 111 (314)
Q Consensus 36 ~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 111 (314)
.+++|.-.+.||+|+||.||+|.. .++..||||++.... ..+.+|+.++.+++|+|+|+++|++.+... ..
T Consensus 73 AT~~Fs~~~~ig~Ggfg~VYkG~l-~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~----~~ 147 (361)
T KOG1187|consen 73 ATNNFSESNLIGEGGFGTVYKGVL-SDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCLEGGE----HR 147 (361)
T ss_pred HHhCCchhcceecCCCeEEEEEEE-CCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEecCCc----eE
Confidence 346888889999999999999994 566999999886533 347899999999999999999999965442 37
Q ss_pred EEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCC--CceecCCCCCcEEEcCCCCcEEEeecCcc
Q 021306 112 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP--RVCHRDLKPQNLLVDPLTHQVKICDFGSA 188 (314)
Q Consensus 112 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~--~i~h~dl~p~Nil~~~~~~~~~l~dfg~~ 188 (314)
++|+||+++ +|.+.+...... +++|.+...|+.++++||.|||... .|+|||||++|||+|. +...||+|||++
T Consensus 148 ~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~-~~~aKlsDFGLa 224 (361)
T KOG1187|consen 148 LLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDE-DFNAKLSDFGLA 224 (361)
T ss_pred EEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECC-CCCEEccCccCc
Confidence 799999994 777777642211 8999999999999999999999832 4999999999999997 899999999999
Q ss_pred ccccc-CCccccc-cccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 021306 189 KQLIA-GEANISY-ICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE 244 (314)
Q Consensus 189 ~~~~~-~~~~~~~-~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~ 244 (314)
+.... ....... .||.+|++||+..... .+.++||||||+++.|++||+.|....
T Consensus 225 ~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~-lt~KsDVySFGVvllElitgr~~~d~~ 281 (361)
T KOG1187|consen 225 KLGPEGDTSVSTTVMGTFGYLAPEYASTGK-LTEKSDVYSFGVVLLELITGRKAVDQS 281 (361)
T ss_pred ccCCccccceeeecCCCCccCChhhhccCC-cCcccccccchHHHHHHHhCCcccCCC
Confidence 65543 2222222 7899999999996544 899999999999999999999887653
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=253.48 Aligned_cols=235 Identities=25% Similarity=0.369 Sum_probs=175.6
Q ss_pred CCCceeeeeE--eecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHhC-CCCceeeeceeeeecCCCCceeEEE
Q 021306 37 TISYMAERVV--GTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVM-DHPNVISLKHCFFSTTSKNELFLNL 113 (314)
Q Consensus 37 ~~~y~~~~~L--g~g~~g~Vy~~~~~~~~~~~~vK~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~l 113 (314)
.++|++.+.+ |+|+||.||++.++.++..+++|.+...... ..|......+ +|+|++++++++... ...++
T Consensus 13 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~-~~e~~~~~~~~~h~~iv~~~~~~~~~-----~~~~i 86 (267)
T PHA03390 13 LKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFN-AIEPMVHQLMKDNPNFIKLYYSVTTL-----KGHVL 86 (267)
T ss_pred HHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcc-hhhHHHHHHhhcCCCEEEEEEEEecC-----CeeEE
Confidence 3467777776 9999999999999999999999988654322 1233333222 799999999988543 34889
Q ss_pred Eeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcccccc
Q 021306 114 VMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 192 (314)
Q Consensus 114 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~ 192 (314)
||||+++ +|.+.+.. +..+++.+++.++.|++.||.+||+ .|++|+||+|+||+++.....++|+|||.+....
T Consensus 87 v~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~ 161 (267)
T PHA03390 87 IMDYIKDGDLFDLLKK----EGKLSEAEVKKIIRQLVEALNDLHK-HNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIG 161 (267)
T ss_pred EEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCCHHHEEEeCCCCeEEEecCccceecC
Confidence 9999985 66665543 3589999999999999999999999 8999999999999999844389999999887543
Q ss_pred cCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHcCC--C--------C
Q 021306 193 AGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQ-LVEIIKVLGT--P--------T 261 (314)
Q Consensus 193 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~-~~~i~~~~~~--~--------~ 261 (314)
.. ....++..|+|||.+.+.. ++.++|+||||+++|+|++|+.||........ .......... + .
T Consensus 162 ~~---~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (267)
T PHA03390 162 TP---SCYDGTLDYFSPEKIKGHN-YDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNVSKNA 237 (267)
T ss_pred CC---ccCCCCCcccChhhhcCCC-CCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCcccccCHHH
Confidence 22 2345688899999996544 78999999999999999999999986543321 1111111111 0 1
Q ss_pred HHHHh---ccCCCCCCCc-ccccccCChhh
Q 021306 262 REEIR---CMNPNYTDFR-FPQIKAHPWHK 287 (314)
Q Consensus 262 ~~~~~---~~~p~~~~~~-~~~l~~~p~~~ 287 (314)
.+.+. ..+|. +|++ ++++++|||+.
T Consensus 238 ~~li~~~l~~~p~-~R~~~~~~~l~h~~~~ 266 (267)
T PHA03390 238 NDFVQSMLKYNIN-YRLTNYNEIIKHPFLK 266 (267)
T ss_pred HHHHHHHhccChh-hCCchHHHHhcCCccc
Confidence 11122 33666 7875 69999999985
|
|
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-36 Score=256.33 Aligned_cols=254 Identities=27% Similarity=0.424 Sum_probs=193.8
Q ss_pred CCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCCcee
Q 021306 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 110 (314)
Q Consensus 38 ~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 110 (314)
++|++.+.||+|++|.||++.+..+++.+++|.+.... ....+|+.+++.++|+||+++++++.... .
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~-----~ 76 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDN-----E 76 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCC-----e
Confidence 57999999999999999999999999999999875421 23347889999999999999999885433 4
Q ss_pred EEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCccc
Q 021306 111 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 189 (314)
Q Consensus 111 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~ 189 (314)
.++++||+.+ +|.+.+.........+++..++.++.|++.|+.|||+ +|++|+||+|+||+++. ++.++|+|||.+.
T Consensus 77 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~H~dl~p~nili~~-~~~~~l~dfg~~~ 154 (267)
T cd08229 77 LNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHS-RRVMHRDIKPANVFITA-TGVVKLGDLGLGR 154 (267)
T ss_pred EEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEEcC-CCCEEECcchhhh
Confidence 7899999986 6666665444445679999999999999999999999 89999999999999998 7889999999886
Q ss_pred ccccCCc-cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHcCCCCHHHHhc
Q 021306 190 QLIAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV-DQLVEIIKVLGTPTREEIRC 267 (314)
Q Consensus 190 ~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~ 267 (314)
....... .....++..|+|||.+.+.. ++.++|+||||+++|+|++|..||.+.... ......+.....+ .
T Consensus 155 ~~~~~~~~~~~~~~~~~~~ape~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~------~ 227 (267)
T cd08229 155 FFSSKTTAAHSLVGTPYYMSPERIHENG-YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYP------P 227 (267)
T ss_pred ccccCCcccccccCCcCccCHHHhcCCC-ccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCC------C
Confidence 5433222 12345678899999986544 789999999999999999999999765432 1111111111111 0
Q ss_pred cCCCCCCCcccccccCChhhhhcccCChHHHHHhcchh
Q 021306 268 MNPNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGSHI 305 (314)
Q Consensus 268 ~~p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~~~ 305 (314)
..+......+.+++..+|...+..+++...+++.++.+
T Consensus 228 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 228 LPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred CCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 11111223466777788888888888888888877654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=255.44 Aligned_cols=240 Identities=28% Similarity=0.507 Sum_probs=187.7
Q ss_pred CceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHhCC---CCceeeeceeeeecCCCCcee
Q 021306 39 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMD---HPNVISLKHCFFSTTSKNELF 110 (314)
Q Consensus 39 ~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~-----~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~~~~ 110 (314)
.|++.+.||+|++|.||+|.+..+++.+++|.+.... ....+|+.+++++. |+|++++++++.. ...
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~-----~~~ 76 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLK-----GPR 76 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeee-----CCE
Confidence 5889999999999999999999999999999886432 23457888888886 9999999998743 234
Q ss_pred EEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCccc
Q 021306 111 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 189 (314)
Q Consensus 111 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~ 189 (314)
.++++||+.+ +|.+.+. ...+++..++.++.|++.++.+||+ .|++|+||+|+||+++. ++.++|+|||.+.
T Consensus 77 ~~lv~e~~~~~~L~~~~~-----~~~l~~~~~~~i~~~i~~~l~~lh~-~~i~H~dl~p~ni~i~~-~~~~~l~dfg~~~ 149 (277)
T cd06917 77 LWIIMEYAEGGSVRTLMK-----AGPIAEKYISVIIREVLVALKYIHK-VGVIHRDIKAANILVTN-TGNVKLCDFGVAA 149 (277)
T ss_pred EEEEEecCCCCcHHHHHH-----ccCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCcCHHHEEEcC-CCCEEEccCCcee
Confidence 7899999987 5544433 2479999999999999999999999 89999999999999998 8899999999987
Q ss_pred ccccCCc-cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCC------C-
Q 021306 190 QLIAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP------T- 261 (314)
Q Consensus 190 ~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~------~- 261 (314)
....... .....++..|+|||.+.+...++.++|+||||+++|+|++|..||...........+.....+. .
T Consensus 150 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (277)
T cd06917 150 LLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYSK 229 (277)
T ss_pred ecCCCccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccCCCCCCCcccCCH
Confidence 6543322 2234577889999998665557889999999999999999999998776544433222211100 1
Q ss_pred --HHHHh-cc--CCCCCCCcccccccCChhhhhcc
Q 021306 262 --REEIR-CM--NPNYTDFRFPQIKAHPWHKVCIF 291 (314)
Q Consensus 262 --~~~~~-~~--~p~~~~~~~~~l~~~p~~~~~~~ 291 (314)
.+.+. ++ +|+ +|+++.+++.|||++....
T Consensus 230 ~~~~~i~~~l~~~p~-~R~~~~~il~~~~~~~~~~ 263 (277)
T cd06917 230 LLREFVAACLDEEPK-ERLSAEELLKSKWIKAHSK 263 (277)
T ss_pred HHHHHHHHHcCCCcc-cCcCHHHHhhChHhhcccc
Confidence 11111 23 666 8999999999999988663
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=252.72 Aligned_cols=254 Identities=28% Similarity=0.436 Sum_probs=195.3
Q ss_pred CCceeeeeEeecCceEEEEEEECCCCcEEEEEEeecc-------ccchHHHHHHHHhCCCCceeeeceeeeecCCCCcee
Q 021306 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 110 (314)
Q Consensus 38 ~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~-------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 110 (314)
++|++.+.||+|++|.||+|.+..+|+.+++|.++.. .....+|++++++++|++++++++++... ..
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~-----~~ 76 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIEN-----NE 76 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecC-----Ce
Confidence 5799999999999999999999989999999987532 22345789999999999999999988543 34
Q ss_pred EEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCccc
Q 021306 111 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 189 (314)
Q Consensus 111 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~ 189 (314)
.+++|||+++ +|...+.........+++.+++.++.|++.|+.+||+ .|++|+||+|+||+++. ++.++|+|||.+.
T Consensus 77 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~h~dl~p~nil~~~-~~~~~l~d~~~~~ 154 (267)
T cd08224 77 LNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHS-KRIMHRDIKPANVFITA-TGVVKLGDLGLGR 154 (267)
T ss_pred EEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHh-CCEecCCcChhhEEECC-CCcEEEeccceee
Confidence 7899999986 7776666544445678999999999999999999999 89999999999999998 7889999999987
Q ss_pred ccccCC-ccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHHHcCCCCHHHHh
Q 021306 190 QLIAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA--VDQLVEIIKVLGTPTREEIR 266 (314)
Q Consensus 190 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~--~~~~~~i~~~~~~~~~~~~~ 266 (314)
...... ......+++.|+|||.+.+.. ++.++|+||||+++|+|++|+.||..... .+....+......+.+
T Consensus 155 ~~~~~~~~~~~~~~~~~y~apE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---- 229 (267)
T cd08224 155 FFSSKTTAAHSLVGTPYYMSPERIHENG-YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLP---- 229 (267)
T ss_pred eccCCCcccceecCCccccCHHHhccCC-CCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCC----
Confidence 543322 122345678899999986544 78999999999999999999999966542 1222222211111111
Q ss_pred ccCCCCCCCcccccccCChhhhhcccCChHHHHHhcchhh
Q 021306 267 CMNPNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGSHIN 306 (314)
Q Consensus 267 ~~~p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~~~~ 306 (314)
.......+.+++..||...+..++....+++.++.+.
T Consensus 230 ---~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 230 ---ADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred ---hhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 1011224667788888888888888888888877653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=256.25 Aligned_cols=207 Identities=29% Similarity=0.517 Sum_probs=170.4
Q ss_pred CceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeEEE
Q 021306 39 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 113 (314)
Q Consensus 39 ~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 113 (314)
+|++.+.||.|++|.||++.+..+++.+++|.++... ....+|+.+++.++|+||+++.+.+.. ...+++
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~l 75 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEA-----DGHLYI 75 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEE-----CCEEEE
Confidence 5899999999999999999999999999999885432 233578889999999999999998843 335889
Q ss_pred Eeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcccccc
Q 021306 114 VMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 192 (314)
Q Consensus 114 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~ 192 (314)
++||+++ ++.+.+.. .....+++..++.++.|++.||.+||+ +|++|+||+|+||+++. ++.++++|||.+....
T Consensus 76 v~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~~~i~~al~~lH~-~~i~H~dl~p~nili~~-~~~~~l~dfg~~~~~~ 151 (255)
T cd08219 76 VMEYCDGGDLMQKIKL--QRGKLFPEDTILQWFVQMCLGVQHIHE-KRVLHRDIKSKNIFLTQ-NGKVKLGDFGSARLLT 151 (255)
T ss_pred EEeeCCCCcHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHhh-CCcccCCCCcceEEECC-CCcEEEcccCcceeec
Confidence 9999986 56555542 134568999999999999999999999 89999999999999998 7889999999987554
Q ss_pred cCCc-cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 021306 193 AGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 255 (314)
Q Consensus 193 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~ 255 (314)
.... .....+++.|+|||.+.+.. ++.++|+||||+++|+|++|..||...+.......+.+
T Consensus 152 ~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~ 214 (255)
T cd08219 152 SPGAYACTYVGTPYYVPPEIWENMP-YNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQ 214 (255)
T ss_pred ccccccccccCCccccCHHHHccCC-cCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhc
Confidence 3222 22345788899999986544 88999999999999999999999988776655555544
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=279.14 Aligned_cols=244 Identities=23% Similarity=0.390 Sum_probs=197.2
Q ss_pred CCceeeeeEeecCceEEEEEEECCCCcEEEEEEeecccc----chHHHHHHHHhCCCCceeeeceeeeecCCCCceeEEE
Q 021306 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR----YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 113 (314)
Q Consensus 38 ~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~~----~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 113 (314)
+-|+|+..||.|+||.||++..+.++-.-|.|.+..... ..--|+++|..+.||+||++++.|+..+. +|+
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enk-----Lwi 106 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENK-----LWI 106 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCc-----eEE
Confidence 358999999999999999999988887777787643221 22357889999999999999998876655 899
Q ss_pred EeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCccccccc
Q 021306 114 VMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA 193 (314)
Q Consensus 114 v~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~~ 193 (314)
+.|||+|+..+.+.- .-+..+++.++..+++|++.||.|||+ ++|+|||||..|||+.. +|.++|.|||.+.....
T Consensus 107 liEFC~GGAVDaiml--EL~r~LtE~QIqvvc~q~ldALn~LHs-~~iIHRDLKAGNiL~Tl-dGdirLADFGVSAKn~~ 182 (1187)
T KOG0579|consen 107 LIEFCGGGAVDAIML--ELGRVLTEDQIQVVCYQVLDALNWLHS-QNIIHRDLKAGNILLTL-DGDIRLADFGVSAKNKS 182 (1187)
T ss_pred EEeecCCchHhHHHH--HhccccchHHHHHHHHHHHHHHHHHhh-cchhhhhccccceEEEe-cCcEeeecccccccchh
Confidence 999999987766653 346889999999999999999999999 89999999999999998 89999999998754332
Q ss_pred -CCcccccccccccccccccc----CCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCC-------
Q 021306 194 -GEANISYICSRFYRAPELIF----GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT------- 261 (314)
Q Consensus 194 -~~~~~~~~~~~~y~aPE~~~----~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~------- 261 (314)
.....++.|||+|||||++. ...+|..++||||||++|.||..+.+|....++...+.+|.+.-.+-.
T Consensus 183 t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS~Ws 262 (1187)
T KOG0579|consen 183 TRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPSHWS 262 (1187)
T ss_pred HHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCcchhh
Confidence 22345689999999999973 344589999999999999999999999999999888877765322111
Q ss_pred ---HHHHh-cc--CCCCCCCcccccccCChhhhhcc
Q 021306 262 ---REEIR-CM--NPNYTDFRFPQIKAHPWHKVCIF 291 (314)
Q Consensus 262 ---~~~~~-~~--~p~~~~~~~~~l~~~p~~~~~~~ 291 (314)
.+.+. |+ +|. .|+++.+|++|||....+.
T Consensus 263 ~~F~DfLk~cL~Knp~-~Rp~aaqll~Hpfv~~~~S 297 (1187)
T KOG0579|consen 263 RSFSDFLKRCLVKNPR-NRPPAAQLLKHPFVQNAPS 297 (1187)
T ss_pred hHHHHHHHHHHhcCCc-cCCCHHHHhhCcccccCCc
Confidence 11111 22 676 6889999999999985554
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=266.58 Aligned_cols=252 Identities=22% Similarity=0.337 Sum_probs=188.4
Q ss_pred CCceeeeeEeecCceEEEEEEE-----CCCCcEEEEEEeeccc-----cchHHHHHHHHhC-CCCceeeeceeeeecCCC
Q 021306 38 ISYMAERVVGTGSFGIVFQAKC-----LETGETVAIKKVLQDR-----RYKNRELQLMRVM-DHPNVISLKHCFFSTTSK 106 (314)
Q Consensus 38 ~~y~~~~~Lg~g~~g~Vy~~~~-----~~~~~~~~vK~~~~~~-----~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~ 106 (314)
++|++.+.||+|+||.||+|.+ ..++..||+|.++... ....+|+.+++.+ +||||+++++++...
T Consensus 35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~--- 111 (375)
T cd05104 35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVG--- 111 (375)
T ss_pred HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccC---
Confidence 4799999999999999999974 3456789999886432 2235799999999 899999999988443
Q ss_pred CceeEEEEeecccc-cHHHHHHhhhh------------------------------------------------------
Q 021306 107 NELFLNLVMEYVPE-SMYRVLKHYSS------------------------------------------------------ 131 (314)
Q Consensus 107 ~~~~~~lv~e~~~~-~l~~~l~~~~~------------------------------------------------------ 131 (314)
...++||||+++ +|.+.+.....
T Consensus 112 --~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 189 (375)
T cd05104 112 --GPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSV 189 (375)
T ss_pred --CcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccc
Confidence 337899999996 66666643110
Q ss_pred -----------------cCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcccccccC
Q 021306 132 -----------------ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG 194 (314)
Q Consensus 132 -----------------~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~~~ 194 (314)
....+++..+..++.||+.||.|||+ +|++|+||||+||+++. +..++|+|||++......
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dlkp~Nill~~-~~~~kl~DfG~a~~~~~~ 267 (375)
T cd05104 190 RSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLAS-KNCIHRDLAARNILLTH-GRITKICDFGLARDIRND 267 (375)
T ss_pred ccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCchhhEEEEC-CCcEEEecCccceeccCc
Confidence 12357889999999999999999999 89999999999999997 788999999998755332
Q ss_pred Ccc---ccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCHHHHhccCC
Q 021306 195 EAN---ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 270 (314)
Q Consensus 195 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~p 270 (314)
... ....++..|+|||.+.+.. ++.++||||||+++|+|++ |..||........+...+...... ..|
T Consensus 268 ~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~-------~~~ 339 (375)
T cd05104 268 SNYVVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRM-------LSP 339 (375)
T ss_pred ccccccCCCCCCcceeChhHhcCCC-CCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccC-------CCC
Confidence 211 1122345799999996654 8999999999999999998 899998876554454444432111 112
Q ss_pred CCCCCcccccccCChhhhhcccCChHHHHHhcch
Q 021306 271 NYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGSH 304 (314)
Q Consensus 271 ~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~~ 304 (314)
......+.+|+..||...+..++....+++.++.
T Consensus 340 ~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 340 ECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred CCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence 2122346677778888888887777777776653
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=253.91 Aligned_cols=250 Identities=20% Similarity=0.280 Sum_probs=192.6
Q ss_pred CCceeeeeEeecCceEEEEEEECCCCcEEEEEEeecccc---chHHHHHHHHhCCCCceeeeceeeeecCCCCceeEEEE
Q 021306 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR---YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLV 114 (314)
Q Consensus 38 ~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~~---~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 114 (314)
.+|.+.+.||+|++|.||+|.++.+++.+++|.+..+.. ...+|+.++++++|+||+++++++.. ...++++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv 80 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR-----EPPFYII 80 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEcC-----CCCcEEE
Confidence 468999999999999999999998999999998875532 34579999999999999999998743 2347899
Q ss_pred eecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCccccccc
Q 021306 115 MEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA 193 (314)
Q Consensus 115 ~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~~ 193 (314)
+||+++ +|.+.+... ....+++..++.++.|++.+|.+||+ +|++|+||+|+||++++ ++.++|+|||.+.....
T Consensus 81 ~e~~~~~~L~~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lH~-~~i~H~dlkp~nil~~~-~~~~kl~df~~~~~~~~ 156 (263)
T cd05052 81 TEFMTYGNLLDYLREC--NRQEVNAVVLLYMATQISSAMEYLEK-KNFIHRDLAARNCLVGE-NHLVKVADFGLSRLMTG 156 (263)
T ss_pred EEeCCCCcHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHh-CCEeecccCcceEEEcC-CCcEEeCCCcccccccc
Confidence 999985 666555431 23568999999999999999999999 89999999999999998 88899999999876543
Q ss_pred CCccc--cccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCHHHHhccCC
Q 021306 194 GEANI--SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 270 (314)
Q Consensus 194 ~~~~~--~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~p 270 (314)
..... ....+..|+|||.+.+.. ++.++||||||+++|+|++ |..||.+.+..+....+.+...... |
T Consensus 157 ~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~--------~ 227 (263)
T cd05052 157 DTYTAHAGAKFPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMER--------P 227 (263)
T ss_pred ceeeccCCCCCccccCCHHHhccCC-CCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCC--------C
Confidence 22111 122355799999986544 7899999999999999998 9999988776655444433221111 1
Q ss_pred CCCCCcccccccCChhhhhcccCChHHHHHhcchh
Q 021306 271 NYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGSHI 305 (314)
Q Consensus 271 ~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~~~ 305 (314)
......+.++++.||...+..++....+.+.++.+
T Consensus 228 ~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 228 EGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 11233466777788887777777777777766543
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-37 Score=241.95 Aligned_cols=213 Identities=31% Similarity=0.581 Sum_probs=182.0
Q ss_pred CCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeecc-ccchHHHHHHHHhCC-CCceeeeceeeeecCCCCceeEEEE
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-RRYKNRELQLMRVMD-HPNVISLKHCFFSTTSKNELFLNLV 114 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~-~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~lv 114 (314)
.++|++++.+|+|.|+.||.|....+.+.+++|.++.- .....+|+.+|+.|. +|||+++.++..++.++. ..+|
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Skt---paLi 113 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKT---PSLI 113 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccC---chhH
Confidence 46899999999999999999999899999999988754 344579999999996 999999999986655443 5699
Q ss_pred eecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcccccccC
Q 021306 115 MEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG 194 (314)
Q Consensus 115 ~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~~~ 194 (314)
+||+.+.-...+- ..++...++.++.|+++||.|||+ .||+|||+||.|++++.....++|+|||+|..+...
T Consensus 114 FE~v~n~Dfk~ly------~tl~d~dIryY~~elLkALdyCHS-~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~ 186 (338)
T KOG0668|consen 114 FEYVNNTDFKQLY------PTLTDYDIRYYIYELLKALDYCHS-MGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 186 (338)
T ss_pred hhhhccccHHHHh------hhhchhhHHHHHHHHHHHHhHHHh-cCcccccCCcceeeechhhceeeeeecchHhhcCCC
Confidence 9999986444332 578889999999999999999999 899999999999999998889999999999887666
Q ss_pred CccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCC-CCCChHHHHHHHHHHcCC
Q 021306 195 EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLF-PGENAVDQLVEIIKVLGT 259 (314)
Q Consensus 195 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf-~~~~~~~~~~~i~~~~~~ 259 (314)
..-.-...+..|--||.+...+.+...-|+|||||++..|+..+.|| .+.+..+++.+|.+-++.
T Consensus 187 ~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt 252 (338)
T KOG0668|consen 187 KEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGT 252 (338)
T ss_pred ceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhCh
Confidence 55555566777889999988888899999999999999999999886 667788888888765443
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=271.38 Aligned_cols=246 Identities=24% Similarity=0.427 Sum_probs=207.5
Q ss_pred CCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCCce
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL 109 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 109 (314)
..+.+++-.||-|+||+|=+++.+.....+|+|++++.. .....|..++..+..++||+++..| .+..
T Consensus 419 l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTf-----rd~k 493 (732)
T KOG0614|consen 419 LSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTF-----RDSK 493 (732)
T ss_pred hhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHh-----ccch
Confidence 346889999999999999999986665568999886532 1223688899999999999999998 6677
Q ss_pred eEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcc
Q 021306 110 FLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 188 (314)
Q Consensus 110 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~ 188 (314)
|+|++||-|-| .++..+.. .+.|+...++.++..++.|+.|||+ +||++|||||+|.+++. ++-+||.|||+|
T Consensus 494 yvYmLmEaClGGElWTiLrd----Rg~Fdd~tarF~~acv~EAfeYLH~-k~iIYRDLKPENllLd~-~Gy~KLVDFGFA 567 (732)
T KOG0614|consen 494 YVYMLMEACLGGELWTILRD----RGSFDDYTARFYVACVLEAFEYLHR-KGIIYRDLKPENLLLDN-RGYLKLVDFGFA 567 (732)
T ss_pred hhhhhHHhhcCchhhhhhhh----cCCcccchhhhhHHHHHHHHHHHHh-cCceeccCChhheeecc-CCceEEeehhhH
Confidence 79999999875 67777765 5889999999999999999999999 99999999999999998 889999999999
Q ss_pred cccccCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCC---------
Q 021306 189 KQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT--------- 259 (314)
Q Consensus 189 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~--------- 259 (314)
+.+.....+..++|||.|.|||++.+.. ...++|.||||+++||+++|.+||++.++...+..|++++..
T Consensus 568 Kki~~g~KTwTFcGTpEYVAPEIILnKG-HD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr~I~k 646 (732)
T KOG0614|consen 568 KKIGSGRKTWTFCGTPEYVAPEIILNKG-HDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPRRITK 646 (732)
T ss_pred HHhccCCceeeecCCcccccchhhhccC-cchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcccccch
Confidence 9999999999999999999999998766 789999999999999999999999999999999888876422
Q ss_pred CCHHHHh--c-cCCCCCCC-----cccccccCChhhhhcccCCh
Q 021306 260 PTREEIR--C-MNPNYTDF-----RFPQIKAHPWHKVCIFHFPK 295 (314)
Q Consensus 260 ~~~~~~~--~-~~p~~~~~-----~~~~l~~~p~~~~~~~~~~~ 295 (314)
.+.+++. | -+|. .|+ .+.+|.+|-||..+..+-+.
T Consensus 647 ~a~~Lik~LCr~~P~-ERLG~~~~gI~DIkkH~Wf~gfdweglr 689 (732)
T KOG0614|consen 647 TATDLIKKLCRDNPT-ERLGYQKGGINDIKKHRWFEGFDWEGLR 689 (732)
T ss_pred hHHHHHHHHHhcCcH-hhhccccCChHHHHhhhhhhcCChhhhh
Confidence 2223333 2 2454 455 47799999999988876443
|
|
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=254.09 Aligned_cols=236 Identities=31% Similarity=0.547 Sum_probs=182.2
Q ss_pred CceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc--------------cchHHHHHHHHhCCCCceeeeceeeeecC
Q 021306 39 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR--------------RYKNRELQLMRVMDHPNVISLKHCFFSTT 104 (314)
Q Consensus 39 ~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~--------------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 104 (314)
+|.+.+.||+|++|.||+|.+..+++.+++|.+.... ....+|+.+++.++|+|++++++.+..
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-- 79 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETT-- 79 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEecc--
Confidence 6899999999999999999988899999999875311 123468889999999999999988733
Q ss_pred CCCceeEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEe
Q 021306 105 SKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKIC 183 (314)
Q Consensus 105 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~ 183 (314)
....++|+||+.+ +|.+.+.. ...+++..++.++.|++.||.+||+ ++++|+||+|+||+++. ++.++|+
T Consensus 80 ---~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~~~nil~~~-~~~~~l~ 150 (272)
T cd06629 80 ---EEYLSIFLEYVPGGSIGSCLRT----YGRFEEQLVRFFTEQVLEGLAYLHS-KGILHRDLKADNLLVDA-DGICKIS 150 (272)
T ss_pred ---CCceEEEEecCCCCcHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHhh-CCeeecCCChhhEEEcC-CCeEEEe
Confidence 3347899999986 55555543 3679999999999999999999999 89999999999999998 8899999
Q ss_pred ecCcccccccCC---ccccccccccccccccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCC
Q 021306 184 DFGSAKQLIAGE---ANISYICSRFYRAPELIFGAT-EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT 259 (314)
Q Consensus 184 dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~-~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~ 259 (314)
|||.+....... ......++..|+|||.+.+.. .++.++|+||||+++|++++|..||...+..+....+......
T Consensus 151 d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 230 (272)
T cd06629 151 DFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSA 230 (272)
T ss_pred eccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccC
Confidence 999987543221 122334677899999986543 3688999999999999999999999776655444433322111
Q ss_pred C-------------CHHHHh---ccCCCCCCCcccccccCChh
Q 021306 260 P-------------TREEIR---CMNPNYTDFRFPQIKAHPWH 286 (314)
Q Consensus 260 ~-------------~~~~~~---~~~p~~~~~~~~~l~~~p~~ 286 (314)
. ..+.+. ..+|. .|+++.++++|||+
T Consensus 231 ~~~~~~~~~~~~~~~~~li~~~l~~~p~-~Rps~~~il~~~~~ 272 (272)
T cd06629 231 PPIPPDVSMNLSPVALDFLNACFTINPD-NRPTARELLQHPFI 272 (272)
T ss_pred CcCCccccccCCHHHHHHHHHHhcCChh-hCCCHHHHhhCCCC
Confidence 0 011111 23566 78999999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=256.28 Aligned_cols=252 Identities=23% Similarity=0.309 Sum_probs=193.1
Q ss_pred CCCceeeeeEeecCceEEEEEEECCCC-----cEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCC
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCLETG-----ETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSK 106 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~~~~-----~~~~vK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 106 (314)
.++|++.+.||+|++|.||+|.....+ ..+++|.+.... ....+|+.++++++|+||+++++++...
T Consensus 4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~--- 80 (283)
T cd05048 4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKE--- 80 (283)
T ss_pred hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCC---
Confidence 357999999999999999999876554 679999886432 2345789999999999999999987433
Q ss_pred CceeEEEEeecccc-cHHHHHHhhhh------------cCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEE
Q 021306 107 NELFLNLVMEYVPE-SMYRVLKHYSS------------ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLV 173 (314)
Q Consensus 107 ~~~~~~lv~e~~~~-~l~~~l~~~~~------------~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~ 173 (314)
...++++||+++ +|.+.+..... ....+++..+..++.|++.||.|||+ +|++|+||||+||++
T Consensus 81 --~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~-~~i~H~dlkp~Nil~ 157 (283)
T cd05048 81 --QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSS-HHFVHRDLAARNCLV 157 (283)
T ss_pred --CceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccccccceEEE
Confidence 337899999985 66666654211 11568899999999999999999999 899999999999999
Q ss_pred cCCCCcEEEeecCcccccccCC---ccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHH
Q 021306 174 DPLTHQVKICDFGSAKQLIAGE---ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQ 249 (314)
Q Consensus 174 ~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~t-g~~pf~~~~~~~~ 249 (314)
+. ++.++|+|||++....... ......+++.|+|||.+.+.. ++.++||||||+++|+|++ |..||.+....+.
T Consensus 158 ~~-~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~ 235 (283)
T cd05048 158 GE-GLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGK-FTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEV 235 (283)
T ss_pred cC-CCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCc-CchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 98 7889999999987543221 122234567899999986554 8999999999999999998 9999998877665
Q ss_pred HHHHHHHcCCCCHHHHhccCCCCCCCcccccccCChhhhhcccCChHHHHHhcch
Q 021306 250 LVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGSH 304 (314)
Q Consensus 250 ~~~i~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~~ 304 (314)
...+.+....+. |......+.+|+..||...+..+.+.+.+.+.+++
T Consensus 236 ~~~i~~~~~~~~--------~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 236 IEMIRSRQLLPC--------PEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred HHHHHcCCcCCC--------cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 554443221111 11123356778888888888888888888777654
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=255.52 Aligned_cols=238 Identities=29% Similarity=0.458 Sum_probs=190.1
Q ss_pred ceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeEE
Q 021306 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 112 (314)
Q Consensus 40 y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 112 (314)
|...+.||+|++|.||+|++..+++.+++|.+.... ....+|+.+++.++|+|++++++++.... ..+
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~~ 97 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEH-----TAW 97 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCC-----EEE
Confidence 777788999999999999998999999999886432 12347889999999999999999885433 378
Q ss_pred EEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcccccc
Q 021306 113 LVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 192 (314)
Q Consensus 113 lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~ 192 (314)
+++||+.+++.+.+.. ...++++.+++.++.|++.++.|||+ +|++|+||+|+||+++. ++.++|+|||.+....
T Consensus 98 lv~e~~~~~l~~~l~~---~~~~l~~~~~~~~~~qi~~al~~LH~-~gi~H~dl~p~nili~~-~~~~kL~dfg~~~~~~ 172 (313)
T cd06633 98 LVMEYCLGSASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHS-HNMIHRDIKAGNILLTE-PGQVKLADFGSASKSS 172 (313)
T ss_pred EEEecCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCChhhEEECC-CCCEEEeecCCCcccC
Confidence 9999999988776653 34678999999999999999999999 89999999999999998 7889999999886432
Q ss_pred cCCccccccccccccccccccC--CCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCC---------
Q 021306 193 AGEANISYICSRFYRAPELIFG--ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT--------- 261 (314)
Q Consensus 193 ~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~--------- 261 (314)
......++..|+|||.+.. ...++.++|+||||+++|+|++|..||...+.......+........
T Consensus 173 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 249 (313)
T cd06633 173 ---PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSF 249 (313)
T ss_pred ---CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCHHH
Confidence 2223456788999999842 23478899999999999999999999988776665555544322111
Q ss_pred HHHHh-c--cCCCCCCCcccccccCChhhhhcc
Q 021306 262 REEIR-C--MNPNYTDFRFPQIKAHPWHKVCIF 291 (314)
Q Consensus 262 ~~~~~-~--~~p~~~~~~~~~l~~~p~~~~~~~ 291 (314)
.+.+. + .+|. .|+++.+++.|||++....
T Consensus 250 ~~li~~~l~~~P~-~Rp~~~~~l~~~~~~~~~~ 281 (313)
T cd06633 250 RGFVDYCLQKIPQ-ERPASAELLRHDFVRRDRP 281 (313)
T ss_pred HHHHHHHccCChh-hCcCHHHHhcCcccCCCch
Confidence 11122 2 3566 8999999999999998664
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=252.83 Aligned_cols=240 Identities=26% Similarity=0.390 Sum_probs=188.1
Q ss_pred CceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeEEE
Q 021306 39 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 113 (314)
Q Consensus 39 ~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 113 (314)
-|++.+.||.|+||.||++.+..+++.+++|.+.... ....+|+.++++++|+||+++++.+... ...++
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~l 79 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKD-----TKLWI 79 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeC-----CeEEE
Confidence 3788999999999999999998899999999875432 2345788999999999999999988433 34889
Q ss_pred Eeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcccccc
Q 021306 114 VMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 192 (314)
Q Consensus 114 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~ 192 (314)
|+||+++ ++.+.+. ...+++..+..++.|++.++.+||+ .|++|+||+|+||+++. ++.++|+|||++....
T Consensus 80 v~e~~~~~~l~~~i~-----~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~h~dl~p~Ni~i~~-~~~~~l~dfg~~~~~~ 152 (277)
T cd06641 80 IMEYLGGGSALDLLE-----PGPLDETQIATILREILKGLDYLHS-EKKIHRDIKAANVLLSE-HGEVKLADFGVAGQLT 152 (277)
T ss_pred EEEeCCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHcc-CCeecCCCCHHhEEECC-CCCEEEeecccceecc
Confidence 9999997 4444443 3578999999999999999999999 89999999999999998 7889999999886543
Q ss_pred cCCc-cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCC-----C---HH
Q 021306 193 AGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP-----T---RE 263 (314)
Q Consensus 193 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~-----~---~~ 263 (314)
.... .....++..|+|||.+.+. .++.++|+||||+++|+|++|..||...........+....... + .+
T Consensus 153 ~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (277)
T cd06641 153 DTQIKRNTFVGTPFWMAPEVIKQS-AYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKE 231 (277)
T ss_pred cchhhhccccCCccccChhhhccC-CCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCCCCCCcccCHHHHH
Confidence 3221 1223567789999998654 47889999999999999999999998777655444443221111 1 11
Q ss_pred HHh---ccCCCCCCCcccccccCChhhhhccc
Q 021306 264 EIR---CMNPNYTDFRFPQIKAHPWHKVCIFH 292 (314)
Q Consensus 264 ~~~---~~~p~~~~~~~~~l~~~p~~~~~~~~ 292 (314)
.+. ..+|+ +|+++.++++|||+.....+
T Consensus 232 ~i~~~l~~~p~-~Rp~~~~~l~~~~~~~~~~~ 262 (277)
T cd06641 232 FVEACLNKEPS-FRPTAKELLKHKFIVRFAKK 262 (277)
T ss_pred HHHHHccCChh-hCcCHHHHHhCHHHhhhhhc
Confidence 122 23677 78999999999999886543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=253.73 Aligned_cols=208 Identities=38% Similarity=0.722 Sum_probs=173.0
Q ss_pred ceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeEEE
Q 021306 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 113 (314)
Q Consensus 40 y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 113 (314)
|++.+.||+|++|.||+++...+++.+++|.+.... .....|+.++++++|+|++++++++... .+.++
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-----~~~~~ 75 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTE-----RKLYL 75 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcC-----CceEE
Confidence 678899999999999999999999999999987542 1234688999999999999999988443 34889
Q ss_pred EeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCccccccc
Q 021306 114 VMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA 193 (314)
Q Consensus 114 v~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~~ 193 (314)
++||+++++.+.+... ...+++..+..++.|++.||.+||+ +|++|+||+|+||+++. ++.++|+|||.+.....
T Consensus 76 v~e~~~~~l~~~i~~~---~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~H~~l~~~ni~~~~-~~~~~l~d~g~~~~~~~ 150 (282)
T cd07829 76 VFEYCDMDLKKYLDKR---PGPLSPNLIKSIMYQLLRGLAYCHS-HRILHRDLKPQNILINR-DGVLKLADFGLARAFGI 150 (282)
T ss_pred EecCcCcCHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCChheEEEcC-CCCEEEecCCcccccCC
Confidence 9999999887777642 2579999999999999999999999 89999999999999998 78899999999875543
Q ss_pred CC-ccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHc
Q 021306 194 GE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVL 257 (314)
Q Consensus 194 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~ 257 (314)
.. .......+..|+|||.+.+...++.++|+||||+++|+|++|..||.+.+..+.+..+.+..
T Consensus 151 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 215 (282)
T cd07829 151 PLRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQIL 215 (282)
T ss_pred CccccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHh
Confidence 32 12223346679999998766568899999999999999999999998887776666665543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=254.95 Aligned_cols=248 Identities=23% Similarity=0.370 Sum_probs=187.3
Q ss_pred ccCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccccc-----hHHHHHHHHhC-CCCceeeeceeeeecCCCCc
Q 021306 35 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY-----KNRELQLMRVM-DHPNVISLKHCFFSTTSKNE 108 (314)
Q Consensus 35 ~~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~~~-----~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~ 108 (314)
-..++|++.+.||+|++|.||+|.+..+++.+++|.++..... ..+|..++.+. .|+||+++++++...
T Consensus 12 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~----- 86 (296)
T cd06618 12 ADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITD----- 86 (296)
T ss_pred CCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecC-----
Confidence 3457899999999999999999999888999999998653221 22455545455 599999999988443
Q ss_pred eeEEEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcc
Q 021306 109 LFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 188 (314)
Q Consensus 109 ~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~ 188 (314)
...+++|||+++.+.+.+.. ....+++..+..++.|++.|+.|||+..|++|+||+|+||+++. ++.++|+|||.+
T Consensus 87 ~~~~~v~e~~~~~l~~l~~~---~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~-~~~~kL~dfg~~ 162 (296)
T cd06618 87 SDVFICMELMSTCLDKLLKR---IQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDA-SGNVKLCDFGIS 162 (296)
T ss_pred CeEEEEeeccCcCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcC-CCCEEECccccc
Confidence 34889999998876665543 24589999999999999999999996249999999999999997 889999999998
Q ss_pred cccccCCccccccccccccccccccCC---CCCCcchhHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHcCCC----
Q 021306 189 KQLIAGEANISYICSRFYRAPELIFGA---TEYTTSIDIWSAGCVLAELLLGQPLFPGENA-VDQLVEIIKVLGTP---- 260 (314)
Q Consensus 189 ~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~~Dv~slG~il~el~tg~~pf~~~~~-~~~~~~i~~~~~~~---- 260 (314)
.............++..|+|||.+.+. ..++.++|+||||+++|+|++|+.||..... .+.+..+.......
T Consensus 163 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (296)
T cd06618 163 GRLVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPN 242 (296)
T ss_pred hhccCCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCCCC
Confidence 765433333334467789999998543 2367899999999999999999999976443 23333333322111
Q ss_pred ---C---HHHHh---ccCCCCCCCcccccccCChhhhhccc
Q 021306 261 ---T---REEIR---CMNPNYTDFRFPQIKAHPWHKVCIFH 292 (314)
Q Consensus 261 ---~---~~~~~---~~~p~~~~~~~~~l~~~p~~~~~~~~ 292 (314)
. .+.+. ..+|. .|++++++++|||++.....
T Consensus 243 ~~~~~~l~~li~~~l~~~p~-~Rp~~~~il~~~~~~~~~~~ 282 (296)
T cd06618 243 EGFSPDFCSFVDLCLTKDHR-KRPKYRELLQHPFIRRYETA 282 (296)
T ss_pred CCCCHHHHHHHHHHccCChh-hCCCHHHHhcChhhhccchh
Confidence 1 12222 23677 89999999999998875543
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=258.66 Aligned_cols=209 Identities=25% Similarity=0.382 Sum_probs=162.7
Q ss_pred CCCceeeeeEeecCceEEEEEEECCCCcE--EEEEEeeccc-----cchHHHHHHHHhC-CCCceeeeceeeeecCCCCc
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCLETGET--VAIKKVLQDR-----RYKNRELQLMRVM-DHPNVISLKHCFFSTTSKNE 108 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~--~~vK~~~~~~-----~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~ 108 (314)
.++|++.+.||+|+||.||+|.++.++.. +++|.++... ....+|+.++.++ +|+||+++++++.. .
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~-----~ 80 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH-----R 80 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECC-----C
Confidence 46899999999999999999998877764 4666654321 2335788999999 89999999998833 3
Q ss_pred eeEEEEeecccc-cHHHHHHhhhh------------cCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcC
Q 021306 109 LFLNLVMEYVPE-SMYRVLKHYSS------------ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP 175 (314)
Q Consensus 109 ~~~~lv~e~~~~-~l~~~l~~~~~------------~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~ 175 (314)
.++++++||+++ +|.+.+..... ....+++.+++.++.|++.|+.|||+ +|++||||||+||+++.
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~-~gi~H~dlkp~Nili~~ 159 (303)
T cd05088 81 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ-KQFIHRDLAARNILVGE 159 (303)
T ss_pred CCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHh-CCccccccchheEEecC
Confidence 348899999985 66666643211 12368999999999999999999999 89999999999999998
Q ss_pred CCCcEEEeecCcccccccCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 021306 176 LTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEI 253 (314)
Q Consensus 176 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~t-g~~pf~~~~~~~~~~~i 253 (314)
++.++|+|||++..............+..|+|||.+.+.. ++.++||||||+++|+|+| |..||...+..+....+
T Consensus 160 -~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~ 236 (303)
T cd05088 160 -NYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSV-YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL 236 (303)
T ss_pred -CCcEEeCccccCcccchhhhcccCCCcccccCHHHHhccC-CcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHH
Confidence 7889999999986432211111122355799999885544 7899999999999999998 99999877765544433
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=257.30 Aligned_cols=250 Identities=22% Similarity=0.282 Sum_probs=180.4
Q ss_pred CCceeeeeEeecCceEEEEEEECCCCc--EEEEEEeeccc-----cchHHHHHHHHhC-CCCceeeeceeeeecCCCCce
Q 021306 38 ISYMAERVVGTGSFGIVFQAKCLETGE--TVAIKKVLQDR-----RYKNRELQLMRVM-DHPNVISLKHCFFSTTSKNEL 109 (314)
Q Consensus 38 ~~y~~~~~Lg~g~~g~Vy~~~~~~~~~--~~~vK~~~~~~-----~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~ 109 (314)
++|++.+.||+|+||.||+|....++. .+++|.++... ....+|+.++.++ .||||+++++++.. ..
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~-----~~ 76 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACEN-----RG 76 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEcc-----CC
Confidence 579999999999999999999877664 46787775321 2345788889888 79999999998743 33
Q ss_pred eEEEEeecccc-cHHHHHHhhhh------------cCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCC
Q 021306 110 FLNLVMEYVPE-SMYRVLKHYSS------------ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPL 176 (314)
Q Consensus 110 ~~~lv~e~~~~-~l~~~l~~~~~------------~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~ 176 (314)
.+++++||+++ +|.+.+..... ....+++..++.++.|++.||.+||+ +|++|+||||+||+++.
T Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~-~~ivH~dlkp~Nill~~- 154 (297)
T cd05089 77 YLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSE-KQFIHRDLAARNVLVGE- 154 (297)
T ss_pred cceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCcCCcceEEECC-
Confidence 47899999985 67766653211 12358899999999999999999999 89999999999999998
Q ss_pred CCcEEEeecCcccccccCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 021306 177 THQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIK 255 (314)
Q Consensus 177 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~t-g~~pf~~~~~~~~~~~i~~ 255 (314)
++.++|+|||++..............+..|+|||.+.+.. ++.++||||||+++|+|++ |..||......+....+.+
T Consensus 155 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~ 233 (297)
T cd05089 155 NLASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSV-YTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQ 233 (297)
T ss_pred CCeEEECCcCCCccccceeccCCCCcCccccCchhhccCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc
Confidence 7889999999986432211111122245699999986544 7899999999999999997 9999988887666655544
Q ss_pred HcCCCCHHHHhccCCCCCCCcccccccCChhhhhcccCChHHHHHhcc
Q 021306 256 VLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGS 303 (314)
Q Consensus 256 ~~~~~~~~~~~~~~p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~ 303 (314)
....+.+. .+ ...+.+++..+|...+..+++.+.+...++
T Consensus 234 ~~~~~~~~---~~-----~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 273 (297)
T cd05089 234 GYRMEKPR---NC-----DDEVYELMRQCWRDRPYERPPFAQISVQLS 273 (297)
T ss_pred CCCCCCCC---CC-----CHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 32211110 11 223445555555555555555555544433
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=254.56 Aligned_cols=251 Identities=24% Similarity=0.313 Sum_probs=189.1
Q ss_pred CCCceeeeeEeecCceEEEEEEECC-----CCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCC
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCLE-----TGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSK 106 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~~-----~~~~~~vK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 106 (314)
.++|.+.+.||+|++|.||+|.+.. +++.+++|.++... ....+|+++++.++|+||+++++++...
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--- 80 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEG--- 80 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecC---
Confidence 3579999999999999999998743 46789999886532 2345799999999999999999988543
Q ss_pred CceeEEEEeecccc-cHHHHHHhhh----------hcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcC
Q 021306 107 NELFLNLVMEYVPE-SMYRVLKHYS----------SANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP 175 (314)
Q Consensus 107 ~~~~~~lv~e~~~~-~l~~~l~~~~----------~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~ 175 (314)
...+++|||+++ +|.+.+.... .....+++.++..++.|++.|+.+||+ +|++|+||+|+||+++.
T Consensus 81 --~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~-~~i~h~dlkp~nili~~ 157 (280)
T cd05049 81 --DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLAS-QHFVHRDLATRNCLVGY 157 (280)
T ss_pred --CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhh-CCeeccccccceEEEcC
Confidence 348899999986 6666554321 123458899999999999999999999 89999999999999998
Q ss_pred CCCcEEEeecCcccccccCCc---cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHH
Q 021306 176 LTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLV 251 (314)
Q Consensus 176 ~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~t-g~~pf~~~~~~~~~~ 251 (314)
++.++|+|||.+........ .....+++.|+|||.+.+.. ++.++||||||+++|+|++ |..||.+.+..+...
T Consensus 158 -~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~ 235 (280)
T cd05049 158 -DLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRK-FTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIE 235 (280)
T ss_pred -CCeEEECCcccceecccCcceecCCCCcccceecChhhhccCC-cchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Confidence 78999999999875432211 12233467899999986655 8999999999999999998 999998877766555
Q ss_pred HHHHHcCCCCHHHHhccCCCCCCCcccccccCChhhhhcccCChHHHHHhcc
Q 021306 252 EIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGS 303 (314)
Q Consensus 252 ~i~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~ 303 (314)
.+.+...... |......+.+++..+|...+..+++...+++.++
T Consensus 236 ~~~~~~~~~~--------~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 236 CITQGRLLQR--------PRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred HHHcCCcCCC--------CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 5443221111 1111224556777777777777777776666554
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=253.46 Aligned_cols=233 Identities=23% Similarity=0.369 Sum_probs=172.3
Q ss_pred eEeecCceEEEEEEECCCCcEEEEEEeecccc-------chHHHHHHH---HhCCCCceeeeceeeeecCCCCceeEEEE
Q 021306 45 VVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YKNRELQLM---RVMDHPNVISLKHCFFSTTSKNELFLNLV 114 (314)
Q Consensus 45 ~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~~-------~~~~e~~~l---~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 114 (314)
.||+|+||.||++.+..+++.+++|.+.+... ...++..++ ....|++++.+++.+... ...++|
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~-----~~~~lv 75 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTP-----DKLCFI 75 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecC-----CeEEEE
Confidence 48999999999999999999999998864321 112333333 334799999998887433 247899
Q ss_pred eeccccc-HHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCccccccc
Q 021306 115 MEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA 193 (314)
Q Consensus 115 ~e~~~~~-l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~~ 193 (314)
|||++++ |.+.+. ....+++..+..++.|++.||.|||+ ++++|+||||+||+++. ++.++|+|||++.....
T Consensus 76 ~e~~~~~~L~~~i~----~~~~l~~~~~~~i~~qi~~al~~lH~-~~ivH~dikp~Nil~~~-~~~~~l~dfg~~~~~~~ 149 (279)
T cd05633 76 LDLMNGGDLHYHLS----QHGVFSEKEMRFYATEIILGLEHMHN-RFVVYRDLKPANILLDE-HGHVRISDLGLACDFSK 149 (279)
T ss_pred EecCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCcCCCCCCHHHEEECC-CCCEEEccCCcceeccc
Confidence 9999974 444433 34679999999999999999999999 89999999999999998 78999999999865432
Q ss_pred CCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHHHcCCC--------CHH
Q 021306 194 GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV--DQLVEIIKVLGTP--------TRE 263 (314)
Q Consensus 194 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~--~~~~~i~~~~~~~--------~~~ 263 (314)
. ......+++.|+|||.+.+...++.++|+||+|+++|+|++|..||...... ............. ..+
T Consensus 150 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (279)
T cd05633 150 K-KPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKS 228 (279)
T ss_pred c-CccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcCCcCCccccCHHHHH
Confidence 2 2223467889999999865455789999999999999999999999764322 1222211111111 112
Q ss_pred HHh---ccCCCCCCC-----cccccccCChhhhhc
Q 021306 264 EIR---CMNPNYTDF-----RFPQIKAHPWHKVCI 290 (314)
Q Consensus 264 ~~~---~~~p~~~~~-----~~~~l~~~p~~~~~~ 290 (314)
.+. ..+|. +|+ ++.++++|||++...
T Consensus 229 li~~~l~~~p~-~R~~~~~~~~~~~~~h~~~~~~~ 262 (279)
T cd05633 229 LLEGLLQRDVS-KRLGCLGRGAQEVKEHVFFKGID 262 (279)
T ss_pred HHHHHhcCCHH-HhcCCCCCCHHHHHhCccccCCC
Confidence 222 33566 777 699999999998855
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=254.45 Aligned_cols=260 Identities=22% Similarity=0.305 Sum_probs=197.2
Q ss_pred CCceeeeeEeecCceEEEEEEEC-----CCCcEEEEEEeeccc----cchHHHHHHHHhCCCCceeeeceeeeecCCCCc
Q 021306 38 ISYMAERVVGTGSFGIVFQAKCL-----ETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 108 (314)
Q Consensus 38 ~~y~~~~~Lg~g~~g~Vy~~~~~-----~~~~~~~vK~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 108 (314)
.+|.+.+.||+|++|.||++++. .++..+++|.+.... ....+|+.++++++|+||+++++++.. .
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~ 79 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGD-----G 79 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEcc-----C
Confidence 46999999999999999999854 245678888876443 345688999999999999999998743 3
Q ss_pred eeEEEEeecccc-cHHHHHHhhh------------hcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcC
Q 021306 109 LFLNLVMEYVPE-SMYRVLKHYS------------SANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP 175 (314)
Q Consensus 109 ~~~~lv~e~~~~-~l~~~l~~~~------------~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~ 175 (314)
...++||||+++ +|.+.+.... .....+++..++.++.||+.|+.+||+ +|++|+||+|+||+++.
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~-~~i~H~dlkp~Nil~~~ 158 (291)
T cd05094 80 DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLAS-QHFVHRDLATRNCLVGA 158 (291)
T ss_pred CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecccCcceEEEcc
Confidence 348899999985 6666554321 112458999999999999999999999 99999999999999998
Q ss_pred CCCcEEEeecCcccccccCCc---cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHH
Q 021306 176 LTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLV 251 (314)
Q Consensus 176 ~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~t-g~~pf~~~~~~~~~~ 251 (314)
++.++|+|||.+........ .....++..|+|||.+.+.. ++.++||||||+++|+|+| |..||...+..+...
T Consensus 159 -~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~ 236 (291)
T cd05094 159 -NLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRK-FTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIE 236 (291)
T ss_pred -CCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 78999999999875433211 12233467799999986654 8899999999999999999 999998877665544
Q ss_pred HHHHHcCCCCHHHHhccCCCCCCCcccccccCChhhhhcccCChHHHHHhcchhhhcCCCCC
Q 021306 252 EIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGSHINAISPRHC 313 (314)
Q Consensus 252 ~i~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (314)
.+....... . +......+.+++..+|.+.+..+++...+.+.++.+.-..|-.+
T Consensus 237 ~~~~~~~~~----~----~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~~~~~~ 290 (291)
T cd05094 237 CITQGRVLE----R----PRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKATPIYL 290 (291)
T ss_pred HHhCCCCCC----C----CccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhhcCccc
Confidence 433221111 0 11112246788888888888888888888888887766555444
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=248.48 Aligned_cols=240 Identities=28% Similarity=0.454 Sum_probs=180.0
Q ss_pred CCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeEE
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 112 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 112 (314)
.++......||+|+||.||++++..++..+++|.+.... ....+|+.++++++|+||+++++++.. ..+.+
T Consensus 7 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~~~ 81 (268)
T cd06624 7 YDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSE-----NGFFK 81 (268)
T ss_pred cccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeecc-----CCEEE
Confidence 344556678999999999999998899999999876432 234688999999999999999998743 34588
Q ss_pred EEeecccc-cHHHHHHhhhhcCCCC--CHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCccc
Q 021306 113 LVMEYVPE-SMYRVLKHYSSANQRM--PLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 189 (314)
Q Consensus 113 lv~e~~~~-~l~~~l~~~~~~~~~l--~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~ 189 (314)
+++||+++ +|.+.+... ...+ ++..+..++.|++.||.|||+ +|++|+||+|+||+++...+.++|+|||.+.
T Consensus 82 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~~qi~~al~~lH~-~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~ 157 (268)
T cd06624 82 IFMEQVPGGSLSALLRSK---WGPLKDNEQTIIFYTKQILEGLKYLHD-NQIVHRDIKGDNVLVNTYSGVVKISDFGTSK 157 (268)
T ss_pred EEEecCCCCCHHHHHHHh---cccCCCcHHHHHHHHHHHHHHHHHHHH-CCEeecCCCHHHEEEcCCCCeEEEecchhhe
Confidence 99999986 666655431 2345 888899999999999999999 8999999999999998756789999999886
Q ss_pred ccccCCc-cccccccccccccccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH--HcCCC----C
Q 021306 190 QLIAGEA-NISYICSRFYRAPELIFGA-TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK--VLGTP----T 261 (314)
Q Consensus 190 ~~~~~~~-~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~--~~~~~----~ 261 (314)
....... .....+++.|+|||.+.+. ..++.++|+||||+++|+|++|..||.............. ..... .
T Consensus 158 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (268)
T cd06624 158 RLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESL 237 (268)
T ss_pred ecccCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCccc
Confidence 5432222 2233467889999998543 2367899999999999999999999976543222111111 11110 1
Q ss_pred ----HHHHh-cc--CCCCCCCcccccccCChh
Q 021306 262 ----REEIR-CM--NPNYTDFRFPQIKAHPWH 286 (314)
Q Consensus 262 ----~~~~~-~~--~p~~~~~~~~~l~~~p~~ 286 (314)
...+. ++ +|. +|+++.+++.|||+
T Consensus 238 ~~~~~~li~~~l~~~p~-~Rpt~~~ll~~~~~ 268 (268)
T cd06624 238 SAEAKNFILRCFEPDPD-KRASAHDLLQDPFL 268 (268)
T ss_pred CHHHHHHHHHHcCCCch-hCCCHHHHHhCCCC
Confidence 11222 33 566 79999999999995
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=245.07 Aligned_cols=235 Identities=28% Similarity=0.479 Sum_probs=187.5
Q ss_pred CceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeEEEE
Q 021306 39 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLV 114 (314)
Q Consensus 39 ~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 114 (314)
.|++.+.||+|++|.||++.+..+++.+++|.+.... ....+|+.++++++|++++++++++... ...+++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~l~ 75 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKK-----DELWIV 75 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-----CeEEEE
Confidence 4889999999999999999998899999999986654 3456899999999999999999987543 337899
Q ss_pred eecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCccccccc
Q 021306 115 MEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA 193 (314)
Q Consensus 115 ~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~~ 193 (314)
+||+++ +|.+.+.. ....+++..++.++.|++.|+.+||. .|++|+||+|+||+++. ++.++|+|||.+.....
T Consensus 76 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lh~-~~i~h~dl~p~ni~i~~-~~~~~l~d~~~~~~~~~ 150 (253)
T cd05122 76 MEFCSGGSLKDLLKS---TNQTLTESQIAYVCKELLKGLEYLHS-NGIIHRDIKAANILLTS-DGEVKLIDFGLSAQLSD 150 (253)
T ss_pred EecCCCCcHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHhhc-CCEecCCCCHHHEEEcc-CCeEEEeeccccccccc
Confidence 999995 66555543 12579999999999999999999999 89999999999999998 88999999999876644
Q ss_pred CCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCC----C------HH
Q 021306 194 GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP----T------RE 263 (314)
Q Consensus 194 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~----~------~~ 263 (314)
........++..|+|||.+.+.. .+.++|+||||+++|+|++|+.||...+............... . .+
T Consensus 151 ~~~~~~~~~~~~~~~PE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (253)
T cd05122 151 TKARNTMVGTPYWMAPEVINGKP-YDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKD 229 (253)
T ss_pred cccccceecCCcccCHHHHcCCC-CCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcCcccccCHHHHH
Confidence 33234456688899999986554 7899999999999999999999998876555544443321111 0 11
Q ss_pred HHh---ccCCCCCCCcccccccCCh
Q 021306 264 EIR---CMNPNYTDFRFPQIKAHPW 285 (314)
Q Consensus 264 ~~~---~~~p~~~~~~~~~l~~~p~ 285 (314)
.+. ..+|. +|+++.++++|||
T Consensus 230 ~i~~~l~~~p~-~R~t~~~~l~~~~ 253 (253)
T cd05122 230 FLKKCLQKNPE-KRPTAEQLLKHPF 253 (253)
T ss_pred HHHHHccCChh-hCCCHHHHhcCCC
Confidence 222 23566 7899999999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=253.90 Aligned_cols=241 Identities=28% Similarity=0.433 Sum_probs=185.8
Q ss_pred CCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeE
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 111 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 111 (314)
.++|++.+.||+|++|.||++.+..+++.+++|.+.... ....+|+.+++.++|+||+++++.+... ..+
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~ 78 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNE-----NNI 78 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecC-----CEE
Confidence 357999999999999999999999999999999876432 2345789999999999999999988543 458
Q ss_pred EEEeeccccc-HHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcccc
Q 021306 112 NLVMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 190 (314)
Q Consensus 112 ~lv~e~~~~~-l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~ 190 (314)
++|+||++++ |.+.+. ..+.+++..++.++.|++.+|.|||+..+++|+||+|+||+++. ++.++|+|||++..
T Consensus 79 ~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~-~~~~~l~d~gl~~~ 153 (284)
T cd06620 79 CMCMEFMDCGSLDRIYK----KGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNS-RGQIKLCDFGVSGE 153 (284)
T ss_pred EEEEecCCCCCHHHHHH----hccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECC-CCcEEEccCCcccc
Confidence 8999999975 444333 24678999999999999999999996358999999999999998 78899999998764
Q ss_pred cccCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChH-----------HHHHHHHHHcCC
Q 021306 191 LIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV-----------DQLVEIIKVLGT 259 (314)
Q Consensus 191 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~-----------~~~~~i~~~~~~ 259 (314)
.... ......++..|+|||.+.+. .++.++|+||||+++|+|++|..||...... +....++.....
T Consensus 154 ~~~~-~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd06620 154 LINS-IADTFVGTSTYMSPERIQGG-KYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPP 231 (284)
T ss_pred hhhh-ccCccccCcccCCHHHHccC-CCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCC
Confidence 4222 22234678899999998655 4789999999999999999999999865542 112222221111
Q ss_pred C------CH---HHHh---ccCCCCCCCcccccccCChhhhhc
Q 021306 260 P------TR---EEIR---CMNPNYTDFRFPQIKAHPWHKVCI 290 (314)
Q Consensus 260 ~------~~---~~~~---~~~p~~~~~~~~~l~~~p~~~~~~ 290 (314)
. +. +.+. ..+|+ +|+++.++++|||+....
T Consensus 232 ~~~~~~~~~~~~~li~~~l~~dp~-~Rpt~~e~~~~~~~~~~~ 273 (284)
T cd06620 232 RLPSSDFPEDLRDFVDACLLKDPT-ERPTPQQLCAMPPFIQAL 273 (284)
T ss_pred CCCchhcCHHHHHHHHHHhcCCcc-cCcCHHHHhcCccccccc
Confidence 0 01 1111 23677 899999999999886654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=252.30 Aligned_cols=234 Identities=24% Similarity=0.396 Sum_probs=173.9
Q ss_pred eEeecCceEEEEEEECCCCcEEEEEEeeccccc-------hHHHH---HHHHhCCCCceeeeceeeeecCCCCceeEEEE
Q 021306 45 VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY-------KNREL---QLMRVMDHPNVISLKHCFFSTTSKNELFLNLV 114 (314)
Q Consensus 45 ~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~~~-------~~~e~---~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 114 (314)
.||+|+||.||++++..+++.|++|.+.+.... ...|. .+++...|++|+++++++.. ...+++|
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~-----~~~~~~v 75 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT-----PDKLSFI 75 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeec-----CCEEEEE
Confidence 489999999999999889999999988653211 12232 33444689999999888743 3348899
Q ss_pred eeccccc-HHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCccccccc
Q 021306 115 MEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA 193 (314)
Q Consensus 115 ~e~~~~~-l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~~ 193 (314)
+||+.|+ |...+. ....+++..++.++.|++.|+.|||+ .+++|+||+|+||+++. ++.++|+|||.+.....
T Consensus 76 ~e~~~g~~L~~~l~----~~~~l~~~~~~~~~~ql~~~l~~lH~-~~i~H~di~p~nili~~-~~~~kl~dfg~~~~~~~ 149 (278)
T cd05606 76 LDLMNGGDLHYHLS----QHGVFSEAEMRFYAAEIILGLEHMHN-RFVVYRDLKPANILLDE-HGHVRISDLGLACDFSK 149 (278)
T ss_pred EecCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCEEcCCCCHHHEEECC-CCCEEEccCcCccccCc
Confidence 9999975 443332 35679999999999999999999999 89999999999999998 78899999999865432
Q ss_pred CCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHHHcCCC--------CHH
Q 021306 194 GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV--DQLVEIIKVLGTP--------TRE 263 (314)
Q Consensus 194 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~--~~~~~i~~~~~~~--------~~~ 263 (314)
. ......++..|+|||.+.+...++.++|+||+|+++|+|++|+.||.+.... ............. ..+
T Consensus 150 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ 228 (278)
T cd05606 150 K-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRS 228 (278)
T ss_pred c-CCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCCCCCcCCHHHHH
Confidence 2 2223467889999999875555789999999999999999999999776322 1222222111111 112
Q ss_pred HHh---ccCCCCCCC-----cccccccCChhhhhcc
Q 021306 264 EIR---CMNPNYTDF-----RFPQIKAHPWHKVCIF 291 (314)
Q Consensus 264 ~~~---~~~p~~~~~-----~~~~l~~~p~~~~~~~ 291 (314)
.+. ..+|. +|+ ++.++++|||++....
T Consensus 229 li~~~l~~~p~-~R~~~~~~~~~~ll~~~~~~~~~~ 263 (278)
T cd05606 229 LLEGLLQRDVN-RRLGCLGRGAQEVKEHPFFRSLDW 263 (278)
T ss_pred HHHHHhhcCHH-hccCCCCCCHHHHHhCccccCCCc
Confidence 222 23555 677 8999999999988653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-35 Score=249.29 Aligned_cols=236 Identities=27% Similarity=0.503 Sum_probs=182.7
Q ss_pred CceeeeeEeecCceEEEEEEECCCCcEEEEEEeecccc------chHHHHHHHHhCCCCceeeeceeeeecCCCCceeEE
Q 021306 39 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR------YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 112 (314)
Q Consensus 39 ~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~~------~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 112 (314)
+|++.+.||+|++|.||++.+..+++.+++|.++.... ...+|..+++.++|+||+++++.... ...++
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-----~~~~~ 75 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVH-----REKVY 75 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEec-----CCEEE
Confidence 58999999999999999999988999999999865433 33578899999999999999987633 33478
Q ss_pred EEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCccccc
Q 021306 113 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 191 (314)
Q Consensus 113 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~ 191 (314)
+++||+++ +|.+.+. ....+++..++.++.|++.|+.+||+ .|++|+||+|+||+++. ++.++|+|||.+...
T Consensus 76 lv~e~~~~~~L~~~~~----~~~~~~~~~~~~i~~~i~~~l~~lh~-~~i~H~dl~~~nil~~~-~~~~kl~d~g~~~~~ 149 (264)
T cd06626 76 IFMEYCSGGTLEELLE----HGRILDEHVIRVYTLQLLEGLAYLHS-HGIVHRDIKPANIFLDH-NGVIKLGDFGCAVKL 149 (264)
T ss_pred EEEecCCCCcHHHHHh----hcCCCChHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECC-CCCEEEccccccccc
Confidence 99999996 5555444 24568999999999999999999999 89999999999999998 889999999998765
Q ss_pred ccCCccc-----cccccccccccccccCCC--CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCC----
Q 021306 192 IAGEANI-----SYICSRFYRAPELIFGAT--EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP---- 260 (314)
Q Consensus 192 ~~~~~~~-----~~~~~~~y~aPE~~~~~~--~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~---- 260 (314)
....... ...+++.|+|||.+.+.. ..+.++||||||+++|++++|+.||...+........+.....+
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 229 (264)
T cd06626 150 KNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPD 229 (264)
T ss_pred CCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCc
Confidence 4332211 234577899999986543 26889999999999999999999997764333332222221111
Q ss_pred -------CHHHHh-c--cCCCCCCCcccccccCChh
Q 021306 261 -------TREEIR-C--MNPNYTDFRFPQIKAHPWH 286 (314)
Q Consensus 261 -------~~~~~~-~--~~p~~~~~~~~~l~~~p~~ 286 (314)
..+.+. + .+|. +|+++.+++.|||.
T Consensus 230 ~~~~~~~~~~li~~~l~~~p~-~R~~~~~i~~~~~~ 264 (264)
T cd06626 230 SLQLSPEGKDFLDRCLESDPK-KRPTASELLQHPFV 264 (264)
T ss_pred ccccCHHHHHHHHHHccCCcc-cCCCHHHHhcCCCC
Confidence 012222 2 3566 78999999999995
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=253.22 Aligned_cols=243 Identities=29% Similarity=0.442 Sum_probs=193.5
Q ss_pred CceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeE
Q 021306 39 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 111 (314)
Q Consensus 39 ~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 111 (314)
.|...+.||+|+||.||++++..++..+++|.+.... ....+|+.++++++|+|++++++++.... ..
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~~ 100 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREH-----TA 100 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCC-----eE
Confidence 4899999999999999999999899999999886432 12346889999999999999999885433 37
Q ss_pred EEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCccccc
Q 021306 112 NLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 191 (314)
Q Consensus 112 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~ 191 (314)
++++||+.|++.+.+.. ...++++.++..++.|++.|+.+||+ +|++|+||+|+||+++. ++.++|+|||++...
T Consensus 101 ~lv~e~~~g~l~~~~~~---~~~~l~~~~~~~i~~~i~~~l~~lH~-~~i~H~dL~p~Nil~~~-~~~~kl~dfg~~~~~ 175 (317)
T cd06635 101 WLVMEYCLGSASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHS-HNMIHRDIKAGNILLTE-PGQVKLADFGSASIA 175 (317)
T ss_pred EEEEeCCCCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCcccEEECC-CCCEEEecCCCcccc
Confidence 89999999987776653 24679999999999999999999999 89999999999999998 788999999987643
Q ss_pred ccCCccccccccccccccccccC--CCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCC--------
Q 021306 192 IAGEANISYICSRFYRAPELIFG--ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT-------- 261 (314)
Q Consensus 192 ~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~-------- 261 (314)
.. .....+++.|+|||.+.+ ...++.++|+||||+++|+|++|+.||...+.......+........
T Consensus 176 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (317)
T cd06635 176 SP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDY 252 (317)
T ss_pred CC---cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCccccHH
Confidence 32 223456788999999742 23478899999999999999999999988776666665554432211
Q ss_pred -HHHHh-cc--CCCCCCCcccccccCChhhhhcccCCh
Q 021306 262 -REEIR-CM--NPNYTDFRFPQIKAHPWHKVCIFHFPK 295 (314)
Q Consensus 262 -~~~~~-~~--~p~~~~~~~~~l~~~p~~~~~~~~~~~ 295 (314)
.+.+. ++ +|. +|+++.++++|+|+.....+...
T Consensus 253 l~~li~~~l~~~p~-~Rpt~~~il~~~~~~~~~~~~~~ 289 (317)
T cd06635 253 FRNFVDSCLQKIPQ-DRPTSEELLKHMFVLRERPETVL 289 (317)
T ss_pred HHHHHHHHccCCcc-cCcCHHHHHhChhhhccCcccch
Confidence 11112 33 566 89999999999998777665543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=267.45 Aligned_cols=236 Identities=26% Similarity=0.431 Sum_probs=187.3
Q ss_pred cCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHh-CCCCceeeeceeeeecCCCCceeEEEE
Q 021306 36 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRV-MDHPNVISLKHCFFSTTSKNELFLNLV 114 (314)
Q Consensus 36 ~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~~~~~~e~~~l~~-l~h~~iv~~~~~~~~~~~~~~~~~~lv 114 (314)
..+.|++...+|.|+|+.|-.+.+..+++..++|++.+.....++|..++.. -+|+||++.++.+ .+....|+|
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~~~~e~~~~~~~~~h~niv~~~~v~-----~~~~~~~~v 394 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADDNQDEIPISLLVRDHPNIVKSHDVY-----EDGKEIYLV 394 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccccccccccchhhhhcCCCcceeeccee-----cCCceeeee
Confidence 5678999999999999999999999999999999998886667777755444 4899999999988 445558999
Q ss_pred eeccccc-HHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCccccccc
Q 021306 115 MEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA 193 (314)
Q Consensus 115 ~e~~~~~-l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~~ 193 (314)
||.+.|+ +++.+. ....+. .++..|+.||+.|+.|||. +|++||||||+|||++...++++|+|||.++....
T Consensus 395 ~e~l~g~ell~ri~----~~~~~~-~e~~~w~~~lv~Av~~LH~-~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~ 468 (612)
T KOG0603|consen 395 MELLDGGELLRRIR----SKPEFC-SEASQWAAELVSAVDYLHE-QGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELER 468 (612)
T ss_pred ehhccccHHHHHHH----hcchhH-HHHHHHHHHHHHHHHHHHh-cCeeecCCChhheeecCCCCcEEEEEechhhhCch
Confidence 9999985 222222 223333 7888999999999999999 99999999999999953378899999999986544
Q ss_pred CCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH------cCCCCHHHHh-
Q 021306 194 GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV------LGTPTREEIR- 266 (314)
Q Consensus 194 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~------~~~~~~~~~~- 266 (314)
. .....-|..|.|||.+. ...++.++|+||||++||+|++|+.||........+...++. .+.++.+.+.
T Consensus 469 ~--~~tp~~t~~y~APEvl~-~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~~s~~vS~~AKdLl~~ 545 (612)
T KOG0603|consen 469 S--CDTPALTLQYVAPEVLA-IQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPKFSECVSDEAKDLLQQ 545 (612)
T ss_pred h--hcccchhhcccChhhhc-cCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCccccccCHHHHHHHHH
Confidence 3 33345588899999996 455999999999999999999999999876555333322221 2223344444
Q ss_pred --ccCCCCCCCcccccccCChh
Q 021306 267 --CMNPNYTDFRFPQIKAHPWH 286 (314)
Q Consensus 267 --~~~p~~~~~~~~~l~~~p~~ 286 (314)
..+|. +|+++.++..|||+
T Consensus 546 LL~~dP~-~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 546 LLQVDPA-LRLGADEIGAHPWF 566 (612)
T ss_pred hccCChh-hCcChhhhccCcch
Confidence 55888 89999999999999
|
|
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=269.32 Aligned_cols=240 Identities=28% Similarity=0.489 Sum_probs=189.4
Q ss_pred eeEeecCceEEEEEEECCCCcEEEEEEeecc----ccchHHHHHHHHhCCCCceeeeceeeeecCCCCceeEEEEeeccc
Q 021306 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQD----RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP 119 (314)
Q Consensus 44 ~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~ 119 (314)
-+||+|.||+||-|++..|...+|+|.+... .+...+|+.+-+.|+|.|||++.|++ .+.+++-|.||-++
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~-----senGf~kIFMEqVP 655 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSV-----SENGFFKIFMEQVP 655 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhcc-----CCCCeEEEEeecCC
Confidence 4899999999999999999999999988633 34456899999999999999999997 44456779999999
Q ss_pred ccHHHHHHhhhhcCCCC--CHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCccccccc-CCc
Q 021306 120 ESMYRVLKHYSSANQRM--PLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA-GEA 196 (314)
Q Consensus 120 ~~l~~~l~~~~~~~~~l--~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~~-~~~ 196 (314)
|+.++.+.. ..-+++ .+..+-.+.+||+.||.|||+ +.|||||||-+|++++.-.+.+||+|||.+++... ...
T Consensus 656 GGSLSsLLr--skWGPlKDNEstm~fYtkQILeGLkYLHe-n~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~ 732 (1226)
T KOG4279|consen 656 GGSLSSLLR--SKWGPLKDNESTMNFYTKQILEGLKYLHE-NKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPC 732 (1226)
T ss_pred CCcHHHHHH--hccCCCccchhHHHHHHHHHHHHhhhhhh-cceeeccccCCcEEEeeccceEEecccccchhhccCCcc
Confidence 754444443 235777 888999999999999999999 89999999999999999899999999999887644 334
Q ss_pred cccccccccccccccccC-CCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH--cCCCCHHH---------
Q 021306 197 NISYICSRFYRAPELIFG-ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV--LGTPTREE--------- 264 (314)
Q Consensus 197 ~~~~~~~~~y~aPE~~~~-~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~--~~~~~~~~--------- 264 (314)
+..+-||..|||||++-. ...|..++|||||||++.||+||++||......+..--.+.. .-++.++.
T Consensus 733 TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~Fi 812 (1226)
T KOG4279|consen 733 TETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFI 812 (1226)
T ss_pred ccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHH
Confidence 556788999999999943 345889999999999999999999999775433221111111 12223322
Q ss_pred HhccCCC-CCCCcccccccCChhhhhcc
Q 021306 265 IRCMNPN-YTDFRFPQIKAHPWHKVCIF 291 (314)
Q Consensus 265 ~~~~~p~-~~~~~~~~l~~~p~~~~~~~ 291 (314)
+.|..|+ -.|+++.+|+..||.++...
T Consensus 813 lrcFepd~~~R~sA~~LL~DpFlq~~~k 840 (1226)
T KOG4279|consen 813 LRCFEPDPCDRPSAKDLLQDPFLQHNNK 840 (1226)
T ss_pred HHHcCCCcccCccHHHhccCcccccCCC
Confidence 2244444 37999999999999988744
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=250.33 Aligned_cols=231 Identities=32% Similarity=0.511 Sum_probs=176.8
Q ss_pred eeEeecCceEEEEEEECCCCcEEEEEEeecccc-------chHHHHH-HHHhCCCCceeeeceeeeecCCCCceeEEEEe
Q 021306 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YKNRELQ-LMRVMDHPNVISLKHCFFSTTSKNELFLNLVM 115 (314)
Q Consensus 44 ~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~~-------~~~~e~~-~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 115 (314)
+.||.|++|.||+|.+..+++.+++|.+.+... ....|.. +.....|+|++++++++.. ...+++++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~-----~~~~~lv~ 76 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQS-----KDYLYLVM 76 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEc-----CCeEEEEE
Confidence 568999999999999988999999998864321 1122333 3445589999999998843 33488999
Q ss_pred ecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcccccccC
Q 021306 116 EYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG 194 (314)
Q Consensus 116 e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~~~ 194 (314)
||+++ +|.+.+. ....+++.++..++.|++.||.|||+ .+++|+||+|+||+++. ++.++|+|||++.....
T Consensus 77 e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~aL~~lH~-~~i~H~dl~p~nil~~~-~~~~~l~dfg~~~~~~~- 149 (260)
T cd05611 77 EYLNGGDCASLIK----TLGGLPEDWAKQYIAEVVLGVEDLHQ-RGIIHRDIKPENLLIDQ-TGHLKLTDFGLSRNGLE- 149 (260)
T ss_pred eccCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEECC-CCcEEEeecccceeccc-
Confidence 99987 5555443 24679999999999999999999999 89999999999999998 78899999998875432
Q ss_pred CccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCC--------C---HH
Q 021306 195 EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP--------T---RE 263 (314)
Q Consensus 195 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~--------~---~~ 263 (314)
.....++..|+|||.+.+.. ++.++|+||||+++|+|++|..||...+.......+....... . .+
T Consensus 150 --~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (260)
T cd05611 150 --NKKFVGTPDYLAPETILGVG-DDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVD 226 (260)
T ss_pred --cccCCCCcCccChhhhcCCC-CcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHH
Confidence 22345678899999987655 7899999999999999999999998887766555554432110 1 11
Q ss_pred HHh---ccCCCCCCCc---ccccccCChhhhhc
Q 021306 264 EIR---CMNPNYTDFR---FPQIKAHPWHKVCI 290 (314)
Q Consensus 264 ~~~---~~~p~~~~~~---~~~l~~~p~~~~~~ 290 (314)
.+. ..+|+ .|++ +.+++.|||++...
T Consensus 227 ~i~~~l~~~p~-~R~~~~~~~~~l~~~~~~~~~ 258 (260)
T cd05611 227 LINRLLCMDPA-KRLGANGYQEIKSHPFFKSIN 258 (260)
T ss_pred HHHHHccCCHH-HccCCCcHHHHHcChHhhcCC
Confidence 122 23566 7884 46999999997644
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=260.43 Aligned_cols=255 Identities=25% Similarity=0.380 Sum_probs=186.9
Q ss_pred CCCceeeeeEeecCceEEEEEEECC-----CCcEEEEEEeeccc-----cchHHHHHHHHhC-CCCceeeeceeeeecCC
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCLE-----TGETVAIKKVLQDR-----RYKNRELQLMRVM-DHPNVISLKHCFFSTTS 105 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~~-----~~~~~~vK~~~~~~-----~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~ 105 (314)
.++|++.+.||+|+||.||+|.... +++.|++|+++... ....+|+.+++++ .|+||+++++++...
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~-- 83 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKP-- 83 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecC--
Confidence 3579999999999999999997443 45789999886432 1234688899998 899999999977533
Q ss_pred CCceeEEEEeecccc-cHHHHHHhhhh-----------------------------------------------------
Q 021306 106 KNELFLNLVMEYVPE-SMYRVLKHYSS----------------------------------------------------- 131 (314)
Q Consensus 106 ~~~~~~~lv~e~~~~-~l~~~l~~~~~----------------------------------------------------- 131 (314)
...+++++||+++ +|.+.+.....
T Consensus 84 --~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (337)
T cd05054 84 --GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEE 161 (337)
T ss_pred --CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchh
Confidence 2347799999996 56555542110
Q ss_pred ----cCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcccccccCCc---cccccccc
Q 021306 132 ----ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA---NISYICSR 204 (314)
Q Consensus 132 ----~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~ 204 (314)
...++++..+..++.|++.||.|||+ +||+||||||+||+++. ++.++|+|||++........ .....++.
T Consensus 162 ~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~-~~ivHrDikp~Nill~~-~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~ 239 (337)
T cd05054 162 GDELYKEPLTLEDLISYSFQVARGMEFLAS-RKCIHRDLAARNILLSE-NNVVKICDFGLARDIYKDPDYVRKGDARLPL 239 (337)
T ss_pred hhHHhhcCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCcceEEEeC-CCcEEEeccccchhcccCcchhhccCCCCCc
Confidence 02368999999999999999999999 89999999999999998 78899999999976533221 11223456
Q ss_pred cccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCHHHHhccCCCCCCCcccccccC
Q 021306 205 FYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAH 283 (314)
Q Consensus 205 ~y~aPE~~~~~~~~~~~~Dv~slG~il~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~ 283 (314)
.|+|||.+.+.. ++.++|||||||++|+|++ |..||.+....+.+...++..... ..|......+.+++..
T Consensus 240 ~y~aPE~~~~~~-~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~l~~~ 311 (337)
T cd05054 240 KWMAPESIFDKV-YTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRM-------RAPEYATPEIYSIMLD 311 (337)
T ss_pred cccCcHHhcCCC-CCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCC-------CCCccCCHHHHHHHHH
Confidence 799999986654 8999999999999999998 999998765544444444322111 1111122345566677
Q ss_pred ChhhhhcccCChHHHHHhcchh
Q 021306 284 PWHKVCIFHFPKHWLLEYGSHI 305 (314)
Q Consensus 284 p~~~~~~~~~~~~~~~~~~~~~ 305 (314)
||...+..+.....+++.++.+
T Consensus 312 cl~~~p~~RPs~~ell~~l~~~ 333 (337)
T cd05054 312 CWHNNPEDRPTFSELVEILGDL 333 (337)
T ss_pred HccCChhhCcCHHHHHHHHHHH
Confidence 7777777777777777766543
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=246.83 Aligned_cols=237 Identities=29% Similarity=0.453 Sum_probs=189.1
Q ss_pred CceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeEE
Q 021306 39 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 112 (314)
Q Consensus 39 ~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 112 (314)
+|++.+.||.|++|.||++++..+++.+++|.+.... ....+|+.++++++|+||+++++++... ...+
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~ 75 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDG-----NKLC 75 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccC-----CEEE
Confidence 5899999999999999999999999999999886432 1234788899999999999999888543 3488
Q ss_pred EEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCccccc
Q 021306 113 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 191 (314)
Q Consensus 113 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~ 191 (314)
+++||+++ +|.+.+.........+++..++.++.|++.||.+||+ .|++|+||+|+||+++. ++.++|+|||.+...
T Consensus 76 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~-~~i~h~~l~~~ni~~~~-~~~~kl~d~g~~~~~ 153 (256)
T cd08530 76 IVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHE-QKILHRDLKSANILLVA-NDLVKIGDLGISKVL 153 (256)
T ss_pred EEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh-CCcccCCCCcceEEEec-CCcEEEeeccchhhh
Confidence 99999986 6766666544445779999999999999999999999 89999999999999998 788999999998765
Q ss_pred ccCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCC--------HH
Q 021306 192 IAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT--------RE 263 (314)
Q Consensus 192 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~--------~~ 263 (314)
... ......+++.|++||.+.+.. ++.++|+||||+++|+|++|+.||...+.......+......+. .+
T Consensus 154 ~~~-~~~~~~~~~~~~~Pe~~~~~~-~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (256)
T cd08530 154 KKN-MAKTQIGTPHYMAPEVWKGRP-YSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQDLQN 231 (256)
T ss_pred ccC-CcccccCCccccCHHHHCCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCchhhCHHHHH
Confidence 443 233345678899999986544 78899999999999999999999988877655444443322221 11
Q ss_pred HHh-cc--CCCCCCCcccccccCCh
Q 021306 264 EIR-CM--NPNYTDFRFPQIKAHPW 285 (314)
Q Consensus 264 ~~~-~~--~p~~~~~~~~~l~~~p~ 285 (314)
.+. ++ +|+ .|+++.++++||+
T Consensus 232 li~~~l~~~p~-~Rp~~~~~l~~p~ 255 (256)
T cd08530 232 FIRSMLQVKPK-LRPNCDKILASPA 255 (256)
T ss_pred HHHHHcCCCcc-cCCCHHHHhcCCC
Confidence 111 23 455 7899999999986
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=251.42 Aligned_cols=257 Identities=25% Similarity=0.385 Sum_probs=197.6
Q ss_pred CCccCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc-----cchHHHHHH-HHhCCCCceeeeceeeeecCCC
Q 021306 33 EPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQL-MRVMDHPNVISLKHCFFSTTSK 106 (314)
Q Consensus 33 ~~~~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~-----~~~~~e~~~-l~~l~h~~iv~~~~~~~~~~~~ 106 (314)
.+...++.+-..+||.|+||+|++..++.+|+..|||.+.... ..+..|.+. ++.-+.||||+++++.+....
T Consensus 59 ~~F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGd- 137 (361)
T KOG1006|consen 59 HTFTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGD- 137 (361)
T ss_pred cccccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCc-
Confidence 4445567788889999999999999999999999999986432 223345544 444579999999998876544
Q ss_pred CceeEEEEeecccccHHHHHHh-hhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeec
Q 021306 107 NELFLNLVMEYVPESMYRVLKH-YSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF 185 (314)
Q Consensus 107 ~~~~~~lv~e~~~~~l~~~l~~-~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~df 185 (314)
.|+.||.|+-++...... +......+++..+-.|....+.||.||-....|+|||+||+|||++. .+.+|||||
T Consensus 138 ----cWiCMELMd~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr-~G~vKLCDF 212 (361)
T KOG1006|consen 138 ----CWICMELMDISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDR-HGDVKLCDF 212 (361)
T ss_pred ----eeeeHHHHhhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEec-CCCEeeecc
Confidence 789999999876655543 33446789999999999999999999998568999999999999998 899999999
Q ss_pred CcccccccCCccccccccccccccccccCCCC-CCcchhHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHcCCCC--
Q 021306 186 GSAKQLIAGEANISYICSRFYRAPELIFGATE-YTTSIDIWSAGCVLAELLLGQPLFPGENA-VDQLVEIIKVLGTPT-- 261 (314)
Q Consensus 186 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~~Dv~slG~il~el~tg~~pf~~~~~-~~~~~~i~~~~~~~~-- 261 (314)
|.+..+...-......|...|||||.+..... +..+||+||||++|||++||+.||.+++. .+++..+..+-.+..
T Consensus 213 GIcGqLv~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~ 292 (361)
T KOG1006|consen 213 GICGQLVDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLF 292 (361)
T ss_pred cchHhHHHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecC
Confidence 99987766655556778889999999965444 88999999999999999999999999865 233333332211110
Q ss_pred --------HH---HHh-cc-CCCCCCCcccccccCChhhhhcccCCh
Q 021306 262 --------RE---EIR-CM-NPNYTDFRFPQIKAHPWHKVCIFHFPK 295 (314)
Q Consensus 262 --------~~---~~~-~~-~p~~~~~~~~~l~~~p~~~~~~~~~~~ 295 (314)
.. .+. |+ ...-.|+....|+++||.|....+-..
T Consensus 293 ~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~~~~~~ 339 (361)
T KOG1006|consen 293 DKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMYAVEGPD 339 (361)
T ss_pred cccccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhhhhcCCc
Confidence 01 111 22 222378999999999999998876554
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-35 Score=255.99 Aligned_cols=205 Identities=29% Similarity=0.473 Sum_probs=162.8
Q ss_pred CCceeeeeEeecCceEEEEEEECCCCcE----EEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCc
Q 021306 38 ISYMAERVVGTGSFGIVFQAKCLETGET----VAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 108 (314)
Q Consensus 38 ~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~----~~vK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 108 (314)
.+|++.+.||+|+||.||+|++..+++. |++|.++... ....+|+.+++.++|+||+++++++...
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~----- 81 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS----- 81 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-----
Confidence 4799999999999999999998766554 8999886432 2345788999999999999999987432
Q ss_pred eeEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCc
Q 021306 109 LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 187 (314)
Q Consensus 109 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~ 187 (314)
..++++||+.+ ++.+.+.. ....+++..+..++.|++.||.|||+ +|++|+||||+||+++. ++.++|+|||+
T Consensus 82 -~~~~v~e~~~~g~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~LH~-~~iiH~dlkp~Nill~~-~~~~kl~DfG~ 155 (316)
T cd05108 82 -TVQLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEE-RRLVHRDLAARNVLVKT-PQHVKITDFGL 155 (316)
T ss_pred -CceeeeecCCCCCHHHHHHh---ccccCCHHHHHHHHHHHHHHHHHHHh-cCeeccccchhheEecC-CCcEEEccccc
Confidence 14588999885 66666553 23568899999999999999999999 89999999999999998 78899999999
Q ss_pred ccccccCCccc---cccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 021306 188 AKQLIAGEANI---SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIK 255 (314)
Q Consensus 188 ~~~~~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~t-g~~pf~~~~~~~~~~~i~~ 255 (314)
+.......... ....+..|+|||.+.+.. ++.++||||||+++|+|++ |..||.+....+ +..++.
T Consensus 156 a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~-~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~-~~~~~~ 225 (316)
T cd05108 156 AKLLGADEKEYHAEGGKVPIKWMALESILHRI-YTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-ISSILE 225 (316)
T ss_pred cccccCCCcceeccCCccceeecChHHhccCC-CCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH-HHHHHh
Confidence 98654332221 122356799999986544 8999999999999999998 999998776554 333433
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=249.74 Aligned_cols=249 Identities=24% Similarity=0.337 Sum_probs=187.7
Q ss_pred CCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeEEE
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 113 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 113 (314)
.++|++++.||+|++|.||++.. .++..+++|.+.... ....+|+.+++.++|+||+++++++.. ....++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~-~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~l 78 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYY-NNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTK-----EEPIYI 78 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEe-cCCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEEcC-----CCCcEE
Confidence 45799999999999999999985 466789999876533 234579999999999999999888733 334789
Q ss_pred Eeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcccccc
Q 021306 114 VMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 192 (314)
Q Consensus 114 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~ 192 (314)
++||+++ +|.+.+.. .....+++..++.++.|++.||.|||+ .+++|+||+|+||+++. ++.++|+|||.+....
T Consensus 79 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~~l~~~l~~LH~-~~i~H~dl~p~nili~~-~~~~~l~dfg~~~~~~ 154 (261)
T cd05072 79 ITEYMAKGSLLDFLKS--DEGGKVLLPKLIDFSAQIAEGMAYIER-KNYIHRDLRAANVLVSE-SLMCKIADFGLARVIE 154 (261)
T ss_pred EEecCCCCcHHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccccchhhEEecC-CCcEEECCCccceecC
Confidence 9999985 66665543 234678899999999999999999999 89999999999999998 8889999999987653
Q ss_pred cCCc--cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCHHHHhccC
Q 021306 193 AGEA--NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 269 (314)
Q Consensus 193 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 269 (314)
.... .....++..|+|||.+.+.. ++.++|+||||+++|+|++ |..||.+.........+.+....+.. ..
T Consensus 155 ~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~-- 228 (261)
T cd05072 155 DNEYTAREGAKFPIKWTAPEAINFGS-FTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRM---EN-- 228 (261)
T ss_pred CCceeccCCCccceecCCHHHhccCC-CChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCC---CC--
Confidence 3221 11223456799999986544 7889999999999999998 99999887766655554433211111 01
Q ss_pred CCCCCCcccccccCChhhhhcccCChHHHHHhcch
Q 021306 270 PNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGSH 304 (314)
Q Consensus 270 p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~~ 304 (314)
....+.+++..||...+..++..+.+.+.++.
T Consensus 229 ---~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 229 ---CPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred ---CCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 11235566667777777776666766666543
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=261.64 Aligned_cols=253 Identities=24% Similarity=0.354 Sum_probs=186.6
Q ss_pred CCCceeeeeEeecCceEEEEEEECCC-----CcEEEEEEeeccc-----cchHHHHHHHHhCC-CCceeeeceeeeecCC
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCLET-----GETVAIKKVLQDR-----RYKNRELQLMRVMD-HPNVISLKHCFFSTTS 105 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~~~-----~~~~~vK~~~~~~-----~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~ 105 (314)
.++|++++.||+|+||.||+|.+... +..||+|.+.... ....+|+.+++++. ||||+++++++..
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~--- 112 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTK--- 112 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEcc---
Confidence 45799999999999999999986432 3579999886432 22357999999996 9999999999843
Q ss_pred CCceeEEEEeecccc-cHHHHHHhhhh-----------------------------------------------------
Q 021306 106 KNELFLNLVMEYVPE-SMYRVLKHYSS----------------------------------------------------- 131 (314)
Q Consensus 106 ~~~~~~~lv~e~~~~-~l~~~l~~~~~----------------------------------------------------- 131 (314)
....++||||+++ +|.+.+.....
T Consensus 113 --~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (400)
T cd05105 113 --SGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVP 190 (400)
T ss_pred --CCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccch
Confidence 3348899999985 66655543110
Q ss_pred ---------------------------------------cCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEE
Q 021306 132 ---------------------------------------ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLL 172 (314)
Q Consensus 132 ---------------------------------------~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil 172 (314)
....+++..+..++.|++.||.|||+ .+++|+||||+||+
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivH~dikp~Nil 269 (400)
T cd05105 191 MLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLAS-KNCVHRDLAARNVL 269 (400)
T ss_pred hhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCChHhEE
Confidence 01358888999999999999999999 89999999999999
Q ss_pred EcCCCCcEEEeecCcccccccCCc---cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHH
Q 021306 173 VDPLTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVD 248 (314)
Q Consensus 173 ~~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~t-g~~pf~~~~~~~ 248 (314)
++. ++.++|+|||++........ .....+++.|+|||.+.+.. ++.++||||||+++|+|++ |..||.......
T Consensus 270 l~~-~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~ 347 (400)
T cd05105 270 LAQ-GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNL-YTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS 347 (400)
T ss_pred EeC-CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCC-CCchhhHHHHHHHHHHHHHCCCCCCcccchhH
Confidence 998 78899999999875433221 11233467799999986544 8899999999999999997 999998765544
Q ss_pred HHHHHHHHcCCCCHHHHhccCCCCCCCcccccccCChhhhhcccCChHHHHHhcch
Q 021306 249 QLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGSH 304 (314)
Q Consensus 249 ~~~~i~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~~ 304 (314)
.+...+....... .|......+.+++..||...+..+++...+.+.++.
T Consensus 348 ~~~~~~~~~~~~~-------~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~ 396 (400)
T cd05105 348 TFYNKIKSGYRMA-------KPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVES 396 (400)
T ss_pred HHHHHHhcCCCCC-------CCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHH
Confidence 4444443321111 011112235667777777777777777777666654
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=254.66 Aligned_cols=239 Identities=23% Similarity=0.387 Sum_probs=186.6
Q ss_pred CCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeEEE
Q 021306 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 113 (314)
Q Consensus 38 ~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 113 (314)
..|.....||+|+||.||++.+..+++.+++|.+.... ....+|+.+++.+.|||++++++.+... ...++
T Consensus 21 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~-----~~~~i 95 (297)
T cd06659 21 SLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVG-----EELWV 95 (297)
T ss_pred hhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeC-----CeEEE
Confidence 34667778999999999999998899999999885422 2335788899999999999999987543 34889
Q ss_pred Eeeccccc-HHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcccccc
Q 021306 114 VMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 192 (314)
Q Consensus 114 v~e~~~~~-l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~ 192 (314)
++||++++ +...+. ...+++..++.++.|++.||.+||+ .|++|+||+|+||+++. ++.++|+|||++....
T Consensus 96 v~e~~~~~~L~~~~~-----~~~~~~~~~~~~~~qi~~~L~~LH~-~~ivH~dl~p~Nill~~-~~~~kL~dfg~~~~~~ 168 (297)
T cd06659 96 LMEFLQGGALTDIVS-----QTRLNEEQIATVCESVLQALCYLHS-QGVIHRDIKSDSILLTL-DGRVKLSDFGFCAQIS 168 (297)
T ss_pred EEecCCCCCHHHHHh-----hcCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHeEEcc-CCcEEEeechhHhhcc
Confidence 99999974 444332 3578999999999999999999999 89999999999999998 8899999999886543
Q ss_pred cCC-ccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCC----------C
Q 021306 193 AGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP----------T 261 (314)
Q Consensus 193 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~----------~ 261 (314)
... ......++..|+|||.+.+.. ++.++|+||||+++|+|++|+.||...+..+....+....... .
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 247 (297)
T cd06659 169 KDVPKRKSLVGTPYWMAPEVISRTP-YGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVL 247 (297)
T ss_pred cccccccceecCccccCHHHHccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCHHH
Confidence 322 122345788899999996544 7899999999999999999999998877665554433221100 0
Q ss_pred HHHHh---ccCCCCCCCcccccccCChhhhhc
Q 021306 262 REEIR---CMNPNYTDFRFPQIKAHPWHKVCI 290 (314)
Q Consensus 262 ~~~~~---~~~p~~~~~~~~~l~~~p~~~~~~ 290 (314)
.+.+. ..+|. +|+++.++++|||+....
T Consensus 248 ~~~i~~~l~~~P~-~Rps~~~ll~~~~~~~~~ 278 (297)
T cd06659 248 RDFLERMLTREPQ-ERATAQELLDHPFLLQTG 278 (297)
T ss_pred HHHHHHHhcCCcc-cCcCHHHHhhChhhccCC
Confidence 12222 33677 899999999999987654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=247.48 Aligned_cols=244 Identities=21% Similarity=0.312 Sum_probs=183.7
Q ss_pred CCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeEEEE
Q 021306 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLV 114 (314)
Q Consensus 38 ~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 114 (314)
++|++.+.||+|+||.||++..+ ++..+++|.+.... ....+|+.++++++||||+++++++.. ....+++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~iv 77 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQ-----QKPLYIV 77 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEcc-----CCCEEEE
Confidence 56899999999999999999864 45679999876432 344679999999999999999998743 2348899
Q ss_pred eecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCccccccc
Q 021306 115 MEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA 193 (314)
Q Consensus 115 ~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~~ 193 (314)
|||+++ +|.+.+.. ....+++..++.++.|++.||.|||+ +|++|+||+|+||+++. ++.++|+|||.+.....
T Consensus 78 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~ni~i~~-~~~~kl~d~g~~~~~~~ 152 (256)
T cd05114 78 TEFMENGCLLNYLRQ---RQGKLSKDMLLSMCQDVCEGMEYLER-NSFIHRDLAARNCLVSS-TGVVKVSDFGMTRYVLD 152 (256)
T ss_pred EEcCCCCcHHHHHHh---CccCCCHHHHHHHHHHHHHHHHHHHH-CCccccccCcceEEEcC-CCeEEECCCCCccccCC
Confidence 999985 56555542 23468999999999999999999999 89999999999999998 78899999998875432
Q ss_pred CCcc--ccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCHHHHhccCC
Q 021306 194 GEAN--ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 270 (314)
Q Consensus 194 ~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~p 270 (314)
.... ....++..|+|||.+.+. .++.++|+||||+++|+|++ |+.||...+..+....+.+..... .|
T Consensus 153 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~--------~~ 223 (256)
T cd05114 153 DEYTSSSGAKFPVKWSPPEVFNFS-KYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLY--------RP 223 (256)
T ss_pred CceeccCCCCCchhhCChhhcccC-ccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCC--------CC
Confidence 2211 122335579999998654 48899999999999999999 999998888766666554432111 11
Q ss_pred CCCCCcccccccCChhhhhcccCChHHHHHh
Q 021306 271 NYTDFRFPQIKAHPWHKVCIFHFPKHWLLEY 301 (314)
Q Consensus 271 ~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~ 301 (314)
......+..++..||...+..++....++..
T Consensus 224 ~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~ 254 (256)
T cd05114 224 KLASMTVYEVMYSCWHEKPEGRPTFAELLRA 254 (256)
T ss_pred CCCCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 1122234566666666666666555555544
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=247.61 Aligned_cols=249 Identities=23% Similarity=0.289 Sum_probs=188.9
Q ss_pred CCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeEEE
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 113 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 113 (314)
.++|++.+.||+|++|.||++.+. +++.|++|.++... ....+|+.++++++|+||+++++++... ...++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~l 78 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLE-----EPIYI 78 (261)
T ss_pred hhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEecC-----CCeee
Confidence 357999999999999999999864 55789999886543 3345789999999999999999887433 33789
Q ss_pred Eeeccc-ccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcccccc
Q 021306 114 VMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 192 (314)
Q Consensus 114 v~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~ 192 (314)
++||++ ++|.+.+... .+..+++..+..++.|++.|+.+||+ .|++|+||+|+||+++. ++.++|+|||++....
T Consensus 79 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~Nil~~~-~~~~~l~dfg~~~~~~ 154 (261)
T cd05068 79 VTELMKYGSLLEYLQGG--AGRALKLPQLIDMAAQVASGMAYLEA-QNYIHRDLAARNVLVGE-NNICKVADFGLARVIK 154 (261)
T ss_pred eeecccCCcHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccCCcceEEEcC-CCCEEECCcceEEEcc
Confidence 999996 5776666532 23578999999999999999999999 89999999999999998 7889999999987654
Q ss_pred cCCcc--ccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCHHHHhccC
Q 021306 193 AGEAN--ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 269 (314)
Q Consensus 193 ~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 269 (314)
..... .....+..|+|||.+.+.. ++.++|+||||+++|+|++ |+.||.+.+.......+.+....+..
T Consensus 155 ~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~------- 226 (261)
T cd05068 155 EDIYEAREGAKFPIKWTAPEAALYNR-FSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPCP------- 226 (261)
T ss_pred CCcccccCCCcCceeccCccccccCC-CCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCC-------
Confidence 22111 1111234699999986544 8899999999999999999 99999888766655554433211111
Q ss_pred CCCCCCcccccccCChhhhhcccCChHHHHHhcch
Q 021306 270 PNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGSH 304 (314)
Q Consensus 270 p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~~ 304 (314)
+. ....+.+++..+|...+..+++...+...++.
T Consensus 227 ~~-~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 227 PG-CPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred Cc-CCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 11 22345667777777777777777777766553
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=260.76 Aligned_cols=281 Identities=22% Similarity=0.336 Sum_probs=203.7
Q ss_pred hhheecCCCceeeeeeeccccCCCCCCccCCCceeeeeEeecCceEEEEEEEC-----CCCcEEEEEEeecccc-----c
Q 021306 8 SAAVVDGSDHVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCL-----ETGETVAIKKVLQDRR-----Y 77 (314)
Q Consensus 8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~Lg~g~~g~Vy~~~~~-----~~~~~~~vK~~~~~~~-----~ 77 (314)
++.+++|.+..-.. +......+.-....++|.+.+.||+|+||.||+|++. .+++.||+|+++.... .
T Consensus 9 ~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~ 86 (401)
T cd05107 9 ESVSSDGHEYIYVD--PMQLPYDSAWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQA 86 (401)
T ss_pred eeeccCCceEEEEC--CCCCCCCCcceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHH
Confidence 34455555554443 3333333344444568999999999999999999864 3456899999875422 2
Q ss_pred hHHHHHHHHhCC-CCceeeeceeeeecCCCCceeEEEEeecccc-cHHHHHHhhhh------------------------
Q 021306 78 KNRELQLMRVMD-HPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSS------------------------ 131 (314)
Q Consensus 78 ~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~------------------------ 131 (314)
..+|+.++.++. |+||+++++++.... ..++|+||+++ +|.+.+.....
T Consensus 87 ~~~E~~~l~~l~~H~niv~~~~~~~~~~-----~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (401)
T cd05107 87 LMSELKIMSHLGPHLNIVNLLGACTKGG-----PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPL 161 (401)
T ss_pred HHHHHHHHHhcCCCCCeEEEEEEEccCC-----CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccc
Confidence 347899999997 999999999884432 37899999995 67666643210
Q ss_pred ----------------------------------------------------------------------cCCCCCHHHH
Q 021306 132 ----------------------------------------------------------------------ANQRMPLIYV 141 (314)
Q Consensus 132 ----------------------------------------------------------------------~~~~l~~~~~ 141 (314)
....+++..+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 241 (401)
T cd05107 162 SQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDL 241 (401)
T ss_pred cccccchhhhhccCccccccCCccccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHH
Confidence 1124678889
Q ss_pred HHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcccccccCC---ccccccccccccccccccCCCCC
Q 021306 142 KLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE---ANISYICSRFYRAPELIFGATEY 218 (314)
Q Consensus 142 ~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~ 218 (314)
+.++.||+.||.|||+ .+++|+||||+||+++. .+.++|+|||++....... ......++..|+|||.+.+.. +
T Consensus 242 ~~~~~qi~~aL~~LH~-~~ivHrdlkp~NiLl~~-~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~ 318 (401)
T cd05107 242 VGFSYQVANGMEFLAS-KNCVHRDLAARNVLICE-GKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNL-Y 318 (401)
T ss_pred HHHHHHHHHHHHHHhc-CCcCcccCCcceEEEeC-CCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCC-C
Confidence 9999999999999999 89999999999999998 7889999999987543221 112234567899999986544 7
Q ss_pred CcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCHHHHhccCCCCCCCcccccccCChhhhhcccCChHH
Q 021306 219 TTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVCIFHFPKHW 297 (314)
Q Consensus 219 ~~~~Dv~slG~il~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~p~~~~~~~~~~~~~ 297 (314)
+.++|+||||+++|||++ |..||......+.....+.....+. .|......+.+|++.||...+..++....
T Consensus 319 ~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~~~~~~~~~~~-------~p~~~~~~l~~li~~cl~~~P~~RPs~~e 391 (401)
T cd05107 319 TTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYRMA-------KPAHASDEIYEIMQKCWEEKFEIRPDFSQ 391 (401)
T ss_pred CcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHHcCCCCC-------CCCCCCHHHHHHHHHHcCCChhHCcCHHH
Confidence 899999999999999998 8999987765555544443321111 12112335677888888888888888888
Q ss_pred HHHhcchh
Q 021306 298 LLEYGSHI 305 (314)
Q Consensus 298 ~~~~~~~~ 305 (314)
+++.++..
T Consensus 392 ll~~L~~~ 399 (401)
T cd05107 392 LVHLVGDL 399 (401)
T ss_pred HHHHHHHH
Confidence 88777654
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=250.20 Aligned_cols=245 Identities=27% Similarity=0.428 Sum_probs=194.2
Q ss_pred ccCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeE
Q 021306 35 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 111 (314)
Q Consensus 35 ~~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 111 (314)
...+.|++.+.||+|++|.||++.+..++..+++|.+.... ....+|+.+++.++|+|++++++++... ...
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~ 90 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVG-----DEL 90 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEEC-----CEE
Confidence 34567999999999999999999998889999999987554 2345789999999999999999988544 348
Q ss_pred EEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcccc
Q 021306 112 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 190 (314)
Q Consensus 112 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~ 190 (314)
++++||+++ +|.+.+... ...+++..+..++.|++.||.+||+ .|++|+||+|+||+++. ++.++|+|||.+..
T Consensus 91 ~lv~e~~~~~~L~~~l~~~---~~~l~~~~~~~i~~~i~~~L~~lH~-~gi~H~dl~p~ni~i~~-~~~~~l~d~~~~~~ 165 (286)
T cd06614 91 WVVMEYMDGGSLTDIITQN---FVRMNEPQIAYVCREVLQGLEYLHS-QNVIHRDIKSDNILLSK-DGSVKLADFGFAAQ 165 (286)
T ss_pred EEEEeccCCCcHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCChhhEEEcC-CCCEEECccchhhh
Confidence 899999995 777666642 1389999999999999999999999 89999999999999997 78899999998765
Q ss_pred cccCCc-cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCC---------
Q 021306 191 LIAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP--------- 260 (314)
Q Consensus 191 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~--------- 260 (314)
...... .....++..|++||.+.+.. ++.++|+||||+++|+|++|+.||...++......+.......
T Consensus 166 ~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (286)
T cd06614 166 LTKEKSKRNSVVGTPYWMAPEVIKRKD-YGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSP 244 (286)
T ss_pred hccchhhhccccCCcccCCHhHhcCCC-CCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhCCH
Confidence 433221 12234577899999986544 7899999999999999999999998877765555544332111
Q ss_pred -CHHHHh---ccCCCCCCCcccccccCChhhhhcc
Q 021306 261 -TREEIR---CMNPNYTDFRFPQIKAHPWHKVCIF 291 (314)
Q Consensus 261 -~~~~~~---~~~p~~~~~~~~~l~~~p~~~~~~~ 291 (314)
..+.+. ..+|. .|+++.+++.|||++...+
T Consensus 245 ~l~~li~~~l~~~p~-~Rpt~~~il~~~~~~~~~~ 278 (286)
T cd06614 245 EFKDFLNKCLVKDPE-KRPSAEELLQHPFLKKACP 278 (286)
T ss_pred HHHHHHHHHhccChh-hCcCHHHHhhChHhhccCc
Confidence 011122 23566 7999999999999998554
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=251.40 Aligned_cols=248 Identities=24% Similarity=0.302 Sum_probs=190.9
Q ss_pred CCceeeeeEeecCceEEEEEEECCCCcEEEEEEeecccc----chHHHHHHHHhCCCCceeeeceeeeecCCCCceeEEE
Q 021306 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR----YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 113 (314)
Q Consensus 38 ~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~~----~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 113 (314)
.+|++.+.||.|++|.||+|.+.. +..+++|.+..... ...+|+.+++.++|+||+++++++... ...++
T Consensus 6 ~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~l 79 (261)
T cd05148 6 EEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVG-----EPVYI 79 (261)
T ss_pred HHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecC-----CCeEE
Confidence 479999999999999999999876 88999998865433 345788999999999999999887433 34789
Q ss_pred Eeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcccccc
Q 021306 114 VMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 192 (314)
Q Consensus 114 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~ 192 (314)
+|||+++ +|.+.+... .+..+++.+++.++.|++.|+.|||+ +|++|+||+|+||+++. ++.++|+|||.+....
T Consensus 80 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~al~~lH~-~~i~h~dl~~~nilv~~-~~~~kl~d~g~~~~~~ 155 (261)
T cd05148 80 ITELMEKGSLLAFLRSP--EGQVLPVASLIDMACQVAEGMAYLEE-QNSIHRDLAARNILVGE-DLVCKVADFGLARLIK 155 (261)
T ss_pred EEeecccCCHHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccccCcceEEEcC-CceEEEccccchhhcC
Confidence 9999986 776666542 34578999999999999999999999 89999999999999998 7889999999987553
Q ss_pred cCCcc-ccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCHHHHhccCC
Q 021306 193 AGEAN-ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 270 (314)
Q Consensus 193 ~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~p 270 (314)
..... ....++..|++||.+.+. .++.++|+||||+++|+|++ |+.||...+..+.+..+......+.+ +
T Consensus 156 ~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~-------~ 227 (261)
T cd05148 156 EDVYLSSDKKIPYKWTAPEAASHG-TFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCP-------A 227 (261)
T ss_pred CccccccCCCCceEecCHHHHccC-CCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcCCCC-------C
Confidence 32211 122345679999998654 48899999999999999998 89999888876666665543222111 1
Q ss_pred CCCCCcccccccCChhhhhcccCChHHHHHhcch
Q 021306 271 NYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGSH 304 (314)
Q Consensus 271 ~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~~ 304 (314)
. ....+.+++..+|...+..+++...+.+.++.
T Consensus 228 ~-~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 228 K-CPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred C-CCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 1 22345566666666666666667777666553
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=249.75 Aligned_cols=236 Identities=30% Similarity=0.548 Sum_probs=187.2
Q ss_pred CCceeeeeEeecCceEEEEEEECCCCcEEEEEEeecc-------ccchHHHHHHHHhCC-CCceeeeceeeeecCCCCce
Q 021306 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRVMD-HPNVISLKHCFFSTTSKNEL 109 (314)
Q Consensus 38 ~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~-------~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~ 109 (314)
++|++.+.||+|++|.||++.+..+++.+++|.+... .....+|..+++++. |+||+++++++. ...
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~-----~~~ 75 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQ-----DEE 75 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhc-----CCc
Confidence 4799999999999999999999999999999988642 123457888999998 999999999873 333
Q ss_pred eEEEEeeccc-ccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcc
Q 021306 110 FLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 188 (314)
Q Consensus 110 ~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~ 188 (314)
..+++||++. ++|.+.+.. ...+++..++.++.|++.||.+||+ .|++|+||+|+||+++. ++.++|+|||.+
T Consensus 76 ~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~ql~~~l~~Lh~-~~~~H~dl~~~ni~i~~-~~~~~l~df~~~ 149 (280)
T cd05581 76 NLYFVLEYAPNGELLQYIRK----YGSLDEKCTRFYAAEILLALEYLHS-KGIIHRDLKPENILLDK-DMHIKITDFGTA 149 (280)
T ss_pred eEEEEEcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCHHHeEECC-CCCEEecCCccc
Confidence 4889999996 466666653 4589999999999999999999999 89999999999999998 788999999998
Q ss_pred cccccCCc---------------------cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChH
Q 021306 189 KQLIAGEA---------------------NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV 247 (314)
Q Consensus 189 ~~~~~~~~---------------------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~ 247 (314)
........ .....++..|+|||...+.. ++.++|+||||++++++++|..||...+..
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~ 228 (280)
T cd05581 150 KVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKP-AGKSSDLWALGCIIYQMLTGKPPFRGSNEY 228 (280)
T ss_pred cccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCC-CChhhhHHHHHHHHHHHHhCCCCCCCccHH
Confidence 75533221 11234567899999986544 788999999999999999999999988766
Q ss_pred HHHHHHHHHcCCCC-------HHHHh---ccCCCCCCCcc----cccccCChh
Q 021306 248 DQLVEIIKVLGTPT-------REEIR---CMNPNYTDFRF----PQIKAHPWH 286 (314)
Q Consensus 248 ~~~~~i~~~~~~~~-------~~~~~---~~~p~~~~~~~----~~l~~~p~~ 286 (314)
..+..+.......+ .+.+. ..+|+ .|+++ +++++|||+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~-~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 229 LTFQKILKLEYSFPPNFPPDAKDLIEKLLVLDPQ-DRLGVNEGYDELKAHPFF 280 (280)
T ss_pred HHHHHHHhcCCCCCCccCHHHHHHHHHHhcCCHh-hCCCcccCHHHHhcCCCC
Confidence 55555543221111 11122 23666 79999 999999996
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=250.34 Aligned_cols=230 Identities=30% Similarity=0.503 Sum_probs=181.1
Q ss_pred EeecCceEEEEEEECCCCcEEEEEEeecccc-------chHHHHHHHHhCCCCceeeeceeeeecCCCCceeEEEEeecc
Q 021306 46 VGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYV 118 (314)
Q Consensus 46 Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~~-------~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~ 118 (314)
||.|++|.||++++..+++.+++|.+..... ...+|..++++++|+||+++++.+. .....++++||+
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~~~~lv~e~~ 75 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQ-----GKKNLYLVMEYL 75 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHhee-----cCcEEEEEEecC
Confidence 6889999999999988899999998865432 3457888999999999999988873 334488999999
Q ss_pred cc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcccccccCC--
Q 021306 119 PE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE-- 195 (314)
Q Consensus 119 ~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~~~~-- 195 (314)
.+ +|.+.+.. ...+++..++.++.|++.||.+||+ .|++|+||+|+||+++. ++.++|+|||++.......
T Consensus 76 ~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~L~~lH~-~~i~H~di~~~nil~~~-~~~~~l~dfg~~~~~~~~~~~ 149 (265)
T cd05579 76 PGGDLASLLEN----VGSLDEDVARIYIAEIVLALEYLHS-NGIIHRDLKPDNILIDS-NGHLKLTDFGLSKVGLVRRQI 149 (265)
T ss_pred CCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-cCeecCCCCHHHeEEcC-CCCEEEEecccchhcccCccc
Confidence 86 66555543 3579999999999999999999999 89999999999999998 8899999999887543321
Q ss_pred -------ccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCC------C-
Q 021306 196 -------ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP------T- 261 (314)
Q Consensus 196 -------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~------~- 261 (314)
......++..|++||...+.. .+.++|+||||+++|++++|..||......+....+....... .
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~-~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (265)
T cd05579 150 NLNDDEKEDKRIVGTPDYIAPEVILGQG-HSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSD 228 (265)
T ss_pred ccccccccccCcccCccccCHHHhcCCC-CCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCccccCCH
Confidence 112234577899999986655 7899999999999999999999998887766655554321111 1
Q ss_pred --HHHHh---ccCCCCCCCcc---cccccCChhhh
Q 021306 262 --REEIR---CMNPNYTDFRF---PQIKAHPWHKV 288 (314)
Q Consensus 262 --~~~~~---~~~p~~~~~~~---~~l~~~p~~~~ 288 (314)
...+. ..+|. +|+++ .++++|||++.
T Consensus 229 ~~~~~i~~~l~~~p~-~Rpt~~~~~~~l~~~~~~~ 262 (265)
T cd05579 229 EAIDLISKLLVPDPE-KRLGAKSIEEIKNHPFFKG 262 (265)
T ss_pred HHHHHHHHHhcCCHh-hcCCCccHHHHhcCccccC
Confidence 11111 23566 89999 99999999974
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=249.69 Aligned_cols=238 Identities=26% Similarity=0.408 Sum_probs=187.2
Q ss_pred CceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeEEEE
Q 021306 39 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLV 114 (314)
Q Consensus 39 ~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 114 (314)
.|...+.||+|++|.||++.+..+++.+++|.+.... ....+|+.+++.+.|+|++++++.+... .+.+++
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~-----~~~~~v 94 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVG-----DELWVV 94 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcC-----CeEEEE
Confidence 4666789999999999999998899999999875332 2235788899999999999999987543 347899
Q ss_pred eecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCccccccc
Q 021306 115 MEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA 193 (314)
Q Consensus 115 ~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~~ 193 (314)
+||+.+ +|.+.+.. .++++..+..++.|++.|+.+||+ +|++|+||+|+||+++. ++.++|+|||.+.....
T Consensus 95 ~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~-~~i~H~dl~p~Nil~~~-~~~~~l~d~g~~~~~~~ 167 (285)
T cd06648 95 MEFLEGGALTDIVTH-----TRMNEEQIATVCLAVLKALSFLHA-QGVIHRDIKSDSILLTS-DGRVKLSDFGFCAQVSK 167 (285)
T ss_pred EeccCCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCChhhEEEcC-CCcEEEcccccchhhcc
Confidence 999986 55554432 578999999999999999999999 89999999999999998 88999999998765433
Q ss_pred CC-ccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCC-------H---
Q 021306 194 GE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT-------R--- 262 (314)
Q Consensus 194 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~-------~--- 262 (314)
.. ......+++.|+|||.+.+.. ++.++|+||||+++|+|++|+.||...++......+........ .
T Consensus 168 ~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 246 (285)
T cd06648 168 EVPRRKSLVGTPYWMAPEVISRLP-YGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLR 246 (285)
T ss_pred CCcccccccCCccccCHHHhcCCC-CCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCcccccCCHHHH
Confidence 22 122345788899999986544 78999999999999999999999988776665555444321110 1
Q ss_pred HHHh-c--cCCCCCCCcccccccCChhhhhc
Q 021306 263 EEIR-C--MNPNYTDFRFPQIKAHPWHKVCI 290 (314)
Q Consensus 263 ~~~~-~--~~p~~~~~~~~~l~~~p~~~~~~ 290 (314)
+.+. + .+|. +|+++.+++.|||++...
T Consensus 247 ~li~~~l~~~p~-~Rpt~~~il~~~~~~~~~ 276 (285)
T cd06648 247 SFLDRMLVRDPA-QRATAAELLNHPFLAKAG 276 (285)
T ss_pred HHHHHHcccChh-hCcCHHHHccCcccccCC
Confidence 1122 2 3666 789999999999997754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=231.69 Aligned_cols=213 Identities=23% Similarity=0.397 Sum_probs=177.5
Q ss_pred CCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeecccc-----chHHHHHHHHhC-CCCceeeeceeeeecCCCCcee
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNRELQLMRVM-DHPNVISLKHCFFSTTSKNELF 110 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~~-----~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~ 110 (314)
.+...-...||+|++|.|=+.++..+|+..|+|.+..... ...+|+.+..+. .+|++|.+++.++....
T Consensus 45 ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regd----- 119 (282)
T KOG0984|consen 45 ADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGD----- 119 (282)
T ss_pred hhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhcccc-----
Confidence 3456778899999999999999999999999999865433 223455554443 68999999998865444
Q ss_pred EEEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcccc
Q 021306 111 LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 190 (314)
Q Consensus 111 ~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~ 190 (314)
.|+.||.|+-++..+..+....++.+++..+-+|+..+++||.|||+.-.++|||+||+|||++. .+++|+||||.+..
T Consensus 120 vwIcME~M~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~-~GqVKiCDFGIsG~ 198 (282)
T KOG0984|consen 120 VWICMELMDTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINY-DGQVKICDFGISGY 198 (282)
T ss_pred EEEeHHHhhhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEcc-CCcEEEccccccee
Confidence 89999999999988888888899999999999999999999999999668999999999999998 89999999999987
Q ss_pred cccCCccccccccccccccccccC---CCCCCcchhHHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHHH
Q 021306 191 LIAGEANISYICSRFYRAPELIFG---ATEYTTSIDIWSAGCVLAELLLGQPLFPGE-NAVDQLVEIIK 255 (314)
Q Consensus 191 ~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~~Dv~slG~il~el~tg~~pf~~~-~~~~~~~~i~~ 255 (314)
+.+.-......|...|+|||.+.. ...|+.++||||||++++||++++.||..+ ++.+++.++.+
T Consensus 199 L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVe 267 (282)
T KOG0984|consen 199 LVDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVE 267 (282)
T ss_pred ehhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhc
Confidence 766555545677888999999842 235889999999999999999999999886 45555555554
|
|
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=248.65 Aligned_cols=253 Identities=26% Similarity=0.362 Sum_probs=194.6
Q ss_pred CCCceeeeeEeecCceEEEEEEECCCCc----EEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCC
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCLETGE----TVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKN 107 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~----~~~vK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 107 (314)
.++|++.+.||+|+||.||+|.++.+|+ .+++|...... ....+|+.++++++|+||+++++++..
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----- 80 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS----- 80 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-----
Confidence 4689999999999999999999876654 58888876543 233578999999999999999998753
Q ss_pred ceeEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecC
Q 021306 108 ELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 186 (314)
Q Consensus 108 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg 186 (314)
...++++||+++ +|.+.+.. ....+++..+..++.|++.||.|||+ ++++|+||+|+||+++. ++.++|+|||
T Consensus 81 -~~~~~v~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~LH~-~~i~H~di~p~nil~~~-~~~~kL~dfg 154 (279)
T cd05057 81 -SQVQLITQLMPLGCLLDYVRN---HKDNIGSQYLLNWCVQIAKGMSYLEE-KRLVHRDLAARNVLVKT-PQHVKITDFG 154 (279)
T ss_pred -CceEEEEecCCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHh-CCEEecccCcceEEEcC-CCeEEECCCc
Confidence 237899999985 66665543 23569999999999999999999999 89999999999999987 7889999999
Q ss_pred cccccccCCcccc---ccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCH
Q 021306 187 SAKQLIAGEANIS---YICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTR 262 (314)
Q Consensus 187 ~~~~~~~~~~~~~---~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~ 262 (314)
.+........... ...+..|+|||.+.+.. ++.++|+||||+++|++++ |+.||.+....+....+.+....+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~-- 231 (279)
T cd05057 155 LAKLLDVDEKEYHAEGGKVPIKWMALESILHRI-YTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLP-- 231 (279)
T ss_pred ccccccCcccceecCCCcccccccCHHHhhcCC-cCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCC--
Confidence 9876543222111 11245799999985444 7899999999999999998 999998887765444443221111
Q ss_pred HHHhccCCCCCCCcccccccCChhhhhcccCChHHHHHhcchhhhcC
Q 021306 263 EEIRCMNPNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGSHINAIS 309 (314)
Q Consensus 263 ~~~~~~~p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (314)
.|......+.+++..||...+..+++...+.+.++++....
T Consensus 232 ------~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05057 232 ------QPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARDP 272 (279)
T ss_pred ------CCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhCC
Confidence 11123345667888888888888888888888887765443
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=250.78 Aligned_cols=239 Identities=25% Similarity=0.365 Sum_probs=185.6
Q ss_pred ceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeEEEEe
Q 021306 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVM 115 (314)
Q Consensus 40 y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 115 (314)
|.....||+|++|.||++....+++.+++|++.... ....+|+.+++.++|+|++++++.+... .+.+++|
T Consensus 22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~ 96 (292)
T cd06657 22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVG-----DELWVVM 96 (292)
T ss_pred hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeC-----CEEEEEE
Confidence 444578999999999999999999999999875322 2345788899999999999999988543 3488999
Q ss_pred ecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcccccccCC
Q 021306 116 EYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE 195 (314)
Q Consensus 116 e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~~~~ 195 (314)
||++++.+..+.. ...+++..++.++.|++.++.+||+ .|++|+||+|+||+++. ++.++|+|||.+.......
T Consensus 97 e~~~~~~L~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~-~givH~dl~p~Nilv~~-~~~~~l~dfg~~~~~~~~~ 170 (292)
T cd06657 97 EFLEGGALTDIVT----HTRMNEEQIAAVCLAVLKALSVLHA-QGVIHRDIKSDSILLTH-DGRVKLSDFGFCAQVSKEV 170 (292)
T ss_pred ecCCCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEECC-CCCEEEcccccceeccccc
Confidence 9999753333322 3568999999999999999999999 89999999999999998 7889999999876543322
Q ss_pred -ccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCC-------CH---HH
Q 021306 196 -ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP-------TR---EE 264 (314)
Q Consensus 196 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~-------~~---~~ 264 (314)
......+++.|+|||.+.+. .++.++|+||+|+++|+|++|..||.+.........+....... .. +.
T Consensus 171 ~~~~~~~~~~~y~~pE~~~~~-~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 249 (292)
T cd06657 171 PRRKSLVGTPYWMAPELISRL-PYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGF 249 (292)
T ss_pred ccccccccCccccCHHHhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCCcccCCHHHHHH
Confidence 22234567889999998544 47899999999999999999999998877665554443332211 11 11
Q ss_pred Hh---ccCCCCCCCcccccccCChhhhhcc
Q 021306 265 IR---CMNPNYTDFRFPQIKAHPWHKVCIF 291 (314)
Q Consensus 265 ~~---~~~p~~~~~~~~~l~~~p~~~~~~~ 291 (314)
+. ..+|. +|+++.+++.|||+...-.
T Consensus 250 i~~~l~~~P~-~R~~~~~ll~~~~~~~~~~ 278 (292)
T cd06657 250 LDRLLVRDPA-QRATAAELLKHPFLAKAGP 278 (292)
T ss_pred HHHHHhCCcc-cCcCHHHHhcChHHhccCC
Confidence 21 23666 8999999999999877653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=245.14 Aligned_cols=237 Identities=32% Similarity=0.511 Sum_probs=185.5
Q ss_pred CceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeEE
Q 021306 39 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 112 (314)
Q Consensus 39 ~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 112 (314)
+|.+.+.||+|++|.||+|.+..+++.+++|.+.... ....+|+.++++++|+||+++++.+.... ....+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---~~~~~ 77 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEE---KNTLN 77 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCC---CCeEE
Confidence 4889999999999999999998899999999886544 23468899999999999999998875431 13478
Q ss_pred EEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCccccc
Q 021306 113 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 191 (314)
Q Consensus 113 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~ 191 (314)
+++||+++ ++.+.+.. ...+++.+++.++.|++.++.+||+ .|++|+||+|+||+++. ++.++|+|||.+...
T Consensus 78 lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~-~~~~h~dl~p~ni~i~~-~~~~~l~d~~~~~~~ 151 (260)
T cd06606 78 IFLEYVSGGSLSSLLKK----FGKLPEPVIRKYTRQILEGLAYLHS-NGIVHRDIKGANILVDS-DGVVKLADFGCAKRL 151 (260)
T ss_pred EEEEecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEEcC-CCCEEEcccccEEec
Confidence 99999965 55555543 3489999999999999999999999 89999999999999998 789999999998766
Q ss_pred ccCCc---cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHH-HcCCC------
Q 021306 192 IAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV-DQLVEIIK-VLGTP------ 260 (314)
Q Consensus 192 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~-~~~~~i~~-~~~~~------ 260 (314)
..... .....++..|+|||.+.+.. .+.++|+||||+++|+|++|..||...+.. .....+.. .....
T Consensus 152 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (260)
T cd06606 152 GDIETGEGTGSVRGTPYWMAPEVIRGEE-YGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLS 230 (260)
T ss_pred ccccccccccCCCCCccccCHhhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccC
Confidence 54432 33455678899999986554 789999999999999999999999877622 22222221 00000
Q ss_pred --CHHHHh---ccCCCCCCCcccccccCChh
Q 021306 261 --TREEIR---CMNPNYTDFRFPQIKAHPWH 286 (314)
Q Consensus 261 --~~~~~~---~~~p~~~~~~~~~l~~~p~~ 286 (314)
..+.+. ..+|+ +|+++.++++|||+
T Consensus 231 ~~l~~~i~~~l~~~p~-~Rp~~~~ll~~~~~ 260 (260)
T cd06606 231 EEAKDFLRKCLRRDPK-KRPTADELLQHPFL 260 (260)
T ss_pred HHHHHHHHHhCcCChh-hCCCHHHHhhCCCC
Confidence 111122 23566 89999999999996
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=250.10 Aligned_cols=253 Identities=16% Similarity=0.182 Sum_probs=175.3
Q ss_pred CCceeeeeEeecCceEEEEEEECCC---CcEEEEEEeeccccchH---------------HHHHHHHhCCCCceeeecee
Q 021306 38 ISYMAERVVGTGSFGIVFQAKCLET---GETVAIKKVLQDRRYKN---------------RELQLMRVMDHPNVISLKHC 99 (314)
Q Consensus 38 ~~y~~~~~Lg~g~~g~Vy~~~~~~~---~~~~~vK~~~~~~~~~~---------------~e~~~l~~l~h~~iv~~~~~ 99 (314)
++|++.+.||+|+||.||+|.+..+ +..+++|.......... .+...+..+.|+++++++++
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 5899999999999999999998777 66777775433222211 12223455689999999887
Q ss_pred eeecCCCCceeEEEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCc
Q 021306 100 FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQ 179 (314)
Q Consensus 100 ~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~ 179 (314)
..... ....+.+++++++..++.+.+.. ....++..++.++.|++.||.|||+ ++++||||||+||+++. ++.
T Consensus 92 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~-~~iiHrDiKp~Nill~~-~~~ 164 (294)
T PHA02882 92 GSFKR-CRMYYRFILLEKLVENTKEIFKR----IKCKNKKLIKNIMKDMLTTLEYIHE-HGISHGDIKPENIMVDG-NNR 164 (294)
T ss_pred eeEec-CCceEEEEEEehhccCHHHHHHh----hccCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcC-CCc
Confidence 54332 22345578889887776665543 2346788899999999999999999 89999999999999997 788
Q ss_pred EEEeecCcccccccCC--------ccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 021306 180 VKICDFGSAKQLIAGE--------ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLV 251 (314)
Q Consensus 180 ~~l~dfg~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~ 251 (314)
++|+|||+++...... ......+|+.|+|||.+.+.. ++.++||||||+++|+|++|+.||.+........
T Consensus 165 ~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~-~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~ 243 (294)
T PHA02882 165 GYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGAC-VTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLI 243 (294)
T ss_pred EEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCC-CCcHHHHHHHHHHHHHHHhCCCCCCccccchHHH
Confidence 9999999987553211 112245789999999986554 8999999999999999999999998774322222
Q ss_pred HHHHH-c-CCCCHHHHhccCCCCCCCcccccccCChhhhhcccCChHHHHHh
Q 021306 252 EIIKV-L-GTPTREEIRCMNPNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEY 301 (314)
Q Consensus 252 ~i~~~-~-~~~~~~~~~~~~p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~ 301 (314)
...+. . ....... ..+......+.++++.+|.-.+..+++...+.+.
T Consensus 244 ~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~ 292 (294)
T PHA02882 244 HAAKCDFIKRLHEGK---IKIKNANKFIYDFIECVTKLSYEEKPDYDALIKI 292 (294)
T ss_pred HHhHHHHHHHhhhhh---hccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHh
Confidence 11110 0 0000000 0011012235567777777666666666665544
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=246.76 Aligned_cols=249 Identities=23% Similarity=0.288 Sum_probs=187.7
Q ss_pred CCCceeeeeEeecCceEEEEEEECCC---CcEEEEEEeecccc-----chHHHHHHHHhCCCCceeeeceeeeecCCCCc
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCLET---GETVAIKKVLQDRR-----YKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 108 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~~~---~~~~~vK~~~~~~~-----~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 108 (314)
.++|++.+.||+|+||.||+|....+ ...+++|.++.... ...+|+.++++++|+||+++++.+.. .
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~ 77 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTK-----S 77 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEec-----C
Confidence 35799999999999999999997644 45799998764322 23468899999999999999998743 2
Q ss_pred eeEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCc
Q 021306 109 LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 187 (314)
Q Consensus 109 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~ 187 (314)
...+++|||+.+ +|.+.+.. ....+++.+++.++.|++.|+.+||+ ++++|+||+|+||+++. ++.++|+|||+
T Consensus 78 ~~~~iv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~Lh~-~~i~H~di~p~nili~~-~~~~~l~dfg~ 152 (266)
T cd05033 78 RPVMIITEYMENGSLDKFLRE---NDGKFTVGQLVGMLRGIASGMKYLSE-MNYVHRDLAARNILVNS-NLVCKVSDFGL 152 (266)
T ss_pred CceEEEEEcCCCCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCcceEEEcC-CCCEEECccch
Confidence 347899999986 56555543 23578999999999999999999999 89999999999999998 78899999999
Q ss_pred ccccccCCcc---ccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCHH
Q 021306 188 AKQLIAGEAN---ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTRE 263 (314)
Q Consensus 188 ~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~ 263 (314)
+......... ....++..|+|||.+.+.. ++.++||||||+++|+|++ |..||......+....+.+....+..
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~-~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~- 230 (266)
T cd05033 153 SRRLEDSEATYTTKGGKIPIRWTAPEAIAYRK-FTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPPP- 230 (266)
T ss_pred hhcccccccceeccCCCCCccccChhhhccCC-CccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCC-
Confidence 8866421111 1122356799999986544 8899999999999999998 99999887766555544432222211
Q ss_pred HHhccCCCCCCCcccccccCChhhhhcccCChHHHHHhcch
Q 021306 264 EIRCMNPNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGSH 304 (314)
Q Consensus 264 ~~~~~~p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~~ 304 (314)
......+.+++..||...+..++....+++.+..
T Consensus 231 -------~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~ 264 (266)
T cd05033 231 -------MDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDK 264 (266)
T ss_pred -------CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence 1122345677777777777777777777666543
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=248.47 Aligned_cols=251 Identities=20% Similarity=0.233 Sum_probs=180.5
Q ss_pred cCCCceeeeeEeecCceEEEEEEECC-----CCcEEEEEEeecccc-----chHHHHHHHHhCCCCceeeeceeeeecCC
Q 021306 36 QTISYMAERVVGTGSFGIVFQAKCLE-----TGETVAIKKVLQDRR-----YKNRELQLMRVMDHPNVISLKHCFFSTTS 105 (314)
Q Consensus 36 ~~~~y~~~~~Lg~g~~g~Vy~~~~~~-----~~~~~~vK~~~~~~~-----~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 105 (314)
..++|++.+.||+|++|.||++.+.. ++..+++|.+..... ...+|+.+++.++|+||+++++++.
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~---- 79 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS---- 79 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc----
Confidence 45689999999999999999998642 356799998754321 2347889999999999999998873
Q ss_pred CCceeEEEEeecccc-cHHHHHHhhhhc------CCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCC
Q 021306 106 KNELFLNLVMEYVPE-SMYRVLKHYSSA------NQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH 178 (314)
Q Consensus 106 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~------~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~ 178 (314)
.....++++||+++ +|.+.+...... ...+++..+..++.|++.||.|||+ .|++|+||||+||+++. ++
T Consensus 80 -~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~~vH~dlkp~Nil~~~-~~ 156 (277)
T cd05062 80 -QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNA-NKFVHRDLAARNCMVAE-DF 156 (277)
T ss_pred -CCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCcchheEEEcC-CC
Confidence 33347899999996 666555432111 1346788899999999999999999 89999999999999998 78
Q ss_pred cEEEeecCcccccccCCcc---ccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 021306 179 QVKICDFGSAKQLIAGEAN---ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEII 254 (314)
Q Consensus 179 ~~~l~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~t-g~~pf~~~~~~~~~~~i~ 254 (314)
.++|+|||++......... ....+++.|+|||.+.+.. ++.++|+||||+++|+|++ |..||.+....+....+.
T Consensus 157 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~ 235 (277)
T cd05062 157 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVM 235 (277)
T ss_pred CEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCC-cCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 8999999998654322111 1123356799999986544 8999999999999999999 789998877765555444
Q ss_pred HHcCCCCHHHHhccCCCCCCCcccccccCChhhhhcccCChHHHHHhc
Q 021306 255 KVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYG 302 (314)
Q Consensus 255 ~~~~~~~~~~~~~~~p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~ 302 (314)
.......+ ......+.+++..+|...+..+.....++..+
T Consensus 236 ~~~~~~~~--------~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l 275 (277)
T cd05062 236 EGGLLDKP--------DNCPDMLFELMRMCWQYNPKMRPSFLEIISSI 275 (277)
T ss_pred cCCcCCCC--------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHh
Confidence 32211111 11112344455555555555555555555443
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=250.10 Aligned_cols=243 Identities=26% Similarity=0.381 Sum_probs=181.3
Q ss_pred eeeeeEeecCceEEEEEEEC----CCCcEEEEEEeecc-----ccchHHHHHHHHhCCCCceeeeceeeeecCCCCceeE
Q 021306 41 MAERVVGTGSFGIVFQAKCL----ETGETVAIKKVLQD-----RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 111 (314)
Q Consensus 41 ~~~~~Lg~g~~g~Vy~~~~~----~~~~~~~vK~~~~~-----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 111 (314)
++.+.||.|.||.||+|... ..+..|+||.++.. .....+|+..+++++||||+++++++..... .
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~-----~ 76 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEP-----L 76 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSS-----E
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccc-----c
Confidence 57899999999999999987 34678999999543 2344588999999999999999999863333 7
Q ss_pred EEEeeccc-ccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcccc
Q 021306 112 NLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 190 (314)
Q Consensus 112 ~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~ 190 (314)
++|+||++ |+|.+.+... ....+++.++..|+.|++.||.|||+ ++++|++|+++||+++. ++.+||+|||++..
T Consensus 77 ~lv~e~~~~g~L~~~L~~~--~~~~~~~~~~~~i~~~i~~~l~~Lh~-~~iiH~~l~~~nill~~-~~~~Kl~~f~~~~~ 152 (259)
T PF07714_consen 77 FLVMEYCPGGSLDDYLKSK--NKEPLSEQQRLSIAIQIAEALSYLHS-NNIIHGNLSPSNILLDS-NGQVKLSDFGLSRP 152 (259)
T ss_dssp EEEEE--TTEBHHHHHHHT--CTTTSBHHHHHHHHHHHHHHHHHHHH-TTEEEST-SGGGEEEET-TTEEEEESTTTGEE
T ss_pred ccccccccccccccccccc--cccccccccccccccccccccccccc-ccccccccccccccccc-cccccccccccccc
Confidence 89999998 5777777652 24679999999999999999999999 89999999999999998 88999999999876
Q ss_pred cccCCc---cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCHHHHh
Q 021306 191 LIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIR 266 (314)
Q Consensus 191 ~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 266 (314)
...... .........|+|||.+.+.. ++.++||||||+++||+++ |+.||.+.+..+....+.+....+.
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~~----- 226 (259)
T PF07714_consen 153 ISEKSKYKNDSSQQLPLRYLAPEVLKDGE-YTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLPI----- 226 (259)
T ss_dssp TTTSSSEEESTTSESGGGGS-HHHHHHSE-ESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETTS-----
T ss_pred ccccccccccccccccccccccccccccc-cccccccccccccccccccccccccccccccccccccccccccee-----
Confidence 522211 12233466799999986655 7999999999999999999 7899998887766665533222111
Q ss_pred ccCCCCCCCcccccccCChhhhhcccCChHHHHHh
Q 021306 267 CMNPNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEY 301 (314)
Q Consensus 267 ~~~p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~ 301 (314)
|......+..++..||...+..++....+++.
T Consensus 227 ---~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~ 258 (259)
T PF07714_consen 227 ---PDNCPKDIYSLIQQCWSHDPEKRPSFQEILQE 258 (259)
T ss_dssp ---BTTSBHHHHHHHHHHT-SSGGGS--HHHHHHH
T ss_pred ---ccchhHHHHHHHHHHcCCChhhCcCHHHHHhc
Confidence 11123346677777887777777766666553
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=247.91 Aligned_cols=238 Identities=24% Similarity=0.440 Sum_probs=182.7
Q ss_pred CceeeeeEeecCceEEEEEEECCCCcEEEEEEeecc---------ccchHHHHHHHHhCCCCceeeeceeeeecCCCCce
Q 021306 39 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD---------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL 109 (314)
Q Consensus 39 ~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~---------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 109 (314)
+|.+.+.||+|++|.||++++..++..+++|..+.. .....+|..+++.++||||+++++++....
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----- 75 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERD----- 75 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCC-----
Confidence 589999999999999999998877766666655421 112346888999999999999999874332
Q ss_pred eEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcc
Q 021306 110 FLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 188 (314)
Q Consensus 110 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~ 188 (314)
..++++||+++ ++.+.+.........+++.+++.++.|++.|+.+||+ .|++|+||+|+||+++. +.++|+|||.+
T Consensus 76 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~i~h~~l~~~nili~~--~~~~l~d~g~~ 152 (260)
T cd08222 76 AFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ-RRILHRDLKAKNIFLKN--NLLKIGDFGVS 152 (260)
T ss_pred ceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHH-cCccccCCChhheEeec--CCEeecccCce
Confidence 37899999986 6666666554556789999999999999999999999 89999999999999975 46999999988
Q ss_pred cccccCCc-cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCH-----
Q 021306 189 KQLIAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR----- 262 (314)
Q Consensus 189 ~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~----- 262 (314)
........ .....+++.|+|||.+.+.. ++.++|+||||+++|+|++|..||...........+........+
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (260)
T cd08222 153 RLLMGSCDLATTFTGTPYYMSPEALKHQG-YDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSR 231 (260)
T ss_pred eecCCCcccccCCCCCcCccCHHHHccCC-CCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCCcchhcH
Confidence 75533221 22344677899999985544 788999999999999999999999876665555444432211111
Q ss_pred ---HHHh---ccCCCCCCCcccccccCChh
Q 021306 263 ---EEIR---CMNPNYTDFRFPQIKAHPWH 286 (314)
Q Consensus 263 ---~~~~---~~~p~~~~~~~~~l~~~p~~ 286 (314)
+.+. ..+|+ +|+++.++++|||+
T Consensus 232 ~~~~li~~~l~~~p~-~Rp~~~~il~~~~~ 260 (260)
T cd08222 232 QLNSIMQSMLNKDPS-LRPSAAEILRNPFI 260 (260)
T ss_pred HHHHHHHHHhcCChh-hCcCHHHHhhCCCC
Confidence 1121 23677 89999999999995
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=245.62 Aligned_cols=246 Identities=22% Similarity=0.284 Sum_probs=184.8
Q ss_pred CCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeecccc--chHHHHHHHHhCCCCceeeeceeeeecCCCCceeEEEE
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR--YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLV 114 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~~--~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 114 (314)
..+|++.+.||+|++|.||++.. .+..+++|.++.+.. ...+|+.++++++|++++++++++.... ...+++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----~~~~lv 78 (256)
T cd05082 5 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEK----GGLYIV 78 (256)
T ss_pred HHhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCCchHHHHHHHHHHHHhCCCCCeeeEEEEEEcCC----CceEEE
Confidence 45799999999999999999976 578899998865433 3458999999999999999998764322 237899
Q ss_pred eecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCccccccc
Q 021306 115 MEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA 193 (314)
Q Consensus 115 ~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~~ 193 (314)
+||+++ +|.+.+... ....+++..++.++.|++.||.+||+ +|++|+||+|+||+++. ++.++|+|||++.....
T Consensus 79 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~nil~~~-~~~~kl~dfg~~~~~~~ 154 (256)
T cd05082 79 TEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEA-NNFVHRDLAARNVLVSE-DNVAKVSDFGLTKEASS 154 (256)
T ss_pred EECCCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHh-CCEeccccchheEEEcC-CCcEEecCCccceeccc
Confidence 999986 666665531 22458899999999999999999999 89999999999999998 88999999999875432
Q ss_pred CCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCHHHHhccCCCC
Q 021306 194 GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 272 (314)
Q Consensus 194 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~p~~ 272 (314)
.. .....+..|+|||.+.+.. ++.++||||||+++|+|++ |+.||...+..+....+.+...... +..
T Consensus 155 ~~--~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~--------~~~ 223 (256)
T cd05082 155 TQ--DTGKLPVKWTAPEALREKK-FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDA--------PDG 223 (256)
T ss_pred cC--CCCccceeecCHHHHccCC-CCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCC--------CCC
Confidence 22 2223356799999986544 8899999999999999998 9999987776555444433221111 111
Q ss_pred CCCcccccccCChhhhhcccCChHHHHHhcc
Q 021306 273 TDFRFPQIKAHPWHKVCIFHFPKHWLLEYGS 303 (314)
Q Consensus 273 ~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~ 303 (314)
....+.+++..+|...+..+++...+.+.++
T Consensus 224 ~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 254 (256)
T cd05082 224 CPPVVYDVMKQCWHLDAATRPSFLQLREQLE 254 (256)
T ss_pred CCHHHHHHHHHHhcCChhhCcCHHHHHHHHh
Confidence 2234556666666666666666666665554
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=249.62 Aligned_cols=251 Identities=22% Similarity=0.249 Sum_probs=187.9
Q ss_pred CCCceeeeeEeecCceEEEEEEECCC-----CcEEEEEEeecccc-----chHHHHHHHHhCCCCceeeeceeeeecCCC
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCLET-----GETVAIKKVLQDRR-----YKNRELQLMRVMDHPNVISLKHCFFSTTSK 106 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~~~-----~~~~~vK~~~~~~~-----~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 106 (314)
.++|++.+.||+|+||.||++.+... +..+++|.+..... ...+|+.+++.++|+||+++++++...
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--- 81 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTG--- 81 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCC---
Confidence 45899999999999999999987643 47899998764432 235788999999999999999988433
Q ss_pred CceeEEEEeecccc-cHHHHHHhhhh------cCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCc
Q 021306 107 NELFLNLVMEYVPE-SMYRVLKHYSS------ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQ 179 (314)
Q Consensus 107 ~~~~~~lv~e~~~~-~l~~~l~~~~~------~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~ 179 (314)
...++++||+++ +|.+.+..... ....+++..+..++.|++.||.|||+ .+++|+||+|+||+++. ++.
T Consensus 82 --~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~di~p~nill~~-~~~ 157 (277)
T cd05032 82 --QPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAA-KKFVHRDLAARNCMVAE-DLT 157 (277)
T ss_pred --CCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccccChheEEEcC-CCC
Confidence 347899999985 66666654221 12357889999999999999999999 89999999999999998 888
Q ss_pred EEEeecCcccccccCCc---cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 021306 180 VKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIK 255 (314)
Q Consensus 180 ~~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~t-g~~pf~~~~~~~~~~~i~~ 255 (314)
++|+|||+++....... .....++..|+|||.+.+.. ++.++||||||+++|++++ |..||.+.+..+....+..
T Consensus 158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~ 236 (277)
T cd05032 158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGV-FTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVID 236 (277)
T ss_pred EEECCcccchhhccCcccccCCCCCccccccCHHHHhcCC-CCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhc
Confidence 99999999875433221 11223467799999986544 8899999999999999998 9999988877665554442
Q ss_pred HcCCCCHHHHhccCCCCCCCcccccccCChhhhhcccCChHHHHHhcc
Q 021306 256 VLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGS 303 (314)
Q Consensus 256 ~~~~~~~~~~~~~~p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~ 303 (314)
...... |......+.++++.+|...+..+++...+++.++
T Consensus 237 ~~~~~~--------~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 237 GGHLDL--------PENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred CCCCCC--------CCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 111111 1111223556777777777777777777766554
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=242.15 Aligned_cols=235 Identities=32% Similarity=0.571 Sum_probs=186.9
Q ss_pred CceeeeeEeecCceEEEEEEECCCCcEEEEEEeecccc------chHHHHHHHHhCCCCceeeeceeeeecCCCCceeEE
Q 021306 39 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR------YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 112 (314)
Q Consensus 39 ~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~~------~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 112 (314)
+|++.+.||+|++|.||++.+..+++.+++|.+..... ...+|++++++++|+|++++++++... ...+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~ 75 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETS-----DSLY 75 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeC-----CEEE
Confidence 58999999999999999999988999999999865542 345888999999999999999887432 3488
Q ss_pred EEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCccccc
Q 021306 113 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 191 (314)
Q Consensus 113 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~ 191 (314)
+++||+++ +|.+.+.. ...+++..++.++.|++.++.+||+ .|++|+||+|+||+++. ++.++|+|||.+...
T Consensus 76 ~v~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~ni~i~~-~~~~~l~d~~~~~~~ 149 (254)
T cd06627 76 IILEYAENGSLRQIIKK----FGPFPESLVAVYVYQVLQGLAYLHE-QGVIHRDIKAANILTTK-DGVVKLADFGVATKL 149 (254)
T ss_pred EEEecCCCCcHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHhh-CCcccCCCCHHHEEECC-CCCEEEeccccceec
Confidence 99999987 55554443 4689999999999999999999999 89999999999999998 789999999998765
Q ss_pred ccCCc-cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCC--------H
Q 021306 192 IAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT--------R 262 (314)
Q Consensus 192 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~--------~ 262 (314)
..... .....++..|+|||...+.. ++.++|+||||+++|+|++|..||...+................ .
T Consensus 150 ~~~~~~~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (254)
T cd06627 150 NDVSKDDASVVGTPYWMAPEVIEMSG-ASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGISPELK 228 (254)
T ss_pred CCCcccccccccchhhcCHhhhcCCC-CCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCCCCCCCCCCHHHH
Confidence 44332 12345678899999986555 78999999999999999999999987776554544432221111 1
Q ss_pred HHHh---ccCCCCCCCcccccccCChh
Q 021306 263 EEIR---CMNPNYTDFRFPQIKAHPWH 286 (314)
Q Consensus 263 ~~~~---~~~p~~~~~~~~~l~~~p~~ 286 (314)
+.+. ..+|+ +|+++.+++.|||+
T Consensus 229 ~~i~~~l~~~p~-~R~~~~~~l~~~~~ 254 (254)
T cd06627 229 DFLMQCFQKDPN-LRPTAKQLLKHPWI 254 (254)
T ss_pred HHHHHHHhCChh-hCcCHHHHhcCCCC
Confidence 1122 23666 78999999999986
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-35 Score=251.21 Aligned_cols=235 Identities=26% Similarity=0.405 Sum_probs=178.9
Q ss_pred EeecCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeEEEEeecc
Q 021306 46 VGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYV 118 (314)
Q Consensus 46 Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~ 118 (314)
||+|+||.||+|.+..+|+.+++|.+.... ....+|+.++++++|+|++++++.+.. ....++|+||+
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~lv~e~~ 75 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFET-----KDDLCLVMTLM 75 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEec-----CCeEEEEEecC
Confidence 689999999999999999999999886421 223478899999999999999888733 33488999999
Q ss_pred cc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcccccccCCcc
Q 021306 119 PE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN 197 (314)
Q Consensus 119 ~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~~~~~~ 197 (314)
++ +|.+.+... ....+++.+++.++.|++.|+.+||+ .|++|+||+|+||+++. ++.++|+|||.+.........
T Consensus 76 ~~~~L~~~l~~~--~~~~~~~~~~~~~~~ql~~~l~~lH~-~~i~H~di~p~Nil~~~-~~~~~l~dfg~~~~~~~~~~~ 151 (277)
T cd05577 76 NGGDLKYHIYNV--GEPGFPEARAIFYAAQIICGLEHLHQ-RRIVYRDLKPENVLLDD-HGNVRISDLGLAVELKGGKKI 151 (277)
T ss_pred CCCcHHHHHHHc--CcCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEECC-CCCEEEccCcchhhhccCCcc
Confidence 96 565555432 12478999999999999999999999 89999999999999998 788999999988765443333
Q ss_pred ccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH---cCC--------CCHHHHh
Q 021306 198 ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV---LGT--------PTREEIR 266 (314)
Q Consensus 198 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~---~~~--------~~~~~~~ 266 (314)
....++..|+|||.+.+.. ++.++|+||||+++|+|++|+.||...........+.+. ... ...+.+.
T Consensus 152 ~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 230 (277)
T cd05577 152 KGRAGTPGYMAPEVLQGEV-YDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCE 230 (277)
T ss_pred ccccCCCCcCCHHHhcCCC-CCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHH
Confidence 3455677899999986655 889999999999999999999999776432111111111 000 0112222
Q ss_pred ---ccCCCCCCC-----cccccccCChhhhhcc
Q 021306 267 ---CMNPNYTDF-----RFPQIKAHPWHKVCIF 291 (314)
Q Consensus 267 ---~~~p~~~~~-----~~~~l~~~p~~~~~~~ 291 (314)
..+|. +|+ ++.+|+.|||++....
T Consensus 231 ~~l~~~p~-~R~~~~~~~~~~ll~h~~~~~~~~ 262 (277)
T cd05577 231 ALLQKDPE-KRLGCRGGSADEVREHPLFKDLNW 262 (277)
T ss_pred HHccCChh-HccCCCcccHHHHHhChhhhcCCh
Confidence 23566 788 7777999999976554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=251.31 Aligned_cols=238 Identities=28% Similarity=0.444 Sum_probs=188.8
Q ss_pred CCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCCcee
Q 021306 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 110 (314)
Q Consensus 38 ~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 110 (314)
+.|...+.||+|++|.||+++++.+++.+++|.+.... ....+|+.+++.++|+|++++.+++... ..
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~ 89 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE-----HT 89 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcC-----Ce
Confidence 35888999999999999999999999999999886321 1234688999999999999999988543 23
Q ss_pred EEEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcccc
Q 021306 111 LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 190 (314)
Q Consensus 111 ~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~ 190 (314)
.++|+||+.|++.+.+.. ...++++.+++.++.|++.|+.+||+ ++++|+||+|+||+++. ++.++|+|||++..
T Consensus 90 ~~lv~e~~~~~l~~~~~~---~~~~l~~~~~~~~~~~l~~~l~~LH~-~~i~H~dl~p~nil~~~-~~~~kl~dfg~~~~ 164 (308)
T cd06634 90 AWLVMEYCLGSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHS-HNMIHRDVKAGNILLSE-PGLVKLGDFGSASI 164 (308)
T ss_pred eEEEEEccCCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHhEEECC-CCcEEECCccccee
Confidence 789999999887766643 24568999999999999999999999 89999999999999998 78899999998875
Q ss_pred cccCCccccccccccccccccccC--CCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCC--------
Q 021306 191 LIAGEANISYICSRFYRAPELIFG--ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP-------- 260 (314)
Q Consensus 191 ~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~-------- 260 (314)
... .....+++.|+|||.+.+ ...++.++||||||+++|+|++|..||...+..+....+.+.....
T Consensus 165 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (308)
T cd06634 165 MAP---ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSE 241 (308)
T ss_pred ecC---cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCcccccH
Confidence 432 223456788999999742 2336889999999999999999999998877655555444432211
Q ss_pred -CHHHHh-c--cCCCCCCCcccccccCChhhhh
Q 021306 261 -TREEIR-C--MNPNYTDFRFPQIKAHPWHKVC 289 (314)
Q Consensus 261 -~~~~~~-~--~~p~~~~~~~~~l~~~p~~~~~ 289 (314)
..+.+. + .+|+ +|+++.++++|||+...
T Consensus 242 ~~~~li~~cl~~~P~-~Rp~~~~ll~~~~~~~~ 273 (308)
T cd06634 242 YFRNFVDSCLQKIPQ-DRPTSEVLLKHRFVLRE 273 (308)
T ss_pred HHHHHHHHHhhCCcc-cCCCHHHHhhCcccccc
Confidence 111222 2 3677 89999999999998774
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=252.34 Aligned_cols=251 Identities=20% Similarity=0.261 Sum_probs=186.6
Q ss_pred CCCceeeeeEeecCceEEEEEEECCC-----CcEEEEEEeecccc-----chHHHHHHHHhCCCCceeeeceeeeecCCC
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCLET-----GETVAIKKVLQDRR-----YKNRELQLMRVMDHPNVISLKHCFFSTTSK 106 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~~~-----~~~~~vK~~~~~~~-----~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 106 (314)
..+|++.+.||+|+||.||+|.+..+ ++.+++|.++.... ...+|..++.+++|+||+++++.+....
T Consensus 4 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~-- 81 (283)
T cd05091 4 LSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQ-- 81 (283)
T ss_pred HHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCC--
Confidence 34689999999999999999987543 57899999875432 2457888999999999999999874332
Q ss_pred CceeEEEEeecccc-cHHHHHHhh------------hhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEE
Q 021306 107 NELFLNLVMEYVPE-SMYRVLKHY------------SSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLV 173 (314)
Q Consensus 107 ~~~~~~lv~e~~~~-~l~~~l~~~------------~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~ 173 (314)
..++++||+.+ ++...+... ......+++..+..++.|++.||.|||+ +|++|+||||+||++
T Consensus 82 ---~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~-~gi~H~dlkp~Nil~ 157 (283)
T cd05091 82 ---PLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSS-HHVVHKDLATRNVLV 157 (283)
T ss_pred ---ceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH-cCccccccchhheEe
Confidence 37799999986 555554321 0112458899999999999999999999 899999999999999
Q ss_pred cCCCCcEEEeecCcccccccCCc---cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHH
Q 021306 174 DPLTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQ 249 (314)
Q Consensus 174 ~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~t-g~~pf~~~~~~~~ 249 (314)
+. ++.++|+|||+++....... .....+++.|+|||.+.+.. ++.++||||||+++|||++ |..||.+....+.
T Consensus 158 ~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~ 235 (283)
T cd05091 158 FD-KLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGK-FSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDV 235 (283)
T ss_pred cC-CCceEecccccccccccchheeeccCccCCccccCHHHHhcCC-CCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 97 78899999999875432211 11223467899999986554 7899999999999999998 8899988877665
Q ss_pred HHHHHHHcCCCCHHHHhccCCCCCCCcccccccCChhhhhcccCChHHHHHhcc
Q 021306 250 LVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGS 303 (314)
Q Consensus 250 ~~~i~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~ 303 (314)
...+.+....+. |.-....+.+++..||...+..++....++..++
T Consensus 236 ~~~i~~~~~~~~--------~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~ 281 (283)
T cd05091 236 IEMIRNRQVLPC--------PDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLR 281 (283)
T ss_pred HHHHHcCCcCCC--------CCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhh
Confidence 555544322111 1111223556777777777777777666666554
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=248.28 Aligned_cols=209 Identities=22% Similarity=0.347 Sum_probs=164.3
Q ss_pred CCCceeeeeEeecCceEEEEEEEC----CCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCC
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCL----ETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKN 107 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~----~~~~~~~vK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 107 (314)
.+.|++.+.||+|+||.||+|... .++..+++|.+.... ....+|+.+++.++|+||+++++++....
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--- 80 (283)
T cd05090 4 LSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQ--- 80 (283)
T ss_pred hhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCC---
Confidence 357999999999999999999853 456789999886432 23457999999999999999999874433
Q ss_pred ceeEEEEeecccc-cHHHHHHhhh-------------hcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEE
Q 021306 108 ELFLNLVMEYVPE-SMYRVLKHYS-------------SANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLV 173 (314)
Q Consensus 108 ~~~~~lv~e~~~~-~l~~~l~~~~-------------~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~ 173 (314)
..+++|||+.+ +|.+.+.... .....+++.++..++.|++.||.|||+ +|++|+||+|+||++
T Consensus 81 --~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~-~~i~H~dlkp~nili 157 (283)
T cd05090 81 --PVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSS-HFFVHKDLAARNILI 157 (283)
T ss_pred --ceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHh-cCeehhccccceEEE
Confidence 37899999986 6665553211 012358899999999999999999999 899999999999999
Q ss_pred cCCCCcEEEeecCcccccccCCc---cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHH
Q 021306 174 DPLTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQ 249 (314)
Q Consensus 174 ~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~t-g~~pf~~~~~~~~ 249 (314)
+. ++.++|+|||++........ .....++..|+|||.+.+.. ++.++|+||||+++|+|++ |..||.+......
T Consensus 158 ~~-~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~ 235 (283)
T cd05090 158 GE-QLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGK-FSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEV 235 (283)
T ss_pred cC-CCcEEeccccccccccCCcceecccCCCccceecChHHhccCC-CCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 98 78899999999875533221 12233456799999986544 7899999999999999998 9999988776544
Q ss_pred HHHH
Q 021306 250 LVEI 253 (314)
Q Consensus 250 ~~~i 253 (314)
...+
T Consensus 236 ~~~~ 239 (283)
T cd05090 236 IEMV 239 (283)
T ss_pred HHHH
Confidence 4433
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=246.33 Aligned_cols=244 Identities=20% Similarity=0.280 Sum_probs=181.1
Q ss_pred CCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeEEEE
Q 021306 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLV 114 (314)
Q Consensus 38 ~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 114 (314)
.+|++.+.||+|++|.||++++. ++..+++|.+.... ....+|+.++++++|+||+++++++. ...+.+++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~lv 77 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCT-----KQRPIFIV 77 (256)
T ss_pred HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEEc-----CCCceEEE
Confidence 46899999999999999999875 56789999886432 23457899999999999999998873 33347899
Q ss_pred eecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCccccccc
Q 021306 115 MEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA 193 (314)
Q Consensus 115 ~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~~ 193 (314)
+||+++ +|.+.+.. ....+++..++.++.|++.|+.+||+ .|++|+||+|+||+++. ++.++|+|||.+.....
T Consensus 78 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dl~p~ni~i~~-~~~~kl~dfg~~~~~~~ 152 (256)
T cd05059 78 TEYMANGCLLNYLRE---RKGKLGTEWLLDMCSDVCEAMEYLES-NGFIHRDLAARNCLVGE-DNVVKVSDFGLARYVLD 152 (256)
T ss_pred EecCCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHH-CCcccccccHhhEEECC-CCcEEECCcccceeccc
Confidence 999986 56655543 23478999999999999999999999 89999999999999998 88899999998875432
Q ss_pred CCcc--ccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCHHHHhccCC
Q 021306 194 GEAN--ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 270 (314)
Q Consensus 194 ~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~p 270 (314)
.... .....+..|+|||.+.+.. ++.++|+||||+++|+|++ |..||...+..+....+......+. |
T Consensus 153 ~~~~~~~~~~~~~~y~~Pe~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~--------~ 223 (256)
T cd05059 153 DQYTSSQGTKFPVKWAPPEVFDYSR-FSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYR--------P 223 (256)
T ss_pred ccccccCCCCCCccccCHHHhccCC-CCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcCCC--------C
Confidence 2111 1112234699999986544 8899999999999999999 8999988776655544433211110 1
Q ss_pred CCCCCcccccccCChhhhhcccCChHHHHHh
Q 021306 271 NYTDFRFPQIKAHPWHKVCIFHFPKHWLLEY 301 (314)
Q Consensus 271 ~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~ 301 (314)
......+.+++..||...+..++....+++.
T Consensus 224 ~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 224 KLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred CCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 1122235566666666666665555555543
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=243.44 Aligned_cols=258 Identities=25% Similarity=0.432 Sum_probs=196.6
Q ss_pred cCCCCCCccCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhC-CCCceeeecee
Q 021306 28 GGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVM-DHPNVISLKHC 99 (314)
Q Consensus 28 ~~~~~~~~~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~-------~~~~~e~~~l~~l-~h~~iv~~~~~ 99 (314)
++++....-.++|.+.++||+|+|.+|.+++.+++.+.||+|.++++- .+.+.|..+..+- +||++|.++.|
T Consensus 240 g~~~~~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhsc 319 (593)
T KOG0695|consen 240 GIKISQGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSC 319 (593)
T ss_pred ccccccccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhh
Confidence 334444444578999999999999999999999999999999887542 3345666666554 79999999999
Q ss_pred eeecCCCCceeEEEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCc
Q 021306 100 FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQ 179 (314)
Q Consensus 100 ~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~ 179 (314)
|+. ...+++|.||++|+ .+....+++..++++.++.+..+|+.||.|||+ +||++||||.+|++++. .++
T Consensus 320 fqt-----esrlffvieyv~gg---dlmfhmqrqrklpeeharfys~ei~lal~flh~-rgiiyrdlkldnvllda-egh 389 (593)
T KOG0695|consen 320 FQT-----ESRLFFVIEYVNGG---DLMFHMQRQRKLPEEHARFYSAEICLALNFLHE-RGIIYRDLKLDNVLLDA-EGH 389 (593)
T ss_pred hcc-----cceEEEEEEEecCc---ceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhh-cCeeeeeccccceEEcc-CCc
Confidence 944 33489999999986 233334457889999999999999999999999 99999999999999999 889
Q ss_pred EEEeecCccccccc-CCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCC-------CCChHHHHH
Q 021306 180 VKICDFGSAKQLIA-GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFP-------GENAVDQLV 251 (314)
Q Consensus 180 ~~l~dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~-------~~~~~~~~~ 251 (314)
+||.|+|.++.-.. ...+..++|||.|.|||++++.. |....|+|+||++++||+.|+.||. ..+.++.+.
T Consensus 390 ikltdygmcke~l~~gd~tstfcgtpnyiapeilrgee-ygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylf 468 (593)
T KOG0695|consen 390 IKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEE-YGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLF 468 (593)
T ss_pred eeecccchhhcCCCCCcccccccCCCcccchhhhcccc-cCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHH
Confidence 99999999875433 34456788999999999998866 9999999999999999999999994 233445555
Q ss_pred HHHHHcC-CCCH----------HHHhccCCCC-----CCCcccccccCChhhhhcccCChH
Q 021306 252 EIIKVLG-TPTR----------EEIRCMNPNY-----TDFRFPQIKAHPWHKVCIFHFPKH 296 (314)
Q Consensus 252 ~i~~~~~-~~~~----------~~~~~~~p~~-----~~~~~~~l~~~p~~~~~~~~~~~~ 296 (314)
+++-... .-++ ..+.+.+|.- -...+.++..|+|+|....+.+.+
T Consensus 469 qvilekqiriprslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idwd~leq 529 (593)
T KOG0695|consen 469 QVILEKQIRIPRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDWDLLEQ 529 (593)
T ss_pred HHHhhhcccccceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCHHHHhh
Confidence 5442210 0010 1111223320 123788999999999777654443
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=254.94 Aligned_cols=201 Identities=21% Similarity=0.341 Sum_probs=156.2
Q ss_pred eeeEeec--CceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeEEEE
Q 021306 43 ERVVGTG--SFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLV 114 (314)
Q Consensus 43 ~~~Lg~g--~~g~Vy~~~~~~~~~~~~vK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 114 (314)
.+.||+| ++|+||++++..+|+.|++|.+.... ....+|+.+++.++|+||+++++++.. ....+++
T Consensus 3 ~~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~-----~~~~~~v 77 (328)
T cd08226 3 QVEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTT-----GSWLWVI 77 (328)
T ss_pred HHHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEec-----CCceEEE
Confidence 3456666 89999999999999999999886432 234578888888999999999999844 3347899
Q ss_pred eecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCccccccc
Q 021306 115 MEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA 193 (314)
Q Consensus 115 ~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~~ 193 (314)
+||+.+ ++.+.+.... ...+++..+..++.|++.||.|||+ .|++|+||||+||+++. ++.++++||+.+.....
T Consensus 78 ~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~-~~ivHrDlkp~Nill~~-~~~~~~~~~~~~~~~~~ 153 (328)
T cd08226 78 SPFMAYGSANSLLKTYF--PEGMSEALIGNILFGALRGLNYLHQ-NGYIHRNIKASHILISG-DGLVSLSGLSHLYSLVR 153 (328)
T ss_pred EecccCCCHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEeC-CCcEEEechHHHhhhhc
Confidence 999996 6665555421 2458999999999999999999999 89999999999999998 78899999986533221
Q ss_pred CCccc--------cccccccccccccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 021306 194 GEANI--------SYICSRFYRAPELIFGA-TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVE 252 (314)
Q Consensus 194 ~~~~~--------~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~ 252 (314)
..... ...++..|+|||.+.+. ..++.++|+||||+++|+|++|+.||...........
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~ 221 (328)
T cd08226 154 NGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQ 221 (328)
T ss_pred cCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHH
Confidence 11110 11234569999998654 3368899999999999999999999987765444433
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=244.44 Aligned_cols=246 Identities=24% Similarity=0.318 Sum_probs=187.6
Q ss_pred CCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeecccc---chHHHHHHHHhCCCCceeeeceeeeecCCCCceeEEE
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR---YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 113 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~~---~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 113 (314)
.++|++.+.||+|++|.||++.. .|+.+++|.+..... ...+|+.+++.++|+||+++++++... ...++
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~--~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~~ 77 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQG-----NPLYI 77 (256)
T ss_pred hhhccceeeeecCCCceEEEEEe--cCcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcCC-----CCeEE
Confidence 45799999999999999999986 578999999976644 345789999999999999999987542 33789
Q ss_pred Eeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcccccc
Q 021306 114 VMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 192 (314)
Q Consensus 114 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~ 192 (314)
++||+++ +|.+.+... ....+++..++.++.|++.|+.|||+ +|++|+||+|+||+++. ++.++|+|||.+....
T Consensus 78 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lh~-~~i~H~di~p~Nili~~-~~~~~l~d~g~~~~~~ 153 (256)
T cd05039 78 VTEYMAKGSLVDYLRSR--GRAVITLAQQLGFALDVCEGMEYLEE-KNFVHRDLAARNVLVSE-DLVAKVSDFGLAKEAS 153 (256)
T ss_pred EEEecCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHh-CCccchhcccceEEEeC-CCCEEEcccccccccc
Confidence 9999995 776665532 12368999999999999999999999 89999999999999998 8889999999987653
Q ss_pred cCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCHHHHhccCCC
Q 021306 193 AGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 271 (314)
Q Consensus 193 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~p~ 271 (314)
.... ....+..|+|||.+.+.. ++.++|+||||+++|+|++ |..||......+....+.+...... |.
T Consensus 154 ~~~~--~~~~~~~~~ape~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~--------~~ 222 (256)
T cd05039 154 QGQD--SGKLPVKWTAPEALREKK-FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEA--------PE 222 (256)
T ss_pred cccc--cCCCcccccCchhhcCCc-CCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCC--------cc
Confidence 2222 223356799999986544 7889999999999999997 9999988776554443332211111 11
Q ss_pred CCCCcccccccCChhhhhcccCChHHHHHhcch
Q 021306 272 YTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGSH 304 (314)
Q Consensus 272 ~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~~ 304 (314)
.....+.++++.+|...+..++....+++.+++
T Consensus 223 ~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 223 GCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred CCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 112235566666776666666666777666543
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=246.24 Aligned_cols=244 Identities=21% Similarity=0.308 Sum_probs=182.2
Q ss_pred CCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeEEEE
Q 021306 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLV 114 (314)
Q Consensus 38 ~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 114 (314)
.+|++.+.||+|++|.||+++.. ++..+++|.+.... ....+|+.++++++||||+++++++... ...+++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv 77 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQ-----RPIYIV 77 (256)
T ss_pred HHeEEeeEecCcccceEEEEEec-CCCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEccC-----CCcEEE
Confidence 46999999999999999999864 44569999886543 2346799999999999999999987432 337899
Q ss_pred eecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCccccccc
Q 021306 115 MEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA 193 (314)
Q Consensus 115 ~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~~ 193 (314)
|||+.+ +|.+.+.. ....+++.+++.++.|++.||.|||+ +|++|+||+|+||+++. ++.++|+|||.+.....
T Consensus 78 ~e~~~~~~l~~~i~~---~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~nili~~-~~~~kl~d~g~~~~~~~ 152 (256)
T cd05113 78 TEYMSNGCLLNYLRE---HGKRFQPSQLLEMCKDVCEGMAYLES-KQFIHRDLAARNCLVDD-QGCVKVSDFGLSRYVLD 152 (256)
T ss_pred EEcCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccccCcceEEEcC-CCCEEECCCccceecCC
Confidence 999986 56555543 23478999999999999999999999 89999999999999998 78899999998875433
Q ss_pred CCc--cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCHHHHhccCC
Q 021306 194 GEA--NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 270 (314)
Q Consensus 194 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~p 270 (314)
... .....++..|+|||.+.+.. ++.++|+||||+++|+|++ |..||......+....+.+......+
T Consensus 153 ~~~~~~~~~~~~~~y~~pe~~~~~~-~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~-------- 223 (256)
T cd05113 153 DEYTSSVGSKFPVRWSPPEVLLYSK-FSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRP-------- 223 (256)
T ss_pred CceeecCCCccChhhCCHHHHhcCc-ccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCCC--------
Confidence 221 11223356799999986544 7899999999999999999 99999887766655555443222111
Q ss_pred CCCCCcccccccCChhhhhcccCChHHHHHh
Q 021306 271 NYTDFRFPQIKAHPWHKVCIFHFPKHWLLEY 301 (314)
Q Consensus 271 ~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~ 301 (314)
......+.+++..||...+..+++...++..
T Consensus 224 ~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 224 HLASEKVYAIMYSCWHEKAEERPTFQQLLSS 254 (256)
T ss_pred CCCCHHHHHHHHHHcCCCcccCCCHHHHHHh
Confidence 1112234556666666666666555555543
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=245.64 Aligned_cols=247 Identities=25% Similarity=0.329 Sum_probs=188.1
Q ss_pred CCceeeeeEeecCceEEEEEEECCCCcEEEEEEeecccc---chHHHHHHHHhCCCCceeeeceeeeecCCCCceeEEEE
Q 021306 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR---YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLV 114 (314)
Q Consensus 38 ~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~~---~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 114 (314)
++|++.+.||+|++|.||+|++..+ ..+++|.++.... ...+|+.+++.++|+||+++++.+.. .+.+++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~------~~~~lv 78 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EPIYIV 78 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEECC------CCcEEE
Confidence 5799999999999999999987655 4699998875332 34678999999999999999876521 126799
Q ss_pred eecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCccccccc
Q 021306 115 MEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA 193 (314)
Q Consensus 115 ~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~~ 193 (314)
|||+++ ++.+.+... ....+++..+..++.|++.||.+||+ .+++|+||+|+||+++. ++.++|+|||.+.....
T Consensus 79 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~-~~i~H~dl~p~Nill~~-~~~~~L~dfg~~~~~~~ 154 (262)
T cd05071 79 TEYMSKGSLLDFLKGE--MGKYLRLPQLVDMAAQIASGMAYVER-MNYVHRDLRAANILVGE-NLVCKVADFGLARLIED 154 (262)
T ss_pred EEcCCCCcHHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHH-CCccccccCcccEEEcC-CCcEEeccCCceeeccc
Confidence 999986 666665431 23468999999999999999999999 89999999999999998 78899999999875533
Q ss_pred CCcc--ccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCHHHHhccCC
Q 021306 194 GEAN--ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 270 (314)
Q Consensus 194 ~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~p 270 (314)
.... ....++..|+|||...+.. ++.++|+||||+++|+|++ |..||.+....+....+......+. .+
T Consensus 155 ~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~-------~~ 226 (262)
T cd05071 155 NEYTARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC-------PP 226 (262)
T ss_pred cccccccCCcccceecCHhHhccCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCCCC-------cc
Confidence 2211 1233456799999985544 8999999999999999999 8899988776655554433221111 11
Q ss_pred CCCCCcccccccCChhhhhcccCChHHHHHhcch
Q 021306 271 NYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGSH 304 (314)
Q Consensus 271 ~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~~ 304 (314)
. ....+.++++.+|.+.+..++....+.+.++.
T Consensus 227 ~-~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~ 259 (262)
T cd05071 227 E-CPESLHDLMCQCWRKEPEERPTFEYLQAFLED 259 (262)
T ss_pred c-cCHHHHHHHHHHccCCcccCCCHHHHHHHHHH
Confidence 1 12345678888888888888777777776654
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=244.42 Aligned_cols=240 Identities=21% Similarity=0.276 Sum_probs=175.4
Q ss_pred eeEeecCceEEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeEEEEeecc
Q 021306 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYV 118 (314)
Q Consensus 44 ~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~ 118 (314)
+.||+|+||.||++.+..+++.+++|.+.... ....+|++++++++|+||+++++++... ...++|+||+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~ 75 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQK-----QPIYIVMELV 75 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-----CCeEEEEeec
Confidence 46899999999999999899999999875432 2346889999999999999999987433 3478999999
Q ss_pred cc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcccccccCCcc
Q 021306 119 PE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN 197 (314)
Q Consensus 119 ~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~~~~~~ 197 (314)
.+ +|.+.+.. ....+++..++.++.|++.||.|||+ +|++|+||+|+||+++. ++.++|+|||.+.........
T Consensus 76 ~~~~L~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~-~~i~H~dl~p~nil~~~-~~~~kl~dfg~~~~~~~~~~~ 150 (252)
T cd05084 76 QGGDFLTFLRT---EGPRLKVKELIQMVENAAAGMEYLES-KHCIHRDLAARNCLVTE-KNVLKISDFGMSREEEDGVYA 150 (252)
T ss_pred cCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccccchheEEEcC-CCcEEECccccCccccccccc
Confidence 86 55555432 23568999999999999999999999 89999999999999998 788999999998754321111
Q ss_pred c---cccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCHHHHhccCCCCC
Q 021306 198 I---SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 273 (314)
Q Consensus 198 ~---~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~p~~~ 273 (314)
. ....+..|+|||.+.+.. ++.++|+||||+++|+|++ |..||...........+......+. |...
T Consensus 151 ~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~~~--------~~~~ 221 (252)
T cd05084 151 STGGMKQIPVKWTAPEALNYGR-YSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPC--------PELC 221 (252)
T ss_pred ccCCCCCCceeecCchhhcCCC-CChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCC--------cccC
Confidence 0 111234699999986554 7899999999999999998 9999987776554443333211111 1111
Q ss_pred CCcccccccCChhhhhcccCChHHHHHhc
Q 021306 274 DFRFPQIKAHPWHKVCIFHFPKHWLLEYG 302 (314)
Q Consensus 274 ~~~~~~l~~~p~~~~~~~~~~~~~~~~~~ 302 (314)
...+.++++.+|...+..++....+...+
T Consensus 222 ~~~~~~li~~~l~~~p~~Rps~~~~~~~l 250 (252)
T cd05084 222 PDAVYRLMERCWEYDPGQRPSFSTVHQEL 250 (252)
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 22344455555555555555555555443
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=247.46 Aligned_cols=211 Identities=24% Similarity=0.331 Sum_probs=163.9
Q ss_pred cCCCceeeeeEeecCceEEEEEEECC-----CCcEEEEEEeecccc-----chHHHHHHHHhCCCCceeeeceeeeecCC
Q 021306 36 QTISYMAERVVGTGSFGIVFQAKCLE-----TGETVAIKKVLQDRR-----YKNRELQLMRVMDHPNVISLKHCFFSTTS 105 (314)
Q Consensus 36 ~~~~y~~~~~Lg~g~~g~Vy~~~~~~-----~~~~~~vK~~~~~~~-----~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 105 (314)
..++|++.+.||+|+||.||+|..+. .+..+++|.+..... ...+|..+++.++|+||+++++++...
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-- 81 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKG-- 81 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC--
Confidence 34689999999999999999997642 355899998764332 234688899999999999999987433
Q ss_pred CCceeEEEEeecccc-cHHHHHHhhhhc------CCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCC
Q 021306 106 KNELFLNLVMEYVPE-SMYRVLKHYSSA------NQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH 178 (314)
Q Consensus 106 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~------~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~ 178 (314)
...+++|||+++ +|.+.+...... ...++...+..++.|++.||.|||+ ++++|+||||+||+++. ++
T Consensus 82 ---~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~i~H~dikp~nili~~-~~ 156 (288)
T cd05061 82 ---QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA-KKFVHRDLAARNCMVAH-DF 156 (288)
T ss_pred ---CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCcCCCCChheEEEcC-CC
Confidence 347899999985 677666542211 1345678889999999999999999 89999999999999998 88
Q ss_pred cEEEeecCcccccccCCc---cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 021306 179 QVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEII 254 (314)
Q Consensus 179 ~~~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~t-g~~pf~~~~~~~~~~~i~ 254 (314)
.++|+|||+++....... .....++..|+|||.+.+.. ++.++|+||||+++|+|++ |..||.+.+..+....+.
T Consensus 157 ~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~-~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~ 235 (288)
T cd05061 157 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGV-FTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVM 235 (288)
T ss_pred cEEECcCCccccccccccccccCCCcccccccCHHHhccCC-CChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 899999999875432211 11122356799999986544 7899999999999999999 789998877766555444
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=251.65 Aligned_cols=255 Identities=24% Similarity=0.365 Sum_probs=187.3
Q ss_pred CCCceeeeeEeecCceEEEEEEECC-------CCcEEEEEEeecccc-----chHHHHHHHHhC-CCCceeeeceeeeec
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCLE-------TGETVAIKKVLQDRR-----YKNRELQLMRVM-DHPNVISLKHCFFST 103 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~~-------~~~~~~vK~~~~~~~-----~~~~e~~~l~~l-~h~~iv~~~~~~~~~ 103 (314)
.++|.+.+.||+|+||.||++++.. ++..+++|.+..+.. ...+|+.+++.+ +|+||+++++++...
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 3689999999999999999998643 235799998875421 234688889988 799999999987433
Q ss_pred CCCCceeEEEEeecccc-cHHHHHHhhhh------------cCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCc
Q 021306 104 TSKNELFLNLVMEYVPE-SMYRVLKHYSS------------ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQN 170 (314)
Q Consensus 104 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~------------~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~N 170 (314)
...++++||+++ +|.+.+..... ....+++.+++.++.|++.||.|||+ +|++|+||+|+|
T Consensus 97 -----~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~-~gi~H~dlkp~N 170 (307)
T cd05098 97 -----GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLAS-KKCIHRDLAARN 170 (307)
T ss_pred -----CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH-CCcccccccHHh
Confidence 347899999985 67766654221 12358999999999999999999999 899999999999
Q ss_pred EEEcCCCCcEEEeecCcccccccCCc---cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCh
Q 021306 171 LLVDPLTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENA 246 (314)
Q Consensus 171 il~~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~t-g~~pf~~~~~ 246 (314)
|+++. ++.++|+|||.+........ .....+++.|+|||.+.+.. ++.++|+||||+++|+|++ |..||.+...
T Consensus 171 ill~~-~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~~l~el~~~g~~p~~~~~~ 248 (307)
T cd05098 171 VLVTE-DNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 248 (307)
T ss_pred eEEcC-CCcEEECCCcccccccccchhhccccCCCccceeChHHhccCC-CCcHHHHHHHHHHHHHHHcCCCCCCCcCCH
Confidence 99998 78899999999875432211 11122346799999986654 7899999999999999998 8899977665
Q ss_pred HHHHHHHHHHcCCCCHHHHhccCCCCCCCcccccccCChhhhhcccCChHHHHHhcchhhh
Q 021306 247 VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGSHINA 307 (314)
Q Consensus 247 ~~~~~~i~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~~~~~ 307 (314)
.+....+ ...... . . |......+.+++..+|...+..+++...+++.++.+..
T Consensus 249 ~~~~~~~-~~~~~~--~----~-~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~ 301 (307)
T cd05098 249 EELFKLL-KEGHRM--D----K-PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILA 301 (307)
T ss_pred HHHHHHH-HcCCCC--C----C-CCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHH
Confidence 4433333 221110 0 1 11122345567777777777777777777777665543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=247.05 Aligned_cols=254 Identities=20% Similarity=0.248 Sum_probs=183.8
Q ss_pred ceeeeeEeecCceEEEEEEECCCCc--EEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCC-CCcee
Q 021306 40 YMAERVVGTGSFGIVFQAKCLETGE--TVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTS-KNELF 110 (314)
Q Consensus 40 y~~~~~Lg~g~~g~Vy~~~~~~~~~--~~~vK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~~~~~ 110 (314)
|.+.+.||+|+||.||+|.+..++. .+++|.++... ....+|..+++.++|+||+++++.++.... .....
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 4578899999999999999877765 68999875431 223578889999999999999987643322 12234
Q ss_pred EEEEeecccc-cHHHHHHhhh--hcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCc
Q 021306 111 LNLVMEYVPE-SMYRVLKHYS--SANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 187 (314)
Q Consensus 111 ~~lv~e~~~~-~l~~~l~~~~--~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~ 187 (314)
.++++||+.+ ++.+.+.... .....+++..+..++.|++.||.|||+ ++|+|+||||+||+++. ++.++|+|||+
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~Nil~~~-~~~~kl~Dfg~ 158 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSS-KSFIHRDLAARNCMLNE-NMNVCVADFGL 158 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHH-CCeeccccchhheEEcC-CCCEEECCCCc
Confidence 6799999985 6655543221 123458999999999999999999999 89999999999999988 78899999999
Q ss_pred ccccccCCc---cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCHH
Q 021306 188 AKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTRE 263 (314)
Q Consensus 188 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~ 263 (314)
+........ ......++.|++||.+.+.. ++.++|+||||+++|+|++ |+.||.+....+....+.+....+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~--- 234 (272)
T cd05075 159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADRV-YTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLK--- 234 (272)
T ss_pred ccccCcccceecCCcccCCcccCCHHHccCCC-cChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCC---
Confidence 876543221 11223456799999986544 8999999999999999999 899998877655444443321111
Q ss_pred HHhccCCCCCCCcccccccCChhhhhcccCChHHHHHhcch
Q 021306 264 EIRCMNPNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGSH 304 (314)
Q Consensus 264 ~~~~~~p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~~ 304 (314)
..+. ....+.+++..+|...+..++....+++.++.
T Consensus 235 ----~~~~-~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~ 270 (272)
T cd05075 235 ----QPPD-CLDGLYSLMSSCWLLNPKDRPSFETLRCELEK 270 (272)
T ss_pred ----CCCC-CCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence 1111 12235566677776666666666666665543
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=248.10 Aligned_cols=255 Identities=28% Similarity=0.372 Sum_probs=186.1
Q ss_pred CCc-eeeeeEeecCceEEEEEEE----CCCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCC
Q 021306 38 ISY-MAERVVGTGSFGIVFQAKC----LETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKN 107 (314)
Q Consensus 38 ~~y-~~~~~Lg~g~~g~Vy~~~~----~~~~~~~~vK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 107 (314)
++| ++.+.||+|+||+||++.. ..++..+++|.++... ....+|+.++++++|+||+++.+++... .
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~ 79 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQ---G 79 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC---C
Confidence 355 9999999999999988653 3567899999886532 2335789999999999999999876432 2
Q ss_pred ceeEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecC
Q 021306 108 ELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 186 (314)
Q Consensus 108 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg 186 (314)
...++++|||+++ +|.+.+. ...+++.+++.++.|++.||.+||+ +|++|+||||+||+++. ++.++|+|||
T Consensus 80 ~~~~~lv~e~~~~~~l~~~~~-----~~~l~~~~~~~i~~~l~~~l~~lH~-~~i~H~dlkp~Nili~~-~~~~~l~dfg 152 (283)
T cd05080 80 GKGLQLIMEYVPLGSLRDYLP-----KHKLNLAQLLLFAQQICEGMAYLHS-QHYIHRDLAARNVLLDN-DRLVKIGDFG 152 (283)
T ss_pred CceEEEEecCCCCCCHHHHHH-----HcCCCHHHHHHHHHHHHHHHHHHHH-CCeeccccChheEEEcC-CCcEEEeecc
Confidence 2347899999996 5554443 2569999999999999999999999 89999999999999998 7889999999
Q ss_pred cccccccCCcc----ccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcC-CC-
Q 021306 187 SAKQLIAGEAN----ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLG-TP- 260 (314)
Q Consensus 187 ~~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~-~~- 260 (314)
++......... ....++..|+|||.+.+.. .+.++||||||+++|+|++|..||...... +........ ..
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~Di~slG~~l~el~tg~~p~~~~~~~--~~~~~~~~~~~~~ 229 (283)
T cd05080 153 LAKAVPEGHEYYRVREDGDSPVFWYAVECLKENK-FSYASDVWSFGVTLYELLTHCDSKQSPPKK--FEEMIGPKQGQMT 229 (283)
T ss_pred cccccCCcchhhccCCCCCCCceeeCHhHhcccC-CCcccccHHHHHHHHHHHhCCCCCCCCcch--hhhhhcccccccc
Confidence 98765432211 1123355699999986544 789999999999999999999998664421 111111000 00
Q ss_pred CHHHHh----cc---CCCCCCCcccccccCChhhhhcccCChHHHHHhcchh
Q 021306 261 TREEIR----CM---NPNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGSHI 305 (314)
Q Consensus 261 ~~~~~~----~~---~p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~~~ 305 (314)
...... .. .|.-....+..++..||...+..+++...+++.++.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~ 281 (283)
T cd05080 230 VVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281 (283)
T ss_pred hhhhhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence 000000 00 0111234677889999998899888888888877654
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=245.55 Aligned_cols=248 Identities=24% Similarity=0.304 Sum_probs=184.2
Q ss_pred CCCceeeeeEeecCceEEEEEEECCCC---cEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCc
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCLETG---ETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 108 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~~~~---~~~~vK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 108 (314)
..+|++.+.||+|+||.||+|.+..++ ..+++|.++... ....+|+.++++++||||+++++++.. .
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~ 77 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTK-----S 77 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-----C
Confidence 357999999999999999999876544 379999876432 234578899999999999999998743 2
Q ss_pred eeEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCc
Q 021306 109 LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 187 (314)
Q Consensus 109 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~ 187 (314)
.+.+++|||+++ +|.+.+.. ....+++.++..++.|++.|+.+||+ ++++|+||+|+||+++. ++.++|+|||.
T Consensus 78 ~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~-~~i~h~dlkp~nili~~-~~~~~l~dfg~ 152 (267)
T cd05066 78 KPVMIVTEYMENGSLDAFLRK---HDGQFTVIQLVGMLRGIASGMKYLSD-MGYVHRDLAARNILVNS-NLVCKVSDFGL 152 (267)
T ss_pred CccEEEEEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCEeehhhchhcEEECC-CCeEEeCCCCc
Confidence 347899999986 55555542 23578999999999999999999999 89999999999999998 78899999999
Q ss_pred ccccccCCccc----cccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCH
Q 021306 188 AKQLIAGEANI----SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTR 262 (314)
Q Consensus 188 ~~~~~~~~~~~----~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~ 262 (314)
+.......... ....+..|+|||.+.+.. ++.++|+||||+++|++++ |..||...+..+....+.+....+..
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 231 (267)
T cd05066 153 SRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRK-FTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPAP 231 (267)
T ss_pred ccccccccceeeecCCCccceeecCHhHhccCc-cCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcCCCC
Confidence 87654322111 111245799999996544 8999999999999999886 99999888766655555433221110
Q ss_pred HHHhccCCCCCCCcccccccCChhhhhcccCChHHHHHhcc
Q 021306 263 EEIRCMNPNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGS 303 (314)
Q Consensus 263 ~~~~~~~p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~ 303 (314)
... ...+.+++..+|.+.+..++....++..++
T Consensus 232 ---~~~-----~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 264 (267)
T cd05066 232 ---MDC-----PAALHQLMLDCWQKDRNERPKFEQIVSILD 264 (267)
T ss_pred ---CCC-----CHHHHHHHHHHcccCchhCCCHHHHHHHHH
Confidence 011 223456666666666666666666666554
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=246.82 Aligned_cols=250 Identities=24% Similarity=0.334 Sum_probs=186.1
Q ss_pred CCCceeeeeEeecCceEEEEEEECCCCc----EEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCC
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCLETGE----TVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKN 107 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~----~~~vK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 107 (314)
.++|++.+.||+|+||.||+|++..+++ .|++|.++... ....+|..+++.+.|+||+++++++...
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~---- 81 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS---- 81 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC----
Confidence 4679999999999999999999877766 47899876432 2335788889999999999999877421
Q ss_pred ceeEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecC
Q 021306 108 ELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 186 (314)
Q Consensus 108 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg 186 (314)
..++++||+++ ++.+.+.. ....+++..+..++.|++.||.|||+ ++++|+||||+||+++. ++.++|+|||
T Consensus 82 --~~~l~~~~~~~g~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~lH~-~~iiH~dlkp~Nil~~~-~~~~kL~dfG 154 (279)
T cd05109 82 --TVQLVTQLMPYGCLLDYVRE---NKDRIGSQDLLNWCVQIAKGMSYLEE-VRLVHRDLAARNVLVKS-PNHVKITDFG 154 (279)
T ss_pred --CcEEEEEcCCCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccccccceEEEcC-CCcEEECCCC
Confidence 15689999985 66666543 23578999999999999999999999 89999999999999987 7789999999
Q ss_pred cccccccCCccc---cccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCH
Q 021306 187 SAKQLIAGEANI---SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTR 262 (314)
Q Consensus 187 ~~~~~~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~ 262 (314)
++.......... ...++..|+|||.+.+.. ++.++||||||+++|||++ |..||.......... .+.....++.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~-~~~~~~~~~~ 232 (279)
T cd05109 155 LARLLDIDETEYHADGGKVPIKWMALESILHRR-FTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPD-LLEKGERLPQ 232 (279)
T ss_pred ceeecccccceeecCCCccchhhCCHHHhccCC-CCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH-HHHCCCcCCC
Confidence 987654332221 123356799999986554 8899999999999999998 999998776544333 3333222111
Q ss_pred HHHhccCCCCCCCcccccccCChhhhhcccCChHHHHHhcchhh
Q 021306 263 EEIRCMNPNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGSHIN 306 (314)
Q Consensus 263 ~~~~~~~p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~~~~ 306 (314)
. + .....+.+++..+|...+..++....+++.+..+.
T Consensus 233 ~------~-~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~ 269 (279)
T cd05109 233 P------P-ICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMA 269 (279)
T ss_pred C------c-cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 1 1 12234556677777777777777777776655543
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=246.69 Aligned_cols=247 Identities=23% Similarity=0.321 Sum_probs=184.2
Q ss_pred CCceeeeeEeecCceEEEEEEECCCCc---EEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCce
Q 021306 38 ISYMAERVVGTGSFGIVFQAKCLETGE---TVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL 109 (314)
Q Consensus 38 ~~y~~~~~Lg~g~~g~Vy~~~~~~~~~---~~~vK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 109 (314)
..|++.+.||+|+||.||+|....+++ .|++|.+.... ..+.+|+.+++.++||||+++.+++.. ..
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~-----~~ 78 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTK-----SR 78 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECC-----CC
Confidence 468999999999999999999876664 69999886432 234578999999999999999988733 33
Q ss_pred eEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcc
Q 021306 110 FLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 188 (314)
Q Consensus 110 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~ 188 (314)
..++++||+++ +|.+.+.. ..+.+++.+++.++.|++.|+.+||+ +|++|+||+|+||+++. +..++|+|||.+
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~~l~~al~~lH~-~g~~H~dl~p~nili~~-~~~~kl~dfg~~ 153 (269)
T cd05065 79 PVMIITEFMENGALDSFLRQ---NDGQFTVIQLVGMLRGIAAGMKYLSE-MNYVHRDLAARNILVNS-NLVCKVSDFGLS 153 (269)
T ss_pred ceEEEEecCCCCcHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHHH-CCEeecccChheEEEcC-CCcEEECCCccc
Confidence 47899999987 55544432 24578999999999999999999999 89999999999999997 788999999988
Q ss_pred cccccCCcccc---cc---ccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCC
Q 021306 189 KQLIAGEANIS---YI---CSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPT 261 (314)
Q Consensus 189 ~~~~~~~~~~~---~~---~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~ 261 (314)
........... .. .+..|+|||.+.+.. ++.++||||||+++|||++ |..||...+..+....+......+.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~~~ 232 (269)
T cd05065 154 RFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRK-FTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPP 232 (269)
T ss_pred cccccCccccccccccCCCcceeecCHhHhccCc-ccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcCCC
Confidence 65433222111 11 134699999986544 7899999999999999886 9999988877665555533222111
Q ss_pred HHHHhccCCCCCCCcccccccCChhhhhcccCChHHHHHhcc
Q 021306 262 REEIRCMNPNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGS 303 (314)
Q Consensus 262 ~~~~~~~~p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~ 303 (314)
+ ++ ....+.+++..+|...+..+++...++..++
T Consensus 233 ~-------~~-~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 266 (269)
T cd05065 233 P-------MD-CPTALHQLMLDCWQKDRNARPKFGQIVSTLD 266 (269)
T ss_pred c-------cc-CCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 1 11 1223556666677666666666666665543
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=249.78 Aligned_cols=257 Identities=19% Similarity=0.268 Sum_probs=185.5
Q ss_pred CCceeeeeEeecCceEEEEEEECC----------------CCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeee
Q 021306 38 ISYMAERVVGTGSFGIVFQAKCLE----------------TGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISL 96 (314)
Q Consensus 38 ~~y~~~~~Lg~g~~g~Vy~~~~~~----------------~~~~~~vK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~ 96 (314)
++|++.+.||+|+||.||++++.. ++..+++|.+.... ....+|+.+++.++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 469999999999999999986432 34578999886432 234579999999999999999
Q ss_pred ceeeeecCCCCceeEEEEeecccc-cHHHHHHhhhh-------cCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCC
Q 021306 97 KHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSS-------ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKP 168 (314)
Q Consensus 97 ~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~-------~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p 168 (314)
++++.... ..++++||+.+ +|.+.+..... ....+++.++..++.|++.||.+||+ .|++|+||||
T Consensus 85 ~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~-~~i~H~dlkp 158 (296)
T cd05095 85 LAVCITSD-----PLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS-LNFVHRDLAT 158 (296)
T ss_pred EEEEecCC-----ccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHH-CCeecccCCh
Confidence 99874433 37899999985 66666654221 11347888999999999999999999 8999999999
Q ss_pred CcEEEcCCCCcEEEeecCcccccccCCc---cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh--CCCCCCC
Q 021306 169 QNLLVDPLTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL--GQPLFPG 243 (314)
Q Consensus 169 ~Nil~~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~t--g~~pf~~ 243 (314)
+||+++. ++.++|+|||.+........ ......+..|++||...+.. ++.++|+||||+++|+|++ |..||..
T Consensus 159 ~Nili~~-~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~DiwSlG~~l~el~~~~~~~p~~~ 236 (296)
T cd05095 159 RNCLVGK-NYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGK-FTTASDVWAFGVTLWEILTLCKEQPYSQ 236 (296)
T ss_pred heEEEcC-CCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCC-ccchhhhhHHHHHHHHHHHhCCCCCccc
Confidence 9999997 78899999999875433221 11122356799999876554 8999999999999999998 7799987
Q ss_pred CChHHHHHHHHHHcCCCCHHHHhccCCCCCCCcccccccCChhhhhcccCChHHHHHhcc
Q 021306 244 ENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGS 303 (314)
Q Consensus 244 ~~~~~~~~~i~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~ 303 (314)
.+..+.+....+........... ..|......+.+++..||.+.+..++....+.+.++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 237 LSDEQVIENTGEFFRDQGRQVYL-PKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred cChHHHHHHHHHHHhhccccccC-CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 76655444332211100000000 011112234667777788777777777777776654
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=245.55 Aligned_cols=248 Identities=21% Similarity=0.270 Sum_probs=184.3
Q ss_pred CCCceeeeeEeecCceEEEEEEECCCCc---EEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCc
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCLETGE---TVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 108 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~---~~~vK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 108 (314)
.++|+..+.||+|++|.||+|+...++. .+++|.+.... ....+|+.++++++|+|++++.+++...
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----- 78 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKF----- 78 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccC-----
Confidence 3579999999999999999999876554 78999876442 2235788999999999999999988433
Q ss_pred eeEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCc
Q 021306 109 LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 187 (314)
Q Consensus 109 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~ 187 (314)
...+++|||+++ +|.+.+.. ....+++.++..++.|++.|+.+||+ .|++|+||+|+||+++. ++.++++|||+
T Consensus 79 ~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~al~~lH~-~~i~H~dlkp~Nili~~-~~~~kl~dfg~ 153 (268)
T cd05063 79 KPAMIITEYMENGALDKYLRD---HDGEFSSYQLVGMLRGIAAGMKYLSD-MNYVHRDLAARNILVNS-NLECKVSDFGL 153 (268)
T ss_pred CCcEEEEEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccccchhhEEEcC-CCcEEECCCcc
Confidence 347899999997 55444432 24678999999999999999999999 89999999999999998 88899999999
Q ss_pred ccccccCCccc----cccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCH
Q 021306 188 AKQLIAGEANI----SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTR 262 (314)
Q Consensus 188 ~~~~~~~~~~~----~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~ 262 (314)
+.......... ....+..|+|||.+.+.. ++.++||||||+++|+|++ |+.||...+..+....+.+....+..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~~~ 232 (268)
T cd05063 154 SRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRK-FTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPAP 232 (268)
T ss_pred ceecccccccceeccCCCcCceecCHHHhhcCC-cChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCCCC
Confidence 87553322111 111234699999986544 7899999999999999998 99999887766555555432211111
Q ss_pred HHHhccCCCCCCCcccccccCChhhhhcccCChHHHHHhcc
Q 021306 263 EEIRCMNPNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGS 303 (314)
Q Consensus 263 ~~~~~~~p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~ 303 (314)
. . ....+.+++..||...+..++....+++.++
T Consensus 233 ~---~-----~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~ 265 (268)
T cd05063 233 M---D-----CPSAVYQLMLQCWQQDRARRPRFVDIVNLLD 265 (268)
T ss_pred C---C-----CCHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence 0 1 1223456666677666666666666666554
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=245.31 Aligned_cols=253 Identities=20% Similarity=0.257 Sum_probs=181.9
Q ss_pred ceeeeeEeecCceEEEEEEECCC---CcEEEEEEeecccc------chHHHHHHHHhCCCCceeeeceeeeecCC-CCce
Q 021306 40 YMAERVVGTGSFGIVFQAKCLET---GETVAIKKVLQDRR------YKNRELQLMRVMDHPNVISLKHCFFSTTS-KNEL 109 (314)
Q Consensus 40 y~~~~~Lg~g~~g~Vy~~~~~~~---~~~~~vK~~~~~~~------~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~~~~ 109 (314)
|++++.||+|+||.||+|....+ +..+++|.++.+.. ...+|...++.++|+||+++++++..... ....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 67899999999999999987654 47899998865422 23578899999999999999987654332 2334
Q ss_pred eEEEEeecccc-cHHHHHHhhh--hcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecC
Q 021306 110 FLNLVMEYVPE-SMYRVLKHYS--SANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 186 (314)
Q Consensus 110 ~~~lv~e~~~~-~l~~~l~~~~--~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg 186 (314)
..++++||+.+ ++...+.... .....+++..+..++.|++.||.|||+ ++++|+||||+||+++. ++.++|+|||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~-~~i~H~dlkp~Nil~~~-~~~~kl~dfg 158 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSN-RNFIHRDLAARNCMLRE-DMTVCVADFG 158 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHh-CCeeccccchheEEECC-CCeEEECCcc
Confidence 57899999986 5655554321 123468999999999999999999999 89999999999999998 7889999999
Q ss_pred cccccccCCc---cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCH
Q 021306 187 SAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTR 262 (314)
Q Consensus 187 ~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~ 262 (314)
.++....... ......+..|+|||.+.+.. ++.++||||||+++|+|++ |..||.+....+....+........+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 237 (273)
T cd05035 159 LSKKIYSGDYYRQGRIAKMPVKWIAIESLADRV-YTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLKQP 237 (273)
T ss_pred ceeeccccccccccccccCCccccCHhhcccCC-CCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence 9875533221 11122356799999985544 7899999999999999999 89999887766555444332211111
Q ss_pred HHHhccCCCCCCCcccccccCChhhhhcccCChHHHHHhcc
Q 021306 263 EEIRCMNPNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGS 303 (314)
Q Consensus 263 ~~~~~~~p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~ 303 (314)
... ...+.+++..+|...+..+++...+...++
T Consensus 238 ---~~~-----~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~ 270 (273)
T cd05035 238 ---EDC-----LDELYDLMYSCWRADPKDRPTFTKLREVLE 270 (273)
T ss_pred ---cCC-----CHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 111 223445555555555555555555554443
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=249.70 Aligned_cols=257 Identities=20% Similarity=0.259 Sum_probs=184.1
Q ss_pred CCceeeeeEeecCceEEEEEEECCC--------------CcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeece
Q 021306 38 ISYMAERVVGTGSFGIVFQAKCLET--------------GETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKH 98 (314)
Q Consensus 38 ~~y~~~~~Lg~g~~g~Vy~~~~~~~--------------~~~~~vK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~ 98 (314)
++|++.+.||+|+||.||++++..+ ...|++|.++... ....+|++++++++|+|++++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 4799999999999999999986543 2358999886532 23457999999999999999999
Q ss_pred eeeecCCCCceeEEEEeecccc-cHHHHHHhhhh--------cCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCC
Q 021306 99 CFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSS--------ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQ 169 (314)
Q Consensus 99 ~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~--------~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~ 169 (314)
++... ...+++|||+.+ +|.+.+..... ....+++..+..++.|++.||.|||+ +|++|+||+|+
T Consensus 85 ~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~-~~i~H~dlkp~ 158 (295)
T cd05097 85 VCVSD-----DPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLAS-LNFVHRDLATR 158 (295)
T ss_pred EEcCC-----CccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHh-cCeeccccChh
Confidence 88433 347899999996 66655543110 01247889999999999999999999 89999999999
Q ss_pred cEEEcCCCCcEEEeecCcccccccCCc---cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh--CCCCCCCC
Q 021306 170 NLLVDPLTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL--GQPLFPGE 244 (314)
Q Consensus 170 Nil~~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~t--g~~pf~~~ 244 (314)
||+++. ++.++|+|||++........ .....++..|+|||.+.+.. ++.++|+||||+++|+|++ |..||...
T Consensus 159 Nill~~-~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwSlG~~l~el~~~~~~~p~~~~ 236 (295)
T cd05097 159 NCLVGN-HYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGK-FTTASDVWAFGVTLWEMFTLCKEQPYSLL 236 (295)
T ss_pred hEEEcC-CCcEEecccccccccccCcceeccCcCcCceeecChhhhccCC-cCchhhHHHHHHHHHHHHHcCCCCCCccc
Confidence 999997 77899999999875432211 11223356799999986554 8999999999999999998 67899887
Q ss_pred ChHHHHHHHHHHcCCCCHHHHhccCCCCCCCcccccccCChhhhhcccCChHHHHHhcc
Q 021306 245 NAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGS 303 (314)
Q Consensus 245 ~~~~~~~~i~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~ 303 (314)
+..+.+..+.+.............++ .....+.+|+..+|.+.+..++..+.++..++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 237 SDEQVIENTGEFFRNQGRQIYLSQTP-LCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred ChHHHHHHHHHhhhhccccccCCCCC-CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 76655554433211110111111111 12334666777777777776666666665543
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=249.75 Aligned_cols=258 Identities=19% Similarity=0.234 Sum_probs=185.5
Q ss_pred CCCceeeeeEeecCceEEEEEEECCCC----------------cEEEEEEeeccc-----cchHHHHHHHHhCCCCceee
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCLETG----------------ETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVIS 95 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~~~~----------------~~~~vK~~~~~~-----~~~~~e~~~l~~l~h~~iv~ 95 (314)
..+|++++.||+|+||.||++.+..++ ..+++|.+.... ....+|+.++++++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 357999999999999999999876543 457999886542 23357899999999999999
Q ss_pred eceeeeecCCCCceeEEEEeecccc-cHHHHHHhhhh-------cCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCC
Q 021306 96 LKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSS-------ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLK 167 (314)
Q Consensus 96 ~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~-------~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~ 167 (314)
+++++... ...++++|++.+ +|...+..... ....+++..++.++.|++.||.|||+ +|++|+|||
T Consensus 84 ~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~-~~i~H~dlk 157 (296)
T cd05051 84 LLGVCTVD-----PPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES-LNFVHRDLA 157 (296)
T ss_pred EEEEEecC-----CCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHH-cCccccccc
Confidence 99987433 347899999986 66666654221 12368999999999999999999999 899999999
Q ss_pred CCcEEEcCCCCcEEEeecCcccccccCC---ccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh--CCCCCC
Q 021306 168 PQNLLVDPLTHQVKICDFGSAKQLIAGE---ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL--GQPLFP 242 (314)
Q Consensus 168 p~Nil~~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~t--g~~pf~ 242 (314)
|+||+++. ++.++|+|||.+....... ......+++.|+|||.+.+.. ++.++||||||+++|+|++ |..||.
T Consensus 158 p~Nili~~-~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~el~~~~~~~p~~ 235 (296)
T cd05051 158 TRNCLVGK-NYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGK-FTTKSDVWAFGVTLWEILTLCREQPYE 235 (296)
T ss_pred hhceeecC-CCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCC-CCccchhhhhHHHHHHHHhcCCCCCCC
Confidence 99999998 7899999999987543222 112234467899999986544 8999999999999999998 778998
Q ss_pred CCChHHHHHHHHHHcCCCCHHHHhccCCCCCCCcccccccCChhhhhcccCChHHHHHhcc
Q 021306 243 GENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGS 303 (314)
Q Consensus 243 ~~~~~~~~~~i~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~ 303 (314)
..+..+.+...................+. ....+.+++..||...+..+++...+++.++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 236 HLTDQQVIENAGHFFRDDGRQIYLPRPPN-CPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred CcChHHHHHHHHhccccccccccCCCccC-CCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 87766655555443211111000000110 1123455666666666666666666655543
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-34 Score=249.46 Aligned_cols=239 Identities=22% Similarity=0.278 Sum_probs=175.9
Q ss_pred ceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeEEE
Q 021306 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 113 (314)
Q Consensus 40 y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 113 (314)
|.+++.+|.| +.||+++...+++.+|+|.++... ....+|+.+++.++|+||+++++++... ...++
T Consensus 4 ~~i~~~~~~~--~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~-----~~~~~ 76 (314)
T cd08216 4 TLIGKCFEDL--MIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVD-----SELYV 76 (314)
T ss_pred hhhhHhhcCC--ceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecC-----CeEEE
Confidence 3344444444 556666666699999999986541 2346889999999999999999988543 33789
Q ss_pred Eeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcccccc
Q 021306 114 VMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 192 (314)
Q Consensus 114 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~ 192 (314)
++||+++ ++.+.+... ....+++..++.++.|++.||.|||+ ++|+|+||+|+||+++. ++.++++||+.+....
T Consensus 77 ~~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~~~~l~~~L~~LH~-~~ivH~dlk~~Nili~~-~~~~kl~d~~~~~~~~ 152 (314)
T cd08216 77 VSPLMAYGSCEDLLKTH--FPEGLPELAIAFILKDVLNALDYIHS-KGFIHRSVKASHILLSG-DGKVVLSGLRYSVSMI 152 (314)
T ss_pred EEeccCCCCHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCcceEEEec-CCceEEecCccceeec
Confidence 9999996 455555432 23568999999999999999999999 89999999999999997 7889999999876543
Q ss_pred cCCc--------cccccccccccccccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCC---
Q 021306 193 AGEA--------NISYICSRFYRAPELIFGA-TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP--- 260 (314)
Q Consensus 193 ~~~~--------~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~--- 260 (314)
.... .....++..|+|||.+.+. ..++.++|+||||+++|+|++|+.||...................
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 232 (314)
T cd08216 153 KHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLD 232 (314)
T ss_pred cccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccc
Confidence 2211 1123346679999998653 347889999999999999999999998776544433322211000
Q ss_pred --------------------------------------CHHH---HhccCCCCCCCcccccccCChhhhhc
Q 021306 261 --------------------------------------TREE---IRCMNPNYTDFRFPQIKAHPWHKVCI 290 (314)
Q Consensus 261 --------------------------------------~~~~---~~~~~p~~~~~~~~~l~~~p~~~~~~ 290 (314)
..+. +...+|+ +|+++.+++.|||++...
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~-~Rpt~~~ll~~p~~~~~~ 302 (314)
T cd08216 233 KSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPE-SRPSASQLLNHSFFKQCK 302 (314)
T ss_pred cCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCC-cCcCHHHHhcCchHhhhc
Confidence 0011 1234787 899999999999998665
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=248.56 Aligned_cols=251 Identities=25% Similarity=0.386 Sum_probs=186.4
Q ss_pred CCceeeeeEeecCceEEEEEEECCC-----CcEEEEEEeecccc-----chHHHHHHHHhC-CCCceeeeceeeeecCCC
Q 021306 38 ISYMAERVVGTGSFGIVFQAKCLET-----GETVAIKKVLQDRR-----YKNRELQLMRVM-DHPNVISLKHCFFSTTSK 106 (314)
Q Consensus 38 ~~y~~~~~Lg~g~~g~Vy~~~~~~~-----~~~~~vK~~~~~~~-----~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~ 106 (314)
++|++.+.||+|++|.||++..... ...+++|.+..... ...+|+.+++++ +|+||+++++++..
T Consensus 12 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~---- 87 (293)
T cd05053 12 DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQ---- 87 (293)
T ss_pred hHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcC----
Confidence 5799999999999999999987643 37899998865322 234788899999 89999999998743
Q ss_pred CceeEEEEeecccc-cHHHHHHhhh------------hcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEE
Q 021306 107 NELFLNLVMEYVPE-SMYRVLKHYS------------SANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLV 173 (314)
Q Consensus 107 ~~~~~~lv~e~~~~-~l~~~l~~~~------------~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~ 173 (314)
...++++|||+++ +|...+.... .....+++..+..++.|++.||.|||+ .+++|+||+|+||++
T Consensus 88 -~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~ivH~dlkp~Nil~ 165 (293)
T cd05053 88 -EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLAS-KKCIHRDLAARNVLV 165 (293)
T ss_pred -CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH-CCccccccceeeEEE
Confidence 2348899999986 6666654321 234678999999999999999999999 899999999999999
Q ss_pred cCCCCcEEEeecCcccccccCCc---cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHH
Q 021306 174 DPLTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQ 249 (314)
Q Consensus 174 ~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~t-g~~pf~~~~~~~~ 249 (314)
+. ++.++|+|||.+........ .....++..|+|||.+.+.. ++.++||||||+++|+|++ |..||.+....+.
T Consensus 166 ~~-~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~ 243 (293)
T cd05053 166 TE-DHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL 243 (293)
T ss_pred cC-CCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCC-cCcccceeehhhHHHHHhcCCCCCCCCCCHHHH
Confidence 98 88999999999876543221 11122346799999985544 7899999999999999998 9999988776655
Q ss_pred HHHHHHHcCCCCHHHHhccCCCCCCCcccccccCChhhhhcccCChHHHHHhcch
Q 021306 250 LVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGSH 304 (314)
Q Consensus 250 ~~~i~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~~ 304 (314)
...+....... .|......+.+++..+|...+..++....+++.++.
T Consensus 244 ~~~~~~~~~~~--------~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~ 290 (293)
T cd05053 244 FKLLKEGYRME--------KPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDR 290 (293)
T ss_pred HHHHHcCCcCC--------CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHH
Confidence 54443322111 111122235566667777666666666666666554
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=244.59 Aligned_cols=239 Identities=23% Similarity=0.265 Sum_probs=179.3
Q ss_pred eEeecCceEEEEEEE--CCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeEEEEee
Q 021306 45 VVGTGSFGIVFQAKC--LETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVME 116 (314)
Q Consensus 45 ~Lg~g~~g~Vy~~~~--~~~~~~~~vK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e 116 (314)
+||+|+||.||+|.+ ..++..+++|.++... ....+|+.+++.+.|+||+++++.+. .. ..++++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~-~~~lv~e 75 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-----AE-SWMLVME 75 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-----CC-CcEEEEe
Confidence 689999999999964 4578899999886432 22357889999999999999988752 11 2579999
Q ss_pred cccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcccccccCC
Q 021306 117 YVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE 195 (314)
Q Consensus 117 ~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~~~~ 195 (314)
|+++ +|.+.+. ....+++..+..++.|++.|+.+||+ +|++|+||||.||+++. ++.++|+|||.+.......
T Consensus 76 ~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~al~~lH~-~~i~H~dlkp~nill~~-~~~~kl~Dfg~~~~~~~~~ 149 (257)
T cd05116 76 LAELGPLNKFLQ----KNKHVTEKNITELVHQVSMGMKYLEE-TNFVHRDLAARNVLLVT-QHYAKISDFGLSKALGADE 149 (257)
T ss_pred cCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCEeecccchhhEEEcC-CCeEEECCCccccccCCCC
Confidence 9996 4555554 34679999999999999999999999 89999999999999998 7889999999987653322
Q ss_pred cc----ccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCHHHHhccCC
Q 021306 196 AN----ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 270 (314)
Q Consensus 196 ~~----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~p 270 (314)
.. ....++..|+|||.+.+. .++.++|+||||+++|+|++ |..||...+..+....+.+....+. |
T Consensus 150 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~--------~ 220 (257)
T cd05116 150 NYYKAKTHGKWPVKWYAPECMNYY-KFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMEC--------P 220 (257)
T ss_pred CeeeecCCCCCCccccCHhHhccC-CcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCC--------C
Confidence 21 112234679999998544 47889999999999999998 9999988776655444433221111 1
Q ss_pred CCCCCcccccccCChhhhhcccCChHHHHHhcch
Q 021306 271 NYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGSH 304 (314)
Q Consensus 271 ~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~~ 304 (314)
......+.+++..+|...+..++....+...+..
T Consensus 221 ~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 221 QRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred CCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 1123346677778887777777777766665543
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=248.69 Aligned_cols=252 Identities=23% Similarity=0.330 Sum_probs=184.8
Q ss_pred CceeeeeEeecCceEEEEEEECC-----CCcEEEEEEeecccc-----chHHHHHHHHhCCCCceeeeceeeeecCCCCc
Q 021306 39 SYMAERVVGTGSFGIVFQAKCLE-----TGETVAIKKVLQDRR-----YKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 108 (314)
Q Consensus 39 ~y~~~~~Lg~g~~g~Vy~~~~~~-----~~~~~~vK~~~~~~~-----~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 108 (314)
+|++.+.||+|+||.||+|.+.. ....+++|.+..... ...+|+.+++.++||||+++++.+.. .
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~ 75 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQ-----D 75 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEec-----C
Confidence 58899999999999999998753 235688887764432 34578999999999999999998743 2
Q ss_pred eeEEEEeecccc-cHHHHHHhhh--------------------hcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCC
Q 021306 109 LFLNLVMEYVPE-SMYRVLKHYS--------------------SANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLK 167 (314)
Q Consensus 109 ~~~~lv~e~~~~-~l~~~l~~~~--------------------~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~ 167 (314)
...++++||+.+ +|.+.+.... .....+++..++.++.|++.||.+||+ .+++|+||+
T Consensus 76 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~ivH~dik 154 (290)
T cd05045 76 GPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAE-MKLVHRDLA 154 (290)
T ss_pred CCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHH-CCeehhhhh
Confidence 337899999995 6666554321 112458899999999999999999999 899999999
Q ss_pred CCcEEEcCCCCcEEEeecCcccccccCCc---cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 021306 168 PQNLLVDPLTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPG 243 (314)
Q Consensus 168 p~Nil~~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~t-g~~pf~~ 243 (314)
|+||+++. ++.++|+|||++........ .....++..|+|||.+.+.. ++.++||||||+++|+|++ |..||.+
T Consensus 155 p~nill~~-~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~-~~~~~Di~slG~~l~el~t~g~~p~~~ 232 (290)
T cd05045 155 ARNVLVAE-GRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIVTLGGNPYPG 232 (290)
T ss_pred hheEEEcC-CCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCC-cchHhHHHHHHHHHHHHHhcCCCCCCC
Confidence 99999998 78899999999875432221 11223356799999986544 8899999999999999999 9999988
Q ss_pred CChHHHHHHHHHHcCCCCHHHHhccCCCCCCCcccccccCChhhhhcccCChHHHHHhcchhh
Q 021306 244 ENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGSHIN 306 (314)
Q Consensus 244 ~~~~~~~~~i~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~~~~ 306 (314)
..+........+....+. |......+.+++..||...+..++....+.+.++.+.
T Consensus 233 ~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~ 287 (290)
T cd05045 233 IAPERLFNLLKTGYRMER--------PENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMM 287 (290)
T ss_pred CCHHHHHHHHhCCCCCCC--------CCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHH
Confidence 776554443322211111 1111224556666777777777777777777666554
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-34 Score=245.72 Aligned_cols=251 Identities=19% Similarity=0.243 Sum_probs=182.3
Q ss_pred CCCceeeeeEeecCceEEEEEEECC-----CCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCC
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCLE-----TGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSK 106 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~~-----~~~~~~vK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 106 (314)
.++|++.+.||+|++|.||+|.+.. ++..+++|.+.... ....+|..+++.++|+||+++++++....
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-- 82 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERL-- 82 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC--
Confidence 4689999999999999999999877 67889999876432 23457888999999999999999875433
Q ss_pred CceeEEEEeecccc-cHHHHHHhhhh---cCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCC--CCcE
Q 021306 107 NELFLNLVMEYVPE-SMYRVLKHYSS---ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPL--THQV 180 (314)
Q Consensus 107 ~~~~~~lv~e~~~~-~l~~~l~~~~~---~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~--~~~~ 180 (314)
..++++||+.| +|.+.+..... ....+++..+..++.||+.|+.|||+ ++++|+||+|+||+++.. ...+
T Consensus 83 ---~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivH~dlkp~nil~~~~~~~~~~ 158 (277)
T cd05036 83 ---PRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEE-NHFIHRDIAARNCLLTCKGPGRVA 158 (277)
T ss_pred ---CcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCEeecccchheEEEeccCCCcce
Confidence 36799999975 66666654221 11358999999999999999999999 899999999999999862 2369
Q ss_pred EEeecCcccccccCCc---cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHH
Q 021306 181 KICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKV 256 (314)
Q Consensus 181 ~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~t-g~~pf~~~~~~~~~~~i~~~ 256 (314)
+|+|||++........ ......+..|+|||.+.+.. ++.++||||||+++|+|++ |..||.+.+..+....+...
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~ 237 (277)
T cd05036 159 KIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGI-FTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGG 237 (277)
T ss_pred EeccCccccccCCccceecCCCCCccHhhCCHHHHhcCC-cCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Confidence 9999999876532211 11122245799999986554 8999999999999999997 99999887766544443322
Q ss_pred cCCCCHHHHhccCCCCCCCcccccccCChhhhhcccCChHHHHHhc
Q 021306 257 LGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYG 302 (314)
Q Consensus 257 ~~~~~~~~~~~~~p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~ 302 (314)
..... .+. ....+.+++..||...+..++....+++.+
T Consensus 238 ~~~~~-------~~~-~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l 275 (277)
T cd05036 238 GRLDP-------PKG-CPGPVYRIMTDCWQHTPEDRPNFATILERI 275 (277)
T ss_pred CcCCC-------CCC-CCHHHHHHHHHHcCCCcccCcCHHHHHHHh
Confidence 11111 011 112344556666666666555555555543
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-34 Score=243.10 Aligned_cols=248 Identities=24% Similarity=0.322 Sum_probs=187.0
Q ss_pred CCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeecccc---chHHHHHHHHhCCCCceeeeceeeeecCCCCceeEEE
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR---YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 113 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~~---~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 113 (314)
.++|++++.||+|+||.||+|.. .+++.+++|.+..... ...+|+.++++++|+|++++++.+. . ...++
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~-~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~-----~~~~~ 77 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYY-NGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT-Q-----EPIYI 77 (260)
T ss_pred hHHceeeeeeccCccceEEeeec-CCCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEc-c-----CCcEE
Confidence 35799999999999999999985 4678899998875432 3457999999999999999988652 1 12679
Q ss_pred Eeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcccccc
Q 021306 114 VMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 192 (314)
Q Consensus 114 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~ 192 (314)
++||+.+ ++.+.+.. ..+..+++.++..++.|++.||.+||+ .|++|+||+|+||+++. ++.++|+|||.+....
T Consensus 78 v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~i~~~i~~al~~LH~-~~i~H~dl~p~ni~i~~-~~~~~l~dfg~~~~~~ 153 (260)
T cd05067 78 ITEYMENGSLVDFLKT--PEGIKLTINKLIDMAAQIAEGMAFIER-KNYIHRDLRAANILVSE-TLCCKIADFGLARLIE 153 (260)
T ss_pred EEEcCCCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHhc-CCeecccccHHhEEEcC-CCCEEEccCcceeecC
Confidence 9999985 66665543 234578999999999999999999999 89999999999999998 7889999999987554
Q ss_pred cCCc--cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCHHHHhccC
Q 021306 193 AGEA--NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 269 (314)
Q Consensus 193 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 269 (314)
.... .....++..|+|||.+.+.. ++.++|+||||+++|++++ |+.||.+.+..+....+.+....+.+
T Consensus 154 ~~~~~~~~~~~~~~~y~~pe~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~------- 225 (260)
T cd05067 154 DNEYTAREGAKFPIKWTAPEAINYGT-FTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRP------- 225 (260)
T ss_pred CCCcccccCCcccccccCHHHhccCC-cCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCC-------
Confidence 2211 11223456799999986544 7899999999999999999 99999887766555544332222211
Q ss_pred CCCCCCcccccccCChhhhhcccCChHHHHHhcch
Q 021306 270 PNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGSH 304 (314)
Q Consensus 270 p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~~ 304 (314)
......+.+++..+|...+..+++.+.+.+.++.
T Consensus 226 -~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 226 -DNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred -CCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 1112235566666777666666677777666543
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-34 Score=241.28 Aligned_cols=228 Identities=31% Similarity=0.529 Sum_probs=179.7
Q ss_pred EeecCceEEEEEEECCCCcEEEEEEeecccc-------chHHHHHHHHhCCCCceeeeceeeeecCCCCceeEEEEeecc
Q 021306 46 VGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYV 118 (314)
Q Consensus 46 Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~~-------~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~ 118 (314)
||.|++|.||++.+..+++.+++|.+..... ...+|+.++++++|+|++++++.+. .....+++|||+
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~~v~e~~ 75 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQ-----TEEKLYLVLEYA 75 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHee-----cCCeeEEEEecC
Confidence 6899999999999988899999998865422 3457889999999999999998873 344588999999
Q ss_pred c-ccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcccccccC-Cc
Q 021306 119 P-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG-EA 196 (314)
Q Consensus 119 ~-~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~~~-~~ 196 (314)
+ ++|.+.+.. ...+++..+..++.|++.|+.+||+ .+++|+||+|+||+++. ++.++|+|||.+...... ..
T Consensus 76 ~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lh~-~~~~H~~l~p~ni~~~~-~~~~~l~d~~~~~~~~~~~~~ 149 (250)
T cd05123 76 PGGELFSHLSK----EGRFSEERARFYAAEIVLALEYLHS-LGIIYRDLKPENILLDA-DGHIKLTDFGLAKELSSEGSR 149 (250)
T ss_pred CCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCcceEEEcC-CCcEEEeecCcceecccCCCc
Confidence 6 466666543 4578999999999999999999999 89999999999999998 788999999998765433 12
Q ss_pred cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCC-------HHH---Hh
Q 021306 197 NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT-------REE---IR 266 (314)
Q Consensus 197 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~-------~~~---~~ 266 (314)
.....++..|+|||.+.+.. .+.++|+||||+++|++++|..||...+.......+.+.....+ .+. ..
T Consensus 150 ~~~~~~~~~~~~Pe~~~~~~-~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l 228 (250)
T cd05123 150 TNTFCGTPEYLAPEVLLGKG-YGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEFLSPEARDLISGLL 228 (250)
T ss_pred ccCCcCCccccChHHhCCCC-CCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHh
Confidence 33345677899999986544 78899999999999999999999987776554444443211110 111 12
Q ss_pred ccCCCCCCCcc---cccccCChh
Q 021306 267 CMNPNYTDFRF---PQIKAHPWH 286 (314)
Q Consensus 267 ~~~p~~~~~~~---~~l~~~p~~ 286 (314)
..+|+ .|+++ .+++.||||
T Consensus 229 ~~~p~-~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 229 QKDPT-KRLGSGGAEEIKAHPFF 250 (250)
T ss_pred cCCHh-hCCCcccHHHHHhCCCC
Confidence 33666 78888 899999996
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-34 Score=242.91 Aligned_cols=249 Identities=24% Similarity=0.330 Sum_probs=185.2
Q ss_pred cCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeEE
Q 021306 36 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 112 (314)
Q Consensus 36 ~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 112 (314)
..++|++.+.||+|++|.||++.+. ++..+++|.+.... ....+|+.++++++|+||+++++++.. ....+
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~ 77 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSE-----EEPIY 77 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeeec-----CCceE
Confidence 3568999999999999999999965 55789999886542 334689999999999999999988733 23478
Q ss_pred EEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCccccc
Q 021306 113 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 191 (314)
Q Consensus 113 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~ 191 (314)
+++||+++ +|.+.+... .+..+++..+..++.|++.|+.+||+ +|++|+||+|+||+++. ++.++|+|||.+...
T Consensus 78 ~v~e~~~~~~L~~~i~~~--~~~~~~~~~~~~~~~~i~~al~~lh~-~~i~h~di~p~nili~~-~~~~~l~d~g~~~~~ 153 (261)
T cd05034 78 IVTEYMSKGSLLDFLKSG--EGKKLRLPQLVDMAAQIAEGMAYLES-RNYIHRDLAARNILVGE-NLVCKIADFGLARLI 153 (261)
T ss_pred EEEeccCCCCHHHHHhcc--ccCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCcchheEEEcC-CCCEEECccccceec
Confidence 99999986 666655431 23578999999999999999999999 89999999999999998 789999999998755
Q ss_pred ccCCc--cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCHHHHhcc
Q 021306 192 IAGEA--NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 268 (314)
Q Consensus 192 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 268 (314)
..... ......+..|+|||.+.+.. ++.++|+||||+++|++++ |+.||.+.+....+..+......+.+..
T Consensus 154 ~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---- 228 (261)
T cd05034 154 EDDEYTAREGAKFPIKWTAPEAANYGR-FTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRPPN---- 228 (261)
T ss_pred cchhhhhhhccCCCccccCHHHhccCC-cCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCC----
Confidence 32111 11122345799999986544 7899999999999999999 9999988877666666554332221110
Q ss_pred CCCCCCCcccccccCChhhhhcccCChHHHHHhcc
Q 021306 269 NPNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGS 303 (314)
Q Consensus 269 ~p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~ 303 (314)
....+.+++..+|...+..+.....+...++
T Consensus 229 ----~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~ 259 (261)
T cd05034 229 ----CPEELYDLMLQCWDKDPEERPTFEYLQSFLE 259 (261)
T ss_pred ----CCHHHHHHHHHHcccCcccCCCHHHHHHHHh
Confidence 1112444555555555555555555555443
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=241.42 Aligned_cols=241 Identities=22% Similarity=0.248 Sum_probs=181.1
Q ss_pred eEeecCceEEEEEEEC--CCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeEEEEeec
Q 021306 45 VVGTGSFGIVFQAKCL--ETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEY 117 (314)
Q Consensus 45 ~Lg~g~~g~Vy~~~~~--~~~~~~~vK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~ 117 (314)
.||+|+||.||+|.+. .++..+++|.+.... ....+|+.++++++|+||+++++++. . ...++|+||
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~-----~~~~lv~e~ 75 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-A-----EALMLVMEM 75 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-C-----CCeEEEEEe
Confidence 4899999999999765 345679999886442 22457899999999999999998762 1 136799999
Q ss_pred ccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcccccccCCc
Q 021306 118 VPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA 196 (314)
Q Consensus 118 ~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~~~~~ 196 (314)
+++ +|.+.+.. ....+++..++.++.|++.||.+||+ +|++|+||||+||+++. ++.++|+|||++........
T Consensus 76 ~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~nil~~~-~~~~kl~dfg~~~~~~~~~~ 150 (257)
T cd05115 76 ASGGPLNKFLSG---KKDEITVSNVVELMHQVSMGMKYLEG-KNFVHRDLAARNVLLVN-QHYAKISDFGLSKALGADDS 150 (257)
T ss_pred CCCCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHh-cCeeecccchheEEEcC-CCcEEeccCCccccccCCcc
Confidence 986 55555432 24679999999999999999999999 89999999999999998 78899999999875433221
Q ss_pred c----ccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCHHHHhccCCC
Q 021306 197 N----ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 271 (314)
Q Consensus 197 ~----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~p~ 271 (314)
. ....++..|+|||.+.+.. ++.++|+||||+++|++++ |..||.+....+....+.+....+ . |.
T Consensus 151 ~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~-------~-~~ 221 (257)
T cd05115 151 YYKARSAGKWPLKWYAPECINFRK-FSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLD-------C-PA 221 (257)
T ss_pred ceeccCCCCCCcccCCHHHHccCC-CCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCC-------C-CC
Confidence 1 1112246799999986544 7899999999999999996 999998887766554443322111 1 11
Q ss_pred CCCCcccccccCChhhhhcccCChHHHHHhcchh
Q 021306 272 YTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGSHI 305 (314)
Q Consensus 272 ~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~~~ 305 (314)
.....+.+++..||...+..++....+.+.++.+
T Consensus 222 ~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 222 ECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 1344566788888888888777777777666543
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=242.97 Aligned_cols=250 Identities=22% Similarity=0.347 Sum_probs=187.9
Q ss_pred CceeeeeEeecCceEEEEEEECC-CCcEEEEEEeeccc--------------cchHHHHHHHH-hCCCCceeeeceeeee
Q 021306 39 SYMAERVVGTGSFGIVFQAKCLE-TGETVAIKKVLQDR--------------RYKNRELQLMR-VMDHPNVISLKHCFFS 102 (314)
Q Consensus 39 ~y~~~~~Lg~g~~g~Vy~~~~~~-~~~~~~vK~~~~~~--------------~~~~~e~~~l~-~l~h~~iv~~~~~~~~ 102 (314)
.|++.+.||+|++|.||++.+.. +++.+++|.+.... ....+|..++. .++|+||+++++.+..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 48899999999999999999887 67899999875321 11234666565 4799999999998843
Q ss_pred cCCCCceeEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEE
Q 021306 103 TTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVK 181 (314)
Q Consensus 103 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~ 181 (314)
....++++||+++ ++.+.+.........+++..++.++.|++.++.+||+..+++|+||+|+||+++. ++.++
T Consensus 81 -----~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~-~~~~~ 154 (269)
T cd08528 81 -----NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGE-DDKVT 154 (269)
T ss_pred -----CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECC-CCcEE
Confidence 3358899999986 6666665544456789999999999999999999995268999999999999998 78899
Q ss_pred EeecCcccccccCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCC
Q 021306 182 ICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 261 (314)
Q Consensus 182 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~ 261 (314)
|+|||.+.............++..|++||.+.+.. ++.++|+||||+++|+|++|+.||...+.......+......+.
T Consensus 155 l~dfg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~-~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 233 (269)
T cd08528 155 ITDFGLAKQKQPESKLTSVVGTILYSCPEIVKNEP-YGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPL 233 (269)
T ss_pred EecccceeecccccccccccCcccCcChhhhcCCC-CchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcC
Confidence 99999987654443333456788899999997644 78999999999999999999999987776555554443322221
Q ss_pred HHHHhccCCCCCCCcccccccCChhhhhcccCChHHHHHhc
Q 021306 262 REEIRCMNPNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYG 302 (314)
Q Consensus 262 ~~~~~~~~p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~ 302 (314)
.. ......+.+++..||...+..++....+.+.+
T Consensus 234 ~~-------~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~ 267 (269)
T cd08528 234 PE-------GMYSEDVTDVITSCLTPDAEARPDIIQVSAMI 267 (269)
T ss_pred Cc-------ccCCHHHHHHHHHHCCCCCccCCCHHHHHHHh
Confidence 11 00123455666777777777766666655543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-34 Score=242.35 Aligned_cols=204 Identities=28% Similarity=0.458 Sum_probs=166.7
Q ss_pred eeEeecCceEEEEEEECCC---CcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeEEEEe
Q 021306 44 RVVGTGSFGIVFQAKCLET---GETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVM 115 (314)
Q Consensus 44 ~~Lg~g~~g~Vy~~~~~~~---~~~~~vK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 115 (314)
+.||+|+||.||++.+... +..+++|.+.... ....+|+..++.++|+|++++++++.. ...+++++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~~~lv~ 75 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTE-----EEPLYLVL 75 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecC-----CCceEEEE
Confidence 4689999999999998865 8899999987543 234578999999999999999998754 33488999
Q ss_pred eccc-ccHHHHHHhhhhc-----CCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCccc
Q 021306 116 EYVP-ESMYRVLKHYSSA-----NQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 189 (314)
Q Consensus 116 e~~~-~~l~~~l~~~~~~-----~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~ 189 (314)
||++ ++|.+.+...... ...+++.+++.++.|++.||.+||+ +|++|+||+|+||+++. ++.++|+|||.+.
T Consensus 76 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~-~~i~H~di~p~nili~~-~~~~~l~dfg~~~ 153 (262)
T cd00192 76 EYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS-KKFVHRDLAARNCLVGE-DLVVKISDFGLSR 153 (262)
T ss_pred EeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHc-CCcccCccCcceEEECC-CCcEEEccccccc
Confidence 9996 5777766643211 3789999999999999999999999 99999999999999998 7899999999997
Q ss_pred ccccCC---ccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 021306 190 QLIAGE---ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIK 255 (314)
Q Consensus 190 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~t-g~~pf~~~~~~~~~~~i~~ 255 (314)
...... ......++..|+|||.+.+. .++.++|+||||+++|+|++ |..||...+..+....+..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~ 222 (262)
T cd00192 154 DVYDDDYYRKKTGGKLPIRWMAPESLKDG-IFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRK 222 (262)
T ss_pred ccccccccccccCCCcCccccCHHHhccC-CcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc
Confidence 664432 12234457789999998655 48999999999999999999 6999998877665555543
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=244.14 Aligned_cols=252 Identities=20% Similarity=0.296 Sum_probs=185.5
Q ss_pred CCceeeeeEeecCceEEEEEEECCCCc----EEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCc
Q 021306 38 ISYMAERVVGTGSFGIVFQAKCLETGE----TVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 108 (314)
Q Consensus 38 ~~y~~~~~Lg~g~~g~Vy~~~~~~~~~----~~~vK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 108 (314)
++|++.+.||+|+||.||+|.+..++. .+++|.+.... .....|...++.+.|+||+++++++.. .
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-----~ 81 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-----A 81 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-----C
Confidence 579999999999999999999877776 46777764322 122355667788999999999987621 1
Q ss_pred eeEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCc
Q 021306 109 LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 187 (314)
Q Consensus 109 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~ 187 (314)
..++++||+++ +|.+.+.. ....+++..+..|+.|++.||.|||+ ++++|+||||+||+++. ++.++|+|||.
T Consensus 82 -~~~~i~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~-~~iiH~dlkp~nili~~-~~~~kl~Dfg~ 155 (279)
T cd05111 82 -SLQLVTQLSPLGSLLDHVRQ---HRDSLDPQRLLNWCVQIAKGMYYLEE-HRMVHRNLAARNILLKS-DSIVQIADFGV 155 (279)
T ss_pred -ccEEEEEeCCCCcHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHH-CCEeccccCcceEEEcC-CCcEEEcCCcc
Confidence 25688999985 66666643 24578999999999999999999999 89999999999999998 88899999999
Q ss_pred ccccccCCcc---ccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCHH
Q 021306 188 AKQLIAGEAN---ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTRE 263 (314)
Q Consensus 188 ~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~ 263 (314)
++........ ....++..|+|||.+.+.. ++.++||||||+++||+++ |..||.+...... ..+++....+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~-~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~-~~~~~~~~~~~-- 231 (279)
T cd05111 156 ADLLYPDDKKYFYSEHKTPIKWMALESILFGR-YTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEV-PDLLEKGERLA-- 231 (279)
T ss_pred ceeccCCCcccccCCCCCcccccCHHHhccCC-cCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH-HHHHHCCCcCC--
Confidence 8755332211 1223456799999986544 8999999999999999998 9999988776543 33333222111
Q ss_pred HHhccCCCCCCCcccccccCChhhhhcccCChHHHHHhcchhhhcC
Q 021306 264 EIRCMNPNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGSHINAIS 309 (314)
Q Consensus 264 ~~~~~~p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (314)
.|......+.+++..||...+..++....+...+..+.--+
T Consensus 232 -----~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~~ 272 (279)
T cd05111 232 -----QPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARDP 272 (279)
T ss_pred -----CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhCC
Confidence 11222334556677777777777777777777666554333
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=245.42 Aligned_cols=246 Identities=24% Similarity=0.328 Sum_probs=180.5
Q ss_pred eeEeecCceEEEEEEECCCCc--EEEEEEeeccc-----cchHHHHHHHHhC-CCCceeeeceeeeecCCCCceeEEEEe
Q 021306 44 RVVGTGSFGIVFQAKCLETGE--TVAIKKVLQDR-----RYKNRELQLMRVM-DHPNVISLKHCFFSTTSKNELFLNLVM 115 (314)
Q Consensus 44 ~~Lg~g~~g~Vy~~~~~~~~~--~~~vK~~~~~~-----~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv~ 115 (314)
+.||+|+||.||++++..++. .+++|.++... ....+|+.++.++ .||||+++++++.. ..+.+++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~-----~~~~~lv~ 75 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH-----RGYLYLAI 75 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEec-----CCCceEEE
Confidence 468999999999999887775 46788776321 2345788999999 79999999998843 33478999
Q ss_pred ecccc-cHHHHHHhhh------------hcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEE
Q 021306 116 EYVPE-SMYRVLKHYS------------SANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKI 182 (314)
Q Consensus 116 e~~~~-~l~~~l~~~~------------~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l 182 (314)
||+++ +|.+.+.... .....+++.+++.++.|++.||.|||+ +|++|+||+|+||+++. ++.++|
T Consensus 76 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~-~~i~H~dikp~nili~~-~~~~kl 153 (270)
T cd05047 76 EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ-KQFIHRDLAARNILVGE-NYVAKI 153 (270)
T ss_pred EeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHH-CCEeecccccceEEEcC-CCeEEE
Confidence 99985 6766665421 112358899999999999999999999 89999999999999998 888999
Q ss_pred eecCcccccccCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCC
Q 021306 183 CDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPT 261 (314)
Q Consensus 183 ~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~ 261 (314)
+|||++..............+..|+|||.+.+. .++.++|+||||+++|+|++ |..||.+.+..+....+........
T Consensus 154 ~dfgl~~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~ 232 (270)
T cd05047 154 ADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYS-VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEK 232 (270)
T ss_pred CCCCCccccchhhhccCCCCccccCChHHHccC-CCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCCCCCC
Confidence 999998533221111112235569999998554 48899999999999999997 9999987766554444422211110
Q ss_pred HHHHhccCCCCCCCcccccccCChhhhhcccCChHHHHHhcchh
Q 021306 262 REEIRCMNPNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGSHI 305 (314)
Q Consensus 262 ~~~~~~~~p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~~~ 305 (314)
|......+.+++..+|...+..++....++..++.+
T Consensus 233 --------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~ 268 (270)
T cd05047 233 --------PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 268 (270)
T ss_pred --------CCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHh
Confidence 111122356778888888777777777777776554
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=241.67 Aligned_cols=246 Identities=24% Similarity=0.312 Sum_probs=184.8
Q ss_pred CCceeeeeEeecCceEEEEEEECCCCcEEEEEEeecccc---chHHHHHHHHhCCCCceeeeceeeeecCCCCceeEEEE
Q 021306 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR---YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLV 114 (314)
Q Consensus 38 ~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~~---~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 114 (314)
++|++.+.||+|++|.||++.+..+ ..+++|.+..... ...+|+.++++++|+|++++++++. . ...+++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~-----~~~~~v 78 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS-E-----EPIYIV 78 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEc-C-----CCcEEE
Confidence 5799999999999999999987544 4689998765432 3457999999999999999988762 1 126799
Q ss_pred eecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCccccccc
Q 021306 115 MEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA 193 (314)
Q Consensus 115 ~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~~ 193 (314)
|||+.+ +|.+.+... ....+++..+..++.|++.||.|||+ .|++|+||+|+||++++ ++.++|+|||.+.....
T Consensus 79 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~-~~i~H~dl~~~Nill~~-~~~~~l~dfg~~~~~~~ 154 (260)
T cd05069 79 TEFMGKGSLLDFLKEG--DGKYLKLPQLVDMAAQIADGMAYIER-MNYIHRDLRAANILVGD-NLVCKIADFGLARLIED 154 (260)
T ss_pred EEcCCCCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHh-CCEeecccCcceEEEcC-CCeEEECCCccceEccC
Confidence 999986 677666532 23458999999999999999999999 89999999999999998 88899999999875432
Q ss_pred CCc--cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCHHHHhccCC
Q 021306 194 GEA--NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 270 (314)
Q Consensus 194 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~p 270 (314)
... .....++..|+|||...+.. ++.++|+||||+++|+|++ |..||.+....+....+......+.. +
T Consensus 155 ~~~~~~~~~~~~~~y~~Pe~~~~~~-~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~-------~ 226 (260)
T cd05069 155 NEYTARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCP-------Q 226 (260)
T ss_pred CcccccCCCccchhhCCHHHhccCC-cChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC-------c
Confidence 221 11223456799999886544 8899999999999999999 99999887776655544332221111 1
Q ss_pred CCCCCcccccccCChhhhhcccCChHHHHHhcc
Q 021306 271 NYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGS 303 (314)
Q Consensus 271 ~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~ 303 (314)
. ....+.++++.+|...+..++....+++.++
T Consensus 227 ~-~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 258 (260)
T cd05069 227 G-CPESLHELMKLCWKKDPDERPTFEYIQSFLE 258 (260)
T ss_pred c-cCHHHHHHHHHHccCCcccCcCHHHHHHHHh
Confidence 1 1224556666677766666666666666654
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=247.51 Aligned_cols=252 Identities=23% Similarity=0.353 Sum_probs=186.4
Q ss_pred ccCCCceeeeeEeecCceEEEEEEEC-----CCCcEEEEEEeeccc-----cchHHHHHHHHhC-CCCceeeeceeeeec
Q 021306 35 KQTISYMAERVVGTGSFGIVFQAKCL-----ETGETVAIKKVLQDR-----RYKNRELQLMRVM-DHPNVISLKHCFFST 103 (314)
Q Consensus 35 ~~~~~y~~~~~Lg~g~~g~Vy~~~~~-----~~~~~~~vK~~~~~~-----~~~~~e~~~l~~l-~h~~iv~~~~~~~~~ 103 (314)
...++|.+.+.||+|+||.||++.+. .++..+++|.++... ....+|+.+++++ +|+||+++++++...
T Consensus 32 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 111 (302)
T cd05055 32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIG 111 (302)
T ss_pred ccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecC
Confidence 34468999999999999999999752 345689999886432 2245799999999 799999999987443
Q ss_pred CCCCceeEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEE
Q 021306 104 TSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKI 182 (314)
Q Consensus 104 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l 182 (314)
. ..++++||+.+ +|.+.+... ....+++.++..++.|++.||.|||+ ++++|+||+|+||+++. +..++|
T Consensus 112 ~-----~~~lv~e~~~~~~L~~~i~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~-~~ivH~dlkp~Nil~~~-~~~~~l 182 (302)
T cd05055 112 G-----PILVITEYCCYGDLLNFLRRK--RESFLTLEDLLSFSYQVAKGMAFLAS-KNCIHRDLAARNVLLTH-GKIVKI 182 (302)
T ss_pred C-----ceEEEEEcCCCCcHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHH-CCeehhhhccceEEEcC-CCeEEE
Confidence 3 37899999985 666655431 12348999999999999999999999 89999999999999987 788999
Q ss_pred eecCcccccccCCc---cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcC
Q 021306 183 CDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLG 258 (314)
Q Consensus 183 ~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~t-g~~pf~~~~~~~~~~~i~~~~~ 258 (314)
+|||.+........ .....++..|+|||.+.+.. ++.++||||||+++|+|++ |..||.+....+..........
T Consensus 183 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~ 261 (302)
T cd05055 183 CDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGY 261 (302)
T ss_pred CCCcccccccCCCceeecCCCCcccccCCHhhhccCC-CCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCC
Confidence 99999875533221 11223456799999986655 7899999999999999998 9999988776555544443221
Q ss_pred CCCHHHHhccCCCCCCCcccccccCChhhhhcccCChHHHHHhcc
Q 021306 259 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGS 303 (314)
Q Consensus 259 ~~~~~~~~~~~p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~ 303 (314)
... .|......+.+++..+|...+..+++...++..+.
T Consensus 262 ~~~-------~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~ 299 (302)
T cd05055 262 RMA-------QPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIG 299 (302)
T ss_pred cCC-------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHH
Confidence 110 11111223556666777666666666666665544
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=247.18 Aligned_cols=250 Identities=24% Similarity=0.314 Sum_probs=186.6
Q ss_pred CCceeeeeEeecCceEEEEEEEC-----CCCcEEEEEEeeccc----cchHHHHHHHHhCCCCceeeeceeeeecCCCCc
Q 021306 38 ISYMAERVVGTGSFGIVFQAKCL-----ETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 108 (314)
Q Consensus 38 ~~y~~~~~Lg~g~~g~Vy~~~~~-----~~~~~~~vK~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 108 (314)
.+|.+++.||+|+||.||++... .++..+++|.+.... ....+|+.+++.++|+||+++++++...
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----- 79 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEG----- 79 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecC-----
Confidence 47899999999999999999743 346688899876432 3356889999999999999999887433
Q ss_pred eeEEEEeecccc-cHHHHHHhhhh-----------cCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCC
Q 021306 109 LFLNLVMEYVPE-SMYRVLKHYSS-----------ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPL 176 (314)
Q Consensus 109 ~~~~lv~e~~~~-~l~~~l~~~~~-----------~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~ 176 (314)
...++++||+++ +|.+.+..... ....+++..+..++.|++.|+.|||+ +|++|+||+|+||+++.
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~-~~i~H~dlkp~nil~~~- 157 (280)
T cd05092 80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLAS-LHFVHRDLATRNCLVGQ- 157 (280)
T ss_pred CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHH-CCeecccccHhhEEEcC-
Confidence 337899999986 66665543211 11358999999999999999999999 89999999999999997
Q ss_pred CCcEEEeecCcccccccCCc---cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 021306 177 THQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVE 252 (314)
Q Consensus 177 ~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~t-g~~pf~~~~~~~~~~~ 252 (314)
++.++|+|||++........ .....+++.|+|||.+.+.. ++.++||||||+++|+|++ |..||......+....
T Consensus 158 ~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~ 236 (280)
T cd05092 158 GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRK-FTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIEC 236 (280)
T ss_pred CCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCC-cCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHH
Confidence 88899999999865432211 11223356799999986554 8999999999999999998 9999988776655554
Q ss_pred HHHHcCCCCHHHHhccCCCCCCCcccccccCChhhhhcccCChHHHHHhcc
Q 021306 253 IIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGS 303 (314)
Q Consensus 253 i~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~ 303 (314)
+.+...... |.-....+.+++..||.+.+..+.....+...++
T Consensus 237 ~~~~~~~~~--------~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 237 ITQGRELER--------PRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred HHcCccCCC--------CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 443321111 1112234667777778777777777777766543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-34 Score=252.74 Aligned_cols=255 Identities=25% Similarity=0.372 Sum_probs=185.7
Q ss_pred CCceeeeeEeecCceEEEEEEEC-----CCCcEEEEEEeeccc-----cchHHHHHHHHhC-CCCceeeeceeeeecCCC
Q 021306 38 ISYMAERVVGTGSFGIVFQAKCL-----ETGETVAIKKVLQDR-----RYKNRELQLMRVM-DHPNVISLKHCFFSTTSK 106 (314)
Q Consensus 38 ~~y~~~~~Lg~g~~g~Vy~~~~~-----~~~~~~~vK~~~~~~-----~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~ 106 (314)
++|++.+.||+|+||.||+|.+. .+++.||+|.++... ....+|+.++.++ .|+||+++++++....
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~-- 84 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG-- 84 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCC--
Confidence 57999999999999999999843 467899999986432 2234789999999 6899999998774322
Q ss_pred CceeEEEEeecccc-cHHHHHHhhhh------------------------------------------------------
Q 021306 107 NELFLNLVMEYVPE-SMYRVLKHYSS------------------------------------------------------ 131 (314)
Q Consensus 107 ~~~~~~lv~e~~~~-~l~~~l~~~~~------------------------------------------------------ 131 (314)
..+++++||+++ +|.+.+.....
T Consensus 85 --~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (343)
T cd05103 85 --GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVE 162 (343)
T ss_pred --CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccch
Confidence 247799999996 66655543110
Q ss_pred ---------cCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcccccccCCcc---cc
Q 021306 132 ---------ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN---IS 199 (314)
Q Consensus 132 ---------~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~~~~~~---~~ 199 (314)
....+++.++..++.|++.||.|||+ +||+|+||||+||+++. ++.++|+|||++......... ..
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~i~H~dikp~Nil~~~-~~~~kl~dfg~~~~~~~~~~~~~~~~ 240 (343)
T cd05103 163 EEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLAS-RKCIHRDLAARNILLSE-NNVVKICDFGLARDIYKDPDYVRKGD 240 (343)
T ss_pred hhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCccCeEEEcC-CCcEEEEecccccccccCcchhhcCC
Confidence 01347888999999999999999999 89999999999999997 788999999998754322111 11
Q ss_pred ccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCHHHHhccCCCCCCCccc
Q 021306 200 YICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFP 278 (314)
Q Consensus 200 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~p~~~~~~~~ 278 (314)
..++..|+|||.+.+.. ++.++|+||||+++|+|++ |..||............+....... .|......+.
T Consensus 241 ~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~ 312 (343)
T cd05103 241 ARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR-------APDYTTPEMY 312 (343)
T ss_pred CCCCcceECcHHhcCCC-CCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCC-------CCCCCCHHHH
Confidence 22356799999986544 8899999999999999997 9999987654433333332211110 1111223355
Q ss_pred ccccCChhhhhcccCChHHHHHhcchhh
Q 021306 279 QIKAHPWHKVCIFHFPKHWLLEYGSHIN 306 (314)
Q Consensus 279 ~l~~~p~~~~~~~~~~~~~~~~~~~~~~ 306 (314)
+++..||...+..++....+++.++.+.
T Consensus 313 ~~~~~cl~~~p~~Rps~~eil~~l~~~~ 340 (343)
T cd05103 313 QTMLDCWHGEPSQRPTFSELVEHLGNLL 340 (343)
T ss_pred HHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 6677778777777777777777766543
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=247.64 Aligned_cols=256 Identities=24% Similarity=0.373 Sum_probs=190.2
Q ss_pred cCCCceeeeeEeecCceEEEEEEEC-------CCCcEEEEEEeeccc-----cchHHHHHHHHhC-CCCceeeeceeeee
Q 021306 36 QTISYMAERVVGTGSFGIVFQAKCL-------ETGETVAIKKVLQDR-----RYKNRELQLMRVM-DHPNVISLKHCFFS 102 (314)
Q Consensus 36 ~~~~y~~~~~Lg~g~~g~Vy~~~~~-------~~~~~~~vK~~~~~~-----~~~~~e~~~l~~l-~h~~iv~~~~~~~~ 102 (314)
..++|.+.+.||+|+||.||++++. .++..+++|.+.... ....+|+.+++.+ +|+||+++++.+..
T Consensus 13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 92 (304)
T cd05101 13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 92 (304)
T ss_pred cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence 3568999999999999999999753 234579999876432 2345788999999 89999999998743
Q ss_pred cCCCCceeEEEEeecccc-cHHHHHHhhhh------------cCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCC
Q 021306 103 TTSKNELFLNLVMEYVPE-SMYRVLKHYSS------------ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQ 169 (314)
Q Consensus 103 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~------------~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~ 169 (314)
. ...+++|||+.+ +|.+.+..... ....++..++..++.|++.||.|||+ +|++|+||||+
T Consensus 93 ~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~-~givH~dlkp~ 166 (304)
T cd05101 93 D-----GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLAS-QKCIHRDLAAR 166 (304)
T ss_pred C-----CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHH-CCeeecccccc
Confidence 3 347899999986 66666654211 12457889999999999999999999 89999999999
Q ss_pred cEEEcCCCCcEEEeecCcccccccCCc---cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 021306 170 NLLVDPLTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGEN 245 (314)
Q Consensus 170 Nil~~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~t-g~~pf~~~~ 245 (314)
||+++. ++.++|+|||.+........ .....+++.|+|||.+.+.. ++.++||||||+++|+|++ |..||.+.+
T Consensus 167 Nili~~-~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~~~ 244 (304)
T cd05101 167 NVLVTE-NNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPGIP 244 (304)
T ss_pred eEEEcC-CCcEEECCCccceecccccccccccCCCCCceeeCchhhccCC-CCchhhHHHHHHHHHHHHcCCCCCcccCC
Confidence 999997 78999999999876543221 11223456799999986644 8899999999999999998 889998877
Q ss_pred hHHHHHHHHHHcCCCCHHHHhccCCCCCCCcccccccCChhhhhcccCChHHHHHhcchhhh
Q 021306 246 AVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGSHINA 307 (314)
Q Consensus 246 ~~~~~~~i~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~~~~~ 307 (314)
..+....+....... .|......+..++..||...+..+.....+++.++.+..
T Consensus 245 ~~~~~~~~~~~~~~~--------~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~ 298 (304)
T cd05101 245 VEELFKLLKEGHRMD--------KPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILT 298 (304)
T ss_pred HHHHHHHHHcCCcCC--------CCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHH
Confidence 665544443221111 011122245567777887777777777777777765544
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=259.32 Aligned_cols=247 Identities=25% Similarity=0.333 Sum_probs=188.8
Q ss_pred CCceeeeeEeecCceEEEEEEECCCCc---E-EEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCC
Q 021306 38 ISYMAERVVGTGSFGIVFQAKCLETGE---T-VAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSK 106 (314)
Q Consensus 38 ~~y~~~~~Lg~g~~g~Vy~~~~~~~~~---~-~~vK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 106 (314)
++-.+.+.||+|+||.||+|+.+..+. . ||+|..+.+. ...-+|+.++++++|||||+++|+......
T Consensus 157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~P- 235 (474)
T KOG0194|consen 157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEP- 235 (474)
T ss_pred cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCc-
Confidence 355667999999999999998875432 3 8999876421 122389999999999999999998754433
Q ss_pred CceeEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeec
Q 021306 107 NELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF 185 (314)
Q Consensus 107 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~df 185 (314)
+++|||+|.| +|.+.|+.. ...++..+...++.+.+.||+|||+ ++++||||-.+|+|++. +..+||+||
T Consensus 236 ----l~ivmEl~~gGsL~~~L~k~---~~~v~~~ek~~~~~~AA~Gl~YLh~-k~~IHRDIAARNcL~~~-~~~vKISDF 306 (474)
T KOG0194|consen 236 ----LMLVMELCNGGSLDDYLKKN---KKSLPTLEKLRFCYDAARGLEYLHS-KNCIHRDIAARNCLYSK-KGVVKISDF 306 (474)
T ss_pred ----cEEEEEecCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHhHHHHHHH-CCCcchhHhHHHheecC-CCeEEeCcc
Confidence 8899999997 666666542 2369999999999999999999999 99999999999999998 777899999
Q ss_pred CcccccccCCccc-cccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHH-cCCCCH
Q 021306 186 GSAKQLIAGEANI-SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKV-LGTPTR 262 (314)
Q Consensus 186 g~~~~~~~~~~~~-~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~t-g~~pf~~~~~~~~~~~i~~~-~~~~~~ 262 (314)
|+++......... ...-...|+|||.+... .++.++|||||||++||+++ |..||.+....+....+... ...+.+
T Consensus 307 GLs~~~~~~~~~~~~~klPirWLAPEtl~~~-~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~ 385 (474)
T KOG0194|consen 307 GLSRAGSQYVMKKFLKKLPIRWLAPETLNTG-IFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIP 385 (474)
T ss_pred ccccCCcceeeccccccCcceecChhhhccC-ccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCC
Confidence 9987553221111 12235779999999665 59999999999999999999 89999999998888777442 222211
Q ss_pred HHHhccCCCCCCCcccccccCChhhhhcccCChHHHHHhcc
Q 021306 263 EEIRCMNPNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGS 303 (314)
Q Consensus 263 ~~~~~~~p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~ 303 (314)
. . ....+..++..||...+..+.+...+.+.++
T Consensus 386 ~----~----~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~ 418 (474)
T KOG0194|consen 386 S----K----TPKELAKVMKQCWKKDPEDRPTMSTIKKKLE 418 (474)
T ss_pred C----C----CHHHHHHHHHHhccCChhhccCHHHHHHHHH
Confidence 1 1 2224566777778777777777666555544
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=240.05 Aligned_cols=248 Identities=29% Similarity=0.529 Sum_probs=201.6
Q ss_pred CCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeecc--c----cchHHHHHHHHhCCCCceeeeceeeeecCCC---C
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD--R----RYKNRELQLMRVMDHPNVISLKHCFFSTTSK---N 107 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~--~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~---~ 107 (314)
.+.|+-...+|+|.||.||+++.+.+|+.|++|++-.+ . ....+|+.+|..++|+|++.+++++-..... .
T Consensus 16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~ 95 (376)
T KOG0669|consen 16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRD 95 (376)
T ss_pred chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccc
Confidence 45789999999999999999999999999999876432 1 1225899999999999999998876433322 3
Q ss_pred ceeEEEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCc
Q 021306 108 ELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 187 (314)
Q Consensus 108 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~ 187 (314)
...+++|+.+|+.+|...+.+ ...+++..++..++.+++.||.|+|. ..|+|||+|+.|++++. ++.++|.|||+
T Consensus 96 r~t~ylVf~~cehDLaGlLsn---~~vr~sls~Ikk~Mk~Lm~GL~~iHr-~kilHRDmKaaNvLIt~-dgilklADFGl 170 (376)
T KOG0669|consen 96 RATFYLVFDFCEHDLAGLLSN---RKVRFSLSEIKKVMKGLMNGLYYIHR-NKILHRDMKAANVLITK-DGILKLADFGL 170 (376)
T ss_pred cceeeeeHHHhhhhHHHHhcC---ccccccHHHHHHHHHHHHHHHHHHHH-hhHHhhcccHhhEEEcC-CceEEeecccc
Confidence 345789999999988888775 34789999999999999999999999 89999999999999998 89999999999
Q ss_pred ccccccCCcc-----ccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCH
Q 021306 188 AKQLIAGEAN-----ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 262 (314)
Q Consensus 188 ~~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~ 262 (314)
++........ .+...|..|++||.+.|...++++.|+|+.||++.+|+||.+.+++++...++..|.+.++...+
T Consensus 171 ar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tk 250 (376)
T KOG0669|consen 171 ARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITK 250 (376)
T ss_pred ccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCc
Confidence 9755432221 22344788999999999999999999999999999999999999999998888877765444332
Q ss_pred HH---------------------------------------------HhccCCCCCCCcccccccCChhhhhc
Q 021306 263 EE---------------------------------------------IRCMNPNYTDFRFPQIKAHPWHKVCI 290 (314)
Q Consensus 263 ~~---------------------------------------------~~~~~p~~~~~~~~~l~~~p~~~~~~ 290 (314)
+. +..++|. +|+.+++.+.|-||--.+
T Consensus 251 evWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~-kR~~ad~alnh~~F~kdp 322 (376)
T KOG0669|consen 251 EVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPT-KRIDADQALNHDFFWKDP 322 (376)
T ss_pred ccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcc-cCcchHhhhchhhhhcCC
Confidence 21 2234666 889999999999876544
|
|
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=247.58 Aligned_cols=254 Identities=24% Similarity=0.367 Sum_probs=183.7
Q ss_pred CCCceeeeeEeecCceEEEEEEECC-------CCcEEEEEEeecccc-----chHHHHHHHHhC-CCCceeeeceeeeec
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCLE-------TGETVAIKKVLQDRR-----YKNRELQLMRVM-DHPNVISLKHCFFST 103 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~~-------~~~~~~vK~~~~~~~-----~~~~e~~~l~~l-~h~~iv~~~~~~~~~ 103 (314)
.++|.+.+.||+|++|.||++++.. ....+++|.++.... ...+|+.+++++ +|+||+++++++..
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~- 89 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQ- 89 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc-
Confidence 3589999999999999999998642 345789998764322 234788889888 69999999998743
Q ss_pred CCCCceeEEEEeecccc-cHHHHHHhhhh------------cCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCc
Q 021306 104 TSKNELFLNLVMEYVPE-SMYRVLKHYSS------------ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQN 170 (314)
Q Consensus 104 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~------------~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~N 170 (314)
...+++++||+++ +|.+.+..... ....+++.++..++.|++.||.|||+ +|++|+||||+|
T Consensus 90 ----~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~-~gi~H~dlkp~N 164 (314)
T cd05099 90 ----EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLES-RRCIHRDLAARN 164 (314)
T ss_pred ----CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHH-CCeeecccccee
Confidence 2347899999985 66666654211 12458999999999999999999999 899999999999
Q ss_pred EEEcCCCCcEEEeecCcccccccCCc---cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCh
Q 021306 171 LLVDPLTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENA 246 (314)
Q Consensus 171 il~~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~t-g~~pf~~~~~ 246 (314)
|+++. ++.++|+|||.++....... .....++..|+|||.+.+.. ++.++|+||||+++|+|++ |..||.+...
T Consensus 165 ill~~-~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~~l~el~~~g~~p~~~~~~ 242 (314)
T cd05099 165 VLVTE-DNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRV-YTHQSDVWSFGILMWEIFTLGGSPYPGIPV 242 (314)
T ss_pred EEEcC-CCcEEEccccccccccccccccccccCCCCccccCHHHHccCC-cCccchhhHHHHHHHHHHhCCCCCCCCCCH
Confidence 99998 78899999999975532211 11122345799999986644 8899999999999999999 8999988776
Q ss_pred HHHHHHHHHHcCCCCHHHHhccCCCCCCCcccccccCChhhhhcccCChHHHHHhcchhh
Q 021306 247 VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGSHIN 306 (314)
Q Consensus 247 ~~~~~~i~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~~~~ 306 (314)
.+....+....... . |......+.+++..||...+..+++...+++.++.+.
T Consensus 243 ~~~~~~~~~~~~~~-------~-~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~ 294 (314)
T cd05099 243 EELFKLLREGHRMD-------K-PSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVL 294 (314)
T ss_pred HHHHHHHHcCCCCC-------C-CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 65555443321110 0 1101113445556666655555566666666655444
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=274.09 Aligned_cols=244 Identities=27% Similarity=0.402 Sum_probs=184.3
Q ss_pred cCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCC-----
Q 021306 36 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTS----- 105 (314)
Q Consensus 36 ~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~----- 105 (314)
-.++|+..+.||+||||.||+|+++-+|..||+|++.... ....+|+.++.+|.|||||+++..|.+...
T Consensus 477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ 556 (1351)
T KOG1035|consen 477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVL 556 (1351)
T ss_pred HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccc
Confidence 4468999999999999999999999999999999997542 223589999999999999997665543111
Q ss_pred -----------------------------------------------C--------------------------------
Q 021306 106 -----------------------------------------------K-------------------------------- 106 (314)
Q Consensus 106 -----------------------------------------------~-------------------------------- 106 (314)
.
T Consensus 557 ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~ 636 (1351)
T KOG1035|consen 557 EIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDS 636 (1351)
T ss_pred cccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccccc
Confidence 0
Q ss_pred ------------------------------CceeEEEEeecccccHHHHHHhhhhcCCCC-CHHHHHHHHHHHHHHHHHh
Q 021306 107 ------------------------------NELFLNLVMEYVPESMYRVLKHYSSANQRM-PLIYVKLYTYQIFRGLAYI 155 (314)
Q Consensus 107 ------------------------------~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l-~~~~~~~i~~ql~~~l~~L 155 (314)
...++||-||||+.++++.+.+. +... .....|++++||+.||.|+
T Consensus 637 e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~---N~~~~~~d~~wrLFreIlEGLaYI 713 (1351)
T KOG1035|consen 637 EGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRR---NHFNSQRDEAWRLFREILEGLAYI 713 (1351)
T ss_pred CCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHh---cccchhhHHHHHHHHHHHHHHHHH
Confidence 01567899999999877777653 2222 4778999999999999999
Q ss_pred hcCCCceecCCCCCcEEEcCCCCcEEEeecCcccccc-------------------cCCccccccccccccccccccCCC
Q 021306 156 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI-------------------AGEANISYICSRFYRAPELIFGAT 216 (314)
Q Consensus 156 H~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~-------------------~~~~~~~~~~~~~y~aPE~~~~~~ 216 (314)
|+ +||+||||||.|||++. ++.|||+|||++.... +.....+..||..|+|||.+.+..
T Consensus 714 H~-~giIHRDLKP~NIFLd~-~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~ 791 (1351)
T KOG1035|consen 714 HD-QGIIHRDLKPRNIFLDS-RNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTS 791 (1351)
T ss_pred Hh-CceeeccCCcceeEEcC-CCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccc
Confidence 99 89999999999999998 8899999999997621 011223567888999999997665
Q ss_pred --CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCH---------------HHHhccCCCCCCCcccc
Q 021306 217 --EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR---------------EEIRCMNPNYTDFRFPQ 279 (314)
Q Consensus 217 --~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~---------------~~~~~~~p~~~~~~~~~ 279 (314)
.|+.++|+|||||+++||+. ||.-.-........++...-|.+ .++...+|+ +||++.+
T Consensus 792 ~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~-kRPtA~e 867 (1351)
T KOG1035|consen 792 SNKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPS-KRPTATE 867 (1351)
T ss_pred cccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCc-cCCCHHH
Confidence 68999999999999999983 45332221111112222211111 123344787 9999999
Q ss_pred cccCChhhh
Q 021306 280 IKAHPWHKV 288 (314)
Q Consensus 280 l~~~p~~~~ 288 (314)
|+++-|+-+
T Consensus 868 LL~s~llpp 876 (1351)
T KOG1035|consen 868 LLNSELLPP 876 (1351)
T ss_pred HhhccCCCc
Confidence 999999886
|
|
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=241.83 Aligned_cols=247 Identities=25% Similarity=0.349 Sum_probs=184.3
Q ss_pred CCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeEEE
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 113 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 113 (314)
.++|++.+.||+|++|.||+|.+. ++..+++|.+.... ....+|+.++++++|++++++++.+.. ...++
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~------~~~~l 77 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVSE------EPIYI 77 (260)
T ss_pred hHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEECC------CCcEE
Confidence 357999999999999999999864 66779999886532 234589999999999999999887621 12679
Q ss_pred Eeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcccccc
Q 021306 114 VMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 192 (314)
Q Consensus 114 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~ 192 (314)
+|||+++ +|.+.+.. .....+++..++.++.|++.||.|||+ ++++|+||+|+||+++. ++.++|+|||.+....
T Consensus 78 v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~~l~~al~~lH~-~~i~H~di~p~Nili~~-~~~~~l~dfg~~~~~~ 153 (260)
T cd05070 78 VTEYMSKGSLLDFLKD--GEGRALKLPNLVDMAAQVAAGMAYIER-MNYIHRDLRSANILVGD-GLVCKIADFGLARLIE 153 (260)
T ss_pred EEEecCCCcHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCccceEEEeC-CceEEeCCceeeeecc
Confidence 9999986 66665543 123568999999999999999999999 89999999999999998 7889999999987543
Q ss_pred cCCcc--ccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCHHHHhccC
Q 021306 193 AGEAN--ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 269 (314)
Q Consensus 193 ~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 269 (314)
..... ....++..|+|||.+.+.. ++.++|+||||+++|+|++ |..||.+.+..+....+......+.
T Consensus 154 ~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~-------- 224 (260)
T cd05070 154 DNEYTARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPC-------- 224 (260)
T ss_pred CcccccccCCCCCccccChHHHhcCC-CcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC--------
Confidence 32211 1223355799999986544 7899999999999999999 8999988776665555433221111
Q ss_pred CCCCCCcccccccCChhhhhcccCChHHHHHhcc
Q 021306 270 PNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGS 303 (314)
Q Consensus 270 p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~ 303 (314)
|.-....+.+++..+|...+..+++...+.+.++
T Consensus 225 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 258 (260)
T cd05070 225 PQDCPISLHELMLQCWKKDPEERPTFEYLQSFLE 258 (260)
T ss_pred CCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHh
Confidence 1112234566666677666666666666655543
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=269.65 Aligned_cols=142 Identities=24% Similarity=0.374 Sum_probs=122.7
Q ss_pred CCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCCce
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL 109 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 109 (314)
.++|++.+.||.|+||.||+|++..+++.||+|+++... ....+|..+++.++|+||++++..+.. ..
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~-----~~ 77 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQS-----AN 77 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEE-----CC
Confidence 468999999999999999999999999999999987542 344678889999999999999887743 33
Q ss_pred eEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcc
Q 021306 110 FLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 188 (314)
Q Consensus 110 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~ 188 (314)
++++||||+.| +|.+.+.. ...+++..++.++.||+.||.|||. ++|+|+||||+|||++. ++.++|+|||++
T Consensus 78 ~~~lVmEy~~g~~L~~li~~----~~~l~~~~~~~i~~qil~aL~yLH~-~gIiHrDLKP~NILl~~-~g~vkL~DFGls 151 (669)
T cd05610 78 NVYLVMEYLIGGDVKSLLHI----YGYFDEEMAVKYISEVALALDYLHR-HGIIHRDLKPDNMLISN-EGHIKLTDFGLS 151 (669)
T ss_pred EEEEEEeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCEEeCCccHHHEEEcC-CCCEEEEeCCCC
Confidence 48899999976 66655543 4678999999999999999999999 89999999999999997 788999999987
Q ss_pred c
Q 021306 189 K 189 (314)
Q Consensus 189 ~ 189 (314)
+
T Consensus 152 ~ 152 (669)
T cd05610 152 K 152 (669)
T ss_pred c
Confidence 4
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=243.71 Aligned_cols=255 Identities=18% Similarity=0.213 Sum_probs=190.4
Q ss_pred cCCCceeeeeEeecCceEEEEEEECC----CCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCC
Q 021306 36 QTISYMAERVVGTGSFGIVFQAKCLE----TGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSK 106 (314)
Q Consensus 36 ~~~~y~~~~~Lg~g~~g~Vy~~~~~~----~~~~~~vK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 106 (314)
..++|++.+.||+|+||.||+|.+.. ++..+++|.+.... ....+|..++++++|+||+++++++....
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~-- 81 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDG-- 81 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCC--
Confidence 35689999999999999999999875 25788999876432 22357888999999999999999765332
Q ss_pred CceeEEEEeecccc-cHHHHHHhhhhc----CCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEE
Q 021306 107 NELFLNLVMEYVPE-SMYRVLKHYSSA----NQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVK 181 (314)
Q Consensus 107 ~~~~~~lv~e~~~~-~l~~~l~~~~~~----~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~ 181 (314)
...+++++|+++ ++.+.+...... ...+++.+++.++.|++.||.|||+ .+++|+||+|+||+++. ++.++
T Consensus 82 --~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~i~H~di~p~nil~~~-~~~~k 157 (280)
T cd05043 82 --EPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK-RGVIHKDIAARNCVIDE-ELQVK 157 (280)
T ss_pred --CCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHH-CCEeecccCHhhEEEcC-CCcEE
Confidence 236799999985 666665543211 1568999999999999999999999 89999999999999997 78999
Q ss_pred EeecCcccccccCCcc---ccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHc
Q 021306 182 ICDFGSAKQLIAGEAN---ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVL 257 (314)
Q Consensus 182 l~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~t-g~~pf~~~~~~~~~~~i~~~~ 257 (314)
|+|||+++........ ....++..|+|||.+.+.. ++.++||||||+++|++++ |+.||...++.+....+....
T Consensus 158 l~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~ 236 (280)
T cd05043 158 ITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKE-YSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGY 236 (280)
T ss_pred ECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCC-CCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCC
Confidence 9999998755322211 1123356699999986544 7899999999999999999 999998877655433332221
Q ss_pred CCCCHHHHhccCCCCCCCcccccccCChhhhhcccCChHHHHHhcchh
Q 021306 258 GTPTREEIRCMNPNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGSHI 305 (314)
Q Consensus 258 ~~~~~~~~~~~~p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~~~ 305 (314)
... .... ....+.+++..||...+..+++...+++.++.+
T Consensus 237 ~~~---~~~~-----~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~ 276 (280)
T cd05043 237 RLA---QPIN-----CPDELFAVMACCWALDPEERPSFSQLVQCLTDF 276 (280)
T ss_pred CCC---CCCc-----CCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 110 0001 122356778888887778888888777776654
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=239.28 Aligned_cols=240 Identities=26% Similarity=0.327 Sum_probs=179.5
Q ss_pred eeEeecCceEEEEEEECCCC---cEEEEEEeecccc-----chHHHHHHHHhCCCCceeeeceeeeecCCCCceeEEEEe
Q 021306 44 RVVGTGSFGIVFQAKCLETG---ETVAIKKVLQDRR-----YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVM 115 (314)
Q Consensus 44 ~~Lg~g~~g~Vy~~~~~~~~---~~~~vK~~~~~~~-----~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 115 (314)
+.||+|+||.||+|++...+ ..+++|.+..... ...+|+.+++++.|+|++++++++. . ...++++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~-----~~~~~v~ 74 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-G-----EPLMLVM 74 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-C-----CceEEEE
Confidence 47899999999999876554 7899998875443 3357889999999999999988753 1 1267999
Q ss_pred ecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcccccccC
Q 021306 116 EYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG 194 (314)
Q Consensus 116 e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~~~ 194 (314)
||+.+ +|.+.+.. ...+++..+..++.|++.++.+||. .+++|+||+|+||+++. ++.++|+|||.+......
T Consensus 75 e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lh~-~~i~H~di~p~nili~~-~~~~kl~df~~~~~~~~~ 148 (257)
T cd05060 75 ELAPLGPLLKYLKK----RREIPVSDLKELAHQVAMGMAYLES-KHFVHRDLAARNVLLVN-RHQAKISDFGMSRALGAG 148 (257)
T ss_pred EeCCCCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHhh-cCeeccCcccceEEEcC-CCcEEeccccccceeecC
Confidence 99985 66666653 4579999999999999999999999 89999999999999998 888999999998765433
Q ss_pred Cccc----cccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCHHHHhccC
Q 021306 195 EANI----SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 269 (314)
Q Consensus 195 ~~~~----~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 269 (314)
.... ...++..|+|||.+.+.. ++.++|+||||+++|+|++ |..||...+..+....+.+....+ .
T Consensus 149 ~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~--------~ 219 (257)
T cd05060 149 SDYYRATTAGRWPLKWYAPECINYGK-FSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLP--------R 219 (257)
T ss_pred CcccccccCccccccccCHHHhcCCC-CCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcCC--------C
Confidence 2211 111235699999986544 8999999999999999998 999998877655444443221111 1
Q ss_pred CCCCCCcccccccCChhhhhcccCChHHHHHhcch
Q 021306 270 PNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGSH 304 (314)
Q Consensus 270 p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~~ 304 (314)
|......+.+++..+|...+..++....+.+.+..
T Consensus 220 ~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~ 254 (257)
T cd05060 220 PEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRR 254 (257)
T ss_pred CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 11122345567777777777777677766666543
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=245.35 Aligned_cols=240 Identities=25% Similarity=0.462 Sum_probs=180.6
Q ss_pred CceeeeeEeecCceEEEEEEEC---CCCcEEEEEEeeccc--------cchHHHHHHHHhC-CCCceeeeceeeeecCCC
Q 021306 39 SYMAERVVGTGSFGIVFQAKCL---ETGETVAIKKVLQDR--------RYKNRELQLMRVM-DHPNVISLKHCFFSTTSK 106 (314)
Q Consensus 39 ~y~~~~~Lg~g~~g~Vy~~~~~---~~~~~~~vK~~~~~~--------~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~ 106 (314)
+|++.+.||.|+||.||+|++. .+|+.|++|.++... ....+|+.++.++ .|++|+++++++.
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~----- 75 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ----- 75 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEee-----
Confidence 5899999999999999999875 478999999886432 2235788899999 5899999988873
Q ss_pred CceeEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeec
Q 021306 107 NELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF 185 (314)
Q Consensus 107 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~df 185 (314)
....+++++||+++ +|.+.+. ....+++..+..++.|++.||.+||+ .|++|+||+|+||+++. ++.++|+||
T Consensus 76 ~~~~~~lv~e~~~~~~L~~~l~----~~~~l~~~~~~~~~~qi~~al~~lH~-~~i~H~dl~p~nil~~~-~~~~kl~df 149 (290)
T cd05613 76 TDTKLHLILDYINGGELFTHLS----QRERFKEQEVQIYSGEIVLALEHLHK-LGIIYRDIKLENILLDS-NGHVVLTDF 149 (290)
T ss_pred cCCeEEEEEecCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHeEECC-CCCEEEeeC
Confidence 33457899999996 5555554 34678999999999999999999999 89999999999999998 789999999
Q ss_pred CcccccccCC--ccccccccccccccccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH---cCC
Q 021306 186 GSAKQLIAGE--ANISYICSRFYRAPELIFGA-TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV---LGT 259 (314)
Q Consensus 186 g~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~---~~~ 259 (314)
|++....... ......++..|+|||.+.+. ..++.++||||||+++|+|++|..||...........+.+. ...
T Consensus 150 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~ 229 (290)
T cd05613 150 GLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP 229 (290)
T ss_pred ccceecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCC
Confidence 9987543322 11234567889999998643 23678899999999999999999999754322222222211 111
Q ss_pred CC--------HHHHh---ccCCCCCCC-----cccccccCChhhhhc
Q 021306 260 PT--------REEIR---CMNPNYTDF-----RFPQIKAHPWHKVCI 290 (314)
Q Consensus 260 ~~--------~~~~~---~~~p~~~~~-----~~~~l~~~p~~~~~~ 290 (314)
+. .+.+. ..+|+ .|+ .+++++.|||+....
T Consensus 230 ~~~~~~~~~~~~ll~~~l~~~p~-~R~~~~~~~~~~l~~~~~~~~~~ 275 (290)
T cd05613 230 PYPQEMSALAKDIIQRLLMKDPK-KRLGCGPSDADEIKKHPFFQKIN 275 (290)
T ss_pred CCCccCCHHHHHHHHHHhcCCHH-HhcCCCCCCHHHHHcCcccccCC
Confidence 11 11122 22565 565 889999999998765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-34 Score=271.62 Aligned_cols=248 Identities=23% Similarity=0.395 Sum_probs=195.0
Q ss_pred CCceeeeeEeecCceEEEEEEECCC-Cc----EEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCC
Q 021306 38 ISYMAERVVGTGSFGIVFQAKCLET-GE----TVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKN 107 (314)
Q Consensus 38 ~~y~~~~~Lg~g~~g~Vy~~~~~~~-~~----~~~vK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 107 (314)
.+-++.+.||+|.||.||.|..... |. .|++|.+++.. ..+-+|+.++..++|||||+++|+.+....
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~-- 769 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGP-- 769 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCC--
Confidence 3678999999999999999987753 32 38888886543 334589999999999999999999876433
Q ss_pred ceeEEEEeecccc-cHHHHHHhhhh---cCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEe
Q 021306 108 ELFLNLVMEYVPE-SMYRVLKHYSS---ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKIC 183 (314)
Q Consensus 108 ~~~~~lv~e~~~~-~l~~~l~~~~~---~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~ 183 (314)
.+|++|||.| +|+..+++... ....++..+...++.|+++|++||++ +++|||||..+|+|++. ...+|++
T Consensus 770 ---~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~-~~fvHRDLAaRNCLL~~-~r~VKIa 844 (1025)
T KOG1095|consen 770 ---PLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLES-KHFVHRDLAARNCLLDE-RRVVKIA 844 (1025)
T ss_pred ---cEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHh-CCCcCcchhhhheeecc-cCcEEEc
Confidence 7799999996 77777765311 14679999999999999999999999 89999999999999998 7899999
Q ss_pred ecCcccccccCCccc---cccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCC
Q 021306 184 DFGSAKQLIAGEANI---SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGT 259 (314)
Q Consensus 184 dfg~~~~~~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~t-g~~pf~~~~~~~~~~~i~~~~~~ 259 (314)
|||+|+.+....... ...-...|||||.+.... ++.++||||||+++||++| |..||.+.+..+.+...+++..-
T Consensus 845 DFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~i-FtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggRL 923 (1025)
T KOG1095|consen 845 DFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGI-FTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGRL 923 (1025)
T ss_pred ccchhHhhhhchheeccCccccceecCCHHHHhhcc-cccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCcc
Confidence 999998443322111 112245699999997644 9999999999999999999 99999999998887767665422
Q ss_pred CCHHHHhccCCCCCCCcccccccCChhhhhcccCChHHHHHh
Q 021306 260 PTREEIRCMNPNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEY 301 (314)
Q Consensus 260 ~~~~~~~~~~p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~ 301 (314)
+ .|.++.-.+.+||..||...+..+....-+.+.
T Consensus 924 ~--------~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q 957 (1025)
T KOG1095|consen 924 D--------PPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQ 957 (1025)
T ss_pred C--------CCCCCChHHHHHHHHHccCChhhCccHHHHHhh
Confidence 2 233344455688888888888777766666554
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=246.31 Aligned_cols=205 Identities=29% Similarity=0.537 Sum_probs=168.1
Q ss_pred CCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeecc---ccchHHHHHHHHhCCC--C----ceeeeceeeeecCCCC
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD---RRYKNRELQLMRVMDH--P----NVISLKHCFFSTTSKN 107 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~---~~~~~~e~~~l~~l~h--~----~iv~~~~~~~~~~~~~ 107 (314)
.++|+++..||+|.||.|-.+.+..++..+|+|+++.- +....-|++++.++.+ | .++++.++| .-
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wF-----dy 162 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWF-----DY 162 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhh-----hc
Confidence 46899999999999999999999999999999988643 3334578888888832 1 256666666 45
Q ss_pred ceeEEEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcC------------
Q 021306 108 ELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP------------ 175 (314)
Q Consensus 108 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~------------ 175 (314)
.++.|+|+|.++-++.+.+... ...+++...++.++.|++.++++||+ .+++|.||||+||++-+
T Consensus 163 rghiCivfellG~S~~dFlk~N--~y~~fpi~~ir~m~~QL~~sv~fLh~-~kl~HTDLKPENILfvss~~~~~~~~k~~ 239 (415)
T KOG0671|consen 163 RGHICIVFELLGLSTFDFLKEN--NYIPFPIDHIRHMGYQLLESVAFLHD-LKLTHTDLKPENILFVSSEYFKTYNPKKK 239 (415)
T ss_pred cCceEEEEeccChhHHHHhccC--CccccchHHHHHHHHHHHHHHHHHHh-cceeecCCChheEEEeccceEEEeccCCc
Confidence 5568999999998988888752 23679999999999999999999999 89999999999999822
Q ss_pred -------CCCcEEEeecCcccccccCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHH
Q 021306 176 -------LTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVD 248 (314)
Q Consensus 176 -------~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~ 248 (314)
.+..++++|||.|....... ...+.|..|.|||++.+-. ++.++||||+||||+|+.||...|+.-+..+
T Consensus 240 ~~~~r~~ks~~I~vIDFGsAtf~~e~h--s~iVsTRHYRAPEViLgLG-wS~pCDvWSiGCIL~ElytG~~LFqtHen~E 316 (415)
T KOG0671|consen 240 VCFIRPLKSTAIKVIDFGSATFDHEHH--STIVSTRHYRAPEVILGLG-WSQPCDVWSIGCILVELYTGETLFQTHENLE 316 (415)
T ss_pred cceeccCCCcceEEEecCCcceeccCc--ceeeeccccCCchheeccC-cCCccCceeeeeEEEEeeccceecccCCcHH
Confidence 12359999999997543332 3456689999999998766 9999999999999999999999999888777
Q ss_pred HHHH
Q 021306 249 QLVE 252 (314)
Q Consensus 249 ~~~~ 252 (314)
.+..
T Consensus 317 HLaM 320 (415)
T KOG0671|consen 317 HLAM 320 (415)
T ss_pred HHHH
Confidence 6643
|
|
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=240.48 Aligned_cols=248 Identities=23% Similarity=0.336 Sum_probs=186.7
Q ss_pred CCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeEEE
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 113 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 113 (314)
.++|++.+.||+|+||.||++.+. .+..+++|.+.... ....+|+.++++++|+||+++++.+.. ...++
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~------~~~~~ 77 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK------EPIYI 77 (260)
T ss_pred ccceeEEeEecCccceEEEEEEec-CCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC------CCeEE
Confidence 457999999999999999999854 55679999876543 234579999999999999999888743 23679
Q ss_pred Eeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcccccc
Q 021306 114 VMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 192 (314)
Q Consensus 114 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~ 192 (314)
++||+++ ++.+.+... ....+++..+..++.|++.||.+||+ .|++|+||+|+||+++. .+.++|+|||.+....
T Consensus 78 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~-~~i~H~dl~p~ni~i~~-~~~~~l~d~~~~~~~~ 153 (260)
T cd05073 78 ITEFMAKGSLLDFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIEQ-RNYIHRDLRAANILVSA-SLVCKIADFGLARVIE 153 (260)
T ss_pred EEEeCCCCcHHHHHHhC--CccccCHHHHHHHHHHHHHHHHHHHh-CCccccccCcceEEEcC-CCcEEECCCcceeecc
Confidence 9999985 777666542 24568889999999999999999999 89999999999999998 8899999999886543
Q ss_pred cCCc--cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCHHHHhccC
Q 021306 193 AGEA--NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 269 (314)
Q Consensus 193 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 269 (314)
.... .....++..|+|||.+.+.. ++.++|+||||+++|++++ |+.||.+.+.......+.+....+..
T Consensus 154 ~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~------- 225 (260)
T cd05073 154 DNEYTAREGAKFPIKWTAPEAINFGS-FTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRP------- 225 (260)
T ss_pred CCCcccccCCcccccccCHhHhccCC-cCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCCCc-------
Confidence 2211 11223356699999986544 7889999999999999999 99999887766555544332221111
Q ss_pred CCCCCCcccccccCChhhhhcccCChHHHHHhcch
Q 021306 270 PNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGSH 304 (314)
Q Consensus 270 p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~~ 304 (314)
+. ....+.+++..+|...+..++....+...++.
T Consensus 226 ~~-~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 226 EN-CPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred cc-CCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 11 12245566777777777777777777666543
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=245.91 Aligned_cols=246 Identities=24% Similarity=0.344 Sum_probs=179.7
Q ss_pred CCceeeeeEeecCceEEEEEEECCCCc----EEEEEEeecccc-----chHHHHHHHHhCCCCceeeeceeeeecCCCCc
Q 021306 38 ISYMAERVVGTGSFGIVFQAKCLETGE----TVAIKKVLQDRR-----YKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 108 (314)
Q Consensus 38 ~~y~~~~~Lg~g~~g~Vy~~~~~~~~~----~~~vK~~~~~~~-----~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 108 (314)
++|++.+.||+|+||.||++.+..++. .+++|.+..... ...+|..+++.+.|+||+++++.+...
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~----- 81 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP----- 81 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-----
Confidence 478999999999999999999877776 468887764432 235788899999999999999987432
Q ss_pred eeEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCc
Q 021306 109 LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 187 (314)
Q Consensus 109 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~ 187 (314)
..++++||+++ ++.+.+.. ....+++..+..++.|++.||.|||+ +|++|+||||+||+++. ++.++|+|||+
T Consensus 82 -~~~~v~e~~~~g~l~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~LH~-~~ivH~dikp~Nill~~-~~~~kL~Dfg~ 155 (303)
T cd05110 82 -TIQLVTQLMPHGCLLDYVHE---HKDNIGSQLLLNWCVQIAKGMMYLEE-RRLVHRDLAARNVLVKS-PNHVKITDFGL 155 (303)
T ss_pred -CceeeehhcCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHhh-cCeeccccccceeeecC-CCceEEccccc
Confidence 14588999985 66665543 23468999999999999999999999 89999999999999987 77899999999
Q ss_pred ccccccCCcc---ccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCHH
Q 021306 188 AKQLIAGEAN---ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTRE 263 (314)
Q Consensus 188 ~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~ 263 (314)
+......... ....++..|+|||.+.+.. ++.++||||||+++|+|++ |+.||.+....+ ...+++.....+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~-~~~~~~~~~~~~~- 232 (303)
T cd05110 156 ARLLEGDEKEYNADGGKMPIKWMALECIHYRK-FTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE-IPDLLEKGERLPQ- 232 (303)
T ss_pred cccccCcccccccCCCccccccCCHHHhccCC-CChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-HHHHHHCCCCCCC-
Confidence 9765432221 1223456799999986544 8899999999999999997 999998776544 3333332221111
Q ss_pred HHhccCCCCCCCcccccccCChhhhhcccCChHHHHHhcc
Q 021306 264 EIRCMNPNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGS 303 (314)
Q Consensus 264 ~~~~~~p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~ 303 (314)
+......+.+++..||...+..++....+...++
T Consensus 233 ------~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~ 266 (303)
T cd05110 233 ------PPICTIDVYMVMVKCWMIDADSRPKFKELAAEFS 266 (303)
T ss_pred ------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 1112334555556666655555555555544443
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=242.13 Aligned_cols=257 Identities=27% Similarity=0.359 Sum_probs=185.2
Q ss_pred CCceeeeeEeecCceEEEEEEE----CCCCcEEEEEEeeccc----cchHHHHHHHHhCCCCceeeeceeeeecCCCCce
Q 021306 38 ISYMAERVVGTGSFGIVFQAKC----LETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL 109 (314)
Q Consensus 38 ~~y~~~~~Lg~g~~g~Vy~~~~----~~~~~~~~vK~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 109 (314)
..|++.+.||+|+||.||++.. ..++..|++|.+.... ....+|+.++++++|+||+++++++.... ..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~---~~ 80 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG---RR 80 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCC---CC
Confidence 4799999999999999999973 4578899999986543 23468999999999999999988764432 23
Q ss_pred eEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcc
Q 021306 110 FLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 188 (314)
Q Consensus 110 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~ 188 (314)
.+++++||+++ +|.+.+.. ....+++..++.++.|++.||.|||+ +|++|+||||+||+++. ++.++|+|||++
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~---~~~~l~~~~~~~~~~~l~~aL~~LH~-~~i~H~dlkp~nili~~-~~~~~l~dfg~~ 155 (284)
T cd05081 81 NLRLVMEYLPYGSLRDYLQK---HRERLDHRKLLLYASQICKGMEYLGS-KRYVHRDLATRNILVES-ENRVKIGDFGLT 155 (284)
T ss_pred ceEEEEEecCCCCHHHHHHh---cCcCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCHhhEEECC-CCeEEECCCccc
Confidence 47899999985 66666543 23568999999999999999999999 89999999999999998 788999999998
Q ss_pred cccccCCccc----cccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCC--CCH
Q 021306 189 KQLIAGEANI----SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT--PTR 262 (314)
Q Consensus 189 ~~~~~~~~~~----~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~--~~~ 262 (314)
.......... ....+..|+|||.+.+.. ++.++|+||||+++|+|++|..|+...... ....+..... ...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~~~~~~~~~~~--~~~~~~~~~~~~~~~ 232 (284)
T cd05081 156 KVLPQDKEYYKVREPGESPIFWYAPESLTESK-FSVASDVWSFGVVLYELFTYSDKSCSPPAE--FMRMMGNDKQGQMIV 232 (284)
T ss_pred ccccCCCcceeecCCCCCceEeeCHHHhccCC-cChHHHHHHHHHHHHHHhhcCCcCCCcchh--hhhhcccccccccch
Confidence 7654322211 111234599999986554 789999999999999999998776443221 1111110000 000
Q ss_pred H----HHh---cc-CCCCCCCcccccccCChhhhhcccCChHHHHHhcchh
Q 021306 263 E----EIR---CM-NPNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGSHI 305 (314)
Q Consensus 263 ~----~~~---~~-~p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~~~ 305 (314)
. .+. .. .+......+.+++..||...+..+++.+.+...++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 233 YHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 0 000 00 1111223577788888888888888888887776644
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=240.58 Aligned_cols=243 Identities=25% Similarity=0.416 Sum_probs=183.3
Q ss_pred Cceee-eeEeecCceEEEEEEECCCCcEEEEEEeeccc----cchHHHHHHHHhC-CCCceeeeceeeeecCCCCceeEE
Q 021306 39 SYMAE-RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVM-DHPNVISLKHCFFSTTSKNELFLN 112 (314)
Q Consensus 39 ~y~~~-~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~----~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~ 112 (314)
-|++. +.||+|+|+.|--+....+|..||||++.+.. ...-+|++++.++ .|+||++++++| ++...+|
T Consensus 78 ~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefF-----Edd~~FY 152 (463)
T KOG0607|consen 78 MYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFF-----EDDTRFY 152 (463)
T ss_pred HHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHh-----cccceEE
Confidence 34444 58999999999999999999999999986642 3345899998888 599999999998 4444488
Q ss_pred EEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCC--cEEEeecCccc
Q 021306 113 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH--QVKICDFGSAK 189 (314)
Q Consensus 113 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~--~~~l~dfg~~~ 189 (314)
+|||-+.| .++..++. ...|++.++.++..+|+.||.+||. +||.|||+||+|||-...+. -+|||||.++.
T Consensus 153 LVfEKm~GGplLshI~~----~~~F~E~EAs~vvkdia~aLdFlH~-kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgS 227 (463)
T KOG0607|consen 153 LVFEKMRGGPLLSHIQK----RKHFNEREASRVVKDIASALDFLHT-KGIAHRDLKPENILCESPNKVSPVKICDFDLGS 227 (463)
T ss_pred EEEecccCchHHHHHHH----hhhccHHHHHHHHHHHHHHHHHHhh-cCcccccCCccceeecCCCCcCceeeecccccc
Confidence 99999997 55555553 5789999999999999999999999 99999999999999976222 49999999875
Q ss_pred ccccC--------Ccccccccccccccccccc----CCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChH----------
Q 021306 190 QLIAG--------EANISYICSRFYRAPELIF----GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV---------- 247 (314)
Q Consensus 190 ~~~~~--------~~~~~~~~~~~y~aPE~~~----~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~---------- 247 (314)
..... ....+.+|+..|||||++. ....|..+.|+||||+|+|-|++|-+||.+.-..
T Consensus 228 g~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~C 307 (463)
T KOG0607|consen 228 GIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVC 307 (463)
T ss_pred ccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCcc
Confidence 43211 1123456677899999962 2345788999999999999999999999764221
Q ss_pred ----HHHHHHHHHcCCC-CH-----------HHHhc---cCCCCCCCcccccccCChhhhhccc
Q 021306 248 ----DQLVEIIKVLGTP-TR-----------EEIRC---MNPNYTDFRFPQIKAHPWHKVCIFH 292 (314)
Q Consensus 248 ----~~~~~i~~~~~~~-~~-----------~~~~~---~~p~~~~~~~~~l~~~p~~~~~~~~ 292 (314)
+.+..-++...-. +. +++.+ .++. .|+++.++++|||.+....+
T Consensus 308 r~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~-~rlsa~~vlnhPw~~~~~~e 370 (463)
T KOG0607|consen 308 RVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAK-QRLSAAQVLNHPWVQRCAPE 370 (463)
T ss_pred HHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHH-hhhhhhhccCCccccccchh
Confidence 2333334433222 22 22222 2333 78899999999998877654
|
|
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=247.60 Aligned_cols=253 Identities=24% Similarity=0.357 Sum_probs=182.1
Q ss_pred CCceeeeeEeecCceEEEEEEECCC-------CcEEEEEEeeccc-----cchHHHHHHHHhC-CCCceeeeceeeeecC
Q 021306 38 ISYMAERVVGTGSFGIVFQAKCLET-------GETVAIKKVLQDR-----RYKNRELQLMRVM-DHPNVISLKHCFFSTT 104 (314)
Q Consensus 38 ~~y~~~~~Lg~g~~g~Vy~~~~~~~-------~~~~~vK~~~~~~-----~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~ 104 (314)
.+|++++.||+|+||.||+|.+... +..+++|.++... ....+|+.+++++ +|+||+++++++..
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~-- 89 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ-- 89 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEcc--
Confidence 4799999999999999999986432 2368999876432 2345788999999 89999999998743
Q ss_pred CCCceeEEEEeecccc-cHHHHHHhhh------------hcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcE
Q 021306 105 SKNELFLNLVMEYVPE-SMYRVLKHYS------------SANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNL 171 (314)
Q Consensus 105 ~~~~~~~~lv~e~~~~-~l~~~l~~~~------------~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Ni 171 (314)
....++++||+++ +|.+.+.... .....++..++..++.|++.||.|||+ +|++|+||+|+||
T Consensus 90 ---~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~-~givH~dlkp~Ni 165 (334)
T cd05100 90 ---DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLAS-QKCIHRDLAARNV 165 (334)
T ss_pred ---CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH-CCeeccccccceE
Confidence 2347899999986 6666665421 123458889999999999999999999 8999999999999
Q ss_pred EEcCCCCcEEEeecCcccccccCCc---cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChH
Q 021306 172 LVDPLTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAV 247 (314)
Q Consensus 172 l~~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~t-g~~pf~~~~~~ 247 (314)
+++. ++.++|+|||+++....... .....++..|+|||.+.+.. ++.++||||||+++|+|++ |..||.+.+..
T Consensus 166 ll~~-~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~~~~~~ 243 (334)
T cd05100 166 LVTE-DNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE 243 (334)
T ss_pred EEcC-CCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCC-cCchhhhHHHHHHHHHHHhcCCCCCCCCCHH
Confidence 9998 78899999999875433221 11122345799999986544 7899999999999999998 88999888766
Q ss_pred HHHHHHHHHcCCCCHHHHhccCCCCCCCcccccccCChhhhhcccCChHHHHHhcchhh
Q 021306 248 DQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGSHIN 306 (314)
Q Consensus 248 ~~~~~i~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~~~~ 306 (314)
+....+......+.+ ......+.+++..+|...+..++....+++.++.+.
T Consensus 244 ~~~~~~~~~~~~~~~--------~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~ 294 (334)
T cd05100 244 ELFKLLKEGHRMDKP--------ANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVL 294 (334)
T ss_pred HHHHHHHcCCCCCCC--------CCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHh
Confidence 655544332211110 001112345555555555555555555555555443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=240.00 Aligned_cols=244 Identities=23% Similarity=0.331 Sum_probs=186.0
Q ss_pred CCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc--cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeEEEE
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR--RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLV 114 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~--~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 114 (314)
.++|++.+.||+|+||.||++.. +++.+++|.++.+. ....+|+.++++++|+|++++.+++.. . ..+++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~-----~~~~v 76 (254)
T cd05083 5 LQKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILH-N-----GLYIV 76 (254)
T ss_pred HHHceeeeeeccCCCCceEeccc--CCCceEEEeecCcchHHHHHHHHHHHHhCCCCCcCeEEEEEcC-C-----CcEEE
Confidence 35799999999999999999864 78889999886542 234688999999999999999988732 1 15799
Q ss_pred eecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCccccccc
Q 021306 115 MEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA 193 (314)
Q Consensus 115 ~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~~ 193 (314)
+||+.+ +|.+.+... ....+++..+..++.|++.|+.+||+ .|++||||+|+||+++. ++.++|+|||.+.....
T Consensus 77 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~al~~lH~-~~~~H~dl~p~nili~~-~~~~kl~Dfg~~~~~~~ 152 (254)
T cd05083 77 MELMSKGNLVNFLRTR--GRALVSVIQLLQFSLDVAEGMEYLES-KKLVHRDLAARNILVSE-DGVAKVSDFGLARVGSM 152 (254)
T ss_pred EECCCCCCHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccccCcceEEEcC-CCcEEECCCccceeccc
Confidence 999985 776666532 23468999999999999999999999 89999999999999998 78899999999875432
Q ss_pred CCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCHHHHhccCCCC
Q 021306 194 GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 272 (314)
Q Consensus 194 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~p~~ 272 (314)
. ......+..|+|||.+.+.. ++.++|+||||+++|+|++ |+.||...+..+....+.+...... +.-
T Consensus 153 ~--~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~--------~~~ 221 (254)
T cd05083 153 G--VDNSKLPVKWTAPEALKHKK-FSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEP--------PEG 221 (254)
T ss_pred c--CCCCCCCceecCHHHhccCC-cCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCCCC--------CCc
Confidence 2 11223356799999986544 7899999999999999998 9999988877655444433211111 111
Q ss_pred CCCcccccccCChhhhhcccCChHHHHHhcc
Q 021306 273 TDFRFPQIKAHPWHKVCIFHFPKHWLLEYGS 303 (314)
Q Consensus 273 ~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~ 303 (314)
....+.+++..+|.+.+..++....+...++
T Consensus 222 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 252 (254)
T cd05083 222 CPADVYVLMTSCWETEPKKRPSFHKLREKLE 252 (254)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHHHc
Confidence 1234567778888877777777777666543
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-36 Score=283.76 Aligned_cols=236 Identities=27% Similarity=0.469 Sum_probs=187.0
Q ss_pred CCceeeeeEeecCceEEEEEEECCCCcEEEEEEeecc------ccchHHHHHHHHhCCCCceeeeceeeeecCCCCceeE
Q 021306 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 111 (314)
Q Consensus 38 ~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 111 (314)
-+|+-...||.|.||.||-|.+..+|+..|+|.++.. .....+|.+++..++|||+|+++++-.+... .
T Consensus 1235 ~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRek-----v 1309 (1509)
T KOG4645|consen 1235 FRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREK-----V 1309 (1509)
T ss_pred eeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHH-----H
Confidence 3688899999999999999999999999999987422 2334689999999999999999998765443 6
Q ss_pred EEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcccc
Q 021306 112 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 190 (314)
Q Consensus 112 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~ 190 (314)
+|.||||.| +|.+.+.+ +...++...+.+..|++.|+.|||+ +|||||||||.||+++. ++.+|++|||.|..
T Consensus 1310 ~IFMEyC~~GsLa~ll~~----gri~dE~vt~vyt~qll~gla~LH~-~gIVHRDIK~aNI~Ld~-~g~iK~~DFGsa~k 1383 (1509)
T KOG4645|consen 1310 YIFMEYCEGGSLASLLEH----GRIEDEMVTRVYTKQLLEGLAYLHE-HGIVHRDIKPANILLDF-NGLIKYGDFGSAVK 1383 (1509)
T ss_pred HHHHHHhccCcHHHHHHh----cchhhhhHHHHHHHHHHHHHHHHHh-cCceecCCCccceeeec-CCcEEeecccceeE
Confidence 799999997 45554443 5678888899999999999999999 89999999999999998 78999999999987
Q ss_pred cccCCc-----cccccccccccccccccCCC--CCCcchhHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHcCCCCH
Q 021306 191 LIAGEA-----NISYICSRFYRAPELIFGAT--EYTTSIDIWSAGCVLAELLLGQPLFPGENA-VDQLVEIIKVLGTPTR 262 (314)
Q Consensus 191 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~--~~~~~~Dv~slG~il~el~tg~~pf~~~~~-~~~~~~i~~~~~~~~~ 262 (314)
+.+... .....||+.|||||.+.+.. ....+.|||||||++.||+||+-||...+. ....+..-.+-.++.+
T Consensus 1384 i~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P 1463 (1509)
T KOG4645|consen 1384 IKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIP 1463 (1509)
T ss_pred ecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCc
Confidence 765432 23577899999999996643 245789999999999999999999988654 3444544445555555
Q ss_pred HHHhccCCCCCCCcccccccCChhh
Q 021306 263 EEIRCMNPNYTDFRFPQIKAHPWHK 287 (314)
Q Consensus 263 ~~~~~~~p~~~~~~~~~l~~~p~~~ 287 (314)
+. ++++.+++.-+||.++|-.|
T Consensus 1464 ~~---ls~~g~dFle~Cl~~dP~~R 1485 (1509)
T KOG4645|consen 1464 ER---LSSEGRDFLEHCLEQDPKMR 1485 (1509)
T ss_pred hh---hhHhHHHHHHHHHhcCchhh
Confidence 54 56665555555555555544
|
|
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=244.24 Aligned_cols=251 Identities=25% Similarity=0.313 Sum_probs=182.7
Q ss_pred CCCceeeeeEeecCceEEEEEEECC-----CCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCC
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCLE-----TGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSK 106 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~~-----~~~~~~vK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 106 (314)
.++|++.+.||+|+||.||+|.+.. ++..+++|.+.... ....+|+.+++.+.|+||+++++++...
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~--- 80 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVG--- 80 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCC---
Confidence 4679999999999999999998753 57889999886432 2345789999999999999999987433
Q ss_pred CceeEEEEeecccc-cHHHHHHhhh------------------hcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCC
Q 021306 107 NELFLNLVMEYVPE-SMYRVLKHYS------------------SANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLK 167 (314)
Q Consensus 107 ~~~~~~lv~e~~~~-~l~~~l~~~~------------------~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~ 167 (314)
...++++||+++ +|.+.+.... .....+++.+++.++.|++.||.+||+ ++++|+||+
T Consensus 81 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~-~~i~H~dl~ 157 (288)
T cd05050 81 --KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSE-RKFVHRDLA 157 (288)
T ss_pred --CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh-CCeeccccc
Confidence 237899999996 6666665321 112357889999999999999999999 899999999
Q ss_pred CCcEEEcCCCCcEEEeecCcccccccCCc---cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 021306 168 PQNLLVDPLTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPG 243 (314)
Q Consensus 168 p~Nil~~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~t-g~~pf~~ 243 (314)
|+||+++. ++.++|+|||.+........ ......+..|+|||.+.+.. ++.++||||||+++|+|++ |..||.+
T Consensus 158 p~nil~~~-~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~~~~~~p~~~ 235 (288)
T cd05050 158 TRNCLVGE-NMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNR-YTTESDVWAYGVVLWEIFSYGMQPYYG 235 (288)
T ss_pred HhheEecC-CCceEECccccceecccCccccccCCCccChhhcCHHHHhcCC-CCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 99999988 88899999999875432211 11223356799999986544 8999999999999999998 8899988
Q ss_pred CChHHHHHHHHHHcCCCCHHHHhccCCCCCCCcccccccCChhhhhcccCChHHHHHhcc
Q 021306 244 ENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGS 303 (314)
Q Consensus 244 ~~~~~~~~~i~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~ 303 (314)
....+....+......+. |......+.+++..+|...+..++....+...++
T Consensus 236 ~~~~~~~~~~~~~~~~~~--------~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~ 287 (288)
T cd05050 236 MAHEEVIYYVRDGNVLSC--------PDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ 287 (288)
T ss_pred CCHHHHHHHHhcCCCCCC--------CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence 776655544432211110 1101223444555555555555555555555543
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=254.35 Aligned_cols=253 Identities=21% Similarity=0.298 Sum_probs=205.1
Q ss_pred CceeeeeEeecCceEEEEEEECCCCcEEEEEEeecc-----ccchHHHHHHHHhCCCCceeeeceeeeecCCCCceeEEE
Q 021306 39 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-----RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 113 (314)
Q Consensus 39 ~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~-----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 113 (314)
...+++.||+|.||.|.+|+. ..+.+||+|.++.+ ++.+.+|+++|.+|+||||+.+.+++...+. +++
T Consensus 539 ~L~~~ekiGeGqFGEVhLCev-eg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DeP-----icm 612 (807)
T KOG1094|consen 539 RLRFKEKIGEGQFGEVHLCEV-EGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDP-----LCM 612 (807)
T ss_pred heehhhhhcCcccceeEEEEe-cCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCc-----hHH
Confidence 578999999999999999994 45799999998643 3556799999999999999999999865444 889
Q ss_pred Eeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcccccc
Q 021306 114 VMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 192 (314)
Q Consensus 114 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~ 192 (314)
|+||++. +|-..+..... ..+.-+....|+.||+.|++||.+ .++|||||.+.|+|++. ..++|++|||.++.+.
T Consensus 613 I~EYmEnGDLnqFl~ahea--pt~~t~~~vsi~tqiasgmaYLes-~nfVHrd~a~rNcLv~~-e~~iKiadfgmsR~ly 688 (807)
T KOG1094|consen 613 ITEYMENGDLNQFLSAHEL--PTAETAPGVSICTQIASGMAYLES-LNFVHRDLATRNCLVDG-EFTIKIADFGMSRNLY 688 (807)
T ss_pred HHHHHhcCcHHHHHHhccC--cccccchhHHHHHHHHHHHHHHHh-hchhhccccccceeecC-cccEEecCcccccccc
Confidence 9999995 66666664322 224566677899999999999999 89999999999999998 8999999999998665
Q ss_pred cCCcc---ccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh--CCCCCCCCChHHHHHHHHHHcCCCCHHHHhc
Q 021306 193 AGEAN---ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL--GQPLFPGENAVDQLVEIIKVLGTPTREEIRC 267 (314)
Q Consensus 193 ~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~t--g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 267 (314)
..... ........|||||.+...+ ++.++|+|+||+++||+++ ...||...+.++...+....+..+.+.....
T Consensus 689 sg~yy~vqgr~vlpiRwmawEsillgk-FttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~ 767 (807)
T KOG1094|consen 689 SGDYYRVQGRAVLPIRWMAWESILLGK-FTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLS 767 (807)
T ss_pred cCCceeeecceeeeeeehhHHHHHhcc-ccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceecc
Confidence 43322 2234467899999997665 8999999999999999875 8899999999888888877776666655554
Q ss_pred cCCCCCCCcccccccCChhhhhcccCChHHHHHhcc
Q 021306 268 MNPNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGS 303 (314)
Q Consensus 268 ~~p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~ 303 (314)
.++. +.-.+.+++-.||.+....+...+.+...+.
T Consensus 768 ~P~~-cp~~lyelml~Cw~~es~~RPsFe~lh~~lq 802 (807)
T KOG1094|consen 768 RPPA-CPQGLYELMLRCWRRESEQRPSFEQLHLFLQ 802 (807)
T ss_pred CCCc-CcHHHHHHHHHHhchhhhcCCCHHHHHHHHH
Confidence 4444 4446779999999999999988887766544
|
|
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-33 Score=236.32 Aligned_cols=243 Identities=21% Similarity=0.335 Sum_probs=178.8
Q ss_pred CCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeEEEE
Q 021306 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLV 114 (314)
Q Consensus 38 ~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 114 (314)
.+|++.+.||+|++|.||++.+. ++..+++|.+.... ....+|+.++++++|++++++++++.. ....+++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~~v 77 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTE-----RSPICLV 77 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEEcc-----CCceEEE
Confidence 47999999999999999999875 46789999886542 335689999999999999999988733 3347899
Q ss_pred eecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCccccccc
Q 021306 115 MEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA 193 (314)
Q Consensus 115 ~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~~ 193 (314)
+||+.+ +|.+.+.. ....+++..++.++.|++.++.+||+ .+++|+||+|+||+++. ++.++|+|||.+.....
T Consensus 78 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lH~-~~i~h~dl~p~ni~i~~-~~~~~l~d~g~~~~~~~ 152 (256)
T cd05112 78 FEFMEHGCLSDYLRA---QRGKFSQETLLGMCLDVCEGMAYLES-SNVIHRDLAARNCLVGE-NQVVKVSDFGMTRFVLD 152 (256)
T ss_pred EEcCCCCcHHHHHHh---CccCCCHHHHHHHHHHHHHHHHHHHH-CCccccccccceEEEcC-CCeEEECCCcceeeccc
Confidence 999997 44444432 23568999999999999999999999 89999999999999997 78899999998865432
Q ss_pred CCc--cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCHHHHhccCC
Q 021306 194 GEA--NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 270 (314)
Q Consensus 194 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~p 270 (314)
... ......+..|+|||.+.+.. ++.++|+||||+++|+|++ |..||...........+.+..... .|
T Consensus 153 ~~~~~~~~~~~~~~~~aPe~~~~~~-~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~--------~~ 223 (256)
T cd05112 153 DQYTSSTGTKFPVKWSSPEVFSFSK-YSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLY--------KP 223 (256)
T ss_pred CcccccCCCccchhhcCHhHhccCC-cChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCC--------CC
Confidence 211 11223356799999986544 8899999999999999998 999998777655555443221111 11
Q ss_pred CCCCCcccccccCChhhhhcccCChHHHHH
Q 021306 271 NYTDFRFPQIKAHPWHKVCIFHFPKHWLLE 300 (314)
Q Consensus 271 ~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~ 300 (314)
......+.+++..+|...+..+.....+++
T Consensus 224 ~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~ 253 (256)
T cd05112 224 RLASQSVYELMQHCWKERPEDRPSFSLLLH 253 (256)
T ss_pred CCCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 111223444555555555555544444443
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=239.91 Aligned_cols=248 Identities=20% Similarity=0.258 Sum_probs=173.6
Q ss_pred eeEeecCceEEEEEEECC--CCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeEEEEee
Q 021306 44 RVVGTGSFGIVFQAKCLE--TGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVME 116 (314)
Q Consensus 44 ~~Lg~g~~g~Vy~~~~~~--~~~~~~vK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e 116 (314)
+.||+|+||.||+|.... ....+++|.+.... ....+|+.+++.++|+||+++++.+... ..++++||
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~-----~~~~lv~e 75 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIES-----IPYLLVLE 75 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCC-----CceEEEEE
Confidence 368999999999996433 34578888765332 2234788899999999999999987433 34889999
Q ss_pred cccc-cHHHHHHhhhh-cCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcccccccC
Q 021306 117 YVPE-SMYRVLKHYSS-ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG 194 (314)
Q Consensus 117 ~~~~-~l~~~l~~~~~-~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~~~ 194 (314)
|+++ +|.+.+..... .....++..++.++.||+.||.|||+ ++++|+||||+||+++. ++.++|+|||++......
T Consensus 76 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nill~~-~~~~kl~dfg~~~~~~~~ 153 (269)
T cd05042 76 FCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ-ADFIHSDLALRNCQLTA-DLSVKIGDYGLALEQYPE 153 (269)
T ss_pred eCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHh-cCEecccccHhheEecC-CCcEEEeccccccccccc
Confidence 9986 66666654221 12335678889999999999999999 89999999999999998 889999999998643222
Q ss_pred Cc---cccccccccccccccccC------CCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCHHH
Q 021306 195 EA---NISYICSRFYRAPELIFG------ATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREE 264 (314)
Q Consensus 195 ~~---~~~~~~~~~y~aPE~~~~------~~~~~~~~Dv~slG~il~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 264 (314)
.. .....++..|+|||.+.. ...++.++||||||+++|+|++ |..||......+.+..++.......+..
T Consensus 154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 233 (269)
T cd05042 154 DYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKP 233 (269)
T ss_pred hheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCC
Confidence 11 112234567999998743 2236789999999999999999 8899988877666665554432211110
Q ss_pred HhccCCCCCCCcccccccCChhhhhcccCChHHHHHhc
Q 021306 265 IRCMNPNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYG 302 (314)
Q Consensus 265 ~~~~~p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~ 302 (314)
.+.+. ......+++..+|. .+..+++...+++.+
T Consensus 234 --~~~~~-~~~~~~~~~~~~~~-dp~~Rpt~~~v~~~l 267 (269)
T cd05042 234 --QLDLK-YSDRWYEVMQFCWL-DPETRPTAEEVHELL 267 (269)
T ss_pred --ccccc-CCHHHHHHHHHHhc-CcccccCHHHHHHHh
Confidence 11111 11123456666774 455556666666554
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-33 Score=238.81 Aligned_cols=247 Identities=19% Similarity=0.190 Sum_probs=173.8
Q ss_pred eeEeecCceEEEEEEEC--CCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeEEEEee
Q 021306 44 RVVGTGSFGIVFQAKCL--ETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVME 116 (314)
Q Consensus 44 ~~Lg~g~~g~Vy~~~~~--~~~~~~~vK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e 116 (314)
+.||+|+||.||+|... .++..+++|.+.... ....+|+.++++++|+||+++++++... ...++|||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e 75 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEV-----TPYLLVME 75 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC-----CCcEEEEE
Confidence 36899999999999864 345679999876432 2345789999999999999999987433 34789999
Q ss_pred cccc-cHHHHHHhhhh-cCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcccccccC
Q 021306 117 YVPE-SMYRVLKHYSS-ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG 194 (314)
Q Consensus 117 ~~~~-~l~~~l~~~~~-~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~~~ 194 (314)
|+++ +|.+.+..... .....++..++.++.|++.|+.|||+ ++++|+||||+||+++. ++.++|+|||.+......
T Consensus 76 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~i~H~dlkp~nil~~~-~~~~kL~dfg~~~~~~~~ 153 (269)
T cd05087 76 FCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK-NNFIHSDLALRNCLLTA-DLTVKIGDYGLSHNKYKE 153 (269)
T ss_pred CCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH-CCEeccccCcceEEEcC-CCcEEECCccccccccCc
Confidence 9995 66666543221 12356777888999999999999999 89999999999999998 788999999998643322
Q ss_pred Cc---cccccccccccccccccCCC------CCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCHHH
Q 021306 195 EA---NISYICSRFYRAPELIFGAT------EYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREE 264 (314)
Q Consensus 195 ~~---~~~~~~~~~y~aPE~~~~~~------~~~~~~Dv~slG~il~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 264 (314)
.. .....++..|+|||.+.+.. .++.++|+||||+++|+|++ |..||......+.............+.
T Consensus 154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~- 232 (269)
T cd05087 154 DYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPK- 232 (269)
T ss_pred ceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCC-
Confidence 11 11233467799999985321 24789999999999999996 999998877655444333221111100
Q ss_pred HhccCCCCCCCcccccccCChhhhhcccCChHHHHHh
Q 021306 265 IRCMNPNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEY 301 (314)
Q Consensus 265 ~~~~~p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~ 301 (314)
..+... ....+..+++.||. .+..+++...+...
T Consensus 233 -~~~~~~-~~~~~~~l~~~c~~-~P~~Rpt~~~l~~~ 266 (269)
T cd05087 233 -PRLKLP-LSDRWYEVMQFCWL-QPEQRPSAEEVHLL 266 (269)
T ss_pred -CccCCC-CChHHHHHHHHHhc-CcccCCCHHHHHHH
Confidence 000000 11234567777884 45666666666544
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-33 Score=236.94 Aligned_cols=240 Identities=26% Similarity=0.346 Sum_probs=177.5
Q ss_pred eeEeecCceEEEEEEECC-CC--cEEEEEEeecccc-----chHHHHHHHHhCCCCceeeeceeeeecCCCCceeEEEEe
Q 021306 44 RVVGTGSFGIVFQAKCLE-TG--ETVAIKKVLQDRR-----YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVM 115 (314)
Q Consensus 44 ~~Lg~g~~g~Vy~~~~~~-~~--~~~~vK~~~~~~~-----~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 115 (314)
+.||+|++|.||++.+.. ++ ..+++|.+..... ...+|+.++++++|+||+++++.+.. ...++++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~~~~v~ 74 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT------HPLMMVT 74 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC------CeEEEEE
Confidence 468999999999999765 33 3689998876544 34579999999999999999988743 3478999
Q ss_pred ecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcccccccC
Q 021306 116 EYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG 194 (314)
Q Consensus 116 e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~~~ 194 (314)
||+++ +|.+.+.... ...+++..++.++.|++.||.+||+ +|++|+||+|+||+++. ++.++|+|||.+......
T Consensus 75 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~-~~i~H~di~p~nil~~~-~~~~kl~dfg~~~~~~~~ 150 (257)
T cd05040 75 ELAPLGSLLDRLRKDA--LGHFLISTLCDYAVQIANGMRYLES-KRFIHRDLAARNILLAS-DDKVKIGDFGLMRALPQN 150 (257)
T ss_pred EecCCCcHHHHHHhcc--cccCcHHHHHHHHHHHHHHHHHHHh-CCccccccCcccEEEec-CCEEEecccccccccccc
Confidence 99975 6766665421 1578999999999999999999999 89999999999999998 789999999998765432
Q ss_pred Cc----cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCHHHHhccC
Q 021306 195 EA----NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 269 (314)
Q Consensus 195 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 269 (314)
.. .....++..|+|||.+.+.. ++.++||||||+++|+|++ |+.||...+..+....+........ .
T Consensus 151 ~~~~~~~~~~~~~~~y~~pE~~~~~~-~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~-------~ 222 (257)
T cd05040 151 EDHYVMEEHLKVPFAWCAPESLRTRT-FSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLE-------R 222 (257)
T ss_pred ccceecccCCCCCceecCHHHhcccC-cCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCC-------C
Confidence 21 11233466799999986544 8899999999999999998 9999988877665555543211110 0
Q ss_pred CCCCCCcccccccCChhhhhcccCChHHHHHh
Q 021306 270 PNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEY 301 (314)
Q Consensus 270 p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~ 301 (314)
|......+.+++..+|...+..++....+.+.
T Consensus 223 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~ 254 (257)
T cd05040 223 PEACPQDIYNVMLQCWAHNPADRPTFAALREF 254 (257)
T ss_pred CccCCHHHHHHHHHHCCCCcccCCCHHHHHHH
Confidence 11112234455555555555555555555443
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-35 Score=264.80 Aligned_cols=248 Identities=25% Similarity=0.341 Sum_probs=204.6
Q ss_pred CCceeeeeEeecCceEEEEEEECCCC---cEEEEEEeec-----cccchHHHHHHHHhCCCCceeeeceeeeecCCCCce
Q 021306 38 ISYMAERVVGTGSFGIVFQAKCLETG---ETVAIKKVLQ-----DRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL 109 (314)
Q Consensus 38 ~~y~~~~~Lg~g~~g~Vy~~~~~~~~---~~~~vK~~~~-----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 109 (314)
.-..|.++||.|.||.|++++.+..| ..||+|.++. .+..+..|+.++-++.||||+++.+++....
T Consensus 629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~----- 703 (996)
T KOG0196|consen 629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSK----- 703 (996)
T ss_pred hheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCc-----
Confidence 35678899999999999999987655 4699999874 3455568999999999999999999884433
Q ss_pred eEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcc
Q 021306 110 FLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 188 (314)
Q Consensus 110 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~ 188 (314)
.+.||+|||++ +|..+|+. .++.|+..++..+++.|+.|++||-+ .|+|||||...|||++. +...|+.|||++
T Consensus 704 PvMIiTEyMENGsLDsFLR~---~DGqftviQLVgMLrGIAsGMkYLsd-m~YVHRDLAARNILVNs-nLvCKVsDFGLS 778 (996)
T KOG0196|consen 704 PVMIITEYMENGSLDSFLRQ---NDGQFTVIQLVGMLRGIASGMKYLSD-MNYVHRDLAARNILVNS-NLVCKVSDFGLS 778 (996)
T ss_pred eeEEEhhhhhCCcHHHHHhh---cCCceEeehHHHHHHHHHHHhHHHhh-cCchhhhhhhhheeecc-ceEEEeccccce
Confidence 38899999996 55555543 45789999999999999999999999 89999999999999999 899999999999
Q ss_pred cccccCCc-ccccc---ccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCHH
Q 021306 189 KQLIAGEA-NISYI---CSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTRE 263 (314)
Q Consensus 189 ~~~~~~~~-~~~~~---~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~ 263 (314)
+...+... ..... -...|.|||.+.-+ +++.++||||+||+|||.++ |.-||.+++.++.+..|.++...|++.
T Consensus 779 Rvledd~~~~ytt~GGKIPiRWTAPEAIa~R-KFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpPm 857 (996)
T KOG0196|consen 779 RVLEDDPEAAYTTLGGKIPIRWTAPEAIAYR-KFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPPM 857 (996)
T ss_pred eecccCCCccccccCCccceeecChhHhhhc-ccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCCC
Confidence 97654432 12222 25679999999654 49999999999999999887 999999999999999998887666543
Q ss_pred HHhccCCCCCCCcccccccCChhhhhcccCChHHHHHhcch
Q 021306 264 EIRCMNPNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGSH 304 (314)
Q Consensus 264 ~~~~~~p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~~ 304 (314)
. +...+.+||..||.+.-..+.....+.+++.+
T Consensus 858 D--------CP~aL~qLMldCWqkdR~~RP~F~qiV~~lDk 890 (996)
T KOG0196|consen 858 D--------CPAALYQLMLDCWQKDRNRRPKFAQIVSTLDK 890 (996)
T ss_pred C--------CcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHH
Confidence 2 35578899999999888888877777666543
|
|
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=234.24 Aligned_cols=239 Identities=23% Similarity=0.343 Sum_probs=179.3
Q ss_pred eeEeecCceEEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeEEEEeecc
Q 021306 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYV 118 (314)
Q Consensus 44 ~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~ 118 (314)
+.||.|++|.||++.+.. ++.+++|.+.... ....+|+.+++++.|+||+++++++... ...++++||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~~v~e~~ 74 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQK-----QPIYIVMELV 74 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecC-----CCeEEEEEcC
Confidence 468999999999999876 9999999876532 2345789999999999999999887433 3478999999
Q ss_pred cc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcccccccCCcc
Q 021306 119 PE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN 197 (314)
Q Consensus 119 ~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~~~~~~ 197 (314)
.+ ++.+.+.. ....+++..+..++.+++.++.+||+ ++++|+||+|+||+++. ++.++|+|||.+.........
T Consensus 75 ~~~~l~~~l~~---~~~~~~~~~~~~~~~~~~~~l~~lH~-~~i~h~di~p~nili~~-~~~~~l~d~g~~~~~~~~~~~ 149 (251)
T cd05041 75 PGGSLLTFLRK---KKNRLTVKKLLQMSLDAAAGMEYLES-KNCIHRDLAARNCLVGE-NNVLKISDFGMSREEEGGIYT 149 (251)
T ss_pred CCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh-CCEehhhcCcceEEEcC-CCcEEEeeccccccccCCcce
Confidence 86 55555432 23568899999999999999999999 89999999999999998 889999999998754321111
Q ss_pred c---cccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCHHHHhccCCCCC
Q 021306 198 I---SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 273 (314)
Q Consensus 198 ~---~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~p~~~ 273 (314)
. ....+..|+|||.+.+.. ++.++|+||||+++|+|++ |..||...........+......+ .|...
T Consensus 150 ~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~~--------~~~~~ 220 (251)
T cd05041 150 VSDGLKQIPIKWTAPEALNYGR-YTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMP--------APQLC 220 (251)
T ss_pred eccccCcceeccCChHhhccCC-CCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCCC--------CCccC
Confidence 1 112245699999986544 8999999999999999999 889998877655444433221111 11212
Q ss_pred CCcccccccCChhhhhcccCChHHHHHhc
Q 021306 274 DFRFPQIKAHPWHKVCIFHFPKHWLLEYG 302 (314)
Q Consensus 274 ~~~~~~l~~~p~~~~~~~~~~~~~~~~~~ 302 (314)
...+.+++..+|...+..+++...+++.+
T Consensus 221 ~~~~~~li~~~l~~~p~~Rp~~~ell~~l 249 (251)
T cd05041 221 PEEIYRLMLQCWAYDPENRPSFSEIYNEL 249 (251)
T ss_pred CHHHHHHHHHHhccChhhCcCHHHHHHHh
Confidence 33466677777777777777777766654
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-33 Score=234.94 Aligned_cols=238 Identities=23% Similarity=0.318 Sum_probs=173.9
Q ss_pred eeEeecCceEEEEEEECCCCcEEEEEEeecccc-----chHHHHHHHHhCCCCceeeeceeeeecCCCCceeEEEEeecc
Q 021306 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYV 118 (314)
Q Consensus 44 ~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~~-----~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~ 118 (314)
+.||+|++|.||++.. .++..+++|.+..... ...+|+.+++.++|+||+++++.+... ...+++|||+
T Consensus 1 ~~ig~g~~g~vy~~~~-~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~ 74 (250)
T cd05085 1 ELLGKGNFGEVFKGTL-KDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQR-----QPIYIVMELV 74 (250)
T ss_pred CccCCCCCceEEEEEe-cCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecC-----CccEEEEECC
Confidence 4689999999999985 4788999998764321 245789999999999999999987433 2378999999
Q ss_pred cc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcccccccCCcc
Q 021306 119 PE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN 197 (314)
Q Consensus 119 ~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~~~~~~ 197 (314)
++ ++.+.+.. ....+++..+..++.|++.+|.+||+ +|++|+||+|+||+++. ++.++|+|||++.........
T Consensus 75 ~~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~-~~~~H~dl~p~nili~~-~~~~~l~d~g~~~~~~~~~~~ 149 (250)
T cd05085 75 PGGDFLSFLRK---KKDELKTKQLVKFALDAAAGMAYLES-KNCIHRDLAARNCLVGE-NNVLKISDFGMSRQEDDGIYS 149 (250)
T ss_pred CCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecccChheEEEcC-CCeEEECCCccceeccccccc
Confidence 86 55544432 23568999999999999999999999 89999999999999998 888999999998654322111
Q ss_pred c--cccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCHHHHhccCCCCCC
Q 021306 198 I--SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 274 (314)
Q Consensus 198 ~--~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~p~~~~ 274 (314)
. ....+..|+|||.+.+.. ++.++|+||||+++|++++ |..||...........+........ .+. ..
T Consensus 150 ~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~-------~~~-~~ 220 (250)
T cd05085 150 SSGLKQIPIKWTAPEALNYGR-YSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSC-------PQK-CP 220 (250)
T ss_pred cCCCCCCcccccCHHHhccCC-CCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCCCC-------CCC-CC
Confidence 1 122345699999986544 7899999999999999998 9999988776655444433211110 111 12
Q ss_pred CcccccccCChhhhhcccCChHHHHHh
Q 021306 275 FRFPQIKAHPWHKVCIFHFPKHWLLEY 301 (314)
Q Consensus 275 ~~~~~l~~~p~~~~~~~~~~~~~~~~~ 301 (314)
..+..++..+|...+..++....+...
T Consensus 221 ~~~~~li~~~l~~~p~~Rp~~~~l~~~ 247 (250)
T cd05085 221 DDVYKVMQRCWDYKPENRPKFSELQKE 247 (250)
T ss_pred HHHHHHHHHHcccCcccCCCHHHHHHH
Confidence 234556666666655555555555443
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-33 Score=237.04 Aligned_cols=237 Identities=14% Similarity=0.137 Sum_probs=169.2
Q ss_pred eeEeecCceEEEEEEECCC------------CcEEEEEEeecccc----chHHHHHHHHhCCCCceeeeceeeeecCCCC
Q 021306 44 RVVGTGSFGIVFQAKCLET------------GETVAIKKVLQDRR----YKNRELQLMRVMDHPNVISLKHCFFSTTSKN 107 (314)
Q Consensus 44 ~~Lg~g~~g~Vy~~~~~~~------------~~~~~vK~~~~~~~----~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 107 (314)
+.||+|++|.||+++.... ...+++|.+..... ...+|+.+++.++||||+++++++....
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~--- 77 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDV--- 77 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC---
Confidence 4689999999999985322 23588887654332 3356788999999999999999875432
Q ss_pred ceeEEEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCC-------cE
Q 021306 108 ELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH-------QV 180 (314)
Q Consensus 108 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~-------~~ 180 (314)
..++++||++++.++.+.. .....+++.+++.++.||+.||.|||+ ++++|+||+|+||+++. ++ .+
T Consensus 78 --~~~lv~e~~~~~~l~~~~~--~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~dlkp~Nill~~-~~~~~~~~~~~ 151 (262)
T cd05077 78 --ENIMVEEFVEFGPLDLFMH--RKSDVLTTPWKFKVAKQLASALSYLED-KDLVHGNVCTKNILLAR-EGIDGECGPFI 151 (262)
T ss_pred --CCEEEEecccCCCHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHhhh-CCeECCCCCcccEEEec-CCccCCCCcee
Confidence 3679999999764444332 234679999999999999999999999 89999999999999976 33 38
Q ss_pred EEeecCcccccccCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHH-hCCCCCCCCChHHHHHHHHHHcCC
Q 021306 181 KICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLGT 259 (314)
Q Consensus 181 ~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~-tg~~pf~~~~~~~~~~~i~~~~~~ 259 (314)
+++|||.+...... ....++..|+|||.+.+...++.++||||||+++|+|+ +|..||......+... ......
T Consensus 152 ~l~d~g~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~-~~~~~~- 226 (262)
T cd05077 152 KLSDPGIPITVLSR---QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKER-FYEGQC- 226 (262)
T ss_pred EeCCCCCCccccCc---ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHH-HHhcCc-
Confidence 99999988644221 22345778999999865555889999999999999998 5889987765433221 111100
Q ss_pred CCHHHHhccCCCCCCCcccccccCChhhhhcccCChHHHHHhc
Q 021306 260 PTREEIRCMNPNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYG 302 (314)
Q Consensus 260 ~~~~~~~~~~p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~ 302 (314)
....|. ...+.+|+..||...+..+++...+++.+
T Consensus 227 ------~~~~~~--~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 227 ------MLVTPS--CKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred ------cCCCCC--hHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 001111 11345667777777777776666666543
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-33 Score=235.94 Aligned_cols=206 Identities=29% Similarity=0.451 Sum_probs=165.5
Q ss_pred ceeeeeEeecCceEEEEEEECCCC----cEEEEEEeecccc-----chHHHHHHHHhCCCCceeeeceeeeecCCCCcee
Q 021306 40 YMAERVVGTGSFGIVFQAKCLETG----ETVAIKKVLQDRR-----YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 110 (314)
Q Consensus 40 y~~~~~Lg~g~~g~Vy~~~~~~~~----~~~~vK~~~~~~~-----~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 110 (314)
+++.+.||.|+||.||++++...+ ..+++|.+..... ...+|+.+++.+.|+||+++++.+... ..
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~ 75 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEE-----EP 75 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCC-----Ce
Confidence 467899999999999999988766 8999999865432 345789999999999999999988443 34
Q ss_pred EEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCccc
Q 021306 111 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 189 (314)
Q Consensus 111 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~ 189 (314)
.+++|||+++ ++.+.+.... ...+++.++..++.|++.|+.+||+ .+++|+||+|+||+++. ++.++|+|||.+.
T Consensus 76 ~~~i~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lh~-~~~~h~dl~~~nil~~~-~~~~~l~dfg~~~ 151 (258)
T smart00219 76 LMIVMEYMEGGDLLDYLRKNR--PKELSLSDLLSFALQIARGMEYLES-KNFIHRDLAARNCLVGE-NLVVKISDFGLSR 151 (258)
T ss_pred eEEEEeccCCCCHHHHHHhhh--hccCCHHHHHHHHHHHHHHHHHHhc-CCeeecccccceEEEcc-CCeEEEcccCCce
Confidence 8899999986 6666554311 1128999999999999999999999 89999999999999998 7799999999987
Q ss_pred ccccCCccc--cccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 021306 190 QLIAGEANI--SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIK 255 (314)
Q Consensus 190 ~~~~~~~~~--~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~t-g~~pf~~~~~~~~~~~i~~ 255 (314)
......... ...+++.|+|||.+.+ ..++.++|+||||+++|+|++ |..||...+.......+.+
T Consensus 152 ~~~~~~~~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~ 219 (258)
T smart00219 152 DLYDDDYYKKKGGKLPIRWMAPESLKD-GKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKK 219 (258)
T ss_pred ecccccccccccCCCcccccChHHhcc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc
Confidence 654332211 1225678999999854 448999999999999999998 8899988776665555543
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=236.53 Aligned_cols=222 Identities=23% Similarity=0.314 Sum_probs=164.2
Q ss_pred cCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHhCCCCceeeeceeeeecCCCCceeEEEEeecccc-cHHHHHH
Q 021306 49 GSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLK 127 (314)
Q Consensus 49 g~~g~Vy~~~~~~~~~~~~vK~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~ 127 (314)
|.+|.||++++..+++.+++|.+...... .+|...+....||||+++++++... ...+++|||++| +|.+.+.
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~~-~~~~~~~~~~~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~ 77 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSSEY-SRERLTIIPHCVPNMVCLHKYIVSE-----DSVFLVLQHAEGGKLWSHIS 77 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchhhh-hhHHHHHHhcCCCceeehhhheecC-----CeEEEEEecCCCCCHHHHHH
Confidence 88999999999999999999998765432 3455555666899999999988433 348899999996 6666554
Q ss_pred hhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcccccccCCcccccccccccc
Q 021306 128 HYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYR 207 (314)
Q Consensus 128 ~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~ 207 (314)
. ...+++..+..++.|++.||.|||+ +|++|+||||+||+++. ++.++++|||.+...... .....++..|+
T Consensus 78 ~----~~~l~~~~~~~~~~ql~~~l~~lH~-~~i~H~dlkp~Nil~~~-~~~~~l~df~~~~~~~~~--~~~~~~~~~y~ 149 (237)
T cd05576 78 K----FLNIPEECVKRWAAEMVVALDALHR-EGIVCRDLNPNNILLDD-RGHIQLTYFSRWSEVEDS--CDGEAVENMYC 149 (237)
T ss_pred H----hcCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHEEEcC-CCCEEEecccchhccccc--cccCCcCcccc
Confidence 3 3569999999999999999999999 89999999999999998 788999999987654332 22334466799
Q ss_pred ccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH---HHcCCCCHHHHh---ccCCCCCCCcc----
Q 021306 208 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII---KVLGTPTREEIR---CMNPNYTDFRF---- 277 (314)
Q Consensus 208 aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~---~~~~~~~~~~~~---~~~p~~~~~~~---- 277 (314)
|||.+.+. .++.++|+||+|+++|+|++|..|+............. ..........+. ..+|+ +|+++
T Consensus 150 aPE~~~~~-~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~-~R~~~~~~~ 227 (237)
T cd05576 150 APEVGGIS-EETEACDWWSLGAILFELLTGKTLVECHPSGINTHTTLNIPEWVSEEARSLLQQLLQFNPT-ERLGAGVAG 227 (237)
T ss_pred CCcccCCC-CCCchhhHHHHHHHHHHHHHCcchhhcCchhcccccccCCcccCCHHHHHHHHHHccCCHH-HhcCCCccc
Confidence 99998544 37899999999999999999998875432110000000 000000111222 33566 67764
Q ss_pred -cccccCChh
Q 021306 278 -PQIKAHPWH 286 (314)
Q Consensus 278 -~~l~~~p~~ 286 (314)
+++++|||+
T Consensus 228 ~~~~~~h~~~ 237 (237)
T cd05576 228 VEDIKSHPFF 237 (237)
T ss_pred hHHHHcCCCC
Confidence 899999996
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-33 Score=240.77 Aligned_cols=241 Identities=27% Similarity=0.443 Sum_probs=178.4
Q ss_pred CceeeeeEeecCceEEEEEEEC---CCCcEEEEEEeeccc--------cchHHHHHHHHhC-CCCceeeeceeeeecCCC
Q 021306 39 SYMAERVVGTGSFGIVFQAKCL---ETGETVAIKKVLQDR--------RYKNRELQLMRVM-DHPNVISLKHCFFSTTSK 106 (314)
Q Consensus 39 ~y~~~~~Lg~g~~g~Vy~~~~~---~~~~~~~vK~~~~~~--------~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~ 106 (314)
+|++.+.||+|++|.||++++. .+++.+++|.+++.. ....+|+.++.++ .|++|+++++++.
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~----- 75 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQ----- 75 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeee-----
Confidence 4899999999999999999864 467889999886432 2234788899999 5999999998873
Q ss_pred CceeEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeec
Q 021306 107 NELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF 185 (314)
Q Consensus 107 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~df 185 (314)
.....++||||+++ +|.+.+. ....+++..++.++.|++.+|.+||+ .+++|+||+|+||+++. ++.++|+||
T Consensus 76 ~~~~~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~ql~~~l~~lH~-~~~~H~dl~p~nil~~~-~~~~~l~df 149 (288)
T cd05583 76 TDTKLHLILDYVNGGELFTHLY----QREHFTESEVRVYIAEIVLALDHLHQ-LGIIYRDIKLENILLDS-EGHVVLTDF 149 (288)
T ss_pred cCCEEEEEEecCCCCcHHHHHh----hcCCcCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHeEECC-CCCEEEEEC
Confidence 33347899999986 5555443 24678999999999999999999999 89999999999999998 788999999
Q ss_pred CcccccccCCc--cccccccccccccccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCChH----HHHHHHHHHcC
Q 021306 186 GSAKQLIAGEA--NISYICSRFYRAPELIFGAT-EYTTSIDIWSAGCVLAELLLGQPLFPGENAV----DQLVEIIKVLG 258 (314)
Q Consensus 186 g~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~-~~~~~~Dv~slG~il~el~tg~~pf~~~~~~----~~~~~i~~~~~ 258 (314)
|++........ .....++..|+|||.+.+.. ..+.++|+||||+++|+|++|..||...... +....+.....
T Consensus 150 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 229 (288)
T cd05583 150 GLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKP 229 (288)
T ss_pred ccccccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCC
Confidence 98865433221 12234678899999985432 2678999999999999999999999654322 11122222111
Q ss_pred CC-------CHHHHh---ccCCCCCCCc---ccccccCChhhhhcc
Q 021306 259 TP-------TREEIR---CMNPNYTDFR---FPQIKAHPWHKVCIF 291 (314)
Q Consensus 259 ~~-------~~~~~~---~~~p~~~~~~---~~~l~~~p~~~~~~~ 291 (314)
.. ..+.+. ..+|+ +|++ +.++++|||++....
T Consensus 230 ~~~~~~~~~l~~li~~~l~~~p~-~R~t~~~~~~~l~~~~~~~~~~ 274 (288)
T cd05583 230 PFPKTMSAEARDFIQKLLEKDPK-KRLGANGADEIKNHPFFQGIDW 274 (288)
T ss_pred CCCcccCHHHHHHHHHHhcCCHh-hccCcchHHHHhcCcccccCCH
Confidence 11 112222 23566 7887 457799999877654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=237.34 Aligned_cols=246 Identities=25% Similarity=0.301 Sum_probs=179.4
Q ss_pred CCceeeeeEeecCceEEEEEEECCC---CcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCce
Q 021306 38 ISYMAERVVGTGSFGIVFQAKCLET---GETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL 109 (314)
Q Consensus 38 ~~y~~~~~Lg~g~~g~Vy~~~~~~~---~~~~~vK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 109 (314)
++|.+.+.||+|++|.||+|.+... ...+++|...... ....+|+.++++++|+||+++++++.. .
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~------~ 79 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE------N 79 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC------C
Confidence 4699999999999999999987544 3468899876433 234578999999999999999987632 1
Q ss_pred eEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcc
Q 021306 110 FLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 188 (314)
Q Consensus 110 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~ 188 (314)
..++++||+++ +|.+.+.. ....+++..++.++.|++.||.+||+ .|++|+||+|+||+++. ++.++|+|||++
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~l~~~l~~lH~-~~~~H~dl~p~nili~~-~~~~~l~d~g~~ 154 (270)
T cd05056 80 PVWIVMELAPLGELRSYLQV---NKYSLDLASLILYSYQLSTALAYLES-KRFVHRDIAARNVLVSS-PDCVKLGDFGLS 154 (270)
T ss_pred CcEEEEEcCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccccChheEEEec-CCCeEEccCcee
Confidence 25699999985 66665543 23468999999999999999999999 89999999999999998 788999999998
Q ss_pred cccccCCccc--cccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCHHHH
Q 021306 189 KQLIAGEANI--SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEI 265 (314)
Q Consensus 189 ~~~~~~~~~~--~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 265 (314)
.......... ...++..|+|||.+.+.. ++.++|+||||+++|++++ |..||.+.+..+....+.+....+.+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~--- 230 (270)
T cd05056 155 RYLEDESYYKASKGKLPIKWMAPESINFRR-FTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMP--- 230 (270)
T ss_pred eecccccceecCCCCccccccChhhhccCC-CCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcCCCC---
Confidence 7554332111 112245799999985544 8899999999999999986 99999888766555444332211111
Q ss_pred hccCCCCCCCcccccccCChhhhhcccCChHHHHHhcc
Q 021306 266 RCMNPNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGS 303 (314)
Q Consensus 266 ~~~~p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~ 303 (314)
...+ ..+.+++..+|...+..+++...+++.+.
T Consensus 231 ~~~~-----~~~~~li~~~l~~~P~~Rpt~~~~~~~l~ 263 (270)
T cd05056 231 PNCP-----PTLYSLMTKCWAYDPSKRPRFTELKAQLS 263 (270)
T ss_pred CCCC-----HHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 1112 23445555555555555555555555443
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-33 Score=259.00 Aligned_cols=252 Identities=20% Similarity=0.258 Sum_probs=165.1
Q ss_pred cCCCceeeeeEeecCceEEEEEEECCC----CcEEEEEEeeccccchHHHHHHHHhCCCCceeeeceeeeecCC-CCcee
Q 021306 36 QTISYMAERVVGTGSFGIVFQAKCLET----GETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTS-KNELF 110 (314)
Q Consensus 36 ~~~~y~~~~~Lg~g~~g~Vy~~~~~~~----~~~~~vK~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~~~~~ 110 (314)
..++|++.+.||+|+||.||+|++..+ +..|++|++...........+.++...+.++..+...+..... .....
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e~~~~e~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 209 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEIWMNERVRRACPNSCADFVYGFLEPVSSKKEDE 209 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhHHHHHHHHHhhchhhHHHHHHhhhcccccccCCc
Confidence 457899999999999999999999888 8999999876432211111112222223333333332222111 33345
Q ss_pred EEEEeecccc-cHHHHHHhhhh----------------cCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEE
Q 021306 111 LNLVMEYVPE-SMYRVLKHYSS----------------ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLV 173 (314)
Q Consensus 111 ~~lv~e~~~~-~l~~~l~~~~~----------------~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~ 173 (314)
+++|+||+++ +|.+.+..... .........+..++.||+.||.|||+ ++|+||||||+|||+
T Consensus 210 ~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~-~gIiHRDLKP~NILl 288 (566)
T PLN03225 210 YWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHS-TGIVHRDVKPQNIIF 288 (566)
T ss_pred eEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHH-CCEEeCcCCHHHEEE
Confidence 7899999986 56665543100 00112244567899999999999999 899999999999999
Q ss_pred cCCCCcEEEeecCcccccccCC--ccccccccccccccccccCCC---------------------CCCcchhHHHHHHH
Q 021306 174 DPLTHQVKICDFGSAKQLIAGE--ANISYICSRFYRAPELIFGAT---------------------EYTTSIDIWSAGCV 230 (314)
Q Consensus 174 ~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~---------------------~~~~~~Dv~slG~i 230 (314)
+..++.++|+|||++....... ......+++.|+|||.+.... .++.++|||||||+
T Consensus 289 ~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGvi 368 (566)
T PLN03225 289 SEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLI 368 (566)
T ss_pred eCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHHHH
Confidence 8756789999999997543221 123456788999999653221 12345699999999
Q ss_pred HHHHHhCCCCCCCCChHHHHHHHHHHcCCC------------CH-----------------HHHh---ccCCCCCCCccc
Q 021306 231 LAELLLGQPLFPGENAVDQLVEIIKVLGTP------------TR-----------------EEIR---CMNPNYTDFRFP 278 (314)
Q Consensus 231 l~el~tg~~pf~~~~~~~~~~~i~~~~~~~------------~~-----------------~~~~---~~~p~~~~~~~~ 278 (314)
+|||+++..|+... ...+..++...+.. .. +.+. ..+|. +|+++.
T Consensus 369 L~el~~~~~~~~~~--~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~-kR~ta~ 445 (566)
T PLN03225 369 FLQMAFPNLRSDSN--LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGR-QRISAK 445 (566)
T ss_pred HHHHHhCcCCCchH--HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcc-cCCCHH
Confidence 99999977665332 22222222211100 00 2222 34777 899999
Q ss_pred ccccCChhhhhcc
Q 021306 279 QIKAHPWHKVCIF 291 (314)
Q Consensus 279 ~l~~~p~~~~~~~ 291 (314)
++++|||++....
T Consensus 446 e~L~Hpff~~~~~ 458 (566)
T PLN03225 446 AALAHPYFDREGL 458 (566)
T ss_pred HHhCCcCcCCCCc
Confidence 9999999987654
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=249.99 Aligned_cols=213 Identities=34% Similarity=0.578 Sum_probs=183.1
Q ss_pred CCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHhCC------CCceeeeceeeeecCCCCc
Q 021306 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMD------HPNVISLKHCFFSTTSKNE 108 (314)
Q Consensus 38 ~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~---~~~~~e~~~l~~l~------h~~iv~~~~~~~~~~~~~~ 108 (314)
++|.+....|+|-|++|..|.+..-|..||||++.... .....|+++|++|. --|+++++..|.+.+
T Consensus 432 ~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hkn---- 507 (752)
T KOG0670|consen 432 SRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKN---- 507 (752)
T ss_pred ceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcc----
Confidence 37899999999999999999999889999999997764 33468999999994 457888888885544
Q ss_pred eeEEEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcc
Q 021306 109 LFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 188 (314)
Q Consensus 109 ~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~ 188 (314)
++|+|+|-+.-+|.+.|..+. .+..|....++.++.||..||..|-. .||+|.||||+||||+...+.+||||||.|
T Consensus 508 -HLClVFE~LslNLRevLKKyG-~nvGL~ikaVRsYaqQLflALklLK~-c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA 584 (752)
T KOG0670|consen 508 -HLCLVFEPLSLNLREVLKKYG-RNVGLHIKAVRSYAQQLFLALKLLKK-CGVLHADIKPDNILVNESKNILKLCDFGSA 584 (752)
T ss_pred -eeEEEehhhhchHHHHHHHhC-cccceeehHHHHHHHHHHHHHHHHHh-cCeeecccCccceEeccCcceeeeccCccc
Confidence 499999999999999998874 45678999999999999999999999 899999999999999998899999999999
Q ss_pred cccccCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCC
Q 021306 189 KQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT 259 (314)
Q Consensus 189 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~ 259 (314)
...... ....+..+..|.|||++.|-+ |....|+||+||+|||+.||+..|++.+.-+++...|..-+.
T Consensus 585 ~~~~en-eitPYLVSRFYRaPEIiLG~~-yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk 653 (752)
T KOG0670|consen 585 SFASEN-EITPYLVSRFYRAPEIILGLP-YDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGK 653 (752)
T ss_pred cccccc-cccHHHHHHhccCcceeecCc-ccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCC
Confidence 765433 333456677899999998866 899999999999999999999999999888888777755433
|
|
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=237.23 Aligned_cols=250 Identities=22% Similarity=0.246 Sum_probs=179.4
Q ss_pred CCceeeeeEeecCceEEEEEEECC-----CCcEEEEEEeecccc-----chHHHHHHHHhCCCCceeeeceeeeecCCCC
Q 021306 38 ISYMAERVVGTGSFGIVFQAKCLE-----TGETVAIKKVLQDRR-----YKNRELQLMRVMDHPNVISLKHCFFSTTSKN 107 (314)
Q Consensus 38 ~~y~~~~~Lg~g~~g~Vy~~~~~~-----~~~~~~vK~~~~~~~-----~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 107 (314)
++|++...||+|+||.||+|+.+. +.+.+++|.+..... ...+|+.++++++|+||+++++.+. .
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~ 79 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCR-----E 79 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEEC-----C
Confidence 579999999999999999999754 346789998754332 3568999999999999999998873 3
Q ss_pred ceeEEEEeecccc-cHHHHHHhhhhc-----CCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEE
Q 021306 108 ELFLNLVMEYVPE-SMYRVLKHYSSA-----NQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVK 181 (314)
Q Consensus 108 ~~~~~lv~e~~~~-~l~~~l~~~~~~-----~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~ 181 (314)
..+.++++||+++ +|.+.+...... ...+++..+..++.|++.||.|||+ .+++|+||+|+||+++. ++.++
T Consensus 80 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~-~~i~H~dlkp~Nili~~-~~~~~ 157 (275)
T cd05046 80 AEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSN-ARFVHRDLAARNCLVSS-QREVK 157 (275)
T ss_pred CCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhh-cCcccCcCccceEEEeC-CCcEE
Confidence 3347899999995 666665532211 1268999999999999999999999 89999999999999998 78899
Q ss_pred EeecCcccccccCC--ccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcC
Q 021306 182 ICDFGSAKQLIAGE--ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLG 258 (314)
Q Consensus 182 l~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~t-g~~pf~~~~~~~~~~~i~~~~~ 258 (314)
++|||.+....... ......++..|+|||.+.+.. ++.++||||||+++|+|++ |..||...........+.....
T Consensus 158 l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~ 236 (275)
T cd05046 158 VSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDD-FSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKL 236 (275)
T ss_pred EcccccccccCcccccccCCceeEEeecChhhhccCC-CCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCc
Confidence 99999876432211 112234466799999986554 7889999999999999999 8899987665544443322111
Q ss_pred CCCHHHHhccCCCCCCCcccccccCChhhhhcccCChHHHHHhc
Q 021306 259 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYG 302 (314)
Q Consensus 259 ~~~~~~~~~~~p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~ 302 (314)
... .+......+.+++..+|...+..++....++..+
T Consensus 237 ~~~-------~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l 273 (275)
T cd05046 237 ELP-------VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSAL 273 (275)
T ss_pred CCC-------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHh
Confidence 000 0111112344455555555555555555555543
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-33 Score=236.65 Aligned_cols=234 Identities=18% Similarity=0.199 Sum_probs=170.3
Q ss_pred eeEeecCceEEEEEEECCCC----------cEEEEEEeeccc---cchHHHHHHHHhCCCCceeeeceeeeecCCCCcee
Q 021306 44 RVVGTGSFGIVFQAKCLETG----------ETVAIKKVLQDR---RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 110 (314)
Q Consensus 44 ~~Lg~g~~g~Vy~~~~~~~~----------~~~~vK~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 110 (314)
+.||+|+||.||++.+..++ ..+++|.+.... ....+|+.++++++|+||+++++++.. . .
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~-----~ 74 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR-D-----E 74 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec-C-----C
Confidence 46899999999999987766 357788765433 344578899999999999999998754 2 2
Q ss_pred EEEEeeccccc-HHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCC-------cEEE
Q 021306 111 LNLVMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH-------QVKI 182 (314)
Q Consensus 111 ~~lv~e~~~~~-l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~-------~~~l 182 (314)
.++++||++++ |.+.+.. ....+++..+..++.||+.||.|||+ +|++|+||||+||+++. ++ .++|
T Consensus 75 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~H~dlkp~Nill~~-~~~~~~~~~~~kl 149 (259)
T cd05037 75 NIMVEEYVKFGPLDVFLHR---EKNNVSLHWKLDVAKQLASALHYLED-KKLVHGNVCGKNILVAR-YGLNEGYVPFIKL 149 (259)
T ss_pred cEEEEEcCCCCcHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHhh-CCeecccCccceEEEec-CccccCCceeEEe
Confidence 67999999974 4444432 12378999999999999999999999 89999999999999987 44 6999
Q ss_pred eecCcccccccCCccccccccccccccccccCC-CCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCC
Q 021306 183 CDFGSAKQLIAGEANISYICSRFYRAPELIFGA-TEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTP 260 (314)
Q Consensus 183 ~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~el~t-g~~pf~~~~~~~~~~~i~~~~~~~ 260 (314)
+|||.+..... .....++..|+|||.+.+. ..++.++|+||||+++|+|++ |..||...+..+...........+
T Consensus 150 ~Dfg~a~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~ 226 (259)
T cd05037 150 SDPGIPITVLS---REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQHRLP 226 (259)
T ss_pred CCCCccccccc---ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhcCCCCC
Confidence 99999875433 2223456679999998665 357899999999999999999 688887775433322221110000
Q ss_pred CHHHHhccCCCCCCCcccccccCChhhhhcccCChHHHHHh
Q 021306 261 TREEIRCMNPNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEY 301 (314)
Q Consensus 261 ~~~~~~~~~p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~ 301 (314)
.| ....+.+++..+|...+..+++...++..
T Consensus 227 --------~~--~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 257 (259)
T cd05037 227 --------MP--DCAELANLINQCWTYDPTKRPSFRAILRD 257 (259)
T ss_pred --------CC--CchHHHHHHHHHhccChhhCCCHHHHHHh
Confidence 01 11234566666666666666665555543
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=260.59 Aligned_cols=263 Identities=25% Similarity=0.386 Sum_probs=209.2
Q ss_pred CccCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHhC-CCCceeeeceeeeecCCCCce
Q 021306 34 PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVM-DHPNVISLKHCFFSTTSKNEL 109 (314)
Q Consensus 34 ~~~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~---~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~ 109 (314)
|.-.+.|++.+.||.|.+|.||+++.+.+++..|+|+...+. ...+.|.++++.. .|||++.+++++...+.....
T Consensus 15 pdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~D 94 (953)
T KOG0587|consen 15 PDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGD 94 (953)
T ss_pred CCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCC
Confidence 334567999999999999999999999999999999875443 3335677788777 699999999999877777788
Q ss_pred eEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcc
Q 021306 110 FLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 188 (314)
Q Consensus 110 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~ 188 (314)
.+|+|||||.| +..+++.... +..+.|+.+..|++.++.|+.+||. ..++|||||-.||+++. ++.+||+|||.+
T Consensus 95 qLWLVMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~-nkviHRDikG~NiLLT~-e~~VKLvDFGvS 170 (953)
T KOG0587|consen 95 QLWLVMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHN-NKVIHRDIKGQNVLLTE-NAEVKLVDFGVS 170 (953)
T ss_pred eEEEEeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhh-cceeeecccCceEEEec-cCcEEEeeeeee
Confidence 89999999996 6666666554 7899999999999999999999999 89999999999999998 889999999998
Q ss_pred cccccCC-ccccccccccccccccccCCC----CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCH-
Q 021306 189 KQLIAGE-ANISYICSRFYRAPELIFGAT----EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR- 262 (314)
Q Consensus 189 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~----~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~- 262 (314)
....... ......|||.|||||++.... .++.++|+||||++..||.-|.+|+.+..+...+..|.+.-.+...
T Consensus 171 aQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPPPkLkr 250 (953)
T KOG0587|consen 171 AQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKR 250 (953)
T ss_pred eeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCCCccccc
Confidence 7665443 345678999999999985432 2567899999999999999999999999998777777543211111
Q ss_pred ---------HHHh-ccCCC-CCCCcccccccCChhhhhcccCChHHHHHhcc
Q 021306 263 ---------EEIR-CMNPN-YTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGS 303 (314)
Q Consensus 263 ---------~~~~-~~~p~-~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~ 303 (314)
+.+. |+..+ -+|+...++++|||.. .+.+.+.+-...+
T Consensus 251 p~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~---e~~~e~qir~~ik 299 (953)
T KOG0587|consen 251 PKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFIT---EQPNERQVRIQIK 299 (953)
T ss_pred hhhHHHHHHHHHHHHHhhccccCcchhhhccCCccc---ccccHHHHHHHHH
Confidence 1111 22222 2799999999999998 3335554444433
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=237.34 Aligned_cols=253 Identities=30% Similarity=0.468 Sum_probs=199.0
Q ss_pred CCCccCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccccch---HHHHHHHHhCC--------CCceeeeceee
Q 021306 32 GEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK---NRELQLMRVMD--------HPNVISLKHCF 100 (314)
Q Consensus 32 ~~~~~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~~~~---~~e~~~l~~l~--------h~~iv~~~~~~ 100 (314)
+.+..+++|.+.+.||=|-|++||++.+..+.+.||+|+.+...... ..|+++|++++ ..+||++++.|
T Consensus 72 GD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~F 151 (590)
T KOG1290|consen 72 GDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHF 151 (590)
T ss_pred cccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccc
Confidence 34455579999999999999999999999999999999988665443 47889998872 35799999998
Q ss_pred eecCCCCceeEEEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEE-------
Q 021306 101 FSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLV------- 173 (314)
Q Consensus 101 ~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~------- 173 (314)
.... ....++|+|+|+++.+|+..+..+ ..+.++...++.|++|++.||.|||...||+|.||||+|||+
T Consensus 152 khsG-pNG~HVCMVfEvLGdnLLklI~~s--~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~e~~~ 228 (590)
T KOG1290|consen 152 KHSG-PNGQHVCMVFEVLGDNLLKLIKYS--NYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCSTEIDP 228 (590)
T ss_pred eecC-CCCcEEEEEehhhhhHHHHHHHHh--CCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeeccccch
Confidence 6544 556789999999999999988864 345688899999999999999999997799999999999999
Q ss_pred --------------------------------------------------------------------------------
Q 021306 174 -------------------------------------------------------------------------------- 173 (314)
Q Consensus 174 -------------------------------------------------------------------------------- 173 (314)
T Consensus 229 ~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~ 308 (590)
T KOG1290|consen 229 AKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPR 308 (590)
T ss_pred hhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccC
Confidence
Q ss_pred -----------------------------cC-------------------------------------------------
Q 021306 174 -----------------------------DP------------------------------------------------- 175 (314)
Q Consensus 174 -----------------------------~~------------------------------------------------- 175 (314)
.+
T Consensus 309 ~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~ 388 (590)
T KOG1290|consen 309 INGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPE 388 (590)
T ss_pred CCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCc
Confidence 00
Q ss_pred CCCcEEEeecCcccccccCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCC------CChHHH
Q 021306 176 LTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG------ENAVDQ 249 (314)
Q Consensus 176 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~------~~~~~~ 249 (314)
.+-++||.|||.|+.... .......|..|+|||++.+.. |+..+||||++|++|||+||...|.. ..+++.
T Consensus 389 ~di~vKIaDlGNACW~~k--hFT~DIQTRQYRapEVllGsg-Y~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDH 465 (590)
T KOG1290|consen 389 CDIRVKIADLGNACWVHK--HFTEDIQTRQYRAPEVLLGSG-YSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDH 465 (590)
T ss_pred cceeEEEeeccchhhhhh--hhchhhhhhhccCcceeecCC-CCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHH
Confidence 001356666666654322 222345578899999998876 99999999999999999999988832 345677
Q ss_pred HHHHHHHcCCCCHHH----------------------------------------------------HhccCCCCCCCcc
Q 021306 250 LVEIIKVLGTPTREE----------------------------------------------------IRCMNPNYTDFRF 277 (314)
Q Consensus 250 ~~~i~~~~~~~~~~~----------------------------------------------------~~~~~p~~~~~~~ 277 (314)
+..|++.++.-++.. +.++.|+ +|+++
T Consensus 466 iA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~Pe-KR~tA 544 (590)
T KOG1290|consen 466 IALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPE-KRPTA 544 (590)
T ss_pred HHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCcc-ccccH
Confidence 888887765544311 1234677 99999
Q ss_pred cccccCChhhhhcc
Q 021306 278 PQIKAHPWHKVCIF 291 (314)
Q Consensus 278 ~~l~~~p~~~~~~~ 291 (314)
.++++|||+++.+.
T Consensus 545 ~~cl~hPwLn~~~~ 558 (590)
T KOG1290|consen 545 AQCLKHPWLNPVAG 558 (590)
T ss_pred HHHhcCccccCCCC
Confidence 99999999997665
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-33 Score=238.85 Aligned_cols=243 Identities=23% Similarity=0.327 Sum_probs=177.7
Q ss_pred eeEeecCceEEEEEEECCCC------cEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeEE
Q 021306 44 RVVGTGSFGIVFQAKCLETG------ETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 112 (314)
Q Consensus 44 ~~Lg~g~~g~Vy~~~~~~~~------~~~~vK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 112 (314)
+.||+|++|.||++++.... +.+++|.+.... ....+|+.+++.++|+||+++++++.... ..+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~ 75 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNE-----PQY 75 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCC-----CeE
Confidence 36899999999999976443 678999875432 23457899999999999999999874332 378
Q ss_pred EEeecccc-cHHHHHHhhhh---cCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCC-----cEEEe
Q 021306 113 LVMEYVPE-SMYRVLKHYSS---ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH-----QVKIC 183 (314)
Q Consensus 113 lv~e~~~~-~l~~~l~~~~~---~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~-----~~~l~ 183 (314)
+++||+++ +|.+.+..... ....+++.++..++.|++.|+.|||+ .+++|+||+|+||+++. ++ .++|+
T Consensus 76 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~i~H~dl~p~nil~~~-~~~~~~~~~~l~ 153 (269)
T cd05044 76 IIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQ-MHFIHRDLAARNCLVSE-KGYDADRVVKIG 153 (269)
T ss_pred EEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHh-CCcccCCCChheEEEec-CCCCCCcceEEC
Confidence 99999985 67666654322 22458899999999999999999999 89999999999999987 44 79999
Q ss_pred ecCcccccccCCc---cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCC
Q 021306 184 DFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGT 259 (314)
Q Consensus 184 dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~t-g~~pf~~~~~~~~~~~i~~~~~~ 259 (314)
|||++........ ......+..|+|||.+.+.. ++.++||||||+++|+|++ |+.||...+..+....+......
T Consensus 154 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~ 232 (269)
T cd05044 154 DFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGK-FTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRL 232 (269)
T ss_pred CcccccccccccccccCcccCCCccccCHHHHccCC-cccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCCcc
Confidence 9999875432211 11223457799999986554 7999999999999999998 99999877765544433221111
Q ss_pred CCHHHHhccCCCCCCCcccccccCChhhhhcccCChHHHHHhc
Q 021306 260 PTREEIRCMNPNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYG 302 (314)
Q Consensus 260 ~~~~~~~~~~p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~ 302 (314)
. .+......+.+++..+|...+..++..+.+.+.+
T Consensus 233 ~--------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l 267 (269)
T cd05044 233 Q--------KPENCPDKIYQLMTNCWAQDPSERPTFDRIQEIL 267 (269)
T ss_pred C--------CcccchHHHHHHHHHHcCCCcccCCCHHHHHHHH
Confidence 1 0111122355677777777777766666666554
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=234.49 Aligned_cols=245 Identities=23% Similarity=0.364 Sum_probs=176.4
Q ss_pred eeEeecCceEEEEEEECC---CCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeEEEEe
Q 021306 44 RVVGTGSFGIVFQAKCLE---TGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVM 115 (314)
Q Consensus 44 ~~Lg~g~~g~Vy~~~~~~---~~~~~~vK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 115 (314)
+.||+|+||.||+|.+.. ++..+++|.+.... ....+|..+++.++|+||+++++.+...+ ...++++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----~~~~lv~ 76 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSE----GSPLVVL 76 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCC----CCcEEEE
Confidence 468999999999998653 34679999875322 23346888999999999999998664322 2367999
Q ss_pred ecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcccccccC
Q 021306 116 EYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG 194 (314)
Q Consensus 116 e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~~~ 194 (314)
||+.+ +|.+.+.. ....+++..+..++.|++.||.|||+ .+++|+||+|+||+++. ++.++|+|||++......
T Consensus 77 e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlk~~nili~~-~~~~kl~dfg~~~~~~~~ 151 (262)
T cd05058 77 PYMKHGDLRNFIRS---ETHNPTVKDLIGFGLQVAKGMEYLAS-KKFVHRDLAARNCMLDE-SFTVKVADFGLARDIYDK 151 (262)
T ss_pred ecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccccCcceEEEcC-CCcEEECCccccccccCC
Confidence 99985 66655543 23456778889999999999999999 89999999999999998 788999999998754321
Q ss_pred C-----ccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCHHHHhcc
Q 021306 195 E-----ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 268 (314)
Q Consensus 195 ~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 268 (314)
. ......++..|+|||.+.+.. ++.++||||||+++|+|++ |..||...+..+....+.+....+.
T Consensus 152 ~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~------- 223 (262)
T cd05058 152 EYYSVHNHTGAKLPVKWMALESLQTQK-FTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQ------- 223 (262)
T ss_pred cceeecccccCcCCccccChhHhccCc-cchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCC-------
Confidence 1 111223456799999986544 8899999999999999999 5677777665554443332211111
Q ss_pred CCCCCCCcccccccCChhhhhcccCChHHHHHhcchhh
Q 021306 269 NPNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGSHIN 306 (314)
Q Consensus 269 ~p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~~~~ 306 (314)
|......+.+++..||...+..++....++..++.+.
T Consensus 224 -~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 224 -PEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred -CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 1111224566777777777777777777777766543
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-32 Score=233.88 Aligned_cols=247 Identities=18% Similarity=0.226 Sum_probs=172.2
Q ss_pred eeEeecCceEEEEEEECCC--CcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeEEEEee
Q 021306 44 RVVGTGSFGIVFQAKCLET--GETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVME 116 (314)
Q Consensus 44 ~~Lg~g~~g~Vy~~~~~~~--~~~~~vK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e 116 (314)
+.||+|+||.||+++...+ ...+++|.+.... ....+|+.+++.++||||+++++.+... ...+++||
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~-----~~~~lv~e 75 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEA-----IPYLLVFE 75 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCC-----CccEEEEe
Confidence 3689999999999975433 3456677665432 2345778889999999999999988433 34789999
Q ss_pred cccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcccccccCC
Q 021306 117 YVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE 195 (314)
Q Consensus 117 ~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~~~~ 195 (314)
|+++ +|.+.+.........+++..++.++.|++.||.|||+ .+++|+||||+||+++. ++.++|+|||++.......
T Consensus 76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~-~~i~H~dikp~nil~~~-~~~~~l~Dfg~~~~~~~~~ 153 (268)
T cd05086 76 YCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHK-HNFLHSDLALRNCFLTS-DLTVKVGDYGIGPSRYKED 153 (268)
T ss_pred cCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH-CCeeccCCccceEEEcC-CccEEecccccccccCcch
Confidence 9996 6666665422223456778889999999999999999 89999999999999998 7889999999875322111
Q ss_pred ---ccccccccccccccccccCC------CCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCHHHH
Q 021306 196 ---ANISYICSRFYRAPELIFGA------TEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEI 265 (314)
Q Consensus 196 ---~~~~~~~~~~y~aPE~~~~~------~~~~~~~Dv~slG~il~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 265 (314)
......++..|+|||.+... ..++.++||||||+++|+|++ |..||...+..+.+..+++........
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~-- 231 (268)
T cd05086 154 YIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFK-- 231 (268)
T ss_pred hhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCC--
Confidence 11234567789999987431 124678999999999999997 678998877766666655432211110
Q ss_pred hccCCCCCCCcccccccCChhhhhcccCChHHHHHh
Q 021306 266 RCMNPNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEY 301 (314)
Q Consensus 266 ~~~~p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~ 301 (314)
..+.+. -...+.+++..||.. +..++..+.+...
T Consensus 232 ~~~~~~-~~~~~~~l~~~c~~~-P~~Rp~~~~i~~~ 265 (268)
T cd05086 232 PQLELP-YSERWYEVLQFCWLS-PEKRATAEEVHRL 265 (268)
T ss_pred CccCCC-CcHHHHHHHHHHhhC-cccCCCHHHHHHH
Confidence 111111 122345566777743 5555666665544
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-34 Score=253.39 Aligned_cols=240 Identities=27% Similarity=0.450 Sum_probs=187.5
Q ss_pred ceeeeeEeecCceEEEEEEECCCCcEEEEEEeecccc-------chHHHHHHHHhCCCCceeeeceeeeecCCCCceeEE
Q 021306 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 112 (314)
Q Consensus 40 y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~~-------~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 112 (314)
|..++.||=|+||.|.++....|...||.|.+.+... ..+.|..||..-..+-||+++-.|.+.+ .+|
T Consensus 631 Fvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkd-----nLY 705 (1034)
T KOG0608|consen 631 FVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKD-----NLY 705 (1034)
T ss_pred eEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCC-----ceE
Confidence 6788999999999999999888999999998865432 2346888999999999999988885444 389
Q ss_pred EEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCccccc
Q 021306 113 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 191 (314)
Q Consensus 113 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~ 191 (314)
+||+|++| ++.++|.. -+.|.+..++.++.++..|+++.|+ .|++||||||+|||+|. ++++||.|||++.-.
T Consensus 706 FVMdYIPGGDmMSLLIr----mgIFeE~LARFYIAEltcAiesVHk-mGFIHRDiKPDNILIDr-dGHIKLTDFGLCTGf 779 (1034)
T KOG0608|consen 706 FVMDYIPGGDMMSLLIR----MGIFEEDLARFYIAELTCAIESVHK-MGFIHRDIKPDNILIDR-DGHIKLTDFGLCTGF 779 (1034)
T ss_pred EEEeccCCccHHHHHHH----hccCHHHHHHHHHHHHHHHHHHHHh-ccceecccCccceEEcc-CCceeeeeccccccc
Confidence 99999997 55555443 4789999999999999999999999 89999999999999999 999999999997422
Q ss_pred ---------ccC------------------C----------------ccccccccccccccccccCCCCCCcchhHHHHH
Q 021306 192 ---------IAG------------------E----------------ANISYICSRFYRAPELIFGATEYTTSIDIWSAG 228 (314)
Q Consensus 192 ---------~~~------------------~----------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG 228 (314)
... . ..-..+||+.|+|||++.. ..++..+|+||.|
T Consensus 780 RWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r-~g~~q~cdwws~g 858 (1034)
T KOG0608|consen 780 RWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLAR-TGYTQLCDWWSVG 858 (1034)
T ss_pred eeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcc-cCccccchhhHhh
Confidence 000 0 0013567899999999954 4489999999999
Q ss_pred HHHHHHHhCCCCCCCCChHHHHHHHHHH-----------cCCCCHHHHh--ccCCC--CCCCcccccccCChhhhhcc
Q 021306 229 CVLAELLLGQPLFPGENAVDQLVEIIKV-----------LGTPTREEIR--CMNPN--YTDFRFPQIKAHPWHKVCIF 291 (314)
Q Consensus 229 ~il~el~tg~~pf~~~~~~~~~~~i~~~-----------~~~~~~~~~~--~~~p~--~~~~~~~~l~~~p~~~~~~~ 291 (314)
+|||||+.|+.||...++-+.-.++++. ++....+++. |.+++ +.+-..+++..||||+.-+.
T Consensus 859 vil~em~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc~sad~RLGkng~d~vKaHpfFkgIDf 936 (1034)
T KOG0608|consen 859 VILYEMLVGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLCCSADSRLGKNGADQVKAHPFFKGIDF 936 (1034)
T ss_pred HHHHHHhhCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHhcChhhhhcccchhhhhcCccccccch
Confidence 9999999999999887766554444432 2222333343 34444 34456778999999987664
|
|
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-33 Score=237.97 Aligned_cols=237 Identities=16% Similarity=0.177 Sum_probs=169.3
Q ss_pred eeEeecCceEEEEEEECCCCc-------EEEEEEeeccc----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeEE
Q 021306 44 RVVGTGSFGIVFQAKCLETGE-------TVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 112 (314)
Q Consensus 44 ~~Lg~g~~g~Vy~~~~~~~~~-------~~~vK~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 112 (314)
+.||+|+||.||+|.+..++. .+++|.+.... ....+|..+++.+.|+|++++++.+..... .+
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~-----~~ 75 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDE-----SI 75 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCC-----cE
Confidence 468999999999999765543 48888775432 233578889999999999999998854332 67
Q ss_pred EEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCC-------cEEEee
Q 021306 113 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH-------QVKICD 184 (314)
Q Consensus 113 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~-------~~~l~d 184 (314)
+||||+++ +|...+.. ....+++..+..++.||+.||.|||+ +|++|+||||+||+++..+. .++++|
T Consensus 76 lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~-~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d 151 (258)
T cd05078 76 MVQEYVKFGSLDTYLKK---NKNLINISWKLEVAKQLAWALHFLED-KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSD 151 (258)
T ss_pred EEEecCCCCcHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCccceEEEecccccccCCCceEEecc
Confidence 99999987 45554442 23468999999999999999999999 89999999999999987332 279999
Q ss_pred cCcccccccCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHHHcCCCCHH
Q 021306 185 FGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLG-QPLFPGENAVDQLVEIIKVLGTPTRE 263 (314)
Q Consensus 185 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg-~~pf~~~~~~~~~~~i~~~~~~~~~~ 263 (314)
||.+..... .....++..|+|||.+.+...++.++|+||||+++|+|++| ..||...+...... .......
T Consensus 152 ~g~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~-~~~~~~~---- 223 (258)
T cd05078 152 PGISITVLP---KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ-FYEDRHQ---- 223 (258)
T ss_pred cccccccCC---chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHH-HHHcccc----
Confidence 998865432 12245677899999997655578999999999999999998 47776666544322 2211110
Q ss_pred HHhccCCCCCCCcccccccCChhhhhcccCChHHHHHhc
Q 021306 264 EIRCMNPNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYG 302 (314)
Q Consensus 264 ~~~~~~p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~ 302 (314)
+++. ....+.+++..+|...+..+.....+++.+
T Consensus 224 ----~~~~-~~~~~~~li~~~l~~~p~~Rps~~~il~~l 257 (258)
T cd05078 224 ----LPAP-KWTELANLINQCMDYEPDFRPSFRAIIRDL 257 (258)
T ss_pred ----CCCC-CcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 1110 112345566666666666665555555543
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=238.09 Aligned_cols=196 Identities=29% Similarity=0.439 Sum_probs=156.8
Q ss_pred CCceeeeeEeecCceEEEEEEE----CCCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCc
Q 021306 38 ISYMAERVVGTGSFGIVFQAKC----LETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 108 (314)
Q Consensus 38 ~~y~~~~~Lg~g~~g~Vy~~~~----~~~~~~~~vK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 108 (314)
..|++.+.||+|+||.||+++. ..++..+++|.++... ....+|+.++++++|+|++++.+++... ..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~ 80 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTED---GG 80 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecC---CC
Confidence 4589999999999999999984 3568899999886432 2345799999999999999999877442 12
Q ss_pred eeEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCc
Q 021306 109 LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 187 (314)
Q Consensus 109 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~ 187 (314)
...++++||++| +|.+.+.. ....+++.++..++.|++.||.+||+ +|++|+||+|+||+++. ++.++|+|||.
T Consensus 81 ~~~~lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~i~~~i~~aL~~lH~-~gi~H~dlkp~Nil~~~-~~~~~l~dfg~ 155 (284)
T cd05079 81 NGIKLIMEFLPSGSLKEYLPR---NKNKINLKQQLKYAVQICKGMDYLGS-RQYVHRDLAARNVLVES-EHQVKIGDFGL 155 (284)
T ss_pred CceEEEEEccCCCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecccchheEEEcC-CCCEEECCCcc
Confidence 347899999986 55555432 23468999999999999999999999 89999999999999998 78899999999
Q ss_pred ccccccCCcc----ccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 021306 188 AKQLIAGEAN----ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFP 242 (314)
Q Consensus 188 ~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~ 242 (314)
+......... ....++..|+|||.+.+.. ++.++||||||+++|+|+++..|+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~-~~~~~Di~slG~il~ellt~~~~~~ 213 (284)
T cd05079 156 TKAIETDKEYYTVKDDLDSPVFWYAPECLIQSK-FYIASDVWSFGVTLYELLTYCDSES 213 (284)
T ss_pred ccccccCccceeecCCCCCCccccCHHHhccCC-CCccccchhhhhhhhhhhcCCCCCc
Confidence 8765432211 1233456799999986654 7899999999999999999877653
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=236.08 Aligned_cols=236 Identities=16% Similarity=0.168 Sum_probs=167.1
Q ss_pred eEeecCceEEEEEEECCC------------------------CcEEEEEEeecccc----chHHHHHHHHhCCCCceeee
Q 021306 45 VVGTGSFGIVFQAKCLET------------------------GETVAIKKVLQDRR----YKNRELQLMRVMDHPNVISL 96 (314)
Q Consensus 45 ~Lg~g~~g~Vy~~~~~~~------------------------~~~~~vK~~~~~~~----~~~~e~~~l~~l~h~~iv~~ 96 (314)
.||+|+||.||++....+ ...+++|.+..... ...+|+.++++++|+||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 589999999999974321 23578887754322 33477889999999999999
Q ss_pred ceeeeecCCCCceeEEEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCC
Q 021306 97 KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPL 176 (314)
Q Consensus 97 ~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~ 176 (314)
++++.... ..++||||++++.++.+.. ...+.+++.++..++.|++.||.|||+ ++++|+||||+||+++..
T Consensus 82 ~~~~~~~~-----~~~lv~ey~~~g~L~~~l~--~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~iiH~dlkp~Nill~~~ 153 (274)
T cd05076 82 HGVCVRGS-----ENIMVEEFVEHGPLDVCLR--KEKGRVPVAWKITVAQQLASALSYLED-KNLVHGNVCAKNILLARL 153 (274)
T ss_pred EEEEEeCC-----ceEEEEecCCCCcHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHc-CCccCCCCCcccEEEecc
Confidence 99885433 3789999999764443332 234678999999999999999999999 899999999999999752
Q ss_pred ------CCcEEEeecCcccccccCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHH-hCCCCCCCCChHHH
Q 021306 177 ------THQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQ 249 (314)
Q Consensus 177 ------~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~-tg~~pf~~~~~~~~ 249 (314)
...++++|||.+...... ....++..|+|||.+.+...++.++|+||||+++|+|+ +|+.||.+..+.+.
T Consensus 154 ~~~~~~~~~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~ 230 (274)
T cd05076 154 GLAEGTSPFIKLSDPGVSFTALSR---EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK 230 (274)
T ss_pred CcccCccceeeecCCccccccccc---cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH
Confidence 124899999987543221 12345677999999866555789999999999999985 69999987765443
Q ss_pred HHHHHHHcCCCCHHHHhccCCCCCCCcccccccCChhhhhcccCChHHHHHh
Q 021306 250 LVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEY 301 (314)
Q Consensus 250 ~~~i~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~ 301 (314)
.. ........+ +. ....+.+++..||...+..++....+++.
T Consensus 231 ~~-~~~~~~~~~--------~~-~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 231 ER-FYEKKHRLP--------EP-SCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred HH-HHHhccCCC--------CC-CChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 22 222111100 00 11234556666666666666555555543
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-32 Score=233.97 Aligned_cols=254 Identities=22% Similarity=0.315 Sum_probs=181.9
Q ss_pred ceeeeeEeecCceEEEEEEECC---CCcEEEEEEeecccc------chHHHHHHHHhCCCCceeeeceeeeecCCCCc-e
Q 021306 40 YMAERVVGTGSFGIVFQAKCLE---TGETVAIKKVLQDRR------YKNRELQLMRVMDHPNVISLKHCFFSTTSKNE-L 109 (314)
Q Consensus 40 y~~~~~Lg~g~~g~Vy~~~~~~---~~~~~~vK~~~~~~~------~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~-~ 109 (314)
|++.+.||+|++|.||+|.... +++.+++|.+..+.. ...+|+.++++++||||+++++.+........ .
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 6788999999999999998653 578999998865421 23578899999999999999997755433221 2
Q ss_pred eEEEEeecccc-cHHHHHHhhh--hcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecC
Q 021306 110 FLNLVMEYVPE-SMYRVLKHYS--SANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 186 (314)
Q Consensus 110 ~~~lv~e~~~~-~l~~~l~~~~--~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg 186 (314)
..++++||+.+ ++...+.... .....+++..++.++.|++.|+.|||+ +|++|+||+|+||+++. +..++|+|||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~-~~i~H~dikp~nili~~-~~~~kl~dfg 158 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSS-KNFIHRDLAARNCMLNE-NMTVCVADFG 158 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCEeecccchhhEEEcC-CCCEEECccc
Confidence 34688899985 5544443211 112357899999999999999999999 89999999999999987 7889999999
Q ss_pred cccccccCCc---cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCH
Q 021306 187 SAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTR 262 (314)
Q Consensus 187 ~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~ 262 (314)
.+........ .....+++.|++||.+.+.. ++.++||||||+++|+|++ |+.||.+.+..+....+.+. ....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~-~~~~- 235 (273)
T cd05074 159 LSKKIYSGDYYRQGCASKLPVKWLALESLADNV-YTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKG-NRLK- 235 (273)
T ss_pred ccccccCCcceecCCCccCchhhcCHhHHhcCc-cchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcC-CcCC-
Confidence 9876533221 11223356799999986554 7889999999999999999 89999877765544433322 1110
Q ss_pred HHHhccCCCCCCCcccccccCChhhhhcccCChHHHHHhcch
Q 021306 263 EEIRCMNPNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGSH 304 (314)
Q Consensus 263 ~~~~~~~p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~~ 304 (314)
..+. ....+.+++..+|...+..+.....++..++.
T Consensus 236 -----~~~~-~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~ 271 (273)
T cd05074 236 -----QPPD-CLEDVYELMCQCWSPEPKCRPSFQHLRDQLEL 271 (273)
T ss_pred -----CCCC-CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence 1111 12245566666666666666666666666553
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-32 Score=234.49 Aligned_cols=252 Identities=27% Similarity=0.354 Sum_probs=185.9
Q ss_pred CCceeeeeEeecCceEEEEEEECC----CCcEEEEEEeecccc-----chHHHHHHHHhCCCCceeeeceeeeecCCCCc
Q 021306 38 ISYMAERVVGTGSFGIVFQAKCLE----TGETVAIKKVLQDRR-----YKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 108 (314)
Q Consensus 38 ~~y~~~~~Lg~g~~g~Vy~~~~~~----~~~~~~vK~~~~~~~-----~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 108 (314)
..|++.+.||+|+||.||+++... +++.+++|.++.... ...+|+++++.+.|+||+++++++... ..
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~---~~ 80 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKP---GG 80 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecC---CC
Confidence 468899999999999999998653 478999999875543 356889999999999999998876432 23
Q ss_pred eeEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCc
Q 021306 109 LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 187 (314)
Q Consensus 109 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~ 187 (314)
.+.++++||+++ ++.+.+.. ....+++..+..++.|++.||.+||+ .|++|+||+|+||+++. ++.++|+|||.
T Consensus 81 ~~~~lv~e~~~~~~l~~~l~~---~~~~~~~~~~~~~~~~l~~aL~~lH~-~~i~H~dl~p~nil~~~-~~~~~l~dfg~ 155 (284)
T cd05038 81 RSLRLIMEYLPSGSLRDYLQR---HRDQINLKRLLLFSSQICKGMDYLGS-QRYIHRDLAARNILVES-EDLVKISDFGL 155 (284)
T ss_pred CceEEEEecCCCCCHHHHHHh---CccccCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHhEEEcC-CCCEEEccccc
Confidence 347899999986 66665543 22369999999999999999999999 89999999999999998 78999999999
Q ss_pred ccccccCCccc----cccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHH--------------H
Q 021306 188 AKQLIAGEANI----SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVD--------------Q 249 (314)
Q Consensus 188 ~~~~~~~~~~~----~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~--------------~ 249 (314)
+.......... ....+..|++||.+.+.. ++.++|+||||+++|+|++|..|+....... .
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~-~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd05038 156 AKVLPEDKDYYYVKEPGESPIFWYAPECLRTSK-FSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTR 234 (284)
T ss_pred ccccccCCcceeccCCCCCcccccCcHHHccCC-CCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHH
Confidence 87654222111 122345699999986554 8899999999999999999999986543211 1
Q ss_pred HHHHHHHcCCCCHHHHhccCCCCCCCcccccccCChhhhhcccCChHHHHHhcchh
Q 021306 250 LVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGSHI 305 (314)
Q Consensus 250 ~~~i~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~~~ 305 (314)
+...+...... ..|......+.+++..+|...+..+++...+.+.++.+
T Consensus 235 ~~~~~~~~~~~-------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 235 LLELLKEGERL-------PRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHHHHHcCCcC-------CCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 11111110000 00111123456777888887777777888887777654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-34 Score=244.36 Aligned_cols=265 Identities=25% Similarity=0.401 Sum_probs=199.0
Q ss_pred eeeeccccCCCCCCccCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccccch-----------HHHHHHHHhCC
Q 021306 21 HIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-----------NRELQLMRVMD 89 (314)
Q Consensus 21 ~~~~~~~~~~~~~~~~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~~~~-----------~~e~~~l~~l~ 89 (314)
.+..+..+...-+|...++|-++.+||+|+|+.||++.+....+.||+|+-.....+. -+|..+-+.|.
T Consensus 446 Ri~NEdnSQFkDHptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLD 525 (775)
T KOG1151|consen 446 RIHNEDNSQFKDHPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELD 525 (775)
T ss_pred hhcccchhhhccCcchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccC
Confidence 3445556667788999999999999999999999999999999999999754332221 26888999999
Q ss_pred CCceeeeceeeeecCCCCceeEEEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcC-CCceecCCCC
Q 021306 90 HPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV-PRVCHRDLKP 168 (314)
Q Consensus 90 h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~-~~i~h~dl~p 168 (314)
||.||+++++|....+ .+|-|+|||+|+-++ .|+..+..+++.+++.|+.||+.||.||.+. ..|+|-||||
T Consensus 526 HpRIVKlYDyfslDtd----sFCTVLEYceGNDLD---FYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKP 598 (775)
T KOG1151|consen 526 HPRIVKLYDYFSLDTD----SFCTVLEYCEGNDLD---FYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKP 598 (775)
T ss_pred cceeeeeeeeeeeccc----cceeeeeecCCCchh---HHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCC
Confidence 9999999999843222 288999999997444 4455778999999999999999999999972 4699999999
Q ss_pred CcEEEcCCC--CcEEEeecCcccccccCCcc--------ccccccccccccccccC---CCCCCcchhHHHHHHHHHHHH
Q 021306 169 QNLLVDPLT--HQVKICDFGSAKQLIAGEAN--------ISYICSRFYRAPELIFG---ATEYTTSIDIWSAGCVLAELL 235 (314)
Q Consensus 169 ~Nil~~~~~--~~~~l~dfg~~~~~~~~~~~--------~~~~~~~~y~aPE~~~~---~~~~~~~~Dv~slG~il~el~ 235 (314)
.|||+-.++ +.+||.|||+++........ ....||..|++||.+.- .++.+.+.||||+|+|+|.++
T Consensus 599 gNILLv~GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQCl 678 (775)
T KOG1151|consen 599 GNILLVNGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCL 678 (775)
T ss_pred ccEEEecCcccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhh
Confidence 999996533 57999999999877544322 23557888999999742 345788999999999999999
Q ss_pred hCCCCCCCCChHHHH-HH--HHHHc--CCC--------CHHHHh-ccC-CCCCCCcccccccCChhhhhccc
Q 021306 236 LGQPLFPGENAVDQL-VE--IIKVL--GTP--------TREEIR-CMN-PNYTDFRFPQIKAHPWHKVCIFH 292 (314)
Q Consensus 236 tg~~pf~~~~~~~~~-~~--i~~~~--~~~--------~~~~~~-~~~-p~~~~~~~~~l~~~p~~~~~~~~ 292 (314)
.|+.||..+.....+ .. |++.. .-| +...++ |+. .--.|+.+.+|.+||++++...+
T Consensus 679 YGrKPFGhnqsQQdILqeNTIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllPh~rr 750 (775)
T KOG1151|consen 679 YGRKPFGHNQSQQDILQENTILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLPHIRR 750 (775)
T ss_pred ccCCCCCCchhHHHHHhhhchhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccchhhh
Confidence 999999776443322 21 22211 001 112222 221 11158889999999999886554
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=244.96 Aligned_cols=247 Identities=20% Similarity=0.298 Sum_probs=194.8
Q ss_pred CceeeeeEeecCceEEEEEEECCCCcEEEEEEeecccc---chHHHHHHHHhCCCCceeeeceeeeecCCCCceeEEEEe
Q 021306 39 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR---YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVM 115 (314)
Q Consensus 39 ~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~~---~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 115 (314)
+......||.|.||.||.+.+++-.-.||||.++.+.. .+..|+.+++.++|||+|++++++..... +|||+
T Consensus 268 dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpP-----FYIiT 342 (1157)
T KOG4278|consen 268 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPP-----FYIIT 342 (1157)
T ss_pred heeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCC-----eEEEE
Confidence 56678899999999999999998888899999987654 34589999999999999999999854433 88999
Q ss_pred eccc-ccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcccccccC
Q 021306 116 EYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG 194 (314)
Q Consensus 116 e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~~~ 194 (314)
|||. |+|++.|....+ ..++.-.+..++.||..|+.||.. ++++||||-..|.|+.. +..+|+.|||+++.....
T Consensus 343 EfM~yGNLLdYLRecnr--~ev~avvLlyMAtQIsSaMeYLEk-knFIHRDLAARNCLVgE-nhiVKvADFGLsRlMtgD 418 (1157)
T KOG4278|consen 343 EFMCYGNLLDYLRECNR--SEVPAVVLLYMATQISSAMEYLEK-KNFIHRDLAARNCLVGE-NHIVKVADFGLSRLMTGD 418 (1157)
T ss_pred ecccCccHHHHHHHhch--hhcchhHHHHHHHHHHHHHHHHHH-hhhhhhhhhhhhccccc-cceEEeeccchhhhhcCC
Confidence 9998 689998887533 456777889999999999999999 99999999999999998 889999999999877554
Q ss_pred Cccc--cccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCHHHHhccCCC
Q 021306 195 EANI--SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 271 (314)
Q Consensus 195 ~~~~--~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~p~ 271 (314)
..+. ......-|.|||.+. ...++.++|||+||++|||+.| |..||.+.+-.+.+..+-++ .+.--|+
T Consensus 419 TYTAHAGAKFPIKWTAPEsLA-yNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkg--------yRM~~Pe 489 (1157)
T KOG4278|consen 419 TYTAHAGAKFPIKWTAPESLA-YNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKG--------YRMDGPE 489 (1157)
T ss_pred ceecccCccCcccccCccccc-ccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhcc--------ccccCCC
Confidence 3322 233356699999984 4448999999999999999999 99999999877655544332 2333455
Q ss_pred CCCCcccccccCChhhhhcccCChHHHHHhcc
Q 021306 272 YTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGS 303 (314)
Q Consensus 272 ~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~ 303 (314)
.+.+...+||..||.-.++-+.-...+...++
T Consensus 490 GCPpkVYeLMraCW~WsPsDRPsFaeiHqafE 521 (1157)
T KOG4278|consen 490 GCPPKVYELMRACWNWSPSDRPSFAEIHQAFE 521 (1157)
T ss_pred CCCHHHHHHHHHHhcCCcccCccHHHHHHHHH
Confidence 56666777777777655554444433333333
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-32 Score=243.03 Aligned_cols=202 Identities=27% Similarity=0.400 Sum_probs=172.5
Q ss_pred CCCccCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccccch------------HHHHHHHHhCC---CCceeee
Q 021306 32 GEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK------------NRELQLMRVMD---HPNVISL 96 (314)
Q Consensus 32 ~~~~~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~~~~------------~~e~~~l~~l~---h~~iv~~ 96 (314)
.++...-.|+..+.||.|+||.|++|.++.+...|++|.+.+++... -.|+.+|..++ |+||+++
T Consensus 555 ~~~~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKl 634 (772)
T KOG1152|consen 555 KEYKKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKL 634 (772)
T ss_pred eeecccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhh
Confidence 45555567999999999999999999999999999999987664322 36899999997 9999999
Q ss_pred ceeeeecCCCCceeEEEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCC
Q 021306 97 KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPL 176 (314)
Q Consensus 97 ~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~ 176 (314)
++.| ++..++|++||-...++ .|..+......+++.++..|++|++.|+++||+ +||+|||||-+|+.++.
T Consensus 635 LdfF-----Eddd~yyl~te~hg~gI--DLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~-~~ivhrdikdenvivd~- 705 (772)
T KOG1152|consen 635 LDFF-----EDDDYYYLETEVHGEGI--DLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHD-QGIVHRDIKDENVIVDS- 705 (772)
T ss_pred hhee-----ecCCeeEEEecCCCCCc--chhhhhhccCccchHHHHHHHHHHHhccccccc-cCceecccccccEEEec-
Confidence 9999 66667899999876431 223334456889999999999999999999999 89999999999999998
Q ss_pred CCcEEEeecCcccccccCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 021306 177 THQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 243 (314)
Q Consensus 177 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~ 243 (314)
++-++|+|||.+... ...+...+.||..|.|||.+.|.+......|||+||++||.++....||..
T Consensus 706 ~g~~klidfgsaa~~-ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 706 NGFVKLIDFGSAAYT-KSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred CCeEEEeeccchhhh-cCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 899999999998744 455666789999999999998877667889999999999999999999964
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-33 Score=228.44 Aligned_cols=229 Identities=35% Similarity=0.636 Sum_probs=187.9
Q ss_pred CCCccCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeecc------ccchHHHHHHHHhCCCCceeeeceeeeecCC
Q 021306 32 GEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRVMDHPNVISLKHCFFSTTS 105 (314)
Q Consensus 32 ~~~~~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 105 (314)
..|...-+.+--+-||-|.||+||.+.+..+|+.+++|++..- ....-+|.+++..++|.|++...++.....-
T Consensus 47 h~Pqqq~Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~ 126 (449)
T KOG0664|consen 47 HPPQQQQDIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANP 126 (449)
T ss_pred CCccccccCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCc
Confidence 3444455667778899999999999999999999999998643 2334589999999999999998877643222
Q ss_pred CCceeEEEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeec
Q 021306 106 KNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF 185 (314)
Q Consensus 106 ~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~df 185 (314)
..-.-+|+++|.+..+|...+- ....++...++-++.||++||+|||+ .+|.||||||.|++++. +..+|||||
T Consensus 127 dfFqEiYV~TELmQSDLHKIIV----SPQ~Ls~DHvKVFlYQILRGLKYLHs-A~ILHRDIKPGNLLVNS-NCvLKICDF 200 (449)
T KOG0664|consen 127 SFFQELYVLTELMQSDLHKIIV----SPQALTPDHVKVFVYQILRGLKYLHT-ANILHRDIKPGNLLVNS-NCILKICDF 200 (449)
T ss_pred hHHHHHHHHHHHHHhhhhheec----cCCCCCcchhhhhHHHHHhhhHHHhh-cchhhccCCCccEEecc-CceEEeccc
Confidence 1111246788888877655543 46789999999999999999999999 89999999999999998 899999999
Q ss_pred CcccccccCCc--cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCHH
Q 021306 186 GSAKQLIAGEA--NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 263 (314)
Q Consensus 186 g~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~ 263 (314)
|+++....... ......|..|.|||.+.|...|+.+.||||+|||+.|++..+..|...++.+++..|...++.|..+
T Consensus 201 GLARvee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~E 280 (449)
T KOG0664|consen 201 GLARTWDQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQE 280 (449)
T ss_pred ccccccchhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHH
Confidence 99986543322 2234568889999999998889999999999999999999999999999999999999998888765
Q ss_pred HHh
Q 021306 264 EIR 266 (314)
Q Consensus 264 ~~~ 266 (314)
.+.
T Consensus 281 aMr 283 (449)
T KOG0664|consen 281 AMK 283 (449)
T ss_pred HHH
Confidence 543
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-31 Score=264.23 Aligned_cols=249 Identities=20% Similarity=0.252 Sum_probs=179.5
Q ss_pred CceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHhCCCCceeeeceeeeecCCCCceeEEEEeecc
Q 021306 39 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYV 118 (314)
Q Consensus 39 ~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~ 118 (314)
.|...+.||+|+||.||+|++..++..||+|.+.........|+..+++++||||+++++++.... ..++||||+
T Consensus 691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~l~~l~HpnIv~~~~~~~~~~-----~~~lv~Ey~ 765 (968)
T PLN00113 691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIADMGKLQHPNIVKLIGLCRSEK-----GAYLIHEYI 765 (968)
T ss_pred hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccccHHHHHHHhhCCCCCcceEEEEEEcCC-----CCEEEEeCC
Confidence 466778999999999999999889999999998766555567899999999999999999985433 378999999
Q ss_pred cc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhh---cCCCceecCCCCCcEEEcCCCCcEEEeecCcccccccC
Q 021306 119 PE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH---TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG 194 (314)
Q Consensus 119 ~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH---~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~~~ 194 (314)
++ +|.+.+. .+++.++..++.|++.|+.||| + .+++||||||+||+++. +...++. ++.......
T Consensus 766 ~~g~L~~~l~-------~l~~~~~~~i~~~ia~~L~yLH~~~~-~~iiH~dlkp~Nil~~~-~~~~~~~-~~~~~~~~~- 834 (968)
T PLN00113 766 EGKNLSEVLR-------NLSWERRRKIAIGIAKALRFLHCRCS-PAVVVGNLSPEKIIIDG-KDEPHLR-LSLPGLLCT- 834 (968)
T ss_pred CCCcHHHHHh-------cCCHHHHHHHHHHHHHHHHHhccCCC-CCeecCCCCHHhEEECC-CCceEEE-ecccccccc-
Confidence 96 5555543 3789999999999999999999 5 69999999999999997 5555554 554432211
Q ss_pred CccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHcCCCCHHHHhccCCCCC
Q 021306 195 EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA-VDQLVEIIKVLGTPTREEIRCMNPNYT 273 (314)
Q Consensus 195 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~p~~~ 273 (314)
.....+++.|+|||.+.+.. ++.++||||||+++|||+||+.||..... ........+...... .....++|...
T Consensus 835 --~~~~~~t~~y~aPE~~~~~~-~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 910 (968)
T PLN00113 835 --DTKCFISSAYVAPETRETKD-ITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDC-HLDMWIDPSIR 910 (968)
T ss_pred --CCCccccccccCcccccCCC-CCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCcc-chhheeCcccc
Confidence 11235678999999986544 89999999999999999999999854321 111222222111100 00011122211
Q ss_pred C---------CcccccccCChhhhhcccCChHHHHHhcchhhh
Q 021306 274 D---------FRFPQIKAHPWHKVCIFHFPKHWLLEYGSHINA 307 (314)
Q Consensus 274 ~---------~~~~~l~~~p~~~~~~~~~~~~~~~~~~~~~~~ 307 (314)
. ..+.+++..||...+..++....+++.++.+..
T Consensus 911 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 911 GDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred CCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence 0 123356677888888888888888887765533
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-32 Score=226.16 Aligned_cols=217 Identities=36% Similarity=0.625 Sum_probs=181.2
Q ss_pred CCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeecc------ccchHHHHHHHHhCCCCceeeeceeeeecCCC-Cce
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSK-NEL 109 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~-~~~ 109 (314)
..+|.-+..+|.|.- .|--+.+.-.++.+++|+.... .+...+|..++..+.|+||++++.+|.-.... ...
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 347888888999988 7778888888999999988543 23346899999999999999999887432221 123
Q ss_pred eEEEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCccc
Q 021306 110 FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 189 (314)
Q Consensus 110 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~ 189 (314)
-.|+|||++..++...+. -.++-+.+..++.|++.|+++||+ .||+||||||+||++.. +..+|+.|||+++
T Consensus 95 e~y~v~e~m~~nl~~vi~------~elDH~tis~i~yq~~~~ik~lhs-~~IihRdLkPsnivv~~-~~~lKi~dfg~ar 166 (369)
T KOG0665|consen 95 EVYLVMELMDANLCQVIL------MELDHETISYILYQMLCGIKHLHS-AGIIHRDLKPSNIVVNS-DCTLKILDFGLAR 166 (369)
T ss_pred hHHHHHHhhhhHHHHHHH------HhcchHHHHHHHHHHHHHHHHHHh-cceeecccCcccceecc-hhheeeccchhhc
Confidence 367999999998877665 457778999999999999999999 89999999999999998 8899999999998
Q ss_pred ccccCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCHH
Q 021306 190 QLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 263 (314)
Q Consensus 190 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~ 263 (314)
.....-....+..+..|.|||.+.+.. +...+||||+||++.||++|+..|.+.+..+++.++++.++.+.+.
T Consensus 167 ~e~~~~~mtpyVvtRyyrapevil~~~-~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~ 239 (369)
T KOG0665|consen 167 TEDTDFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPS 239 (369)
T ss_pred ccCcccccCchhheeeccCchheeccC-CcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHH
Confidence 654442334466788899999998877 8999999999999999999999999999999999999887776553
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-32 Score=244.33 Aligned_cols=243 Identities=25% Similarity=0.369 Sum_probs=192.7
Q ss_pred CCceeeeeEeecCceEEEEEEECC-CC--cEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCce
Q 021306 38 ISYMAERVVGTGSFGIVFQAKCLE-TG--ETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL 109 (314)
Q Consensus 38 ~~y~~~~~Lg~g~~g~Vy~~~~~~-~~--~~~~vK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 109 (314)
++.++.++||+|.||.|+++.++. +| -.||||.+..+. ..+.+|+..+.+|+|+|++++|+++.+..
T Consensus 110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~qp----- 184 (1039)
T KOG0199|consen 110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLDQP----- 184 (1039)
T ss_pred HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeeccch-----
Confidence 367889999999999999998874 33 368999987553 34579999999999999999999986421
Q ss_pred eEEEEeeccc-ccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcc
Q 021306 110 FLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 188 (314)
Q Consensus 110 ~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~ 188 (314)
+.+|+|.++ |+|++.|.. .....|-...+..++.||+.|+.||.. +++|||||-..|+++-. ...+||+|||+.
T Consensus 185 -~mMV~ELaplGSLldrLrk--a~~~~llv~~Lcdya~QiA~aM~YLes-krlvHRDLAARNlllas-prtVKI~DFGLm 259 (1039)
T KOG0199|consen 185 -AMMVFELAPLGSLLDRLRK--AKKAILLVSRLCDYAMQIAKAMQYLES-KRLVHRDLAARNLLLAS-PRTVKICDFGLM 259 (1039)
T ss_pred -hhHHhhhcccchHHHHHhh--ccccceeHHHHHHHHHHHHHHHHHHhh-hhhhhhhhhhhhheecc-cceeeeecccce
Confidence 569999999 688888876 345678889999999999999999999 99999999999999998 778999999999
Q ss_pred cccccCCcccc----ccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCHH
Q 021306 189 KQLIAGEANIS----YICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTRE 263 (314)
Q Consensus 189 ~~~~~~~~~~~----~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~ 263 (314)
+.+........ ......|.|||.++... ++-++|||++|+++|||++ |+.||.+....+.+.++-++ +
T Consensus 260 RaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~k-FShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~------e 332 (1039)
T KOG0199|consen 260 RALGENEDMYVMAPQRKVPFAWCAPESLRHRK-FSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAG------E 332 (1039)
T ss_pred eccCCCCcceEecCCCcCcccccCHhHhcccc-ccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcccc------c
Confidence 87654433221 11244599999997655 8999999999999999999 89999999988877776432 1
Q ss_pred HHhccCCCCCCCcccccccCChhhhhcccCChHHHH
Q 021306 264 EIRCMNPNYTDFRFPQIKAHPWHKVCIFHFPKHWLL 299 (314)
Q Consensus 264 ~~~~~~p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~ 299 (314)
.+. -|..+.-.+.++++.||--.+.-+.+..+|.
T Consensus 333 rLp--RPk~csedIY~imk~cWah~paDRptFsair 366 (1039)
T KOG0199|consen 333 RLP--RPKYCSEDIYQIMKNCWAHNPADRPTFSAIR 366 (1039)
T ss_pred cCC--CCCCChHHHHHHHHHhccCCccccccHHHHH
Confidence 111 1122333577888888877777666666653
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.9e-32 Score=232.54 Aligned_cols=255 Identities=22% Similarity=0.288 Sum_probs=186.9
Q ss_pred CCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeec-cccchHHHHHHHHh--CCCCceeeeceeeeecCCCCceeEEE
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQ-DRRYKNRELQLMRV--MDHPNVISLKHCFFSTTSKNELFLNL 113 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~-~~~~~~~e~~~l~~--l~h~~iv~~~~~~~~~~~~~~~~~~l 113 (314)
..+.++++.||+|.||.||+|++ -|+.||||+|.. ++....+|.++.+. |+|+||+.++..=...+ ..-.++|+
T Consensus 210 arqI~L~e~IGkGRyGEVwrG~w--rGe~VAVKiF~srdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~-gs~TQLwL 286 (513)
T KOG2052|consen 210 ARQIVLQEIIGKGRFGEVWRGRW--RGEDVAVKIFSSRDERSWFRETEIYQTVMLRHENILGFIAADNKDN-GSWTQLWL 286 (513)
T ss_pred hheeEEEEEecCccccceeeccc--cCCceEEEEecccchhhhhhHHHHHHHHHhccchhhhhhhccccCC-CceEEEEE
Confidence 35789999999999999999988 688999999964 45555677776554 69999999987532222 33467999
Q ss_pred Eeeccc-ccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcC-------CCceecCCCCCcEEEcCCCCcEEEeec
Q 021306 114 VMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV-------PRVCHRDLKPQNLLVDPLTHQVKICDF 185 (314)
Q Consensus 114 v~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~-------~~i~h~dl~p~Nil~~~~~~~~~l~df 185 (314)
|++|.+ |||.+.|.. ..++.+...+++..++.||.+||.. ..|.|||||..||++.. ++...|+|+
T Consensus 287 vTdYHe~GSL~DyL~r-----~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKk-n~~C~IADL 360 (513)
T KOG2052|consen 287 VTDYHEHGSLYDYLNR-----NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKK-NGTCCIADL 360 (513)
T ss_pred eeecccCCcHHHHHhh-----ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEcc-CCcEEEeec
Confidence 999999 688888874 7899999999999999999999951 46999999999999998 999999999
Q ss_pred CcccccccCC-----ccccccccccccccccccCCCCC-----CcchhHHHHHHHHHHHHhC----------CCCCCCCC
Q 021306 186 GSAKQLIAGE-----ANISYICSRFYRAPELIFGATEY-----TTSIDIWSAGCVLAELLLG----------QPLFPGEN 245 (314)
Q Consensus 186 g~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~-----~~~~Dv~slG~il~el~tg----------~~pf~~~~ 245 (314)
|+|....... ......||..|||||++...... -..+||||||.++||++.. +.||.+.-
T Consensus 361 GLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~V 440 (513)
T KOG2052|consen 361 GLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVV 440 (513)
T ss_pred eeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCC
Confidence 9997655432 23346789999999998543221 1369999999999998753 47887654
Q ss_pred hHHHHHHHHHH------cCCCCHHHHhccCCCCCCCcccccccCChhhhhcccCChHHHHHhcc
Q 021306 246 AVDQLVEIIKV------LGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGS 303 (314)
Q Consensus 246 ~~~~~~~i~~~------~~~~~~~~~~~~~p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~ 303 (314)
+.+.-.+-|+. +.+..+..+ .-+|.++ .+..||+.||...++.+.+.--+...+.
T Consensus 441 p~DPs~eeMrkVVCv~~~RP~ipnrW-~s~~~l~--~m~klMkeCW~~Np~aRltALriKKtl~ 501 (513)
T KOG2052|consen 441 PSDPSFEEMRKVVCVQKLRPNIPNRW-KSDPALR--VMAKLMKECWYANPAARLTALRIKKTLA 501 (513)
T ss_pred CCCCCHHHHhcceeecccCCCCCccc-ccCHHHH--HHHHHHHHhhcCCchhhhHHHHHHHHHH
Confidence 33322222221 111111111 1112211 3457899999999998877665554443
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-30 Score=217.75 Aligned_cols=224 Identities=35% Similarity=0.638 Sum_probs=176.2
Q ss_pred CceEEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeEEEEeecccc-cHH
Q 021306 50 SFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMY 123 (314)
Q Consensus 50 ~~g~Vy~~~~~~~~~~~~vK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~ 123 (314)
+||.||+++...+++.+++|.+.... ....+|+..+++++|++++++.+.+... ...++++||+++ +|.
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-----~~~~l~~e~~~~~~L~ 75 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDE-----DKLYLVMEYCDGGDLF 75 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeC-----CEEEEEEeCCCCCCHH
Confidence 58999999998889999999986542 3456899999999999999999987543 347899999998 666
Q ss_pred HHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcccccccCCcccccccc
Q 021306 124 RVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICS 203 (314)
Q Consensus 124 ~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 203 (314)
+.+.. ...++...++.++.+++.++.+||+ .+++|+||+|.||+++. ++.++++|||.+.............++
T Consensus 76 ~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~h~~i~~~ni~~~~-~~~~~l~d~~~~~~~~~~~~~~~~~~~ 149 (244)
T smart00220 76 DLLKK----RGRLSEDEARFYARQILSALEYLHS-NGIIHRDLKPENILLDE-DGHVKLADFGLARQLDPGGLLTTFVGT 149 (244)
T ss_pred HHHHh----ccCCCHHHHHHHHHHHHHHHHHHHH-cCeecCCcCHHHeEECC-CCcEEEccccceeeeccccccccccCC
Confidence 65543 2348999999999999999999999 89999999999999998 788999999999876554344455667
Q ss_pred ccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCC-------C----HHHHh-cc--C
Q 021306 204 RFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP-------T----REEIR-CM--N 269 (314)
Q Consensus 204 ~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~-------~----~~~~~-~~--~ 269 (314)
..|++||...+.. ++.++|+||||++++++++|..||................... . .+.+. ++ +
T Consensus 150 ~~~~~pE~~~~~~-~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~ 228 (244)
T smart00220 150 PEYMAPEVLLGKG-YGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKD 228 (244)
T ss_pred cCCCCHHHHccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCC
Confidence 8899999986444 7889999999999999999999998744333444333322221 1 11111 22 5
Q ss_pred CCCCCCcccccccCChh
Q 021306 270 PNYTDFRFPQIKAHPWH 286 (314)
Q Consensus 270 p~~~~~~~~~l~~~p~~ 286 (314)
|+ .|+++.++++|||+
T Consensus 229 p~-~Rp~~~~~~~~~~~ 244 (244)
T smart00220 229 PE-KRLTAEEALQHPFF 244 (244)
T ss_pred ch-hccCHHHHhhCCCC
Confidence 66 79999999999995
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-31 Score=229.91 Aligned_cols=259 Identities=23% Similarity=0.294 Sum_probs=189.8
Q ss_pred CCccCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeecc-ccchHHHHHHHHh--CCCCceeeeceeeeecCCCCce
Q 021306 33 EPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-RRYKNRELQLMRV--MDHPNVISLKHCFFSTTSKNEL 109 (314)
Q Consensus 33 ~~~~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~-~~~~~~e~~~l~~--l~h~~iv~~~~~~~~~~~~~~~ 109 (314)
.-....+.++.+++|+|+||.||+|.. +++.||||+|+.. +..+++|.++... ++|+||+++++.-...... .-
T Consensus 205 pl~~l~pl~l~eli~~Grfg~V~KaqL--~~~~VAVKifp~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~-~~ 281 (534)
T KOG3653|consen 205 PLLELDPLQLLELIGRGRFGCVWKAQL--DNRLVAVKIFPEQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTAD-RM 281 (534)
T ss_pred ccccCCchhhHHHhhcCccceeehhhc--cCceeEEEecCHHHHHHHHhHHHHHhccCccchhHHHhhchhccCCcc-cc
Confidence 333456789999999999999999986 6799999999754 4556777777665 5899999998875433322 33
Q ss_pred eEEEEeeccc-ccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcC--------CCceecCCCCCcEEEcCCCCcE
Q 021306 110 FLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV--------PRVCHRDLKPQNLLVDPLTHQV 180 (314)
Q Consensus 110 ~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~--------~~i~h~dl~p~Nil~~~~~~~~ 180 (314)
.+++|++|.+ |+|.+.|.. ..+++....+++..|++||+|||+. ..|+|||||..|||+.. +...
T Consensus 282 eywLVt~fh~kGsL~dyL~~-----ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~-DlTc 355 (534)
T KOG3653|consen 282 EYWLVTEFHPKGSLCDYLKA-----NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKN-DLTC 355 (534)
T ss_pred ceeEEeeeccCCcHHHHHHh-----ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEcc-CCcE
Confidence 4789999999 577777764 7899999999999999999999962 46999999999999998 8999
Q ss_pred EEeecCcccccccCC---ccccccccccccccccccCCCCCC-----cchhHHHHHHHHHHHHhCCC------------C
Q 021306 181 KICDFGSAKQLIAGE---ANISYICSRFYRAPELIFGATEYT-----TSIDIWSAGCVLAELLLGQP------------L 240 (314)
Q Consensus 181 ~l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~-----~~~Dv~slG~il~el~tg~~------------p 240 (314)
.|+|||+|.++.... ...+..||.+|||||++.+...+. .+.||||+|.+||||++... |
T Consensus 356 cIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlp 435 (534)
T KOG3653|consen 356 CIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLP 435 (534)
T ss_pred EeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCc
Confidence 999999998775432 234578899999999997655444 46999999999999998642 2
Q ss_pred CCC---C--ChHHHHHHHHH-HcCCCCHHHHhccCCCCCCCcccccccCChhhhhcccCChHHHHHhcc
Q 021306 241 FPG---E--NAVDQLVEIIK-VLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGS 303 (314)
Q Consensus 241 f~~---~--~~~~~~~~i~~-~~~~~~~~~~~~~~p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~ 303 (314)
|.. . +-+++.....+ +..+..++.+.+. +. --.+.+.+..||...+.++.+...+.+-+-
T Consensus 436 fe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h-~~--~~~l~et~EeCWDhDaeARLTA~Cv~eR~~ 501 (534)
T KOG3653|consen 436 FEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKH-AG--MAVLCETIEECWDHDAEARLTAGCVEERMA 501 (534)
T ss_pred hhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcC-cc--HHHHHHHHHHHcCCchhhhhhhHHHHHHHH
Confidence 321 1 11112222222 2222233333322 21 113567788889988888888887666543
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-30 Score=235.41 Aligned_cols=207 Identities=24% Similarity=0.305 Sum_probs=145.5
Q ss_pred ccCCCceeeeeEeecCceEEEEEEEC----------------CCCcEEEEEEeeccccc------------------hHH
Q 021306 35 KQTISYMAERVVGTGSFGIVFQAKCL----------------ETGETVAIKKVLQDRRY------------------KNR 80 (314)
Q Consensus 35 ~~~~~y~~~~~Lg~g~~g~Vy~~~~~----------------~~~~~~~vK~~~~~~~~------------------~~~ 80 (314)
...++|++.+.||+|+||.||++... ..++.|+||++...... ...
T Consensus 142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~v 221 (507)
T PLN03224 142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMV 221 (507)
T ss_pred ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHH
Confidence 35679999999999999999999642 24567999998643211 123
Q ss_pred HHHHHHhCCCCce-----eeeceeeeecCC---CCceeEEEEeecccc-cHHHHHHhhh-----------h---------
Q 021306 81 ELQLMRVMDHPNV-----ISLKHCFFSTTS---KNELFLNLVMEYVPE-SMYRVLKHYS-----------S--------- 131 (314)
Q Consensus 81 e~~~l~~l~h~~i-----v~~~~~~~~~~~---~~~~~~~lv~e~~~~-~l~~~l~~~~-----------~--------- 131 (314)
|+.++.+++|.++ +++++++..... ......++|+||+++ +|.+.+.... .
T Consensus 222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~ 301 (507)
T PLN03224 222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM 301 (507)
T ss_pred HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence 5556666766554 455565533211 112347899999996 6666554211 0
Q ss_pred cCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcccccccCCccc--ccccccccccc
Q 021306 132 ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI--SYICSRFYRAP 209 (314)
Q Consensus 132 ~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~--~~~~~~~y~aP 209 (314)
....+++..++.++.|++.+|.|||+ .+++|+||||+||+++. ++.++|+|||++.......... ...+++.|+||
T Consensus 302 ~~~~~~~~~~~~i~~ql~~aL~~lH~-~~ivHrDLKp~NILl~~-~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP 379 (507)
T PLN03224 302 PQDKRDINVIKGVMRQVLTGLRKLHR-IGIVHRDIKPENLLVTV-DGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP 379 (507)
T ss_pred ccccCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCchHhEEECC-CCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence 11235677899999999999999999 89999999999999998 7889999999986543222111 12337889999
Q ss_pred ccccCCCC---------------------CCcchhHHHHHHHHHHHHhCCC-CCCC
Q 021306 210 ELIFGATE---------------------YTTSIDIWSAGCVLAELLLGQP-LFPG 243 (314)
Q Consensus 210 E~~~~~~~---------------------~~~~~Dv~slG~il~el~tg~~-pf~~ 243 (314)
|.+..... .....|+||+||++|+|++|.. ||.+
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~ 435 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVAN 435 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccc
Confidence 99753211 1124699999999999999885 7754
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=237.66 Aligned_cols=245 Identities=28% Similarity=0.395 Sum_probs=190.4
Q ss_pred eeeeeEeecCceEEEEEEECCC--C--cEEEEEEeecc-----ccchHHHHHHHHhCCCCceeeeceeeeecCCCCceeE
Q 021306 41 MAERVVGTGSFGIVFQAKCLET--G--ETVAIKKVLQD-----RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 111 (314)
Q Consensus 41 ~~~~~Lg~g~~g~Vy~~~~~~~--~--~~~~vK~~~~~-----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 111 (314)
++.+.||.|-||.||+|....- | --||||.-+.+ ...+-.|+.+++++.||||++++|++.+. ..
T Consensus 392 tl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~------P~ 465 (974)
T KOG4257|consen 392 TLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ------PM 465 (974)
T ss_pred cHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc------ce
Confidence 4556899999999999987532 3 35788877653 33345789999999999999999987432 17
Q ss_pred EEEeeccc-ccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcccc
Q 021306 112 NLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 190 (314)
Q Consensus 112 ~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~ 190 (314)
|||||.++ |.|...|+. ....++......++.||+.||.|||+ +.+|||||-..||++.. ...+||+|||+++.
T Consensus 466 WivmEL~~~GELr~yLq~---nk~sL~l~tL~ly~~Qi~talaYLeS-krfVHRDIAaRNiLVsS-p~CVKLaDFGLSR~ 540 (974)
T KOG4257|consen 466 WIVMELAPLGELREYLQQ---NKDSLPLRTLTLYCYQICTALAYLES-KRFVHRDIAARNILVSS-PQCVKLADFGLSRY 540 (974)
T ss_pred eEEEecccchhHHHHHHh---ccccchHHHHHHHHHHHHHHHHHHHh-hchhhhhhhhhheeecC-cceeeecccchhhh
Confidence 89999999 556555553 34678999999999999999999999 89999999999999998 77899999999987
Q ss_pred cccCCcccccc--ccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCHHHHhc
Q 021306 191 LIAGEANISYI--CSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRC 267 (314)
Q Consensus 191 ~~~~~~~~~~~--~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 267 (314)
........... ...-|||||.+.-+ .++.++|||-||+++||++. |..||.+....+.+-.+-++-..|
T Consensus 541 ~ed~~yYkaS~~kLPIKWmaPESINfR-rFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP------- 612 (974)
T KOG4257|consen 541 LEDDAYYKASRGKLPIKWMAPESINFR-RFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLP------- 612 (974)
T ss_pred ccccchhhccccccceeecCccccchh-cccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCC-------
Confidence 65543322212 24569999999544 48999999999999999988 999999988777766665443322
Q ss_pred cCCCCCCCcccccccCChhhhhcccCChHHHHHhcchh
Q 021306 268 MNPNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGSHI 305 (314)
Q Consensus 268 ~~p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~~~ 305 (314)
++|. +.+.+..|+..||-..+..+.....+...+..+
T Consensus 613 ~P~n-CPp~LYslmskcWayeP~kRPrftei~~~lsdv 649 (974)
T KOG4257|consen 613 CPPN-CPPALYSLMSKCWAYEPSKRPRFTEIKAILSDV 649 (974)
T ss_pred CCCC-CChHHHHHHHHHhccCcccCCcHHHHHHHHHHH
Confidence 2222 566788899999988888888777666655443
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-31 Score=241.69 Aligned_cols=239 Identities=28% Similarity=0.394 Sum_probs=181.2
Q ss_pred eeeeeEeecCce-EEEEEEECCCCcEEEEEEeecccc-chHHHHHHHHhC-CCCceeeeceeeeecCCCCceeEEEEeec
Q 021306 41 MAERVVGTGSFG-IVFQAKCLETGETVAIKKVLQDRR-YKNRELQLMRVM-DHPNVISLKHCFFSTTSKNELFLNLVMEY 117 (314)
Q Consensus 41 ~~~~~Lg~g~~g-~Vy~~~~~~~~~~~~vK~~~~~~~-~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv~e~ 117 (314)
.-.+.+|.|+.| .||+|.. .|+.||||.+-.+.. ..++|+..++.. +||||+++++.- ++..+.||..|.
T Consensus 512 ~~~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~e~~~~A~rEi~lL~eSD~H~NviRyyc~E-----~d~qF~YIalEL 584 (903)
T KOG1027|consen 512 SPKEILGYGSNGTVVFRGVY--EGREVAVKRLLEEFFDFAQREIQLLQESDEHPNVIRYYCSE-----QDRQFLYIALEL 584 (903)
T ss_pred ccHHHcccCCCCcEEEEEee--CCceehHHHHhhHhHHHHHHHHHHHHhccCCCceEEEEeec-----cCCceEEEEehH
Confidence 344678888886 5799987 889999999876655 568999998887 699999997765 555678999999
Q ss_pred ccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcC----CCCcEEEeecCccccccc
Q 021306 118 VPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP----LTHQVKICDFGSAKQLIA 193 (314)
Q Consensus 118 ~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~----~~~~~~l~dfg~~~~~~~ 193 (314)
|..+|.+.+...............+.++.|++.||++||+ -+||||||||.|||+.. ....++|+|||++++...
T Consensus 585 C~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHs-l~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~ 663 (903)
T KOG1027|consen 585 CACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHS-LKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAG 663 (903)
T ss_pred hhhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHh-cccccccCCCceEEEEccCCCcceeEEecccccccccCC
Confidence 9999988887521111111214567788999999999999 89999999999999976 235799999999998866
Q ss_pred CCcc----ccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHc------CC---
Q 021306 194 GEAN----ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVL------GT--- 259 (314)
Q Consensus 194 ~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~t-g~~pf~~~~~~~~~~~i~~~~------~~--- 259 (314)
.... ....||.+|+|||.+.+.. -+.++|||||||++|+.++ |.+||.+.-.. -.+|+.+. ..
T Consensus 664 ~~sS~~r~s~~sGt~GW~APE~L~~~~-~~~avDiFslGCvfyYvltgG~HpFGd~~~R--~~NIl~~~~~L~~L~~~~d 740 (903)
T KOG1027|consen 664 GKSSFSRLSGGSGTSGWQAPEQLREDR-KTQAVDIFSLGCVFYYVLTGGSHPFGDSLER--QANILTGNYTLVHLEPLPD 740 (903)
T ss_pred CcchhhcccCCCCcccccCHHHHhccc-cCcccchhhcCceEEEEecCCccCCCchHHh--hhhhhcCccceeeeccCch
Confidence 5443 3457899999999997665 5779999999999999999 58999765433 22333221 11
Q ss_pred -CCHHHHhc---cCCCCCCCcccccccCChhhhhcc
Q 021306 260 -PTREEIRC---MNPNYTDFRFPQIKAHPWHKVCIF 291 (314)
Q Consensus 260 -~~~~~~~~---~~p~~~~~~~~~l~~~p~~~~~~~ 291 (314)
.+.+++.. ..|. .|+++.+++.||+|=..+.
T Consensus 741 ~eA~dLI~~ml~~dP~-~RPsa~~VL~HPlFW~~ek 775 (903)
T KOG1027|consen 741 CEAKDLISRMLNPDPQ-LRPSATDVLNHPLFWDSEK 775 (903)
T ss_pred HHHHHHHHHhcCCCcc-cCCCHHHHhCCCccCChHH
Confidence 22344443 3566 8999999999997655554
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.2e-29 Score=207.21 Aligned_cols=205 Identities=33% Similarity=0.570 Sum_probs=167.4
Q ss_pred ceeeeeEeecCceEEEEEEECCCCcEEEEEEeecc-----ccchHHHHHHHHhCCCCceeeeceeeeecCCCCceeEEEE
Q 021306 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-----RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLV 114 (314)
Q Consensus 40 y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~-----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 114 (314)
|.+.+.||.|++|.||++....+++.+++|.+... .....+|+..+++++|+|++++++.+... ...+++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~-----~~~~~v 75 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDP-----EPLYLV 75 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecC-----CceEEE
Confidence 67889999999999999999888999999998754 33446789999999999999999887433 347899
Q ss_pred eecccc-cHHHHHHhhhhcCCC-CCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcccccc
Q 021306 115 MEYVPE-SMYRVLKHYSSANQR-MPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 192 (314)
Q Consensus 115 ~e~~~~-~l~~~l~~~~~~~~~-l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~ 192 (314)
+|++++ +|.+.+.. ... +++..+..++.+++.++.+||+ .+++|+||+|.||+++. ++.++|+|||.+....
T Consensus 76 ~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~h~di~~~ni~v~~-~~~~~l~d~g~~~~~~ 149 (225)
T smart00221 76 MEYCEGGDLFDYLRK----KGGKLSEEEARFYLRQILEALEYLHS-LGIVHRDLKPENILLGM-DGLVKLADFGLARFIH 149 (225)
T ss_pred EeccCCCCHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcC-CCCEEEeeCceeeEec
Confidence 999998 76666553 233 8999999999999999999999 89999999999999998 6899999999987664
Q ss_pred cCC--ccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCC-CChHHHHHHHHH
Q 021306 193 AGE--ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG-ENAVDQLVEIIK 255 (314)
Q Consensus 193 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~-~~~~~~~~~i~~ 255 (314)
... ......++..|++||.+.+...++.++|+|+||+++++|++|+.||.. .+....+.+.+.
T Consensus 150 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~ 215 (225)
T smart00221 150 RDLAALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWS 215 (225)
T ss_pred CcccccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHh
Confidence 432 223445677899999984334477899999999999999999999977 455544444444
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-30 Score=235.99 Aligned_cols=244 Identities=27% Similarity=0.369 Sum_probs=191.3
Q ss_pred CceeeeeEeecCceEEEEEEECCCCc----EEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCce
Q 021306 39 SYMAERVVGTGSFGIVFQAKCLETGE----TVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL 109 (314)
Q Consensus 39 ~y~~~~~Lg~g~~g~Vy~~~~~~~~~----~~~vK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 109 (314)
..+..++||+|+||+||+|.+...|+ +|++|.+.... ....+|+..+.++.|+|+++++++.....
T Consensus 697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~----- 771 (1177)
T KOG1025|consen 697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST----- 771 (1177)
T ss_pred hhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-----
Confidence 45677899999999999999887665 67888775432 33457889999999999999999875433
Q ss_pred eEEEEeeccc-ccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcc
Q 021306 110 FLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 188 (314)
Q Consensus 110 ~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~ 188 (314)
+-||++|++ |.|++.++. ...++-.+..+.|..||++|++|||. +.++||||-.+||||.. .+.+|+.|||++
T Consensus 772 -~qlvtq~mP~G~LlDyvr~---hr~~igsq~lLnw~~QIAkgM~YLe~-qrlVHrdLaaRNVLVks-P~hvkitdfgla 845 (1177)
T KOG1025|consen 772 -LQLVTQLMPLGCLLDYVRE---HRDNIGSQDLLNWCYQIAKGMKYLEE-QRLVHRDLAARNVLVKS-PNHVKITDFGLA 845 (1177)
T ss_pred -HHHHHHhcccchHHHHHHH---hhccccHHHHHHHHHHHHHHHHHHHh-cchhhhhhhhhheeecC-CCeEEEEecchh
Confidence 448999999 577777765 34778899999999999999999999 89999999999999998 889999999999
Q ss_pred cccccCCccccccc---cccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCHHH
Q 021306 189 KQLIAGEANISYIC---SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREE 264 (314)
Q Consensus 189 ~~~~~~~~~~~~~~---~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 264 (314)
+............+ .+-|+|-|.++.. .++.++||||+|+++||++| |..||.+....+.-. .++.. +.
T Consensus 846 ~ll~~d~~ey~~~~gK~pikwmale~i~~~-~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~d-lle~g-----eR 918 (1177)
T KOG1025|consen 846 KLLAPDEKEYSAPGGKVPIKWMALESIRIR-KYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPD-LLEKG-----ER 918 (1177)
T ss_pred hccCcccccccccccccCcHHHHHHHhhcc-CCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhH-HHhcc-----cc
Confidence 97766555444333 4569999999654 49999999999999999999 999999988765433 33221 11
Q ss_pred HhccCCCCCCCcccccccCChhhhhcccCChHHHHHhc
Q 021306 265 IRCMNPNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYG 302 (314)
Q Consensus 265 ~~~~~p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~ 302 (314)
. -.|...-+.+.+++-.||.-+...+.....+-+..
T Consensus 919 -L-sqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~f 954 (1177)
T KOG1025|consen 919 -L-SQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEF 954 (1177)
T ss_pred -C-CCCCCccHHHHHHHHHHhccCcccCccHHHHHHHH
Confidence 1 12333667788888888888887776666555443
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-28 Score=232.46 Aligned_cols=251 Identities=24% Similarity=0.378 Sum_probs=190.6
Q ss_pred CceeeeeEeecCceEEEEEEECC-------CCcEEEEEEeeccc-----cchHHHHHHHHhC-CCCceeeeceeeeecCC
Q 021306 39 SYMAERVVGTGSFGIVFQAKCLE-------TGETVAIKKVLQDR-----RYKNRELQLMRVM-DHPNVISLKHCFFSTTS 105 (314)
Q Consensus 39 ~y~~~~~Lg~g~~g~Vy~~~~~~-------~~~~~~vK~~~~~~-----~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~ 105 (314)
+..+.+.||.|.||.|+++.... ....||||..+... .....|+++++.+ .|+||+.+.+++..
T Consensus 297 ~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~--- 373 (609)
T KOG0200|consen 297 NLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQ--- 373 (609)
T ss_pred hccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeecc---
Confidence 44677799999999999997541 14579999886433 3445788888888 59999999998854
Q ss_pred CCceeEEEEeeccc-ccHHHHHHhhh---hc-------C--CCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEE
Q 021306 106 KNELFLNLVMEYVP-ESMYRVLKHYS---SA-------N--QRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLL 172 (314)
Q Consensus 106 ~~~~~~~lv~e~~~-~~l~~~l~~~~---~~-------~--~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil 172 (314)
...+++|+||+. |+|++.+.... .. . ..++..+...++.||+.|++||++ ..++||||-..||+
T Consensus 374 --~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~-~~~vHRDLAaRNVL 450 (609)
T KOG0200|consen 374 --DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLAS-VPCVHRDLAARNVL 450 (609)
T ss_pred --CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhh-CCccchhhhhhhEE
Confidence 334889999999 68888887644 00 1 139999999999999999999999 89999999999999
Q ss_pred EcCCCCcEEEeecCcccccccCCccc--ccc--ccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChH
Q 021306 173 VDPLTHQVKICDFGSAKQLIAGEANI--SYI--CSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAV 247 (314)
Q Consensus 173 ~~~~~~~~~l~dfg~~~~~~~~~~~~--~~~--~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~t-g~~pf~~~~~~ 247 (314)
+.. +..+|++|||+++......... ... -...|||||.+.. ..++.++||||+|++|||+++ |..||.+....
T Consensus 451 i~~-~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~-~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~ 528 (609)
T KOG0200|consen 451 ITK-NKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFD-RVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPT 528 (609)
T ss_pred ecC-CCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhcc-CcccccchhhHHHHHHHHHhhCCCCCCCCCCcH
Confidence 998 8899999999998543322221 111 2345999999976 559999999999999999999 99999986633
Q ss_pred HHHHHHHHHcCCCCHHHHhccCCCCCCCcccccccCChhhhhcccCChHHHHHhcch
Q 021306 248 DQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGSH 304 (314)
Q Consensus 248 ~~~~~i~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~~ 304 (314)
..+.+.++. -...-.|..+...+..+|+.||...+..+.....+.+.+..
T Consensus 529 ~~l~~~l~~-------G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~ 578 (609)
T KOG0200|consen 529 EELLEFLKE-------GNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEK 578 (609)
T ss_pred HHHHHHHhc-------CCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHH
Confidence 333333332 22223455556667789999998888888887777776655
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-29 Score=206.24 Aligned_cols=196 Identities=22% Similarity=0.349 Sum_probs=152.3
Q ss_pred CCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHhC-CCCceeeeceeeeecCCCCceeEE
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVM-DHPNVISLKHCFFSTTSKNELFLN 112 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~---~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~ 112 (314)
.+.|.|.+.||+|.||.+-+++++.+++.+++|.+.... ..+.+|...---| -|.||+.-++..+. ...+++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFq----t~d~Yv 98 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQ----TSDAYV 98 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhh----cCceEE
Confidence 468999999999999999999999999999999987653 3344555443333 58999998876543 333688
Q ss_pred EEeeccc-ccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcC-CCCcEEEeecCcccc
Q 021306 113 LVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP-LTHQVKICDFGSAKQ 190 (314)
Q Consensus 113 lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~-~~~~~~l~dfg~~~~ 190 (314)
+++||++ |+|.+-+. ...+.+...+.++.|++.||.|+|+ +++||||||.+|||+-. +..++||||||..+.
T Consensus 99 F~qE~aP~gdL~snv~-----~~GigE~~~K~v~~ql~SAi~fMHs-knlVHRdlK~eNiLif~~df~rvKlcDFG~t~k 172 (378)
T KOG1345|consen 99 FVQEFAPRGDLRSNVE-----AAGIGEANTKKVFAQLLSAIEFMHS-KNLVHRDLKAENILIFDADFYRVKLCDFGLTRK 172 (378)
T ss_pred EeeccCccchhhhhcC-----cccccHHHHHHHHHHHHHHHHHhhc-cchhhcccccceEEEecCCccEEEeeecccccc
Confidence 9999999 45544433 3568888999999999999999999 99999999999999954 345899999999876
Q ss_pred cccCCccccccccccccccccccC----CCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 021306 191 LIAGEANISYICSRFYRAPELIFG----ATEYTTSIDIWSAGCVLAELLLGQPLFPGE 244 (314)
Q Consensus 191 ~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~~Dv~slG~il~el~tg~~pf~~~ 244 (314)
....-.... .+..|.+||.+.. .-...+.+|+|.||+++|.++||+.||+..
T Consensus 173 ~g~tV~~~~--~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka 228 (378)
T KOG1345|consen 173 VGTTVKYLE--YVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKA 228 (378)
T ss_pred cCceehhhh--hhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhh
Confidence 533222222 2445888888632 223567899999999999999999999754
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-29 Score=226.50 Aligned_cols=256 Identities=24% Similarity=0.355 Sum_probs=202.5
Q ss_pred CCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeecc----ccchHHHHHHHHhCCCCceeeeceeeeecCCCCceeEE
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD----RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 112 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 112 (314)
-++|+++..+|+|.||.||+++++.+++..++|.++.+ ....+.|+-+++.++|+||+.+++.+...+. +|
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dk-----lw 88 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDK-----LW 88 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcC-----cE
Confidence 35799999999999999999999999999999998754 3445789999999999999999999854443 89
Q ss_pred EEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcccccc
Q 021306 113 LVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 192 (314)
Q Consensus 113 lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~ 192 (314)
+.||||+|+.+ +......+++++.++..++++.+++++|||+ .|-+|||||-.||++++ .+.+++.|||.+..+.
T Consensus 89 icMEycgggsl---Qdiy~~TgplselqiayvcRetl~gl~ylhs-~gk~hRdiKGanilltd-~gDvklaDfgvsaqit 163 (829)
T KOG0576|consen 89 ICMEYCGGGSL---QDIYHVTGPLSELQIAYVCRETLQGLKYLHS-QGKIHRDIKGANILLTD-EGDVKLADFGVSAQIT 163 (829)
T ss_pred EEEEecCCCcc---cceeeecccchhHHHHHHHhhhhccchhhhc-CCcccccccccceeecc-cCceeecccCchhhhh
Confidence 99999997522 2223346899999999999999999999999 89999999999999998 8899999999887654
Q ss_pred cC-Ccccccccccccccccccc--CCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCH-HH----
Q 021306 193 AG-EANISYICSRFYRAPELIF--GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR-EE---- 264 (314)
Q Consensus 193 ~~-~~~~~~~~~~~y~aPE~~~--~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~-~~---- 264 (314)
.. .....+.||+.|||||+-. ....|...+|+|++|++..|+.--+.|-....+...+...-+..-+++. ..
T Consensus 164 ati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kw 243 (829)
T KOG0576|consen 164 ATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKW 243 (829)
T ss_pred hhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccc
Confidence 33 3345688999999999952 1223789999999999999999999998888887666544333322221 11
Q ss_pred ------Hh----ccCCCCCCCcccccccCChhhhhcccCChHHHHHhcc
Q 021306 265 ------IR----CMNPNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGS 303 (314)
Q Consensus 265 ------~~----~~~p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~ 303 (314)
+- ..+|- +|++++.++.|||-.....+.....+++-.+
T Consensus 244 s~~fh~fvK~altknpK-kRptaeklL~h~fvs~~l~~rl~~eLLdK~n 291 (829)
T KOG0576|consen 244 SEFFHNFVKGALTKNPK-KRPTAEKLLQHPFVSQTLSRRLAIELLDKVN 291 (829)
T ss_pred hHHHHHHHHHHhcCCCc-cCCChhhheeceeeccchhhHHHHHHHHHcc
Confidence 00 12565 8999999999999888865555445554444
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.4e-27 Score=197.06 Aligned_cols=208 Identities=23% Similarity=0.349 Sum_probs=170.7
Q ss_pred CCCCCCccCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeecc--ccchHHHHHHHHhCC-CCceeeeceeeeecCC
Q 021306 29 GKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD--RRYKNRELQLMRVMD-HPNVISLKHCFFSTTS 105 (314)
Q Consensus 29 ~~~~~~~~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~--~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~ 105 (314)
..++..+.+-+|++++.||+|+||.++.+++.-++++||+|.-+.. ....+.|....+.|. .+.|...+ ++.
T Consensus 19 s~s~~~~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~APQLrdEYr~YKlL~g~~GIP~vY--YFG--- 93 (449)
T KOG1165|consen 19 SSSGVLMVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAPQLRDEYRTYKLLGGTEGIPQVY--YFG--- 93 (449)
T ss_pred CCCCceEecccceeccccccCcceeeecccccccCceEEEEeccccCCcchHHHHHHHHHHHcCCCCCCcee--eec---
Confidence 3445556677999999999999999999999999999999976543 344567888888884 56666653 222
Q ss_pred CCceeEEEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCC----CCcEE
Q 021306 106 KNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPL----THQVK 181 (314)
Q Consensus 106 ~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~----~~~~~ 181 (314)
+...+-.+|+|.++.+|.+.+.- .+..|+...+..++.||+.-++++|+ +.+++|||||+|+|+... .+.+.
T Consensus 94 qeG~~NiLVidLLGPSLEDLFD~---CgR~FSvKTV~miA~Qmi~rie~vH~-k~LIYRDIKPdNFLIGrp~~k~~n~Ih 169 (449)
T KOG1165|consen 94 QEGKYNILVIDLLGPSLEDLFDL---CGRRFSVKTVAMIAKQMITRIEYVHE-KDLIYRDIKPDNFLIGRPGTKDANVIH 169 (449)
T ss_pred cccchhhhhhhhhCcCHHHHHHH---hcCcccHHhHHHHHHHHHHHHHHHHh-cceeecccCccceeecCCCCCCCceEE
Confidence 44455679999999999887764 36889999999999999999999999 999999999999999642 34699
Q ss_pred EeecCcccccccCCc--------cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCh
Q 021306 182 ICDFGSAKQLIAGEA--------NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA 246 (314)
Q Consensus 182 l~dfg~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~ 246 (314)
++|||+|+.+..+.. ..+..||..||+-....|+. -+.+.|+-|||.++++++-|..||.+...
T Consensus 170 iiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrE-QSRRDDLEaLGHvFmYFLRGsLPWQGLKA 241 (449)
T KOG1165|consen 170 IIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGRE-QSRRDDLEALGHVFMYFLRGSLPWQGLKA 241 (449)
T ss_pred EEeccchhhhcCccccccCccccccccccceeeeEeeccccch-hhhhhhHHHhhhhhhhhccCCCccccccC
Confidence 999999988765443 23566899999998888776 58999999999999999999999998643
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.8e-27 Score=186.43 Aligned_cols=221 Identities=22% Similarity=0.303 Sum_probs=173.0
Q ss_pred ccCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeecccc--chHHHHHHHHhCCC-CceeeeceeeeecCCCCceeE
Q 021306 35 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR--YKNRELQLMRVMDH-PNVISLKHCFFSTTSKNELFL 111 (314)
Q Consensus 35 ~~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~~--~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~~~~~ 111 (314)
..+++|++++.||+|+||.+|++....+|+.||+|.-++..+ ....|..+.+.|++ ..|..+..+. .+..+-
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hpqL~yEskvY~iL~~g~GiP~i~~y~-----~e~~yn 86 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHPQLLYESKVYRILQGGVGIPHIRHYG-----TEKDYN 86 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCcchhHHHHHHHHhccCCCCchhhhhc-----cccccc
Confidence 446799999999999999999999999999999998765544 34578888888864 3444444433 344456
Q ss_pred EEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCC--CCcEEEeecCccc
Q 021306 112 NLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPL--THQVKICDFGSAK 189 (314)
Q Consensus 112 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~--~~~~~l~dfg~~~ 189 (314)
.+||+.++.+|.+.+.-+ ...++...+..++-||+.-++|+|. ++++||||||+|+++.-+ .+++.|+|||+++
T Consensus 87 vlVMdLLGPsLEdLfnfC---~R~ftmkTvLMLaDQml~RiEyvH~-r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaK 162 (341)
T KOG1163|consen 87 VLVMDLLGPSLEDLFNFC---SRRFTMKTVLMLADQMLSRIEYVHL-RNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAK 162 (341)
T ss_pred eeeeeccCccHHHHHHHH---hhhhhHHhHHHHHHHHHHHHHHHHh-hccccccCCccceeeccccccceEEEEeccchh
Confidence 799999999998877653 5789999999999999999999999 999999999999999753 3579999999998
Q ss_pred ccccCCc--------cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHHcC
Q 021306 190 QLIAGEA--------NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA---VDQLVEIIKVLG 258 (314)
Q Consensus 190 ~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~---~~~~~~i~~~~~ 258 (314)
++-.... .....||..|.+-....+.. -+.+.|+-|+|.+|.++-.|..||++..+ .+.+++|.+.-.
T Consensus 163 ky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~e-qSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~ 241 (341)
T KOG1163|consen 163 KYRDIRTRQHIPYREDRNLTGTARYASINAHLGIE-QSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKM 241 (341)
T ss_pred hhccccccccCccccCCccceeeeehhhhhhhhhh-hhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhc
Confidence 7754332 33466788998877765544 47889999999999999999999998644 344555655544
Q ss_pred CCCHHHH
Q 021306 259 TPTREEI 265 (314)
Q Consensus 259 ~~~~~~~ 265 (314)
..+.+.+
T Consensus 242 s~~ie~L 248 (341)
T KOG1163|consen 242 STPIEVL 248 (341)
T ss_pred CCCHHHH
Confidence 4444443
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-25 Score=184.87 Aligned_cols=208 Identities=33% Similarity=0.557 Sum_probs=164.1
Q ss_pred EeecCceEEEEEEECCCCcEEEEEEeecccc-----chHHHHHHHHhCCCCceeeeceeeeecCCCCceeEEEEeeccc-
Q 021306 46 VGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP- 119 (314)
Q Consensus 46 Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~~-----~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~- 119 (314)
||+|.+|.||++....+++.+++|.+..... ...+|+..++.++|++++++++++... ...++++|+++
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-----~~~~~~~e~~~~ 75 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDE-----NHLYLVMEYCEG 75 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecC-----CeEEEEEecCCC
Confidence 6899999999999987899999999976654 467899999999999999999887433 34789999999
Q ss_pred ccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcccccccCC-ccc
Q 021306 120 ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE-ANI 198 (314)
Q Consensus 120 ~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~~~~-~~~ 198 (314)
+++.+.+... ...+++..++.++.+++.++.+||+ .|++|+||+|.||+++..++.++|+||+.+....... ...
T Consensus 76 ~~l~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~-~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~ 151 (215)
T cd00180 76 GSLKDLLKEN---EGKLSEDEILRILLQILEGLEYLHS-NGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLK 151 (215)
T ss_pred CcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhh
Confidence 4666655431 1478999999999999999999999 8999999999999999745789999999987554332 122
Q ss_pred cccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCHHHHhccCCCCCCCccc
Q 021306 199 SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFP 278 (314)
Q Consensus 199 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~p~~~~~~~~ 278 (314)
...+...|++||.+......+.++|+|++|++++++ ..+..++. .....+|+ .|+++.
T Consensus 152 ~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------~~~~~~l~--------~~l~~~p~-~R~~~~ 209 (215)
T cd00180 152 TIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------PELKDLIR--------KMLQKDPE-KRPSAK 209 (215)
T ss_pred cccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH-------------HHHHHHHH--------HHhhCCcc-cCcCHH
Confidence 345577899999986543578999999999999999 23333332 12234566 788888
Q ss_pred ccccCC
Q 021306 279 QIKAHP 284 (314)
Q Consensus 279 ~l~~~p 284 (314)
++++++
T Consensus 210 ~l~~~~ 215 (215)
T cd00180 210 EILEHL 215 (215)
T ss_pred HHhhCC
Confidence 888764
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-27 Score=205.11 Aligned_cols=210 Identities=29% Similarity=0.490 Sum_probs=168.2
Q ss_pred CCCCccCCCceeeeeEeecCceEEEEEEECC---CCcEEEEEEeeccc--cchHHHHHHHHhC-CCCceeeeceeeeecC
Q 021306 31 NGEPKQTISYMAERVVGTGSFGIVFQAKCLE---TGETVAIKKVLQDR--RYKNRELQLMRVM-DHPNVISLKHCFFSTT 104 (314)
Q Consensus 31 ~~~~~~~~~y~~~~~Lg~g~~g~Vy~~~~~~---~~~~~~vK~~~~~~--~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~ 104 (314)
...|...+.|.+++.||.|.|+.||++.+.. ..+.|++|.+.... ....+|+++|..+ .+.||+++.+++
T Consensus 29 q~~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p~ri~~El~~L~~~gG~~ni~~~~~~~---- 104 (418)
T KOG1167|consen 29 QDIPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSPSRILNELEMLYRLGGSDNIIKLNGCF---- 104 (418)
T ss_pred hhhhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCchHHHHHHHHHHHhccchhhhcchhhh----
Confidence 4567777899999999999999999999887 68899999986543 4456899998888 689999999988
Q ss_pred CCCceeEEEEeeccccc-HHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEe
Q 021306 105 SKNELFLNLVMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKIC 183 (314)
Q Consensus 105 ~~~~~~~~lv~e~~~~~-l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~ 183 (314)
.......+|+||++.. ..+.+ ..++..+++.+++.+++||.++|. +||+||||||+||+.+...+.-.|+
T Consensus 105 -rnnd~v~ivlp~~~H~~f~~l~-------~~l~~~~i~~Yl~~ll~Al~~~h~-~GIvHRDiKpsNFL~n~~t~rg~Lv 175 (418)
T KOG1167|consen 105 -RNNDQVAIVLPYFEHDRFRDLY-------RSLSLAEIRWYLRNLLKALAHLHK-NGIVHRDIKPSNFLYNRRTQRGVLV 175 (418)
T ss_pred -ccCCeeEEEecccCccCHHHHH-------hcCCHHHHHHHHHHHHHHhhhhhc-cCccccCCCccccccccccCCceEE
Confidence 3334488999999974 33333 346789999999999999999999 9999999999999999988899999
Q ss_pred ecCccccccc----------------C-----------------------------CccccccccccccccccccCCCCC
Q 021306 184 DFGSAKQLIA----------------G-----------------------------EANISYICSRFYRAPELIFGATEY 218 (314)
Q Consensus 184 dfg~~~~~~~----------------~-----------------------------~~~~~~~~~~~y~aPE~~~~~~~~ 218 (314)
|||++..... . .......||++|.|||++...+.-
T Consensus 176 DFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Q 255 (418)
T KOG1167|consen 176 DFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQ 255 (418)
T ss_pred echhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCc
Confidence 9999852100 0 001124578999999999877777
Q ss_pred CcchhHHHHHHHHHHHHhCCCCCCC-CChHHHHHHH
Q 021306 219 TTSIDIWSAGCVLAELLLGQPLFPG-ENAVDQLVEI 253 (314)
Q Consensus 219 ~~~~Dv~slG~il~el~tg~~pf~~-~~~~~~~~~i 253 (314)
+++.||||.|+|+.-+++++.||-. .+..+.+.++
T Consensus 256 ttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei 291 (418)
T KOG1167|consen 256 TTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEI 291 (418)
T ss_pred CCccceeeccceeehhhccccccccCccccchHHHH
Confidence 8999999999999999999999844 3333334333
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.5e-24 Score=189.78 Aligned_cols=200 Identities=21% Similarity=0.250 Sum_probs=161.2
Q ss_pred CceeeeeEeecCceEEEEEEECCCC-cEEEEEEeecccc----chHHHHHHHHhCCC----CceeeeceeeeecCCCCce
Q 021306 39 SYMAERVVGTGSFGIVFQAKCLETG-ETVAIKKVLQDRR----YKNRELQLMRVMDH----PNVISLKHCFFSTTSKNEL 109 (314)
Q Consensus 39 ~y~~~~~Lg~g~~g~Vy~~~~~~~~-~~~~vK~~~~~~~----~~~~e~~~l~~l~h----~~iv~~~~~~~~~~~~~~~ 109 (314)
+|++.+.||+|+||.||+|.+..++ ..+|+|....... ....|..++..+.. .++..+++... ....
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~----~~~~ 94 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGR----STED 94 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEecc----CCCc
Confidence 7999999999999999999987764 6788887765321 46688888888863 56777665542 2344
Q ss_pred eEEEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCC----CcEEEeec
Q 021306 110 FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLT----HQVKICDF 185 (314)
Q Consensus 110 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~----~~~~l~df 185 (314)
+.|+||+.++.+|.+...... .+.++...+..++.|++.+|.+||+ .|++||||||.|+.+.... ..+.|+||
T Consensus 95 ~~~iVM~l~G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~-~G~iHRDiKp~N~~~g~~~~~~~~~~~llDf 171 (322)
T KOG1164|consen 95 FNFIVMSLLGPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHS-KGFIHRDIKPENFVVGQSSRSEVRTLYLLDF 171 (322)
T ss_pred eeEEEEeccCccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHh-cCcccCCcCHHHeeecCCCCcccceEEEEec
Confidence 578999999999988765432 6889999999999999999999999 8999999999999998743 56999999
Q ss_pred Cccc--ccccCC--------c-cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCh
Q 021306 186 GSAK--QLIAGE--------A-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA 246 (314)
Q Consensus 186 g~~~--~~~~~~--------~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~ 246 (314)
|+++ .+.... . .....||..|.++....+.. .+.+.|+||++.++.++..|..||.+...
T Consensus 172 Glar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e-~~r~DDles~~Y~l~el~~g~LPW~~~~~ 242 (322)
T KOG1164|consen 172 GLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIE-QGRRDDLESLFYMLLELLKGSLPWEALEM 242 (322)
T ss_pred CCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCc-cCCchhhhhHHHHHHHHhcCCCCCccccc
Confidence 9998 432211 1 12344899999999987655 79999999999999999999999977654
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.6e-25 Score=190.75 Aligned_cols=211 Identities=19% Similarity=0.258 Sum_probs=165.1
Q ss_pred CceeeeeEeecCceEEEEEEECCC-----CcEEEEEEeeccccchH-----HHHHHHHhCCCCceeeeceeeeecCCCCc
Q 021306 39 SYMAERVVGTGSFGIVFQAKCLET-----GETVAIKKVLQDRRYKN-----RELQLMRVMDHPNVISLKHCFFSTTSKNE 108 (314)
Q Consensus 39 ~y~~~~~Lg~g~~g~Vy~~~~~~~-----~~~~~vK~~~~~~~~~~-----~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 108 (314)
++++...+.+|.||+||.|.+++. .+.+.+|.++......+ .|.-++..+.|||+.++.++.... .
T Consensus 285 Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~----~ 360 (563)
T KOG1024|consen 285 RVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIED----Y 360 (563)
T ss_pred heechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeec----c
Confidence 677888899999999999976643 34566776665544433 566667777999999998876432 2
Q ss_pred eeEEEEeeccc-ccHHHHHHhhhh----cCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEe
Q 021306 109 LFLNLVMEYVP-ESMYRVLKHYSS----ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKIC 183 (314)
Q Consensus 109 ~~~~lv~e~~~-~~l~~~l~~~~~----~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~ 183 (314)
...++++.+.. |+|..++..... ..+.++-.++..++.|++.|+.|||+ +|++|.||-..|.++++ ..++||+
T Consensus 361 ~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~-~~ViHkDiAaRNCvIdd-~LqVklt 438 (563)
T KOG1024|consen 361 ATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHN-HGVIHKDIAARNCVIDD-QLQVKLT 438 (563)
T ss_pred CcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHh-cCcccchhhhhcceehh-heeEEec
Confidence 23668889888 677777763321 12457888999999999999999999 99999999999999998 8999999
Q ss_pred ecCcccccccCCcc---ccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHH
Q 021306 184 DFGSAKQLIAGEAN---ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKV 256 (314)
Q Consensus 184 dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~t-g~~pf~~~~~~~~~~~i~~~ 256 (314)
|=.+++..-..... .+.-....||+||.+.+.. ++.++|+||||++||||+| |+.||...++.++...+..+
T Consensus 439 DsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~-yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdG 514 (563)
T KOG1024|consen 439 DSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSH-YSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDG 514 (563)
T ss_pred cchhccccCcccccccCCCCCCcccccCHHHHhhhh-hcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhcc
Confidence 99988755332221 1222355699999997655 9999999999999999999 99999999999988777665
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=1e-25 Score=220.93 Aligned_cols=194 Identities=14% Similarity=0.132 Sum_probs=131.3
Q ss_pred CCC-CceeeeceeeeecCC--CCceeEEEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceec
Q 021306 88 MDH-PNVISLKHCFFSTTS--KNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 164 (314)
Q Consensus 88 l~h-~~iv~~~~~~~~~~~--~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~ 164 (314)
++| .||.++++++..... .....+++++|+++++|.+.+.. ....+++.+++.++.||+.||.|||+ +||+||
T Consensus 29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~-~gIvHr 104 (793)
T PLN00181 29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECEDVSLRQWLDN---PDRSVDAFECFHVFRQIVEIVNAAHS-QGIVVH 104 (793)
T ss_pred hhHHHHHHHhhcccCCccccccccchhhhhhccCCccHHHHHhc---ccccccHHHHHHHHHHHHHHHHHHHh-CCeeec
Confidence 344 466666665521111 11123668899999998888753 24669999999999999999999999 999999
Q ss_pred CCCCCcEEEcC------------------CCCcEEEeecCcccccccCC-----------------cccccccccccccc
Q 021306 165 DLKPQNLLVDP------------------LTHQVKICDFGSAKQLIAGE-----------------ANISYICSRFYRAP 209 (314)
Q Consensus 165 dl~p~Nil~~~------------------~~~~~~l~dfg~~~~~~~~~-----------------~~~~~~~~~~y~aP 209 (314)
||||+|||++. .+..++++|||+++...... ......+|+.|+||
T Consensus 105 DlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~AP 184 (793)
T PLN00181 105 NVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSP 184 (793)
T ss_pred cCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceECh
Confidence 99999999964 13446666666664321100 00113467889999
Q ss_pred ccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCC-----CHHH---H---hccCCCCCCCccc
Q 021306 210 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP-----TREE---I---RCMNPNYTDFRFP 278 (314)
Q Consensus 210 E~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~-----~~~~---~---~~~~p~~~~~~~~ 278 (314)
|.+.+.. ++.++|||||||++|||++|..|+..... ....+.....++ .+.. + ...+|. +|+++.
T Consensus 185 E~~~~~~-~~~~sDVwSlGviL~ELl~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~~P~-~Rps~~ 260 (793)
T PLN00181 185 EEDNGSS-SNCASDVYRLGVLLFELFCPVSSREEKSR--TMSSLRHRVLPPQILLNWPKEASFCLWLLHPEPS-CRPSMS 260 (793)
T ss_pred hhhccCC-CCchhhhhhHHHHHHHHhhCCCchhhHHH--HHHHHHHhhcChhhhhcCHHHHHHHHHhCCCChh-hCcChH
Confidence 9987655 89999999999999999999988754321 122221111111 1111 1 123565 899999
Q ss_pred ccccCChhhhh
Q 021306 279 QIKAHPWHKVC 289 (314)
Q Consensus 279 ~l~~~p~~~~~ 289 (314)
++++|||+...
T Consensus 261 eil~h~~~~~~ 271 (793)
T PLN00181 261 ELLQSEFINEP 271 (793)
T ss_pred HHhhchhhhhh
Confidence 99999999764
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.6e-24 Score=186.92 Aligned_cols=162 Identities=19% Similarity=0.244 Sum_probs=121.4
Q ss_pred CCCccCCCceeeeeEeecCceEEEEEEECC-CCcEEEEEEeecc---------ccchHHHHHHHHhCCCCceeeeceeee
Q 021306 32 GEPKQTISYMAERVVGTGSFGIVFQAKCLE-TGETVAIKKVLQD---------RRYKNRELQLMRVMDHPNVISLKHCFF 101 (314)
Q Consensus 32 ~~~~~~~~y~~~~~Lg~g~~g~Vy~~~~~~-~~~~~~vK~~~~~---------~~~~~~e~~~l~~l~h~~iv~~~~~~~ 101 (314)
..+...++|++.+.||+|+||+||+|.++. +++.+|+|+.... .....+|+.++++++|+|+++.+..+
T Consensus 12 ~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~- 90 (365)
T PRK09188 12 QIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT- 90 (365)
T ss_pred ccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc-
Confidence 344556789999999999999999999876 6788899986422 22357999999999999998532211
Q ss_pred ecCCCCceeEEEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCC-CCCcEEEcCCCCcE
Q 021306 102 STTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDL-KPQNLLVDPLTHQV 180 (314)
Q Consensus 102 ~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl-~p~Nil~~~~~~~~ 180 (314)
. ..++||||++|..+..+. ... ...++.|++.+|.+||+ +||+|||| ||+||+++. ++.+
T Consensus 91 --~-----~~~LVmE~~~G~~L~~~~-------~~~---~~~~~~~i~~aL~~lH~-~gIiHrDL~KP~NILv~~-~~~i 151 (365)
T PRK09188 91 --G-----KDGLVRGWTEGVPLHLAR-------PHG---DPAWFRSAHRALRDLHR-AGITHNDLAKPQNWLMGP-DGEA 151 (365)
T ss_pred --C-----CcEEEEEccCCCCHHHhC-------ccc---hHHHHHHHHHHHHHHHH-CCCeeCCCCCcceEEEcC-CCCE
Confidence 1 167999999985443221 111 14678899999999999 89999999 999999987 7789
Q ss_pred EEeecCcccccccCCcc---------cccccccccccccccc
Q 021306 181 KICDFGSAKQLIAGEAN---------ISYICSRFYRAPELIF 213 (314)
Q Consensus 181 ~l~dfg~~~~~~~~~~~---------~~~~~~~~y~aPE~~~ 213 (314)
+|+|||+++........ ....+++.|.|||.+.
T Consensus 152 kLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~ 193 (365)
T PRK09188 152 AVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALT 193 (365)
T ss_pred EEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCC
Confidence 99999999865432211 1234567788999873
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.2e-23 Score=166.28 Aligned_cols=109 Identities=25% Similarity=0.282 Sum_probs=90.5
Q ss_pred ccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcccccccCCcccc
Q 021306 120 ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS 199 (314)
Q Consensus 120 ~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~ 199 (314)
|+|.+.+.. .+.++++.+++.++.|++.||.|||+ ++ ||+||+++. ++.+++ ||.+.......
T Consensus 1 GsL~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~lH~-~~------kp~Nil~~~-~~~~~~--fG~~~~~~~~~---- 63 (176)
T smart00750 1 VSLADILEV---RGRPLNEEEIWAVCLQCLRALRELHR-QA------KSGNILLTW-DGLLKL--DGSVAFKTPEQ---- 63 (176)
T ss_pred CcHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHh-cC------CcccEeEcC-ccceee--ccceEeecccc----
Confidence 466666653 24679999999999999999999999 77 999999988 778888 99887543321
Q ss_pred ccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCh
Q 021306 200 YICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA 246 (314)
Q Consensus 200 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~ 246 (314)
..+++.|+|||.+.+.. ++.++||||||+++|+|++|+.||.....
T Consensus 64 ~~g~~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~p~~~~~~ 109 (176)
T smart00750 64 SRVDPYFMAPEVIQGQS-YTEKADIYSLGITLYEALDYELPYNEERE 109 (176)
T ss_pred CCCcccccChHHhcCCC-CcchhhHHHHHHHHHHHHhCCCCccccch
Confidence 25789999999997655 88999999999999999999999976544
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.2e-24 Score=199.19 Aligned_cols=241 Identities=25% Similarity=0.394 Sum_probs=178.3
Q ss_pred CCc-eeeeeEeecCceEEEEEEECCCCcEEEEEEeec----cccc------hHHHHHHHHhCCCCceeeeceeeeecCCC
Q 021306 38 ISY-MAERVVGTGSFGIVFQAKCLETGETVAIKKVLQ----DRRY------KNRELQLMRVMDHPNVISLKHCFFSTTSK 106 (314)
Q Consensus 38 ~~y-~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~----~~~~------~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 106 (314)
..| .....+|.|.+|.|+.+......+.+..|.+.. .... ...|.-+-..+.|+|++.....+++...
T Consensus 317 ~~y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~- 395 (601)
T KOG0590|consen 317 EKYGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDG- 395 (601)
T ss_pred cccCCccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhccc-
Confidence 345 567789999999888888776666666665541 1111 1234445666799999888777654433
Q ss_pred CceeEEEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecC
Q 021306 107 NELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 186 (314)
Q Consensus 107 ~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg 186 (314)
..-.||||+++|...+.. ...++..++..++.|++.|++|+|+ .||.|+|+||+|+++.. .+.++++|||
T Consensus 396 ----~~~~mE~~~~Dlf~~~~~----~~~~~~~e~~c~fKqL~~Gv~y~h~-~GiahrdlK~enll~~~-~g~lki~Dfg 465 (601)
T KOG0590|consen 396 ----ILQSMEYCPYDLFSLVMS----NGKLTPLEADCFFKQLLRGVKYLHS-MGLAHRDLKLENLLVTE-NGILKIIDFG 465 (601)
T ss_pred ----chhhhhcccHHHHHHHhc----ccccchhhhhHHHHHHHHHHHHHHh-cCceeccCccccEEEec-CCceEEeecC
Confidence 223499999977766653 3589999999999999999999999 89999999999999998 8899999999
Q ss_pred cccccccCCc-----cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHH-----------
Q 021306 187 SAKQLIAGEA-----NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQL----------- 250 (314)
Q Consensus 187 ~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~----------- 250 (314)
.+........ .....|+..|+|||.+.+........||||.|++++.|++|+.||......+..
T Consensus 466 ~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~ 545 (601)
T KOG0590|consen 466 AASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRN 545 (601)
T ss_pred cceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccc
Confidence 9865433322 335677889999999987775567899999999999999999999765433221
Q ss_pred -----HHHHHHcCCCCHHHHh---ccCCCCCCCcccccccCChhhhhc
Q 021306 251 -----VEIIKVLGTPTREEIR---CMNPNYTDFRFPQIKAHPWHKVCI 290 (314)
Q Consensus 251 -----~~i~~~~~~~~~~~~~---~~~p~~~~~~~~~l~~~p~~~~~~ 290 (314)
..+...+....+..+. .++|. +|+++++|++.+|+|.-.
T Consensus 546 ~~~~~~~~~~~lp~~~~~~~~~~l~~~P~-~R~ti~~i~~d~W~~~i~ 592 (601)
T KOG0590|consen 546 IFEGPNRLLSLLPRETRIIIYRMLQLDPT-KRITIEQILNDEWIRSIE 592 (601)
T ss_pred cccChHHHHHhchhhHHHHHHHHccCChh-heecHHHHhhChHhhhcc
Confidence 2222223333333333 34676 999999999999998654
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.1e-21 Score=159.52 Aligned_cols=135 Identities=19% Similarity=0.232 Sum_probs=103.5
Q ss_pred eeeEeecCceEEEEEEECCCCcEEEEEEeecccc-------------c-----------------hHHHHHHHHhCCCCc
Q 021306 43 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------------Y-----------------KNRELQLMRVMDHPN 92 (314)
Q Consensus 43 ~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~~-------------~-----------------~~~e~~~l~~l~h~~ 92 (314)
...||+|++|.||+|.+. +|+.||+|.++.... . ..+|...+.++.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 468999999999999976 899999999865421 1 123888899998777
Q ss_pred eeeeceeeeecCCCCceeEEEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHh-hcCCCceecCCCCCcE
Q 021306 93 VISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI-HTVPRVCHRDLKPQNL 171 (314)
Q Consensus 93 iv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~L-H~~~~i~h~dl~p~Ni 171 (314)
+....... ... .++||||++|+.+.... .....+++..+..++.|++.+|.++ |+ .||+||||||+||
T Consensus 81 v~~p~~~~--~~~-----~~iVmE~i~g~~l~~~~---~~~~~~~~~~~~~i~~qi~~~L~~l~H~-~giiHrDlkP~NI 149 (190)
T cd05147 81 IPCPEPIL--LKS-----HVLVMEFIGDDGWAAPR---LKDAPLSESKARELYLQVIQIMRILYQD-CRLVHADLSEYNL 149 (190)
T ss_pred CCCCcEEE--ecC-----CEEEEEEeCCCCCcchh---hhcCCCCHHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHE
Confidence 64332221 111 36999999985322111 1246789999999999999999999 68 8999999999999
Q ss_pred EEcCCCCcEEEeecCccccc
Q 021306 172 LVDPLTHQVKICDFGSAKQL 191 (314)
Q Consensus 172 l~~~~~~~~~l~dfg~~~~~ 191 (314)
++++ +.++|+|||++...
T Consensus 150 li~~--~~v~LiDFG~a~~~ 167 (190)
T cd05147 150 LYHD--GKLYIIDVSQSVEH 167 (190)
T ss_pred EEEC--CcEEEEEccccccC
Confidence 9984 57999999998754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.2e-22 Score=168.92 Aligned_cols=203 Identities=24% Similarity=0.294 Sum_probs=127.2
Q ss_pred CceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccccch-------HHHHHHHHhCC----------CCceeeeceeee
Q 021306 39 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-------NRELQLMRVMD----------HPNVISLKHCFF 101 (314)
Q Consensus 39 ~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~~~~-------~~e~~~l~~l~----------h~~iv~~~~~~~ 101 (314)
++..++.||.|+++.||.+.+..+++.+++|.+....... ++|.-....+. |-.++...+...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 5788999999999999999999999999999985433221 22222222211 112222222211
Q ss_pred --------ecCCC-Cce---eEEEEeecccccHHHHHHhhhhcCC---CCCHHHHHHHHHHHHHHHHHhhcCCCceecCC
Q 021306 102 --------STTSK-NEL---FLNLVMEYVPESMYRVLKHYSSANQ---RMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDL 166 (314)
Q Consensus 102 --------~~~~~-~~~---~~~lv~e~~~~~l~~~l~~~~~~~~---~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl 166 (314)
..... ... -.+++|+-+.++|...+........ .+.......+..|+++.+++||. .|++|+||
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~-~GlVHgdi 171 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHS-YGLVHGDI 171 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH-TTEEEST-
T ss_pred EcCCCcceecCCCCccceeehhhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhh-cceEeccc
Confidence 11111 111 1367889888888776554322222 23333345566899999999999 89999999
Q ss_pred CCCcEEEcCCCCcEEEeecCcccccccCCccccccccccccccccccCC-------CCCCcchhHHHHHHHHHHHHhCCC
Q 021306 167 KPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGA-------TEYTTSIDIWSAGCVLAELLLGQP 239 (314)
Q Consensus 167 ~p~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-------~~~~~~~Dv~slG~il~el~tg~~ 239 (314)
+|+|++++. ++.+.|+||+........... ...+..|.+||..... ..++.+.|.|+||+++|.|+||..
T Consensus 172 ~~~nfll~~-~G~v~Lg~F~~~~r~g~~~~~--~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~l 248 (288)
T PF14531_consen 172 KPENFLLDQ-DGGVFLGDFSSLVRAGTRYRC--SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRL 248 (288)
T ss_dssp SGGGEEE-T-TS-EEE--GGGEEETTEEEEG--GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-
T ss_pred ceeeEEEcC-CCCEEEcChHHHeecCceeec--cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccC
Confidence 999999999 899999999887654322111 3345668899876332 236889999999999999999999
Q ss_pred CCCCCC
Q 021306 240 LFPGEN 245 (314)
Q Consensus 240 pf~~~~ 245 (314)
||....
T Consensus 249 Pf~~~~ 254 (288)
T PF14531_consen 249 PFGLSS 254 (288)
T ss_dssp STCCCG
T ss_pred CCCCCC
Confidence 997654
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.8e-21 Score=160.39 Aligned_cols=170 Identities=12% Similarity=0.103 Sum_probs=123.3
Q ss_pred CCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc----cc---------hHHHHHHHHhCCCCceeeeceeeeec
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RY---------KNRELQLMRVMDHPNVISLKHCFFST 103 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~----~~---------~~~e~~~l~~l~h~~iv~~~~~~~~~ 103 (314)
.++|++.+.||.|+||.||++.. ++..+++|.+.... .. .++|+..+.++.|++|..+.+++...
T Consensus 30 ~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 30 SYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 36899999999999999999765 56789999986321 11 35778889999999999998876543
Q ss_pred CCC---CceeEEEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcE
Q 021306 104 TSK---NELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQV 180 (314)
Q Consensus 104 ~~~---~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~ 180 (314)
... .....+++|||++|..+..+. .+++. .+.+++.++..+|. .|++|||++|+||++++ ++ +
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~-------~~~~~----~~~~i~~~l~~lH~-~gi~H~Dikp~Nili~~-~g-i 173 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMP-------EISED----VKAKIKASIESLHQ-HGMVSGDPHKGNFIVSK-NG-L 173 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhh-------hccHH----HHHHHHHHHHHHHH-cCCccCCCChHHEEEeC-CC-E
Confidence 211 123367999999985222221 23332 35599999999999 89999999999999997 56 9
Q ss_pred EEeecCcccccccCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHH
Q 021306 181 KICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAEL 234 (314)
Q Consensus 181 ~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el 234 (314)
+|+|||............. .+..+. +..++|+||||+++..+
T Consensus 174 ~liDfg~~~~~~e~~a~d~-----------~vler~-y~~~~di~~lg~~~~~~ 215 (232)
T PRK10359 174 RIIDLSGKRCTAQRKAKDR-----------IDLERH-YGIKNEIKDLGYYLLIY 215 (232)
T ss_pred EEEECCCcccccchhhHHH-----------HHHHhH-hcccccccceeEeehHH
Confidence 9999998865422111110 222333 56789999999998755
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.86 E-value=7.8e-20 Score=160.45 Aligned_cols=195 Identities=35% Similarity=0.508 Sum_probs=156.7
Q ss_pred ceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCC-ceeeeceeeeecCCCCceeE
Q 021306 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHP-NVISLKHCFFSTTSKNELFL 111 (314)
Q Consensus 40 y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~-------~~~~~e~~~l~~l~h~-~iv~~~~~~~~~~~~~~~~~ 111 (314)
|++.+.||.|+|+.||++.+. ..+++|.+.... ....+|..++..+.|+ +++++.+.+.... ..
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~-----~~ 73 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEG-----SL 73 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCC-----EE
Confidence 789999999999999999986 778888875432 2345788889999988 7999988873222 26
Q ss_pred EEEeecccccHHHHHHhhhhcC---CCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcc
Q 021306 112 NLVMEYVPESMYRVLKHYSSAN---QRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 188 (314)
Q Consensus 112 ~lv~e~~~~~l~~~l~~~~~~~---~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~ 188 (314)
+++++++.++.+..+.. .. ..++......++.|++.++.++|+ .+++|+|+||+||+++.....++++|||.+
T Consensus 74 ~~~~~~~~~~~l~~~~~---~~~~~~~~~~~~~~~~~~~~~~~l~~~H~-~~~~hrd~kp~nil~~~~~~~~~l~dfg~~ 149 (384)
T COG0515 74 YLVMEYVDGGSLEDLLK---KIGRKGPLSESEALFILAQILSALEYLHS-KGIIHRDIKPENILLDRDGRVVKLIDFGLA 149 (384)
T ss_pred EEEEecCCCCcHHHHHH---hcccccCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHeeecCCCCeEEEeccCcc
Confidence 79999999753332222 22 279999999999999999999999 899999999999999983337999999998
Q ss_pred cccccCC-------ccccccccccccccccccCC--CCCCcchhHHHHHHHHHHHHhCCCCCCCCCh
Q 021306 189 KQLIAGE-------ANISYICSRFYRAPELIFGA--TEYTTSIDIWSAGCVLAELLLGQPLFPGENA 246 (314)
Q Consensus 189 ~~~~~~~-------~~~~~~~~~~y~aPE~~~~~--~~~~~~~Dv~slG~il~el~tg~~pf~~~~~ 246 (314)
....... ......++..|++||.+.+. ...+...|+||+|++++++++|..||.....
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~ 216 (384)
T COG0515 150 KLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKN 216 (384)
T ss_pred eecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCc
Confidence 7543332 23456778999999999763 4578999999999999999999999877764
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.6e-20 Score=150.40 Aligned_cols=182 Identities=16% Similarity=0.097 Sum_probs=132.6
Q ss_pred ceeeeeEeecCceEEEEEEECCCCcEEEEEEeecccc--------chHHHHHHHHhCC-CCceeeeceeeeecCCCCcee
Q 021306 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR--------YKNRELQLMRVMD-HPNVISLKHCFFSTTSKNELF 110 (314)
Q Consensus 40 y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~~--------~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~ 110 (314)
..+...|++|+||+||.+.. .+.+++.+.+..... ..++|+++++++. ++++++++++. .
T Consensus 4 ~~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~~----~----- 72 (218)
T PRK12274 4 PAVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHWD----G----- 72 (218)
T ss_pred cccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEEc----C-----
Confidence 45788999999999998764 777888776654332 3568999999995 47788876641 1
Q ss_pred EEEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCC-CCCcEEEcCCCCcEEEeecCccc
Q 021306 111 LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDL-KPQNLLVDPLTHQVKICDFGSAK 189 (314)
Q Consensus 111 ~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl-~p~Nil~~~~~~~~~l~dfg~~~ 189 (314)
.+++|||+.|..+.... +.. ...++.|++.+|.++|+ +||+|+|| ||+||+++. ++.++|+|||++.
T Consensus 73 ~~lvmeyI~G~~L~~~~---------~~~-~~~~~~qi~~~L~~lH~-~GIvHrDL~kp~NILv~~-~g~i~LIDFG~A~ 140 (218)
T PRK12274 73 RHLDRSYLAGAAMYQRP---------PRG-DLAYFRAARRLLQQLHR-CGVAHNDLAKEANWLVQE-DGSPAVIDFQLAV 140 (218)
T ss_pred EEEEEeeecCccHHhhh---------hhh-hHHHHHHHHHHHHHHHH-CcCccCCCCCcceEEEcC-CCCEEEEECCCce
Confidence 57999999985332111 001 13467899999999999 89999999 799999987 7789999999997
Q ss_pred ccccCCcc--------------ccccccccccccccccCCCCCC-cchhHHHHHHHHHHHHhCCCCCCCC
Q 021306 190 QLIAGEAN--------------ISYICSRFYRAPELIFGATEYT-TSIDIWSAGCVLAELLLGQPLFPGE 244 (314)
Q Consensus 190 ~~~~~~~~--------------~~~~~~~~y~aPE~~~~~~~~~-~~~Dv~slG~il~el~tg~~pf~~~ 244 (314)
........ .....++.+++|+...--...+ .+.+.++.|.-+|.++|+..|+.+.
T Consensus 141 ~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 141 RGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED 210 (218)
T ss_pred ecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence 54432210 0112366777777653222233 6789999999999999999887544
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.3e-20 Score=180.80 Aligned_cols=194 Identities=22% Similarity=0.376 Sum_probs=146.9
Q ss_pred CccCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccccch-HHHHHHHHhCC---CCceeeeceeeeecCCCCce
Q 021306 34 PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-NRELQLMRVMD---HPNVISLKHCFFSTTSKNEL 109 (314)
Q Consensus 34 ~~~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~~~~-~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~~~ 109 (314)
+..++.|.|.++||+|+||.||+|.... |+.+|+|.-+....+. ---..++.+|+ -+.|..+..+..-.+.
T Consensus 694 ~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~---- 768 (974)
T KOG1166|consen 694 EVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFYICLQVMERLKPQMLPSIMHISSAHVFQNA---- 768 (974)
T ss_pred eecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeeeehHHHHHhhchhhhcchHHHHHHHccCCc----
Confidence 3445689999999999999999999765 9999999765543322 11222333333 2344455444432222
Q ss_pred eEEEEeeccc-ccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcC------CCCcEEE
Q 021306 110 FLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP------LTHQVKI 182 (314)
Q Consensus 110 ~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~------~~~~~~l 182 (314)
-.+|+||.+ |+|++.+. ..+.+++..+..++.||+..+++||. .+|+||||||+|+++.. +...++|
T Consensus 769 -S~lv~ey~~~Gtlld~~N----~~~~m~e~lv~~~~~qml~ive~lH~-~~IIHgDiKPDNfll~~~~~~~~~~~~l~l 842 (974)
T KOG1166|consen 769 -SVLVSEYSPYGTLLDLIN----TNKVMDEYLVMFFSCQMLRIVEHLHA-MGIIHGDIKPDNFLLRREICADSDSKGLYL 842 (974)
T ss_pred -ceeeeeccccccHHHhhc----cCCCCCchhhhHHHHHHHHHHHHHHh-cceecccCCcceeEeecccCCCCcccceEE
Confidence 459999999 67777766 46889999999999999999999999 89999999999999943 2346999
Q ss_pred eecCccccccc---CCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCC
Q 021306 183 CDFGSAKQLIA---GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQP 239 (314)
Q Consensus 183 ~dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~ 239 (314)
+|||.+.-... .........|..+-++|...|++ +++..|.|.|+.+++-|+.|+.
T Consensus 843 IDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grp-WtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 843 IDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRP-WTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred EecccceeeeEcCCCcEEeeeeccccchhHHHhcCCC-CchhhhhHHHHHHHHHHHHHHH
Confidence 99998854322 22333455688899999997766 9999999999999999999984
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=7.5e-22 Score=186.95 Aligned_cols=229 Identities=28% Similarity=0.457 Sum_probs=161.8
Q ss_pred CceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc-----c-chH--HHHHHHHhCCCCceeeeceeeeecCCCCcee
Q 021306 39 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----R-YKN--RELQLMRVMDHPNVISLKHCFFSTTSKNELF 110 (314)
Q Consensus 39 ~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~-----~-~~~--~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 110 (314)
+|...+.||++.|=+|.++++. .|. +++|.|-+.. + ..+ +|++ ...+++||.+++.... .....
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~-eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~-----~t~kA 95 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDR-EGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVL-----VTDKA 95 (1431)
T ss_pred ceeeecccCchhhhhhhhccCC-Cce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHH-----HhhHH
Confidence 6889999999999999999964 444 8999874332 1 111 2333 5556999999986553 22223
Q ss_pred EEEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcccc
Q 021306 111 LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 190 (314)
Q Consensus 111 ~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~ 190 (314)
.|+|-+|+..+|++-+.. ..-+...+.+.|+.||+.||..+|+ .||+|||||.+|||+.. -+.+.|.||..-+.
T Consensus 96 AylvRqyvkhnLyDRlST----RPFL~~iEKkWiaFQLL~al~qcH~-~gVcHGDIKsENILiTS-WNW~~LtDFAsFKP 169 (1431)
T KOG1240|consen 96 AYLVRQYVKHNLYDRLST----RPFLVLIEKKWIAFQLLKALSQCHK-LGVCHGDIKSENILITS-WNWLYLTDFASFKP 169 (1431)
T ss_pred HHHHHHHHhhhhhhhhcc----chHHHHHHHHHHHHHHHHHHHHHHH-cCccccccccceEEEee-echhhhhcccccCC
Confidence 568889999999888774 3557888899999999999999999 89999999999999998 88899999997765
Q ss_pred cccCCcc---cc-ccc----cccccccccccCC----------CCCCcchhHHHHHHHHHHHHh-CCCCCC--------C
Q 021306 191 LIAGEAN---IS-YIC----SRFYRAPELIFGA----------TEYTTSIDIWSAGCVLAELLL-GQPLFP--------G 243 (314)
Q Consensus 191 ~~~~~~~---~~-~~~----~~~y~aPE~~~~~----------~~~~~~~Dv~slG~il~el~t-g~~pf~--------~ 243 (314)
...+... .. +.. -.+|.|||.+... ...+++.||||+||++.|+++ |++||. .
T Consensus 170 tYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~ 249 (1431)
T KOG1240|consen 170 TYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRS 249 (1431)
T ss_pred ccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhc
Confidence 4322211 11 111 2359999997431 115678999999999999999 889983 1
Q ss_pred CChHHHHHHHHHHcCCC-CHHHHh---ccCCCCCCCcccccccC
Q 021306 244 ENAVDQLVEIIKVLGTP-TREEIR---CMNPNYTDFRFPQIKAH 283 (314)
Q Consensus 244 ~~~~~~~~~i~~~~~~~-~~~~~~---~~~p~~~~~~~~~l~~~ 283 (314)
.+ .......++..... .+.++. ..+|+ +|+++++.++.
T Consensus 250 ~~-~~~~e~~Le~Ied~~~Rnlil~Mi~rdPs-~RlSAedyL~~ 291 (1431)
T KOG1240|consen 250 GN-ADDPEQLLEKIEDVSLRNLILSMIQRDPS-KRLSAEDYLQK 291 (1431)
T ss_pred cC-ccCHHHHHHhCcCccHHHHHHHHHccCch-hccCHHHHHHh
Confidence 11 12223333333333 233333 44777 78888887765
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.83 E-value=4.3e-20 Score=150.54 Aligned_cols=137 Identities=18% Similarity=0.186 Sum_probs=105.5
Q ss_pred eeeeEeecCceEEEEEEECCCCcEEEEEEeecccc------------------------------chHHHHHHHHhCCCC
Q 021306 42 AERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR------------------------------YKNRELQLMRVMDHP 91 (314)
Q Consensus 42 ~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~~------------------------------~~~~e~~~l~~l~h~ 91 (314)
+...||+|++|.||+|.+. +|+.||+|.++.... ..++|...+.++.++
T Consensus 1 ~~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~ 79 (190)
T cd05145 1 INGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEA 79 (190)
T ss_pred CCceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhC
Confidence 3578999999999999976 899999999865321 113677888888888
Q ss_pred ceeeeceeeeecCCCCceeEEEEeeccccc-HHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCc
Q 021306 92 NVISLKHCFFSTTSKNELFLNLVMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQN 170 (314)
Q Consensus 92 ~iv~~~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~N 170 (314)
++.....+... . .++||||++|+ +..... ....++...+..++.|++.++.++|...||+|+||||+|
T Consensus 80 ~i~~p~~~~~~--~-----~~lVmE~~~g~~~~~~~l----~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~N 148 (190)
T cd05145 80 GVPVPEPILLK--K-----NVLVMEFIGDDGSPAPRL----KDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYN 148 (190)
T ss_pred CCCCceEEEec--C-----CEEEEEEecCCCchhhhh----hhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhh
Confidence 87443333211 1 36999999985 222211 235688899999999999999999973599999999999
Q ss_pred EEEcCCCCcEEEeecCcccccc
Q 021306 171 LLVDPLTHQVKICDFGSAKQLI 192 (314)
Q Consensus 171 il~~~~~~~~~l~dfg~~~~~~ 192 (314)
|+++ ++.++|+|||++....
T Consensus 149 Ill~--~~~~~liDFG~a~~~~ 168 (190)
T cd05145 149 ILYH--DGKPYIIDVSQAVELD 168 (190)
T ss_pred EEEE--CCCEEEEEcccceecC
Confidence 9998 5789999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=8.8e-22 Score=177.55 Aligned_cols=191 Identities=27% Similarity=0.421 Sum_probs=150.8
Q ss_pred eEeecCceEEEEEEEC---CCCcEEEEEEeeccc------cchHHHHHHHHhCC-CCceeeeceeeeecCCCCceeEEEE
Q 021306 45 VVGTGSFGIVFQAKCL---ETGETVAIKKVLQDR------RYKNRELQLMRVMD-HPNVISLKHCFFSTTSKNELFLNLV 114 (314)
Q Consensus 45 ~Lg~g~~g~Vy~~~~~---~~~~~~~vK~~~~~~------~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~lv 114 (314)
.+|+|.||.|++++-. ..+..|++|..++.. .....|..++...+ ||.+++++-.++. ....+++
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt-----~~kl~l~ 75 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQT-----DGKLYLI 75 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeecc-----ccchhHh
Confidence 3789999999988632 346778888765421 12345677777776 9999999877743 3337799
Q ss_pred eecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcccccccC
Q 021306 115 MEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG 194 (314)
Q Consensus 115 ~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~~~ 194 (314)
.++..|+ .+.........+++...+.+...++.++.++|+ .+++|+|+|++||+++. .+.+++.|||+++.....
T Consensus 76 ld~~rgg---~lft~l~~~~~f~~~~~~~~~aelaLald~lh~-l~iiyrd~k~enilld~-~Ghi~~tdfglske~v~~ 150 (612)
T KOG0603|consen 76 LDFLRGG---DLFTRLSKEVMFDELDVAFYLAELALALDHLHK-LGIAYRDYKLENVLLLL-EGHIKLTDFGLSKEAVKE 150 (612)
T ss_pred hhhcccc---hhhhccccCCchHHHHHHHHHHHHHHHHhhcch-hHHHHhcccccceeecc-cCccccCCchhhhHhHhh
Confidence 9999885 223333445778899999999999999999999 89999999999999999 899999999999866544
Q ss_pred CccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 021306 195 EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 255 (314)
Q Consensus 195 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~ 255 (314)
... +||..|||||++.+ ...++|.||+|+++++|+||..||.+ +....|.+
T Consensus 151 ~~~---cgt~eymApEI~~g---h~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~ 201 (612)
T KOG0603|consen 151 KIA---CGTYEYRAPEIING---HLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILK 201 (612)
T ss_pred hhc---ccchhhhhhHhhhc---cCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhh
Confidence 433 78999999999963 67889999999999999999999988 44555554
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.79 E-value=6.1e-19 Score=148.15 Aligned_cols=140 Identities=16% Similarity=0.129 Sum_probs=105.8
Q ss_pred CceeeeeEeecCceEEEEEE-ECCCCcEEEEEEeecccc----------------------------chHHHHHHHHhCC
Q 021306 39 SYMAERVVGTGSFGIVFQAK-CLETGETVAIKKVLQDRR----------------------------YKNRELQLMRVMD 89 (314)
Q Consensus 39 ~y~~~~~Lg~g~~g~Vy~~~-~~~~~~~~~vK~~~~~~~----------------------------~~~~e~~~l~~l~ 89 (314)
-|.+.+.||+|++|.||+|. +..+|+.|++|.+..... ..++|+..+.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 48899999999999999998 667999999998864321 1247888888886
Q ss_pred CCceeeeceeeeecCCCCceeEEEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCC-ceecCCCC
Q 021306 90 HPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR-VCHRDLKP 168 (314)
Q Consensus 90 h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~-i~h~dl~p 168 (314)
+. .+.+...+.. .. .++||||++|..+... ......+...++..++.|++.++.+||+ .| ++|+||||
T Consensus 109 ~~-~i~~p~~~~~-~~-----~~lV~E~~~g~~L~~~---~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~g~iiH~Dikp 177 (237)
T smart00090 109 EA-GVPVPKPIAW-RR-----NVLVMEFIGGDGLPAP---RLKDVEPEEEEEFELYDDILEEMRKLYK-EGELVHGDLSE 177 (237)
T ss_pred hc-CCCCCeeeEe-cC-----ceEEEEEecCCccccc---ccccCCcchHHHHHHHHHHHHHHHHHHh-cCCEEeCCCCh
Confidence 53 2333333311 11 4699999998532221 1123456677788999999999999999 89 99999999
Q ss_pred CcEEEcCCCCcEEEeecCccccc
Q 021306 169 QNLLVDPLTHQVKICDFGSAKQL 191 (314)
Q Consensus 169 ~Nil~~~~~~~~~l~dfg~~~~~ 191 (314)
+||+++ ++.++|+|||.+...
T Consensus 178 ~NIli~--~~~i~LiDFg~a~~~ 198 (237)
T smart00090 178 YNILVH--DGKVVIIDVSQSVEL 198 (237)
T ss_pred hhEEEE--CCCEEEEEChhhhcc
Confidence 999998 567999999988643
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.2e-19 Score=171.87 Aligned_cols=217 Identities=23% Similarity=0.395 Sum_probs=148.7
Q ss_pred CCCCccCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHhCCCCceeeeceeeeecCCCCcee
Q 021306 31 NGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 110 (314)
Q Consensus 31 ~~~~~~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 110 (314)
...|-+. .|..++.+..|+||.||.++++.+.+.+++| ++++.-..++ |..+.+.
T Consensus 77 ~~~p~e~-df~~IklisngAygavylvrh~~trqrfa~k-iNkq~lilRn------------ilt~a~n----------- 131 (1205)
T KOG0606|consen 77 RRAPSES-DFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNLILRN------------ILTFAGN----------- 131 (1205)
T ss_pred ccCCCcc-ccceeEeeccCCCCceeeeeccccccchhhc-ccccchhhhc------------cccccCC-----------
Confidence 3344433 6999999999999999999999999999994 5544332222 3332211
Q ss_pred EEEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcccc
Q 021306 111 LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 190 (314)
Q Consensus 111 ~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~ 190 (314)
.++| |+-...+. .-++++. +++.+++|||+ .||+|+|+||+|.++.. -+++|+.|||+++.
T Consensus 132 pfvv-----gDc~tllk----~~g~lPv--------dmvla~Eylh~-ygivhrdlkpdnllIT~-mGhiKlTDfgLsk~ 192 (1205)
T KOG0606|consen 132 PFVV-----GDCATLLK----NIGPLPV--------DMVLAVEYLHS-YGIVHRDLKPDNLLITS-MGHIKLTDFGLSKK 192 (1205)
T ss_pred ccee-----chhhhhcc----cCCCCcc--------hhhHHhHhhcc-CCeecCCCCCCcceeee-cccccccchhhhhh
Confidence 1122 32222222 1234443 33778999999 99999999999999998 89999999999764
Q ss_pred cccCC----------------ccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 021306 191 LIAGE----------------ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 254 (314)
Q Consensus 191 ~~~~~----------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~ 254 (314)
..... .....++||.|.|||++.-+. |...+|+|++|+|+|+++-|+.||.+.++++.+...+
T Consensus 193 GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqg-ygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~vi 271 (1205)
T KOG0606|consen 193 GLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQG-YGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVI 271 (1205)
T ss_pred hhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhc-cCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhh
Confidence 32111 112346799999999996444 8999999999999999999999999999998887777
Q ss_pred HHcCCC----------CHHHHh---ccCCC--CCCCcccccccCChhhhhccc
Q 021306 255 KVLGTP----------TREEIR---CMNPN--YTDFRFPQIKAHPWHKVCIFH 292 (314)
Q Consensus 255 ~~~~~~----------~~~~~~---~~~p~--~~~~~~~~l~~~p~~~~~~~~ 292 (314)
.....- ..+.+. ..+|. +.-...-++++|++++.-...
T Consensus 272 sd~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~ 324 (1205)
T KOG0606|consen 272 SDDIEWPEEDEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWK 324 (1205)
T ss_pred hhhccccccCcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccc
Confidence 542211 112222 22333 112255678888888766654
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=4.6e-18 Score=139.63 Aligned_cols=137 Identities=18% Similarity=0.250 Sum_probs=101.0
Q ss_pred eeeeeEeecCceEEEEEEECCCCcEEEEEEeecc----ccchHHHHHHHHhC-----CCCceeeeceeeeecCCCCceeE
Q 021306 41 MAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD----RRYKNRELQLMRVM-----DHPNVISLKHCFFSTTSKNELFL 111 (314)
Q Consensus 41 ~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~----~~~~~~e~~~l~~l-----~h~~iv~~~~~~~~~~~~~~~~~ 111 (314)
.-.+.||+|++|.||. +..++.. ++|++... .....+|+.+++.+ .||||+++++++..... ....+
T Consensus 5 ~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g-~g~v~ 80 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCG-TGYVY 80 (210)
T ss_pred CCcceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCC-CeEEE
Confidence 4457899999999995 5666666 68887643 33457899999999 57999999998855321 12223
Q ss_pred EEEeeccc---ccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHH-HHhhcCCCceecCCCCCcEEEcCC---CCcEEEee
Q 021306 112 NLVMEYVP---ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL-AYIHTVPRVCHRDLKPQNLLVDPL---THQVKICD 184 (314)
Q Consensus 112 ~lv~e~~~---~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l-~~LH~~~~i~h~dl~p~Nil~~~~---~~~~~l~d 184 (314)
.+|+||.+ ++|.+.+.. ..+++. ..++.|++.++ .|||+ ++|+|+||||+||+++.. ..+++|+|
T Consensus 81 ~~I~e~~G~~~~tL~~~l~~-----~~~~e~--~~~~~~~L~~l~~yLh~-~~IvhrDlKp~NILl~~~~~~~~~~~LiD 152 (210)
T PRK10345 81 DVIADFDGKPSITLTEFAEQ-----CRYEED--VAQLRQLLKKLKRYLLD-NRIVTMELKPQNILCQRISESEVIPVVCD 152 (210)
T ss_pred EEEecCCCCcchhHHHHHHc-----ccccHh--HHHHHHHHHHHHHHHHH-CCEeecCCCHHHEEEeccCCCCCcEEEEE
Confidence 47899954 477776643 346555 35677888777 99999 999999999999999742 34799999
Q ss_pred cCccc
Q 021306 185 FGSAK 189 (314)
Q Consensus 185 fg~~~ 189 (314)
++.+.
T Consensus 153 g~G~~ 157 (210)
T PRK10345 153 NIGES 157 (210)
T ss_pred CCCCc
Confidence 55443
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=3.5e-19 Score=152.75 Aligned_cols=150 Identities=21% Similarity=0.305 Sum_probs=111.9
Q ss_pred CCCceeeeceeeeecCC----------------------CCceeEEEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHH
Q 021306 89 DHPNVISLKHCFFSTTS----------------------KNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTY 146 (314)
Q Consensus 89 ~h~~iv~~~~~~~~~~~----------------------~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ 146 (314)
+|||||++...|.+... .....+|+||.-...+|...+-. ...+....+.++.
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~tLr~yl~~-----~~~s~r~~~~~la 348 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQTLREYLWT-----RHRSYRTGRVILA 348 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchhhHHHHHhc-----CCCchHHHHHHHH
Confidence 69999998777755322 12345689998888887777653 5677788888999
Q ss_pred HHHHHHHHhhcCCCceecCCCCCcEEEcCC---CCcEEEeecCcccccccCC-------ccccccccccccccccccCCC
Q 021306 147 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPL---THQVKICDFGSAKQLIAGE-------ANISYICSRFYRAPELIFGAT 216 (314)
Q Consensus 147 ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~---~~~~~l~dfg~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~ 216 (314)
|++.|+.|||+ +|+.|||+|.+||++.-+ --.+.+.|||.+--..... .....-|....||||+....+
T Consensus 349 QlLEav~hL~~-hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~P 427 (598)
T KOG4158|consen 349 QLLEAVTHLHK-HGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVP 427 (598)
T ss_pred HHHHHHHHHHH-ccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCC
Confidence 99999999999 999999999999999432 2368899999764222211 112233456689999974433
Q ss_pred CC-----CcchhHHHHHHHHHHHHhCCCCCCCC
Q 021306 217 EY-----TTSIDIWSAGCVLAELLLGQPLFPGE 244 (314)
Q Consensus 217 ~~-----~~~~Dv~slG~il~el~tg~~pf~~~ 244 (314)
.. -.++|.|+.|.+.||+++...||.+.
T Consensus 428 Gp~avvny~kAD~WA~GalaYEIfg~~NPFY~r 460 (598)
T KOG4158|consen 428 GPNAVVNYEKADTWAAGALAYEIFGRSNPFYKR 460 (598)
T ss_pred CCceeeccchhhhhhhhhhHHHHhccCCccccc
Confidence 21 24899999999999999999999873
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.7e-18 Score=141.78 Aligned_cols=201 Identities=20% Similarity=0.313 Sum_probs=148.7
Q ss_pred CCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeec------cccchHHHHHHHHhCCCCceeeeceeeeecCCCCcee
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQ------DRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 110 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 110 (314)
..+..+...|.....|..|++++. |..++.|++.. ..+.+++|.-.++.+.||||+++++.+..+..
T Consensus 189 ~~~lnl~tkl~e~hsgelwrgrwq--gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppn----- 261 (448)
T KOG0195|consen 189 VSSLNLITKLAESHSGELWRGRWQ--GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPN----- 261 (448)
T ss_pred hhhhhhhhhhccCCCccccccccc--CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCC-----
Confidence 345667778888999999999984 55677776642 24556788888999999999999998854433
Q ss_pred EEEEeeccc-ccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCcee-cCCCCCcEEEcCCCCc--EEEeecC
Q 021306 111 LNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH-RDLKPQNLLVDPLTHQ--VKICDFG 186 (314)
Q Consensus 111 ~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h-~dl~p~Nil~~~~~~~--~~l~dfg 186 (314)
+.++..|++ |+|+..+.. ..+...+-.++.+++.++++++.|||+...++- --|+...+++|+ +.. +-+.|--
T Consensus 262 lv~isq~mp~gslynvlhe--~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmide-dltarismad~k 338 (448)
T KOG0195|consen 262 LVIISQYMPFGSLYNVLHE--QTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDE-DLTARISMADTK 338 (448)
T ss_pred ceEeeeeccchHHHHHHhc--CccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecc-hhhhheecccce
Confidence 779999999 688877764 234557788999999999999999999544443 367888999987 444 3344433
Q ss_pred cccccccCCccccccccccccccccccCCCCC--CcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 021306 187 SAKQLIAGEANISYICSRFYRAPELIFGATEY--TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEI 253 (314)
Q Consensus 187 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~--~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i 253 (314)
++.. .......|.|++||.++..+.. -.++|+|||++++||+.|...||.+..+.+.--++
T Consensus 339 fsfq------e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmki 401 (448)
T KOG0195|consen 339 FSFQ------EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKI 401 (448)
T ss_pred eeee------ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhh
Confidence 3321 1122347889999999654422 25799999999999999999999999887654333
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.71 E-value=2.1e-17 Score=149.04 Aligned_cols=213 Identities=24% Similarity=0.338 Sum_probs=155.4
Q ss_pred HHhCCCCceeeeceeeeecCCCCceeEEEEeeccc-ccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCcee
Q 021306 85 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 163 (314)
Q Consensus 85 l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h 163 (314)
++.+.|.|+.++++....... .++|.+||+ |+|.+.+.. ....+++.....+++++++|+.|||.+...+|
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~-----~~~i~~~c~rGsl~D~i~~---~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~h 72 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPE-----MIVIWEYCSRGSLLDILSN---EDIKLDYFFILSFIRDISKGLAYLHNSPIGYH 72 (484)
T ss_pred CcccchhhhhhheeeEecCCc-----eEEEEeeecCccHHhHHhc---cccCccHHHHHHHHHHHHHHHHHHhcCcceee
Confidence 357899999999998876533 789999999 677777765 45778999999999999999999999434499
Q ss_pred cCCCCCcEEEcCCCCcEEEeecCcccccccC---CccccccccccccccccccCCC--C----CCcchhHHHHHHHHHHH
Q 021306 164 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAG---EANISYICSRFYRAPELIFGAT--E----YTTSIDIWSAGCVLAEL 234 (314)
Q Consensus 164 ~dl~p~Nil~~~~~~~~~l~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~--~----~~~~~Dv~slG~il~el 234 (314)
+.++..|.+++. ...+|+.|||+....... ...........|.|||.+++.. . .+.+.|+||+|++++|+
T Consensus 73 g~l~s~nClvd~-~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei 151 (484)
T KOG1023|consen 73 GALKSSNCLVDS-RWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEI 151 (484)
T ss_pred eeeccccceeee-eEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHH
Confidence 999999999998 889999999998655320 1111111234599999997631 1 36779999999999999
Q ss_pred HhCCCCCCCC----ChHHHHHHHHHHcCCCCHHHHhccCCCCCCCcccccccCChhhhhcccCChHHHHHhcchhhhc
Q 021306 235 LLGQPLFPGE----NAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGSHINAI 308 (314)
Q Consensus 235 ~tg~~pf~~~----~~~~~~~~i~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 308 (314)
++.+.||... ++.+.+..+.+....+.+..+...+ +. ....-.+++.||.+.+..+...+.+...++.++..
T Consensus 152 ~~r~~~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~-e~-~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~ 227 (484)
T KOG1023|consen 152 LFRSGPFDLRNLVEDPDEIILRVKKGGSNPFRPSIELLN-EL-PPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKG 227 (484)
T ss_pred HhccCccccccccCChHHHHHHHHhcCCCCcCcchhhhh-hc-chHHHHHHHHhcccChhhCccHHHHHhhhhhhccc
Confidence 9999999763 2223333333313333333333222 21 12567889999999999988888887777766554
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.2e-16 Score=131.30 Aligned_cols=132 Identities=19% Similarity=0.170 Sum_probs=99.5
Q ss_pred CceeeeeEeecCceEEEEEEECCCCcEEEEEEeecccc--------------------------chHHHHHHHHhCCCCc
Q 021306 39 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR--------------------------YKNRELQLMRVMDHPN 92 (314)
Q Consensus 39 ~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~~--------------------------~~~~e~~~l~~l~h~~ 92 (314)
.|.+.+.||+|++|.||++.. .+|+.+++|.+..... ...+|..++..+.+.+
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 94 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALD-PDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG 94 (198)
T ss_pred hhhcCCccccCcceEEEEEEc-CCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence 488999999999999999986 4899999998654320 1246777777776664
Q ss_pred e--eeeceeeeecCCCCceeEEEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCc
Q 021306 93 V--ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQN 170 (314)
Q Consensus 93 i--v~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~N 170 (314)
+ ...++ .. ..+++|||++|..+..+.. ......++.+++.++.++|. .|++|+||+|+|
T Consensus 95 i~v~~~~~----~~-----~~~lv~e~~~g~~L~~~~~---------~~~~~~~~~~i~~~l~~lh~-~gi~H~Dl~p~N 155 (198)
T cd05144 95 FPVPKPID----WN-----RHAVVMEYIDGVELYRVRV---------LEDPEEVLDEILEEIVKAYK-HGIIHGDLSEFN 155 (198)
T ss_pred CCCCceee----cC-----CceEEEEEeCCcchhhccc---------cccHHHHHHHHHHHHHHHHH-CCCCcCCCCccc
Confidence 2 22221 11 1479999999853332211 13456788899999999999 899999999999
Q ss_pred EEEcCCCCcEEEeecCccccc
Q 021306 171 LLVDPLTHQVKICDFGSAKQL 191 (314)
Q Consensus 171 il~~~~~~~~~l~dfg~~~~~ 191 (314)
|+++. ++.++|+|||.+...
T Consensus 156 ill~~-~~~~~liDfg~~~~~ 175 (198)
T cd05144 156 ILVDD-DEKIYIIDWPQMVST 175 (198)
T ss_pred EEEcC-CCcEEEEECCccccC
Confidence 99998 889999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.70 E-value=2e-16 Score=131.22 Aligned_cols=129 Identities=20% Similarity=0.322 Sum_probs=100.3
Q ss_pred eeEeecCceEEEEEEECCCCcEEEEEEeeccc------------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeE
Q 021306 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 111 (314)
Q Consensus 44 ~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~------------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 111 (314)
+.||+|++|.||+|.. +|..+++|...... ....+|..++..+.|+++.....++..... .
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~-----~ 74 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPEN-----F 74 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCC-----C
Confidence 5789999999999986 77789999754321 123478889999998887766555433322 5
Q ss_pred EEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcccc
Q 021306 112 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 190 (314)
Q Consensus 112 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~ 190 (314)
+++|||++| ++.+.+.. . .. ....++.+++.++.++|+ .|++|+|++|.||+++ ++.++++|||.+..
T Consensus 75 ~lv~e~~~G~~L~~~~~~----~---~~-~~~~i~~~i~~~l~~lH~-~~i~H~Dl~p~Nil~~--~~~~~liDf~~a~~ 143 (211)
T PRK14879 75 IIVMEYIEGEPLKDLINS----N---GM-EELELSREIGRLVGKLHS-AGIIHGDLTTSNMILS--GGKIYLIDFGLAEF 143 (211)
T ss_pred EEEEEEeCCcCHHHHHHh----c---cH-HHHHHHHHHHHHHHHHHh-CCcccCCCCcccEEEE--CCCEEEEECCcccC
Confidence 699999997 55554432 1 11 778899999999999999 8999999999999998 56799999999864
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.68 E-value=4.6e-16 Score=127.80 Aligned_cols=125 Identities=20% Similarity=0.317 Sum_probs=93.3
Q ss_pred eEeecCceEEEEEEECCCCcEEEEEEeeccc------------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeEE
Q 021306 45 VVGTGSFGIVFQAKCLETGETVAIKKVLQDR------------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 112 (314)
Q Consensus 45 ~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~------------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 112 (314)
.||+|++|.||++.. ++..+++|...... ....+|..+++.+.++++.....+...... .+
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~-----~~ 73 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDN-----KT 73 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCC-----CE
Confidence 479999999999984 67889999854321 122468889999988775544333332221 56
Q ss_pred EEeeccccc-HHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcccc
Q 021306 113 LVMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 190 (314)
Q Consensus 113 lv~e~~~~~-l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~ 190 (314)
++|||++|. +.+.+.. ... .++.+++.+|.+||+ .|++|+|++|.||+++ ++.++++|||.+..
T Consensus 74 lv~e~~~g~~l~~~~~~----~~~-------~~~~~i~~~l~~lH~-~gi~H~Dl~~~Nil~~--~~~~~liDfg~a~~ 138 (199)
T TIGR03724 74 IVMEYIEGKPLKDVIEE----GND-------ELLREIGRLVGKLHK-AGIVHGDLTTSNIIVR--DDKLYLIDFGLGKY 138 (199)
T ss_pred EEEEEECCccHHHHHhh----cHH-------HHHHHHHHHHHHHHH-CCeecCCCCcceEEEE--CCcEEEEECCCCcC
Confidence 999999974 4443321 111 778899999999999 8999999999999998 57899999999864
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.66 E-value=1.1e-15 Score=143.81 Aligned_cols=132 Identities=19% Similarity=0.251 Sum_probs=99.0
Q ss_pred CCCceeeeeEeecCceEEEEEEECCCCcEEEEEEe-ecc-----------ccchHHHHHHHHhCCCCceeeeceeeeecC
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKV-LQD-----------RRYKNRELQLMRVMDHPNVISLKHCFFSTT 104 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~-~~~-----------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 104 (314)
...|...+.||+|+||.||++..... .+++|+. .+. .....+|+.+++.++|++++....+.....
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~--~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~ 409 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGR--DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPE 409 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCc--cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCC
Confidence 34567789999999999999986433 3444432 111 122457999999999999887655543322
Q ss_pred CCCceeEEEEeeccccc-HHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEe
Q 021306 105 SKNELFLNLVMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKIC 183 (314)
Q Consensus 105 ~~~~~~~~lv~e~~~~~-l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~ 183 (314)
. .++||||++|. |.+.+. ....++.|++.+|.+||+ .|++||||||+||+++ ++.++|+
T Consensus 410 ~-----~~lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~-~giiHrDlkp~NILl~--~~~~~li 469 (535)
T PRK09605 410 E-----KTIVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHK-AGIVHGDLTTSNFIVR--DDRLYLI 469 (535)
T ss_pred C-----CEEEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHh-CCCccCCCChHHEEEE--CCcEEEE
Confidence 2 56999999974 443332 346788999999999999 8999999999999994 6789999
Q ss_pred ecCcccc
Q 021306 184 DFGSAKQ 190 (314)
Q Consensus 184 dfg~~~~ 190 (314)
|||+++.
T Consensus 470 DFGla~~ 476 (535)
T PRK09605 470 DFGLGKY 476 (535)
T ss_pred eCccccc
Confidence 9999875
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.64 E-value=9.8e-17 Score=142.55 Aligned_cols=122 Identities=29% Similarity=0.472 Sum_probs=100.5
Q ss_pred ceeEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecC
Q 021306 108 ELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 186 (314)
Q Consensus 108 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg 186 (314)
..+++|.|++|.. +|.+.+. ........+......++.|++.++.| ++.+|+|+||.||+... +.+++|.|||
T Consensus 328 ~~~lyI~Mn~c~~~tledWl~-rr~~~e~~s~s~~~~~~~q~~~~~~y----k~~ihrdlkp~nif~~~-d~q~kIgDFg 401 (516)
T KOG1033|consen 328 KVYLYIQMNLCEKETLEDWLR-RRRTGEERSLSLMLDIFKQIAPAVEY----KGLIHRDLKPSNIFFSD-DDQLKIGDFG 401 (516)
T ss_pred ccchhhhhhhhhhhhHHHHhh-CCCcccccchhHHHHHHHhhccchhh----ccchhhhcccccccccc-chhhhhhhhh
Confidence 4468899999996 5555554 33445567778899999999999999 58999999999999988 7799999999
Q ss_pred cccccccCC-------ccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh
Q 021306 187 SAKQLIAGE-------ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL 236 (314)
Q Consensus 187 ~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~t 236 (314)
+........ ......+|..||+||.+.++. ++.++||||||++|+|++.
T Consensus 402 l~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~-y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 402 LVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQ-YSEKVDIYALGLILAELLI 457 (516)
T ss_pred heeecccCCcccchhhhhhhcccccccCCHHHHhhhh-hhhhcchhhHHHHHHHHHH
Confidence 987655444 334567899999999998766 9999999999999999987
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.61 E-value=4.6e-15 Score=120.62 Aligned_cols=132 Identities=25% Similarity=0.211 Sum_probs=90.8
Q ss_pred eeeeEeecCceEEEEEEECCCCcEEEEEEeeccccch----------------------------HHHHHHHHhCCCCc-
Q 021306 42 AERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK----------------------------NRELQLMRVMDHPN- 92 (314)
Q Consensus 42 ~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~~~~----------------------------~~e~~~l~~l~h~~- 92 (314)
+.+.||+|++|.||+|.+. +++.|++|.+....... ..|...+..+.+..
T Consensus 1 ~~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~ 79 (187)
T cd05119 1 VGGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGV 79 (187)
T ss_pred CCcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCC
Confidence 3568999999999999965 89999999876532111 12333333333222
Q ss_pred -eeeeceeeeecCCCCceeEEEEeecccccH-H-HHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCC
Q 021306 93 -VISLKHCFFSTTSKNELFLNLVMEYVPESM-Y-RVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQ 169 (314)
Q Consensus 93 -iv~~~~~~~~~~~~~~~~~~lv~e~~~~~l-~-~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~ 169 (314)
+.+.+.+ . ..+++|||++|+. . ..+... ... .+++.++.+++.++.++|...|++|+||+|+
T Consensus 80 ~~~~~~~~----~-----~~~lv~e~~~g~~~~~~~l~~~-----~~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~ 144 (187)
T cd05119 80 PVPKPIDL----N-----RHVLVMEFIGGDGIPAPRLKDV-----RLL-EDPEELYDQILELMRKLYREAGLVHGDLSEY 144 (187)
T ss_pred CCCceEec----C-----CCEEEEEEeCCCCccChhhhhh-----hhc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChh
Confidence 2222211 1 1479999999821 1 122211 011 6678899999999999997469999999999
Q ss_pred cEEEcCCCCcEEEeecCccccc
Q 021306 170 NLLVDPLTHQVKICDFGSAKQL 191 (314)
Q Consensus 170 Nil~~~~~~~~~l~dfg~~~~~ 191 (314)
||+++ ++.++++|||.+...
T Consensus 145 Nili~--~~~~~liDfg~a~~~ 164 (187)
T cd05119 145 NILVD--DGKVYIIDVPQAVEI 164 (187)
T ss_pred hEEEE--CCcEEEEECcccccc
Confidence 99999 678999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.59 E-value=2.8e-14 Score=120.18 Aligned_cols=133 Identities=18% Similarity=0.229 Sum_probs=96.0
Q ss_pred eeEe-ecCceEEEEEEECCCCcEEEEEEeecc-----------------ccchHHHHHHHHhCCCCce--eeeceeeeec
Q 021306 44 RVVG-TGSFGIVFQAKCLETGETVAIKKVLQD-----------------RRYKNRELQLMRVMDHPNV--ISLKHCFFST 103 (314)
Q Consensus 44 ~~Lg-~g~~g~Vy~~~~~~~~~~~~vK~~~~~-----------------~~~~~~e~~~l~~l~h~~i--v~~~~~~~~~ 103 (314)
..|| .|+.|+||.+.. .+..+++|.+... .....+|..++..+.|+++ +..++.....
T Consensus 37 ~~lg~~~g~gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred ceeecCCCCccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 4676 788889999986 4778999987431 1123579999999988875 4444443221
Q ss_pred CCCCceeEEEEeecccc--cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEE
Q 021306 104 TSKNELFLNLVMEYVPE--SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVK 181 (314)
Q Consensus 104 ~~~~~~~~~lv~e~~~~--~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~ 181 (314)
. ......++|+|+++| ++...+. ..++++.. +.|++.++.+||+ .||+|+||||.|||++. ++.++
T Consensus 115 ~-~~~~~~~lV~e~l~G~~~L~~~l~-----~~~l~~~~----~~~i~~~l~~lH~-~GI~HrDlkp~NILv~~-~~~v~ 182 (239)
T PRK01723 115 H-GLFYRADILIERIEGARDLVALLQ-----EAPLSEEQ----WQAIGQLIARFHD-AGVYHADLNAHNILLDP-DGKFW 182 (239)
T ss_pred c-CcceeeeEEEEecCCCCCHHHHHh-----cCCCCHHH----HHHHHHHHHHHHH-CCCCCCCCCchhEEEcC-CCCEE
Confidence 1 111223599999996 5554443 24566554 4689999999999 89999999999999997 67899
Q ss_pred EeecCcccc
Q 021306 182 ICDFGSAKQ 190 (314)
Q Consensus 182 l~dfg~~~~ 190 (314)
|+|||.+..
T Consensus 183 LIDfg~~~~ 191 (239)
T PRK01723 183 LIDFDRGEL 191 (239)
T ss_pred EEECCCccc
Confidence 999998864
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.57 E-value=2.4e-14 Score=111.73 Aligned_cols=131 Identities=21% Similarity=0.238 Sum_probs=102.4
Q ss_pred eeeeEeecCceEEEEEEECCCCcEEEEEEeecccc--chHHHHHHHHhCCC--CceeeeceeeeecCCCCceeEEEEeec
Q 021306 42 AERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR--YKNRELQLMRVMDH--PNVISLKHCFFSTTSKNELFLNLVMEY 117 (314)
Q Consensus 42 ~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~~--~~~~e~~~l~~l~h--~~iv~~~~~~~~~~~~~~~~~~lv~e~ 117 (314)
+++.||+|.++.||++... +..+++|....... ...+|...++.+++ .++++++..... ....++++||
T Consensus 2 ~~~~i~~g~~~~v~~~~~~--~~~~~iK~~~~~~~~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~-----~~~~~~v~e~ 74 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTK--DEDYVLKINPSREKGADREREVAILQLLARKGLPVPKVLASGES-----DGWSYLLMEW 74 (155)
T ss_pred cceecccccccceEEEEec--CCeEEEEecCCCCchhHHHHHHHHHHHHHHcCCCCCeEEEEcCC-----CCccEEEEEe
Confidence 5678999999999999973 47899998866543 56788999999876 477777665522 2347899999
Q ss_pred ccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcC--CCceecCCCCCcEEEcCCCCcEEEeecCcccc
Q 021306 118 VPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV--PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 190 (314)
Q Consensus 118 ~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~--~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~ 190 (314)
+.|..... ++......++.+++.++..+|.. .+++|+|++|.||++++ .+.++++||+.+..
T Consensus 75 ~~g~~~~~----------~~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~-~~~~~l~Df~~~~~ 138 (155)
T cd05120 75 IEGETLDE----------VSEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDD-GKILGIIDWEYAGY 138 (155)
T ss_pred cCCeeccc----------CCHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEEC-CcEEEEEecccccC
Confidence 99852221 15566777889999999999983 26999999999999998 78899999998763
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.52 E-value=9.6e-16 Score=144.21 Aligned_cols=241 Identities=23% Similarity=0.323 Sum_probs=172.0
Q ss_pred CCCceeeeeEeecCceEEEEEEECCC-CcEEEEEEeeccc---cc---hHHHHHHHHhCC-CCceeeeceeeeecCCCCc
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCLET-GETVAIKKVLQDR---RY---KNRELQLMRVMD-HPNVISLKHCFFSTTSKNE 108 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~~~-~~~~~vK~~~~~~---~~---~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~ 108 (314)
...|.+.+.||+|.++.|-......+ ...++.|.+.... .. ...|..+-+.+. |.|++++++.. ...
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~-----~~~ 93 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPS-----SSP 93 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCcc-----CCC
Confidence 34699999999999999988876443 3456666554332 11 124666777776 99999998877 333
Q ss_pred eeEEEEeeccccc-HHHHHHhhhhcCC-CCCHHHHHHHHHHHHHHHHHhh-cCCCceecCCCCCcEEEcCCCC-cEEEee
Q 021306 109 LFLNLVMEYVPES-MYRVLKHYSSANQ-RMPLIYVKLYTYQIFRGLAYIH-TVPRVCHRDLKPQNLLVDPLTH-QVKICD 184 (314)
Q Consensus 109 ~~~~lv~e~~~~~-l~~~l~~~~~~~~-~l~~~~~~~i~~ql~~~l~~LH-~~~~i~h~dl~p~Nil~~~~~~-~~~l~d 184 (314)
.+.+++++|..|+ +..... ..+. ..+...+..++.|+..++.|+| . .++.|+|++|+|.+++. .+ .+++.|
T Consensus 94 ~~~~~~~~~s~g~~~f~~i~---~~~~~~~~~~~~~~~~~ql~s~l~~~H~~-~~~~h~~ikP~n~~l~~-s~~~l~~~d 168 (601)
T KOG0590|consen 94 RSYLLSLSYSDGGSLFSKIS---HPDSTGTSSSSASRYLPQLNSGLSYLHPE-NGVTHRDIKPSNSLLDE-SGSALKIAD 168 (601)
T ss_pred cccccccCcccccccccccc---cCCccCCCCcchhhhhhhhccCccccCcc-cccccCCCCCccchhcc-CCCcccCCC
Confidence 4477999997764 222221 2333 5677778899999999999999 8 89999999999999998 66 899999
Q ss_pred cCccccccc-CCc---cccccc-cccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHH-HHHHHHc-
Q 021306 185 FGSAKQLIA-GEA---NISYIC-SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQL-VEIIKVL- 257 (314)
Q Consensus 185 fg~~~~~~~-~~~---~~~~~~-~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~-~~i~~~~- 257 (314)
||+|..+.. ... .....+ ++.|+|||...+.....+..|+||.|+++.-+++|..|+......... ...+...
T Consensus 169 f~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~ 248 (601)
T KOG0590|consen 169 FGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKG 248 (601)
T ss_pred chhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeeccccc
Confidence 999986655 222 223556 889999999977544678899999999999999999998765443322 1222111
Q ss_pred ----------CCCCHHHHhc---cCCCCCCCcccccccCChhhh
Q 021306 258 ----------GTPTREEIRC---MNPNYTDFRFPQIKAHPWHKV 288 (314)
Q Consensus 258 ----------~~~~~~~~~~---~~p~~~~~~~~~l~~~p~~~~ 288 (314)
.......+.. .+|+ .|.+.+++..+||...
T Consensus 249 ~~~~~~~~~~~~~~~~~l~k~l~~~~~-~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 249 RFTQLPWNSISDQAHDLLHKILKENPS-NRLSIEELKLDNWLSS 291 (601)
T ss_pred ccccCccccCChhhhhcccccccCCch-hccccccccccccccc
Confidence 1111111111 2455 7999999999999888
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.43 E-value=2e-13 Score=115.09 Aligned_cols=231 Identities=19% Similarity=0.243 Sum_probs=149.5
Q ss_pred EEEEEEECCCCcEEEEEEeec----ccc--chHH--HHHHHHhCCCCceeeeceeeeecCCCCceeEEEEeeccc-ccHH
Q 021306 53 IVFQAKCLETGETVAIKKVLQ----DRR--YKNR--ELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMY 123 (314)
Q Consensus 53 ~Vy~~~~~~~~~~~~vK~~~~----~~~--~~~~--e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~ 123 (314)
.||++.+...|-+++...+.. +.+ ...+ -..-+.++-|.||++++.++-+....+.....+++||++ |++.
T Consensus 81 ~v~lamd~e~g~evvwneVq~~~rK~~~~qeek~~~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~ 160 (458)
T KOG1266|consen 81 DVYLAMDTEEGVEVVWNEVQFSERKNPKEQEEKRRAVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLK 160 (458)
T ss_pred HHHHHhhhccCchhhHHHHHHHHhcChhhCHHHHHHHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHH
Confidence 456666666666665543321 111 0111 123356668999999999997666545555778999998 6777
Q ss_pred HHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcC-CCceecCCCCCcEEEcCCCCcEEEeecCcccccccCC-----cc
Q 021306 124 RVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV-PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE-----AN 197 (314)
Q Consensus 124 ~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~-~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~~~~-----~~ 197 (314)
..|+.-......+....+.+|+.||+.||.|||+. .-|+|+++..+.|++.. ++-+++..-.-........ ..
T Consensus 161 ~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifiq~-ngLIkig~~ap~s~h~s~~~~~~~Ek 239 (458)
T KOG1266|consen 161 QFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFIQH-NGLIKIGSVAPDSTHPSVNSTREAEK 239 (458)
T ss_pred HHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhheeecC-CceEEecccCccccchhhhhhhHhhh
Confidence 77877666778899999999999999999999983 46999999999999996 7766654322111100000 11
Q ss_pred ccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCC-CCCCCh---HHHHHHHHHHcCCCCH-HHHh-cc--C
Q 021306 198 ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL-FPGENA---VDQLVEIIKVLGTPTR-EEIR-CM--N 269 (314)
Q Consensus 198 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~p-f~~~~~---~~~~~~i~~~~~~~~~-~~~~-~~--~ 269 (314)
....+-++|.+||.=. ..+.+.++|||++|++..+|.-|..- -.+.+. ++.+.+.+..+..... ..+. |+ .
T Consensus 240 ~~~~~~~g~~a~~sg~-~tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~~i~~len~lqr~~i~kcl~~e 318 (458)
T KOG1266|consen 240 SVNTSLPGFSAPESGT-TTNTTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIANVIIGLENGLQRGSITKCLEGE 318 (458)
T ss_pred hccccCCccccCCcCc-ccccccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhhhheeeccCccccCcCcccccCC
Confidence 1122356788998742 23367899999999999999988743 434332 2333333333333221 1222 33 3
Q ss_pred CCCCCCcccccccCChh
Q 021306 270 PNYTDFRFPQIKAHPWH 286 (314)
Q Consensus 270 p~~~~~~~~~l~~~p~~ 286 (314)
|. .|++++.++.||.+
T Consensus 319 P~-~rp~ar~llfHpll 334 (458)
T KOG1266|consen 319 PN-GRPDARLLLFHPLL 334 (458)
T ss_pred CC-CCcchhhhhcCcee
Confidence 44 78899999999964
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.38 E-value=4.1e-12 Score=116.57 Aligned_cols=184 Identities=21% Similarity=0.256 Sum_probs=129.7
Q ss_pred CCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeecccc----chHHHHHHHHhCCCCceeeeceeeeecCCCCceeEE
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR----YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 112 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~~----~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 112 (314)
.-.|.+ +...-++.+..-.+..+.++.++.+...+.... ...+-++.++.++||+|+++++.+... ...|
T Consensus 12 ~fpY~l-e~~~~~~~a~~~~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~-----~~~y 85 (690)
T KOG1243|consen 12 QFPYDL-EETAFSSEALWPDGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEE-----GTLY 85 (690)
T ss_pred cCCccc-ccccCCCcccccccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhccc-----CceE
Confidence 335666 444444444332455577888888888765443 234667889999999999999988433 3488
Q ss_pred EEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcccccc
Q 021306 113 LVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 192 (314)
Q Consensus 113 lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~ 192 (314)
+|+|-+.. +...+.. +....+..-+.||+.||.+||...+++|++|....|+++. .+..+|++|..+....
T Consensus 86 lvTErV~P-l~~~lk~-------l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~-~GeWkLggle~v~~~~ 156 (690)
T KOG1243|consen 86 LVTERVRP-LETVLKE-------LGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNE-SGEWKLGGLELVSKAS 156 (690)
T ss_pred EEeecccc-HHHHHHH-------hHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcC-CCcEEEeeeEEEeccc
Confidence 99998874 1223332 3367788889999999999985479999999999999999 8999999999886554
Q ss_pred cCCc-cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCC
Q 021306 193 AGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQ 238 (314)
Q Consensus 193 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~ 238 (314)
.... ......-..|..|+.+.. -....|.|.||+++++++.|.
T Consensus 157 ~~~~~~~~~~~~~s~~~P~~~~~---s~~s~D~~~Lg~li~el~ng~ 200 (690)
T KOG1243|consen 157 GFNAPAKSLYLIESFDDPEEIDP---SEWSIDSWGLGCLIEELFNGS 200 (690)
T ss_pred cCCcccccchhhhcccChhhcCc---cccchhhhhHHHHHHHHhCcc
Confidence 3332 111111223566665522 124569999999999999993
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.37 E-value=5.7e-13 Score=120.73 Aligned_cols=195 Identities=26% Similarity=0.321 Sum_probs=149.9
Q ss_pred CceeeeeEee--cCceEEEEEEE--CCCCcEEEEEEeec------cccchHHHHHHHHhC-CCCceeeeceeeeecCCCC
Q 021306 39 SYMAERVVGT--GSFGIVFQAKC--LETGETVAIKKVLQ------DRRYKNRELQLMRVM-DHPNVISLKHCFFSTTSKN 107 (314)
Q Consensus 39 ~y~~~~~Lg~--g~~g~Vy~~~~--~~~~~~~~vK~~~~------~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~ 107 (314)
.+.+...+|. |.+|.||.+.. ..++..+++|.-+. ......+|..--+++ .|++.++.+..+ .+
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~-----e~ 189 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAW-----EG 189 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccc-----cc
Confidence 5678889999 99999999998 78899999997432 222334555555555 588888866666 44
Q ss_pred ceeEEEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHH----HHHHhhcCCCceecCCCCCcEEEcCCCCcEEEe
Q 021306 108 ELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFR----GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKIC 183 (314)
Q Consensus 108 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~----~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~ 183 (314)
....++-+|++..++...... ...-++...++..+.+... |+.++|. .+++|.|++|.||++..+....+++
T Consensus 190 ~~~lfiqtE~~~~sl~~~~~~---~~~~~p~~~l~~~~~~~~~~~~~al~~~hs-~~~~~~~~kp~~i~~~~~~~s~~~~ 265 (524)
T KOG0601|consen 190 SGILFIQTELCGESLQSYCHT---PCNFLPDNLLWNSLRDWLSRDVTALSHLHS-NNIVHDDLKPANIFTTSDWTSCKLT 265 (524)
T ss_pred CCcceeeeccccchhHHhhhc---ccccCCchhhhhHHhhhhhcccccccccCC-CcccccccchhheecccccceeecC
Confidence 555889999999765544332 3445888899999999999 9999999 8999999999999999843789999
Q ss_pred ecCcccccccCCccc------cccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 021306 184 DFGSAKQLIAGEANI------SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE 244 (314)
Q Consensus 184 dfg~~~~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~ 244 (314)
|||+...+....... ...+...|++||...+ -++..+|+|++|.+..+..+|..+....
T Consensus 266 df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~--l~~~~~di~sl~ev~l~~~l~~~~~~~g 330 (524)
T KOG0601|consen 266 DFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG--LATFASDIFSLGEVILEAILGSHLPSVG 330 (524)
T ss_pred CcceeEEccCCccccceeeeecCCCCceEeChhhhcc--ccchHhhhcchhhhhHhhHhhcccccCC
Confidence 999988765544222 2245667999999854 3689999999999999999987665443
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.35 E-value=8.3e-12 Score=100.90 Aligned_cols=132 Identities=20% Similarity=0.228 Sum_probs=92.7
Q ss_pred eeeEeecCceEEEEEEECC------CCcEEEEEEeec--------------ccc------------ch----HHHHHHHH
Q 021306 43 ERVVGTGSFGIVFQAKCLE------TGETVAIKKVLQ--------------DRR------------YK----NRELQLMR 86 (314)
Q Consensus 43 ~~~Lg~g~~g~Vy~~~~~~------~~~~~~vK~~~~--------------~~~------------~~----~~e~~~l~ 86 (314)
...||.|--+.||.|.... .+..+|+|+++. +.+ .. ++|...|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3578899999999998543 357899998731 100 01 26888888
Q ss_pred hCCCC--ceeeeceeeeecCCCCceeEEEEeeccccc-HH-HHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHh-hcCCCc
Q 021306 87 VMDHP--NVISLKHCFFSTTSKNELFLNLVMEYVPES-MY-RVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI-HTVPRV 161 (314)
Q Consensus 87 ~l~h~--~iv~~~~~~~~~~~~~~~~~~lv~e~~~~~-l~-~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~L-H~~~~i 161 (314)
++... .+..++.+ .. .++||||++++ +. ..+. +..++..++..+..+++.++..| |+ .|+
T Consensus 82 rl~~~Gv~vP~pi~~----~~-----~~lvME~Ig~~~~~~~~Lk-----d~~~~~~~~~~i~~~i~~~l~~l~H~-~gl 146 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KK-----HVLVMSFIGDDQVPAPKLK-----DAKLNDEEMKNAYYQVLSMMKQLYKE-CNL 146 (197)
T ss_pred HHHHcCCCCCeEEEe----cC-----CEEEEEEcCCCCccchhhh-----ccccCHHHHHHHHHHHHHHHHHHHHh-CCe
Confidence 87543 23333322 11 45999999863 21 1122 23456667778889999999988 88 899
Q ss_pred eecCCCCCcEEEcCCCCcEEEeecCccccc
Q 021306 162 CHRDLKPQNLLVDPLTHQVKICDFGSAKQL 191 (314)
Q Consensus 162 ~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~ 191 (314)
+||||++.||+++. +.+.++|||.+...
T Consensus 147 VHGDLs~~NIL~~~--~~v~iIDF~qav~~ 174 (197)
T cd05146 147 VHADLSEYNMLWHD--GKVWFIDVSQSVEP 174 (197)
T ss_pred ecCCCCHHHEEEEC--CcEEEEECCCceeC
Confidence 99999999999974 57999999988654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.34 E-value=7.3e-12 Score=99.99 Aligned_cols=125 Identities=15% Similarity=0.180 Sum_probs=89.2
Q ss_pred eeeEeecCceEEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeEEEEeeccc
Q 021306 43 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP 119 (314)
Q Consensus 43 ~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~ 119 (314)
++.|+.|..+.||++.. .+..+++|...... ...++|+.+++.+....+++-.-.+ ... . .++||||++
T Consensus 3 ~~~l~~G~~~~vy~~~~--~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~-~~~---~--~~lv~e~i~ 74 (170)
T cd05151 3 ISPLKGGMTNKNYRVEV--ANKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYF-DPE---T--GVLITEFIE 74 (170)
T ss_pred eeecCCcccCceEEEEE--CCeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEE-eCC---C--CeEEEEecC
Confidence 46788899999999986 47889999876543 3456888898888655544322121 111 1 358999999
Q ss_pred ccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCc-----eecCCCCCcEEEcCCCCcEEEeecCccc
Q 021306 120 ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRV-----CHRDLKPQNLLVDPLTHQVKICDFGSAK 189 (314)
Q Consensus 120 ~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i-----~h~dl~p~Nil~~~~~~~~~l~dfg~~~ 189 (314)
|...... . .....++.+++.++..||. .++ +|+|++|.||+++ ++.++++||+.+.
T Consensus 75 G~~l~~~--------~---~~~~~~~~~l~~~l~~LH~-~~~~~~~~~HgD~~~~Nil~~--~~~~~liDf~~a~ 135 (170)
T cd05151 75 GSELLTE--------D---FSDPENLEKIAKLLKKLHS-SPLPDLVPCHNDLLPGNFLLD--DGRLWLIDWEYAG 135 (170)
T ss_pred CCccccc--------c---ccCHHHHHHHHHHHHHHhC-CCCCCceeecCCCCcCcEEEE--CCeEEEEeccccc
Confidence 8522111 0 1123456789999999999 674 9999999999998 4579999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.33 E-value=1.2e-11 Score=113.04 Aligned_cols=138 Identities=20% Similarity=0.232 Sum_probs=88.5
Q ss_pred eeeEeecCceEEEEEEECCCCcEEEEEEeecccc--------------------------------------------ch
Q 021306 43 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR--------------------------------------------YK 78 (314)
Q Consensus 43 ~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~~--------------------------------------------~~ 78 (314)
.+.||.|++|.||+|+. .+|+.||||+...... ..
T Consensus 122 ~~plasaSigQVh~A~l-~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf 200 (437)
T TIGR01982 122 EKPLAAASIAQVHRARL-VDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDL 200 (437)
T ss_pred CcceeeeehhheEEEEe-cCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCH
Confidence 35799999999999985 5899999998753210 01
Q ss_pred HHHHHHHHhC----CCCceeeeceeeeecCCCCceeEEEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHH-HHH
Q 021306 79 NRELQLMRVM----DHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFR-GLA 153 (314)
Q Consensus 79 ~~e~~~l~~l----~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~-~l~ 153 (314)
.+|+..+.++ ++..-+.+..++....+ ..+++|||++|..+..+..... ...+ ...++.+++. .+.
T Consensus 201 ~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~----~~vLvmE~i~G~~L~~~~~~~~--~~~~---~~~ia~~~~~~~l~ 271 (437)
T TIGR01982 201 RREAANASELGENFKNDPGVYVPEVYWDRTS----ERVLTMEWIDGIPLSDIAALDE--AGLD---RKALAENLARSFLN 271 (437)
T ss_pred HHHHHHHHHHHHhcCCCCCEEeCCEehhhcC----CceEEEEeECCcccccHHHHHh--cCCC---HHHHHHHHHHHHHH
Confidence 1233333333 23333444444322221 2469999999843322222111 1122 2344555555 467
Q ss_pred HhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcccccc
Q 021306 154 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 192 (314)
Q Consensus 154 ~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~ 192 (314)
.+|. .|++|+|++|.||+++. ++.++++|||++....
T Consensus 272 ql~~-~g~~H~D~hPgNilv~~-~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 272 QVLR-DGFFHADLHPGNIFVLK-DGKIIALDFGIVGRLS 308 (437)
T ss_pred HHHh-CCceeCCCCcccEEECC-CCcEEEEeCCCeeECC
Confidence 8899 89999999999999987 7889999999987654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.32 E-value=9.4e-12 Score=115.31 Aligned_cols=142 Identities=17% Similarity=0.185 Sum_probs=89.3
Q ss_pred CCceeeeeEeecCceEEEEEEECCCCcEEEEEEeecccc-----------------------------------------
Q 021306 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR----------------------------------------- 76 (314)
Q Consensus 38 ~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~~----------------------------------------- 76 (314)
..|.. +.||+|++|.||+|+.+.+|+.||||.......
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 45666 789999999999999887799999998853310
Q ss_pred ---chHHHHHHHHhC----CCCceeeeceeeeecCCCCceeEEEEeecccccHHHHHHhhhhcCC---CCCHHHHHHHHH
Q 021306 77 ---YKNRELQLMRVM----DHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQ---RMPLIYVKLYTY 146 (314)
Q Consensus 77 ---~~~~e~~~l~~l----~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~---~l~~~~~~~i~~ 146 (314)
...+|+..+.++ .+...+.+..++.+.. ...++||||+.|.-.+.+......+. .+.+..+..++.
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~s----t~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~ 274 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYC----SETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFT 274 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccC----CCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHH
Confidence 011233222222 2333344444442221 22569999999853332222111111 244444444444
Q ss_pred HHHHHHHHhhcCCCceecCCCCCcEEEcCCCC----cEEEeecCccccccc
Q 021306 147 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH----QVKICDFGSAKQLIA 193 (314)
Q Consensus 147 ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~----~~~l~dfg~~~~~~~ 193 (314)
|+ .. .|++|+|++|.||+++. ++ +++++|||+......
T Consensus 275 Qi-------f~-~GffHaDpHPGNIlv~~-~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 275 QV-------FR-DGFFHADMHPGNIFVSY-DPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred HH-------Hh-CCeeeCCCChHHeEEec-CCCCCCeEEEEecceEEECCH
Confidence 44 45 79999999999999987 55 899999999876543
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.28 E-value=5.5e-11 Score=92.94 Aligned_cols=139 Identities=17% Similarity=0.223 Sum_probs=98.1
Q ss_pred eeeeEeecCceEEEEEEECCCCcEEEEEEe-ecc-----------ccchHHHHHHHHhCCCCceeeeceeeeecCCCCce
Q 021306 42 AERVVGTGSFGIVFQAKCLETGETVAIKKV-LQD-----------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL 109 (314)
Q Consensus 42 ~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~-~~~-----------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 109 (314)
....+-+|+-+.|+++.+ .|+.+++|.- .+. +....+|+..+.++.--.|.-..-++.+...
T Consensus 11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~---- 84 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYG---- 84 (229)
T ss_pred cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCC----
Confidence 567888999999999976 7888888853 221 2233478888888754444332223333332
Q ss_pred eEEEEeecccc--cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcE--EEeec
Q 021306 110 FLNLVMEYVPE--SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQV--KICDF 185 (314)
Q Consensus 110 ~~~lv~e~~~~--~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~--~l~df 185 (314)
-.++|||++| ++.+.+.... ......+....+++.+-..+.-||. .+|+||||..+||++.++++++ .++||
T Consensus 85 -~~i~ME~~~g~~~vk~~i~~~~--~~~~~d~~~~~~~~~iG~~igklH~-ndiiHGDLTTSNill~~~~~~~~~~lIdf 160 (229)
T KOG3087|consen 85 -GQIYMEFIDGASTVKDFILSTM--EDESEDEGLAELARRIGELIGKLHD-NDIIHGDLTTSNILLRSDGNQITPILIDF 160 (229)
T ss_pred -CeEEEEeccchhHHHHHHHHHc--cCcccchhHHHHHHHHHHHHHHhhh-CCeecccccccceEEecCCCcCceEEEee
Confidence 3489999998 5555555432 2223333346778888889999999 8999999999999998866665 89999
Q ss_pred Ccccc
Q 021306 186 GSAKQ 190 (314)
Q Consensus 186 g~~~~ 190 (314)
|++..
T Consensus 161 gls~~ 165 (229)
T KOG3087|consen 161 GLSSV 165 (229)
T ss_pred cchhc
Confidence 99864
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.20 E-value=6.5e-10 Score=99.52 Aligned_cols=171 Identities=22% Similarity=0.304 Sum_probs=129.6
Q ss_pred CceEEEEEEECCCCcEEEEEEeeccccc----hHHHHHHHHhCCCCceeeeceeeeecCCCCceeEEEEeecccc--cHH
Q 021306 50 SFGIVFQAKCLETGETVAIKKVLQDRRY----KNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE--SMY 123 (314)
Q Consensus 50 ~~g~Vy~~~~~~~~~~~~vK~~~~~~~~----~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~--~l~ 123 (314)
.-.+.|++....+|..|++|++.-++.. .-.-++.++++.|.|+|++.++|. ...-+...+++|++|.++ +|+
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~-t~tF~D~SlvlvYDYyP~s~TL~ 366 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFL-TYTFGDLSLVLVYDYYPSSPTLY 366 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhh-hhccCcceEEEEEecCCCCchHH
Confidence 3467899999999999999999433222 235688899999999999999886 333455668899999995 666
Q ss_pred HHHHhh-----------hhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcccccc
Q 021306 124 RVLKHY-----------SSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 192 (314)
Q Consensus 124 ~~l~~~-----------~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~ 192 (314)
+....- -..+..++++.+|.++.||..||.++|+ .|+..+-|.|.+|+++. +.++++...|......
T Consensus 367 d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHs-sGLAck~L~~~kIlv~G-~~RIriS~C~i~Dvl~ 444 (655)
T KOG3741|consen 367 DLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHS-SGLACKTLDLKKILVTG-KMRIRISGCGIMDVLQ 444 (655)
T ss_pred HHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHh-cCceeecccHhHeEeeC-cceEEEecccceeeec
Confidence 655431 1123457899999999999999999999 89999999999999997 6688888877765443
Q ss_pred cCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCC
Q 021306 193 AGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL 240 (314)
Q Consensus 193 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~p 240 (314)
... . +.+.+ -.+-|.-.||.++..|.||..=
T Consensus 445 ~d~-----------~--~~le~----~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 445 EDP-----------T--EPLES----QQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CCC-----------C--cchhH----HhhhhHHHHHHHHHHHhhcccc
Confidence 222 0 11211 2356999999999999999633
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.15 E-value=5.2e-10 Score=87.82 Aligned_cols=127 Identities=17% Similarity=0.240 Sum_probs=84.5
Q ss_pred eeEeecCceEEEEEEECCCCcEEEEEEe-ecc-----------ccchHHHHHHHHhCCCCceeeeceeeeecCCCCceeE
Q 021306 44 RVVGTGSFGIVFQAKCLETGETVAIKKV-LQD-----------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 111 (314)
Q Consensus 44 ~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~-~~~-----------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 111 (314)
..+++|+-+.+|.+.. -|..+++|.= ++. .....+|+.++.+++-..|.-..-+.++... .
T Consensus 2 ~~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~-----~ 74 (204)
T COG3642 2 DLIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDN-----G 74 (204)
T ss_pred chhhCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCC-----C
Confidence 3567899999999865 4445666643 221 1222478888888765444333223333333 4
Q ss_pred EEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcccc
Q 021306 112 NLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 190 (314)
Q Consensus 112 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~ 190 (314)
.|+|||++|.++..... .. . ..++..+-..+.-||. .||+||||+++||++.. +.+.++|||++..
T Consensus 75 ~I~me~I~G~~lkd~l~---~~---~----~~~~r~vG~~vg~lH~-~givHGDLTtsNiIl~~--~~i~~IDfGLg~~ 140 (204)
T COG3642 75 LIVMEYIEGELLKDALE---EA---R----PDLLREVGRLVGKLHK-AGIVHGDLTTSNIILSG--GRIYFIDFGLGEF 140 (204)
T ss_pred EEEEEEeCChhHHHHHH---hc---c----hHHHHHHHHHHHHHHh-cCeecCCCccceEEEeC--CcEEEEECCcccc
Confidence 59999999976553322 11 2 2344555566777999 89999999999999985 3499999999874
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.14 E-value=2.7e-11 Score=115.98 Aligned_cols=253 Identities=20% Similarity=0.240 Sum_probs=172.8
Q ss_pred cCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeecc-------ccchHHHHHHHHhCCCCceeeeceeeeecCCCCc
Q 021306 36 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 108 (314)
Q Consensus 36 ~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~-------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 108 (314)
..+.+.+.+-+.+|.++.++.++-..+|.....|..... .+....+-.+...-.+|.++...-.+ ...
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~-----~~r 876 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSF-----PCR 876 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCC-----CCC
Confidence 345788888999999999999987666754444433221 11112222222222345555443221 111
Q ss_pred eeEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCc
Q 021306 109 LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 187 (314)
Q Consensus 109 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~ 187 (314)
...+++++|..+ ++...+.. -...+.+-++..+..+..+.++||. ..+.|+|++|.|++... .+...+.+|+.
T Consensus 877 sP~~L~~~~~~~~~~~Skl~~----~~~~saepaRs~i~~~vqs~e~L~s-~~r~h~~~~p~~~l~~~-~gh~~l~~~~t 950 (1205)
T KOG0606|consen 877 SPLPLVGHYLNGGDLPSKLHN----SGCLSAEPARSPILERVQSLESLHS-SLRKHRDLKPDSLLIAY-DGHRPLTDFGT 950 (1205)
T ss_pred CCcchhhHHhccCCchhhhhc----CCCcccccccchhHHHHhhhhcccc-chhhcccccccchhhcc-cCCcccCcccc
Confidence 226699999975 55555553 3467777788888899999999999 67999999999999988 88888999873
Q ss_pred ccccccC--------------------------------CccccccccccccccccccCCCCCCcchhHHHHHHHHHHHH
Q 021306 188 AKQLIAG--------------------------------EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELL 235 (314)
Q Consensus 188 ~~~~~~~--------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~ 235 (314)
....... .......+|+.|.+||...+.. ....+|+|++|+++++.+
T Consensus 951 ~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~-hgs~ad~~~~g~~l~e~l 1029 (1205)
T KOG0606|consen 951 LSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRR-HGSAADWWSSGVCLFEVL 1029 (1205)
T ss_pred ccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCccccccc-CCCcchhhhhhhhhhhhh
Confidence 3211000 0112244688899999997766 788899999999999999
Q ss_pred hCCCCCCCCChHHHHHHHHHHcCCCC----------HHHHh---ccCCCCCCCccc---ccccCChhhhhcccCChHHHH
Q 021306 236 LGQPLFPGENAVDQLVEIIKVLGTPT----------REEIR---CMNPNYTDFRFP---QIKAHPWHKVCIFHFPKHWLL 299 (314)
Q Consensus 236 tg~~pf~~~~~~~~~~~i~~~~~~~~----------~~~~~---~~~p~~~~~~~~---~l~~~p~~~~~~~~~~~~~~~ 299 (314)
+|..||....++..+.++.++..+.+ .+.+. ...+. +|..+. +...||+++..+++.+.+...
T Consensus 1030 ~g~pp~na~tpq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~-qr~~a~~~~e~k~~~~~~~~~~~~l~~q~~ 1108 (1205)
T KOG0606|consen 1030 TGIPPFNAETPQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPT-QRLGAKGAAEVKGHPFFQDVDWENLALQKA 1108 (1205)
T ss_pred cCCCCCCCcchhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCch-hccCcccccccccCCccCCCCccccccccC
Confidence 99999999999988888876532221 11122 22333 566666 899999999999987776544
Q ss_pred Hh
Q 021306 300 EY 301 (314)
Q Consensus 300 ~~ 301 (314)
..
T Consensus 1109 ~~ 1110 (1205)
T KOG0606|consen 1109 EF 1110 (1205)
T ss_pred cc
Confidence 43
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.12 E-value=5.2e-10 Score=90.14 Aligned_cols=121 Identities=26% Similarity=0.298 Sum_probs=76.9
Q ss_pred EEEEEEECCCCcEEEEEEeecc--------------c----------------cchHHHHHHHHhCCCCc--eeeeceee
Q 021306 53 IVFQAKCLETGETVAIKKVLQD--------------R----------------RYKNRELQLMRVMDHPN--VISLKHCF 100 (314)
Q Consensus 53 ~Vy~~~~~~~~~~~~vK~~~~~--------------~----------------~~~~~e~~~l~~l~h~~--iv~~~~~~ 100 (314)
.||.|.. .+|..+|+|..+.. . ...++|...|.++.... +.+++.+.
T Consensus 1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 3888884 57889999987421 0 11147899999997664 34443221
Q ss_pred eecCCCCceeEEEEeeccc--ccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHH-hhcCCCceecCCCCCcEEEcCCC
Q 021306 101 FSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY-IHTVPRVCHRDLKPQNLLVDPLT 177 (314)
Q Consensus 101 ~~~~~~~~~~~~lv~e~~~--~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~-LH~~~~i~h~dl~p~Nil~~~~~ 177 (314)
. ..+||||++ |..+..+.. ..++......++.+++..+.. +|. .||+||||++.||+++. +
T Consensus 80 -----~----~~ivME~I~~~G~~~~~l~~-----~~~~~~~~~~~~~~il~~~~~~~~~-~givHGDLs~~NIlv~~-~ 143 (188)
T PF01163_consen 80 -----R----NVIVMEYIGEDGVPLPRLKD-----VDLSPEEPKELLEEILEEIIKMLHK-AGIVHGDLSEYNILVDD-G 143 (188)
T ss_dssp -----T----TEEEEE--EETTEEGGCHHH-----CGGGGSTHHHHHHHHHHHHHHHHHC-TTEEESS-STTSEEEET-T
T ss_pred -----C----CEEEEEecCCCccchhhHHh-----ccccchhHHHHHHHHHHHHHHHHHh-cCceecCCChhhEEeec-c
Confidence 1 349999999 743333433 222234456677788875444 678 89999999999999997 3
Q ss_pred CcEEEeecCccccc
Q 021306 178 HQVKICDFGSAKQL 191 (314)
Q Consensus 178 ~~~~l~dfg~~~~~ 191 (314)
.+.++|||.+...
T Consensus 144 -~~~iIDf~qav~~ 156 (188)
T PF01163_consen 144 -KVYIIDFGQAVDS 156 (188)
T ss_dssp -CEEE--GTTEEET
T ss_pred -eEEEEecCcceec
Confidence 8999999988644
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.08 E-value=4.5e-09 Score=89.66 Aligned_cols=140 Identities=11% Similarity=0.046 Sum_probs=92.4
Q ss_pred eEeecCceEEEEEEECCCCcEEEEEEeeccc---------------cchHHHHHHHHhCCCCceeee--ceeeeecCCCC
Q 021306 45 VVGTGSFGIVFQAKCLETGETVAIKKVLQDR---------------RYKNRELQLMRVMDHPNVISL--KHCFFSTTSKN 107 (314)
Q Consensus 45 ~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~---------------~~~~~e~~~l~~l~h~~iv~~--~~~~~~~~~~~ 107 (314)
.+.......|+++.. +|+.|.+|...... ....+|...+.++...+|... +.+........
T Consensus 29 ~v~~~~~rrvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 29 VFRELEGRRTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred EEecCCCceEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 333333345666654 67788999663211 124578877777744443332 22221111111
Q ss_pred ceeEEEEeecccc--cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcC------CCCc
Q 021306 108 ELFLNLVMEYVPE--SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP------LTHQ 179 (314)
Q Consensus 108 ~~~~~lv~e~~~~--~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~------~~~~ 179 (314)
...-++|||++++ ++.+.+.... ..+.+......++.+++..+..||. .||+|+|+++.||+++. +...
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~--~~~~~~~~~~~ll~~la~~i~~LH~-~Gi~HgDL~~~NiLl~~~~~~~~~~~~ 183 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWA--TNPPDPRLKRMLIKRVATMVRDMHA-AGINHRDCYICHFLLHLPFPGREEDLK 183 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHH-CcCccCCCChhhEEEeccccCCCCCce
Confidence 2335699999998 4655554321 2456677788999999999999999 89999999999999974 2467
Q ss_pred EEEeecCccc
Q 021306 180 VKICDFGSAK 189 (314)
Q Consensus 180 ~~l~dfg~~~ 189 (314)
+.|+||+.+.
T Consensus 184 ~~LIDl~r~~ 193 (268)
T PRK15123 184 LSVIDLHRAQ 193 (268)
T ss_pred EEEEECCccc
Confidence 9999999885
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.03 E-value=4.7e-09 Score=92.05 Aligned_cols=198 Identities=14% Similarity=0.153 Sum_probs=130.8
Q ss_pred ceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccccch--HHHHHHHHhCCCCceee----eceeeeecCCCCceeEEE
Q 021306 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK--NRELQLMRVMDHPNVIS----LKHCFFSTTSKNELFLNL 113 (314)
Q Consensus 40 y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~~~~--~~e~~~l~~l~h~~iv~----~~~~~~~~~~~~~~~~~l 113 (314)
......||+|+-+-+|-.-.- ...+.|++....... ++-..+.+--.||-+.. ........ .+.....+
T Consensus 13 i~~gr~LgqGgea~ly~l~e~---~d~VAKIYh~Pppa~~aqk~a~la~~p~~p~~~~rvaWPqa~L~G~--~~~~~iGf 87 (637)
T COG4248 13 IPPGRPLGQGGEADLYTLGEV---RDQVAKIYHAPPPAAQAQKVAELAATPDAPLLNYRVAWPQATLHGG--RRGKVIGF 87 (637)
T ss_pred cCCCccccCCccceeeecchh---hchhheeecCCCchHHHHHHHHhccCCCCcchhhhhcccHHHhhCC--CccceeEE
Confidence 456788999999999865432 224566665433222 22222222224544332 10111111 12223678
Q ss_pred Eeecccc--cHHHHHHhh--hhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCccc
Q 021306 114 VMEYVPE--SMYRVLKHY--SSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 189 (314)
Q Consensus 114 v~e~~~~--~l~~~l~~~--~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~ 189 (314)
+|+.++| .....+.-. .+..-...+..+.+.++.|+.+...||. .|.+-||++++|+++++ ++.+.|+|-..-.
T Consensus 88 lmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~-~Gh~vGDVn~~~~lVsd-~~~V~LVdsDsfq 165 (637)
T COG4248 88 LMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHE-HGHVVGDVNQNSFLVSD-DSKVVLVDSDSFQ 165 (637)
T ss_pred ecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHh-cCCcccccCccceeeec-CceEEEEccccee
Confidence 8898886 333222221 1112346788899999999999999999 89999999999999998 8889999876554
Q ss_pred ccccCCccccccccccccccccccC----CCCCCcchhHHHHHHHHHHHHhC-CCCCCCC
Q 021306 190 QLIAGEANISYICSRFYRAPELIFG----ATEYTTSIDIWSAGCVLAELLLG-QPLFPGE 244 (314)
Q Consensus 190 ~~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~~Dv~slG~il~el~tg-~~pf~~~ 244 (314)
...+........+.+.|++||.-.- ....+..+|.|.||+++++++.| ++||.+.
T Consensus 166 i~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI 225 (637)
T COG4248 166 INANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGI 225 (637)
T ss_pred eccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcc
Confidence 4445555566778899999998531 12246789999999999999995 9999764
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.01 E-value=7.6e-09 Score=86.12 Aligned_cols=140 Identities=18% Similarity=0.181 Sum_probs=92.1
Q ss_pred eeeEeecCceEEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCc--eeeeceeeeecCCCCceeEEEEe
Q 021306 43 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPN--VISLKHCFFSTTSKNELFLNLVM 115 (314)
Q Consensus 43 ~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~-----~~~~~e~~~l~~l~h~~--iv~~~~~~~~~~~~~~~~~~lv~ 115 (314)
.+.|+.|..+.+|++... +|+.+++|...... ....+|..+++.+.+.+ +.+++...... ......+++|
T Consensus 3 ~~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~--~~~~~~~~v~ 79 (223)
T cd05154 3 VRQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDP--SVLGTPFYVM 79 (223)
T ss_pred ceecCCCccceEEEEEec-CCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCC--CccCCceEEE
Confidence 367889999999999863 46889999876532 34578999999987644 34444333211 1112356999
Q ss_pred ecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcC-------------------------------------
Q 021306 116 EYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV------------------------------------- 158 (314)
Q Consensus 116 e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~------------------------------------- 158 (314)
||++|....... . ...+++.+...++.+++.++..||+.
T Consensus 80 e~i~G~~l~~~~---~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (223)
T cd05154 80 ERVDGRVLRDRL---L-RPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPP 155 (223)
T ss_pred EEeCCEecCCCC---C-CCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccH
Confidence 999985221111 0 02355555556666666666666631
Q ss_pred ------------------CCceecCCCCCcEEEcCC-CCcEEEeecCccc
Q 021306 159 ------------------PRVCHRDLKPQNLLVDPL-THQVKICDFGSAK 189 (314)
Q Consensus 159 ------------------~~i~h~dl~p~Nil~~~~-~~~~~l~dfg~~~ 189 (314)
..++|+|++|.||+++.. ++.+.++||+.+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~ 205 (223)
T cd05154 156 AMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT 205 (223)
T ss_pred HHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence 346999999999999873 3457899999875
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.98 E-value=2.7e-10 Score=103.62 Aligned_cols=193 Identities=20% Similarity=0.220 Sum_probs=137.5
Q ss_pred CCCceeeeeEeecCceEEEEEEEC-CCCcEEEEEEeeccccch------HHHHHHHHhC-CCCceeeeceeeeecCCCCc
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCL-ETGETVAIKKVLQDRRYK------NRELQLMRVM-DHPNVISLKHCFFSTTSKNE 108 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~-~~~~~~~vK~~~~~~~~~------~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~ 108 (314)
..+|.++..||.|.|+.|+.+... .++..|++|...+..... -.|..+...+ .|.+++.....|...+.
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~--- 340 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQ--- 340 (524)
T ss_pred cCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccc---
Confidence 457899999999999999988755 678899999775443222 2344444443 68888887776644333
Q ss_pred eeEEEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcc
Q 021306 109 LFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 188 (314)
Q Consensus 109 ~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~ 188 (314)
.++-.|||.+...+.-. ..-..+.+...+.+..|++.++.++|+ ..++|+|++|+||++...++..++.||+.+
T Consensus 341 --~~ip~e~~~~~s~~l~~---~~~~~~d~~~~~~~~~q~~~~l~~i~s-~~~~~~d~~psni~i~~~~~~~~~~~~~~~ 414 (524)
T KOG0601|consen 341 --GYIPLEFCEGGSSSLRS---VTSQMLDEDPRLRLTAQILTALNVIHS-KLFVHLDVKPSNILISNDGFFSKLGDFGCW 414 (524)
T ss_pred --ccCchhhhcCcchhhhh---HHHHhcCcchhhhhHHHHHhccccccc-hhhhcccccccceeeccchhhhhccccccc
Confidence 45888999864332222 223567888899999999999999999 899999999999999874477888999987
Q ss_pred cccccCCcccccccccccc-ccccccCCCCCCcchhHHHHHHHHHHHHhCCCC
Q 021306 189 KQLIAGEANISYICSRFYR-APELIFGATEYTTSIDIWSAGCVLAELLLGQPL 240 (314)
Q Consensus 189 ~~~~~~~~~~~~~~~~~y~-aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~p 240 (314)
....- ..........+. ..|.+.....+..+.|++|||..+.+.++|...
T Consensus 415 t~~~~--~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~l 465 (524)
T KOG0601|consen 415 TRLAF--SSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPL 465 (524)
T ss_pred cccce--ecccccccccccccchhhccccccccccccccccccccccccCccc
Confidence 64211 111122233333 355555555578899999999999999998744
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.91 E-value=1.4e-08 Score=84.56 Aligned_cols=131 Identities=20% Similarity=0.171 Sum_probs=93.4
Q ss_pred ceeeeeEeecCceEEEEEEECCCCcEEEEEEeecc--------------------------ccchHHHHHHHHhCCCC--
Q 021306 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD--------------------------RRYKNRELQLMRVMDHP-- 91 (314)
Q Consensus 40 y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~--------------------------~~~~~~e~~~l~~l~h~-- 91 (314)
+.+++.||-|--+.||.|.+ ..|.++++|.-+.. +...++|.+.|.+|...
T Consensus 93 e~iG~~IGvGKEsdVY~~~~-~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAID-PKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEEC-CCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 46789999999999999995 47899999953210 11125788888888654
Q ss_pred ceeeeceeeeecCCCCceeEEEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcE
Q 021306 92 NVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNL 171 (314)
Q Consensus 92 ~iv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Ni 171 (314)
.+.+.+++ +...+|||+++|-.+ .. -+++.+....++..|+.-+...-. .|++|||+++-||
T Consensus 172 ~VP~P~~~---------nRHaVvMe~ieG~eL---~~-----~r~~~en~~~il~~il~~~~~~~~-~GiVHGDlSefNI 233 (304)
T COG0478 172 KVPKPIAW---------NRHAVVMEYIEGVEL---YR-----LRLDVENPDEILDKILEEVRKAYR-RGIVHGDLSEFNI 233 (304)
T ss_pred CCCCcccc---------ccceeeeehccccee---ec-----ccCcccCHHHHHHHHHHHHHHHHH-cCccccCCchheE
Confidence 44444322 125699999999522 11 222345555666667666666667 7999999999999
Q ss_pred EEcCCCCcEEEeecCcccc
Q 021306 172 LVDPLTHQVKICDFGSAKQ 190 (314)
Q Consensus 172 l~~~~~~~~~l~dfg~~~~ 190 (314)
++++ ++.+.++||-.+..
T Consensus 234 lV~~-dg~~~vIDwPQ~v~ 251 (304)
T COG0478 234 LVTE-DGDIVVIDWPQAVP 251 (304)
T ss_pred EEec-CCCEEEEeCccccc
Confidence 9998 88899999987653
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.88 E-value=9.5e-08 Score=77.66 Aligned_cols=138 Identities=13% Similarity=0.081 Sum_probs=96.2
Q ss_pred eecCceEEEEEEECCCCcEEEEEEee----------ccccchHHHHHHHHhCCCCcee--eeceeeeecCCCCceeEEEE
Q 021306 47 GTGSFGIVFQAKCLETGETVAIKKVL----------QDRRYKNRELQLMRVMDHPNVI--SLKHCFFSTTSKNELFLNLV 114 (314)
Q Consensus 47 g~g~~g~Vy~~~~~~~~~~~~vK~~~----------~~~~~~~~e~~~l~~l~h~~iv--~~~~~~~~~~~~~~~~~~lv 114 (314)
|+||-+.|+.... .|+.+-+|.-. ..+..+.+|...+.++...++. +.. ++..........-+||
T Consensus 27 ~rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 27 RRNGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred CCCCcceEEEEEe--CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 4577788888765 45578888653 1233446888888888544433 222 2222222345567899
Q ss_pred eecccc--cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCC-CcEEEeecCcccc
Q 021306 115 MEYVPE--SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLT-HQVKICDFGSAKQ 190 (314)
Q Consensus 115 ~e~~~~--~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~-~~~~l~dfg~~~~ 190 (314)
+|-++| +|.+.+... .-.+.+..+...++.+++.++.-||. .|+.|+|+.+.||+++..+ ..+.++||..++.
T Consensus 104 Te~L~g~~~L~~~l~~~--~~~~~~~~~k~~il~~va~~ia~LH~-~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 104 TEDMAGFISIADWYAQH--AVSPYSDEVRQAMLKAVALAFKKMHS-VNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EEeCCCCccHHHHHhcC--CcCCcchHHHHHHHHHHHHHHHHHHH-CCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 999885 666655431 12356788888999999999999999 8999999999999998522 2499999998764
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.82 E-value=1.1e-07 Score=77.54 Aligned_cols=135 Identities=16% Similarity=0.183 Sum_probs=85.7
Q ss_pred CCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccccchH-------------HHHHHHHhC---CCCceeeeceeee
Q 021306 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-------------RELQLMRVM---DHPNVISLKHCFF 101 (314)
Q Consensus 38 ~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~~~~~-------------~e~~~l~~l---~h~~iv~~~~~~~ 101 (314)
++|.+.+.+-.....-|.+..- +|+.+++|.........+ +....+.++ ....+..++.+..
T Consensus 31 ~~~~~~kv~k~~~r~~ValIei--~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~e 108 (229)
T PF06176_consen 31 NNYKIIKVFKNTKRNYVALIEI--DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAE 108 (229)
T ss_pred CCceEEEeecCCCccEEEEEEE--CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeee
Confidence 5789999998887777776664 789999998765433222 222222222 2223333222222
Q ss_pred ecCCCCceeEEEEeeccccc-HHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcE
Q 021306 102 STTSKNELFLNLVMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQV 180 (314)
Q Consensus 102 ~~~~~~~~~~~lv~e~~~~~-l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~ 180 (314)
.....-....+++|||++|- +.+. ..+++. +...+..++..+|+ .|++|||.+|.|+++.. +.+
T Consensus 109 kk~~~~~~~~~ll~EYIeG~~l~d~--------~~i~e~----~~~ki~~~ikqlH~-~G~~HGD~hpgNFlv~~--~~i 173 (229)
T PF06176_consen 109 KKIFRYTSSYVLLMEYIEGVELNDI--------EDIDED----LAEKIVEAIKQLHK-HGFYHGDPHPGNFLVSN--NGI 173 (229)
T ss_pred eeeccceeEEEEEEEEecCeecccc--------hhcCHH----HHHHHHHHHHHHHH-cCCccCCCCcCcEEEEC--CcE
Confidence 22222234466899999994 2221 112322 33466778999999 89999999999999985 459
Q ss_pred EEeecCccc
Q 021306 181 KICDFGSAK 189 (314)
Q Consensus 181 ~l~dfg~~~ 189 (314)
+++|++..+
T Consensus 174 ~iID~~~k~ 182 (229)
T PF06176_consen 174 RIIDTQGKR 182 (229)
T ss_pred EEEECcccc
Confidence 999998765
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.79 E-value=1.5e-09 Score=100.35 Aligned_cols=141 Identities=16% Similarity=0.249 Sum_probs=93.7
Q ss_pred HHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcccccccCCccc----------cccccccccccccccCCCCC
Q 021306 149 FRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI----------SYICSRFYRAPELIFGATEY 218 (314)
Q Consensus 149 ~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~----------~~~~~~~y~aPE~~~~~~~~ 218 (314)
+.|+.++|...++||++|.|++|.++. ++.+||+.|+.+.......... .......|.|||++.+.. .
T Consensus 109 ~dgl~flh~sAk~VH~ni~p~~i~~na-~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~-~ 186 (700)
T KOG2137|consen 109 ADGLAFLHRSAKVVHGNIQPEAIVVNA-NGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTT-N 186 (700)
T ss_pred cchhhhhccCcceeecccchhheeecc-CcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcccc-c
Confidence 389999999789999999999999998 8899999999876543321110 011244699999997644 7
Q ss_pred CcchhHHHHHHHHHHHH-hCCCCCCCCChHHHHHHHH-------HHcC----CCCHHHHh---ccCCCCCCCcccccccC
Q 021306 219 TTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEII-------KVLG----TPTREEIR---CMNPNYTDFRFPQIKAH 283 (314)
Q Consensus 219 ~~~~Dv~slG~il~el~-tg~~pf~~~~~~~~~~~i~-------~~~~----~~~~~~~~---~~~p~~~~~~~~~l~~~ 283 (314)
++++|+||+|+++|.+. .|+..+...........-. ...+ ....+.+. ..++. .|+++..+...
T Consensus 187 ~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~-~rp~~~~l~~~ 265 (700)
T KOG2137|consen 187 TPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSA-VRPTLDLLLSI 265 (700)
T ss_pred cccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcc-cCcchhhhhcc
Confidence 89999999999999998 4666665443221111111 1111 11122222 12344 45689999999
Q ss_pred Chhhhhccc
Q 021306 284 PWHKVCIFH 292 (314)
Q Consensus 284 p~~~~~~~~ 292 (314)
|++....-.
T Consensus 266 ~ff~D~~~~ 274 (700)
T KOG2137|consen 266 PFFSDPGLK 274 (700)
T ss_pred cccCCchhh
Confidence 998876643
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.75 E-value=1.5e-07 Score=77.67 Aligned_cols=107 Identities=18% Similarity=0.223 Sum_probs=74.7
Q ss_pred hHHHHHHHHhCCCCcee--eeceeeeecCCCCceeEEEEeecccc--cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHH
Q 021306 78 KNRELQLMRVMDHPNVI--SLKHCFFSTTSKNELFLNLVMEYVPE--SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 153 (314)
Q Consensus 78 ~~~e~~~l~~l~h~~iv--~~~~~~~~~~~~~~~~~~lv~e~~~~--~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~ 153 (314)
..+|...+..+....|. ..+.+..... ......++|+|++++ +|.+.+.. ....+......++.+++..+.
T Consensus 58 a~~E~~~~~~L~~~Gi~tP~pva~~~~r~-~~~~~s~lite~l~~~~~L~~~~~~----~~~~~~~~~~~ll~~l~~~i~ 132 (206)
T PF06293_consen 58 AKREWRNLQRLREAGIPTPEPVAYGERRK-GGGYRSYLITEALPGAQDLRDLLQQ----WEQLDPSQRRELLRALARLIA 132 (206)
T ss_pred HHHHHHHHHHHHHcCCCCCcEEEEEEEcC-CCceeEEEEEEeCCCcccHHHHHHh----hcccchhhHHHHHHHHHHHHH
Confidence 35677766666433332 2222222211 222445799999997 45555543 223677778899999999999
Q ss_pred HhhcCCCceecCCCCCcEEEcCCC--CcEEEeecCcccc
Q 021306 154 YIHTVPRVCHRDLKPQNLLVDPLT--HQVKICDFGSAKQ 190 (314)
Q Consensus 154 ~LH~~~~i~h~dl~p~Nil~~~~~--~~~~l~dfg~~~~ 190 (314)
-||. .|++|+|+++.|||++..+ ..+.++||+.+..
T Consensus 133 ~lH~-~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 133 KLHD-AGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHH-CcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 9999 9999999999999999833 2799999998764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.54 E-value=1e-06 Score=72.88 Aligned_cols=133 Identities=19% Similarity=0.158 Sum_probs=88.0
Q ss_pred eEeecCceEEEEEEECCCCcEEEEEEeeccccc----------------------------hHHHHHHHHhCCCCc--ee
Q 021306 45 VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY----------------------------KNRELQLMRVMDHPN--VI 94 (314)
Q Consensus 45 ~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~~~----------------------------~~~e~~~l~~l~h~~--iv 94 (314)
.|.+|.-+.||+|. ..++..+|+|+++..... ..+|..-|+++.... +.
T Consensus 55 ~istGKEA~Vy~a~-~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP 133 (268)
T COG1718 55 CISTGKEANVYLAE-TGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVP 133 (268)
T ss_pred eecCCcceEEEeec-cCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCC
Confidence 56667778999998 467899999998532111 125666666664333 22
Q ss_pred eeceeeeecCCCCceeEEEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEc
Q 021306 95 SLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVD 174 (314)
Q Consensus 95 ~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~ 174 (314)
+.+.+. . ..++|||++.. -.-.-...+.++...++..+..+++..+.-|-...++||+||+.-|||+.
T Consensus 134 ~Pi~~~-----~----nVLvMEfIg~~---g~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~ 201 (268)
T COG1718 134 EPIAFR-----N----NVLVMEFIGDD---GLPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH 201 (268)
T ss_pred Cceeec-----C----CeEEEEeccCC---CCCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE
Confidence 222222 1 34999999853 01111112344555567788888888888776646999999999999999
Q ss_pred CCCCcEEEeecCcccccc
Q 021306 175 PLTHQVKICDFGSAKQLI 192 (314)
Q Consensus 175 ~~~~~~~l~dfg~~~~~~ 192 (314)
++.+.+|||+.+....
T Consensus 202 --~~~p~iID~~QaV~~~ 217 (268)
T COG1718 202 --DGEPYIIDVSQAVTID 217 (268)
T ss_pred --CCeEEEEECccccccC
Confidence 5679999999986543
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.44 E-value=5.9e-07 Score=83.17 Aligned_cols=138 Identities=18% Similarity=0.180 Sum_probs=82.3
Q ss_pred eeEeecCceEEEEEEECCCCcEEEEEEeeccc--------------------------------------------cchH
Q 021306 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR--------------------------------------------RYKN 79 (314)
Q Consensus 44 ~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~--------------------------------------------~~~~ 79 (314)
+-|+.++-|.||+|+. .+|+.||||+....- -...
T Consensus 131 ~PiAsASIaQVH~A~L-~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVL-KSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEe-cCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 5778999999999995 469999999873210 0001
Q ss_pred HHHHHHHhC----CCCceeeeceeeeecCCCCceeEEEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHh
Q 021306 80 RELQLMRVM----DHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 155 (314)
Q Consensus 80 ~e~~~l~~l----~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~L 155 (314)
+|+.-+.++ +..--+.+..++-+..+ .-.++|||++|.-.+.+.... ...++...+...+.++ .+..+
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~----~~VLtmE~i~Gi~i~d~~~l~--~~g~d~k~ia~~~~~~--f~~q~ 281 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVPKVYWEYTT----RRVLTMEWIDGIKISDIAALK--SAGIDRKELAELLVRA--FLRQL 281 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEeceeehhccC----CcEEEEEeeCCEecccHHHHH--hcCCCHHHHHHHHHHH--HHHHH
Confidence 344433333 22222344444422111 245999999983222222111 1334433333222222 13333
Q ss_pred hcCCCceecCCCCCcEEEcCCCCcEEEeecCcccccc
Q 021306 156 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 192 (314)
Q Consensus 156 H~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~ 192 (314)
-. .|++|+|.+|.||+++. ++++.+.|||......
T Consensus 282 ~~-dgffHaDpHpGNi~v~~-~g~i~~lDfGi~g~l~ 316 (517)
T COG0661 282 LR-DGFFHADPHPGNILVRS-DGRIVLLDFGIVGRLD 316 (517)
T ss_pred Hh-cCccccCCCccceEEec-CCcEEEEcCcceecCC
Confidence 34 69999999999999998 7899999999987653
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.28 E-value=9.3e-06 Score=67.91 Aligned_cols=75 Identities=19% Similarity=0.205 Sum_probs=48.8
Q ss_pred eeeEeecCceEEEEEEECCCCcEEEEEEeecc--ccchHHHHHHHHhCCCCce--eeeceeeeecCCCCceeEEEEeecc
Q 021306 43 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQD--RRYKNRELQLMRVMDHPNV--ISLKHCFFSTTSKNELFLNLVMEYV 118 (314)
Q Consensus 43 ~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~--~~~~~~e~~~l~~l~h~~i--v~~~~~~~~~~~~~~~~~~lv~e~~ 118 (314)
++.|+.|..+.||++.... ..+++|..... .....+|..+++.+....+ .+++... .........+++|+++
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~--~~~~~~~~~~~~~~~i 77 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPPDAAERLRREAAVLRQLAEHGIPVPRVLAFD--TSDEFNGFPYLLMEYI 77 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSHHHHHHHHHHHHHHHHHHHTTSBS--EEEEE--EETEETSEEEEEEEEE
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCCCCHHHHHHHHHHHHHHHhcCCCCceEEeec--ccccccccceEEEEEe
Confidence 5678999999999999643 58999987655 3344678888877754433 3333322 1112233367999999
Q ss_pred ccc
Q 021306 119 PES 121 (314)
Q Consensus 119 ~~~ 121 (314)
+|.
T Consensus 78 ~g~ 80 (239)
T PF01636_consen 78 PGR 80 (239)
T ss_dssp SSE
T ss_pred ccc
Confidence 984
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.25 E-value=6.7e-08 Score=88.97 Aligned_cols=187 Identities=19% Similarity=0.120 Sum_probs=132.4
Q ss_pred CceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHhCCCCc-eeeeceeeeecCCCCceeEEEEeec
Q 021306 39 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPN-VISLKHCFFSTTSKNELFLNLVMEY 117 (314)
Q Consensus 39 ~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~~~~~~e~~~l~~l~h~~-iv~~~~~~~~~~~~~~~~~~lv~e~ 117 (314)
-|...+.+++++++.+++.+...+.... .+.+... ....-++++|.+.+||| .+..++-+ +...+.++.+++
T Consensus 243 ws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~-l~~rl~~eLLdK~n~P~~~v~~~~d~-----~~E~~~~i~~~i 315 (829)
T KOG0576|consen 243 WSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT-LSRRLAIELLDKVNNPNPVVRYLEDY-----DGEDYLWIPMRI 315 (829)
T ss_pred chHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc-hhhHHHHHHHHHccCCCCcccccccC-----Ccccccchhhhh
Confidence 5667788899999999999875554433 6655544 44456889999999999 44433322 556678999999
Q ss_pred cccc--HHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcccccccCC
Q 021306 118 VPES--MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE 195 (314)
Q Consensus 118 ~~~~--l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~~~~ 195 (314)
++++ ..... ....-.+...+...+.+.-+++++++|+ .--+|+| ||+... +..+..+|+....+....
T Consensus 316 ~s~~rs~~~~~---~~se~~~~~~~~~~~~r~et~~l~~l~~-~~~~~~d----~~l~s~--~~~~~~~~~v~~~L~~~~ 385 (829)
T KOG0576|consen 316 CSTGRSSALEM---TVSEIALEQYQFAYPLRKETRPLAELHS-SYKVHRD----NILGSE--EEVKLLDFAVPPQLTRTM 385 (829)
T ss_pred hcCCccccccC---ChhhHhhhhhhhhhhhhhhccccccccc-ccccCcc----cccccc--cccccccccCCcccCccc
Confidence 9864 11111 0112234445566666777788999998 4457877 777664 568899999887665544
Q ss_pred ccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 021306 196 ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 243 (314)
Q Consensus 196 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~ 243 (314)
......+++.++|||...... +....|.|++|.-..+|.-|-+|-..
T Consensus 386 ~~~t~~~~~~~~~pev~~~~~-~~~~p~~~~~~~~~~~~ap~~pPr~~ 432 (829)
T KOG0576|consen 386 KPRTAIGTPEPLAPEVIQENT-IDGCPDSGSLAVSAIQMAPGLPPRSS 432 (829)
T ss_pred ccccCCCCCCCCCchhhcccc-cccCCCccCCCcchhhcCCCCCCCCC
Confidence 455677899999999886544 77889999999888888888877654
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.21 E-value=7e-06 Score=76.01 Aligned_cols=138 Identities=18% Similarity=0.228 Sum_probs=84.7
Q ss_pred eeeeEeecCceEEEEEEECCCCcEEEEEEeeccc-----------------------------------------cchHH
Q 021306 42 AERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----------------------------------------RYKNR 80 (314)
Q Consensus 42 ~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~-----------------------------------------~~~~~ 80 (314)
--+.|+..+.|.||+|+- .+|+.||||.-+..- -.+.+
T Consensus 165 ~~~piaaASlaQVhrA~L-~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~ 243 (538)
T KOG1235|consen 165 DEEPIAAASLAQVHRARL-KNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTK 243 (538)
T ss_pred CcchhhhcchhheEEEEe-cCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHH
Confidence 346789999999999995 469999999763210 00112
Q ss_pred HHH----HHHhCCCCc---eeeeceeeeecCCCCceeEEEEeeccccc---HHHHHHhhhhcCCCCCHHHHHHHHHHHHH
Q 021306 81 ELQ----LMRVMDHPN---VISLKHCFFSTTSKNELFLNLVMEYVPES---MYRVLKHYSSANQRMPLIYVKLYTYQIFR 150 (314)
Q Consensus 81 e~~----~l~~l~h~~---iv~~~~~~~~~~~~~~~~~~lv~e~~~~~---l~~~l~~~~~~~~~l~~~~~~~i~~ql~~ 150 (314)
|++ +.+.++|-+ -|.+..++.+... .-.++|||++|. -.+.+.. ..++...+..-+.+...
T Consensus 244 EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st----~RVLtME~~~G~~i~Dl~~i~~-----~gi~~~~i~~~l~~~~~ 314 (538)
T KOG1235|consen 244 EAKNAERFRENFKDFSLLTYVLVPKVYWDLST----KRVLTMEYVDGIKINDLDAIDK-----RGISPHDILNKLVEAYL 314 (538)
T ss_pred HHHhHHHHHHHHHhcccccceeCCeehhhcCc----ceEEEEEecCCccCCCHHHHHH-----cCCCHHHHHHHHHHHHH
Confidence 222 233334444 2234344322222 146999999983 2233332 45666655444433322
Q ss_pred HHHHhhcCCCceecCCCCCcEEEcC---CCCcEEEeecCcccccc
Q 021306 151 GLAYIHTVPRVCHRDLKPQNLLVDP---LTHQVKICDFGSAKQLI 192 (314)
Q Consensus 151 ~l~~LH~~~~i~h~dl~p~Nil~~~---~~~~~~l~dfg~~~~~~ 192 (314)
..+-. .|++|+|-+|.||++.+ .+..+.+.|+|+.....
T Consensus 315 --~qIf~-~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 315 --EQIFK-TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred --HHHHh-cCCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 22333 68999999999999994 36789999999987553
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.20 E-value=2.4e-05 Score=65.35 Aligned_cols=69 Identities=14% Similarity=0.077 Sum_probs=44.3
Q ss_pred eeEeecCceEEEEEEECCCCcEEEEEEeeccc--cchHHHHHHHHhCCCCce--eeeceeeeecCCCCceeEEEEeeccc
Q 021306 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR--RYKNRELQLMRVMDHPNV--ISLKHCFFSTTSKNELFLNLVMEYVP 119 (314)
Q Consensus 44 ~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~--~~~~~e~~~l~~l~h~~i--v~~~~~~~~~~~~~~~~~~lv~e~~~ 119 (314)
..||+|..+.||+. .+..+++|...... ....+|.++++.+....+ .+.+.+. ......+++||+++
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~~~~~i~~E~~~l~~l~~~glpvP~~~~~~-----~~~~~~glv~e~i~ 77 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPGFDKETIKREFDASRKVFSLGIPTPHPFDLV-----EDGGRLGLIYELIV 77 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCCCCHHHHHHHHHHHHHHHHcCCCCCceEEEE-----ecCCeeeeeeeecC
Confidence 57899999999974 24467899876532 234688888888754433 2333322 11112568999999
Q ss_pred cc
Q 021306 120 ES 121 (314)
Q Consensus 120 ~~ 121 (314)
|.
T Consensus 78 G~ 79 (226)
T TIGR02172 78 GK 79 (226)
T ss_pred Cc
Confidence 84
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.19 E-value=1e-05 Score=63.46 Aligned_cols=126 Identities=22% Similarity=0.339 Sum_probs=85.4
Q ss_pred ceeeeeEeecCceEEEEEEECCCCcEEEEEEeecc--ccchHHHHHHHHhCCCCceeeeceeeeecCCCCceeEEEEeec
Q 021306 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD--RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEY 117 (314)
Q Consensus 40 y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~ 117 (314)
-++.+.|++|.+|.||++.+ .|..+++|.-..+ +...+.|++++..++-.++.+=. +++.. .++.|||
T Consensus 24 ~~v~~~L~KG~~s~Vyl~~~--~~~~~a~Kvrr~ds~r~~l~kEakiLeil~g~~~~p~v-y~yg~-------~~i~me~ 93 (201)
T COG2112 24 LRVEKELAKGTTSVVYLGEW--RGGEVALKVRRRDSPRRNLEKEAKILEILAGEGVTPEV-YFYGE-------DFIRMEY 93 (201)
T ss_pred hhhhhhhhcccccEEEEeec--cCceEEEEEecCCcchhhHHHHHHHHHHhhhcCCCceE-EEech-------hhhhhhh
Confidence 45678999999999999987 5668899976544 45567899999999876665521 11211 2366999
Q ss_pred ccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCC-CC-cEEEcCCCCcEEEeecCccc
Q 021306 118 VPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLK-PQ-NLLVDPLTHQVKICDFGSAK 189 (314)
Q Consensus 118 ~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~-p~-Nil~~~~~~~~~l~dfg~~~ 189 (314)
+.| .|.+.... .+...+ ..++....-|-. .||-|+.|+ |. ||++. ++.+.|+||..|+
T Consensus 94 i~G~~L~~~~~~-------~~rk~l----~~vlE~a~~LD~-~GI~H~El~~~~k~vlv~--~~~~~iIDFd~At 154 (201)
T COG2112 94 IDGRPLGKLEIG-------GDRKHL----LRVLEKAYKLDR-LGIEHGELSRPWKNVLVN--DRDVYIIDFDSAT 154 (201)
T ss_pred hcCcchhhhhhc-------ccHHHH----HHHHHHHHHHHH-hccchhhhcCCceeEEec--CCcEEEEEccchh
Confidence 998 43332221 122333 345555555666 799999987 44 55555 4489999999986
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.99 E-value=2.4e-05 Score=77.23 Aligned_cols=204 Identities=21% Similarity=0.294 Sum_probs=125.3
Q ss_pred HHHHHHHHhCCCCceeeeceeeeecCCCCceeEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhc
Q 021306 79 NRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT 157 (314)
Q Consensus 79 ~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~ 157 (314)
..|.+.+.++.|+|++.++.+-......+ ....+..+++++ ++...+++ -+.++.+..+.+..+++.++.++|+
T Consensus 230 E~e~~~l~k~~~~n~~~~~~~~le~~~~g-~~~~v~~~~~s~~~~~~~~q~----v~~i~~~~~r~~~~~~~~GL~~~h~ 304 (1351)
T KOG1035|consen 230 EIELESLSKIAHDNLGGYFVYGLERLFRG-IVLDVLQEICSKVELRSLLQS----VGSIPLETLRILHQKLLEGLAYLHS 304 (1351)
T ss_pred HHHHHHHHhhccccccceeEEeehhhcch-HHHHHHHhhcCccchHHHHhh----ccccCHHHHHHHHHHHhhhHHHHHH
Confidence 35667788899999999877654332222 122345577775 55555554 4778999999999999999999999
Q ss_pred CCCceecCCCCC---cEEEcCCCCcEEEe--ecCcccccccCCccccccccccccccccccCCC-CCCcchhHHHHHHHH
Q 021306 158 VPRVCHRDLKPQ---NLLVDPLTHQVKIC--DFGSAKQLIAGEANISYICSRFYRAPELIFGAT-EYTTSIDIWSAGCVL 231 (314)
Q Consensus 158 ~~~i~h~dl~p~---Nil~~~~~~~~~l~--dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~~Dv~slG~il 231 (314)
....|.-+..+ +.-++. .+.+... ||+.+.................+.++|...... +.....|+|.+|..+
T Consensus 305 -~~l~~v~L~~s~~~~~~~~~-e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~ 382 (1351)
T KOG1035|consen 305 -LSLEHVVLSASSSKESTVDG-EGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLL 382 (1351)
T ss_pred -hccceeEEecccccccccCc-cceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHHHH
Confidence 65555444443 222222 3344444 888887766655555555566677888774332 123347999999999
Q ss_pred HHHHhCCCCCCCCChHHHHHHHHHHcCC-CCHHHHhcc---CCCCCCCcccccccCChhhhhcccC
Q 021306 232 AELLLGQPLFPGENAVDQLVEIIKVLGT-PTREEIRCM---NPNYTDFRFPQIKAHPWHKVCIFHF 293 (314)
Q Consensus 232 ~el~tg~~pf~~~~~~~~~~~i~~~~~~-~~~~~~~~~---~p~~~~~~~~~l~~~p~~~~~~~~~ 293 (314)
..+..|..+-..... ....+..... ........+ +++ +|+...+++.||+.+....-.
T Consensus 383 ~~~~~~~~i~~~~~~---~~~~l~~~~~~~~~d~~~~~~~~~~~-~Rl~~~~ll~~~f~~~~~~~~ 444 (1351)
T KOG1035|consen 383 LQLSQGEDISEKSAV---PVSLLDVLSTSELLDALPKCLDEDSE-ERLSALELLTHPFLRFPTDNE 444 (1351)
T ss_pred hhhhhcCcccccccc---hhhhhccccchhhhhhhhhhcchhhh-hccchhhhhhchhcccccccc
Confidence 999987754322111 1111111111 111222211 133 688899999999988776543
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.98 E-value=0.0001 Score=73.24 Aligned_cols=78 Identities=18% Similarity=0.192 Sum_probs=50.5
Q ss_pred eeeeEeecCceEEEEEEECCCC--cEEEEEEeecc-----ccchHHHHHHHHhCC-CCce--eeeceeeeecCCCCceeE
Q 021306 42 AERVVGTGSFGIVFQAKCLETG--ETVAIKKVLQD-----RRYKNRELQLMRVMD-HPNV--ISLKHCFFSTTSKNELFL 111 (314)
Q Consensus 42 ~~~~Lg~g~~g~Vy~~~~~~~~--~~~~vK~~~~~-----~~~~~~e~~~l~~l~-h~~i--v~~~~~~~~~~~~~~~~~ 111 (314)
.++.++.|.++.+|+......+ ..+++|+.... .....+|..+++.+. |.++ .+++..+.+ ....+..
T Consensus 42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d--~~v~G~~ 119 (822)
T PLN02876 42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTD--ASVIGTA 119 (822)
T ss_pred eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecC--CCcCCCc
Confidence 4677888999999998764332 46888876432 234568999999985 6664 333333222 1112235
Q ss_pred EEEeeccccc
Q 021306 112 NLVMEYVPES 121 (314)
Q Consensus 112 ~lv~e~~~~~ 121 (314)
|+||||++|.
T Consensus 120 flVME~v~G~ 129 (822)
T PLN02876 120 FYIMEYLEGR 129 (822)
T ss_pred eEEEEecCCc
Confidence 7999999974
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.94 E-value=0.00014 Score=58.93 Aligned_cols=126 Identities=22% Similarity=0.333 Sum_probs=87.1
Q ss_pred CCceeeeeEeecCc-eEEEEEEECCCCcEEEEEEeec-----c--------c------------cchHHHHHHH---HhC
Q 021306 38 ISYMAERVVGTGSF-GIVFQAKCLETGETVAIKKVLQ-----D--------R------------RYKNRELQLM---RVM 88 (314)
Q Consensus 38 ~~y~~~~~Lg~g~~-g~Vy~~~~~~~~~~~~vK~~~~-----~--------~------------~~~~~e~~~l---~~l 88 (314)
.+++..+.||.|.- |.||+++. +|+.||+|.+.. . . ..+..|.... +..
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 68999999999999 99999987 788999999421 0 0 0112454444 444
Q ss_pred CCCce--eeeceeeeecCC-------------CCceeEEEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHH
Q 021306 89 DHPNV--ISLKHCFFSTTS-------------KNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 153 (314)
Q Consensus 89 ~h~~i--v~~~~~~~~~~~-------------~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~ 153 (314)
.+.++ +++++++.-... .......||.||++.. ..++...+. +|.+-+.
T Consensus 115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~------------~~~~~~~~~----~~~~dl~ 178 (207)
T PF13095_consen 115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDD------------PPLQIRDIP----QMLRDLK 178 (207)
T ss_pred cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCc------------cccchhHHH----HHHHHHH
Confidence 55566 899998754421 1122346888887764 134445554 6666678
Q ss_pred HhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcc
Q 021306 154 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 188 (314)
Q Consensus 154 ~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~ 188 (314)
.+|+ .||+-+|+++.|.. + -+|+|||.+
T Consensus 179 ~~~k-~gI~~~Dv~~~ny~-~-----G~lvDfs~~ 206 (207)
T PF13095_consen 179 ILHK-LGIVPRDVKPRNYR-G-----GKLVDFSSS 206 (207)
T ss_pred HHHH-CCeeeccCcccccc-C-----CEEEecccC
Confidence 8999 89999999999986 2 268999864
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.92 E-value=0.00013 Score=59.44 Aligned_cols=131 Identities=19% Similarity=0.312 Sum_probs=86.5
Q ss_pred eeeEeecCceEEEEEEECCCCcEEEEEEeeccc--------------------cchHHHHHHHHhCC------CCceeee
Q 021306 43 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR--------------------RYKNRELQLMRVMD------HPNVISL 96 (314)
Q Consensus 43 ~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~--------------------~~~~~e~~~l~~l~------h~~iv~~ 96 (314)
...||+|+.-.||.-- .....+||+..... ....+|+.....+. +.+|.++
T Consensus 6 ~~~i~~G~~R~cy~HP---~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 6 SDLIAQGGERDCYQHP---DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CcccccCCCceEEECC---CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 4578999999998654 44557888776554 33346666655555 7889999
Q ss_pred ceeeeecCCCCceeEEEEeeccc---ccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEE
Q 021306 97 KHCFFSTTSKNELFLNLVMEYVP---ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLV 173 (314)
Q Consensus 97 ~~~~~~~~~~~~~~~~lv~e~~~---~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~ 173 (314)
+|....... ..+|+|.+. |+....+..+.. .+.+++ ..... +-....+|-. .+|+.+|++|.||++
T Consensus 83 ~G~veT~~G-----~Glv~e~I~d~dG~~s~TL~~~l~-~~~~~~-~~~~~---L~~f~~~l~~-~~Iv~~dl~~~NIv~ 151 (199)
T PF10707_consen 83 YGFVETNLG-----LGLVVELIRDADGNISPTLEDYLK-EGGLTE-ELRQA---LDEFKRYLLD-HHIVIRDLNPHNIVV 151 (199)
T ss_pred eEEEecCCc-----eEEEEEEEECCCCCcCccHHHHHH-cCCccH-HHHHH---HHHHHHHHHH-cCCeecCCCcccEEE
Confidence 998855444 668888764 443344444432 355666 44433 3344667777 799999999999999
Q ss_pred cCCC--C-cEEEee-cCc
Q 021306 174 DPLT--H-QVKICD-FGS 187 (314)
Q Consensus 174 ~~~~--~-~~~l~d-fg~ 187 (314)
.... . .+.|+| ||.
T Consensus 152 ~~~~~~~~~lvlIDG~G~ 169 (199)
T PF10707_consen 152 QRRDSGEFRLVLIDGLGE 169 (199)
T ss_pred EecCCCceEEEEEeCCCC
Confidence 6522 2 578888 443
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.91 E-value=0.0003 Score=59.10 Aligned_cols=70 Identities=13% Similarity=0.208 Sum_probs=44.2
Q ss_pred eeeEeecCceEEEEEEECC-CCcEEEEEEeecccc---chHHHHHHHHhCCCCceeeeceeeeecCCCCceeEEEEeecc
Q 021306 43 ERVVGTGSFGIVFQAKCLE-TGETVAIKKVLQDRR---YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYV 118 (314)
Q Consensus 43 ~~~Lg~g~~g~Vy~~~~~~-~~~~~~vK~~~~~~~---~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~ 118 (314)
++.|..|-...+|++.... .++.|++|....... ...+|..+++.+....+++-+-.. . . -++++||+
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~gl~P~v~~~--~--~----~~~l~e~i 74 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELIIDRERELRIHKLLSKHGLAPKLYAT--F--Q----NGLIYEFI 74 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccceecHHHHHHHHHHHHhCCCCCeEEEE--e--C----CcEEEEee
Confidence 4567778888999997432 357899997754322 224788888888554444322111 1 1 13799999
Q ss_pred cc
Q 021306 119 PE 120 (314)
Q Consensus 119 ~~ 120 (314)
+|
T Consensus 75 ~G 76 (235)
T cd05157 75 PG 76 (235)
T ss_pred CC
Confidence 87
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.88 E-value=0.00022 Score=60.37 Aligned_cols=30 Identities=30% Similarity=0.361 Sum_probs=26.0
Q ss_pred CCceecCCCCCcEEEcCCCCcEEEeecCccc
Q 021306 159 PRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 189 (314)
Q Consensus 159 ~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~ 189 (314)
..++|+|+.|.||++++ +..+.|+||+.+.
T Consensus 163 ~~l~HgD~~~~Nil~~~-~~~~~iIDwe~a~ 192 (244)
T cd05150 163 LVVTHGDACLPNIIVDP-GKFSGFIDLGRLG 192 (244)
T ss_pred eEEECCCCCCccEEEeC-CcEEEEEEccccc
Confidence 45899999999999998 6667899999774
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.83 E-value=9.9e-05 Score=64.67 Aligned_cols=138 Identities=18% Similarity=0.220 Sum_probs=95.8
Q ss_pred eeeeeEeecCceEEEEEEECCCCcEEEEEEeecc------------------------------ccchHHHHHHHHhCCC
Q 021306 41 MAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------------------------------RRYKNRELQLMRVMDH 90 (314)
Q Consensus 41 ~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~------------------------------~~~~~~e~~~l~~l~h 90 (314)
.+..+|..|--+.||-|. ..+|..+|||+++-. ..+..+|..-|+++..
T Consensus 147 ~inGCiSTGKEANVYHat-~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~ 225 (520)
T KOG2270|consen 147 EINGCISTGKEANVYHAT-EEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNN 225 (520)
T ss_pred ecccccccCccceeEeee-cCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHh
Confidence 355577778888999998 568888999987421 0111356667777766
Q ss_pred CceeeeceeeeecCCCCceeEEEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCc
Q 021306 91 PNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQN 170 (314)
Q Consensus 91 ~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~N 170 (314)
..| ++....+... ..+||+|+++. -+-.....+..++...+..+-.|++.-+.-|.+..++||.||+--|
T Consensus 226 aGI-P~PePIlLk~------hVLVM~FlGrd---gw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN 295 (520)
T KOG2270|consen 226 AGI-PCPEPILLKN------HVLVMEFLGRD---GWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFN 295 (520)
T ss_pred cCC-CCCCceeeec------ceEeeeeccCC---CCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhh
Confidence 553 3333222111 34999999853 1111122356788788888888888888888765799999999999
Q ss_pred EEEcCCCCcEEEeecCccccc
Q 021306 171 LLVDPLTHQVKICDFGSAKQL 191 (314)
Q Consensus 171 il~~~~~~~~~l~dfg~~~~~ 191 (314)
+|+. ++.+.+||.+.+...
T Consensus 296 ~Lyh--dG~lyiIDVSQSVE~ 314 (520)
T KOG2270|consen 296 LLYH--DGKLYIIDVSQSVEH 314 (520)
T ss_pred heEE--CCEEEEEEccccccC
Confidence 9998 578999999987543
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.76 E-value=0.00033 Score=58.94 Aligned_cols=30 Identities=40% Similarity=0.579 Sum_probs=25.1
Q ss_pred CCceecCCCCCcEEEcCCCCcEEEeecCccc
Q 021306 159 PRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 189 (314)
Q Consensus 159 ~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~ 189 (314)
.+++|+|+++.||+++. +...-++||+.+.
T Consensus 164 ~~l~HGD~~~~Nvlv~~-~~i~giIDw~~a~ 193 (235)
T cd05155 164 PVWFHGDLAPGNLLVQD-GRLSAVIDFGCLG 193 (235)
T ss_pred ceEEeCCCCCCcEEEEC-CCEEEEEeCcccC
Confidence 46899999999999986 5556799999874
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.63 E-value=0.00023 Score=57.62 Aligned_cols=102 Identities=20% Similarity=0.167 Sum_probs=75.7
Q ss_pred HHHHHHHHhCCC-CceeeeceeeeecCCCCceeEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhh
Q 021306 79 NRELQLMRVMDH-PNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 156 (314)
Q Consensus 79 ~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH 156 (314)
++|..+++.+.+ +++++++|.+ . -++++||.+. +++.. ......-...++.....++.+++..+.+++
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~C-----G----~~~v~E~~~~~~~~~~-~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~ 76 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSC-----G----RFYVVEYVGAGSLYGI-YRPLSQFLQSPWEQRAKIALQLLELLEELD 76 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeEC-----C----CEEEEEeecCcccccc-ccccccccccCHHHHHHHHHHHHHHHHHHh
Confidence 467888888866 5888888877 3 3478899985 33211 000111245789999999999999999998
Q ss_pred cC--CCceecCCCCCcEEEcCCCCcEEEeecCccccc
Q 021306 157 TV--PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 191 (314)
Q Consensus 157 ~~--~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~ 191 (314)
.. ..+...|++++|+-++. ++.++++|.+.+...
T Consensus 77 ~~~~~~~~lcDv~~~nfgv~~-~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 77 HGPLGFFYLCDVSPDNFGVND-DGRLKLIDLDDVFVE 112 (188)
T ss_pred cCCCCcEEEeecchHHeEEeC-CCcEEEEechhcchh
Confidence 72 23667999999999997 788999999977543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.45 E-value=0.0016 Score=55.55 Aligned_cols=133 Identities=17% Similarity=0.242 Sum_probs=72.9
Q ss_pred EeecCceEEEEEEECCCCcEEEEEEeecccc----chHHHHHHHHhCCCCceeeeceeeeecCCCCceeEEEEeeccccc
Q 021306 46 VGTGSFGIVFQAKCLETGETVAIKKVLQDRR----YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPES 121 (314)
Q Consensus 46 Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~~----~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~~ 121 (314)
+..|-.+.+|++.. +++.+++|....... ..++|..+++.+....+++-.- +.. . -++|+||++|.
T Consensus 4 ~~~G~tn~~y~~~~--~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i-~~~---~----~~~v~e~i~G~ 73 (256)
T TIGR02721 4 LSGGLTNRSWRIEH--PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPI-LVN---E----HWLLVEWLEGE 73 (256)
T ss_pred CCCcCcCCeEEEEe--CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceE-EEe---C----CEEEEEeccCc
Confidence 45577788898873 567888997654322 3467888888886544432211 111 1 24889999873
Q ss_pred HHH---------------HHHhhhh---cCCCCCHH-HHHHHHHHH---------HHHHHHhhc-------CCCceecCC
Q 021306 122 MYR---------------VLKHYSS---ANQRMPLI-YVKLYTYQI---------FRGLAYIHT-------VPRVCHRDL 166 (314)
Q Consensus 122 l~~---------------~l~~~~~---~~~~l~~~-~~~~i~~ql---------~~~l~~LH~-------~~~i~h~dl 166 (314)
... .+..... ...+++.. .+..+..++ ...+..+-. ...++|+|+
T Consensus 74 ~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl 153 (256)
T TIGR02721 74 VITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDV 153 (256)
T ss_pred ccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCC
Confidence 221 1111111 11122221 111211111 111222211 135899999
Q ss_pred CCCcEEEcCCCCcEEEeecCcccc
Q 021306 167 KPQNLLVDPLTHQVKICDFGSAKQ 190 (314)
Q Consensus 167 ~p~Nil~~~~~~~~~l~dfg~~~~ 190 (314)
.|.||++++ ++ +.++||+.+..
T Consensus 154 ~~~Nil~~~-~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 154 HAYNLVVTP-QG-LKLIDWEYASD 175 (256)
T ss_pred CcCcEEEeC-CC-CEEEeccccCc
Confidence 999999987 44 78999998753
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.41 E-value=0.0046 Score=55.95 Aligned_cols=71 Identities=23% Similarity=0.332 Sum_probs=45.3
Q ss_pred eeeEeecCceEEEEEEECCCCcEEEEEEeec-----------cccchHHHHHHHHhCC---CCceeeeceeeeecCCCCc
Q 021306 43 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQ-----------DRRYKNRELQLMRVMD---HPNVISLKHCFFSTTSKNE 108 (314)
Q Consensus 43 ~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~-----------~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~~ 108 (314)
.+.||.|.+..||++.....++.++||.-.. .......|.+.|+.+. ..++++++.+ +...
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~--- 105 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEEL--- 105 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCC---
Confidence 4688999999999999754336899997431 1122356777777753 2334444432 2111
Q ss_pred eeEEEEeecccc
Q 021306 109 LFLNLVMEYVPE 120 (314)
Q Consensus 109 ~~~~lv~e~~~~ 120 (314)
.++|||++++
T Consensus 106 --~~lVME~L~~ 115 (401)
T PRK09550 106 --AVTVMEDLSD 115 (401)
T ss_pred --CEEEEecCCC
Confidence 4599999875
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=97.33 E-value=0.0029 Score=56.07 Aligned_cols=30 Identities=23% Similarity=0.340 Sum_probs=26.2
Q ss_pred ceecCCCCCcEEEcCCCCcEEEeecCcccc
Q 021306 161 VCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 190 (314)
Q Consensus 161 i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~ 190 (314)
++|+|+.+.||++++.++.++++||..+..
T Consensus 184 ~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 184 FAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred EEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 799999999999986467899999998853
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.33 E-value=0.0047 Score=54.46 Aligned_cols=30 Identities=30% Similarity=0.261 Sum_probs=25.7
Q ss_pred CCceecCCCCCcEEEcCCCCcEEEeecCccc
Q 021306 159 PRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 189 (314)
Q Consensus 159 ~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~ 189 (314)
.+++|+|++|.||+++. +...-++||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~~~~iIDf~~~~ 216 (319)
T PRK05231 187 RGVIHADLFRDNVLFEG-DRLSGFIDFYFAC 216 (319)
T ss_pred cccCCCCCCCCcEEEEC-CceEEEEeccccc
Confidence 58999999999999985 5556899999875
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.27 E-value=0.0039 Score=54.28 Aligned_cols=144 Identities=13% Similarity=0.007 Sum_probs=75.1
Q ss_pred eeeEeecCceEEEEEEECCCCcEEEEEEeec-cccchHHHHHHHHhCCCCc--eeeeceeeeec-CCCCceeEEEEeecc
Q 021306 43 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQ-DRRYKNRELQLMRVMDHPN--VISLKHCFFST-TSKNELFLNLVMEYV 118 (314)
Q Consensus 43 ~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~-~~~~~~~e~~~l~~l~h~~--iv~~~~~~~~~-~~~~~~~~~lv~e~~ 118 (314)
.+.|..|....+|++.. ++..+++|.... .......|..++..+.... +.+++...... .....+..+++++++
T Consensus 19 i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~i 96 (296)
T cd05153 19 FEGISAGIENTNYFVTT--DSGRYVLTLFEKVSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEFL 96 (296)
T ss_pred eecccCccccceEEEEe--CCCcEEEEEcCCCChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEeC
Confidence 55677777789999874 345789998764 2233456777777774333 22322210000 001112357899999
Q ss_pred cccHHH-----HHH-------hhhh--cCCC------CCHHHHHH------------HHHHHHHHHHHhhc------CCC
Q 021306 119 PESMYR-----VLK-------HYSS--ANQR------MPLIYVKL------------YTYQIFRGLAYIHT------VPR 160 (314)
Q Consensus 119 ~~~l~~-----~l~-------~~~~--~~~~------l~~~~~~~------------i~~ql~~~l~~LH~------~~~ 160 (314)
+|.... .+. .... .... ........ ....+..++..+.. ..+
T Consensus 97 ~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~~ 176 (296)
T cd05153 97 AGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPRG 176 (296)
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCCc
Confidence 873210 111 0000 0000 00000000 01112222333331 147
Q ss_pred ceecCCCCCcEEEcCCCCcEEEeecCccc
Q 021306 161 VCHRDLKPQNLLVDPLTHQVKICDFGSAK 189 (314)
Q Consensus 161 i~h~dl~p~Nil~~~~~~~~~l~dfg~~~ 189 (314)
++|+|++|.||+++. +..+.|+||+.+.
T Consensus 177 l~HgD~~~~Nil~~~-~~~~~iIDfe~a~ 204 (296)
T cd05153 177 VIHADLFRDNVLFDG-DELSGVIDFYFAC 204 (296)
T ss_pred CCccCcCcccEEEeC-CceEEEeehhhhc
Confidence 999999999999997 6667899999875
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.25 E-value=0.0035 Score=55.01 Aligned_cols=30 Identities=37% Similarity=0.385 Sum_probs=26.4
Q ss_pred CCceecCCCCCcEEEcCCCCcEEEeecCccc
Q 021306 159 PRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 189 (314)
Q Consensus 159 ~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~ 189 (314)
.+++|+|+++.||+++. ++...++||+.+.
T Consensus 187 ~~l~HgD~~~~Nvl~~~-~~~~~vIDfd~~~ 216 (307)
T TIGR00938 187 RGVIHADLFPDNVLFDG-DSVKGVIDFYFAC 216 (307)
T ss_pred CccCCCCCCcCcEEEEC-CceEEEeeccccc
Confidence 68999999999999987 5566899999875
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.22 E-value=0.0067 Score=54.13 Aligned_cols=139 Identities=18% Similarity=0.230 Sum_probs=77.3
Q ss_pred eeeeEeecCceEEEEEEECC----CCcEEEEEEeeccccc---hHHHHHHHHhCCCCceee-eceeeeecCCCCceeEEE
Q 021306 42 AERVVGTGSFGIVFQAKCLE----TGETVAIKKVLQDRRY---KNRELQLMRVMDHPNVIS-LKHCFFSTTSKNELFLNL 113 (314)
Q Consensus 42 ~~~~Lg~g~~g~Vy~~~~~~----~~~~~~vK~~~~~~~~---~~~e~~~l~~l~h~~iv~-~~~~~~~~~~~~~~~~~l 113 (314)
-+..|..|-...+|++.... .++.|++|........ ..+|..+++.+...++.+ +++.+ .. +.
T Consensus 40 ~i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR~~E~~~~~~l~~~gl~P~~~~~~-----~~----g~ 110 (344)
T PLN02236 40 QVIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDRDDEIRTFECMSRHGQGPRLLGRF-----PN----GR 110 (344)
T ss_pred EEEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeechHHHHHHHHHHHHcCCCCceEEEE-----CC----ce
Confidence 33455557888999987432 2468999987654322 357888888886544443 33333 11 14
Q ss_pred EeecccccHHH-----------H----HHhhhhcC---C--CCCHHHHHHHHHHHH-----------------HHHHH--
Q 021306 114 VMEYVPESMYR-----------V----LKHYSSAN---Q--RMPLIYVKLYTYQIF-----------------RGLAY-- 154 (314)
Q Consensus 114 v~e~~~~~l~~-----------~----l~~~~~~~---~--~l~~~~~~~i~~ql~-----------------~~l~~-- 154 (314)
|.+|++|..+. . +....... . .....++..++.++. ..+..
T Consensus 111 v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~ 190 (344)
T PLN02236 111 VEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLE 190 (344)
T ss_pred EEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHH
Confidence 67777652111 0 11111111 1 112233334432221 11111
Q ss_pred ------hhcCCCceecCCCCCcEEEcCCCCcEEEeecCcccc
Q 021306 155 ------IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 190 (314)
Q Consensus 155 ------LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~ 190 (314)
.+. ..++|+|+++.||++++.++.+.++||..+..
T Consensus 191 ~~~~~~~~~-~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 191 KELSGDDQE-IGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred HHhcccCCC-ceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 112 46899999999999987457899999998863
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.17 E-value=0.00034 Score=60.41 Aligned_cols=131 Identities=15% Similarity=0.154 Sum_probs=86.2
Q ss_pred ceeeeeEeecCceEEEEEEECCCCcEEEEEEeec----------cc----------------cchHHHHHHHHhCC-CCc
Q 021306 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQ----------DR----------------RYKNRELQLMRVMD-HPN 92 (314)
Q Consensus 40 y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~----------~~----------------~~~~~e~~~l~~l~-h~~ 92 (314)
+.++++||=|.-+-||.+-+ ..|+++++|.-.. .+ -...+|...++.|. |-.
T Consensus 94 ~svGnqIGVGKESDIY~v~d-~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVAD-EEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhccccccccccceEEEec-CCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 67889999999999999984 5788999985311 00 01136677777763 322
Q ss_pred eee-eceeeeecCCCCceeEEEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcE
Q 021306 93 VIS-LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNL 171 (314)
Q Consensus 93 iv~-~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Ni 171 (314)
-|+ .+++ +..++|||++.|-.+..+. .... +..+...+...+.-|-. +|++|||.+-=||
T Consensus 173 pVPkpiD~---------~RH~Vvmelv~g~Pl~~v~------~v~d---~~~ly~~lm~~Iv~la~-~GlIHgDFNEFNi 233 (465)
T KOG2268|consen 173 PVPKPIDH---------NRHCVVMELVDGYPLRQVR------HVED---PPTLYDDLMGLIVRLAN-HGLIHGDFNEFNI 233 (465)
T ss_pred CCCCcccc---------cceeeHHHhhcccceeeee------ecCC---hHHHHHHHHHHHHHHHH-cCceecccchhee
Confidence 222 2111 1267999999884222221 1122 23344455566777888 8999999999999
Q ss_pred EEcCCCCcEEEeecCccccc
Q 021306 172 LVDPLTHQVKICDFGSAKQL 191 (314)
Q Consensus 172 l~~~~~~~~~l~dfg~~~~~ 191 (314)
+++. +..+++|||-.....
T Consensus 234 mv~d-d~~i~vIDFPQmvS~ 252 (465)
T KOG2268|consen 234 MVKD-DDKIVVIDFPQMVST 252 (465)
T ss_pred EEec-CCCEEEeechHhhcc
Confidence 9997 778999999865443
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.16 E-value=0.0059 Score=53.38 Aligned_cols=31 Identities=32% Similarity=0.494 Sum_probs=26.6
Q ss_pred CCceecCCCCCcEEEcCC---CCcEEEeecCccc
Q 021306 159 PRVCHRDLKPQNLLVDPL---THQVKICDFGSAK 189 (314)
Q Consensus 159 ~~i~h~dl~p~Nil~~~~---~~~~~l~dfg~~~ 189 (314)
..++|+|+.+.||+++.. .+.+.++||..+.
T Consensus 179 ~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 179 VVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred ceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 478999999999999873 2679999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.10 E-value=0.0091 Score=53.02 Aligned_cols=29 Identities=24% Similarity=0.293 Sum_probs=24.7
Q ss_pred CCceecCCCCCcEEEcCCCCcEEEeecCccc
Q 021306 159 PRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 189 (314)
Q Consensus 159 ~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~ 189 (314)
..++|||+.+.||++++ + .++++|+..+.
T Consensus 192 ~~llHGDl~~gNi~~~~-~-~~~~iD~e~~~ 220 (370)
T TIGR01767 192 ETLLHGDLHSGSIFVSE-H-ETKVIDPEFAF 220 (370)
T ss_pred ceeeeccCCcccEEEcC-C-CCEEEcCcccc
Confidence 67899999999999986 3 47899998765
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.80 E-value=0.024 Score=49.72 Aligned_cols=29 Identities=28% Similarity=0.558 Sum_probs=25.0
Q ss_pred CCceecCCCCCcEEEcCCCCcEEEeecCccc
Q 021306 159 PRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 189 (314)
Q Consensus 159 ~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~ 189 (314)
.+++|||+.+.||+++. +.+.++||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~--~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD--NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC--CcEEEEECcccc
Confidence 58999999999999986 458899999764
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.59 E-value=0.024 Score=51.05 Aligned_cols=71 Identities=18% Similarity=0.236 Sum_probs=43.8
Q ss_pred eeeEeecCceEEEEEEECCCCcEEEEEEeec----------cccchHHHHHHHHhCC--CC-ceeeeceeeeecCCCCce
Q 021306 43 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQ----------DRRYKNRELQLMRVMD--HP-NVISLKHCFFSTTSKNEL 109 (314)
Q Consensus 43 ~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~----------~~~~~~~e~~~l~~l~--h~-~iv~~~~~~~~~~~~~~~ 109 (314)
.+.||.|...-||++.+...++.++||.-.. ...+..-|.+.|+... .| ++.+++. ++...
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~--~D~e~---- 107 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYL--FDSVM---- 107 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEE--ECcHH----
Confidence 6788999999999999743356799996531 1122245777777652 23 3444432 22222
Q ss_pred eEEEEeecccc
Q 021306 110 FLNLVMEYVPE 120 (314)
Q Consensus 110 ~~~lv~e~~~~ 120 (314)
..+|||+++.
T Consensus 108 -~~~vMEdL~~ 117 (409)
T PRK12396 108 -NCCVMEDLSD 117 (409)
T ss_pred -hhHHHHhCcc
Confidence 4588999863
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.47 E-value=0.1 Score=45.00 Aligned_cols=32 Identities=28% Similarity=0.458 Sum_probs=25.3
Q ss_pred CCceecCCCCCcEEEcCCCCcEEEeecCcccc
Q 021306 159 PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 190 (314)
Q Consensus 159 ~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~ 190 (314)
..++|+|++|.||+++++....-|+||+.+..
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 35899999999999986323356999998763
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.45 E-value=0.066 Score=48.52 Aligned_cols=70 Identities=19% Similarity=0.247 Sum_probs=44.0
Q ss_pred eeeeEeecCceEEEEEEECCCCcEEEEEEeec-----------cccchHHHHHHHHhCC---CCceeeeceeeeecCCCC
Q 021306 42 AERVVGTGSFGIVFQAKCLETGETVAIKKVLQ-----------DRRYKNRELQLMRVMD---HPNVISLKHCFFSTTSKN 107 (314)
Q Consensus 42 ~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~-----------~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~ 107 (314)
..+.||.|....||++.+ .+..++||.-.. .......|+..|+.+. ..++.+++.+. ++
T Consensus 36 ~~~eiggGn~N~VyrV~~--~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~d-----ed 108 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVS--SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFD-----RT 108 (418)
T ss_pred eEEEcCCCceeeEEEEEc--CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEEC-----CC
Confidence 577889999999999986 345689997641 1222235566666553 23455554433 11
Q ss_pred ceeEEEEeecccc
Q 021306 108 ELFLNLVMEYVPE 120 (314)
Q Consensus 108 ~~~~~lv~e~~~~ 120 (314)
. .+++||++++
T Consensus 109 ~--~vlvME~L~~ 119 (418)
T PLN02756 109 M--ALIGMRYLEP 119 (418)
T ss_pred C--CEEEEeecCC
Confidence 1 4588999976
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.40 E-value=0.054 Score=47.43 Aligned_cols=31 Identities=32% Similarity=0.629 Sum_probs=26.5
Q ss_pred CCceecCCCCCcEEEcCCCCcEEEeecCcccc
Q 021306 159 PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 190 (314)
Q Consensus 159 ~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~ 190 (314)
..++|||+++.|+++++ ..-+-++||+.+..
T Consensus 198 ~~lvHGD~~~gNlii~~-~~~~gVlDwe~~~l 228 (321)
T COG3173 198 PVLVHGDYRPGNLIIDP-GRPTGVLDWELATL 228 (321)
T ss_pred ceeeeCCcccCCEEEeC-CCeeEEEecccccc
Confidence 35899999999999998 44499999999863
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.18 E-value=0.071 Score=46.80 Aligned_cols=30 Identities=23% Similarity=0.283 Sum_probs=26.5
Q ss_pred CCceecCCCCCcEEEcCCCCcEEEeecCccc
Q 021306 159 PRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 189 (314)
Q Consensus 159 ~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~ 189 (314)
.+++|+|+.+.|+++++ ++.+.++||..+.
T Consensus 196 ~~lcHgD~~~~Nvl~~~-~~~~~iIDfd~~~ 225 (309)
T TIGR02904 196 TVLVHGKLSLSHFLYDE-TRGGYFINFEKAS 225 (309)
T ss_pred eeeeCCCCcHHhEEEcC-CCCEEEEEhhhcc
Confidence 48999999999999987 6678999998875
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.12 E-value=0.16 Score=45.99 Aligned_cols=29 Identities=31% Similarity=0.337 Sum_probs=24.5
Q ss_pred CCceecCCCCCcEEEcCCCCcEEEeecCccc
Q 021306 159 PRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 189 (314)
Q Consensus 159 ~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~ 189 (314)
...+|+|+.+.||+.+. ..+.++||..+.
T Consensus 227 ~VfCHNDL~~gNIL~~~--~~l~lID~EYA~ 255 (383)
T PTZ00384 227 VLFCHNDLFFTNILDFN--QGIYFIDFDFAG 255 (383)
T ss_pred eeeeeccCCcccEEecC--CCEEEEEecccc
Confidence 46799999999999864 469999999875
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=96.12 E-value=0.001 Score=68.02 Aligned_cols=154 Identities=15% Similarity=0.035 Sum_probs=104.4
Q ss_pred HHHHhCCCCceeeeceeeeecCCCCceeEEEEeeccc-ccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCC-
Q 021306 83 QLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR- 160 (314)
Q Consensus 83 ~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~- 160 (314)
..++...|+++...+......... ..+..++|+. |.+.+.+..-.....++...-+.....+.+.+..-+|+..+
T Consensus 1281 de~~~~~h~~~~~~p~rI~ps~s~---ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnl 1357 (2724)
T KOG1826|consen 1281 DELREAKHYLTEVDPLRIPPSEST---EEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNL 1357 (2724)
T ss_pred hhhhhhhceeeecccccCCCCCCh---HHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccC
Confidence 344556788887765544222211 1457888887 46777776655555556655555555554666777665322
Q ss_pred ---ceecCCCCCcEEEcCCCCcEEEeecCccccc-ccCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh
Q 021306 161 ---VCHRDLKPQNLLVDPLTHQVKICDFGSAKQL-IAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL 236 (314)
Q Consensus 161 ---i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~t 236 (314)
-+|.++++.|.++.. +..+++.++|+.+.. ..........+++.|++|+.. +.-.++.++|+|..|+.+|....
T Consensus 1358 g~T~v~~~Lkf~lpmIVt-ny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~-N~ik~t~rsdilr~s~~ly~rs~ 1435 (2724)
T KOG1826|consen 1358 GNTNVSKSLKFTLPMIVT-NYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIK-NEIKFTKRSDILRRSLSLYLRSD 1435 (2724)
T ss_pred Cccchhhhhhhhccceec-CCcccccccccccccCchHhhhhhhhCCHHHHHHHHH-HHHhhhhHHHHHHHHHHHHHHhc
Confidence 578999999999998 778999999999832 222233345667888998886 44457778999999999999877
Q ss_pred CCCCC
Q 021306 237 GQPLF 241 (314)
Q Consensus 237 g~~pf 241 (314)
|..+|
T Consensus 1436 ~n~~f 1440 (2724)
T KOG1826|consen 1436 GNAYF 1440 (2724)
T ss_pred ccHHH
Confidence 76665
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=96.07 E-value=0.07 Score=46.59 Aligned_cols=106 Identities=8% Similarity=-0.018 Sum_probs=62.3
Q ss_pred ceeeeeEeecCceEEEEEEECCCCcEEEEEEeecc--ccchHHHHHHHHhCCCC---ceeeeceeeeecCCCCceeEEEE
Q 021306 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD--RRYKNRELQLMRVMDHP---NVISLKHCFFSTTSKNELFLNLV 114 (314)
Q Consensus 40 y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~--~~~~~~e~~~l~~l~h~---~iv~~~~~~~~~~~~~~~~~~lv 114 (314)
-.-.+.||.|..+.||.... .++ .+++|..+.. ......|+..++.+... .+.++++.+.... ..+..++|
T Consensus 16 ~~~~~~i~~G~~~~vy~~~~-~~~-~~~~k~~~~~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~--~~g~~~LV 91 (297)
T PRK10593 16 LSRVECISEQPYAALWALYD-SQG-NPMPLMARSFSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQ--SPGPDVLL 91 (297)
T ss_pred hheeeecCCccceeEEEEEc-CCC-CEEEEEecccccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCC--cCCCeEEE
Confidence 34567899999999999974 233 5677765442 24667899998888542 3444544332211 12236799
Q ss_pred eecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhc
Q 021306 115 MEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT 157 (314)
Q Consensus 115 ~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~ 157 (314)
||+++|.... . ...+......+..+++.++..||+
T Consensus 92 mE~i~G~~~~---~-----~~~~~~~~~~l~~~l~~~La~LH~ 126 (297)
T PRK10593 92 LERLRGVSVE---A-----PARTPERWEQLKDQIVEGLLAWHR 126 (297)
T ss_pred EeccCCEecC---C-----CCCCHHHHHHHHHHHHHHHHHHhC
Confidence 9999984211 0 012223334445555566666665
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.82 E-value=0.043 Score=48.59 Aligned_cols=75 Identities=17% Similarity=0.175 Sum_probs=59.0
Q ss_pred CCceeEEEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeec
Q 021306 106 KNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF 185 (314)
Q Consensus 106 ~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~df 185 (314)
.+..|.|++|++..+.+.. -.....+++..++.+.+..+.-+...-..-|+|+...||+++ .|++.|+||
T Consensus 296 de~~y~yl~~kdhgt~is~--------ik~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId--~GnvtLIDf 365 (488)
T COG5072 296 DETLYLYLHFKDHGTPISI--------IKADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID--EGNVTLIDF 365 (488)
T ss_pred CCceEEEEEEecCCceeee--------eecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee--cCceEEEEe
Confidence 4566788999987765321 133456888899999988888887645688999999999999 678999999
Q ss_pred Ccccc
Q 021306 186 GSAKQ 190 (314)
Q Consensus 186 g~~~~ 190 (314)
.+++.
T Consensus 366 klsRl 370 (488)
T COG5072 366 KLSRL 370 (488)
T ss_pred eeeec
Confidence 99984
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.65 E-value=0.25 Score=43.69 Aligned_cols=28 Identities=25% Similarity=0.315 Sum_probs=23.9
Q ss_pred CCceecCCCCCcEEEcCCCCcEEEeecCccc
Q 021306 159 PRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 189 (314)
Q Consensus 159 ~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~ 189 (314)
.+++|+|+.+.||+++ + .+.++||+.+.
T Consensus 196 ~~liHgD~h~~NvL~~--d-~~~iIDFDd~~ 223 (325)
T PRK11768 196 LLRLHGDCHPGNILWR--D-GPHFVDLDDAR 223 (325)
T ss_pred ccceecCCCchhcccc--C-CcEEEeCCCCC
Confidence 5799999999999995 3 47899999875
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.05 E-value=0.46 Score=43.89 Aligned_cols=71 Identities=14% Similarity=0.152 Sum_probs=43.6
Q ss_pred eeeeEeecCceEEEEEEECCC--------CcEEEEEEeecccc---chHHHHHHHHhCCCCceee-eceeeeecCCCCce
Q 021306 42 AERVVGTGSFGIVFQAKCLET--------GETVAIKKVLQDRR---YKNRELQLMRVMDHPNVIS-LKHCFFSTTSKNEL 109 (314)
Q Consensus 42 ~~~~Lg~g~~g~Vy~~~~~~~--------~~~~~vK~~~~~~~---~~~~e~~~l~~l~h~~iv~-~~~~~~~~~~~~~~ 109 (314)
-++.|..|-...+|++..... ++.|++|+.-.... ...+|..+++.+...+|.+ +++.+ .
T Consensus 109 ~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te~lIdR~~E~~v~~~ls~~gi~P~l~~~f-----~--- 180 (442)
T PTZ00296 109 RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVDELYNPISEFEVYKTMSKYRIAPQLLNTF-----S--- 180 (442)
T ss_pred EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCccceeCHHHHHHHHHHHHHCCCCCceEEEe-----C---
Confidence 455666677788999875421 56899998755432 2356777777775544443 33333 1
Q ss_pred eEEEEeeccccc
Q 021306 110 FLNLVMEYVPES 121 (314)
Q Consensus 110 ~~~lv~e~~~~~ 121 (314)
-+.|.+|++|.
T Consensus 181 -gg~I~efi~g~ 191 (442)
T PTZ00296 181 -GGRIEEWLYGD 191 (442)
T ss_pred -CCEEEEeeCCc
Confidence 12577888763
|
|
| >COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism] | Back alignment and domain information |
|---|
Probab=94.45 E-value=0.089 Score=45.17 Aligned_cols=51 Identities=24% Similarity=0.300 Sum_probs=38.7
Q ss_pred HHHHHHHHHHHHHHHHhhcC-CCceecCCCCCcEEEcCCCCcEEEeecCcccc
Q 021306 139 IYVKLYTYQIFRGLAYIHTV-PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 190 (314)
Q Consensus 139 ~~~~~i~~ql~~~l~~LH~~-~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~ 190 (314)
......+..+-.++...+.. .-++|+|+.|+|++.++ .+.+.|+||..|..
T Consensus 132 ~~~~~~~~~l~~~l~~~~~~~~v~cH~Dl~~~N~l~t~-~~~l~LIDWEyAg~ 183 (269)
T COG0510 132 HLLRKKLKELRRALEEVPKDDLVPCHNDLNPGNLLLTD-KGGLFLIDWEYAGL 183 (269)
T ss_pred HHHHHHHHHHHHHhhhcCCCceeeecCCCCccceEEcC-CCcEEEEecccCCC
Confidence 33444555666666666661 25899999999999997 68899999998864
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.29 E-value=0.17 Score=46.93 Aligned_cols=118 Identities=24% Similarity=0.299 Sum_probs=70.6
Q ss_pred HHHHHHhCCCCceeeeceeeeecCCCCceeEEEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCC
Q 021306 81 ELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR 160 (314)
Q Consensus 81 e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~ 160 (314)
...+++.+.|+|...+++...... . ...+|+|++.-++.+.+... ++...... . ++
T Consensus 32 r~~~lktl~~~~l~~yl~~~r~~~---~-r~IVV~e~~~~Sled~~~~~-----~l~~~s~~--------------~-~~ 87 (725)
T KOG1093|consen 32 RFQYLKSLQHDNLCQYLDFSRGKH---E-RVIVVMEHYTMSLEDILKTG-----NLKDESLL--------------A-HG 87 (725)
T ss_pred hhHHHHhhcCccceeeEeeecCcc---c-eEEEEehhhccchHHHHHhc-----ccchhhhc--------------c-cc
Confidence 456788889999999877542211 1 26799999999988877642 22111111 1 23
Q ss_pred ceecCCCCCcEEEcCCCCcEEEeecCcccccccCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCC
Q 021306 161 VCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL 240 (314)
Q Consensus 161 i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~p 240 (314)
+.|- |+ +..+| .++.. | |- ...+++||||+|.++.++.-|...
T Consensus 88 ~~~~-----~~--------~~~td-~~~t~---------------~--~~------~~~pKsdVwsl~~i~~el~L~~~l 130 (725)
T KOG1093|consen 88 VLHL-----NI--------IYITD-HFLTK---------------Y--PS------PIGPKSDVWSLGFIILELYLGISL 130 (725)
T ss_pred ccee-----hh--------hhccc-ccccc---------------C--CC------CCCcchhhhhHHHHHHHHHHhhHH
Confidence 3221 11 22223 11100 0 10 012599999999999999999988
Q ss_pred CCCCChHHHHHHHHHHcCC
Q 021306 241 FPGENAVDQLVEIIKVLGT 259 (314)
Q Consensus 241 f~~~~~~~~~~~i~~~~~~ 259 (314)
+......+....+.+-...
T Consensus 131 ~~~~~~s~~l~~i~k~~~~ 149 (725)
T KOG1093|consen 131 EAELTESEYLEILLKYYTD 149 (725)
T ss_pred HHHHHHHHHHHHHHHhccC
Confidence 8777776666666554433
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=94.01 E-value=0.43 Score=41.39 Aligned_cols=74 Identities=12% Similarity=0.103 Sum_probs=41.8
Q ss_pred ceeeeeEeecCceEEEEEEECCCCcEEEEEEeecc-ccchHHHHHHHHhCC---CCceeeeceeeeecCCCCceeEEEEe
Q 021306 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-RRYKNRELQLMRVMD---HPNVISLKHCFFSTTSKNELFLNLVM 115 (314)
Q Consensus 40 y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~-~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~~~~~~lv~ 115 (314)
-+-.+.++.|....+|+.. .+++.+.+|.-... ...+..|++-|+.|. --.+.+++.+-..... .++++
T Consensus 19 i~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~-----~fLll 91 (288)
T PF03881_consen 19 ITSIEPVSGGDINEAYRLD--TDGGSYFVKVNSESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDD-----AFLLL 91 (288)
T ss_dssp --EEEEE--SSSSEEEEEE--TTS-EEEEEEEEGGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSC-----CEEEE
T ss_pred eeeeEecCCCChhheEEEE--CCCccEEEEecChhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCC-----ceEEE
Confidence 3556788889999999987 57889999977643 344577888777773 3334444444322211 36999
Q ss_pred ecccc
Q 021306 116 EYVPE 120 (314)
Q Consensus 116 e~~~~ 120 (314)
||++.
T Consensus 92 e~l~~ 96 (288)
T PF03881_consen 92 EFLEM 96 (288)
T ss_dssp E----
T ss_pred EeecC
Confidence 99863
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=93.66 E-value=0.076 Score=43.75 Aligned_cols=32 Identities=38% Similarity=0.623 Sum_probs=21.3
Q ss_pred CCceecCCCCCcEEEcCCCCcEEEeecCcccc
Q 021306 159 PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 190 (314)
Q Consensus 159 ~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~ 190 (314)
..++|+|+.+.||+++..++.++++||..+..
T Consensus 143 ~v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 143 LVFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred ceEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 35899999999999944488999999998863
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.00 E-value=0.092 Score=42.26 Aligned_cols=29 Identities=21% Similarity=0.338 Sum_probs=24.7
Q ss_pred CceecCCCCCcEEEcCCCCcEEEeecCcccc
Q 021306 160 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 190 (314)
Q Consensus 160 ~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~ 190 (314)
..+|+|+.|.||++++ ++ ++++||+.+..
T Consensus 78 ~p~H~D~~~~N~~~~~-~~-~~lIDwe~a~~ 106 (188)
T PRK10271 78 APLHMDVHAGNLVHSA-SG-LRLIDWEYAGD 106 (188)
T ss_pred eeecCCCCCccEEEEC-CC-EEEEeCCcccC
Confidence 4699999999999986 55 89999998863
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=92.18 E-value=0.3 Score=43.23 Aligned_cols=29 Identities=38% Similarity=0.544 Sum_probs=25.0
Q ss_pred ceecCCCCCcEEEcCCCCcEEEeecCccc
Q 021306 161 VCHRDLKPQNLLVDPLTHQVKICDFGSAK 189 (314)
Q Consensus 161 i~h~dl~p~Nil~~~~~~~~~l~dfg~~~ 189 (314)
++|+|+.|.||+++.++....++||+-+.
T Consensus 199 iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 199 IIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred eeecCCCccceeEcCCCCeeeEEEccccc
Confidence 99999999999999843358899999875
|
|
| >smart00587 CHK ZnF_C4 abd HLH domain containing kinases domain | Back alignment and domain information |
|---|
Probab=91.29 E-value=0.63 Score=37.83 Aligned_cols=31 Identities=23% Similarity=0.278 Sum_probs=25.7
Q ss_pred CCceecCCCCCcEEEcCCC-C---cEEEeecCccc
Q 021306 159 PRVCHRDLKPQNLLVDPLT-H---QVKICDFGSAK 189 (314)
Q Consensus 159 ~~i~h~dl~p~Nil~~~~~-~---~~~l~dfg~~~ 189 (314)
..++|||+.+.||++..+. + .+.++||..+.
T Consensus 120 ~vl~HgD~~~~N~~~~~~~~~~~~~~~liDfq~~~ 154 (196)
T smart00587 120 NVLNHGDLWANNIMFKYDDEGKPEDVALIDFQLSH 154 (196)
T ss_pred eEEeeCCCCccceeeccCCCCCccceEEEecccCC
Confidence 5789999999999998532 2 68999999875
|
subfamily of choline kinases |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 314 | ||||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-110 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-109 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-109 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-109 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-109 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-109 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-109 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-109 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-108 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-108 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-108 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-108 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-108 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-108 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-108 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-108 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-108 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-107 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-107 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-106 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-105 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 1e-100 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 3e-76 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 2e-68 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-38 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-38 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 6e-38 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 9e-38 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-37 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-37 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-37 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-37 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-37 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-37 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-37 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-37 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-37 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 1e-37 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 1e-37 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-37 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-37 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-37 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-37 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-37 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-37 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-37 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 1e-37 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-37 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-37 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-37 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-37 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-37 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 3e-37 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 3e-37 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-37 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-37 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-37 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 5e-37 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-37 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-37 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 6e-37 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 6e-37 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 7e-37 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 8e-37 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 9e-37 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-36 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-36 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-36 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-36 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-36 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-36 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-36 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-36 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-36 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-36 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-36 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 4e-36 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 4e-36 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 4e-36 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 4e-36 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 4e-36 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 4e-36 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 4e-36 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 4e-36 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 6e-36 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 8e-36 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 8e-36 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 8e-36 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-35 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 1e-35 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-35 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-35 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-35 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-35 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-35 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 5e-35 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-35 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 7e-35 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-34 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-34 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-34 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-34 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-34 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-34 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-34 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-34 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-34 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-34 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-34 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-34 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-34 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-34 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-34 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-34 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 3e-34 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 3e-34 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 3e-34 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 3e-34 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 3e-34 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 3e-34 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 3e-34 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 3e-34 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 3e-34 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 3e-34 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 3e-34 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 3e-34 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 3e-34 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 3e-34 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 3e-34 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 3e-34 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 3e-34 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 3e-34 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 4e-34 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 4e-34 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 4e-34 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 4e-34 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 4e-34 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 4e-34 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 4e-34 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 4e-34 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 4e-34 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 4e-34 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 4e-34 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 4e-34 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 5e-34 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 5e-34 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 5e-34 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 8e-34 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 8e-34 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 9e-34 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-33 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 1e-33 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-33 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-33 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-33 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-33 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-33 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 3e-33 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 3e-33 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 4e-33 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-33 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-33 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-32 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-31 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-31 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-31 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 6e-31 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 6e-31 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 8e-31 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 4e-30 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 4e-30 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 7e-30 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 8e-30 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 8e-30 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 9e-30 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-29 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-29 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 1e-29 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-29 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-29 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-29 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-29 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 3e-29 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 4e-29 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 5e-29 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 7e-29 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 9e-29 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 9e-29 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 9e-29 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 9e-29 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 9e-29 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 1e-28 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 1e-28 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 1e-28 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 1e-28 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-28 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 1e-28 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-28 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-28 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 3e-28 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-28 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 8e-28 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 8e-28 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-27 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-27 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 3e-27 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 3e-27 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 3e-27 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 3e-27 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-27 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-27 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-27 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 7e-27 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 7e-27 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 3e-26 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 4e-26 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 6e-25 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 5e-23 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-22 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-22 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-22 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 2e-22 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 2e-22 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-22 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-22 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 3e-22 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 3e-22 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 3e-22 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-22 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 4e-22 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 8e-22 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 8e-22 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 1e-21 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 1e-21 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 1e-21 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 1e-21 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 1e-21 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 1e-21 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 1e-21 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 1e-21 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 1e-21 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 1e-21 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 1e-21 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 1e-21 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 2e-21 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 2e-21 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 3e-21 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 3e-21 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 8e-21 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 9e-21 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 9e-21 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 9e-21 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 9e-21 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 9e-21 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-20 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 1e-20 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 1e-20 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 2e-20 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 2e-20 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 4e-20 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 7e-20 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 8e-20 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-19 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-19 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-19 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-19 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-19 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 4e-19 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 5e-19 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 8e-19 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 8e-19 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-19 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-19 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 9e-19 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 9e-19 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-19 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-19 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-18 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-18 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-18 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-18 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-18 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-18 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-18 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-18 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 3e-18 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 6e-18 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 7e-18 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 9e-18 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-17 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-17 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-17 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-17 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-17 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-17 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-17 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-17 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-17 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-17 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 3e-17 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 3e-17 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 3e-17 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 3e-17 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 3e-17 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 3e-17 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 3e-17 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 3e-17 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-17 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 3e-17 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 3e-17 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 4e-17 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 4e-17 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 4e-17 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-17 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 4e-17 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 4e-17 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-17 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-17 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-17 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 4e-17 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 4e-17 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 4e-17 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 4e-17 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 4e-17 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 4e-17 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 4e-17 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 4e-17 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 5e-17 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 5e-17 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 5e-17 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 5e-17 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 5e-17 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 5e-17 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 5e-17 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 5e-17 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 6e-17 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 6e-17 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 6e-17 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 6e-17 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 6e-17 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 6e-17 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 6e-17 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 6e-17 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 6e-17 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 6e-17 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 6e-17 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 6e-17 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 7e-17 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 7e-17 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 8e-17 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 9e-17 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 9e-17 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-16 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-16 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-16 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-16 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-16 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-16 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-16 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-16 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-16 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-16 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-16 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-16 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-16 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-16 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 1e-16 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-16 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-16 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-16 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-16 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-16 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-16 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-16 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-16 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-16 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-16 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-16 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-16 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 2e-16 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-16 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-16 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-16 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-16 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-16 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-16 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-16 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-16 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-16 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-16 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-16 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-16 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-16 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 3e-16 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 3e-16 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 3e-16 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 3e-16 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-16 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 3e-16 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 3e-16 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 3e-16 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-16 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 4e-16 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 4e-16 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 4e-16 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 5e-16 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 5e-16 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 5e-16 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 5e-16 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 5e-16 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 6e-16 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 6e-16 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 6e-16 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 6e-16 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 7e-16 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 7e-16 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 7e-16 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 9e-16 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 9e-16 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 1e-15 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-15 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-15 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-15 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-15 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 2e-15 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-15 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-15 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 3e-15 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 3e-15 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 3e-15 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 3e-15 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 3e-15 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 3e-15 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 3e-15 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 3e-15 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 3e-15 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 3e-15 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 3e-15 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 3e-15 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 3e-15 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 4e-15 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 4e-15 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 4e-15 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-15 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 4e-15 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 4e-15 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 5e-15 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 5e-15 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 5e-15 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 5e-15 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 7e-15 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 7e-15 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 7e-15 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 7e-15 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 7e-15 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-15 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 8e-15 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-15 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 8e-15 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-15 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 8e-15 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 9e-15 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 1e-14 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-14 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-14 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-14 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-14 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-14 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-14 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-14 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-14 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-14 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-14 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 3e-14 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 3e-14 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 3e-14 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 3e-14 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 3e-14 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-14 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 3e-14 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 3e-14 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-14 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 3e-14 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 3e-14 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 3e-14 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 3e-14 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 4e-14 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 4e-14 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 5e-14 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 6e-14 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 6e-14 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 6e-14 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 7e-14 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 7e-14 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 7e-14 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 7e-14 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 8e-14 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 8e-14 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 9e-14 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 9e-14 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 9e-14 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 9e-14 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 9e-14 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 9e-14 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 9e-14 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 9e-14 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-13 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-13 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-13 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-13 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-13 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-13 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-13 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-13 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-13 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-13 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-13 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 2e-13 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-13 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-13 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 3e-13 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 3e-13 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 3e-13 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 3e-13 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-13 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 3e-13 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 3e-13 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 4e-13 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 4e-13 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 5e-13 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 5e-13 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 5e-13 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-13 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 5e-13 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-13 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-13 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 5e-13 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 6e-13 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 6e-13 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-13 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 6e-13 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 6e-13 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 6e-13 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 6e-13 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 6e-13 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 6e-13 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 6e-13 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-13 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 7e-13 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 7e-13 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 7e-13 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 8e-13 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 8e-13 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 8e-13 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 9e-13 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 9e-13 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-12 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-12 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 1e-12 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 1e-12 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-12 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-12 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-12 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-12 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-12 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-12 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-12 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-12 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-12 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-12 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-12 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-12 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-12 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-12 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-12 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-12 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-12 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-12 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-12 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-12 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-12 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-12 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-12 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 2e-12 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-12 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-12 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 3e-12 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 3e-12 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 3e-12 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 3e-12 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 3e-12 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 3e-12 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 3e-12 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 3e-12 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 3e-12 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 4e-12 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 4e-12 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 4e-12 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 4e-12 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 4e-12 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 4e-12 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-12 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-12 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 4e-12 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 4e-12 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 4e-12 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 4e-12 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-12 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 5e-12 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 5e-12 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 5e-12 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 5e-12 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-12 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-12 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 6e-12 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-12 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 6e-12 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 6e-12 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-12 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 6e-12 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 6e-12 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 7e-12 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 7e-12 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 7e-12 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 7e-12 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 8e-12 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 8e-12 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 8e-12 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 8e-12 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 9e-12 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-12 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 9e-12 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-11 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-11 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-11 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-11 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 1e-11 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-11 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 1e-11 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-11 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 1e-11 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-11 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 1e-11 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-11 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-11 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 1e-11 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-11 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-11 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-11 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 1e-11 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-11 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-11 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-11 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-11 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-11 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 2e-11 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 3e-11 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 3e-11 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 3e-11 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 3e-11 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-11 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 3e-11 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 3e-11 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 3e-11 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-11 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 3e-11 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 3e-11 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 3e-11 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 3e-11 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 3e-11 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 4e-11 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 4e-11 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 4e-11 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 4e-11 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 4e-11 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 5e-11 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 5e-11 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 6e-11 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 6e-11 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 6e-11 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 6e-11 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 7e-11 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-11 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 7e-11 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 7e-11 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 8e-11 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 8e-11 | ||
| 2x7g_A | 389 | Structure Of Human Serine-Arginine-Rich Protein-Spe | 8e-11 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 9e-11 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 9e-11 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 9e-11 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 9e-11 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 9e-11 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-10 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-10 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-10 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-10 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-10 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 1e-10 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 1e-10 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 1e-10 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 1e-10 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-10 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-10 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-10 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-10 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-10 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 1e-10 | ||
| 3beg_A | 381 | Crystal Structure Of Sr Protein Kinase 1 Complexed | 1e-10 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 2e-10 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-10 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-10 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-10 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 2e-10 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 2e-10 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-10 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-10 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-10 | ||
| 1wbp_A | 397 | Srpk1 Bound To 9mer Docking Motif Peptide Length = | 2e-10 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 2e-10 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 2e-10 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-10 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 2e-10 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 2e-10 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-10 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-10 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-10 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 3e-10 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 3e-10 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 3e-10 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 3e-10 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-10 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-10 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 3e-10 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 3e-10 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 4e-10 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 4e-10 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 4e-10 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 5e-10 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 5e-10 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 5e-10 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 5e-10 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 5e-10 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 5e-10 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 5e-10 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 5e-10 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 5e-10 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 6e-10 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 6e-10 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 6e-10 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 6e-10 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 6e-10 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 6e-10 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 6e-10 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 7e-10 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 8e-10 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 8e-10 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 9e-10 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 9e-10 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 1e-09 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 1e-09 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 1e-09 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 1e-09 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 1e-09 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 1e-09 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 1e-09 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 1e-09 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 1e-09 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 2e-09 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 2e-09 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 2e-09 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 2e-09 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-09 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 2e-09 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-09 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-09 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 3e-09 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 3e-09 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 3e-09 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 3e-09 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 3e-09 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 3e-09 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 3e-09 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 3e-09 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 3e-09 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 3e-09 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 3e-09 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 3e-09 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 4e-09 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 4e-09 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 4e-09 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 4e-09 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 4e-09 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-09 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 5e-09 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 8e-09 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-08 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-08 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-08 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 1e-08 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-08 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-08 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 3e-08 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 3e-08 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 3e-08 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 5e-08 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-08 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 5e-08 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 5e-08 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-08 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 6e-08 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 6e-08 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 7e-08 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 8e-08 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 8e-08 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 9e-08 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 9e-08 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 1e-07 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 1e-07 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-07 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-07 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-07 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 1e-07 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-07 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-07 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 1e-07 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-07 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 1e-07 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 1e-07 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-07 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-07 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-07 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 2e-07 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 2e-07 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-07 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-07 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-07 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-07 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-07 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-07 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-07 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-07 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-07 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-07 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-07 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-07 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-07 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-07 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-07 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-07 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-07 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-07 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-07 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 3e-07 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 3e-07 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 3e-07 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 3e-07 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 3e-07 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-07 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 4e-07 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 4e-07 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 4e-07 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 5e-07 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-07 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 6e-07 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 7e-07 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 8e-07 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-07 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 9e-07 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 9e-07 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 9e-07 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 9e-07 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 9e-07 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 9e-07 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 9e-07 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-06 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 1e-06 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 1e-06 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-06 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 1e-06 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-06 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-06 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-06 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 1e-06 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-06 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-06 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-06 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-06 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-06 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-06 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-06 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-06 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-06 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 2e-06 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 3e-06 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-06 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-06 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 3e-06 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 3e-06 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 4e-06 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 4e-06 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-06 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 5e-06 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 6e-06 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 8e-06 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 8e-06 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 8e-06 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-05 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-05 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-05 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-05 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 4e-05 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 4e-05 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 6e-05 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 6e-05 | ||
| 4hni_A | 296 | Crystal Structure Of Ck1e In Complex With Pf4800567 | 8e-05 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-04 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-04 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-04 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 2e-04 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-04 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 2e-04 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 3e-04 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 3e-04 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 3e-04 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 3e-04 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 4e-04 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 4e-04 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 5e-04 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 5e-04 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 5e-04 | ||
| 3uys_A | 296 | Crystal Structure Of Apo Human Ck1d Length = 296 | 5e-04 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 5e-04 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 5e-04 | ||
| 1ckj_A | 317 | Casein Kinase I Delta Truncation Mutant Containing | 5e-04 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 6e-04 | ||
| 2c47_A | 313 | Structure Of Casein Kinase 1 Gamma 2 Length = 313 | 9e-04 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 9e-04 |
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2C47|A Chain A, Structure Of Casein Kinase 1 Gamma 2 Length = 313 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 494 bits (1273), Expect = e-177
Identities = 170/286 (59%), Positives = 223/286 (77%), Gaps = 4/286 (1%)
Query: 4 DKEMSAAVVDGSDHVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETG 63
+ ++ ++ D I GK GE ++ I+Y +V+G GSFG+VFQAK +E+
Sbjct: 7 NAPLNGVKLNPLDDPNKVIKVLASDGKTGEQRE-IAYTNCKVIGNGSFGVVFQAKLVESD 65
Query: 64 ETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSK-NELFLNLVMEYVPESM 122
E VAIKKVLQD+R+KNRELQ+MR++ HPNV+ LK F+S K +E+FLNLV+EYVPE++
Sbjct: 66 E-VAIKKVLQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETV 124
Query: 123 YRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKI 182
YR +HY+ Q MP++ +KLY YQ+ R LAYIH++ +CHRD+KPQNLL+DP + +K+
Sbjct: 125 YRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI-GICHRDIKPQNLLLDPPSGVLKL 183
Query: 183 CDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFP 242
DFGSAK LIAGE N+SYICSR+YRAPELIFGAT YTT+IDIWS GCV+AEL+ GQPLFP
Sbjct: 184 IDFGSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFP 243
Query: 243 GENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKV 288
GE+ +DQLVEIIKVLGTP+RE+I+ MNPNY + +FPQI+ HP+ KV
Sbjct: 244 GESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKV 289
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 493 bits (1271), Expect = e-176
Identities = 180/280 (64%), Positives = 232/280 (82%), Gaps = 4/280 (1%)
Query: 12 VDGSDHVTGHIISTTIG--GKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIK 69
+ S G ++T + G+ + Q +SY +V+G GSFG+V+QAK ++GE VAIK
Sbjct: 26 MKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIK 85
Query: 70 KVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSK-NELFLNLVMEYVPESMYRVLKH 128
KVLQD+R+KNRELQ+MR +DH N++ L++ F+S+ K +E++LNLV++YVPE++YRV +H
Sbjct: 86 KVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH 145
Query: 129 YSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 188
YS A Q +P+IYVKLY YQ+FR LAYIH+ +CHRD+KPQNLL+DP T +K+CDFGSA
Sbjct: 146 YSRAKQTLPVIYVKLYMYQLFRSLAYIHSF-GICHRDIKPQNLLLDPDTAVLKLCDFGSA 204
Query: 189 KQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVD 248
KQL+ GE N+SYICSR+YRAPELIFGAT+YT+SID+WSAGCVLAELLLGQP+FPG++ VD
Sbjct: 205 KQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD 264
Query: 249 QLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKV 288
QLVEIIKVLGTPTRE+IR MNPNYT+F+FPQIKAHPW KV
Sbjct: 265 QLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKV 304
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 481 bits (1240), Expect = e-172
Identities = 123/284 (43%), Positives = 184/284 (64%), Gaps = 8/284 (2%)
Query: 20 GHIISTTIGGKNGEP--KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY 77
G ++S E K+ + ER+ G G+FG V K TG +VAIKKV+QD R+
Sbjct: 3 GSMMSLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF 62
Query: 78 KNRELQLMRVM---DHPNVISLKHCFFSTTSK--NELFLNLVMEYVPESMYRVLKHYSSA 132
+NRELQ+M+ + HPN++ L+ F++ + +++LN+VMEYVP++++R ++Y
Sbjct: 63 RNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRR 122
Query: 133 NQRMPLIYVKLYTYQIFRGLAYIHTV-PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 191
P I +K++ +Q+ R + +H VCHRD+KP N+LV+ +K+CDFGSAK+L
Sbjct: 123 QVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKL 182
Query: 192 IAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLV 251
E N++YICSR+YRAPELIFG YTT++DIWS GC+ AE++LG+P+F G+N+ QL
Sbjct: 183 SPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLH 242
Query: 252 EIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVCIFHFPK 295
EI++VLG P+RE +R +NP++TD K PW V H K
Sbjct: 243 EIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLK 286
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 454 bits (1171), Expect = e-161
Identities = 134/298 (44%), Positives = 196/298 (65%), Gaps = 38/298 (12%)
Query: 32 GEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHP 91
G + Y + +GTGSFGIV + +E+G+ A+KKVLQD RYKNREL +M+V+DH
Sbjct: 1 GLETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHV 60
Query: 92 NVISLKHCFFSTTSK---------------------------------NELFLNLVMEYV 118
N+I L F++T + +LN++MEYV
Sbjct: 61 NIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV 120
Query: 119 PESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH 178
P+++++VLK + + + +P+ + +Y YQ+FR + +IH++ +CHRD+KPQNLLV+ +
Sbjct: 121 PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL-GICHRDIKPQNLLVNSKDN 179
Query: 179 QVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQ 238
+K+CDFGSAK+LI E +++YICSRFYRAPEL+ GATEYT SID+WS GCV EL+LG+
Sbjct: 180 TLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGK 239
Query: 239 PLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVCIFHFPKH 296
PLF GE ++DQLV II+++GTPT+E++ MNP+YT+ RFP +KA W K+ P+
Sbjct: 240 PLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKI----LPEG 293
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 247 bits (633), Expect = 3e-81
Identities = 82/245 (33%), Positives = 133/245 (54%), Gaps = 19/245 (7%)
Query: 46 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISLKHC 99
+G GS+G+VF+ + +TG+ VAIKK L+ RE+++++ + HPN+++L
Sbjct: 11 IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70
Query: 100 FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 159
F K L L V EY ++ L Y + +P VK T+Q + + + H
Sbjct: 71 F---RRKRRLHL--VFEYCDHTVLHELDRY---QRGVPEHLVKSITWQTLQAVNFCHKH- 121
Query: 160 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL-IAGEANISYICSRFYRAPELIFGATEY 218
HRD+KP+N+L+ +K+CDFG A+ L + + +R+YR+PEL+ G T+Y
Sbjct: 122 NCIHRDVKPENILITK-HSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQY 180
Query: 219 TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE--EIRCMNPNYTDFR 276
+D+W+ GCV AELL G PL+PG++ VDQL I K LG ++ N ++ +
Sbjct: 181 GPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVK 240
Query: 277 FPQIK 281
P +
Sbjct: 241 IPDPE 245
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 247 bits (633), Expect = 7e-81
Identities = 85/254 (33%), Positives = 140/254 (55%), Gaps = 20/254 (7%)
Query: 46 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISLKHC 99
VG GS+G+V + + +TG VAIKK L+ K RE++L++ + H N+++L
Sbjct: 33 VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEV 92
Query: 100 FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 159
K +L V E+V ++ L+ + + V+ Y +QI G+ + H+
Sbjct: 93 C---KKKKRWYL--VFEFVDHTILDDLELF---PNGLDYQVVQKYLFQIINGIGFCHSH- 143
Query: 160 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL-IAGEANISYICSRFYRAPELIFGATEY 218
+ HRD+KP+N+LV + VK+CDFG A+ L GE + +R+YRAPEL+ G +Y
Sbjct: 144 NIIHRDIKPENILVSQ-SGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKY 202
Query: 219 TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE--EIRCMNPNYTDFR 276
++D+W+ GC++ E+ +G+PLFPG++ +DQL I+ LG E+ NP + R
Sbjct: 203 GKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVR 262
Query: 277 FPQIKAH-PWHKVC 289
P+IK P +
Sbjct: 263 LPEIKEREPLERRY 276
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 243 bits (622), Expect = 2e-79
Identities = 75/277 (27%), Positives = 134/277 (48%), Gaps = 33/277 (11%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV-LQD-----RRYKNRELQLMRVMDHPNV 93
YM + +G G G+VF A + + VAIKK+ L D RE++++R +DH N+
Sbjct: 13 YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHAL--REIKIIRRLDHDNI 70
Query: 94 ISLKHCFFSTTSKNELFLN---------LVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 144
+ + + S+ + +V EY+ + VL+ + + +L+
Sbjct: 71 VKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQ-----GPLLEEHARLF 125
Query: 145 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS----Y 200
YQ+ RGL YIH+ V HRDLKP NL ++ +KI DFG A+ + ++
Sbjct: 126 MYQLLRGLKYIHSA-NVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEG 184
Query: 201 ICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 260
+ +++YR+P L+ YT +ID+W+AGC+ AE+L G+ LF G + ++Q+ I++ +
Sbjct: 185 LVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVV 244
Query: 261 TREEIRCMNPNYTDF--RFPQIKAHPWHKVCIFHFPK 295
E+ + + + P ++ P
Sbjct: 245 HEEDRQELLSVIPVYIRNDMTEPHKPLTQL----LPG 277
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 239 bits (611), Expect = 2e-77
Identities = 90/259 (34%), Positives = 138/259 (53%), Gaps = 30/259 (11%)
Query: 46 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---------RELQLMRVMDHPNVISL 96
+G G F V++A+ T + VAIKK+ R + RE++L++ + HPN+I L
Sbjct: 18 LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77
Query: 97 KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 156
F ++ ++LV +++ + ++K + + ++K Y +GL Y+H
Sbjct: 78 LDAFGHKSN-----ISLVFDFMETDLEVIIK---DNSLVLTPSHIKAYMLMTLQGLEYLH 129
Query: 157 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISY---ICSRFYRAPELIF 213
+ HRDLKP NLL+D +K+ DFG AK G N +Y + +R+YRAPEL+F
Sbjct: 130 QH-WILHRDLKPNNLLLDE-NGVLKLADFGLAKSF--GSPNRAYTHQVVTRWYRAPELLF 185
Query: 214 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI---RCMNP 270
GA Y +D+W+ GC+LAELLL P PG++ +DQL I + LGTPT EE C P
Sbjct: 186 GARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPT-EEQWPDMCSLP 244
Query: 271 NYTDFRFPQIKAHPWHKVC 289
+Y F P H +
Sbjct: 245 DYVT--FKSFPGIPLHHIF 261
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 236 bits (605), Expect = 2e-76
Identities = 80/278 (28%), Positives = 145/278 (52%), Gaps = 35/278 (12%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV-------LQDRRYKNRELQLMRVMDHPN 92
+ + ++G G++G+V A TGE VAIKK+ R RE+++++ H N
Sbjct: 13 FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTL--REIKILKHFKHEN 70
Query: 93 VISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 152
+I++ + + +N + ++ E + ++RV+ Q + +++ + YQ R +
Sbjct: 71 IITIFNIQRPDSFENFNEVYIIQELMQTDLHRVIS-----TQMLSDDHIQYFIYQTLRAV 125
Query: 153 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS-----------YI 201
+H V HRDLKP NLL++ +K+CDFG A+ + A+ S ++
Sbjct: 126 KVLHGS-NVIHRDLKPSNLLINS-NCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFV 183
Query: 202 CSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 261
+R+YRAPE++ + +Y+ ++D+WS GC+LAEL L +P+FPG + QL+ I ++GTP
Sbjct: 184 ATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPH 243
Query: 262 REEI--RCMNPNYTDF--RFPQIKAHPWHKVCIFHFPK 295
+ +P ++ P A P K+ FP+
Sbjct: 244 SDNDLRCIESPRAREYIKSLPMYPAAPLEKM----FPR 277
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 237 bits (606), Expect = 2e-76
Identities = 81/277 (29%), Positives = 128/277 (46%), Gaps = 33/277 (11%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---------------RELQL 84
Y +R + +GS+G V G VAIK+V RE++L
Sbjct: 24 YTVQRFISSGSYGAVCAGVD-SEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRL 82
Query: 85 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPL--IYVK 142
+ HPN++ L+ F L LV E + + +V+ QR+ + +++
Sbjct: 83 LNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHD-----QRIVISPQHIQ 137
Query: 143 LYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC 202
+ Y I GL +H V HRDL P N+L+ + + ICDF A++ A Y+
Sbjct: 138 YFMYHILLGLHVLHEA-GVVHRDLHPGNILLAD-NNDITICDFNLAREDTADANKTHYVT 195
Query: 203 SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 262
R+YRAPEL+ +T +D+WSAGCV+AE+ + LF G +QL +I++V+GTP
Sbjct: 196 HRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKI 255
Query: 263 EEIRCM-NP---NYTDFRFPQIKAHPWHKVCIFHFPK 295
E++ +P +Y + A W V P
Sbjct: 256 EDVVMFSSPSARDYLRNSLSNVPARAWTAV----VPT 288
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 235 bits (601), Expect = 4e-76
Identities = 81/266 (30%), Positives = 139/266 (52%), Gaps = 32/266 (12%)
Query: 39 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---------RELQLMRVMD 89
+Y+ +G G++ V++ K T VA+K++ R ++ RE+ L++ +
Sbjct: 3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEI----RLEHEEGAPCTAIREVSLLKDLK 58
Query: 90 HPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIF 149
H N+++L + S L LV EY+ + + + L + + VKL+ +Q+
Sbjct: 59 HANIVTLHDIIHTEKS-----LTLVFEYLDKDLKQYLDDC---GNIINMHNVKLFLFQLL 110
Query: 150 RGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISY---ICSRFY 206
RGLAY H +V HRDLKPQNLL++ ++K+ DFG A+ +Y + + +Y
Sbjct: 111 RGLAYCHR-QKVLHRDLKPQNLLINE-RGELKLADFGLARAK--SIPTKTYDNEVVTLWY 166
Query: 207 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE--- 263
R P+++ G+T+Y+T ID+W GC+ E+ G+PLFPG +QL I ++LGTPT E
Sbjct: 167 RPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWP 226
Query: 264 EIRCMNPNYTDFRFPQIKAHPWHKVC 289
I + + +P+ +A
Sbjct: 227 GILSN-EEFKTYNYPKYRAEALLSHA 251
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 234 bits (599), Expect = 3e-75
Identities = 90/270 (33%), Positives = 146/270 (54%), Gaps = 27/270 (10%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV-------LQDRRYKNRELQLMRVMDHPN 92
Y +G G++G+V A VAIKK+ R RE++++ H N
Sbjct: 29 YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL--REIKILLRFRHEN 86
Query: 93 VISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 152
+I + + T + + +V + + +Y++LK Q + ++ + YQI RGL
Sbjct: 87 IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGL 141
Query: 153 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS----YICSRFYRA 208
YIH+ V HRDLKP NLL++ T +KICDFG A+ + Y+ +R+YRA
Sbjct: 142 KYIHSA-NVLHRDLKPSNLLLNT-TCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 199
Query: 209 PELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 268
PE++ + YT SIDIWS GC+LAE+L +P+FPG++ +DQL I+ +LG+P++E++ C+
Sbjct: 200 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 259
Query: 269 -NPNYTDF--RFPQIKAHPWHKVCIFHFPK 295
N ++ P PW+++ FP
Sbjct: 260 INLKARNYLLSLPHKNKVPWNRL----FPN 285
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 232 bits (593), Expect = 8e-75
Identities = 71/257 (27%), Positives = 128/257 (49%), Gaps = 19/257 (7%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-NRELQLMRVM-DHPNVISLK 97
Y R +G G + VF+A + E V +K + ++ K RE++++ + PN+I+L
Sbjct: 38 YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLA 97
Query: 98 HCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT 157
S+ LV E+V + ++ L Q + ++ Y Y+I + L Y H+
Sbjct: 98 DIVKDPVSRTPA---LVFEHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHS 148
Query: 158 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATE 217
+ + HRD+KP N+++D ++++ D+G A+ G+ + SR+++ PEL+
Sbjct: 149 M-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQM 207
Query: 218 YTTSIDIWSAGCVLAELLLG-QPLFPGENAVDQLVEIIKVLGTPTREEIRC-----MNPN 271
Y S+D+WS GC+LA ++ +P F G + DQLV I KVLGT + ++P
Sbjct: 208 YDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPR 267
Query: 272 YTDFRFPQIKAHPWHKV 288
+ D + W +
Sbjct: 268 FND-ILGRHSRKRWERF 283
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 234 bits (599), Expect = 3e-74
Identities = 84/282 (29%), Positives = 140/282 (49%), Gaps = 26/282 (9%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQ--------DRRYKNRELQLMRVMDHP 91
Y + +G+G+ GIV A VAIKK+ + R Y REL LM+ ++H
Sbjct: 64 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAY--RELVLMKCVNHK 121
Query: 92 NVISLKHCFFSTTSKNEL-FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 150
N+ISL + F + E + LVME + ++ +V++ + + YQ+
Sbjct: 122 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLC 175
Query: 151 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPE 210
G+ ++H+ + HRDLKP N++V +KI DFG A+ Y+ +R+YRAPE
Sbjct: 176 GIKHLHSA-GIIHRDLKPSNIVVKS-DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPE 233
Query: 211 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 270
+I G Y ++DIWS GC++ E++ + LFPG + +DQ ++I+ LGTP E ++ + P
Sbjct: 234 VILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 292
Query: 271 NYTDF--RFPQIKAHPWHKVCIFHFPKHWLLEYGSHINAISP 310
++ P+ + K+ FP H +
Sbjct: 293 TVRNYVENRPKYAGLTFPKL----FPDSLFPADSEHNKLKAS 330
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 231 bits (592), Expect = 3e-74
Identities = 89/268 (33%), Positives = 144/268 (53%), Gaps = 27/268 (10%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV--------LQDRRYKNRELQLMRVMDHP 91
Y + VG+G++G V A TG VAIKK+ R Y REL+L++ M H
Sbjct: 27 YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAY--RELRLLKHMRHE 84
Query: 92 NVISLKHCFFSTTSKNELF-LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 150
NVI L F + ++ LVM ++ + +++K ++++ ++ YQ+ +
Sbjct: 85 NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMK-----HEKLGEDRIQFLVYQMLK 139
Query: 151 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPE 210
GL YIH + HRDLKP NL V+ ++KI DFG A+Q A Y+ +R+YRAPE
Sbjct: 140 GLRYIHAA-GIIHRDLKPGNLAVNE-DCELKILDFGLARQ--ADSEMTGYVVTRWYRAPE 195
Query: 211 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM-N 269
+I YT ++DIWS GC++AE++ G+ LF G + +DQL EI+KV GTP E ++ + +
Sbjct: 196 VILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQS 255
Query: 270 PNYTDF--RFPQIKAHPWHKVCIFHFPK 295
++ P+++ + +
Sbjct: 256 DEAKNYMKGLPELEKKDFASI----LTN 279
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 229 bits (587), Expect = 3e-74
Identities = 88/256 (34%), Positives = 143/256 (55%), Gaps = 26/256 (10%)
Query: 46 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISLKHC 99
VG G++G+V++AK G VA+K++ D + RE+ L++ + HPN++SL
Sbjct: 29 VGEGTYGVVYKAKD-SQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDV 87
Query: 100 FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 159
S L LV E++ + + +VL + +K+Y YQ+ RG+A+ H
Sbjct: 88 IHSERC-----LTLVFEFMEKDLKKVLDEN---KTGLQDSQIKIYLYQLLRGVAHCHQH- 138
Query: 160 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISY---ICSRFYRAPELIFGAT 216
R+ HRDLKPQNLL++ +K+ DFG A+ G SY + + +YRAP+++ G+
Sbjct: 139 RILHRDLKPQNLLINS-DGALKLADFGLARAF--GIPVRSYTHEVVTLWYRAPDVLMGSK 195
Query: 217 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE---EIRCMNPNYT 273
+Y+TS+DIWS GC+ AE++ G+PLFPG DQL +I +LGTP +++ + P +
Sbjct: 196 KYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQEL-PLWK 254
Query: 274 DFRFPQIKAHPWHKVC 289
F + PW +
Sbjct: 255 QRTFQVFEKKPWSSII 270
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 231 bits (590), Expect = 3e-74
Identities = 90/268 (33%), Positives = 141/268 (52%), Gaps = 28/268 (10%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV--------LQDRRYKNRELQLMRVMDHP 91
Y++ VG+G++G V A +GE VAIKK+ R Y REL L++ M H
Sbjct: 26 YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAY--RELLLLKHMQHE 83
Query: 92 NVISLKHCFFSTTSKNELF-LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 150
NVI L F +S + LVM ++ + +++ + ++ YQ+ +
Sbjct: 84 NVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMG------LKFSEEKIQYLVYQMLK 137
Query: 151 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPE 210
GL YIH+ V HRDLKP NL V+ ++KI DFG A+ A Y+ +R+YRAPE
Sbjct: 138 GLKYIHSA-GVVHRDLKPGNLAVNE-DCELKILDFGLARH--ADAEMTGYVVTRWYRAPE 193
Query: 211 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM-N 269
+I Y ++DIWS GC++AE+L G+ LF G++ +DQL +I+KV G P E ++ + +
Sbjct: 194 VILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLND 253
Query: 270 PNYTDF--RFPQIKAHPWHKVCIFHFPK 295
+ PQ + ++ FP+
Sbjct: 254 KAAKSYIQSLPQTPRKDFTQL----FPR 277
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 230 bits (588), Expect = 4e-74
Identities = 85/259 (32%), Positives = 135/259 (52%), Gaps = 30/259 (11%)
Query: 46 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISLKHC 99
+G G++G V++A T ETVAIK++ + + RE+ L++ + H N+I LK
Sbjct: 42 LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSV 101
Query: 100 FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 159
+ L L + EY LK Y N + + +K + YQ+ G+ + H+
Sbjct: 102 I---HHNHRLHL--IFEY----AENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHS-R 151
Query: 160 RVCHRDLKPQNLLVDPLTH----QVKICDFGSAKQLIAGEANISY---ICSRFYRAPELI 212
R HRDLKPQNLL+ +KI DFG A+ G + I + +YR PE++
Sbjct: 152 RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF--GIPIRQFTHEIITLWYRPPEIL 209
Query: 213 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE---EIRCMN 269
G+ Y+TS+DIWS C+ AE+L+ PLFPG++ +DQL +I +VLG P + +
Sbjct: 210 LGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTAL- 268
Query: 270 PNYTDFRFPQIKAHPWHKV 288
P++ FP+ + +V
Sbjct: 269 PDWKQS-FPKFRGKTLKRV 286
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 230 bits (589), Expect = 8e-74
Identities = 86/284 (30%), Positives = 139/284 (48%), Gaps = 30/284 (10%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV--------LQDRRYKNRELQLMRVMDHP 91
Y + +G+G+ GIV A VAIKK+ R Y REL LM+ ++H
Sbjct: 27 YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAY--RELVLMKCVNHK 84
Query: 92 NVISLKHCFFSTTSKNEL-FLNLVMEYVPESMYRVLKHYSSANQRMPL--IYVKLYTYQI 148
N+I L + F S E + +VME + ++ +V+ +M L + YQ+
Sbjct: 85 NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVI--------QMELDHERMSYLLYQM 136
Query: 149 FRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRA 208
G+ ++H+ + HRDLKP N++V +KI DFG A+ Y+ +R+YRA
Sbjct: 137 LCGIKHLHSA-GIIHRDLKPSNIVVKS-DCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 194
Query: 209 PELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 268
PE+I G Y ++DIWS GC++ E++ G LFPG + +DQ ++I+ LGTP E ++ +
Sbjct: 195 PEVILG-MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL 253
Query: 269 NPNYTDF--RFPQIKAHPWHKVCIFHFPKHWLLEYGSHINAISP 310
P + P+ + + K+ FP H +
Sbjct: 254 QPTVRTYVENRPKYAGYSFEKL----FPDVLFPADSEHNKLKAS 293
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 226 bits (578), Expect = 3e-73
Identities = 83/256 (32%), Positives = 139/256 (54%), Gaps = 27/256 (10%)
Query: 46 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISLKHC 99
+G G++G+V++A+ GET A+KK+ ++ + RE+ +++ + H N++ L
Sbjct: 10 IGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 100 FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 159
+ L LV E++ + + ++L + + K + Q+ G+AY H
Sbjct: 69 IHTKKR-----LVLVFEHLDQDLKKLLDVC---EGGLESVTAKSFLLQLLNGIAYCHDR- 119
Query: 160 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISY---ICSRFYRAPELIFGAT 216
RV HRDLKPQNLL++ ++KI DFG A+ G Y I + +YRAP+++ G+
Sbjct: 120 RVLHRDLKPQNLLINR-EGELKIADFGLARAF--GIPVRKYTHEIVTLWYRAPDVLMGSK 176
Query: 217 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE---EIRCMNPNYT 273
+Y+T+IDIWS GC+ AE++ G PLFPG + DQL+ I ++LGTP + + + P Y
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTEL-PKYD 235
Query: 274 DFRFPQIKAHPWHKVC 289
F + PW
Sbjct: 236 PN-FTVYEPLPWESFL 250
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 225 bits (577), Expect = 1e-72
Identities = 83/268 (30%), Positives = 138/268 (51%), Gaps = 36/268 (13%)
Query: 46 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---------RELQLMRVMDHPNVISL 96
+G G++ V++ TG VA+K+V + + RE+ LM+ + H N++ L
Sbjct: 13 LGNGTYATVYKGLNKTTGVYVALKEV----KLDSEEGTPSTAIREISLMKELKHENIVRL 68
Query: 97 KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSAN--QRMPLIYVKLYTYQIFRGLAY 154
+ L LV E++ + + + + N + + L VK + +Q+ +GLA+
Sbjct: 69 YDVIHTENK-----LTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAF 123
Query: 155 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISY---ICSRFYRAPEL 211
H ++ HRDLKPQNLL++ Q+K+ DFG A+ G ++ + + +YRAP++
Sbjct: 124 CHEN-KILHRDLKPQNLLINK-RGQLKLGDFGLARAF--GIPVNTFSSEVVTLWYRAPDV 179
Query: 212 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 271
+ G+ Y+TSIDIWS GC+LAE++ G+PLFPG N +QL I ++GTP E + P+
Sbjct: 180 LMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPN-ESLW---PS 235
Query: 272 YTDF-----RFPQIKAHPWHKVCIFHFP 294
T Q +V H
Sbjct: 236 VTKLPKYNPNIQQRPPRDLRQVLQPHTK 263
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 226 bits (578), Expect = 4e-72
Identities = 91/268 (33%), Positives = 142/268 (52%), Gaps = 27/268 (10%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQ--------DRRYKNRELQLMRVMDHP 91
Y VG+G++G V A +TG VA+KK+ + R Y REL+L++ M H
Sbjct: 31 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY--RELRLLKHMKHE 88
Query: 92 NVISLKHCFFSTTSKNELF-LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 150
NVI L F S E + LV + + ++K Q++ +V+ YQI R
Sbjct: 89 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILR 143
Query: 151 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPE 210
GL YIH+ + HRDLKP NL V+ ++KI DFG A+ + Y+ +R+YRAPE
Sbjct: 144 GLKYIHSA-DIIHRDLKPSNLAVNE-DCELKILDFGLARH--TADEMTGYVATRWYRAPE 199
Query: 211 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM-N 269
++ Y ++DIWS GC++AELL G+ LFPG + +DQL I++++GTP E ++ + +
Sbjct: 200 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 259
Query: 270 PNYTDF--RFPQIKAHPWHKVCIFHFPK 295
+ ++ Q+ + V F
Sbjct: 260 ESARNYIQSLTQMPKMNFANV----FIG 283
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 223 bits (571), Expect = 5e-72
Identities = 89/257 (34%), Positives = 137/257 (53%), Gaps = 27/257 (10%)
Query: 46 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISLKHC 99
+G G++G VF+AK ET E VA+K+V D + RE+ L++ + H N++ L
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 100 FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 159
S L LV E+ + + + S N + VK + +Q+ +GL + H+
Sbjct: 70 LHSDKK-----LTLVFEFCDQDLKKYFD---SCNGDLDPEIVKSFLFQLLKGLGFCHSR- 120
Query: 160 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISY---ICSRFYRAPELIFGAT 216
V HRDLKPQNLL++ ++K+ +FG A+ G Y + + +YR P+++FGA
Sbjct: 121 NVLHRDLKPQNLLINR-NGELKLANFGLARAF--GIPVRCYSAEVVTLWYRPPDVLFGAK 177
Query: 217 EYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLGTPTRE---EIRCMNPNY 272
Y+TSID+WSAGC+ AEL G+PLFPG + DQL I ++LGTPT E + + P+Y
Sbjct: 178 LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL-PDY 236
Query: 273 TDFRFPQIKAHPWHKVC 289
+ V
Sbjct: 237 KPYPMYPAT-TSLVNVV 252
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 222 bits (569), Expect = 1e-71
Identities = 76/262 (29%), Positives = 125/262 (47%), Gaps = 30/262 (11%)
Query: 46 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---------RE---LQLMRVMDHPNV 93
+G G++G V++A+ +G VA+K V RE L+ + +HPNV
Sbjct: 17 IGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNV 76
Query: 94 ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 153
+ L ++ + E+ + LV E+V + + L + +P +K Q RGL
Sbjct: 77 VRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLD--KAPPPGLPAETIKDLMRQFLRGLD 134
Query: 154 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISY---ICSRFYRAPE 210
++H + HRDLKP+N+LV VK+ DFG A+ ++ + + +YRAPE
Sbjct: 135 FLHAN-CIVHRDLKPENILVTS-GGTVKLADFGLAR---IYSYQMALTPVVVTLWYRAPE 189
Query: 211 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 270
++ +T Y T +D+WS GC+ AE+ +PLF G + DQL +I ++G P ++ P
Sbjct: 190 VLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDW----P 244
Query: 271 NYT---DFRFPQIKAHPWHKVC 289
FP P V
Sbjct: 245 RDVSLPRGAFPPRGPRPVQSVV 266
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 224 bits (574), Expect = 2e-71
Identities = 75/305 (24%), Positives = 148/305 (48%), Gaps = 46/305 (15%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVL---QD-----RRYKNRELQLMRVM-DH 90
Y + +G G++GIV+++ TGE VA+KK+ Q+ R + RE+ ++ + H
Sbjct: 11 YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTF--REIMILTELSGH 68
Query: 91 PNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 150
N+++L + + + +++L V +Y+ ++ V++ + ++ + YQ+ +
Sbjct: 69 ENIVNLLNVLRAD-NDRDVYL--VFDYMETDLHAVIR-----ANILEPVHKQYVVYQLIK 120
Query: 151 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS----------- 199
+ Y+H+ + HRD+KP N+L++ VK+ DFG ++ + +
Sbjct: 121 VIKYLHSG-GLLHRDMKPSNILLN-AECHVKVADFGLSRSFVNIRRVTNNIPLSINENTE 178
Query: 200 -----------YICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVD 248
Y+ +R+YRAPE++ G+T+YT ID+WS GC+L E+L G+P+FPG + ++
Sbjct: 179 NFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMN 238
Query: 249 QLVEIIKVLGTPTREEIRCM-NPNYTDF--RFPQIKAHPWHKVCIFHFPKHWLLEYGSHI 305
QL II V+ P+ E++ + +P + LL +
Sbjct: 239 QLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPK 298
Query: 306 NAISP 310
+
Sbjct: 299 ADCNE 303
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 222 bits (568), Expect = 8e-71
Identities = 71/279 (25%), Positives = 123/279 (44%), Gaps = 37/279 (13%)
Query: 46 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN----------RELQLMRVMDHPNVIS 95
+G G+FG VF+A+ +TG+ VA+KKV +N RE+++++++ H NV++
Sbjct: 25 IGQGTFGEVFKARHRKTGQKVALKKV----LMENEKEGFPITALREIKILQLLKHENVVN 80
Query: 96 LK---HCFFSTTSKNELFLNLVMEYVPESMYRVLKHY-SSANQRMPLIYVKLYTYQIFRG 151
L S ++ + + LV ++ L S+ + L +K + G
Sbjct: 81 LIEICRTKASPYNRCKGSIYLVFDF----CEHDLAGLLSNVLVKFTLSEIKRVMQMLLNG 136
Query: 152 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ--LIAGEANISY---ICSRFY 206
L YIH ++ HRD+K N+L+ +K+ DFG A+ L Y + + +Y
Sbjct: 137 LYYIHRN-KILHRDMKAANVLITR-DGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWY 194
Query: 207 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE--- 263
R PEL+ G +Y ID+W AGC++AE+ P+ G QL I ++ G+ T E
Sbjct: 195 RPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWP 254
Query: 264 EIRCMNPNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYG 302
+ Y + + + Y
Sbjct: 255 NVDNY-ELYEKLELVKGQKRKVKD----RLKAYVRDPYA 288
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 218 bits (559), Expect = 8e-70
Identities = 83/261 (31%), Positives = 131/261 (50%), Gaps = 30/261 (11%)
Query: 46 VGTGSFGIVFQAK-CLETGETVAIKKVLQDRRYKN-------RE---LQLMRVMDHPNVI 94
+G G++G VF+A+ G VA+K+V + RE L+ + +HPNV+
Sbjct: 19 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTG-EEGMPLSTIREVAVLRHLETFEHPNVV 77
Query: 95 SLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 154
L + + E L LV E+V + + L +P +K +Q+ RGL +
Sbjct: 78 RLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDF 135
Query: 155 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISY---ICSRFYRAPEL 211
+H+ RV HRDLKPQN+LV + Q+K+ DFG A+ ++ + + +YRAPE+
Sbjct: 136 LHSH-RVVHRDLKPQNILVTS-SGQIKLADFGLAR---IYSFQMALTSVVVTLWYRAPEV 190
Query: 212 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 271
+ ++ Y T +D+WS GC+ AE+ +PLF G + VDQL +I+ V+G P E+ P
Sbjct: 191 LLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW----PR 245
Query: 272 YT---DFRFPQIKAHPWHKVC 289
F A P K
Sbjct: 246 DVALPRQAFHSKSAQPIEKFV 266
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 220 bits (563), Expect = 6e-69
Identities = 84/326 (25%), Positives = 134/326 (41%), Gaps = 82/326 (25%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD--------RRYKNRELQLMRVMDHP 91
Y ++GTGS+G V +A VAIKK+L+ R RE+ ++ ++H
Sbjct: 55 YEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRIL--REIAILNRLNHD 112
Query: 92 NVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 151
+V+ + + L +V+E ++ + + +++K Y + G
Sbjct: 113 HVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFR----TPVYLTELHIKTLLYNLLVG 168
Query: 152 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS------------ 199
+ Y+H+ + HRDLKP N LV+ VK+CDFG A+ + E S
Sbjct: 169 VKYVHSA-GILHRDLKPANCLVN-QDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMN 226
Query: 200 ----------------YICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL------- 236
++ +R+YRAPELI YT +ID+WS GC+ AELL
Sbjct: 227 LVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVA 286
Query: 237 ----GQPLFPGENAV--------------------DQLVEIIKVLGTPTREEIRCM-NPN 271
PLFPG + DQL I +LGTP+ E+I + +
Sbjct: 287 YHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKED 346
Query: 272 YTDF--RFPQIKAHPWHKVCIFHFPK 295
+ FP+ + + FP
Sbjct: 347 AKRYIRIFPKREGTDLAER----FPA 368
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 215 bits (548), Expect = 2e-67
Identities = 82/279 (29%), Positives = 137/279 (49%), Gaps = 34/279 (12%)
Query: 46 VGTGSFGIVFQAKCLE--TGETVAIKKVLQDRRYKN--RELQLMRVMDHPNVISLKHCFF 101
VG G++G V++AK + + A+K++ + RE+ L+R + HPNVISL+ F
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 88
Query: 102 STTSKNELFLNLVMEYVPESMYRVLKHYSSA-----NQRMPLIYVKLYTYQIFRGLAYIH 156
S + + L+ +Y ++ ++K + ++ ++P VK YQI G+ Y+H
Sbjct: 89 SHADRK---VWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 145
Query: 157 TVPRVCHRDLKPQNLLVDPLTH---QVKICDFGSAKQLIAGEANISYICSR----FYRAP 209
V HRDLKP N+LV +VKI D G A+ + ++ + +YRAP
Sbjct: 146 AN-WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 204
Query: 210 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV---------DQLVEIIKVLGTP 260
EL+ GA YT +IDIW+ GC+ AELL +P+F DQL I V+G P
Sbjct: 205 ELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFP 264
Query: 261 TRE---EIRCMNPNYTDFRFPQIKAHPWHKVCIFHFPKH 296
+ +I+ M P ++ + + + + + +
Sbjct: 265 ADKDWEDIKKM-PEHSTL-MKDFRRNTYTNCSLIKYMEK 301
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 215 bits (550), Expect = 3e-67
Identities = 86/320 (26%), Positives = 135/320 (42%), Gaps = 78/320 (24%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV------LQD--RRYKNRELQLMRVMDHP 91
Y+ + ++G GS+G V+ A T + VAIKKV L D R RE+ ++ +
Sbjct: 28 YIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRIL--REITILNRLKSD 85
Query: 92 NVISLKHCFFSTTSK--NELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIF 149
+I L +EL++ V+E + ++ K + ++K Y +
Sbjct: 86 YIIRLYDLIIPDDLLKFDELYI--VLEIADSDLKKLFK----TPIFLTEEHIKTILYNLL 139
Query: 150 RGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS---------- 199
G +IH + HRDLKP N L++ VK+CDFG A+ + + +
Sbjct: 140 LGENFIHES-GIIHRDLKPANCLLNQ-DCSVKVCDFGLARTINSEKDTNIVNDLEENEEP 197
Query: 200 -------------YICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQ-------- 238
++ +R+YRAPELI YT SIDIWS GC+ AELL
Sbjct: 198 GPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPT 257
Query: 239 ---PLFPG-----------------ENAVDQLVEIIKVLGTPTREEIRCM-NPNYTDF-- 275
PLFPG ++ DQL I ++GTPT ++++ + P +
Sbjct: 258 NRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIK 317
Query: 276 RFPQIKAHPWHKVCIFHFPK 295
FP K + +P
Sbjct: 318 LFPHRKPINLKQK----YPS 333
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 190 bits (484), Expect = 5e-58
Identities = 81/238 (34%), Positives = 128/238 (53%), Gaps = 21/238 (8%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRVM------DH 90
Y + ++G GSFG V +A E VAIK + + + N E++L+ +M
Sbjct: 56 YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMK 115
Query: 91 PNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 150
++ LK F +N L L V E + ++Y +L++ + + + L + + Q+
Sbjct: 116 YYIVHLKRHF---MFRNHLCL--VFEMLSYNLYDLLRNTN--FRGVSLNLTRKFAQQMCT 168
Query: 151 GLAYIHTV-PRVCHRDLKPQN-LLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRA 208
L ++ T + H DLKP+N LL +P +KI DFGS+ Q G+ YI SRFYR+
Sbjct: 169 ALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ--LGQRIYQYIQSRFYRS 226
Query: 209 PELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 266
PE++ G Y +ID+WS GC+L E+ G+PLF G N VDQ+ +I++VLG P +
Sbjct: 227 PEVLLGM-PYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILD 283
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 190 bits (485), Expect = 1e-57
Identities = 82/237 (34%), Positives = 130/237 (54%), Gaps = 21/237 (8%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRVM------DH 90
Y +V+G GSFG V +A + + VA+K V ++R+ E++++ + +
Sbjct: 99 YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNT 158
Query: 91 PNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 150
NVI + F T +N + + E + ++Y ++K + Q L V+ + + I +
Sbjct: 159 MNVIHMLENF---TFRNHICM--TFELLSMNLYELIK--KNKFQGFSLPLVRKFAHSILQ 211
Query: 151 GLAYIHTVPRVCHRDLKPQN-LLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAP 209
L +H R+ H DLKP+N LL +K+ DFGS+ + +YI SRFYRAP
Sbjct: 212 CLDALHK-NRIIHCDLKPENILLKQQGRSGIKVIDFGSSC--YEHQRVYTYIQSRFYRAP 268
Query: 210 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 266
E+I GA Y ID+WS GC+LAELL G PL PGE+ DQL +I++LG P+++ +
Sbjct: 269 EVILGA-RYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLD 324
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 181 bits (461), Expect = 1e-54
Identities = 71/251 (28%), Positives = 123/251 (49%), Gaps = 29/251 (11%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRVM-----DHP 91
Y+ R +G G F V+ AK + VA+K V D+ Y E++L++ +
Sbjct: 21 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKE 80
Query: 92 NVISLKHC-----FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTY 146
+ + H F+ N + + +V E + E++ ++K Y ++ +PLIYVK +
Sbjct: 81 DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYE--HRGIPLIYVKQISK 138
Query: 147 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQ-----VKICDFGSAKQLIAGEANISYI 201
Q+ GL Y+H + H D+KP+N+L++ + +KI D G+A E + I
Sbjct: 139 QLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACW--YDEHYTNSI 196
Query: 202 CSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA------VDQLVEIIK 255
+R YR+PE++ GA + DIWS C++ EL+ G LF + D + +II+
Sbjct: 197 QTREYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIE 255
Query: 256 VLGTPTREEIR 266
+LG +R
Sbjct: 256 LLGELPSYLLR 266
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 176 bits (449), Expect = 1e-53
Identities = 63/264 (23%), Positives = 102/264 (38%), Gaps = 29/264 (10%)
Query: 14 GSDHVTGHIISTTIGGKNGEPKQTIS-----YMAERVVGTGSFGIVFQAKCLETGETVAI 68
GS H H S + Y+ + +G G F V + L G A+
Sbjct: 2 GSSHHHHHHSSGREN--LYFQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYAL 59
Query: 69 KKVL----QDRRYKNRELQLMRVMDHPNVISLKHCFF-STTSKNELFLNLVMEYVPE-SM 122
K++L QDR RE + R+ +HPN++ L +K+E + L++ + ++
Sbjct: 60 KRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAW--LLLPFFKRGTL 117
Query: 123 YRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKI 182
+ ++ + + I RGL IH HRDLKP N+L+ Q +
Sbjct: 118 WNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA-KGYAHRDLKPTNILLGD-EGQPVL 175
Query: 183 CDFGSAK----------QLIAGEANISYICSRFYRAPELIFGA--TEYTTSIDIWSAGCV 230
D GS Q + + + C+ YRAPEL D+WS GCV
Sbjct: 176 MDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCV 235
Query: 231 LAELLLGQPLFPGENAVDQLVEII 254
L ++ G+ + V +
Sbjct: 236 LYAMMFGEGPYDMVFQKGDSVALA 259
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 3e-53
Identities = 62/263 (23%), Positives = 102/263 (38%), Gaps = 29/263 (11%)
Query: 39 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVL------QDRRYKNRELQ-LMRVMDHP 91
S+ +G GS+G VF+ + E G A+K+ + +DR K E+ +V HP
Sbjct: 58 SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHP 117
Query: 92 NVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 151
+ L+ + L L E S+ + + + +P V Y
Sbjct: 118 CCVRLEQAWEEGGI-----LYLQTELCGPSLQQHCEAW---GASLPEAQVWGYLRDTLLA 169
Query: 152 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPEL 211
LA++H+ + H D+KP N+ + P + K+ DFG +L A Y APEL
Sbjct: 170 LAHLHS-QGLVHLDVKPANIFLGP-RGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPEL 227
Query: 212 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR--EEIR--- 266
+ Y T+ D++S G + E+ L G QL + E+R
Sbjct: 228 L--QGSYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLPPEFTAGLSSELRSVL 285
Query: 267 --CMNPNYTDFRF--PQIKAHPW 285
+ P+ R + A P
Sbjct: 286 VMMLEPDPKL-RATAEALLALPV 307
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 1e-52
Identities = 62/259 (23%), Positives = 112/259 (43%), Gaps = 43/259 (16%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRVM-----DHP 91
++ R +G G+FG V + ++ + A+K V ++Y E +++ + ++
Sbjct: 37 FLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNN 96
Query: 92 NVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 151
N++ F + + L + E + S+Y ++ + + +KLY +I +
Sbjct: 97 NIVKYHGKF---MYYDHMCL--IFEPLGPSLYEIITRNN--YNGFHIEDIKLYCIEILKA 149
Query: 152 LAYIHTVPRVCHRDLKPQN-LLVDPLTH-----------------------QVKICDFGS 187
L Y+ + + H DLKP+N LL DP +K+ DFG
Sbjct: 150 LNYLRKM-SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGC 208
Query: 188 AKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV 247
A + + S I +R YRAPE+I + S D+WS GCVLAEL G LF +
Sbjct: 209 A--TFKSDYHGSIINTRQYRAPEVILNL-GWDVSSDMWSFGCVLAELYTGSLLFRTHEHM 265
Query: 248 DQLVEIIKVLGTPTREEIR 266
+ L + ++ + +
Sbjct: 266 EHLAMMESIIQPIPKNMLY 284
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 9e-52
Identities = 63/255 (24%), Positives = 110/255 (43%), Gaps = 39/255 (15%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETG-ETVAIKKVLQDRRYKN---RELQLMRVM------D 89
Y +G G+FG V + + G VA+K V RY E+Q++ +
Sbjct: 16 YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNS 75
Query: 90 HPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIF 149
+ + F + + V E + S Y +K L +++ YQI
Sbjct: 76 TFRCVQMLEWF---EHHGHICI--VFELLGLSTYDFIKENG--FLPFRLDHIRKMAYQIC 128
Query: 150 RGLAYIHTVPRVCHRDLKPQN-LLVD-----------------PLTHQVKICDFGSAKQL 191
+ + ++H+ ++ H DLKP+N L V + +K+ DFGSA
Sbjct: 129 KSVNFLHSN-KLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSA--T 185
Query: 192 IAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLV 251
E + + + +R YRAPE+I ++ D+WS GC+L E LG +FP ++ + L
Sbjct: 186 YDDEHHSTLVSTRHYRAPEVILA-LGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLA 244
Query: 252 EIIKVLGTPTREEIR 266
+ ++LG + I+
Sbjct: 245 MMERILGPLPKHMIQ 259
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 2e-51
Identities = 60/255 (23%), Positives = 105/255 (41%), Gaps = 39/255 (15%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETG-ETVAIKKVLQDRRYKN---RELQLMRVM------D 89
Y +G G+FG V + G VA+K + +Y+ E+ +++ + +
Sbjct: 21 YEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKEN 80
Query: 90 HPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIF 149
+ + F + + E + ++ + LK + Q PL +V+ YQ+
Sbjct: 81 KFLCVLMSDWF---NFHGHMCI--AFELLGKNTFEFLKENN--FQPYPLPHVRHMAYQLC 133
Query: 150 RGLAYIHTVPRVCHRDLKPQN-LLVDPLTH-----------------QVKICDFGSAKQL 191
L ++H ++ H DLKP+N L V+ +++ DFGSA
Sbjct: 134 HALRFLHEN-QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA--T 190
Query: 192 IAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLV 251
E + + + +R YR PE+I + D+WS GC+L E G LF + LV
Sbjct: 191 FDHEHHTTIVATRHYRPPEVILE-LGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLV 249
Query: 252 EIIKVLGTPTREEIR 266
+ K+LG I
Sbjct: 250 MMEKILGPIPSHMIH 264
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 4e-51
Identities = 68/226 (30%), Positives = 109/226 (48%), Gaps = 18/226 (7%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV-------LQDRRYKNRELQLMRVMDHPN 92
+ E+ +G G F V++A CL G VA+KKV + R +E+ L++ ++HPN
Sbjct: 34 FRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 93
Query: 93 VISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 151
VI F LN+V+E + R++KH+ + +P V Y Q+
Sbjct: 94 VIKYYASFIEDNE-----LNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSA 148
Query: 152 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI-SYICSRFYRAPE 210
L ++H+ RV HRD+KP N+ + T VK+ D G + + S + + +Y +PE
Sbjct: 149 LEHMHS-RRVMHRDIKPANVFITA-TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE 206
Query: 211 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA-VDQLVEIIK 255
I Y DIWS GC+L E+ Q F G+ + L + I+
Sbjct: 207 RIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIE 251
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 1e-49
Identities = 63/265 (23%), Positives = 108/265 (40%), Gaps = 23/265 (8%)
Query: 20 GHIISTTIGGKNGEPKQTIS-YMAERVVGTGSFGIVFQAKCLETGETVAIKKV-LQDRRY 77
G +++ + + E ++ + + VG GSFG V + K +TG A+KKV L+ +
Sbjct: 39 GVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV--F 96
Query: 78 KNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRM 136
+ EL + P ++ L +N+ ME + S+ +++K +
Sbjct: 97 RVEELVACAGLSSPRIVPLYGAVREGPW-----VNIFMELLEGGSLGQLIKQMG----CL 147
Query: 137 PLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA 196
P Y Q GL Y+HT R+ H D+K N+L+ + +CDFG A L
Sbjct: 148 PEDRALYYLGQALEGLEYLHTR-RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL 206
Query: 197 NISYICSR------FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQL 250
S + + APE++ G +DIWS+ C++ +L G +
Sbjct: 207 GKSLLTGDYIPGTETHMAPEVVMG-KPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLC 265
Query: 251 VEIIKVLGTPTREEIRCMNPNYTDF 275
++I P RE P
Sbjct: 266 LKIAS-EPPPIREIPPSCAPLTAQA 289
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 1e-49
Identities = 59/228 (25%), Positives = 96/228 (42%), Gaps = 18/228 (7%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV------LQDRRYKNRELQLMRVMDHPNV 93
Y +GTGS+G + + G+ + K++ +++ E+ L+R + HPN+
Sbjct: 8 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 67
Query: 94 ISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 152
+ T+ L +VMEY + V+ + Q + +V Q+ L
Sbjct: 68 VRYYDRIIDRTNT---TLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124
Query: 153 AYIH----TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYR 207
H V HRDLKP N+ +D VK+ DFG A+ L + + +Y
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDG-KQNVKLGDFGLARILNHDTSFAKTFVGTPYYM 183
Query: 208 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 255
+PE + Y DIWS GC+L EL P F + +L I+
Sbjct: 184 SPEQMNRM-SYNEKSDIWSLGCLLYELCALMPPFTAFS-QKELAGKIR 229
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 6e-49
Identities = 65/307 (21%), Positives = 112/307 (36%), Gaps = 51/307 (16%)
Query: 17 HVTGHIISTTIGGKNGEPKQTIS-----YMAERVVGTGSFGIVFQAKCLETGETVAIKKV 71
H H S G Q++S Y + +G+G VFQ E + AIK V
Sbjct: 2 HHHHHHSSGVDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYV 60
Query: 72 ----LQDRRYKN--RELQLMRVMDHPN--VISLKHCFFSTTSKNELFLNLVMEYVPESMY 123
++ + E+ + + + +I L + ++ +VME +
Sbjct: 61 NLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE-----ITDQYIYMVMECGNIDLN 115
Query: 124 RVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKIC 183
LK + + K Y + + IH + H DLKP N L+ +K+
Sbjct: 116 SWLKKK----KSIDPWERKSYWKNMLEAVHTIHQH-GIVHSDLKPANFLIV--DGMLKLI 168
Query: 184 DFGSAKQLIAGEANI---SYICSRFYRAPELIFGA----------TEYTTSIDIWSAGCV 230
DFG A Q+ ++ S + + Y PE I ++ + D+WS GC+
Sbjct: 169 DFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCI 228
Query: 231 LAELLLGQPLFPG-ENAVDQLVEIIKVLGTPTREEI----------RCMNPNYTD-FRFP 278
L + G+ F N + +L II +I C+ + P
Sbjct: 229 LYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIP 288
Query: 279 QIKAHPW 285
++ AHP+
Sbjct: 289 ELLAHPY 295
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 2e-48
Identities = 59/279 (21%), Positives = 102/279 (36%), Gaps = 46/279 (16%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPN- 92
Y + +G+G VFQ E + AIK V + E+ + + +
Sbjct: 58 YSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 116
Query: 93 -VISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 151
+I L + ++ +VME + LK + + K Y +
Sbjct: 117 KIIRLYDYE-----ITDQYIYMVMECGNIDLNSWLKKK----KSIDPWERKSYWKNMLEA 167
Query: 152 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI---SYICSRFYRA 208
+ IH + H DLKP N L+ +K+ DFG A Q+ ++ S + + Y
Sbjct: 168 VHTIHQH-GIVHSDLKPANFLIV--DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMP 224
Query: 209 PELIFGA----------TEYTTSIDIWSAGCVLAELLLGQPLFPG-ENAVDQLVEIIKVL 257
PE I ++ + D+WS GC+L + G+ F N + +L II
Sbjct: 225 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPN 284
Query: 258 GTPTREEI----------RCMNPNYTD-FRFPQIKAHPW 285
+I C+ + P++ AHP+
Sbjct: 285 HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPY 323
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 3e-48
Identities = 61/244 (25%), Positives = 103/244 (42%), Gaps = 20/244 (8%)
Query: 21 HIISTTIGGKNGEPKQTIS-YMAERVVGTGSFGIVFQAKCLETGETVAIKKV------LQ 73
H S G Q++ Y+ + +G GSFG K E G IK++ +
Sbjct: 6 HHSSGVDLGTENLYFQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSK 65
Query: 74 DRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSA 132
+R RE+ ++ M HPN++ + F S L +VM+Y +++ +
Sbjct: 66 EREESRREVAVLANMKHPNIVQYRESFEENGS-----LYIVMDYCEGGDLFKRINAQK-- 118
Query: 133 NQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 192
+ + QI L ++H ++ HRD+K QN+ + V++ DFG A+ L
Sbjct: 119 GVLFQEDQILDWFVQICLALKHVHD-RKILHRDIKSQNIFLTK-DGTVQLGDFGIARVLN 176
Query: 193 AGEANISYIC-SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLV 251
+ + +Y +PE+ Y DIW+ GCVL EL + F + + LV
Sbjct: 177 STVELARACIGTPYYLSPEICEN-KPYNNKSDIWALGCVLYELCTLKHAFEAGS-MKNLV 234
Query: 252 EIIK 255
I
Sbjct: 235 LKII 238
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 4e-48
Identities = 55/228 (24%), Positives = 103/228 (45%), Gaps = 19/228 (8%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHC 99
+ ++G+G FG VF+AK G+T IK+V + RE++ + +DH N++ C
Sbjct: 13 FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGC 72
Query: 100 F-----------FSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQ 147
+ +++ L + ME+ + ++ + ++ +++ + Q
Sbjct: 73 WDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR--GEKLDKVLALELFEQ 130
Query: 148 IFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYR 207
I +G+ YIH+ ++ +RDLKP N+ + T QVKI DFG L + Y
Sbjct: 131 ITKGVDYIHS-KKLINRDLKPSNIFLVD-TKQVKIGDFGLVTSLKNDGKRTRSKGTLRYM 188
Query: 208 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 255
+PE I +Y +D+++ G +LAELL ++
Sbjct: 189 SPEQISS-QDYGKEVDLYALGLILAELL--HVCDTAFETSKFFTDLRD 233
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 5e-48
Identities = 59/279 (21%), Positives = 102/279 (36%), Gaps = 46/279 (16%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPN- 92
Y + +G+G VFQ E + AIK V + E+ + + +
Sbjct: 11 YSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 69
Query: 93 -VISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 151
+I L + ++ +VME + LK + + K Y +
Sbjct: 70 KIIRLYDYE-----ITDQYIYMVMECGNIDLNSWLKKK----KSIDPWERKSYWKNMLEA 120
Query: 152 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI---SYICSRFYRA 208
+ IH + H DLKP N L+ +K+ DFG A Q+ ++ S + + Y
Sbjct: 121 VHTIHQH-GIVHSDLKPANFLIV--DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMP 177
Query: 209 PELIFG----------ATEYTTSIDIWSAGCVLAELLLGQPLFPG-ENAVDQLVEIIKVL 257
PE I ++ + D+WS GC+L + G+ F N + +L II
Sbjct: 178 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPN 237
Query: 258 GTPTREEI----------RCMNPNYTD-FRFPQIKAHPW 285
+I C+ + P++ AHP+
Sbjct: 238 HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPY 276
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 6e-47
Identities = 53/232 (22%), Positives = 106/232 (45%), Gaps = 21/232 (9%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKNRELQLMRVMDHPNVI 94
++ ++G G+ VF+ + +TG+ AIK L+ + RE ++++ ++H N++
Sbjct: 11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIV 70
Query: 95 SLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 153
L TT+++ L+ME+ P S+Y VL+ S+A +P + + G+
Sbjct: 71 KLFAIEEETTTRH---KVLIMEFCPCGSLYTVLEEPSNAY-GLPESEFLIVLRDVVGGMN 126
Query: 154 YIHTVPRVCHRDLKPQNLLVDPLT---HQVKICDFGSAKQLIAGEANISYICSRFYRAPE 210
++ + HR++KP N++ K+ DFG+A++L E +S + Y P+
Sbjct: 127 HLREN-GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPD 185
Query: 211 LIFGAT-------EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 255
+ A +Y ++D+WS G G F + E++
Sbjct: 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMY 237
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 7e-47
Identities = 56/239 (23%), Positives = 105/239 (43%), Gaps = 17/239 (7%)
Query: 45 VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISLKH 98
+G GSF V++ ET VA ++ + K+ E ++++ + HPN++
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 99 CFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT 157
+ ST + + LV E + ++ LK + + M + ++ + QI +GL ++HT
Sbjct: 93 SWESTVKGKK-CIVLVTELMTSGTLKTYLKRF----KVMKIKVLRSWCRQILKGLQFLHT 147
Query: 158 -VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGAT 216
P + HRDLK N+ + T VKI D G A A A + I + + APE+
Sbjct: 148 RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK-AVIGTPEFMAPEMY--EE 204
Query: 217 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 275
+Y S+D+++ G + E+ + + Q+ + G + P +
Sbjct: 205 KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRV-TSGVKPASFDKVAIPEVKEI 262
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 6e-46
Identities = 65/275 (23%), Positives = 119/275 (43%), Gaps = 39/275 (14%)
Query: 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-RYKNRELQLMRVMD-HPNVIS 95
IS+ + V+G G+ G + + + VA+K++L + + +RE+QL+R D HPNVI
Sbjct: 24 ISFCPKDVLGHGAEGTIV-YRGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIR 82
Query: 96 LKHCFFSTTSKNELFLNLVMEYVPESMY-RVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 154
K+ F + +E ++ V + + P+ ++ Q GLA+
Sbjct: 83 YFCTE-----KDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQ----QTTSGLAH 133
Query: 155 IHTVPRVCHRDLKPQNLLVDP----LTHQVKICDFGSAKQLIAGEANISY---IC-SRFY 206
+H++ + HRDLKP N+L+ + I DFG K+L G + S + + +
Sbjct: 134 LHSL-NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGW 192
Query: 207 RAPELIFGATE--YTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKV-LGTPTR 262
APE++ + T ++DI+SAGCV ++ G F + + L
Sbjct: 193 IAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHP 252
Query: 263 EEI----------RCMNPNYTDFRF--PQIKAHPW 285
E+ + + + R + HP+
Sbjct: 253 EKHEDVIARELIEKMIAMDPQK-RPSAKHVLKHPF 286
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 6e-46
Identities = 63/204 (30%), Positives = 106/204 (51%), Gaps = 16/204 (7%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIKKV-LQDRRYKN---RELQLMRVMDHPNVISLKHC 99
V+G G++GIV+ + L +AIK++ +D RY E+ L + + H N++
Sbjct: 28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQ---- 83
Query: 100 FFSTTSKNELFLNLVMEYVPE-SMYRVLKH-YSSANQRMPLIYVKLYTYQIFRGLAYIHT 157
+ + S+N F+ + ME VP S+ +L+ + I YT QI GL Y+H
Sbjct: 84 YLGSFSENG-FIKIFMEQVPGGSLSALLRSKWGPLKDNEQTI--GFYTKQILEGLKYLHD 140
Query: 158 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA-GEANISYICSRFYRAPELIFGAT 216
++ HRD+K N+L++ + +KI DFG++K+L ++ + Y APE+I
Sbjct: 141 -NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGP 199
Query: 217 E-YTTSIDIWSAGCVLAELLLGQP 239
Y + DIWS GC + E+ G+P
Sbjct: 200 RGYGKAADIWSLGCTIIEMATGKP 223
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 8e-46
Identities = 47/233 (20%), Positives = 101/233 (43%), Gaps = 23/233 (9%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKNRELQLMRVMDHPNVI 94
++ ++G G+ VF+ + +TG+ AIK L+ + RE ++++ ++H N++
Sbjct: 11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIV 70
Query: 95 SLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 152
L TT+++ L+ME+ P + + ++ +P + + G+
Sbjct: 71 KLFAIEEETTTRH---KVLIMEFCPCGSLYTVLEEPSNA--YGLPESEFLIVLRDVVGGM 125
Query: 153 AYIHTVPRVCHRDLKPQNLLVDPLT---HQVKICDFGSAKQLIAGEANISYICSRFYRAP 209
++ + HR++KP N++ K+ DFG+A++L E +S + Y P
Sbjct: 126 NHLREN-GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHP 184
Query: 210 ELIFGAT-------EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 255
++ A +Y ++D+WS G G F + E++
Sbjct: 185 DMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMY 237
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 4e-45
Identities = 61/288 (21%), Positives = 107/288 (37%), Gaps = 51/288 (17%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRVMDHPNVISL 96
+ V+G G+FG V +A+ AIKK+ + E+ L+ ++H V+
Sbjct: 8 FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRY 67
Query: 97 KHCF--------FSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQ 147
+ T K + L + MEY ++Y ++ + QR Q
Sbjct: 68 YAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRD---EYWRLFRQ 124
Query: 148 IFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR--- 204
I L+YIH+ + HRDLKP N+ +D + VKI DFG AK + +
Sbjct: 125 ILEALSYIHS-QGIIHRDLKPMNIFIDE-SRNVKIGDFGLAKNVHRSLDILKLDSQNLPG 182
Query: 205 ------------FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVE 252
Y A E++ G Y ID++S G + E++ P G +++
Sbjct: 183 SSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI--YPFSTGME-RVNILK 239
Query: 253 IIK--VLGTPTREEI-----------RCMNPNYTDFRF--PQIKAHPW 285
++ + P + ++ + R + W
Sbjct: 240 KLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNK-RPGARTLLNSGW 286
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 7e-45
Identities = 64/272 (23%), Positives = 112/272 (41%), Gaps = 32/272 (11%)
Query: 33 EPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIK----KVLQDRRYKN---RELQLM 85
+P+ Y+ R +G G F F+ +T E A K +L + E+ +
Sbjct: 10 DPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIH 69
Query: 86 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLY 144
R + H +V+ F + +F +V+E S+ + K + + + Y
Sbjct: 70 RSLAHQHVVGFHGFF---EDNDFVF--VVLELCRRRSLLELHK----RRKALTEPEARYY 120
Query: 145 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-S 203
QI G Y+H RV HRDLK NL ++ +VKI DFG A ++ +C +
Sbjct: 121 LRQIVLGCQYLHR-NRVIHRDLKLGNLFLNE-DLEVKIGDFGLATKVEYDGERKKVLCGT 178
Query: 204 RFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV------- 256
Y APE++ ++ +D+WS GC++ LL+G+P F + + I K
Sbjct: 179 PNYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKH 237
Query: 257 LGTPTREEIRCM---NPNYTDFRFPQIKAHPW 285
+ I+ M +P ++ +
Sbjct: 238 INPVAASLIQKMLQTDPT-ARPTINELLNDEF 268
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 1e-44
Identities = 60/232 (25%), Positives = 96/232 (41%), Gaps = 30/232 (12%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVL----QDRRYKNRELQLMRVM-DHPNVI 94
RV+ G F V++A+ + +G A+K++L + R +E+ M+ + HPN++
Sbjct: 30 LRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIV 89
Query: 95 SLKHCFF-----STTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIF 149
S T + E L+ E + LK + + V YQ
Sbjct: 90 QFCSAASIGKEESDTGQAEFL--LLTELCKGQLVEFLKK-MESRGPLSCDTVLKIFYQTC 146
Query: 150 RGLAYIHT-VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG-------------E 195
R + ++H P + HRDLK +NLL+ +K+CDFGSA + E
Sbjct: 147 RAVQHMHRQKPPIIHRDLKVENLLLSN-QGTIKLCDFGSATTISHYPDYSWSAQRRALVE 205
Query: 196 ANISYICSRFYRAPELI--FGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 245
I+ + YR PE+I + DIW+ GC+L L Q F
Sbjct: 206 EEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGA 257
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 3e-44
Identities = 64/272 (23%), Positives = 112/272 (41%), Gaps = 32/272 (11%)
Query: 33 EPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIK----KVLQDRRYKN---RELQLM 85
+P+ Y+ R +G G F F+ +T E A K +L + E+ +
Sbjct: 36 DPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIH 95
Query: 86 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLY 144
R + H +V+ F + +F +V+E S+ + K + + + Y
Sbjct: 96 RSLAHQHVVGFHGFF---EDNDFVF--VVLELCRRRSLLELHK----RRKALTEPEARYY 146
Query: 145 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-S 203
QI G Y+H RV HRDLK NL ++ +VKI DFG A ++ +C +
Sbjct: 147 LRQIVLGCQYLHR-NRVIHRDLKLGNLFLNE-DLEVKIGDFGLATKVEYDGERKKVLCGT 204
Query: 204 RFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV------- 256
Y APE++ ++ +D+WS GC++ LL+G+P F + + I K
Sbjct: 205 PNYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKH 263
Query: 257 LGTPTREEIRCM---NPNYTDFRFPQIKAHPW 285
+ I+ M +P ++ +
Sbjct: 264 INPVAASLIQKMLQTDPT-ARPTINELLNDEF 294
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 4e-44
Identities = 53/242 (21%), Positives = 99/242 (40%), Gaps = 33/242 (13%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVL-----QDRRYKNRELQLMRVMDHPNVI 94
+ + +G G FG+VF+AK AIK++ R RE++ + ++HP ++
Sbjct: 7 FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 66
Query: 95 SLKHCFF-------STTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTY 146
+ + S +++L + M+ E++ + + +R
Sbjct: 67 RYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEER-ERSVCLHIFL 125
Query: 147 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR-- 204
QI + ++H+ + HRDLKP N+ VK+ DFG + E + +
Sbjct: 126 QIAEAVEFLHS-KGLMHRDLKPSNIFFTM-DDVVKVGDFGLVTAMDQDEEEQTVLTPMPA 183
Query: 205 -----------FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEI 253
Y +PE I G Y+ +DI+S G +L ELL P F + + +
Sbjct: 184 YARHTGQVGTKLYMSPEQIHG-NSYSHKVDIFSLGLILFELL--YP-FSTQMERVRTLTD 239
Query: 254 IK 255
++
Sbjct: 240 VR 241
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 4e-44
Identities = 74/282 (26%), Positives = 119/282 (42%), Gaps = 30/282 (10%)
Query: 28 GGKNGEPKQTI--SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----R 80
GG++ + + +GTG FG V + +TGE VAIK+ Q+ KN
Sbjct: 2 GGRSPSLPTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCL 61
Query: 81 ELQLMRVMDHPNVISLKHCFFSTTSKNELFLN-LVMEYVPE-SMYRVLKHYSSANQRMPL 138
E+Q+M+ ++HPNV+S + L L MEY + + L + + +
Sbjct: 62 EIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCC-GLKE 120
Query: 139 IYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQ--VKICDFGSAKQLIAGEA 196
++ I L Y+H R+ HRDLKP+N+++ P + KI D G AK+L GE
Sbjct: 121 GPIRTLLSDISSALRYLHEN-RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL 179
Query: 197 NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 256
++ + Y APEL+ +YT ++D WS G + E + G F Q ++
Sbjct: 180 CTEFVGTLQYLAPELLEQ-KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVR- 237
Query: 257 LGTPTREEIRCMNPNYTDFRFP-------------QIKAHPW 285
+ E I + +F K W
Sbjct: 238 --EKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERW 277
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 1e-43
Identities = 34/298 (11%), Positives = 77/298 (25%), Gaps = 56/298 (18%)
Query: 39 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-------NRELQLMRVMDHP 91
+ G +VF + +E E A+K + +
Sbjct: 63 KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGE 122
Query: 92 NVISLKHCFFSTTSKNELFLN---------------------LVMEYVP---ESMYRVLK 127
+ + + + + L+M E ++ L
Sbjct: 123 SPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLD 182
Query: 128 HYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 187
++ + + T Q+ R A + + + H P NL + P ++ + D +
Sbjct: 183 FVYVFRGDEGILALHILTAQLIRLAANLQSK-GLVHGHFTPDNLFIMP-DGRLMLGDVSA 240
Query: 188 AKQLIAGEANISYICSRFYRAPELIFG-ATEYTTSIDIWSAGCVLAELLLGQPLFPGENA 246
+ G + Y E + +T +++ W G + + F
Sbjct: 241 LWK--VGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTP 298
Query: 247 VDQLVEIIKVLGTPTREEI-----------------RCMNPNYTDFRFP--QIKAHPW 285
+ L P + + R +N + R + P
Sbjct: 299 GIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRR-RLLPLEAMETPE 355
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 1e-43
Identities = 50/281 (17%), Positives = 94/281 (33%), Gaps = 46/281 (16%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV------LQDRRYKNRELQLMRVM-DHPN 92
+ +G+G FG VF+ G AIK+ D + RE+ V+ H +
Sbjct: 13 FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSH 72
Query: 93 VISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 151
V+ + + + EY S+ + +K Q+ RG
Sbjct: 73 VVRYFSAWAEDDH-----MLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRG 127
Query: 152 LAYIHTVPRVCHRDLKPQNLLVDP------------------LTHQVKICDFGSAKQLIA 193
L YIH+ + H D+KP N+ + KI D G ++
Sbjct: 128 LRYIHS-MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI-- 184
Query: 194 GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVE- 252
+ + A E++ + DI++ + +PL + ++ +
Sbjct: 185 -SSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHEIRQG 243
Query: 253 ----IIKVLGTPTREEIR-CMNPNYTDFRFP---QIKAHPW 285
I +VL E ++ ++P+ R P + H
Sbjct: 244 RLPRIPQVLSQEFTELLKVMIHPDPER-R-PSAMALVKHSV 282
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 2e-43
Identities = 68/274 (24%), Positives = 119/274 (43%), Gaps = 32/274 (11%)
Query: 32 GEPKQTIS-YMAERVVGTGSFGIVFQAKCLETGETVAIK----KVLQDRRYKN---RELQ 83
+ I + ++G GSF V++A+ + TG VAIK K + E++
Sbjct: 4 TCIGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVK 63
Query: 84 LMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVK 142
+ + HP+++ L + F N ++ LV+E M R LK + + +
Sbjct: 64 IHCQLKHPSILELYNYF---EDSNYVY--LVLEMCHNGEMNRYLK---NRVKPFSENEAR 115
Query: 143 LYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC 202
+ +QI G+ Y+H+ + HRDL NLL+ +KI DFG A QL +C
Sbjct: 116 HFMHQIITGMLYLHSH-GILHRDLTLSNLLLT-RNMNIKIADFGLATQLKMPHEKHYTLC 173
Query: 203 -SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV----- 256
+ Y +PE+ + + D+WS GC+ LL+G+P F + + L +++
Sbjct: 174 GTPNYISPEIATR-SAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMP 232
Query: 257 --LGTPTREEIRCM---NPNYTDFRFPQIKAHPW 285
L ++ I + NP + HP+
Sbjct: 233 SFLSIEAKDLIHQLLRRNPA-DRLSLSSVLDHPF 265
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 1e-42
Identities = 66/261 (25%), Positives = 118/261 (45%), Gaps = 34/261 (13%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYK--NRELQLMRVMDHPNVISL 96
R +G G FG V+ A+ ++ +A+K ++ + RE+++ + HPN++ L
Sbjct: 15 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74
Query: 97 KHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 155
F ++ L++EY P ++YR L+ + Y ++ L+Y
Sbjct: 75 YGYFH---DATRVY--LILEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYC 125
Query: 156 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPELIFG 214
H+ RV HRD+KP+NLL+ ++KI DFG + + +C + Y PE+I G
Sbjct: 126 HS-KRVIHRDIKPENLLLG-SAGELKIADFGWSVHAPSSRRTD--LCGTLDYLPPEMIEG 181
Query: 215 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV-------LGTPTREEIRC 267
+ +D+WS G + E L+G+P F + I +V + R+ I
Sbjct: 182 -RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISR 240
Query: 268 M---NPNYTDFRFPQIKAHPW 285
+ NP+ ++ HPW
Sbjct: 241 LLKHNPS-QRPMLREVLEHPW 260
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 1e-41
Identities = 72/301 (23%), Positives = 125/301 (41%), Gaps = 56/301 (18%)
Query: 31 NGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-RYKNRELQLMR-VM 88
N E ++E+++G GS G V + G VA+K++L D E++L+
Sbjct: 8 NFEQSLKNLVVSEKILGYGSSGTVV-FQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESD 66
Query: 89 DHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMY-RVLKH--YSSANQRMPLIYVKLYT 145
DHPNVI +C +T + FL + +E ++ V +
Sbjct: 67 DHPNVIRY-YCSETT----DRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLL 121
Query: 146 YQIFRGLAYIHTVPRVCHRDLKPQNLLVD------------PLTHQVKICDFGSAKQLIA 193
QI G+A++H++ ++ HRDLKPQN+LV ++ I DFG K+L +
Sbjct: 122 RQIASGVAHLHSL-KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDS 180
Query: 194 GEANISYICSRF-----YRAPELIFGATE------YTTSIDIWSAGCVLAELL-LGQPLF 241
G+++ + +RAPEL+ + T SIDI+S GCV +L G+ F
Sbjct: 181 GQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPF 240
Query: 242 PGENAVDQLVEIIK------VLGTPTREEI---------RCMNPNYTDFRF--PQIKAHP 284
+ + II+ + + + ++ + R ++ HP
Sbjct: 241 GDKY--SRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLK-RPTAMKVLRHP 297
Query: 285 W 285
Sbjct: 298 L 298
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 2e-41
Identities = 72/269 (26%), Positives = 118/269 (43%), Gaps = 32/269 (11%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKN---RELQLMRVMDHP 91
Y+ ++G GS+G V + ET A+K K+ + + +E+QL+R + H
Sbjct: 7 YLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHK 66
Query: 92 NVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 151
NVI L ++ K ++++ VMEY M +L +R P+ Y Q+ G
Sbjct: 67 NVIQLVDVLYNEE-KQKMYM--VMEYCVCGMQEMLDS--VPEKRFPVCQAHGYFCQLIDG 121
Query: 152 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG-SAKQLIAGEANISYIC--SRFYRA 208
L Y+H+ + H+D+KP NLL+ +KI G + + S ++
Sbjct: 122 LEYLHSQ-GIVHKDIKPGNLLLT-TGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQP 179
Query: 209 PELIFGATEYT-TSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV--------LGT 259
PE+ G ++ +DIWSAG L + G F G+N + +L E I G
Sbjct: 180 PEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN-IYKLFENIGKGSYAIPGDCGP 238
Query: 260 PTREEIRCM---NPNYTDFRFPQIKAHPW 285
P + ++ M P F QI+ H W
Sbjct: 239 PLSDLLKGMLEYEPA-KRFSIRQIRQHSW 266
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 8e-41
Identities = 55/221 (24%), Positives = 103/221 (46%), Gaps = 16/221 (7%)
Query: 45 VVGTGSFGIVFQAKCLETGETVAIKKV-----LQDRRYKNRELQ-LMRVMDHPNVISLKH 98
+G G++G+V + + + +G+ +A+K++ Q+++ +L MR +D P ++
Sbjct: 14 ELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYG 73
Query: 99 CFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV 158
F + + ME + S+ + K Q +P + I + L ++H+
Sbjct: 74 ALFREGD-----VWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK 128
Query: 159 PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFG---A 215
V HRD+KP N+L++ QVK+CDFG + L+ A + Y APE I
Sbjct: 129 LSVIHRDVKPSNVLIN-ALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQ 187
Query: 216 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAV-DQLVEIIK 255
Y+ DIWS G + EL + + + QL ++++
Sbjct: 188 KGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVE 228
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 2e-40
Identities = 61/261 (23%), Positives = 116/261 (44%), Gaps = 34/261 (13%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYK--NRELQLMRVMDHPNVISL 96
R +G G FG V+ A+ + +A+K ++ ++ RE+++ + HPN++ +
Sbjct: 20 RPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRM 79
Query: 97 KHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 155
+ +F + + L++E+ P +Y+ L+ + R + ++ L Y
Sbjct: 80 -YNYFHDRKR----IYLMLEFAPRGELYKELQK----HGRFDEQRSATFMEELADALHYC 130
Query: 156 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPELIFG 214
H +V HRD+KP+NLL+ ++KI DFG + + C + Y PE+I G
Sbjct: 131 HE-RKVIHRDIKPENLLMG-YKGELKIADFGWSVHAPSLRRRTM--CGTLDYLPPEMIEG 186
Query: 215 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV-------LGTPTREEIRC 267
+ +D+W AG + E L+G P F + + I+ V L +++ I
Sbjct: 187 -KTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSKDLISK 245
Query: 268 M---NPNYTDFRFPQIKAHPW 285
+ +P + HPW
Sbjct: 246 LLRYHPP-QRLPLKGVMEHPW 265
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 4e-40
Identities = 73/299 (24%), Positives = 119/299 (39%), Gaps = 54/299 (18%)
Query: 21 HIISTTIGGKNGEPKQTIS--YMAERVVGTGSFGIVFQAKCLETGETVAIK-----KVLQ 73
H + G +N + TI ++ +R +G+G+FG V + +G IK +
Sbjct: 3 HHHHHSSGRENLYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQV 62
Query: 74 DRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP--------ESMYRV 125
E+++++ +DHPN+I + F ++ + +VME S
Sbjct: 63 PMEQIEAEIEVLKSLDHPNIIKIFEVF-----EDYHNMYIVMETCEGGELLERIVSAQAR 117
Query: 126 LKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH--QVKIC 183
K S YV Q+ LAY H+ V H+DLKP+N+L + +KI
Sbjct: 118 GKALSEG-------YVAELMKQMMNALAYFHSQ-HVVHKDLKPENILFQDTSPHSPIKII 169
Query: 184 DFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 243
DFG A+ + E + + + Y APE+ + T DIWSAG V+ LL G F G
Sbjct: 170 DFGLAELFKSDEHSTNAAGTALYMAPEVFKR--DVTFKCDIWSAGVVMYFLLTGCLPFTG 227
Query: 244 ENAVDQLVEIIKVLGTPTREE------------IRCM---NPNYTDFRF--PQIKAHPW 285
+ + + P ++ M +P R Q+ H W
Sbjct: 228 TSLEEVQQKATY--KEPNYAVECRPLTPQAVDLLKQMLTKDPER---RPSAAQVLHHEW 281
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 143 bits (361), Expect = 4e-40
Identities = 69/266 (25%), Positives = 120/266 (45%), Gaps = 19/266 (7%)
Query: 26 TIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVL-----QDRRYKNR 80
T K GE K + +G G+ G+VF+ +G +A K + R R
Sbjct: 22 TQKQKVGELKDDD-FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIR 80
Query: 81 ELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLI 139
ELQ++ + P ++ F+S +++ ME++ S+ +VLK R+P
Sbjct: 81 ELQVLHECNSPYIVGFYGAFYSDGE-----ISICMEHMDGGSLDQVLKK----AGRIPEQ 131
Query: 140 YVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS 199
+ + + +GL Y+ ++ HRD+KP N+LV+ ++K+CDFG + QLI AN S
Sbjct: 132 ILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSMAN-S 189
Query: 200 YICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT 259
++ +R Y +PE + G Y+ DIWS G L E+ +G+ P +A + + +
Sbjct: 190 FVGTRSYMSPERLQGTH-YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEG 248
Query: 260 PTREEIRCMNPNYTDFRFPQIKAHPW 285
E + + P
Sbjct: 249 DAAETPPRPRTPGRPLNKFGMDSRPP 274
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 7e-40
Identities = 70/229 (30%), Positives = 110/229 (48%), Gaps = 28/229 (12%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVL-------QDRRYKNRELQLMRVMDHPN 92
Y +RV+G GSFG V K TG+ A+K + D+ RE+QL++ +DHPN
Sbjct: 28 YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPN 87
Query: 93 VISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLK--HYSSANQRMPLIYVKLYTYQI 148
++ L F +++ + LV E E ++ +S Q+
Sbjct: 88 IMKLYEFF-----EDKGYFYLVGEVYTGGELFDEIISRKRFSEV-------DAARIIRQV 135
Query: 149 FRGLAYIHTVPRVCHRDLKPQNLLVDPLTH--QVKICDFGSAKQLIAGEANISYICSRFY 206
G+ Y+H ++ HRDLKP+NLL++ + ++I DFG + A + I + +Y
Sbjct: 136 LSGITYMHKN-KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYY 194
Query: 207 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 255
APE++ G Y D+WS G +L LL G P F G N D L ++ K
Sbjct: 195 IAPEVLHG--TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEK 241
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 8e-40
Identities = 74/282 (26%), Positives = 118/282 (41%), Gaps = 46/282 (16%)
Query: 32 GEPKQTIS--YMAERVVGTGSFGIVFQAKCLETGETVAIK----KVLQDRRYKNRELQLM 85
G K I+ Y E +G GS+G V A T A K ++D +E+++M
Sbjct: 1 GSTKGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIM 60
Query: 86 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLK--HYSSANQRMPLIYV 141
+ +DHPN+I L F ++ + LVME E RV+ + +
Sbjct: 61 KSLDHPNIIRLYETF-----EDNTDIYLVMELCTGGELFERVVHKRVFRES-------DA 108
Query: 142 KLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH--QVKICDFGSAKQLIAGEANIS 199
+ +AY H + V HRDLKP+N L + +K+ DFG A + G+ +
Sbjct: 109 ARIMKDVLSAVAYCHKL-NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRT 167
Query: 200 YICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT 259
+ + +Y +P+++ G Y D WSAG ++ LL G P F + +++I + GT
Sbjct: 168 KVGTPYYVSPQVLEG--LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIRE--GT 223
Query: 260 PTREE-------------IRCM-NPNYTDFRF--PQIKAHPW 285
T E IR + + R Q H W
Sbjct: 224 FTFPEKDWLNVSPQAESLIRRLLTKSPKQ-RITSLQALEHEW 264
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 1e-39
Identities = 53/311 (17%), Positives = 97/311 (31%), Gaps = 58/311 (18%)
Query: 24 STTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIK-----------KVL 72
+ + GE +T + V+G +A ETGE+ + +
Sbjct: 61 PFRVESELGERPRT--LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIK 118
Query: 73 QDRRYKNR---------------------ELQLMRVMDHPNVISLKHCFFSTTSKNELFL 111
Q + R L++ +I ++ + FL
Sbjct: 119 QMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFL 178
Query: 112 NLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNL 171
M+ ++ VL +SS ++ + T Q+ R LA +H + H L+P ++
Sbjct: 179 YPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY-GLVHTYLRPVDI 237
Query: 172 LVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELI----------FGATEYTTS 221
++D V + F + A + SR + PEL T T S
Sbjct: 238 VLDQ-RGGVFLTGFEHLVRD---GARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFS 293
Query: 222 IDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK-VLGTPTREEIR-----CMNPNYTD- 274
D W+ G V+ + + A+ I + P + +R + D
Sbjct: 294 FDAWALGLVIYWIWCADLPITKDAALGGSEWIFRSCKNIP--QPVRALLEGFLRYPKEDR 351
Query: 275 FRFPQIKAHPW 285
Q P
Sbjct: 352 LLPLQAMETPE 362
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 1e-39
Identities = 61/247 (24%), Positives = 108/247 (43%), Gaps = 29/247 (11%)
Query: 23 ISTTIGGKNGEPKQTIS--YMAERVVGTGSFGIVFQAKCLETGETVAIKKVL------QD 74
+ T G K +S Y + +G+G++G V + T AIK +
Sbjct: 20 LQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSS 79
Query: 75 RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLK--HYS 130
E+ +++++DHPN++ L F +++ LVME E ++ ++
Sbjct: 80 NSKLLEEVAVLKLLDHPNIMKLYDFF-----EDKRNYYLVMECYKGGELFDEIIHRMKFN 134
Query: 131 SANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH--QVKICDFGSA 188
+ Q+ G+ Y+H + HRDLKP+NLL++ +KI DFG +
Sbjct: 135 EV-------DAAVIIKQVLSGVTYLHKH-NIVHRDLKPENLLLESKEKDALIKIVDFGLS 186
Query: 189 KQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVD 248
+ + + +Y APE++ +Y D+WS G +L LL G P F G+ +
Sbjct: 187 AVFENQKKMKERLGTAYYIAPEVLRK--KYDEKCDVWSIGVILFILLAGYPPFGGQTDQE 244
Query: 249 QLVEIIK 255
L ++ K
Sbjct: 245 ILRKVEK 251
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 2e-39
Identities = 65/228 (28%), Positives = 103/228 (45%), Gaps = 27/228 (11%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVL------QDRRYKNRELQLMRVMDHPNV 93
Y ++G GSFG V + K T + A+K + +D RE++L++ +DHPN+
Sbjct: 24 YNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNI 83
Query: 94 ISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLK--HYSSANQRMPLIYVKLYTYQIF 149
+ L ++ +V E E ++K +S Q+F
Sbjct: 84 MKLFEIL-----EDSSSFYIVGELYTGGELFDEIIKRKRFSEH-------DAARIIKQVF 131
Query: 150 RGLAYIHTVPRVCHRDLKPQNLLVDPLTH--QVKICDFGSAKQLIAGEANISYICSRFYR 207
G+ Y+H + HRDLKP+N+L++ +KI DFG + I + +Y
Sbjct: 132 SGITYMHKH-NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYI 190
Query: 208 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 255
APE++ G Y D+WSAG +L LL G P F G+N D L +
Sbjct: 191 APEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVET 236
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 6e-39
Identities = 67/282 (23%), Positives = 120/282 (42%), Gaps = 52/282 (18%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKN-------RELQLMRV 87
Y+ + +G+G+ G V A +T + VAI+ K + E+++++
Sbjct: 137 YIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKK 196
Query: 88 MDHPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYT 145
++HP +I +K+ F + +V+E + E +V+ + +R+ KLY
Sbjct: 197 LNHPCIIKIKNFFDAED------YYIVLELMEGGELFDKVVGN-----KRLKEATCKLYF 245
Query: 146 YQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH--QVKICDFGSAKQLIAGEANISYIC- 202
YQ+ + Y+H + HRDLKP+N+L+ +KI DFG +K L + +C
Sbjct: 246 YQMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL-MRTLCG 303
Query: 203 SRFYRAPELIFGATE--YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV---- 256
+ Y APE++ Y ++D WS G +L L G P F L + I
Sbjct: 304 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYN 363
Query: 257 --------LGTPTREEIRCM---NPNYTDFRF--PQIKAHPW 285
+ + ++ + +P RF + HPW
Sbjct: 364 FIPEVWAEVSEKALDLVKKLLVVDPK---ARFTTEEALRHPW 402
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 6e-39
Identities = 45/240 (18%), Positives = 96/240 (40%), Gaps = 38/240 (15%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKN----------------REL 82
R + G F + + + + A+K + + R + EL
Sbjct: 37 RTLNQGKFNKIILCE--KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNEL 94
Query: 83 QLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-----ESMYRVLKHYSSANQRMP 137
Q++ + + ++ + T+ +E+++ + EY+ + + +P
Sbjct: 95 QIITDIKNEYCLTCEGII---TNYDEVYI--IYEYMENDSILKFDEYFFVLDKNYTCFIP 149
Query: 138 LIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN 197
+ +K + +YIH +CHRD+KP N+L+D +VK+ DFG ++ ++ +
Sbjct: 150 IQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDK-NGRVKLSDFGESEYMVDKKIK 208
Query: 198 ISYIC-SRFYRAPELIFGATEY-TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 255
S + + PE + Y +DIWS G L + F + ++ +L I+
Sbjct: 209 GS--RGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIR 266
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 1e-38
Identities = 60/222 (27%), Positives = 106/222 (47%), Gaps = 17/222 (7%)
Query: 45 VVGTGSFGIVFQAKCLETGETVAIKKV-----LQDRRYKNRELQ-LMRVMDHPNVISLKH 98
+G G++G V + +G+ +A+K++ ++++ +L +MR D P ++
Sbjct: 29 EIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYG 88
Query: 99 CFFSTTSKNELFLNLVMEYVPESMYRVLKH-YSSANQRMPLIYVKLYTYQIFRGLAYIHT 157
F + ME + S + K+ YS + +P + T + L ++
Sbjct: 89 ALFREGD-----CWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE 143
Query: 158 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATE 217
++ HRD+KP N+L+D + +K+CDFG + QL+ A R Y APE I +
Sbjct: 144 NLKIIHRDIKPSNILLD-RSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSAS 202
Query: 218 ---YTTSIDIWSAGCVLAELLLGQPLFPGENAV-DQLVEIIK 255
Y D+WS G L EL G+ +P N+V DQL +++K
Sbjct: 203 RQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVK 244
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 1e-38
Identities = 70/288 (24%), Positives = 115/288 (39%), Gaps = 41/288 (14%)
Query: 24 STTIGGKNGEPKQTI-SYMAERVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRY 77
T G + Y + +G+G+FG+ + T E VA+K + +
Sbjct: 5 PVTTGPLDMPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQ 64
Query: 78 KNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQR 135
RE+ R + HPN++ K + L ++MEY E L R
Sbjct: 65 --REIINHRSLRHPNIVRFKEVI---LTPTHLA--IIMEYASGGE-----LYERICNAGR 112
Query: 136 MPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP-LTHQVKICDFGSAKQLIAG 194
+ + Q+ G++Y H++ ++CHRDLK +N L+D ++KICDFG +K +
Sbjct: 113 FSEDEARFFFQQLLSGVSYCHSM-QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 171
Query: 195 EANISYICSRFYRAPELIFGATEYT-TSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEI 253
S + + Y APE++ EY D+WS G L +L+G F +
Sbjct: 172 SQPKSTVGTPAYIAPEVLLR-QEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKT 230
Query: 254 IKV-------------LGTPTREEIRCM---NPNYTDFRFPQIKAHPW 285
I+ + I + +P T P+IK H W
Sbjct: 231 IQRILSVKYSIPDDIRISPECCHLISRIFVADPA-TRISIPEIKTHSW 277
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 138 bits (348), Expect = 2e-38
Identities = 73/313 (23%), Positives = 121/313 (38%), Gaps = 74/313 (23%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVL---------QDRRYKNRELQLMRVMDH 90
Y + +G GS+G+V A +T AIK + +D E++LM+ + H
Sbjct: 28 YHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHH 87
Query: 91 PNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKL----- 143
PN+ L + ++E ++ LVME + ++ + + + VK
Sbjct: 88 PNIARLYEVY-----EDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPC 142
Query: 144 ------------------------------YTYQIFRGLAYIHTVPRVCHRDLKPQNLLV 173
QIF L Y+H +CHRD+KP+N L
Sbjct: 143 PECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ-GICHRDIKPENFLF 201
Query: 174 D-PLTHQVKICDFGSAKQLIAGEANISYIC-----SRFYRAPELIFGATE-YTTSIDIWS 226
+ ++K+ DFG +K+ Y + ++ APE++ E Y D WS
Sbjct: 202 STNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWS 261
Query: 227 AGCVLAELLLGQPLFPGENAVDQLVEIIK---VLGTPTREEI---------RCMNPNYTD 274
AG +L LL+G FPG N D + +++ P + +N N +
Sbjct: 262 AGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDE 321
Query: 275 FRF--PQIKAHPW 285
RF + HPW
Sbjct: 322 -RFDAMRALQHPW 333
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 2e-38
Identities = 80/280 (28%), Positives = 115/280 (41%), Gaps = 38/280 (13%)
Query: 28 GGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKN--R 80
G K+ + Y+ +G G+FG V + TG VA+K K+ R
Sbjct: 1 GSKHDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKR 60
Query: 81 ELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPL 138
E+Q +++ HP++I L ++ + F +VMEYV E L Y + R+
Sbjct: 61 EIQNLKLFRHPHIIKLYQVI---STPTDFF--MVMEYVSGGE-----LFDYICKHGRVEE 110
Query: 139 IYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG-SAKQLIAGEAN 197
+ + QI + Y H V HRDLKP+N+L+D KI DFG S
Sbjct: 111 MEARRLFQQILSAVDYCHRH-MVVHRDLKPENVLLDA-HMNAKIADFGLSNMMSDGEFLR 168
Query: 198 ISYIC-SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 256
S C S Y APE+I G +DIWS G +L LL G F E+ V L + I+
Sbjct: 169 TS--CGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEH-VPTLFKKIRG 225
Query: 257 --------LGTPTREEIRCM---NPNYTDFRFPQIKAHPW 285
L + M +P I+ H W
Sbjct: 226 GVFYIPEYLNRSVATLLMHMLQVDPL-KRATIKDIREHEW 264
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 3e-38
Identities = 63/215 (29%), Positives = 102/215 (47%), Gaps = 18/215 (8%)
Query: 43 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--RELQLMRVMDHPNVISLKHCF 100
E VVG G+FG+V +AK + VAIK++ + K EL+ + ++HPN++
Sbjct: 13 EEVVGRGAFGVVCKAKW--RAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVK----L 66
Query: 101 FSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH--T 157
+ + LVMEY S+Y VL H + + + Q +G+AY+H
Sbjct: 67 YGACLNP---VCLVMEYAEGGSLYNVL-HGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ 122
Query: 158 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATE 217
+ HRDLKP NLL+ +KICDFG+A + + S + APE+ G +
Sbjct: 123 PKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI--QTHMTNNKGSAAWMAPEVFEG-SN 179
Query: 218 YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVE 252
Y+ D++S G +L E++ + F +
Sbjct: 180 YSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIM 214
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 3e-38
Identities = 67/284 (23%), Positives = 117/284 (41%), Gaps = 56/284 (19%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIK----KVLQDRRYKN--------RELQLMRV 87
Y+ + +G+G+ G V A +T + VAIK + + E+++++
Sbjct: 12 YIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKK 71
Query: 88 MDHPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLK--HYSSANQRMPLIYVKL 143
++HP +I +K+ FF +V+E + E +V+ A + L
Sbjct: 72 LNHPCIIKIKN-FFDAED-----YYIVLELMEGGELFDKVVGNKRLKEATCK-------L 118
Query: 144 YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH--QVKICDFGSAKQLIAGEANISYI 201
Y YQ+ + Y+H + HRDLKP+N+L+ +KI DFG +K L + +
Sbjct: 119 YFYQMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL-MRTL 176
Query: 202 C-SRFYRAPELIFGATE--YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV-- 256
C + Y APE++ Y ++D WS G +L L G P F L + I
Sbjct: 177 CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGK 236
Query: 257 ----------LGTPTREEIRCM---NPNYTDFRF--PQIKAHPW 285
+ + ++ + +P RF + HPW
Sbjct: 237 YNFIPEVWAEVSEKALDLVKKLLVVDPKA---RFTTEEALRHPW 277
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 4e-38
Identities = 57/224 (25%), Positives = 94/224 (41%), Gaps = 18/224 (8%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIK----KVLQDRRYKNRELQLMRVMDHPNVIS 95
Y +G+G+FG+V + TG K D+ E+ +M + HP +I+
Sbjct: 53 YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLIN 112
Query: 96 LKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 153
L F K E+ L++E++ E R+ ++ V Y Q GL
Sbjct: 113 LHDAF---EDKYEMV--LILEFLSGGELFDRIAAEDYKMSEA----EVINYMRQACEGLK 163
Query: 154 YIHTVPRVCHRDLKPQNLL-VDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELI 212
++H + H D+KP+N++ VKI DFG A +L E + + APE I
Sbjct: 164 HMHEH-SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPE-I 221
Query: 213 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 256
D+W+ G + LL G F GE+ ++ L + +
Sbjct: 222 VDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRC 265
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 6e-38
Identities = 60/233 (25%), Positives = 103/233 (44%), Gaps = 25/233 (10%)
Query: 18 VTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY 77
V H I + + + Y + +G GS+ + + T A+K + + +R
Sbjct: 4 VGVHSIVQQLHRNSIQFTDG--YEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD 61
Query: 78 KNRELQLM-RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLK--HYSSA 132
E++++ R HPN+I+LK + + ++ +V E + E + ++L+ +S
Sbjct: 62 PTEEIEILLRYGQHPNIITLKDVY-----DDGKYVYVVTELMKGGELLDKILRQKFFSER 116
Query: 133 NQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLV---DPLTHQVKICDFGSAK 189
+ I + + Y+H V HRDLKP N+L ++ICDFG AK
Sbjct: 117 EASA-------VLFTITKTVEYLHAQ-GVVHRDLKPSNILYVDESGNPESIRICDFGFAK 168
Query: 190 QLIAGEANISYIC-SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLF 241
QL A + C + + APE + Y + DIWS G +L +L G F
Sbjct: 169 QLRAENGLLMTPCYTANFVAPE-VLERQGYDAACDIWSLGVLLYTMLTGYTPF 220
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 6e-38
Identities = 58/239 (24%), Positives = 101/239 (42%), Gaps = 38/239 (15%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIK-----------------KVLQDRRYKNREL 82
Y R +G+G++G V K AIK + + E+
Sbjct: 38 YFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEI 97
Query: 83 QLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLK--HYSSANQRMPL 138
L++ +DHPN+I L F +++ + LV E+ E +++ +
Sbjct: 98 SLLKSLDHPNIIKLFDVF-----EDKKYFYLVTEFYEGGELFEQIINRHKFDEC------ 146
Query: 139 IYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH--QVKICDFGSAKQLIAGEA 196
QI G+ Y+H + HRD+KP+N+L++ +KI DFG +
Sbjct: 147 -DAANIMKQILSGICYLHKH-NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYK 204
Query: 197 NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 255
+ + +Y APE++ +Y D+WS G ++ LL G P F G+N D + ++ K
Sbjct: 205 LRDRLGTAYYIAPEVLKK--KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEK 261
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 8e-38
Identities = 63/270 (23%), Positives = 114/270 (42%), Gaps = 38/270 (14%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKNRELQLMRVMDHPNVI 94
+ + +G G++G V A T E VA+K + + +E+ + ++++H NV+
Sbjct: 9 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 68
Query: 95 SLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 152
N +L +EY E L + MP + + +Q+ G+
Sbjct: 69 KFYGHR---REGNIQYL--FLEYCSGGE-----LFDRIEPDIGMPEPDAQRFFHQLMAGV 118
Query: 153 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN--ISYIC-SRFYRAP 209
Y+H + + HRD+KP+NLL+D +KI DFG A ++ +C + Y AP
Sbjct: 119 VYLHGI-GITHRDIKPENLLLDE-RDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 210 ELIFGATEYT-TSIDIWSAGCVLAELLLGQ-PLFPGENAVDQLVEIIK---------VLG 258
EL+ E+ +D+WS G VL +L G+ P ++ + + + +
Sbjct: 177 ELLKR-REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKID 235
Query: 259 TPTREEIRCM---NPNYTDFRFPQIKAHPW 285
+ + + NP+ P IK W
Sbjct: 236 SAPLALLHKILVENPS-ARITIPDIKKDRW 264
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 1e-37
Identities = 60/227 (26%), Positives = 101/227 (44%), Gaps = 27/227 (11%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIK----KVLQDRRYKNRELQLMRVMDHPNVIS 95
++ V+G+G+F VF K TG+ A+K E+ +++ + H N+++
Sbjct: 11 FIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVT 70
Query: 96 LKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLK--HYSSANQRMPLIYVKLYTYQIFRG 151
L+ + S + LVM+ V E R+L+ Y+ + L Q+
Sbjct: 71 LEDIY---ESTTHYY--LVMQLVSGGELFDRILERGVYTEKDAS-------LVIQQVLSA 118
Query: 152 LAYIHTVPRVCHRDLKPQNLLVDPLTH--QVKICDFGSAKQLIAGEANISYIC-SRFYRA 208
+ Y+H + HRDLKP+NLL ++ I DFG +K + +S C + Y A
Sbjct: 119 VKYLHEN-GIVHRDLKPENLLYLTPEENSKIMITDFGLSK--MEQNGIMSTACGTPGYVA 175
Query: 209 PELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 255
PE + Y+ ++D WS G + LL G P F E +I +
Sbjct: 176 PE-VLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKE 221
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 136 bits (343), Expect = 1e-37
Identities = 27/242 (11%), Positives = 77/242 (31%), Gaps = 32/242 (13%)
Query: 39 SYMAERVVGTGSFGIVFQAKC-----LETGETVAIK----KVLQDRRYKNRELQLMRVMD 89
++G G+F V++A + + +K + + ++ ++
Sbjct: 66 LVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSM 125
Query: 90 HPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQ 147
+ +N L V E + + + ++ + MP V + +
Sbjct: 126 QHMFMKFYSAHLF---QNGSVL--VGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMR 180
Query: 148 IFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQ----------VKICDFGSAKQLIAGEAN 197
+ + +H + H D+KP N ++ + + + D G + +
Sbjct: 181 MLYMIEQVHDC-EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKG 239
Query: 198 ---ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLF-PGENAVDQLVEI 253
+ + ++ E++ + ID + + +L G + E + +
Sbjct: 240 TIFTAKCETSGFQCVEMLSN-KPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGL 298
Query: 254 IK 255
+
Sbjct: 299 FR 300
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 1e-37
Identities = 54/222 (24%), Positives = 99/222 (44%), Gaps = 20/222 (9%)
Query: 45 VVGTGSFGIVFQAKCLETGETVAIKKV-----LQDRRYKNRELQ-LMRVMDHPNVISLKH 98
+G+G+ G V++ + +TG +A+K++ ++ + +L +++ D P ++
Sbjct: 32 EMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFG 91
Query: 99 CFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV 158
F + T + + ME + K +P + T I + L Y+
Sbjct: 92 TFITNTD-----VFIAMELMGTC---AEKLKKRMQGPIPERILGKMTVAIVKALYYLKEK 143
Query: 159 PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELI----FG 214
V HRD+KP N+L+D Q+K+CDFG + +L+ +A Y APE I
Sbjct: 144 HGVIHRDVKPSNILLD-ERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPT 202
Query: 215 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV-DQLVEIIK 255
+Y D+WS G L EL GQ + + L ++++
Sbjct: 203 KPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQ 244
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 2e-37
Identities = 49/219 (22%), Positives = 87/219 (39%), Gaps = 30/219 (13%)
Query: 43 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----------RELQLMRVMDHP 91
E+ +G G FG+V + + ++ VAIK ++ RE+ +M ++HP
Sbjct: 24 EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83
Query: 92 NVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFR 150
N++ + +VME+VP +Y L + I
Sbjct: 84 NIVK----LYGLMHNP---PRMVMEFVPCGDLYHRLLD---KAHPIKWSVKLRLMLDIAL 133
Query: 151 GLAYIHTV-PRVCHRDLKPQNLLVD----PLTHQVKICDFGSAKQLIAGEANISYICSRF 205
G+ Y+ P + HRDL+ N+ + K+ DFG ++ + + + +
Sbjct: 134 GIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ--QSVHSVSGLLGNFQ 191
Query: 206 YRAPELIFGATE-YTTSIDIWSAGCVLAELLLGQPLFPG 243
+ APE I E YT D +S +L +L G+ F
Sbjct: 192 WMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDE 230
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 2e-37
Identities = 69/306 (22%), Positives = 123/306 (40%), Gaps = 61/306 (19%)
Query: 28 GGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKN--- 79
G +G+ Q Y + +G GS+G+V A A+K K+++ +
Sbjct: 3 SGSSGDCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPP 62
Query: 80 ----------------------RELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEY 117
+E+ +++ +DHPNV+ L +++ L++ V E
Sbjct: 63 PRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKL-VEVLDDPNEDHLYM--VFEL 119
Query: 118 VP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP 175
V M + + + Y + +G+ Y+H ++ HRD+KP NLLV
Sbjct: 120 VNQGPVMEVP------TLKPLSEDQARFYFQDLIKGIEYLHYQ-KIIHRDIKPSNLLVGE 172
Query: 176 LTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPELIFGAT-EYT-TSIDIWSAGCVLA 232
+KI DFG + + +A +S + + APE + ++ ++D+W+ G L
Sbjct: 173 -DGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLY 231
Query: 233 ELLLGQPLFPGENAVDQLVEIIK----------VLGTPTREEIRCM---NPNYTDFRFPQ 279
+ GQ F E + L IK + ++ I M NP + P+
Sbjct: 232 CFVFGQCPFMDER-IMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPE-SRIVVPE 289
Query: 280 IKAHPW 285
IK HPW
Sbjct: 290 IKLHPW 295
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 2e-37
Identities = 56/223 (25%), Positives = 101/223 (45%), Gaps = 18/223 (8%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV----LQDRRYKNRELQLMRVMDHPNVIS 95
Y +GTG+FG+V + TG A K V D+ +E+Q M V+ HP +++
Sbjct: 159 YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVN 218
Query: 96 LKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 153
L F + ++ E++ E +V ++ ++ + Y++ Q+ +GL
Sbjct: 219 LHDAFEDDNE-----MVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMR----QVCKGLC 269
Query: 154 YIHTVPRVCHRDLKPQNLL-VDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELI 212
++H H DLKP+N++ ++++K+ DFG L ++ + + APE+
Sbjct: 270 HMHEN-NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVA 328
Query: 213 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 255
G D+WS G + LL G F GEN + L +
Sbjct: 329 EG-KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKS 370
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 3e-37
Identities = 57/226 (25%), Positives = 97/226 (42%), Gaps = 22/226 (9%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLM-RVMDHPNVISLKH 98
+ +V+G G G V Q T E A+K +LQD RE++L R P+++ +
Sbjct: 64 KVTSQVLGLGINGKVLQIFNKRTQEKFALK-MLQDCPKARREVELHWRASQCPHIVRI-V 121
Query: 99 CFFSTTSKNELFLNLVMEYVP------ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 152
+ L +VME + R + ++ I +
Sbjct: 122 DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTER-------EASEIMKSIGEAI 174
Query: 153 AYIHTVPRVCHRDLKPQNLLV---DPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAP 209
Y+H++ + HRD+KP+NLL P +K+ DFG AK+ + + + + +Y AP
Sbjct: 175 QYLHSI-NIAHRDVKPENLLYTSKRPNA-ILKLTDFGFAKETTSHNSLTTPCYTPYYVAP 232
Query: 210 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 255
E + G +Y S D+WS G ++ LL G P F + + +
Sbjct: 233 E-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT 277
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 4e-37
Identities = 53/226 (23%), Positives = 100/226 (44%), Gaps = 25/226 (11%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVA---IKKVLQDRRYKNRELQLMRVMDHPNVISL 96
YM +G G FGIV + + +T +K D+ +E+ ++ + H N++ L
Sbjct: 7 YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHL 66
Query: 97 KHCFFSTTSKNELFLNLVMEYVP--ESMYRVLK---HYSSANQRMPLIYVKLYTYQIFRG 151
F S EL ++ E++ + R+ + + Y +Q+
Sbjct: 67 HESF---ESMEELV--MIFEFISGLDIFERINTSAFELNERE-------IVSYVHQVCEA 114
Query: 152 LAYIHTVPRVCHRDLKPQNLL-VDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAP 209
L ++H+ + H D++P+N++ + +KI +FG A+QL G+ N + + Y AP
Sbjct: 115 LQFLHSH-NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD-NFRLLFTAPEYYAP 172
Query: 210 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 255
E + +T+ D+WS G ++ LL G F E + I+
Sbjct: 173 E-VHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMN 217
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 4e-37
Identities = 74/266 (27%), Positives = 117/266 (43%), Gaps = 35/266 (13%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKN--RELQLMRVMDHPN 92
Y+ +G GSFG V A +T + VA+K + + + RE+ ++++ HP+
Sbjct: 11 YIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPH 70
Query: 93 VISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 152
+I L T+ ++ + V+EY ++ Y +RM + + QI +
Sbjct: 71 IIKLYDVI---TTPTDIVM--VIEYAGGELF----DYIVEKKRMTEDEGRRFFQQIICAI 121
Query: 153 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG-SAKQLIAGEANISYIC-SRFYRAPE 210
Y H ++ HRDLKP+NLL+D VKI DFG S S C S Y APE
Sbjct: 122 EYCHRH-KIVHRDLKPENLLLDD-NLNVKIADFGLSNIMTDGNFLKTS--CGSPNYAAPE 177
Query: 211 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV--------LGTPTR 262
+I G +D+WS G VL +L+G+ F E + L + + L +
Sbjct: 178 VINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEF-IPNLFKKVNSCVYVMPDFLSPGAQ 236
Query: 263 EEIRCM---NPNYTDFRFPQIKAHPW 285
IR M +P +I+ PW
Sbjct: 237 SLIRRMIVADPM-QRITIQEIRRDPW 261
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 5e-37
Identities = 64/228 (28%), Positives = 103/228 (45%), Gaps = 27/228 (11%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIK----KVLQDRRYKN--RELQLMRVMDHPNV 93
Y ++G GSFG V + K T + A+K +++ RE++L++ +DHPN+
Sbjct: 24 YNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNI 83
Query: 94 ISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLK--HYSSANQRMPLIYVKLYTYQIF 149
+ L ++ +V E E ++K +S Q+F
Sbjct: 84 MKLFEIL-----EDSSSFYIVGELYTGGELFDEIIKRKRFSEH-------DAARIIKQVF 131
Query: 150 RGLAYIHTVPRVCHRDLKPQNLLVDPLTH--QVKICDFGSAKQLIAGEANISYICSRFYR 207
G+ Y+H + HRDLKP+N+L++ +KI DFG + I + +Y
Sbjct: 132 SGITYMHKH-NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYI 190
Query: 208 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 255
APE++ G Y D+WSAG +L LL G P F G+N D L +
Sbjct: 191 APEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVET 236
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 5e-37
Identities = 79/287 (27%), Positives = 125/287 (43%), Gaps = 41/287 (14%)
Query: 26 TIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYK-N 79
+I E +Y + +G G+F V A+ + TG VAIK ++ K
Sbjct: 3 SIASCADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLF 62
Query: 80 RELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMP 137
RE+++M++++HPN++ L ++ L+ L+MEY E + Y A+ RM
Sbjct: 63 REVRIMKILNHPNIVKLFEVI---ETEKTLY--LIMEYASGGE-----VFDYLVAHGRMK 112
Query: 138 LIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN 197
+ QI + Y H R+ HRDLK +NLL+D +KI DFG + + G
Sbjct: 113 EKEARSKFRQIVSAVQYCHQK-RIVHRDLKAENLLLDA-DMNIKIADFGFSNEFTVGGK- 169
Query: 198 ISYIC-SRFYRAPELIFGATEYT-TSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 255
+ C + Y APEL G +Y +D+WS G +L L+ G F G+N + +L E +
Sbjct: 170 LDAFCGAPPYAAPELFQG-KKYDGPEVDVWSLGVILYTLVSGSLPFDGQN-LKELRERVL 227
Query: 256 V--------LGTPTREEIRCM---NPNYTDFRF--PQIKAHPWHKVC 289
+ T ++ NP R QI W
Sbjct: 228 RGKYRIPFYMSTDCENLLKRFLVLNPIK---RGTLEQIMKDRWINAG 271
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 8e-37
Identities = 64/272 (23%), Positives = 115/272 (42%), Gaps = 42/272 (15%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKNRELQLMRVMDHPNVI 94
+ + +G G++G V A T E VA+K + + +E+ + ++++H NV+
Sbjct: 9 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 68
Query: 95 SLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 152
N +L +EY E L + MP + + +Q+ G+
Sbjct: 69 KFYGHR---REGNIQYL--FLEYCSGGE-----LFDRIEPDIGMPEPDAQRFFHQLMAGV 118
Query: 153 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN--ISYIC-SRFYRAP 209
Y+H + + HRD+KP+NLL+D +KI DFG A ++ +C + Y AP
Sbjct: 119 VYLHGI-GITHRDIKPENLLLDE-RDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 210 ELIFGATEYT-TSIDIWSAGCVLAELLLGQ-PLFPGENAVDQLVEIIKV---------LG 258
EL+ E+ +D+WS G VL +L G+ P ++ + + + +
Sbjct: 177 ELLKR-REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKID 235
Query: 259 TPTREEIRCM---NPN--YTDFRFPQIKAHPW 285
+ + + NP+ T P IK W
Sbjct: 236 SAPLALLHKILVENPSARIT---IPDIKKDRW 264
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 9e-37
Identities = 50/223 (22%), Positives = 92/223 (41%), Gaps = 23/223 (10%)
Query: 43 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLM-RVMDHPNVISLKHCFF 101
++V+G G G V + TG+ A+K +L D +E+ + P+++ + +
Sbjct: 34 KQVLGLGVNGKVLECFHRRTGQKCALK-LLYDSPKARQEVDHHWQASGGPHIVCILD-VY 91
Query: 102 STTSKNELFLNLVMEYVP------ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 155
+ L ++ME + R + ++ I + ++
Sbjct: 92 ENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTER-------EAAEIMRDIGTAIQFL 144
Query: 156 HTVPRVCHRDLKPQNLLVDPLTH--QVKICDFGSAKQLIAGEANISYIC-SRFYRAPELI 212
H+ + HRD+KP+NLL +K+ DFG AK+ + C + +Y APE +
Sbjct: 145 HSH-NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA--LQTPCYTPYYVAPE-V 200
Query: 213 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 255
G +Y S D+WS G ++ LL G P F + +
Sbjct: 201 LGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKR 243
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 1e-36
Identities = 62/235 (26%), Positives = 102/235 (43%), Gaps = 33/235 (14%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIK----------KVLQDRRYKNRELQLMRVMD 89
Y +G+G F IV + + TG+ A K + R RE+ ++R +
Sbjct: 7 YEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIR 66
Query: 90 HPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLK--HYSSANQRMPLIYVKLYT 145
HPN+I+L F +K ++ L++E V E + + + +
Sbjct: 67 HPNIITLHDIF---ENKTDVV--LILELVSGGELFDFLAEKESLTEDE-------ATQFL 114
Query: 146 YQIFRGLAYIHTVPRVCHRDLKPQNLLV---DPLTHQVKICDFGSAKQLIAGEANISYIC 202
QI G+ Y+H+ R+ H DLKP+N+++ + ++K+ DFG A ++ AG I
Sbjct: 115 KQILDGVHYLHSK-RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE-FKNIF 172
Query: 203 -SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 256
+ + APE I D+WS G + LL G F GE + L I V
Sbjct: 173 GTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAV 226
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 2e-36
Identities = 55/229 (24%), Positives = 93/229 (40%), Gaps = 27/229 (11%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNV 93
Y +G G+F +V + + G+ A + + RE ++ R++ HPN+
Sbjct: 13 YQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNI 72
Query: 94 ISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLK--HYSSANQRMPLIYVKLYTYQIF 149
+ L E L+ + V E ++ +YS A QI
Sbjct: 73 VRLHDSI-----SEEGHHYLIFDLVTGGELFEDIVAREYYSEA-------DASHCIQQIL 120
Query: 150 RGLAYIHTVPRVCHRDLKPQNLL-VDPLTH-QVKICDFGSAKQLIAGEANISYIC-SRFY 206
+ + H + V HR+LKP+NLL L VK+ DFG A ++ + + Y
Sbjct: 121 EAVLHCHQM-GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGY 179
Query: 207 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 255
+PE + Y +D+W+ G +L LL+G P F E+ +I
Sbjct: 180 LSPE-VLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKA 227
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 2e-36
Identities = 67/237 (28%), Positives = 113/237 (47%), Gaps = 20/237 (8%)
Query: 27 IGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIK----KVLQDRRYKNREL 82
+ K G + ++G G FG V + + TG +A K + ++D+ E+
Sbjct: 78 VTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEI 137
Query: 83 QLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIY 140
+M +DH N+I L F SKN++ LVMEYV E R++ + + +++
Sbjct: 138 SVMNQLDHANLIQLYDAF---ESKNDIV--LVMEYVDGGELFDRIIDESYNLTELDTILF 192
Query: 141 VKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLL-VDPLTHQVKICDFGSAKQLIAGEANIS 199
+K QI G+ ++H + + H DLKP+N+L V+ Q+KI DFG A++ E +
Sbjct: 193 MK----QICEGIRHMHQM-YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE-KLK 246
Query: 200 YIC-SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 255
+ + APE + + D+WS G + LL G F G+N + L I+
Sbjct: 247 VNFGTPEFLAPE-VVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILA 302
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 4e-36
Identities = 64/220 (29%), Positives = 101/220 (45%), Gaps = 19/220 (8%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRV-------MDHPNVISL 96
RV+G G FG VF + TG+ A KK+ + R K + Q V + ++SL
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL 250
Query: 97 KHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 154
+ F T + L LVM + + Y + + N YT QI GL +
Sbjct: 251 AYAF-ETKTD----LCLVMTIMNGGDIRYH-IYNVDEDNPGFQEPRAIFYTAQIVSGLEH 304
Query: 155 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPELIF 213
+H + +RDLKP+N+L+D + V+I D G A +L AG+ + + APEL+
Sbjct: 305 LHQR-NIIYRDLKPENVLLDDDGN-VRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLL 362
Query: 214 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEI 253
G EY S+D ++ G L E++ + F + E+
Sbjct: 363 G-EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKEL 401
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 4e-36
Identities = 65/229 (28%), Positives = 101/229 (44%), Gaps = 28/229 (12%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIK----KVLQDRRYKN--RELQLMRVMDHPNV 93
Y + +G G+F +V + TG A K K L R ++ RE ++ R + HPN+
Sbjct: 8 YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNI 67
Query: 94 ISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLK--HYSSANQRMPLIYVKLYTYQIF 149
+ L + E F LV + V E ++ YS A+ QI
Sbjct: 68 VRLHDSI-----QEESFHYLVFDLVTGGELFEDIVAREFYSEADAS-------HCIQQIL 115
Query: 150 RGLAYIHTVPRVCHRDLKPQNLLVD--PLTHQVKICDFGSAKQLIAGEANISYIC-SRFY 206
+AY H+ + HR+LKP+NLL+ VK+ DFG A ++ EA + Y
Sbjct: 116 ESIAYCHSN-GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA-WHGFAGTPGY 173
Query: 207 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 255
+PE + Y+ +DIW+ G +L LL+G P F E+ +I
Sbjct: 174 LSPE-VLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKA 221
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 5e-36
Identities = 59/266 (22%), Positives = 106/266 (39%), Gaps = 34/266 (12%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKN-----RELQLMRVMD 89
Y ++G+G FG V+ + VAIK ++ N E+ L++ +
Sbjct: 45 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 104
Query: 90 H--PNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQ 147
VI L F + L ++E L + + + + + +Q
Sbjct: 105 SGFSGVIRLLDWF---ERPDSFVL--ILERPEPVQD--LFDFITERGALQEELARSFFWQ 157
Query: 148 IFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFY 206
+ + + H V HRD+K +N+L+D ++K+ DFGS L + +R Y
Sbjct: 158 VLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--VYTDFDGTRVY 214
Query: 207 RAPELIFGATEYT-TSIDIWSAGCVLAELLLGQPLFPGENAVDQ-LVEIIKVLGTPTREE 264
PE I Y S +WS G +L +++ G F + + + V + + + +
Sbjct: 215 SPPEWIRY-HRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHL 273
Query: 265 IRCM---NPN--YTDFRFPQIKAHPW 285
IR P+ T F +I+ HPW
Sbjct: 274 IRWCLALRPSDRPT---FEEIQNHPW 296
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 5e-36
Identities = 51/314 (16%), Positives = 95/314 (30%), Gaps = 65/314 (20%)
Query: 31 NGEPKQTISYMAER--------VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNREL 82
G+P + S + ER V+G +A ETGE+ + R + +
Sbjct: 63 TGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAI 122
Query: 83 QLMR--------------------------------VMDHPNVISLKHCFFSTTSKNELF 110
+ M+ +I ++ + F
Sbjct: 123 KQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFF 182
Query: 111 LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQN 170
L M+ ++ VL +SS ++ + T Q+ R LA +H + H L+P +
Sbjct: 183 LYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY-GLVHTYLRPVD 241
Query: 171 LLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELI---------FGATEYTTS 221
+++D V + F G + +S R + PE T T +
Sbjct: 242 IVLDQ-RGGVFLTGFEHLV--RDGASAVS-PIGRGFAPPETTAERMLPFGQHHPTLMTFA 297
Query: 222 IDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK-VLGTPT--REEIRCM---NPNYTDF 275
D W+ G + + + A+ I + P R +
Sbjct: 298 FDTWTLGLAIYWIWCADLPNTDDAALGGSEWIFRSCKNIPQPVRALLEGFLRYPKED--- 354
Query: 276 RF--PQIKAHPWHK 287
R Q P ++
Sbjct: 355 RLLPLQAMETPEYE 368
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 6e-36
Identities = 56/235 (23%), Positives = 93/235 (39%), Gaps = 34/235 (14%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIK---------KVLQDRRYKNRELQLMRVMDH 90
Y V+G G F +V + ETG+ A+K RE + ++ H
Sbjct: 26 YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85
Query: 91 PNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIY----VKLY 144
P+++ L + ++ L +V E++ + + ++K + Y Y
Sbjct: 86 PHIVELLETY-----SSDGMLYMVFEFMDGADLCFEIVKRADAGFV-----YSEAVASHY 135
Query: 145 TYQIFRGLAYIHTVPRVCHRDLKPQNLLV---DPLTHQVKICDFGSAKQLIAGEANISYI 201
QI L Y H + HRD+KP +L+ + + VK+ FG A QL
Sbjct: 136 MRQILEALRYCHDN-NIIHRDVKPHCVLLASKEN-SAPVKLGGFGVAIQLGESGLVAGGR 193
Query: 202 C-SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 255
+ + APE + Y +D+W G +L LL G F G ++L E I
Sbjct: 194 VGTPHFMAPE-VVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK--ERLFEGII 245
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 7e-36
Identities = 62/216 (28%), Positives = 97/216 (44%), Gaps = 29/216 (13%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDR--RYKNRELQLMRVMDHPNVISL 96
+++G GSF V A+ L T AIK ++++ Y RE +M +DHP + L
Sbjct: 36 KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 95
Query: 97 KHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 154
F +++ L + Y E L Y + YT +I L Y
Sbjct: 96 YFTF-----QDDEKLYFGLSYAKNGE-----LLKYIRKIGSFDETCTRFYTAEIVSALEY 145
Query: 155 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF-----YRAP 209
+H + HRDLKP+N+L++ H ++I DFG+AK L + F Y +P
Sbjct: 146 LHGK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQAR--ANSFVGTAQYVSP 201
Query: 210 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 245
EL+ S D+W+ GC++ +L+ G P F N
Sbjct: 202 ELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGN 236
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 9e-36
Identities = 70/256 (27%), Positives = 111/256 (43%), Gaps = 35/256 (13%)
Query: 21 HIISTTIGGKNGEPKQTIS---------YMAERVVGTGSFGIVFQAKCLETGETVAIK-- 69
H+ S T G + G + + Y + +G G+F +V + TG A K
Sbjct: 3 HMASMTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKII 62
Query: 70 --KVLQDRRYKN--RELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMY 123
K L R ++ RE ++ R + HPN++ L + E F LV + V E
Sbjct: 63 NTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI-----QEESFHYLVFDLVTGGELFE 117
Query: 124 RVLK--HYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVD--PLTHQ 179
++ YS A+ QI +AY H+ + HR+LKP+NLL+
Sbjct: 118 DIVAREFYSEADAS-------HCIQQILESIAYCHSN-GIVHRNLKPENLLLASKAKGAA 169
Query: 180 VKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQP 239
VK+ DFG A ++ EA + + Y +PE + Y+ +DIW+ G +L LL+G P
Sbjct: 170 VKLADFGLAIEVNDSEAWHGFAGTPGYLSPE-VLKKDPYSKPVDIWACGVILYILLVGYP 228
Query: 240 LFPGENAVDQLVEIIK 255
F E+ +I
Sbjct: 229 PFWDEDQHRLYAQIKA 244
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 1e-35
Identities = 57/235 (24%), Positives = 101/235 (42%), Gaps = 33/235 (14%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIK----------KVLQDRRYKNRELQLMRVMD 89
Y +G+G F +V + + TG A K + R RE+ +++ +
Sbjct: 13 YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 90 HPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLK--HYSSANQRMPLIYVKLYT 145
HPNVI+L + +K ++ L++E V E + + + +
Sbjct: 73 HPNVITLHEVY---ENKTDVI--LILELVAGGELFDFLAEKESLTEEE-------ATEFL 120
Query: 146 YQIFRGLAYIHTVPRVCHRDLKPQNLLV---DPLTHQVKICDFGSAKQLIAGEANISYIC 202
QI G+ Y+H++ ++ H DLKP+N+++ + ++KI DFG A ++ G I
Sbjct: 121 KQILNGVYYLHSL-QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-FKNIF 178
Query: 203 -SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 256
+ + APE I D+WS G + LL G F G+ + L + V
Sbjct: 179 GTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV 232
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 1e-35
Identities = 67/236 (28%), Positives = 106/236 (44%), Gaps = 26/236 (11%)
Query: 31 NGEPKQTIS--YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--RELQLMR 86
+G + +S + E +G G+ IV++ K T + A+K + + K E+ ++
Sbjct: 44 DGSNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLL 103
Query: 87 VMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLK--HYSSANQRMPLIYVK 142
+ HPN+I LK F + E+ L V+E V E R+++ +YS +
Sbjct: 104 RLSHPNIIKLKEIF---ETPTEISL--VLELVTGGELFDRIVEKGYYSERDAA------- 151
Query: 143 LYTYQIFRGLAYIHTVPRVCHRDLKPQNLL-VDPLTH-QVKICDFGSAKQLIAGEANISY 200
QI +AY+H + HRDLKP+NLL P +KI DFG +K + +
Sbjct: 152 DAVKQILEAVAYLHEN-GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL-MKT 209
Query: 201 IC-SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 255
+C + Y APE I Y +D+WS G + LL G F E + I
Sbjct: 210 VCGTPGYCAPE-ILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRIL 264
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 1e-35
Identities = 60/240 (25%), Positives = 101/240 (42%), Gaps = 39/240 (16%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIK-------------KVLQDRRYKNRELQ-LM 85
Y + ++G G +V + T + A+K +V + R +E+ L
Sbjct: 19 YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 78
Query: 86 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLK--HYSSANQRMPLIYV 141
+V HPN+I LK + + F LV + + E + + S R
Sbjct: 79 KVSGHPNIIQLKDTY-----ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETR------ 127
Query: 142 KLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYI 201
+ + +H + + HRDLKP+N+L+D +K+ DFG + QL GE + +
Sbjct: 128 -KIMRALLEVICALHKL-NIVHRDLKPENILLDD-DMNIKLTDFGFSCQLDPGEK-LREV 183
Query: 202 C-SRFYRAPELIFGATE-----YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 255
C + Y APE+I + Y +D+WS G ++ LL G P F + L I+
Sbjct: 184 CGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMS 243
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 1e-35
Identities = 81/280 (28%), Positives = 118/280 (42%), Gaps = 39/280 (13%)
Query: 29 GKNGEPKQTI-SYMAERVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKN--R 80
+ + + I Y+ +G G+FG V K TG VA+K K+ R
Sbjct: 6 KQKHDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRR 65
Query: 81 ELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPL 138
E+Q +++ HP++I L ++ +++F+ VMEYV E L Y N R+
Sbjct: 66 EIQNLKLFRHPHIIKLYQVI---STPSDIFM--VMEYVSGGE-----LFDYICKNGRLDE 115
Query: 139 IYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG-SAKQLIAGEAN 197
+ QI G+ Y H V HRDLKP+N+L+D KI DFG S
Sbjct: 116 KESRRLFQQILSGVDYCHRH-MVVHRDLKPENVLLDA-HMNAKIADFGLSNMMSDGEFLR 173
Query: 198 ISYIC-SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 256
S C S Y APE+I G +DIWS+G +L LL G F ++ V L + I
Sbjct: 174 TS--CGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDH-VPTLFKKICD 230
Query: 257 --------LGTPTREEIRCM---NPNYTDFRFPQIKAHPW 285
L ++ M +P I+ H W
Sbjct: 231 GIFYTPQYLNPSVISLLKHMLQVDPM-KRATIKDIREHEW 269
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-35
Identities = 59/235 (25%), Positives = 98/235 (41%), Gaps = 33/235 (14%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIK----------KVLQDRRYKNRELQLMRVMD 89
Y +G+G F IV + + TG A K + R RE+ ++R +
Sbjct: 14 YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 90 HPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLK--HYSSANQRMPLIYVKLYT 145
H NVI+L + ++ ++ L++E V E + + S +
Sbjct: 74 HHNVITLHDVY---ENRTDVV--LILELVSGGELFDFLAQKESLSEEE-------ATSFI 121
Query: 146 YQIFRGLAYIHTVPRVCHRDLKPQNLLV---DPLTHQVKICDFGSAKQLIAGEANISYIC 202
QI G+ Y+HT ++ H DLKP+N+++ + +K+ DFG A ++ G I
Sbjct: 122 KQILDGVNYLHTK-KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE-FKNIF 179
Query: 203 -SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 256
+ + APE I D+WS G + LL G F G+ + L I V
Sbjct: 180 GTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSV 233
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 2e-35
Identities = 65/219 (29%), Positives = 103/219 (47%), Gaps = 32/219 (14%)
Query: 43 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--------RELQLMRVMDHPNVI 94
E ++G G FG V++A + G+ VA+K D +E +L ++ HPN+I
Sbjct: 12 EEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNII 69
Query: 95 SLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 153
+L+ N L LVME+ + RVL +R+P + + QI RG+
Sbjct: 70 ALRGV--CLKEPN---LCLVMEFARGGPLNRVLS-----GKRIPPDILVNWAVQIARGMN 119
Query: 154 YIH--TVPRVCHRDLKPQNLLVD-------PLTHQVKICDFGSAKQLIAGEANISYICSR 204
Y+H + + HRDLK N+L+ +KI DFG A+ +S +
Sbjct: 120 YLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR-EWHRTTKMSAAGAY 178
Query: 205 FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 243
+ APE+I + ++ D+WS G +L ELL G+ F G
Sbjct: 179 AWMAPEVIRASM-FSKGSDVWSYGVLLWELLTGEVPFRG 216
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 2e-35
Identities = 60/210 (28%), Positives = 103/210 (49%), Gaps = 19/210 (9%)
Query: 43 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISL 96
+ +G GSFG V +A+ G VA+K +++ + RE+ +M+ + HPN++
Sbjct: 42 KEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLF 99
Query: 97 KHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 155
+ T L + V EY+ S+YR+L H S A +++ Y + +G+ Y+
Sbjct: 100 MG---AVTQPPNLSI--VTEYLSRGSLYRLL-HKSGAREQLDERRRLSMAYDVAKGMNYL 153
Query: 156 HTV-PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI-SYICSRFYRAPELIF 213
H P + HR+LK NLLVD + VK+CDFG ++ + + S + + APE++
Sbjct: 154 HNRNPPIVHRNLKSPNLLVDK-KYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLR 212
Query: 214 GATEYTTSIDIWSAGCVLAELLLGQPLFPG 243
D++S G +L EL Q +
Sbjct: 213 D-EPSNEKSDVYSFGVILWELATLQQPWGN 241
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 3e-35
Identities = 60/216 (27%), Positives = 99/216 (45%), Gaps = 25/216 (11%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--RELQLM-RVMDHPNVISL 96
+ ++ +G GSF I + ++ + A+ K++ R N +E+ + HPN++ L
Sbjct: 13 DLKDKPLGEGSFSICRKCVHKKSNQAFAV-KIISKRMEANTQKEITALKLCEGHPNIVKL 71
Query: 97 KHCFFSTTSKNELFLNLVMEYVP--ESMYRVLK--HYSSANQRMPLIYVKLYTYQIFRGL 152
F ++L LVME + E R+ K H+S ++ +
Sbjct: 72 HEVF-----HDQLHTFLVMELLNGGELFERIKKKKHFSETEASY-------IMRKLVSAV 119
Query: 153 AYIHTVPRVCHRDLKPQNLL-VDPLTH-QVKICDFGSAKQLIAGEANISYIC-SRFYRAP 209
+++H V V HRDLKP+NLL D + ++KI DFG A+ + C + Y AP
Sbjct: 120 SHMHDV-GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAP 178
Query: 210 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 245
E + Y S D+WS G +L +L GQ F +
Sbjct: 179 E-LLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHD 213
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 4e-35
Identities = 57/229 (24%), Positives = 102/229 (44%), Gaps = 38/229 (16%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIK------------KVLQDRRYKNRELQLMR- 86
Y + V+G G +V + TG A+K ++ + R RE ++R
Sbjct: 96 YDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQ 155
Query: 87 VMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLK--HYSSANQRMPLIYVK 142
V HP++I+L + S++ F+ LV + + E + + S R
Sbjct: 156 VAGHPHIITLIDSYESSS-----FMFLVFDLMRKGELFDYLTEKVALSEKETR------- 203
Query: 143 LYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC 202
+ ++++H + HRDLKP+N+L+D Q+++ DFG + L GE + +C
Sbjct: 204 SIMRSLLEAVSFLHAN-NIVHRDLKPENILLDD-NMQIRLSDFGFSCHLEPGEK-LRELC 260
Query: 203 -SRFYRAPELIFGATE-----YTTSIDIWSAGCVLAELLLGQPLFPGEN 245
+ Y APE++ + + Y +D+W+ G +L LL G P F
Sbjct: 261 GTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRR 309
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 4e-35
Identities = 59/235 (25%), Positives = 99/235 (42%), Gaps = 33/235 (14%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIK----------KVLQDRRYKNRELQLMRVMD 89
Y +G+G F IV + + TG A K + R RE+ ++R +
Sbjct: 14 YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVL 73
Query: 90 HPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLK--HYSSANQRMPLIYVKLYT 145
HPN+I+L + ++ ++ L++E V E + + S +
Sbjct: 74 HPNIITLHDVY---ENRTDVV--LILELVSGGELFDFLAQKESLSEEE-------ATSFI 121
Query: 146 YQIFRGLAYIHTVPRVCHRDLKPQNLLV---DPLTHQVKICDFGSAKQLIAGEANISYIC 202
QI G+ Y+HT ++ H DLKP+N+++ + +K+ DFG A ++ G I
Sbjct: 122 KQILDGVNYLHTK-KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE-FKNIF 179
Query: 203 -SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 256
+ + APE I D+WS G + LL G F G+ + L I V
Sbjct: 180 GTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAV 233
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 1e-34
Identities = 57/219 (26%), Positives = 103/219 (47%), Gaps = 27/219 (12%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRE-----------LQLMRVMDHPN 92
R++G G FG V+ + +TG+ A+K L +R K ++ L L+ D P
Sbjct: 195 RIIGRGGFGEVYGCRKADTGKMYAMK-CLDKKRIKMKQGETLALNERIMLSLVSTGDCPF 253
Query: 93 VISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 150
++ + + F + ++L +++ + + Y + +H ++ Y +I
Sbjct: 254 IVCMSYAF---HTPDKLSF--ILDLMNGGDLHYHLSQH-----GVFSEADMRFYAAEIIL 303
Query: 151 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPE 210
GL ++H V +RDLKP N+L+D H V+I D G A + + + + + Y APE
Sbjct: 304 GLEHMHNR-FVVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPH-ASVGTHGYMAPE 360
Query: 211 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQ 249
++ Y +S D +S GC+L +LL G F D+
Sbjct: 361 VLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK 399
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 1e-34
Identities = 60/219 (27%), Positives = 98/219 (44%), Gaps = 20/219 (9%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRV-------MDHPNVISL 96
RV+G G FG V + TG+ A KK+ + R K + + ++ V+SL
Sbjct: 190 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL 249
Query: 97 KHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 154
+ + T L LV+ + + + + Y P Y +I GL
Sbjct: 250 AYAY-ETKDA----LCLVLTLMNGGDLKFHI---YHMGQAGFPEARAVFYAAEICCGLED 301
Query: 155 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFG 214
+H R+ +RDLKP+N+L+D H ++I D G A + G+ + + Y APE++
Sbjct: 302 LHRE-RIVYRDLKPENILLDDHGH-IRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKN 359
Query: 215 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEI 253
YT S D W+ GC+L E++ GQ F + E+
Sbjct: 360 -ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEV 397
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 4e-34
Identities = 62/284 (21%), Positives = 114/284 (40%), Gaps = 46/284 (16%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKN-------RELQLMRV 87
Y +G+G+FG V+ A E + V +K KVL+D ++ E+ ++
Sbjct: 26 YSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSR 85
Query: 88 MDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQ 147
++H N+I + F +N+ F LVME + L + + R+ Q
Sbjct: 86 VEHANIIKVLDIF-----ENQGFFQLVMEKHGSGLD--LFAFIDRHPRLDEPLASYIFRQ 138
Query: 148 IFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFY 206
+ + Y+ + HRD+K +N+++ +K+ DFGSA L G+ C + Y
Sbjct: 139 LVSAVGYLRLK-DIIHRDIKDENIVIAE-DFTIKLIDFGSAAYLERGK-LFYTFCGTIEY 195
Query: 207 RAPELIFGATEYT-TSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK-------VLG 258
APE++ G Y +++WS G L L+ + F +L E ++ ++
Sbjct: 196 CAPEVLMG-NPYRGPELEMWSLGVTLYTLVFEENPF------CELEETVEAAIHPPYLVS 248
Query: 259 TPTREEIRCM---NPN--YTDFRFPQIKAHPWHKVCIFHFPKHW 297
+ + P T ++ PW + W
Sbjct: 249 KELMSLVSGLLQPVPERRTT---LEKLVTDPWVTQPVNLADYTW 289
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 4e-34
Identities = 62/268 (23%), Positives = 101/268 (37%), Gaps = 36/268 (13%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKN-----RELQLMRVMD 89
Y ++G G FG VF L VAIK +VL + E+ L+ +
Sbjct: 33 YRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVG 92
Query: 90 ----HPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYT 145
HP VI L +F T LV+E + L Y + + + +
Sbjct: 93 AGGGHPGVIRL-LDWFETQEG----FMLVLERPLPAQD--LFDYITEKGPLGEGPSRCFF 145
Query: 146 YQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SR 204
Q+ + + H+ V HRD+K +N+L+D K+ DFGS L + +R
Sbjct: 146 GQVVAAIQHCHSR-GVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDE--PYTDFDGTR 202
Query: 205 FYRAPELIFGATEYT-TSIDIWSAGCVLAELLLGQPLFPGENAVDQ-LVEIIKVLGTPTR 262
Y PE I +Y +WS G +L +++ G F + + + + +
Sbjct: 203 VYSPPEWISR-HQYHALPATVWSLGILLYDMVCGDIPFERDQEILEAELHFPAHVSPDCC 261
Query: 263 EEIRCM---NPN--YTDFRFPQIKAHPW 285
IR P+ + +I PW
Sbjct: 262 ALIRRCLAPKPSSRPS---LEEILLDPW 286
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 1e-33
Identities = 59/224 (26%), Positives = 104/224 (46%), Gaps = 25/224 (11%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDR--RYKNRELQLMRVMDHPNVISL 96
R +G GSFG V + +T + A+K K ++ R +ELQ+M+ ++HP +++L
Sbjct: 21 RAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNL 80
Query: 97 KHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 154
+ F +F +V++ + + Y + + N VKL+ ++ L Y
Sbjct: 81 WYS-FQDEED--MF--MVVDLLLGGDLRYHLQQ-----NVHFKEETVKLFICELVMALDY 130
Query: 155 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIF- 213
+ R+ HRD+KP N+L+D H V I DF A L + ++ Y APE+
Sbjct: 131 LQNQ-RIIHRDMKPDNILLDEHGH-VHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSS 188
Query: 214 -GATEYTTSIDIWSAGCVLAELLLGQPLFPGENA--VDQLVEII 254
Y+ ++D WS G ELL G+ + ++ ++V
Sbjct: 189 RKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTF 232
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-33
Identities = 58/232 (25%), Positives = 88/232 (37%), Gaps = 42/232 (18%)
Query: 43 ERVVGTGSFGIVFQAKCLETGETVAIK----KVLQDRRYKNRELQLM-RVMDHPNVISLK 97
E V+G G+ V L T + A+K + R RE++++ + H NV+ L
Sbjct: 18 EDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELI 77
Query: 98 HCFFSTTSKNELFLNLVMEYVP--ESMYRVLK--HYSSANQRMPLIYVKLYTYQIFRGLA 153
F + E LV E + + + K H++ + + L
Sbjct: 78 EFF-----EEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASV-------VVQDVASALD 125
Query: 154 YIHTVPRVCHRDLKPQNLLVDPLTHQ-----VKICDFGSAKQLIAGEANISYICSR---- 204
++H + HRDLKP+N+L H VKICDF +
Sbjct: 126 FLHN-KGIAHRDLKPENIL---CEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTP 181
Query: 205 ----FYRAPELI----FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVD 248
Y APE++ A+ Y D+WS G +L LL G P F G D
Sbjct: 182 CGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSD 233
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-33
Identities = 63/222 (28%), Positives = 108/222 (48%), Gaps = 25/222 (11%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR--------ELQLMRVMDHPNVIS 95
+++G G+FG V K TG A+K +L+ + E ++++ HP + +
Sbjct: 154 KLLGKGTFGKVILVKEKATGRYYAMK-ILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTA 212
Query: 96 LKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 153
LK+ F T + L VMEY E + + S + + Y +I L
Sbjct: 213 LKYSF-QTHDR----LCFVMEYANGGELFFHL-----SRERVFSEDRARFYGAEIVSALD 262
Query: 154 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPELI 212
Y+H+ V +RDLK +NL++D H +KI DFG K+ I A + C + Y APE++
Sbjct: 263 YLHSEKNVVYRDLKLENLMLDKDGH-IKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVL 321
Query: 213 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 254
+Y ++D W G V+ E++ G+ F ++ ++L E+I
Sbjct: 322 ED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-HEKLFELI 361
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 5e-33
Identities = 53/216 (24%), Positives = 89/216 (41%), Gaps = 34/216 (15%)
Query: 43 ERVVGTGSFGIVFQAKCLETGETVAIKKVL-QDRRYKNRE--LQLMRVMDHPNVIS-LKH 98
+ +G G +G V+ K GE VA+K + RE + +M H N++ +
Sbjct: 42 VKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAA 99
Query: 99 CFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYS-SANQRMPLIYVKLYTYQIFRGLAYIH 156
T S +L+L + +Y S+Y LK + A + L Y GL ++H
Sbjct: 100 DIKGTGSWTQLYL--ITDYHENGSLYDYLKSTTLDAKSMLKLAY------SSVSGLCHLH 151
Query: 157 TV-------PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICS-----R 204
T P + HRDLK +N+LV I D G A + I+ + + +
Sbjct: 152 TEIFSTQGKPAIAHRDLKSKNILVKK-NGTCCIADLGLAVKFISDTNEVDIPPNTRVGTK 210
Query: 205 FYRAPELIFGAT-----EYTTSIDIWSAGCVLAELL 235
Y PE++ + + D++S G +L E+
Sbjct: 211 RYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVA 246
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 6e-33
Identities = 58/232 (25%), Positives = 103/232 (44%), Gaps = 31/232 (13%)
Query: 41 MAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDH-PNV 93
+ + +G G F +V Q TG+ A K + + RR ++ E+ ++ + P V
Sbjct: 32 LTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRV 91
Query: 94 ISLKHCFFSTTSKNELFLNLVMEYVP------ESMYRVLKHYSSANQRMPLIYVKLYTYQ 147
I+L + + +E+ L++EY + + + S + V Q
Sbjct: 92 INLHEVY---ENTSEII--LILEYAAGGEIFSLCLPELAEMVSEND-------VIRLIKQ 139
Query: 148 IFRGLAYIHTVPRVCHRDLKPQNLLVDPLT--HQVKICDFGSAKQLIAGEANISYIC-SR 204
I G+ Y+H + H DLKPQN+L+ + +KI DFG ++++ + I +
Sbjct: 140 ILEGVYYLHQN-NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE-LREIMGTP 197
Query: 205 FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 256
Y APE I TT+ D+W+ G + LL F GE+ + + I +V
Sbjct: 198 EYLAPE-ILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQV 248
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 7e-33
Identities = 39/211 (18%), Positives = 78/211 (36%), Gaps = 22/211 (10%)
Query: 43 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISL 96
+ G +++ + G + +K + R N E +R+ HPNV+ +
Sbjct: 15 LTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPV 72
Query: 97 KHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 155
S L+ ++P S+Y VL + N + + + RG+A++
Sbjct: 73 LGA---CQSPPAPHPTLITHWMPYGSLYNVL--HEGTNFVVDQSQAVKFALDMARGMAFL 127
Query: 156 HTV-PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFG 214
HT+ P + L +++++D +I + + + APE +
Sbjct: 128 HTLEPLIPRHALNSRSVMID-EDMTARISMADVKFSFQSPGRMYAPA----WVAPEALQK 182
Query: 215 --ATEYTTSIDIWSAGCVLAELLLGQPLFPG 243
S D+WS +L EL+ + F
Sbjct: 183 KPEDTNRRSADMWSFAVLLWELVTREVPFAD 213
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 9e-33
Identities = 54/229 (23%), Positives = 87/229 (37%), Gaps = 49/229 (21%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLM-RVMDHPNVISLKH 98
+ +V+G G G V Q T E A+ K+LQD RE++L R P+++ +
Sbjct: 20 KVTSQVLGLGINGKVLQIFNKRTQEKFAL-KMLQDCPKARREVELHWRASQCPHIVRIVD 78
Query: 99 CFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYT--------YQI 148
+ L +VME + E R+ A +T I
Sbjct: 79 -VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA-----------FTEREASEIMKSI 126
Query: 149 FRGLAYIHTVPRVCHRDLKPQNLLVDPLTH--QVKICDFGSAKQLIAGEANISYICSRFY 206
+ Y+H++ + HRD+KP+NLL +K+ DFG AK+
Sbjct: 127 GEAIQYLHSI-NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTGE------------ 173
Query: 207 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 255
+Y S D+WS G ++ LL G P F + + +
Sbjct: 174 ----------KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT 212
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-32
Identities = 54/216 (25%), Positives = 88/216 (40%), Gaps = 34/216 (15%)
Query: 43 ERVVGTGSFGIVFQAKCLETGETVAIKKVL-QDRRYKNRE--LQLMRVMDHPNVIS-LKH 98
VG G +G V++ GE VA+K +D + RE L ++ H N++ +
Sbjct: 13 LECVGKGRYGEVWRGSWQ--GENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIAS 70
Query: 99 CFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYS-SANQRMPLIYVKLYTYQIFRGLAYIH 156
S S +L+L + Y S+Y L+ + + ++ I GLA++H
Sbjct: 71 DMTSRHSSTQLWL--ITHYHEMGSLYDYLQLTTLDTVSCLRIVL------SIASGLAHLH 122
Query: 157 TV-------PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICS-----R 204
P + HRDLK +N+LV Q I D G A + + +
Sbjct: 123 IEIFGTQGKPAIAHRDLKSKNILVKK-NGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTK 181
Query: 205 FYRAPELI-----FGATEYTTSIDIWSAGCVLAELL 235
Y APE++ + +DIW+ G VL E+
Sbjct: 182 RYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVA 217
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 1e-32
Identities = 61/276 (22%), Positives = 112/276 (40%), Gaps = 48/276 (17%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIK-----KVLQ--DRRYKNRELQLMRVMDHPNVISL 96
+V+G G+FG V K + A+K ++L+ + E ++ D + +L
Sbjct: 80 KVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTL 139
Query: 97 KHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 154
+ F +++ L LVM+Y + + S R+P + Y ++ +
Sbjct: 140 HYAF-----QDDNNLYLVMDYYVGGDLLT----LLSKFEDRLPEEMARFYLAEMVIAIDS 190
Query: 155 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF-----YRAP 209
+H + HRD+KP N+L+D H +++ DFGS +L+ S + Y +P
Sbjct: 191 VHQL-HYVHRDIKPDNILMDMNGH-IRLADFGSCLKLMEDGTVQSSV---AVGTPDYISP 245
Query: 210 ELI----FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV-LGTPTREE 264
E++ G Y D WS G + E+L G+ F E+ V+ +I+ +
Sbjct: 246 EILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQ 305
Query: 265 IRCMNPNYTDF----------RF-----PQIKAHPW 285
+ ++ N D R K HP+
Sbjct: 306 VTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPF 341
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 2e-32
Identities = 68/223 (30%), Positives = 108/223 (48%), Gaps = 27/223 (12%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ---------LMRVMDHPNVI 94
+++G GSFG VF A+ +T + AIK L+ + L +HP +
Sbjct: 23 KMLGKGSFGKVFLAEFKKTNQFFAIK-ALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLT 81
Query: 95 SLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 152
+ F T L VMEY+ + MY + + L Y +I GL
Sbjct: 82 HMFCTF-QTKEN----LFFVMEYLNGGDLMYHIQSC-----HKFDLSRATFYAAEIILGL 131
Query: 153 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPEL 211
++H+ + +RDLK N+L+D H +KI DFG K+ + G+A + C + Y APE+
Sbjct: 132 QFLHSK-GIVYRDLKLDNILLDKDGH-IKIADFGMCKENMLGDAKTNTFCGTPDYIAPEI 189
Query: 212 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 254
+ G +Y S+D WS G +L E+L+GQ F G++ ++L I
Sbjct: 190 LLG-QKYNHSVDWWSFGVLLYEMLIGQSPFHGQD-EEELFHSI 230
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-32
Identities = 60/217 (27%), Positives = 98/217 (45%), Gaps = 25/217 (11%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----RELQLMRVMDHPNVI 94
Y + V+G+G+ +V A C E VAIK++ ++ + +E+Q M HPN++
Sbjct: 17 YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIV 76
Query: 95 SLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLI----YVKLYTYQIF 149
S F K+EL+ LVM+ + S+ ++KH + + + + ++
Sbjct: 77 SYYTSFV---VKDELW--LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVL 131
Query: 150 RGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR----- 204
GL Y+H HRD+K N+L+ V+I DFG + L A +I+ R
Sbjct: 132 EGLEYLHKN-GQIHRDVKAGNILLG-EDGSVQIADFGVSAFL-ATGGDITRNKVRKTFVG 188
Query: 205 --FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQP 239
+ APE++ Y DIWS G EL G
Sbjct: 189 TPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAA 225
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-32
Identities = 58/231 (25%), Positives = 100/231 (43%), Gaps = 35/231 (15%)
Query: 43 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQ----DRRYKNRELQLMRVMDHPNVISLKH 98
V+G G FG + ETGE + +K++++ +R +E+++MR ++HPNV+
Sbjct: 15 GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLK--- 71
Query: 99 CFF--STTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 155
F K LN + EY+ ++ ++K S + + P + I G+AY+
Sbjct: 72 -FIGVLYKDKR---LNFITEYIKGGTLRGIIK---SMDSQYPWSQRVSFAKDIASGMAYL 124
Query: 156 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYR-------- 207
H++ + HRDL N LV V + DFG A+ ++ + + S
Sbjct: 125 HSM-NIIHRDLNSHNCLVRE-NKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTV 182
Query: 208 -------APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLV 251
APE+I G Y +D++S G VL E++ P
Sbjct: 183 VGNPYWMAPEMING-RSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDF 232
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 2e-32
Identities = 68/222 (30%), Positives = 107/222 (48%), Gaps = 25/222 (11%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ--------LMRVMDHPNVIS 95
RV+G GSFG V A+ ETG+ A+K + +D ++ +++ L +HP +
Sbjct: 29 RVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 88
Query: 96 LKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 153
L CF + + LF VME+V + M+ + K +R + Y +I L
Sbjct: 89 LFCCF---QTPDRLFF--VMEFVNGGDLMFHIQKS-----RRFDEARARFYAAEIISALM 138
Query: 154 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPELI 212
++H + +RDLK N+L+D H K+ DFG K+ I + C + Y APE++
Sbjct: 139 FLHDK-GIIYRDLKLDNVLLDHEGH-CKLADFGMCKEGICNGVTTATFCGTPDYIAPEIL 196
Query: 213 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 254
Y ++D W+ G +L E+L G F EN D L E I
Sbjct: 197 QE-MLYGPAVDWWAMGVLLYEMLCGHAPFEAEN-EDDLFEAI 236
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 3e-32
Identities = 65/223 (29%), Positives = 105/223 (47%), Gaps = 27/223 (12%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQ-DRRYKNRELQ--------LMRVMDHPNVI 94
+V+G GSFG V A+ A+K VLQ K +E + L++ + HP ++
Sbjct: 44 KVIGKGSFGKVLLARHKAEEVFYAVK-VLQKKAILKKKEEKHIMSERNVLLKNVKHPFLV 102
Query: 95 SLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 152
L F T K L V++Y+ E Y + + + + Y +I L
Sbjct: 103 GLHFSF-QTADK----LYFVLDYINGGELFYHLQRE-----RCFLEPRARFYAAEIASAL 152
Query: 153 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPEL 211
Y+H++ + +RDLKP+N+L+D H + + DFG K+ I + S C + Y APE+
Sbjct: 153 GYLHSL-NIVYRDLKPENILLDSQGH-IVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEV 210
Query: 212 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 254
+ Y ++D W G VL E+L G P F N ++ + I
Sbjct: 211 LHK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRN-TAEMYDNI 251
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 3e-32
Identities = 60/222 (27%), Positives = 109/222 (49%), Gaps = 26/222 (11%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR--------ELQLMRVMDHPNVIS 95
+++G G+FG V + TG A+K +L+ + E ++++ HP + +
Sbjct: 11 KLLGKGTFGKVILVREKATGRYYAMK-ILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTA 69
Query: 96 LKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 153
LK+ F T + L VMEY E + + + + + Y +I L
Sbjct: 70 LKYAF-QTHDR----LCFVMEYANGGELFFHLSRE-----RVFTEERARFYGAEIVSALE 119
Query: 154 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPELI 212
Y+H+ V +RD+K +NL++D H +KI DFG K+ I+ A + C + Y APE++
Sbjct: 120 YLHSR-DVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFCGTPEYLAPEVL 177
Query: 213 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 254
+Y ++D W G V+ E++ G+ F ++ ++L E+I
Sbjct: 178 ED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-HERLFELI 217
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 5e-32
Identities = 57/222 (25%), Positives = 94/222 (42%), Gaps = 34/222 (15%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLM----RVM---DHPNVISL 96
+V+G G+F V K +TG+ A+K + + K E+ V+ D + L
Sbjct: 67 KVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQL 126
Query: 97 KHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 154
F +N L+ LVMEY + + S +R+P + Y +I +
Sbjct: 127 HFAF---QDENYLY--LVMEYYVGGDLLT----LLSKFGERIPAEMARFYLAEIVMAIDS 177
Query: 155 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF-----YRAP 209
+H + HRD+KP N+L+D H +++ DFGS +L A S + Y +P
Sbjct: 178 VHRL-GYVHRDIKPDNILLDRCGH-IRLADFGSCLKLRADGTVRSLV---AVGTPDYLSP 232
Query: 210 ELI------FGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 245
E++ G Y D W+ G E+ GQ F ++
Sbjct: 233 EILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADS 274
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 5e-32
Identities = 55/224 (24%), Positives = 100/224 (44%), Gaps = 26/224 (11%)
Query: 43 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISL 96
+ +G+GSFG V++ K VA+K + E+ ++R H N++
Sbjct: 29 GQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL- 84
Query: 97 KHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 155
F ++ +L + V ++ S+Y L ++ + + + Q RG+ Y+
Sbjct: 85 ---FMGYSTAPQLAI--VTQWCEGSSLYHHLH---ASETKFEMKKLIDIARQTARGMDYL 136
Query: 156 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF---YRAPELI 212
H + HRDLK N+ + + VKI DFG A + + + + APE+I
Sbjct: 137 HA-KSIIHRDLKSNNIFLHE-DNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVI 194
Query: 213 FGATE--YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 254
Y+ D+++ G VL EL+ GQ + N DQ++E++
Sbjct: 195 RMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMV 238
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 6e-32
Identities = 52/216 (24%), Positives = 89/216 (41%), Gaps = 34/216 (15%)
Query: 43 ERVVGTGSFGIVFQAKCLETGETVAIKKVL-QDRRYKNRE--LQLMRVMDHPNVIS-LKH 98
+ +G G FG V++ K GE VA+K ++ R RE + ++ H N++ +
Sbjct: 47 QESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAA 104
Query: 99 CFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYS-SANQRMPLIYVKLYTYQIFRGLAYIH 156
+ +L+L V +Y S++ L Y+ + + L GLA++H
Sbjct: 105 DNKDNGTWTQLWL--VSDYHEHGSLFDYLNRYTVTVEGMIKLAL------STASGLAHLH 156
Query: 157 TV-------PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICS-----R 204
P + HRDLK +N+LV I D G A + + I + +
Sbjct: 157 MEIVGTQGKPAIAHRDLKSKNILVKK-NGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 215
Query: 205 FYRAPELIFGAT-----EYTTSIDIWSAGCVLAELL 235
Y APE++ + E DI++ G V E+
Sbjct: 216 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 251
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 9e-32
Identities = 67/222 (30%), Positives = 104/222 (46%), Gaps = 25/222 (11%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ--------LMRVMDHPNVIS 95
V+G GSFG V ++ T E A+K + +D ++ +++ L P +
Sbjct: 26 MVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQ 85
Query: 96 LKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 153
L CF T + L VMEYV + MY + + R + Y +I GL
Sbjct: 86 LHSCF-QTMDR----LYFVMEYVNGGDLMYHIQQV-----GRFKEPHAVFYAAEIAIGLF 135
Query: 154 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPELI 212
++ + + +RDLK N+++D H +KI DFG K+ I C + Y APE+I
Sbjct: 136 FLQSK-GIIYRDLKLDNVMLDSEGH-IKIADFGMCKENIWDGVTTKTFCGTPDYIAPEII 193
Query: 213 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 254
Y S+D W+ G +L E+L GQ F GE+ D+L + I
Sbjct: 194 AY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGED-EDELFQSI 233
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-31
Identities = 53/287 (18%), Positives = 100/287 (34%), Gaps = 77/287 (26%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----RELQLMRVMDHPNVI 94
+ + +G G FG+VF+AK AIK++ R RE++ + ++HP ++
Sbjct: 8 FEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 67
Query: 95 SLKH----------------------------------------------------CFFS 102
+
Sbjct: 68 RYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQL 127
Query: 103 TTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRV 161
S +++L + M+ E++ + S R + + ++ QI + ++H+ +
Sbjct: 128 QPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFI-QIAEAVEFLHS-KGL 185
Query: 162 CHRDLKPQNLLVDPLTHQVKICDFGSAKQLI-------------AGEANISYICSRFYRA 208
HRDLKP N+ VK+ DFG + A + + ++ Y +
Sbjct: 186 MHRDLKPSNIFFTM-DDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMS 244
Query: 209 PELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 255
PE I G Y+ +DI+S G +L ELL V + ++
Sbjct: 245 PEQIHG-NNYSHKVDIFSLGLILFELL--YSFSTQMERVRIITDVRN 288
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 121 bits (304), Expect = 1e-31
Identities = 69/289 (23%), Positives = 115/289 (39%), Gaps = 71/289 (24%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK---NRELQLMRVM-----DHP 91
Y R +G G F V+ + ++ + VA+K V Y E++L++ + + P
Sbjct: 39 YHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDP 98
Query: 92 N---VISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQI 148
N V+ L F + N + +V E + + + + + Q +PL VK Q+
Sbjct: 99 NREMVVQLLDDF-KISGVNGTHICMVFEVLGHHLLKWIIKSN--YQGLPLPCVKKIIQQV 155
Query: 149 FRGLAYIHTVPRVCHRDLKPQNLLV----------------------------------- 173
+GL Y+HT R+ H D+KP+N+L+
Sbjct: 156 LQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPA 215
Query: 174 -------------DPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTT 220
+ +VKI D G+A + I +R YR+ E++ G+ Y T
Sbjct: 216 TAGNFLVNPLEPKNAEKLKVKIADLGNAC--WVHKHFTEDIQTRQYRSLEVLIGS-GYNT 272
Query: 221 SIDIWSAGCVLAELLLGQPLFPGENA------VDQLVEIIKVLGTPTRE 263
DIWS C+ EL G LF + D + II++LG R+
Sbjct: 273 PADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRK 321
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 1e-31
Identities = 55/219 (25%), Positives = 102/219 (46%), Gaps = 33/219 (15%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDR--RYKNRELQLMRVMDHPNVISL 96
+V+G G+FG V + T + A+K ++++ + E +M + P V+ L
Sbjct: 75 KVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL 134
Query: 97 KHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 154
+ F +++ +L +VMEY+P + + ++ N +P + + YT ++ L
Sbjct: 135 FYAF-----QDDRYLYMVMEYMPGGD-LVNLMS-----NYDVPEKWARFYTAEVVLALDA 183
Query: 155 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF-----YRAP 209
IH++ HRD+KP N+L+D H +K+ DFG+ ++ Y +P
Sbjct: 184 IHSM-GFIHRDVKPDNMLLDKSGH-LKLADFGTCMKMNKEGMVRCDT---AVGTPDYISP 238
Query: 210 ELIF---GATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 245
E++ G Y D WS G L E+L+G F ++
Sbjct: 239 EVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS 277
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-31
Identities = 62/252 (24%), Positives = 106/252 (42%), Gaps = 33/252 (13%)
Query: 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVL-QDRRYKNRE--LQLMRVMDHPNV 93
++ V G FG V++A+ E VA+K QD++ E + + M H N+
Sbjct: 23 SMPLQLLEVKARGRFGCVWKAQL--LNEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENI 80
Query: 94 IS-LKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYS-SANQRMPLIYVKLYTYQIFR 150
+ + T+ +L+L + + + S+ LK S N+ + + R
Sbjct: 81 LQFIGAEKRGTSVDVDLWL--ITAFHEKGSLSDFLKANVVSWNELCHIAET------MAR 132
Query: 151 GLAYIHT---------VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG--EANIS 199
GLAY+H P + HRD+K +N+L+ I DFG A + AG +
Sbjct: 133 GLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKN-NLTACIADFGLALKFEAGKSAGDTH 191
Query: 200 YIC-SRFYRAPELIFGA----TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 254
+R Y APE++ GA + ID+++ G VL EL G L
Sbjct: 192 GQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEE 251
Query: 255 KVLGTPTREEIR 266
++ P+ E+++
Sbjct: 252 EIGQHPSLEDMQ 263
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 3e-31
Identities = 64/251 (25%), Positives = 121/251 (48%), Gaps = 22/251 (8%)
Query: 31 NGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVL----QDRRYKNRELQLMR 86
G+PK+ Y +G G+ G V+ A + TG+ VAI+++ + E+ +MR
Sbjct: 15 VGDPKKK--YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMR 72
Query: 87 VMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYT 145
+PN+++ + +EL+ +VMEY+ S+ V+ M +
Sbjct: 73 ENKNPNIVNYLDSYL---VGDELW--VVMEYLAGGSLTDVVT-----ETCMDEGQIAAVC 122
Query: 146 YQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN-ISYICSR 204
+ + L ++H+ +V HRD+K N+L+ + VK+ DFG Q+ ++ + + +
Sbjct: 123 RECLQALEFLHSN-QVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSTMVGTP 180
Query: 205 FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 264
++ APE++ Y +DIWS G + E++ G+P + EN + L I GTP +
Sbjct: 181 YWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN-GTPELQN 238
Query: 265 IRCMNPNYTDF 275
++ + DF
Sbjct: 239 PEKLSAIFRDF 249
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 4e-31
Identities = 64/211 (30%), Positives = 108/211 (51%), Gaps = 26/211 (12%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-------RELQLMRVMDHPN 92
+ R +G GSFG V+ A+ + E VAIKK+ + N +E++ ++ + HPN
Sbjct: 56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 93 VISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 152
I + C+ ++ + LVMEY S +L+ + + + + + T+ +GL
Sbjct: 116 TIQYRGCYL---REHTAW--LVMEYCLGSASDLLEVH---KKPLQEVEIAAVTHGALQGL 167
Query: 153 AYIHTVPRVCHRDLKPQNLLVDPLTH--QVKICDFGSAKQLIAGEANISYICSRFYRAPE 210
AY+H+ + HRD+K N+L L+ VK+ DFGSA + AN S++ + ++ APE
Sbjct: 168 AYLHSH-NMIHRDVKAGNIL---LSEPGLVKLGDFGSASIM--APAN-SFVGTPYWMAPE 220
Query: 211 LIFGATE--YTTSIDIWSAGCVLAELLLGQP 239
+I E Y +D+WS G EL +P
Sbjct: 221 VILAMDEGQYDGKVDVWSLGITCIELAERKP 251
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 6e-31
Identities = 57/217 (26%), Positives = 106/217 (48%), Gaps = 24/217 (11%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ--------LMRVMDHPNVIS 95
RV+G GS+ V + +T A+K V ++ + ++ + +HP ++
Sbjct: 15 RVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 74
Query: 96 LKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 153
L C F T S+ L V+EYV + M+ + + +++P + + Y+ +I L
Sbjct: 75 LHSC-FQTESR----LFFVIEYVNGGDLMFHMQRQ-----RKLPEEHARFYSAEISLALN 124
Query: 154 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPELI 212
Y+H + +RDLK N+L+D H +K+ D+G K+ + S C + Y APE++
Sbjct: 125 YLHER-GIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEIL 182
Query: 213 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQ 249
G +Y S+D W+ G ++ E++ G+ F + D
Sbjct: 183 RG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDN 218
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 8e-31
Identities = 52/245 (21%), Positives = 96/245 (39%), Gaps = 41/245 (16%)
Query: 43 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISL 96
++G G FG V+ + VAI+ + +R ++ RE+ R H NV+
Sbjct: 38 GELIGKGRFGQVYHGRWHGE---VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLF 94
Query: 97 K-HCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 154
C S L + + ++Y V++ A + + + +I +G+ Y
Sbjct: 95 MGAC----MSPPHLAI--ITSLCKGRTLYSVVR---DAKIVLDVNKTRQIAQEIVKGMGY 145
Query: 155 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF------YRA 208
+H + H+DLK +N+ D +V I DFG +A R + A
Sbjct: 146 LHAKGIL-HKDLKSKNVFYD--NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLA 202
Query: 209 PELIFGATE--------YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 260
PE+I + ++ D+++ G + EL + F + A II +GT
Sbjct: 203 PEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPA----EAIIWQMGTG 258
Query: 261 TREEI 265
+ +
Sbjct: 259 MKPNL 263
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 9e-31
Identities = 59/229 (25%), Positives = 107/229 (46%), Gaps = 36/229 (15%)
Query: 44 RVVGTGSFGIVFQAKCL---ETGETVAIK-----KVLQDRRYKNR---ELQLMRVMDHPN 92
RV+G G +G VFQ + + TG+ A+K ++++ + E ++ + HP
Sbjct: 23 RVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPF 82
Query: 93 VISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 150
++ L + F T K L L++EY+ E ++ + Y +I
Sbjct: 83 IVDLIYAF-QTGGK----LYLILEYLSGGELFMQLERE-----GIFMEDTACFYLAEISM 132
Query: 151 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF----- 205
L ++H + +RDLKP+N++++ H VK+ DFG K+ I F
Sbjct: 133 ALGHLHQK-GIIYRDLKPENIMLNHQGH-VKLTDFGLCKESIHDGTV----THTFCGTIE 186
Query: 206 YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 254
Y APE++ + + ++D WS G ++ ++L G P F GEN + ++ I
Sbjct: 187 YMAPEILMR-SGHNRAVDWWSLGALMYDMLTGAPPFTGEN-RKKTIDKI 233
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 9e-31
Identities = 69/243 (28%), Positives = 115/243 (47%), Gaps = 22/243 (9%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--RELQLMRVMDHPNVISLK 97
+ +G GS+G V++A ETG+ VAIK+V + + +E+ +M+ D P+V+
Sbjct: 31 FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYY 90
Query: 98 HCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 156
+F +L+ +VMEY S+ +++ N+ + + +GL Y+H
Sbjct: 91 GSYF---KNTDLW--IVMEYCGAGSVSDIIR---LRNKTLTEDEIATILQSTLKGLEYLH 142
Query: 157 TVPRVCHRDLKPQNLLVDPLTH--QVKICDFGSAKQLIA--GEANISYICSRFYRAPELI 212
+ R HRD+K N+L L K+ DFG A QL + N + I + F+ APE+I
Sbjct: 143 FM-RKIHRDIKAGNIL---LNTEGHAKLADFGVAGQLTDTMAKRN-TVIGTPFWMAPEVI 197
Query: 213 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 272
Y DIWS G E+ G+P + + + + I PT + + N+
Sbjct: 198 QEI-GYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTN-PPPTFRKPELWSDNF 255
Query: 273 TDF 275
TDF
Sbjct: 256 TDF 258
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-30
Identities = 58/208 (27%), Positives = 96/208 (46%), Gaps = 22/208 (10%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----RELQLMRVMDHPNVI 94
+ +G GSFG VF+ T + VAIK + + +E+ ++ D P V
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 95 SLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 153
+ T L ++MEY+ S +L+ + + +I +GL
Sbjct: 84 KYYGSYLKDTK-----LWIIMEYLGGGSALDLLE-----PGPLDETQIATILREILKGLD 133
Query: 154 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA--GEANISYICSRFYRAPEL 211
Y+H+ + HRD+K N+L+ +VK+ DFG A QL + N +++ + F+ APE+
Sbjct: 134 YLHSE-KKIHRDIKAANVLLS-EHGEVKLADFGVAGQLTDTQIKRN-TFVGTPFWMAPEV 190
Query: 212 IFGATEYTTSIDIWSAGCVLAELLLGQP 239
I + Y + DIWS G EL G+P
Sbjct: 191 IKQS-AYDSKADIWSLGITAIELARGEP 217
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-30
Identities = 42/225 (18%), Positives = 85/225 (37%), Gaps = 25/225 (11%)
Query: 47 GTGSFGIVFQAKCLETGETVAIKKV----LQDRRYKN--RELQLMRVMDHPNVISLKHCF 100
G V A+ TGE V ++++ + EL + ++ +HPN++ + F
Sbjct: 36 GFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATF 95
Query: 101 FSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 159
+ L +V ++ S ++ + M + + + + L YIH +
Sbjct: 96 IADNE-----LWVVTSFMAYGSAKDLICTHF--MDGMNELAIAYILQGVLKALDYIHHM- 147
Query: 160 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA--------GEANISYICSRFYRAPEL 211
HR +K ++L+ + +V + S +I+ + + + +PE+
Sbjct: 148 GYVHRSVKASHILIS-VDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEV 206
Query: 212 IF-GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 255
+ Y DI+S G EL G F A L+E +
Sbjct: 207 LQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLN 251
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-30
Identities = 61/223 (27%), Positives = 110/223 (49%), Gaps = 26/223 (11%)
Query: 44 RVVGTGSFGIVFQAK---CLETGETVAIK-----KVLQDRRYKNR-ELQLMRVMDHPNVI 94
+V+G GSFG VF K + + A+K + R + + E ++ ++HP ++
Sbjct: 30 KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIV 89
Query: 95 SLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 152
L + F T K L L+++++ + R+ K VK Y ++ L
Sbjct: 90 KLHYAF-QTEGK----LYLILDFLRGGDLFTRLSKE-----VMFTEEDVKFYLAELALAL 139
Query: 153 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPEL 211
++H++ + +RDLKP+N+L+D H +K+ DFG +K+ I E C + Y APE+
Sbjct: 140 DHLHSL-GIIYRDLKPENILLDEEGH-IKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEV 197
Query: 212 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 254
+ +T S D WS G ++ E+L G F G++ + + +I
Sbjct: 198 VNR-RGHTQSADWWSFGVLMFEMLTGTLPFQGKD-RKETMTMI 238
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 3e-30
Identities = 56/217 (25%), Positives = 106/217 (48%), Gaps = 24/217 (11%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ--------LMRVMDHPNVIS 95
RV+G GS+ V + +T A++ V ++ + ++ + +HP ++
Sbjct: 58 RVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 117
Query: 96 LKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 153
L C F T S+ L V+EYV + M+ + + +++P + + Y+ +I L
Sbjct: 118 LHSC-FQTESR----LFFVIEYVNGGDLMFHMQRQ-----RKLPEEHARFYSAEISLALN 167
Query: 154 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPELI 212
Y+H + +RDLK N+L+D H +K+ D+G K+ + S C + Y APE++
Sbjct: 168 YLHER-GIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEIL 225
Query: 213 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQ 249
G +Y S+D W+ G ++ E++ G+ F + D
Sbjct: 226 RG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDN 261
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 3e-30
Identities = 67/222 (30%), Positives = 104/222 (46%), Gaps = 25/222 (11%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ--------LMRVMDHPNVIS 95
V+G GSFG V ++ T E A+K + +D ++ +++ L P +
Sbjct: 347 MVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQ 406
Query: 96 LKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 153
L CF T + L VMEYV + MY + + R + Y +I GL
Sbjct: 407 LHSCF-QTMDR----LYFVMEYVNGGDLMYHIQQV-----GRFKEPHAVFYAAEIAIGLF 456
Query: 154 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPELI 212
++ + + +RDLK N+++D H +KI DFG K+ I C + Y APE+I
Sbjct: 457 FLQSK-GIIYRDLKLDNVMLDSEGH-IKIADFGMCKENIWDGVTTKTFCGTPDYIAPEII 514
Query: 213 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 254
Y S+D W+ G +L E+L GQ F GE+ D+L + I
Sbjct: 515 AY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGED-EDELFQSI 554
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 4e-30
Identities = 58/214 (27%), Positives = 104/214 (48%), Gaps = 21/214 (9%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV---LQDRRYKNRELQLMR-VMDHPNVIS 95
+ +VG G++G V++ + ++TG+ AIK + + +E+ +++ H N+ +
Sbjct: 26 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 85
Query: 96 LKHCFFSTTSKNELF-LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 153
F L LVME+ S+ ++K ++ + ++ +I RGL+
Sbjct: 86 YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIK--NTKGNTLKEEWIAYICREILRGLS 143
Query: 154 YIHTVPRVCHRDLKPQNLLVDPLTH--QVKICDFGSAKQLIA--GEANISYICSRFYRAP 209
++H +V HRD+K QN+L LT +VK+ DFG + QL G N ++I + ++ AP
Sbjct: 144 HLHQ-HKVIHRDIKGQNVL---LTENAEVKLVDFGVSAQLDRTVGRRN-TFIGTPYWMAP 198
Query: 210 ELI----FGATEYTTSIDIWSAGCVLAELLLGQP 239
E+I Y D+WS G E+ G P
Sbjct: 199 EVIACDENPDATYDFKSDLWSLGITAIEMAEGAP 232
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 4e-30
Identities = 63/251 (25%), Positives = 117/251 (46%), Gaps = 22/251 (8%)
Query: 31 NGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVL----QDRRYKNRELQLMR 86
G+P+ + +G GS GIV A+ +G VA+K + Q R E+ +MR
Sbjct: 40 QGDPRLL--LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMR 97
Query: 87 VMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYT 145
H NV+ + + EL+ ++ME++ ++ ++ R+ +
Sbjct: 98 DYQHFNVVEMYKSYL---VGEELW--VLMEFLQGGALTDIVSQ-----VRLNEEQIATVC 147
Query: 146 YQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN-ISYICSR 204
+ + LAY+H V HRD+K ++L+ L +VK+ DFG Q+ S + +
Sbjct: 148 EAVLQALAYLHA-QGVIHRDIKSDSILLT-LDGRVKLSDFGFCAQISKDVPKRKSLVGTP 205
Query: 205 FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 264
++ APE+I + Y T +DIWS G ++ E++ G+P + ++ V + + P +
Sbjct: 206 YWMAPEVISR-SLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDS-PPPKLKN 263
Query: 265 IRCMNPNYTDF 275
++P DF
Sbjct: 264 SHKVSPVLRDF 274
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 5e-30
Identities = 70/273 (25%), Positives = 122/273 (44%), Gaps = 54/273 (19%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDR--RYKNRELQLMRVMDHPNVISL 96
+ +GTGSFG V K E+G A+K KV++ + + E ++++ ++ P ++ L
Sbjct: 47 KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 97 KHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 154
+ F K+ L +VMEYV E + + R + + Y QI Y
Sbjct: 107 EFSF-----KDNSNLYMVMEYVAGGE-----MFSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 155 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPELIF 213
+H++ + +RDLKP+NLL+D + +++ DFG AK++ + +C + APE+I
Sbjct: 157 LHSL-DLIYRDLKPENLLIDQQGY-IQVTDFGFAKRV---KGRTWTLCGTPEALAPEIIL 211
Query: 214 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR---CMNP 270
Y ++D W+ G ++ E+ G P F + Q+ E I ++R +
Sbjct: 212 S-KGYNKAVDWWALGVLIYEMAAGYPPFFADQ-PIQIYEKI------VSGKVRFPSHFSS 263
Query: 271 NYTDF-----------RF-------PQIKAHPW 285
+ D RF IK H W
Sbjct: 264 DLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKW 296
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 1e-29
Identities = 64/228 (28%), Positives = 104/228 (45%), Gaps = 41/228 (17%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDR--RYKNRELQLMRVMDHPNVISL 96
R +GTGSFG V + G A+K V++ + + N E ++ ++ HP +I +
Sbjct: 12 RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 71
Query: 97 KHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 154
F ++ + ++M+Y+ E + K +QR P K Y ++ L Y
Sbjct: 72 WGTF-----QDAQQIFMIMDYIEGGELFSLLRK-----SQRFPNPVAKFYAAEVCLALEY 121
Query: 155 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG--------EANISYICSRFY 206
+H+ + +RDLKP+N+L+D H +KI DFG AK + + Y
Sbjct: 122 LHSK-DIIYRDLKPENILLDKNGH-IKITDFGFAKYVPDVTYTLCGTPD----------Y 169
Query: 207 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 254
APE++ Y SID WS G ++ E+L G F N + E I
Sbjct: 170 IAPEVVST-KPYNKSIDWWSFGILIYEMLAGYTPFYDSN-TMKTYEKI 215
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 1e-29
Identities = 63/257 (24%), Positives = 110/257 (42%), Gaps = 42/257 (16%)
Query: 40 YMAERVVGTGSFGIVFQAKCLE-TGETVAIKKVLQD-------RRYKNRELQLMRVMDHP 91
Y + + G G ++ A G V +K L E Q + + HP
Sbjct: 82 YEVKGCIAHGGLGWIYLALDRNVNGRPVVLK-GLVHSGDAEAQAMAM-AERQFLAEVVHP 139
Query: 92 NVISLKHCFFSTTSKNELFLN-LVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIF 149
+++ + F T ++ + +VMEYV +S+ R Q++P+ Y +I
Sbjct: 140 SIVQI-FNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKG------QKLPVAEAIAYLLEIL 192
Query: 150 RGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL-----IAGEANISYICSR 204
L+Y+H++ V + DLKP+N+++ Q+K+ D G+ ++ + G
Sbjct: 193 PALSYLHSIGLV-YNDLKPENIMLTE--EQLKLIDLGAVSRINSFGYLYGTPG------- 242
Query: 205 FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR-E 263
++APE++ T + DI++ G LA L L P G VD L E VL T
Sbjct: 243 -FQAPEIVRTGP--TVATDIYTVGRTLAALTLDLPTRNGR-YVDGLPEDDPVLKTYDSYG 298
Query: 264 EI--RCMNPNYTDFRFP 278
+ R ++P+ RF
Sbjct: 299 RLLRRAIDPDPRQ-RFT 314
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 3e-29
Identities = 57/232 (24%), Positives = 111/232 (47%), Gaps = 35/232 (15%)
Query: 44 RVVGTGSFGIVFQAKCL---ETGETVAIKKVLQDRRYKNRELQ---------LMRVMDHP 91
+V+GTG++G VF + + +TG+ A+K + + + + L + P
Sbjct: 60 KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 119
Query: 92 NVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIF 149
+++L + F T +K L+L+++Y+ E + + +R V++Y +I
Sbjct: 120 FLVTLHYAF-QTETK----LHLILDYINGGELFTHLSQR-----ERFTEHEVQIYVGEIV 169
Query: 150 RGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF---- 205
L ++H + + +RD+K +N+L+D H V + DFG +K+ +A E F
Sbjct: 170 LALEHLHKL-GIIYRDIKLENILLDSNGH-VVLTDFGLSKEFVADETER---AYDFCGTI 224
Query: 206 -YRAPELIFGATE-YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 255
Y AP+++ G + ++D WS G ++ ELL G F + + EI +
Sbjct: 225 EYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISR 276
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 3e-29
Identities = 50/213 (23%), Positives = 105/213 (49%), Gaps = 26/213 (12%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVL----QDRRYKNRELQLMRVMDHPNVIS 95
+ +G G+FG V++AK ETG A K + ++ E++++ DHP ++
Sbjct: 21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80
Query: 96 LKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 154
L ++ +L+ +++E+ P ++ ++ ++ + +++ Q+ L +
Sbjct: 81 LLGAYY---HDGKLW--IMIEFCPGGAVDAIMLE---LDRGLTEPQIQVVCRQMLEALNF 132
Query: 155 IHTVPRVCHRDLKPQNLLVDPLTH--QVKICDFGSAKQLIA--GEANISYICSRFYRAPE 210
+H+ R+ HRDLK N+L +T +++ DFG + + + + + S+I + ++ APE
Sbjct: 133 LHSK-RIIHRDLKAGNVL---MTLEGDIRLADFGVSAKNLKTLQKRD-SFIGTPYWMAPE 187
Query: 211 LIFGAT----EYTTSIDIWSAGCVLAELLLGQP 239
++ T Y DIWS G L E+ +P
Sbjct: 188 VVMCETMKDTPYDYKADIWSLGITLIEMAQIEP 220
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 8e-29
Identities = 66/253 (26%), Positives = 110/253 (43%), Gaps = 37/253 (14%)
Query: 43 ERVVGTGSFGIVFQAKCLETGETVAIKKV-LQDRRYKNRELQLMRV--MDHPNVISLKHC 99
++G G +G V++ VA+K +R+ E + RV M+H N+
Sbjct: 18 LELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVG 75
Query: 100 FFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT- 157
T+ + LVMEY P S+ + L ++S + + + RGLAY+HT
Sbjct: 76 DERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRL-----AHSVTRGLAYLHTE 130
Query: 158 -------VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE---------ANISYI 201
P + HRDL +N+LV I DFG + +L A IS +
Sbjct: 131 LPRGDHYKPAISHRDLNSRNVLVKN-DGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEV 189
Query: 202 CSRFYRAPELIFGA------TEYTTSIDIWSAGCVLAELLLG-QPLFPGENAVD-QLVEI 253
+ Y APE++ GA +D+++ G + E+ + LFPGE+ + Q+
Sbjct: 190 GTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQ 249
Query: 254 IKVLGTPTREEIR 266
+V PT E+++
Sbjct: 250 TEVGNHPTFEDMQ 262
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 1e-28
Identities = 67/240 (27%), Positives = 110/240 (45%), Gaps = 37/240 (15%)
Query: 21 HIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------ 74
H+I I + Y +G G V+ A+ VAIK +
Sbjct: 3 HMIGKIINER---------YKIVDKLGGGGMSTVYLAEDTILNIKVAIK-AIFIPPREKE 52
Query: 75 ---RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSS 131
+R++ RE+ + H N++S+ +++ + LVMEY+ L Y
Sbjct: 53 ETLKRFE-REVHNSSQLSHQNIVSM----IDVDEEDDCYY-LVMEYIEG---PTLSEYIE 103
Query: 132 ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 191
++ + + +T QI G+ + H + R+ HRD+KPQN+L+D +KI DFG AK
Sbjct: 104 SHGPLSVDTAINFTNQILDGIKHAHDM-RIVHRDIKPQNILIDS-NKTLKIFDFGIAK-- 159
Query: 192 IAGEANISY----ICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV 247
E +++ + + Y +PE G + DI+S G VL E+L+G+P F GE AV
Sbjct: 160 ALSETSLTQTNHVLGTVQYFSPEQAKGEATDECT-DIYSIGIVLYEMLVGEPPFNGETAV 218
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-28
Identities = 59/224 (26%), Positives = 98/224 (43%), Gaps = 28/224 (12%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD---------RRYKNRELQLMRVMDH 90
Y ++G G V A+ L VA+K VL+ R++ RE Q ++H
Sbjct: 14 YELGEILGFGGMSEVHLARDLRDHRDVAVK-VLRADLARDPSFYLRFR-REAQNAAALNH 71
Query: 91 PNVISLKHCFFSTTSKNELFLN---LVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQ 147
P ++++ + T +VMEYV L+ M
Sbjct: 72 PAIVAV----YDTGEAETPAGPLPYIVMEYVDG---VTLRDIVHTEGPMTPKRAIEVIAD 124
Query: 148 IFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISY----ICS 203
+ L + H + HRD+KP N+++ T+ VK+ DFG A+ + +++ I +
Sbjct: 125 ACQALNFSHQN-GIIHRDVKPANIMISA-TNAVKVMDFGIARAIADSGNSVTQTAAVIGT 182
Query: 204 RFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV 247
Y +PE G + S D++S GCVL E+L G+P F G++ V
Sbjct: 183 AQYLSPEQARGDSVDARS-DVYSLGCVLYEVLTGEPPFTGDSPV 225
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-26
Identities = 50/219 (22%), Positives = 83/219 (37%), Gaps = 26/219 (11%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVL-----QDRRYK---NRELQLMRVMDHP 91
Y R+VG G G V++A+ VA+K ++ D ++ RE + + P
Sbjct: 36 YRLRRLVGRGGMGDVYEAEDTVRERIVALK-LMSETLSSDPVFRTRMQREARTAGRLQEP 94
Query: 92 NVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 151
+V+ + + L + M + L + QI
Sbjct: 95 HVVPI----HDFGEIDGQ-LYVDMRLING---VDLAAMLRRQGPLAPPRAVAIVRQIGSA 146
Query: 152 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI----SYICSRFYR 207
L H HRD+KP+N+LV + DFG A + + + + + +Y
Sbjct: 147 LDAAHAA-GATHRDVKPENILVSA-DDFAYLVDFGIASAT--TDEKLTQLGNTVGTLYYM 202
Query: 208 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA 246
APE + T DI++ CVL E L G P + G+
Sbjct: 203 APERFSES-HATYRADIYALTCVLYECLTGSPPYQGDQL 240
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 7e-23
Identities = 64/210 (30%), Positives = 107/210 (50%), Gaps = 30/210 (14%)
Query: 43 ERVVGTGSFGIVFQAK----CLETGETVAIKKVLQDRRYKN-----RELQLMRVMDHPNV 93
+ +G G+FG V + TGE VA+KK LQ ++ RE+++++ + H N+
Sbjct: 15 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKK-LQHSTEEHLRDFEREIEILKSLQHDNI 73
Query: 94 ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQ-RMPLIYVKLYTYQIFRGL 152
+ K ++ L+MEY+P Y L+ Y ++ R+ I + YT QI +G+
Sbjct: 74 VKYKGV--CYSAGRRNLK-LIMEYLP---YGSLRDYLQKHKERIDHIKLLQYTSQICKGM 127
Query: 153 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR-------F 205
Y+ T R HRDL +N+LV+ ++VKI DFG K L + + + F
Sbjct: 128 EYLGTK-RYIHRDLATRNILVEN-ENRVKIGDFGLTKVL---PQDKEFFKVKEPGESPIF 182
Query: 206 YRAPELIFGATEYTTSIDIWSAGCVLAELL 235
+ APE + ++++ + D+WS G VL EL
Sbjct: 183 WYAPESLT-ESKFSVASDVWSFGVVLYELF 211
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 1e-22
Identities = 68/228 (29%), Positives = 98/228 (42%), Gaps = 30/228 (13%)
Query: 43 ERVVGTGSFGIVFQAK----CLETGETVAIKKVLQDRRYKN-----RELQLMRVMDHPNV 93
R +G G FG V TGE VA+K + D ++ +E+ ++R + H ++
Sbjct: 36 IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHI 95
Query: 94 ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 153
I K C L LVMEYVP L+ Y + + L + L+ QI G+A
Sbjct: 96 IKYKGC---CEDAGAASLQLVMEYVP---LGSLRDYLPRH-SIGLAQLLLFAQQICEGMA 148
Query: 154 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR-------FY 206
Y+H HRDL +N+L+D VKI DFG AK + Y R F+
Sbjct: 149 YLHAQ-HYIHRDLAARNVLLDN-DRLVKIGDFGLAKAV---PEGHEYYRVREDGDSPVFW 203
Query: 207 RAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEI 253
APE + + + D+WS G L ELL +L+ I
Sbjct: 204 YAPECLKEYK-FYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGI 250
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 2e-22
Identities = 64/209 (30%), Positives = 105/209 (50%), Gaps = 28/209 (13%)
Query: 43 ERVVGTGSFGIVFQAKCL----ETGETVAIKK----VLQDRRYKNRELQLMRVMDHPNVI 94
+ +G G+FG V + TGE VA+KK + R RE+++++ + H N++
Sbjct: 46 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 105
Query: 95 SLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQ-RMPLIYVKLYTYQIFRGLA 153
K ++ L+MEY+P Y L+ Y ++ R+ I + YT QI +G+
Sbjct: 106 KYKGV--CYSAGRRNLK-LIMEYLP---YGSLRDYLQKHKERIDHIKLLQYTSQICKGME 159
Query: 154 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR-------FY 206
Y+ T R HRDL +N+LV+ ++VKI DFG K L + Y + F+
Sbjct: 160 YLGTK-RYIHRDLATRNILVEN-ENRVKIGDFGLTKVL---PQDKEYYKVKEPGESPIFW 214
Query: 207 RAPELIFGATEYTTSIDIWSAGCVLAELL 235
APE + ++++ + D+WS G VL EL
Sbjct: 215 YAPESLT-ESKFSVASDVWSFGVVLYELF 242
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 2e-22
Identities = 62/210 (29%), Positives = 98/210 (46%), Gaps = 29/210 (13%)
Query: 43 ERVVGTGSFGIVFQAKCL----ETGETVAIKKVLQDRRYKN-----RELQLMRVMDHPNV 93
R +G G FG V + TGE VA+K + + + +E++++R + H N+
Sbjct: 26 IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 85
Query: 94 ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSAN-QRMPLIYVKLYTYQIFRGL 152
+ K T L+ME++P LK Y N ++ L Y QI +G+
Sbjct: 86 VKYKGI--CTEDGGNGIK-LIMEFLP---SGSLKEYLPKNKNKINLKQQLKYAVQICKGM 139
Query: 153 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR-------F 205
Y+ + + HRDL +N+LV+ HQVKI DFG K + E + Y + F
Sbjct: 140 DYLGSR-QYVHRDLAARNVLVES-EHQVKIGDFGLTKAI---ETDKEYYTVKDDRDSPVF 194
Query: 206 YRAPELIFGATEYTTSIDIWSAGCVLAELL 235
+ APE + + + + D+WS G L ELL
Sbjct: 195 WYAPECLMQSK-FYIASDVWSFGVTLHELL 223
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 4e-22
Identities = 50/228 (21%), Positives = 88/228 (38%), Gaps = 40/228 (17%)
Query: 43 ERVVGTGSFGIVFQAKCLETGE---TVAIKKVLQDRRYKN------RELQLMRVMDHPNV 93
R++G G FG V +A+ + VA+K + D + RE M+ DHP+V
Sbjct: 28 GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHV 87
Query: 94 ISLKH-CFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKL--YTYQIF 149
L S +++ ++ ++ L L L + I
Sbjct: 88 AKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIA 147
Query: 150 RGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYR-- 207
G+ Y+ + HRDL +N ++ V + DFG ++++ +G+ +YR
Sbjct: 148 CGMEYLSSR-NFIHRDLAARNCMLAE-DMTVCVADFGLSRKIYSGD---------YYRQG 196
Query: 208 ----------APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 243
A E L YT D+W+ G + E++ GQ + G
Sbjct: 197 CASKLPVKWLALESLADN--LYTVHSDVWAFGVTMWEIMTRGQTPYAG 242
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 5e-22
Identities = 61/210 (29%), Positives = 97/210 (46%), Gaps = 30/210 (14%)
Query: 43 ERVVGTGSFGIVFQAK----CLETGETVAIKKVLQDRRYKN-----RELQLMRVMDHPNV 93
+G G+FG V + TG VA+K LQ RE+Q+++ + +
Sbjct: 28 ISQLGKGNFGSVELCRYDPLGDNTGALVAVK-QLQHSGPDQQRDFQREIQILKALHSDFI 86
Query: 94 ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQ-RMPLIYVKLYTYQIFRGL 152
+ + + ++ L LVMEY+P L+ + ++ R+ + LY+ QI +G+
Sbjct: 87 VKYRGVSYGPGRQS---LRLVMEYLP---SGCLRDFLQRHRARLDASRLLLYSSQICKGM 140
Query: 153 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR-------F 205
Y+ + R HRDL +N+LV+ VKI DFG AK L + Y R F
Sbjct: 141 EYLGSR-RCVHRDLAARNILVES-EAHVKIADFGLAKLL---PLDKDYYVVREPGQSPIF 195
Query: 206 YRAPELIFGATEYTTSIDIWSAGCVLAELL 235
+ APE + ++ D+WS G VL EL
Sbjct: 196 WYAPESLS-DNIFSRQSDVWSFGVVLYELF 224
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 9e-22
Identities = 47/227 (20%), Positives = 87/227 (38%), Gaps = 39/227 (17%)
Query: 43 ERVVGTGSFGIVFQAKCLETGE---TVAIKKV------LQDRRYKNRELQLMRVMDHPNV 93
+++G G FG V + + VA+K + ++ E M+ HPNV
Sbjct: 39 GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98
Query: 94 ISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKL--YTYQIFR 150
I L +S+ +++ ++ ++ L + + L + I
Sbjct: 99 IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIAL 158
Query: 151 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYR--- 207
G+ Y+ HRDL +N ++ V + DFG +K++ +G+ +YR
Sbjct: 159 GMEYLSNR-NFLHRDLAARNCMLRD-DMTVCVADFGLSKKIYSGD---------YYRQGR 207
Query: 208 ---------APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 243
A E L YT+ D+W+ G + E+ G +PG
Sbjct: 208 IAKMPVKWIAIESLADRV--YTSKSDVWAFGVTMWEIATRGMTPYPG 252
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 6e-21
Identities = 60/227 (26%), Positives = 101/227 (44%), Gaps = 30/227 (13%)
Query: 43 ERVVGTGSFGIVFQAKCLETGE----TVAIK--KVLQDRRYKN---RELQLMRVMDHPNV 93
+V+G+G+FG V++ + GE VAIK + + E +M +D+P+V
Sbjct: 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79
Query: 94 ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQ-RMPLIYVKLYTYQIFRGL 152
L + + L+ + +P + L Y ++ + Y+ + QI +G+
Sbjct: 80 CRL----LGICLTSTVQ--LITQLMP---FGCLLDYVREHKDNIGSQYLLNWCVQIAKGM 130
Query: 153 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF---YRAP 209
Y+ R+ HRDL +N+LV VKI DFG AK L A E + + A
Sbjct: 131 NYLEDR-RLVHRDLAARNVLVKT-PQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 188
Query: 210 E-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVD--QLVE 252
E ++ YT D+WS G + EL+ G + G A + ++E
Sbjct: 189 ESILHR--IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 233
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 7e-20
Identities = 60/243 (24%), Positives = 102/243 (41%), Gaps = 38/243 (15%)
Query: 43 ERVVGTGSFGIVFQAKCL-----ETGETVAIKKV-----LQDRRYKNRELQLM-RVMDHP 91
+ +G G+FG V +A + TVA+K + L +R EL+++ + +H
Sbjct: 28 GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHM 87
Query: 92 NVISLKHCFFSTTSKNELFLNLVMEYV-------------PESMYRVLKHYSSANQRMPL 138
N+++L + L ++ EY + + + L
Sbjct: 88 NIVNLLGA----CTIGGPTL-VITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 139 IYVKLYT--YQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA 196
L + YQ+ +G+A++ + HRDL +N+L+ KICDFG A+ +
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASK-NCIHRDLAARNILLTH-GRITKICDFGLARDIKNDSN 200
Query: 197 NISYICSRF-YR--APELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVE 252
+ +R + APE IF YT D+WS G L EL LG +PG + +
Sbjct: 201 YVVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK 259
Query: 253 IIK 255
+IK
Sbjct: 260 MIK 262
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 8e-20
Identities = 50/210 (23%), Positives = 86/210 (40%), Gaps = 27/210 (12%)
Query: 43 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--RELQLMRVMDHPNVISLKHCF 100
+ +G G FG V G VA+K + D + E +M + H N++ L
Sbjct: 26 LQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQL---- 79
Query: 101 FSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKL--YTYQIFRGLAYIHTV 158
+ + L +V EY+ L Y + R L L ++ + + Y+
Sbjct: 80 LGVIVEEKGGLYIVTEYMA---KGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 136
Query: 159 PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF-YR--APE-LIFG 214
HRDL +N+LV + K+ DFG K+ + + + + APE L
Sbjct: 137 -NFVHRDLAARNVLVSE-DNVAKVSDFGLTKEASSTQDT-----GKLPVKWTAPEALREK 189
Query: 215 ATEYTTSIDIWSAGCVLAELL-LGQPLFPG 243
+++T D+WS G +L E+ G+ +P
Sbjct: 190 --KFSTKSDVWSFGILLWEIYSFGRVPYPR 217
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 88.3 bits (219), Expect = 8e-20
Identities = 52/210 (24%), Positives = 96/210 (45%), Gaps = 21/210 (10%)
Query: 43 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRVMDHPNVISLKHC 99
+ +G G +G V++ + TVA+K + +D +E +M+ + HPN++ L
Sbjct: 225 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQL--- 281
Query: 100 FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKL--YTYQIFRGLAYIHT 157
++ F ++ E++ Y L Y R + V L QI + Y+
Sbjct: 282 -LGVCTREPPFY-IITEFMT---YGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 336
Query: 158 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF---YRAPELIFG 214
HR+L +N LV H VK+ DFG + +L+ G+ ++ ++F + APE +
Sbjct: 337 K-NFIHRNLAARNCLVGE-NHLVKVADFGLS-RLMTGDTYTAHAGAKFPIKWTAPESLAY 393
Query: 215 ATEYTTSIDIWSAGCVLAELL-LGQPLFPG 243
++ D+W+ G +L E+ G +PG
Sbjct: 394 NK-FSIKSDVWAFGVLLWEIATYGMSPYPG 422
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 1e-19
Identities = 63/233 (27%), Positives = 108/233 (46%), Gaps = 41/233 (17%)
Query: 34 PKQTISYMAERVVGTGSFGIVFQAKCLETGE---TVAIK--KVLQDRRYKN---RELQLM 85
P + + ++RV+G G FG+V+ + ++ + AIK + + + RE LM
Sbjct: 17 PHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLM 76
Query: 86 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMP----LIYV 141
R ++HPNV++L E ++++ Y+ + L + + QR P LI
Sbjct: 77 RGLNHPNVLAL----IGIMLPPEGLPHVLLPYMC---HGDLLQFIRSPQRNPTVKDLIS- 128
Query: 142 KLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYI 201
+ Q+ RG+ Y+ + HRDL +N ++D + VK+ DFG A+ ++ E Y
Sbjct: 129 --FGLQVARGMEYLAEQ-KFVHRDLAARNCMLDE-SFTVKVADFGLARDILDRE----YY 180
Query: 202 CSRFYR---------APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 243
+ +R A E L +TT D+WS G +L ELL G P +
Sbjct: 181 SVQQHRHARLPVKWTALESLQTYR--FTTKSDVWSFGVLLWELLTRGAPPYRH 231
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 1e-19
Identities = 53/226 (23%), Positives = 96/226 (42%), Gaps = 28/226 (12%)
Query: 43 ERVVGTGSFGIVFQAKCLETGE----TVAIK--KVLQDRRYKN---RELQLMRVMDHPNV 93
+V+G+G FG V + + GE V IK + R+ + + +DH ++
Sbjct: 18 LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHI 77
Query: 94 ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQ-RMPLIYVKLYTYQIFRGL 152
+ L + L LV +Y+P L + ++ + + + QI +G+
Sbjct: 78 VRL----LGLCPGSSLQ--LVTQYLP---LGSLLDHVRQHRGALGPQLLLNWGVQIAKGM 128
Query: 153 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF---YRAP 209
Y+ + HR+L +N+L+ QV++ DFG A L + + Y ++ + A
Sbjct: 129 YYLEEH-GMVHRNLAARNVLLKS-PSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMAL 186
Query: 210 ELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVD--QLVE 252
E I YT D+WS G + EL+ G + G + L+E
Sbjct: 187 ESIHFGK-YTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLE 231
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 3e-19
Identities = 64/226 (28%), Positives = 103/226 (45%), Gaps = 28/226 (12%)
Query: 43 ERVVGTGSFGIVFQAKCLETGE----TVAIKKVLQDRRYKN-----RELQLMRVMDHPNV 93
+V+G+G+FG V++ + GE VAIK++ + K E +M +D+P+V
Sbjct: 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79
Query: 94 ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQ-RMPLIYVKLYTYQIFRGL 152
L TS + L+ + +P + L Y ++ + Y+ + QI +G+
Sbjct: 80 CRLLGI--CLTST----VQLITQLMP---FGCLLDYVREHKDNIGSQYLLNWCVQIAKGM 130
Query: 153 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF---YRAP 209
Y+ R+ HRDL +N+LV VKI DFG AK L A E + + A
Sbjct: 131 NYLEDR-RLVHRDLAARNVLVKT-PQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 188
Query: 210 ELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVD--QLVE 252
E I YT D+WS G + EL+ G + G A + ++E
Sbjct: 189 ESILHRI-YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 233
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 5e-19
Identities = 54/211 (25%), Positives = 98/211 (46%), Gaps = 23/211 (10%)
Query: 43 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRVMDHPNVISLKHC 99
+ +G G +G V++ + TVA+K + +D +E +M+ + HPN++ L
Sbjct: 18 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQL--- 74
Query: 100 FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKL--YTYQIFRGLAYIHT 157
++ F ++ E++ Y L Y R + V L QI + Y+
Sbjct: 75 -LGVCTREPPFY-IITEFMT---YGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 129
Query: 158 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF---YRAPE-LIF 213
HRDL +N LV H VK+ DFG ++ L+ G+ ++ ++F + APE L +
Sbjct: 130 K-NFIHRDLAARNCLVGE-NHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAY 186
Query: 214 GATEYTTSIDIWSAGCVLAELL-LGQPLFPG 243
+++ D+W+ G +L E+ G +PG
Sbjct: 187 N--KFSIKSDVWAFGVLLWEIATYGMSPYPG 215
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 86.1 bits (213), Expect = 6e-19
Identities = 57/210 (27%), Positives = 91/210 (43%), Gaps = 23/210 (10%)
Query: 43 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRVMDHPNVISLKHC 99
E +G G FG V+ T VAIK + +E Q+M+ + H ++ L
Sbjct: 272 EVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL--- 327
Query: 100 FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKL--YTYQIFRGLAYIHT 157
++ S+ ++ +V EY+ L + L +L QI G+AY+
Sbjct: 328 -YAVVSEEPIY--IVTEYMS---KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 381
Query: 158 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF---YRAPELIFG 214
+ HRDL+ N+LV K+ DFG A+ LI + ++F + APE
Sbjct: 382 M-NYVHRDLRAANILVGE-NLVCKVADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALY 438
Query: 215 ATEYTTSIDIWSAGCVLAELL-LGQPLFPG 243
+T D+WS G +L EL G+ +PG
Sbjct: 439 GR-FTIKSDVWSFGILLTELTTKGRVPYPG 467
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 85.6 bits (212), Expect = 6e-19
Identities = 57/210 (27%), Positives = 91/210 (43%), Gaps = 23/210 (10%)
Query: 43 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRVMDHPNVISLKHC 99
E +G G FG V+ T VAIK + +E Q+M+ + H ++ L
Sbjct: 189 EVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL--- 244
Query: 100 FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKL--YTYQIFRGLAYIHT 157
++ S+ ++ +V EY+ L + L +L QI G+AY+
Sbjct: 245 -YAVVSEEPIY--IVTEYMS---KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 298
Query: 158 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF---YRAPELIFG 214
+ HRDL+ N+LV K+ DFG A+ LI + ++F + APE
Sbjct: 299 M-NYVHRDLRAANILVGE-NLVCKVADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALY 355
Query: 215 ATEYTTSIDIWSAGCVLAELL-LGQPLFPG 243
+T D+WS G +L EL G+ +PG
Sbjct: 356 GR-FTIKSDVWSFGILLTELTTKGRVPYPG 384
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 6e-19
Identities = 34/262 (12%), Positives = 52/262 (19%), Gaps = 60/262 (22%)
Query: 7 MSAAVVDGSDHVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETV 66
S+A D V G G+ Y G +QA V
Sbjct: 12 ESSAPPDDVQLVPGA---RIANGR---------YRLLIFHGGVPPLQFWQALDTALDRQV 59
Query: 67 AIKKVL----QDRRYKNR---ELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP 119
A+ V + +D P V + L +V E++
Sbjct: 60 ALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARV----LDVVHTRAGGL-VVAEWIR 114
Query: 120 -ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH 178
S+ V + + H V P + V
Sbjct: 115 GGSLQEVAD------TSPSPVGAIRAMQSLAAAADAAHRAG-VALSIDHPSRVRVSI-DG 166
Query: 179 QVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQ 238
V + DI G L LL+ +
Sbjct: 167 DVVLAYPA-------------------TMPDA--------NPQDDIRGIGASLYALLVNR 199
Query: 239 PLFPGENAVDQLVEIIKVLGTP 260
P L +
Sbjct: 200 WPLPEAGVRSGLAPAERDTAGQ 221
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 6e-19
Identities = 50/210 (23%), Positives = 86/210 (40%), Gaps = 27/210 (12%)
Query: 43 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--RELQLMRVMDHPNVISLKHCF 100
+ +G G FG V G VA+K + D + E +M + H N++ L
Sbjct: 198 LQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQL---- 251
Query: 101 FSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKL--YTYQIFRGLAYIHTV 158
+ + L +V EY+ L Y + R L L ++ + + Y+
Sbjct: 252 LGVIVEEKGGLYIVTEYMA---KGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 308
Query: 159 PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF-YR--APE-LIFG 214
HRDL +N+LV + K+ DFG K+ + + + + APE L
Sbjct: 309 -NFVHRDLAARNVLVSE-DNVAKVSDFGLTKEASSTQDT-----GKLPVKWTAPEALREK 361
Query: 215 ATEYTTSIDIWSAGCVLAELL-LGQPLFPG 243
+++T D+WS G +L E+ G+ +P
Sbjct: 362 --KFSTKSDVWSFGILLWEIYSFGRVPYPR 389
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 9e-19
Identities = 50/220 (22%), Positives = 92/220 (41%), Gaps = 33/220 (15%)
Query: 41 MAERVVGTGSFGIVFQAKCLETGET--VAIKKVLQDRRYKN------RELQLMRVMDHPN 92
+ ++ +G+G+FG V + VA+K + + E +M+ +D+P
Sbjct: 20 LEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPY 79
Query: 93 VISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 152
++ + LVME L Y N+ + + +Q+ G+
Sbjct: 80 IVRM----IGICEAESWM--LVMEMAE---LGPLNKYLQQNRHVKDKNIIELVHQVSMGM 130
Query: 153 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYR----- 207
Y+ HRDL +N+L+ H KI DFG +K L A E +Y ++ +
Sbjct: 131 KYLEES-NFVHRDLAARNVLLVT-QHYAKISDFGLSKALRADE---NYYKAQTHGKWPVK 185
Query: 208 --APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 243
APE + + ++++ D+WS G ++ E GQ + G
Sbjct: 186 WYAPECINYY--KFSSKSDVWSFGVLMWEAFSYGQKPYRG 223
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 1e-18
Identities = 54/226 (23%), Positives = 94/226 (41%), Gaps = 45/226 (19%)
Query: 43 ERVVGTGSFGIVFQAKCLETGE---TVAIKKV-----LQDRRYKNRELQLMRVMDHPNVI 94
V+G G FG V+ L+ A+K + + + E +M+ HPNV+
Sbjct: 30 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 89
Query: 95 SLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKL-YTYQIFRGLA 153
SL S+ +V+ Y+ + L+++ P + + + Q+ +G+
Sbjct: 90 SLLGI--CLRSEGSPL--VVLPYMK---HGDLRNFIRNETHNPTVKDLIGFGLQVAKGMK 142
Query: 154 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYR------ 207
Y+ + + HRDL +N ++D VK+ DFG A+ + E +Y
Sbjct: 143 YLASK-KFVHRDLAARNCMLDE-KFTVKVADFGLARDMYDKE---------YYSVHNKTG 191
Query: 208 --------APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 243
A E L ++TT D+WS G +L EL+ G P +P
Sbjct: 192 AKLPVKWMALESLQTQ--KFTTKSDVWSFGVLLWELMTRGAPPYPD 235
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 2e-18
Identities = 51/212 (24%), Positives = 90/212 (42%), Gaps = 23/212 (10%)
Query: 43 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR-----ELQLMRVMDHPNVISLK 97
+G G+FG VF + VA+K + + E ++++ HPN++ L
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRL- 177
Query: 98 HCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 156
++ + +VME V L+ + R+ + + G+ Y+
Sbjct: 178 ---IGVCTQKQPIY-IVMELVQGGDFLTFLR---TEGARLRVKTLLQMVGDAAAGMEYLE 230
Query: 157 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF-YR--APE-LI 212
+ + HRDL +N LV + +KI DFG +++ G S + + APE L
Sbjct: 231 SKCCI-HRDLAARNCLVTE-KNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALN 288
Query: 213 FGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 243
+G Y++ D+WS G +L E LG +P
Sbjct: 289 YG--RYSSESDVWSFGILLWETFSLGASPYPN 318
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 3e-18
Identities = 59/243 (24%), Positives = 103/243 (42%), Gaps = 50/243 (20%)
Query: 44 RVVGTGSFGIVFQAKCLETGE-----TVAIKKV-----LQDRRYKNRELQLMRVMDHPNV 93
R +G GSFG+V++ + VAIK V +++R E +M+ + +V
Sbjct: 31 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 90
Query: 94 ISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLK----HYSSANQRMPLIYVKL--YTY 146
+ L S+ + L ++ME + + L+ ++ P K+
Sbjct: 91 VRLLGV----VSQGQPTL-VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAG 145
Query: 147 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFY 206
+I G+AY++ V HRDL +N +V VKI DFG + + + +Y
Sbjct: 146 EIADGMAYLNANKFV-HRDLAARNCMVAE-DFTVKIGDFGMTRDIYETD---------YY 194
Query: 207 R------------APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVE 252
R +PE L G +TT D+WS G VL E+ L + + G + +Q++
Sbjct: 195 RKGGKGLLPVRWMSPESLKDG--VFTTYSDVWSFGVVLWEIATLAEQPYQGLS-NEQVLR 251
Query: 253 IIK 255
+
Sbjct: 252 FVM 254
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 3e-18
Identities = 59/249 (23%), Positives = 103/249 (41%), Gaps = 53/249 (21%)
Query: 44 RVVGTGSFGIVFQAKCL-----ETGETVAIKKV-----LQDRRYKNRELQLMRVMD-HPN 92
+ +G G+FG V +A T TVA+K + + R EL+++ + H N
Sbjct: 33 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92
Query: 93 VISLKHCFFSTTSKNELFLNLVMEYV-------------PESMYRVLKHYSSANQRMPLI 139
V++L T L +++E+ E + + + L
Sbjct: 93 VVNLLGA--CTKPGGPLM--VIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLE 148
Query: 140 YVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS 199
++ Y++Q+ +G+ ++ + + HRDL +N+L+ + VKICDFG A+ +
Sbjct: 149 HLICYSFQVAKGMEFLAS-RKCIHRDLAARNILLSE-KNVVKICDFGLARDIY----KDP 202
Query: 200 YICSRFYR------------APELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENA 246
Y APE IF YT D+WS G +L E+ LG +PG
Sbjct: 203 D-----YVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKI 256
Query: 247 VDQLVEIIK 255
++ +K
Sbjct: 257 DEEFCRRLK 265
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 6e-18
Identities = 54/224 (24%), Positives = 93/224 (41%), Gaps = 41/224 (18%)
Query: 43 ERVVGTGSFGIVFQAKCLETGE---TVAIKKV-----LQDRRYKNRELQLMRVMDHPNVI 94
V+G G FG V+ L+ A+K + + + E +M+ HPNV+
Sbjct: 94 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 153
Query: 95 SLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMP----LIYVKLYTYQIFR 150
SL S+ +V+ Y+ + L+++ P LI + Q+ +
Sbjct: 154 SLLGI--CLRSEGSPL--VVLPYMK---HGDLRNFIRNETHNPTVKDLIG---FGLQVAK 203
Query: 151 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYR--- 207
G+ ++ + + HRDL +N ++D VK+ DFG A+ + E +
Sbjct: 204 GMKFLASK-KFVHRDLAARNCMLDE-KFTVKVADFGLARDMYDKE----FDSVHNKTGAK 257
Query: 208 ------APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 243
A E L ++TT D+WS G +L EL+ G P +P
Sbjct: 258 LPVKWMALESLQTQ--KFTTKSDVWSFGVLLWELMTRGAPPYPD 299
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 7e-18
Identities = 54/211 (25%), Positives = 98/211 (46%), Gaps = 25/211 (11%)
Query: 43 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRVMDHPNVISLKHC 99
E+ +G G FG V+ A + VA+K + E +M+ + H ++ L
Sbjct: 193 EKKLGAGQFGEVWMATYNKHT-KVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKL--- 248
Query: 100 FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKL--YTYQIFRGLAYIHT 157
+ +K ++ ++ E++ L + +++ KL ++ QI G+A+I
Sbjct: 249 -HAVVTKEPIY--IITEFMA---KGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ 302
Query: 158 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF---YRAPE-LIF 213
HRDL+ N+LV + KI DFG A ++I + ++F + APE + F
Sbjct: 303 R-NYIHRDLRAANILVSA-SLVCKIADFGLA-RVIEDNEYTAREGAKFPIKWTAPEAINF 359
Query: 214 GATEYTTSIDIWSAGCVLAELL-LGQPLFPG 243
G +T D+WS G +L E++ G+ +PG
Sbjct: 360 G--SFTIKSDVWSFGILLMEIVTYGRIPYPG 388
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 1e-17
Identities = 58/249 (23%), Positives = 101/249 (40%), Gaps = 54/249 (21%)
Query: 43 ERVVGTGSFGIVFQAKCLETGE-----TVAIKKV-----LQDRRYKNRELQLM-RVMDHP 91
+ +G G+FG V +A G+ VA+K + ++ EL++M + H
Sbjct: 51 GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHE 110
Query: 92 NVISLKHCFFSTTSKNELFLNLVMEYVP---------ESMYRVLKHYSSANQRMPLIYVK 142
N+++L + L ++ EY + + A
Sbjct: 111 NIVNLLGA----CTHGGPVL-VITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRD 165
Query: 143 L--YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISY 200
L ++ Q+ +G+A++ + HRD+ +N+L+ H KI DFG A+ ++ N S
Sbjct: 166 LLHFSSQVAQGMAFLASK-NCIHRDVAARNVLLTN-GHVAKIGDFGLARDIM----NDSN 219
Query: 201 ICSRFYR------------APELIFGATEYTTSIDIWSAGCVLAELL-LG-QPLFPGENA 246
Y APE IF YT D+WS G +L E+ LG P +PG
Sbjct: 220 -----YIVKGNARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGLNP-YPGILV 272
Query: 247 VDQLVEIIK 255
+ +++K
Sbjct: 273 NSKFYKLVK 281
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 1e-17
Identities = 62/258 (24%), Positives = 100/258 (38%), Gaps = 63/258 (24%)
Query: 43 ERVVGTGSFGIVFQAKCL-----ETGETVAIKKV-----LQDRRYKNRELQLM-RVMDHP 91
+V+G+G+FG V A VA+K + +R EL++M ++ H
Sbjct: 50 GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHE 109
Query: 92 NVISLKHCFFSTTSKNELFLNLVMEYVP------------------ESMYRVLKHYSSAN 133
N+++L T ++ L+ EY E Y K
Sbjct: 110 NIVNLLGA---CTLSGPIY--LIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 164
Query: 134 QRMPLIYVKL--YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 191
L + L + YQ+ +G+ ++ HRDL +N+LV VKICDFG A+ +
Sbjct: 165 DLNVLTFEDLLCFAYQVAKGMEFLEFK-SCVHRDLAARNVLVTH-GKVVKICDFGLARDI 222
Query: 192 IAGEANISYICSRFYR------------APELIFGATEYTTSIDIWSAGCVLAEL--LLG 237
++ Y APE +F YT D+WS G +L E+ L
Sbjct: 223 MSDSN---------YVVRGNARLPVKWMAPESLFEGI-YTIKSDVWSYGILLWEIFSLGV 272
Query: 238 QPLFPGENAVDQLVEIIK 255
P +PG ++I+
Sbjct: 273 NP-YPGIPVDANFYKLIQ 289
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 1e-17
Identities = 56/211 (26%), Positives = 94/211 (44%), Gaps = 25/211 (11%)
Query: 43 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRVMDHPNVISLKHC 99
+G G FG V+ VA+K + Q + E LM+ + H ++ L
Sbjct: 18 VERLGAGQFGEVWMGYYNGHT-KVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRL--- 73
Query: 100 FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKL--YTYQIFRGLAYIHT 157
++ ++ ++ ++ EY+ L + + L KL QI G+A+I
Sbjct: 74 -YAVVTQEPIY--IITEYMENG---SLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE 127
Query: 158 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF-YR--APE-LIF 213
HRDL+ N+LV T KI DFG A +LI + ++F + APE + +
Sbjct: 128 R-NYIHRDLRAANILVSD-TLSCKIADFGLA-RLIEDNEYTAREGAKFPIKWTAPEAINY 184
Query: 214 GATEYTTSIDIWSAGCVLAELL-LGQPLFPG 243
G +T D+WS G +L E++ G+ +PG
Sbjct: 185 G--TFTIKSDVWSFGILLTEIVTHGRIPYPG 213
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 80.8 bits (199), Expect = 4e-17
Identities = 58/220 (26%), Positives = 95/220 (43%), Gaps = 33/220 (15%)
Query: 41 MAERVVGTGSFGIVFQAKCLETGET--VAIKKVLQDRRYKNR-----ELQLMRVMDHPNV 93
+A+ +G G+FG V Q + VAIK + Q + E Q+M +D+P +
Sbjct: 339 IADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYI 398
Query: 94 ISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 152
+ L L LVME +++ L + +P+ V +Q+ G+
Sbjct: 399 VRL----IGVCQAEALM--LVMEMAGGGPLHKFLV---GKREEIPVSNVAELLHQVSMGM 449
Query: 153 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYR----- 207
Y+ HR+L +N+L+ H KI DFG +K L A + SY +R
Sbjct: 450 KYLEEK-NFVHRNLAARNVLLVN-RHYAKISDFGLSKALGADD---SYYTARSAGKWPLK 504
Query: 208 --APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 243
APE + F ++++ D+WS G + E L GQ +
Sbjct: 505 WYAPECINFR--KFSSRSDVWSYGVTMWEALSYGQKPYKK 542
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 4e-17
Identities = 60/258 (23%), Positives = 100/258 (38%), Gaps = 64/258 (24%)
Query: 43 ERVVGTGSFGIVFQAKCL-----ETGETVAIKKV-----LQDRRYKNRELQLMRVMDHPN 92
+ +G G FG V +A TVA+K + + R E +++ ++HP+
Sbjct: 28 GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPH 87
Query: 93 VISLKHCFFSTTSKNELFLNLVMEYVP-------------------ESMYRVLKHYSSAN 133
VI L + L L++EY S
Sbjct: 88 VIKLYGA---CSQDGPLL--LIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142
Query: 134 QRMPLIYVKL--YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 191
L L + +QI +G+ Y+ + ++ HRDL +N+LV ++KI DFG ++ +
Sbjct: 143 DERALTMGDLISFAWQISQGMQYLAEM-KLVHRDLAARNILVAE-GRKMKISDFGLSRDV 200
Query: 192 IAGEANISYICSRFYR------------APELIFGATEYTTSIDIWSAGCVLAELL-LG- 237
Y A E +F YTT D+WS G +L E++ LG
Sbjct: 201 Y----EEDS-----YVKRSQGRIPVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIVTLGG 250
Query: 238 QPLFPGENAVDQLVEIIK 255
P +PG ++L ++K
Sbjct: 251 NP-YPGIP-PERLFNLLK 266
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 6e-17
Identities = 55/217 (25%), Positives = 100/217 (46%), Gaps = 29/217 (13%)
Query: 43 ERVVGTGSFGIVFQAKCLETGE---TVAIKKVLQDRRYKNR-----ELQLMRVMDHPNVI 94
E+++G+G G V + G+ VAIK + + R E +M DHPN+I
Sbjct: 54 EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113
Query: 95 SLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 153
L ++ L + +V EY+ S+ L+ + M L+ + G+
Sbjct: 114 RL----EGVVTRGRLAM-IVTEYMENGSLDTFLRTHDGQFTIMQLVG---MLRGVGAGMR 165
Query: 154 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICS--RF-YR--A 208
Y+ + HRDL +N+LVD K+ DFG ++ ++ + + +Y + + R A
Sbjct: 166 YLSDL-GYVHRDLAARNVLVDS-NLVCKVSDFGLSR-VLEDDPDAAYTTTGGKIPIRWTA 222
Query: 209 PE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 243
PE + F ++++ D+WS G V+ E+L G+ +
Sbjct: 223 PEAIAFR--TFSSASDVWSFGVVMWEVLAYGERPYWN 257
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 6e-17
Identities = 58/259 (22%), Positives = 103/259 (39%), Gaps = 59/259 (22%)
Query: 34 PKQTISYMAERVVGTGSFGIVFQAKCLETGE-----TVAIKKV----LQDRRYKNRELQL 84
++ I R +G G+FG VF A+C VA+K + L R+ RE +L
Sbjct: 13 KRRDIVLK--RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAEL 70
Query: 85 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-----------ESMYRVLKHYSSAN 133
+ + H +++ + + +V EY+ +L
Sbjct: 71 LTNLQHEHIVKFYGV----CGDGDPLI-MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQ 125
Query: 134 QRMPLIYVKLY--TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 191
+ L ++ QI G+ Y+ + HRDL +N LV VKI DFG ++ +
Sbjct: 126 AKGELGLSQMLHIASQIASGMVYLASQ-HFVHRDLATRNCLVGA-NLLVKIGDFGMSRDV 183
Query: 192 IAGEANISYICSRFYR------------APE-LIFGATEYTTSIDIWSAGCVLAELL-LG 237
+ + +YR PE +++ ++TT D+WS G +L E+ G
Sbjct: 184 YSTD---------YYRVGGHTMLPIRWMPPESIMYR--KFTTESDVWSFGVILWEIFTYG 232
Query: 238 -QPLFPGENAVDQLVEIIK 255
QP + + +++E I
Sbjct: 233 KQP-WFQLS-NTEVIECIT 249
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 6e-17
Identities = 54/218 (24%), Positives = 99/218 (45%), Gaps = 31/218 (14%)
Query: 43 ERVVGTGSFGIVFQAKCLETGE---TVAIKKVLQDRRYKNR-----ELQLMRVMDHPNVI 94
++VVG G FG V + + +VAIK + K R E +M DHPN+I
Sbjct: 50 DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 95 SLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 153
L +K++ + +V EY+ S+ L+ + + + L+ I G+
Sbjct: 110 RL----EGVVTKSKPVM-IVTEYMENGSLDSFLRKHDAQFTVIQLVG---MLRGIASGMK 161
Query: 154 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYR------ 207
Y+ + HRDL +N+L++ K+ DFG + L + + +R +
Sbjct: 162 YLSDM-GYVHRDLAARNILINS-NLVCKVSDFGLGRVL--EDDPEAAYTTRGGKIPIRWT 217
Query: 208 APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 243
+PE + + ++T++ D+WS G VL E++ G+ +
Sbjct: 218 SPEAIAYR--KFTSASDVWSYGIVLWEVMSYGERPYWE 253
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 8e-17
Identities = 59/220 (26%), Positives = 93/220 (42%), Gaps = 33/220 (15%)
Query: 41 MAERVVGTGSFGIVFQAKCLETGET--VAIKKVLQDRRYKNR-----ELQLMRVMDHPNV 93
+A+ +G G+FG V Q + VAIK + Q + E Q+M +D+P +
Sbjct: 13 IADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYI 72
Query: 94 ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHY-SSANQRMPLIYVKLYTYQIFRGL 152
+ L L LVME L + + +P+ V +Q+ G+
Sbjct: 73 VRL----IGVCQAEALM--LVMEMAG---GGPLHKFLVGKREEIPVSNVAELLHQVSMGM 123
Query: 153 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYR----- 207
Y+ HRDL +N+L+ H KI DFG +K L A + SY +R
Sbjct: 124 KYLEEK-NFVHRDLAARNVLLVN-RHYAKISDFGLSKALGADD---SYYTARSAGKWPLK 178
Query: 208 --APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 243
APE + F ++++ D+WS G + E L GQ +
Sbjct: 179 WYAPECINFR--KFSSRSDVWSYGVTMWEALSYGQKPYKK 216
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 1e-16
Identities = 57/249 (22%), Positives = 99/249 (39%), Gaps = 56/249 (22%)
Query: 43 ERVVGTGSFGIVFQAKCLETGE-----TVAIKKV----LQDRRYKNRELQLMRVMDHPNV 93
+ +G G+FG VF A+C VA+K + R+ RE +L+ ++ H ++
Sbjct: 46 KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHI 105
Query: 94 ISLKHCFFSTTSKNELFLNLVMEYVP----------ESMYRVLKHYSSANQRMPLIYVKL 143
+ ++ L +V EY+ L PL +L
Sbjct: 106 VRFFGV----CTEGRPLL-MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQL 160
Query: 144 --YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYI 201
Q+ G+ Y+ + HRDL +N LV VKI DFG ++ + + +
Sbjct: 161 LAVASQVAAGMVYLAGL-HFVHRDLATRNCLVGQ-GLVVKIGDFGMSRDIYSTD------ 212
Query: 202 CSRFYR------------APE-LIFGATEYTTSIDIWSAGCVLAELL-LG-QPLFPGENA 246
+YR PE +++ ++TT D+WS G VL E+ G QP + +
Sbjct: 213 ---YYRVGGRTMLPIRWMPPESILYR--KFTTESDVWSFGVVLWEIFTYGKQP-WYQLS- 265
Query: 247 VDQLVEIIK 255
+ ++ I
Sbjct: 266 NTEAIDCIT 274
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 1e-16
Identities = 47/210 (22%), Positives = 88/210 (41%), Gaps = 23/210 (10%)
Query: 43 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRVMDHPNVISLKHC 99
+ +G+G FG+V L + VAIK + + + E ++M + HP ++ L
Sbjct: 13 VQEIGSGQFGLVHLGYWLNKDK-VAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQL--- 68
Query: 100 FFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV 158
+ + LV E++ + L+ L+ + G+AY+
Sbjct: 69 -YGVCLEQAPIC-LVTEFMEHGCLSDYLRTQRGLFAAETLLG---MCLDVCEGMAYLEEA 123
Query: 159 PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF---YRAPE-LIFG 214
V HRDL +N LV +K+ DFG + + + S ++F + +PE F
Sbjct: 124 -CVIHRDLAARNCLVGE-NQVIKVSDFGMTR-FVLDDQYTSSTGTKFPVKWASPEVFSFS 180
Query: 215 ATEYTTSIDIWSAGCVLAELL-LGQPLFPG 243
Y++ D+WS G ++ E+ G+ +
Sbjct: 181 --RYSSKSDVWSFGVLMWEVFSEGKIPYEN 208
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 77.6 bits (192), Expect = 2e-16
Identities = 59/222 (26%), Positives = 95/222 (42%), Gaps = 51/222 (22%)
Query: 43 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ-----LMRVMDHPNVISL- 96
+ ++G G FG V++ L G VA+K+ + E + L HP+++SL
Sbjct: 44 KFLIGHGVFGKVYKGV-LRDGAKVALKRRTPESSQGIEEFETEIETLSFC-RHPHLVSLI 101
Query: 97 KHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPL-------IYVKLYTYQI 148
C +NE+ L + +Y+ ++ R L Y S M + I +
Sbjct: 102 GFC----DERNEMIL--IYKYMENGNLKRHL--YGSDLPTMSMSWEQRLEICI-----GA 148
Query: 149 FRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF--- 205
RGL Y+HT + HRD+K N+L+D KI DFG +K E + +++ +
Sbjct: 149 ARGLHYLHT-RAIIHRDVKSINILLDE-NFVPKITDFGISK--KGTELDQTHLSTVVKGT 204
Query: 206 --YRAPELIFGATEY------TTSIDIWSAGCVLAELLLGQP 239
Y P EY T D++S G VL E+L +
Sbjct: 205 LGYIDP-------EYFIKGRLTEKSDVYSFGVVLFEVLCARS 239
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 2e-16
Identities = 48/231 (20%), Positives = 85/231 (36%), Gaps = 47/231 (20%)
Query: 43 ERVVGTGSFGIVFQAKCL-----ETGETVAIKKV-----LQDRRYKNRELQLMRVMDHPN 92
R +G G+FG V++ + + VA+K + QD E ++ +H N
Sbjct: 76 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 135
Query: 93 VISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVL-KHYSSANQRMPLIYVKL--YTYQI 148
++ + ++ +++E + + L + +Q L + L I
Sbjct: 136 IVRCIGV----SLQSLPRF-ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 190
Query: 149 FRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQ--VKICDFGSAKQLIAGEANISYICSRFY 206
G Y+ HRD+ +N L+ KI DFG A+ + +Y
Sbjct: 191 ACGCQYLEEN-HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAG---------YY 240
Query: 207 R------------APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 243
R PE + G +T+ D WS G +L E+ LG +P
Sbjct: 241 RKGGCAMLPVKWMPPEAFMEG--IFTSKTDTWSFGVLLWEIFSLGYMPYPS 289
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 78.4 bits (193), Expect = 3e-16
Identities = 57/218 (26%), Positives = 94/218 (43%), Gaps = 34/218 (15%)
Query: 43 ERVVGTGSFGIVFQAKCLETGE---TVAIKKVLQDRRYKNR-----ELQLMRVMDHPNVI 94
R +G G FG V Q + VAIK R E MR DHP+++
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 454
Query: 95 SLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQ-RMPLIYVKLYTYQIFRGLA 153
L ++N ++ ++ME L+ + + + L + LY YQ+ LA
Sbjct: 455 KL----IGVITENPVW--IIMELCT---LGELRSFLQVRKFSLDLASLILYAYQLSTALA 505
Query: 154 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYR------ 207
Y+ + V HRD+ +N+LV VK+ DFG ++ + + +Y + +
Sbjct: 506 YLESKRFV-HRDIAARNVLVSS-NDCVKLGDFGLSRYM----EDSTYYKASKGKLPIKWM 559
Query: 208 APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 243
APE + F +T++ D+W G + E+L G F G
Sbjct: 560 APESINFR--RFTSASDVWMFGVCMWEILMHGVKPFQG 595
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 3e-16
Identities = 49/231 (21%), Positives = 85/231 (36%), Gaps = 47/231 (20%)
Query: 43 ERVVGTGSFGIVFQAKCL-----ETGETVAIKKV-----LQDRRYKNRELQLMRVMDHPN 92
R +G G+FG V++ + + VA+K + QD E ++ +H N
Sbjct: 35 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 94
Query: 93 VISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVL-KHYSSANQRMPLIYVKL--YTYQI 148
++ + ++ ++ME + + L + +Q L + L I
Sbjct: 95 IVRCIGV----SLQSLPRF-ILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 149
Query: 149 FRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQ--VKICDFGSAKQLIAGEANISYICSRFY 206
G Y+ HRD+ +N L+ KI DFG A+ + +Y
Sbjct: 150 ACGCQYLEEN-HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAS---------YY 199
Query: 207 R------------APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 243
R PE + G +T+ D WS G +L E+ LG +P
Sbjct: 200 RKGGCAMLPVKWMPPEAFMEG--IFTSKTDTWSFGVLLWEIFSLGYMPYPS 248
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 3e-16
Identities = 58/220 (26%), Positives = 90/220 (40%), Gaps = 34/220 (15%)
Query: 43 ERVVGTGSFGIVFQAKC-LETGET--VAIKKVLQDRRYKN-------RELQLMRVMDHPN 92
+G GSFG+V + + +G+T VA+K + D + RE+ M +DH N
Sbjct: 23 LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 82
Query: 93 VISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQ-RMPLIYVKLYTYQIFRG 151
+I L + + +V E P L +Q L + Y Q+ G
Sbjct: 83 LIRL----YGVVLTPPMK--MVTELAP---LGSLLDRLRKHQGHFLLGTLSRYAVQVAEG 133
Query: 152 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYR---- 207
+ Y+ + R HRDL +NLL+ VKI DFG + L + Y+ +
Sbjct: 134 MGYLESK-RFIHRDLAARNLLLAT-RDLVKIGDFGLMRALPQNDD--HYVMQEHRKVPFA 189
Query: 208 --APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 243
APE L ++ + D W G L E+ GQ + G
Sbjct: 190 WCAPESLKTRT--FSHASDTWMFGVTLWEMFTYGQEPWIG 227
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 4e-16
Identities = 46/250 (18%), Positives = 83/250 (33%), Gaps = 49/250 (19%)
Query: 19 TGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK 78
G ++ G + ++ + +G+G FG+++ A E A V + +
Sbjct: 27 EGKVLDDMEGNQ---------WVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQEN 77
Query: 79 N---RELQLMRVMDHPNVISLK--------------HCFFSTTSKNELFLNLVMEYVPES 121
EL+ + + + I + T K + +VME +
Sbjct: 78 GPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGID 137
Query: 122 MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLT-HQV 180
L+ S N V ++ L YIH V H D+K NLL+ QV
Sbjct: 138 ----LQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYV-HGDIKAANLLLGYKNPDQV 192
Query: 181 KICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSI------------DIWSAG 228
+ D+G + + + Y + G E+ TS+ D+ G
Sbjct: 193 YLADYGLSYRYCPNGNHKQYQ----ENPRKGHNGTIEF-TSLDAHKGVALSRRSDVEILG 247
Query: 229 CVLAELLLGQ 238
+ L G+
Sbjct: 248 YCMLRWLCGK 257
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 4e-16
Identities = 35/227 (15%), Positives = 77/227 (33%), Gaps = 44/227 (19%)
Query: 43 ERVVGTGSFGIVFQAKCLETGET-------VAIKKVLQDRRYKN----RELQLMRVMDHP 91
+G G+F +F+ E G+ V +K + + R + +M + H
Sbjct: 13 NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHK 72
Query: 92 NVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFR 150
+++ + + + LV E+V S+ LK + + + Q+
Sbjct: 73 HLVLN----YGVCVCGDENI-LVQEFVKFGSLDTYLKKNKNCINILWKLE---VAKQLAA 124
Query: 151 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQ-------VKICDFGSAKQLIAGEANISYICS 203
+ ++ + H ++ +N+L+ + +K+ D G + ++ +
Sbjct: 125 AMHFLEEN-TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD-------- 175
Query: 204 RFYR------APELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 243
+ PE I + D WS G L E+ G
Sbjct: 176 -ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSA 221
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 4e-16
Identities = 49/213 (23%), Positives = 95/213 (44%), Gaps = 29/213 (13%)
Query: 43 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRVMDHPNVISLKHC 99
+ +G+G FG+V K VA+K + + ++ +E Q M + HP ++
Sbjct: 13 LKELGSGQFGVVKLGKWKGQ-YDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKF--- 68
Query: 100 FFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV 158
+ SK +V EY+ + L+ + + L+ Y + G+A++ +
Sbjct: 69 -YGVCSKEYPIY-IVTEYISNGCLLNYLRSHGKGLEPSQLLE---MCYDVCEGMAFLESH 123
Query: 159 PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYR------APE-L 211
+ HRDL +N LVD VK+ DFG + ++ + Y+ S + APE
Sbjct: 124 -QFIHRDLAARNCLVDR-DLCVKVSDFGMTRYVLDDQ----YVSSVGTKFPVKWSAPEVF 177
Query: 212 IFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 243
+ +Y++ D+W+ G ++ E+ LG+ +
Sbjct: 178 HYF--KYSSKSDVWAFGILMWEVFSLGKMPYDL 208
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 5e-16
Identities = 60/252 (23%), Positives = 105/252 (41%), Gaps = 57/252 (22%)
Query: 43 ERVVGTGSFGIVFQAKCL-------ETGETVAIKKV-----LQDRRYKNRELQLM-RVMD 89
+ +G G+FG V A+ + VA+K + +D E+++M +
Sbjct: 74 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 133
Query: 90 HPNVISLKHCFFSTTSKNELFLNLVMEYVP-----------ESMYRVLKHYSSANQRMPL 138
H N+I+L +++ +++EY + S N L
Sbjct: 134 HKNIINLLGA----CTQDGPLY-VIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 188
Query: 139 IYVKL--YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA 196
L YQ+ RG+ Y+ + + HRDL +N+LV + +KI DFG A+ + +
Sbjct: 189 SSKDLVSCAYQVARGMEYLAS-KKCIHRDLAARNVLVTE-DNVMKIADFGLARDIHHID- 245
Query: 197 NISYICSRFYR------------APELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 243
+Y+ APE +F YT D+WS G +L E+ LG +PG
Sbjct: 246 --------YYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPYPG 296
Query: 244 ENAVDQLVEIIK 255
V++L +++K
Sbjct: 297 VP-VEELFKLLK 307
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 6e-16
Identities = 51/218 (23%), Positives = 97/218 (44%), Gaps = 30/218 (13%)
Query: 43 ERVVGTGSFGIVFQAKCLETGE----TVAIKKV-----LQDRRYKNRELQLMRVMDHPNV 93
++V+G G FG V++ + VAIK + + R E +M H N+
Sbjct: 49 QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNI 108
Query: 94 ISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 152
I L SK + + ++ EY+ ++ + L+ + L+ I G+
Sbjct: 109 IRL----EGVISKYKPMM-IITEYMENGALDKFLREKDGEFSVLQLVG---MLRGIAAGM 160
Query: 153 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICS--RF-YR-- 207
Y+ + HRDL +N+LV+ K+ DFG ++ ++ + +Y S + R
Sbjct: 161 KYLANM-NYVHRDLAARNILVNS-NLVCKVSDFGLSR-VLEDDPEATYTTSGGKIPIRWT 217
Query: 208 APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 243
APE + + +T++ D+WS G V+ E++ G+ +
Sbjct: 218 APEAISYRK--FTSASDVWSFGIVMWEVMTYGERPYWE 253
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 6e-16
Identities = 63/268 (23%), Positives = 107/268 (39%), Gaps = 68/268 (25%)
Query: 34 PKQTISYMAERVVGTGSFGIVFQAKCL-----ETGETVAIKKV-----LQDRRYKNRELQ 83
P+ I Y+ R +G G+FG VFQA+ E VA+K + + RE
Sbjct: 45 PRNNIEYV--RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAA 102
Query: 84 LMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYV-------------PESMYRVLKHYS 130
LM D+PN++ L + + L+ EY+ P ++ +
Sbjct: 103 LMAEFDNPNIVKLLGV----CAVGKPMC-LLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 157
Query: 131 SANQRMPLIYVKLYT--------YQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKI 182
S R+ + Q+ G+AY+ + HRDL +N LV VKI
Sbjct: 158 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER-KFVHRDLATRNCLVGE-NMVVKI 215
Query: 183 CDFGSAKQLIAGEANISYICSRFYR------------APE-LIFGATEYTTSIDIWSAGC 229
DFG ++ + + + +Y+ PE + + YTT D+W+ G
Sbjct: 216 ADFGLSRNIYSAD---------YYKADGNDAIPIRWMPPESIFYN--RYTTESDVWAYGV 264
Query: 230 VLAELL-LG-QPLFPGENAVDQLVEIIK 255
VL E+ G QP + G ++++ ++
Sbjct: 265 VLWEIFSYGLQP-YYGMA-HEEVIYYVR 290
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 7e-16
Identities = 55/239 (23%), Positives = 88/239 (36%), Gaps = 57/239 (23%)
Query: 43 ERVVGTGSFGIVFQAKCL-----ETGETVAIKKV-----LQDRRYKNRELQLMRVMDHPN 92
+G FG V++ E + VAIK + R E L + HPN
Sbjct: 14 MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPN 73
Query: 93 VISLKHCFFSTTSKNELFLNLVMEYVP-----------ESMYRVLKHYSSANQRMPLIYV 141
V+ L +K++ ++ Y V + L
Sbjct: 74 VVCLLGV----VTKDQPLS-MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPP 128
Query: 142 KL--YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS 199
QI G+ Y+ + V H+DL +N+LV VKI D G +++ A +
Sbjct: 129 DFVHLVAQIAAGMEYLSSH-HVVHKDLATRNVLVYD-KLNVKISDLGLFREVYAAD---- 182
Query: 200 YICSRFYR------------APE-LIFGATEYTTSIDIWSAGCVLAELL-LG-QPLFPG 243
+Y+ APE +++G +++ DIWS G VL E+ G QP + G
Sbjct: 183 -----YYKLLGNSLLPIRWMAPEAIMYG--KFSIDSDIWSYGVVLWEVFSYGLQP-YCG 233
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 74.9 bits (185), Expect = 8e-16
Identities = 55/218 (25%), Positives = 100/218 (45%), Gaps = 34/218 (15%)
Query: 43 ERVVGTGSFGIVFQAKCLETGET---VAIKKVLQDRRYKNR-----ELQLMRVMDHPNVI 94
R++G G FG V++ VA+K +D N+ E +M+ +DHP+++
Sbjct: 17 NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 76
Query: 95 SLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQ-RMPLIYVKLYTYQIFRGLA 153
L + + ++ME P Y L HY N+ + ++ + LY+ QI + +A
Sbjct: 77 KL----IGIIEEEPTW--IIMELYP---YGELGHYLERNKNSLKVLTLVLYSLQICKAMA 127
Query: 154 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYR------ 207
Y+ ++ HRD+ +N+LV VK+ DFG ++ + + Y + R
Sbjct: 128 YLESI-NCVHRDIAVRNILVAS-PECVKLGDFGLSRYIEDED----YYKASVTRLPIKWM 181
Query: 208 APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 243
+PE + F +TT+ D+W + E+L G+ F
Sbjct: 182 SPESINFRR--FTTASDVWMFAVCMWEILSFGKQPFFW 217
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 9e-16
Identities = 57/223 (25%), Positives = 92/223 (41%), Gaps = 44/223 (19%)
Query: 43 ERVVGTGSFGIVFQAKCLETGE---TVAIKKVLQDRRYKNR-----ELQLMRVMDHPNVI 94
R +G G FG V Q + VAIK R E MR DHP+++
Sbjct: 20 GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 79
Query: 95 SLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQ-RMPLIYVKLYTYQIFRGLA 153
L ++N ++ ++ME L+ + + + L + LY YQ+ LA
Sbjct: 80 KL----IGVITENPVW--IIMELCT---LGELRSFLQVRKYSLDLASLILYAYQLSTALA 130
Query: 154 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYR------ 207
Y+ + R HRD+ +N+LV VK+ DFG ++ + +Y+
Sbjct: 131 YLESK-RFVHRDIAARNVLVSS-NDCVKLGDFGLSRYMEDST---------YYKASKGKL 179
Query: 208 -----APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 243
APE + F +T++ D+W G + E+L G F G
Sbjct: 180 PIKWMAPESINFRR--FTSASDVWMFGVCMWEILMHGVKPFQG 220
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 1e-15
Identities = 46/223 (20%), Positives = 82/223 (36%), Gaps = 43/223 (19%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--RELQLMRVMDH-PNVISL 96
Y R +G GSFG++F+ L + VAIK + E + +++ + ++
Sbjct: 12 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNV 71
Query: 97 KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 156
+ + L LV++ + S+ +L ++ + V + Q+ + IH
Sbjct: 72 YYF-----GQEGLHNVLVIDLLGPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIH 123
Query: 157 TVPRVCHRDLKPQNLLV----DPLTHQVKICDFGSAKQLIAGEANISYICSRF-----YR 207
V +RD+KP N L+ + + + DFG K Y YR
Sbjct: 124 EKSLV-YRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF---------YRDPVTKQHIPYR 173
Query: 208 APELIFGATEYTTSI------------DIWSAGCVLAELLLGQ 238
+ + G Y SI D+ + G V L G
Sbjct: 174 EKKNLSGTARY-MSINTHLGREQSRRDDLEALGHVFMYFLRGS 215
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 75.3 bits (184), Expect = 1e-15
Identities = 46/273 (16%), Positives = 74/273 (27%), Gaps = 72/273 (26%)
Query: 46 VGTGSFGIVFQAKCLETGETVAIKKV-LQDRRYKNRE--------------------LQL 84
+G G FG VFQ VAIK + ++ N L
Sbjct: 28 IGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSG 85
Query: 85 MRVMDHPNVISLKHCFF---------------------------STTSKNELFLNLVMEY 117
I L ++LF+ L E+
Sbjct: 86 EVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEF 145
Query: 118 VPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLT 177
+ ++ SS K +Q+ LA R HRDL N+L+ T
Sbjct: 146 GGIDLEQMRTKLSSLAT------AKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKK-T 198
Query: 178 HQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLG 237
K+ + K L +YT S V ++ +
Sbjct: 199 SLKKLHYTLNGKSSTIPSCG-------------LQVSIIDYTLSRLERDGIVVFCDVSMD 245
Query: 238 QPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 270
+ LF G+ D +I +++ +P
Sbjct: 246 EDLFTGDG--DYQFDIYRLMKKENNNRWGEYHP 276
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 1e-15
Identities = 61/252 (24%), Positives = 109/252 (43%), Gaps = 57/252 (22%)
Query: 43 ERVVGTGSFGIVFQAKCL-------ETGETVAIKKV-----LQDRRYKNRELQLM-RVMD 89
+ +G G FG V A+ + + TVA+K + +D E+++M +
Sbjct: 86 GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 145
Query: 90 HPNVISLKHCFFSTTSKNELFLNLVMEYVPE-----------SMYRVLKHYSSANQRMPL 138
H N+I+L +++ +++EY + + + +
Sbjct: 146 HKNIINLLGA----CTQDGPLY-VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200
Query: 139 IYVKL--YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA 196
+ L TYQ+ RG+ Y+ + + HRDL +N+LV + +KI DFG A+ +
Sbjct: 201 TFKDLVSCTYQLARGMEYLAS-QKCIHRDLAARNVLVTE-NNVMKIADFGLARDIN---- 254
Query: 197 NISYICSRFYR------------APELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 243
NI Y Y+ APE +F YT D+WS G ++ E+ LG +PG
Sbjct: 255 NIDY-----YKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPG 308
Query: 244 ENAVDQLVEIIK 255
V++L +++K
Sbjct: 309 IP-VEELFKLLK 319
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 2e-15
Identities = 58/240 (24%), Positives = 102/240 (42%), Gaps = 56/240 (23%)
Query: 43 ERVVGTGSFGIVFQAKCL-------ETGETVAIKKV-----LQDRRYKNRELQLM-RVMD 89
+ +G G+FG V A+ + + TVA+K + +D E+++M +
Sbjct: 40 GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 90 HPNVISLKHCFFSTTSKNELFLNLVMEYVPE-----------SMYRVLKHYSSANQRMPL 138
H N+I+L +++ +++EY + + + +
Sbjct: 100 HKNIINLLGA----CTQDGPLY-VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 139 IYVKL--YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA 196
+ L TYQ+ RG+ Y+ + + HRDL +N+LV + +KI DFG A+ +
Sbjct: 155 TFKDLVSCTYQLARGMEYLAS-QKCIHRDLAARNVLVTE-NNVMKIADFGLARDI----N 208
Query: 197 NISYICSRFYR------------APELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 243
NI Y Y+ APE +F YT D+WS G ++ E+ LG +PG
Sbjct: 209 NIDY-----YKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPG 262
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 3e-15
Identities = 44/223 (19%), Positives = 83/223 (37%), Gaps = 43/223 (19%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIK--KVLQDRRYKNRELQLMRVMDH-PNVISL 96
+ + +G G+FG + K L T E VAIK + + E + + + + +
Sbjct: 11 FRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQV 70
Query: 97 KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 156
+ + +V+E + S+ + ++ L V + Q+ + Y+H
Sbjct: 71 YYF-----GPCGKYNAMVLELLGPSLEDLFD---LCDRTFSLKTVLMIAIQLISRMEYVH 122
Query: 157 TVPRVCHRDLKPQNLLV----DPLTHQVKICDFGSAKQLIAGEANISYICSRF-----YR 207
+ + +RD+KP+N L+ + + I DF AK+ YI YR
Sbjct: 123 SK-NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE---------YIDPETKKHIPYR 172
Query: 208 APELIFGATEYTTSI------------DIWSAGCVLAELLLGQ 238
+ + G Y SI D+ + G + L G
Sbjct: 173 EHKSLTGTARY-MSINTHLGKEQSRRDDLEALGHMFMYFLRGS 214
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 4e-15
Identities = 48/210 (22%), Positives = 94/210 (44%), Gaps = 23/210 (10%)
Query: 43 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRVMDHPNVISLKHC 99
+ +GTG FG+V K VAIK + + ++ E ++M + H ++ L
Sbjct: 29 LKELGTGQFGVVKYGKWRGQ-YDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQL--- 84
Query: 100 FFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV 158
+ +K ++ EY+ + L+ Q L+ + + Y+ +
Sbjct: 85 -YGVCTKQRPIF-IITEYMANGCLLNYLREMRHRFQTQQLLE---MCKDVCEAMEYLESK 139
Query: 159 PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF-YR--APE-LIFG 214
+ HRDL +N LV+ VK+ DFG ++ + + S + S+F R PE L++
Sbjct: 140 -QFLHRDLAARNCLVND-QGVVKVSDFGLSR-YVLDDEYTSSVGSKFPVRWSPPEVLMYS 196
Query: 215 ATEYTTSIDIWSAGCVLAELL-LGQPLFPG 243
++++ DIW+ G ++ E+ LG+ +
Sbjct: 197 --KFSSKSDIWAFGVLMWEIYSLGKMPYER 224
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 72.2 bits (178), Expect = 1e-14
Identities = 56/217 (25%), Positives = 100/217 (46%), Gaps = 40/217 (18%)
Query: 43 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR-----ELQLMRVMDHPNVISLK 97
+ ++G G FG V++ + L G VA+K++ ++R E++++ + H N++ L+
Sbjct: 35 KNILGRGGFGKVYKGR-LADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLR 93
Query: 98 HCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPL-------IYVKLYTYQIF 149
T L LV Y+ S+ L + PL I +
Sbjct: 94 GF--CMTPTERL---LVYPYMANGSVASCL--RERPESQPPLDWPKRQRIALG-----SA 141
Query: 150 RGLAYIHTV--PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF-- 205
RGLAY+H P++ HRD+K N+L+D + + DFG AK + + +++ +
Sbjct: 142 RGLAYLHDHCDPKIIHRDVKAANILLDE-EFEAVVGDFGLAKLM---DYKDTHVTTAVRG 197
Query: 206 ---YRAPE-LIFGATEYTTSIDIWSAGCVLAELLLGQ 238
+ APE L G + + D++ G +L EL+ GQ
Sbjct: 198 TIGHIAPEYLSTGKS--SEKTDVFGYGVMLLELITGQ 232
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 2e-14
Identities = 41/252 (16%), Positives = 82/252 (32%), Gaps = 50/252 (19%)
Query: 19 TGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETG--------ETVAIKK 70
TG +++ G + + + + GI+++A T + ++K
Sbjct: 32 TGTVLTDKSGRQ---------WKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKL 82
Query: 71 VLQDRRYKNRELQLMRVMDHPNVISLK-----------HCFFSTTSKNELFLNLVMEYVP 119
+D R N + R V K C +++ LV+ +
Sbjct: 83 DAKDGRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRF-LVLPSLG 141
Query: 120 ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLT-H 178
S+ L + V ++ L ++H V H ++ +N+ VDP
Sbjct: 142 RSLQSALDVSP--KHVLSERSVLQVACRLLDALEFLHENEYV-HGNVTAENIFVDPEDQS 198
Query: 179 QVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSI------------DIWS 226
QV + +G A + +++Y G E+ S+ D+ S
Sbjct: 199 QVTLAGYGFAFRYCPSGKHVAY---VEGSRSPHE-GDLEF-ISMDLHKGCGPSRRSDLQS 253
Query: 227 AGCVLAELLLGQ 238
G + + L G
Sbjct: 254 LGYCMLKWLYGF 265
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 3e-14
Identities = 58/236 (24%), Positives = 97/236 (41%), Gaps = 56/236 (23%)
Query: 43 ERVVGTGSFGIVFQAKCLETGE--TVAIKKV-----LQDRRYKNRELQLM-RVMDHPNVI 94
+ V+G G+FG V +A+ + G AIK++ D R EL+++ ++ HPN+I
Sbjct: 30 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89
Query: 95 SLKHCFFSTTSKNELFLNLVMEYVP-----------ESMYRVLKHYSSANQRMPLIYVKL 143
+L + L+ L +EY P + + + L +L
Sbjct: 90 NLLGA---CEHRGYLY--LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144
Query: 144 --YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYI 201
+ + RG+ Y+ + HRDL +N+LV + KI DFG ++
Sbjct: 145 LHFAADVARGMDYLSQK-QFIHRDLAARNILVGE-NYVAKIADFGLSR-------GQEV- 194
Query: 202 CSRFYR------------APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 243
Y A E L + YTT+ D+WS G +L E++ LG + G
Sbjct: 195 ----YVKKTMGRLPVRWMAIESLNYS--VYTTNSDVWSYGVLLWEIVSLGGTPYCG 244
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 3e-14
Identities = 59/217 (27%), Positives = 95/217 (43%), Gaps = 44/217 (20%)
Query: 45 VVGTGSFGIVFQAKCLETGETVAIKK--------VLQ-DRRYKNRELQLMRVMDHPNVIS 95
+G G FG+V++ + TVA+KK + +++ E+++M H N++
Sbjct: 38 KMGEGGFGVVYKG-YVN-NTTVAVKKLAAMVDITTEELKQQFDQ-EIKVMAKCQHENLVE 94
Query: 96 LKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPL-------IYVKLYTYQ 147
L S+ + LV Y+P S +L S + PL I
Sbjct: 95 LLGF--SSDGDDLC---LVYVYMPNGS---LLDRLSCLDGTPPLSWHMRCKIAQG----- 141
Query: 148 IFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF-- 205
G+ ++H + HRD+K N+L+D KI DFG A+ + + + + SR
Sbjct: 142 AANGINFLHENHHI-HRDIKSANILLDE-AFTAKISDFGLAR--ASEKFAQTVMTSRIVG 197
Query: 206 ---YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQP 239
Y APE + G E T DI+S G VL E++ G P
Sbjct: 198 TTAYMAPEALRG--EITPKSDIYSFGVVLLEIITGLP 232
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 71.6 bits (175), Expect = 4e-14
Identities = 50/216 (23%), Positives = 92/216 (42%), Gaps = 31/216 (14%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--RELQLMRVM-DHPNVISL 96
+ R +G+GSFG ++ ++T E VAIK ++ E ++ R++ + ++
Sbjct: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNV 68
Query: 97 KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 156
+ + LVM+ + S+ + ++++ L V + Q+ + ++H
Sbjct: 69 RWF-----GVEGDYNVLVMDLLGPSLEDLFN---FCSRKLSLKTVLMLADQMINRVEFVH 120
Query: 157 TVPRVCHRDLKPQNLLV--DPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFG 214
+ HRD+KP N L+ +QV I DFG AK+ + +I YR + + G
Sbjct: 121 SK-SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH-QHIP---YRENKNLTG 175
Query: 215 ATEYTTSI------------DIWSAGCVLAELLLGQ 238
Y S+ D+ S G VL L G
Sbjct: 176 TARY-ASVNTHLGIEQSRRDDLESLGYVLMYFLRGS 210
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 4e-14
Identities = 55/216 (25%), Positives = 90/216 (41%), Gaps = 31/216 (14%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--RELQLMRVMDH-PNVISL 96
Y R +G+GSFG ++ + GE VAIK ++ E ++ ++M + ++
Sbjct: 11 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTI 70
Query: 97 KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 156
+ C + +VME + S+ + +++ L V L Q+ + YIH
Sbjct: 71 RWC-----GAEGDYNVMVMELLGPSLEDLFN---FCSRKFSLKTVLLLADQMISRIEYIH 122
Query: 157 TVPRVCHRDLKPQNLLV--DPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFG 214
+ HRD+KP N L+ + V I DFG AK+ + +I YR + + G
Sbjct: 123 SK-NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH-QHIP---YRENKNLTG 177
Query: 215 ATEYTTSI------------DIWSAGCVLAELLLGQ 238
Y SI D+ S G VL LG
Sbjct: 178 TARY-ASINTHLGIEQSRRDDLESLGYVLMYFNLGS 212
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 3e-13
Identities = 44/251 (17%), Positives = 80/251 (31%), Gaps = 50/251 (19%)
Query: 20 GHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQA-----KCLETGETVAIKKVLQD 74
G II+ + +G G FG ++ A + + + +K D
Sbjct: 26 GEIITDMAAAA---------WKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSD 76
Query: 75 RRYKNRELQLMRVMDHPNVISLK--------------HCFFSTTSKNELFLNLVMEYVPE 120
EL+ + P I + + ++M+
Sbjct: 77 NGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGS 136
Query: 121 SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLT-HQ 179
+ ++ + + +R V + +I L YIH V H D+K NLL++ Q
Sbjct: 137 DLQKIYE---ANAKRFSRKTVLQLSLRILDILEYIHEHEYV-HGDIKASNLLLNYKNPDQ 192
Query: 180 VKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSI------------DIWSA 227
V + D+G A + + +Y G E+ TSI D+
Sbjct: 193 VYLVDYGLAYRYCPEGVHKAYA----ADPKRCHDGTIEF-TSIDAHNGVAPSRRGDLEIL 247
Query: 228 GCVLAELLLGQ 238
G + + L G
Sbjct: 248 GYCMIQWLTGH 258
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 61.9 bits (150), Expect = 5e-11
Identities = 49/187 (26%), Positives = 82/187 (43%), Gaps = 12/187 (6%)
Query: 77 YKNRELQLMRVMDHPNVI--SLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQ 134
YK + + + D+ I LK S TS + +E S +
Sbjct: 128 YKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPED-LY 186
Query: 135 RMPLIYVKL--YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 192
+ L L Y++Q+ +G+ ++ + + HRDL +N+L+ + VKICDFG A+ +
Sbjct: 187 KDFLTLEHLICYSFQVAKGMEFLASRKCI-HRDLAARNILLSE-KNVVKICDFGLARDIY 244
Query: 193 AGEANISYICSRF---YRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVD 248
+ +R + APE IF YT D+WS G +L E+ LG +PG +
Sbjct: 245 KDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 303
Query: 249 QLVEIIK 255
+ +K
Sbjct: 304 EFCRRLK 310
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 314 | |||
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.95 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.92 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.88 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.82 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.68 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.23 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.12 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.0 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.91 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.67 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.55 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.27 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.22 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.13 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.11 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.11 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.05 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.71 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.48 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.34 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.33 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.26 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.2 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.18 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.1 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.1 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.03 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.97 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.97 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.77 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.31 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.97 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 83.09 |
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-56 Score=378.74 Aligned_cols=242 Identities=29% Similarity=0.435 Sum_probs=190.2
Q ss_pred CCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCCce
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL 109 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 109 (314)
.++|++.+.||+|+||.||+|+++.+|+.||+|.+.+.. ....+|+.++++++||||+++++++... .
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~-----~ 86 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSK-----D 86 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECS-----S
T ss_pred eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEEC-----C
Confidence 468999999999999999999999999999999986432 2346899999999999999999998443 3
Q ss_pred eEEEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCccc
Q 021306 110 FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 189 (314)
Q Consensus 110 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~ 189 (314)
.+|+||||++|+|.+.+.. .+++++.+++.++.||+.||.|||+ +||+||||||+||+++. ++.+||+|||+|+
T Consensus 87 ~~~ivmEy~~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~-~~IiHRDiKP~NILl~~-~~~vkl~DFGla~ 160 (275)
T 3hyh_A 87 EIIMVIEYAGNELFDYIVQ----RDKMSEQEARRFFQQIISAVEYCHR-HKIVHRDLKPENLLLDE-HLNVKIADFGLSN 160 (275)
T ss_dssp EEEEEEECCCEEHHHHHHH----SCSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCTTTEEECT-TCCEEECCSSCC-
T ss_pred EEEEEEeCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCChHHeEECC-CCCEEEeecCCCe
Confidence 4899999999998887764 5789999999999999999999999 99999999999999998 8899999999998
Q ss_pred ccccCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCC-------H
Q 021306 190 QLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT-------R 262 (314)
Q Consensus 190 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~-------~ 262 (314)
............||+.|+|||.+.+...++.++|||||||++|+|+||+.||.+.+..+.+..+.+.....+ .
T Consensus 161 ~~~~~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~ 240 (275)
T 3hyh_A 161 IMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAA 240 (275)
T ss_dssp --------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTSCHHHH
T ss_pred ecCCCCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 765555555678999999999997766457899999999999999999999999887777776665432221 1
Q ss_pred HHHh---ccCCCCCCCcccccccCChhhhhc
Q 021306 263 EEIR---CMNPNYTDFRFPQIKAHPWHKVCI 290 (314)
Q Consensus 263 ~~~~---~~~p~~~~~~~~~l~~~p~~~~~~ 290 (314)
+.+. ..+|. +|++++++++|||++...
T Consensus 241 ~li~~~L~~dP~-~R~s~~eil~hpw~k~~~ 270 (275)
T 3hyh_A 241 GLIKRMLIVNPL-NRISIHEIMQDDWFKVDL 270 (275)
T ss_dssp HHHHHHSCSSGG-GSCCHHHHHHCHHHHTTC
T ss_pred HHHHHHccCChh-HCcCHHHHHcCcccccCC
Confidence 1222 34677 899999999999998543
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-55 Score=378.41 Aligned_cols=243 Identities=27% Similarity=0.486 Sum_probs=203.9
Q ss_pred CCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeecc-------ccchHHHHHHHHhCCCCceeeeceeeeecCCCCce
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL 109 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~-------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 109 (314)
.++|++.+.||+|+||+||+|+++.+|+.||+|.+.+. .....+|+.++++++|||||++++++.+ ..
T Consensus 31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-----~~ 105 (311)
T 4aw0_A 31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQD-----DE 105 (311)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC-----SS
T ss_pred ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEe-----CC
Confidence 46799999999999999999999999999999998643 1334689999999999999999999844 33
Q ss_pred eEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcc
Q 021306 110 FLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 188 (314)
Q Consensus 110 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~ 188 (314)
.+|+|||||+| +|.+.+.. .+.+++.+++.++.||+.||.|||+ +||+||||||+|||++. ++.+||+|||++
T Consensus 106 ~~yivmEy~~gG~L~~~i~~----~~~l~e~~~~~~~~qi~~al~ylH~-~~IiHRDlKPeNILl~~-~g~vKl~DFGla 179 (311)
T 4aw0_A 106 KLYFGLSYAKNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYLHG-KGIIHRDLKPENILLNE-DMHIQITDFGTA 179 (311)
T ss_dssp EEEEEECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECT-TSCEEECCCTTC
T ss_pred EEEEEEecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCccCCCCHHHeEEcC-CCCEEEEEcCCc
Confidence 48999999996 77777654 4789999999999999999999999 99999999999999998 889999999999
Q ss_pred cccccCC---ccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCC----
Q 021306 189 KQLIAGE---ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT---- 261 (314)
Q Consensus 189 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~---- 261 (314)
+...... .....+||+.|+|||.+.+.. ++.++|||||||++|+|+||+.||.+.+..+.+.++.+..-..+
T Consensus 180 ~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~-y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~p~~~s 258 (311)
T 4aw0_A 180 KVLSPESKQARANSFVGTAQYVSPELLTEKS-ACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFF 258 (311)
T ss_dssp EECCTTTTCCCBCCCCSCGGGCCHHHHHHSC-BCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTCC
T ss_pred eecCCCCCcccccCcccCcccCCHHHHcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCcccC
Confidence 8664322 234568999999999997655 89999999999999999999999999998888888776532221
Q ss_pred ---HHHHh---ccCCCCCCCcccc------cccCChhhhhccc
Q 021306 262 ---REEIR---CMNPNYTDFRFPQ------IKAHPWHKVCIFH 292 (314)
Q Consensus 262 ---~~~~~---~~~p~~~~~~~~~------l~~~p~~~~~~~~ 292 (314)
.+.+. ..+|. +|+++++ |++||||+..+.+
T Consensus 259 ~~~~dli~~lL~~dp~-~R~t~~e~~~~~~i~~Hp~F~~idw~ 300 (311)
T 4aw0_A 259 PKARDLVEKLLVLDAT-KRLGCEEMEGYGPLKAHPFFESVTWE 300 (311)
T ss_dssp HHHHHHHHHHSCSSGG-GSTTSGGGTCHHHHHTSGGGTTCCCT
T ss_pred HHHHHHHHHHccCCHh-HCcChHHHcCCHHHHCCCCcCCCCHH
Confidence 12222 34677 8999988 5899999877654
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-54 Score=377.85 Aligned_cols=239 Identities=26% Similarity=0.393 Sum_probs=202.2
Q ss_pred CCceeeeeEeecCceEEEEEEECCCCcEEEEEEeecc----ccchHHHHHHHHhCCCCceeeeceeeeecCCCCceeEEE
Q 021306 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD----RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 113 (314)
Q Consensus 38 ~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 113 (314)
..|++.+.||+|+||.||+|+++.+|+.||+|++... .....+|+.++++++|||||++++++.... .+|+
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~-----~~~i 148 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGD-----ELWV 148 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETT-----EEEE
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC-----EEEE
Confidence 4699999999999999999999999999999998643 234568999999999999999999996543 3899
Q ss_pred Eeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcccccc
Q 021306 114 VMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 192 (314)
Q Consensus 114 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~ 192 (314)
|||||+| +|.+.+.. ..+++.+++.++.||+.||.|||+ +||+||||||+|||++. ++.+||+|||+++...
T Consensus 149 vmEy~~gg~L~~~l~~-----~~l~e~~~~~~~~qi~~aL~ylH~-~~IiHRDlKp~NILl~~-~g~vKl~DFGla~~~~ 221 (346)
T 4fih_A 149 VMEFLEGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHA-QGVIHRDIKSDSILLTH-DGRVKLSDFGFCAQVS 221 (346)
T ss_dssp EECCCTTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECT-TCCEEECCCTTCEECC
T ss_pred EEeCCCCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCCHHHEEECC-CCCEEEecCcCceecC
Confidence 9999996 66665543 579999999999999999999999 99999999999999998 8899999999998765
Q ss_pred cCC-ccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCC----------
Q 021306 193 AGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT---------- 261 (314)
Q Consensus 193 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~---------- 261 (314)
... ......||+.|+|||++.+.. ++.++|||||||++|||++|+.||.+.+..+.+..+........
T Consensus 222 ~~~~~~~~~~GTp~YmAPEvl~~~~-y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~ 300 (346)
T 4fih_A 222 KEVPRRKSLVGTPYWMAPELISRLP-YGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSL 300 (346)
T ss_dssp SSSCCBCCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCSCGGGSCHHH
T ss_pred CCCCcccccccCcCcCCHHHHCCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccccCCHHH
Confidence 433 344578999999999996554 89999999999999999999999999998888877766543221
Q ss_pred HHHHh---ccCCCCCCCcccccccCChhhhhc
Q 021306 262 REEIR---CMNPNYTDFRFPQIKAHPWHKVCI 290 (314)
Q Consensus 262 ~~~~~---~~~p~~~~~~~~~l~~~p~~~~~~ 290 (314)
.+.+. ..+|. +|+++.++++|||++...
T Consensus 301 ~dli~~~L~~dP~-~R~ta~e~l~Hp~~~~~~ 331 (346)
T 4fih_A 301 KGFLDRLLVRDPA-QRATAAELLKHPFLAKAG 331 (346)
T ss_dssp HHHHHHHSCSSTT-TSCCHHHHTTCGGGGGCC
T ss_pred HHHHHHHcCCChh-HCcCHHHHhcCHhhcCCC
Confidence 11222 34777 899999999999998654
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-54 Score=380.40 Aligned_cols=250 Identities=25% Similarity=0.381 Sum_probs=201.6
Q ss_pred CCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCCcee
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 110 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 110 (314)
.++|++++.||+|+||.||+|+++.+|+.||+|.+.+.. ....+|+.++++++|||||++++++.+.. .
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~-----~ 97 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENG-----S 97 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT-----E
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECC-----E
Confidence 368999999999999999999999999999999986542 23468999999999999999999985433 4
Q ss_pred EEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCccc
Q 021306 111 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 189 (314)
Q Consensus 111 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~ 189 (314)
+|+|||||+| +|.+.+.. .....+++.+++.|+.||+.||.|||+ +||+||||||+|||++. ++.+||+|||+++
T Consensus 98 ~yiVmEy~~gg~L~~~i~~--~~~~~~~e~~~~~~~~qi~~aL~ylH~-~~IiHRDlKp~NILl~~-~g~vKl~DFGla~ 173 (350)
T 4b9d_A 98 LYIVMDYCEGGDLFKRINA--QKGVLFQEDQILDWFVQICLALKHVHD-RKILHRDIKSQNIFLTK-DGTVQLGDFGIAR 173 (350)
T ss_dssp EEEEEECCTTCBHHHHHHH--TTTCCCCHHHHHHHHHHHHHHHHHHHH-TTCEETTCCGGGEEECT-TCCEEECSTTEES
T ss_pred EEEEEeCCCCCcHHHHHHH--cCCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeccCCHHHEEECC-CCCEEEcccccce
Confidence 8999999985 77777754 234568999999999999999999999 99999999999999998 8899999999998
Q ss_pred ccccCC-ccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCH------
Q 021306 190 QLIAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR------ 262 (314)
Q Consensus 190 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~------ 262 (314)
...... ......||+.|+|||.+.+.. ++.++|||||||++|||+||+.||.+.+..+.+.++++...++..
T Consensus 174 ~~~~~~~~~~~~~GT~~YmAPE~l~~~~-y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~s~~ 252 (350)
T 4b9d_A 174 VLNSTVELARACIGTPYYLSPEICENKP-YNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYD 252 (350)
T ss_dssp CCCHHHHHHHHHHSCCTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTTSCHH
T ss_pred eecCCcccccccCCCccccCHHHHCCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccCCHH
Confidence 664332 223467999999999997655 899999999999999999999999999988888888776433221
Q ss_pred --HHHh---ccCCCCCCCcccccccCChhhhhcccCChHH
Q 021306 263 --EEIR---CMNPNYTDFRFPQIKAHPWHKVCIFHFPKHW 297 (314)
Q Consensus 263 --~~~~---~~~p~~~~~~~~~l~~~p~~~~~~~~~~~~~ 297 (314)
+.+. ..+|. +|+++.++++|||++....+.....
T Consensus 253 ~~~li~~~L~~dP~-~R~s~~e~l~hp~~~~~~~~~~~~~ 291 (350)
T 4b9d_A 253 LRSLVSQLFKRNPR-DRPSVNSILEKGFIAKRIEKFLSPQ 291 (350)
T ss_dssp HHHHHHHHTCSSGG-GSCCHHHHHTSHHHHTTGGGTSCHH
T ss_pred HHHHHHHHccCChh-HCcCHHHHhcCHHhhcCCCcCCCch
Confidence 1222 34777 8999999999999986655544433
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-53 Score=379.32 Aligned_cols=239 Identities=26% Similarity=0.393 Sum_probs=202.1
Q ss_pred CCceeeeeEeecCceEEEEEEECCCCcEEEEEEeecc----ccchHHHHHHHHhCCCCceeeeceeeeecCCCCceeEEE
Q 021306 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD----RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 113 (314)
Q Consensus 38 ~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 113 (314)
+.|++.+.||+|+||.||+|+++.+|+.||+|++... .....+|+.++++++|||||+++++|.... .+|+
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~-----~~~i 225 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGD-----ELWV 225 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETT-----EEEE
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECC-----EEEE
Confidence 4699999999999999999999999999999998643 234568999999999999999999996543 3899
Q ss_pred Eeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcccccc
Q 021306 114 VMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 192 (314)
Q Consensus 114 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~ 192 (314)
|||||+| +|.+.+.. ..+++.+++.++.||+.||.|||+ +||+||||||+|||++. ++.+||+|||+++...
T Consensus 226 VmEy~~gG~L~~~i~~-----~~l~e~~~~~~~~qil~aL~ylH~-~~IiHRDiKp~NILl~~-~g~vKl~DFGla~~~~ 298 (423)
T 4fie_A 226 VMEFLEGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHA-QGVIHRDIKSDSILLTH-DGRVKLSDFGFCAQVS 298 (423)
T ss_dssp EEECCTTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSTTTEEECT-TCCEEECCCTTCEECC
T ss_pred EEeCCCCCcHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHH-CCeecccCCHHHEEEcC-CCCEEEecCccceECC
Confidence 9999996 66665543 579999999999999999999999 99999999999999998 8899999999998765
Q ss_pred cCC-ccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCC----------
Q 021306 193 AGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT---------- 261 (314)
Q Consensus 193 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~---------- 261 (314)
... .....+||+.|||||++.+.. ++.++|||||||++|||++|+.||.+.+..+.+..+........
T Consensus 299 ~~~~~~~~~~GTp~YmAPEvl~~~~-y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~ 377 (423)
T 4fie_A 299 KEVPRRKSLVGTPYWMAPELISRLP-YGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSL 377 (423)
T ss_dssp SSCCCBCCCEECTTTCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSSCHHH
T ss_pred CCCccccccccCcCcCCHHHHCCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCcccccCCHHH
Confidence 433 344578999999999996554 89999999999999999999999999998888877766533221
Q ss_pred HHHHh---ccCCCCCCCcccccccCChhhhhc
Q 021306 262 REEIR---CMNPNYTDFRFPQIKAHPWHKVCI 290 (314)
Q Consensus 262 ~~~~~---~~~p~~~~~~~~~l~~~p~~~~~~ 290 (314)
.+.+. ..+|. +|+++.+|++|||++...
T Consensus 378 ~dli~~~L~~dP~-~R~ta~ell~Hp~~~~~~ 408 (423)
T 4fie_A 378 KGFLDRLLVRDPA-QRATAAELLKHPFLAKAG 408 (423)
T ss_dssp HHHHHHHSCSSTT-TSCCHHHHTTCGGGGGCC
T ss_pred HHHHHHHcCCChh-HCcCHHHHhcCHHhcCCC
Confidence 12222 34777 899999999999998654
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-53 Score=363.99 Aligned_cols=239 Identities=23% Similarity=0.354 Sum_probs=193.5
Q ss_pred ceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeEEE
Q 021306 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 113 (314)
Q Consensus 40 y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 113 (314)
|++.++||+|+||.||+|.++.++..||+|.+.... ..+.+|+.++++++|||||++++++.... .....+++
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~-~~~~~~~l 106 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGKKCIVL 106 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEE-TTEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeecc-CCCcEEEE
Confidence 478889999999999999999999999999986432 23468999999999999999999885432 23455789
Q ss_pred Eeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCC--ceecCCCCCcEEEcCCCCcEEEeecCcccc
Q 021306 114 VMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR--VCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 190 (314)
Q Consensus 114 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~--i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~ 190 (314)
|||||+| +|.+.+.. ...+++..++.|+.||+.||.|||+ +| |+||||||+|||++..++.+||+|||+|+.
T Consensus 107 vmEy~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~ylH~-~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~ 181 (290)
T 3fpq_A 107 VTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHT-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp EEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHT-SSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred EEeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCCEEecccChhheeEECCCCCEEEEeCcCCEe
Confidence 9999996 77766654 4789999999999999999999999 88 999999999999986578999999999975
Q ss_pred cccCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCC-------H-
Q 021306 191 LIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT-------R- 262 (314)
Q Consensus 191 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~-------~- 262 (314)
.. ........||+.|+|||.+.+ .++.++|||||||++|||+||+.||.+.+....+...+.....+. +
T Consensus 182 ~~-~~~~~~~~GTp~YmAPE~~~~--~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 258 (290)
T 3fpq_A 182 KR-ASFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPE 258 (290)
T ss_dssp CC-TTSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHH
T ss_pred CC-CCccCCcccCccccCHHHcCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCccCCHH
Confidence 43 333445689999999999854 389999999999999999999999988766555555544322221 1
Q ss_pred --HHHh---ccCCCCCCCcccccccCChhhh
Q 021306 263 --EEIR---CMNPNYTDFRFPQIKAHPWHKV 288 (314)
Q Consensus 263 --~~~~---~~~p~~~~~~~~~l~~~p~~~~ 288 (314)
+.+. ..+|. +|+++.++++|||++.
T Consensus 259 ~~~li~~~L~~dP~-~R~s~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 259 VKEIIEGCIRQNKD-ERYSIKDLLNHAFFQE 288 (290)
T ss_dssp HHHHHHHHSCSSGG-GSCCHHHHHTSGGGC-
T ss_pred HHHHHHHHccCChh-HCcCHHHHhcCccccC
Confidence 1222 23676 8999999999999974
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-52 Score=376.13 Aligned_cols=247 Identities=35% Similarity=0.620 Sum_probs=207.5
Q ss_pred cCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCC-CCc
Q 021306 36 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTS-KNE 108 (314)
Q Consensus 36 ~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~~~ 108 (314)
.+++|++++.||+|+||+||+|+++.+|+.||+|++++.. ....+|+.+++.++|||||++++++..... ...
T Consensus 52 i~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~ 131 (398)
T 4b99_A 52 VGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEF 131 (398)
T ss_dssp CCSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTC
T ss_pred CCCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccC
Confidence 3468999999999999999999999999999999996542 223479999999999999999998754321 233
Q ss_pred eeEEEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcc
Q 021306 109 LFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 188 (314)
Q Consensus 109 ~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~ 188 (314)
..+|+|||||+|+|.+.+.. .+++++.+++.++.||+.||.|||+ +||+||||||+|||++. ++.+||+|||++
T Consensus 132 ~~~~ivmE~~~g~L~~~i~~----~~~l~~~~~~~~~~qil~al~ylH~-~~iiHRDlKP~NIl~~~-~~~~Ki~DFGla 205 (398)
T 4b99_A 132 KSVYVVLDLMESDLHQIIHS----SQPLTLEHVRYFLYQLLRGLKYMHS-AQVIHRDLKPSNLLVNE-NCELKIGDFGMA 205 (398)
T ss_dssp CCEEEEEECCSEEHHHHHTS----SSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECT-TCCEEECCCTTC
T ss_pred CEEEEEEeCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CcCcCCCcCccccccCC-CCCEEEeeccee
Confidence 45889999999998877753 5789999999999999999999999 99999999999999998 889999999999
Q ss_pred cccccC-----CccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCHH
Q 021306 189 KQLIAG-----EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 263 (314)
Q Consensus 189 ~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~ 263 (314)
+..... .......||+.|+|||++.+...++.++||||+||++|||++|+.||.+.+..+++..|++..+.+...
T Consensus 206 ~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~ 285 (398)
T 4b99_A 206 RGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPA 285 (398)
T ss_dssp BCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGG
T ss_pred eecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChH
Confidence 765332 223356899999999998877668999999999999999999999999999999999988776554321
Q ss_pred --------------------------------------HH---hccCCCCCCCcccccccCChhhhh
Q 021306 264 --------------------------------------EI---RCMNPNYTDFRFPQIKAHPWHKVC 289 (314)
Q Consensus 264 --------------------------------------~~---~~~~p~~~~~~~~~l~~~p~~~~~ 289 (314)
.+ ...+|. +|+++.++++|||++..
T Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~-~R~ta~e~L~Hp~f~~~ 351 (398)
T 4b99_A 286 VIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPS-ARISAAAALRHPFLAKY 351 (398)
T ss_dssp GTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTT-TSCCHHHHTTSGGGTTT
T ss_pred HhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChh-HCcCHHHHhcCHhhCcC
Confidence 12 234787 89999999999999753
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-53 Score=367.74 Aligned_cols=241 Identities=26% Similarity=0.419 Sum_probs=194.2
Q ss_pred CCCceeeeeEeecCceEEEEEEEC---CCCcEEEEEEeecc------ccchHHHHHHHHhCCCCceeeeceeeeecCCCC
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCL---ETGETVAIKKVLQD------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKN 107 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~---~~~~~~~vK~~~~~------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 107 (314)
.++|++.+.||+|+||+||+|++. .+++.||+|.+++. .....+|+.++++++|||||++++++.+..
T Consensus 23 p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~--- 99 (304)
T 3ubd_A 23 PSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEG--- 99 (304)
T ss_dssp GGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETT---
T ss_pred ccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECC---
Confidence 468999999999999999999974 46789999998643 223467999999999999999999985433
Q ss_pred ceeEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecC
Q 021306 108 ELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 186 (314)
Q Consensus 108 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg 186 (314)
.+|+|||||+| +|.+.+.. .+.+++.+++.++.||+.||.|||+ +||+||||||+|||++. ++.+||+|||
T Consensus 100 --~~~ivmEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH~-~~IiHRDlKp~NILl~~-~g~vKl~DFG 171 (304)
T 3ubd_A 100 --KLYLILDFLRGGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHS-LGIIYRDLKPENILLDE-EGHIKLTDFG 171 (304)
T ss_dssp --EEEEEECCCTTCEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSSCCGGGEEECT-TSCEEEESSE
T ss_pred --EEEEEEEcCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCcCCCCCHHHeEEcC-CCCEEecccc
Confidence 48999999996 77776654 4789999999999999999999999 99999999999999998 8899999999
Q ss_pred cccccccC-CccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCC----
Q 021306 187 SAKQLIAG-EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT---- 261 (314)
Q Consensus 187 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~---- 261 (314)
+|+..... .......||+.|+|||.+.+.. ++.++|||||||++|+|+||+.||.+.+..+.+..+.+.....+
T Consensus 172 la~~~~~~~~~~~~~~GT~~YmAPE~~~~~~-y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s 250 (304)
T 3ubd_A 172 LSKESIDHEKKAYSFCGTVEYMAPEVVNRRG-HTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLS 250 (304)
T ss_dssp EEEC-----CCCCSCCCCGGGCCHHHHHTSC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSC
T ss_pred cceeccCCCccccccccCcccCCHHHhccCC-CCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCcCC
Confidence 99865432 3344578999999999997655 89999999999999999999999999998888888776533222
Q ss_pred ---HHHHh---ccCCCCCCCc-----ccccccCChhhhhc
Q 021306 262 ---REEIR---CMNPNYTDFR-----FPQIKAHPWHKVCI 290 (314)
Q Consensus 262 ---~~~~~---~~~p~~~~~~-----~~~l~~~p~~~~~~ 290 (314)
.+.+. ..+|. +|++ +++|++|||++..+
T Consensus 251 ~~~~~li~~~L~~dP~-~R~ta~~~~~~eil~Hp~f~~id 289 (304)
T 3ubd_A 251 PEAQSLLRMLFKRNPA-NRLGAGPDGVEEIKRHSFFSTID 289 (304)
T ss_dssp HHHHHHHHHHTCSSGG-GSTTCSTTTHHHHHTSGGGTTCC
T ss_pred HHHHHHHHHHcccCHH-HCCCCCcCCHHHHHcCccccCCC
Confidence 12222 33677 7887 47999999998654
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-52 Score=366.44 Aligned_cols=208 Identities=26% Similarity=0.371 Sum_probs=176.4
Q ss_pred CCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHhCCCCceeeeceeeeecCCCCceeEEEEee
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVME 116 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e 116 (314)
.+.|++.+.||+|+||.||+|+++.+|+.||+|+++.+.. ..+|+.++++++|||||++++++.+.. .+|+|||
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-~~~E~~il~~l~HpnIV~l~~~~~~~~-----~~~ivmE 130 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-RVEELVACAGLSSPRIVPLYGAVREGP-----WVNIFME 130 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-CTHHHHTTTTCCCTTBCCEEEEEEETT-----EEEEEEC
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-HHHHHHHHHhCCCCCCCcEEEEEEECC-----EEEEEEe
Confidence 4578999999999999999999999999999999976543 457999999999999999999985433 4889999
Q ss_pred cccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcccccccCC
Q 021306 117 YVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE 195 (314)
Q Consensus 117 ~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~~~~ 195 (314)
||+| +|.+.+.. .+++++.+++.++.||+.||.|||+ +||+||||||+|||++.++..+||+|||+++......
T Consensus 131 y~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH~-~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~ 205 (336)
T 4g3f_A 131 LLEGGSLGQLIKQ----MGCLPEDRALYYLGQALEGLEYLHT-RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG 205 (336)
T ss_dssp CCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHT-TTEECSCCCGGGEEECTTSCCEEECCCTTCEEC----
T ss_pred ccCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCC
Confidence 9996 77777654 4689999999999999999999999 9999999999999999834479999999998654322
Q ss_pred c------cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q 021306 196 A------NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 256 (314)
Q Consensus 196 ~------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~ 256 (314)
. ....+||+.|+|||.+.+.. ++.++|||||||++|||+||+.||.+.+..+.+..+...
T Consensus 206 ~~~~~~~~~~~~GT~~YmAPE~~~~~~-y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~ 271 (336)
T 4g3f_A 206 LGKSLLTGDYIPGTETHMAPEVVMGKP-CDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASE 271 (336)
T ss_dssp --------CCCCCCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHS
T ss_pred cccceecCCccccCccccCHHHHCCCC-CCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcC
Confidence 1 12346899999999997655 899999999999999999999999988776666666654
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-50 Score=351.55 Aligned_cols=261 Identities=22% Similarity=0.316 Sum_probs=208.9
Q ss_pred CCceeeeeEeecCceEEEEEEEC-----CCCcEEEEEEeeccc----cchHHHHHHHHhCCCCceeeeceeeeecCCCCc
Q 021306 38 ISYMAERVVGTGSFGIVFQAKCL-----ETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 108 (314)
Q Consensus 38 ~~y~~~~~Lg~g~~g~Vy~~~~~-----~~~~~~~vK~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 108 (314)
++|.+.+.||+|+||.||+|++. .++..||||.++... ..+.+|+.++++++|||||++++++.+..
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~---- 88 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGD---- 88 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS----
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC----
Confidence 57999999999999999999875 357899999986542 33568999999999999999999985433
Q ss_pred eeEEEEeecccc-cHHHHHHhhh---------hcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCC
Q 021306 109 LFLNLVMEYVPE-SMYRVLKHYS---------SANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH 178 (314)
Q Consensus 109 ~~~~lv~e~~~~-~l~~~l~~~~---------~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~ 178 (314)
.+++|||||++ +|.+.+.... .....+++.+++.++.|++.||.|||+ ++|+||||||+|||++. ++
T Consensus 89 -~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~-~~iiHRDlKp~NILl~~-~~ 165 (299)
T 4asz_A 89 -PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLAS-QHFVHRDLATRNCLVGE-NL 165 (299)
T ss_dssp -SEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECG-GG
T ss_pred -EEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCccCHhhEEECC-CC
Confidence 38899999995 7877776431 124579999999999999999999999 89999999999999998 88
Q ss_pred cEEEeecCcccccccCCc---cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 021306 179 QVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEII 254 (314)
Q Consensus 179 ~~~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~t-g~~pf~~~~~~~~~~~i~ 254 (314)
.+||+|||+++....... .....+|+.|+|||.+.+.. ++.++|||||||++|||+| |+.||.+.+..+.+..+.
T Consensus 166 ~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~-~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~ 244 (299)
T 4asz_A 166 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRK-FTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECIT 244 (299)
T ss_dssp CEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH
T ss_pred cEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 999999999976543322 22345799999999997655 8999999999999999999 999999998887777776
Q ss_pred HHcCCCCHHHHhccCCCCCCCcccccccCChhhhhcccCChHHHHHhcchhhhcCCCCCC
Q 021306 255 KVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGSHINAISPRHCD 314 (314)
Q Consensus 255 ~~~~~~~~~~~~~~~p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (314)
++...+. |......+.+|+..||...+..+++...+...++.+.-..|...|
T Consensus 245 ~~~~~~~--------p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~~p~~ld 296 (299)
T 4asz_A 245 QGRVLQR--------PRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKASPVYLD 296 (299)
T ss_dssp HTCCCCC--------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCCCSC
T ss_pred cCCCCCC--------CccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCCcccc
Confidence 5432221 111233577888899999988888888888888887776776554
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-50 Score=356.74 Aligned_cols=210 Identities=28% Similarity=0.468 Sum_probs=172.3
Q ss_pred CCccCCCceeeeeEeecCceEEEEEEEC---CCCcEEEEEEeecccc--chHHHHHHHHhC-CCCceeeeceeeeecCCC
Q 021306 33 EPKQTISYMAERVVGTGSFGIVFQAKCL---ETGETVAIKKVLQDRR--YKNRELQLMRVM-DHPNVISLKHCFFSTTSK 106 (314)
Q Consensus 33 ~~~~~~~y~~~~~Lg~g~~g~Vy~~~~~---~~~~~~~vK~~~~~~~--~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~ 106 (314)
.|...++|++.+.||+|+||.||+|+++ .+++.||+|.+.+... ...+|+.+++.+ .||||+++++++...
T Consensus 16 ~p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~--- 92 (361)
T 4f9c_A 16 VPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQCLTVAGGQDNVMGVKYCFRKN--- 92 (361)
T ss_dssp SGGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSCHHHHHHHHHHHHHTCSBTTBCCCSEEEEET---
T ss_pred cCCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccCHHHHHHHHHHHHHhcCCCCCceEEEEEEEC---
Confidence 3566788999999999999999999875 4678999998865433 345899999988 699999999998543
Q ss_pred CceeEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeec
Q 021306 107 NELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF 185 (314)
Q Consensus 107 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~df 185 (314)
.++++||||++| +|.+.+ +.+++.+++.++.||+.||.|||+ +||+||||||+|||++...+.+||+||
T Consensus 93 --~~~~lvmE~~~g~~L~~~~-------~~l~~~~~~~~~~qll~al~ylH~-~gIiHRDiKPeNiLl~~~~~~~kl~DF 162 (361)
T 4f9c_A 93 --DHVVIAMPYLEHESFLDIL-------NSLSFQEVREYMLNLFKALKRIHQ-FGIVHRDVKPSNFLYNRRLKKYALVDF 162 (361)
T ss_dssp --TEEEEEEECCCCCCHHHHH-------TTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEETTTTEEEECCC
T ss_pred --CEEEEEEeCCCcccHHHHH-------cCCCHHHHHHHHHHHHHHHHHHHH-CCeEeCcCCHHHeEEeCCCCeEEECcC
Confidence 348999999986 666554 358999999999999999999999 999999999999999885589999999
Q ss_pred CcccccccCCc-----------------------------cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh
Q 021306 186 GSAKQLIAGEA-----------------------------NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL 236 (314)
Q Consensus 186 g~~~~~~~~~~-----------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~t 236 (314)
|+|+....... .....||+.|+|||.+.+...++.++||||+||++|+|++
T Consensus 163 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~ 242 (361)
T 4f9c_A 163 GLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLS 242 (361)
T ss_dssp TTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHH
T ss_pred CCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHH
Confidence 99975432211 1234689999999999776668999999999999999999
Q ss_pred CCCCCCC-CChHHHHHHHHH
Q 021306 237 GQPLFPG-ENAVDQLVEIIK 255 (314)
Q Consensus 237 g~~pf~~-~~~~~~~~~i~~ 255 (314)
|+.||.. .+..+++..+++
T Consensus 243 G~~Pf~~~~~~~~~l~~I~~ 262 (361)
T 4f9c_A 243 GRYPFYKASDDLTALAQIMT 262 (361)
T ss_dssp TCSSSSCCSSHHHHHHHHHH
T ss_pred CCCCCCCCCCHHHHHHHHHH
Confidence 9999954 455556655554
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-50 Score=347.85 Aligned_cols=245 Identities=21% Similarity=0.350 Sum_probs=179.6
Q ss_pred CCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCC------
Q 021306 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSK------ 106 (314)
Q Consensus 38 ~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~------ 106 (314)
++|++.+.||+|+||.||+|+++.+|+.||+|+++... ....+|+.++++++|||||++++++...+..
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 57999999999999999999999999999999986432 2345899999999999999999998765432
Q ss_pred -CceeEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEee
Q 021306 107 -NELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICD 184 (314)
Q Consensus 107 -~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~d 184 (314)
...++|+|||||+| +|.+.+... ......++..++.++.||+.||.|||+ +||+||||||+|||++. ++.+||+|
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~-~~~~~~~~~~~~~i~~qi~~al~ylH~-~~IiHRDlKp~NILl~~-~~~vKl~D 161 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGR-CTIEERERSVCLHIFLQIAEAVEFLHS-KGLMHRDLKPSNIFFTM-DDVVKVGD 161 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTC-CSGGGSCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECT-TCCEEECC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhc-CCCChhHHHHHHHHHHHHHHHHHHHHH-CcCccccCcHHHeEECC-CCcEEEcc
Confidence 34467899999986 666666532 111235667789999999999999999 89999999999999998 78999999
Q ss_pred cCcccccccCCc-------------cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 021306 185 FGSAKQLIAGEA-------------NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLV 251 (314)
Q Consensus 185 fg~~~~~~~~~~-------------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~ 251 (314)
||+|+....... .....||+.|+|||.+.+.. ++.++|||||||++|||++ ||.+........
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~-y~~~~DiwSlGvilyell~---Pf~~~~~~~~~~ 237 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNS-YSHKVDIFSLGLILFELLY---PFSTQMERVRTL 237 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTTCC-CCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHH
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCC-CCCHHHHHHHHHHHHHHcc---CCCCccHHHHHH
Confidence 999986543221 12356899999999997654 8999999999999999996 886543222222
Q ss_pred HHHHHcCCCC---------HHHHh---ccCCCCCCCcccccccCChhhhhc
Q 021306 252 EIIKVLGTPT---------REEIR---CMNPNYTDFRFPQIKAHPWHKVCI 290 (314)
Q Consensus 252 ~i~~~~~~~~---------~~~~~---~~~p~~~~~~~~~l~~~p~~~~~~ 290 (314)
..+.....++ .+.+. ..+|. +|+++.++++|||++...
T Consensus 238 ~~~~~~~~p~~~~~~~~~~~~li~~~L~~dP~-~Rps~~eil~h~~~~~~~ 287 (299)
T 4g31_A 238 TDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPM-ERPEAINIIENAVFEDLD 287 (299)
T ss_dssp HHHHTTCCCHHHHHHCHHHHHHHHHHTCSSGG-GSCCHHHHHTSGGGCCC-
T ss_pred HHHhcCCCCCCCcccCHHHHHHHHHHcCCChh-HCcCHHHHhcCHhhCCCC
Confidence 2222222221 11222 23677 899999999999998653
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=349.88 Aligned_cols=262 Identities=22% Similarity=0.296 Sum_probs=203.0
Q ss_pred CCCceeeeeEeecCceEEEEEEEC-----CCCcEEEEEEeeccc----cchHHHHHHHHhCCCCceeeeceeeeecCCCC
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCL-----ETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKN 107 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~-----~~~~~~~vK~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 107 (314)
.++|.+.++||+|+||.||+|++. .+++.||||.++... ..+.+|+.++++++|||||++++++.+..
T Consensus 40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~--- 116 (329)
T 4aoj_A 40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGR--- 116 (329)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS---
T ss_pred HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC---
Confidence 457999999999999999999865 368899999986532 34568999999999999999999985433
Q ss_pred ceeEEEEeecccc-cHHHHHHhhhh-----------cCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcC
Q 021306 108 ELFLNLVMEYVPE-SMYRVLKHYSS-----------ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP 175 (314)
Q Consensus 108 ~~~~~lv~e~~~~-~l~~~l~~~~~-----------~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~ 175 (314)
.+++|||||++ +|.+.+..... ...++++.++..|+.|++.||.|||+ ++|+||||||+|||++.
T Consensus 117 --~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~-~~iiHRDLKp~NILl~~ 193 (329)
T 4aoj_A 117 --PLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG-LHFVHRDLATRNCLVGQ 193 (329)
T ss_dssp --SEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEET
T ss_pred --EEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhc-CCeecccccHhhEEECC
Confidence 38899999995 77777654321 23579999999999999999999999 89999999999999998
Q ss_pred CCCcEEEeecCcccccccCC---ccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHH
Q 021306 176 LTHQVKICDFGSAKQLIAGE---ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLV 251 (314)
Q Consensus 176 ~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~t-g~~pf~~~~~~~~~~ 251 (314)
++.+||+|||+++...... ......+|+.|+|||.+.+.. ++.++|||||||++|||+| |+.||.+.+..+.+.
T Consensus 194 -~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~-~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~ 271 (329)
T 4aoj_A 194 -GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRK-FTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAID 271 (329)
T ss_dssp -TTEEEECCCC----------------CCCCGGGCCHHHHTTCC-CCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHH
T ss_pred -CCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCC-CCccccccchHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 8899999999998653322 123356799999999997655 8999999999999999999 999999998887777
Q ss_pred HHHHHcCCCCHHHHhccCCCCCCCcccccccCChhhhhcccCChHHHHHhcchhhhcCCCCCC
Q 021306 252 EIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGSHINAISPRHCD 314 (314)
Q Consensus 252 ~i~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (314)
.+.+....+. |......+.+|+..||...+..+++...+.+.++.+.-.+|...|
T Consensus 272 ~i~~g~~~~~--------p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~pp~~ld 326 (329)
T 4aoj_A 272 CITQGRELER--------PRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLD 326 (329)
T ss_dssp HHHHTCCCCC--------CTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHSCC----
T ss_pred HHHcCCCCCC--------cccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhCCccccc
Confidence 7665432221 111334577888999999999998889898888888776665543
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-49 Score=341.70 Aligned_cols=253 Identities=22% Similarity=0.264 Sum_probs=202.7
Q ss_pred CCCceeeeeEeecCceEEEEEEEC-----CCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCC
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCL-----ETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSK 106 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~-----~~~~~~~vK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 106 (314)
..++++.+.||+|+||.||+|+.. .+++.||||.++... ..+.+|+.++++++|||||++++++....
T Consensus 25 ~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~-- 102 (308)
T 4gt4_A 25 LSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQ-- 102 (308)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS--
T ss_pred HHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECC--
Confidence 457899999999999999999863 467899999986432 34568999999999999999999985433
Q ss_pred CceeEEEEeecccc-cHHHHHHhhhh------------cCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEE
Q 021306 107 NELFLNLVMEYVPE-SMYRVLKHYSS------------ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLV 173 (314)
Q Consensus 107 ~~~~~~lv~e~~~~-~l~~~l~~~~~------------~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~ 173 (314)
.+++|||||++ +|.+.+..... ....+++.++..++.|++.||.|||+ ++|+||||||+|||+
T Consensus 103 ---~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~-~~iiHRDLK~~NILl 178 (308)
T 4gt4_A 103 ---PLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSS-HHVVHKDLATRNVLV 178 (308)
T ss_dssp ---SCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEE
T ss_pred ---EEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh-CCCCCCCccccceEE
Confidence 37899999995 78777754211 12469999999999999999999999 899999999999999
Q ss_pred cCCCCcEEEeecCcccccccCC---ccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHH
Q 021306 174 DPLTHQVKICDFGSAKQLIAGE---ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQ 249 (314)
Q Consensus 174 ~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~t-g~~pf~~~~~~~~ 249 (314)
+. ++.+||+|||+++...... ......+|+.|+|||.+.+.. ++.++|||||||++|||+| |..||.+.+..+.
T Consensus 179 ~~-~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~-~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~ 256 (308)
T 4gt4_A 179 YD-KLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGK-FSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDV 256 (308)
T ss_dssp CG-GGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHH
T ss_pred CC-CCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCC-CCccchhhhHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 98 8899999999998654322 223456799999999997655 9999999999999999998 8999999988777
Q ss_pred HHHHHHHcCCCCHHHHhccCCCCCCCcccccccCChhhhhcccCChHHHHHhcchh
Q 021306 250 LVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGSHI 305 (314)
Q Consensus 250 ~~~i~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~~~ 305 (314)
+..+.++...+. |......+.+|+..||...+..+++...+.+.++.+
T Consensus 257 ~~~i~~~~~~~~--------p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 257 VEMIRNRQVLPC--------PDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp HHHHHTTCCCCC--------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred HHHHHcCCCCCC--------cccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 766654432222 111333577889999999999998888888777654
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-49 Score=369.81 Aligned_cols=247 Identities=23% Similarity=0.352 Sum_probs=196.0
Q ss_pred CCCccCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc-------cchH---HHHHHHHhCCCCceeeeceeee
Q 021306 32 GEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKN---RELQLMRVMDHPNVISLKHCFF 101 (314)
Q Consensus 32 ~~~~~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~-------~~~~---~e~~~l~~l~h~~iv~~~~~~~ 101 (314)
..|...++|++.+.||+|+||.||+|+++.+|+.||+|.+.+.. .... +++.+++.++|||||+++++|.
T Consensus 183 ~~~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~ 262 (689)
T 3v5w_A 183 NIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFH 262 (689)
T ss_dssp TCCCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEE
T ss_pred CCCCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEE
Confidence 45677889999999999999999999999999999999986432 1112 3356667789999999999994
Q ss_pred ecCCCCceeEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcE
Q 021306 102 STTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQV 180 (314)
Q Consensus 102 ~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~ 180 (314)
+ ...+|+|||||+| +|...+.. .+.+++..++.++.||+.||.|||+ +||+||||||+|||++. ++.+
T Consensus 263 ~-----~~~lylVmEy~~GGdL~~~l~~----~~~l~E~~a~~y~~qIl~aL~yLH~-~gIiHRDLKPeNILld~-~G~v 331 (689)
T 3v5w_A 263 T-----PDKLSFILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMHN-RFVVYRDLKPANILLDE-HGHV 331 (689)
T ss_dssp C-----SSEEEEEECCCCSCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCSGGGEEECT-TSCE
T ss_pred E-----CCEEEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCchHHeEEeC-CCCE
Confidence 4 3448999999996 67766654 4789999999999999999999999 99999999999999998 8899
Q ss_pred EEeecCcccccccCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHHc
Q 021306 181 KICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA---VDQLVEIIKVL 257 (314)
Q Consensus 181 ~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~---~~~~~~i~~~~ 257 (314)
||+|||+|+..... .....+||+.|+|||++.+...++.++|+|||||++|||++|..||.+.+. .+....+....
T Consensus 332 KL~DFGlA~~~~~~-~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~ 410 (689)
T 3v5w_A 332 RISDLGLACDFSKK-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMA 410 (689)
T ss_dssp EECCCTTCEECSSC-CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCC
T ss_pred EecccceeeecCCC-CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCC
Confidence 99999999866443 334578999999999996555589999999999999999999999976432 22233333221
Q ss_pred CCC-------CHHHHh---ccCCCCCCCc-----ccccccCChhhhhcc
Q 021306 258 GTP-------TREEIR---CMNPNYTDFR-----FPQIKAHPWHKVCIF 291 (314)
Q Consensus 258 ~~~-------~~~~~~---~~~p~~~~~~-----~~~l~~~p~~~~~~~ 291 (314)
... ..+.+. ..+|. +|++ +++|++||||+..+.
T Consensus 411 ~~~p~~~S~~a~dLI~~lL~~dP~-~Rl~~~~~ga~ei~~HpfF~~idW 458 (689)
T 3v5w_A 411 VELPDSFSPELRSLLEGLLQRDVN-RRLGCLGRGAQEVKESPFFRSLDW 458 (689)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSCGG-GCTTCSSSTHHHHTTSGGGTTCCH
T ss_pred CCCCccCCHHHHHHHHHHccCCHh-HCCCCCCCCHHHHhcCccccCCCH
Confidence 111 112222 34777 7887 689999999987654
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-48 Score=337.86 Aligned_cols=256 Identities=23% Similarity=0.282 Sum_probs=195.4
Q ss_pred CCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCCcee
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 110 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 110 (314)
.+++++.+.||+|+||.||+|+.. ..||||.++... ..+.+|+.++++++|||||++++++.. . .
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~-----~ 105 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-D-----N 105 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-S-----S
T ss_pred HHHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-C-----e
Confidence 468899999999999999999854 358999886322 334689999999999999999997631 1 2
Q ss_pred EEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCccc
Q 021306 111 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 189 (314)
Q Consensus 111 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~ 189 (314)
+++|||||+| +|.+.+.. ...++++.++..|+.|++.||.|||+ ++|+||||||+|||++. ++.+||+|||+|+
T Consensus 106 ~~iVmEy~~gGsL~~~l~~---~~~~l~~~~~~~i~~qia~gL~yLH~-~~IiHRDlKp~NILl~~-~~~~Ki~DFGla~ 180 (307)
T 3omv_A 106 LAIVTQWCEGSSLYKHLHV---QETKFQMFQLIDIARQTAQGMDYLHA-KNIIHRDMKSNNIFLHE-GLTVKIGDFGLAT 180 (307)
T ss_dssp CEEEEECCSSCBHHHHHHT---SCCCCCHHHHHHHHHHHHHHHHHHHH-TTCBCSCCCSSSEEEET-TEEEEECCCSSCB
T ss_pred EEEEEEcCCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCccCCccCHHHEEECC-CCcEEEeeccCce
Confidence 6799999995 77776653 34679999999999999999999999 89999999999999998 8899999999997
Q ss_pred ccccCC---ccccccccccccccccccCC--CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcC-CCCHH
Q 021306 190 QLIAGE---ANISYICSRFYRAPELIFGA--TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLG-TPTRE 263 (314)
Q Consensus 190 ~~~~~~---~~~~~~~~~~y~aPE~~~~~--~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~-~~~~~ 263 (314)
...... ......||+.|+|||.+.+. ..++.++|||||||++|||+||+.||.+.+....+..++.... .+...
T Consensus 181 ~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~ 260 (307)
T 3omv_A 181 VKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLS 260 (307)
T ss_dssp C------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCST
T ss_pred ecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcc
Confidence 654321 23346789999999998643 3489999999999999999999999998877666666655432 22111
Q ss_pred HHhccCCCCCCCcccccccCChhhhhcccCChHHHHHhcchhhhcCC
Q 021306 264 EIRCMNPNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGSHINAISP 310 (314)
Q Consensus 264 ~~~~~~p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (314)
.+.+. ....+.+|+..||...+..+++...+++.++.++...|
T Consensus 261 ---~~~~~-~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~lp 303 (307)
T 3omv_A 261 ---KLYKN-CPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLP 303 (307)
T ss_dssp ---TSCTT-SCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTCC
T ss_pred ---ccccc-chHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccCC
Confidence 11111 22346677788888888888777777777666654443
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-48 Score=366.57 Aligned_cols=243 Identities=26% Similarity=0.408 Sum_probs=205.0
Q ss_pred CCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeEE
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 112 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 112 (314)
.++|++.+.||+|+||.||+|+++.+|+.||+|.+.... ....+|+.+|+.++||||++++++|.. ...++
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-----~~~~~ 230 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFED-----DNEMV 230 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEC-----SSEEE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEE-----CCEEE
Confidence 468999999999999999999999999999999986543 334689999999999999999999843 34489
Q ss_pred EEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCC-CCcEEEeecCcccc
Q 021306 113 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPL-THQVKICDFGSAKQ 190 (314)
Q Consensus 113 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~-~~~~~l~dfg~~~~ 190 (314)
+|||||+| +|.+.+.. ..+.+++.+++.++.||+.||.|||+ +||+||||||+|||++.. .+.+||+|||+++.
T Consensus 231 iv~E~~~gg~L~~~i~~---~~~~l~e~~~~~~~~qi~~al~ylH~-~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~ 306 (573)
T 3uto_A 231 MIYEFMSGGELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHMHE-NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAH 306 (573)
T ss_dssp EEEECCCCCBHHHHHTC---TTSCEEHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESSSSCCCEEECCCSSCEE
T ss_pred EEEeecCCCcHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeccCChhhccccCCCCCCEEEeeccceeE
Confidence 99999996 67666542 34689999999999999999999999 899999999999999862 47899999999988
Q ss_pred cccCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCH--------
Q 021306 191 LIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR-------- 262 (314)
Q Consensus 191 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~-------- 262 (314)
...........||+.|+|||.+.+.. ++.++|||||||++|+|++|..||.+.+..+.+..+.+.......
T Consensus 307 ~~~~~~~~~~~GT~~y~APEv~~~~~-y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 385 (573)
T 3uto_A 307 LDPKQSVKVTTGTAEFAAPEVAEGKP-VGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISE 385 (573)
T ss_dssp CCTTSEEEEECSSGGGCCHHHHTTCC-BCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCH
T ss_pred ccCCCceeeeEECccccCHHHhCCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCH
Confidence 76655556678999999999997655 899999999999999999999999999988888887765332221
Q ss_pred ---HHHh---ccCCCCCCCcccccccCChhhhhc
Q 021306 263 ---EEIR---CMNPNYTDFRFPQIKAHPWHKVCI 290 (314)
Q Consensus 263 ---~~~~---~~~p~~~~~~~~~l~~~p~~~~~~ 290 (314)
+.+. ..+|. +|+++.++++|||++...
T Consensus 386 ~~~dli~~~L~~dp~-~R~t~~e~l~Hpw~~~~~ 418 (573)
T 3uto_A 386 DGKDFIRKLLLADPN-TRMTIHQALEHPWLTPGN 418 (573)
T ss_dssp HHHHHHHTTSCSSGG-GSCCHHHHHHSTTTSCCC
T ss_pred HHHHHHHHHccCChh-HCcCHHHHhcCcCcCCCC
Confidence 2222 33677 899999999999998644
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=340.47 Aligned_cols=228 Identities=68% Similarity=1.201 Sum_probs=200.1
Q ss_pred cCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHhCCCCceeeeceeeeecCC-CCceeEEEE
Q 021306 36 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTS-KNELFLNLV 114 (314)
Q Consensus 36 ~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~~~~~~~lv 114 (314)
...+|++.+.||+|+||.||+|++..+++.||+|++..+.....+|+.+++.++|+||+++++++..... ....++++|
T Consensus 52 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv 131 (420)
T 1j1b_A 52 QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLV 131 (420)
T ss_dssp EEEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTTSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEE
T ss_pred ccceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEee
Confidence 3457999999999999999999999999999999998877777899999999999999999998765433 445677899
Q ss_pred eecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcccccccC
Q 021306 115 MEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG 194 (314)
Q Consensus 115 ~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~~~ 194 (314)
|||+++++.+.+..+......+++..++.++.||+.||.|||+ +||+||||||+|||++.+.+.+||+|||+++.....
T Consensus 132 ~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~~ 210 (420)
T 1j1b_A 132 LDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 210 (420)
T ss_dssp EECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT-TTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred hhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCChhhEEEeCCCCeEEeccchhhhhcccC
Confidence 9999999988888776777899999999999999999999999 899999999999999975678999999999876555
Q ss_pred CccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCHHH
Q 021306 195 EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 264 (314)
Q Consensus 195 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 264 (314)
.......+|+.|+|||.+.+...++.++|||||||++|||++|+.||.+.+..+.+.++++.++.+..+.
T Consensus 211 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~ 280 (420)
T 1j1b_A 211 EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 280 (420)
T ss_dssp CCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred CCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 5555677899999999997765689999999999999999999999999998889998888766654433
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-47 Score=336.85 Aligned_cols=255 Identities=25% Similarity=0.368 Sum_probs=202.0
Q ss_pred CCceeeeeEeecCceEEEEEEECCC-----CcEEEEEEeeccc-----cchHHHHHHHHhCCC-CceeeeceeeeecCCC
Q 021306 38 ISYMAERVVGTGSFGIVFQAKCLET-----GETVAIKKVLQDR-----RYKNRELQLMRVMDH-PNVISLKHCFFSTTSK 106 (314)
Q Consensus 38 ~~y~~~~~Lg~g~~g~Vy~~~~~~~-----~~~~~vK~~~~~~-----~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~ 106 (314)
++|++.+.||+|+||.||+|++..+ ++.||+|.++... ..+.+|+.++++++| ||||++++++....
T Consensus 64 ~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~-- 141 (353)
T 4ase_A 64 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG-- 141 (353)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTT--
T ss_pred HHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecC--
Confidence 6899999999999999999997654 3689999986532 334579999999976 89999999875432
Q ss_pred CceeEEEEeecccc-cHHHHHHhhhh------------cCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEE
Q 021306 107 NELFLNLVMEYVPE-SMYRVLKHYSS------------ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLV 173 (314)
Q Consensus 107 ~~~~~~lv~e~~~~-~l~~~l~~~~~------------~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~ 173 (314)
..+++|||||++ +|.+.+..... ....+++.++..++.|++.||.|||+ ++|+||||||+|||+
T Consensus 142 --~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~-~~iiHRDLK~~NILl 218 (353)
T 4ase_A 142 --GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS-RKCIHRDLAARNILL 218 (353)
T ss_dssp --SCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEE
T ss_pred --CEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhh-CCeecCccCccceee
Confidence 237899999995 78777765322 13458999999999999999999999 899999999999999
Q ss_pred cCCCCcEEEeecCcccccccCCc---cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHH
Q 021306 174 DPLTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQ 249 (314)
Q Consensus 174 ~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~t-g~~pf~~~~~~~~ 249 (314)
+. ++.+||+|||+|+....... .....+|+.|+|||.+.+.. ++.++|||||||++|||+| |+.||.+.+..+.
T Consensus 219 ~~-~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~-y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~ 296 (353)
T 4ase_A 219 SE-KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 296 (353)
T ss_dssp CG-GGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH
T ss_pred CC-CCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCC-CCCcccEeehHHHHHHHHhCCCCCCCCCCHHHH
Confidence 98 88999999999986543322 22456789999999997655 8999999999999999998 9999998776555
Q ss_pred HHHHHHHcCCCCHHHHhccCCCCCCCcccccccCChhhhhcccCChHHHHHhcchhh
Q 021306 250 LVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGSHIN 306 (314)
Q Consensus 250 ~~~i~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~~~~ 306 (314)
+..++.....+. .|+.....+.+++..||...+..+++...+++.+..+.
T Consensus 297 ~~~~i~~g~~~~-------~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~ll 346 (353)
T 4ase_A 297 FCRRLKEGTRMR-------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 346 (353)
T ss_dssp HHHHHHHTCCCC-------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHcCCCCC-------CCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 655555432221 12223345778888899998888888888888876653
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=332.37 Aligned_cols=253 Identities=49% Similarity=0.938 Sum_probs=217.3
Q ss_pred cCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHhCCCCceeeeceeeeecCC----------
Q 021306 36 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTS---------- 105 (314)
Q Consensus 36 ~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~---------- 105 (314)
..++|++.+.||+|+||.||+|++..+|+.||+|++..+.....+|+.+++.++|+||+++++++.....
T Consensus 5 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~ 84 (383)
T 3eb0_A 5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPD 84 (383)
T ss_dssp -CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTSCCHHHHHHTTCCCTTBCCEEEEEEEC------------
T ss_pred ccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcchHHHHHHHHHHcCCCCccchhheeeecCccccccccccc
Confidence 3568999999999999999999999999999999998887777899999999999999999998865432
Q ss_pred -----------------------CCceeEEEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCce
Q 021306 106 -----------------------KNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVC 162 (314)
Q Consensus 106 -----------------------~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~ 162 (314)
....++++||||++++|.+.+..+...+..+++..++.++.||+.||.|||+ +||+
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~gi~ 163 (383)
T 3eb0_A 85 DHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS-LGIC 163 (383)
T ss_dssp -------------------------CCEEEEEECCCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT-TTEE
T ss_pred ccccccccccccccccccccccCCCceEEEEEEecCCccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CcCc
Confidence 3345688999999999999998877778899999999999999999999999 8999
Q ss_pred ecCCCCCcEEEcCCCCcEEEeecCcccccccCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 021306 163 HRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFP 242 (314)
Q Consensus 163 h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~ 242 (314)
||||||+||+++..++.++|+|||++.............+++.|+|||.+.+...++.++||||||+++|+|++|+.||.
T Consensus 164 H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~ 243 (383)
T 3eb0_A 164 HRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFS 243 (383)
T ss_dssp CSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred cCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCC
Confidence 99999999999855789999999999876665556667789999999998776668999999999999999999999999
Q ss_pred CCChHHHHHHHHHHcCCCCHHH------------------------------------Hh---ccCCCCCCCcccccccC
Q 021306 243 GENAVDQLVEIIKVLGTPTREE------------------------------------IR---CMNPNYTDFRFPQIKAH 283 (314)
Q Consensus 243 ~~~~~~~~~~i~~~~~~~~~~~------------------------------------~~---~~~p~~~~~~~~~l~~~ 283 (314)
+.+..+.+..+++..+.+..+. +. ..+|. +|+++.++++|
T Consensus 244 ~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~-~R~t~~e~l~h 322 (383)
T 3eb0_A 244 GETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPD-LRINPYEAMAH 322 (383)
T ss_dssp CSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGG-GSCCHHHHHTS
T ss_pred CCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChh-hCCCHHHHhcC
Confidence 9999999999988766654322 11 22566 78999999999
Q ss_pred Chhhhhc
Q 021306 284 PWHKVCI 290 (314)
Q Consensus 284 p~~~~~~ 290 (314)
||++...
T Consensus 323 p~f~~~~ 329 (383)
T 3eb0_A 323 PFFDHLR 329 (383)
T ss_dssp GGGHHHH
T ss_pred HHHHHHH
Confidence 9988654
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=331.88 Aligned_cols=260 Identities=61% Similarity=1.060 Sum_probs=219.7
Q ss_pred cCCCCCCccCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHhCCCCceeeeceeeeecCC-C
Q 021306 28 GGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTS-K 106 (314)
Q Consensus 28 ~~~~~~~~~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~ 106 (314)
.+..+.. ...+|++.+.||+|+||.||+|++..+++ +++|++........+|+.+++.++|+||+++++++..... .
T Consensus 31 ~~~~~~~-~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~ 108 (394)
T 4e7w_A 31 DGKTGEQ-REIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKK 108 (394)
T ss_dssp ESSSCCE-EEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTSCCHHHHHHHTCCCTTBCCEEEEEEEESSSS
T ss_pred CCCCCCc-ccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcchHHHHHHHHHhCCCCCcceEEEEEEecCCCC
Confidence 3344433 34589999999999999999999876665 8999888777777899999999999999999999876554 4
Q ss_pred CceeEEEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecC
Q 021306 107 NELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 186 (314)
Q Consensus 107 ~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg 186 (314)
...++++||||+++++...+..+......+++..++.++.||+.||.|||+ +||+||||||+||+++..++.++|+|||
T Consensus 109 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~Nill~~~~~~~kL~DFG 187 (394)
T 4e7w_A 109 DEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHS-IGICHRDIKPQNLLLDPPSGVLKLIDFG 187 (394)
T ss_dssp SCEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred CceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH-CCccCCCCCHHHEEEcCCCCcEEEeeCC
Confidence 566788999999999888887776677899999999999999999999999 8999999999999999548899999999
Q ss_pred cccccccCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCHHHH-
Q 021306 187 SAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI- 265 (314)
Q Consensus 187 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~- 265 (314)
+++............+|+.|+|||.+.+...++.++|||||||++|+|++|+.||.+.+..+.+..+++..+.+..+.+
T Consensus 188 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~ 267 (394)
T 4e7w_A 188 SAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIK 267 (394)
T ss_dssp TCEECCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred CcccccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 9987665555666788999999999977666899999999999999999999999999999999998887665543321
Q ss_pred -----------------------------------h---ccCCCCCCCcccccccCChhhhhcc
Q 021306 266 -----------------------------------R---CMNPNYTDFRFPQIKAHPWHKVCIF 291 (314)
Q Consensus 266 -----------------------------------~---~~~p~~~~~~~~~l~~~p~~~~~~~ 291 (314)
. ..+|. +|+++.++++|||++....
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~-~R~t~~e~l~hp~f~~~~~ 330 (394)
T 4e7w_A 268 TMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPS-ARLTAIEALCHPFFDELRT 330 (394)
T ss_dssp HHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGG-GSCCHHHHHTSGGGSTTTS
T ss_pred hhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChh-hCCCHHHHhcChhhhhhcc
Confidence 1 22565 7999999999999876544
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=324.46 Aligned_cols=244 Identities=28% Similarity=0.438 Sum_probs=203.2
Q ss_pred ccCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCCc
Q 021306 35 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 108 (314)
Q Consensus 35 ~~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 108 (314)
...++|++.+.||+|+||.||+|++..+|+.||+|++.... ....+|+.+++.++||||+++++++...
T Consensus 12 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~----- 86 (328)
T 3fe3_A 12 PHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETE----- 86 (328)
T ss_dssp CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECS-----
T ss_pred CccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC-----
Confidence 34568999999999999999999999999999999986542 2235899999999999999999988433
Q ss_pred eeEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCc
Q 021306 109 LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 187 (314)
Q Consensus 109 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~ 187 (314)
..+++||||++| +|.+.+.. .+.+++.+++.++.|++.||.|||+ +||+||||||+||+++. ++.++|+|||+
T Consensus 87 ~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH~-~~ivHrDlkp~NIll~~-~~~~kl~DFG~ 160 (328)
T 3fe3_A 87 KTLYLIMEYASGGEVFDYLVA----HGRMKEKEARSKFRQIVSAVQYCHQ-KRIVHRDLKAENLLLDA-DMNIKIADFGF 160 (328)
T ss_dssp SEEEEEECCCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECT-TSCEEECSTTC
T ss_pred CEEEEEEECCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCEeccCCCHHHEEEcC-CCCEEEeeccC
Confidence 348899999975 77776654 3679999999999999999999999 89999999999999998 88999999999
Q ss_pred ccccccCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCC------
Q 021306 188 AKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT------ 261 (314)
Q Consensus 188 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~------ 261 (314)
+.............+|+.|+|||.+.+....+.++||||||+++|+|++|+.||.+.+..+....+.......+
T Consensus 161 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~ 240 (328)
T 3fe3_A 161 SNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTD 240 (328)
T ss_dssp CGGGSSSCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHH
T ss_pred ceecCCCCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHH
Confidence 98765555555677899999999998766456899999999999999999999999988777776665432221
Q ss_pred -HHHHh---ccCCCCCCCcccccccCChhhhhc
Q 021306 262 -REEIR---CMNPNYTDFRFPQIKAHPWHKVCI 290 (314)
Q Consensus 262 -~~~~~---~~~p~~~~~~~~~l~~~p~~~~~~ 290 (314)
.+.+. ..+|. +|++++++++|||++...
T Consensus 241 ~~~li~~~L~~dP~-~R~t~~eil~h~~~~~~~ 272 (328)
T 3fe3_A 241 CENLLKRFLVLNPI-KRGTLEQIMKDRWINAGH 272 (328)
T ss_dssp HHHHHHHHCCSSTT-TSCCHHHHTTCTTTTTTC
T ss_pred HHHHHHHHCCCChh-HCcCHHHHhcCHhhcCCC
Confidence 12222 34777 899999999999997643
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-45 Score=337.29 Aligned_cols=242 Identities=33% Similarity=0.574 Sum_probs=200.4
Q ss_pred CCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCC-CCce
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTS-KNEL 109 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~~~~ 109 (314)
.++|++.+.||+|+||.||+|++..+++.||+|++.... ....+|+.+++.++||||+++++++..... ....
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 568999999999999999999999999999999986532 233589999999999999999999854432 2234
Q ss_pred eEEEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCccc
Q 021306 110 FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 189 (314)
Q Consensus 110 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~ 189 (314)
.+++||||+++++.+.+. ..+++..++.++.||+.||.|||+ +||+||||||+||+++. ++.++|+|||+++
T Consensus 141 ~~~lv~E~~~~~l~~~~~------~~l~~~~~~~~~~qil~aL~~lH~-~~iiHrDlkp~NIll~~-~~~~kl~DFG~a~ 212 (464)
T 3ttj_A 141 DVYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKS-DCTLKILDFGLAR 212 (464)
T ss_dssp EEEEEEECCSEEHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECT-TSCEEECCCCCC-
T ss_pred eEEEEEeCCCCCHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCChHhEEEeC-CCCEEEEEEEeee
Confidence 578999999999877664 459999999999999999999999 89999999999999998 8899999999998
Q ss_pred ccccCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCHH------
Q 021306 190 QLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE------ 263 (314)
Q Consensus 190 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~------ 263 (314)
............+|+.|+|||.+.+.. ++.++|||||||++|+|++|+.||.+.+..+++..+++.++.+.+.
T Consensus 213 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~ 291 (464)
T 3ttj_A 213 TAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 291 (464)
T ss_dssp ----CCCC----CCCTTCCHHHHTTCC-CCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSC
T ss_pred ecCCCcccCCCcccccccCHHHHcCCC-CCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcc
Confidence 765554455678899999999997654 8999999999999999999999999999999999988877665322
Q ss_pred -------------------------------------------HHh---ccCCCCCCCcccccccCChhhh
Q 021306 264 -------------------------------------------EIR---CMNPNYTDFRFPQIKAHPWHKV 288 (314)
Q Consensus 264 -------------------------------------------~~~---~~~p~~~~~~~~~l~~~p~~~~ 288 (314)
.+. ..+|. +|+++.++++|||++.
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~-~R~ta~e~L~Hp~~~~ 361 (464)
T 3ttj_A 292 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPA-KRISVDDALQHPYINV 361 (464)
T ss_dssp HHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTT-TSCCHHHHHTSTTTGG
T ss_pred hhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChh-hCCCHHHHhcChhhhh
Confidence 111 33777 8999999999999974
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=325.52 Aligned_cols=256 Identities=20% Similarity=0.242 Sum_probs=186.1
Q ss_pred CCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccccc-hH--HHHHHHHhCCCCceeeeceeeeecCCCCceeEEEE
Q 021306 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY-KN--RELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLV 114 (314)
Q Consensus 38 ~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~~~-~~--~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 114 (314)
.+|.+.+.||+|+||.||+|++ +|+.||||+++..... .. .|+..+.+++|||||++++++..... ....+++|
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~-~~~~~~lV 79 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNG-TWTQLWLV 79 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECS-SSEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCC-CceEEEEE
Confidence 4689999999999999999987 6899999998654322 22 34555567899999999999865432 22347899
Q ss_pred eecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCC--------CceecCCCCCcEEEcCCCCcEEEeec
Q 021306 115 MEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP--------RVCHRDLKPQNLLVDPLTHQVKICDF 185 (314)
Q Consensus 115 ~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~--------~i~h~dl~p~Nil~~~~~~~~~l~df 185 (314)
||||++ +|.+.+.. .++++..+..++.|++.||.|||+ + +|+||||||+|||++. ++.+||+||
T Consensus 80 ~Ey~~~gsL~~~l~~-----~~l~~~~~~~i~~~ia~gl~ylH~-~~~~~~~~~~IiHRDlKp~NILl~~-~~~~Ki~DF 152 (303)
T 3hmm_A 80 SDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHM-EIVGTQGKPAIAHRDLKSKNILVKK-NGTCCIADL 152 (303)
T ss_dssp EECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHC-CBCSTTCBCCEECSCCCGGGEEECT-TSCEEECCC
T ss_pred ecCCCCCcHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHH-hhhhccCCCCEeeccCCcccEEECC-CCCEEEEeC
Confidence 999995 77777753 579999999999999999999997 6 9999999999999998 889999999
Q ss_pred CcccccccCCc-----cccccccccccccccccCCC-----CCCcchhHHHHHHHHHHHHhCCCCCCCCCh---------
Q 021306 186 GSAKQLIAGEA-----NISYICSRFYRAPELIFGAT-----EYTTSIDIWSAGCVLAELLLGQPLFPGENA--------- 246 (314)
Q Consensus 186 g~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~-----~~~~~~Dv~slG~il~el~tg~~pf~~~~~--------- 246 (314)
|+++....... .....||+.|+|||.+.+.. .++.++|||||||++|||+||..||.....
T Consensus 153 Gla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~ 232 (303)
T 3hmm_A 153 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV 232 (303)
T ss_dssp TTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTS
T ss_pred CCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcc
Confidence 99986544322 12356899999999986542 256799999999999999999776533211
Q ss_pred -----HHHHHHHH-HHcCCC-CHHHHhccCCCCCCCcccccccCChhhhhcccCChHHHHHhcchhh
Q 021306 247 -----VDQLVEII-KVLGTP-TREEIRCMNPNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGSHIN 306 (314)
Q Consensus 247 -----~~~~~~i~-~~~~~~-~~~~~~~~~p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~~~~ 306 (314)
.+.+...+ .....+ .+.... +++ ....+.+|+..||...+..+++...+.+.++.+.
T Consensus 233 ~~~~~~~~~~~~~~~~~~rp~~p~~~~--~~~-~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~ 296 (303)
T 3hmm_A 233 PSDPSVEEMRKVVCEQKLRPNIPNRWQ--SCE-ALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296 (303)
T ss_dssp CSSCCHHHHHHHHTTSCCCCCCCGGGG--SSH-HHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred cccchHHHHHHHHhcccCCCCCCcccc--chH-HHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 11122111 111011 111000 000 0013567899999999999999888888876553
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-45 Score=320.27 Aligned_cols=246 Identities=36% Similarity=0.674 Sum_probs=202.2
Q ss_pred ccCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCCc
Q 021306 35 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 108 (314)
Q Consensus 35 ~~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 108 (314)
...++|++.+.||+|+||.||+|++. +++.||+|.+.... ....+|+.++++++||||+++++++.. .
T Consensus 18 ~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~ 91 (311)
T 3niz_A 18 GLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHS-----E 91 (311)
T ss_dssp CSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECC-----S
T ss_pred chHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEcc-----C
Confidence 34578999999999999999999975 68999999986432 234589999999999999999999843 3
Q ss_pred eeEEEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcc
Q 021306 109 LFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 188 (314)
Q Consensus 109 ~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~ 188 (314)
..+++||||+++++.+.+.. ....+++..++.++.|++.||.|||+ +||+||||||+||+++. ++.++|+|||++
T Consensus 92 ~~~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivH~Dikp~NIl~~~-~~~~kl~Dfg~a 166 (311)
T 3niz_A 92 RCLTLVFEFMEKDLKKVLDE---NKTGLQDSQIKIYLYQLLRGVAHCHQ-HRILHRDLKPQNLLINS-DGALKLADFGLA 166 (311)
T ss_dssp SCEEEEEECCSEEHHHHHHT---CTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECT-TCCEEECCCTTC
T ss_pred CEEEEEEcCCCCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCchHhEEECC-CCCEEEccCcCc
Confidence 34889999999998887764 34569999999999999999999999 89999999999999998 789999999999
Q ss_pred cccccCC-ccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCH-----
Q 021306 189 KQLIAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR----- 262 (314)
Q Consensus 189 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~----- 262 (314)
....... ......+|+.|+|||.+.+...++.++||||||+++|+|++|+.||.+.+..+.+..+.+..+.+.+
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 246 (311)
T 3niz_A 167 RAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQ 246 (311)
T ss_dssp EETTSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGG
T ss_pred eecCCCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhh
Confidence 7654332 2234567999999999877666899999999999999999999999998887778777775544322
Q ss_pred --------------------------------HHHh---ccCCCCCCCcccccccCChhhhhccc
Q 021306 263 --------------------------------EEIR---CMNPNYTDFRFPQIKAHPWHKVCIFH 292 (314)
Q Consensus 263 --------------------------------~~~~---~~~p~~~~~~~~~l~~~p~~~~~~~~ 292 (314)
+.+. ..+|. +|+++.++++|||++....+
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~-~Rpt~~ell~hp~f~~~~~~ 310 (311)
T 3niz_A 247 VQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPN-KRISARDAMNHPYFKDLDPQ 310 (311)
T ss_dssp GTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTT-TSCCHHHHHTSGGGTTSCTT
T ss_pred hhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChh-HCCCHHHHhcCcccccCCcc
Confidence 1222 34677 89999999999999987654
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-45 Score=318.52 Aligned_cols=250 Identities=31% Similarity=0.536 Sum_probs=204.1
Q ss_pred cCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc---------cchHHHHHHHHhC---CCCceeeeceeeeec
Q 021306 36 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---------RYKNRELQLMRVM---DHPNVISLKHCFFST 103 (314)
Q Consensus 36 ~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~---------~~~~~e~~~l~~l---~h~~iv~~~~~~~~~ 103 (314)
..++|++.+.||+|+||.||+|++..+++.||+|.+.... ....+|+.+++++ +||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 3568999999999999999999999999999999986432 2345677777666 499999999998776
Q ss_pred CCCCceeEEEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEe
Q 021306 104 TSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKIC 183 (314)
Q Consensus 104 ~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~ 183 (314)
.......+++++||+.++|.+.+... ....+++.+++.++.|++.||.|||+ +||+|+||||+||+++. ++.++|+
T Consensus 87 ~~~~~~~~~lv~e~~~~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~Dlkp~Nil~~~-~~~~kl~ 162 (308)
T 3g33_A 87 RTDREIKVTLVFEHVDQDLRTYLDKA--PPPGLPAETIKDLMRQFLRGLDFLHA-NCIVHRDLKPENILVTS-GGTVKLA 162 (308)
T ss_dssp CSSSEEEEEEEEECCCCBHHHHHHTC--CTTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCTTTEEECT-TSCEEEC
T ss_pred CCCCceeEEEEehhhhcCHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEEcC-CCCEEEe
Confidence 65566678899999999988877652 22349999999999999999999999 89999999999999998 7899999
Q ss_pred ecCcccccccCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCH-
Q 021306 184 DFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR- 262 (314)
Q Consensus 184 dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~- 262 (314)
|||++.............+|+.|+|||.+.+.. ++.++||||||+++|+|++|+.||.+.+..+.+..+.+..+.+..
T Consensus 163 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 241 (308)
T 3g33_A 163 DFGLARIYSYQMALTPVVVTLWYRAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPED 241 (308)
T ss_dssp SCSCTTTSTTCCCSGGGGCCCSSCCHHHHHTSC-CCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred eCccccccCCCcccCCccccccccCchHHcCCC-CCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence 999998765555555677899999999997655 899999999999999999999999999998888888876543321
Q ss_pred ---------------------------------HHHh---ccCCCCCCCcccccccCChhhhhcc
Q 021306 263 ---------------------------------EEIR---CMNPNYTDFRFPQIKAHPWHKVCIF 291 (314)
Q Consensus 263 ---------------------------------~~~~---~~~p~~~~~~~~~l~~~p~~~~~~~ 291 (314)
+.+. ..+|. +|+++.++++|||++....
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~-~R~t~~e~l~h~~~~~~~~ 305 (308)
T 3g33_A 242 DWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPH-KRISAFRALQHSYLHKDEG 305 (308)
T ss_dssp TSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTT-TSCCHHHHHTSTTC-----
T ss_pred hccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCc-cCCCHHHHhcCccccCCCC
Confidence 1222 34677 8999999999999987543
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-45 Score=314.86 Aligned_cols=242 Identities=35% Similarity=0.612 Sum_probs=200.3
Q ss_pred CCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeE
Q 021306 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 111 (314)
Q Consensus 38 ~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 111 (314)
++|++.+.||+|+||.||+|++..+++.||+|.+.... ....+|+.++++++||||+++++++.... .+
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~ 76 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDK-----KL 76 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT-----EE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCC-----EE
Confidence 58999999999999999999999999999999986443 23358999999999999999999985433 48
Q ss_pred EEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCccccc
Q 021306 112 NLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 191 (314)
Q Consensus 112 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~ 191 (314)
++||||+++++.+.+.. .+..+++..++.++.|++.||.|||+ +||+|+||||+||+++. ++.++|+|||++...
T Consensus 77 ~lv~e~~~~~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH~-~~ivH~dikp~Nil~~~-~~~~kl~Dfg~~~~~ 151 (292)
T 3o0g_A 77 TLVFEFCDQDLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHS-RNVLHRDLKPQNLLINR-NGELKLANFGLARAF 151 (292)
T ss_dssp EEEEECCSEEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECT-TSCEEECCCTTCEEC
T ss_pred EEEEecCCCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcC-CCCEEEeecccceec
Confidence 89999999998777654 35789999999999999999999999 89999999999999998 889999999999765
Q ss_pred ccCC-ccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCC-CCCCChHHHHHHHHHHcCCCCH-------
Q 021306 192 IAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL-FPGENAVDQLVEIIKVLGTPTR------- 262 (314)
Q Consensus 192 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~p-f~~~~~~~~~~~i~~~~~~~~~------- 262 (314)
.... ......+|+.|+|||.+.+...++.++||||||+++|+|++|..| |.+.+..+.+..+.+..+.+..
T Consensus 152 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 231 (292)
T 3o0g_A 152 GIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMT 231 (292)
T ss_dssp CSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGG
T ss_pred CCccccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhc
Confidence 4322 233456789999999997766689999999999999999998777 6667777777777765544321
Q ss_pred -----------------------------HHHh---ccCCCCCCCcccccccCChhhhhc
Q 021306 263 -----------------------------EEIR---CMNPNYTDFRFPQIKAHPWHKVCI 290 (314)
Q Consensus 263 -----------------------------~~~~---~~~p~~~~~~~~~l~~~p~~~~~~ 290 (314)
+.+. ..+|. +|+++.++++|||++...
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~-~R~t~~e~l~hp~f~~~~ 290 (292)
T 3o0g_A 232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPV-QRISAEEALQHPYFSDFC 290 (292)
T ss_dssp GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGG-GSCCHHHHHTSGGGTTC-
T ss_pred ccccccccccccCCcchhhcccccChHHHHHHHHHhccChh-hCCCHHHHhcCcccccCC
Confidence 2222 33677 899999999999998654
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-45 Score=324.56 Aligned_cols=244 Identities=25% Similarity=0.396 Sum_probs=202.0
Q ss_pred ccCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc----------cchHHHHHHHHhCCCCceeeeceeeeecC
Q 021306 35 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----------RYKNRELQLMRVMDHPNVISLKHCFFSTT 104 (314)
Q Consensus 35 ~~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~----------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 104 (314)
...+.|++.+.||+|+||.||+|+++.+|+.||+|.+++.. ....+|+.++++++||||+++++++..
T Consensus 9 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-- 86 (361)
T 2yab_A 9 KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYEN-- 86 (361)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEEC--
T ss_pred ChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEe--
Confidence 34568999999999999999999999999999999986542 234689999999999999999999843
Q ss_pred CCCceeEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCC---cE
Q 021306 105 SKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH---QV 180 (314)
Q Consensus 105 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~---~~ 180 (314)
...+++||||++| +|.+.+. ....+++..++.++.||+.||.|||+ +||+|+||||+||+++..+. .+
T Consensus 87 ---~~~~~lv~e~~~gg~L~~~l~----~~~~l~~~~~~~i~~qi~~aL~~LH~-~givHrDlkp~NIll~~~~~~~~~v 158 (361)
T 2yab_A 87 ---RTDVVLILELVSGGELFDFLA----QKESLSEEEATSFIKQILDGVNYLHT-KKIAHFDLKPENIMLLDKNIPIPHI 158 (361)
T ss_dssp ---SSEEEEEEECCCSCBHHHHHT----TCSCCBHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEESCTTSSSCCE
T ss_pred ---CCEEEEEEEcCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEEeCCCCCccCE
Confidence 3348899999975 6766654 35789999999999999999999999 89999999999999987332 79
Q ss_pred EEeecCcccccccCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCC
Q 021306 181 KICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 260 (314)
Q Consensus 181 ~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~ 260 (314)
+|+|||++.............||+.|+|||.+.+.. ++.++||||||+++|+|++|..||.+.+..+.+..+.+.....
T Consensus 159 kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~ 237 (361)
T 2yab_A 159 KLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEP-LGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDF 237 (361)
T ss_dssp EECCCSSCEECCTTCCCCCCCSCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCC
T ss_pred EEEecCCceEcCCCCccccCCCCccEECchHHcCCC-CCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC
Confidence 999999998765554445567899999999996544 8999999999999999999999999988887777776543322
Q ss_pred CH-----------HHHh---ccCCCCCCCcccccccCChhhhhc
Q 021306 261 TR-----------EEIR---CMNPNYTDFRFPQIKAHPWHKVCI 290 (314)
Q Consensus 261 ~~-----------~~~~---~~~p~~~~~~~~~l~~~p~~~~~~ 290 (314)
.. +.+. ..+|. +|+++.++++|||++...
T Consensus 238 ~~~~~~~~s~~~~~li~~~L~~dP~-~R~t~~e~l~hp~~~~~~ 280 (361)
T 2yab_A 238 DEEFFSQTSELAKDFIRKLLVKETR-KRLTIQEALRHPWITPVD 280 (361)
T ss_dssp CHHHHTTSCHHHHHHHHHHSCSSTT-TSCCHHHHHTSTTTSCSS
T ss_pred CchhccCCCHHHHHHHHHHCCCChh-HCcCHHHHhcCcCcCCCc
Confidence 22 1222 33677 899999999999998543
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=317.40 Aligned_cols=248 Identities=34% Similarity=0.637 Sum_probs=190.9
Q ss_pred CCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeE
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 111 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 111 (314)
.++|++.+.||+|+||.||+|.+..+++.||+|.++... ....+|+.++++++||||+++++++.. ...+
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~~~~ 78 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHT-----ENKL 78 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECC-----TTEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEE-----CCeE
Confidence 357999999999999999999999999999999986432 234589999999999999999999843 3348
Q ss_pred EEEeecccccHHHHHHhhhhc--CCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCccc
Q 021306 112 NLVMEYVPESMYRVLKHYSSA--NQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 189 (314)
Q Consensus 112 ~lv~e~~~~~l~~~l~~~~~~--~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~ 189 (314)
++||||++++|.+.+...... ...+++..++.++.||+.||.|||+ +||+||||||+||+++. ++.++|+|||++.
T Consensus 79 ~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~-~~ivH~Dlkp~NIl~~~-~~~~kl~Dfg~~~ 156 (317)
T 2pmi_A 79 TLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE-NKILHRDLKPQNLLINK-RGQLKLGDFGLAR 156 (317)
T ss_dssp EEEEECCCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECT-TCCEEECCCSSCE
T ss_pred EEEEEecCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCChHHeEEcC-CCCEEECcCccce
Confidence 899999999988887654322 2469999999999999999999999 89999999999999998 7899999999997
Q ss_pred ccccCC-ccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCH------
Q 021306 190 QLIAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR------ 262 (314)
Q Consensus 190 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~------ 262 (314)
...... ......+|+.|+|||.+.+...++.++||||||+++|+|++|+.||.+.+..+.+..+.+..+.+..
T Consensus 157 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 236 (317)
T 2pmi_A 157 AFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSV 236 (317)
T ss_dssp ETTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGG
T ss_pred ecCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhh
Confidence 654322 2234567999999999976556899999999999999999999999999988888877765443211
Q ss_pred -----------------------------------HHH---hccCCCCCCCcccccccCChhhhhccc
Q 021306 263 -----------------------------------EEI---RCMNPNYTDFRFPQIKAHPWHKVCIFH 292 (314)
Q Consensus 263 -----------------------------------~~~---~~~~p~~~~~~~~~l~~~p~~~~~~~~ 292 (314)
+.+ ...+|. +|+++.++++|||++.....
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~-~Rpt~~e~l~hp~f~~~~~~ 303 (317)
T 2pmi_A 237 TKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPD-MRLSAKQALHHPWFAEYYHH 303 (317)
T ss_dssp GGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGG-GSCCHHHHTTSGGGGGGCC-
T ss_pred hhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcc-cCCCHHHHhCChhhhcccch
Confidence 111 133666 89999999999999987654
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=326.43 Aligned_cols=216 Identities=32% Similarity=0.665 Sum_probs=174.6
Q ss_pred cCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhCC-CCceeeeceeeeecCCCCc
Q 021306 36 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMD-HPNVISLKHCFFSTTSKNE 108 (314)
Q Consensus 36 ~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~------~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~ 108 (314)
..++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+|+.+++.+. |+||+++++++.... .
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~---~ 83 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADN---D 83 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTT---S
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCC---C
Confidence 3468999999999999999999999999999999885432 22347889999997 999999999885432 2
Q ss_pred eeEEEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcc
Q 021306 109 LFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 188 (314)
Q Consensus 109 ~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~ 188 (314)
..+++||||++++|...+.. ..+++..++.++.||+.||.|||+ .||+||||||+||+++. ++.++|+|||++
T Consensus 84 ~~~~lv~e~~~~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~-~~ivHrDlkp~NIll~~-~~~~kl~DFG~a 156 (388)
T 3oz6_A 84 RDVYLVFDYMETDLHAVIRA-----NILEPVHKQYVVYQLIKVIKYLHS-GGLLHRDMKPSNILLNA-ECHVKVADFGLS 156 (388)
T ss_dssp SCEEEEEECCSEEHHHHHHH-----TCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECT-TCCEEECCCTTC
T ss_pred CEEEEEecccCcCHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHh-CCEEeCCCCHHHeEEcC-CCCEEecCCccc
Confidence 34789999999998877764 579999999999999999999999 89999999999999998 889999999999
Q ss_pred cccccC----------------------CccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCh
Q 021306 189 KQLIAG----------------------EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA 246 (314)
Q Consensus 189 ~~~~~~----------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~ 246 (314)
+..... .......+|+.|+|||.+.+...++.++|||||||++|+|++|+.||.+.+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~ 236 (388)
T 3oz6_A 157 RSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSST 236 (388)
T ss_dssp EESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred ccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 754321 1122356899999999997766689999999999999999999999999999
Q ss_pred HHHHHHHHHHcCCCC
Q 021306 247 VDQLVEIIKVLGTPT 261 (314)
Q Consensus 247 ~~~~~~i~~~~~~~~ 261 (314)
.+++..++...+.+.
T Consensus 237 ~~~~~~i~~~~~~p~ 251 (388)
T 3oz6_A 237 MNQLERIIGVIDFPS 251 (388)
T ss_dssp HHHHHHHHHHHCCCC
T ss_pred HHHHHHHHHhcCCCC
Confidence 888888887665544
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=312.33 Aligned_cols=239 Identities=34% Similarity=0.658 Sum_probs=196.0
Q ss_pred CCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeE
Q 021306 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 111 (314)
Q Consensus 38 ~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 111 (314)
++|++.+.||+|+||.||+|++ .+++.+|+|++.... ....+|+.++++++||||+++++++.... ..
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~ 75 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKK-----RL 75 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSS-----CE
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCC-----eE
Confidence 5899999999999999999997 678999999986432 23358999999999999999999985433 38
Q ss_pred EEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCccccc
Q 021306 112 NLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 191 (314)
Q Consensus 112 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~ 191 (314)
++||||+++++.+.+.. ....+++..++.++.|++.||.|||+ +||+|+||||+||+++. ++.++|+|||++...
T Consensus 76 ~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nil~~~-~~~~kl~Dfg~~~~~ 150 (288)
T 1ob3_A 76 VLVFEHLDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHD-RRVLHRDLKPQNLLINR-EGELKIADFGLARAF 150 (288)
T ss_dssp EEEEECCSEEHHHHHHT---STTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECT-TSCEEECCTTHHHHH
T ss_pred EEEEEecCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEEcC-CCCEEEeECcccccc
Confidence 89999999998887764 24679999999999999999999999 89999999999999998 889999999998765
Q ss_pred ccCC-ccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCH--------
Q 021306 192 IAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR-------- 262 (314)
Q Consensus 192 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~-------- 262 (314)
.... ......+|+.|+|||.+.+...++.++||||||+++|+|++|+.||.+.+..+.+..+.+..+.+..
T Consensus 151 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (288)
T 1ob3_A 151 GIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTE 230 (288)
T ss_dssp CC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred CccccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhc
Confidence 4322 2234567999999999976666899999999999999999999999999888888877765433211
Q ss_pred ----------------------------HHHh---ccCCCCCCCcccccccCChhhh
Q 021306 263 ----------------------------EEIR---CMNPNYTDFRFPQIKAHPWHKV 288 (314)
Q Consensus 263 ----------------------------~~~~---~~~p~~~~~~~~~l~~~p~~~~ 288 (314)
+.+. ..+|. +|+++.++++|||++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~-~Rpt~~e~l~hp~f~~ 286 (288)
T 1ob3_A 231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPN-QRITAKQALEHAYFKE 286 (288)
T ss_dssp STTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTT-TSCCHHHHHTSGGGGC
T ss_pred ccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcc-cCCCHHHHhcCcchhh
Confidence 1222 33677 8999999999999975
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-44 Score=310.07 Aligned_cols=243 Identities=24% Similarity=0.399 Sum_probs=200.5
Q ss_pred cCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeE
Q 021306 36 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 111 (314)
Q Consensus 36 ~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 111 (314)
..++|++.+.||+|+||.||+|++..+++.||+|.+.... ....+|+.++++++||||+++++++.... .+
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-----~~ 92 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGD-----EL 92 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETT-----EE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECC-----EE
Confidence 3468999999999999999999999999999999986433 23458999999999999999999886543 38
Q ss_pred EEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcccc
Q 021306 112 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 190 (314)
Q Consensus 112 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~ 190 (314)
++||||+.| +|.+.+.. ..+++.+++.++.|++.||.|||+ +||+||||||+||+++. ++.++|+|||++..
T Consensus 93 ~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~Dlkp~Nil~~~-~~~~kl~Dfg~~~~ 165 (297)
T 3fxz_A 93 WVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHS-NQVIHRDIKSDNILLGM-DGSVKLTDFGFCAQ 165 (297)
T ss_dssp EEEEECCTTCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECT-TCCEEECCCTTCEE
T ss_pred EEEEECCCCCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHh-CCceeCCCCHHHEEECC-CCCEEEeeCCCcee
Confidence 899999975 77666653 469999999999999999999999 89999999999999998 78899999999876
Q ss_pred cccCCc-cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCC--------
Q 021306 191 LIAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT-------- 261 (314)
Q Consensus 191 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~-------- 261 (314)
...... .....+|+.|+|||.+.+.. ++.++||||||+++|+|++|+.||.+.+.......+........
T Consensus 166 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (297)
T 3fxz_A 166 ITPEQSKRSTMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSA 244 (297)
T ss_dssp CCSTTCCBCCCCSCGGGCCHHHHHCSC-BCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCH
T ss_pred cCCcccccCCccCCcCccChhhhcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCH
Confidence 543322 33456899999999997655 89999999999999999999999999888777776665543221
Q ss_pred --HHHHh---ccCCCCCCCcccccccCChhhhhccc
Q 021306 262 --REEIR---CMNPNYTDFRFPQIKAHPWHKVCIFH 292 (314)
Q Consensus 262 --~~~~~---~~~p~~~~~~~~~l~~~p~~~~~~~~ 292 (314)
.+.+. ..+|. +|+++.++++|||++....-
T Consensus 245 ~~~~li~~~l~~dp~-~Rps~~ell~h~~~~~~~~~ 279 (297)
T 3fxz_A 245 IFRDFLNRCLEMDVE-KRGSAKELLQHQFLKIAKPL 279 (297)
T ss_dssp HHHHHHHHHSCSSTT-TSCCHHHHTTCGGGGGCCCG
T ss_pred HHHHHHHHHccCChh-HCcCHHHHhhChhhcccCcc
Confidence 12222 33677 89999999999999976543
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=318.72 Aligned_cols=249 Identities=34% Similarity=0.598 Sum_probs=199.8
Q ss_pred CCccCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCC
Q 021306 33 EPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSK 106 (314)
Q Consensus 33 ~~~~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 106 (314)
.....++|++.+.||+|+||.||+|++..+++.||+|.+.... ....+|+.++++++||||+++++++....
T Consensus 29 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-- 106 (329)
T 3gbz_A 29 SATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNH-- 106 (329)
T ss_dssp ---CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETT--
T ss_pred cccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCC--
Confidence 3445678999999999999999999999999999999986432 23458999999999999999999985433
Q ss_pred CceeEEEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcC----CCCcEEE
Q 021306 107 NELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP----LTHQVKI 182 (314)
Q Consensus 107 ~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~----~~~~~~l 182 (314)
.+++||||++++|.+.+.. ...+++..++.++.||+.||.|||+ +||+|+||||+||+++. ....++|
T Consensus 107 ---~~~lv~e~~~~~L~~~~~~----~~~~~~~~~~~i~~ql~~~l~~LH~-~~ivH~Dlkp~NIll~~~~~~~~~~~kl 178 (329)
T 3gbz_A 107 ---RLHLIFEYAENDLKKYMDK----NPDVSMRVIKSFLYQLINGVNFCHS-RRCLHRDLKPQNLLLSVSDASETPVLKI 178 (329)
T ss_dssp ---EEEEEEECCSEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEEC-----CCEEEE
T ss_pred ---EEEEEEecCCCCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCEECCCCCHHHEEEecCCCCccceEEE
Confidence 3889999999998887764 4679999999999999999999999 89999999999999953 2456999
Q ss_pred eecCcccccccCC-ccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCC
Q 021306 183 CDFGSAKQLIAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 261 (314)
Q Consensus 183 ~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~ 261 (314)
+|||++....... ......+|+.|+|||.+.+...++.++||||||+++|+|++|+.||.+.+..+.+..+.+..+.+.
T Consensus 179 ~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~ 258 (329)
T 3gbz_A 179 GDFGLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPD 258 (329)
T ss_dssp CCTTHHHHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred CcCCCccccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCc
Confidence 9999997654322 223456689999999997766689999999999999999999999999998888888877654332
Q ss_pred H-------------------------------------HHHh---ccCCCCCCCcccccccCChhhhhccc
Q 021306 262 R-------------------------------------EEIR---CMNPNYTDFRFPQIKAHPWHKVCIFH 292 (314)
Q Consensus 262 ~-------------------------------------~~~~---~~~p~~~~~~~~~l~~~p~~~~~~~~ 292 (314)
. +.+. ..+|. +|+++.++++|||++....+
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~-~R~t~~e~l~hp~f~~~~~~ 328 (329)
T 3gbz_A 259 DTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPV-KRISAKNALEHPYFSHNDFD 328 (329)
T ss_dssp TTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGG-GSCCHHHHHTSGGGSSSCSC
T ss_pred hhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChh-hCCCHHHHhCCcccCCCCCC
Confidence 1 1222 33676 89999999999999876643
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-44 Score=320.15 Aligned_cols=255 Identities=42% Similarity=0.825 Sum_probs=204.3
Q ss_pred ccCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccccch---HHHHHHHHhCCCCceeeeceeeeecCC--CCce
Q 021306 35 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK---NRELQLMRVMDHPNVISLKHCFFSTTS--KNEL 109 (314)
Q Consensus 35 ~~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~~~~---~~e~~~l~~l~h~~iv~~~~~~~~~~~--~~~~ 109 (314)
...++|++.+.||+|+||.||+|++..+++.||+|++..+.... .+++..+..++||||+++++++..... ....
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 99 (360)
T 3e3p_A 20 KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDI 99 (360)
T ss_dssp HHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCE
T ss_pred hhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccce
Confidence 34568999999999999999999999999999999986654333 455666778899999999999866443 3455
Q ss_pred eEEEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhh--cCCCceecCCCCCcEEEcCCCCcEEEeecCc
Q 021306 110 FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH--TVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 187 (314)
Q Consensus 110 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH--~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~ 187 (314)
++++||||+++++...+..+......+++..++.++.|++.||.||| + +||+|+||||+||+++..++.++|+|||+
T Consensus 100 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~-~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~ 178 (360)
T 3e3p_A 100 YLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGS 178 (360)
T ss_dssp EEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTT-TCCBCSCCCGGGEEEETTTTEEEECCCTT
T ss_pred eEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCC-CCeecCcCCHHHEEEeCCCCcEEEeeCCC
Confidence 67899999999998888877777889999999999999999999999 8 89999999999999986578999999999
Q ss_pred ccccccCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCHHH---
Q 021306 188 AKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE--- 264 (314)
Q Consensus 188 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~--- 264 (314)
+.............+|+.|+|||.+.+...++.++||||||+++|+|++|+.||.+.+....+..+.+..+.+....
T Consensus 179 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (360)
T 3e3p_A 179 AKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRK 258 (360)
T ss_dssp CBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred ceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHh
Confidence 98776555555667899999999987766689999999999999999999999999998888888887655543221
Q ss_pred ------------------------------------Hh---ccCCCCCCCcccccccCChhhhhcc
Q 021306 265 ------------------------------------IR---CMNPNYTDFRFPQIKAHPWHKVCIF 291 (314)
Q Consensus 265 ------------------------------------~~---~~~p~~~~~~~~~l~~~p~~~~~~~ 291 (314)
+. ..+|. +|+++.++++|||++....
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~-~Rpt~~e~l~hp~f~~~~~ 323 (360)
T 3e3p_A 259 LNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPE-ERMKPYEALCHPYFDELHD 323 (360)
T ss_dssp HCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGG-GSCCHHHHTTSGGGGGGGC
T ss_pred cccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCcc-ccCCHHHHhcCccccccCC
Confidence 11 23566 8999999999999987643
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=316.79 Aligned_cols=245 Identities=31% Similarity=0.604 Sum_probs=200.1
Q ss_pred CCceeeeeEeecCceEEEEEEECCCCcEEEEEEeecccc-----chHHHHHHHHhCCCCceeeeceeeeecCCCCceeEE
Q 021306 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 112 (314)
Q Consensus 38 ~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~~-----~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 112 (314)
++|++.+.||+|+||.||+|++..+++.||+|.+..... ...+|+.++++++||||+++++++.... ..+
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~~ 76 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEK-----SLT 76 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSS-----CEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCC-----EEE
Confidence 589999999999999999999999999999998864332 2347999999999999999999985433 388
Q ss_pred EEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcccccc
Q 021306 113 LVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 192 (314)
Q Consensus 113 lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~ 192 (314)
+||||+++++.+.+.. ....+++..++.++.||+.||.|||+ +||+|+||||+||+++. ++.++|+|||++....
T Consensus 77 lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivH~Dikp~NIl~~~-~~~~kl~Dfg~a~~~~ 151 (324)
T 3mtl_A 77 LVFEYLDKDLKQYLDD---CGNIINMHNVKLFLFQLLRGLAYCHR-QKVLHRDLKPQNLLINE-RGELKLADFGLARAKS 151 (324)
T ss_dssp EEEECCSEEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHH-TTEEESSCCGGGEEECT-TCCEEECSSSEEECC-
T ss_pred EEecccccCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCccCCCcCHHHEEECC-CCCEEEccCccccccc
Confidence 9999999998887765 34679999999999999999999999 89999999999999998 7899999999987554
Q ss_pred cCC-ccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCH---------
Q 021306 193 AGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR--------- 262 (314)
Q Consensus 193 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~--------- 262 (314)
... ......+|+.|+|||.+.+...++.++||||||+++|+|++|+.||.+.+..+.+..+.+..+.+..
T Consensus 152 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 231 (324)
T 3mtl_A 152 IPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSN 231 (324)
T ss_dssp -----------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGC
T ss_pred CCccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcc
Confidence 322 2234567899999999977666899999999999999999999999999988888888876554432
Q ss_pred ----------------------------HHHh---ccCCCCCCCcccccccCChhhhhcccC
Q 021306 263 ----------------------------EEIR---CMNPNYTDFRFPQIKAHPWHKVCIFHF 293 (314)
Q Consensus 263 ----------------------------~~~~---~~~p~~~~~~~~~l~~~p~~~~~~~~~ 293 (314)
+.+. ..+|. +|+++.++++|||+.....+.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~-~R~t~~e~l~hp~f~~~~~~~ 292 (324)
T 3mtl_A 232 EEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGR-NRISAEDAMKHPFFLSLGERI 292 (324)
T ss_dssp HHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGG-GSCCHHHHTTSGGGGGGCSTT
T ss_pred hhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcc-cCCCHHHHhcChhhhhccccc
Confidence 1222 33676 899999999999998776543
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=318.28 Aligned_cols=241 Identities=23% Similarity=0.362 Sum_probs=198.1
Q ss_pred CCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCCce
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL 109 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 109 (314)
.++|++.+.||+|+||.||+|+++.+|+.||+|.+++.. ....+|..+++.++||||+++++++... .
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-----~ 78 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTH-----D 78 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECS-----S
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeC-----C
Confidence 468999999999999999999999999999999986532 2345789999999999999999988443 3
Q ss_pred eEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcc
Q 021306 110 FLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 188 (314)
Q Consensus 110 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~ 188 (314)
.+++||||++| +|...+.. ...+++..++.++.||+.||.|||+ +||+||||||+||+++. ++.++|+|||++
T Consensus 79 ~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~-~g~vkL~DFG~a 152 (337)
T 1o6l_A 79 RLCFVMEYANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHS-RDVVYRDIKLENLMLDK-DGHIKITDFGLC 152 (337)
T ss_dssp EEEEEEECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECT-TSCEEECCCTTC
T ss_pred EEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCcCCHHHEEECC-CCCEEEeeccch
Confidence 48899999986 66665543 4679999999999999999999999 89999999999999998 889999999999
Q ss_pred ccccc-CCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCC------
Q 021306 189 KQLIA-GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT------ 261 (314)
Q Consensus 189 ~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~------ 261 (314)
+.... ........+|+.|+|||.+.+.. ++.++|+||||+++|+|++|+.||.+.+.......+.......+
T Consensus 153 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~ 231 (337)
T 1o6l_A 153 KEGISDGATMKTFCGTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPE 231 (337)
T ss_dssp BCSCCTTCCBCCCEECGGGCCGGGGSSSC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHH
T ss_pred hhcccCCCcccccccChhhCChhhhcCCC-CCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHH
Confidence 75432 23344567899999999996654 89999999999999999999999998887777666665422211
Q ss_pred -HHHHh---ccCCCCCCC-----cccccccCChhhhhc
Q 021306 262 -REEIR---CMNPNYTDF-----RFPQIKAHPWHKVCI 290 (314)
Q Consensus 262 -~~~~~---~~~p~~~~~-----~~~~l~~~p~~~~~~ 290 (314)
.+.+. ..+|. +|+ ++.++++|||++...
T Consensus 232 ~~~li~~lL~~dP~-~R~g~~~~~~~ei~~h~~f~~~~ 268 (337)
T 1o6l_A 232 AKSLLAGLLKKDPK-QRLGGGPSDAKEVMEHRFFLSIN 268 (337)
T ss_dssp HHHHHHHHTCSSTT-TSTTCSTTTHHHHHTSGGGTTCC
T ss_pred HHHHHHHHhhcCHH-HhcCCCCCCHHHHHcCCCcCCCC
Confidence 12222 34677 788 899999999997643
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=325.11 Aligned_cols=244 Identities=28% Similarity=0.463 Sum_probs=197.8
Q ss_pred CccCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeecc-------ccchHHHHHHHHhCCCCceeeeceeeeecCCC
Q 021306 34 PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSK 106 (314)
Q Consensus 34 ~~~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~-------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 106 (314)
+...++|++.+.||+|+||.||+|.+..+++.||+|.+... .....+|+.+++.++||||+++++++...
T Consensus 5 ~~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~--- 81 (336)
T 3h4j_B 5 KRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTP--- 81 (336)
T ss_dssp CSEETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECS---
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC---
Confidence 34557899999999999999999999999999999998643 22456899999999999999999998543
Q ss_pred CceeEEEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecC
Q 021306 107 NELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 186 (314)
Q Consensus 107 ~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg 186 (314)
...++||||++|++.+.+.. ...+++.+++.++.|++.||.|||+ +||+||||||+||+++. ++.++|+|||
T Consensus 82 --~~~~lv~E~~~g~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~-~givH~Dlkp~NIll~~-~~~~kl~DFG 153 (336)
T 3h4j_B 82 --TDIVMVIEYAGGELFDYIVE----KKRMTEDEGRRFFQQIICAIEYCHR-HKIVHRDLKPENLLLDD-NLNVKIADFG 153 (336)
T ss_dssp --SEEEEEECCCCEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-HTCCCCCCSTTTEEECT-TCCEEECCSS
T ss_pred --CEEEEEEECCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCchhhEEEcC-CCCEEEEEec
Confidence 34889999999998887764 3679999999999999999999999 89999999999999998 7899999999
Q ss_pred cccccccCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCC------
Q 021306 187 SAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP------ 260 (314)
Q Consensus 187 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~------ 260 (314)
++.............+|+.|+|||.+.+....+.++||||||+++|+|++|+.||.+.........+.......
T Consensus 154 ~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~ 233 (336)
T 3h4j_B 154 LSNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLSP 233 (336)
T ss_dssp CTBTTTTSBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSSCCCCCTTSCH
T ss_pred cceeccCCcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCcccCCH
Confidence 99876555555566789999999999776645789999999999999999999997754433222211111000
Q ss_pred -CHHHHh---ccCCCCCCCcccccccCChhhhh
Q 021306 261 -TREEIR---CMNPNYTDFRFPQIKAHPWHKVC 289 (314)
Q Consensus 261 -~~~~~~---~~~p~~~~~~~~~l~~~p~~~~~ 289 (314)
..+.+. ..+|. +|+++.++++|||++..
T Consensus 234 ~~~~li~~~L~~dP~-~Rpt~~eil~hp~~~~~ 265 (336)
T 3h4j_B 234 GAQSLIRRMIVADPM-QRITIQEIRRDPWFNVN 265 (336)
T ss_dssp HHHHHHHTTSCSSGG-GSCCHHHHTTCHHHHTT
T ss_pred HHHHHHHHHcCCChh-HCcCHHHHHhChhhccC
Confidence 112222 33666 89999999999999864
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-45 Score=323.21 Aligned_cols=243 Identities=28% Similarity=0.429 Sum_probs=194.9
Q ss_pred ccCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhC-CCCceeeeceeeeecCCC
Q 021306 35 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVM-DHPNVISLKHCFFSTTSK 106 (314)
Q Consensus 35 ~~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~-------~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~ 106 (314)
...++|++.+.||+|+||.||+|+++.+++.||+|.+++.. ....+|..+++.+ +||||+++++++...
T Consensus 20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~--- 96 (353)
T 3txo_A 20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTP--- 96 (353)
T ss_dssp ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECS---
T ss_pred CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeC---
Confidence 34578999999999999999999999999999999987532 2234788888887 799999999998443
Q ss_pred CceeEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeec
Q 021306 107 NELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF 185 (314)
Q Consensus 107 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~df 185 (314)
..+++||||++| +|...+.. ...+++..++.++.||+.||.|||+ +||+||||||+||+++. ++.++|+||
T Consensus 97 --~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~givHrDlkp~NILl~~-~g~ikL~DF 168 (353)
T 3txo_A 97 --DRLFFVMEFVNGGDLMFHIQK----SRRFDEARARFYAAEIISALMFLHD-KGIIYRDLKLDNVLLDH-EGHCKLADF 168 (353)
T ss_dssp --SEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECT-TSCEEECCC
T ss_pred --CEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCcccCCCHHHEEECC-CCCEEEccc
Confidence 348899999986 66666653 4679999999999999999999999 89999999999999998 889999999
Q ss_pred Cccccccc-CCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCH--
Q 021306 186 GSAKQLIA-GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR-- 262 (314)
Q Consensus 186 g~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~-- 262 (314)
|+++.... ........+|+.|+|||.+.+.. ++.++||||||+++|+|++|+.||.+.+..+.+..+.+.....+.
T Consensus 169 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~ 247 (353)
T 3txo_A 169 GMCKEGICNGVTTATFCGTPDYIAPEILQEML-YGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWL 247 (353)
T ss_dssp TTCBCSCC---------CCGGGCCHHHHHHHH-CTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTS
T ss_pred cceeecccCCccccccCCCcCeEChhhcCCCC-cCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Confidence 99875332 23344567899999999996654 899999999999999999999999999988888877765332221
Q ss_pred -----HH---HhccCCCCCCCcc------cccccCChhhhhc
Q 021306 263 -----EE---IRCMNPNYTDFRF------PQIKAHPWHKVCI 290 (314)
Q Consensus 263 -----~~---~~~~~p~~~~~~~------~~l~~~p~~~~~~ 290 (314)
+. +...+|. +|+++ +++++|||++...
T Consensus 248 ~~~~~~li~~lL~~dP~-~R~~~~~~~~~~~il~hp~f~~~~ 288 (353)
T 3txo_A 248 HEDATGILKSFMTKNPT-MRLGSLTQGGEHAILRHPFFKEID 288 (353)
T ss_dssp CHHHHHHHHHHTCSSGG-GSTTSGGGTCTHHHHTSGGGTTCC
T ss_pred CHHHHHHHHHHhhhCHH-HccCCcccCCHHHHhhCCcccCCC
Confidence 12 2234677 89888 8899999998654
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=326.13 Aligned_cols=246 Identities=25% Similarity=0.409 Sum_probs=200.0
Q ss_pred ccCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeecc-------ccchHHHHHHHHhCCCCceeeeceeeeecCCCC
Q 021306 35 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKN 107 (314)
Q Consensus 35 ~~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~-------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 107 (314)
...++|++.+.||+|+||.||+|+++.+++.||+|.+++. .....+|..+++.++||||+++++++..
T Consensus 66 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~----- 140 (410)
T 3v8s_A 66 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD----- 140 (410)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC-----
T ss_pred cCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE-----
Confidence 3456899999999999999999999999999999998642 2335689999999999999999999843
Q ss_pred ceeEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecC
Q 021306 108 ELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 186 (314)
Q Consensus 108 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg 186 (314)
...+++||||++| +|.+.+.. ..+++..++.++.||+.||.|||+ +||+||||||+||+++. ++.++|+|||
T Consensus 141 ~~~~~lV~E~~~gg~L~~~l~~-----~~~~e~~~~~~~~qi~~aL~~LH~-~givHrDLKp~NILl~~-~g~ikL~DFG 213 (410)
T 3v8s_A 141 DRYLYMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHS-MGFIHRDVKPDNMLLDK-SGHLKLADFG 213 (410)
T ss_dssp SSEEEEEECCCTTEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECT-TSCEEECCCT
T ss_pred CCEEEEEEeCCCCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH-CCeEeccCCHHHeeECC-CCCEEEeccc
Confidence 3348899999975 77766643 579999999999999999999999 89999999999999998 8899999999
Q ss_pred cccccccCCc--cccccccccccccccccCCCC---CCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHc---C
Q 021306 187 SAKQLIAGEA--NISYICSRFYRAPELIFGATE---YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVL---G 258 (314)
Q Consensus 187 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~---~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~---~ 258 (314)
+++....... .....||+.|+|||.+.+... ++.++||||||+++|+|++|+.||.+.+..+.+..+++.. .
T Consensus 214 ~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~ 293 (410)
T 3v8s_A 214 TCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLT 293 (410)
T ss_dssp TCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCC
T ss_pred eeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhcccccc
Confidence 9976544332 235678999999999965432 6789999999999999999999999999888888887542 2
Q ss_pred CCC--------HHHHh-cc--CCC-CCCCcccccccCChhhhhccc
Q 021306 259 TPT--------REEIR-CM--NPN-YTDFRFPQIKAHPWHKVCIFH 292 (314)
Q Consensus 259 ~~~--------~~~~~-~~--~p~-~~~~~~~~l~~~p~~~~~~~~ 292 (314)
.+. .+.+. ++ +|. +.|+++++|++|||++....+
T Consensus 294 ~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~w~ 339 (410)
T 3v8s_A 294 FPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWA 339 (410)
T ss_dssp CCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSSCC
T ss_pred CCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCCCHH
Confidence 111 12222 12 333 228999999999999876544
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=317.81 Aligned_cols=245 Identities=36% Similarity=0.639 Sum_probs=205.8
Q ss_pred CCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeE
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 111 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 111 (314)
+++|++.+.||+|+||.||+|++..+++.||+|.+.... ....+|+.++++++||||+++++++...........
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 458999999999999999999999999999999986432 234589999999999999999998865544444558
Q ss_pred EEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCccccc
Q 021306 112 NLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 191 (314)
Q Consensus 112 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~ 191 (314)
++++||++++|.+.+.. ..+++.+++.++.||+.||.|||+ +||+|+||||+||+++. ++.++|+|||++...
T Consensus 106 ~iv~e~~~~~L~~~l~~-----~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dikp~NIl~~~-~~~~kl~Dfg~a~~~ 178 (364)
T 3qyz_A 106 YIVQDLMETDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHS-ANVLHRDLKPSNLLLNT-TCDLKICDFGLARVA 178 (364)
T ss_dssp EEEEECCSEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECT-TCCEEECCCTTCEEC
T ss_pred EEEEcccCcCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCChHhEEECC-CCCEEEEeCcceEec
Confidence 89999999998887764 579999999999999999999999 89999999999999998 888999999999765
Q ss_pred ccCCc----cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCHH----
Q 021306 192 IAGEA----NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE---- 263 (314)
Q Consensus 192 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~---- 263 (314)
..... .....+|+.|+|||.+.+...++.++||||||+++|+|++|+.||.+.+..+.+..+.+..+.+..+
T Consensus 179 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 258 (364)
T 3qyz_A 179 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 258 (364)
T ss_dssp CGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHT
T ss_pred CCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence 43222 1234679999999997666668999999999999999999999999998888888887665554332
Q ss_pred ----------------------------------HH---hccCCCCCCCcccccccCChhhhh
Q 021306 264 ----------------------------------EI---RCMNPNYTDFRFPQIKAHPWHKVC 289 (314)
Q Consensus 264 ----------------------------------~~---~~~~p~~~~~~~~~l~~~p~~~~~ 289 (314)
.+ ...+|. +|+++.++++|||++..
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~-~R~t~~e~l~hp~~~~~ 320 (364)
T 3qyz_A 259 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPH-KRIEVEQALAHPYLEQY 320 (364)
T ss_dssp CCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTT-TSCCHHHHHTSGGGTTT
T ss_pred hhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChh-hCCCHHHHhcCcchhhc
Confidence 11 133677 89999999999999865
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-44 Score=315.01 Aligned_cols=246 Identities=23% Similarity=0.376 Sum_probs=203.9
Q ss_pred cCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeEE
Q 021306 36 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 112 (314)
Q Consensus 36 ~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 112 (314)
..++|++.+.||+|+||.||+|.+..+++.+++|.+.... ....+|+.+++.++||||+++++++.... .++
T Consensus 3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-----~~~ 77 (321)
T 1tki_A 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESME-----ELV 77 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETT-----EEE
T ss_pred hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEecCC-----EEE
Confidence 3578999999999999999999999999999999986443 23468999999999999999999985433 388
Q ss_pred EEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCC-CCcEEEeecCcccc
Q 021306 113 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPL-THQVKICDFGSAKQ 190 (314)
Q Consensus 113 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~-~~~~~l~dfg~~~~ 190 (314)
+||||++| +|.+.+.. ....+++.+++.++.|++.||.|||+ +||+|+||||+||+++.. ++.++|+|||++..
T Consensus 78 lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~-~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~ 153 (321)
T 1tki_A 78 MIFEFISGLDIFERINT---SAFELNEREIVSYVHQVCEALQFLHS-HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQ 153 (321)
T ss_dssp EEECCCCCCBHHHHHTS---SSCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESSSSCCCEEECCCTTCEE
T ss_pred EEEEeCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCCCcCCCCHHHEEEccCCCCCEEEEECCCCeE
Confidence 99999986 77666643 23579999999999999999999999 899999999999999863 57899999999987
Q ss_pred cccCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCHH-------
Q 021306 191 LIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE------- 263 (314)
Q Consensus 191 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~------- 263 (314)
...........+++.|+|||.+.+.. ++.++||||||+++|+|++|..||.+.+..+.+..+.+........
T Consensus 154 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 232 (321)
T 1tki_A 154 LKPGDNFRLLFTAPEYYAPEVHQHDV-VSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISI 232 (321)
T ss_dssp CCTTCEEEEEESCGGGSCHHHHTTCE-ECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCH
T ss_pred CCCCCccccccCChhhcCcHHhcCCC-CCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCH
Confidence 65554445567899999999996654 7899999999999999999999999988888777777654433322
Q ss_pred ----HHh---ccCCCCCCCcccccccCChhhhhccc
Q 021306 264 ----EIR---CMNPNYTDFRFPQIKAHPWHKVCIFH 292 (314)
Q Consensus 264 ----~~~---~~~p~~~~~~~~~l~~~p~~~~~~~~ 292 (314)
.+. ..+|. +|+++.++++|||++.....
T Consensus 233 ~~~~li~~~L~~dp~-~Rpt~~e~l~hp~~~~~~~~ 267 (321)
T 1tki_A 233 EAMDFVDRLLVKERK-SRMTASEALQHPWLKQKIER 267 (321)
T ss_dssp HHHHHHHTTSCSSGG-GSCCHHHHHHSHHHHSCGGG
T ss_pred HHHHHHHHHcCCChh-HCcCHHHHhcChhhccCccc
Confidence 122 22566 89999999999999876543
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-44 Score=316.35 Aligned_cols=259 Identities=27% Similarity=0.490 Sum_probs=209.2
Q ss_pred ccCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeecccc------chHHHHHHHHhCCCCceeeeceeeeecCCC--
Q 021306 35 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR------YKNRELQLMRVMDHPNVISLKHCFFSTTSK-- 106 (314)
Q Consensus 35 ~~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~~------~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~-- 106 (314)
...++|++.+.||+|+||.||+|++..+|+.||+|++..... ...+|+.++++++|+||+++++++......
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 93 (351)
T 3mi9_A 14 DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYN 93 (351)
T ss_dssp CBGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-----
T ss_pred ccccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccc
Confidence 456789999999999999999999999999999998854322 235899999999999999999988654321
Q ss_pred -CceeEEEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeec
Q 021306 107 -NELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF 185 (314)
Q Consensus 107 -~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~df 185 (314)
....+++||||+++++...+.. ....+++.+++.++.||+.||.|||+ +||+||||||+||+++. ++.++|+||
T Consensus 94 ~~~~~~~lv~e~~~~~l~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~-~~ivH~Dlkp~NIl~~~-~~~~kl~Df 168 (351)
T 3mi9_A 94 RCKGSIYLVFDFCEHDLAGLLSN---VLVKFTLSEIKRVMQMLLNGLYYIHR-NKILHRDMKAANVLITR-DGVLKLADF 168 (351)
T ss_dssp ---CEEEEEEECCSEEHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECT-TSCEEECCC
T ss_pred cCCceEEEEEeccCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHH-CCeeCCCCCHHHEEEcC-CCCEEEccc
Confidence 1345789999999998887764 34679999999999999999999999 89999999999999998 789999999
Q ss_pred CcccccccC-----CccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCC
Q 021306 186 GSAKQLIAG-----EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 260 (314)
Q Consensus 186 g~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~ 260 (314)
|++...... .......+|+.|+|||.+.+...++.++||||||+++|+|++|+.||.+.+....+..+.+..+..
T Consensus 169 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~ 248 (351)
T 3mi9_A 169 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI 248 (351)
T ss_dssp TTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred hhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence 999765321 122335678999999999776668999999999999999999999999999888887777655443
Q ss_pred CH---------------------------------------HHHh---ccCCCCCCCcccccccCChhhhhcccCChHHH
Q 021306 261 TR---------------------------------------EEIR---CMNPNYTDFRFPQIKAHPWHKVCIFHFPKHWL 298 (314)
Q Consensus 261 ~~---------------------------------------~~~~---~~~p~~~~~~~~~l~~~p~~~~~~~~~~~~~~ 298 (314)
.. +.+. ..+|. +|+++.++++|||++..........+
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~-~R~t~~e~l~hp~f~~~~~~~~~~~~ 327 (351)
T 3mi9_A 249 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPA-QRIDSDDALNHDFFWSDPMPSDLKGM 327 (351)
T ss_dssp CTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGG-GSCCHHHHHTSGGGGSSSCCCCSHHH
T ss_pred ChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChh-hCCCHHHHhCCCCcCCCCCccccccc
Confidence 22 1222 33677 89999999999999876665444444
Q ss_pred H
Q 021306 299 L 299 (314)
Q Consensus 299 ~ 299 (314)
+
T Consensus 328 ~ 328 (351)
T 3mi9_A 328 L 328 (351)
T ss_dssp H
T ss_pred c
Confidence 3
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-44 Score=329.46 Aligned_cols=248 Identities=34% Similarity=0.576 Sum_probs=188.4
Q ss_pred ccCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCCc
Q 021306 35 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 108 (314)
Q Consensus 35 ~~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 108 (314)
...++|++.+.||+|+||.||+|+++.+++.||+|++.... ....+|+.+++.++|+||+++++++.....+..
T Consensus 50 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 129 (458)
T 3rp9_A 50 QIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKF 129 (458)
T ss_dssp CSCTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTC
T ss_pred ccCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccC
Confidence 34578999999999999999999999999999999986532 234589999999999999999999866544444
Q ss_pred eeEEEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcc
Q 021306 109 LFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 188 (314)
Q Consensus 109 ~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~ 188 (314)
..+++||||++++|.+.+.. ...+++..++.++.||+.||.|||+ .||+||||||+|||++. ++.++|+|||++
T Consensus 130 ~~~~lv~e~~~~~L~~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~-~~iiHrDlKp~NILl~~-~~~~kl~DFGla 203 (458)
T 3rp9_A 130 DELYVVLEIADSDFKKLFRT----PVYLTELHIKTLLYNLLVGVKYVHS-AGILHRDLKPANCLVNQ-DCSVKVCDFGLA 203 (458)
T ss_dssp CCEEEEECCCSEEHHHHHHS----SCCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECT-TCCEEECCCTTC
T ss_pred ceEEEEEeccccchhhhccc----CCCCCHHHHHHHHHHHHHHHHHHHh-CCcCCCCCChhhEEECC-CCCEeecccccc
Confidence 56889999999998877753 5679999999999999999999999 89999999999999998 889999999999
Q ss_pred cccccCC----------------------------ccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh----
Q 021306 189 KQLIAGE----------------------------ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL---- 236 (314)
Q Consensus 189 ~~~~~~~----------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~t---- 236 (314)
+...... ......+|+.|+|||.+.....++.++|||||||++|||++
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~ 283 (458)
T 3rp9_A 204 RTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKE 283 (458)
T ss_dssp BCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTT
T ss_pred hhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccc
Confidence 7653221 12235679999999987555568999999999999999999
Q ss_pred -------CCCCCCCCCh--------------------HHHHHHHHHHcCCCCHH--------------------------
Q 021306 237 -------GQPLFPGENA--------------------VDQLVEIIKVLGTPTRE-------------------------- 263 (314)
Q Consensus 237 -------g~~pf~~~~~--------------------~~~~~~i~~~~~~~~~~-------------------------- 263 (314)
|+.+|.+.+. .+++..+.+.++.+..+
T Consensus 284 ~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 363 (458)
T 3rp9_A 284 NVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLA 363 (458)
T ss_dssp TCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGG
T ss_pred cccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHH
Confidence 7777866542 34555555555444321
Q ss_pred ------------HH---hccCCCCCCCcccccccCChhhhh
Q 021306 264 ------------EI---RCMNPNYTDFRFPQIKAHPWHKVC 289 (314)
Q Consensus 264 ------------~~---~~~~p~~~~~~~~~l~~~p~~~~~ 289 (314)
.+ ...+|. +|+++.++++|||++..
T Consensus 364 ~~~~~~s~~~~dLl~~mL~~dP~-~R~t~~e~L~Hp~f~~~ 403 (458)
T 3rp9_A 364 ERFPASSADAIHLLKRMLVFNPN-KRITINECLAHPFFKEV 403 (458)
T ss_dssp GGSTTSCHHHHHHHHHHSCSSTT-TSCCHHHHHHSGGGTTT
T ss_pred HHCCCCCHHHHHHHHHHhccCcc-ccCCHHHHhcCHhhhhc
Confidence 22 234777 89999999999999865
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-44 Score=316.35 Aligned_cols=243 Identities=26% Similarity=0.456 Sum_probs=197.6
Q ss_pred ccCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhC-CCCceeeeceeeeecCCC
Q 021306 35 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVM-DHPNVISLKHCFFSTTSK 106 (314)
Q Consensus 35 ~~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~-------~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~ 106 (314)
...++|++.+.||+|+||.||+|+++.+++.||+|.+++.. .....|..++..+ +||||+++++++...
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~--- 90 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTK--- 90 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECS---
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeC---
Confidence 44578999999999999999999999999999999987542 2234677788766 999999999988443
Q ss_pred CceeEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeec
Q 021306 107 NELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF 185 (314)
Q Consensus 107 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~df 185 (314)
..+++||||++| +|.+.+.. ...+++.+++.++.||+.||.|||+ +||+||||||+||+++. ++.++|+||
T Consensus 91 --~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~-~g~vkL~DF 162 (345)
T 1xjd_A 91 --ENLFFVMEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLHS-KGIVYRDLKLDNILLDK-DGHIKIADF 162 (345)
T ss_dssp --SEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECT-TSCEEECCC
T ss_pred --CEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeCCCChhhEEECC-CCCEEEeEC
Confidence 348899999986 77666654 3679999999999999999999999 89999999999999998 789999999
Q ss_pred Cccccccc-CCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCC---
Q 021306 186 GSAKQLIA-GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT--- 261 (314)
Q Consensus 186 g~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~--- 261 (314)
|+++.... ........||+.|+|||.+.+.. ++.++|+||||+++|+|++|+.||.+.+..+.+..+.......+
T Consensus 163 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~ 241 (345)
T 1xjd_A 163 GMCKENMLGDAKTNTFCGTPDYIAPEILLGQK-YNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWL 241 (345)
T ss_dssp TTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTS
T ss_pred hhhhhcccCCCcccCCCCCcccCChhhhcCCC-CCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCCCCccc
Confidence 99975432 22344567899999999997654 89999999999999999999999999888777776665432221
Q ss_pred ----HHHHh---ccCCCCCCCccc-ccccCChhhhhc
Q 021306 262 ----REEIR---CMNPNYTDFRFP-QIKAHPWHKVCI 290 (314)
Q Consensus 262 ----~~~~~---~~~p~~~~~~~~-~l~~~p~~~~~~ 290 (314)
.+.+. ..+|. +|+++. +|++|||++...
T Consensus 242 s~~~~~li~~lL~~dp~-~R~~~~~~i~~hp~f~~~~ 277 (345)
T 1xjd_A 242 EKEAKDLLVKLFVREPE-KRLGVRGDIRQHPLFREIN 277 (345)
T ss_dssp CHHHHHHHHHHSCSSGG-GSBTTBSCGGGSGGGTTCC
T ss_pred CHHHHHHHHHHhcCCHh-HcCCChHHHHcCccccCCC
Confidence 12222 33677 899998 999999998654
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=311.99 Aligned_cols=239 Identities=27% Similarity=0.480 Sum_probs=198.5
Q ss_pred CCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCCce
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL 109 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 109 (314)
.++|++.+.||+|+||.||+|+++.+|+.||+|.+++.. ....+|..+++.++||||+++++++.. ..
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~-----~~ 79 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQD-----AQ 79 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEEC-----SS
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEe-----CC
Confidence 468999999999999999999999999999999986532 233578999999999999999998843 33
Q ss_pred eEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcc
Q 021306 110 FLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 188 (314)
Q Consensus 110 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~ 188 (314)
.+++||||++| +|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+||+++. ++.++|+|||++
T Consensus 80 ~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~-~g~~kL~Dfg~a 153 (318)
T 1fot_A 80 QIFMIMDYIEGGELFSLLRK----SQRFPNPVAKFYAAEVCLALEYLHS-KDIIYRDLKPENILLDK-NGHIKITDFGFA 153 (318)
T ss_dssp EEEEEECCCCSCBHHHHHHH----TSSCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCCGGGEEECT-TSCEEECCCSSC
T ss_pred EEEEEEeCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCChheEEEcC-CCCEEEeecCcc
Confidence 48899999986 77766653 4689999999999999999999999 89999999999999998 889999999999
Q ss_pred cccccCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCC-------
Q 021306 189 KQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT------- 261 (314)
Q Consensus 189 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~------- 261 (314)
..... ......+|+.|+|||.+.+.. ++.++|+||||+++|+|++|+.||.+.+..+.+..+.+.....+
T Consensus 154 ~~~~~--~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~ 230 (318)
T 1fot_A 154 KYVPD--VTYTLCGTPDYIAPEVVSTKP-YNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDV 230 (318)
T ss_dssp EECSS--CBCCCCSCTTTCCHHHHTTCC-BCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSCHHH
T ss_pred eecCC--ccccccCCccccCHhHhcCCC-CCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHH
Confidence 76533 233467899999999996654 89999999999999999999999999888887777776532211
Q ss_pred HHHHh---ccCCCCCCC-----cccccccCChhhhhc
Q 021306 262 REEIR---CMNPNYTDF-----RFPQIKAHPWHKVCI 290 (314)
Q Consensus 262 ~~~~~---~~~p~~~~~-----~~~~l~~~p~~~~~~ 290 (314)
.+.+. ..+|. +|+ +++++++|||++...
T Consensus 231 ~~li~~lL~~dp~-~R~~~~~~~~~~i~~hp~f~~~~ 266 (318)
T 1fot_A 231 KDLLSRLITRDLS-QRLGNLQNGTEDVKNHPWFKEVV 266 (318)
T ss_dssp HHHHHHHTCSCTT-TCTTSSTTTTHHHHTSGGGSSCC
T ss_pred HHHHHHHhccCHH-HcCCCcCCCHHHHhcCccccCCC
Confidence 12222 33666 788 899999999997543
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=321.77 Aligned_cols=249 Identities=34% Similarity=0.536 Sum_probs=197.8
Q ss_pred cCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCCce
Q 021306 36 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL 109 (314)
Q Consensus 36 ~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 109 (314)
..++|++.+.||+|+||.||+|++..+++.||+|++.... ....+|+.+++.++|+||+++++++.........
T Consensus 24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 103 (432)
T 3n9x_A 24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD 103 (432)
T ss_dssp CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence 4578999999999999999999999999999999986532 2345899999999999999999988654333334
Q ss_pred eEEEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCccc
Q 021306 110 FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 189 (314)
Q Consensus 110 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~ 189 (314)
.+++||||++++|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+||+++. ++.++|+|||+++
T Consensus 104 ~~~lv~e~~~~~L~~~~~~----~~~l~~~~~~~i~~qil~aL~~LH~-~givHrDlkp~NILl~~-~~~~kL~DFGla~ 177 (432)
T 3n9x_A 104 ELYIVLEIADSDLKKLFKT----PIFLTEEHIKTILYNLLLGENFIHE-SGIIHRDLKPANCLLNQ-DCSVKVCDFGLAR 177 (432)
T ss_dssp CEEEEEECCSEEHHHHHHS----SCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECT-TCCEEECCCTTCE
T ss_pred eEEEEEecCCcCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCCCCCCCHHHeEECC-CCCEEEccCCCcc
Confidence 5889999999998887753 5679999999999999999999999 89999999999999998 8899999999998
Q ss_pred ccccCCc-----------------------cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhC---------
Q 021306 190 QLIAGEA-----------------------NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLG--------- 237 (314)
Q Consensus 190 ~~~~~~~-----------------------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg--------- 237 (314)
....... .....+|+.|+|||.+.....++.++|||||||++|+|++|
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~ 257 (432)
T 3n9x_A 178 TINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPT 257 (432)
T ss_dssp EC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGG
T ss_pred cccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccc
Confidence 6543221 24467799999999976666689999999999999999984
Q ss_pred --CCCCCCCC-----------------hHHHHHHHHHHcCCCCHH-----------------------------------
Q 021306 238 --QPLFPGEN-----------------AVDQLVEIIKVLGTPTRE----------------------------------- 263 (314)
Q Consensus 238 --~~pf~~~~-----------------~~~~~~~i~~~~~~~~~~----------------------------------- 263 (314)
.++|.+.+ ..+++..+++.++.+..+
T Consensus 258 ~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 337 (432)
T 3n9x_A 258 NRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDD 337 (432)
T ss_dssp GCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHH
T ss_pred cccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHH
Confidence 44454443 245555566555544332
Q ss_pred ---HH---hccCCCCCCCcccccccCChhhhhcc
Q 021306 264 ---EI---RCMNPNYTDFRFPQIKAHPWHKVCIF 291 (314)
Q Consensus 264 ---~~---~~~~p~~~~~~~~~l~~~p~~~~~~~ 291 (314)
.+ ...+|. +|+++.++++|||++....
T Consensus 338 ~~dLl~~mL~~dP~-~R~ta~e~L~Hp~f~~~~~ 370 (432)
T 3n9x_A 338 GINLLESMLKFNPN-KRITIDQALDHPYLKDVRK 370 (432)
T ss_dssp HHHHHHHHSCSSTT-TSCCHHHHHTCGGGTTTCC
T ss_pred HHHHHHHHhcCCcc-cCCCHHHHhcChhhhhccC
Confidence 11 234777 8999999999999987543
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-44 Score=324.99 Aligned_cols=246 Identities=24% Similarity=0.391 Sum_probs=199.9
Q ss_pred CCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeecc-------ccchHHHHHHHHhCCCCceeeeceeeeecCCCCce
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL 109 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~-------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 109 (314)
.++|++.+.||+|+||.||+|+++.+++.||+|.+++. .....+|..++..++||||+++++++.. ..
T Consensus 73 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~-----~~ 147 (437)
T 4aw2_A 73 REDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD-----DN 147 (437)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC-----SS
T ss_pred hhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-----CC
Confidence 46899999999999999999999999999999998642 2235689999999999999999998844 33
Q ss_pred eEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcc
Q 021306 110 FLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 188 (314)
Q Consensus 110 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~ 188 (314)
.+++||||++| +|.+.+.. ....+++..++.++.||+.||.|||+ +||+||||||+||+++. ++.+||+|||++
T Consensus 148 ~~~lV~Ey~~gg~L~~~l~~---~~~~l~e~~~~~~~~qi~~aL~~LH~-~giiHrDLKp~NILl~~-~g~vkL~DFGla 222 (437)
T 4aw2_A 148 NLYLVMDYYVGGDLLTLLSK---FEDRLPEEMARFYLAEMVIAIDSVHQ-LHYVHRDIKPDNILMDM-NGHIRLADFGSC 222 (437)
T ss_dssp EEEEEECCCTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECT-TSCEEECCCTTC
T ss_pred EEEEEEecCCCCcHHHHHHH---ccCCCCHHHHHHHHHHHHHHHHHHHh-CCeEecccCHHHeeEcC-CCCEEEcchhhh
Confidence 48899999975 77776653 24679999999999999999999999 89999999999999998 889999999999
Q ss_pred cccccCCc--ccccccccccccccccc----CCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHc---CC
Q 021306 189 KQLIAGEA--NISYICSRFYRAPELIF----GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVL---GT 259 (314)
Q Consensus 189 ~~~~~~~~--~~~~~~~~~y~aPE~~~----~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~---~~ 259 (314)
+....... .....||+.|+|||.+. +...++.++||||||+++|||++|+.||.+.+..+.+..++... ..
T Consensus 223 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~ 302 (437)
T 4aw2_A 223 LKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQF 302 (437)
T ss_dssp EECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCC
T ss_pred hhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccC
Confidence 76544332 22357899999999986 23448999999999999999999999999999888888876532 11
Q ss_pred C------C---HHHHhc---cCCC-CCCCcccccccCChhhhhccc
Q 021306 260 P------T---REEIRC---MNPN-YTDFRFPQIKAHPWHKVCIFH 292 (314)
Q Consensus 260 ~------~---~~~~~~---~~p~-~~~~~~~~l~~~p~~~~~~~~ 292 (314)
+ . .+.+.. .+|. +.|++++++++|||++....+
T Consensus 303 p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~w~ 348 (437)
T 4aw2_A 303 PTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDWD 348 (437)
T ss_dssp CSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCCTT
T ss_pred CcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCCHH
Confidence 1 1 122322 2333 238899999999999876544
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-44 Score=317.68 Aligned_cols=242 Identities=27% Similarity=0.403 Sum_probs=199.3
Q ss_pred cCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCCce
Q 021306 36 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL 109 (314)
Q Consensus 36 ~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 109 (314)
..++|++.+.||+|+||.||+|.++.+++.||+|.+.... ....+|+.++++++||||+++++++.. ..
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~-----~~ 101 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE-----ES 101 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC-----SS
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEe-----CC
Confidence 3468999999999999999999999999999999986542 234589999999999999999998843 33
Q ss_pred eEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCC--CCcEEEeecC
Q 021306 110 FLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPL--THQVKICDFG 186 (314)
Q Consensus 110 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~--~~~~~l~dfg 186 (314)
..++||||+.| +|.+.+. ....+++..++.++.||+.||.|||+ +||+|+||||+||+++.. +..++|+|||
T Consensus 102 ~~~lv~e~~~gg~L~~~l~----~~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG 176 (362)
T 2bdw_A 102 FHYLVFDLVTGGELFEDIV----AREFYSEADASHCIQQILESIAYCHS-NGIVHRNLKPENLLLASKAKGAAVKLADFG 176 (362)
T ss_dssp EEEEEECCCCSCBHHHHHT----TCSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCSGGGEEESCSSTTCCEEECCCT
T ss_pred EEEEEEecCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeccCchHHEEEecCCCCCCEEEeecC
Confidence 48899999986 6666554 35679999999999999999999999 899999999999999863 2469999999
Q ss_pred cccccccCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCH----
Q 021306 187 SAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR---- 262 (314)
Q Consensus 187 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~---- 262 (314)
++.............+|+.|+|||.+.+.. ++.++||||||+++|+|++|..||.+.+..+....+.......+.
T Consensus 177 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 255 (362)
T 2bdw_A 177 LAIEVNDSEAWHGFAGTPGYLSPEVLKKDP-YSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWD 255 (362)
T ss_dssp TCBCCTTCCSCCCSCSCTTTCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGG
T ss_pred cceEecCCcccccCCCCccccCHHHHccCC-CCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCccccc
Confidence 998765544444567899999999996544 899999999999999999999999998887777776665332211
Q ss_pred -------HHHh---ccCCCCCCCcccccccCChhhhh
Q 021306 263 -------EEIR---CMNPNYTDFRFPQIKAHPWHKVC 289 (314)
Q Consensus 263 -------~~~~---~~~p~~~~~~~~~l~~~p~~~~~ 289 (314)
+.+. ..+|. +|+++.++++|||+...
T Consensus 256 ~~~~~~~~li~~~L~~dP~-~R~t~~e~l~hp~~~~~ 291 (362)
T 2bdw_A 256 TVTPEAKSLIDSMLTVNPK-KRITADQALKVPWICNR 291 (362)
T ss_dssp GSCHHHHHHHHHHSCSSGG-GSCCHHHHTTSHHHHTH
T ss_pred CCCHHHHHHHHHHcCCChh-hCcCHHHHhcCcccCCC
Confidence 1122 23666 89999999999999753
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-44 Score=320.23 Aligned_cols=246 Identities=24% Similarity=0.448 Sum_probs=192.7
Q ss_pred CCCccCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhC-CCCceeeeceeeeec
Q 021306 32 GEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVM-DHPNVISLKHCFFST 103 (314)
Q Consensus 32 ~~~~~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~-------~~~~~e~~~l~~l-~h~~iv~~~~~~~~~ 103 (314)
......++|++.+.||+|+||.||+|+++.+++.||+|.+++.. ....+|..++.++ +||||+++++++..
T Consensus 46 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~- 124 (396)
T 4dc2_A 46 SSSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT- 124 (396)
T ss_dssp ---CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEEC-
T ss_pred ccCCChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEE-
Confidence 34455678999999999999999999999999999999987542 2235788888776 89999999999844
Q ss_pred CCCCceeEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEE
Q 021306 104 TSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKI 182 (314)
Q Consensus 104 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l 182 (314)
...+++||||++| +|...+.. ...+++..++.++.||+.||.|||+ +||+||||||+||+++. ++.++|
T Consensus 125 ----~~~~~lV~E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~-~givHrDLKp~NILl~~-~g~ikL 194 (396)
T 4dc2_A 125 ----ESRLFFVIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHE-RGIIYRDLKLDNVLLDS-EGHIKL 194 (396)
T ss_dssp ----SSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECT-TSCEEE
T ss_pred ----CCEEEEEEEcCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCEEeccCCHHHEEECC-CCCEEE
Confidence 3348899999986 66665553 4679999999999999999999999 89999999999999998 889999
Q ss_pred eecCcccccc-cCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC--------hHHHHHHH
Q 021306 183 CDFGSAKQLI-AGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN--------AVDQLVEI 253 (314)
Q Consensus 183 ~dfg~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~--------~~~~~~~i 253 (314)
+|||+++... .........||+.|+|||.+.+.. ++.++||||||+++|+|++|+.||.... ..+.+...
T Consensus 195 ~DFGla~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~-~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~ 273 (396)
T 4dc2_A 195 TDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGED-YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQV 273 (396)
T ss_dssp CCCTTCBCCCCTTCCBCCCCBCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHH
T ss_pred eecceeeecccCCCccccccCCcccCCchhhcCCC-CChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHH
Confidence 9999997532 233445567899999999997654 8999999999999999999999996432 12223333
Q ss_pred HHHcCCCC--------HHHHh---ccCCCCCCCcc------cccccCChhhhhc
Q 021306 254 IKVLGTPT--------REEIR---CMNPNYTDFRF------PQIKAHPWHKVCI 290 (314)
Q Consensus 254 ~~~~~~~~--------~~~~~---~~~p~~~~~~~------~~l~~~p~~~~~~ 290 (314)
+....... .+.+. ..+|. +|+++ .++++|||++...
T Consensus 274 i~~~~~~~p~~~s~~~~~li~~lL~~dP~-~R~~~~~~~~~~ei~~Hpff~~i~ 326 (396)
T 4dc2_A 274 ILEKQIRIPRSLSVKAASVLKSFLNKDPK-ERLGCHPQTGFADIQGHPFFRNVD 326 (396)
T ss_dssp HHHCCCCCCTTSCHHHHHHHHHHTCSCTT-TSTTCSTTTHHHHHHHSTTTTTCC
T ss_pred HhccccCCCCcCCHHHHHHHHHHhcCCHh-HcCCCCCCCCHHHHhcCccccCCC
Confidence 33222111 12222 34777 88885 6999999998654
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=314.88 Aligned_cols=246 Identities=26% Similarity=0.379 Sum_probs=197.6
Q ss_pred cCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeecc---------ccchHHHHHHHHhCCCCceeeeceeeeecCCC
Q 021306 36 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD---------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSK 106 (314)
Q Consensus 36 ~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~---------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 106 (314)
..++|++.+.||+|+||.||+|.++.+++.||+|.+... .....+|+.+++.++||||+++++++....
T Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-- 99 (351)
T 3c0i_A 22 FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDG-- 99 (351)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETT--
T ss_pred cccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC--
Confidence 346899999999999999999999999999999998532 233568999999999999999999885433
Q ss_pred CceeEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCC--CCcEEEe
Q 021306 107 NELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPL--THQVKIC 183 (314)
Q Consensus 107 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~--~~~~~l~ 183 (314)
.+++||||++| +|.+.+......+..+++..++.++.||+.||.|||+ +||+||||||+||+++.. ...++|+
T Consensus 100 ---~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~-~~ivHrDlkp~NIl~~~~~~~~~vkl~ 175 (351)
T 3c0i_A 100 ---MLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD-NNIIHRDVKPHCVLLASKENSAPVKLG 175 (351)
T ss_dssp ---EEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECSSSTTCCEEEC
T ss_pred ---EEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCChHHeEEecCCCCCcEEEe
Confidence 48899999995 7777776655556679999999999999999999999 899999999999999862 2349999
Q ss_pred ecCcccccccCCc-cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCH
Q 021306 184 DFGSAKQLIAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 262 (314)
Q Consensus 184 dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~ 262 (314)
|||++........ .....+|+.|+|||.+.+.. ++.++||||||+++|+|++|..||.+.. .+....+.+......+
T Consensus 176 Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~~~~~~~~ 253 (351)
T 3c0i_A 176 GFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREP-YGKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMNP 253 (351)
T ss_dssp CCTTCEECCTTSCBCCCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHTCCCCCH
T ss_pred cCcceeEecCCCeeecCCcCCcCccCHHHHcCCC-CCchHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcCCCCCCc
Confidence 9999976644332 23456899999999996654 8999999999999999999999998754 3445555443322221
Q ss_pred -----------HHHh---ccCCCCCCCcccccccCChhhhhc
Q 021306 263 -----------EEIR---CMNPNYTDFRFPQIKAHPWHKVCI 290 (314)
Q Consensus 263 -----------~~~~---~~~p~~~~~~~~~l~~~p~~~~~~ 290 (314)
+.+. ..+|. +|+++.++++|||++...
T Consensus 254 ~~~~~~s~~~~~li~~~L~~dP~-~R~s~~e~l~hp~~~~~~ 294 (351)
T 3c0i_A 254 RQWSHISESAKDLVRRMLMLDPA-ERITVYEALNHPWLKERD 294 (351)
T ss_dssp HHHTTSCHHHHHHHHHHTCSSTT-TSCCHHHHHTSHHHHTHH
T ss_pred cccccCCHHHHHHHHHHCCCChh-HCcCHHHHhcChhhcCCc
Confidence 1122 33677 899999999999998643
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=317.48 Aligned_cols=247 Identities=25% Similarity=0.377 Sum_probs=196.9
Q ss_pred CCccCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCC
Q 021306 33 EPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTS 105 (314)
Q Consensus 33 ~~~~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 105 (314)
.....++|++.+.||+|+||.||+|++..+++.||+|.+.+.. ....+|+.+++.++||||+++++++...
T Consensus 10 ~~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~-- 87 (384)
T 4fr4_A 10 EDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDE-- 87 (384)
T ss_dssp CCCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS--
T ss_pred CCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC--
Confidence 3445679999999999999999999999999999999986432 2345899999999999999999988543
Q ss_pred CCceeEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEee
Q 021306 106 KNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICD 184 (314)
Q Consensus 106 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~d 184 (314)
..+++||||+.| +|...+. ....+++..++.++.||+.||.|||+ +||+||||||+||+++. ++.++|+|
T Consensus 88 ---~~~~lv~e~~~gg~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~LH~-~givHrDlkp~NIll~~-~g~vkL~D 158 (384)
T 4fr4_A 88 ---EDMFMVVDLLLGGDLRYHLQ----QNVHFKEETVKLFICELVMALDYLQN-QRIIHRDMKPDNILLDE-HGHVHITD 158 (384)
T ss_dssp ---SEEEEEECCCTTEEHHHHHH----TTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECT-TSCEEECC
T ss_pred ---CEEEEEEecCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCcHHHeEECC-CCCEEEec
Confidence 348899999986 5655554 35789999999999999999999999 89999999999999998 88999999
Q ss_pred cCcccccccCCccccccccccccccccccCC--CCCCcchhHHHHHHHHHHHHhCCCCCCCCC---hHHHHHHHHHHcCC
Q 021306 185 FGSAKQLIAGEANISYICSRFYRAPELIFGA--TEYTTSIDIWSAGCVLAELLLGQPLFPGEN---AVDQLVEIIKVLGT 259 (314)
Q Consensus 185 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~~Dv~slG~il~el~tg~~pf~~~~---~~~~~~~i~~~~~~ 259 (314)
||++.............||+.|+|||.+.+. ..++.++||||||+++|+|++|+.||.... ..+....+......
T Consensus 159 FG~a~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~ 238 (384)
T 4fr4_A 159 FNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVT 238 (384)
T ss_dssp CTTCEECCTTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCC
T ss_pred cceeeeccCCCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccC
Confidence 9999876655555667889999999998642 347889999999999999999999997533 22222322222211
Q ss_pred CC-------HHHHh---ccCCCCCCCc-ccccccCChhhhhcc
Q 021306 260 PT-------REEIR---CMNPNYTDFR-FPQIKAHPWHKVCIF 291 (314)
Q Consensus 260 ~~-------~~~~~---~~~p~~~~~~-~~~l~~~p~~~~~~~ 291 (314)
.+ .+.+. ..+|. +|++ ++++++|||++....
T Consensus 239 ~p~~~s~~~~~li~~lL~~dP~-~R~s~~~~l~~hp~f~~~~w 280 (384)
T 4fr4_A 239 YPSAWSQEMVSLLKKLLEPNPD-QRFSQLSDVQNFPYMNDINW 280 (384)
T ss_dssp CCTTSCHHHHHHHHHHSCSSGG-GSCCSHHHHHTSGGGTTCCH
T ss_pred CCCcCCHHHHHHHHHHhcCCHh-HhcccHHHHHcChhhhcCCH
Confidence 11 11222 33677 7887 899999999986553
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-44 Score=313.69 Aligned_cols=243 Identities=25% Similarity=0.406 Sum_probs=200.2
Q ss_pred cCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc----------cchHHHHHHHHhCCCCceeeeceeeeecCC
Q 021306 36 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----------RYKNRELQLMRVMDHPNVISLKHCFFSTTS 105 (314)
Q Consensus 36 ~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~----------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 105 (314)
..++|++.+.||+|+||.||+|++..+++.||+|.+.... ....+|+.++++++||||+++++++..
T Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--- 85 (326)
T 2y0a_A 9 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYEN--- 85 (326)
T ss_dssp HHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC---
T ss_pred cccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEe---
Confidence 3467999999999999999999999999999999986532 234689999999999999999998843
Q ss_pred CCceeEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCC----cE
Q 021306 106 KNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH----QV 180 (314)
Q Consensus 106 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~----~~ 180 (314)
....++||||+++ +|.+.+. ....+++.+++.++.||+.||.|||+ +||+|+||||+||+++. ++ .+
T Consensus 86 --~~~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~Dlkp~NIll~~-~~~~~~~~ 157 (326)
T 2y0a_A 86 --KTDVILILELVAGGELFDFLA----EKESLTEEEATEFLKQILNGVYYLHS-LQIAHFDLKPENIMLLD-RNVPKPRI 157 (326)
T ss_dssp --SSEEEEEEECCCSCBHHHHHT----TSSCCBHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESC-SSSSSCCE
T ss_pred --CCEEEEEEEcCCCCCHHHHHH----hcCCcCHHHHHHHHHHHHHHHHHHHH-CCeEcCCCCHHHEEEec-CCCCCCCE
Confidence 3348899999975 7766664 35679999999999999999999999 89999999999999987 44 79
Q ss_pred EEeecCcccccccCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCC
Q 021306 181 KICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 260 (314)
Q Consensus 181 ~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~ 260 (314)
+|+|||++.............+|+.|+|||.+.+.. ++.++||||||+++|+|++|..||.+.+..+.+..+.......
T Consensus 158 kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~ 236 (326)
T 2y0a_A 158 KIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEP-LGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEF 236 (326)
T ss_dssp EECCCTTCEECCTTSCCCCCCSCTTTCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCC
T ss_pred EEEECCCCeECCCCCccccccCCcCcCCceeecCCC-CCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCc
Confidence 999999998765444444567899999999986544 8999999999999999999999999988877776665543222
Q ss_pred CH-----------HHHh---ccCCCCCCCcccccccCChhhhhcc
Q 021306 261 TR-----------EEIR---CMNPNYTDFRFPQIKAHPWHKVCIF 291 (314)
Q Consensus 261 ~~-----------~~~~---~~~p~~~~~~~~~l~~~p~~~~~~~ 291 (314)
.. +.+. ..+|. +|+++.++++|||++....
T Consensus 237 ~~~~~~~~~~~~~~li~~~L~~dP~-~Rpt~~e~l~hp~~~~~~~ 280 (326)
T 2y0a_A 237 EDEYFSNTSALAKDFIRRLLVKDPK-KRMTIQDSLQHPWIKPKDT 280 (326)
T ss_dssp CHHHHTTSCHHHHHHHHHHSCSSGG-GSCCHHHHHHSTTTSCCSH
T ss_pred CccccccCCHHHHHHHHHHccCChh-hCCCHHHHhcCCCccCCcc
Confidence 21 1222 23666 8999999999999986543
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-43 Score=313.96 Aligned_cols=247 Identities=32% Similarity=0.576 Sum_probs=198.8
Q ss_pred CCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc---------------cchHHHHHHHHhCCCCceeeeceeee
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---------------RYKNRELQLMRVMDHPNVISLKHCFF 101 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~---------------~~~~~e~~~l~~l~h~~iv~~~~~~~ 101 (314)
.++|++.+.||+|+||.||+|.+. +++.||+|++.... ....+|+.++++++||||+++++++.
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 99 (362)
T 3pg1_A 21 QSPYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFV 99 (362)
T ss_dssp TCSCEEEEEEEEETTEEEEEEECT-TSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEE
T ss_pred ccceEEeEEeccCCCEEEEEEECC-CCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEE
Confidence 468999999999999999999965 59999999885421 23468999999999999999999987
Q ss_pred ecCCCCceeEEEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEE
Q 021306 102 STTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVK 181 (314)
Q Consensus 102 ~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~ 181 (314)
.........+++||||++|++.+.+.. ....+++..++.++.||+.||.|||+ +||+|+||||+||+++. ++.++
T Consensus 100 ~~~~~~~~~~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dlkp~NIl~~~-~~~~k 174 (362)
T 3pg1_A 100 HFEEPAMHKLYLVTELMRTDLAQVIHD---QRIVISPQHIQYFMYHILLGLHVLHE-AGVVHRDLHPGNILLAD-NNDIT 174 (362)
T ss_dssp ECCTTTCCEEEEEEECCSEEHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECT-TCCEE
T ss_pred eccCCCcceEEEEEccCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHH-CcCEecCCChHHEEEcC-CCCEE
Confidence 766566667899999999998887763 34579999999999999999999999 89999999999999998 78899
Q ss_pred EeecCcccccccCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCC
Q 021306 182 ICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 261 (314)
Q Consensus 182 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~ 261 (314)
|+|||++.............+++.|+|||.+.+...++.++||||||+++|+|++|+.||.+.+..+.+..+.+..+.+.
T Consensus 175 l~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~ 254 (362)
T 3pg1_A 175 ICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPK 254 (362)
T ss_dssp ECCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred EEecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCC
Confidence 99999997655555555567889999999987655689999999999999999999999999998888888877655443
Q ss_pred HH---------------------------------------HHh---ccCCCCCCCcccccccCChhhhhc
Q 021306 262 RE---------------------------------------EIR---CMNPNYTDFRFPQIKAHPWHKVCI 290 (314)
Q Consensus 262 ~~---------------------------------------~~~---~~~p~~~~~~~~~l~~~p~~~~~~ 290 (314)
.. .+. ..+|. +|+++.++++|||++...
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~-~Rpt~~ell~hp~f~~~~ 324 (362)
T 3pg1_A 255 IEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQ-RRISTEQALRHPYFESLF 324 (362)
T ss_dssp HHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGG-GSCCHHHHHTSGGGTTTC
T ss_pred hHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChh-hCCCHHHHHcCchhhhcc
Confidence 22 111 23666 899999999999998753
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=307.50 Aligned_cols=244 Identities=34% Similarity=0.636 Sum_probs=195.5
Q ss_pred CCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeecccc------chHHHHHHHHhCCCCceeeeceeeeecCCCCcee
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR------YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 110 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~~------~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 110 (314)
.++|++.+.||+|+||.||+|++..+++.||+|++..... ...+|+.++++++||||+++++++.... .
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-----~ 76 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKR-----R 76 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT-----E
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCC-----e
Confidence 3689999999999999999999999999999998865432 2347999999999999999999985433 3
Q ss_pred EEEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcccc
Q 021306 111 LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 190 (314)
Q Consensus 111 ~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~ 190 (314)
.++||||++++++..+.. ....+++..++.++.|++.||.|||+ +|++|+||||+||+++. ++.++|+|||.+..
T Consensus 77 ~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~i~~~l~~~l~~lH~-~~ivH~dlkp~Nil~~~-~~~~kl~Dfg~~~~ 151 (311)
T 4agu_A 77 LHLVFEYCDHTVLHELDR---YQRGVPEHLVKSITWQTLQAVNFCHK-HNCIHRDVKPENILITK-HSVIKLCDFGFARL 151 (311)
T ss_dssp EEEEEECCSEEHHHHHHH---TSSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECT-TSCEEECCCTTCEE
T ss_pred EEEEEEeCCCchHHHHHh---hhcCCCHHHHHHHHHHHHHHHHHHHH-CCCcCCCCChhhEEEcC-CCCEEEeeCCCchh
Confidence 789999999875555443 35679999999999999999999999 89999999999999998 78999999999976
Q ss_pred cccCC-ccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCH-------
Q 021306 191 LIAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR------- 262 (314)
Q Consensus 191 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~------- 262 (314)
..... ......+++.|+|||.+.+...++.++||||||+++|+|++|+.||.+.+..+....+.+..+...+
T Consensus 152 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (311)
T 4agu_A 152 LTGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFS 231 (311)
T ss_dssp CC------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHH
T ss_pred ccCcccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccc
Confidence 54322 2234567889999999977666899999999999999999999999999888877776665433211
Q ss_pred -------------------------------HHHh---ccCCCCCCCcccccccCChhhhhcc
Q 021306 263 -------------------------------EEIR---CMNPNYTDFRFPQIKAHPWHKVCIF 291 (314)
Q Consensus 263 -------------------------------~~~~---~~~p~~~~~~~~~l~~~p~~~~~~~ 291 (314)
+.+. ..+|. +|+++.++++|||++....
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~-~Rpt~~ell~hp~f~~~~~ 293 (311)
T 4agu_A 232 TNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPT-ERLTCEQLLHHPYFENIRE 293 (311)
T ss_dssp TCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTT-TSCCHHHHHTSGGGTTCC-
T ss_pred cccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChh-hcCCHHHHhcChHHHhccC
Confidence 1222 33677 8999999999999987653
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=314.43 Aligned_cols=243 Identities=26% Similarity=0.443 Sum_probs=201.0
Q ss_pred CCccCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCC
Q 021306 33 EPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTS 105 (314)
Q Consensus 33 ~~~~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 105 (314)
.+...++|++.+.||+|+||.||+|+++.+|+.||+|.+.+.. ....+|..+++.++||||+++++++..
T Consensus 36 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--- 112 (350)
T 1rdq_E 36 NTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD--- 112 (350)
T ss_dssp CCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC---
T ss_pred cCCCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc---
Confidence 3455679999999999999999999999999999999986432 234579999999999999999998843
Q ss_pred CCceeEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEee
Q 021306 106 KNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICD 184 (314)
Q Consensus 106 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~d 184 (314)
...+++||||++| +|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+||+++. ++.++|+|
T Consensus 113 --~~~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~-~g~~kL~D 184 (350)
T 1rdq_E 113 --NSNLYMVMEYVAGGEMFSHLRR----IGRFSEPHARFYAAQIVLTFEYLHS-LDLIYRDLKPENLLIDQ-QGYIQVTD 184 (350)
T ss_dssp --SSEEEEEEECCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECT-TSCEEECC
T ss_pred --CCEEEEEEcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCccceEEECC-CCCEEEcc
Confidence 3348899999975 77776654 3679999999999999999999999 89999999999999998 88999999
Q ss_pred cCcccccccCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCC---
Q 021306 185 FGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT--- 261 (314)
Q Consensus 185 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~--- 261 (314)
||++..... ......+|+.|+|||.+.+.. ++.++||||||+++|+|++|..||.+.+..+.+..+.......+
T Consensus 185 Fg~a~~~~~--~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~ 261 (350)
T 1rdq_E 185 FGFAKRVKG--RTWTLCGTPEALAPEIILSKG-YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHF 261 (350)
T ss_dssp CTTCEECSS--CBCCCEECGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTC
T ss_pred cccceeccC--CcccccCCccccCHHHhcCCC-CCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Confidence 999986543 233467899999999997654 89999999999999999999999999888877777766432211
Q ss_pred ----HHHHh---ccCCCCCCCc-----ccccccCChhhhhc
Q 021306 262 ----REEIR---CMNPNYTDFR-----FPQIKAHPWHKVCI 290 (314)
Q Consensus 262 ----~~~~~---~~~p~~~~~~-----~~~l~~~p~~~~~~ 290 (314)
.+.+. ..+|. +|++ +++|++|||++...
T Consensus 262 ~~~~~~li~~lL~~dp~-~R~~~~~~~~~ei~~h~~f~~~~ 301 (350)
T 1rdq_E 262 SSDLKDLLRNLLQVDLT-KRFGNLKNGVNDIKNHKWFATTD 301 (350)
T ss_dssp CHHHHHHHHHHSCSCTT-TCTTSSTTTTHHHHTSGGGTTCC
T ss_pred CHHHHHHHHHHhhcCHH-hccCCccCCHHHHHhCcCcCCCC
Confidence 12222 34677 7887 99999999998654
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=304.46 Aligned_cols=245 Identities=27% Similarity=0.407 Sum_probs=195.7
Q ss_pred ccCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCce
Q 021306 35 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL 109 (314)
Q Consensus 35 ~~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 109 (314)
...++|++.+.||+|+||.||+|++..++..+++|.+.... ....+|+.++++++||||+++++++.. ..
T Consensus 19 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~~ 93 (285)
T 3is5_A 19 TIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFED-----YH 93 (285)
T ss_dssp CHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----SS
T ss_pred ChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheec-----CC
Confidence 34578999999999999999999999999999999987543 334689999999999999999998843 33
Q ss_pred eEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCC--CCcEEEeecC
Q 021306 110 FLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPL--THQVKICDFG 186 (314)
Q Consensus 110 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~--~~~~~l~dfg 186 (314)
..++||||+++ +|.+.+......+..+++..++.++.|++.||.|||+ +||+|+||||+||+++.. .+.++|+|||
T Consensus 94 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg 172 (285)
T 3is5_A 94 NMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS-QHVVHKDLKPENILFQDTSPHSPIKIIDFG 172 (285)
T ss_dssp EEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCSGGGEEESSSSTTCCEEECCCC
T ss_pred eEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHh-CCEEECCCCHHHEEEecCCCCCCEEEEeee
Confidence 48899999986 8888887665567889999999999999999999999 899999999999999542 4679999999
Q ss_pred cccccccCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCC------
Q 021306 187 SAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP------ 260 (314)
Q Consensus 187 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~------ 260 (314)
++.............+++.|+|||.+.+ .++.++||||||+++|+|++|+.||.+.+..+....+.......
T Consensus 173 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (285)
T 3is5_A 173 LAELFKSDEHSTNAAGTALYMAPEVFKR--DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRP 250 (285)
T ss_dssp CCCC----------CTTGGGCCHHHHTT--CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC--CC
T ss_pred cceecCCcccCcCcccccCcCChHHhcc--CCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccccCc
Confidence 9986655544555678999999999843 37899999999999999999999999888766555544332211
Q ss_pred -CH---HHHh---ccCCCCCCCcccccccCChhhh
Q 021306 261 -TR---EEIR---CMNPNYTDFRFPQIKAHPWHKV 288 (314)
Q Consensus 261 -~~---~~~~---~~~p~~~~~~~~~l~~~p~~~~ 288 (314)
.+ +.+. ..+|. +|+++.++++|||++.
T Consensus 251 ~~~~~~~li~~~L~~dP~-~Rps~~e~l~hp~f~~ 284 (285)
T 3is5_A 251 LTPQAVDLLKQMLTKDPE-RRPSAAQVLHHEWFKQ 284 (285)
T ss_dssp CCHHHHHHHHHHTCSCTT-TSCCHHHHHTSGGGGC
T ss_pred CCHHHHHHHHHHccCChh-hCcCHHHHhcCHHhhc
Confidence 11 1222 33676 8999999999999985
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=310.73 Aligned_cols=244 Identities=25% Similarity=0.343 Sum_probs=193.4
Q ss_pred ccCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCce
Q 021306 35 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL 109 (314)
Q Consensus 35 ~~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 109 (314)
...++|++.+.||+|+||.||+|++..+++.||+|.+.... ....+|+.+++.++|+||+++++++.. ..
T Consensus 4 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-----~~ 78 (323)
T 3tki_A 4 PFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE-----GN 78 (323)
T ss_dssp TTTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEEC-----SS
T ss_pred cHhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEec-----CC
Confidence 34578999999999999999999999999999999985432 345689999999999999999998843 33
Q ss_pred eEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcc
Q 021306 110 FLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 188 (314)
Q Consensus 110 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~ 188 (314)
..++||||+++ +|.+. ......+++.+++.++.||+.||.|||+ +||+|+||||+||+++. ++.++|+|||++
T Consensus 79 ~~~lv~e~~~~~~L~~~----l~~~~~~~~~~~~~i~~qi~~aL~~LH~-~givH~Dlkp~NIll~~-~~~~kl~Dfg~a 152 (323)
T 3tki_A 79 IQYLFLEYCSGGELFDR----IEPDIGMPEPDAQRFFHQLMAGVVYLHG-IGITHRDIKPENLLLDE-RDNLKISDFGLA 152 (323)
T ss_dssp EEEEEEECCTTEEGGGG----SBTTTBCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECT-TCCEEECCCTTC
T ss_pred eEEEEEEcCCCCcHHHH----HhhcCCCCHHHHHHHHHHHHHHHHHHHH-CCccccccchHHEEEeC-CCCEEEEEeecc
Confidence 47899999987 54433 3446789999999999999999999999 89999999999999998 789999999999
Q ss_pred cccccCC---ccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCC----
Q 021306 189 KQLIAGE---ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT---- 261 (314)
Q Consensus 189 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~---- 261 (314)
....... ......+|+.|+|||.+.+....+.++||||||+++|+|++|+.||.+.+................
T Consensus 153 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 232 (323)
T 3tki_A 153 TVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWK 232 (323)
T ss_dssp EECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGG
T ss_pred ceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccc
Confidence 7553222 123456799999999997766457899999999999999999999987665433332222211111
Q ss_pred ------HHHH---hccCCCCCCCcccccccCChhhhhc
Q 021306 262 ------REEI---RCMNPNYTDFRFPQIKAHPWHKVCI 290 (314)
Q Consensus 262 ------~~~~---~~~~p~~~~~~~~~l~~~p~~~~~~ 290 (314)
.+.+ ...+|. +|+++.++++|||++...
T Consensus 233 ~~~~~~~~li~~~L~~dP~-~R~t~~eil~h~~~~~~~ 269 (323)
T 3tki_A 233 KIDSAPLALLHKILVENPS-ARITIPDIKKDRWYNKPL 269 (323)
T ss_dssp GSCHHHHHHHHHHSCSSTT-TSCCHHHHTTCTTTTCCC
T ss_pred cCCHHHHHHHHHHccCChh-hCcCHHHHhhChhhcccc
Confidence 1122 234677 899999999999997643
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=312.31 Aligned_cols=246 Identities=24% Similarity=0.427 Sum_probs=193.3
Q ss_pred CCCccCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhC-CCCceeeeceeeeec
Q 021306 32 GEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVM-DHPNVISLKHCFFST 103 (314)
Q Consensus 32 ~~~~~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~-------~~~~~e~~~l~~l-~h~~iv~~~~~~~~~ 103 (314)
+.+...++|++.+.||+|+||.||+|+++.+++.||+|.+.+.. ....+|..+++++ +||||+++++++..
T Consensus 3 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~- 81 (345)
T 3a8x_A 3 MDPLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT- 81 (345)
T ss_dssp CCCCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-
T ss_pred CCCCchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEe-
Confidence 34556678999999999999999999999999999999997542 2235788888887 89999999999844
Q ss_pred CCCCceeEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEE
Q 021306 104 TSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKI 182 (314)
Q Consensus 104 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l 182 (314)
...+++||||++| +|...+.. ...+++..++.++.||+.||.|||+ +||+||||||+||+++. ++.++|
T Consensus 82 ----~~~~~lv~e~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~-~g~~kL 151 (345)
T 3a8x_A 82 ----ESRLFFVIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHE-RGIIYRDLKLDNVLLDS-EGHIKL 151 (345)
T ss_dssp ----SSEEEEEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECT-TSCEEE
T ss_pred ----CCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCHHHEEECC-CCCEEE
Confidence 3348899999986 67666653 3679999999999999999999999 89999999999999998 889999
Q ss_pred eecCccccccc-CCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCC---------ChHHHHHH
Q 021306 183 CDFGSAKQLIA-GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE---------NAVDQLVE 252 (314)
Q Consensus 183 ~dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~---------~~~~~~~~ 252 (314)
+|||+++.... ........+|+.|+|||.+.+.. ++.++|+||||+++|+|++|+.||... ........
T Consensus 152 ~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~ 230 (345)
T 3a8x_A 152 TDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGED-YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQV 230 (345)
T ss_dssp CCGGGCBCSCCTTCCBCCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHH
T ss_pred EeccccccccCCCCcccccCCCccccCccccCCCC-CChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHH
Confidence 99999975332 23344567899999999997654 899999999999999999999999752 22222233
Q ss_pred HHHHcCCCC-------HHHH---hccCCCCCCCcc------cccccCChhhhhc
Q 021306 253 IIKVLGTPT-------REEI---RCMNPNYTDFRF------PQIKAHPWHKVCI 290 (314)
Q Consensus 253 i~~~~~~~~-------~~~~---~~~~p~~~~~~~------~~l~~~p~~~~~~ 290 (314)
+.......+ .+.+ ...+|. +|+++ .++++|||++...
T Consensus 231 i~~~~~~~p~~~s~~~~~li~~lL~~dP~-~R~~~~~~~~~~~i~~hp~f~~~~ 283 (345)
T 3a8x_A 231 ILEKQIRIPRSLSVKAASVLKSFLNKDPK-ERLGCHPQTGFADIQGHPFFRNVD 283 (345)
T ss_dssp HHHCCCCCCTTSCHHHHHHHHHHTCSSTT-TSTTCCTTTHHHHHHTSGGGTTCC
T ss_pred HHcCCCCCCCCCCHHHHHHHHHHhcCCHh-HCCCCCCcCCHHHHhcCCccCCCC
Confidence 333211111 1222 234777 88885 7999999998654
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-43 Score=314.16 Aligned_cols=244 Identities=36% Similarity=0.627 Sum_probs=198.2
Q ss_pred cCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCC-CCc
Q 021306 36 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTS-KNE 108 (314)
Q Consensus 36 ~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~~~ 108 (314)
..++|++.+.||+|+||.||+|.+..+|+.||+|++.... ....+|+.+++.++||||+++++++..... ...
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 102 (367)
T 1cm8_A 23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 102 (367)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred ecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence 3468999999999999999999999999999999985432 233589999999999999999998854322 122
Q ss_pred eeEEEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcc
Q 021306 109 LFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 188 (314)
Q Consensus 109 ~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~ 188 (314)
..+++||||++++|.+.+.. ..+++..++.++.||+.||.|||+ +||+||||||+||+++. ++.++|+|||++
T Consensus 103 ~~~~lv~e~~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~-~~ivH~Dlkp~NIll~~-~~~~kl~Dfg~a 175 (367)
T 1cm8_A 103 TDFYLVMPFMGTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHA-AGIIHRDLKPGNLAVNE-DCELKILDFGLA 175 (367)
T ss_dssp CCCEEEEECCSEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECT-TCCEEECCCTTC
T ss_pred ceEEEEEecCCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH-CCccccCcCHHHEEEcC-CCCEEEEeeecc
Confidence 34689999998888877754 579999999999999999999999 89999999999999998 889999999999
Q ss_pred cccccCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCHHH----
Q 021306 189 KQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE---- 264 (314)
Q Consensus 189 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~---- 264 (314)
+.... ......+|+.|+|||.+.+...++.++|||||||++|+|++|+.||.+.+..+++..+++..+.++.+.
T Consensus 176 ~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~ 253 (367)
T 1cm8_A 176 RQADS--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRL 253 (367)
T ss_dssp EECCS--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTC
T ss_pred ccccc--ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHh
Confidence 86543 233456799999999997755689999999999999999999999999998888888887766554321
Q ss_pred -------------------------------------HhccCCCCCCCcccccccCChhhhh
Q 021306 265 -------------------------------------IRCMNPNYTDFRFPQIKAHPWHKVC 289 (314)
Q Consensus 265 -------------------------------------~~~~~p~~~~~~~~~l~~~p~~~~~ 289 (314)
+...+|. +|+++.++++|||++..
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~-~R~t~~e~l~hp~f~~~ 314 (367)
T 1cm8_A 254 QSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAE-QRVTAGEALAHPYFESL 314 (367)
T ss_dssp SCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTT-TSCCHHHHHHSGGGTTT
T ss_pred hhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChh-HCCCHHHHhcChHHHhh
Confidence 1123677 89999999999999764
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=323.93 Aligned_cols=243 Identities=23% Similarity=0.365 Sum_probs=198.9
Q ss_pred cCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCCce
Q 021306 36 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL 109 (314)
Q Consensus 36 ~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 109 (314)
..++|++.+.||+|+||.||+|.+..+|+.+|+|.+.... ....+|+.++++++||||+++++++.. ..
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-----~~ 83 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISE-----EG 83 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEEC-----SS
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEE-----CC
Confidence 4568999999999999999999999999999999986543 234689999999999999999998843 33
Q ss_pred eEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcC--CCCcEEEeecC
Q 021306 110 FLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP--LTHQVKICDFG 186 (314)
Q Consensus 110 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~--~~~~~~l~dfg 186 (314)
..++||||+.| +|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+||+++. .++.++|+|||
T Consensus 84 ~~~lv~E~~~gg~L~~~i~~----~~~~~e~~~~~i~~qil~aL~~lH~-~givHrDlKp~NIll~~~~~~~~vkL~DFG 158 (444)
T 3soa_A 84 HHYLIFDLVTGGELFEDIVA----REYYSEADASHCIQQILEAVLHCHQ-MGVVHRNLKPENLLLASKLKGAAVKLADFG 158 (444)
T ss_dssp EEEEEECCCBCCBHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCSSTTEEESBSSTTCCEEECCCS
T ss_pred EEEEEEEeCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEEeccCCCCcEEEccCc
Confidence 48899999986 67666654 5779999999999999999999999 89999999999999984 25789999999
Q ss_pred cccccccCCc-cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCH---
Q 021306 187 SAKQLIAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR--- 262 (314)
Q Consensus 187 ~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~--- 262 (314)
++........ .....+|+.|+|||.+.+.. ++.++||||||+++|+|++|..||.+.+..+.+..+.+.....+.
T Consensus 159 ~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~-~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 237 (444)
T 3soa_A 159 LAIEVEGEQQAWFGFAGTPGYLSPEVLRKDP-YGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEW 237 (444)
T ss_dssp SCBCCCTTCCBCCCSCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTT
T ss_pred eeEEecCCCceeecccCCcccCCHHHhcCCC-CCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCcccc
Confidence 9976644332 23467899999999996544 899999999999999999999999999888777777765332211
Q ss_pred --------HHHh---ccCCCCCCCcccccccCChhhhhc
Q 021306 263 --------EEIR---CMNPNYTDFRFPQIKAHPWHKVCI 290 (314)
Q Consensus 263 --------~~~~---~~~p~~~~~~~~~l~~~p~~~~~~ 290 (314)
+.+. ..+|. +|+++.++++|||++...
T Consensus 238 ~~~s~~~~~li~~~L~~dP~-~Rpta~e~L~hp~~~~~~ 275 (444)
T 3soa_A 238 DTVTPEAKDLINKMLTINPS-KRITAAEALKHPWISHRS 275 (444)
T ss_dssp TTSCHHHHHHHHHHSCSSTT-TSCCHHHHHHSCTTHHHH
T ss_pred ccCCHHHHHHHHHHcCCChh-HCCCHHHHhcCccccCCc
Confidence 1122 33677 899999999999997653
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=314.71 Aligned_cols=243 Identities=27% Similarity=0.385 Sum_probs=197.3
Q ss_pred ccCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhC-CCCceeeeceeeeecCCC
Q 021306 35 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVM-DHPNVISLKHCFFSTTSK 106 (314)
Q Consensus 35 ~~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~-------~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~ 106 (314)
...++|++.+.||+|+||.||+|+++.+++.||+|.+++.. ....+|..++..+ .||+|+++++++..
T Consensus 17 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~---- 92 (353)
T 2i0e_A 17 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT---- 92 (353)
T ss_dssp --CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEEC----
T ss_pred CchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEc----
Confidence 44578999999999999999999999999999999987532 2234788888877 89999999998843
Q ss_pred CceeEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeec
Q 021306 107 NELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF 185 (314)
Q Consensus 107 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~df 185 (314)
...+++||||++| +|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+||+++. ++.++|+||
T Consensus 93 -~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~givHrDlkp~NIll~~-~g~vkL~DF 165 (353)
T 2i0e_A 93 -MDRLYFVMEYVNGGDLMYHIQQ----VGRFKEPHAVFYAAEIAIGLFFLQS-KGIIYRDLKLDNVMLDS-EGHIKIADF 165 (353)
T ss_dssp -SSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECT-TSCEEECCC
T ss_pred -CCEEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCEEeccCCHHHEEEcC-CCcEEEEeC
Confidence 3348899999986 77766654 3679999999999999999999999 89999999999999998 889999999
Q ss_pred Cccccccc-CCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCC---
Q 021306 186 GSAKQLIA-GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT--- 261 (314)
Q Consensus 186 g~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~--- 261 (314)
|+++.... ........||+.|+|||.+.+.. ++.++|+||||+++|+|++|+.||.+.+..+.+..++......+
T Consensus 166 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~ 244 (353)
T 2i0e_A 166 GMCKENIWDGVTTKTFCGTPDYIAPEIIAYQP-YGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSM 244 (353)
T ss_dssp TTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCC-BSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTS
T ss_pred CcccccccCCcccccccCCccccChhhhcCCC-cCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCCCC
Confidence 99975432 22344567899999999996654 89999999999999999999999999888877777776432221
Q ss_pred ----HHHHh---ccCCCCCCC-----cccccccCChhhhhc
Q 021306 262 ----REEIR---CMNPNYTDF-----RFPQIKAHPWHKVCI 290 (314)
Q Consensus 262 ----~~~~~---~~~p~~~~~-----~~~~l~~~p~~~~~~ 290 (314)
.+.+. ..+|. +|+ ++++|++|||++...
T Consensus 245 s~~~~~li~~lL~~dP~-~R~~~~~~~~~~i~~h~~f~~~~ 284 (353)
T 2i0e_A 245 SKEAVAICKGLMTKHPG-KRLGCGPEGERDIKEHAFFRYID 284 (353)
T ss_dssp CHHHHHHHHHHTCSCTT-SCTTCSTTHHHHHHTSGGGTTCC
T ss_pred CHHHHHHHHHHhhcCHH-HcCCCCCCCHHHHhcCccccCCC
Confidence 12222 34677 788 468999999997543
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=307.87 Aligned_cols=245 Identities=26% Similarity=0.442 Sum_probs=191.2
Q ss_pred CCCccCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc------------------------------cchHHH
Q 021306 32 GEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------------------------------RYKNRE 81 (314)
Q Consensus 32 ~~~~~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~------------------------------~~~~~e 81 (314)
+.....++|++.+.||+|+||.||+|++..+++.||+|.+.... ....+|
T Consensus 7 ~~~~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E 86 (298)
T 2zv2_A 7 GDCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQE 86 (298)
T ss_dssp ---CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHH
T ss_pred CCceeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHH
Confidence 34445679999999999999999999999999999999986432 234689
Q ss_pred HHHHHhCCCCceeeeceeeeecCCCCceeEEEEeeccccc-HHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCC
Q 021306 82 LQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR 160 (314)
Q Consensus 82 ~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~ 160 (314)
+.++++++||||+++++++.... ...+++||||++++ |.+ + ....++++.+++.++.|++.||.|||+ +|
T Consensus 87 ~~~l~~l~h~~iv~~~~~~~~~~---~~~~~lv~e~~~~~~l~~-~----~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ 157 (298)
T 2zv2_A 87 IAILKKLDHPNVVKLVEVLDDPN---EDHLYMVFELVNQGPVME-V----PTLKPLSEDQARFYFQDLIKGIEYLHY-QK 157 (298)
T ss_dssp HHHHHTCCCTTBCCEEEEEECSS---SSEEEEEEECCTTCBSCC-S----SCSSCCCHHHHHHHHHHHHHHHHHHHH-TT
T ss_pred HHHHHhCCCCCCCeEEEEEEcCC---CCEEEEEEecCCCCcHHH-H----hhcCCCCHHHHHHHHHHHHHHHHHHHH-CC
Confidence 99999999999999999885422 33578999999864 322 1 234679999999999999999999999 89
Q ss_pred ceecCCCCCcEEEcCCCCcEEEeecCcccccccCCc-cccccccccccccccccCCCC--CCcchhHHHHHHHHHHHHhC
Q 021306 161 VCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA-NISYICSRFYRAPELIFGATE--YTTSIDIWSAGCVLAELLLG 237 (314)
Q Consensus 161 i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~--~~~~~Dv~slG~il~el~tg 237 (314)
|+|+||||+||+++. ++.++|+|||++........ .....+|+.|+|||.+.+... .+.++||||||+++|+|++|
T Consensus 158 ivH~Dlkp~Nil~~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g 236 (298)
T 2zv2_A 158 IIHRDIKPSNLLVGE-DGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFG 236 (298)
T ss_dssp EECCCCCGGGEEECT-TSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHS
T ss_pred eeccCCCHHHEEECC-CCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHC
Confidence 999999999999998 78999999999976543322 234567999999999865442 36789999999999999999
Q ss_pred CCCCCCCChHHHHHHHHHHcCCC------CH---HHHh---ccCCCCCCCcccccccCChhh
Q 021306 238 QPLFPGENAVDQLVEIIKVLGTP------TR---EEIR---CMNPNYTDFRFPQIKAHPWHK 287 (314)
Q Consensus 238 ~~pf~~~~~~~~~~~i~~~~~~~------~~---~~~~---~~~p~~~~~~~~~l~~~p~~~ 287 (314)
+.||.+.+.......+....... .. +.+. ..+|. +|+++.++++|||++
T Consensus 237 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~-~R~s~~e~l~hp~~~ 297 (298)
T 2zv2_A 237 QCPFMDERIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPE-SRIVVPEIKLHPWVT 297 (298)
T ss_dssp SCSSCCSSHHHHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTT-TSCCHHHHTTCHHHH
T ss_pred CCCCCCccHHHHHHHHhcccCCCCCccccCHHHHHHHHHHhhcChh-hCCCHHHHhcCcccc
Confidence 99998887766555554432211 11 1222 33677 899999999999985
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=319.88 Aligned_cols=248 Identities=25% Similarity=0.408 Sum_probs=200.7
Q ss_pred cCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeecc-------ccchHHHHHHHHhCCCCceeeeceeeeecCCCCc
Q 021306 36 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 108 (314)
Q Consensus 36 ~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~-------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 108 (314)
..++|++.+.||+|+||.||+|+++.+++.||+|.+++. .....+|..++..++|+||+++++++.. .
T Consensus 59 ~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~-----~ 133 (412)
T 2vd5_A 59 QRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQD-----E 133 (412)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEEC-----S
T ss_pred ChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEee-----C
Confidence 457899999999999999999999999999999998642 2335689999999999999999998843 3
Q ss_pred eeEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCc
Q 021306 109 LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 187 (314)
Q Consensus 109 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~ 187 (314)
..+++||||++| +|.+.+... +..+++..++.++.||+.||.|||+ +||+||||||+||+++. ++.++|+|||+
T Consensus 134 ~~~~lVmE~~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~LH~-~giiHrDLKp~NILld~-~g~vkL~DFGl 208 (412)
T 2vd5_A 134 NYLYLVMEYYVGGDLLTLLSKF---GERIPAEMARFYLAEIVMAIDSVHR-LGYVHRDIKPDNILLDR-CGHIRLADFGS 208 (412)
T ss_dssp SEEEEEECCCCSCBHHHHHHHH---SSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECT-TSCEEECCCTT
T ss_pred CEEEEEEcCCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecccCHHHeeecC-CCCEEEeechh
Confidence 458999999975 777776542 3579999999999999999999999 89999999999999998 88999999999
Q ss_pred ccccccCCc--cccccccccccccccccC------CCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH---
Q 021306 188 AKQLIAGEA--NISYICSRFYRAPELIFG------ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV--- 256 (314)
Q Consensus 188 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~------~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~--- 256 (314)
+........ .....||+.|+|||.+.+ ...++.++||||||+++|||++|+.||.+.+..+.+..+++.
T Consensus 209 a~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~ 288 (412)
T 2vd5_A 209 CLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEH 288 (412)
T ss_dssp CEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHH
T ss_pred heeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccC
Confidence 976544332 223578999999999862 234789999999999999999999999999888887777643
Q ss_pred cCCC------C---HHHHhc-c-CCCCCC---CcccccccCChhhhhcccCC
Q 021306 257 LGTP------T---REEIRC-M-NPNYTD---FRFPQIKAHPWHKVCIFHFP 294 (314)
Q Consensus 257 ~~~~------~---~~~~~~-~-~p~~~~---~~~~~l~~~p~~~~~~~~~~ 294 (314)
...+ . .+.+.. + +|. +| .+++++++|||++....+.+
T Consensus 289 ~~~p~~~~~~s~~~~dli~~lL~~p~-~Rlgr~~~~ei~~Hpff~~i~w~~l 339 (412)
T 2vd5_A 289 LSLPLVDEGVPEEARDFIQRLLCPPE-TRLGRGGAGDFRTHPFFFGLDWDGL 339 (412)
T ss_dssp CCCC----CCCHHHHHHHHTTSSCGG-GCTTTTTHHHHHTSGGGTTCCSTTS
T ss_pred cCCCccccCCCHHHHHHHHHHcCChh-hcCCCCCHHHHhcCCCcCCCCHHHH
Confidence 2111 1 122221 2 555 44 58999999999987765543
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-43 Score=311.06 Aligned_cols=215 Identities=28% Similarity=0.498 Sum_probs=180.9
Q ss_pred cCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHhCC-----CCceeeeceeeeecCCCC
Q 021306 36 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMD-----HPNVISLKHCFFSTTSKN 107 (314)
Q Consensus 36 ~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~---~~~~~e~~~l~~l~-----h~~iv~~~~~~~~~~~~~ 107 (314)
..++|++.+.||+|+||.||+|++..+++.||+|.+.... .....|..+++.+. |+||+++++++....
T Consensus 33 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~--- 109 (360)
T 3llt_A 33 LNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYD--- 109 (360)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETT---
T ss_pred ecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECC---
Confidence 3578999999999999999999999999999999986432 33457889999986 999999999885543
Q ss_pred ceeEEEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcC------------
Q 021306 108 ELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP------------ 175 (314)
Q Consensus 108 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~------------ 175 (314)
..++||||+.++|.+.+... ....+++.+++.++.||+.||.|||+ +||+||||||+||+++.
T Consensus 110 --~~~lv~e~~~~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~~~~~~~~~~~~ 184 (360)
T 3llt_A 110 --HMCLIFEPLGPSLYEIITRN--NYNGFHIEDIKLYCIEILKALNYLRK-MSLTHTDLKPENILLDDPYFEKSLITVRR 184 (360)
T ss_dssp --EEEEEECCCCCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEESCTTCCEEEEEEEC
T ss_pred --eeEEEEcCCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCCcccEEEccccccccccchhc
Confidence 38899999988988887752 23469999999999999999999999 89999999999999974
Q ss_pred ------------CCCcEEEeecCcccccccCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 021306 176 ------------LTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 243 (314)
Q Consensus 176 ------------~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~ 243 (314)
.++.++|+|||++..... ......+|+.|+|||.+.+.. ++.++||||||+++|+|++|+.||.+
T Consensus 185 ~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~--~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf~~ 261 (360)
T 3llt_A 185 VTDGKKIQIYRTKSTGIKLIDFGCATFKSD--YHGSIINTRQYRAPEVILNLG-WDVSSDMWSFGCVLAELYTGSLLFRT 261 (360)
T ss_dssp TTTCCEEEEEEESCCCEEECCCTTCEETTS--CCCSCCSCGGGCCHHHHTTCC-CCTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred ccccccccccccCCCCEEEEeccCceecCC--CCcCccCcccccCcHHHcCCC-CCCccchHHHHHHHHHHHHCCCCCCC
Confidence 267899999999975433 233456799999999997655 89999999999999999999999999
Q ss_pred CChHHHHHHHHHHcCCCC
Q 021306 244 ENAVDQLVEIIKVLGTPT 261 (314)
Q Consensus 244 ~~~~~~~~~i~~~~~~~~ 261 (314)
.+..+.+..+.......+
T Consensus 262 ~~~~~~~~~~~~~~~~~p 279 (360)
T 3llt_A 262 HEHMEHLAMMESIIQPIP 279 (360)
T ss_dssp SSHHHHHHHHHHHTCCCC
T ss_pred CcHHHHHHHHHHhcCCCC
Confidence 888877777666554443
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=314.87 Aligned_cols=216 Identities=34% Similarity=0.599 Sum_probs=173.1
Q ss_pred cCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCC-CCc
Q 021306 36 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTS-KNE 108 (314)
Q Consensus 36 ~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~~~ 108 (314)
..++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+|+.+++.++||||+++++++..... ...
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 102 (371)
T 2xrw_A 23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 102 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTC
T ss_pred hhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccc
Confidence 3468999999999999999999999999999999986532 223579999999999999999998854331 222
Q ss_pred eeEEEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcc
Q 021306 109 LFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 188 (314)
Q Consensus 109 ~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~ 188 (314)
...++||||+++++.+.+. ..+++..++.++.||+.||.|||+ +||+||||||+||+++. ++.++|+|||++
T Consensus 103 ~~~~lv~e~~~~~l~~~~~------~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~Dlkp~NIl~~~-~~~~kl~Dfg~a 174 (371)
T 2xrw_A 103 QDVYIVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKS-DCTLKILDFGLA 174 (371)
T ss_dssp CEEEEEEECCSEEHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECT-TSCEEECCCCC-
T ss_pred cceEEEEEcCCCCHHHHHh------hccCHHHHHHHHHHHHHHHHHHHH-CCeecccCCHHHEEEcC-CCCEEEEEeecc
Confidence 3578999999999887764 468999999999999999999999 89999999999999998 789999999999
Q ss_pred cccccCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCC
Q 021306 189 KQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 260 (314)
Q Consensus 189 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~ 260 (314)
.............+|+.|+|||.+.+.. ++.++||||||+++|+|++|+.||.+.+..+.+..+++..+.+
T Consensus 175 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~ 245 (371)
T 2xrw_A 175 RTAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTP 245 (371)
T ss_dssp ---------------CTTCCHHHHTTCC-CCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCC
T ss_pred cccccccccCCceecCCccCHHHhcCCC-CCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 8665444444567899999999997654 8999999999999999999999999998888887777655443
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-43 Score=303.49 Aligned_cols=250 Identities=23% Similarity=0.347 Sum_probs=188.9
Q ss_pred cCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccccc------hHHHHHHHHhCCCCceeeeceeeeecCCCCce
Q 021306 36 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY------KNRELQLMRVMDHPNVISLKHCFFSTTSKNEL 109 (314)
Q Consensus 36 ~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~~~------~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 109 (314)
..++|++.+.||+|+||.||+|++..+++.||+|.+...... ..++...++.++||||+++++++....
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~----- 79 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREG----- 79 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSS-----
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccC-----
Confidence 456899999999999999999999999999999998654221 124445578889999999999885433
Q ss_pred eEEEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCC-CceecCCCCCcEEEcCCCCcEEEeecCcc
Q 021306 110 FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP-RVCHRDLKPQNLLVDPLTHQVKICDFGSA 188 (314)
Q Consensus 110 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~-~i~h~dl~p~Nil~~~~~~~~~l~dfg~~ 188 (314)
..++||||+++++.+.+......+..+++..++.++.|++.||.|||+ + |++|+||||+||+++. ++.++|+|||++
T Consensus 80 ~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~~i~H~dlkp~Nil~~~-~~~~kl~Dfg~~ 157 (290)
T 3fme_A 80 DVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS-KLSVIHRDVKPSNVLINA-LGQVKMCDFGIS 157 (290)
T ss_dssp SEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH-HSCCCCCCCSGGGCEECT-TCCEEBCCC---
T ss_pred CEEEEEehhccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh-cCCeecCCCCHHHEEECC-CCCEEEeecCCc
Confidence 388999999999988887766677899999999999999999999999 8 9999999999999998 789999999999
Q ss_pred cccccCCccccccccccccccccc---cCCCCCCcchhHHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHHHHcCCCC---
Q 021306 189 KQLIAGEANISYICSRFYRAPELI---FGATEYTTSIDIWSAGCVLAELLLGQPLFPGE-NAVDQLVEIIKVLGTPT--- 261 (314)
Q Consensus 189 ~~~~~~~~~~~~~~~~~y~aPE~~---~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~-~~~~~~~~i~~~~~~~~--- 261 (314)
.............+++.|+|||.+ .....++.++||||||+++|+|++|+.||... .....+...........
T Consensus 158 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (290)
T 3fme_A 158 GYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPAD 237 (290)
T ss_dssp ------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCCTT
T ss_pred ccccccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCcccc
Confidence 866555444555789999999997 23445789999999999999999999999874 44444444444332221
Q ss_pred ---H---HHHh---ccCCCCCCCcccccccCChhhhhcccC
Q 021306 262 ---R---EEIR---CMNPNYTDFRFPQIKAHPWHKVCIFHF 293 (314)
Q Consensus 262 ---~---~~~~---~~~p~~~~~~~~~l~~~p~~~~~~~~~ 293 (314)
. +.+. ..+|. +|+++.++++|||++......
T Consensus 238 ~~~~~~~~li~~~l~~~p~-~Rpt~~e~l~hp~f~~~~~~~ 277 (290)
T 3fme_A 238 KFSAEFVDFTSQCLKKNSK-ERPTYPELMQHPFFTLHESKG 277 (290)
T ss_dssp TSCHHHHHHHHHHTCSSGG-GSCCHHHHTTSHHHHHHHHSC
T ss_pred cCCHHHHHHHHHHhhcChh-hCcCHHHHHhCcccccCcccc
Confidence 1 1121 23666 899999999999998766543
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-43 Score=323.43 Aligned_cols=243 Identities=29% Similarity=0.437 Sum_probs=201.9
Q ss_pred ccCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCC
Q 021306 35 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKN 107 (314)
Q Consensus 35 ~~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 107 (314)
...++|++.+.||+|+||.||+|++..+|+.||+|.+.... ....+|+.+++.++||||+++++++...
T Consensus 13 ~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~---- 88 (476)
T 2y94_A 13 VKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTP---- 88 (476)
T ss_dssp CEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECS----
T ss_pred ceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC----
Confidence 34568999999999999999999999999999999986432 2346899999999999999999988443
Q ss_pred ceeEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecC
Q 021306 108 ELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 186 (314)
Q Consensus 108 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg 186 (314)
..+++||||++| +|.+.+. ..+.+++.+++.++.||+.||.|||+ +||+||||||+||+++. ++.++|+|||
T Consensus 89 -~~~~lv~E~~~gg~L~~~l~----~~~~l~~~~~~~i~~qi~~aL~~LH~-~givHrDLkp~NIll~~-~~~vkL~DFG 161 (476)
T 2y94_A 89 -SDIFMVMEYVSGGELFDYIC----KNGRLDEKESRRLFQQILSGVDYCHR-HMVVHRDLKPENVLLDA-HMNAKIADFG 161 (476)
T ss_dssp -SEEEEEEECCSSEEHHHHTT----SSSSCCHHHHHHHHHHHHHHHHHHHT-TTEECSCCSGGGEEECT-TCCEEECCCS
T ss_pred -CEEEEEEeCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCCCcccccHHHEEEec-CCCeEEEecc
Confidence 348899999975 6655543 45789999999999999999999999 89999999999999998 7889999999
Q ss_pred cccccccCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCC-----
Q 021306 187 SAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT----- 261 (314)
Q Consensus 187 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~----- 261 (314)
++.............+|+.|+|||.+.+....+.++||||||+++|+|++|+.||.+.+.......+.......+
T Consensus 162 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~ 241 (476)
T 2y94_A 162 LSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLNP 241 (476)
T ss_dssp SCEECCTTCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCCCTTCCH
T ss_pred chhhccccccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCCCccCCH
Confidence 998765544445567899999999997766457899999999999999999999998887777776665432221
Q ss_pred --HHHHh---ccCCCCCCCcccccccCChhhhh
Q 021306 262 --REEIR---CMNPNYTDFRFPQIKAHPWHKVC 289 (314)
Q Consensus 262 --~~~~~---~~~p~~~~~~~~~l~~~p~~~~~ 289 (314)
.+.+. ..+|. +|+++.++++|||++..
T Consensus 242 ~~~~Li~~~L~~dP~-~Rpt~~eil~hp~~~~~ 273 (476)
T 2y94_A 242 SVISLLKHMLQVDPM-KRATIKDIREHEWFKQD 273 (476)
T ss_dssp HHHHHHHHHTCSSTT-TSCCHHHHHTCHHHHTT
T ss_pred HHHHHHHHHcCCCch-hCcCHHHHHhCHHhhhc
Confidence 12222 34777 89999999999999764
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-43 Score=308.90 Aligned_cols=244 Identities=25% Similarity=0.435 Sum_probs=191.5
Q ss_pred CccCCCceeeeeEeecCceEEEEEEEC---CCCcEEEEEEeeccc--------cchHHHHHHHHhCCCCceeeeceeeee
Q 021306 34 PKQTISYMAERVVGTGSFGIVFQAKCL---ETGETVAIKKVLQDR--------RYKNRELQLMRVMDHPNVISLKHCFFS 102 (314)
Q Consensus 34 ~~~~~~y~~~~~Lg~g~~g~Vy~~~~~---~~~~~~~vK~~~~~~--------~~~~~e~~~l~~l~h~~iv~~~~~~~~ 102 (314)
....++|++.+.||+|+||.||+|++. .+++.||+|.+++.. ....+|+.++++++||||+++++++..
T Consensus 13 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 92 (327)
T 3a62_A 13 KIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQT 92 (327)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEEC
T ss_pred CCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEc
Confidence 344578999999999999999999985 689999999986532 234579999999999999999998854
Q ss_pred cCCCCceeEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEE
Q 021306 103 TTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVK 181 (314)
Q Consensus 103 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~ 181 (314)
.. .+++||||++| +|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+||+++. ++.++
T Consensus 93 ~~-----~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~Dlkp~Nill~~-~~~~k 161 (327)
T 3a62_A 93 GG-----KLYLILEYLSGGELFMQLER----EGIFMEDTACFYLAEISMALGHLHQ-KGIIYRDLKPENIMLNH-QGHVK 161 (327)
T ss_dssp SS-----CEEEEEECCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCTTTEEECT-TSCEE
T ss_pred CC-----EEEEEEeCCCCCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHh-CCEEcccCCHHHeEECC-CCcEE
Confidence 33 38899999985 67666653 4679999999999999999999999 89999999999999998 78999
Q ss_pred EeecCcccccccC-CccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCC
Q 021306 182 ICDFGSAKQLIAG-EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 260 (314)
Q Consensus 182 l~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~ 260 (314)
|+|||++...... .......+|+.|+|||.+.+.. ++.++||||||+++|+|++|+.||.+.+..+.+..+.+.....
T Consensus 162 l~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~ 240 (327)
T 3a62_A 162 LTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSG-HNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNL 240 (327)
T ss_dssp ECCCSCC----------CTTSSCCTTSCHHHHTTSC-CCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCC
T ss_pred EEeCCcccccccCCccccccCCCcCccCHhhCcCCC-CCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCC
Confidence 9999998754322 2233456899999999996654 8999999999999999999999999988877777776643222
Q ss_pred C-------HHHHh---ccCCCCCCC-----cccccccCChhhhhc
Q 021306 261 T-------REEIR---CMNPNYTDF-----RFPQIKAHPWHKVCI 290 (314)
Q Consensus 261 ~-------~~~~~---~~~p~~~~~-----~~~~l~~~p~~~~~~ 290 (314)
+ .+.+. ..+|. +|+ ++.++++|||++...
T Consensus 241 p~~~~~~~~~li~~~L~~dp~-~R~~~~~~~~~e~l~hp~f~~~~ 284 (327)
T 3a62_A 241 PPYLTQEARDLLKKLLKRNAA-SRLGAGPGDAGEVQAHPFFRHIN 284 (327)
T ss_dssp CTTSCHHHHHHHHHHSCSCGG-GSTTSSTTTHHHHHHSGGGSSCC
T ss_pred CCCCCHHHHHHHHHHHhcCHh-hccCCCCCCHHHHHcCCcccCCC
Confidence 1 12222 33666 787 778999999997543
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-44 Score=318.20 Aligned_cols=243 Identities=27% Similarity=0.464 Sum_probs=182.0
Q ss_pred ccCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeE
Q 021306 35 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 111 (314)
Q Consensus 35 ~~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 111 (314)
...++|++.+.||+|+||.||++++..+++.||+|.+.... ....+|+.+++.++||||+++++++... ..+
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-----~~~ 91 (361)
T 3uc3_A 17 HDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILTP-----THL 91 (361)
T ss_dssp CCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEEECS-----SEE
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEEeeC-----CEE
Confidence 34578999999999999999999999999999999987543 3356899999999999999999998543 348
Q ss_pred EEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCC--cEEEeecCcc
Q 021306 112 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH--QVKICDFGSA 188 (314)
Q Consensus 112 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~--~~~l~dfg~~ 188 (314)
++||||+.+ +|.+.+.. .+.+++..++.++.||+.||.|||+ +||+||||||+||+++. ++ .++|+|||++
T Consensus 92 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~ql~~~L~~LH~-~~ivH~Dlkp~Nill~~-~~~~~~kl~Dfg~a 165 (361)
T 3uc3_A 92 AIIMEYASGGELYERICN----AGRFSEDEARFFFQQLLSGVSYCHS-MQICHRDLKLENTLLDG-SPAPRLKICDFGYS 165 (361)
T ss_dssp EEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCCSCCCCGGGEEECS-SSSCCEEECCCCCC
T ss_pred EEEEEeCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEEcC-CCCceEEEeecCcc
Confidence 899999975 77666653 3679999999999999999999999 89999999999999986 43 4999999998
Q ss_pred cccccCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH----cCCC----
Q 021306 189 KQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV----LGTP---- 260 (314)
Q Consensus 189 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~----~~~~---- 260 (314)
+............+|+.|+|||.+.+....+.++||||||+++|+|++|+.||.+.........+++. ....
T Consensus 166 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (361)
T 3uc3_A 166 KSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDI 245 (361)
T ss_dssp ---------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTS
T ss_pred ccccccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcC
Confidence 75544444455678999999999977653345599999999999999999999875543223332222 1111
Q ss_pred --CH---HHHh---ccCCCCCCCcccccccCChhhhh
Q 021306 261 --TR---EEIR---CMNPNYTDFRFPQIKAHPWHKVC 289 (314)
Q Consensus 261 --~~---~~~~---~~~p~~~~~~~~~l~~~p~~~~~ 289 (314)
.. +.+. ..+|. +|+++.++++|||+...
T Consensus 246 ~~s~~~~~li~~~L~~dP~-~Rps~~ell~hp~f~~~ 281 (361)
T 3uc3_A 246 RISPECCHLISRIFVADPA-TRISIPEIKTHSWFLKN 281 (361)
T ss_dssp CCCHHHHHHHHHHSCSCTT-TSCCHHHHHTSHHHHTT
T ss_pred CCCHHHHHHHHHHccCChh-HCcCHHHHHhCcchhcC
Confidence 11 1222 34677 89999999999999554
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-43 Score=310.99 Aligned_cols=244 Identities=35% Similarity=0.623 Sum_probs=198.1
Q ss_pred cCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc---------cchHHHHHHHHhCCCCceeeeceeeeecCCC
Q 021306 36 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---------RYKNRELQLMRVMDHPNVISLKHCFFSTTSK 106 (314)
Q Consensus 36 ~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~---------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 106 (314)
..++|++.+.||+|+||.||+|++..+|+.||+|.+.... ....+|+.++++++||||+++++++....
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-- 85 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS-- 85 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT--
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCC--
Confidence 3468999999999999999999999999999999986421 23458999999999999999999984433
Q ss_pred CceeEEEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecC
Q 021306 107 NELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 186 (314)
Q Consensus 107 ~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg 186 (314)
..++||||+++++...+.. ....+++..++.++.|++.||.|||+ +||+|+||||+||+++. ++.++|+|||
T Consensus 86 ---~~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dlkp~Nil~~~-~~~~kl~Dfg 157 (346)
T 1ua2_A 86 ---NISLVFDFMETDLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLHQ-HWILHRDLKPNNLLLDE-NGVLKLADFG 157 (346)
T ss_dssp ---CCEEEEECCSEEHHHHHTT---CCSSCCSSHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECT-TCCEEECCCG
T ss_pred ---ceEEEEEcCCCCHHHHHHh---cCcCCCHHHHHHHHHHHHHHHHHHHH-CCEECCCCCHHHEEEcC-CCCEEEEecc
Confidence 3789999999998777653 34578999999999999999999999 89999999999999998 7899999999
Q ss_pred cccccccCC-ccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCH---
Q 021306 187 SAKQLIAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR--- 262 (314)
Q Consensus 187 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~--- 262 (314)
++....... ......+|+.|+|||.+.+...++.++||||||+++|+|++|..||.+.+..+.+..+.+..+.+..
T Consensus 158 ~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 237 (346)
T 1ua2_A 158 LAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQW 237 (346)
T ss_dssp GGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred cceeccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhh
Confidence 997654322 2334567999999999976666889999999999999999999999999988888888876543321
Q ss_pred --------------------------------HHHh---ccCCCCCCCcccccccCChhhhhc
Q 021306 263 --------------------------------EEIR---CMNPNYTDFRFPQIKAHPWHKVCI 290 (314)
Q Consensus 263 --------------------------------~~~~---~~~p~~~~~~~~~l~~~p~~~~~~ 290 (314)
+.+. ..+|. +|+++.++++|||++...
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~-~Rpt~~ell~h~~f~~~~ 299 (346)
T 1ua2_A 238 PDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPC-ARITATQALKMKYFSNRP 299 (346)
T ss_dssp SSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTT-TSCCHHHHHTSGGGTSSS
T ss_pred hhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChh-hCCCHHHHhcChhhhcCC
Confidence 1111 33677 899999999999997543
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-43 Score=315.56 Aligned_cols=245 Identities=24% Similarity=0.378 Sum_probs=200.3
Q ss_pred cCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeecc----ccchHHHHHHHHhCCCCceeeeceeeeecCCCCceeE
Q 021306 36 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD----RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 111 (314)
Q Consensus 36 ~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 111 (314)
..++|++.+.||+|+||.||+|.+..+++.+|+|.+... .....+|+.++++++||||+++++++.. ...+
T Consensus 49 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~-----~~~~ 123 (387)
T 1kob_A 49 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFED-----KYEM 123 (387)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEEC-----SSEE
T ss_pred cccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEe-----CCEE
Confidence 456899999999999999999999999999999998654 2345689999999999999999999843 3348
Q ss_pred EEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcC-CCCcEEEeecCccc
Q 021306 112 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP-LTHQVKICDFGSAK 189 (314)
Q Consensus 112 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~-~~~~~~l~dfg~~~ 189 (314)
++||||+.| +|.+.+.. ....+++.+++.++.||+.||.|||+ +||+||||||+||+++. ..+.++|+|||++.
T Consensus 124 ~lv~E~~~gg~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~-~givHrDlkp~NIll~~~~~~~vkL~DFG~a~ 199 (387)
T 1kob_A 124 VLILEFLSGGELFDRIAA---EDYKMSEAEVINYMRQACEGLKHMHE-HSIVHLDIKPENIMCETKKASSVKIIDFGLAT 199 (387)
T ss_dssp EEEEECCCCCBHHHHTTC---TTCCBCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESSTTCCCEEECCCTTCE
T ss_pred EEEEEcCCCCcHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecccchHHeEEecCCCCceEEEecccce
Confidence 899999986 66655542 34579999999999999999999999 89999999999999975 25679999999998
Q ss_pred ccccCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCC--------C
Q 021306 190 QLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP--------T 261 (314)
Q Consensus 190 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~--------~ 261 (314)
............+|+.|+|||.+.+.. ++.++||||||+++|+|++|..||.+.+..+.+..+.+..... .
T Consensus 200 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 278 (387)
T 1kob_A 200 KLNPDEIVKVTTATAEFAAPEIVDREP-VGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVS 278 (387)
T ss_dssp ECCTTSCEEEECSSGGGCCHHHHTTCC-BCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSC
T ss_pred ecCCCcceeeeccCCCccCchhccCCC-CCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCC
Confidence 765544444567899999999996544 8999999999999999999999999988877777666542111 1
Q ss_pred ---HHHHh---ccCCCCCCCcccccccCChhhhhcc
Q 021306 262 ---REEIR---CMNPNYTDFRFPQIKAHPWHKVCIF 291 (314)
Q Consensus 262 ---~~~~~---~~~p~~~~~~~~~l~~~p~~~~~~~ 291 (314)
.+.+. ..+|. +|+++.++++|||++....
T Consensus 279 ~~~~~li~~~L~~dP~-~Rpt~~ell~hp~~~~~~~ 313 (387)
T 1kob_A 279 PEAKDFIKNLLQKEPR-KRLTVHDALEHPWLKGDHS 313 (387)
T ss_dssp HHHHHHHHTTSCSSGG-GSCCHHHHHTSTTTSSCCT
T ss_pred HHHHHHHHHHcCCChh-HCcCHHHHhhCccccCCcc
Confidence 12222 23666 8999999999999986543
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=324.00 Aligned_cols=248 Identities=26% Similarity=0.416 Sum_probs=202.7
Q ss_pred CccCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc-----------------cchHHHHHHHHhCCCCceeee
Q 021306 34 PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----------------RYKNRELQLMRVMDHPNVISL 96 (314)
Q Consensus 34 ~~~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~-----------------~~~~~e~~~l~~l~h~~iv~~ 96 (314)
....++|++++.||+|+||.||+|+++.+++.+|+|.+.... ....+|+.++++++||||+++
T Consensus 32 ~~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~ 111 (504)
T 3q5i_A 32 GKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKL 111 (504)
T ss_dssp SCGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCE
T ss_pred CCcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeE
Confidence 345678999999999999999999999999999999986432 234589999999999999999
Q ss_pred ceeeeecCCCCceeEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcC
Q 021306 97 KHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP 175 (314)
Q Consensus 97 ~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~ 175 (314)
++++.. ...+++||||++| +|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+||+++.
T Consensus 112 ~~~~~~-----~~~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~Dlkp~Nil~~~ 181 (504)
T 3q5i_A 112 FDVFED-----KKYFYLVTEFYEGGELFEQIIN----RHKFDECDAANIMKQILSGICYLHK-HNIVHRDIKPENILLEN 181 (504)
T ss_dssp EEEEEC-----SSEEEEEEECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEESS
T ss_pred EEEEEc-----CCEEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeCCCcHHHEEEec
Confidence 999843 3448899999986 77666654 3679999999999999999999999 89999999999999987
Q ss_pred CC--CcEEEeecCcccccccCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 021306 176 LT--HQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEI 253 (314)
Q Consensus 176 ~~--~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i 253 (314)
.+ ..++|+|||++.............+|+.|+|||.+.+ .++.++||||||+++|+|++|..||.+.+..+.+..+
T Consensus 182 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 259 (504)
T 3q5i_A 182 KNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKK--KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKV 259 (504)
T ss_dssp TTCCSSEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred CCCCccEEEEECCCCEEcCCCCccccccCCcCCCCHHHhcc--CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 33 2699999999987665555556678999999999853 3899999999999999999999999999888777777
Q ss_pred HHHcCCCCH-----------HHHh---ccCCCCCCCcccccccCChhhhhcccCC
Q 021306 254 IKVLGTPTR-----------EEIR---CMNPNYTDFRFPQIKAHPWHKVCIFHFP 294 (314)
Q Consensus 254 ~~~~~~~~~-----------~~~~---~~~p~~~~~~~~~l~~~p~~~~~~~~~~ 294 (314)
.+....... +.+. ..+|. +|+++.++++|||++.......
T Consensus 260 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~-~R~t~~e~l~h~~~~~~~~~~~ 313 (504)
T 3q5i_A 260 EKGKYYFDFNDWKNISDEAKELIKLMLTYDYN-KRCTAEEALNSRWIKKYANNIN 313 (504)
T ss_dssp HHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTT-TSCCHHHHHTSHHHHHTCCCCC
T ss_pred HcCCCCCCccccCCCCHHHHHHHHHHcCCChh-HCCCHHHHhcCHhhhhchhccc
Confidence 664332221 1222 33677 8999999999999998776543
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=313.10 Aligned_cols=213 Identities=21% Similarity=0.311 Sum_probs=174.9
Q ss_pred CCccCCCceeeeeEeec--CceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecC
Q 021306 33 EPKQTISYMAERVVGTG--SFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTT 104 (314)
Q Consensus 33 ~~~~~~~y~~~~~Lg~g--~~g~Vy~~~~~~~~~~~~vK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 104 (314)
-...+++|++.+.||+| +||.||+|++..+++.||+|.+.... ....+|+.++++++||||+++++++....
T Consensus 20 ~~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 99 (389)
T 3gni_B 20 FLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADN 99 (389)
T ss_dssp CCCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred ccCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECC
Confidence 33456789999999999 99999999999999999999997543 23457999999999999999999986543
Q ss_pred CCCceeEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEe
Q 021306 105 SKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKIC 183 (314)
Q Consensus 105 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~ 183 (314)
.+++||||+++ +|.+.+... ....+++..++.++.||+.||.|||+ +||+||||||+||+++. ++.++|+
T Consensus 100 -----~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivHrDlkp~NIll~~-~~~~kl~ 170 (389)
T 3gni_B 100 -----ELWVVTSFMAYGSAKDLICTH--FMDGMNELAIAYILQGVLKALDYIHH-MGYVHRSVKASHILISV-DGKVYLS 170 (389)
T ss_dssp -----EEEEEEECCTTCBHHHHHHHT--CTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECT-TCCEEEC
T ss_pred -----EEEEEEEccCCCCHHHHHhhh--cccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcC-CCCEEEc
Confidence 38899999985 666666542 23669999999999999999999999 89999999999999998 8899999
Q ss_pred ecCcccccccCC--------ccccccccccccccccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 021306 184 DFGSAKQLIAGE--------ANISYICSRFYRAPELIFGA-TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 254 (314)
Q Consensus 184 dfg~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~ 254 (314)
|||.+....... ......+|+.|+|||.+.+. ..++.++|||||||++|+|++|+.||.+.+..+.+..++
T Consensus 171 dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~ 250 (389)
T 3gni_B 171 GLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKL 250 (389)
T ss_dssp CGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-
T ss_pred ccccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHh
Confidence 999876442221 11223678889999999763 448999999999999999999999998876655554433
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=316.28 Aligned_cols=215 Identities=37% Similarity=0.638 Sum_probs=181.2
Q ss_pred ccCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeecccc---chHHHHHHHHhC------CCCceeeeceeeeecCC
Q 021306 35 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR---YKNRELQLMRVM------DHPNVISLKHCFFSTTS 105 (314)
Q Consensus 35 ~~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~~---~~~~e~~~l~~l------~h~~iv~~~~~~~~~~~ 105 (314)
...++|++.+.||+|+||.||+|++..+++.||+|.+..... ...+|+.+++.+ .|+||+++++++....
T Consensus 94 ~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~- 172 (429)
T 3kvw_A 94 HVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRN- 172 (429)
T ss_dssp EETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETT-
T ss_pred cccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCC-
Confidence 345689999999999999999999999999999999976532 335677777776 5779999999885433
Q ss_pred CCceeEEEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCc--EEEe
Q 021306 106 KNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQ--VKIC 183 (314)
Q Consensus 106 ~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~--~~l~ 183 (314)
.++++|||++++|.+.+... ....+++..++.++.||+.||.|||+ +||+||||||+||+++. ++. ++|+
T Consensus 173 ----~~~lv~e~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlKp~NILl~~-~~~~~vkL~ 244 (429)
T 3kvw_A 173 ----HICMTFELLSMNLYELIKKN--KFQGFSLPLVRKFAHSILQCLDALHK-NRIIHCDLKPENILLKQ-QGRSGIKVI 244 (429)
T ss_dssp ----EEEEEECCCCCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHH-HTEECSCCSGGGEEESS-TTSCCEEEC
T ss_pred ----eEEEEEeccCCCHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEEcc-CCCcceEEe
Confidence 48899999999998887752 23459999999999999999999999 89999999999999998 554 9999
Q ss_pred ecCcccccccCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCC
Q 021306 184 DFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 261 (314)
Q Consensus 184 dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~ 261 (314)
|||++..... ......+|+.|+|||.+.+.. ++.++|||||||++|+|++|..||.+.+..+.+..+++..+.++
T Consensus 245 DFG~a~~~~~--~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~ 319 (429)
T 3kvw_A 245 DFGSSCYEHQ--RVYTYIQSRFYRAPEVILGAR-YGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPS 319 (429)
T ss_dssp CCTTCEETTC--CCCSSCSCGGGCCHHHHHTBC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred ecccceecCC--cccccCCCCCccChHHHhCCC-CCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCC
Confidence 9999965432 233457899999999997655 89999999999999999999999999999888888887655544
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-43 Score=313.95 Aligned_cols=244 Identities=24% Similarity=0.410 Sum_probs=193.8
Q ss_pred CccCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccccc-------hHHHHHH-HHhCCCCceeeeceeeeecCC
Q 021306 34 PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY-------KNRELQL-MRVMDHPNVISLKHCFFSTTS 105 (314)
Q Consensus 34 ~~~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~~~-------~~~e~~~-l~~l~h~~iv~~~~~~~~~~~ 105 (314)
....++|++.+.||+|+||.||+|+++.+++.||+|.+++.... ..+|..+ ++.++||||+++++++..
T Consensus 34 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~--- 110 (373)
T 2r5t_A 34 HAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQT--- 110 (373)
T ss_dssp TCCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEEC---
T ss_pred CCChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEe---
Confidence 34557899999999999999999999999999999998754321 1234444 466899999999998844
Q ss_pred CCceeEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEee
Q 021306 106 KNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICD 184 (314)
Q Consensus 106 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~d 184 (314)
...+++||||++| +|...+.. ...+++..++.++.||+.||.|||+ +||+||||||+||+++. ++.++|+|
T Consensus 111 --~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~givHrDlkp~NIll~~-~g~ikL~D 182 (373)
T 2r5t_A 111 --ADKLYFVLDYINGGELFYHLQR----ERCFLEPRARFYAAEIASALGYLHS-LNIVYRDLKPENILLDS-QGHIVLTD 182 (373)
T ss_dssp --SSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECT-TSCEEECC
T ss_pred --CCEEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCHHHEEECC-CCCEEEee
Confidence 3348899999986 66666653 4679999999999999999999999 89999999999999998 88999999
Q ss_pred cCccccccc-CCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCC--
Q 021306 185 FGSAKQLIA-GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT-- 261 (314)
Q Consensus 185 fg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~-- 261 (314)
||+++.... ........||+.|+|||.+.+.. ++.++|+||||+++|+|++|..||.+.+..+.+..++......+
T Consensus 183 FG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~ 261 (373)
T 2r5t_A 183 FGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQP-YDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPN 261 (373)
T ss_dssp CCBCGGGBCCCCCCCSBSCCCCCCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCCCCSS
T ss_pred CccccccccCCCccccccCCccccCHHHhCCCC-CCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccCCCCC
Confidence 999975332 23344567899999999997654 89999999999999999999999999888888877776532211
Q ss_pred -----HHHHh---ccCCCCCCCcc----cccccCChhhhhc
Q 021306 262 -----REEIR---CMNPNYTDFRF----PQIKAHPWHKVCI 290 (314)
Q Consensus 262 -----~~~~~---~~~p~~~~~~~----~~l~~~p~~~~~~ 290 (314)
.+.+. ..+|. +|++. .++++|||++...
T Consensus 262 ~~~~~~~li~~lL~~dp~-~R~~~~~~~~~i~~h~~f~~~~ 301 (373)
T 2r5t_A 262 ITNSARHLLEGLLQKDRT-KRLGAKDDFMEIKSHVFFSLIN 301 (373)
T ss_dssp SCHHHHHHHHHHTCSSGG-GSTTTTTTHHHHHTSGGGTTCC
T ss_pred CCHHHHHHHHHHcccCHH-hCCCCCCCHHHHhCCccccCCC
Confidence 12222 33666 78876 5899999997643
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-43 Score=310.28 Aligned_cols=250 Identities=26% Similarity=0.375 Sum_probs=186.5
Q ss_pred CCCccCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc--cchHHHHHHHHhCCCCceeeeceeeeecCCCCce
Q 021306 32 GEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR--RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL 109 (314)
Q Consensus 32 ~~~~~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~--~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 109 (314)
......++|++.+.||+|+||.||+|++..+++.||+|.+.... ....+|+.++++++||||+++++++... .
T Consensus 47 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~ 121 (349)
T 2w4o_A 47 NRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIFETP-----T 121 (349)
T ss_dssp BCSCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC----------CHHHHHCCCTTBCCEEEEEECS-----S
T ss_pred ccccccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchhHHHHHHHHHHHHhCCCCCCcceeeeEecC-----C
Confidence 34455678999999999999999999999999999999987543 3456899999999999999999998443 3
Q ss_pred eEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcC--CCCcEEEeecC
Q 021306 110 FLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP--LTHQVKICDFG 186 (314)
Q Consensus 110 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~--~~~~~~l~dfg 186 (314)
..++||||+++ +|.+.+. ....+++.+++.++.|++.||.|||+ +||+|+||||+||+++. .++.++|+|||
T Consensus 122 ~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg 196 (349)
T 2w4o_A 122 EISLVLELVTGGELFDRIV----EKGYYSERDAADAVKQILEAVAYLHE-NGIVHRDLKPENLLYATPAPDAPLKIADFG 196 (349)
T ss_dssp EEEEEECCCCSCBHHHHHT----TCSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEESSSSTTCCEEECCCC
T ss_pred eEEEEEEeCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCcccEEEecCCCCCCEEEccCc
Confidence 48899999985 7666654 35679999999999999999999999 89999999999999973 36789999999
Q ss_pred cccccccCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHH-HHHHHHcCCC-----
Q 021306 187 SAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQL-VEIIKVLGTP----- 260 (314)
Q Consensus 187 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~-~~i~~~~~~~----- 260 (314)
++.............+|+.|+|||.+.+.. ++.++||||||+++|+|++|..||.+....... ..+.+.....
T Consensus 197 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~ 275 (349)
T 2w4o_A 197 LSKIVEHQVLMKTVCGTPGYCAPEILRGCA-YGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWW 275 (349)
T ss_dssp ----------------CGGGSCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTT
T ss_pred cccccCcccccccccCCCCccCHHHhcCCC-CCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchh
Confidence 998665444444567899999999997654 899999999999999999999999877665533 3333322111
Q ss_pred ---C---HHHHh---ccCCCCCCCcccccccCChhhhhcccC
Q 021306 261 ---T---REEIR---CMNPNYTDFRFPQIKAHPWHKVCIFHF 293 (314)
Q Consensus 261 ---~---~~~~~---~~~p~~~~~~~~~l~~~p~~~~~~~~~ 293 (314)
. .+.+. ..+|. +|+++.++++|||+.......
T Consensus 276 ~~~~~~~~~li~~~L~~dP~-~Rpt~~e~l~hp~~~~~~~~~ 316 (349)
T 2w4o_A 276 DEVSLNAKDLVRKLIVLDPK-KRLTTFQALQHPWVTGKAANF 316 (349)
T ss_dssp TTSCHHHHHHHHTTSCSSGG-GSCCHHHHHHSTTTTSTTCCC
T ss_pred hhCCHHHHHHHHHHccCChh-hCcCHHHHhcCcccCCCccch
Confidence 1 11222 23676 899999999999998776544
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=306.93 Aligned_cols=247 Identities=30% Similarity=0.595 Sum_probs=199.9
Q ss_pred cCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCcee
Q 021306 36 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 110 (314)
Q Consensus 36 ~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 110 (314)
..++|++.+.||+|+||.||+|.+..+|+.||+|.+.... ....+|+.++++++|+||+++++++..........
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 88 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE 88 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence 4568999999999999999999999999999999986432 22348999999999999999998875443333456
Q ss_pred EEEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcccc
Q 021306 111 LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 190 (314)
Q Consensus 111 ~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~ 190 (314)
.++++||+.++|.+.+.. ..+++..++.++.|++.||.|||+ +|++|+||||+||+++. ++.++|+|||++..
T Consensus 89 ~~lv~e~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~-~~ivH~Dlkp~Nil~~~-~~~~kl~Dfg~a~~ 161 (353)
T 2b9h_A 89 VYIIQELMQTDLHRVIST-----QMLSDDHIQYFIYQTLRAVKVLHG-SNVIHRDLKPSNLLINS-NCDLKVCDFGLARI 161 (353)
T ss_dssp EEEEECCCSEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEECT-TCCEEECCCTTCEE
T ss_pred EEEEEeccCccHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEEcC-CCcEEEEecccccc
Confidence 889999999998887764 579999999999999999999999 89999999999999998 78899999999976
Q ss_pred cccCCc-----------cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCC
Q 021306 191 LIAGEA-----------NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT 259 (314)
Q Consensus 191 ~~~~~~-----------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~ 259 (314)
...... .....+|+.|+|||.+.+...++.++||||||+++|+|++|+.||.+.+..+.+..+....+.
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 241 (353)
T 2b9h_A 162 IDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGT 241 (353)
T ss_dssp CC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred cccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCC
Confidence 542211 112457889999999866566899999999999999999999999998877766666554332
Q ss_pred CC---------------------------------------HHHHh---ccCCCCCCCcccccccCChhhhhc
Q 021306 260 PT---------------------------------------REEIR---CMNPNYTDFRFPQIKAHPWHKVCI 290 (314)
Q Consensus 260 ~~---------------------------------------~~~~~---~~~p~~~~~~~~~l~~~p~~~~~~ 290 (314)
+. .+.+. ..+|. +|+++.++++|||++...
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~-~Rpt~~ell~hp~~~~~~ 313 (353)
T 2b9h_A 242 PHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPA-KRITAKEALEHPYLQTYH 313 (353)
T ss_dssp CCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGG-GSCCHHHHHTSGGGTTTC
T ss_pred CchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcc-cCCCHHHHhcCccccccC
Confidence 21 01122 23666 899999999999998654
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-43 Score=311.13 Aligned_cols=241 Identities=24% Similarity=0.405 Sum_probs=194.0
Q ss_pred cCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHhC-CCCceeeeceeeeecCCCCceeEEEE
Q 021306 36 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVM-DHPNVISLKHCFFSTTSKNELFLNLV 114 (314)
Q Consensus 36 ~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv 114 (314)
..++|++.+.||+|+||.||+|+++.+++.||+|.+.+......+|++++.++ +||||+++++++.. ...+++|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~-----~~~~~lv 94 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLRYGQHPNIITLKDVYDD-----GKYVYVV 94 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCCCHHHHHHHHHHTTSTTBCCEEEEEEC-----SSEEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCChHHHHHHHHHhcCCCCcCeEEEEEEc-----CCEEEEE
Confidence 45689999999999999999999999999999999988777778899888887 79999999999843 3458899
Q ss_pred eecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCC---cEEEeecCcccc
Q 021306 115 MEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH---QVKICDFGSAKQ 190 (314)
Q Consensus 115 ~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~---~~~l~dfg~~~~ 190 (314)
|||+.| +|.+.+.. ...+++.+++.++.||+.||.|||+ +||+||||||+||++...++ .++|+|||++..
T Consensus 95 ~E~~~gg~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~-~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~ 169 (342)
T 2qr7_A 95 TELMKGGELLDKILR----QKFFSEREASAVLFTITKTVEYLHA-QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQ 169 (342)
T ss_dssp ECCCCSCBHHHHHHT----CTTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEE
T ss_pred EeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcEeccCCHHHEEEecCCCCcCeEEEEECCCccc
Confidence 999986 77766653 5679999999999999999999999 89999999999999865333 599999999986
Q ss_pred cccCC-ccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCC---ChHHHHHHHHHHcCCC------
Q 021306 191 LIAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE---NAVDQLVEIIKVLGTP------ 260 (314)
Q Consensus 191 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~---~~~~~~~~i~~~~~~~------ 260 (314)
..... ......+|+.|+|||.+.+.. ++.++||||||+++|+|++|..||.+. +..+.+..+....-..
T Consensus 170 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 248 (342)
T 2qr7_A 170 LRAENGLLMTPCYTANFVAPEVLERQG-YDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWN 248 (342)
T ss_dssp CBCTTCCBCCSSCCSSCCCHHHHHHHH-HHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTT
T ss_pred CcCCCCceeccCCCccccCHHHhcCCC-CCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCccccc
Confidence 54332 233456799999999986544 788999999999999999999999763 3334444443322111
Q ss_pred --C---HHHHh---ccCCCCCCCcccccccCChhhh
Q 021306 261 --T---REEIR---CMNPNYTDFRFPQIKAHPWHKV 288 (314)
Q Consensus 261 --~---~~~~~---~~~p~~~~~~~~~l~~~p~~~~ 288 (314)
. .+.+. ..+|. +|+++.++++|||+..
T Consensus 249 ~~s~~~~~li~~~L~~dP~-~R~t~~~il~hp~~~~ 283 (342)
T 2qr7_A 249 SVSDTAKDLVSKMLHVDPH-QRLTAALVLRHPWIVH 283 (342)
T ss_dssp TSCHHHHHHHHHHTCSSTT-TSCCHHHHTTSHHHHT
T ss_pred cCCHHHHHHHHHHCCCChh-HCcCHHHHhcCCeecC
Confidence 1 12222 34777 8999999999999964
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=304.24 Aligned_cols=244 Identities=32% Similarity=0.617 Sum_probs=196.7
Q ss_pred cCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeecccc------chHHHHHHHHhCCCCceeeeceeeeecCCCCce
Q 021306 36 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR------YKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL 109 (314)
Q Consensus 36 ~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~~------~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 109 (314)
..++|++.+.||+|+||.||+|++..+++.|++|.+..... ...+|+.++++++||||+++++++....
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----- 97 (331)
T 4aaa_A 23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKK----- 97 (331)
T ss_dssp CGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT-----
T ss_pred hhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCC-----
Confidence 34689999999999999999999999999999999864432 2347999999999999999999985433
Q ss_pred eEEEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCccc
Q 021306 110 FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 189 (314)
Q Consensus 110 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~ 189 (314)
..++||||++++++..+.. ....+++..++.++.|++.||.+||+ +|++|+||||+||+++. ++.++|+|||++.
T Consensus 98 ~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivH~dlkp~Nil~~~-~~~~kl~Dfg~~~ 172 (331)
T 4aaa_A 98 RWYLVFEFVDHTILDDLEL---FPNGLDYQVVQKYLFQIINGIGFCHS-HNIIHRDIKPENILVSQ-SGVVKLCDFGFAR 172 (331)
T ss_dssp EEEEEEECCSEEHHHHHHH---STTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECT-TSCEEECCCTTC-
T ss_pred EEEEEEecCCcchHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHH-CCEEccCcChheEEEcC-CCcEEEEeCCCce
Confidence 3889999999986665543 35679999999999999999999999 89999999999999998 7899999999997
Q ss_pred ccccCC-ccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCH------
Q 021306 190 QLIAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR------ 262 (314)
Q Consensus 190 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~------ 262 (314)
...... ......+++.|+|||.+.+...++.++||||||+++|+|++|+.||.+.+..+.+..++...+...+
T Consensus 173 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (331)
T 4aaa_A 173 TLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELF 252 (331)
T ss_dssp -----------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHH
T ss_pred eecCCccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHh
Confidence 654322 2234567899999999977656899999999999999999999999999888887777655433211
Q ss_pred --------------------------------HHHh---ccCCCCCCCcccccccCChhhhhc
Q 021306 263 --------------------------------EEIR---CMNPNYTDFRFPQIKAHPWHKVCI 290 (314)
Q Consensus 263 --------------------------------~~~~---~~~p~~~~~~~~~l~~~p~~~~~~ 290 (314)
+.+. ..+|. +|+++.++++|||++...
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~-~Rpt~~ell~hp~f~~~~ 314 (331)
T 4aaa_A 253 NKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPD-KRPFCAELLHHDFFQMDG 314 (331)
T ss_dssp HHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGG-GSCCGGGGGGSHHHHGGG
T ss_pred hhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcc-cCCCHHHHhcCchhccCC
Confidence 1111 23666 899999999999998764
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=305.95 Aligned_cols=242 Identities=25% Similarity=0.393 Sum_probs=199.7
Q ss_pred cCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc----------cchHHHHHHHHhCCCCceeeeceeeeecCC
Q 021306 36 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----------RYKNRELQLMRVMDHPNVISLKHCFFSTTS 105 (314)
Q Consensus 36 ~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~----------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 105 (314)
..++|++.+.||+|+||.||+|++..+++.||+|.+.... ....+|+.++++++||||+++++++..
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--- 86 (321)
T 2a2a_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYEN--- 86 (321)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC---
T ss_pred hhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEec---
Confidence 3467999999999999999999999999999999986532 234689999999999999999998843
Q ss_pred CCceeEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCC----cE
Q 021306 106 KNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH----QV 180 (314)
Q Consensus 106 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~----~~ 180 (314)
....++||||+++ +|.+.+.. ...+++..++.++.|++.||.|||+ +|++|+||+|+||+++. ++ .+
T Consensus 87 --~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~-~~ivH~dikp~NIl~~~-~~~~~~~~ 158 (321)
T 2a2a_A 87 --RTDVVLILELVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYLHT-KKIAHFDLKPENIMLLD-KNIPIPHI 158 (321)
T ss_dssp --SSEEEEEECCCCSCBHHHHHHT----CSCEEHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEESC-TTSSSCCE
T ss_pred --CCEEEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCChHHEEEec-CCCCcCCE
Confidence 3348899999975 77766653 5679999999999999999999999 89999999999999987 44 79
Q ss_pred EEeecCcccccccCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCC
Q 021306 181 KICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 260 (314)
Q Consensus 181 ~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~ 260 (314)
+|+|||++.............+++.|+|||.+.+.. ++.++||||||+++|+|++|..||.+.+..+.+..+.+.....
T Consensus 159 kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~ 237 (321)
T 2a2a_A 159 KLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEP-LGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDF 237 (321)
T ss_dssp EECCCTTCEECCTTCCCCCCCSCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCC
T ss_pred EEccCccceecCccccccccCCCCCccCcccccCCC-CCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhccccc
Confidence 999999998765544445567899999999996544 8999999999999999999999999988877776665543322
Q ss_pred CH-----------HHHh---ccCCCCCCCcccccccCChhhhhc
Q 021306 261 TR-----------EEIR---CMNPNYTDFRFPQIKAHPWHKVCI 290 (314)
Q Consensus 261 ~~-----------~~~~---~~~p~~~~~~~~~l~~~p~~~~~~ 290 (314)
.. +.+. ..+|. +|+++.++++|||+....
T Consensus 238 ~~~~~~~~~~~~~~li~~~l~~dp~-~Rps~~e~l~hp~~~~~~ 280 (321)
T 2a2a_A 238 DEEFFSHTSELAKDFIRKLLVKETR-KRLTIQEALRHPWITPVD 280 (321)
T ss_dssp CHHHHTTCCHHHHHHHHTTSCSSTT-TSCCHHHHHHSTTTSCSS
T ss_pred ChhhhcccCHHHHHHHHHHcCCChh-hCcCHHHHhcCccccCCC
Confidence 21 1222 23666 899999999999998654
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=297.60 Aligned_cols=243 Identities=28% Similarity=0.415 Sum_probs=201.9
Q ss_pred cCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeE
Q 021306 36 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 111 (314)
Q Consensus 36 ~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 111 (314)
..++|++.+.||+|+||.||+|.+..++..+++|++.... ....+|+.++++++||||+++++++.. ....
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~~ 81 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFED-----NTDI 81 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----SSEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEec-----CCeE
Confidence 4568999999999999999999999999999999986532 345689999999999999999998843 3348
Q ss_pred EEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEE---cCCCCcEEEeecCc
Q 021306 112 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLV---DPLTHQVKICDFGS 187 (314)
Q Consensus 112 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~---~~~~~~~~l~dfg~ 187 (314)
++||||+++ +|.+.+.. ...+++..++.++.|++.||.+||+ +|++|+||+|+||++ +. ++.++|+|||.
T Consensus 82 ~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~-~~i~H~dlkp~Nil~~~~~~-~~~~~l~Dfg~ 155 (277)
T 3f3z_A 82 YLVMELCTGGELFERVVH----KRVFRESDAARIMKDVLSAVAYCHK-LNVAHRDLKPENFLFLTDSP-DSPLKLIDFGL 155 (277)
T ss_dssp EEEEECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEESSSST-TCCEEECCCTT
T ss_pred EEEEeccCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccCCCCCHHHEEEecCCC-CCcEEEEeccc
Confidence 899999986 66666653 4679999999999999999999999 899999999999999 54 77899999999
Q ss_pred ccccccCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCHH----
Q 021306 188 AKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE---- 263 (314)
Q Consensus 188 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~---- 263 (314)
+.............+++.|+|||.+.+ . ++.++||||||+++|+|++|+.||.+.+..+....+.+.....+..
T Consensus 156 ~~~~~~~~~~~~~~~t~~y~aPE~~~~-~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (277)
T 3f3z_A 156 AARFKPGKMMRTKVGTPYYVSPQVLEG-L-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLN 233 (277)
T ss_dssp CEECCTTSCBCCCCSCTTTCCHHHHTT-C-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTT
T ss_pred ceeccCccchhccCCCCCccChHHhcc-c-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhc
Confidence 987665555556678999999999854 3 7999999999999999999999999988877777776654333322
Q ss_pred -------HHh---ccCCCCCCCcccccccCChhhhhccc
Q 021306 264 -------EIR---CMNPNYTDFRFPQIKAHPWHKVCIFH 292 (314)
Q Consensus 264 -------~~~---~~~p~~~~~~~~~l~~~p~~~~~~~~ 292 (314)
.+. ..+|. +|+++.++++|||++.....
T Consensus 234 ~~~~~~~li~~~l~~dp~-~R~s~~~~l~h~~~~~~~~~ 271 (277)
T 3f3z_A 234 VSPQAESLIRRLLTKSPK-QRITSLQALEHEWFEKQLSS 271 (277)
T ss_dssp SCHHHHHHHHHHTCSSTT-TSCCHHHHTTSHHHHHHHCC
T ss_pred CCHHHHHHHHHHccCChh-hCcCHHHHhcCHHHhccccc
Confidence 111 23666 89999999999999876554
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=309.14 Aligned_cols=242 Identities=36% Similarity=0.632 Sum_probs=196.9
Q ss_pred CCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCC-Cce
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSK-NEL 109 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~-~~~ 109 (314)
.++|++.+.||+|+||.||+|.+..+|+.||+|++.... ....+|+.+++.++||||+++++++...... ...
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 358999999999999999999999999999999987532 2335899999999999999999988544331 112
Q ss_pred eEEEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCccc
Q 021306 110 FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 189 (314)
Q Consensus 110 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~ 189 (314)
.+++||||+.+++.+.+. ..+++..++.++.|++.||.|||+ +||+|+||||+||+++. ++.++|+|||++.
T Consensus 121 ~~~lv~e~~~~~l~~~~~------~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dikp~NIll~~-~~~~kL~Dfg~a~ 192 (371)
T 4exu_A 121 DFYLVMPFMQTDLQKIMG------MEFSEEKIQYLVYQMLKGLKYIHS-AGVVHRDLKPGNLAVNE-DCELKILDFGLAR 192 (371)
T ss_dssp CCEEEEECCCEEHHHHTT------SCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECT-TCCEEECSTTCC-
T ss_pred eEEEEEccccccHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHH-CCCcCCCcCHHHeEECC-CCCEEEEecCccc
Confidence 247999999998766553 569999999999999999999999 89999999999999998 8889999999997
Q ss_pred ccccCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCHH------
Q 021306 190 QLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE------ 263 (314)
Q Consensus 190 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~------ 263 (314)
..... .....+|+.|+|||.+.+...++.++||||||+++|+|++|+.||.+.+..+.+..+.+..+.+...
T Consensus 193 ~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 270 (371)
T 4exu_A 193 HADAE--MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLN 270 (371)
T ss_dssp ---------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCS
T ss_pred ccccC--cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhh
Confidence 55332 3345679999999999775668999999999999999999999999999888888877655443221
Q ss_pred --------------------------------HHh---ccCCCCCCCcccccccCChhhhh
Q 021306 264 --------------------------------EIR---CMNPNYTDFRFPQIKAHPWHKVC 289 (314)
Q Consensus 264 --------------------------------~~~---~~~p~~~~~~~~~l~~~p~~~~~ 289 (314)
.+. ..+|. +|+++.++++|||++..
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~-~Rpt~~ell~hp~f~~~ 330 (371)
T 4exu_A 271 DKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVD-KRLTAAQALTHPFFEPF 330 (371)
T ss_dssp CHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTT-TSCCHHHHHTSGGGTTT
T ss_pred hhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChh-hcCCHHHHhcCcccccC
Confidence 111 33677 89999999999999864
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-42 Score=301.03 Aligned_cols=254 Identities=34% Similarity=0.587 Sum_probs=206.4
Q ss_pred CCCccCCCceeeeeEeecCceEEEEEEEC-CCCcEEEEEEeeccc------cchHHHHHHHHhC---CCCceeeeceeee
Q 021306 32 GEPKQTISYMAERVVGTGSFGIVFQAKCL-ETGETVAIKKVLQDR------RYKNRELQLMRVM---DHPNVISLKHCFF 101 (314)
Q Consensus 32 ~~~~~~~~y~~~~~Lg~g~~g~Vy~~~~~-~~~~~~~vK~~~~~~------~~~~~e~~~l~~l---~h~~iv~~~~~~~ 101 (314)
+.....++|++.+.||+|+||.||+|++. .+++.||+|.+.... ....+|+.+++.+ +||||+++++++.
T Consensus 5 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~ 84 (326)
T 1blx_A 5 GLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCT 84 (326)
T ss_dssp CCCCGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEE
T ss_pred cccCchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeee
Confidence 34455679999999999999999999985 678999999886432 2345777777666 8999999999886
Q ss_pred ecCCCCceeEEEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEE
Q 021306 102 STTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVK 181 (314)
Q Consensus 102 ~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~ 181 (314)
..........++|+||++++|.+.+... ....+++..++.++.|++.||.|||+ +|++|+||||+||+++. ++.++
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~-~gi~H~dlkp~Nili~~-~~~~k 160 (326)
T 1blx_A 85 VSRTDRETKLTLVFEHVDQDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHS-HRVVHRDLKPQNILVTS-SGQIK 160 (326)
T ss_dssp EEECSSEEEEEEEEECCSCBHHHHHHHS--CTTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECT-TCCEE
T ss_pred ecccCCCceEEEEEecCCCCHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCHHHeEEcC-CCCEE
Confidence 4444456678899999999988887653 23459999999999999999999999 89999999999999998 78999
Q ss_pred EeecCcccccccCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCC
Q 021306 182 ICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 261 (314)
Q Consensus 182 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~ 261 (314)
|+|||.+.............+++.|+|||.+.+.. ++.++||||||+++|+|++|+.||.+.+..+.+..+++..+.+.
T Consensus 161 l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~ 239 (326)
T 1blx_A 161 LADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPG 239 (326)
T ss_dssp ECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred EecCcccccccCCCCccccccccceeCHHHHhcCC-CCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCC
Confidence 99999997665444444566789999999996654 89999999999999999999999999998888888876544322
Q ss_pred H----------------------------------HHHh---ccCCCCCCCcccccccCChhhhhcc
Q 021306 262 R----------------------------------EEIR---CMNPNYTDFRFPQIKAHPWHKVCIF 291 (314)
Q Consensus 262 ~----------------------------------~~~~---~~~p~~~~~~~~~l~~~p~~~~~~~ 291 (314)
. +.+. ..+|. +|+++.++++|||++....
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~-~Rpt~~e~l~hp~~~~~~~ 305 (326)
T 1blx_A 240 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPA-KRISAYSALSHPYFQDLER 305 (326)
T ss_dssp GGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTT-TSCCHHHHHTSGGGTTCCC
T ss_pred cccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcc-cCCCHHHHhcCccccccch
Confidence 1 1122 23676 8999999999999987654
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=311.50 Aligned_cols=217 Identities=30% Similarity=0.450 Sum_probs=177.1
Q ss_pred CCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHhCC--------CCceeeeceeeeecCC
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMD--------HPNVISLKHCFFSTTS 105 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~---~~~~~e~~~l~~l~--------h~~iv~~~~~~~~~~~ 105 (314)
.++|++.+.||+|+||.||+|++..+++.||+|.+.... ....+|+.+++.++ |+||+++++++....
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~- 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG- 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE-
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC-
Confidence 468999999999999999999999999999999997543 33457888988885 788999999875322
Q ss_pred CCceeEEEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCC-CceecCCCCCcEEEcCCC-------
Q 021306 106 KNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP-RVCHRDLKPQNLLVDPLT------- 177 (314)
Q Consensus 106 ~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~-~i~h~dl~p~Nil~~~~~------- 177 (314)
.....+++||||+.+++++.+... ....+++..++.++.||+.||.|||+ + ||+||||||+||+++..+
T Consensus 115 ~~~~~~~lv~e~~~~~l~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~-~~givHrDikp~NIll~~~~~~~~~~~ 191 (397)
T 1wak_A 115 VNGTHICMVFEVLGHHLLKWIIKS--NYQGLPLPCVKKIIQQVLQGLDYLHT-KCRIIHTDIKPENILLSVNEQYIRRLA 191 (397)
T ss_dssp TTEEEEEEEECCCCCBHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHHH-TTCEECCCCSGGGEEECCCHHHHHHHH
T ss_pred CCCceEEEEEeccCccHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHH-hCCEecCCCCHHHeeEeccchhhhhhh
Confidence 234568899999999988877652 23579999999999999999999999 8 999999999999998632
Q ss_pred -----------------------------------------CcEEEeecCcccccccCCccccccccccccccccccCCC
Q 021306 178 -----------------------------------------HQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGAT 216 (314)
Q Consensus 178 -----------------------------------------~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 216 (314)
..++|+|||.+...... .....+|+.|+|||.+.+..
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~--~~~~~gt~~y~aPE~~~~~~ 269 (397)
T 1wak_A 192 AEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH--FTEDIQTRQYRSLEVLIGSG 269 (397)
T ss_dssp HHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC--SCSCCSCGGGCCHHHHHTSC
T ss_pred hhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc--CccCCCCCcccCChhhcCCC
Confidence 27999999999765432 33456799999999997655
Q ss_pred CCCcchhHHHHHHHHHHHHhCCCCCCCCC------hHHHHHHHHHHcCCC
Q 021306 217 EYTTSIDIWSAGCVLAELLLGQPLFPGEN------AVDQLVEIIKVLGTP 260 (314)
Q Consensus 217 ~~~~~~Dv~slG~il~el~tg~~pf~~~~------~~~~~~~i~~~~~~~ 260 (314)
++.++||||||+++|+|++|+.||.+.+ ..+.+..+.+..+..
T Consensus 270 -~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (397)
T 1wak_A 270 -YNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKV 318 (397)
T ss_dssp -CCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSC
T ss_pred -CCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCC
Confidence 8999999999999999999999997654 334455555544443
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-43 Score=312.94 Aligned_cols=243 Identities=36% Similarity=0.615 Sum_probs=186.2
Q ss_pred CCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCC-CCce
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTS-KNEL 109 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~~~~ 109 (314)
.++|++.+.||+|+||.||+|.+..+|+.||+|++.... ....+|+.+++.++||||+++++++..... ....
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 468999999999999999999999999999999986432 233589999999999999999998754321 1223
Q ss_pred eEEEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCccc
Q 021306 110 FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 189 (314)
Q Consensus 110 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~ 189 (314)
.+++++|+++++|.+.+.. ..+++..++.++.||+.||.|||+ +||+||||||+||+++. ++.++|+|||+++
T Consensus 108 ~~~lv~e~~~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~-~givH~Dlkp~NIll~~-~~~~kL~DFG~a~ 180 (367)
T 2fst_X 108 DVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS-ADIIHRDLKPSNLAVNE-DCELKILDFGLAR 180 (367)
T ss_dssp CCEEEEECCCEECC----------CCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECT-TCCEEECC-----
T ss_pred eEEEEecccCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCCHhhEEECC-CCCEEEeeccccc
Confidence 4689999998887666542 679999999999999999999999 89999999999999998 8899999999997
Q ss_pred ccccCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCHH------
Q 021306 190 QLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE------ 263 (314)
Q Consensus 190 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~------ 263 (314)
..... .....+|+.|+|||.+.+...++.++|||||||++|+|++|+.||.+.+..+.+..+++..+.+..+
T Consensus 181 ~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~ 258 (367)
T 2fst_X 181 HTADE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 258 (367)
T ss_dssp ------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCC
T ss_pred ccccc--CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhh
Confidence 64332 3345779999999999775668999999999999999999999999999888888888766554322
Q ss_pred --------------------------------HHh---ccCCCCCCCcccccccCChhhhh
Q 021306 264 --------------------------------EIR---CMNPNYTDFRFPQIKAHPWHKVC 289 (314)
Q Consensus 264 --------------------------------~~~---~~~p~~~~~~~~~l~~~p~~~~~ 289 (314)
.+. ..+|. +|+++.++++|||++..
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~-~R~t~~e~L~hp~~~~~ 318 (367)
T 2fst_X 259 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSD-KRITAAQALAHAYFAQY 318 (367)
T ss_dssp CHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGG-GSCCHHHHHTSGGGTTT
T ss_pred hHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcc-cCcCHHHHhcChhhhhc
Confidence 111 23666 89999999999999854
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=320.67 Aligned_cols=246 Identities=28% Similarity=0.437 Sum_probs=201.5
Q ss_pred ccCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeecc------ccchHHHHHHHHhCCCCceeeeceeeeecCCCCc
Q 021306 35 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 108 (314)
Q Consensus 35 ~~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 108 (314)
...++|++.+.||+|+||.||+|++..+++.||+|.+... .....+|+.++++++||||+++++++.. .
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-----~ 93 (486)
T 3mwu_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILED-----S 93 (486)
T ss_dssp HHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-----S
T ss_pred ChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEc-----C
Confidence 4557899999999999999999999999999999998532 2334689999999999999999999843 3
Q ss_pred eeEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcC--CCCcEEEeec
Q 021306 109 LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP--LTHQVKICDF 185 (314)
Q Consensus 109 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~--~~~~~~l~df 185 (314)
..+++||||+.| +|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+||+++. .++.++|+||
T Consensus 94 ~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~Dlkp~Nil~~~~~~~~~~kl~Df 168 (486)
T 3mwu_A 94 SSFYIVGELYTGGELFDEIIK----RKRFSEHDAARIIKQVFSGITYMHK-HNIVHRDLKPENILLESKEKDCDIKIIDF 168 (486)
T ss_dssp SEEEEEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEESSSSTTCCEEECSC
T ss_pred CEEEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeccCchHHEEEecCCCCCCEEEEEC
Confidence 348899999986 77666654 3679999999999999999999999 89999999999999964 2457999999
Q ss_pred CcccccccCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCH---
Q 021306 186 GSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR--- 262 (314)
Q Consensus 186 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~--- 262 (314)
|++.............+|+.|+|||.+.+ .++.++||||||+++|+|++|..||.+.+..+.+..+.........
T Consensus 169 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 246 (486)
T 3mwu_A 169 GLSTCFQQNTKMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQW 246 (486)
T ss_dssp SCTTTBCCC----CCTTGGGGCCGGGGGS--CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGG
T ss_pred CcCeECCCCCccCCCcCCCCCCCHHHhCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCccc
Confidence 99987655554555678999999999865 3899999999999999999999999999888877777665322211
Q ss_pred --------HHHh---ccCCCCCCCcccccccCChhhhhcccC
Q 021306 263 --------EEIR---CMNPNYTDFRFPQIKAHPWHKVCIFHF 293 (314)
Q Consensus 263 --------~~~~---~~~p~~~~~~~~~l~~~p~~~~~~~~~ 293 (314)
+.+. ..+|. +|+++.++++|||++....+.
T Consensus 247 ~~~s~~~~~li~~~L~~dp~-~R~t~~~~l~hp~~~~~~~~~ 287 (486)
T 3mwu_A 247 RTISDDAKDLIRKMLTFHPS-LRITATQCLEHPWIQKYSSET 287 (486)
T ss_dssp GGSCHHHHHHHHHHTCSSTT-TSCCHHHHHHCHHHHHTCCCC
T ss_pred CCCCHHHHHHHHHHcCCChh-hCcCHHHHhcCHhhccCcccC
Confidence 1222 33677 899999999999998776543
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-42 Score=305.23 Aligned_cols=241 Identities=27% Similarity=0.415 Sum_probs=199.3
Q ss_pred CCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCCcee
Q 021306 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 110 (314)
Q Consensus 38 ~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 110 (314)
+.|++.+.||+|+||.||+|++..+++.||+|.+.... ....+|+.++++++||||+++++++.... .
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-----~ 128 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH-----T 128 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT-----E
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC-----e
Confidence 46999999999999999999999999999999986432 23458999999999999999999985543 3
Q ss_pred EEEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcccc
Q 021306 111 LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 190 (314)
Q Consensus 111 ~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~ 190 (314)
.++||||+.|++.+.+.. ...++++.+++.++.|++.||.|||+ +||+||||||+||+++. ++.++|+|||++..
T Consensus 129 ~~lv~e~~~g~l~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~-~~~~kL~DfG~a~~ 203 (348)
T 1u5q_A 129 AWLVMEYCLGSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHS-HNMIHRDVKAGNILLSE-PGLVKLGDFGSASI 203 (348)
T ss_dssp EEEEEECCSEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCSGGGEEEET-TTEEEECCCTTCBS
T ss_pred EEEEEecCCCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCCHHHEEECC-CCCEEEeeccCcee
Confidence 889999999998877754 24689999999999999999999999 89999999999999998 88999999999875
Q ss_pred cccCCccccccccccccccccccC--CCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCC-------
Q 021306 191 LIAGEANISYICSRFYRAPELIFG--ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT------- 261 (314)
Q Consensus 191 ~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~------- 261 (314)
... .....+|+.|+|||.+.+ ...++.++||||||+++|+|++|+.||.+.+....+..+.+......
T Consensus 204 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (348)
T 1u5q_A 204 MAP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSE 280 (348)
T ss_dssp SSS---BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCCTTSCH
T ss_pred cCC---CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCH
Confidence 532 234568999999999853 34478999999999999999999999999888777776665432221
Q ss_pred --HHHHh---ccCCCCCCCcccccccCChhhhhccc
Q 021306 262 --REEIR---CMNPNYTDFRFPQIKAHPWHKVCIFH 292 (314)
Q Consensus 262 --~~~~~---~~~p~~~~~~~~~l~~~p~~~~~~~~ 292 (314)
.+.+. ..+|. +|+++.++++|||+......
T Consensus 281 ~l~~li~~~l~~dP~-~Rps~~~ll~h~~~~~~~~~ 315 (348)
T 1u5q_A 281 YFRNFVDSCLQKIPQ-DRPTSEVLLKHRFVLRERPP 315 (348)
T ss_dssp HHHHHHHHHTCSSGG-GSCCHHHHTTCHHHHSCCCT
T ss_pred HHHHHHHHHcccChh-hCcCHHHHhhChhhhccCCc
Confidence 11222 23666 89999999999999766543
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-43 Score=305.08 Aligned_cols=236 Identities=25% Similarity=0.310 Sum_probs=182.3
Q ss_pred CCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccccch------HHHHH-HHHhCCCCceeeeceeeeecCCCCcee
Q 021306 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK------NRELQ-LMRVMDHPNVISLKHCFFSTTSKNELF 110 (314)
Q Consensus 38 ~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~~~~------~~e~~-~l~~l~h~~iv~~~~~~~~~~~~~~~~ 110 (314)
++|++.+.||+|+||.||+|++..+++.||+|++....... ..|.. +.+..+|+||+++++++... ..
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~-----~~ 131 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEG-----GI 131 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET-----TE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeC-----CE
Confidence 67999999999999999999999999999999875432211 23333 33444999999999998543 34
Q ss_pred EEEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcccc
Q 021306 111 LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 190 (314)
Q Consensus 111 ~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~ 190 (314)
+++||||++++|.+.+... +..+++..++.++.|++.||.|||+ +||+|+||||+||+++. ++.++|+|||++..
T Consensus 132 ~~lv~e~~~~~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dikp~NIll~~-~~~~kl~DFG~a~~ 206 (311)
T 3p1a_A 132 LYLQTELCGPSLQQHCEAW---GASLPEAQVWGYLRDTLLALAHLHS-QGLVHLDVKPANIFLGP-RGRCKLGDFGLLVE 206 (311)
T ss_dssp EEEEEECCCCBHHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECG-GGCEEECCCTTCEE
T ss_pred EEEEEeccCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCCCHHHEEECC-CCCEEEccceeeee
Confidence 8899999999988877653 4679999999999999999999999 89999999999999998 78999999999877
Q ss_pred cccCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCC------CC---
Q 021306 191 LIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT------PT--- 261 (314)
Q Consensus 191 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~------~~--- 261 (314)
...........+|+.|+|||.+.+ .++.++||||||+++|+|++|..|+.+...... +.+.... ..
T Consensus 207 ~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~l 281 (311)
T 3p1a_A 207 LGTAGAGEVQEGDPRYMAPELLQG--SYGTAADVFSLGLTILEVACNMELPHGGEGWQQ---LRQGYLPPEFTAGLSSEL 281 (311)
T ss_dssp CC------CCCCCGGGCCGGGGGT--CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHHH---HTTTCCCHHHHTTSCHHH
T ss_pred cccCCCCcccCCCccccCHhHhcC--CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHH---HhccCCCcccccCCCHHH
Confidence 655544555668999999999865 489999999999999999999777655433222 2111100 11
Q ss_pred HHHHh---ccCCCCCCCcccccccCChhhhh
Q 021306 262 REEIR---CMNPNYTDFRFPQIKAHPWHKVC 289 (314)
Q Consensus 262 ~~~~~---~~~p~~~~~~~~~l~~~p~~~~~ 289 (314)
.+.+. ..+|. +|+++.++++|||++.+
T Consensus 282 ~~li~~~L~~dP~-~Rpt~~ell~hp~~~~p 311 (311)
T 3p1a_A 282 RSVLVMMLEPDPK-LRATAEALLALPVLRQP 311 (311)
T ss_dssp HHHHHHHSCSSTT-TSCCHHHHHTSGGGSCC
T ss_pred HHHHHHHcCCChh-hCcCHHHHHhCccccCC
Confidence 11222 33677 89999999999999753
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=313.96 Aligned_cols=249 Identities=34% Similarity=0.560 Sum_probs=185.8
Q ss_pred CCCcee-eeeEeecCceEEEEEEEC--CCCcEEEEEEeeccc--cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeE
Q 021306 37 TISYMA-ERVVGTGSFGIVFQAKCL--ETGETVAIKKVLQDR--RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 111 (314)
Q Consensus 37 ~~~y~~-~~~Lg~g~~g~Vy~~~~~--~~~~~~~vK~~~~~~--~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 111 (314)
.+.|++ .+.||+|+||.||+|+++ .+++.||+|.+.... ....+|+.++++++||||+++++++.... ...+
T Consensus 19 ~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~---~~~~ 95 (405)
T 3rgf_A 19 EDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHA---DRKV 95 (405)
T ss_dssp HHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCCHHHHHHHHHHHHCCCTTBCCCCEEEEETT---TTEE
T ss_pred hhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCCHHHHHHHHHHHhcCCCCeeeEeeEEecCC---CCeE
Confidence 346777 558999999999999966 568899999987543 34568999999999999999999986532 2348
Q ss_pred EEEeecccccHHHHHHhhhhc-----CCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEc---CCCCcEEEe
Q 021306 112 NLVMEYVPESMYRVLKHYSSA-----NQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVD---PLTHQVKIC 183 (314)
Q Consensus 112 ~lv~e~~~~~l~~~l~~~~~~-----~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~---~~~~~~~l~ 183 (314)
++||||+.++|.+.+...... ...+++..++.++.||+.||.|||+ +||+||||||+||++. ..++.++|+
T Consensus 96 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~ivH~Dlkp~NIll~~~~~~~~~~kl~ 174 (405)
T 3rgf_A 96 WLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA-NWVLHRDLKPANILVMGEGPERGRVKIA 174 (405)
T ss_dssp EEEEECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECCSSTTTTCEEEC
T ss_pred EEEEeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHh-CCEeCCCcCHHHeEEecCCCCCCcEEEE
Confidence 899999999988887643321 2359999999999999999999999 8999999999999993 226789999
Q ss_pred ecCcccccccCC----ccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCh---------HHHH
Q 021306 184 DFGSAKQLIAGE----ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA---------VDQL 250 (314)
Q Consensus 184 dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~---------~~~~ 250 (314)
|||++....... ......+|+.|+|||.+.+...++.++|||||||++|+|++|+.||.+... .+.+
T Consensus 175 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l 254 (405)
T 3rgf_A 175 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQL 254 (405)
T ss_dssp CTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHH
T ss_pred ECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHH
Confidence 999997654321 223456799999999997766689999999999999999999999976654 3556
Q ss_pred HHHHHHcCCCCH---------------------------------------------HHH---hccCCCCCCCccccccc
Q 021306 251 VEIIKVLGTPTR---------------------------------------------EEI---RCMNPNYTDFRFPQIKA 282 (314)
Q Consensus 251 ~~i~~~~~~~~~---------------------------------------------~~~---~~~~p~~~~~~~~~l~~ 282 (314)
..+++.++.+.. +.+ ...+|. +|+++.++++
T Consensus 255 ~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~-~R~ta~e~L~ 333 (405)
T 3rgf_A 255 DRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPI-KRITSEQAMQ 333 (405)
T ss_dssp HHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGG-GSCCHHHHHT
T ss_pred HHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcc-cCCCHHHHhc
Confidence 666655544321 112 234677 8999999999
Q ss_pred CChhhhhc
Q 021306 283 HPWHKVCI 290 (314)
Q Consensus 283 ~p~~~~~~ 290 (314)
|||++...
T Consensus 334 hp~f~~~~ 341 (405)
T 3rgf_A 334 DPYFLEDP 341 (405)
T ss_dssp SGGGTSSS
T ss_pred ChhhccCC
Confidence 99997643
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-42 Score=319.76 Aligned_cols=249 Identities=26% Similarity=0.379 Sum_probs=197.9
Q ss_pred CCccCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCC
Q 021306 33 EPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTS 105 (314)
Q Consensus 33 ~~~~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 105 (314)
.+...++|++.+.||+|+||.||+|+++.+|+.||+|.+.+.. ....+|..++++++||||+++++++..
T Consensus 180 ~~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~--- 256 (543)
T 3c4z_A 180 QPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFET--- 256 (543)
T ss_dssp SCCCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEEC---
T ss_pred ccCChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEee---
Confidence 4456679999999999999999999999999999999986432 234579999999999999999998843
Q ss_pred CCceeEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEee
Q 021306 106 KNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICD 184 (314)
Q Consensus 106 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~d 184 (314)
...+++||||++| +|...+.........+++..++.++.||+.||.|||+ +||+||||||+||+++. ++.++|+|
T Consensus 257 --~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~-~gIvHrDLKP~NILl~~-~g~vkL~D 332 (543)
T 3c4z_A 257 --KTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ-RNIIYRDLKPENVLLDD-DGNVRISD 332 (543)
T ss_dssp --SSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECT-TSCEEECC
T ss_pred --CCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHH-cCCcccCCChHHEEEeC-CCCEEEee
Confidence 3348899999985 7777666543335679999999999999999999999 89999999999999998 88999999
Q ss_pred cCcccccccCCc-cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC----hHHHHHHHHHHcCC
Q 021306 185 FGSAKQLIAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN----AVDQLVEIIKVLGT 259 (314)
Q Consensus 185 fg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~----~~~~~~~i~~~~~~ 259 (314)
||++........ .....||+.|+|||.+.+.. ++.++|||||||++|+|++|+.||.+.+ ..+....+......
T Consensus 333 FGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~-~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~ 411 (543)
T 3c4z_A 333 LGLAVELKAGQTKTKGYAGTPGFMAPELLLGEE-YDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVT 411 (543)
T ss_dssp CTTCEECCTTCCCBCCCCSCTTTSCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCC
T ss_pred cceeeeccCCCcccccccCCccccChhhhcCCC-CChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccC
Confidence 999986544332 23457899999999997654 8999999999999999999999998753 23334444433221
Q ss_pred CC-------HHHHh---ccCCCCCCCc-----ccccccCChhhhhc
Q 021306 260 PT-------REEIR---CMNPNYTDFR-----FPQIKAHPWHKVCI 290 (314)
Q Consensus 260 ~~-------~~~~~---~~~p~~~~~~-----~~~l~~~p~~~~~~ 290 (314)
.+ .+.+. ..+|. +|++ +++|++|||++...
T Consensus 412 ~p~~~s~~~~~li~~lL~~dP~-~R~~~~~~~a~ei~~Hpff~~i~ 456 (543)
T 3c4z_A 412 YPDKFSPASKDFCEALLQKDPE-KRLGFRDGSCDGLRTHPLFRDIS 456 (543)
T ss_dssp CCTTSCHHHHHHHHHHSCSSGG-GSCCCBTTBSHHHHTSGGGTTCC
T ss_pred CCcccCHHHHHHHHHhccCCHh-HCCCCcccCHHHHHcCccccCCC
Confidence 11 11222 33666 7885 57899999998754
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=304.14 Aligned_cols=246 Identities=27% Similarity=0.494 Sum_probs=194.7
Q ss_pred ccCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeecc-ccchHHHHHHHHhCC-CCceeeeceeeeecCCCCceeEE
Q 021306 35 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-RRYKNRELQLMRVMD-HPNVISLKHCFFSTTSKNELFLN 112 (314)
Q Consensus 35 ~~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~-~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~ 112 (314)
...++|++.+.||+|+||.||+|++..+++.||+|.+... .....+|+.++++++ |+||+++++++.... ....+
T Consensus 33 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~---~~~~~ 109 (330)
T 3nsz_A 33 GNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPV---SRTPA 109 (330)
T ss_dssp EEGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTT---TCCEE
T ss_pred cCCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccchHHHHHHHHHHHHcCCCCCEEEeeeeeccCC---CCceE
Confidence 3457899999999999999999999999999999998744 344578999999997 999999999885422 33478
Q ss_pred EEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcccccc
Q 021306 113 LVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 192 (314)
Q Consensus 113 lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~ 192 (314)
++|||+.++.+..+. ..+++.+++.++.||+.||.|||+ +||+|+||||+||+++..+..++|+|||++....
T Consensus 110 lv~e~~~~~~l~~~~------~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~ 182 (330)
T 3nsz_A 110 LVFEHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHS-MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 182 (330)
T ss_dssp EEEECCCCCCHHHHG------GGCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred EEEeccCchhHHHHH------HhCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcC
Confidence 999999975333332 348999999999999999999999 8999999999999999745589999999998665
Q ss_pred cCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHHHHcCCC-----------
Q 021306 193 AGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE-NAVDQLVEIIKVLGTP----------- 260 (314)
Q Consensus 193 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~-~~~~~~~~i~~~~~~~----------- 260 (314)
.........+++.|+|||.+.+...++.++||||||+++|+|++|+.||... +..+.+..+.+..+.+
T Consensus 183 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 262 (330)
T 3nsz_A 183 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 262 (330)
T ss_dssp TTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTC
T ss_pred CCCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhcc
Confidence 5555555678899999999977566899999999999999999999999543 4444444443322110
Q ss_pred ------------------------------C---HHHHh---ccCCCCCCCcccccccCChhhhhcc
Q 021306 261 ------------------------------T---REEIR---CMNPNYTDFRFPQIKAHPWHKVCIF 291 (314)
Q Consensus 261 ------------------------------~---~~~~~---~~~p~~~~~~~~~l~~~p~~~~~~~ 291 (314)
. .+.+. ..+|. +|+++.++++|||++....
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~-~Rpta~e~l~hp~f~~~~~ 328 (330)
T 3nsz_A 263 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQ-SRLTAREAMEHPYFYTVVK 328 (330)
T ss_dssp CCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGG-GSCCHHHHHTSGGGTTCC-
T ss_pred ccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcc-cCCCHHHHhcCccHhhhcc
Confidence 1 11222 23666 8999999999999987654
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-42 Score=296.21 Aligned_cols=246 Identities=27% Similarity=0.443 Sum_probs=197.7
Q ss_pred CccCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeecc-------ccchHHHHHHHHhCCCCceeeeceeeeecCCC
Q 021306 34 PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSK 106 (314)
Q Consensus 34 ~~~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~-------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 106 (314)
+...++|++.+.||+|+||.||+|++..+++.|++|.+... .....+|+.++++++||||+++++++...
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--- 81 (279)
T 3fdn_A 5 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDA--- 81 (279)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS---
T ss_pred eeecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecC---
Confidence 44567899999999999999999999999999999998543 23346899999999999999999988433
Q ss_pred CceeEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeec
Q 021306 107 NELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF 185 (314)
Q Consensus 107 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~df 185 (314)
...++||||+++ ++.+.+.. ...+++..++.++.|++.||.|||+ +||+|+||+|+||+++. ++.++|+||
T Consensus 82 --~~~~lv~e~~~~~~l~~~l~~----~~~~~~~~~~~~~~qi~~~l~~LH~-~~i~H~dlkp~Nili~~-~~~~~l~Df 153 (279)
T 3fdn_A 82 --TRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHS-KRVIHRDIKPENLLLGS-AGELKIADF 153 (279)
T ss_dssp --SEEEEEECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHT-TTCEECCCCGGGEEECT-TSCEEECSC
T ss_pred --CEEEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCEecccCChHhEEEcC-CCCEEEEec
Confidence 348899999995 67666654 3679999999999999999999999 89999999999999998 889999999
Q ss_pred CcccccccCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCC----
Q 021306 186 GSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT---- 261 (314)
Q Consensus 186 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~---- 261 (314)
|++...... ......+++.|+|||.+.+.. ++.++||||||+++|+|++|..||...+..+....+.......+
T Consensus 154 g~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (279)
T 3fdn_A 154 GWSVHAPSS-RRTDLCGTLDYLPPEMIEGRM-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVT 231 (279)
T ss_dssp CEESCC---------CCCCTTCCHHHHTTCC-CCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTSC
T ss_pred cccccCCcc-cccccCCCCCccCHhHhccCC-CCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCCCCcCC
Confidence 988654332 233456789999999986544 78999999999999999999999998887776666554332221
Q ss_pred ---HHHHh---ccCCCCCCCcccccccCChhhhhcccC
Q 021306 262 ---REEIR---CMNPNYTDFRFPQIKAHPWHKVCIFHF 293 (314)
Q Consensus 262 ---~~~~~---~~~p~~~~~~~~~l~~~p~~~~~~~~~ 293 (314)
.+.+. ..+|. +|+++.++++|||++......
T Consensus 232 ~~~~~li~~~l~~~p~-~Rps~~e~l~h~~~~~~~~~~ 268 (279)
T 3fdn_A 232 EGARDLISRLLKHNPS-QRPMLREVLEHPWITANSSKP 268 (279)
T ss_dssp HHHHHHHHHHCCSSGG-GSCCHHHHHHCHHHHHHCSSC
T ss_pred HHHHHHHHHHhccChh-hCCCHHHHhhCccccCCccCc
Confidence 12222 23666 899999999999999877543
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-43 Score=322.90 Aligned_cols=244 Identities=30% Similarity=0.501 Sum_probs=202.7
Q ss_pred ccCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeecc-------ccchHHHHHHHHhCCCCceeeeceeeeecCCCC
Q 021306 35 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKN 107 (314)
Q Consensus 35 ~~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~-------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 107 (314)
...++|++.+.||+|+||.||+|++..+++.||+|.+... .....+|+.++++++||||+++++++..
T Consensus 23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~----- 97 (484)
T 3nyv_A 23 IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFED----- 97 (484)
T ss_dssp CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEEC-----
T ss_pred cccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEe-----
Confidence 3457899999999999999999999999999999998543 2234689999999999999999999843
Q ss_pred ceeEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcC--CCCcEEEee
Q 021306 108 ELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP--LTHQVKICD 184 (314)
Q Consensus 108 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~--~~~~~~l~d 184 (314)
...+++|+||+.+ +|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+||+++. .++.++|+|
T Consensus 98 ~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~Dlkp~Nil~~~~~~~~~~kl~D 172 (484)
T 3nyv_A 98 KGYFYLVGEVYTGGELFDEIIS----RKRFSEVDAARIIRQVLSGITYMHK-NKIVHRDLKPENLLLESKSKDANIRIID 172 (484)
T ss_dssp SSEEEEEECCCCSCBHHHHHHT----CSCCBHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEESSSSTTCCEEECC
T ss_pred CCEEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCCHHHEEEecCCCCCcEEEEe
Confidence 3458899999986 66666553 5789999999999999999999999 89999999999999952 267899999
Q ss_pred cCcccccccCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCC---
Q 021306 185 FGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT--- 261 (314)
Q Consensus 185 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~--- 261 (314)
||++.............+|+.|+|||.+.+ .++.++||||||+++|+|++|..||.+.+..+.+..+.+......
T Consensus 173 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 250 (484)
T 3nyv_A 173 FGLSTHFEASKKMKDKIGTAYYIAPEVLHG--TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQ 250 (484)
T ss_dssp TTHHHHBCCCCSHHHHTTGGGTCCHHHHHT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGG
T ss_pred eeeeEEcccccccccCCCCccccCceeecC--CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcc
Confidence 999987665555556778999999999865 389999999999999999999999999998887777766532221
Q ss_pred --------HHHHh---ccCCCCCCCcccccccCChhhhhcc
Q 021306 262 --------REEIR---CMNPNYTDFRFPQIKAHPWHKVCIF 291 (314)
Q Consensus 262 --------~~~~~---~~~p~~~~~~~~~l~~~p~~~~~~~ 291 (314)
.+.+. ..+|. +|+++.++++|||++....
T Consensus 251 ~~~~s~~~~~li~~~L~~dp~-~R~s~~e~l~h~~~~~~~~ 290 (484)
T 3nyv_A 251 WKKVSESAKDLIRKMLTYVPS-MRISARDALDHEWIQTYTK 290 (484)
T ss_dssp GGGSCHHHHHHHHHHTCSSGG-GSCCHHHHHTSHHHHHHTC
T ss_pred cccCCHHHHHHHHHHCCCChh-HCcCHHHHhhChhhccccc
Confidence 11122 33677 8999999999999987654
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=318.65 Aligned_cols=243 Identities=24% Similarity=0.360 Sum_probs=192.5
Q ss_pred cCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCCc
Q 021306 36 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 108 (314)
Q Consensus 36 ~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 108 (314)
..++|++.+.||+|+||.||+|++..+++.||+|.+.... ....+|+.+++.++||||+++++++....
T Consensus 146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~---- 221 (446)
T 4ejn_A 146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHD---- 221 (446)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETT----
T ss_pred ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCC----
Confidence 4578999999999999999999999999999999986432 22347888899999999999999985443
Q ss_pred eeEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCc
Q 021306 109 LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 187 (314)
Q Consensus 109 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~ 187 (314)
.+++||||+++ +|...+.. ...+++..++.++.||+.||.|||+.+||+||||||+||+++. ++.++|+|||+
T Consensus 222 -~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~-~~~~kl~DFG~ 295 (446)
T 4ejn_A 222 -RLCFVMEYANGGELFFHLSR----ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDK-DGHIKITDFGL 295 (446)
T ss_dssp -EEEEEECCCSSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECS-SSCEEECCCCC
T ss_pred -EEEEEEeeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECC-CCCEEEccCCC
Confidence 38899999986 66665543 4689999999999999999999995259999999999999998 78999999999
Q ss_pred ccccccC-CccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCC-----
Q 021306 188 AKQLIAG-EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT----- 261 (314)
Q Consensus 188 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~----- 261 (314)
+...... .......+|+.|+|||.+.+.. ++.++||||||+++|+|++|+.||.+.+.......+.......+
T Consensus 296 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~ 374 (446)
T 4ejn_A 296 CKEGIKDGATMKTFCGTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGP 374 (446)
T ss_dssp CCTTCC-----CCSSSCGGGCCHHHHHTSC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCH
T ss_pred ceeccCCCcccccccCCccccCHhhcCCCC-CCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCccCCH
Confidence 9754322 2234467899999999997654 89999999999999999999999999888777766665432221
Q ss_pred --HHHHh---ccCCCCCCC-----cccccccCChhhhhc
Q 021306 262 --REEIR---CMNPNYTDF-----RFPQIKAHPWHKVCI 290 (314)
Q Consensus 262 --~~~~~---~~~p~~~~~-----~~~~l~~~p~~~~~~ 290 (314)
.+.+. ..+|. +|+ ++.++++|||++...
T Consensus 375 ~~~~li~~~L~~dP~-~R~~~~~~t~~ell~hp~f~~~~ 412 (446)
T 4ejn_A 375 EAKSLLSGLLKKDPK-QRLGGGSEDAKEIMQHRFFAGIV 412 (446)
T ss_dssp HHHHHHHHHTCSSTT-TSTTCSTTTHHHHHTSGGGTTCC
T ss_pred HHHHHHHHHcccCHH-HhCCCCCCCHHHHHhCccccCCC
Confidence 12222 34777 788 999999999998764
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-42 Score=301.52 Aligned_cols=248 Identities=30% Similarity=0.562 Sum_probs=194.0
Q ss_pred CCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc----cchHHHHHHHHhCCCCceeeeceeeeecCC-------
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTS------- 105 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~------- 105 (314)
.++|++.+.||+|+||.||+|.+..+++.|++|.+.... ....+|+.++++++||||+++++++.....
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 468999999999999999999999999999999886443 234589999999999999999987643211
Q ss_pred --CCceeEEEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEe
Q 021306 106 --KNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKIC 183 (314)
Q Consensus 106 --~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~ 183 (314)
......++||||++++|.+.+. ..++++..++.++.|++.||.|||+ +|++|+||||+||+++..++.++|+
T Consensus 90 ~~~~~~~~~lv~e~~~~~L~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nil~~~~~~~~kl~ 163 (320)
T 2i6l_A 90 SLTELNSVYIVQEYMETDLANVLE-----QGPLLEEHARLFMYQLLRGLKYIHS-ANVLHRDLKPANLFINTEDLVLKIG 163 (320)
T ss_dssp -CCSCSEEEEEEECCSEEHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCSGGGEEEETTTTEEEEC
T ss_pred cccccCceeEEeeccCCCHHHHhh-----cCCccHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEEcCCCCeEEEc
Confidence 2234578999999999887765 3679999999999999999999999 8999999999999998657799999
Q ss_pred ecCcccccccC----CccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCC
Q 021306 184 DFGSAKQLIAG----EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT 259 (314)
Q Consensus 184 dfg~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~ 259 (314)
|||.+...... .......+++.|+|||.+.+...++.++||||||+++|+|++|+.||.+.+..+....+.+....
T Consensus 164 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 243 (320)
T 2i6l_A 164 DFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPV 243 (320)
T ss_dssp CCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCC
T ss_pred cCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence 99999765322 11223456888999999876556899999999999999999999999998887777776654322
Q ss_pred C----------------------------------CH---HHHh-c--cCCCCCCCcccccccCChhhhhcc
Q 021306 260 P----------------------------------TR---EEIR-C--MNPNYTDFRFPQIKAHPWHKVCIF 291 (314)
Q Consensus 260 ~----------------------------------~~---~~~~-~--~~p~~~~~~~~~l~~~p~~~~~~~ 291 (314)
. .. +.+. + .+|. +|+++.++++|||++....
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~-~Rpt~~ell~hp~~~~~~~ 314 (320)
T 2i6l_A 244 VHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPM-DRLTAEEALSHPYMSIYSF 314 (320)
T ss_dssp CCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGG-GSCCHHHHHTSHHHHTTCC
T ss_pred CchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCcc-ccCCHHHHhCCcccccccC
Confidence 1 11 1122 2 2566 8999999999999986554
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=297.38 Aligned_cols=238 Identities=24% Similarity=0.394 Sum_probs=195.0
Q ss_pred CceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeEEEE
Q 021306 39 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLV 114 (314)
Q Consensus 39 ~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 114 (314)
.|...+.||+|+||.||+|++..+|+.||+|.+.... ....+|+.++++++|+||+++++++.... ..++|
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~~lv 120 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGE-----ELWVL 120 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETT-----EEEEE
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECC-----EEEEE
Confidence 5888999999999999999999899999999986443 23458999999999999999999886543 38899
Q ss_pred eecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCccccccc
Q 021306 115 MEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA 193 (314)
Q Consensus 115 ~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~~ 193 (314)
|||+++ +|.+.+. ...+++..++.++.|++.||.|||+ +||+|+||||+||+++. ++.++|+|||++.....
T Consensus 121 ~e~~~~~~L~~~l~-----~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dlkp~NIll~~-~~~~kl~Dfg~~~~~~~ 193 (321)
T 2c30_A 121 MEFLQGGALTDIVS-----QVRLNEEQIATVCEAVLQALAYLHA-QGVIHRDIKSDSILLTL-DGRVKLSDFGFCAQISK 193 (321)
T ss_dssp ECCCCSCBHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECT-TCCEEECCCTTCEECCS
T ss_pred EecCCCCCHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEECC-CCcEEEeeeeeeeeccc
Confidence 999986 5555443 3579999999999999999999999 89999999999999998 78999999999876543
Q ss_pred CC-ccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCC----------H
Q 021306 194 GE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT----------R 262 (314)
Q Consensus 194 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~----------~ 262 (314)
.. ......+|+.|+|||.+.+.. ++.++||||||+++|+|++|+.||.+.+..+....+........ .
T Consensus 194 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 272 (321)
T 2c30_A 194 DVPKRKSLVGTPYWMAPEVISRSL-YATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLR 272 (321)
T ss_dssp SSCCBCCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCTTGGGSCHHHH
T ss_pred CccccccccCCccccCHhhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCcCccccCCHHHH
Confidence 32 233457899999999996544 89999999999999999999999998887776665554432211 1
Q ss_pred HHHh---ccCCCCCCCcccccccCChhhhhc
Q 021306 263 EEIR---CMNPNYTDFRFPQIKAHPWHKVCI 290 (314)
Q Consensus 263 ~~~~---~~~p~~~~~~~~~l~~~p~~~~~~ 290 (314)
+.+. ..+|. +|+++.++++|||+....
T Consensus 273 ~li~~~l~~dp~-~Rps~~ell~hp~~~~~~ 302 (321)
T 2c30_A 273 DFLERMLVRDPQ-ERATAQELLDHPFLLQTG 302 (321)
T ss_dssp HHHHHHSCSSTT-TSCCHHHHHTSGGGGGCC
T ss_pred HHHHHHccCChh-hCcCHHHHhcChhhccCC
Confidence 1222 33677 899999999999998655
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-42 Score=295.42 Aligned_cols=249 Identities=24% Similarity=0.419 Sum_probs=202.8
Q ss_pred CccCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeecc-------ccchHHHHHHHHhCCCCceeeeceeeeecCCC
Q 021306 34 PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSK 106 (314)
Q Consensus 34 ~~~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~-------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 106 (314)
+...++|++.+.||+|++|.||+|++..+++.|++|.+... .....+|+.++++++|+||+++++++...
T Consensus 10 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--- 86 (284)
T 2vgo_A 10 KFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDR--- 86 (284)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS---
T ss_pred chhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcC---
Confidence 34457899999999999999999999999999999998643 23346899999999999999999988433
Q ss_pred CceeEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeec
Q 021306 107 NELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF 185 (314)
Q Consensus 107 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~df 185 (314)
...+++|||+++ +|.+.+.. ...+++..++.++.|++.||.+||+ +|++|+||+|+||+++. ++.++|+||
T Consensus 87 --~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~Nil~~~-~~~~kl~Df 158 (284)
T 2vgo_A 87 --KRIYLMLEFAPRGELYKELQK----HGRFDEQRSATFMEELADALHYCHE-RKVIHRDIKPENLLMGY-KGELKIADF 158 (284)
T ss_dssp --SEEEEEECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCSGGGEEECT-TCCEEECCC
T ss_pred --CEEEEEEEeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCHHHEEEcC-CCCEEEecc
Confidence 348899999986 77776654 3679999999999999999999999 89999999999999998 788999999
Q ss_pred CcccccccCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCC----
Q 021306 186 GSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT---- 261 (314)
Q Consensus 186 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~---- 261 (314)
|.+...... ......+++.|+|||.+.+.. ++.++||||||+++|+|++|..||...+..+....+.......+
T Consensus 159 g~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T 2vgo_A 159 GWSVHAPSL-RRRTMCGTLDYLPPEMIEGKT-HDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLS 236 (284)
T ss_dssp TTCEECSSS-CBCCCCSCGGGCCHHHHTTCC-BCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSC
T ss_pred cccccCccc-ccccccCCCCcCCHHHhccCC-CCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccccCCCCcCC
Confidence 998654332 233456789999999997654 78999999999999999999999998887766665554321111
Q ss_pred ---HHHHh---ccCCCCCCCcccccccCChhhhhcccCChH
Q 021306 262 ---REEIR---CMNPNYTDFRFPQIKAHPWHKVCIFHFPKH 296 (314)
Q Consensus 262 ---~~~~~---~~~p~~~~~~~~~l~~~p~~~~~~~~~~~~ 296 (314)
.+.+. ..+|. +|+++.++++|||++....+..+.
T Consensus 237 ~~~~~li~~~l~~~p~-~Rps~~~ll~h~~~~~~~~~~~p~ 276 (284)
T 2vgo_A 237 DGSKDLISKLLRYHPP-QRLPLKGVMEHPWVKANSRRVLPP 276 (284)
T ss_dssp HHHHHHHHHHSCSSGG-GSCCHHHHHTCHHHHHHCCCCCCC
T ss_pred HHHHHHHHHHhhcCHh-hCCCHHHHhhCHHHHhhccccCCC
Confidence 11222 23666 899999999999999888776654
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=314.19 Aligned_cols=243 Identities=26% Similarity=0.442 Sum_probs=185.3
Q ss_pred CCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc------------cchHHHHHHHHhCCCCceeeeceeeeecC
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------------RYKNRELQLMRVMDHPNVISLKHCFFSTT 104 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~------------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 104 (314)
.++|++.+.||+|+||.||+|.+..+++.||+|.+.... ....+|+.++++++||||+++++++. .
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~- 211 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-A- 211 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-S-
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-c-
Confidence 468999999999999999999999999999999986532 13468999999999999999999862 1
Q ss_pred CCCceeEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCC--CCcEE
Q 021306 105 SKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPL--THQVK 181 (314)
Q Consensus 105 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~--~~~~~ 181 (314)
. ..++||||+++ +|.+ +......+++.+++.++.|++.||.|||+ +||+||||||+||+++.. +..++
T Consensus 212 ---~-~~~lv~e~~~~g~L~~----~l~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~ivHrDlkp~NIll~~~~~~~~~k 282 (419)
T 3i6u_A 212 ---E-DYYIVLELMEGGELFD----KVVGNKRLKEATCKLYFYQMLLAVQYLHE-NGIIHRDLKPENVLLSSQEEDCLIK 282 (419)
T ss_dssp ---S-EEEEEEECCTTCBGGG----GTSSSCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEESSSSSSCCEE
T ss_pred ---C-ceEEEEEcCCCCcHHH----HHhccCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCChHhEEEecCCCcceEE
Confidence 1 16799999987 5433 33446789999999999999999999999 899999999999999752 34599
Q ss_pred EeecCcccccccCCccccccccccccccccccC--CCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCC
Q 021306 182 ICDFGSAKQLIAGEANISYICSRFYRAPELIFG--ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT 259 (314)
Q Consensus 182 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~ 259 (314)
|+|||++.............+|+.|+|||.+.+ ...++.++||||||+++|+|++|..||.+......+...+.....
T Consensus 283 l~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~ 362 (419)
T 3i6u_A 283 ITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKY 362 (419)
T ss_dssp ECCSSTTTSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCC
T ss_pred EeecccceecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCC
Confidence 999999987655444455678999999999853 344788999999999999999999999876544334333333221
Q ss_pred -CCH-----------HHHh---ccCCCCCCCcccccccCChhhhhcc
Q 021306 260 -PTR-----------EEIR---CMNPNYTDFRFPQIKAHPWHKVCIF 291 (314)
Q Consensus 260 -~~~-----------~~~~---~~~p~~~~~~~~~l~~~p~~~~~~~ 291 (314)
..+ +.+. ..+|. +|+++.++++|||++....
T Consensus 363 ~~~~~~~~~~~~~~~~li~~~L~~dP~-~Rps~~e~l~hp~~~~~~~ 408 (419)
T 3i6u_A 363 NFIPEVWAEVSEKALDLVKKLLVVDPK-ARFTTEEALRHPWLQDEDM 408 (419)
T ss_dssp CCCHHHHTTSCHHHHHHHHHHSCSSTT-TSCCHHHHHHSGGGCCHHH
T ss_pred CCCchhhcccCHHHHHHHHHHccCChh-HCcCHHHHhCCcccCChhH
Confidence 111 1222 33777 8999999999999987654
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-42 Score=297.03 Aligned_cols=244 Identities=26% Similarity=0.386 Sum_probs=199.7
Q ss_pred cCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCCce
Q 021306 36 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL 109 (314)
Q Consensus 36 ~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 109 (314)
..++|++.+.||+|+||.||+|.+..+++.|++|.+.... ....+|+.++++++|+||+++++++.. ..
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~ 78 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE-----ES 78 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC-----SS
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEc-----CC
Confidence 4578999999999999999999999999999999986543 234579999999999999999998843 33
Q ss_pred eEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCC--CCcEEEeecC
Q 021306 110 FLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPL--THQVKICDFG 186 (314)
Q Consensus 110 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~--~~~~~l~dfg 186 (314)
..+++|||+.+ ++.+.+.. ...+++..++.++.|++.||.+||+ +|++|+||+|+||+++.. ...++|+|||
T Consensus 79 ~~~~v~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg 153 (284)
T 3kk8_A 79 FHYLVFDLVTGGELFEDIVA----REFYSEADASHCIQQILESIAYCHS-NGIVHRNLKPENLLLASKAKGAAVKLADFG 153 (284)
T ss_dssp EEEEEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEESSSSTTCCEEECCCT
T ss_pred EEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcCcCCCCHHHEEEecCCCCCcEEEeece
Confidence 47899999986 66666653 3679999999999999999999999 899999999999999762 2349999999
Q ss_pred cccccccCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCC-----
Q 021306 187 SAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT----- 261 (314)
Q Consensus 187 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~----- 261 (314)
.+.............+++.|+|||.+.+.. ++.++||||||+++|+|++|+.||.+.+.......+.......+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T 3kk8_A 154 LAIEVNDSEAWHGFAGTPGYLSPEVLKKDP-YSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWD 232 (284)
T ss_dssp TCEECCSSCBCCCSCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTT
T ss_pred eeEEcccCccccCCCCCcCCcCchhhcCCC-CCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhc
Confidence 997665554445567899999999996654 79999999999999999999999999888777766665532221
Q ss_pred ---H---HHHh---ccCCCCCCCcccccccCChhhhhcc
Q 021306 262 ---R---EEIR---CMNPNYTDFRFPQIKAHPWHKVCIF 291 (314)
Q Consensus 262 ---~---~~~~---~~~p~~~~~~~~~l~~~p~~~~~~~ 291 (314)
. +.+. ..+|. +|+++.++++|||++....
T Consensus 233 ~~~~~~~~li~~~l~~dp~-~Rps~~~~l~h~~~~~~~~ 270 (284)
T 3kk8_A 233 TVTPEAKSLIDSMLTVNPK-KRITADQALKVPWICNRER 270 (284)
T ss_dssp TSCHHHHHHHHHHSCSSTT-TSCCHHHHTTSHHHHSCCC
T ss_pred ccCHHHHHHHHHHcccChh-hCCCHHHHhcCccccCChh
Confidence 1 1111 33677 8999999999999976543
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=307.74 Aligned_cols=251 Identities=26% Similarity=0.438 Sum_probs=197.0
Q ss_pred cCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc---------cchHHHHHHHHhCCCCceeeeceeeeecCCC
Q 021306 36 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---------RYKNRELQLMRVMDHPNVISLKHCFFSTTSK 106 (314)
Q Consensus 36 ~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~---------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 106 (314)
..++|++.+.||+|+||.||+|++..+++.+|+|.+.... ....+|+.++++++||||+++++++..
T Consensus 24 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~---- 99 (345)
T 3hko_A 24 LQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED---- 99 (345)
T ss_dssp HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC----
T ss_pred hhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc----
Confidence 3468999999999999999999999999999999986432 334689999999999999999999843
Q ss_pred CceeEEEEeecccc-cHHHHHHhhhhc------------------------------------CCCCCHHHHHHHHHHHH
Q 021306 107 NELFLNLVMEYVPE-SMYRVLKHYSSA------------------------------------NQRMPLIYVKLYTYQIF 149 (314)
Q Consensus 107 ~~~~~~lv~e~~~~-~l~~~l~~~~~~------------------------------------~~~l~~~~~~~i~~ql~ 149 (314)
....++||||++| +|.+.+..+... ...+++..++.++.||+
T Consensus 100 -~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~ 178 (345)
T 3hko_A 100 -EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIF 178 (345)
T ss_dssp -SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHH
T ss_pred -CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHH
Confidence 3348899999975 666655321111 22357888999999999
Q ss_pred HHHHHhhcCCCceecCCCCCcEEEcCCC-CcEEEeecCcccccccCCc-----cccccccccccccccccCC-CCCCcch
Q 021306 150 RGLAYIHTVPRVCHRDLKPQNLLVDPLT-HQVKICDFGSAKQLIAGEA-----NISYICSRFYRAPELIFGA-TEYTTSI 222 (314)
Q Consensus 150 ~~l~~LH~~~~i~h~dl~p~Nil~~~~~-~~~~l~dfg~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~-~~~~~~~ 222 (314)
.||.|||+ +||+|+||||+||+++.++ ..++|+|||++........ .....+++.|+|||.+.+. ..++.++
T Consensus 179 ~~l~~LH~-~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 257 (345)
T 3hko_A 179 SALHYLHN-QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257 (345)
T ss_dssp HHHHHHHH-TTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred HHHHHHHH-CCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence 99999999 8999999999999998622 2899999999976533221 2345679999999998642 4578999
Q ss_pred hHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCH-----------HHHh---ccCCCCCCCcccccccCChhhh
Q 021306 223 DIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR-----------EEIR---CMNPNYTDFRFPQIKAHPWHKV 288 (314)
Q Consensus 223 Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~-----------~~~~---~~~p~~~~~~~~~l~~~p~~~~ 288 (314)
||||||+++|+|++|+.||.+.+..+....+......... +.+. ..+|. +|+++.++++|||++.
T Consensus 258 DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~-~Rps~~~~l~hp~~~~ 336 (345)
T 3hko_A 258 DAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVD-ERFDAMRALQHPWISQ 336 (345)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTT-TSCCHHHHHHSHHHHT
T ss_pred HHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChh-HCCCHHHHhcChhhcc
Confidence 9999999999999999999999888877777765432211 1121 23666 8999999999999998
Q ss_pred hcccC
Q 021306 289 CIFHF 293 (314)
Q Consensus 289 ~~~~~ 293 (314)
...++
T Consensus 337 ~~~~~ 341 (345)
T 3hko_A 337 FSDKI 341 (345)
T ss_dssp TSSCS
T ss_pred ChHhh
Confidence 77654
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-42 Score=320.48 Aligned_cols=247 Identities=27% Similarity=0.437 Sum_probs=197.9
Q ss_pred CCccCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCC
Q 021306 33 EPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTS 105 (314)
Q Consensus 33 ~~~~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 105 (314)
.+...++|++.+.||+|+||.||+|+++.+|+.||+|.+.+.. ....+|..+++.++||||+++++++..
T Consensus 179 ~~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~--- 255 (576)
T 2acx_A 179 QPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYET--- 255 (576)
T ss_dssp SCCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEEC---
T ss_pred cCccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEee---
Confidence 4456678999999999999999999999999999999986432 223579999999999999999998843
Q ss_pred CCceeEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEee
Q 021306 106 KNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICD 184 (314)
Q Consensus 106 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~d 184 (314)
...+++||||++| +|...+... ....+++..++.++.||+.||.|||+ +||+||||||+||+++. ++.++|+|
T Consensus 256 --~~~l~lVmEy~~gg~L~~~l~~~--~~~~l~e~~~~~i~~qIl~aL~yLH~-~gIvHrDLKPeNILld~-~g~vKL~D 329 (576)
T 2acx_A 256 --KDALCLVLTLMNGGDLKFHIYHM--GQAGFPEARAVFYAAEICCGLEDLHR-ERIVYRDLKPENILLDD-HGHIRISD 329 (576)
T ss_dssp --SSEEEEEECCCCSCBHHHHHHSS--SSCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECT-TSCEEECC
T ss_pred --CCEEEEEEEcCCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHH-CCEeccCCchheEEEeC-CCCeEEEe
Confidence 3348899999985 666666532 23459999999999999999999999 89999999999999998 88999999
Q ss_pred cCcccccccCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHHcCCCC
Q 021306 185 FGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA---VDQLVEIIKVLGTPT 261 (314)
Q Consensus 185 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~---~~~~~~i~~~~~~~~ 261 (314)
||++.............||+.|+|||.+.+.. ++.++||||||+++|+|++|+.||.+.+. ...+...+.......
T Consensus 330 FGla~~~~~~~~~~~~~GT~~Y~APEvl~~~~-~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~ 408 (576)
T 2acx_A 330 LGLAVHVPEGQTIKGRVGTVGYMAPEVVKNER-YTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEY 408 (576)
T ss_dssp CTTCEECCTTCCEECCCSCGGGCCHHHHTTCE-ESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCC
T ss_pred cccceecccCccccccCCCccccCHHHHcCCC-CCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccC
Confidence 99998765544445568899999999997654 89999999999999999999999987542 233444443332221
Q ss_pred --------HHHHh---ccCCCCCCC-----cccccccCChhhhhc
Q 021306 262 --------REEIR---CMNPNYTDF-----RFPQIKAHPWHKVCI 290 (314)
Q Consensus 262 --------~~~~~---~~~p~~~~~-----~~~~l~~~p~~~~~~ 290 (314)
.+.+. ..+|. +|+ ++.++++|||++...
T Consensus 409 p~~~s~~~~dLI~~lL~~dP~-~R~g~~~~sa~eil~HpfF~~i~ 452 (576)
T 2acx_A 409 SERFSPQARSLCSQLLCKDPA-ERLGCRGGSAREVKEHPLFKKLN 452 (576)
T ss_dssp CTTSCHHHHHHHHHHTCSSGG-GSTTCSSSHHHHHHTSGGGTTCC
T ss_pred CccCCHHHHHHHHHhccCCHH-HcCCCCCCCHHHHHhChhhccCC
Confidence 12222 34676 788 789999999998643
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-42 Score=303.62 Aligned_cols=244 Identities=21% Similarity=0.366 Sum_probs=194.0
Q ss_pred CCccCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc------------cchHHHHHHHHhCCCCceeeeceee
Q 021306 33 EPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------------RYKNRELQLMRVMDHPNVISLKHCF 100 (314)
Q Consensus 33 ~~~~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~------------~~~~~e~~~l~~l~h~~iv~~~~~~ 100 (314)
.....++|++.+.||+|+||.||+|++..+++.||+|.+.... ....+|+.++++++||||+++++++
T Consensus 19 ~~~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~ 98 (335)
T 3dls_A 19 EGEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIF 98 (335)
T ss_dssp TTHHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEE
T ss_pred CcccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 3345578999999999999999999999999999999987542 2345899999999999999999988
Q ss_pred eecCCCCceeEEEEeecccc--cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCC
Q 021306 101 FSTTSKNELFLNLVMEYVPE--SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH 178 (314)
Q Consensus 101 ~~~~~~~~~~~~lv~e~~~~--~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~ 178 (314)
.. ...+++||||+.+ ++.+.+. ....+++..++.++.||+.||.|||+ +||+|+||||+||+++. ++
T Consensus 99 ~~-----~~~~~lv~e~~~~g~~l~~~~~----~~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dlkp~NIll~~-~~ 167 (335)
T 3dls_A 99 EN-----QGFFQLVMEKHGSGLDLFAFID----RHPRLDEPLASYIFRQLVSAVGYLRL-KDIIHRDIKDENIVIAE-DF 167 (335)
T ss_dssp EC-----SSEEEEEEECCTTSCBHHHHHH----TCCCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECT-TS
T ss_pred ee-----CCEEEEEEEeCCCCccHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHh-CCeEEeccCHHHEEEcC-CC
Confidence 43 3348899999864 6666554 35679999999999999999999999 89999999999999998 78
Q ss_pred cEEEeecCcccccccCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcC
Q 021306 179 QVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLG 258 (314)
Q Consensus 179 ~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~ 258 (314)
.++|+|||++.............+|+.|+|||.+.+....+.++||||||+++|+|++|+.||....... ........
T Consensus 168 ~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~~~~~ 245 (335)
T 3dls_A 168 TIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETV--EAAIHPPY 245 (335)
T ss_dssp CEEECCCTTCEECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGT--TTCCCCSS
T ss_pred cEEEeecccceECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHH--hhccCCCc
Confidence 9999999999876655555566789999999999776645889999999999999999999997633210 00000000
Q ss_pred CCC---HHH---HhccCCCCCCCcccccccCChhhhhc
Q 021306 259 TPT---REE---IRCMNPNYTDFRFPQIKAHPWHKVCI 290 (314)
Q Consensus 259 ~~~---~~~---~~~~~p~~~~~~~~~l~~~p~~~~~~ 290 (314)
... .+. +...+|. +|+++.++++|||++...
T Consensus 246 ~~~~~l~~li~~~L~~dP~-~Rps~~ell~hp~~~~~~ 282 (335)
T 3dls_A 246 LVSKELMSLVSGLLQPVPE-RRTTLEKLVTDPWVTQPV 282 (335)
T ss_dssp CCCHHHHHHHHHHTCSSGG-GSCCHHHHHHCTTTTCCC
T ss_pred ccCHHHHHHHHHHccCChh-hCcCHHHHhcCccccCCc
Confidence 001 111 2234666 899999999999998654
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=301.49 Aligned_cols=245 Identities=25% Similarity=0.391 Sum_probs=199.2
Q ss_pred CCccCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCC
Q 021306 33 EPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTS 105 (314)
Q Consensus 33 ~~~~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 105 (314)
.+...++|++.+.||+|+||.||++++..+++.+++|.+.... ....+|+.+++.++|+||+++++++..
T Consensus 36 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--- 112 (335)
T 2owb_A 36 DPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFED--- 112 (335)
T ss_dssp ETTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC---
T ss_pred CcccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec---
Confidence 4556679999999999999999999999999999999986542 234579999999999999999998843
Q ss_pred CCceeEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEee
Q 021306 106 KNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICD 184 (314)
Q Consensus 106 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~d 184 (314)
....+++|||+.+ +|.+.+.. ...+++.+++.++.||+.||.|||+ +||+|+||+|+||+++. ++.++|+|
T Consensus 113 --~~~~~lv~e~~~~~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~dlkp~NIl~~~-~~~~kl~D 184 (335)
T 2owb_A 113 --NDFVFVVLELCRRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYLHR-NRVIHRDLKLGNLFLNE-DLEVKIGD 184 (335)
T ss_dssp --SSEEEEEECCCTTCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEECT-TCCEEECC
T ss_pred --CCeEEEEEecCCCCCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCEecCCCchhEEEcC-CCCEEEee
Confidence 3348899999995 66665543 4679999999999999999999999 89999999999999998 78899999
Q ss_pred cCcccccccCC-ccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCC--
Q 021306 185 FGSAKQLIAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT-- 261 (314)
Q Consensus 185 fg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~-- 261 (314)
||++....... ......+++.|+|||.+.+.. ++.++||||||+++|+|++|+.||......+....+.+.....+
T Consensus 185 fg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 263 (335)
T 2owb_A 185 FGLATKVEYDGERKKVLCGTPNYIAPEVLSKKG-HSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKH 263 (335)
T ss_dssp CTTCEECCSTTCCBCCCCSCCSSCCHHHHHTSC-BCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTT
T ss_pred ccCceecccCcccccccCCCccccCHHHhccCC-CCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCCCCcc
Confidence 99997654322 233456789999999997654 78999999999999999999999998887766666554422211
Q ss_pred -----HHHHh---ccCCCCCCCcccccccCChhhhhc
Q 021306 262 -----REEIR---CMNPNYTDFRFPQIKAHPWHKVCI 290 (314)
Q Consensus 262 -----~~~~~---~~~p~~~~~~~~~l~~~p~~~~~~ 290 (314)
.+.+. ..+|. +|+++.++++|||++...
T Consensus 264 ~~~~~~~li~~~l~~dp~-~Rps~~ell~~~~~~~~~ 299 (335)
T 2owb_A 264 INPVAASLIQKMLQTDPT-ARPTINELLNDEFFTSGY 299 (335)
T ss_dssp SCHHHHHHHHHHTCSSGG-GSCCGGGGGGSHHHHTSC
T ss_pred CCHHHHHHHHHHccCChh-HCcCHHHHhcCccccCCC
Confidence 11222 33666 899999999999997653
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=304.47 Aligned_cols=246 Identities=24% Similarity=0.365 Sum_probs=189.6
Q ss_pred cCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeecccc-------chHHHHHHHHhCCCCceeeeceeeeecCCCCc
Q 021306 36 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 108 (314)
Q Consensus 36 ~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~~-------~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 108 (314)
..++|++.+.||+|+||.||+|++..+++.||+|.+..... ...+|+.++++++||||+++++++..... ..
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~-~~ 88 (311)
T 3ork_A 10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETP-AG 88 (311)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEET-TE
T ss_pred ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCC-CC
Confidence 45689999999999999999999999999999999875421 23578888999999999999998755432 23
Q ss_pred eeEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCc
Q 021306 109 LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 187 (314)
Q Consensus 109 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~ 187 (314)
...++||||++| +|.+.+.. ..++++.+++.++.|++.||.|||+ +||+|+||||+||+++. ++.++|+|||+
T Consensus 89 ~~~~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nil~~~-~~~~kl~Dfg~ 162 (311)
T 3ork_A 89 PLPYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSHQ-NGIIHRDVKPANIMISA-TNAVKVMDFGI 162 (311)
T ss_dssp EEEEEEEECCCEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEEET-TSCEEECCCSC
T ss_pred cccEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCCcCCCCHHHEEEcC-CCCEEEeeccC
Confidence 446899999985 77766653 4679999999999999999999999 89999999999999998 78899999999
Q ss_pred ccccccCCc----cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCHH
Q 021306 188 AKQLIAGEA----NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 263 (314)
Q Consensus 188 ~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~ 263 (314)
+........ .....+++.|+|||.+.+.. ++.++||||||+++|+|++|+.||.+.+..+....+......+...
T Consensus 163 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 241 (311)
T 3ork_A 163 ARAIADSGNSVTQTAAVIGTAQYLSPEQARGDS-VDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSA 241 (311)
T ss_dssp C------------------CCTTCCHHHHHTCC-CCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHH
T ss_pred cccccccccccccccccCcCcccCCHHHhcCCC-CCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCccc
Confidence 976543221 22345799999999997654 8999999999999999999999999988877776666554333221
Q ss_pred H-----------Hh---ccCCCCCCCcccccccCChhhhhc
Q 021306 264 E-----------IR---CMNPNYTDFRFPQIKAHPWHKVCI 290 (314)
Q Consensus 264 ~-----------~~---~~~p~~~~~~~~~l~~~p~~~~~~ 290 (314)
. +. ..+|. +|++..+++.|+|++...
T Consensus 242 ~~~~~~~~l~~li~~~l~~dP~-~R~~~~~~l~~~l~~~~~ 281 (311)
T 3ork_A 242 RHEGLSADLDAVVLKALAKNPE-NRYQTAAEMRADLVRVHN 281 (311)
T ss_dssp HSTTCCHHHHHHHHHHTCSSGG-GSCSSHHHHHHHHHHHHT
T ss_pred ccCCCCHHHHHHHHHHHhcCHh-hChhhHHHHHHHHHHHhc
Confidence 1 11 22454 677777777777776543
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=296.38 Aligned_cols=247 Identities=23% Similarity=0.380 Sum_probs=199.4
Q ss_pred ccCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc-------------cchHHHHHHHHhCC-CCceeeeceee
Q 021306 35 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------------RYKNRELQLMRVMD-HPNVISLKHCF 100 (314)
Q Consensus 35 ~~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~-------------~~~~~e~~~l~~l~-h~~iv~~~~~~ 100 (314)
...++|++.+.||+|++|.||+|.+..+++.|++|.+.... ....+|+.+++++. ||||+++++++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY 93 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence 44578999999999999999999999999999999986432 22347888999995 99999999988
Q ss_pred eecCCCCceeEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCc
Q 021306 101 FSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQ 179 (314)
Q Consensus 101 ~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~ 179 (314)
.. ....++||||+++ +|.+.+.. ...+++..++.++.|++.||.+||+ +|++|+||+|+||+++. ++.
T Consensus 94 ~~-----~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~Nil~~~-~~~ 162 (298)
T 1phk_A 94 ET-----NTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHK-LNIVHRDLKPENILLDD-DMN 162 (298)
T ss_dssp EC-----SSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECT-TCC
T ss_pred cc-----CCeEEEEEeccCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCcceEEEcC-CCc
Confidence 43 3448899999985 77776654 3679999999999999999999999 89999999999999998 788
Q ss_pred EEEeecCcccccccCCcccccccccccccccccc-----CCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 021306 180 VKICDFGSAKQLIAGEANISYICSRFYRAPELIF-----GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 254 (314)
Q Consensus 180 ~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~ 254 (314)
++|+|||.+.............+++.|+|||.+. ....++.++||||||+++|+|++|..||.+.+.......+.
T Consensus 163 ~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~ 242 (298)
T 1phk_A 163 IKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIM 242 (298)
T ss_dssp EEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred EEEecccchhhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHh
Confidence 9999999998665544445567899999999985 23347889999999999999999999999888777666666
Q ss_pred HHcCCCCH-----------HHHh---ccCCCCCCCcccccccCChhhhhcccC
Q 021306 255 KVLGTPTR-----------EEIR---CMNPNYTDFRFPQIKAHPWHKVCIFHF 293 (314)
Q Consensus 255 ~~~~~~~~-----------~~~~---~~~p~~~~~~~~~l~~~p~~~~~~~~~ 293 (314)
+....... +.+. ..+|. +|+++.++++|||++....+.
T Consensus 243 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~-~Rps~~~ll~h~~~~~~~~~~ 294 (298)
T 1phk_A 243 SGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQ-KRYTAEEALAHPFFQQYVVEE 294 (298)
T ss_dssp HTCCCCCTTTGGGSCHHHHHHHHHHCCSSGG-GSCCHHHHTTSGGGCTTC---
T ss_pred cCCcccCcccccccCHHHHHHHHHHccCCcc-cCCCHHHHHhChHhhhccchh
Confidence 54322111 1122 23666 899999999999998776543
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-42 Score=318.40 Aligned_cols=241 Identities=27% Similarity=0.441 Sum_probs=196.5
Q ss_pred cCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCCce
Q 021306 36 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL 109 (314)
Q Consensus 36 ~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 109 (314)
..++|++++.||+|+||.||+|+++.++..+|+|.+.+.. ....+|+.+++.++||||+++++++.. ..
T Consensus 35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-----~~ 109 (494)
T 3lij_A 35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFED-----KR 109 (494)
T ss_dssp HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEEC-----SS
T ss_pred hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEe-----CC
Confidence 3457999999999999999999999999999999986432 334689999999999999999999843 33
Q ss_pred eEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCC--CCcEEEeecC
Q 021306 110 FLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPL--THQVKICDFG 186 (314)
Q Consensus 110 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~--~~~~~l~dfg 186 (314)
.+++||||+.| +|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+||+++.. +..++|+|||
T Consensus 110 ~~~lv~e~~~~g~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG 184 (494)
T 3lij_A 110 NYYLVMECYKGGELFDEIIH----RMKFNEVDAAVIIKQVLSGVTYLHK-HNIVHRDLKPENLLLESKEKDALIKIVDFG 184 (494)
T ss_dssp EEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEESCSSTTCCEEECCCT
T ss_pred EEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCChhhEEEeCCCCCCcEEEEECC
Confidence 48899999986 67666654 3679999999999999999999999 899999999999999762 3459999999
Q ss_pred cccccccCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCH----
Q 021306 187 SAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR---- 262 (314)
Q Consensus 187 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~---- 262 (314)
++.............+|+.|+|||.+.+ .++.++||||||+++|+|++|..||.+.+..+.+..+.+.......
T Consensus 185 ~a~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 262 (494)
T 3lij_A 185 LSAVFENQKKMKERLGTAYYIAPEVLRK--KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWK 262 (494)
T ss_dssp TCEECBTTBCBCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGT
T ss_pred CCeECCCCccccccCCCcCeeCHHHHcc--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcc
Confidence 9987665555556678999999999853 3899999999999999999999999999988877777665333211
Q ss_pred -------HHHh---ccCCCCCCCcccccccCChhhhh
Q 021306 263 -------EEIR---CMNPNYTDFRFPQIKAHPWHKVC 289 (314)
Q Consensus 263 -------~~~~---~~~p~~~~~~~~~l~~~p~~~~~ 289 (314)
+.+. ..+|. +|+++.++++|||++..
T Consensus 263 ~~s~~~~~li~~~L~~dp~-~R~s~~e~l~hp~~~~~ 298 (494)
T 3lij_A 263 NVSEGAKDLIKQMLQFDSQ-RRISAQQALEHPWIKEM 298 (494)
T ss_dssp TSCHHHHHHHHHHTCSSTT-TSCCHHHHHTCHHHHHH
T ss_pred cCCHHHHHHHHHHCCCChh-hCccHHHHhcCcccccC
Confidence 1222 34677 89999999999999864
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-42 Score=300.53 Aligned_cols=241 Identities=25% Similarity=0.428 Sum_probs=173.1
Q ss_pred CCceee---eeEeecCceEEEEEEECCCCcEEEEEEeeccc-cchHHHHHHHHhCC-CCceeeeceeeeecCCCCceeEE
Q 021306 38 ISYMAE---RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-RYKNRELQLMRVMD-HPNVISLKHCFFSTTSKNELFLN 112 (314)
Q Consensus 38 ~~y~~~---~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~-~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~ 112 (314)
++|++. +.||+|+||.||+|+++.+++.||+|.+.... ....+|+.+++.+. ||||+++++++.. ....+
T Consensus 8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~-----~~~~~ 82 (325)
T 3kn6_A 8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHEVFHD-----QLHTF 82 (325)
T ss_dssp HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGGGHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-----SSEEE
T ss_pred hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChhhhhhHHHHHHHHHHhcCCCCeeEEEEEEEc-----CCEEE
Confidence 457775 78999999999999999999999999987643 44568999999997 9999999999843 33488
Q ss_pred EEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCC--CcEEEeecCccc
Q 021306 113 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLT--HQVKICDFGSAK 189 (314)
Q Consensus 113 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~--~~~~l~dfg~~~ 189 (314)
+||||++| +|.+.+.. ...+++.+++.++.|++.||.|||+ +||+||||||+||+++..+ ..++|+|||++.
T Consensus 83 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~-~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~ 157 (325)
T 3kn6_A 83 LVMELLNGGELFERIKK----KKHFSETEASYIMRKLVSAVSHMHD-VGVVHRDLKPENLLFTDENDNLEIKIIDFGFAR 157 (325)
T ss_dssp EEECCCCSCBHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEEEC----CEEEECCCTTCE
T ss_pred EEEEccCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCHHHEEEecCCCcccEEEeccccce
Confidence 99999986 77766654 5789999999999999999999999 8999999999999998622 279999999997
Q ss_pred ccccCC-ccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCh-------HHHHHHHHHHcCCCC
Q 021306 190 QLIAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA-------VDQLVEIIKVLGTPT 261 (314)
Q Consensus 190 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~-------~~~~~~i~~~~~~~~ 261 (314)
...... ......+|+.|+|||.+.+.. ++.++||||||+++|+|++|+.||.+.+. .+....+.+......
T Consensus 158 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~ 236 (325)
T 3kn6_A 158 LKPPDNQPLKTPCFTLHYAAPELLNQNG-YDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFE 236 (325)
T ss_dssp ECCC----------------------CC-CCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCC
T ss_pred ecCCCCCcccccCCCcCccCHHHhcCCC-CCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCC
Confidence 554332 223456789999999996554 89999999999999999999999976543 233333332211111
Q ss_pred -----------HHHHh---ccCCCCCCCcccccccCChhhhhc
Q 021306 262 -----------REEIR---CMNPNYTDFRFPQIKAHPWHKVCI 290 (314)
Q Consensus 262 -----------~~~~~---~~~p~~~~~~~~~l~~~p~~~~~~ 290 (314)
.+.+. ..+|. +|+++.++++|||++...
T Consensus 237 ~~~~~~~s~~~~~li~~~L~~dP~-~Rpt~~ell~h~w~~~~~ 278 (325)
T 3kn6_A 237 GEAWKNVSQEAKDLIQGLLTVDPN-KRLKMSGLRYNEWLQDGS 278 (325)
T ss_dssp SHHHHTSCHHHHHHHHHHHCCCTT-TCCCTTTSTTCGGGCTTC
T ss_pred cccccCCCHHHHHHHHHHCCCChh-HCCCHHHHhcChhhccCc
Confidence 11222 34777 899999999999998653
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=299.87 Aligned_cols=253 Identities=25% Similarity=0.338 Sum_probs=190.5
Q ss_pred CCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCCce
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL 109 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 109 (314)
.++|++.+.||+|+||.||++++..+++.|++|.+.... ....+|+.++++++||||+++++++.. ..
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~-----~~ 84 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEE-----DD 84 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEEC-----SS
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeee-----CC
Confidence 468999999999999999999999999999999885322 234589999999999999999998743 33
Q ss_pred eEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcc
Q 021306 110 FLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 188 (314)
Q Consensus 110 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~ 188 (314)
.+++||||++| +|.+.+.. ..++++..++.++.|++.||.|||+ +|++|+||||+||+++. ++.++|+|||++
T Consensus 85 ~~~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~Dlkp~Nil~~~-~~~~kl~Dfg~~ 158 (294)
T 4eqm_A 85 CYYLVMEYIEGPTLSEYIES----HGPLSVDTAINFTNQILDGIKHAHD-MRIVHRDIKPQNILIDS-NKTLKIFDFGIA 158 (294)
T ss_dssp EEEEEEECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECT-TSCEEECCCSSS
T ss_pred eEEEEEeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECC-CCCEEEEeCCCc
Confidence 48899999986 77766654 3679999999999999999999999 89999999999999998 789999999999
Q ss_pred cccccCCc--cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCHHH-H
Q 021306 189 KQLIAGEA--NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE-I 265 (314)
Q Consensus 189 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~-~ 265 (314)
........ .....+|+.|+|||.+.+.. ++.++||||||+++|+|++|+.||.+.+........++......... .
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (294)
T 4eqm_A 159 KALSETSLTQTNHVLGTVQYFSPEQAKGEA-TDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVR 237 (294)
T ss_dssp TTC-------------CCSSCCHHHHHTCC-CCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSC
T ss_pred cccccccccccCccccCccccCHhHhcCCC-CCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcc
Confidence 76543322 22356799999999997655 78999999999999999999999999887766555554332222111 1
Q ss_pred hccCCCCCCCcccccccCChhhhhcccCChHHHHHh
Q 021306 266 RCMNPNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEY 301 (314)
Q Consensus 266 ~~~~p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~ 301 (314)
..+++.+.++...++...|-.|+...+...+.+...
T Consensus 238 ~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~ 273 (294)
T 4eqm_A 238 KDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSV 273 (294)
T ss_dssp TTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTS
T ss_pred cCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHH
Confidence 233444445555555555555554443334444333
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=303.17 Aligned_cols=216 Identities=37% Similarity=0.621 Sum_probs=178.5
Q ss_pred ccCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeecccc---chHHHHHHHHhCC-CC-----ceeeeceeeeecCC
Q 021306 35 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR---YKNRELQLMRVMD-HP-----NVISLKHCFFSTTS 105 (314)
Q Consensus 35 ~~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~~---~~~~e~~~l~~l~-h~-----~iv~~~~~~~~~~~ 105 (314)
...++|++.+.||+|+||.||+|++..+++.||+|.++.... ...+|+.+++.++ |+ +|+++.+++....
T Consensus 51 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~- 129 (382)
T 2vx3_A 51 KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRN- 129 (382)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETT-
T ss_pred EeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCC-
Confidence 345799999999999999999999999999999999975532 2346777887774 44 4888888875433
Q ss_pred CCceeEEEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhc-CCCceecCCCCCcEEEcC-CCCcEEEe
Q 021306 106 KNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT-VPRVCHRDLKPQNLLVDP-LTHQVKIC 183 (314)
Q Consensus 106 ~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~-~~~i~h~dl~p~Nil~~~-~~~~~~l~ 183 (314)
..++||||++++|.+.+... ....+++..++.++.|++.||.|||. ..||+||||||+||+++. .++.++|+
T Consensus 130 ----~~~lv~e~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~ 203 (382)
T 2vx3_A 130 ----HLCLVFEMLSYNLYDLLRNT--NFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIV 203 (382)
T ss_dssp ----EEEEEEECCCCBHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEEC
T ss_pred ----ceEEEEecCCCCHHHHHhhc--CcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEE
Confidence 48899999999998888753 22569999999999999999999994 169999999999999953 36789999
Q ss_pred ecCcccccccCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCC
Q 021306 184 DFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 260 (314)
Q Consensus 184 dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~ 260 (314)
|||++..... ......+|+.|+|||.+.+.. ++.++||||||+++|+|++|+.||.+.+..+.+..+++..+.+
T Consensus 204 DFG~a~~~~~--~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~ 277 (382)
T 2vx3_A 204 DFGSSCQLGQ--RIYQYIQSRFYRSPEVLLGMP-YDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIP 277 (382)
T ss_dssp CCTTCEETTC--CCCSSCSCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSC
T ss_pred eccCceeccc--ccccccCCccccChHHHcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 9999976533 233457799999999997655 8999999999999999999999999999888888888765443
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=291.80 Aligned_cols=243 Identities=28% Similarity=0.423 Sum_probs=189.7
Q ss_pred cCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCCc
Q 021306 36 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 108 (314)
Q Consensus 36 ~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 108 (314)
..++|++.+.||+|++|.||+|++..+++.|++|.+.... ....+|+.+++.++|+||+++++++...
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----- 83 (276)
T 2h6d_A 9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTP----- 83 (276)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS-----
T ss_pred eeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecC-----
Confidence 3468999999999999999999999999999999986432 2345899999999999999999988443
Q ss_pred eeEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCc
Q 021306 109 LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 187 (314)
Q Consensus 109 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~ 187 (314)
...++||||+++ +|.+.+.. ...+++..++.++.|++.||.+||+ +|++|+||+|+||+++. ++.++|+|||.
T Consensus 84 ~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~Nil~~~-~~~~~l~dfg~ 157 (276)
T 2h6d_A 84 TDFFMVMEYVSGGELFDYICK----HGRVEEMEARRLFQQILSAVDYCHR-HMVVHRDLKPENVLLDA-HMNAKIADFGL 157 (276)
T ss_dssp SEEEEEEECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-HCSSCCCCCGGGEEECT-TSCEEECCCCG
T ss_pred CeEEEEEeccCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCccCCCChhhEEECC-CCCEEEeeccc
Confidence 348899999985 77777654 3679999999999999999999999 89999999999999998 78899999999
Q ss_pred ccccccCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCC------
Q 021306 188 AKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT------ 261 (314)
Q Consensus 188 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~------ 261 (314)
+.............+++.|+|||.+.+....+.++||||||+++|+|++|+.||...+.......+.......+
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (276)
T 2h6d_A 158 SNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRS 237 (276)
T ss_dssp GGCCCC-------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHH
T ss_pred ccccCCCcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccCchhcCHH
Confidence 97665444444556789999999997655446899999999999999999999988877666555544322111
Q ss_pred -HHHHh---ccCCCCCCCcccccccCChhhhhc
Q 021306 262 -REEIR---CMNPNYTDFRFPQIKAHPWHKVCI 290 (314)
Q Consensus 262 -~~~~~---~~~p~~~~~~~~~l~~~p~~~~~~ 290 (314)
.+.+. ..+|. +|+++.++++|||++...
T Consensus 238 l~~li~~~l~~~p~-~Rps~~~~l~h~~~~~~~ 269 (276)
T 2h6d_A 238 VATLLMHMLQVDPL-KRATIKDIREHEWFKQDL 269 (276)
T ss_dssp HHHHHHHHTCSSGG-GSCCHHHHHHSHHHHTTC
T ss_pred HHHHHHHHccCChh-hCCCHHHHHhChhhccCc
Confidence 11222 23666 899999999999997654
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-42 Score=294.20 Aligned_cols=245 Identities=26% Similarity=0.456 Sum_probs=172.1
Q ss_pred ccCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCC
Q 021306 35 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKN 107 (314)
Q Consensus 35 ~~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 107 (314)
...++|++.+.||+|+||.||+|++..+++.|++|.+.... ....+|+.++++++||||+++++++..
T Consensus 8 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----- 82 (278)
T 3cok_A 8 EKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFED----- 82 (278)
T ss_dssp SSGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEEC-----
T ss_pred cccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEcc-----
Confidence 34568999999999999999999999999999999986432 345689999999999999999998843
Q ss_pred ceeEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecC
Q 021306 108 ELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 186 (314)
Q Consensus 108 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg 186 (314)
....+++|||+++ +|.+.+.. ...++++.+++.++.|++.||.|||+ +|++|+||+|+||+++. ++.++|+|||
T Consensus 83 ~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~Nili~~-~~~~kl~dfg 157 (278)
T 3cok_A 83 SNYVYLVLEMCHNGEMNRYLKN---RVKPFSENEARHFMHQIITGMLYLHS-HGILHRDLTLSNLLLTR-NMNIKIADFG 157 (278)
T ss_dssp SSEEEEEEECCTTEEHHHHHHT---CSSCCCHHHHHHHHHHHHHHHHHHHH-TTEECSSCCGGGEEECT-TCCEEECCCT
T ss_pred CCeEEEEEecCCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEEcC-CCCEEEEeec
Confidence 3348899999986 66666553 23679999999999999999999999 89999999999999998 7889999999
Q ss_pred cccccccCC-ccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCC-C---C
Q 021306 187 SAKQLIAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT-P---T 261 (314)
Q Consensus 187 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~-~---~ 261 (314)
.+....... ......+++.|+|||.+.+.. ++.++||||||+++|+|++|+.||...+..+.+..+...... + .
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (278)
T 3cok_A 158 LATQLKMPHEKHYTLCGTPNYISPEIATRSA-HGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLS 236 (278)
T ss_dssp TCEECC-----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSSCCCCCTTSC
T ss_pred ceeeccCCCCcceeccCCCCcCCcchhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhcccCCccccC
Confidence 987654322 223456789999999986544 789999999999999999999999876654443332211100 0 1
Q ss_pred ---HHHHh---ccCCCCCCCcccccccCChhhhhcc
Q 021306 262 ---REEIR---CMNPNYTDFRFPQIKAHPWHKVCIF 291 (314)
Q Consensus 262 ---~~~~~---~~~p~~~~~~~~~l~~~p~~~~~~~ 291 (314)
.+.+. ..+|. +|+++.++++|||++....
T Consensus 237 ~~~~~li~~~l~~dp~-~Rps~~~~l~h~~~~~~~~ 271 (278)
T 3cok_A 237 IEAKDLIHQLLRRNPA-DRLSLSSVLDHPFMSRNSS 271 (278)
T ss_dssp HHHHHHHHHHSCSSGG-GSCCHHHHTTSTTTC----
T ss_pred HHHHHHHHHHcccCHh-hCCCHHHHhcCccccCCCC
Confidence 11222 33666 8999999999999987654
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=303.79 Aligned_cols=238 Identities=25% Similarity=0.429 Sum_probs=196.8
Q ss_pred CCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc------------cchHHHHHHHHhC-CCCceeeeceeeeecC
Q 021306 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------------RYKNRELQLMRVM-DHPNVISLKHCFFSTT 104 (314)
Q Consensus 38 ~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~------------~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~ 104 (314)
++|++.+.||+|++|.||+|++..+|+.||||.+.... ....+|+.+++++ +||||+++++++..
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~-- 171 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYES-- 171 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEB--
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEee--
Confidence 57999999999999999999998899999999986542 2335788899998 89999999998843
Q ss_pred CCCceeEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEe
Q 021306 105 SKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKIC 183 (314)
Q Consensus 105 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~ 183 (314)
....++||||++| +|.+.+.. ...+++..++.++.||+.||.|||+ .|++|+||||+||+++. ++.++|+
T Consensus 172 ---~~~~~lv~e~~~g~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~-~gi~H~Dlkp~NIl~~~-~~~ikl~ 242 (365)
T 2y7j_A 172 ---SSFMFLVFDLMRKGELFDYLTE----KVALSEKETRSIMRSLLEAVSFLHA-NNIVHRDLKPENILLDD-NMQIRLS 242 (365)
T ss_dssp ---SSEEEEEECCCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECT-TCCEEEC
T ss_pred ---CCEEEEEEEeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEECC-CCCEEEE
Confidence 3348899999987 77666653 3679999999999999999999999 89999999999999998 8899999
Q ss_pred ecCcccccccCCccccccccccccccccccCC-----CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcC
Q 021306 184 DFGSAKQLIAGEANISYICSRFYRAPELIFGA-----TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLG 258 (314)
Q Consensus 184 dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~ 258 (314)
|||++.............+|+.|+|||.+.+. ..++.++||||||+++|+|++|..||.+.+....+..+.....
T Consensus 243 DfG~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~ 322 (365)
T 2y7j_A 243 DFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQY 322 (365)
T ss_dssp CCTTCEECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC
T ss_pred ecCcccccCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCC
Confidence 99999876555555556789999999998532 2478899999999999999999999998887777766665543
Q ss_pred CCCHH-----------HHh---ccCCCCCCCcccccccCChhh
Q 021306 259 TPTRE-----------EIR---CMNPNYTDFRFPQIKAHPWHK 287 (314)
Q Consensus 259 ~~~~~-----------~~~---~~~p~~~~~~~~~l~~~p~~~ 287 (314)
..... .+. ..+|. +|+++.++++|||++
T Consensus 323 ~~~~~~~~~~~~~~~~li~~~L~~dP~-~Rps~~ell~hp~f~ 364 (365)
T 2y7j_A 323 QFSSPEWDDRSSTVKDLISRLLQVDPE-ARLTAEQALQHPFFE 364 (365)
T ss_dssp CCCHHHHSSSCHHHHHHHHHHSCSSTT-TSCCHHHHHHSGGGC
T ss_pred CCCCcccccCCHHHHHHHHHHcCCChh-HCcCHHHHhcCcccC
Confidence 32221 122 33677 899999999999986
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-42 Score=301.27 Aligned_cols=214 Identities=24% Similarity=0.394 Sum_probs=174.9
Q ss_pred CCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeE
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 111 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 111 (314)
.++|++.+.||+|+||.||+|++..+++.||+|.+.... ....+|+.++++++||||+++++++.... ....
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---~~~~ 84 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETT---TRHK 84 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTT---TCCE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCC---CceE
Confidence 468999999999999999999999999999999986432 23358999999999999999999875433 2347
Q ss_pred EEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEE----cCCCCcEEEeecC
Q 021306 112 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLV----DPLTHQVKICDFG 186 (314)
Q Consensus 112 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~----~~~~~~~~l~dfg 186 (314)
++||||+++ +|.+.+... .....+++.+++.++.|++.||.|||+ +||+|+||||+||++ +. .+.++|+|||
T Consensus 85 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dlkp~NIll~~~~~~-~~~~kL~Dfg 161 (319)
T 4euu_A 85 VLIMEFCPCGSLYTVLEEP-SNAYGLPESEFLIVLRDVVGGMNHLRE-NGIVHRNIKPGNIMRVIGEDG-QSVYKLTDFG 161 (319)
T ss_dssp EEEEECCTTCBHHHHHHSG-GGTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEEECTTS-CEEEEECCCT
T ss_pred EEEEeCCCCCCHHHHHHHh-ccccCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCCCHHHEEEeccCCC-CceEEEccCC
Confidence 899999985 777766542 233459999999999999999999999 899999999999998 54 6679999999
Q ss_pred cccccccCCccccccccccccccccccC-------CCCCCcchhHHHHHHHHHHHHhCCCCCCCCC----hHHHHHHHHH
Q 021306 187 SAKQLIAGEANISYICSRFYRAPELIFG-------ATEYTTSIDIWSAGCVLAELLLGQPLFPGEN----AVDQLVEIIK 255 (314)
Q Consensus 187 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Dv~slG~il~el~tg~~pf~~~~----~~~~~~~i~~ 255 (314)
++.............+|+.|+|||.+.. ...++.++||||||+++|+|++|+.||.... ..+.+..++.
T Consensus 162 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 241 (319)
T 4euu_A 162 AARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241 (319)
T ss_dssp TCEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHH
T ss_pred CceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhc
Confidence 9987665555555678999999999852 2447899999999999999999999997533 2344444544
Q ss_pred H
Q 021306 256 V 256 (314)
Q Consensus 256 ~ 256 (314)
.
T Consensus 242 ~ 242 (319)
T 4euu_A 242 G 242 (319)
T ss_dssp H
T ss_pred C
Confidence 3
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=293.63 Aligned_cols=245 Identities=25% Similarity=0.391 Sum_probs=197.8
Q ss_pred CCccCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCC
Q 021306 33 EPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTS 105 (314)
Q Consensus 33 ~~~~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 105 (314)
.|...++|++.+.||+|+||.||++++..+++.+++|.+.... ....+|+.++++++|+||+++++++..
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--- 86 (294)
T 2rku_A 10 DPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFED--- 86 (294)
T ss_dssp ETTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC---
T ss_pred CCCcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeecc---
Confidence 4556678999999999999999999999999999999986542 233578999999999999999998843
Q ss_pred CCceeEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEee
Q 021306 106 KNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICD 184 (314)
Q Consensus 106 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~d 184 (314)
....+++|||+++ +|.+.+.. ...+++.+++.++.|++.||.+||+ +|++|+||+|+||+++. ++.++|+|
T Consensus 87 --~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dl~p~Nil~~~-~~~~kl~d 158 (294)
T 2rku_A 87 --NDFVFVVLELCRRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYLHR-NRVIHRDLKLGNLFLNE-DLEVKIGD 158 (294)
T ss_dssp --SSEEEEEEECCTTCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECT-TCCEEECC
T ss_pred --CCEEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCChHhEEEcC-CCCEEEEe
Confidence 3348899999995 66665543 4679999999999999999999999 89999999999999998 78899999
Q ss_pred cCcccccccCC-ccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCC--
Q 021306 185 FGSAKQLIAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT-- 261 (314)
Q Consensus 185 fg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~-- 261 (314)
||.+....... ......+++.|+|||.+.+.. ++.++||||||+++|+|++|+.||......+....+.......+
T Consensus 159 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 237 (294)
T 2rku_A 159 FGLATKVEYDGERKKVLCGTPNYIAPEVLSKKG-HSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKH 237 (294)
T ss_dssp CTTCEECCSTTCCBCCCCSCCSSCCHHHHTTSC-BCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTT
T ss_pred ccCceecccCccccccccCCCCcCCcchhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccCCCccc
Confidence 99987654322 233456788999999996544 78999999999999999999999998887766655544322111
Q ss_pred --H---HHHh---ccCCCCCCCcccccccCChhhhhc
Q 021306 262 --R---EEIR---CMNPNYTDFRFPQIKAHPWHKVCI 290 (314)
Q Consensus 262 --~---~~~~---~~~p~~~~~~~~~l~~~p~~~~~~ 290 (314)
. +.+. ..+|. +|+++.++++|||++...
T Consensus 238 ~~~~~~~li~~~l~~~p~-~Rps~~~ll~~~~~~~~~ 273 (294)
T 2rku_A 238 INPVAASLIQKMLQTDPT-ARPTINELLNDEFFTSGY 273 (294)
T ss_dssp SCHHHHHHHHHHTCSSGG-GSCCGGGGGGSHHHHTSC
T ss_pred cCHHHHHHHHHHcccChh-hCcCHHHHhhChheecCC
Confidence 1 1122 33666 899999999999997643
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-42 Score=327.01 Aligned_cols=242 Identities=27% Similarity=0.385 Sum_probs=198.9
Q ss_pred cCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhC-CCCceeeeceeeeecCCCC
Q 021306 36 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVM-DHPNVISLKHCFFSTTSKN 107 (314)
Q Consensus 36 ~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~-------~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~ 107 (314)
..++|++.+.||+|+||.||+|+++.+++.||+|.+++.. .....|..++..+ .|++|++++.++. .
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~-----~ 413 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQ-----T 413 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECB-----C
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEE-----e
Confidence 4568999999999999999999999999999999987532 2234678888877 7999999999884 3
Q ss_pred ceeEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecC
Q 021306 108 ELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 186 (314)
Q Consensus 108 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg 186 (314)
...+++||||++| +|...+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++. ++.++|+|||
T Consensus 414 ~~~~~lV~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~gIiHrDLKp~NILl~~-~g~ikL~DFG 487 (674)
T 3pfq_A 414 MDRLYFVMEYVNGGDLMYHIQQ----VGRFKEPHAVFYAAEIAIGLFFLQS-KGIIYRDLKLDNVMLDS-EGHIKIADFG 487 (674)
T ss_dssp SSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TSEECCCCCSTTEEECS-SSCEEECCCT
T ss_pred CCEEEEEEeCcCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeEeccCChhhEEEcC-CCcEEEeecc
Confidence 3458899999986 67666654 3679999999999999999999999 89999999999999998 8899999999
Q ss_pred ccccccc-CCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCC----
Q 021306 187 SAKQLIA-GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT---- 261 (314)
Q Consensus 187 ~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~---- 261 (314)
+++.... ........||+.|+|||.+.+.. ++.++||||||+++|||++|+.||.+.+..+.+..+++.....+
T Consensus 488 la~~~~~~~~~~~~~~GT~~Y~APE~l~~~~-~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s 566 (674)
T 3pfq_A 488 MCKENIWDGVTTKTFCGTPDYIAPEIIAYQP-YGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMS 566 (674)
T ss_dssp TCEECCCTTCCBCCCCSCSSSCCHHHHTCCC-BSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCCCTTSC
T ss_pred eeeccccCCcccccccCCCcccCHhhhcCCC-CCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCccCC
Confidence 9975332 23344567899999999996554 89999999999999999999999999998888888776533222
Q ss_pred ---HHHH---hccCCCCCCCcc-----cccccCChhhhhc
Q 021306 262 ---REEI---RCMNPNYTDFRF-----PQIKAHPWHKVCI 290 (314)
Q Consensus 262 ---~~~~---~~~~p~~~~~~~-----~~l~~~p~~~~~~ 290 (314)
.+.+ ...+|. +|+++ ++|++||||+...
T Consensus 567 ~~~~~li~~lL~~dP~-~R~~~~~~~~~ei~~h~ff~~i~ 605 (674)
T 3pfq_A 567 KEAVAICKGLMTKHPG-KRLGCGPEGERDIKEHAFFRYID 605 (674)
T ss_dssp HHHHHHHHHHSCSSST-TCTTCSTTHHHHHHSSGGGSSCC
T ss_pred HHHHHHHHHHccCCHH-HCCCCCCCcHHHHhcCccccCCC
Confidence 1222 234777 89987 8999999998644
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=290.36 Aligned_cols=244 Identities=25% Similarity=0.351 Sum_probs=191.9
Q ss_pred CCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeE
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 111 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 111 (314)
.++|++.+.||+|++|.||+|.+..+++.|++|.+.... ....+|+.+++.++|+||+++++++... ...
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~ 80 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREG-----NIQ 80 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEET-----TEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcC-----CEE
Confidence 457999999999999999999999999999999986443 3346899999999999999999988543 337
Q ss_pred EEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcccc
Q 021306 112 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 190 (314)
Q Consensus 112 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~ 190 (314)
++|+||+++ +|.+. ......+++..++.++.|++.||.+||+ +|++|+||+|+||+++. ++.++|+|||.+..
T Consensus 81 ~lv~e~~~~~~L~~~----l~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~Nil~~~-~~~~kl~dfg~~~~ 154 (276)
T 2yex_A 81 YLFLEYCSGGELFDR----IEPDIGMPEPDAQRFFHQLMAGVVYLHG-IGITHRDIKPENLLLDE-RDNLKISDFGLATV 154 (276)
T ss_dssp EEEEECCTTEEGGGG----SBTTTBCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECT-TCCEEECCCTTCEE
T ss_pred EEEEEecCCCcHHHH----HhhccCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCChHHEEEcc-CCCEEEeeCCCccc
Confidence 899999987 54443 3345689999999999999999999999 89999999999999998 78899999999875
Q ss_pred cccCC---ccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHcCCC------
Q 021306 191 LIAGE---ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQ-LVEIIKVLGTP------ 260 (314)
Q Consensus 191 ~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~-~~~i~~~~~~~------ 260 (314)
..... ......+++.|+|||.+.+....+.++||||||+++|+|++|+.||........ +..+.......
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (276)
T 2yex_A 155 FRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKI 234 (276)
T ss_dssp CEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGS
T ss_pred cCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhc
Confidence 53322 123356788999999997655457899999999999999999999987654322 22222211111
Q ss_pred C---HHHHh---ccCCCCCCCcccccccCChhhhhccc
Q 021306 261 T---REEIR---CMNPNYTDFRFPQIKAHPWHKVCIFH 292 (314)
Q Consensus 261 ~---~~~~~---~~~p~~~~~~~~~l~~~p~~~~~~~~ 292 (314)
. .+.+. ..+|. +|+++.++++|||++....+
T Consensus 235 ~~~~~~li~~~l~~~p~-~Rps~~~il~~~~~~~~~~~ 271 (276)
T 2yex_A 235 DSAPLALLHKILVENPS-ARITIPDIKKDRWYNKPLKK 271 (276)
T ss_dssp CHHHHHHHHHHSCSSTT-TSCCHHHHTTCTTTTCCCC-
T ss_pred CHHHHHHHHHHCCCCch-hCCCHHHHhcCccccChhhc
Confidence 1 11122 33677 89999999999999876553
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=306.58 Aligned_cols=249 Identities=24% Similarity=0.373 Sum_probs=185.4
Q ss_pred ccCCCceee-eeEeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHH-HhCCCCceeeeceeeeecCCCCceeEE
Q 021306 35 KQTISYMAE-RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLM-RVMDHPNVISLKHCFFSTTSKNELFLN 112 (314)
Q Consensus 35 ~~~~~y~~~-~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~~~~~~e~~~l-~~l~h~~iv~~~~~~~~~~~~~~~~~~ 112 (314)
...++|.+. +.||+|+||.||++.++.+++.||+|.+... ....+|+.++ +..+|+||+++++++.... .+..+++
T Consensus 58 ~~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~-~~~~~~~ 135 (400)
T 1nxk_A 58 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-PKARREVELHWRASQCPHIVRIVDVYENLY-AGRKCLL 135 (400)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEEEEE
T ss_pred cccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-hhHHHHHHHHHHhcCCCCcceEeEEEeecc-cCCcEEE
Confidence 345678887 7899999999999999999999999998644 3456777775 5568999999999875322 2345688
Q ss_pred EEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCC--CCcEEEeecCccc
Q 021306 113 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPL--THQVKICDFGSAK 189 (314)
Q Consensus 113 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~--~~~~~l~dfg~~~ 189 (314)
+||||++| +|.+.+... ....+++.+++.++.||+.||.|||+ +||+||||||+||+++.. ++.++|+|||++.
T Consensus 136 lv~E~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~ 212 (400)
T 1nxk_A 136 IVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHS-INIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 212 (400)
T ss_dssp EEEECCCSEEHHHHHHCC-----CCBHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred EEEEeCCCCcHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCcCcceEEEecCCCCccEEEEeccccc
Confidence 99999986 777776542 23469999999999999999999999 899999999999999863 5679999999998
Q ss_pred ccccCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHH----HHHHHHHHcCC-C----
Q 021306 190 QLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVD----QLVEIIKVLGT-P---- 260 (314)
Q Consensus 190 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~----~~~~i~~~~~~-~---- 260 (314)
............+|+.|+|||.+.+. .++.++||||||+++|+|++|+.||.+.+... ....+....-. +
T Consensus 213 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 291 (400)
T 1nxk_A 213 ETTSHNSLTTPCYTPYYVAPEVLGPE-KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW 291 (400)
T ss_dssp ECC-----------CTTCCGGGSCCC-CSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTTTT
T ss_pred ccCCCCccccCCCCCCccCHhhcCCC-CCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCCccc
Confidence 66544444556789999999999654 48999999999999999999999997765322 22333322111 1
Q ss_pred ---C---HHHHh---ccCCCCCCCcccccccCChhhhhc
Q 021306 261 ---T---REEIR---CMNPNYTDFRFPQIKAHPWHKVCI 290 (314)
Q Consensus 261 ---~---~~~~~---~~~p~~~~~~~~~l~~~p~~~~~~ 290 (314)
. .+.+. ..+|. +|+++.++++|||+....
T Consensus 292 ~~~s~~~~~li~~~L~~dP~-~Rpt~~eil~hp~~~~~~ 329 (400)
T 1nxk_A 292 SEVSEEVKMLIRNLLKTEPT-QRMTITEFMNHPWIMQST 329 (400)
T ss_dssp TTSCHHHHHHHHTTSCSSGG-GSCCHHHHHHSHHHHTTT
T ss_pred ccCCHHHHHHHHHHCCCChh-HCcCHHHHhcCccccCCC
Confidence 1 12222 23666 899999999999997543
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-41 Score=289.72 Aligned_cols=244 Identities=24% Similarity=0.362 Sum_probs=194.1
Q ss_pred ccCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCCc
Q 021306 35 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 108 (314)
Q Consensus 35 ~~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 108 (314)
..+..|++.+.||+|+||.||+|.+..++..|++|.+.... ....+|+.++++++||||+++++++.... ...
T Consensus 23 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~ 101 (290)
T 1t4h_A 23 NDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGK 101 (290)
T ss_dssp TTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES-SSC
T ss_pred cCceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecccc-CCC
Confidence 34557999999999999999999999999999999986432 22457999999999999999999875543 334
Q ss_pred eeEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCC--ceecCCCCCcEEEcCCCCcEEEeec
Q 021306 109 LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR--VCHRDLKPQNLLVDPLTHQVKICDF 185 (314)
Q Consensus 109 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~--i~h~dl~p~Nil~~~~~~~~~l~df 185 (314)
.++++||||+++ +|.+.+.. ...+++..++.++.||+.||.|||+ +| ++|+||||+||+++..++.++|+||
T Consensus 102 ~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~~~i~H~dikp~Nil~~~~~~~~kl~Df 176 (290)
T 1t4h_A 102 KCIVLVTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHT-RTPPIIHRDLKCDNIFITGPTGSVKIGDL 176 (290)
T ss_dssp EEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHT-SSSCCCCSCCCGGGEEESSTTSCEEECCT
T ss_pred ceEEEEEEecCCCCHHHHHHH----ccCCCHHHHHHHHHHHHHHHHHHHc-CCCCEEECCCCHHHEEEECCCCCEEEeeC
Confidence 567899999976 77776654 3679999999999999999999999 88 9999999999999854789999999
Q ss_pred CcccccccCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCC----
Q 021306 186 GSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT---- 261 (314)
Q Consensus 186 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~---- 261 (314)
|++..... .......+++.|+|||.+.+ .++.++||||||+++|+|++|+.||.+..........+.....+.
T Consensus 177 g~~~~~~~-~~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 253 (290)
T 1t4h_A 177 GLATLKRA-SFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDK 253 (290)
T ss_dssp TGGGGCCT-TSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGG
T ss_pred CCcccccc-cccccccCCcCcCCHHHHhc--cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccCC
Confidence 99864432 23334567999999998853 389999999999999999999999988665555544443322211
Q ss_pred ---H---HHHh-c--cCCCCCCCcccccccCChhhh
Q 021306 262 ---R---EEIR-C--MNPNYTDFRFPQIKAHPWHKV 288 (314)
Q Consensus 262 ---~---~~~~-~--~~p~~~~~~~~~l~~~p~~~~ 288 (314)
+ +.+. + .+|. +|+++.++++|||++.
T Consensus 254 ~~~~~l~~li~~~l~~dp~-~Rps~~ell~h~~f~~ 288 (290)
T 1t4h_A 254 VAIPEVKEIIEGCIRQNKD-ERYSIKDLLNHAFFQE 288 (290)
T ss_dssp CCCHHHHHHHHHHSCSSGG-GSCCHHHHHTSGGGC-
T ss_pred CCCHHHHHHHHHHccCChh-hCCCHHHHhhCccccc
Confidence 1 1122 2 3566 8999999999999975
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=300.94 Aligned_cols=243 Identities=36% Similarity=0.630 Sum_probs=194.8
Q ss_pred CCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCC-Cce
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSK-NEL 109 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~-~~~ 109 (314)
.++|++.+.||+|+||.||+|++..+|+.||+|.+.... ....+|+.+++.++||||+++++++...... ...
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 358999999999999999999999999999999986532 2335799999999999999999988543321 112
Q ss_pred eEEEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCccc
Q 021306 110 FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 189 (314)
Q Consensus 110 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~ 189 (314)
.++++|||+.++|.+.+ ...+++.+++.++.||+.||.|||+ +|++|+||||+||+++. ++.++|+|||++.
T Consensus 103 ~~~lv~e~~~~~l~~~~------~~~~~~~~~~~i~~qi~~al~~LH~-~~ivH~dlkp~NIl~~~-~~~~kl~Dfg~~~ 174 (353)
T 3coi_A 103 DFYLVMPFMQTDLQKIM------GLKFSEEKIQYLVYQMLKGLKYIHS-AGVVHRDLKPGNLAVNE-DCELKILDFGLAR 174 (353)
T ss_dssp CCEEEEECCSEEGGGTT------TSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSSCCGGGEEECT-TCCEEECSTTCTT
T ss_pred eEEEEeccccCCHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEeECC-CCcEEEeeccccc
Confidence 35799999998765443 2469999999999999999999999 89999999999999998 7899999999997
Q ss_pred ccccCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCH-------
Q 021306 190 QLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR------- 262 (314)
Q Consensus 190 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~------- 262 (314)
..... .....+++.|+|||.+.+...++.++||||||+++|+|++|+.||.+.+..+.+..+.+..+.+..
T Consensus 175 ~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 252 (353)
T 3coi_A 175 HADAE--MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLN 252 (353)
T ss_dssp C----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCS
T ss_pred CCCCC--ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHh
Confidence 54332 234567899999999876556899999999999999999999999999888877777665433221
Q ss_pred -------------------------------HHHh---ccCCCCCCCcccccccCChhhhhc
Q 021306 263 -------------------------------EEIR---CMNPNYTDFRFPQIKAHPWHKVCI 290 (314)
Q Consensus 263 -------------------------------~~~~---~~~p~~~~~~~~~l~~~p~~~~~~ 290 (314)
+.+. ..+|. +|+++.++++|||++...
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~-~Rpt~~e~l~hp~f~~~~ 313 (353)
T 3coi_A 253 DKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVD-KRLTAAQALTHPFFEPFR 313 (353)
T ss_dssp CHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTT-TSCCHHHHHTSGGGTTTC
T ss_pred hHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcc-cCCCHHHHhcCcchhhcc
Confidence 1111 23676 899999999999998643
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=299.19 Aligned_cols=244 Identities=21% Similarity=0.356 Sum_probs=184.5
Q ss_pred CCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCC------
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTS------ 105 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~------ 105 (314)
.++|++.+.||+|+||.||+|+++.+++.||+|+++... ....+|+.++++++||||+++++++.....
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 467999999999999999999999999999999986432 334689999999999999999998865432
Q ss_pred ----------------------------------------------CCceeEEEEeecccc-cHHHHHHhhhhcCCCCCH
Q 021306 106 ----------------------------------------------KNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPL 138 (314)
Q Consensus 106 ----------------------------------------------~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~ 138 (314)
....+.+++|||+++ +|.+.+... ......++
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~ 163 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRR-CSLEDREH 163 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTC-CSGGGSCH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcc-cCccchhh
Confidence 123357899999997 666665542 22344677
Q ss_pred HHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcccccccCC-------------cccccccccc
Q 021306 139 IYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE-------------ANISYICSRF 205 (314)
Q Consensus 139 ~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~~~~-------------~~~~~~~~~~ 205 (314)
..++.++.||+.||.|||+ +||+||||||+||+++. ++.++|+|||++....... ......+|+.
T Consensus 164 ~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~-~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 241 (332)
T 3qd2_B 164 GVCLHIFIQIAEAVEFLHS-KGLMHRDLKPSNIFFTM-DDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECT-TCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred HHHHHHHHHHHHHHHHHHh-CCeeecCCCcccEEEeC-CCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence 7899999999999999999 89999999999999998 7899999999998654432 1223467999
Q ss_pred ccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCC---------HHHH---hccCCCCC
Q 021306 206 YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT---------REEI---RCMNPNYT 273 (314)
Q Consensus 206 y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~---------~~~~---~~~~p~~~ 273 (314)
|+|||.+.+.. ++.++||||||+++|+|++|..|+.... ...........+. .+.+ ...+|. +
T Consensus 242 y~aPE~~~~~~-~~~~~Di~slG~il~el~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~-~ 316 (332)
T 3qd2_B 242 YMSPEQIHGNN-YSHKVDIFSLGLILFELLYSFSTQMERV---RIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPT-E 316 (332)
T ss_dssp GSCHHHHHCCC-CCTHHHHHHHHHHHHHHHSCCCCHHHHH---HHHHHHHTTCCCHHHHHHCHHHHHHHHHHHCSSGG-G
T ss_pred ccChHHhcCCC-CcchhhHHHHHHHHHHHHHcCCChhHHH---HHHHHhhccCCCcccccCChhHHHHHHHHccCCCC-c
Confidence 99999997654 8999999999999999999877652211 1111111111111 1112 233666 8
Q ss_pred CCcccccccCChhhh
Q 021306 274 DFRFPQIKAHPWHKV 288 (314)
Q Consensus 274 ~~~~~~l~~~p~~~~ 288 (314)
|+++.++++|||++.
T Consensus 317 Rps~~~~l~~~~f~~ 331 (332)
T 3qd2_B 317 RPEATDIIENAIFEN 331 (332)
T ss_dssp SCCHHHHHHSTTCCC
T ss_pred CCCHHHHhhchhhhc
Confidence 999999999999874
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-42 Score=307.11 Aligned_cols=241 Identities=27% Similarity=0.380 Sum_probs=191.9
Q ss_pred Ccee--eeeEeecCceEEEEEEECCCCcEEEEEEeecc----ccchHHHHHHHHhCCCCceeeeceeeeecCCCCceeEE
Q 021306 39 SYMA--ERVVGTGSFGIVFQAKCLETGETVAIKKVLQD----RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 112 (314)
Q Consensus 39 ~y~~--~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 112 (314)
.|++ .+.||+|+||.||+|++..+|+.||+|.++.. .....+|+.++++++||||+++++++... ..++
T Consensus 88 ~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-----~~~~ 162 (373)
T 2x4f_A 88 FYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESK-----NDIV 162 (373)
T ss_dssp TEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECS-----SEEE
T ss_pred ceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEEC-----CEEE
Confidence 3444 67899999999999999999999999998753 23456899999999999999999988443 3488
Q ss_pred EEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEc-CCCCcEEEeecCcccc
Q 021306 113 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVD-PLTHQVKICDFGSAKQ 190 (314)
Q Consensus 113 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~-~~~~~~~l~dfg~~~~ 190 (314)
+||||+++ +|.+.+.. ....+++..++.++.||+.||.|||+ +||+||||||+||++. ..++.++|+|||++..
T Consensus 163 lv~E~~~~~~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~ 238 (373)
T 2x4f_A 163 LVMEYVDGGELFDRIID---ESYNLTELDTILFMKQICEGIRHMHQ-MYILHLDLKPENILCVNRDAKQIKIIDFGLARR 238 (373)
T ss_dssp EEEECCTTCEEHHHHHH---TGGGCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEEEETTTTEEEECCCSSCEE
T ss_pred EEEeCCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCCHHHEEEecCCCCcEEEEeCCCcee
Confidence 99999986 66666653 23579999999999999999999999 8999999999999984 2267899999999987
Q ss_pred cccCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCC---------
Q 021306 191 LIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT--------- 261 (314)
Q Consensus 191 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~--------- 261 (314)
...........+|+.|+|||.+.+. .++.++||||||+++|+|++|+.||.+.+..+.+..+.+......
T Consensus 239 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 317 (373)
T 2x4f_A 239 YKPREKLKVNFGTPEFLAPEVVNYD-FVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISE 317 (373)
T ss_dssp CCTTCBCCCCCSSCTTCCHHHHTTC-BCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCH
T ss_pred cCCccccccccCCCcEeChhhccCC-CCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCH
Confidence 6555444456789999999998654 489999999999999999999999999988888887776532221
Q ss_pred --HHHHh---ccCCCCCCCcccccccCChhhhhc
Q 021306 262 --REEIR---CMNPNYTDFRFPQIKAHPWHKVCI 290 (314)
Q Consensus 262 --~~~~~---~~~p~~~~~~~~~l~~~p~~~~~~ 290 (314)
.+.+. ..+|. +|+++.++++|||++...
T Consensus 318 ~~~~li~~~L~~dp~-~Rps~~e~l~hp~~~~~~ 350 (373)
T 2x4f_A 318 EAKEFISKLLIKEKS-WRISASEALKHPWLSDHK 350 (373)
T ss_dssp HHHHHHHTTSCSSGG-GSCCHHHHHHSHHHHCHH
T ss_pred HHHHHHHHHcCCChh-hCCCHHHHhcCcCcCCCc
Confidence 11222 23566 899999999999998764
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=297.47 Aligned_cols=253 Identities=19% Similarity=0.201 Sum_probs=191.4
Q ss_pred ccCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeecc--ccchHHHHHHHHhC-CCCceeeeceeeeecCCCCceeE
Q 021306 35 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD--RRYKNRELQLMRVM-DHPNVISLKHCFFSTTSKNELFL 111 (314)
Q Consensus 35 ~~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~--~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~ 111 (314)
..+++|++.+.||+|+||.||+|++..+++.||+|.+... .....+|+.+++++ +|+||+++++++... ...
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~-----~~~ 80 (330)
T 2izr_A 6 MVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGPCG-----KYN 80 (330)
T ss_dssp EETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSSCCHHHHHHHHHHHCSCTTSCCEEEEEEET-----TEE
T ss_pred EEcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHhhCCCCCCEEEEEEecC-----Ccc
Confidence 4467899999999999999999999999999999998644 34467899999999 999999999987543 347
Q ss_pred EEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCc-----EEEeecC
Q 021306 112 NLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQ-----VKICDFG 186 (314)
Q Consensus 112 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~-----~~l~dfg 186 (314)
++||||+.++|.+.+... ...+++..++.++.|++.||.|||+ +||+||||||+||+++. ++. ++|+|||
T Consensus 81 ~lv~e~~~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~-~~iiHrDlkp~Nill~~-~~~~~~~~~kl~DFg 155 (330)
T 2izr_A 81 AMVLELLGPSLEDLFDLC---DRTFSLKTVLMIAIQLISRMEYVHS-KNLIYRDVKPENFLIGR-PGNKTQQVIHIIDFA 155 (330)
T ss_dssp EEEEECCCCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECC-GGGTCTTSEEECCCT
T ss_pred EEEEEeCCCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHeeecc-CCCCCCceEEEEEcc
Confidence 899999977888877642 4689999999999999999999999 89999999999999987 555 9999999
Q ss_pred cccccccCCc--------cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHH
Q 021306 187 SAKQLIAGEA--------NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA---VDQLVEIIK 255 (314)
Q Consensus 187 ~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~---~~~~~~i~~ 255 (314)
++........ .....+|+.|+|||.+.+.. ++.++||||||+++|+|++|+.||.+.+. .+.+..+..
T Consensus 156 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~ 234 (330)
T 2izr_A 156 LAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKE-QSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGD 234 (330)
T ss_dssp TCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHH
T ss_pred cceeeecCCCCccccccccCCcCCCccccChHHHcCCC-CCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHh
Confidence 9986543322 23456899999999997654 89999999999999999999999987543 333333333
Q ss_pred HcCCCCHHHHhccCCCCCCCcccccccCChhhhhcccCChHHHHHhcc
Q 021306 256 VLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGS 303 (314)
Q Consensus 256 ~~~~~~~~~~~~~~p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~ 303 (314)
.....+........| .+.+++..+|...+..+++.+.+.+.++
T Consensus 235 ~~~~~~~~~~~~~~p-----~~~~li~~~l~~~p~~RP~~~~l~~~l~ 277 (330)
T 2izr_A 235 TKRATPIEVLCENFP-----EMATYLRYVRRLDFFEKPDYDYLRKLFT 277 (330)
T ss_dssp HHHHSCHHHHTTTCH-----HHHHHHHHHHHCCTTCCCCHHHHHHHHH
T ss_pred hhccCCHHHHhccCh-----HHHHHHHHHHhCCCCCCCCHHHHHHHHH
Confidence 221122222111111 3445555555555555555554444433
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=293.03 Aligned_cols=248 Identities=27% Similarity=0.413 Sum_probs=197.3
Q ss_pred cCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc--------cchHHHHHHHHhCCCCceeeeceeeeecCCCC
Q 021306 36 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR--------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKN 107 (314)
Q Consensus 36 ~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~--------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 107 (314)
..++|++.+.||+|+||.||++.+..+++.+++|.+.... ....+|+.++++++|+||+++++++....
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--- 79 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEE--- 79 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC----
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCC---
Confidence 3568999999999999999999999999999999986432 33468999999999999999999875322
Q ss_pred ceeEEEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCc
Q 021306 108 ELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 187 (314)
Q Consensus 108 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~ 187 (314)
....++||||+.+++.+.+... ....+++..++.++.||+.||.|||+ +|++|+||||+||+++. ++.++|+|||.
T Consensus 80 ~~~~~lv~e~~~~~l~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~-~~i~H~dlkp~NIl~~~-~~~~kl~dfg~ 155 (305)
T 2wtk_C 80 KQKMYMVMEYCVCGMQEMLDSV--PEKRFPVCQAHGYFCQLIDGLEYLHS-QGIVHKDIKPGNLLLTT-GGTLKISALGV 155 (305)
T ss_dssp --CEEEEEECCSEEHHHHHHHS--TTCSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECT-TCCEEECCCTT
T ss_pred CCeEEEEehhccCCHHHHHHhC--cccccCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCcccEEEcC-CCcEEeecccc
Confidence 2347899999999977776643 34679999999999999999999999 89999999999999998 78999999999
Q ss_pred ccccccC---CccccccccccccccccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCC--
Q 021306 188 AKQLIAG---EANISYICSRFYRAPELIFGAT-EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT-- 261 (314)
Q Consensus 188 ~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~-~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~-- 261 (314)
+...... .......+++.|+|||.+.+.. ..+.++||||||+++|+|++|+.||.+.+..+....+.+.....+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~ 235 (305)
T 2wtk_C 156 AEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGD 235 (305)
T ss_dssp CEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCCSS
T ss_pred ccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCCCCCCc
Confidence 8765322 1223455789999999986533 247799999999999999999999998887766665554322211
Q ss_pred -----HHHHh---ccCCCCCCCcccccccCChhhhhcc
Q 021306 262 -----REEIR---CMNPNYTDFRFPQIKAHPWHKVCIF 291 (314)
Q Consensus 262 -----~~~~~---~~~p~~~~~~~~~l~~~p~~~~~~~ 291 (314)
.+.+. ..+|. +|+++.++++|||++....
T Consensus 236 ~~~~l~~li~~~l~~dp~-~Rps~~~ll~~~~~~~~~~ 272 (305)
T 2wtk_C 236 CGPPLSDLLKGMLEYEPA-KRFSIRQIRQHSWFRKKHP 272 (305)
T ss_dssp SCHHHHHHHHHHTCSSTT-TSCCHHHHHHSHHHHSCCC
T ss_pred cCHHHHHHHHHHccCChh-hCCCHHHHhcCcccccCCC
Confidence 12222 33677 8999999999999976543
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-41 Score=289.30 Aligned_cols=251 Identities=25% Similarity=0.353 Sum_probs=200.1
Q ss_pred CccCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCC
Q 021306 34 PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKN 107 (314)
Q Consensus 34 ~~~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 107 (314)
|...++|++.+.||+|+||.||++++..+++.|++|.+.... ....+|+.++++++||||+++++++....
T Consensus 2 p~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--- 78 (279)
T 2w5a_A 2 PSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRT--- 78 (279)
T ss_dssp -CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGG---
T ss_pred CCchhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCC---
Confidence 456679999999999999999999999999999999986432 23458999999999999999999875432
Q ss_pred ceeEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCC-----ceecCCCCCcEEEcCCCCcEE
Q 021306 108 ELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR-----VCHRDLKPQNLLVDPLTHQVK 181 (314)
Q Consensus 108 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~-----i~h~dl~p~Nil~~~~~~~~~ 181 (314)
....++||||+++ +|.+.+.........+++..++.++.|++.||.+||+ +| ++|+||+|+||+++. ++.++
T Consensus 79 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~~~~~~ivH~dl~p~NIl~~~-~~~~k 156 (279)
T 2w5a_A 79 NTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR-RSDGGHTVLHRDLKPANVFLDG-KQNVK 156 (279)
T ss_dssp GTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH-HC------CCCCCSGGGEEECS-SSCEE
T ss_pred CceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhc-ccCCCCeeEEeccchhhEEEcC-CCCEE
Confidence 2347899999986 8888887655556679999999999999999999999 88 999999999999998 78899
Q ss_pred EeecCcccccccCCc-cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCC
Q 021306 182 ICDFGSAKQLIAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 260 (314)
Q Consensus 182 l~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~ 260 (314)
|+|||.+........ .....+++.|+|||.+.+.. ++.++||||||+++|+|++|+.||...+..+....+.......
T Consensus 157 l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~ 235 (279)
T 2w5a_A 157 LGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMS-YNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRR 235 (279)
T ss_dssp ECCCCHHHHC---CHHHHHHHSCCTTCCHHHHHCC--CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC
T ss_pred EecCchheeeccccccccccCCCccccChHHhccCC-CCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhccccc
Confidence 999999876543221 22356789999999997654 8899999999999999999999999888766666555543221
Q ss_pred C-----H---HHHh---ccCCCCCCCcccccccCChhhhhcc
Q 021306 261 T-----R---EEIR---CMNPNYTDFRFPQIKAHPWHKVCIF 291 (314)
Q Consensus 261 ~-----~---~~~~---~~~p~~~~~~~~~l~~~p~~~~~~~ 291 (314)
. . +.+. ..+|. +|+++.+|++|+|...+..
T Consensus 236 ~~~~~~~~l~~li~~~l~~~p~-~Rps~~~ll~~~~~~~~~~ 276 (279)
T 2w5a_A 236 IPYRYSDELNEIITRMLNLKDY-HRPSVEEILENPLILEHHH 276 (279)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGG-GSCCHHHHHTSTTCCGGGS
T ss_pred CCcccCHHHHHHHHHHcCCCcc-cCCCHHHHHhChhhhhhcc
Confidence 1 1 1122 23566 7999999999999877653
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=293.74 Aligned_cols=243 Identities=27% Similarity=0.435 Sum_probs=194.5
Q ss_pred CCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc----------cchHHHHHHHHhCCCCceeeeceeeeecCCC
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----------RYKNRELQLMRVMDHPNVISLKHCFFSTTSK 106 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~----------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 106 (314)
.++|++.+.||+|+||.||+|++..+++.+++|.++... ....+|+.++++++||||+++++++...
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--- 80 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENK--- 80 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS---
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCC---
Confidence 357999999999999999999999999999999986432 2346899999999999999999988543
Q ss_pred CceeEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCC----cEE
Q 021306 107 NELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH----QVK 181 (314)
Q Consensus 107 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~----~~~ 181 (314)
...++||||+++ +|.+.+.. ...+++.+++.++.|++.||.+||+ +|++|+||+|+||+++. ++ .++
T Consensus 81 --~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~Nil~~~-~~~~~~~~k 152 (283)
T 3bhy_A 81 --TDVVLILELVSGGELFDFLAE----KESLTEDEATQFLKQILDGVHYLHS-KRIAHFDLKPENIMLLD-KNVPNPRIK 152 (283)
T ss_dssp --SEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEESC-SSSSSCCEE
T ss_pred --CeEEEEEeecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCChHHEEEec-CCCCCCceE
Confidence 348899999974 77776653 4679999999999999999999999 89999999999999987 44 799
Q ss_pred EeecCcccccccCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCC
Q 021306 182 ICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 261 (314)
Q Consensus 182 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~ 261 (314)
|+|||.+.............+++.|+|||.+.+.. ++.++||||||+++|+|++|..||.+.+..+....+........
T Consensus 153 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T 3bhy_A 153 LIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYEP-LGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFD 231 (283)
T ss_dssp ECCCTTCEECC--------CCCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCC
T ss_pred EEecccceeccCCCcccccCCCcCccCcceecCCC-CCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCc
Confidence 99999998665444444556789999999986544 89999999999999999999999999887776666554322222
Q ss_pred H-----------HHHh-c--cCCCCCCCcccccccCChhhhhccc
Q 021306 262 R-----------EEIR-C--MNPNYTDFRFPQIKAHPWHKVCIFH 292 (314)
Q Consensus 262 ~-----------~~~~-~--~~p~~~~~~~~~l~~~p~~~~~~~~ 292 (314)
. +.+. + .+|. +|+++.++++|||++....+
T Consensus 232 ~~~~~~~~~~~~~li~~~l~~dp~-~Rps~~~~l~h~~~~~~~~~ 275 (283)
T 3bhy_A 232 EEYFSNTSELAKDFIRRLLVKDPK-RRMTIAQSLEHSWIKAIRRR 275 (283)
T ss_dssp HHHHTTCCHHHHHHHHTTSCSSGG-GSCCHHHHHHCHHHHHHHHC
T ss_pred chhcccCCHHHHHHHHHHccCCHh-HCcCHHHHHhCHHHHHHHHH
Confidence 1 1122 2 2566 89999999999999876554
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=293.68 Aligned_cols=244 Identities=25% Similarity=0.474 Sum_probs=195.8
Q ss_pred cCCCceeeeeEeecCceEEEEEEE-CCCCcEEEEEEeeccc---cchHHHHHHHHhCCCC------ceeeeceeeeecCC
Q 021306 36 QTISYMAERVVGTGSFGIVFQAKC-LETGETVAIKKVLQDR---RYKNRELQLMRVMDHP------NVISLKHCFFSTTS 105 (314)
Q Consensus 36 ~~~~y~~~~~Lg~g~~g~Vy~~~~-~~~~~~~~vK~~~~~~---~~~~~e~~~l~~l~h~------~iv~~~~~~~~~~~ 105 (314)
..++|++.+.||+|+||.||+|.+ ..+++.||+|.++... ....+|+.+++.++|+ +++++++++....
T Consensus 12 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~- 90 (339)
T 1z57_A 12 LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHG- 90 (339)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETT-
T ss_pred ccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCC-
Confidence 346899999999999999999998 5588999999987543 3345788888888655 4889988874433
Q ss_pred CCceeEEEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCC---------
Q 021306 106 KNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPL--------- 176 (314)
Q Consensus 106 ~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~--------- 176 (314)
..++||||+++++.+.+... ...++++..++.++.||+.||.|||+ +||+|+||||+||+++..
T Consensus 91 ----~~~lv~e~~~~~l~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dlkp~Nil~~~~~~~~~~~~~ 163 (339)
T 1z57_A 91 ----HICIVFELLGLSTYDFIKEN--GFLPFRLDHIRKMAYQICKSVNFLHS-NKLTHTDLKPENILFVQSDYTEAYNPK 163 (339)
T ss_dssp ----EEEEEEECCCCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESCCCEEEEEC--
T ss_pred ----cEEEEEcCCCCCHHHHHHhc--CCCCCcHHHHHHHHHHHHHHHHHHHH-CCCcCCCCCHHHEEEeccccccccCCc
Confidence 48899999988998887652 23478999999999999999999999 899999999999999863
Q ss_pred ---------CCcEEEeecCcccccccCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChH
Q 021306 177 ---------THQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV 247 (314)
Q Consensus 177 ---------~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~ 247 (314)
++.++|+|||++..... ......+|+.|+|||.+.+.. ++.++||||||+++|+|++|..||...+..
T Consensus 164 ~~~~~~~~~~~~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~pf~~~~~~ 240 (339)
T 1z57_A 164 IKRDERTLINPDIKVVDFGSATYDDE--HHSTLVSTRHYRAPEVILALG-WSQPCDVWSIGCILIEYYLGFTVFPTHDSK 240 (339)
T ss_dssp --CEEEEESCCCEEECCCSSCEETTS--CCCSSCSCGGGCCHHHHTTSC-CCTHHHHHHHHHHHHHHHHSSCSCCCSCHH
T ss_pred cccccccccCCCceEeeCcccccCcc--ccccccCCccccChHHhhCCC-CCcchhhHHHHHHHHHHHhCCCCCCCCChH
Confidence 34699999999875432 233456799999999997654 899999999999999999999999998887
Q ss_pred HHHHHHHHHcCCCCH---------------------------------------------------HHHh---ccCCCCC
Q 021306 248 DQLVEIIKVLGTPTR---------------------------------------------------EEIR---CMNPNYT 273 (314)
Q Consensus 248 ~~~~~i~~~~~~~~~---------------------------------------------------~~~~---~~~p~~~ 273 (314)
+....+.+..+..+. +.+. ..+|. +
T Consensus 241 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~-~ 319 (339)
T 1z57_A 241 EHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPA-K 319 (339)
T ss_dssp HHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTT-T
T ss_pred HHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcc-c
Confidence 766666554443322 1222 33677 8
Q ss_pred CCcccccccCChhhhhcc
Q 021306 274 DFRFPQIKAHPWHKVCIF 291 (314)
Q Consensus 274 ~~~~~~l~~~p~~~~~~~ 291 (314)
|+++.++++|||++....
T Consensus 320 Rpt~~ell~hp~f~~~~~ 337 (339)
T 1z57_A 320 RITLREALKHPFFDLLKK 337 (339)
T ss_dssp SCCHHHHTTSGGGGGGGC
T ss_pred ccCHHHHhcCHHHHHHhc
Confidence 999999999999986543
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-41 Score=292.23 Aligned_cols=240 Identities=25% Similarity=0.393 Sum_probs=196.0
Q ss_pred CCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeEE
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 112 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 112 (314)
.++|++.+.||+|+||.||+|++..+|+.|++|.+.... ....+|+.++++++||||+++++++.. ....+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~ 82 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYES-----TTHYY 82 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEEC-----SSEEE
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhccc-----CCEEE
Confidence 458999999999999999999999999999999987542 334689999999999999999998843 33488
Q ss_pred EEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEE---cCCCCcEEEeecCcc
Q 021306 113 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLV---DPLTHQVKICDFGSA 188 (314)
Q Consensus 113 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~---~~~~~~~~l~dfg~~ 188 (314)
++|||+++ +|.+.+.. ...+++..++.++.|++.||.+||+ +|++|+||+|+||++ +. ++.++|+|||.+
T Consensus 83 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dikp~NIl~~~~~~-~~~~kl~Dfg~~ 156 (304)
T 2jam_A 83 LVMQLVSGGELFDRILE----RGVYTEKDASLVIQQVLSAVKYLHE-NGIVHRDLKPENLLYLTPEE-NSKIMITDFGLS 156 (304)
T ss_dssp EEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCSCCGGGCEESSSST-TCCEEBCSCSTT
T ss_pred EEEEcCCCccHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEEecCCC-CCCEEEccCCcc
Confidence 99999985 77776654 3679999999999999999999999 899999999999999 44 778999999998
Q ss_pred cccccCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCC-------
Q 021306 189 KQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT------- 261 (314)
Q Consensus 189 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~------- 261 (314)
..... .......+++.|+|||.+.+.. ++.++||||||+++|+|++|..||.+.+.......+.+......
T Consensus 157 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 234 (304)
T 2jam_A 157 KMEQN-GIMSTACGTPGYVAPEVLAQKP-YSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDI 234 (304)
T ss_dssp CCCCC-BTTHHHHSCCCBCCTTTBSSCS-CCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTS
T ss_pred eecCC-CccccccCCCCccChHHhccCC-CCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccC
Confidence 75432 2233456799999999996544 89999999999999999999999999887776666665432211
Q ss_pred -H---HHHh---ccCCCCCCCcccccccCChhhhhc
Q 021306 262 -R---EEIR---CMNPNYTDFRFPQIKAHPWHKVCI 290 (314)
Q Consensus 262 -~---~~~~---~~~p~~~~~~~~~l~~~p~~~~~~ 290 (314)
. +.+. ..+|. +|+++.++++|||++...
T Consensus 235 ~~~~~~li~~~l~~dp~-~Rps~~~~l~h~~~~~~~ 269 (304)
T 2jam_A 235 SESAKDFICHLLEKDPN-ERYTCEKALSHPWIDGNT 269 (304)
T ss_dssp CHHHHHHHHHHHCSSTT-TSCCHHHHHTSHHHHSSC
T ss_pred CHHHHHHHHHHcCCChh-HCcCHHHHhcCccccCCC
Confidence 1 1122 33677 899999999999998654
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=298.04 Aligned_cols=250 Identities=24% Similarity=0.347 Sum_probs=195.0
Q ss_pred ccCCCceee-eeEeecCceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhCC-CCceeeeceeeeecCCC
Q 021306 35 KQTISYMAE-RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMD-HPNVISLKHCFFSTTSK 106 (314)
Q Consensus 35 ~~~~~y~~~-~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~------~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~ 106 (314)
...+.|.+. +.||+|+||.||+|++..+++.||+|.+.... ....+|+.+++++. ||||+++++++..
T Consensus 25 ~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~---- 100 (327)
T 3lm5_A 25 NFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYEN---- 100 (327)
T ss_dssp HHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEEC----
T ss_pred hhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEe----
Confidence 344678888 89999999999999999999999999986532 23457888898884 6999999999843
Q ss_pred CceeEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcC--CCCcEEEe
Q 021306 107 NELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP--LTHQVKIC 183 (314)
Q Consensus 107 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~--~~~~~~l~ 183 (314)
....++||||+.+ +|.+.+.. .....+++.+++.++.||+.||.|||+ +||+||||||+||+++. .++.++|+
T Consensus 101 -~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~i~~ql~~~L~~LH~-~givH~Dikp~NIl~~~~~~~~~~kL~ 176 (327)
T 3lm5_A 101 -TSEIILILEYAAGGEIFSLCLP--ELAEMVSENDVIRLIKQILEGVYYLHQ-NNIVHLDLKPQNILLSSIYPLGDIKIV 176 (327)
T ss_dssp -SSEEEEEEECCTTEEGGGGGSS--CC-CCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEESCBTTBCCEEEC
T ss_pred -CCeEEEEEEecCCCcHHHHHHH--hcccCCCHHHHHHHHHHHHHHHHHHHH-CCeecCcCChHHEEEecCCCCCcEEEe
Confidence 3348899999997 54443321 224679999999999999999999999 89999999999999986 24689999
Q ss_pred ecCcccccccCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCH-
Q 021306 184 DFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR- 262 (314)
Q Consensus 184 dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~- 262 (314)
|||++.............+++.|+|||.+.+.. ++.++||||||+++|+|++|+.||.+.+..+....+.+.......
T Consensus 177 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 255 (327)
T 3lm5_A 177 DFGMSRKIGHACELREIMGTPEYLAPEILNYDP-ITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEE 255 (327)
T ss_dssp CGGGCEEC---------CCCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT
T ss_pred eCccccccCCccccccccCCcCccCCeeecCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCch
Confidence 999998765544445567899999999996554 899999999999999999999999998888777776664333221
Q ss_pred ----------HHHh---ccCCCCCCCcccccccCChhhhhcccCC
Q 021306 263 ----------EEIR---CMNPNYTDFRFPQIKAHPWHKVCIFHFP 294 (314)
Q Consensus 263 ----------~~~~---~~~p~~~~~~~~~l~~~p~~~~~~~~~~ 294 (314)
+.+. ..+|. +|+++.++++|||++....+..
T Consensus 256 ~~~~~~~~~~~li~~~L~~dP~-~Rpt~~~ll~h~~~~~~~~~~~ 299 (327)
T 3lm5_A 256 TFSSVSQLATDFIQSLLVKNPE-KRPTAEICLSHSWLQQWDFENL 299 (327)
T ss_dssp TTTTSCHHHHHHHHHHSCSSGG-GSCCHHHHTTCGGGCCCCTTCC
T ss_pred hhcccCHHHHHHHHHHcCCChh-hCcCHHHHhCCHhhcccccccc
Confidence 1122 23666 8999999999999987665443
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=296.64 Aligned_cols=243 Identities=25% Similarity=0.446 Sum_probs=195.7
Q ss_pred CCCceeeeeEeecCceEEEEEEECCCC-cEEEEEEeeccc---cchHHHHHHHHhCCCCc------eeeeceeeeecCCC
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCLETG-ETVAIKKVLQDR---RYKNRELQLMRVMDHPN------VISLKHCFFSTTSK 106 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~~~~-~~~~vK~~~~~~---~~~~~e~~~l~~l~h~~------iv~~~~~~~~~~~~ 106 (314)
.++|++.+.||+|+||.||+|.+..++ +.||+|.++... ....+|+.++++++|++ ++.+.+++....
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~-- 95 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHG-- 95 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETT--
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCC--
Confidence 468999999999999999999998776 789999987542 33457888998887655 778777774332
Q ss_pred CceeEEEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcC-----------
Q 021306 107 NELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP----------- 175 (314)
Q Consensus 107 ~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~----------- 175 (314)
..++||||+++++.+.+... ....+++.+++.++.||+.||.|||+ +||+|+||||+||+++.
T Consensus 96 ---~~~lv~e~~~~~l~~~l~~~--~~~~~~~~~~~~i~~qi~~~L~~lH~-~~ivH~Dlkp~NIll~~~~~~~~~~~~~ 169 (355)
T 2eu9_A 96 ---HMCIAFELLGKNTFEFLKEN--NFQPYPLPHVRHMAYQLCHALRFLHE-NQLTHTDLKPENILFVNSEFETLYNEHK 169 (355)
T ss_dssp ---EEEEEEECCCCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCCGGGEEESCCCEEEEECCC-
T ss_pred ---eEEEEEeccCCChHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEEecccccccccccc
Confidence 48899999999988877652 23579999999999999999999999 89999999999999932
Q ss_pred -------CCCcEEEeecCcccccccCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHH
Q 021306 176 -------LTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVD 248 (314)
Q Consensus 176 -------~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~ 248 (314)
.++.++|+|||++..... ......+|+.|+|||.+.+.. ++.++||||||+++|+|++|..||.+.+..+
T Consensus 170 ~~~~~~~~~~~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 246 (355)
T 2eu9_A 170 SCEEKSVKNTSIRVADFGSATFDHE--HHTTIVATRHYRPPEVILELG-WAQPCDVWSIGCILFEYYRGFTLFQTHENRE 246 (355)
T ss_dssp CCCEEEESCCCEEECCCTTCEETTS--CCCSSCSCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred cccccccCCCcEEEeecCccccccc--cccCCcCCCcccCCeeeecCC-CCCccchHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 267899999999975432 223456799999999997654 8999999999999999999999999988877
Q ss_pred HHHHHHHHcCCCCH---------------------------------------------------HHHh---ccCCCCCC
Q 021306 249 QLVEIIKVLGTPTR---------------------------------------------------EEIR---CMNPNYTD 274 (314)
Q Consensus 249 ~~~~i~~~~~~~~~---------------------------------------------------~~~~---~~~p~~~~ 274 (314)
.+..+.+..+..+. +.+. ..+|. +|
T Consensus 247 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~-~R 325 (355)
T 2eu9_A 247 HLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPA-QR 325 (355)
T ss_dssp HHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTT-TS
T ss_pred HHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChh-hC
Confidence 77666655544332 1122 33677 89
Q ss_pred CcccccccCChhhhhcc
Q 021306 275 FRFPQIKAHPWHKVCIF 291 (314)
Q Consensus 275 ~~~~~l~~~p~~~~~~~ 291 (314)
+++.++++|||++....
T Consensus 326 pt~~e~l~hp~f~~~~~ 342 (355)
T 2eu9_A 326 ITLAEALLHPFFAGLTP 342 (355)
T ss_dssp CCHHHHTTSGGGGGCCH
T ss_pred cCHHHHhcChhhcCCCh
Confidence 99999999999987543
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=289.44 Aligned_cols=254 Identities=26% Similarity=0.389 Sum_probs=199.1
Q ss_pred cCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc--cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeEEE
Q 021306 36 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR--RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 113 (314)
Q Consensus 36 ~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~--~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 113 (314)
..++|++.+.||+|+||.||+|.+..+|+.|++|.+.... ....+|+.++++++||||+++++++.... ..++
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~l 101 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNT-----DLWI 101 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSCCHHHHHHHHHHHTCCCTTBCCEEEEEEETT-----EEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCC-----EEEE
Confidence 3468999999999999999999999999999999987543 34568999999999999999999885433 3789
Q ss_pred Eeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcccccc
Q 021306 114 VMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 192 (314)
Q Consensus 114 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~ 192 (314)
||||+++ +|.+.+.. ....+++..++.++.|++.||.+||+ .|++|+||+|+||+++. ++.++|+|||.+....
T Consensus 102 v~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~-~~i~H~dl~p~Nil~~~-~~~~kl~dfg~~~~~~ 176 (314)
T 3com_A 102 VMEYCGAGSVSDIIRL---RNKTLTEDEIATILQSTLKGLEYLHF-MRKIHRDIKAGNILLNT-EGHAKLADFGVAGQLT 176 (314)
T ss_dssp EEECCTTEEHHHHHHH---HTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECT-TCCEEECCCTTCEECB
T ss_pred EeecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh-CCCcCCCcCHHHEEECC-CCCEEEeecccchhhh
Confidence 9999987 67666642 35789999999999999999999999 89999999999999998 7889999999997654
Q ss_pred cCC-ccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCC----------
Q 021306 193 AGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT---------- 261 (314)
Q Consensus 193 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~---------- 261 (314)
... ......+++.|+|||.+.+.. ++.++||||||+++|+|++|+.||...+.......+........
T Consensus 177 ~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 255 (314)
T 3com_A 177 DTMAKRNTVIGTPFWMAPEVIQEIG-YNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNF 255 (314)
T ss_dssp TTBSCBCCCCSCGGGCCHHHHSSSC-BCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHH
T ss_pred hhccccCccCCCCCccChhhcCCCC-CCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCCcccCCHHH
Confidence 332 223456788999999996654 88999999999999999999999998887666555444322111
Q ss_pred HHHHh---ccCCCCCCCcccccccCChhhhhcccCChHHHHHh
Q 021306 262 REEIR---CMNPNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEY 301 (314)
Q Consensus 262 ~~~~~---~~~p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~ 301 (314)
.+.+. ..+|. +|+++.++++|||++..........+++.
T Consensus 256 ~~li~~~l~~dp~-~Rpt~~~ll~~~~~~~~~~~~~~~~~~~~ 297 (314)
T 3com_A 256 TDFVKQCLVKSPE-QRATATQLLQHPFVRSAKGVSILRDLINE 297 (314)
T ss_dssp HHHHHHHTCSCTT-TSCCHHHHTTSHHHHTCCCGGGGHHHHHH
T ss_pred HHHHHHHccCChh-hCcCHHHHHhCHHHhcCCcchHHHHHhhh
Confidence 11222 23676 89999999999999987765555555444
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=288.24 Aligned_cols=241 Identities=27% Similarity=0.403 Sum_probs=196.6
Q ss_pred CCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeE
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 111 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 111 (314)
.+.|++.+.||+|+||.||+|++..+++.|++|.+.... ....+|+.++++++|+||+++++++.... ..
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~ 95 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDT-----KL 95 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETT-----EE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-----eE
Confidence 356999999999999999999999999999999986442 33468999999999999999999885433 38
Q ss_pred EEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcccc
Q 021306 112 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 190 (314)
Q Consensus 112 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~ 190 (314)
++||||+++ +|.+.+. ..++++..++.++.|++.||.+||+ +|++|+||+|+||+++. ++.++|+|||.+..
T Consensus 96 ~lv~e~~~~~~L~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~Nil~~~-~~~~kl~Dfg~~~~ 168 (303)
T 3a7i_A 96 WIIMEYLGGGSALDLLE-----PGPLDETQIATILREILKGLDYLHS-EKKIHRDIKAANVLLSE-HGEVKLADFGVAGQ 168 (303)
T ss_dssp EEEEECCTTEEHHHHHT-----TSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECT-TSCEEECCCTTCEE
T ss_pred EEEEEeCCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCccCCCChheEEECC-CCCEEEeeccccee
Confidence 899999987 6666554 3679999999999999999999999 89999999999999998 78899999999976
Q ss_pred cccCC-ccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCC--------
Q 021306 191 LIAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT-------- 261 (314)
Q Consensus 191 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~-------- 261 (314)
..... ......+++.|+|||.+.+.. ++.++||||||+++|+|++|+.||...........+.+......
T Consensus 169 ~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 247 (303)
T 3a7i_A 169 LTDTQIKRNTFVGTPFWMAPEVIKQSA-YDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPL 247 (303)
T ss_dssp CBTTBCCBCCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCSSCCHHH
T ss_pred cCccccccCccCCCcCccCHHHHhcCC-CCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCCCCccccCHHH
Confidence 54332 223456788999999996554 78999999999999999999999998887766655544332211
Q ss_pred HHHHh-c--cCCCCCCCcccccccCChhhhhcc
Q 021306 262 REEIR-C--MNPNYTDFRFPQIKAHPWHKVCIF 291 (314)
Q Consensus 262 ~~~~~-~--~~p~~~~~~~~~l~~~p~~~~~~~ 291 (314)
.+.+. + .+|. +|+++.++++|||+.....
T Consensus 248 ~~li~~~l~~dp~-~Rps~~~ll~~~~~~~~~~ 279 (303)
T 3a7i_A 248 KEFVEACLNKEPS-FRPTAKELLKHKFILRNAK 279 (303)
T ss_dssp HHHHHHHCCSSGG-GSCCHHHHTTCHHHHHHCC
T ss_pred HHHHHHHcCCChh-hCcCHHHHhhChhhhcCCC
Confidence 11222 2 3666 8999999999999977654
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=296.92 Aligned_cols=243 Identities=27% Similarity=0.457 Sum_probs=190.9
Q ss_pred CCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc------------cchHHHHHHHHhCCCCceeeeceeeeecC
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------------RYKNRELQLMRVMDHPNVISLKHCFFSTT 104 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~------------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 104 (314)
.++|++.+.||+|+||.||+|++..+++.||+|.+.... ....+|+.++++++||||+++++++.. .
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~ 87 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-E 87 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEES-S
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcC-C
Confidence 368999999999999999999999999999999986432 234689999999999999999988732 1
Q ss_pred CCCceeEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCC--CcEE
Q 021306 105 SKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLT--HQVK 181 (314)
Q Consensus 105 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~--~~~~ 181 (314)
. .++||||+++ +|.+.+. ....+++..++.++.||+.||.|||+ +|++|+||||+||+++..+ ..++
T Consensus 88 ~-----~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~NIl~~~~~~~~~~k 157 (322)
T 2ycf_A 88 D-----YYIVLELMEGGELFDKVV----GNKRLKEATCKLYFYQMLLAVQYLHE-NGIIHRDLKPENVLLSSQEEDCLIK 157 (322)
T ss_dssp S-----EEEEEECCTTEETHHHHS----TTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEESSSSSSCCEE
T ss_pred c-----eEEEEecCCCCcHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHEEEecCCCCCeEE
Confidence 1 6799999986 6666554 35789999999999999999999999 8999999999999998622 2499
Q ss_pred EeecCcccccccCCcccccccccccccccccc--CCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCC
Q 021306 182 ICDFGSAKQLIAGEANISYICSRFYRAPELIF--GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT 259 (314)
Q Consensus 182 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~ 259 (314)
|+|||++.............+++.|+|||.+. +...++.++||||||+++|+|++|..||........+...+.....
T Consensus 158 l~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 237 (322)
T 2ycf_A 158 ITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKY 237 (322)
T ss_dssp ECCCTTCEECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCC
T ss_pred EccCccceecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCcc
Confidence 99999998664443334456799999999974 2345789999999999999999999999876544333333332211
Q ss_pred -CCH-----------HHHh---ccCCCCCCCcccccccCChhhhhcc
Q 021306 260 -PTR-----------EEIR---CMNPNYTDFRFPQIKAHPWHKVCIF 291 (314)
Q Consensus 260 -~~~-----------~~~~---~~~p~~~~~~~~~l~~~p~~~~~~~ 291 (314)
..+ +.+. ..+|. +|+++.++++|||++....
T Consensus 238 ~~~~~~~~~~~~~~~~li~~~l~~dP~-~Rps~~~~l~h~~~~~~~~ 283 (322)
T 2ycf_A 238 NFIPEVWAEVSEKALDLVKKLLVVDPK-ARFTTEEALRHPWLQDEDM 283 (322)
T ss_dssp CCCHHHHTTSCHHHHHHHHHHSCSSTT-TSCCHHHHHTSGGGCCHHH
T ss_pred ccCchhhhhcCHHHHHHHHHHcccCHh-hCCCHHHHhhCcCcCCHHH
Confidence 111 1122 33677 8999999999999987664
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-41 Score=297.74 Aligned_cols=247 Identities=25% Similarity=0.436 Sum_probs=189.7
Q ss_pred CCCccCCCceeeeeEeecCceEEEEEEEC---CCCcEEEEEEeeccc--------cchHHHHHHHHhC-CCCceeeecee
Q 021306 32 GEPKQTISYMAERVVGTGSFGIVFQAKCL---ETGETVAIKKVLQDR--------RYKNRELQLMRVM-DHPNVISLKHC 99 (314)
Q Consensus 32 ~~~~~~~~y~~~~~Lg~g~~g~Vy~~~~~---~~~~~~~vK~~~~~~--------~~~~~e~~~l~~l-~h~~iv~~~~~ 99 (314)
......++|++.+.||+|+||.||+|++. .+++.||+|.++... ....+|+.+++.+ .|+||++++++
T Consensus 48 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 127 (355)
T 1vzo_A 48 AEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYA 127 (355)
T ss_dssp CCCCCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEE
T ss_pred cccccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEE
Confidence 33445579999999999999999999984 489999999886432 3345789999999 69999999998
Q ss_pred eeecCCCCceeEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCC
Q 021306 100 FFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH 178 (314)
Q Consensus 100 ~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~ 178 (314)
+.... .+++||||+++ +|.+.+.. ...+++..++.++.||+.||.|||+ +||+|+||||+||+++. ++
T Consensus 128 ~~~~~-----~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~-~~ 196 (355)
T 1vzo_A 128 FQTET-----KLHLILDYINGGELFTHLSQ----RERFTEHEVQIYVGEIVLALEHLHK-LGIIYRDIKLENILLDS-NG 196 (355)
T ss_dssp EEETT-----EEEEEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECT-TS
T ss_pred EeeCc-----eEEEEeecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECC-CC
Confidence 85433 38899999986 77776654 3679999999999999999999999 89999999999999998 88
Q ss_pred cEEEeecCcccccccCC--ccccccccccccccccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCh----HHHHH
Q 021306 179 QVKICDFGSAKQLIAGE--ANISYICSRFYRAPELIFGA-TEYTTSIDIWSAGCVLAELLLGQPLFPGENA----VDQLV 251 (314)
Q Consensus 179 ~~~l~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~el~tg~~pf~~~~~----~~~~~ 251 (314)
.++|+|||++....... ......+|+.|+|||.+.+. ..++.++||||||+++|+|++|+.||..... .....
T Consensus 197 ~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~ 276 (355)
T 1vzo_A 197 HVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISR 276 (355)
T ss_dssp CEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHH
T ss_pred cEEEeeCCCCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHH
Confidence 99999999987553322 22345689999999999753 3478899999999999999999999975432 22222
Q ss_pred HHHHHcCCCC-------HHHHh---ccCCCCCCC-----cccccccCChhhhhc
Q 021306 252 EIIKVLGTPT-------REEIR---CMNPNYTDF-----RFPQIKAHPWHKVCI 290 (314)
Q Consensus 252 ~i~~~~~~~~-------~~~~~---~~~p~~~~~-----~~~~l~~~p~~~~~~ 290 (314)
.+.......+ .+.+. ..+|. +|+ +++++++|||++...
T Consensus 277 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~-~R~~~~~~s~~ell~h~~f~~~~ 329 (355)
T 1vzo_A 277 RILKSEPPYPQEMSALAKDLIQRLLMKDPK-KRLGCGPRDADEIKEHLFFQKIN 329 (355)
T ss_dssp HHHHCCCCCCTTSCHHHHHHHHHHTCSSGG-GSTTSSTTTHHHHHTSGGGTTCC
T ss_pred HHhccCCCCCcccCHHHHHHHHHHhhhCHH-HhcCCCCCCHHHHHcCcchhcCC
Confidence 2222211111 11222 23666 788 999999999998654
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-41 Score=288.70 Aligned_cols=246 Identities=19% Similarity=0.208 Sum_probs=190.2
Q ss_pred CCccCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhC-CCCceeeeceeeeecCC
Q 021306 33 EPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVM-DHPNVISLKHCFFSTTS 105 (314)
Q Consensus 33 ~~~~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~------~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~ 105 (314)
.....++|++.+.||+|+||.||+|++..+++.|++|.+.... ....+|+..+..+ +||||+++++++....
T Consensus 6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~- 84 (289)
T 1x8b_A 6 KSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDD- 84 (289)
T ss_dssp CCHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETT-
T ss_pred cccccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCC-
Confidence 3445678999999999999999999999999999999987532 2234677788888 9999999999885433
Q ss_pred CCceeEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcC---------
Q 021306 106 KNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP--------- 175 (314)
Q Consensus 106 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~--------- 175 (314)
..++||||+++ +|.+.+.........+++.+++.++.||+.||.|||+ +||+|+||||+||+++.
T Consensus 85 ----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~Dikp~NIl~~~~~~~~~~~~ 159 (289)
T 1x8b_A 85 ----HMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHS-MSLVHMDIKPSNIFISRTSIPNAASE 159 (289)
T ss_dssp ----EEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEC----------
T ss_pred ----eEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHh-CCEeecCCCHHHEEEcCCCCCccccc
Confidence 48899999986 8888887655555789999999999999999999999 89999999999999984
Q ss_pred ---------CCCcEEEeecCcccccccCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCh
Q 021306 176 ---------LTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA 246 (314)
Q Consensus 176 ---------~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~ 246 (314)
....++|+|||.+....... ...+++.|+|||.+.+...++.++||||||+++|+|++|..|+.....
T Consensus 160 ~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~ 236 (289)
T 1x8b_A 160 EGDEDDWASNKVMFKIGDLGHVTRISSPQ---VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ 236 (289)
T ss_dssp ----------CCCEEECCCTTCEETTCSC---CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH
T ss_pred ccccccccCCceEEEEcccccccccCCcc---ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH
Confidence 14479999999987654332 345789999999997665567899999999999999999988755443
Q ss_pred HHHHHHHHHHcCCCC-----H---HHHh---ccCCCCCCCcccccccCChhhhhcc
Q 021306 247 VDQLVEIIKVLGTPT-----R---EEIR---CMNPNYTDFRFPQIKAHPWHKVCIF 291 (314)
Q Consensus 247 ~~~~~~i~~~~~~~~-----~---~~~~---~~~p~~~~~~~~~l~~~p~~~~~~~ 291 (314)
...+.+...... . +.+. ..+|. +|+++.++++|||++....
T Consensus 237 ---~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~-~Rps~~~ll~h~~~~~~~~ 288 (289)
T 1x8b_A 237 ---WHEIRQGRLPRIPQVLSQEFTELLKVMIHPDPE-RRPSAMALVKHSVLLSASR 288 (289)
T ss_dssp ---HHHHHTTCCCCCSSCCCHHHHHHHHHHTCSSGG-GSCCHHHHHTCTTC-----
T ss_pred ---HHHHHcCCCCCCCcccCHHHHHHHHHHhCCCcc-cCCCHHHHhhChHhhhhcc
Confidence 233332221111 1 1122 23666 8999999999999987543
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=296.74 Aligned_cols=252 Identities=31% Similarity=0.543 Sum_probs=196.8
Q ss_pred CCCccCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHhCC-----------CCceeeec
Q 021306 32 GEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMD-----------HPNVISLK 97 (314)
Q Consensus 32 ~~~~~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~---~~~~~e~~~l~~l~-----------h~~iv~~~ 97 (314)
+.+...++|++.+.||+|+||.||+|++..+++.||+|.+.... ....+|+.+++++. |+||++++
T Consensus 13 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~ 92 (373)
T 1q8y_A 13 GEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLL 92 (373)
T ss_dssp TCEETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCC
T ss_pred CCcccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHH
Confidence 34455679999999999999999999999999999999987543 33457888888875 88999999
Q ss_pred eeeeecCCCCceeEEEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCC-CceecCCCCCcEEEcC-
Q 021306 98 HCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP-RVCHRDLKPQNLLVDP- 175 (314)
Q Consensus 98 ~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~-~i~h~dl~p~Nil~~~- 175 (314)
+++.... ....++++++|++.++|.+.+... ....+++..++.++.||+.||.|||+ + ||+|+||||+||+++.
T Consensus 93 ~~~~~~~-~~~~~~~lv~e~~~~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~-~~~ivH~Dikp~NIll~~~ 168 (373)
T 1q8y_A 93 DHFNHKG-PNGVHVVMVFEVLGENLLALIKKY--EHRGIPLIYVKQISKQLLLGLDYMHR-RCGIIHTDIKPENVLMEIV 168 (373)
T ss_dssp EEEEEEE-TTEEEEEEEECCCCEEHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHHH-TTCEECSCCSGGGEEEEEE
T ss_pred HHhhccC-CCCceEEEEEecCCCCHHHHHHHh--hccCCcHHHHHHHHHHHHHHHHHHHh-cCCEEecCCChHHeEEecc
Confidence 9886543 234468899999988988888753 23569999999999999999999999 8 9999999999999953
Q ss_pred ----CCCcEEEeecCcccccccCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC------
Q 021306 176 ----LTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN------ 245 (314)
Q Consensus 176 ----~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~------ 245 (314)
....++|+|||++...... .....+|+.|+|||.+.+.. ++.++||||||+++|+|++|+.||.+.+
T Consensus 169 ~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~ 245 (373)
T 1q8y_A 169 DSPENLIQIKIADLGNACWYDEH--YTNSIQTREYRSPEVLLGAP-WGCGADIWSTACLIFELITGDFLFEPDEGHSYTK 245 (373)
T ss_dssp ETTTTEEEEEECCCTTCEETTBC--CCSCCSCGGGCCHHHHHTCC-CCTHHHHHHHHHHHHHHHHSSCCC---------C
T ss_pred CCCcCcceEEEcccccccccCCC--CCCCCCCccccCcHHHhCCC-CCchHhHHHHHHHHHHHHhCCCCCCCCcccccCC
Confidence 1347999999999765432 23456799999999997655 8999999999999999999999998654
Q ss_pred hHHHHHHHHHHcCCCCH-------------------------------------------------HHHh---ccCCCCC
Q 021306 246 AVDQLVEIIKVLGTPTR-------------------------------------------------EEIR---CMNPNYT 273 (314)
Q Consensus 246 ~~~~~~~i~~~~~~~~~-------------------------------------------------~~~~---~~~p~~~ 273 (314)
..+.+..+++..+..+. +.+. ..+|. +
T Consensus 246 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~-~ 324 (373)
T 1q8y_A 246 DDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPR-K 324 (373)
T ss_dssp HHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTT-T
T ss_pred hHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCcc-c
Confidence 33444555444333221 1222 23677 8
Q ss_pred CCcccccccCChhhhhcc
Q 021306 274 DFRFPQIKAHPWHKVCIF 291 (314)
Q Consensus 274 ~~~~~~l~~~p~~~~~~~ 291 (314)
|+++.++++|||++....
T Consensus 325 Rpt~~ell~hp~f~~~~~ 342 (373)
T 1q8y_A 325 RADAGGLVNHPWLKDTLG 342 (373)
T ss_dssp CBCHHHHHTCGGGTTCTT
T ss_pred cCCHHHHhhChhhhcccC
Confidence 999999999999987543
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=288.72 Aligned_cols=242 Identities=29% Similarity=0.458 Sum_probs=196.9
Q ss_pred CCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCCcee
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 110 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 110 (314)
.++|++.+.||+|++|.||+|++..+++.|++|.+.... ....+|+.++++++||||+++++++... ..
T Consensus 21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~ 95 (287)
T 2wei_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDS-----SS 95 (287)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECS-----SE
T ss_pred hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCC-----Ce
Confidence 458999999999999999999999999999999986432 2345899999999999999999988433 34
Q ss_pred EEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCC--CCcEEEeecCc
Q 021306 111 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPL--THQVKICDFGS 187 (314)
Q Consensus 111 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~--~~~~~l~dfg~ 187 (314)
.++++||+.+ +|.+.+.. ...+++.+++.++.||+.||.+||+ +|++|+||+|+||+++.. +..++|+|||+
T Consensus 96 ~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~-~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~ 170 (287)
T 2wei_A 96 FYIVGELYTGGELFDEIIK----RKRFSEHDAARIIKQVFSGITYMHK-HNIVHRDLKPENILLESKEKDCDIKIIDFGL 170 (287)
T ss_dssp EEEEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEESCSSTTCCEEECSTTG
T ss_pred EEEEEEccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCChhhEEEecCCCcccEEEeccCc
Confidence 8899999975 77666654 3679999999999999999999999 899999999999999763 34799999999
Q ss_pred ccccccCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCC------
Q 021306 188 AKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT------ 261 (314)
Q Consensus 188 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~------ 261 (314)
+.............+++.|+|||.+.+ . ++.++||||||+++|+|++|..||.+.+..+....+.+......
T Consensus 171 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (287)
T 2wei_A 171 STCFQQNTKMKDRIGTAYYIAPEVLRG-T-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRT 248 (287)
T ss_dssp GGTBCCCSSCSCHHHHHTTCCHHHHTT-C-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTT
T ss_pred ceeecCCCccccccCcccccChHHhcC-C-CCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhh
Confidence 886655444445567889999999864 3 78999999999999999999999999887776666655432211
Q ss_pred --H---HHHh---ccCCCCCCCcccccccCChhhhhcc
Q 021306 262 --R---EEIR---CMNPNYTDFRFPQIKAHPWHKVCIF 291 (314)
Q Consensus 262 --~---~~~~---~~~p~~~~~~~~~l~~~p~~~~~~~ 291 (314)
. +.+. ..+|. +|+++.++++|||++....
T Consensus 249 ~~~~~~~li~~~l~~dp~-~Rps~~ell~hp~~~~~~~ 285 (287)
T 2wei_A 249 ISDDAKDLIRKMLTFHPS-LRITATQCLEHPWIQKYSS 285 (287)
T ss_dssp SCHHHHHHHHHHTCSSGG-GSCCHHHHHHSHHHHHHCC
T ss_pred cCHHHHHHHHHHcccChh-hCcCHHHHhcCHHHhcccc
Confidence 1 1122 23666 8999999999999987654
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-41 Score=292.85 Aligned_cols=244 Identities=25% Similarity=0.368 Sum_probs=183.2
Q ss_pred cCCCceee-eeEeecCceEEEEEEECCCCcEEEEEEeeccc----cchHHHHHHHHhC-CCCceeeeceeeeecCCCCce
Q 021306 36 QTISYMAE-RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVM-DHPNVISLKHCFFSTTSKNEL 109 (314)
Q Consensus 36 ~~~~y~~~-~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~----~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~ 109 (314)
..+.|++. +.||+|+||.||+|++..+++.||+|.+.... ....+|+.+++++ +||||+++++++....
T Consensus 10 ~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~----- 84 (316)
T 2ac3_A 10 FEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEED----- 84 (316)
T ss_dssp TTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT-----
T ss_pred cceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCC-----
Confidence 45689996 78999999999999999999999999986543 2345888888884 7999999999985433
Q ss_pred eEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCC---cEEEeec
Q 021306 110 FLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH---QVKICDF 185 (314)
Q Consensus 110 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~---~~~l~df 185 (314)
.+++||||+++ +|.+.+.. ...+++..++.++.||+.||.|||+ +||+|+||||+||+++. ++ .++|+||
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~dlkp~Nil~~~-~~~~~~~kl~Df 158 (316)
T 2ac3_A 85 RFYLVFEKMRGGSILSHIHK----RRHFNELEASVVVQDVASALDFLHN-KGIAHRDLKPENILCEH-PNQVSPVKICDF 158 (316)
T ss_dssp EEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEESC-SSSSCSEEECCT
T ss_pred EEEEEEEcCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHh-CCceeCCCCHHHEEEcc-CCCcCceEEEEc
Confidence 48899999984 77776654 3679999999999999999999999 89999999999999987 44 3999999
Q ss_pred CcccccccCC--------ccccccccccccccccccC----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCh-------
Q 021306 186 GSAKQLIAGE--------ANISYICSRFYRAPELIFG----ATEYTTSIDIWSAGCVLAELLLGQPLFPGENA------- 246 (314)
Q Consensus 186 g~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~----~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~------- 246 (314)
|++....... ......+|+.|+|||.+.+ ...++.++||||||+++|+|++|+.||.+...
T Consensus 159 g~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~ 238 (316)
T 2ac3_A 159 DLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDR 238 (316)
T ss_dssp TCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC--
T ss_pred cCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccc
Confidence 9987543211 1123457899999999854 12368899999999999999999999987542
Q ss_pred --------HHHHHHHHHHcCCCCH-----------HHHh---ccCCCCCCCcccccccCChhhhhcc
Q 021306 247 --------VDQLVEIIKVLGTPTR-----------EEIR---CMNPNYTDFRFPQIKAHPWHKVCIF 291 (314)
Q Consensus 247 --------~~~~~~i~~~~~~~~~-----------~~~~---~~~p~~~~~~~~~l~~~p~~~~~~~ 291 (314)
......+.+.....+. +.+. ..+|. +|+++.++++|||++....
T Consensus 239 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~-~Rps~~e~l~hp~~~~~~~ 304 (316)
T 2ac3_A 239 GEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAK-QRLSAAQVLQHPWVQGCAP 304 (316)
T ss_dssp --CCHHHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTT-TSCCHHHHHHSTTCC----
T ss_pred cccchhHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChh-hCCCHHHHhcChhhcCCCC
Confidence 1222333322211111 1222 33677 8999999999999987654
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=300.32 Aligned_cols=240 Identities=24% Similarity=0.364 Sum_probs=185.7
Q ss_pred CCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhCC--CCceeeeceeeeecCCCCc
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMD--HPNVISLKHCFFSTTSKNE 108 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~------~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~~~~~ 108 (314)
+.+|++.+.||+|+||.||++.+. +++.||+|.+.... ....+|+.++++++ |+||+++++++...
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~----- 128 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD----- 128 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS-----
T ss_pred CCceEEEEEEccCCCeEEEEEEcC-CCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecC-----
Confidence 456999999999999999999975 48999999986543 23468999999996 59999999987533
Q ss_pred eeEEEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcc
Q 021306 109 LFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 188 (314)
Q Consensus 109 ~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~ 188 (314)
..+++|||+..++|.+.+.. ...+++.+++.++.||+.||.|||+ +||+||||||+||+++ ++.++|+|||++
T Consensus 129 ~~~~lv~E~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~-~~ivHrDlkp~NIll~--~~~~kl~DFG~a 201 (390)
T 2zmd_A 129 QYIYMVMECGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQ-HGIVHSDLKPANFLIV--DGMLKLIDFGIA 201 (390)
T ss_dssp SEEEEEEECCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHT-TTCCCCCCCGGGEEES--SSCEEECCCSSS
T ss_pred CEEEEEEecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCHHHEEEE--CCeEEEEecCcc
Confidence 34889999777788877764 4689999999999999999999999 8999999999999996 568999999999
Q ss_pred cccccCCc---cccccccccccccccccC----------CCCCCcchhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHH
Q 021306 189 KQLIAGEA---NISYICSRFYRAPELIFG----------ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV-DQLVEII 254 (314)
Q Consensus 189 ~~~~~~~~---~~~~~~~~~y~aPE~~~~----------~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~-~~~~~i~ 254 (314)
........ .....+|+.|+|||.+.+ ...++.++||||||+++|+|++|+.||.+.... ..+..++
T Consensus 202 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~ 281 (390)
T 2zmd_A 202 NQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII 281 (390)
T ss_dssp CCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHH
T ss_pred ccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHh
Confidence 86543321 234568999999999864 134789999999999999999999999876433 3344443
Q ss_pred HHcCC---C---CH---HHHh---ccCCCCCCCcccccccCChhhhhc
Q 021306 255 KVLGT---P---TR---EEIR---CMNPNYTDFRFPQIKAHPWHKVCI 290 (314)
Q Consensus 255 ~~~~~---~---~~---~~~~---~~~p~~~~~~~~~l~~~p~~~~~~ 290 (314)
..... + .. +.+. ..+|. +|+++.++++|||++...
T Consensus 282 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~-~Rps~~ell~hp~~~~~~ 328 (390)
T 2zmd_A 282 DPNHEIEFPDIPEKDLQDVLKCCLKRDPK-QRISIPELLAHPYVQIQT 328 (390)
T ss_dssp CTTSCCCCCCCSCHHHHHHHHHHTCSSTT-TSCCHHHHHTSHHHHSCC
T ss_pred CccccCCCCccchHHHHHHHHHHcccChh-hCCCHHHHhhCcCccccC
Confidence 22111 0 11 1222 33677 899999999999998543
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-41 Score=299.82 Aligned_cols=263 Identities=14% Similarity=0.114 Sum_probs=195.2
Q ss_pred cCCCceeeeeEeecCceEEEEEEECCC-----CcEEEEEEeeccccchHHH---------------HHHHHhCCCCceee
Q 021306 36 QTISYMAERVVGTGSFGIVFQAKCLET-----GETVAIKKVLQDRRYKNRE---------------LQLMRVMDHPNVIS 95 (314)
Q Consensus 36 ~~~~y~~~~~Lg~g~~g~Vy~~~~~~~-----~~~~~vK~~~~~~~~~~~e---------------~~~l~~l~h~~iv~ 95 (314)
..++|++.+.||+|+||.||+|.+..+ ++.||+|.+........+| ...++.++|+||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 345899999999999999999998764 5889999987655433333 33455668999999
Q ss_pred eceeeeecCCCCceeEEEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEc-
Q 021306 96 LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVD- 174 (314)
Q Consensus 96 ~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~- 174 (314)
+++++.... ....+.++||||+.++|.+.+.. ....+++.+++.++.||+.||.|||+ +||+||||||+||+++
T Consensus 113 ~~~~~~~~~-~~~~~~~lv~e~~g~~L~~~~~~---~~~~l~~~~~~~i~~qi~~~l~~lH~-~~iiHrDlkp~Nill~~ 187 (364)
T 3op5_A 113 YWGSGLHDK-NGKSYRFMIMDRFGSDLQKIYEA---NAKRFSRKTVLQLSLRILDILEYIHE-HEYVHGDIKASNLLLNY 187 (364)
T ss_dssp EEEEEEEEE-TTEEEEEEEEECEEEEHHHHHHH---TTSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEEES
T ss_pred EEeeeeecc-CCcceEEEEEeCCCCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHH-CCeEEecCCHHHEEEec
Confidence 999876533 33456889999997788877764 34679999999999999999999999 8999999999999998
Q ss_pred -CCCCcEEEeecCcccccccCCcc--------ccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 021306 175 -PLTHQVKICDFGSAKQLIAGEAN--------ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 245 (314)
Q Consensus 175 -~~~~~~~l~dfg~~~~~~~~~~~--------~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~ 245 (314)
. ++.++|+|||+++........ ....+|+.|+|||.+.+.. ++.++||||||+++|+|+||+.||.+..
T Consensus 188 ~~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~g~~Pf~~~~ 265 (364)
T 3op5_A 188 KN-PDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVA-PSRRGDLEILGYCMIQWLTGHLPWEDNL 265 (364)
T ss_dssp SC-TTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred CC-CCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCC-CCchhhHHHHHHHHHHHHhCCCCccccc
Confidence 5 788999999999765432211 2334899999999997655 8999999999999999999999998643
Q ss_pred hHHHHHHHHH-HcCCCCHHHHh-ccCCCCCCCcccccccCChhhhhcccCChHHHHHhcchh
Q 021306 246 AVDQLVEIIK-VLGTPTREEIR-CMNPNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGSHI 305 (314)
Q Consensus 246 ~~~~~~~i~~-~~~~~~~~~~~-~~~p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~~~ 305 (314)
.......... .........+. ++.+.-....+.+++..||...+..++....+.+.+..+
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~ 327 (364)
T 3op5_A 266 KDPKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQG 327 (364)
T ss_dssp TCHHHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred cCHHHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Confidence 3333332222 22222222222 222222234567788888888888877777777765544
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-41 Score=292.35 Aligned_cols=251 Identities=24% Similarity=0.356 Sum_probs=186.4
Q ss_pred CCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCCcee
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 110 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 110 (314)
.++|++.+.||+|+||.||+|++ +++.||+|.+.... ....+|+.++++++||||+++++++.... .
T Consensus 36 ~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-----~ 108 (309)
T 3p86_A 36 WCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPP-----N 108 (309)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT-----C
T ss_pred hhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC-----c
Confidence 46899999999999999999987 68899999986543 22357999999999999999999884333 3
Q ss_pred EEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCC--ceecCCCCCcEEEcCCCCcEEEeecCc
Q 021306 111 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR--VCHRDLKPQNLLVDPLTHQVKICDFGS 187 (314)
Q Consensus 111 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~--i~h~dl~p~Nil~~~~~~~~~l~dfg~ 187 (314)
+++||||+++ +|.+.+... .....+++..++.++.|++.||.|||+ +| |+||||||+||+++. ++.++|+|||+
T Consensus 109 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~~~ivH~Dikp~NIll~~-~~~~kL~Dfg~ 185 (309)
T 3p86_A 109 LSIVTEYLSRGSLYRLLHKS-GAREQLDERRRLSMAYDVAKGMNYLHN-RNPPIVHRNLKSPNLLVDK-KYTVKVCDFGL 185 (309)
T ss_dssp CEEEEECCTTCBHHHHHHST-THHHHSCHHHHHHHHHHHHHHHHHHHT-SSSCCCCTTCCGGGEEECT-TCCEEECCCC-
T ss_pred eEEEEecCCCCcHHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCEECCCCChhhEEEeC-CCcEEECCCCC
Confidence 7899999986 777766532 111249999999999999999999999 89 999999999999998 88999999999
Q ss_pred ccccccCC-ccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCHHHHh
Q 021306 188 AKQLIAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 266 (314)
Q Consensus 188 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 266 (314)
+....... ......+|+.|+|||.+.+.. ++.++||||||+++|+|++|+.||.+.+..+....+........
T Consensus 186 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~----- 259 (309)
T 3p86_A 186 SRLKASTFLSSKSAAGTPEWMAPEVLRDEP-SNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLE----- 259 (309)
T ss_dssp ----------------CCTTSCHHHHTTCC-CCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCC-----
T ss_pred CccccccccccccCCCCccccChhhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC-----
Confidence 87543322 233456799999999997655 79999999999999999999999999887766555533222111
Q ss_pred ccCCCCCCCcccccccCChhhhhcccCChHHHHHhcchh
Q 021306 267 CMNPNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGSHI 305 (314)
Q Consensus 267 ~~~p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~~~ 305 (314)
+ |......+.++++.+|...+..++....+++.++.+
T Consensus 260 -~-~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~ 296 (309)
T 3p86_A 260 -I-PRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPL 296 (309)
T ss_dssp -C-CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -C-CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 1 111223455667777777777777777777766544
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=295.65 Aligned_cols=241 Identities=24% Similarity=0.378 Sum_probs=185.5
Q ss_pred cCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhCCC--CceeeeceeeeecCCCC
Q 021306 36 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDH--PNVISLKHCFFSTTSKN 107 (314)
Q Consensus 36 ~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~------~~~~~e~~~l~~l~h--~~iv~~~~~~~~~~~~~ 107 (314)
.+++|++.+.||+|+||.||++.+ .+++.||+|.+.... ....+|+.++++++| +||+++++++..
T Consensus 7 ~~~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~----- 80 (343)
T 3dbq_A 7 KGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT----- 80 (343)
T ss_dssp SSCEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-----
T ss_pred ecCEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEee-----
Confidence 456899999999999999999996 578999999986542 234579999999987 999999998843
Q ss_pred ceeEEEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCc
Q 021306 108 ELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 187 (314)
Q Consensus 108 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~ 187 (314)
...+++|||+..++|.+.+.. ...+++.+++.++.||+.||.|||+ +||+||||||+||+++ ++.++|+|||+
T Consensus 81 ~~~~~lv~e~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~-~~iiHrDikp~NIll~--~~~~kl~DFG~ 153 (343)
T 3dbq_A 81 DQYIYMVMECGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQ-HGIVHSDLKPANFLIV--DGMLKLIDFGI 153 (343)
T ss_dssp SSEEEEEECCCSEEHHHHHHH----SCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEEE--TTEEEECCCSS
T ss_pred CCEEEEEEeCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCcceEEEE--CCcEEEeeccc
Confidence 335889999888888887764 5789999999999999999999999 8999999999999997 56799999999
Q ss_pred ccccccCCc---cccccccccccccccccC----------CCCCCcchhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHH
Q 021306 188 AKQLIAGEA---NISYICSRFYRAPELIFG----------ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV-DQLVEI 253 (314)
Q Consensus 188 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~----------~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~-~~~~~i 253 (314)
+........ .....+|+.|+|||.+.+ ...++.++||||||+++|+|++|+.||...... ..+..+
T Consensus 154 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~ 233 (343)
T 3dbq_A 154 ANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI 233 (343)
T ss_dssp SCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHH
T ss_pred ccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHH
Confidence 976543322 224568999999999853 244788999999999999999999999875443 333333
Q ss_pred HHHcCC------CC---HHHHh---ccCCCCCCCcccccccCChhhhhc
Q 021306 254 IKVLGT------PT---REEIR---CMNPNYTDFRFPQIKAHPWHKVCI 290 (314)
Q Consensus 254 ~~~~~~------~~---~~~~~---~~~p~~~~~~~~~l~~~p~~~~~~ 290 (314)
+..... .. .+.+. ..+|. +|+++.++++|||++...
T Consensus 234 ~~~~~~~~~~~~~~~~l~~li~~~L~~dp~-~Rpt~~e~l~hp~~~~~~ 281 (343)
T 3dbq_A 234 IDPNHEIEFPDIPEKDLQDVLKCCLKRDPK-QRISIPELLAHPYVQIQT 281 (343)
T ss_dssp HCTTSCCCCCCCSCHHHHHHHHHHTCSSTT-TSCCHHHHHTSHHHHSCC
T ss_pred hcCCcccCCcccCCHHHHHHHHHHcCCChh-HCCCHHHHHhCccccccC
Confidence 321111 01 11222 33677 899999999999998543
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-40 Score=289.36 Aligned_cols=256 Identities=24% Similarity=0.381 Sum_probs=196.4
Q ss_pred CCCCccCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeecc---ccchHHHHHHHHhC-CCCceeeeceeeeecCCC
Q 021306 31 NGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD---RRYKNRELQLMRVM-DHPNVISLKHCFFSTTSK 106 (314)
Q Consensus 31 ~~~~~~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~---~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~ 106 (314)
.......++|++.+.||+|+||.||+|++..+++.|++|.+... .....+|+.+++++ +|+||+++++++......
T Consensus 17 ~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~ 96 (326)
T 2x7f_A 17 SALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP 96 (326)
T ss_dssp CCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--
T ss_pred hhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCc
Confidence 34445577899999999999999999999999999999998643 33456889999998 899999999988654321
Q ss_pred -CceeEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEee
Q 021306 107 -NELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICD 184 (314)
Q Consensus 107 -~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~d 184 (314)
....+++||||+++ +|.+.+... ....+++..++.++.||+.||.|||+ +|++|+||+|+||+++. ++.++|+|
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~dlkp~NIl~~~-~~~~kl~D 172 (326)
T 2x7f_A 97 GMDDQLWLVMEFCGAGSVTDLIKNT--KGNTLKEEWIAYICREILRGLSHLHQ-HKVIHRDIKGQNVLLTE-NAEVKLVD 172 (326)
T ss_dssp CCCCEEEEEEECCTTEEHHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCSGGGEEECT-TCCEEECC
T ss_pred cccceEEEEEEcCCCCcHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCcHHHEEEcC-CCCEEEee
Confidence 13457899999986 777776642 23579999999999999999999999 89999999999999998 88899999
Q ss_pred cCcccccccCC-ccccccccccccccccccC----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCC
Q 021306 185 FGSAKQLIAGE-ANISYICSRFYRAPELIFG----ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT 259 (314)
Q Consensus 185 fg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~----~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~ 259 (314)
||++....... ......+++.|+|||.+.+ ...++.++||||||+++|+|++|..||.+.+.......+......
T Consensus 173 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 252 (326)
T 2x7f_A 173 FGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAP 252 (326)
T ss_dssp CTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC
T ss_pred CcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccc
Confidence 99987654322 2234567899999999852 234789999999999999999999999988877666655543222
Q ss_pred CC---------HHHHh-c--cCCCCCCCcccccccCChhhhhcc
Q 021306 260 PT---------REEIR-C--MNPNYTDFRFPQIKAHPWHKVCIF 291 (314)
Q Consensus 260 ~~---------~~~~~-~--~~p~~~~~~~~~l~~~p~~~~~~~ 291 (314)
.. .+.+. + .+|. +|+++.++++|||++....
T Consensus 253 ~~~~~~~~~~l~~li~~~l~~dp~-~Rps~~~ll~hp~~~~~~~ 295 (326)
T 2x7f_A 253 RLKSKKWSKKFQSFIESCLVKNHS-QRPATEQLMKHPFIRDQPN 295 (326)
T ss_dssp CCSCSCSCHHHHHHHHHHCCSSGG-GSCCHHHHHTSHHHHCCTT
T ss_pred cCCccccCHHHHHHHHHHhccChh-hCCCHHHHhhChHHhhCcc
Confidence 11 11222 2 3666 8999999999999987654
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=310.76 Aligned_cols=248 Identities=17% Similarity=0.134 Sum_probs=181.2
Q ss_pred CCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHH---HHHHhCCCCceeeece-------e
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNREL---QLMRVMDHPNVISLKH-------C 99 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~-------~~~~~e~---~~l~~l~h~~iv~~~~-------~ 99 (314)
.++|++.+.||+|+||.||+|++..+|+.||+|.+.... ....+|+ .++++++||||+++++ +
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 568999999999999999999998899999999986431 2345788 4455568999999984 3
Q ss_pred eeecCC---------CCc---eeEEEEeecccccHHHHHHhhhhc---CCCCCHHHHHHHHHHHHHHHHHhhcCCCceec
Q 021306 100 FFSTTS---------KNE---LFLNLVMEYVPESMYRVLKHYSSA---NQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 164 (314)
Q Consensus 100 ~~~~~~---------~~~---~~~~lv~e~~~~~l~~~l~~~~~~---~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~ 164 (314)
+..... ... ...+++|||++|+|.+.+...... ...+++..++.++.||+.||.|||+ +||+||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivHr 230 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH-YGLVHT 230 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECCSEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHH-TTEECS
T ss_pred hhccCCccccccccCCCceEEEEEEEEEeccCCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHh-CCeecC
Confidence 322210 111 126799999999998888753211 1234458888999999999999999 899999
Q ss_pred CCCCCcEEEcCCCCcEEEeecCcccccccCCccccccccccccccccccCC----------CCCCcchhHHHHHHHHHHH
Q 021306 165 DLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGA----------TEYTTSIDIWSAGCVLAEL 234 (314)
Q Consensus 165 dl~p~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----------~~~~~~~Dv~slG~il~el 234 (314)
||||+||+++. ++.++|+|||++..... ......+ +.|+|||.+.+. ..++.++||||||+++|+|
T Consensus 231 Dikp~NIll~~-~~~~kL~DFG~a~~~~~--~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~el 306 (377)
T 3byv_A 231 YLRPVDIVLDQ-RGGVFLTGFEHLVRDGA--RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWI 306 (377)
T ss_dssp CCCGGGEEECT-TCCEEECCGGGCEETTC--EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHH
T ss_pred CCCHHHEEEcC-CCCEEEEechhheecCC--cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHH
Confidence 99999999998 78999999999975322 2334455 889999999765 2489999999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHHHHcCCCCHH---HH---hccCCCCCCCcccccccCChhhhhc
Q 021306 235 LLGQPLFPGENAVDQLVEIIKVLGTPTRE---EI---RCMNPNYTDFRFPQIKAHPWHKVCI 290 (314)
Q Consensus 235 ~tg~~pf~~~~~~~~~~~i~~~~~~~~~~---~~---~~~~p~~~~~~~~~l~~~p~~~~~~ 290 (314)
++|+.||.+.+.......+.......+.. .+ ...+|. +|+++.++++|||++...
T Consensus 307 ltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~-~Rpt~~e~l~hp~f~~~~ 367 (377)
T 3byv_A 307 WCADLPITKDAALGGSEWIFRSCKNIPQPVRALLEGFLRYPKE-DRLLPLQAMETPEYEQLR 367 (377)
T ss_dssp HHSSCCC------CCSGGGGSSCCCCCHHHHHHHHHHTCSSGG-GCCCHHHHHTSHHHHHHH
T ss_pred HHCCCCCcccccccchhhhhhhccCCCHHHHHHHHHHcCCCch-hCCCHHHHhhChHHHHHH
Confidence 99999998765444333333222222222 22 233666 899999999999998654
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=297.70 Aligned_cols=201 Identities=29% Similarity=0.530 Sum_probs=169.6
Q ss_pred ccCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCce
Q 021306 35 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL 109 (314)
Q Consensus 35 ~~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 109 (314)
...++|++.+.||+|+||.||++++..+++.||+|.+.... ....+|+.++++++|+||+++++++....
T Consensus 30 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----- 104 (360)
T 3eqc_A 30 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG----- 104 (360)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETT-----
T ss_pred cccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECC-----
Confidence 34568999999999999999999999999999999987542 23458899999999999999999885433
Q ss_pred eEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCC-CceecCCCCCcEEEcCCCCcEEEeecCc
Q 021306 110 FLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP-RVCHRDLKPQNLLVDPLTHQVKICDFGS 187 (314)
Q Consensus 110 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~-~i~h~dl~p~Nil~~~~~~~~~l~dfg~ 187 (314)
..++||||+++ +|.+.+.. ...+++..++.++.|++.||.|||+ + ||+|+||||+||+++. ++.++|+|||+
T Consensus 105 ~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lh~-~~~i~H~dlkp~Nil~~~-~~~~kl~Dfg~ 178 (360)
T 3eqc_A 105 EISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLRE-KHKIMHRDVKPSNILVNS-RGEIKLCDFGV 178 (360)
T ss_dssp EEEEEECCCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-HHCCCCSCCSGGGEEECT-TCCEEECCCCC
T ss_pred EEEEEEECCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-hCCEEcCCccHHHEEECC-CCCEEEEECCC
Confidence 38899999986 77776654 3679999999999999999999998 6 9999999999999998 78899999999
Q ss_pred ccccccCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHH
Q 021306 188 AKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVD 248 (314)
Q Consensus 188 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~ 248 (314)
+...... ......+++.|+|||.+.+.. ++.++||||||+++|+|++|+.||...+..+
T Consensus 179 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~ 237 (360)
T 3eqc_A 179 SGQLIDS-MANSFVGTRSYMSPERLQGTH-YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKE 237 (360)
T ss_dssp CHHHHHH-C----CCCCTTCCHHHHTTCC-CSHHHHHHHHHHHHHHHHHTSCCSSCCCHHH
T ss_pred Ccccccc-cccCCCCCCCeECHHHHcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 8654322 223456799999999997654 8999999999999999999999998776543
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-41 Score=296.42 Aligned_cols=252 Identities=23% Similarity=0.380 Sum_probs=173.2
Q ss_pred CCCccCCCceeee-eEeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHhCCCCceeeeceeeeecCCCCcee
Q 021306 32 GEPKQTISYMAER-VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 110 (314)
Q Consensus 32 ~~~~~~~~y~~~~-~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 110 (314)
......++|++.+ .||+|+||.||+|+++.+++.||+|.+.......++....++.++|+||+++++++.... ....+
T Consensus 22 ~~~~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~-~~~~~ 100 (336)
T 3fhr_A 22 KKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQASGGPHIVCILDVYENMH-HGKRC 100 (336)
T ss_dssp BCSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEEE
T ss_pred CCccccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHHHHHHHHHHHHhcCCCChHHHHHHHhhcc-CCCce
Confidence 3444567899965 699999999999999999999999999876655555666678889999999999875432 23456
Q ss_pred EEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCC--CCcEEEeecCc
Q 021306 111 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPL--THQVKICDFGS 187 (314)
Q Consensus 111 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~--~~~~~l~dfg~ 187 (314)
+++||||++| +|.+.+... ....+++.+++.++.||+.||.|||+ +||+|+||||+||+++.. ++.++|+|||+
T Consensus 101 ~~lv~e~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~ql~~~l~~LH~-~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~ 177 (336)
T 3fhr_A 101 LLIIMECMEGGELFSRIQER--GDQAFTEREAAEIMRDIGTAIQFLHS-HNIAHRDVKPENLLYTSKEKDAVLKLTDFGF 177 (336)
T ss_dssp EEEEEECCTTEEHHHHHHTC---CCCCBHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEEeccCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEEecCCCceEEEecccc
Confidence 7899999987 777777642 23579999999999999999999999 899999999999999862 34599999999
Q ss_pred ccccccCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH-----cCCC--
Q 021306 188 AKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV-----LGTP-- 260 (314)
Q Consensus 188 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~-----~~~~-- 260 (314)
+...... ......+++.|+|||.+.+.. ++.++||||||+++|+|++|..||.+...........+. ...+
T Consensus 178 ~~~~~~~-~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (336)
T 3fhr_A 178 AKETTQN-ALQTPCYTPYYVAPEVLGPEK-YDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNP 255 (336)
T ss_dssp CEEC-----------------------CH-HHHHHHHHHHHHHHHHHHHSSCCC---------------------CCCTT
T ss_pred ceecccc-ccccCCCCcCccChhhhCCCC-CCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCch
Confidence 9755432 233456789999999985544 789999999999999999999999776544332111111 1111
Q ss_pred -----CH---HHHh---ccCCCCCCCcccccccCChhhhhc
Q 021306 261 -----TR---EEIR---CMNPNYTDFRFPQIKAHPWHKVCI 290 (314)
Q Consensus 261 -----~~---~~~~---~~~p~~~~~~~~~l~~~p~~~~~~ 290 (314)
.. +.+. ..+|. +|+++.++++|||++...
T Consensus 256 ~~~~~~~~~~~li~~~L~~dP~-~Rpt~~ell~hp~~~~~~ 295 (336)
T 3fhr_A 256 EWSEVSEDAKQLIRLLLKTDPT-ERLTITQFMNHPWINQSM 295 (336)
T ss_dssp TSTTCCHHHHHHHHHHSCSSGG-GSCCHHHHHHSHHHHTGG
T ss_pred hhccCCHHHHHHHHHHCCCChh-HCcCHHHHhcCccccccc
Confidence 11 1222 33666 899999999999998654
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=287.57 Aligned_cols=247 Identities=24% Similarity=0.419 Sum_probs=194.0
Q ss_pred ccCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc----cchHHHHHHHHhCCCCceeeeceeeeecCCCCcee
Q 021306 35 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 110 (314)
Q Consensus 35 ~~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 110 (314)
...++|++.+.||+|+||.||+|++..+++.+++|.+.... ....+|+.+++.++||||+++++++.... .
T Consensus 16 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~ 90 (302)
T 2j7t_A 16 DPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDG-----K 90 (302)
T ss_dssp CGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC------C
T ss_pred CCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCC-----e
Confidence 34568999999999999999999999999999999886432 33457999999999999999999885433 3
Q ss_pred EEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCccc
Q 021306 111 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 189 (314)
Q Consensus 111 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~ 189 (314)
.++||||+++ ++.+.+.. ....+++..++.++.|++.||.|||+ +|++|+||+|+||+++. ++.++|+|||++.
T Consensus 91 ~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~Nil~~~-~~~~kl~Dfg~~~ 165 (302)
T 2j7t_A 91 LWIMIEFCPGGAVDAIMLE---LDRGLTEPQIQVVCRQMLEALNFLHS-KRIIHRDLKAGNVLMTL-EGDIRLADFGVSA 165 (302)
T ss_dssp EEEEEECCTTEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCSGGGEEECT-TSCEEECCCHHHH
T ss_pred EEEEEEeCCCCcHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHhc-CCcccCCCCHHHEEECC-CCCEEEEECCCCc
Confidence 8899999987 55554443 24679999999999999999999999 89999999999999998 7889999999875
Q ss_pred ccccC-Ccccccccccccccccccc----CCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCC---
Q 021306 190 QLIAG-EANISYICSRFYRAPELIF----GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT--- 261 (314)
Q Consensus 190 ~~~~~-~~~~~~~~~~~y~aPE~~~----~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~--- 261 (314)
..... .......+++.|+|||.+. ....++.++||||||+++|+|++|..||...+.......+.+......
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 245 (302)
T 2j7t_A 166 KNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTP 245 (302)
T ss_dssp HHHHHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSG
T ss_pred cccccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcccCCc
Confidence 33221 1223356789999999984 234478999999999999999999999999888776666655432211
Q ss_pred -------HHHHh---ccCCCCCCCcccccccCChhhhhccc
Q 021306 262 -------REEIR---CMNPNYTDFRFPQIKAHPWHKVCIFH 292 (314)
Q Consensus 262 -------~~~~~---~~~p~~~~~~~~~l~~~p~~~~~~~~ 292 (314)
.+.+. ..+|. +|+++.++++|||++.....
T Consensus 246 ~~~~~~l~~li~~~l~~dp~-~Rps~~~ll~h~~~~~~~~~ 285 (302)
T 2j7t_A 246 SKWSVEFRDFLKIALDKNPE-TRPSAAQLLEHPFVSSITSN 285 (302)
T ss_dssp GGSCHHHHHHHHHHSCSCTT-TSCCHHHHTTSTTTTTCCCC
T ss_pred cccCHHHHHHHHHHcccChh-hCCCHHHHhcChHHhhhccc
Confidence 11222 23677 89999999999999987653
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-40 Score=284.15 Aligned_cols=254 Identities=18% Similarity=0.216 Sum_probs=197.1
Q ss_pred cCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeecc--ccchHHHHHHHHhC-CCCceeeeceeeeecCCCCceeEE
Q 021306 36 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD--RRYKNRELQLMRVM-DHPNVISLKHCFFSTTSKNELFLN 112 (314)
Q Consensus 36 ~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~--~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~ 112 (314)
..++|++.+.||+|+||.||+|++..+++.||+|.+... .....+|+.+++++ .|++++++++++... ...+
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~-----~~~~ 82 (298)
T 1csn_A 8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEG-----LHNV 82 (298)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEET-----TEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCccHHHHHHHHHHHHHhcCCCCCeEEeecCCC-----ceeE
Confidence 456899999999999999999999999999999988643 34457899999999 799999999887433 3478
Q ss_pred EEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCC-----cEEEeecCc
Q 021306 113 LVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH-----QVKICDFGS 187 (314)
Q Consensus 113 lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~-----~~~l~dfg~ 187 (314)
++|||+.++|.+.+.. .+.++++.+++.++.|++.||.|||+ +||+|+||||+||+++. ++ .++|+|||+
T Consensus 83 lv~e~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~Dlkp~NIl~~~-~~~~~~~~~kl~Dfg~ 157 (298)
T 1csn_A 83 LVIDLLGPSLEDLLDL---CGRKFSVKTVAMAAKQMLARVQSIHE-KSLVYRDIKPDNFLIGR-PNSKNANMIYVVDFGM 157 (298)
T ss_dssp EEEECCCCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCCGGGEEECC-SSSTTTTCEEECCCTT
T ss_pred EEEEecCCCHHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEecc-CCCCCCCeEEEEECcc
Confidence 9999997788888764 24579999999999999999999999 89999999999999986 43 399999999
Q ss_pred ccccccCCc--------cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCC---ChHHHHHHHHHH
Q 021306 188 AKQLIAGEA--------NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE---NAVDQLVEIIKV 256 (314)
Q Consensus 188 ~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~---~~~~~~~~i~~~ 256 (314)
+........ .....+|+.|+|||.+.+.. ++.++||||||+++|+|++|+.||.+. ...+.+..+...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 236 (298)
T 1csn_A 158 VKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGRE-QSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEK 236 (298)
T ss_dssp CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHH
T ss_pred ccccccccccccccccCccCCCCCcccCCchhhcCCC-CChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhh
Confidence 976544322 23456789999999996655 899999999999999999999999874 333444444433
Q ss_pred cCCCCHHHH-hccCCCCCCCcccccccCChhhhhcccCChHHHHHhcchh
Q 021306 257 LGTPTREEI-RCMNPNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGSHI 305 (314)
Q Consensus 257 ~~~~~~~~~-~~~~p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~~~ 305 (314)
......... ..+++ .+.+++..+|...+..+++...+.+.++.+
T Consensus 237 ~~~~~~~~~~~~~~~-----~l~~li~~~l~~dp~~RP~~~~l~~~l~~~ 281 (298)
T 1csn_A 237 KQSTPLRELCAGFPE-----EFYKYMHYARNLAFDATPDYDYLQGLFSKV 281 (298)
T ss_dssp HHHSCHHHHTTTSCH-----HHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred ccCccHHHHHhhCcH-----HHHHHHHHHhcCCcccCCCHHHHHHHHHHH
Confidence 222222222 12222 356677777777777777777666665543
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-41 Score=299.89 Aligned_cols=247 Identities=11% Similarity=0.069 Sum_probs=171.9
Q ss_pred CCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeecccc-------chHHHHHHHHhC--CCCceeeeceee-------
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YKNRELQLMRVM--DHPNVISLKHCF------- 100 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~~-------~~~~e~~~l~~l--~h~~iv~~~~~~------- 100 (314)
..+|++.+.||+|+||.||+|++..+++.||+|.+..... ...+|+.+++.+ +||||++++..+
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 3459999999999999999999999999999999976432 224664434444 699988855333
Q ss_pred eecCCC------------CceeEEEEeecccccHHHHHHhhhhcCCCCCHHHH------HHHHHHHHHHHHHhhcCCCce
Q 021306 101 FSTTSK------------NELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYV------KLYTYQIFRGLAYIHTVPRVC 162 (314)
Q Consensus 101 ~~~~~~------------~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~------~~i~~ql~~~l~~LH~~~~i~ 162 (314)
...... ....+++||||++++|.+.+.... ..+.+... ..++.||+.||.|||+ +||+
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~---~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~-~~iv 216 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLD---FVYVFRGDEGILALHILTAQLIRLAANLQS-KGLV 216 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCSEEHHHHHHHHH---HSCCCCHHHHHHHHHHHHHHHHHHHHHHHH-TTEE
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCCCCHHHHHHHhc---cccchhhhhhhhhHHHHHHHHHHHHHHHHH-CCCc
Confidence 221110 014478999999999998887642 23444444 6777999999999999 8999
Q ss_pred ecCCCCCcEEEcCCCCcEEEeecCcccccccCCccccccccccccccccccCC-CCCCcchhHHHHHHHHHHHHhCCCCC
Q 021306 163 HRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGA-TEYTTSIDIWSAGCVLAELLLGQPLF 241 (314)
Q Consensus 163 h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~el~tg~~pf 241 (314)
||||||+||+++. ++.++|+|||+++.... ......+++.|+|||.+.+. ..++.++||||||+++|+|++|+.||
T Consensus 217 HrDikp~NIll~~-~~~~kL~DFG~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf 293 (371)
T 3q60_A 217 HGHFTPDNLFIMP-DGRLMLGDVSALWKVGT--RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPF 293 (371)
T ss_dssp ETTCSGGGEEECT-TSCEEECCGGGEEETTC--EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCST
T ss_pred cCcCCHHHEEECC-CCCEEEEecceeeecCC--CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCC
Confidence 9999999999998 78999999999986532 22245667999999999651 34899999999999999999999999
Q ss_pred CCCChHHH--HHH---HHH---Hc-----CCCCH---HH---HhccCCCCCCCcccccccCChhhhhcc
Q 021306 242 PGENAVDQ--LVE---IIK---VL-----GTPTR---EE---IRCMNPNYTDFRFPQIKAHPWHKVCIF 291 (314)
Q Consensus 242 ~~~~~~~~--~~~---i~~---~~-----~~~~~---~~---~~~~~p~~~~~~~~~l~~~p~~~~~~~ 291 (314)
.+...... ... ... .. ...+. +. +...+|. +|+++.++++|||++....
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~-~Rpt~~e~l~hp~f~~~~~ 361 (371)
T 3q60_A 294 GLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRR-RRLLPLEAMETPEFLQLQN 361 (371)
T ss_dssp TBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTT-TCCCHHHHTTSHHHHHHHH
T ss_pred CCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChh-hCCCHHHHhcCHHHHHHHH
Confidence 87633210 000 000 00 00011 11 2234677 8999999999999987654
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=291.67 Aligned_cols=254 Identities=23% Similarity=0.299 Sum_probs=197.9
Q ss_pred ccCCCceeeeeEeecCceEEEEEEECCCCc---EEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCC
Q 021306 35 KQTISYMAERVVGTGSFGIVFQAKCLETGE---TVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSK 106 (314)
Q Consensus 35 ~~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~---~~~vK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 106 (314)
...++|++.+.||+|+||.||+|++..+++ .||+|.++... ....+|+.++++++||||+++++++..
T Consensus 46 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---- 121 (325)
T 3kul_A 46 IEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTR---- 121 (325)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECG----
T ss_pred cChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe----
Confidence 345689999999999999999999986554 59999987532 234579999999999999999998843
Q ss_pred CceeEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeec
Q 021306 107 NELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF 185 (314)
Q Consensus 107 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~df 185 (314)
....++||||+++ +|.+.+.. ....+++.+++.++.|++.||.|||+ +||+|+||||+||+++. ++.++|+||
T Consensus 122 -~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dlkp~NIll~~-~~~~kl~Df 195 (325)
T 3kul_A 122 -GRLAMIVTEYMENGSLDTFLRT---HDGQFTIMQLVGMLRGVGAGMRYLSD-LGYVHRDLAARNVLVDS-NLVCKVSDF 195 (325)
T ss_dssp -GGCCEEEEECCTTCBHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECT-TCCEEECCC
T ss_pred -CCccEEEeeCCCCCcHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHH-CCeeCCCCCcceEEECC-CCCEEECCC
Confidence 3347899999986 77766643 34679999999999999999999999 89999999999999998 889999999
Q ss_pred CcccccccCCc----cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCC
Q 021306 186 GSAKQLIAGEA----NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTP 260 (314)
Q Consensus 186 g~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~t-g~~pf~~~~~~~~~~~i~~~~~~~ 260 (314)
|++........ .....+|+.|+|||.+.+.. ++.++||||||+++|+|++ |..||.+....+....+......+
T Consensus 196 g~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~ 274 (325)
T 3kul_A 196 GLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRT-FSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLP 274 (325)
T ss_dssp SSCEECC----CCEECC---CCGGGSCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCC
T ss_pred CcccccccCccceeeccCCCCcccccCHhHhcCCC-CCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCC
Confidence 99976543221 11233466899999996554 8999999999999999999 999999988877666665543222
Q ss_pred CHHHHhccCCCCCCCcccccccCChhhhhcccCChHHHHHhcchhhh
Q 021306 261 TREEIRCMNPNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGSHINA 307 (314)
Q Consensus 261 ~~~~~~~~~p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~~~~~ 307 (314)
.+ ......+.+++..+|...+..+++...+++.++.+..
T Consensus 275 ~~--------~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~ 313 (325)
T 3kul_A 275 AP--------MGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIR 313 (325)
T ss_dssp CC--------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CC--------CCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 11 1122346677777787777777777777777766543
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=289.64 Aligned_cols=252 Identities=23% Similarity=0.378 Sum_probs=188.1
Q ss_pred CCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeecc----ccchHHHHHHHHhCCCCceeeeceeeeecCCCCceeEE
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD----RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 112 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 112 (314)
.++|++.+.||+|+||.||+|.+..+++.+++|.+... .....+|+.++++++||||+++++++.... ..+
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-----~~~ 83 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDK-----RLN 83 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT-----EEE
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCC-----eeE
Confidence 46899999999999999999999999999999988543 233468999999999999999999986433 388
Q ss_pred EEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCccccc
Q 021306 113 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 191 (314)
Q Consensus 113 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~ 191 (314)
+||||+++ +|.+.+.. ....+++.+++.++.|++.||.|||+ +||+|+||||+||+++. ++.++|+|||++...
T Consensus 84 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~dlkp~Nil~~~-~~~~kl~Dfg~~~~~ 158 (310)
T 3s95_A 84 FITEYIKGGTLRGIIKS---MDSQYPWSQRVSFAKDIASGMAYLHS-MNIIHRDLNSHNCLVRE-NKNVVVADFGLARLM 158 (310)
T ss_dssp EEEECCTTCBHHHHHHH---CCTTSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSTTSEEECT-TSCEEECCCTTCEEC
T ss_pred EEEEecCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCCcCeEEECC-CCCEEEeecccceec
Confidence 99999986 77766654 35679999999999999999999999 89999999999999998 888999999999765
Q ss_pred ccCCcc---------------ccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q 021306 192 IAGEAN---------------ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 256 (314)
Q Consensus 192 ~~~~~~---------------~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~ 256 (314)
...... ....+|+.|+|||.+.+.. ++.++||||||+++|+|++|..||............
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~--- 234 (310)
T 3s95_A 159 VDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRS-YDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGL--- 234 (310)
T ss_dssp C--------------------CCCCSCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSB---
T ss_pred ccccccccccccccccccccccccCCCcceeCHHHhcCCC-CCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhh---
Confidence 332221 1346789999999997644 899999999999999999999998764322110000
Q ss_pred cCCCCHHHHhccCCCCCCCcccccccCChhhhhcccCChHHHHHhcchh
Q 021306 257 LGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGSHI 305 (314)
Q Consensus 257 ~~~~~~~~~~~~~p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~~~ 305 (314)
..........|......+.+++..+|...+..+++...+.+.++.+
T Consensus 235 ---~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l 280 (310)
T 3s95_A 235 ---NVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETL 280 (310)
T ss_dssp ---CHHHHHHHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---hhhccccccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 0000111111111223355566666666666666666665555544
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=295.19 Aligned_cols=256 Identities=24% Similarity=0.365 Sum_probs=199.6
Q ss_pred cCCCceeeeeEeecCceEEEEEEEC-------CCCcEEEEEEeeccc-----cchHHHHHHHHhC-CCCceeeeceeeee
Q 021306 36 QTISYMAERVVGTGSFGIVFQAKCL-------ETGETVAIKKVLQDR-----RYKNRELQLMRVM-DHPNVISLKHCFFS 102 (314)
Q Consensus 36 ~~~~y~~~~~Lg~g~~g~Vy~~~~~-------~~~~~~~vK~~~~~~-----~~~~~e~~~l~~l-~h~~iv~~~~~~~~ 102 (314)
..++|++.+.||+|+||.||+|++. .++..||+|.++... ....+|+.+++++ +||||+++++++..
T Consensus 79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 158 (370)
T 2psq_A 79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 158 (370)
T ss_dssp CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS
T ss_pred cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc
Confidence 3468999999999999999999874 345689999987542 2345899999999 89999999998843
Q ss_pred cCCCCceeEEEEeecccc-cHHHHHHhhhh------------cCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCC
Q 021306 103 TTSKNELFLNLVMEYVPE-SMYRVLKHYSS------------ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQ 169 (314)
Q Consensus 103 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~------------~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~ 169 (314)
. ..+++||||+++ +|.+.+..... ....+++.+++.++.||+.||.|||+ +||+||||||+
T Consensus 159 ~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~ 232 (370)
T 2psq_A 159 D-----GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS-QKCIHRDLAAR 232 (370)
T ss_dssp S-----SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGG
T ss_pred C-----CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh-CCeeccccchh
Confidence 3 337899999986 78777765321 12468999999999999999999999 89999999999
Q ss_pred cEEEcCCCCcEEEeecCcccccccCCc---cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 021306 170 NLLVDPLTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGEN 245 (314)
Q Consensus 170 Nil~~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~t-g~~pf~~~~ 245 (314)
||+++. ++.++|+|||++........ .....+++.|+|||.+.+.. ++.++||||||+++|+|++ |..||.+..
T Consensus 233 NIll~~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DvwslG~il~ellt~g~~p~~~~~ 310 (370)
T 2psq_A 233 NVLVTE-NNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPGIP 310 (370)
T ss_dssp GEEECT-TCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred hEEECC-CCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCC-CCcHHHHHHHHHHHHHHHcCCCCCCCCCC
Confidence 999998 88999999999975543221 22344577899999997654 8999999999999999999 999999887
Q ss_pred hHHHHHHHHHHcCCCCHHHHhccCCCCCCCcccccccCChhhhhcccCChHHHHHhcchhhh
Q 021306 246 AVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGSHINA 307 (314)
Q Consensus 246 ~~~~~~~i~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~~~~~ 307 (314)
..+....+........ |......+.+++..||...+..+.+...+++.++.+..
T Consensus 311 ~~~~~~~~~~~~~~~~--------~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~ 364 (370)
T 2psq_A 311 VEELFKLLKEGHRMDK--------PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 364 (370)
T ss_dssp GGGHHHHHHTTCCCCC--------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHhcCCCCCC--------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 7665554443321111 11123346678888888888888888888888776554
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=292.86 Aligned_cols=248 Identities=24% Similarity=0.372 Sum_probs=177.6
Q ss_pred cCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeecc-----ccchHHHHHHHHhCCCCceeeeceeeeecCCCCcee
Q 021306 36 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-----RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 110 (314)
Q Consensus 36 ~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~-----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 110 (314)
..++|++.+.||+|++|.||+|.+..+++.|++|.+... .....+|+.++++++||||+++++++.... .
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~ 87 (303)
T 2vwi_A 13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKD-----E 87 (303)
T ss_dssp CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSS-----C
T ss_pred chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecC-----C
Confidence 356899999999999999999999889999999987543 233457888899999999999999885443 3
Q ss_pred EEEEeecccc-cHHHHHHhhhh----cCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeec
Q 021306 111 LNLVMEYVPE-SMYRVLKHYSS----ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF 185 (314)
Q Consensus 111 ~~lv~e~~~~-~l~~~l~~~~~----~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~df 185 (314)
.++||||+++ +|.+.+..... ....+++..++.++.|++.||.|||+ +|++|+||+|+||+++. ++.++|+||
T Consensus 88 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dl~p~Nil~~~-~~~~kl~df 165 (303)
T 2vwi_A 88 LWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK-NGQIHRDVKAGNILLGE-DGSVQIADF 165 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCSGGGEEECT-TCCEEECCC
T ss_pred cEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCCCCChhhEEEcC-CCCEEEEec
Confidence 7899999975 77777764322 24569999999999999999999999 89999999999999998 788999999
Q ss_pred CcccccccCC------ccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCC
Q 021306 186 GSAKQLIAGE------ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT 259 (314)
Q Consensus 186 g~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~ 259 (314)
|.+....... ......+++.|+|||.+.+...++.++||||||+++|+|++|+.||.............+....
T Consensus 166 g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 245 (303)
T 2vwi_A 166 GVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPP 245 (303)
T ss_dssp HHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCC
T ss_pred cchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCC
Confidence 9986543221 1223467889999999865445799999999999999999999999887766655544433211
Q ss_pred CC--------------H---HHHh---ccCCCCCCCcccccccCChhhhhcc
Q 021306 260 PT--------------R---EEIR---CMNPNYTDFRFPQIKAHPWHKVCIF 291 (314)
Q Consensus 260 ~~--------------~---~~~~---~~~p~~~~~~~~~l~~~p~~~~~~~ 291 (314)
.. . +.+. ..+|. +|+++.++++|||++....
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~-~Rps~~~ll~h~~~~~~~~ 296 (303)
T 2vwi_A 246 SLETGVQDKEMLKKYGKSFRKMISLCLQKDPE-KRPTAAELLRHKFFQKAKN 296 (303)
T ss_dssp CTTC-----CCCCCCCHHHHHHHHHHCCSSGG-GSCCHHHHHTSTTC-----
T ss_pred ccccccccchhhhhhhHHHHHHHHHHccCChh-hCcCHHHHhhChhhhcCCC
Confidence 11 1 1122 23666 8999999999999987554
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=294.08 Aligned_cols=251 Identities=19% Similarity=0.304 Sum_probs=194.9
Q ss_pred cCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc---------------------cchHHHHHHHHhCCCCcee
Q 021306 36 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---------------------RYKNRELQLMRVMDHPNVI 94 (314)
Q Consensus 36 ~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~---------------------~~~~~e~~~l~~l~h~~iv 94 (314)
..++|++.+.||+|+||.||+|++ +++.||+|.+.... ....+|+.++++++||||+
T Consensus 29 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~ 106 (348)
T 2pml_X 29 YINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCL 106 (348)
T ss_dssp EETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBC
T ss_pred ccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcc
Confidence 456899999999999999999998 99999999986432 4457899999999999999
Q ss_pred eeceeeeecCCCCceeEEEEeecccc-cHHHHHHhh--hhc--CCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCC
Q 021306 95 SLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHY--SSA--NQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQ 169 (314)
Q Consensus 95 ~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~--~~~--~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~ 169 (314)
++++++... ...++||||+++ +|.+.+... ... ...+++..++.++.|++.||.|||+.+|++|+||+|+
T Consensus 107 ~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~ 181 (348)
T 2pml_X 107 TCEGIITNY-----DEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPS 181 (348)
T ss_dssp CCSEEEESS-----SEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGG
T ss_pred eEEEEEeeC-----CeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChH
Confidence 999998543 348899999997 554431100 222 5789999999999999999999996359999999999
Q ss_pred cEEEcCCCCcEEEeecCcccccccCCccccccccccccccccccCCCCCCc-chhHHHHHHHHHHHHhCCCCCCCCCh-H
Q 021306 170 NLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTT-SIDIWSAGCVLAELLLGQPLFPGENA-V 247 (314)
Q Consensus 170 Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~~Dv~slG~il~el~tg~~pf~~~~~-~ 247 (314)
||+++. ++.++|+|||.+...... ......+++.|+|||.+.+...++. ++||||||+++|+|++|+.||...+. .
T Consensus 182 Nil~~~-~~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~ 259 (348)
T 2pml_X 182 NILMDK-NGRVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLV 259 (348)
T ss_dssp GEEECT-TSCEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSH
T ss_pred hEEEcC-CCcEEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHH
Confidence 999998 789999999999765433 3334567899999999976644555 99999999999999999999988776 4
Q ss_pred HHHHHHHHHcCCCC-----------------------H---HHHh---ccCCCCCCCcccccccCChhhhhcccCChH
Q 021306 248 DQLVEIIKVLGTPT-----------------------R---EEIR---CMNPNYTDFRFPQIKAHPWHKVCIFHFPKH 296 (314)
Q Consensus 248 ~~~~~i~~~~~~~~-----------------------~---~~~~---~~~p~~~~~~~~~l~~~p~~~~~~~~~~~~ 296 (314)
+....+.......+ . +.+. ..+|. +|+++.++++|||++....+....
T Consensus 260 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~-~Rps~~e~l~hp~f~~~~~~~~~~ 336 (348)
T 2pml_X 260 ELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPA-ERITSEDALKHEWLADTNIEDLRE 336 (348)
T ss_dssp HHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGG-GSCCHHHHHTSGGGTTCCHHHHHH
T ss_pred HHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChh-hCCCHHHHhcCccccCCCHHHHHH
Confidence 44444433211111 1 1122 23666 899999999999998766543333
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=289.89 Aligned_cols=255 Identities=22% Similarity=0.233 Sum_probs=180.2
Q ss_pred CCCCccCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeec
Q 021306 31 NGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFST 103 (314)
Q Consensus 31 ~~~~~~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 103 (314)
+..+...++|++.+.||+|+||.||+|++..+++.|++|.+.... ....+|+.++++++||||+++++++...
T Consensus 27 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~ 106 (309)
T 2h34_A 27 SREGTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEID 106 (309)
T ss_dssp -------CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET
T ss_pred cCCCcEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeC
Confidence 345556789999999999999999999999999999999986542 2345899999999999999999988543
Q ss_pred CCCCceeEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEE
Q 021306 104 TSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKI 182 (314)
Q Consensus 104 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l 182 (314)
. ..++++||+++ +|.+.+.. ..++++.+++.++.|++.||.|||+ +||+|+||+|+||+++. ++.++|
T Consensus 107 ~-----~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dlkp~NIl~~~-~~~~kl 175 (309)
T 2h34_A 107 G-----QLYVDMRLINGVDLAAMLRR----QGPLAPPRAVAIVRQIGSALDAAHA-AGATHRDVKPENILVSA-DDFAYL 175 (309)
T ss_dssp T-----EEEEEEECCCCEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECT-TSCEEE
T ss_pred C-----eEEEEEEecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CcCCcCCCChHHEEEcC-CCCEEE
Confidence 3 48899999986 77776654 3679999999999999999999999 89999999999999998 789999
Q ss_pred eecCcccccccCC--ccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCC
Q 021306 183 CDFGSAKQLIAGE--ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 260 (314)
Q Consensus 183 ~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~ 260 (314)
+|||++....... ......+++.|+|||.+.+.. ++.++||||||+++|+|++|+.||.+.+.. .....+......
T Consensus 176 ~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~~~ 253 (309)
T 2h34_A 176 VDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESH-ATYRADIYALTCVLYECLTGSPPYQGDQLS-VMGAHINQAIPR 253 (309)
T ss_dssp CSCCC----------------CCGGGCCGGGTCC-----CCCHHHHHHHHHHHHHHSSCSSCSCHHH-HHHHHHHSCCCC
T ss_pred ecCccCccccccccccccccCCCcCccCHHHHcCCC-CCchHhHHHHHHHHHHHHHCCCCCCCchHH-HHHHHhccCCCC
Confidence 9999987554322 122456789999999986544 789999999999999999999999887654 333333332222
Q ss_pred CHHHHhccCCCCCCCcccccccCChhhhhcccC-ChHHHHHhcc
Q 021306 261 TREEIRCMNPNYTDFRFPQIKAHPWHKVCIFHF-PKHWLLEYGS 303 (314)
Q Consensus 261 ~~~~~~~~~p~~~~~~~~~l~~~p~~~~~~~~~-~~~~~~~~~~ 303 (314)
.......+++. +.+++..+|...+..+. ..+.+.+.++
T Consensus 254 ~~~~~~~~~~~-----l~~li~~~l~~dP~~Rp~s~~~l~~~l~ 292 (309)
T 2h34_A 254 PSTVRPGIPVA-----FDAVIARGMAKNPEDRYVTCGDLSAAAH 292 (309)
T ss_dssp GGGTSTTCCTH-----HHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred ccccCCCCCHH-----HHHHHHHhccCCHHHHHHhHHHHHHHHH
Confidence 22222233443 33444444444444443 3444444433
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=283.24 Aligned_cols=260 Identities=22% Similarity=0.236 Sum_probs=195.2
Q ss_pred CCCccCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc--cchHHHHHHHHhCCCCceeeeceeeeecCCCCce
Q 021306 32 GEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR--RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL 109 (314)
Q Consensus 32 ~~~~~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~--~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 109 (314)
......++|++.+.||+|+||.||+|++..+++.||+|.+.... ....+|+.+++.++|++++..+..+... ..
T Consensus 3 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~----~~ 78 (296)
T 3uzp_A 3 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAE----GD 78 (296)
T ss_dssp --CEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSCCHHHHHHHHHHHHTTSTTCCCEEEEEEE----TT
T ss_pred ccceeccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcchhHHHHHHHHHHHhhcCCCCCccccccCC----CC
Confidence 34456789999999999999999999999999999999886543 3457899999999998887776655432 22
Q ss_pred eEEEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEc--CCCCcEEEeecCc
Q 021306 110 FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVD--PLTHQVKICDFGS 187 (314)
Q Consensus 110 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~--~~~~~~~l~dfg~ 187 (314)
..+++|||+.++|.+.+.. ....+++.+++.++.|++.||.|||+ +|++|+||||+||+++ ..++.++|+|||+
T Consensus 79 ~~~lv~e~~~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~ 154 (296)
T 3uzp_A 79 YNVMVMELLGPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHS-KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGL 154 (296)
T ss_dssp EEEEEEECCCCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEECCGGGTTCEEECCCTT
T ss_pred ceEEEEEecCCCHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCCHHHeEEecCCCCCeEEEeeCCC
Confidence 4789999998888887763 24679999999999999999999999 8999999999999995 2277899999999
Q ss_pred ccccccCCc--------cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC---hHHHHHHHHHH
Q 021306 188 AKQLIAGEA--------NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN---AVDQLVEIIKV 256 (314)
Q Consensus 188 ~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~---~~~~~~~i~~~ 256 (314)
+........ .....+++.|+|||.+.+.. ++.++||||||+++|+|++|+.||.+.. ..+.+..+...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 233 (296)
T 3uzp_A 155 AKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIE-QSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK 233 (296)
T ss_dssp CEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHH
T ss_pred cccccccccccccccccccccccccccCChhhhcCCC-CCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhccc
Confidence 976544322 23456789999999997655 8999999999999999999999998743 22334444433
Q ss_pred cCCCCHHHH-hccCCCCCCCcccccccCChhhhhcccCChHHHHHhcchh
Q 021306 257 LGTPTREEI-RCMNPNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGSHI 305 (314)
Q Consensus 257 ~~~~~~~~~-~~~~p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~~~ 305 (314)
....+...+ ..+++ .+.++++.+|...+..+++...+.+.++.+
T Consensus 234 ~~~~~~~~~~~~~~~-----~l~~li~~~l~~dp~~Rps~~~l~~~l~~~ 278 (296)
T 3uzp_A 234 KMSTPIEVLCKGYPS-----EFATYLNFCRSLRFDDKPDYSYLRQLFRNL 278 (296)
T ss_dssp HHHSCHHHHTTTSCH-----HHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred ccCCchHHHHhhCCH-----HHHHHHHHHHhcCcCcCCCHHHHHHHHHHH
Confidence 222222222 12222 355566666666666666666666665543
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=296.67 Aligned_cols=252 Identities=21% Similarity=0.264 Sum_probs=200.8
Q ss_pred cCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCcee
Q 021306 36 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 110 (314)
Q Consensus 36 ~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 110 (314)
..++|++.+.||+|+||.||+|++..+++.||+|.++... ....+|+.++++++||||+++++++... ..
T Consensus 112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-----~~ 186 (377)
T 3cbl_A 112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQK-----QP 186 (377)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSS-----SS
T ss_pred chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecC-----CC
Confidence 3468999999999999999999999899999999986542 3446899999999999999999988433 23
Q ss_pred EEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCccc
Q 021306 111 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 189 (314)
Q Consensus 111 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~ 189 (314)
+++||||+++ +|.+.+.. .+..+++.+++.++.|++.||.|||+ +|++||||||+||+++. ++.++|+|||++.
T Consensus 187 ~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivHrDlkp~Nil~~~-~~~~kl~DfG~s~ 261 (377)
T 3cbl_A 187 IYIVMELVQGGDFLTFLRT---EGARLRVKTLLQMVGDAAAGMEYLES-KCCIHRDLAARNCLVTE-KNVLKISDFGMSR 261 (377)
T ss_dssp CEEEEECCTTCBHHHHHHH---HGGGCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECT-TCCEEECCGGGCE
T ss_pred cEEEEEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCcCCcccCHHHEEEcC-CCcEEECcCCCce
Confidence 7899999985 77777654 23569999999999999999999999 89999999999999998 7899999999987
Q ss_pred ccccCCcc---ccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCHHHH
Q 021306 190 QLIAGEAN---ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEI 265 (314)
Q Consensus 190 ~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 265 (314)
........ ....+++.|+|||.+.+.. ++.++||||||+++|||++ |..||.+.+..+....+.+....+.
T Consensus 262 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~---- 336 (377)
T 3cbl_A 262 EEADGVYAASGGLRQVPVKWTAPEALNYGR-YSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPC---- 336 (377)
T ss_dssp ECTTSEEECCSSCCEEEGGGSCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCCCC----
T ss_pred ecCCCceeecCCCCCCCcCcCCHhHhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC----
Confidence 54322111 1123466799999986554 8899999999999999998 9999999887665554443222111
Q ss_pred hccCCCCCCCcccccccCChhhhhcccCChHHHHHhcchhh
Q 021306 266 RCMNPNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGSHIN 306 (314)
Q Consensus 266 ~~~~p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~~~~ 306 (314)
|......+.+|+..||...+..+++...+++.++.+.
T Consensus 337 ----~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~ 373 (377)
T 3cbl_A 337 ----PELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIR 373 (377)
T ss_dssp ----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 2222335678888999988888888888888877654
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=285.97 Aligned_cols=251 Identities=24% Similarity=0.357 Sum_probs=173.7
Q ss_pred cCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeecccc-----chHHHHH-HHHhCCCCceeeeceeeeecCCCCce
Q 021306 36 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNRELQ-LMRVMDHPNVISLKHCFFSTTSKNEL 109 (314)
Q Consensus 36 ~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~~-----~~~~e~~-~l~~l~h~~iv~~~~~~~~~~~~~~~ 109 (314)
..++|++.+.||+|+||.||+|.++.+++.||+|.+..... ...+|.. +++.++||||+++++++... .
T Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~-----~ 94 (327)
T 3aln_A 20 TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFRE-----G 94 (327)
T ss_dssp CSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECS-----S
T ss_pred CHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeC-----C
Confidence 34689999999999999999999999999999999875422 1123443 67778999999999988543 3
Q ss_pred eEEEEeecccccHHHHHHhhhh-cCCCCCHHHHHHHHHHHHHHHHHhhcCC-CceecCCCCCcEEEcCCCCcEEEeecCc
Q 021306 110 FLNLVMEYVPESMYRVLKHYSS-ANQRMPLIYVKLYTYQIFRGLAYIHTVP-RVCHRDLKPQNLLVDPLTHQVKICDFGS 187 (314)
Q Consensus 110 ~~~lv~e~~~~~l~~~l~~~~~-~~~~l~~~~~~~i~~ql~~~l~~LH~~~-~i~h~dl~p~Nil~~~~~~~~~l~dfg~ 187 (314)
..++||||+++++.+.+..... ....+++..++.++.|++.||.+||+ + |++|+||||+||+++. ++.++|+|||+
T Consensus 95 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~~ivH~dlkp~NIll~~-~~~~kl~Dfg~ 172 (327)
T 3aln_A 95 DCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE-NLKIIHRDIKPSNILLDR-SGNIKLCDFGI 172 (327)
T ss_dssp EEEEEECCCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHH-HHSCCCSCCCGGGEEEET-TTEEEECCCSS
T ss_pred ceEEEEeecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhc-cCCEeECCCCHHHEEEcC-CCCEEEccCCC
Confidence 4789999999998877764322 25789999999999999999999999 8 9999999999999998 88999999999
Q ss_pred ccccccCCcccccccccccccccccc---CCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHcCC----
Q 021306 188 AKQLIAGEANISYICSRFYRAPELIF---GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV-DQLVEIIKVLGT---- 259 (314)
Q Consensus 188 ~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~-~~~~~i~~~~~~---- 259 (314)
+.............+++.|+|||.+. ....++.++||||||+++|+|++|+.||.+.... +.+..+......
T Consensus 173 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 252 (327)
T 3aln_A 173 SGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSN 252 (327)
T ss_dssp SCC------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCCCCC
T ss_pred ceecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCCCCC
Confidence 97665444444456889999999983 2334789999999999999999999999875432 222222111111
Q ss_pred -----CCH---HHHh---ccCCCCCCCcccccccCChhhhhcccCC
Q 021306 260 -----PTR---EEIR---CMNPNYTDFRFPQIKAHPWHKVCIFHFP 294 (314)
Q Consensus 260 -----~~~---~~~~---~~~p~~~~~~~~~l~~~p~~~~~~~~~~ 294 (314)
... +.+. ..+|. +|+++.++++|||+.....+..
T Consensus 253 ~~~~~~~~~l~~li~~~l~~dp~-~Rps~~ell~hp~~~~~~~~~~ 297 (327)
T 3aln_A 253 SEEREFSPSFINFVNLCLTKDES-KRPKYKELLKHPFILMYEERAV 297 (327)
T ss_dssp CSSCCCCHHHHHHHHHHTCSSGG-GSCCHHHHTTSHHHHHHHHSCC
T ss_pred cccccCCHHHHHHHHHHhhCChh-hCcCHHHHHhChHHHHhHhhHH
Confidence 011 1122 23666 8999999999999988765543
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=290.80 Aligned_cols=260 Identities=24% Similarity=0.287 Sum_probs=194.4
Q ss_pred CCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeecccc---chHHHHHHHHhCCCCceeeeceeeeecCCCCceeEEE
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR---YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 113 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~~---~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 113 (314)
.++|++.+.||+|+||.||+|++ .++.||+|.+..... ...+|+.++++++||||+++++++..... ....+++
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~-~~~~~~l 99 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQL--LNEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTS-VDVDLWL 99 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECS-SSEEEEE
T ss_pred hhhchhhheecccCceEEEEEEE--CCCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCC-CCceEEE
Confidence 45899999999999999999987 479999999865432 22457778899999999999999865432 2344789
Q ss_pred Eeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCC----------CceecCCCCCcEEEcCCCCcEEE
Q 021306 114 VMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP----------RVCHRDLKPQNLLVDPLTHQVKI 182 (314)
Q Consensus 114 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~----------~i~h~dl~p~Nil~~~~~~~~~l 182 (314)
||||+++ +|.+.+.. ..+++..++.++.|++.||.|||+ . ||+|+||||+||+++. ++.++|
T Consensus 100 v~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~al~~LH~-~~~~l~~~~~~~ivH~Dlkp~Nill~~-~~~~kL 172 (322)
T 3soc_A 100 ITAFHEKGSLSDFLKA-----NVVSWNELCHIAETMARGLAYLHE-DIPGLKDGHKPAISHRDIKSKNVLLKN-NLTACI 172 (322)
T ss_dssp EEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHTC-CEEEETTEEECEEECSCCSGGGEEECT-TCCEEE
T ss_pred EEecCCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHh-hccccccccCCCEEeCCCChHhEEECC-CCeEEE
Confidence 9999986 77777754 569999999999999999999999 8 9999999999999998 889999
Q ss_pred eecCcccccccCCc---cccccccccccccccccCC----CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 021306 183 CDFGSAKQLIAGEA---NISYICSRFYRAPELIFGA----TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 255 (314)
Q Consensus 183 ~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~----~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~ 255 (314)
+|||++........ .....+|+.|+|||.+.+. ..++.++||||||+++|+|++|+.||.+............
T Consensus 173 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~ 252 (322)
T 3soc_A 173 ADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEE 252 (322)
T ss_dssp CCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHH
T ss_pred ccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhh
Confidence 99999976543322 2235679999999998653 2355688999999999999999999976543221111111
Q ss_pred HcCCCCHHHHh------ccCCCCCC--------CcccccccCChhhhhcccCChHHHHHhcchhh
Q 021306 256 VLGTPTREEIR------CMNPNYTD--------FRFPQIKAHPWHKVCIFHFPKHWLLEYGSHIN 306 (314)
Q Consensus 256 ~~~~~~~~~~~------~~~p~~~~--------~~~~~l~~~p~~~~~~~~~~~~~~~~~~~~~~ 306 (314)
....+....+. ...|.+.. ..+.+++..||...+..+++...+++.++.+.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~ 317 (322)
T 3soc_A 253 IGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQ 317 (322)
T ss_dssp HCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred hccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 11112211111 01111111 11667888888888888888888888877654
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=283.97 Aligned_cols=246 Identities=26% Similarity=0.391 Sum_probs=186.6
Q ss_pred CCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHhCCCCceeeeceeeeecCC--------
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMDHPNVISLKHCFFSTTS-------- 105 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-------- 105 (314)
.++|++.+.||+|+||.||+|++..+++.|++|.+.... ....+|+.++++++||||+++++++.....
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAV 84 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhccc
Confidence 457999999999999999999999999999999986543 234589999999999999999998765321
Q ss_pred CCceeEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEee
Q 021306 106 KNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICD 184 (314)
Q Consensus 106 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~d 184 (314)
......++||||+++ +|.+.+.. ....+++..++.++.|++.||.+||+ +|++|+||+|+||+++. ++.++|+|
T Consensus 85 ~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~-~~i~H~dlkp~Nil~~~-~~~~kl~d 159 (303)
T 1zy4_A 85 KKKSTLFIQMEYCENGTLYDLIHS---ENLNQQRDEYWRLFRQILEALSYIHS-QGIIHRDLKPMNIFIDE-SRNVKIGD 159 (303)
T ss_dssp -CEEEEEEEEECCCSCBHHHHHHH---SCGGGCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECT-TSCEEECC
T ss_pred ccCCceEEEEecCCCCCHHHhhhc---cccccchHHHHHHHHHHHHHHHHHHh-CCeecccCCHHhEEEcC-CCCEEEee
Confidence 235568899999985 78777764 34578899999999999999999999 89999999999999998 78899999
Q ss_pred cCcccccccC---------------CccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 021306 185 FGSAKQLIAG---------------EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQ 249 (314)
Q Consensus 185 fg~~~~~~~~---------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~ 249 (314)
||.+...... .......+++.|+|||.+.+...++.++||||||+++|+|++ ||........
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~ 236 (303)
T 1zy4_A 160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVN 236 (303)
T ss_dssp CCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHH
T ss_pred CcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHH
Confidence 9998755321 112234578899999999766568999999999999999998 6654333222
Q ss_pred HHHHHHHcCCC-C-----------HHHHh---ccCCCCCCCcccccccCChhhhhcc
Q 021306 250 LVEIIKVLGTP-T-----------REEIR---CMNPNYTDFRFPQIKAHPWHKVCIF 291 (314)
Q Consensus 250 ~~~i~~~~~~~-~-----------~~~~~---~~~p~~~~~~~~~l~~~p~~~~~~~ 291 (314)
....+...... + .+.+. ..+|. +|+++.++++|||++....
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~-~Rps~~~ll~h~~~~~~~~ 292 (303)
T 1zy4_A 237 ILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPN-KRPGARTLLNSGWLPVKHQ 292 (303)
T ss_dssp HHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGG-GSCCHHHHHHSSCSCCCCH
T ss_pred HHHhccccccccCccccccchHHHHHHHHHHHhcCcc-cCcCHHHHhCCCCcCCCCh
Confidence 33333221111 0 11222 23666 8999999999999976543
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=285.39 Aligned_cols=262 Identities=27% Similarity=0.420 Sum_probs=191.8
Q ss_pred ccCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCC
Q 021306 35 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKN 107 (314)
Q Consensus 35 ~~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 107 (314)
...++|++.+.||+|+||.||+|.+..+++.|++|.+.... ....+|+.++++++|+||+++++++....
T Consensus 29 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--- 105 (310)
T 2wqm_A 29 NTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDN--- 105 (310)
T ss_dssp SSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT---
T ss_pred ccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC---
Confidence 45578999999999999999999999999999999986421 23458999999999999999999886533
Q ss_pred ceeEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecC
Q 021306 108 ELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 186 (314)
Q Consensus 108 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg 186 (314)
..+++|||+.+ +|.+.+.........+++..++.++.|++.||.+||+ +|++|+||+|+||+++. ++.++|+|||
T Consensus 106 --~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~i~H~dl~p~NIl~~~-~~~~kl~Dfg 181 (310)
T 2wqm_A 106 --ELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHS-RRVMHRDIKPANVFITA-TGVVKLGDLG 181 (310)
T ss_dssp --EEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECT-TSCEEECCC-
T ss_pred --cEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhh-CCeeCCCCcHHHEEEcC-CCCEEEEecc
Confidence 38899999986 8888777665567789999999999999999999999 89999999999999998 8899999999
Q ss_pred cccccccCCc-cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHcCCCCHHH
Q 021306 187 SAKQLIAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV-DQLVEIIKVLGTPTREE 264 (314)
Q Consensus 187 ~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~-~~~~~i~~~~~~~~~~~ 264 (314)
++........ .....+++.|+|||.+.+.. ++.++||||||+++|+|++|+.||.+.... ..+...+.....+.
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--- 257 (310)
T 2wqm_A 182 LGRFFSSKTTAAHSLVGTPYYMSPERIHENG-YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPP--- 257 (310)
T ss_dssp -----------------CCSSCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCC---
T ss_pred ceeeecCCCccccccCCCeeEeChHHhCCCC-CCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCC---
Confidence 9875543222 23356788999999986544 899999999999999999999999765321 22222222211111
Q ss_pred HhccCCCCCCCcccccccCChhhhhcccCChHHHHHhcchhhhcCC
Q 021306 265 IRCMNPNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGSHINAISP 310 (314)
Q Consensus 265 ~~~~~p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (314)
..+......+.+++..+|...+..+.....+++.++.+....+
T Consensus 258 ---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~ 300 (310)
T 2wqm_A 258 ---LPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTA 300 (310)
T ss_dssp ---CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred ---CcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhh
Confidence 0111112246677888888888888888888888777765443
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=279.31 Aligned_cols=250 Identities=21% Similarity=0.325 Sum_probs=196.1
Q ss_pred cCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeEE
Q 021306 36 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 112 (314)
Q Consensus 36 ~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 112 (314)
..++|++.+.||+|+||.||++++. +++.|++|.+.... ....+|+.++++++||||+++++++... ...+
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~~ 81 (269)
T 4hcu_A 8 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ-----APIC 81 (269)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSS-----SSEE
T ss_pred ChhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEecC-----CceE
Confidence 3468999999999999999999976 57789999987543 3356899999999999999999988433 3388
Q ss_pred EEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCccccc
Q 021306 113 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 191 (314)
Q Consensus 113 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~ 191 (314)
+||||+++ +|.+.+.. ....+++..++.++.|++.||.+||+ +|++|+||||+||+++. ++.++|+|||++...
T Consensus 82 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~lH~-~~i~H~dikp~Nil~~~-~~~~kl~Dfg~~~~~ 156 (269)
T 4hcu_A 82 LVFEFMEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEE-ACVIHRDLAARNCLVGE-NQVIKVSDFGMTRFV 156 (269)
T ss_dssp EEEECCTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECG-GGCEEECCTTGGGGB
T ss_pred EEEEeCCCCcHHHHHHh---cCcccCHHHHHHHHHHHHHHHHHHHh-CCeecCCcchheEEEcC-CCCEEeccccccccc
Confidence 99999986 67666643 34579999999999999999999999 89999999999999987 788999999998754
Q ss_pred ccCC--ccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCHHHHhcc
Q 021306 192 IAGE--ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 268 (314)
Q Consensus 192 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 268 (314)
.... ......+++.|+|||.+.+.. ++.++||||||+++|+|++ |+.||.+.+..+....+........
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~------- 228 (269)
T 4hcu_A 157 LDDQYTSSTGTKFPVKWASPEVFSFSR-YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK------- 228 (269)
T ss_dssp CCHHHHSTTSTTCCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCC-------
T ss_pred cccccccccCcccccccCCHHHhcCCC-CCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCCC-------
Confidence 3321 122344567899999996554 8999999999999999999 9999999888776666654322221
Q ss_pred CCCCCCCcccccccCChhhhhcccCChHHHHHhcchh
Q 021306 269 NPNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGSHI 305 (314)
Q Consensus 269 ~p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~~~ 305 (314)
|......+.+++..+|...+..++....+++.++.+
T Consensus 229 -~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l 264 (269)
T 4hcu_A 229 -PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI 264 (269)
T ss_dssp -CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -CCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHH
Confidence 221233456677777777777777777777666544
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=282.31 Aligned_cols=258 Identities=22% Similarity=0.244 Sum_probs=191.1
Q ss_pred CccCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeecc--ccchHHHHHHHHhCCCCceeeeceeeeecCCCCceeE
Q 021306 34 PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD--RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 111 (314)
Q Consensus 34 ~~~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 111 (314)
....++|++.+.||+|+||.||+|++..+++.||+|.+... .....+|..+++.++|++++..+..+... ....
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~----~~~~ 80 (296)
T 4hgt_A 5 LRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAE----GDYN 80 (296)
T ss_dssp ------CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---CCCHHHHHHHHHHHTTSTTCCCEEEEEEE----TTEE
T ss_pred cccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccchHHHHHHHHHHHhcCCCCCCeeeeecCC----CCce
Confidence 34567899999999999999999999999999999986543 34567899999999999888877665432 2247
Q ss_pred EEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEE---cCCCCcEEEeecCcc
Q 021306 112 NLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLV---DPLTHQVKICDFGSA 188 (314)
Q Consensus 112 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~---~~~~~~~~l~dfg~~ 188 (314)
+++|||+.++|.+.+.. ....+++.+++.++.|++.||.|||+ +||+|+||||+||++ +. ++.++|+|||++
T Consensus 81 ~lv~e~~~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~-~~ivH~Dlkp~NIl~~~~~~-~~~~kL~Dfg~a 155 (296)
T 4hgt_A 81 VMVMELLGPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHS-KNFIHRDVKPDNFLMGLGKK-GNLVYIIDFGLA 155 (296)
T ss_dssp EEEEECCCCBHHHHHHH---TTSCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECCGGG-TTCEEECCCTTC
T ss_pred EEEEEccCCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeeeeccCC-CCeEEEecCccc
Confidence 89999998888887764 24679999999999999999999999 899999999999999 55 778999999999
Q ss_pred cccccCCc--------cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHc
Q 021306 189 KQLIAGEA--------NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV---DQLVEIIKVL 257 (314)
Q Consensus 189 ~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~---~~~~~i~~~~ 257 (314)
........ .....+++.|+|||.+.+.. ++.++||||||+++|+|++|+.||.+.+.. ..+..+....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 234 (296)
T 4hgt_A 156 KKYRDARTHQHIPYRENKNLTGTARYASINTHLGIE-QSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK 234 (296)
T ss_dssp EECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHH
T ss_pred eeccCcccCccCCCCcccccCCCccccchHHhcCCC-CCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhccc
Confidence 76544322 22456789999999997655 899999999999999999999999875332 2333333322
Q ss_pred CCCCHHHH-hccCCCCCCCcccccccCChhhhhcccCChHHHHHhcchhh
Q 021306 258 GTPTREEI-RCMNPNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGSHIN 306 (314)
Q Consensus 258 ~~~~~~~~-~~~~p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~~~~ 306 (314)
...+.... ..+++ .+.+++..+|...+..+++...+.+.++.+.
T Consensus 235 ~~~~~~~~~~~~~~-----~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~ 279 (296)
T 4hgt_A 235 MSTPIEVLCKGYPS-----EFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 279 (296)
T ss_dssp HHSCHHHHTTTSCH-----HHHHHHHHHHTSCTTCCCCHHHHHHHHHHHH
T ss_pred ccchhhhhhccCCH-----HHHHHHHHHHhcCCCCCCCHHHHHHHHHHHH
Confidence 22222211 12222 3556666666666666666666666655443
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=276.67 Aligned_cols=252 Identities=20% Similarity=0.304 Sum_probs=200.2
Q ss_pred cCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeEE
Q 021306 36 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 112 (314)
Q Consensus 36 ~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 112 (314)
..++|++.+.||+|+||.||++++. ++..||+|.++... ....+|+.++++++||||+++++++.. ....+
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~~~ 79 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSK-----EYPIY 79 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEECS-----SSSEE
T ss_pred chhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEEcc-----CCceE
Confidence 4568999999999999999999865 67789999987543 334689999999999999999998833 33488
Q ss_pred EEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCccccc
Q 021306 113 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 191 (314)
Q Consensus 113 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~ 191 (314)
+||||+++ +|.+.+... ...+++.+++.++.|++.||.+||+ +|++|+||||+||+++. ++.++|+|||.+...
T Consensus 80 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dikp~Nil~~~-~~~~~l~Dfg~~~~~ 154 (268)
T 3sxs_A 80 IVTEYISNGCLLNYLRSH---GKGLEPSQLLEMCYDVCEGMAFLES-HQFIHRDLAARNCLVDR-DLCVKVSDFGMTRYV 154 (268)
T ss_dssp EEEECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHH-TTEEESSCSGGGEEECT-TCCEEECCTTCEEEC
T ss_pred EEEEccCCCcHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCcCcceEEECC-CCCEEEccCccceec
Confidence 99999985 677766542 3569999999999999999999999 89999999999999998 889999999998755
Q ss_pred ccCCc--cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCHHHHhcc
Q 021306 192 IAGEA--NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 268 (314)
Q Consensus 192 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 268 (314)
..... .....+++.|+|||.+.+.. ++.++||||||+++|+|++ |+.||...+..+....+.+......
T Consensus 155 ~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~------- 226 (268)
T 3sxs_A 155 LDDQYVSSVGTKFPVKWSAPEVFHYFK-YSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYR------- 226 (268)
T ss_dssp CTTCEEECCSCCCCGGGCCHHHHHHSE-EETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCC-------
T ss_pred chhhhhcccCCCcCcccCCHHHHhccC-CchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCC-------
Confidence 43322 12234466799999996544 7899999999999999999 9999998887766665544322211
Q ss_pred CCCCCCCcccccccCChhhhhcccCChHHHHHhcchhhh
Q 021306 269 NPNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGSHINA 307 (314)
Q Consensus 269 ~p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~~~~~ 307 (314)
|......+.+++..+|...+..+++...+++.++.+.-
T Consensus 227 -~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (268)
T 3sxs_A 227 -PHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264 (268)
T ss_dssp -CTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred -CCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence 22223346778888888888888888888888776653
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=280.53 Aligned_cols=250 Identities=22% Similarity=0.354 Sum_probs=189.4
Q ss_pred ccCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc-----------cchHHHHHHHHhCCCCceeeeceeeeec
Q 021306 35 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----------RYKNRELQLMRVMDHPNVISLKHCFFST 103 (314)
Q Consensus 35 ~~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~-----------~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 103 (314)
...++|++.+.||+|+||.||+|++..+++.||+|.+.... ....+|+.++++++||||+++++++.
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-- 93 (287)
T 4f0f_A 16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMH-- 93 (287)
T ss_dssp CCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEET--
T ss_pred hhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeec--
Confidence 34568999999999999999999999999999999985322 33468999999999999999999873
Q ss_pred CCCCceeEEEEeeccc-ccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCC--ceecCCCCCcEEEcCCCCc-
Q 021306 104 TSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR--VCHRDLKPQNLLVDPLTHQ- 179 (314)
Q Consensus 104 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~--i~h~dl~p~Nil~~~~~~~- 179 (314)
... ++||||++ ++|.+.+.. ....+++..++.++.|++.||.|||+ +| ++|+||||+||+++. ++.
T Consensus 94 ---~~~--~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~l~~~l~~lH~-~~~~ivH~dikp~Nil~~~-~~~~ 163 (287)
T 4f0f_A 94 ---NPP--RMVMEFVPCGDLYHRLLD---KAHPIKWSVKLRLMLDIALGIEYMQN-QNPPIVHRDLRSPNIFLQS-LDEN 163 (287)
T ss_dssp ---TTT--EEEEECCTTCBHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHT-SSSCCBCSCCSGGGEEESC-CCTT
T ss_pred ---CCC--eEEEEecCCCCHHHHHhc---ccCCccHHHHHHHHHHHHHHHHHHHh-CCCCeecCCCCcceEEEec-cCCC
Confidence 222 48999998 577666653 34679999999999999999999999 89 999999999999987 444
Q ss_pred ----EEEeecCcccccccCCccccccccccccccccccC-CCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHH-HHH
Q 021306 180 ----VKICDFGSAKQLIAGEANISYICSRFYRAPELIFG-ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQL-VEI 253 (314)
Q Consensus 180 ----~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~-~~i 253 (314)
++|+|||++..... ......+++.|+|||.+.+ ...++.++||||||+++|+|++|+.||...+..... ...
T Consensus 164 ~~~~~kl~Dfg~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 241 (287)
T 4f0f_A 164 APVCAKVADFGLSQQSVH--SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINM 241 (287)
T ss_dssp CSCCEEECCCTTCBCCSS--CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHH
T ss_pred CceeEEeCCCCccccccc--cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHH
Confidence 99999999875432 3334567999999999843 233688999999999999999999999876544332 222
Q ss_pred HHHcCCCCHHHHhccCCCCCCCcccccccCChhhhhcccCChHHHHHhcch
Q 021306 254 IKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGSH 304 (314)
Q Consensus 254 ~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~~ 304 (314)
........ . + |......+.+++..+|...+..+++...+++.++.
T Consensus 242 ~~~~~~~~-~----~-~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 242 IREEGLRP-T----I-PEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp HHHSCCCC-C----C-CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred HhccCCCC-C----C-CcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 22111110 0 1 11122345667777777777777777777766543
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=285.33 Aligned_cols=207 Identities=27% Similarity=0.442 Sum_probs=155.7
Q ss_pred CCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc----cchHHHHHHHHhCC-CCceeeeceeeeecCC---CCce
Q 021306 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMD-HPNVISLKHCFFSTTS---KNEL 109 (314)
Q Consensus 38 ~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~----~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~---~~~~ 109 (314)
.+|++.+.||+|+||.||+|++..+++.||+|.+.... ....+|+.+++++. ||||+++++++..... ....
T Consensus 28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~ 107 (337)
T 3ll6_A 28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQA 107 (337)
T ss_dssp EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSE
T ss_pred ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCc
Confidence 48999999999999999999999999999999885432 23457888999996 9999999998754322 3455
Q ss_pred eEEEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCC--ceecCCCCCcEEEcCCCCcEEEeecCc
Q 021306 110 FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR--VCHRDLKPQNLLVDPLTHQVKICDFGS 187 (314)
Q Consensus 110 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~--i~h~dl~p~Nil~~~~~~~~~l~dfg~ 187 (314)
.+++++||+.|+|.+.+... ....++++.+++.++.||+.||.|||+ +| |+|+||||+||+++. ++.++|+|||+
T Consensus 108 ~~~lv~e~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~~~ivH~Dikp~NIl~~~-~~~~kl~Dfg~ 184 (337)
T 3ll6_A 108 EFLLLTELCKGQLVEFLKKM-ESRGPLSCDTVLKIFYQTCRAVQHMHR-QKPPIIHRDLKVENLLLSN-QGTIKLCDFGS 184 (337)
T ss_dssp EEEEEEECCSEEHHHHHHHH-HTTCSCCHHHHHHHHHHHHHHHHHHHT-SSSCCBCCCCCGGGCEECT-TSCEEBCCCTT
T ss_pred eEEEEEEecCCCHHHHHHHh-hccCCCCHHHHHHHHHHHHHHHHHHHh-CCCCEEEccCCcccEEECC-CCCEEEecCcc
Confidence 68899999999998887653 235679999999999999999999999 89 999999999999998 78999999999
Q ss_pred ccccccCCcc-------------cccccccccccccccc--CCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChH
Q 021306 188 AKQLIAGEAN-------------ISYICSRFYRAPELIF--GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV 247 (314)
Q Consensus 188 ~~~~~~~~~~-------------~~~~~~~~y~aPE~~~--~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~ 247 (314)
+......... ....+++.|+|||.+. ....++.++||||||+++|+|++|+.||......
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~ 259 (337)
T 3ll6_A 185 ATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL 259 (337)
T ss_dssp CBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC------
T ss_pred ceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH
Confidence 9765432211 1345788999999983 2334788999999999999999999999765543
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=289.65 Aligned_cols=249 Identities=22% Similarity=0.347 Sum_probs=179.1
Q ss_pred CCccCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeecccc------chHHHHHHHHhCCCCceeeeceeeeecCCC
Q 021306 33 EPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR------YKNRELQLMRVMDHPNVISLKHCFFSTTSK 106 (314)
Q Consensus 33 ~~~~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~~------~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 106 (314)
-....++|++.+.||+|+||.||+|++..+++.|++|.+..... ...++..+++.++||||+++++++...
T Consensus 20 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~--- 96 (318)
T 2dyl_A 20 YQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITN--- 96 (318)
T ss_dssp EECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS---
T ss_pred hhhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecC---
Confidence 34456789999999999999999999999999999999875432 122444567888999999999988543
Q ss_pred CceeEEEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCC-CceecCCCCCcEEEcCCCCcEEEeec
Q 021306 107 NELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP-RVCHRDLKPQNLLVDPLTHQVKICDF 185 (314)
Q Consensus 107 ~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~-~i~h~dl~p~Nil~~~~~~~~~l~df 185 (314)
...++||||+++.+...... ....+++..++.++.|++.||.|||+ + |++|+||+|+||+++. ++.++|+||
T Consensus 97 --~~~~lv~e~~~~~~~~l~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~-~~~i~H~dlkp~Nil~~~-~~~~kl~df 169 (318)
T 2dyl_A 97 --TDVFIAMELMGTCAEKLKKR---MQGPIPERILGKMTVAIVKALYYLKE-KHGVIHRDVKPSNILLDE-RGQIKLCDF 169 (318)
T ss_dssp --SEEEEEECCCSEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHH-HHCCCCCCCCGGGEEECT-TSCEEECCC
T ss_pred --CcEEEEEeccCCcHHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHh-hCCEEeCCCCHHHEEECC-CCCEEEEEC
Confidence 34889999996555444332 25789999999999999999999998 6 9999999999999998 789999999
Q ss_pred CcccccccCCccccccccccccccccccC----CCCCCcchhHHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHHHHcCCC
Q 021306 186 GSAKQLIAGEANISYICSRFYRAPELIFG----ATEYTTSIDIWSAGCVLAELLLGQPLFPGE-NAVDQLVEIIKVLGTP 260 (314)
Q Consensus 186 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~~Dv~slG~il~el~tg~~pf~~~-~~~~~~~~i~~~~~~~ 260 (314)
|++.............+++.|+|||.+.+ ...++.++||||||+++|+|++|+.||... ...+.+..+.+.....
T Consensus 170 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 249 (318)
T 2dyl_A 170 GISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPL 249 (318)
T ss_dssp TTC--------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCC
T ss_pred CCchhccCCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCC
Confidence 99976655444445678999999999852 334788999999999999999999999874 4444455555442221
Q ss_pred -------CH---HHHh-c--cCCCCCCCcccccccCChhhhhccc
Q 021306 261 -------TR---EEIR-C--MNPNYTDFRFPQIKAHPWHKVCIFH 292 (314)
Q Consensus 261 -------~~---~~~~-~--~~p~~~~~~~~~l~~~p~~~~~~~~ 292 (314)
+. +.+. + .+|. +|+++.++++|||++.....
T Consensus 250 ~~~~~~~~~~l~~li~~~l~~dp~-~Rps~~~ll~h~~~~~~~~~ 293 (318)
T 2dyl_A 250 LPGHMGFSGDFQSFVKDCLTKDHR-KRPKYNKLLEHSFIKRYETL 293 (318)
T ss_dssp CCSSSCCCHHHHHHHHHHTCSCTT-TSCCHHHHTTSHHHHHHHHS
T ss_pred CCccCCCCHHHHHHHHHHccCChh-HCcCHHHHhhCHHHHhcccc
Confidence 11 1122 2 3676 89999999999999876543
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=289.72 Aligned_cols=264 Identities=14% Similarity=0.118 Sum_probs=194.2
Q ss_pred cCCCceeeeeEeecCceEEEEEEECC---CCcEEEEEEeeccccc---------------hHHHHHHHHhCCCCceeeec
Q 021306 36 QTISYMAERVVGTGSFGIVFQAKCLE---TGETVAIKKVLQDRRY---------------KNRELQLMRVMDHPNVISLK 97 (314)
Q Consensus 36 ~~~~y~~~~~Lg~g~~g~Vy~~~~~~---~~~~~~vK~~~~~~~~---------------~~~e~~~l~~l~h~~iv~~~ 97 (314)
..++|++.+.||+|+||.||+|++.. ++..+++|.+...... ..+|+..++.++|+||++++
T Consensus 35 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~ 114 (345)
T 2v62_A 35 EGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFY 114 (345)
T ss_dssp TSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEE
T ss_pred cCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceee
Confidence 34689999999999999999999987 7889999998754322 23566777888999999999
Q ss_pred eeeeecCCCCceeEEEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCC
Q 021306 98 HCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLT 177 (314)
Q Consensus 98 ~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~ 177 (314)
+++.... ....+.++||||+.++|.+.+.. ...+++.+++.++.||+.||.|||+ +||+||||||+||+++. +
T Consensus 115 ~~~~~~~-~~~~~~~lv~e~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~-~ 187 (345)
T 2v62_A 115 GSGLTEF-KGRSYRFMVMERLGIDLQKISGQ----NGTFKKSTVLQLGIRMLDVLEYIHE-NEYVHGDIKAANLLLGY-K 187 (345)
T ss_dssp EEEEEES-SSCEEEEEEEECEEEEHHHHCBG----GGBCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEES-S
T ss_pred ccccccc-CCCcEEEEEEeccCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCcCHHHEEEcc-C
Confidence 9886532 23456889999996677766543 3489999999999999999999999 89999999999999987 4
Q ss_pred C--cEEEeecCcccccccCCc--------cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCC-Ch
Q 021306 178 H--QVKICDFGSAKQLIAGEA--------NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE-NA 246 (314)
Q Consensus 178 ~--~~~l~dfg~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~-~~ 246 (314)
+ .++|+|||+++....... .....+++.|+|||.+.+.. ++.++||||||+++|+|++|+.||.+. ..
T Consensus 188 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~g~~pf~~~~~~ 266 (345)
T 2v62_A 188 NPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVA-LSRRSDVEILGYCMLRWLCGKLPWEQNLKD 266 (345)
T ss_dssp STTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCC-CCHHHHHHHHHHHHHHHHHSSCTTGGGTTC
T ss_pred CCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCC-CCchhhHHHHHHHHHHHHhCCCCccccccc
Confidence 4 899999999976532211 13456789999999997654 899999999999999999999999653 22
Q ss_pred HHHHHHHHHHcCCCCHHHHhccCC-CCCCCcccccccCChhhhhcccCChHHHHHhcchhhh
Q 021306 247 VDQLVEIIKVLGTPTREEIRCMNP-NYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGSHINA 307 (314)
Q Consensus 247 ~~~~~~i~~~~~~~~~~~~~~~~p-~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~~~~~ 307 (314)
...............+..+....+ ......+.+++..+|...+..++....+++.++....
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 267 PVAVQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp HHHHHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred cHHHHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence 223333333322222333322222 1123357788888888888888888888888876554
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-40 Score=286.68 Aligned_cols=287 Identities=21% Similarity=0.295 Sum_probs=201.3
Q ss_pred hhhhhhheecCCCceeeeeeeccccCCCCCCccCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeecc----ccchH
Q 021306 4 DKEMSAAVVDGSDHVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD----RRYKN 79 (314)
Q Consensus 4 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~----~~~~~ 79 (314)
++++...+..|.+...+..... ..++|++.+.||+|+||.||++++..+++.||+|.+... .....
T Consensus 5 ~~~~~~~~~~~~~~~~g~~~~i----------~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~ 74 (317)
T 2buj_A 5 HHHHHHSSGRENLYFQGHMVII----------DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQ 74 (317)
T ss_dssp -----------CCSEEEEEEEE----------TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHH
T ss_pred cccccccccccceeecccEEEE----------CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHH
Confidence 3344444455555555554322 234899999999999999999999999999999988543 23346
Q ss_pred HHHHHHHhCCCCceeeeceeeeecCCCCceeEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcC
Q 021306 80 RELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV 158 (314)
Q Consensus 80 ~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~ 158 (314)
+|+.++++++||||+++++++.... ......++|+||+.+ +|.+.+......+..+++.+++.++.||+.||.|||+
T Consensus 75 ~E~~~l~~l~h~~iv~~~~~~~~~~-~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~- 152 (317)
T 2buj_A 75 READMHRLFNHPNILRLVAYCLRER-GAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA- 152 (317)
T ss_dssp HHHHHHHTCCCTTBCCCCEEEEEEE-TTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH-
T ss_pred HHHHHHhhcCCCCeeeEEEEEEecc-CCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-
Confidence 8999999999999999999885432 234457899999996 8888887765567889999999999999999999999
Q ss_pred CCceecCCCCCcEEEcCCCCcEEEeecCcccccccCCcc----------ccccccccccccccccCCC--CCCcchhHHH
Q 021306 159 PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN----------ISYICSRFYRAPELIFGAT--EYTTSIDIWS 226 (314)
Q Consensus 159 ~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~~~~~~----------~~~~~~~~y~aPE~~~~~~--~~~~~~Dv~s 226 (314)
+|++|+||||+||+++. ++.++|+|||.+......... ....+++.|+|||.+.+.. .++.++||||
T Consensus 153 ~~ivH~dlkp~NIl~~~-~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~s 231 (317)
T 2buj_A 153 KGYAHRDLKPTNILLGD-EGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWS 231 (317)
T ss_dssp TTEECCCCCGGGEEECT-TSCEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHH
T ss_pred CCcccCCCCHHHEEEcC-CCCEEEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHH
Confidence 89999999999999988 788999999988654321111 1234588999999986433 2588999999
Q ss_pred HHHHHHHHHhCCCCCCCCChH-HHHHHHHHHcCCCCHHHHhccCCCCCCCcccccccCChhhhhcccCChHHHHHhcchh
Q 021306 227 AGCVLAELLLGQPLFPGENAV-DQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGSHI 305 (314)
Q Consensus 227 lG~il~el~tg~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~~~ 305 (314)
||+++|+|++|+.||...... .............+ ..+. ....+.+++..+|...+..+++...+++.++.+
T Consensus 232 lG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~------~~~~-~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~ 304 (317)
T 2buj_A 232 LGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSIP------QSPR-HSSALWQLLNSMMTVDPHQRPHIPLLLSQLEAL 304 (317)
T ss_dssp HHHHHHHHHHSSCTTHHHHHTTSCHHHHHHCC--CC------CCTT-SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred HHHHHHHHHhCCCChhhhhcccchhhHHhhccCCCC------cccc-CCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhc
Confidence 999999999999999542110 01111111100000 0111 123456677777777777777777788777766
Q ss_pred hhcCC
Q 021306 306 NAISP 310 (314)
Q Consensus 306 ~~~~~ 310 (314)
....|
T Consensus 305 ~~~~~ 309 (317)
T 2buj_A 305 QPPAP 309 (317)
T ss_dssp CCCCC
T ss_pred CCCCC
Confidence 65444
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=280.40 Aligned_cols=247 Identities=26% Similarity=0.419 Sum_probs=186.8
Q ss_pred CCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeEE
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 112 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 112 (314)
.++|.....||+|+||.||+|++..+++.|++|.+.... ....+|+.+++.++||||+++++++.... ..+
T Consensus 21 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~~~ 95 (295)
T 2clq_A 21 YDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENG-----FIK 95 (295)
T ss_dssp BCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETT-----EEE
T ss_pred ccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCC-----cEE
Confidence 345666669999999999999999999999999986543 33468999999999999999999885433 478
Q ss_pred EEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCccccc
Q 021306 113 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 191 (314)
Q Consensus 113 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~ 191 (314)
+||||+++ +|.+.+... .....+++..++.++.|++.||.+||+ +|++|+||+|+||+++..++.++|+|||.+...
T Consensus 96 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~ 173 (295)
T 2clq_A 96 IFMEQVPGGSLSALLRSK-WGPLKDNEQTIGFYTKQILEGLKYLHD-NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRL 173 (295)
T ss_dssp EEEECCSEEEHHHHHHHT-TCCCTTCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEETTTCCEEECCTTTCEES
T ss_pred EEEEeCCCCCHHHHHHhh-ccCCCccHHHHHHHHHHHHHHHHHHHh-CCEEccCCChhhEEEECCCCCEEEeeccccccc
Confidence 99999975 676666542 223467899999999999999999999 899999999999999876778999999998765
Q ss_pred ccCC-ccccccccccccccccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHH-HHHHHH-cCCC-----CH
Q 021306 192 IAGE-ANISYICSRFYRAPELIFGA-TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQL-VEIIKV-LGTP-----TR 262 (314)
Q Consensus 192 ~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~-~~i~~~-~~~~-----~~ 262 (314)
.... ......+++.|+|||.+.+. ..++.++||||||+++|+|++|+.||......... ...... .... ..
T Consensus 174 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (295)
T 2clq_A 174 AGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSA 253 (295)
T ss_dssp CC-----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCTTSCH
T ss_pred CCCCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccccccCCH
Confidence 4322 22345678899999998653 23788999999999999999999999765433222 222111 1111 11
Q ss_pred ---HHHh---ccCCCCCCCcccccccCChhhhhcc
Q 021306 263 ---EEIR---CMNPNYTDFRFPQIKAHPWHKVCIF 291 (314)
Q Consensus 263 ---~~~~---~~~p~~~~~~~~~l~~~p~~~~~~~ 291 (314)
+.+. ..+|. +|+++.++++|||++....
T Consensus 254 ~~~~li~~~l~~dp~-~Rps~~~ll~~~~~~~~~~ 287 (295)
T 2clq_A 254 EAKAFILKCFEPDPD-KRACANDLLVDEFLKVSSK 287 (295)
T ss_dssp HHHHHHHHTTCSSTT-TSCCHHHHHTSGGGCC---
T ss_pred HHHHHHHHHccCChh-hCCCHHHHhcChhhhhccc
Confidence 1222 23676 8999999999999987654
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=284.93 Aligned_cols=240 Identities=24% Similarity=0.401 Sum_probs=190.4
Q ss_pred CccCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc----------cchHHHHHHHHhCC--CCceeeeceeee
Q 021306 34 PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----------RYKNRELQLMRVMD--HPNVISLKHCFF 101 (314)
Q Consensus 34 ~~~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~----------~~~~~e~~~l~~l~--h~~iv~~~~~~~ 101 (314)
....++|++.+.||+|+||.||+|++..+++.||+|.+.... ....+|+.++++++ |+||+++++++.
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~ 118 (320)
T 3a99_A 39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE 118 (320)
T ss_dssp -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence 344568999999999999999999999999999999986542 33458999999996 599999999885
Q ss_pred ecCCCCceeEEEEeeccc--ccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCc
Q 021306 102 STTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQ 179 (314)
Q Consensus 102 ~~~~~~~~~~~lv~e~~~--~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~ 179 (314)
.. ...++++|++. ++|.+.+.. ...+++..++.++.|++.||.|||+ +||+|+||||+||+++..++.
T Consensus 119 ~~-----~~~~lv~e~~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dlkp~NIll~~~~~~ 188 (320)
T 3a99_A 119 RP-----DSFVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHN-CGVLHRDIKDENILIDLNRGE 188 (320)
T ss_dssp CS-----SEEEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEETTTTE
T ss_pred cC-----CcEEEEEEcCCCCccHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcEeCCCCHHHEEEeCCCCC
Confidence 43 34789999997 577777654 4689999999999999999999999 899999999999999954789
Q ss_pred EEEeecCcccccccCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHc--
Q 021306 180 VKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVL-- 257 (314)
Q Consensus 180 ~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~-- 257 (314)
++|+|||++...... ......+++.|+|||.+.+....+.++||||||+++|+|++|+.||..... +....
T Consensus 189 ~kL~Dfg~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~------~~~~~~~ 261 (320)
T 3a99_A 189 LKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVF 261 (320)
T ss_dssp EEECCCTTCEECCSS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHHCCCC
T ss_pred EEEeeCccccccccc-cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh------hhccccc
Confidence 999999998765432 233456799999999987665457889999999999999999999965421 11110
Q ss_pred -CCC-C---HHHH---hccCCCCCCCcccccccCChhhhhcc
Q 021306 258 -GTP-T---REEI---RCMNPNYTDFRFPQIKAHPWHKVCIF 291 (314)
Q Consensus 258 -~~~-~---~~~~---~~~~p~~~~~~~~~l~~~p~~~~~~~ 291 (314)
... . .+.+ ...+|. +|+++.++++|||++....
T Consensus 262 ~~~~~~~~~~~li~~~l~~dp~-~Rps~~~ll~hp~~~~~~~ 302 (320)
T 3a99_A 262 FRQRVSSECQHLIRWCLALRPS-DRPTFEEIQNHPWMQDVLL 302 (320)
T ss_dssp CSSCCCHHHHHHHHHHTCSSGG-GSCCHHHHHTSGGGSSCCC
T ss_pred ccccCCHHHHHHHHHHccCChh-hCcCHHHHhcCHhhcCccC
Confidence 000 1 1112 233666 8999999999999987653
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-40 Score=290.25 Aligned_cols=255 Identities=24% Similarity=0.311 Sum_probs=199.1
Q ss_pred cCCCceeeeeEeecCceEEEEEEEC-----CCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCC
Q 021306 36 QTISYMAERVVGTGSFGIVFQAKCL-----ETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTS 105 (314)
Q Consensus 36 ~~~~y~~~~~Lg~g~~g~Vy~~~~~-----~~~~~~~vK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 105 (314)
..++|++.+.||+|+||.||+|++. .+++.|++|.++... ....+|+.++++++||||+++++++...
T Consensus 45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-- 122 (343)
T 1luf_A 45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVG-- 122 (343)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS--
T ss_pred cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccC--
Confidence 3468999999999999999999987 345899999987542 2346899999999999999999988443
Q ss_pred CCceeEEEEeecccc-cHHHHHHhhhhc--------------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCceec
Q 021306 106 KNELFLNLVMEYVPE-SMYRVLKHYSSA--------------------NQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 164 (314)
Q Consensus 106 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~--------------------~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~ 164 (314)
...++||||+++ +|.+.+...... ...+++.+++.++.||+.||.|||+ +||+|+
T Consensus 123 ---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~ivH~ 198 (343)
T 1luf_A 123 ---KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE-RKFVHR 198 (343)
T ss_dssp ---SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH-TTCCCS
T ss_pred ---CceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCeecC
Confidence 337899999986 788777653211 2679999999999999999999999 899999
Q ss_pred CCCCCcEEEcCCCCcEEEeecCcccccccCC---ccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCC
Q 021306 165 DLKPQNLLVDPLTHQVKICDFGSAKQLIAGE---ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPL 240 (314)
Q Consensus 165 dl~p~Nil~~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~t-g~~p 240 (314)
||||+||+++. ++.++|+|||++....... ......+++.|+|||.+.+.. ++.++||||||+++|+|++ |..|
T Consensus 199 Dlkp~NIl~~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~p 276 (343)
T 1luf_A 199 DLATRNCLVGE-NMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNR-YTTESDVWAYGVVLWEIFSYGLQP 276 (343)
T ss_dssp CCSGGGEEECG-GGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred CCCcceEEECC-CCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCC-cCcccccHHHHHHHHHHHhcCCCc
Confidence 99999999997 7899999999987543321 122345688899999987654 8999999999999999999 9999
Q ss_pred CCCCChHHHHHHHHHHcCCCCHHHHhccCCCCCCCcccccccCChhhhhcccCChHHHHHhcchhh
Q 021306 241 FPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGSHIN 306 (314)
Q Consensus 241 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~~~~ 306 (314)
|.+.+..+....+.+...... |......+.++++.+|...+..++....+.+.++.+.
T Consensus 277 ~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~ 334 (343)
T 1luf_A 277 YYGMAHEEVIYYVRDGNILAC--------PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 334 (343)
T ss_dssp TTTSCHHHHHHHHHTTCCCCC--------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCCCChHHHHHHHhCCCcCCC--------CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHH
Confidence 998887766655544321111 1112334667788888888888878887877776554
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=285.98 Aligned_cols=255 Identities=20% Similarity=0.296 Sum_probs=174.5
Q ss_pred cCCCceeeeeEeecCceEEEEEEECCCCc---EEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCC
Q 021306 36 QTISYMAERVVGTGSFGIVFQAKCLETGE---TVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSK 106 (314)
Q Consensus 36 ~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~---~~~vK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 106 (314)
..++|++.+.||+|+||.||+|++..++. .||+|.++... ....+|+.++++++||||+++++++......
T Consensus 21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (323)
T 3qup_A 21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK 100 (323)
T ss_dssp C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence 34689999999999999999999877665 89999886432 3345899999999999999999988654332
Q ss_pred C-ceeEEEEeecccc-cHHHHHHhhhh--cCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEE
Q 021306 107 N-ELFLNLVMEYVPE-SMYRVLKHYSS--ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKI 182 (314)
Q Consensus 107 ~-~~~~~lv~e~~~~-~l~~~l~~~~~--~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l 182 (314)
+ ....++++||+.+ +|.+.+..... ....+++.+++.++.|++.||.|||+ +|++|+||||+||+++. ++.++|
T Consensus 101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~-~~ivH~Dikp~NIli~~-~~~~kl 178 (323)
T 3qup_A 101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSS-RNFIHRDLAARNCMLAE-DMTVCV 178 (323)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECT-TSCEEE
T ss_pred cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHc-CCcccCCCCcceEEEcC-CCCEEE
Confidence 1 1224799999986 77776654322 12369999999999999999999999 89999999999999998 789999
Q ss_pred eecCcccccccCCc---cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcC
Q 021306 183 CDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLG 258 (314)
Q Consensus 183 ~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~t-g~~pf~~~~~~~~~~~i~~~~~ 258 (314)
+|||++........ .....+++.|+|||.+.+.. ++.++||||||+++|+|++ |..||.+.+..+....+.....
T Consensus 179 ~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~ 257 (323)
T 3qup_A 179 ADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNL-YTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNR 257 (323)
T ss_dssp CCCCC-----------------CCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC
T ss_pred eeccccccccccccccccccccCcccccCchhhcCCC-CCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCCC
Confidence 99999976543322 12334567899999986654 8999999999999999999 9999999888777766665432
Q ss_pred CCCH--------HHHh-c--cCCCCCCCc-------ccccccCChhhhhcccCC
Q 021306 259 TPTR--------EEIR-C--MNPNYTDFR-------FPQIKAHPWHKVCIFHFP 294 (314)
Q Consensus 259 ~~~~--------~~~~-~--~~p~~~~~~-------~~~l~~~p~~~~~~~~~~ 294 (314)
...+ +.+. + .+|. +|++ +++++.|||........+
T Consensus 258 ~~~~~~~~~~l~~li~~~l~~dp~-~Rps~~~l~~~l~~~l~~~~~~~~~~~pl 310 (323)
T 3qup_A 258 LKQPPECMEEVYDLMYQCWSADPK-QRPSFTCLRMELENILGHLSVLSTSQDPL 310 (323)
T ss_dssp CCCCTTCCHHHHHHHHHTTCSSGG-GSCCHHHHHHHHHHHHHC-----------
T ss_pred CCCCCccCHHHHHHHHHHccCChh-hCcCHHHHHHHHHHHHHHhhhcCCCCCCC
Confidence 2211 1111 2 2555 7888 778888888877665543
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=289.53 Aligned_cols=258 Identities=24% Similarity=0.355 Sum_probs=198.3
Q ss_pred ccCCCceeeeeEeecCceEEEEEEECC-------CCcEEEEEEeeccc-----cchHHHHHHHHhC-CCCceeeeceeee
Q 021306 35 KQTISYMAERVVGTGSFGIVFQAKCLE-------TGETVAIKKVLQDR-----RYKNRELQLMRVM-DHPNVISLKHCFF 101 (314)
Q Consensus 35 ~~~~~y~~~~~Lg~g~~g~Vy~~~~~~-------~~~~~~vK~~~~~~-----~~~~~e~~~l~~l-~h~~iv~~~~~~~ 101 (314)
...++|++.+.||+|+||.||+|++.. ++..||+|+++... ....+|+.+++++ +||||+++++++.
T Consensus 66 i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 145 (382)
T 3tt0_A 66 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 145 (382)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeec
Confidence 345789999999999999999999754 33579999986543 2345899999999 9999999999884
Q ss_pred ecCCCCceeEEEEeecccc-cHHHHHHhhhh------------cCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCC
Q 021306 102 STTSKNELFLNLVMEYVPE-SMYRVLKHYSS------------ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKP 168 (314)
Q Consensus 102 ~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~------------~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p 168 (314)
.. ...++||||+++ +|.+.+..... ....+++.+++.++.||+.||.|||+ +||+||||||
T Consensus 146 ~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp 219 (382)
T 3tt0_A 146 QD-----GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS-KKCIHRDLAA 219 (382)
T ss_dssp SS-----SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCG
T ss_pred cC-----CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCc
Confidence 33 337899999986 88877765321 12469999999999999999999999 8999999999
Q ss_pred CcEEEcCCCCcEEEeecCcccccccCC---ccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q 021306 169 QNLLVDPLTHQVKICDFGSAKQLIAGE---ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGE 244 (314)
Q Consensus 169 ~Nil~~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~t-g~~pf~~~ 244 (314)
+||+++. ++.++|+|||++....... ......+++.|+|||.+.+.. ++.++||||||+++|+|++ |..||.+.
T Consensus 220 ~NIll~~-~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwslG~il~ellt~g~~p~~~~ 297 (382)
T 3tt0_A 220 RNVLVTE-DNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPYPGV 297 (382)
T ss_dssp GGEEECT-TCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred ceEEEcC-CCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCC-CCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999998 7899999999997654322 222344578899999997654 8999999999999999999 99999988
Q ss_pred ChHHHHHHHHHHcCCCCHHHHhccCCCCCCCcccccccCChhhhhcccCChHHHHHhcchhhhc
Q 021306 245 NAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGSHINAI 308 (314)
Q Consensus 245 ~~~~~~~~i~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 308 (314)
+..+....+.+...... |......+.+++..+|...+..++....+++.++.+...
T Consensus 298 ~~~~~~~~~~~~~~~~~--------~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 353 (382)
T 3tt0_A 298 PVEELFKLLKEGHRMDK--------PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 353 (382)
T ss_dssp CHHHHHHHHHTTCCCCC--------CSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHcCCCCCC--------CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 87765555544322111 111223455677777777777777777777776655443
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=291.65 Aligned_cols=215 Identities=19% Similarity=0.265 Sum_probs=172.5
Q ss_pred ccCCCceeeeeEeecCceEEEEEE-----ECCCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecC
Q 021306 35 KQTISYMAERVVGTGSFGIVFQAK-----CLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTT 104 (314)
Q Consensus 35 ~~~~~y~~~~~Lg~g~~g~Vy~~~-----~~~~~~~~~vK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 104 (314)
...++|++.+.||+|+||.||+|+ +..+++.||+|.++... ....+|+.++++++||||+++++++....
T Consensus 68 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 147 (367)
T 3l9p_A 68 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL 147 (367)
T ss_dssp CCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred cCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence 335689999999999999999999 44577899999986432 23457999999999999999999884332
Q ss_pred CCCceeEEEEeecccc-cHHHHHHhhhh---cCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCC--CC
Q 021306 105 SKNELFLNLVMEYVPE-SMYRVLKHYSS---ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPL--TH 178 (314)
Q Consensus 105 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~---~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~--~~ 178 (314)
..++||||+.+ +|.+.+..... ....+++.+++.++.||+.||.|||+ +||+||||||+||+++.. +.
T Consensus 148 -----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~~~~~ 221 (367)
T 3l9p_A 148 -----PRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE-NHFIHRDIAARNCLLTCPGPGR 221 (367)
T ss_dssp -----SCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEESCSSTTC
T ss_pred -----CCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHh-CCeeCCCCChhhEEEecCCCCc
Confidence 36899999975 88877765431 22469999999999999999999999 899999999999999851 34
Q ss_pred cEEEeecCcccccccC---CccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 021306 179 QVKICDFGSAKQLIAG---EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEII 254 (314)
Q Consensus 179 ~~~l~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~t-g~~pf~~~~~~~~~~~i~ 254 (314)
.++|+|||+++..... .......+|+.|+|||.+.+.. ++.++||||||+++|+|++ |..||.+.+..+....+.
T Consensus 222 ~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~ 300 (367)
T 3l9p_A 222 VAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGI-FTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT 300 (367)
T ss_dssp CEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH
T ss_pred eEEECCCccccccccccccccCCCcCCcccEECHHHhcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 6999999999754322 2223355688999999986654 8999999999999999998 999999988877666665
Q ss_pred HH
Q 021306 255 KV 256 (314)
Q Consensus 255 ~~ 256 (314)
..
T Consensus 301 ~~ 302 (367)
T 3l9p_A 301 SG 302 (367)
T ss_dssp TT
T ss_pred cC
Confidence 54
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=280.20 Aligned_cols=202 Identities=27% Similarity=0.427 Sum_probs=174.6
Q ss_pred cCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHhCCCCceeeeceeeeecCC----------
Q 021306 36 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTS---------- 105 (314)
Q Consensus 36 ~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~---------- 105 (314)
..++|++.+.||+|+||.||+|++..+++.|++|.+........+|+.++++++||||+++++++.....
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~ 88 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSS 88 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCSGGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccccccc
Confidence 3468999999999999999999999899999999998877788899999999999999999998743211
Q ss_pred -CCceeEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEe
Q 021306 106 -KNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKIC 183 (314)
Q Consensus 106 -~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~ 183 (314)
.....++++|||+++ +|.+.+... ....+++..++.++.||+.||.+||+ +|++|+||+|+||+++. ++.++|+
T Consensus 89 ~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dlkp~Nil~~~-~~~~kl~ 164 (284)
T 2a19_B 89 RSKTKCLFIQMEFCDKGTLEQWIEKR--RGEKLDKVLALELFEQITKGVDYIHS-KKLINRDLKPSNIFLVD-TKQVKIG 164 (284)
T ss_dssp CCEEEEEEEEECCCCSCBHHHHHHHG--GGSCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEEE-TTEEEEC
T ss_pred ccCcceEEEEEeccCCCCHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccCCHHHEEEcC-CCCEEEC
Confidence 224457899999996 887777642 24679999999999999999999999 89999999999999998 8899999
Q ss_pred ecCcccccccCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 021306 184 DFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFP 242 (314)
Q Consensus 184 dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~ 242 (314)
|||++.............+++.|+|||.+.+.. ++.++||||||+++|+|++|..|+.
T Consensus 165 Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~~~~~~ 222 (284)
T 2a19_B 165 DFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQD-YGKEVDLYALGLILAELLHVCDTAF 222 (284)
T ss_dssp CCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSC-CCTHHHHHHHHHHHHHHHSCCSSHH
T ss_pred cchhheeccccccccccCCcccccChhhhccCC-CcchhhhHHHHHHHHHHHhcCCcch
Confidence 999998765554445567899999999997654 8999999999999999999998874
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-39 Score=296.51 Aligned_cols=259 Identities=22% Similarity=0.260 Sum_probs=194.0
Q ss_pred CCccCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeecc--ccchHHHHHHHHhCCCCceeeeceeeeecCCCCcee
Q 021306 33 EPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD--RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 110 (314)
Q Consensus 33 ~~~~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 110 (314)
+|...++|++.+.||+|+||.||+|++..+++.||||++... .....+|..+++.++|.+.+..+..+.. ...+
T Consensus 2 ~~~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~il~~L~~~~~i~~i~~~~~----~~~~ 77 (483)
T 3sv0_A 2 EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRWFGV----EGDY 77 (483)
T ss_dssp CCEETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSCCHHHHHHHHHHTTTSTTCCCEEEEEE----ETTE
T ss_pred CCCcCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccHHHHHHHHHHHHhcCCCCCCeEEEEEe----eCCE
Confidence 567788999999999999999999999999999999987643 3446789999999988665555544432 2234
Q ss_pred EEEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEc--CCCCcEEEeecCcc
Q 021306 111 LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVD--PLTHQVKICDFGSA 188 (314)
Q Consensus 111 ~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~--~~~~~~~l~dfg~~ 188 (314)
.++||||+.++|.+.+.. ....+++.+++.++.||+.||.|||+ +||+||||||+|||++ ..++.++|+|||++
T Consensus 78 ~~lvme~~g~sL~~ll~~---~~~~l~~~~~~~i~~qi~~aL~yLH~-~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla 153 (483)
T 3sv0_A 78 NVLVMDLLGPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153 (483)
T ss_dssp EEEEEECCCCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECCGGGTTCEEECCCTTC
T ss_pred EEEEEECCCCCHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHH-CCEeecccCcceEEEecCCCCCeEEEEeCCcc
Confidence 789999998888887764 24679999999999999999999999 8999999999999994 22788999999999
Q ss_pred cccccCCcc--------ccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHHc
Q 021306 189 KQLIAGEAN--------ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA---VDQLVEIIKVL 257 (314)
Q Consensus 189 ~~~~~~~~~--------~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~---~~~~~~i~~~~ 257 (314)
+........ ....+|+.|+|||.+.+.. ++.++||||||+++|+|++|+.||.+... .+.+..+....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~ 232 (483)
T 3sv0_A 154 KKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK 232 (483)
T ss_dssp EECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHH
T ss_pred eeccCCccccccccccccccCCCccccCHHHhcCCC-CChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcc
Confidence 866443221 2456799999999997655 89999999999999999999999987543 33344333322
Q ss_pred CCCCHHHH-hccCCCCCCCcccccccCChhhhhcccCChHHHHHhcchh
Q 021306 258 GTPTREEI-RCMNPNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGSHI 305 (314)
Q Consensus 258 ~~~~~~~~-~~~~p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~~~ 305 (314)
.......+ ..+++ .+.+++..||...+..+.....+.+.++.+
T Consensus 233 ~~~~~~~l~~~~p~-----~l~~li~~cl~~dP~~RPs~~el~~~L~~l 276 (483)
T 3sv0_A 233 VATSIEALCRGYPT-----EFASYFHYCRSLRFDDKPDYSYLKRLFRDL 276 (483)
T ss_dssp HHSCHHHHHTTSCH-----HHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred ccccHHHHhcCCcH-----HHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 21222222 12222 345566666666666666666666555544
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=282.23 Aligned_cols=261 Identities=22% Similarity=0.284 Sum_probs=190.5
Q ss_pred CccCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeecccc-chHHHHHHHHh--CCCCceeeeceeeeecCCCCcee
Q 021306 34 PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-YKNRELQLMRV--MDHPNVISLKHCFFSTTSKNELF 110 (314)
Q Consensus 34 ~~~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~~-~~~~e~~~l~~--l~h~~iv~~~~~~~~~~~~~~~~ 110 (314)
....++|++.+.||+|+||.||++++ +++.||+|.+..... ...+|.+++.. ++||||+++++++.... .....
T Consensus 4 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~-~~~~~ 80 (301)
T 3q4u_A 4 RTVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSR-HSSTQ 80 (301)
T ss_dssp CCCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEE-TTEEE
T ss_pred ccccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccccchhhHHHHHHHHHhhccCcCeeeEEEeecccc-CCCce
Confidence 44567999999999999999999987 789999999875432 23456666666 79999999999865432 33455
Q ss_pred EEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhh--------cCCCceecCCCCCcEEEcCCCCcEE
Q 021306 111 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH--------TVPRVCHRDLKPQNLLVDPLTHQVK 181 (314)
Q Consensus 111 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH--------~~~~i~h~dl~p~Nil~~~~~~~~~ 181 (314)
+++||||+++ +|.+.+. ...+++..++.++.|++.||.||| + +||+||||||+||+++. ++.++
T Consensus 81 ~~lv~e~~~~g~L~~~l~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~-~~ivH~Dlkp~Nill~~-~~~~k 153 (301)
T 3q4u_A 81 LWLITHYHEMGSLYDYLQ-----LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGK-PAIAHRDLKSKNILVKK-NGQCC 153 (301)
T ss_dssp EEEEECCCTTCBHHHHHT-----TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCB-CEEECSCCCGGGEEECT-TSCEE
T ss_pred eEEehhhccCCCHHHHHh-----hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCC-CCeecCCCChHhEEEcC-CCCEE
Confidence 7899999986 7777664 367999999999999999999999 8 89999999999999998 78999
Q ss_pred EeecCcccccccCCcc-----ccccccccccccccccCCC-----CCCcchhHHHHHHHHHHHHhC----------CCCC
Q 021306 182 ICDFGSAKQLIAGEAN-----ISYICSRFYRAPELIFGAT-----EYTTSIDIWSAGCVLAELLLG----------QPLF 241 (314)
Q Consensus 182 l~dfg~~~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~-----~~~~~~Dv~slG~il~el~tg----------~~pf 241 (314)
|+|||++......... ....+|+.|+|||.+.+.. .++.++||||||+++|+|++| +.||
T Consensus 154 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf 233 (301)
T 3q4u_A 154 IADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPF 233 (301)
T ss_dssp ECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred EeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccc
Confidence 9999998755433222 2236799999999996653 234789999999999999999 8888
Q ss_pred CCCCh----HHHHHHHHHHcCCCCHHHHhccCCCCCCCcccccccCChhhhhcccCChHHHHHhcchh
Q 021306 242 PGENA----VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGSHI 305 (314)
Q Consensus 242 ~~~~~----~~~~~~i~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~~~ 305 (314)
..... ..............+. ......+......+.++++.||...+..+++...+++.++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 234 YDVVPNDPSFEDMRKVVCVDQQRPN-IPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp TTTSCSSCCHHHHHHHHTTSCCCCC-CCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred cccCCCCcchhhhhHHHhccCCCCC-CChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 65422 1222222211110000 000000000112356777888888888888888888777654
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=278.42 Aligned_cols=251 Identities=20% Similarity=0.291 Sum_probs=194.5
Q ss_pred ccCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeE
Q 021306 35 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 111 (314)
Q Consensus 35 ~~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 111 (314)
...++|++.+.||+|+||.||++.+. ++..|++|.+.... ....+|+.++++++|+||+++++++.. ....
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~~ 94 (283)
T 3gen_A 21 IDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK-----QRPI 94 (283)
T ss_dssp CCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECS-----SSSE
T ss_pred CCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEec-----CCCe
Confidence 44568999999999999999999865 67789999987543 334689999999999999999998843 3348
Q ss_pred EEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcccc
Q 021306 112 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 190 (314)
Q Consensus 112 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~ 190 (314)
++||||+++ +|.+.+... ...+++.+++.++.|++.||.+||+ +|++|+||||+||+++. ++.++|+|||.+..
T Consensus 95 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dikp~Nili~~-~~~~kl~Dfg~~~~ 169 (283)
T 3gen_A 95 FIITEYMANGCLLNYLREM---RHRFQTQQLLEMCKDVCEAMEYLES-KQFLHRDLAARNCLVND-QGVVKVSDFGLSRY 169 (283)
T ss_dssp EEEECCCTTCBHHHHHHCG---GGCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSSCSGGGEEECT-TSCEEECSTTGGGG
T ss_pred EEEEeccCCCcHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHH-CCccCCCCccceEEEcC-CCCEEEcccccccc
Confidence 899999975 777766542 3569999999999999999999999 89999999999999998 88999999999875
Q ss_pred cccCC--ccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCHHHHhc
Q 021306 191 LIAGE--ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRC 267 (314)
Q Consensus 191 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 267 (314)
..... ......+++.|+|||.+.+.. ++.++||||||+++|+|++ |+.||...+..+....+.+......
T Consensus 170 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~------ 242 (283)
T 3gen_A 170 VLDDEYTSSVGSKFPVRWSPPEVLMYSK-FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYR------ 242 (283)
T ss_dssp BCCHHHHSTTSTTSCGGGCCHHHHHHCC-CSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCC------
T ss_pred ccccccccccCCccCcccCCHHHhccCC-CCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCC------
Confidence 53321 122334567899999997554 8999999999999999998 9999999888776666654432221
Q ss_pred cCCCCCCCcccccccCChhhhhcccCChHHHHHhcchh
Q 021306 268 MNPNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGSHI 305 (314)
Q Consensus 268 ~~p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~~~ 305 (314)
|......+.+++..+|...+..+.+...+++.+..+
T Consensus 243 --~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~ 278 (283)
T 3gen_A 243 --PHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 278 (283)
T ss_dssp --CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred --CCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 121233456677777777777777777777666544
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=283.54 Aligned_cols=262 Identities=27% Similarity=0.363 Sum_probs=193.1
Q ss_pred cCCCceeeeeEeecCceEEEEEE----ECCCCcEEEEEEeeccc----cchHHHHHHHHhCCCCceeeeceeeeecCCCC
Q 021306 36 QTISYMAERVVGTGSFGIVFQAK----CLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKN 107 (314)
Q Consensus 36 ~~~~y~~~~~Lg~g~~g~Vy~~~----~~~~~~~~~vK~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 107 (314)
..++|++.+.||+|+||.||+|+ +..+++.||+|.+.... ....+|+.++++++||||+++++++.....
T Consensus 8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-- 85 (295)
T 3ugc_A 8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR-- 85 (295)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHH--
T ss_pred CHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC--
Confidence 45689999999999999999998 56689999999986543 234689999999999999999998754322
Q ss_pred ceeEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecC
Q 021306 108 ELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 186 (314)
Q Consensus 108 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg 186 (314)
..+++||||+++ +|.+.+... ...+++..++.++.|++.||.|||+ +||+|+||||+||+++. ++.++|+|||
T Consensus 86 -~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dikp~Nil~~~-~~~~kl~Dfg 159 (295)
T 3ugc_A 86 -RNLKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGT-KRYIHRDLATRNILVEN-ENRVKIGDFG 159 (295)
T ss_dssp -TSCEEEEECCTTCBHHHHHHHC---GGGCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEEE-TTEEEECCCC
T ss_pred -CceEEEEEeCCCCCHHHHHHhc---ccccCHHHHHHHHHHHHHHHHHHhc-CCcccCCCCHhhEEEcC-CCeEEEccCc
Confidence 236799999975 777777642 3469999999999999999999999 89999999999999998 7899999999
Q ss_pred cccccccCCc----cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCC-
Q 021306 187 SAKQLIAGEA----NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT- 261 (314)
Q Consensus 187 ~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~- 261 (314)
++........ .....++..|+|||.+.+.. ++.++||||||+++|+|++|..||...... ............
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~~~~~~~~~--~~~~~~~~~~~~~ 236 (295)
T 3ugc_A 160 LTKVLPQDKEFFKVKEPGESPIFWYAPESLTESK-FSVASDVWSFGVVLYELFTYIEKSKSPPAE--FMRMIGNDKQGQM 236 (295)
T ss_dssp SCC-------------CTTCGGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHHTTCTTCSHHHH--HHHHHCTTCCTHH
T ss_pred ccccccCCcceeeeccCCCCccceeCcHHhcCCC-CChHHHHHHHHHHHHHHHhcccccCCChHH--HHhhhcCccccch
Confidence 9976543321 12233566799999997654 899999999999999999999998654321 111100000000
Q ss_pred -----HHHHh----ccCCCCCCCcccccccCChhhhhcccCChHHHHHhcchhhhc
Q 021306 262 -----REEIR----CMNPNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGSHINAI 308 (314)
Q Consensus 262 -----~~~~~----~~~p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 308 (314)
...+. ...|......+.++++.||...+..+++...+++.++.+.-.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~ 292 (295)
T 3ugc_A 237 IVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN 292 (295)
T ss_dssp HHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred hHHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence 00000 001221233467788888888888888888888888776543
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-39 Score=294.57 Aligned_cols=253 Identities=22% Similarity=0.285 Sum_probs=202.5
Q ss_pred ccCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc--cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeEE
Q 021306 35 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR--RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 112 (314)
Q Consensus 35 ~~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~--~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 112 (314)
...++|++.+.||+|+||.||++.+ +++.||+|.++... ....+|+.++++++||||+++++++.... ..++
T Consensus 190 i~~~~~~~~~~lG~G~fg~V~~~~~--~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~~~~ 263 (450)
T 1k9a_A 190 LNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEK----GGLY 263 (450)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEESSCTTSHHHHHHHHHHHTCCCTTBCCEEEEEECTT----SCEE
T ss_pred cChHHeEEEeeecCcCCeeEEEEEe--cCCeEEEEEeCCchHHHHHHHHHHHHHhccCCCEEEEEEEEEcCC----CceE
Confidence 3457899999999999999999987 47899999997643 34568999999999999999999875432 2378
Q ss_pred EEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCccccc
Q 021306 113 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 191 (314)
Q Consensus 113 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~ 191 (314)
+||||+++ +|.+.+... ....+++..++.++.|++.||.|||+ +|++||||||+||+++. ++.++|+|||+++..
T Consensus 264 iv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivHrDlkp~Nill~~-~~~~kl~DfG~a~~~ 339 (450)
T 1k9a_A 264 IVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEG-NNFVHRDLAARNVLVSE-DNVAKVSDFGLTKEA 339 (450)
T ss_dssp EEEECCTTCBHHHHHHHH--CTTTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEECT-TSCEEECCCTTCEEC
T ss_pred EEEEecCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCCHhhEEECC-CCCEEEeeCCCcccc
Confidence 99999986 788777642 23457999999999999999999999 89999999999999998 789999999998754
Q ss_pred ccCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCHHHHhccCC
Q 021306 192 IAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 270 (314)
Q Consensus 192 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~p 270 (314)
... .....+++.|+|||.+.+.. ++.++||||||+++|+|++ |+.||.+.+..+....+.++...+ .|
T Consensus 340 ~~~--~~~~~~~~~y~aPE~~~~~~-~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~--------~p 408 (450)
T 1k9a_A 340 SST--QDTGKLPVKWTAPEALREKK-FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMD--------AP 408 (450)
T ss_dssp C--------CCCTTTSCHHHHHSSC-CCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCCC--------CC
T ss_pred ccc--ccCCCCCcceeCHHHhcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC--------CC
Confidence 322 12235578899999997654 8999999999999999998 999999887766665554432221 12
Q ss_pred CCCCCcccccccCChhhhhcccCChHHHHHhcchhhhc
Q 021306 271 NYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGSHINAI 308 (314)
Q Consensus 271 ~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 308 (314)
......+.+|++.||...+..+++...+.+.++.++..
T Consensus 409 ~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 409 DGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 22344577889999999999999999998888877654
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=293.64 Aligned_cols=214 Identities=25% Similarity=0.398 Sum_probs=173.2
Q ss_pred CCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeE
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 111 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 111 (314)
.++|++.+.||+|+||.||+|++..+++.||+|.+.... ....+|+.++++++||||+++++++.... ....
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~---~~~~ 84 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETT---TRHK 84 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTT---TCCE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCC---CCee
Confidence 468999999999999999999999999999999986532 23358999999999999999999875433 2347
Q ss_pred EEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEE----cCCCCcEEEeecC
Q 021306 112 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLV----DPLTHQVKICDFG 186 (314)
Q Consensus 112 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~----~~~~~~~~l~dfg 186 (314)
++||||+++ +|.+.+... .....+++..++.++.|++.||.|||+ +||+||||||+||++ +. .+.++|+|||
T Consensus 85 ~lv~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~~~~~-~~~~kL~DFG 161 (396)
T 4eut_A 85 VLIMEFCPCGSLYTVLEEP-SNAYGLPESEFLIVLRDVVGGMNHLRE-NGIVHRNIKPGNIMRVIGEDG-QSVYKLTDFG 161 (396)
T ss_dssp EEEECCCTTEEHHHHTTSG-GGTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEEEECTTS-CEEEEECCGG
T ss_pred EEEEecCCCCCHHHHHHhh-hcccCCCHHHHHHHHHHHHHHHHHHHH-CCEEECCcCHHHEEEeecCCC-ceeEEEecCC
Confidence 899999986 666665532 223449999999999999999999999 899999999999998 54 6679999999
Q ss_pred cccccccCCccccccccccccccccccCC-------CCCCcchhHHHHHHHHHHHHhCCCCCCCC----ChHHHHHHHHH
Q 021306 187 SAKQLIAGEANISYICSRFYRAPELIFGA-------TEYTTSIDIWSAGCVLAELLLGQPLFPGE----NAVDQLVEIIK 255 (314)
Q Consensus 187 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-------~~~~~~~Dv~slG~il~el~tg~~pf~~~----~~~~~~~~i~~ 255 (314)
++.............+|+.|+|||.+.+. ..++.++||||||+++|+|++|+.||... ...+.+..++.
T Consensus 162 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~ 241 (396)
T 4eut_A 162 AARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241 (396)
T ss_dssp GCEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHH
T ss_pred CceEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhc
Confidence 99876555444556789999999998541 33678999999999999999999999643 33344555544
Q ss_pred H
Q 021306 256 V 256 (314)
Q Consensus 256 ~ 256 (314)
.
T Consensus 242 ~ 242 (396)
T 4eut_A 242 G 242 (396)
T ss_dssp S
T ss_pred C
Confidence 3
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-39 Score=280.14 Aligned_cols=265 Identities=19% Similarity=0.241 Sum_probs=193.0
Q ss_pred CCCccCCCceeeeeEeecCceEEEEEEECC---CCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeee
Q 021306 32 GEPKQTISYMAERVVGTGSFGIVFQAKCLE---TGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFS 102 (314)
Q Consensus 32 ~~~~~~~~y~~~~~Lg~g~~g~Vy~~~~~~---~~~~~~vK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~ 102 (314)
......++|++.+.||+|+||.||+|.+.. ++..|++|.++... ....+|+.++++++||||+++++++..
T Consensus 28 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 107 (313)
T 3brb_A 28 DVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIE 107 (313)
T ss_dssp TTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC
T ss_pred hcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEee
Confidence 333455789999999999999999998765 45689999986432 224579999999999999999999876
Q ss_pred cCCCCceeEEEEeecccc-cHHHHHHhhh--hcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCc
Q 021306 103 TTSKNELFLNLVMEYVPE-SMYRVLKHYS--SANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQ 179 (314)
Q Consensus 103 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~--~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~ 179 (314)
.........++++||+.+ +|.+.+.... .....+++.+++.++.|++.||.|||+ +||+|+||||+||+++. ++.
T Consensus 108 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~dikp~NIli~~-~~~ 185 (313)
T 3brb_A 108 MSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSN-RNFLHRDLAARNCMLRD-DMT 185 (313)
T ss_dssp -------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHT-TTCCCCCCSGGGEEECT-TSC
T ss_pred ccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCcceEEEcC-CCc
Confidence 554444456899999996 7776664322 234679999999999999999999999 89999999999999998 788
Q ss_pred EEEeecCcccccccCC---ccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 021306 180 VKICDFGSAKQLIAGE---ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIK 255 (314)
Q Consensus 180 ~~l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~t-g~~pf~~~~~~~~~~~i~~ 255 (314)
++|+|||++....... ......+++.|+|||.+.+.. ++.++||||||+++|+|++ |..||.+....+....+..
T Consensus 186 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~ 264 (313)
T 3brb_A 186 VCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRV-YTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLH 264 (313)
T ss_dssp EEECSCSCC----------------CCGGGSCHHHHHSSC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHT
T ss_pred EEEeecCcceecccccccCcccccCCCccccCchhhcCCC-ccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHc
Confidence 9999999987654322 122234577899999996654 8999999999999999999 9999998887766665554
Q ss_pred HcCCCCHHHHhccCCCCCCCcccccccCChhhhhcccCChHHHHHhcchhhh
Q 021306 256 VLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGSHINA 307 (314)
Q Consensus 256 ~~~~~~~~~~~~~~p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~~~~~ 307 (314)
......+ +. ....+.+++..+|...+..+++...+.+.++.+..
T Consensus 265 ~~~~~~~-------~~-~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~ 308 (313)
T 3brb_A 265 GHRLKQP-------ED-CLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLE 308 (313)
T ss_dssp TCCCCCB-------TT-CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCC-------cc-ccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 3222111 11 12245667777777777777777888777766543
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=288.58 Aligned_cols=256 Identities=25% Similarity=0.365 Sum_probs=195.1
Q ss_pred CCCceeeeeEeecCceEEEEEE-----ECCCCcEEEEEEeeccc-----cchHHHHHHHHhC-CCCceeeeceeeeecCC
Q 021306 37 TISYMAERVVGTGSFGIVFQAK-----CLETGETVAIKKVLQDR-----RYKNRELQLMRVM-DHPNVISLKHCFFSTTS 105 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~-----~~~~~~~~~vK~~~~~~-----~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~ 105 (314)
.++|++.+.||+|+||.||+|+ +..+++.||+|.++... ....+|+.+++++ .||||+++++++....
T Consensus 21 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~- 99 (359)
T 3vhe_A 21 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG- 99 (359)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT-
T ss_pred ccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCC-
Confidence 4689999999999999999998 55677999999987542 2345899999999 7899999999875432
Q ss_pred CCceeEEEEeecccc-cHHHHHHhhhhc----------------------------------------------------
Q 021306 106 KNELFLNLVMEYVPE-SMYRVLKHYSSA---------------------------------------------------- 132 (314)
Q Consensus 106 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~---------------------------------------------------- 132 (314)
..+++||||+++ +|.+.+......
T Consensus 100 ---~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (359)
T 3vhe_A 100 ---GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDV 176 (359)
T ss_dssp ---SCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------------
T ss_pred ---CceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchh
Confidence 236799999986 777777653211
Q ss_pred ----------CCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcccccccCCc---ccc
Q 021306 133 ----------NQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA---NIS 199 (314)
Q Consensus 133 ----------~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~~~~~---~~~ 199 (314)
...+++..++.++.||+.||.|||+ +||+|+||||+||+++. ++.++|+|||++........ ...
T Consensus 177 ~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~-~~ivH~Dikp~NIll~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~ 254 (359)
T 3vhe_A 177 EEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS-RKCIHRDLAARNILLSE-KNVVKICDFGLARDIYKDPDYVRKGD 254 (359)
T ss_dssp -------CTTTTCBCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECG-GGCEEECCCGGGSCTTSCTTCEEC--
T ss_pred hhcccccchhccccCHHHHHHHHHHHHHHHHHHHH-CCcccCCCChhhEEEcC-CCcEEEEeccceeeecccccchhccc
Confidence 1229999999999999999999999 89999999999999997 78899999999975533221 223
Q ss_pred ccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCHHHHhccCCCCCCCccc
Q 021306 200 YICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFP 278 (314)
Q Consensus 200 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~p~~~~~~~~ 278 (314)
..+|+.|+|||.+.+.. ++.++||||||+++|+|++ |..||.+....+.+...+........ |......+.
T Consensus 255 ~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~l~ 326 (359)
T 3vhe_A 255 ARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA-------PDYTTPEMY 326 (359)
T ss_dssp CEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCC-------CTTCCHHHH
T ss_pred cCCCceeEChhhhcCCC-CCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCC-------CCCCCHHHH
Confidence 45688899999987644 8999999999999999998 99999987765555555544322211 111223355
Q ss_pred ccccCChhhhhcccCChHHHHHhcchhh
Q 021306 279 QIKAHPWHKVCIFHFPKHWLLEYGSHIN 306 (314)
Q Consensus 279 ~l~~~p~~~~~~~~~~~~~~~~~~~~~~ 306 (314)
+++..+|...+..+++...+++.++.+.
T Consensus 327 ~li~~~l~~dP~~Rps~~ell~~L~~~~ 354 (359)
T 3vhe_A 327 QTMLDCWHGEPSQRPTFSELVEHLGNLL 354 (359)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence 6666677777777777777777666543
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=276.10 Aligned_cols=247 Identities=28% Similarity=0.421 Sum_probs=183.1
Q ss_pred cCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc--------cchHHHHHHHHhCCCCceeeeceeeeecCCCC
Q 021306 36 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR--------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKN 107 (314)
Q Consensus 36 ~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~--------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 107 (314)
..++|++.+.||+|+||.||++.+ +++.+++|.+.... ....+|+.+++.++||||+++++++...
T Consensus 5 ~~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---- 78 (271)
T 3dtc_A 5 DFAELTLEEIIGIGGFGKVYRAFW--IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKE---- 78 (271)
T ss_dssp CTTSEEEEEEEEEETTEEEEEEEE--TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC----
T ss_pred chhheeeeeeeccCCCeEEEEEEE--cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC----
Confidence 356899999999999999999997 58899999885432 2345899999999999999999988433
Q ss_pred ceeEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCC---ceecCCCCCcEEEcCC-------
Q 021306 108 ELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR---VCHRDLKPQNLLVDPL------- 176 (314)
Q Consensus 108 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~---i~h~dl~p~Nil~~~~------- 176 (314)
...++||||+++ +|.+.+. ...+++..++.++.|++.||.|||+ +| ++|+||||+||+++..
T Consensus 79 -~~~~lv~e~~~~~~L~~~~~-----~~~~~~~~~~~i~~~l~~~l~~lH~-~~~~~i~H~dikp~Nil~~~~~~~~~~~ 151 (271)
T 3dtc_A 79 -PNLCLVMEFARGGPLNRVLS-----GKRIPPDILVNWAVQIARGMNYLHD-EAIVPIIHRDLKSSNILILQKVENGDLS 151 (271)
T ss_dssp ---CEEEEECCTTEEHHHHHT-----SSCCCHHHHHHHHHHHHHHHHHHHH-SSSSCCCCSCCSGGGEEESSCCSSSCCS
T ss_pred -CceEEEEEcCCCCCHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceeecCCchHHEEEeccccccccc
Confidence 337899999986 5554443 4689999999999999999999999 88 8999999999999852
Q ss_pred CCcEEEeecCcccccccCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q 021306 177 THQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 256 (314)
Q Consensus 177 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~ 256 (314)
++.++|+|||.+....... .....+++.|+|||.+.+.. ++.++||||||+++|+|++|+.||.+.+.......+...
T Consensus 152 ~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 229 (271)
T 3dtc_A 152 NKILKITDFGLAREWHRTT-KMSAAGAYAWMAPEVIRASM-FSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMN 229 (271)
T ss_dssp SCCEEECCCCC--------------CCGGGSCHHHHHHCC-CSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTS
T ss_pred CcceEEccCCccccccccc-ccCCCCccceeCHHHhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcC
Confidence 5679999999997554332 23456799999999986654 899999999999999999999999988876655544432
Q ss_pred cCCCCHHHHhccCCCCCCCcccccccCChhhhhcccCChHHHHHhcch
Q 021306 257 LGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGSH 304 (314)
Q Consensus 257 ~~~~~~~~~~~~~p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~~ 304 (314)
..... .|......+.+++..+|...+..++....+++.++.
T Consensus 230 ~~~~~-------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~ 270 (271)
T 3dtc_A 230 KLALP-------IPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270 (271)
T ss_dssp CCCCC-------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred CCCCC-------CCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence 21111 111122345667777777777777777777776654
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=283.52 Aligned_cols=208 Identities=24% Similarity=0.362 Sum_probs=168.1
Q ss_pred cCCCceeeeeEeecCceEEEEEEECCCCcE----EEEEEeecc-----ccchHHHHHHHHhCCCCceeeeceeeeecCCC
Q 021306 36 QTISYMAERVVGTGSFGIVFQAKCLETGET----VAIKKVLQD-----RRYKNRELQLMRVMDHPNVISLKHCFFSTTSK 106 (314)
Q Consensus 36 ~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~----~~vK~~~~~-----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 106 (314)
..++|++.+.||+|+||.||+|++..+++. +++|.+... .....+|+.++++++||||+++++++. .
T Consensus 11 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~--- 86 (325)
T 3kex_A 11 KETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-G--- 86 (325)
T ss_dssp CTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-B---
T ss_pred CHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-C---
Confidence 346899999999999999999999888776 677766432 233458999999999999999999773 1
Q ss_pred CceeEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeec
Q 021306 107 NELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF 185 (314)
Q Consensus 107 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~df 185 (314)
...++|+||+.+ +|.+.+.. ....+++..++.++.||+.||.|||+ +||+||||||+||+++. ++.++|+||
T Consensus 87 --~~~~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dikp~Nil~~~-~~~~kl~Df 159 (325)
T 3kex_A 87 --SSLQLVTQYLPLGSLLDHVRQ---HRGALGPQLLLNWGVQIAKGMYYLEE-HGMVHRNLAARNVLLKS-PSQVQVADF 159 (325)
T ss_dssp --SSEEEEEECCTTCBSHHHHHS---SGGGSCTTHHHHHHHHHHHHHHHHHH-TTCCCSCCSSTTEEESS-SSCEEECSC
T ss_pred --CccEEEEEeCCCCCHHHHHHH---ccccCCHHHHHHHHHHHHHHHHHHHh-CCCCCCccchheEEECC-CCeEEECCC
Confidence 127799999985 77766653 23579999999999999999999999 89999999999999988 788999999
Q ss_pred CcccccccCCc---cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 021306 186 GSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIK 255 (314)
Q Consensus 186 g~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~t-g~~pf~~~~~~~~~~~i~~ 255 (314)
|+++....... .....++..|+|||.+.+.. ++.++||||||+++|+|++ |..||.+....+....+..
T Consensus 160 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~ 232 (325)
T 3kex_A 160 GVADLLPPDDKQLLYSEAKTPIKWMALESIHFGK-YTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEK 232 (325)
T ss_dssp SGGGGSCCCTTCCC-----CCTTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHT
T ss_pred CcccccCcccccccccCCCCcccccChHHhccCC-CChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHc
Confidence 99986543322 22344577899999997555 8999999999999999999 9999998876665554443
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=284.51 Aligned_cols=253 Identities=22% Similarity=0.301 Sum_probs=190.2
Q ss_pred cCCCceeeeeEeecCceEEEEEEECCCCcEE--EEEEeecc-----ccchHHHHHHHHhC-CCCceeeeceeeeecCCCC
Q 021306 36 QTISYMAERVVGTGSFGIVFQAKCLETGETV--AIKKVLQD-----RRYKNRELQLMRVM-DHPNVISLKHCFFSTTSKN 107 (314)
Q Consensus 36 ~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~--~vK~~~~~-----~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~ 107 (314)
..++|++.+.||+|+||.||+|++..++..+ ++|.++.. .....+|+.+++++ +||||+++++++....
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~--- 99 (327)
T 1fvr_A 23 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG--- 99 (327)
T ss_dssp CGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT---
T ss_pred cHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCC---
Confidence 3479999999999999999999998888865 88987642 23356899999999 8999999999985433
Q ss_pred ceeEEEEeecccc-cHHHHHHhhh------------hcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEc
Q 021306 108 ELFLNLVMEYVPE-SMYRVLKHYS------------SANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVD 174 (314)
Q Consensus 108 ~~~~~lv~e~~~~-~l~~~l~~~~------------~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~ 174 (314)
..++||||+++ +|.+.+.... .....+++.+++.++.||+.||.+||+ +||+|+||||+||+++
T Consensus 100 --~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~dlkp~NIl~~ 176 (327)
T 1fvr_A 100 --YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ-KQFIHRDLAARNILVG 176 (327)
T ss_dssp --EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEC
T ss_pred --ceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCccceEEEc
Confidence 48899999975 8877776432 223579999999999999999999999 8999999999999999
Q ss_pred CCCCcEEEeecCcccccccCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 021306 175 PLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEI 253 (314)
Q Consensus 175 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~t-g~~pf~~~~~~~~~~~i 253 (314)
. ++.++|+|||++.............+++.|+|||.+.+.. ++.++||||||+++|+|++ |+.||.+.+..+....+
T Consensus 177 ~-~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~ 254 (327)
T 1fvr_A 177 E-NYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSV-YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL 254 (327)
T ss_dssp G-GGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHG
T ss_pred C-CCeEEEcccCcCccccccccccCCCCCccccChhhhcccc-CCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHh
Confidence 7 7889999999987543333333445578899999986544 7899999999999999998 99999988876655544
Q ss_pred HHHcCCCCHHHHhccCCCCCCCcccccccCChhhhhcccCChHHHHHhcch
Q 021306 254 IKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGSH 304 (314)
Q Consensus 254 ~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~~ 304 (314)
.+......+ ..++ ..+.+++..+|...+..+++...+++.++.
T Consensus 255 ~~~~~~~~~---~~~~-----~~l~~li~~~l~~dp~~Rps~~ell~~L~~ 297 (327)
T 1fvr_A 255 PQGYRLEKP---LNCD-----DEVYDLMRQCWREKPYERPSFAQILVSLNR 297 (327)
T ss_dssp GGTCCCCCC---TTBC-----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred hcCCCCCCC---CCCC-----HHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 332211111 0112 234455555555555555555555555443
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=294.52 Aligned_cols=241 Identities=26% Similarity=0.379 Sum_probs=179.7
Q ss_pred CCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc-cchHHHHHHHHhC-CCCceeeeceeeeecCCCCceeEEEEe
Q 021306 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-RYKNRELQLMRVM-DHPNVISLKHCFFSTTSKNELFLNLVM 115 (314)
Q Consensus 38 ~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~-~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv~ 115 (314)
.+|++.+.||+|+||.|+. ....+++.||||++..+. ....+|+.+++.+ +||||+++++++... ...++||
T Consensus 24 ~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~-----~~~~lv~ 97 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRYFCTEKDR-----QFQYIAI 97 (432)
T ss_dssp EEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTEEECHHHHHHHHHSCCCTTBCCEEEEEEET-----TEEEEEE
T ss_pred EEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHHHHHHHHHHHHHhccCCCCcCeEEEEEecC-----CEEEEEE
Confidence 3699999999999999763 335689999999986543 4457899999999 899999999887433 3488999
Q ss_pred ecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCC----CCcEEEeecCccccc
Q 021306 116 EYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPL----THQVKICDFGSAKQL 191 (314)
Q Consensus 116 e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~----~~~~~l~dfg~~~~~ 191 (314)
||++|+|.+.+.. ....+++..++.++.||+.||.|||+ +||+||||||+||+++.. ...++|+|||++...
T Consensus 98 E~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~ 173 (432)
T 3p23_A 98 ELCAATLQEYVEQ---KDFAHLGLEPITLLQQTTSGLAHLHS-LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL 173 (432)
T ss_dssp ECCSEEHHHHHHS---SSCCCCSSCHHHHHHHHHHHHHHHHH-TTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC
T ss_pred ECCCCCHHHHHHh---cCCCccchhHHHHHHHHHHHHHHHHH-CcCEeCCCCHHHEEEecCCCCCceeEEEecccceeec
Confidence 9999998888764 23445556678899999999999999 899999999999999531 336889999999765
Q ss_pred ccCC----ccccccccccccccccccC--CCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCC----
Q 021306 192 IAGE----ANISYICSRFYRAPELIFG--ATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTP---- 260 (314)
Q Consensus 192 ~~~~----~~~~~~~~~~y~aPE~~~~--~~~~~~~~Dv~slG~il~el~t-g~~pf~~~~~~~~~~~i~~~~~~~---- 260 (314)
.... ......+|+.|+|||.+.+ ...++.++|||||||++|+|++ |..||........ ..+.......
T Consensus 174 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~-~~~~~~~~~~~~~~ 252 (432)
T 3p23_A 174 AVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQA-NILLGACSLDCLHP 252 (432)
T ss_dssp ------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHH-HHHTTCCCCTTSCT
T ss_pred cCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHH-HHHhccCCccccCc
Confidence 4332 2234568999999999964 3346789999999999999999 9999976554332 2222111111
Q ss_pred -------CHHHHh---ccCCCCCCCcccccccCChhhhhc
Q 021306 261 -------TREEIR---CMNPNYTDFRFPQIKAHPWHKVCI 290 (314)
Q Consensus 261 -------~~~~~~---~~~p~~~~~~~~~l~~~p~~~~~~ 290 (314)
..+.+. ..+|. +|+++.++++|||+....
T Consensus 253 ~~~~~~~~~~li~~~L~~dP~-~Rps~~evl~hp~f~~~~ 291 (432)
T 3p23_A 253 EKHEDVIARELIEKMIAMDPQ-KRPSAKHVLKHPFFWSLE 291 (432)
T ss_dssp TCHHHHHHHHHHHHHSCSSGG-GSCCHHHHHTSTTTCCHH
T ss_pred cccccHHHHHHHHHHHhCCHh-hCCCHHHHHhCccccChH
Confidence 012222 33666 899999999999997544
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=282.02 Aligned_cols=271 Identities=23% Similarity=0.333 Sum_probs=198.7
Q ss_pred eeeeccccCCCCCCccCCCceeeeeEeecCceEEEEEEEC-------CCCcEEEEEEeeccc-----cchHHHHHHHHhC
Q 021306 21 HIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCL-------ETGETVAIKKVLQDR-----RYKNRELQLMRVM 88 (314)
Q Consensus 21 ~~~~~~~~~~~~~~~~~~~y~~~~~Lg~g~~g~Vy~~~~~-------~~~~~~~vK~~~~~~-----~~~~~e~~~l~~l 88 (314)
..++........-....++|++.+.||+|+||.||+|++. .++..||+|.+.... ....+|+.+++++
T Consensus 18 ~~s~~~~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l 97 (334)
T 2pvf_A 18 GVSEYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMI 97 (334)
T ss_dssp -----CCCCCTTTBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHH
T ss_pred ccccccCCCCccccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHh
Confidence 3344444444444445679999999999999999999975 357789999987543 2345889999999
Q ss_pred -CCCceeeeceeeeecCCCCceeEEEEeecccc-cHHHHHHhhhh------------cCCCCCHHHHHHHHHHHHHHHHH
Q 021306 89 -DHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSS------------ANQRMPLIYVKLYTYQIFRGLAY 154 (314)
Q Consensus 89 -~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~------------~~~~l~~~~~~~i~~ql~~~l~~ 154 (314)
+||||+++++++... ...++||||+++ +|.+.+..... ....+++.+++.++.||+.||.|
T Consensus 98 ~~hp~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~ 172 (334)
T 2pvf_A 98 GKHKNIINLLGACTQD-----GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEY 172 (334)
T ss_dssp CCCTTBCCEEEEECSS-----SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHH
T ss_pred hcCCCEeeEEEEEccC-----CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHH
Confidence 899999999988432 347899999986 78777764321 12358999999999999999999
Q ss_pred hhcCCCceecCCCCCcEEEcCCCCcEEEeecCcccccccCCc---cccccccccccccccccCCCCCCcchhHHHHHHHH
Q 021306 155 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVL 231 (314)
Q Consensus 155 LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il 231 (314)
||+ +||+|+||||+||+++. ++.++|+|||++........ .....+++.|+|||.+.+.. ++.++||||||+++
T Consensus 173 LH~-~~ivH~Dlkp~NIll~~-~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il 249 (334)
T 2pvf_A 173 LAS-QKCIHRDLAARNVLVTE-NNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLM 249 (334)
T ss_dssp HHH-TTEECSCCSGGGEEECT-TCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCE-ECHHHHHHHHHHHH
T ss_pred HHh-CCeeCCCCccceEEEcC-CCCEEEccccccccccccccccccCCCCcccceeChHHhcCCC-cChHHHHHHHHHHH
Confidence 999 89999999999999998 78999999999976543321 22234577899999986654 79999999999999
Q ss_pred HHHHh-CCCCCCCCChHHHHHHHHHHcCCCCHHHHhccCCCCCCCcccccccCChhhhhcccCChHHHHHhcchhhh
Q 021306 232 AELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGSHINA 307 (314)
Q Consensus 232 ~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~~~~~ 307 (314)
|+|++ |..||.+....+....+........ |......+.++++.+|...+..+++...+++.++.+..
T Consensus 250 ~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~ 318 (334)
T 2pvf_A 250 WEIFTLGGSPYPGIPVEELFKLLKEGHRMDK--------PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 318 (334)
T ss_dssp HHHHTTSCCSSTTCCHHHHHHHHHHTCCCCC--------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHhCCCCCcCcCCHHHHHHHHhcCCCCCC--------CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 99999 9999998887666555544322211 11122235566777777777777777777777665543
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-39 Score=279.46 Aligned_cols=256 Identities=23% Similarity=0.332 Sum_probs=197.7
Q ss_pred CCCceeeeeEeecCceEEEEEEE-----CCCCcEEEEEEeeccc-----cchHHHHHHHHhC-CCCceeeeceeeeecCC
Q 021306 37 TISYMAERVVGTGSFGIVFQAKC-----LETGETVAIKKVLQDR-----RYKNRELQLMRVM-DHPNVISLKHCFFSTTS 105 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~-----~~~~~~~~vK~~~~~~-----~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~ 105 (314)
.++|++.+.||+|+||.||+|.+ ..+++.|++|.+.... ....+|+.+++++ +||||+++++++....
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~- 100 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG- 100 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCC-
Confidence 46899999999999999999985 4577899999987543 3345899999999 9999999999884433
Q ss_pred CCceeEEEEeecccc-cHHHHHHhhhh--------------cCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCc
Q 021306 106 KNELFLNLVMEYVPE-SMYRVLKHYSS--------------ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQN 170 (314)
Q Consensus 106 ~~~~~~~lv~e~~~~-~l~~~l~~~~~--------------~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~N 170 (314)
..++||||+++ +|.+.+..... ....+++.+++.++.||+.||.|||+ +|++|+||||+|
T Consensus 101 ----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~N 175 (313)
T 1t46_A 101 ----PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS-KNCIHRDLAARN 175 (313)
T ss_dssp ----SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGG
T ss_pred ----CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCccce
Confidence 37899999986 88877765321 12359999999999999999999999 899999999999
Q ss_pred EEEcCCCCcEEEeecCcccccccCCc---cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCh
Q 021306 171 LLVDPLTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENA 246 (314)
Q Consensus 171 il~~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~t-g~~pf~~~~~ 246 (314)
|+++. ++.++|+|||++........ .....+++.|+|||.+.+.. ++.++||||||+++|+|++ |..||.+...
T Consensus 176 il~~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~~~~~ 253 (313)
T 1t46_A 176 ILLTH-GRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGIFLWELFSLGSSPYPGMPV 253 (313)
T ss_dssp EEEET-TTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred EEEcC-CCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCC-CChHHHHHHHHHHHHHHHhCCCCCCCcccc
Confidence 99998 88999999999976544322 12234577899999986654 8999999999999999999 9999988776
Q ss_pred HHHHHHHHHHcCCCCHHHHhccCCCCCCCcccccccCChhhhhcccCChHHHHHhcchhhh
Q 021306 247 VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGSHINA 307 (314)
Q Consensus 247 ~~~~~~i~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~~~~~ 307 (314)
.......+....... .|......+.+++..+|...+..+++...+++.++.+..
T Consensus 254 ~~~~~~~~~~~~~~~-------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 307 (313)
T 1t46_A 254 DSKFYKMIKEGFRML-------SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307 (313)
T ss_dssp SHHHHHHHHHTCCCC-------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hhHHHHHhccCCCCC-------CcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence 666665555432211 111122345667777777777777777777777665543
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=281.59 Aligned_cols=255 Identities=22% Similarity=0.304 Sum_probs=193.6
Q ss_pred cCCCceeeeeEeecCceEEEEEEEC-----CCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCC
Q 021306 36 QTISYMAERVVGTGSFGIVFQAKCL-----ETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTS 105 (314)
Q Consensus 36 ~~~~y~~~~~Lg~g~~g~Vy~~~~~-----~~~~~~~vK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 105 (314)
..++|++.+.||+|+||.||+|.+. .+++.|++|.+.... ....+|+.++++++||||+++++++...
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-- 98 (314)
T 2ivs_A 21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQD-- 98 (314)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS--
T ss_pred chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecC--
Confidence 3568999999999999999999873 456899999986542 2345799999999999999999988433
Q ss_pred CCceeEEEEeeccc-ccHHHHHHhhhh--------------------cCCCCCHHHHHHHHHHHHHHHHHhhcCCCceec
Q 021306 106 KNELFLNLVMEYVP-ESMYRVLKHYSS--------------------ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 164 (314)
Q Consensus 106 ~~~~~~~lv~e~~~-~~l~~~l~~~~~--------------------~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~ 164 (314)
...++||||++ ++|.+.+..... ....+++.+++.++.||+.||.|||+ +|++|+
T Consensus 99 ---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~ 174 (314)
T 2ivs_A 99 ---GPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE-MKLVHR 174 (314)
T ss_dssp ---SSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHH-TTEECC
T ss_pred ---CceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHH-CCCccc
Confidence 33789999998 578777765322 12358999999999999999999999 899999
Q ss_pred CCCCCcEEEcCCCCcEEEeecCcccccccCCc---cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCC
Q 021306 165 DLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPL 240 (314)
Q Consensus 165 dl~p~Nil~~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~t-g~~p 240 (314)
||||+||+++. ++.++|+|||++........ .....+++.|+|||.+.+.. ++.++||||||+++|+|++ |..|
T Consensus 175 dikp~NIli~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~p 252 (314)
T 2ivs_A 175 DLAARNILVAE-GRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIVTLGGNP 252 (314)
T ss_dssp CCSGGGEEEET-TTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCS
T ss_pred ccchheEEEcC-CCCEEEccccccccccccccceeccCCCCcccccChhhhcCCC-cCchhhHHHHHHHHHHHHhCCCCC
Confidence 99999999998 88999999999876543222 12234577899999997654 7999999999999999999 9999
Q ss_pred CCCCChHHHHHHHHHHcCCCCHHHHhccCCCCCCCcccccccCChhhhhcccCChHHHHHhcchhh
Q 021306 241 FPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGSHIN 306 (314)
Q Consensus 241 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~~~~ 306 (314)
|.+.........+........+ ..+ ...+.+++..+|...+..++....+++.++.+.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~---~~~-----~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~ 310 (314)
T 2ivs_A 253 YPGIPPERLFNLLKTGHRMERP---DNC-----SEEMYRLMLQCWKQEPDKRPVFADISKDLEKMM 310 (314)
T ss_dssp STTCCGGGHHHHHHTTCCCCCC---TTC-----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCHHHHHHHhhcCCcCCCC---ccC-----CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 9988876555444332211111 111 223556666666666666666777776665543
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=283.12 Aligned_cols=243 Identities=24% Similarity=0.359 Sum_probs=182.1
Q ss_pred CccCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc----------cchHHHHHHHHhC----CCCceeeecee
Q 021306 34 PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----------RYKNRELQLMRVM----DHPNVISLKHC 99 (314)
Q Consensus 34 ~~~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~----------~~~~~e~~~l~~l----~h~~iv~~~~~ 99 (314)
....++|++.+.||+|+||.||+|++..+++.|++|.+.... ....+|+.+++++ +|+||++++++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~ 106 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW 106 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence 344568999999999999999999999999999999986432 2335789998888 89999999998
Q ss_pred eeecCCCCceeEEEEeec-cc-ccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCC
Q 021306 100 FFSTTSKNELFLNLVMEY-VP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLT 177 (314)
Q Consensus 100 ~~~~~~~~~~~~~lv~e~-~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~ 177 (314)
+... ...++++|+ +. ++|.+.+.. ...+++..++.++.||+.||.|||+ +|++|+||+|+||+++..+
T Consensus 107 ~~~~-----~~~~~v~e~~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nil~~~~~ 176 (312)
T 2iwi_A 107 FETQ-----EGFMLVLERPLPAQDLFDYITE----KGPLGEGPSRCFFGQVVAAIQHCHS-RGVVHRDIKDENILIDLRR 176 (312)
T ss_dssp C----------CEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-HTEECCCCSGGGEEEETTT
T ss_pred EecC-----CeEEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCChhhEEEeCCC
Confidence 8443 236799998 55 477777654 3679999999999999999999999 8999999999999999448
Q ss_pred CcEEEeecCcccccccCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHc
Q 021306 178 HQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVL 257 (314)
Q Consensus 178 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~ 257 (314)
+.++|+|||++...... ......+++.|+|||.+.+....+.++||||||+++|+|++|+.||..... +....
T Consensus 177 ~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~~~ 249 (312)
T 2iwi_A 177 GCAKLIDFGSGALLHDE-PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE------ILEAE 249 (312)
T ss_dssp TEEEECCCSSCEECCSS-CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHHTC
T ss_pred CeEEEEEcchhhhcccC-cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH------Hhhhc
Confidence 89999999998765433 233456789999999987655445689999999999999999999965321 11111
Q ss_pred CC----CC---HHHH---hccCCCCCCCcccccccCChhhhhcccCC
Q 021306 258 GT----PT---REEI---RCMNPNYTDFRFPQIKAHPWHKVCIFHFP 294 (314)
Q Consensus 258 ~~----~~---~~~~---~~~~p~~~~~~~~~l~~~p~~~~~~~~~~ 294 (314)
.. .. .+.+ ...+|. +|+++.++++|||++....+..
T Consensus 250 ~~~~~~~~~~~~~li~~~l~~~p~-~Rps~~e~l~~~~~~~~~~~~~ 295 (312)
T 2iwi_A 250 LHFPAHVSPDCCALIRRCLAPKPS-SRPSLEEILLDPWMQTPAEDVP 295 (312)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSTT-TSCCHHHHHHSTTTCC------
T ss_pred cCCcccCCHHHHHHHHHHccCChh-hCcCHHHHhcChhhcCchhccc
Confidence 11 01 1112 233666 8999999999999998765543
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=289.28 Aligned_cols=252 Identities=23% Similarity=0.290 Sum_probs=180.5
Q ss_pred CccCCCceeeeeEeecCceEEEEEEEC---CCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCC
Q 021306 34 PKQTISYMAERVVGTGSFGIVFQAKCL---ETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTS 105 (314)
Q Consensus 34 ~~~~~~y~~~~~Lg~g~~g~Vy~~~~~---~~~~~~~vK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 105 (314)
....++|++.+.||+|+||.||+|++. .++..||+|.++... ....+|+.++++++||||+++++++...
T Consensus 41 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-- 118 (373)
T 2qol_A 41 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKS-- 118 (373)
T ss_dssp BCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS--
T ss_pred hcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC--
Confidence 334568999999999999999999876 467789999986532 2345899999999999999999988433
Q ss_pred CCceeEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEee
Q 021306 106 KNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICD 184 (314)
Q Consensus 106 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~d 184 (314)
...++||||+++ +|.+.+.. ....+++.+++.++.|++.||.|||+ +||+||||||+||+++. ++.++|+|
T Consensus 119 ---~~~~lv~e~~~~~sL~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~-~~~~kl~D 190 (373)
T 2qol_A 119 ---KPVMIVTEYMENGSLDSFLRK---HDAQFTVIQLVGMLRGIASGMKYLSD-MGYVHRDLAARNILINS-NLVCKVSD 190 (373)
T ss_dssp ---SSCEEEEECCTTCBHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECT-TCCEEECC
T ss_pred ---CceEEEEeCCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeCCCCCcceEEEcC-CCCEEECc
Confidence 337899999975 77776653 34579999999999999999999999 89999999999999998 88999999
Q ss_pred cCcccccccCCcc----ccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCC
Q 021306 185 FGSAKQLIAGEAN----ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGT 259 (314)
Q Consensus 185 fg~~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~t-g~~pf~~~~~~~~~~~i~~~~~~ 259 (314)
||++......... ....+++.|+|||.+.+.. ++.++||||||+++|+|++ |+.||.+.+..+....+......
T Consensus 191 fg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~ 269 (373)
T 2qol_A 191 FGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK-FTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRL 269 (373)
T ss_dssp C----------------------CTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEEC
T ss_pred CccccccccCCccceeccCCCcCCCccChhhhccCC-cCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC
Confidence 9999765432211 1223466799999996554 8999999999999999998 99999988877666655443222
Q ss_pred CCHHHHhccCCCCCCCcccccccCChhhhhcccCChHHHHHhcch
Q 021306 260 PTREEIRCMNPNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGSH 304 (314)
Q Consensus 260 ~~~~~~~~~~p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~~ 304 (314)
+.+. -....+.+++..||...+..++....+++.++.
T Consensus 270 ~~~~--------~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~ 306 (373)
T 2qol_A 270 PPPM--------DCPAALYQLMLDCWQKDRNNRPKFEQIVSILDK 306 (373)
T ss_dssp CCCT--------TCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCc--------cccHHHHHHHHHHhCcChhhCcCHHHHHHHHHH
Confidence 2111 011234455555555555555555555555443
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=278.54 Aligned_cols=251 Identities=20% Similarity=0.280 Sum_probs=192.1
Q ss_pred ccCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeE
Q 021306 35 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 111 (314)
Q Consensus 35 ~~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 111 (314)
...++|++.+.||+|+||.||+|.+..++..|++|.+.... ....+|+.++++++||||+++++++.. ....
T Consensus 10 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~~ 84 (288)
T 3kfa_A 10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR-----EPPF 84 (288)
T ss_dssp CCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEECS-----SSSE
T ss_pred ccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc-----CCCE
Confidence 35678999999999999999999999999999999987654 334589999999999999999998843 3338
Q ss_pred EEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcccc
Q 021306 112 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 190 (314)
Q Consensus 112 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~ 190 (314)
++||||+++ +|.+.+... ....+++..++.++.|++.||.+||+ +|++|+||||+||+++. ++.++|+|||.+..
T Consensus 85 ~~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~-~~i~H~dikp~Nil~~~-~~~~~l~Dfg~~~~ 160 (288)
T 3kfa_A 85 YIITEFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEK-KNFIHRDLAARNCLVGE-NHLVKVADFGLSRL 160 (288)
T ss_dssp EEEEECCTTEEHHHHHHHC--CTTTSCHHHHHHHHHHHHHHHHHHHH-HTCCCSCCSGGGEEECG-GGCEEECCCCGGGT
T ss_pred EEEEEcCCCCcHHHHHHhc--ccCCccHhHHHHHHHHHHHHHHHHHH-CCccCCCCCcceEEEcC-CCCEEEccCcccee
Confidence 899999995 777777542 34669999999999999999999999 89999999999999988 78899999999976
Q ss_pred cccCCc--cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCHHHHhc
Q 021306 191 LIAGEA--NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRC 267 (314)
Q Consensus 191 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 267 (314)
...... .....+++.|+|||.+.+.. ++.++||||||+++|+|++ |..||.+.+.......+.+......+. .
T Consensus 161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---~ 236 (288)
T 3kfa_A 161 MTGDTYTAHAGAKFPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPE---G 236 (288)
T ss_dssp SCSSSSEEETTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCT---T
T ss_pred ccCCccccccCCccccCcCChhhhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCCCCCC---C
Confidence 543322 22344577899999996554 8999999999999999999 999999888766555544332221111 1
Q ss_pred cCCCCCCCcccccccCChhhhhcccCChHHHHHhcc
Q 021306 268 MNPNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGS 303 (314)
Q Consensus 268 ~~p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~ 303 (314)
+++ .+.+++..+|...+..++....+++.++
T Consensus 237 ~~~-----~l~~li~~~l~~dp~~Rps~~~~~~~l~ 267 (288)
T 3kfa_A 237 CPE-----KVYELMRACWQWNPSDRPSFAEIHQAFE 267 (288)
T ss_dssp CCH-----HHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCH-----HHHHHHHHHhCCChhhCcCHHHHHHHHH
Confidence 122 2344444445444444445555555443
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=275.48 Aligned_cols=248 Identities=14% Similarity=0.150 Sum_probs=189.0
Q ss_pred cCCCceeeeeEeecCceEEEEEEECCCC-------cEEEEEEeeccc----cchHHHHHHHHhCCCCceeeeceeeeecC
Q 021306 36 QTISYMAERVVGTGSFGIVFQAKCLETG-------ETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTT 104 (314)
Q Consensus 36 ~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~-------~~~~vK~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 104 (314)
..++|++.+.||+|+||.||+|++..++ ..|++|.+.... ....+|+.++++++||||+++++++....
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 85 (289)
T 4fvq_A 6 RNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGD 85 (289)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTT
T ss_pred chhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCC
Confidence 4568999999999999999999988776 479999886543 23458999999999999999999985433
Q ss_pred CCCceeEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCc----
Q 021306 105 SKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQ---- 179 (314)
Q Consensus 105 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~---- 179 (314)
..++||||+++ +|.+.+.. ....+++.+++.++.||+.||.|||+ +||+||||||+||+++. ++.
T Consensus 86 -----~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dlkp~NIll~~-~~~~~~~ 155 (289)
T 4fvq_A 86 -----ENILVQEFVKFGSLDTYLKK---NKNCINILWKLEVAKQLAAAMHFLEE-NTLIHGNVCAKNILLIR-EEDRKTG 155 (289)
T ss_dssp -----CCEEEEECCTTCBHHHHHHH---TGGGCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEEEE-CCBGGGT
T ss_pred -----CCEEEEECCCCCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHhh-CCeECCCcCcceEEEec-CCccccc
Confidence 36799999985 77777764 23449999999999999999999999 89999999999999987 544
Q ss_pred ----EEEeecCcccccccCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCC-CCCCCCChHHHHHHHH
Q 021306 180 ----VKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQ-PLFPGENAVDQLVEII 254 (314)
Q Consensus 180 ----~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~-~pf~~~~~~~~~~~i~ 254 (314)
++|+|||.+..... .....+++.|+|||.+.+...++.++||||||+++|+|++|. .||...+... .....
T Consensus 156 ~~~~~kl~Dfg~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~-~~~~~ 231 (289)
T 4fvq_A 156 NPPFIKLSDPGISITVLP---KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR-KLQFY 231 (289)
T ss_dssp BCCEEEECCCCSCTTTSC---HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH-HHHHH
T ss_pred ccceeeeccCcccccccC---ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHH-HHHHh
Confidence 99999999865422 223456888999999976455899999999999999999955 5555555443 33333
Q ss_pred HHcCCCCHHHHhccCCCCCCCcccccccCChhhhhcccCChHHHHHhcchhh
Q 021306 255 KVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGSHIN 306 (314)
Q Consensus 255 ~~~~~~~~~~~~~~~p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~~~~ 306 (314)
..... ..+. ....+.++++.+|...+..+.+...+++.++.+.
T Consensus 232 ~~~~~--------~~~~-~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~ 274 (289)
T 4fvq_A 232 EDRHQ--------LPAP-KAAELANLINNCMDYEPDHRPSFRAIIRDLNSLF 274 (289)
T ss_dssp HTTCC--------CCCC-SSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC
T ss_pred hccCC--------CCCC-CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 22111 1111 2334566777777777777777777777766554
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-39 Score=283.54 Aligned_cols=256 Identities=24% Similarity=0.344 Sum_probs=194.4
Q ss_pred CCCceeeeeEeecCceEEEEEEEC-----CCCcEEEEEEeecc-----ccchHHHHHHHHhC-CCCceeeeceeeeecCC
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCL-----ETGETVAIKKVLQD-----RRYKNRELQLMRVM-DHPNVISLKHCFFSTTS 105 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~-----~~~~~~~vK~~~~~-----~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~ 105 (314)
.++|++.+.||+|+||.||+|++. .++..||+|.+... .....+|+.+++++ +||||+++++++....
T Consensus 44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~- 122 (344)
T 1rjb_A 44 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG- 122 (344)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-
T ss_pred HHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC-
Confidence 468999999999999999999973 45678999998643 23346899999999 8999999999884432
Q ss_pred CCceeEEEEeecccc-cHHHHHHhhhhc-------------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCceecC
Q 021306 106 KNELFLNLVMEYVPE-SMYRVLKHYSSA-------------------NQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRD 165 (314)
Q Consensus 106 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~-------------------~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~d 165 (314)
..++||||+++ +|.+.+...... ...+++..++.++.||+.||.|||+ +||+|+|
T Consensus 123 ----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~D 197 (344)
T 1rjb_A 123 ----PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF-KSCVHRD 197 (344)
T ss_dssp ----SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH-TTEEETT
T ss_pred ----ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHh-CCcccCC
Confidence 37899999985 888777643211 1348999999999999999999999 8999999
Q ss_pred CCCCcEEEcCCCCcEEEeecCcccccccCCc---cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCC
Q 021306 166 LKPQNLLVDPLTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLF 241 (314)
Q Consensus 166 l~p~Nil~~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~t-g~~pf 241 (314)
|||+||+++. ++.++|+|||++........ .....+++.|+|||.+.+.. ++.++||||||+++|+|+| |..||
T Consensus 198 ikp~NIll~~-~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~p~ 275 (344)
T 1rjb_A 198 LAARNVLVTH-GKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGI-YTIKSDVWSYGILLWEIFSLGVNPY 275 (344)
T ss_dssp CSGGGEEEET-TTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred CChhhEEEcC-CCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCC-CChhHhHHHHHHHHHHHHcCCCCCc
Confidence 9999999998 88999999999976543322 22344577899999986654 8999999999999999998 99999
Q ss_pred CCCChHHHHHHHHHHcCCCCHHHHhccCCCCCCCcccccccCChhhhhcccCChHHHHHhcchhhh
Q 021306 242 PGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGSHINA 307 (314)
Q Consensus 242 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~~~~~ 307 (314)
.+......+..++....... .|......+.+++..+|...+..++....+++.++.+..
T Consensus 276 ~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 334 (344)
T 1rjb_A 276 PGIPVDANFYKLIQNGFKMD-------QPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLA 334 (344)
T ss_dssp TTCCCSHHHHHHHHTTCCCC-------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred ccCCcHHHHHHHHhcCCCCC-------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence 88876666665555432211 111123345566667777777777777777766655443
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=289.31 Aligned_cols=258 Identities=12% Similarity=0.093 Sum_probs=187.4
Q ss_pred CCCceeeeeEeecCceEEEEEEECC--------CCcEEEEEEeeccccchHHHHHHHHhCCCCceeee------------
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCLE--------TGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISL------------ 96 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~~--------~~~~~~vK~~~~~~~~~~~e~~~l~~l~h~~iv~~------------ 96 (314)
.++|++.+.||+|+||.||+|++.. +++.||+|.+... ....+|+.++++++||||+++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i 119 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAI 119 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSC
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-chHHHHHHHHHHhcccchhhhhhhhccCCccCc
Confidence 4689999999999999999999987 4889999998765 456789999999999999984
Q ss_pred ---ceeeeecCCCCceeEEEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEE
Q 021306 97 ---KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLV 173 (314)
Q Consensus 97 ---~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~ 173 (314)
++++.. .....++||||+.++|.+.+... ....+++.+++.++.||+.||.|||+ +||+|+||||+||++
T Consensus 120 ~~~~~~~~~----~~~~~~lv~e~~~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dikp~NIl~ 192 (352)
T 2jii_A 120 PTCMGFGVH----QDKYRFLVLPSLGRSLQSALDVS--PKHVLSERSVLQVACRLLDALEFLHE-NEYVHGNVTAENIFV 192 (352)
T ss_dssp CCCCEEEEE----TTTEEEEEEECCCEEHHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHH-TTCBCSCCCGGGEEE
T ss_pred cchhhcccc----CCcEEEEEecCCCcCHHHHHHhC--CcCCCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCCHHHEEE
Confidence 333322 13357899999977888887642 23679999999999999999999999 899999999999999
Q ss_pred cCCCC--cEEEeecCcccccccCCc--------cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 021306 174 DPLTH--QVKICDFGSAKQLIAGEA--------NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 243 (314)
Q Consensus 174 ~~~~~--~~~l~dfg~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~ 243 (314)
+. ++ .++|+|||++........ .....+++.|+|||.+.+.. ++.++||||||+++|+|++|+.||.+
T Consensus 193 ~~-~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~pf~~ 270 (352)
T 2jii_A 193 DP-EDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCG-PSRRSDLQSLGYCMLKWLYGFLPWTN 270 (352)
T ss_dssp ET-TEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred cC-CCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCC-CCchhhHHHHHHHHHHHHhCCCCccc
Confidence 98 65 899999999976543221 12346789999999997654 89999999999999999999999987
Q ss_pred CC-hHHHHHHHHHHcCCCCHHHHhcc-CCCCCCCcccccccCChhhhhcccCChHHHHHhcch
Q 021306 244 EN-AVDQLVEIIKVLGTPTREEIRCM-NPNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGSH 304 (314)
Q Consensus 244 ~~-~~~~~~~i~~~~~~~~~~~~~~~-~p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~~ 304 (314)
.. ....+.................. ...-....+.++++.+|...+..+++...+++.++.
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~ 333 (352)
T 2jii_A 271 CLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEA 333 (352)
T ss_dssp GTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHH
T ss_pred CCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHH
Confidence 64 33333333332111111110000 000012234556666666666666666666655443
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=276.92 Aligned_cols=243 Identities=23% Similarity=0.346 Sum_probs=183.8
Q ss_pred ccCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhCC--CCceeeeceeeeecCCC
Q 021306 35 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMD--HPNVISLKHCFFSTTSK 106 (314)
Q Consensus 35 ~~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~------~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~~~ 106 (314)
..+++|++.+.||+|+||.||++.+. +++.||+|.+.... ....+|+.++++++ |+||+++++++...
T Consensus 25 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~--- 100 (313)
T 3cek_A 25 VKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD--- 100 (313)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECS---
T ss_pred eccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecC---
Confidence 34568999999999999999999964 68899999986432 23458899999997 59999999987432
Q ss_pred CceeEEEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecC
Q 021306 107 NELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 186 (314)
Q Consensus 107 ~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg 186 (314)
...+++||+..++|.+.+.. ...+++.+++.++.|++.||.|||+ +|++|+||||+||+++ ++.++|+|||
T Consensus 101 --~~~~lv~e~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~dlkp~NIl~~--~~~~kL~Dfg 171 (313)
T 3cek_A 101 --QYIYMVMECGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQ-HGIVHSDLKPANFLIV--DGMLKLIDFG 171 (313)
T ss_dssp --SEEEEEECCCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEEE--TTEEEECCCS
T ss_pred --CEEEEEEecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCcccEEEE--CCeEEEeecc
Confidence 34889999877888887764 4689999999999999999999999 8999999999999997 4789999999
Q ss_pred cccccccCCc---cccccccccccccccccCC----------CCCCcchhHHHHHHHHHHHHhCCCCCCCCChH-HHHHH
Q 021306 187 SAKQLIAGEA---NISYICSRFYRAPELIFGA----------TEYTTSIDIWSAGCVLAELLLGQPLFPGENAV-DQLVE 252 (314)
Q Consensus 187 ~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~----------~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~-~~~~~ 252 (314)
++........ .....+++.|+|||.+.+. ..++.++||||||+++|+|++|+.||...... ..+..
T Consensus 172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~ 251 (313)
T 3cek_A 172 IANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHA 251 (313)
T ss_dssp SSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHH
T ss_pred ccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHH
Confidence 9976543322 1234678999999998641 34788999999999999999999999876443 23333
Q ss_pred HHHHcCC-----C-CH---HHHh---ccCCCCCCCcccccccCChhhhhcc
Q 021306 253 IIKVLGT-----P-TR---EEIR---CMNPNYTDFRFPQIKAHPWHKVCIF 291 (314)
Q Consensus 253 i~~~~~~-----~-~~---~~~~---~~~p~~~~~~~~~l~~~p~~~~~~~ 291 (314)
+...... . .. +.+. ..+|. +|+++.++++|||++....
T Consensus 252 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~-~Rps~~ell~h~~~~~~~~ 301 (313)
T 3cek_A 252 IIDPNHEIEFPDIPEKDLQDVLKCCLKRDPK-QRISIPELLAHPYVQIQTH 301 (313)
T ss_dssp HHCTTSCCCCCCCSCHHHHHHHHHHTCSSTT-TSCCHHHHHTSHHHHCC--
T ss_pred HHhcccccCCcccchHHHHHHHHHHccCCcc-cCcCHHHHhcCccccCCCC
Confidence 3321111 0 11 1222 23666 8999999999999986543
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=271.95 Aligned_cols=250 Identities=21% Similarity=0.321 Sum_probs=197.1
Q ss_pred CCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeEEE
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 113 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 113 (314)
.++|++.+.||+|+||.||++.+. +++.|++|.+.... ....+|+.++++++||||+++++++... ...++
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~l 80 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ-----APICL 80 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECSS-----SSCEE
T ss_pred hhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEccC-----CCeEE
Confidence 468999999999999999999975 67889999987543 3456899999999999999999988443 23789
Q ss_pred Eeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcccccc
Q 021306 114 VMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 192 (314)
Q Consensus 114 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~ 192 (314)
+|||+++ +|.+.+.. ....+++..++.++.|++.||.+||+ +|++|+||+|+||+++. ++.++|+|||.+....
T Consensus 81 v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~Nili~~-~~~~kl~dfg~~~~~~ 155 (267)
T 3t9t_A 81 VTEFMEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEE-ACVIHRDLAARNCLVGE-NQVIKVSDFGMTRFVL 155 (267)
T ss_dssp EECCCTTCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSSCCGGGEEECG-GGCEEECCTTGGGGBC
T ss_pred EEeCCCCCcHHHHHhh---CcccCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCchheEEECC-CCCEEEcccccccccc
Confidence 9999985 77776654 24678999999999999999999999 89999999999999987 7889999999987543
Q ss_pred cCC--ccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCHHHHhccC
Q 021306 193 AGE--ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 269 (314)
Q Consensus 193 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 269 (314)
... ......+++.|+|||.+.+.. ++.++||||||+++|+|++ |+.||.+.+..+....+....... .
T Consensus 156 ~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~--------~ 226 (267)
T 3t9t_A 156 DDQYTSSTGTKFPVKWASPEVFSFSR-YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLY--------K 226 (267)
T ss_dssp CHHHHSTTSTTCCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCC--------C
T ss_pred cccccccccccccccccChhhhcCCC-ccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCC--------C
Confidence 221 112344567899999996544 7999999999999999999 899999888776666554432211 1
Q ss_pred CCCCCCcccccccCChhhhhcccCChHHHHHhcchhh
Q 021306 270 PNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGSHIN 306 (314)
Q Consensus 270 p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~~~~ 306 (314)
|......+.+++..+|...+..++....+++.++.+.
T Consensus 227 ~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~ 263 (267)
T 3t9t_A 227 PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIA 263 (267)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 1212334667777777777777777777777766543
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=281.41 Aligned_cols=256 Identities=22% Similarity=0.330 Sum_probs=196.8
Q ss_pred ccCCCceeeeeEeecCceEEEEEEECCCCc-----EEEEEEeeccc-----cchHHHHHHHHhC-CCCceeeeceeeeec
Q 021306 35 KQTISYMAERVVGTGSFGIVFQAKCLETGE-----TVAIKKVLQDR-----RYKNRELQLMRVM-DHPNVISLKHCFFST 103 (314)
Q Consensus 35 ~~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~-----~~~vK~~~~~~-----~~~~~e~~~l~~l-~h~~iv~~~~~~~~~ 103 (314)
...++|++.+.||+|+||.||+|.+..+++ .|++|.+.... ....+|+.+++++ +||||+++++++...
T Consensus 43 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 122 (333)
T 2i1m_A 43 FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHG 122 (333)
T ss_dssp CCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecC
Confidence 345689999999999999999999876654 79999886542 3345899999999 899999999988433
Q ss_pred CCCCceeEEEEeecccc-cHHHHHHhhhh----------cCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEE
Q 021306 104 TSKNELFLNLVMEYVPE-SMYRVLKHYSS----------ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLL 172 (314)
Q Consensus 104 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~----------~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil 172 (314)
. ..++||||+++ +|.+.+..... ....+++..++.++.|++.||.|||+ +||+|+||||+||+
T Consensus 123 ~-----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dlkp~NIl 196 (333)
T 2i1m_A 123 G-----PVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS-KNCIHRDVAARNVL 196 (333)
T ss_dssp S-----SCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGCE
T ss_pred C-----ceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhc-CCcccCCcccceEE
Confidence 2 37899999986 88877765322 14578999999999999999999999 89999999999999
Q ss_pred EcCCCCcEEEeecCcccccccCCc---cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHH
Q 021306 173 VDPLTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVD 248 (314)
Q Consensus 173 ~~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~t-g~~pf~~~~~~~ 248 (314)
++. ++.++|+|||++........ .....+++.|+|||.+.+.. ++.++||||||+++|+|++ |..||.+.....
T Consensus 197 ~~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~p~~~~~~~~ 274 (333)
T 2i1m_A 197 LTN-GHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGLNPYPGILVNS 274 (333)
T ss_dssp EEG-GGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSH
T ss_pred ECC-CCeEEECccccccccccccceeecCCCCCCccccCHHHhccCC-CChHHHHHHHHHHHHHHHcCCCCCCcccchhH
Confidence 998 78999999999976543322 12234577899999986654 8999999999999999999 999998877666
Q ss_pred HHHHHHHHcCCCCHHHHhccCCCCCCCcccccccCChhhhhcccCChHHHHHhcchh
Q 021306 249 QLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGSHI 305 (314)
Q Consensus 249 ~~~~i~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~~~ 305 (314)
....+........ .|......+.+++..+|...+..++....+++.++.+
T Consensus 275 ~~~~~~~~~~~~~-------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~ 324 (333)
T 2i1m_A 275 KFYKLVKDGYQMA-------QPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQ 324 (333)
T ss_dssp HHHHHHHHTCCCC-------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHhcCCCCC-------CCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHH
Confidence 6666655432211 1111233455677777777777777777776665543
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-39 Score=275.46 Aligned_cols=251 Identities=25% Similarity=0.304 Sum_probs=183.2
Q ss_pred ccCCCceeeeeEeecCceEEEEEEECCC---CcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCC
Q 021306 35 KQTISYMAERVVGTGSFGIVFQAKCLET---GETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSK 106 (314)
Q Consensus 35 ~~~~~y~~~~~Lg~g~~g~Vy~~~~~~~---~~~~~vK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 106 (314)
...++|++.+.||+|+||.||+|++..+ +..+++|.+.... ....+|+.++++++||||+++++++.. .
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~-- 88 (281)
T 1mp8_A 12 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-N-- 88 (281)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-S--
T ss_pred EehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEcc-C--
Confidence 3456899999999999999999998654 4579999876432 234589999999999999999998621 1
Q ss_pred CceeEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeec
Q 021306 107 NELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF 185 (314)
Q Consensus 107 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~df 185 (314)
..++||||+++ +|.+.+.. ....+++..++.++.|++.||.|||+ +|++|+||||+||+++. ++.++|+||
T Consensus 89 ---~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nil~~~-~~~~kl~Df 160 (281)
T 1mp8_A 89 ---PVWIIMELCTLGELRSFLQV---RKYSLDLASLILYAYQLSTALAYLES-KRFVHRDIAARNVLVSS-NDCVKLGDF 160 (281)
T ss_dssp ---SCEEEEECCTTEEHHHHHHH---TTTTSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEEE-TTEEEECC-
T ss_pred ---ccEEEEecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh-CCeecccccHHHEEECC-CCCEEECcc
Confidence 26799999996 77776653 24579999999999999999999999 89999999999999998 789999999
Q ss_pred CcccccccCCc--cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCH
Q 021306 186 GSAKQLIAGEA--NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTR 262 (314)
Q Consensus 186 g~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~ 262 (314)
|++........ .....+++.|+|||.+.+.. ++.++||||||+++|+|++ |..||.+....+....+.+....+.
T Consensus 161 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~~~- 238 (281)
T 1mp8_A 161 GLSRYMEDSTYYKASKGKLPIKWMAPESINFRR-FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPM- 238 (281)
T ss_dssp ------------------CCGGGCCHHHHHHCC-CSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCC-
T ss_pred ccccccCcccccccccCCCcccccChhhcccCC-CCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCCCC-
Confidence 99976543322 12234467899999986544 8999999999999999997 9999998887766665544322111
Q ss_pred HHHhccCCCCCCCcccccccCChhhhhcccCChHHHHHhcchh
Q 021306 263 EEIRCMNPNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGSHI 305 (314)
Q Consensus 263 ~~~~~~~p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~~~ 305 (314)
.+. ....+.+++..+|...+..++....+++.++.+
T Consensus 239 ------~~~-~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 274 (281)
T 1mp8_A 239 ------PPN-CPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 274 (281)
T ss_dssp ------CTT-CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ------CCC-CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 111 223355666666666666666666666665544
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=292.19 Aligned_cols=256 Identities=23% Similarity=0.335 Sum_probs=203.6
Q ss_pred cCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeEE
Q 021306 36 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 112 (314)
Q Consensus 36 ~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 112 (314)
..++|++.+.||+|+||.||+|.+. ++..||+|.++... ....+|+.++++++||||+++++++. .. ..+
T Consensus 186 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~-----~~~ 258 (454)
T 1qcf_A 186 PRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KE-----PIY 258 (454)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SS-----SCE
T ss_pred chHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CC-----ccE
Confidence 3468999999999999999999975 57789999987543 33468999999999999999998863 11 267
Q ss_pred EEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCccccc
Q 021306 113 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 191 (314)
Q Consensus 113 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~ 191 (314)
+||||+.+ +|.+.+... ....+++..++.++.||+.||.|||+ +||+||||||+||+++. ++.+||+|||+++..
T Consensus 259 lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivHrDlkp~Nill~~-~~~~kl~DFG~a~~~ 334 (454)
T 1qcf_A 259 IITEFMAKGSLLDFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIEQ-RNYIHRDLRAANILVSA-SLVCKIADFGLARVI 334 (454)
T ss_dssp EEECCCTTCBHHHHHHSH--HHHTCCHHHHHHHHHHHHHHHHHHHH-TTCCCSSCSGGGEEECT-TCCEEECSTTGGGGB
T ss_pred EEEeecCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCCHHHEEECC-CCcEEEeeCCCceEc
Confidence 99999985 787777642 12468899999999999999999999 89999999999999998 889999999999765
Q ss_pred ccCCc--cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCHHHHhcc
Q 021306 192 IAGEA--NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 268 (314)
Q Consensus 192 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 268 (314)
..... .....+++.|+|||.+.+.. ++.++||||||+++|||+| |+.||.+.+..+....+.+....+.
T Consensus 335 ~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~------- 406 (454)
T 1qcf_A 335 EDNEYTAREGAKFPIKWTAPEAINFGS-FTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPR------- 406 (454)
T ss_dssp CCHHHHTTCSSSSCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCC-------
T ss_pred CCCceeccCCCcccccccCHHHhccCC-CCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC-------
Confidence 32211 12233467899999996544 8999999999999999999 9999999888777766655433222
Q ss_pred CCCCCCCcccccccCChhhhhcccCChHHHHHhcchhhhcCCC
Q 021306 269 NPNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGSHINAISPR 311 (314)
Q Consensus 269 ~p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (314)
|......+.+|+..||...+..+++...+.+.++.+......
T Consensus 407 -~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~~~ 448 (454)
T 1qcf_A 407 -PENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTATES 448 (454)
T ss_dssp -CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSSCC
T ss_pred -CCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhcccc
Confidence 111233467888889988888888889998888877665443
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-39 Score=275.19 Aligned_cols=257 Identities=22% Similarity=0.293 Sum_probs=194.9
Q ss_pred CCCCccCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc--cchHHHHHHHHhCCCCceeeeceeeeecCCCCc
Q 021306 31 NGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR--RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 108 (314)
Q Consensus 31 ~~~~~~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~--~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 108 (314)
+.-+...++|++.+.||+|++|.||++++ +++.|++|.++... ....+|+.++++++||||+++++++....
T Consensus 14 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---- 87 (278)
T 1byg_A 14 SGWALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEK---- 87 (278)
T ss_dssp -CCBCCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC-----
T ss_pred ccccCChhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC----
Confidence 33445567999999999999999999987 58899999987543 33468999999999999999999864322
Q ss_pred eeEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCc
Q 021306 109 LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 187 (314)
Q Consensus 109 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~ 187 (314)
...+++|||+++ +|.+.+.... ...+++..++.++.|++.||.+||+ +|++|+||+|+||+++. ++.++|+|||.
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~Nil~~~-~~~~~l~Dfg~ 163 (278)
T 1byg_A 88 GGLYIVTEYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEG-NNFVHRDLAARNVLVSE-DNVAKVSDFGL 163 (278)
T ss_dssp -CCEEEECCCTTEEHHHHHHHHH--HHHCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECT-TSCEEECCCCC
T ss_pred CceEEEEecCCCCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCcceEEEeC-CCcEEEeeccc
Confidence 237799999986 8877776421 2348999999999999999999999 89999999999999998 78999999999
Q ss_pred ccccccCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCHHHHh
Q 021306 188 AKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIR 266 (314)
Q Consensus 188 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 266 (314)
+...... .....+++.|+|||.+.+.. ++.++||||||+++|+|++ |+.||......+....+.+......
T Consensus 164 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~----- 235 (278)
T 1byg_A 164 TKEASST--QDTGKLPVKWTAPEALREKK-FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDA----- 235 (278)
T ss_dssp --------------CCTTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCC-----
T ss_pred ccccccc--ccCCCccccccCHHHhCCCC-CCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCC-----
Confidence 8754332 22335678899999986544 8999999999999999998 9999988876655554433221111
Q ss_pred ccCCCCCCCcccccccCChhhhhcccCChHHHHHhcchhhhc
Q 021306 267 CMNPNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGSHINAI 308 (314)
Q Consensus 267 ~~~p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 308 (314)
|......+.++++.+|...+..++....+.+.++.++..
T Consensus 236 ---~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~ 274 (278)
T 1byg_A 236 ---PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274 (278)
T ss_dssp ---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---cccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence 111233466788888888888888888888887776543
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=280.63 Aligned_cols=207 Identities=28% Similarity=0.440 Sum_probs=163.8
Q ss_pred cCCCceeeeeEeecCceEEEEEEECCCCcE----EEEEEeecc-----ccchHHHHHHHHhCCCCceeeeceeeeecCCC
Q 021306 36 QTISYMAERVVGTGSFGIVFQAKCLETGET----VAIKKVLQD-----RRYKNRELQLMRVMDHPNVISLKHCFFSTTSK 106 (314)
Q Consensus 36 ~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~----~~vK~~~~~-----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 106 (314)
..++|++.+.||+|+||.||+|++..+++. |++|.+... .....+|+.++++++||||+++++++...
T Consensus 13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--- 89 (327)
T 3poz_A 13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS--- 89 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS---
T ss_pred CHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC---
Confidence 346899999999999999999998877765 477766432 23346899999999999999999988532
Q ss_pred CceeEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeec
Q 021306 107 NELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF 185 (314)
Q Consensus 107 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~df 185 (314)
. .++++||+.+ +|.+.+.. ....+++..++.++.|++.||.|||+ +||+||||||+||+++. ++.++|+||
T Consensus 90 --~-~~~v~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivH~Dikp~NIll~~-~~~~kl~Df 161 (327)
T 3poz_A 90 --T-VQLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLED-RRLVHRDLAARNVLVKT-PQHVKITDF 161 (327)
T ss_dssp --S-EEEEEECCTTCBHHHHHHH---STTSCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEEE-TTEEEECCT
T ss_pred --C-eEEEEEecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHhh-CCeeCCCCChheEEECC-CCCEEEccC
Confidence 1 5688888885 77776654 34679999999999999999999999 89999999999999998 889999999
Q ss_pred CcccccccCCcc---ccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 021306 186 GSAKQLIAGEAN---ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEII 254 (314)
Q Consensus 186 g~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~t-g~~pf~~~~~~~~~~~i~ 254 (314)
|+++........ ....+|+.|+|||.+.+.. ++.++||||||+++|+|++ |+.||.+....+....+.
T Consensus 162 g~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~ 233 (327)
T 3poz_A 162 GLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI-YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 233 (327)
T ss_dssp THHHHHTTTCC-------CCCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH
T ss_pred cceeEccCCcccccccCCCccccccChHHhccCC-CCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHH
Confidence 999765433322 2234477899999997654 8999999999999999999 999999887765544443
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=278.39 Aligned_cols=215 Identities=23% Similarity=0.313 Sum_probs=174.5
Q ss_pred CccCCCceeeeeEeecCceEEEEEEEC-----CCCcEEEEEEeecccc-----chHHHHHHHHhCCCCceeeeceeeeec
Q 021306 34 PKQTISYMAERVVGTGSFGIVFQAKCL-----ETGETVAIKKVLQDRR-----YKNRELQLMRVMDHPNVISLKHCFFST 103 (314)
Q Consensus 34 ~~~~~~y~~~~~Lg~g~~g~Vy~~~~~-----~~~~~~~vK~~~~~~~-----~~~~e~~~l~~l~h~~iv~~~~~~~~~ 103 (314)
....++|++.+.||+|+||.||+|++. .+++.|++|.+..... ...+|+.++++++|+||+++++++...
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 100 (322)
T 1p4o_A 21 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 100 (322)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS
T ss_pred cchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccC
Confidence 344578999999999999999999876 3578899999865432 245799999999999999999988433
Q ss_pred CCCCceeEEEEeecccc-cHHHHHHhhhh------cCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCC
Q 021306 104 TSKNELFLNLVMEYVPE-SMYRVLKHYSS------ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPL 176 (314)
Q Consensus 104 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~------~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~ 176 (314)
...++||||+++ +|.+.+..... ...++++..++.++.|++.||.+||+ +||+|+||||+||+++.
T Consensus 101 -----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dikp~NIli~~- 173 (322)
T 1p4o_A 101 -----QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA-NKFVHRDLAARNCMVAE- 173 (322)
T ss_dssp -----SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH-TTCBCSCCSGGGEEECT-
T ss_pred -----CccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHH-CCCccCCCccceEEEcC-
Confidence 237899999985 88777765321 12567999999999999999999999 89999999999999998
Q ss_pred CCcEEEeecCcccccccCCc---cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 021306 177 THQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVE 252 (314)
Q Consensus 177 ~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~t-g~~pf~~~~~~~~~~~ 252 (314)
++.++|+|||++........ .....+++.|+|||.+.+.. ++.++||||||+++|+|++ |..||.+.+..+....
T Consensus 174 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~ 252 (322)
T 1p4o_A 174 DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF 252 (322)
T ss_dssp TCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHH
T ss_pred CCeEEECcCccccccccccccccccCCCCCCCccChhhhccCC-CCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHH
Confidence 78999999999875533221 12234578899999986554 8999999999999999999 8999998887766665
Q ss_pred HHHH
Q 021306 253 IIKV 256 (314)
Q Consensus 253 i~~~ 256 (314)
+.+.
T Consensus 253 ~~~~ 256 (322)
T 1p4o_A 253 VMEG 256 (322)
T ss_dssp HHTT
T ss_pred HHcC
Confidence 5543
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-39 Score=297.97 Aligned_cols=253 Identities=19% Similarity=0.275 Sum_probs=199.8
Q ss_pred cCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeEE
Q 021306 36 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 112 (314)
Q Consensus 36 ~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 112 (314)
..++|++.+.||+|+||.||+|.++.++..||+|.++... ..+.+|+.++++++||||+++++++... ..++
T Consensus 218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-----~~~~ 292 (495)
T 1opk_A 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE-----PPFY 292 (495)
T ss_dssp CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSS-----SSCE
T ss_pred CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEecC-----CcEE
Confidence 3467999999999999999999999889999999987543 3346899999999999999999988433 2378
Q ss_pred EEeeccc-ccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCccccc
Q 021306 113 LVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 191 (314)
Q Consensus 113 lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~ 191 (314)
+||||+. |+|.+.+... ....+++..++.++.||+.||.|||+ +||+||||||+||+++. ++.+||+|||+++..
T Consensus 293 lv~E~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivHrDlkp~NIll~~-~~~~kl~DFG~a~~~ 368 (495)
T 1opk_A 293 IITEFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEK-KNFIHRNLAARNCLVGE-NHLVKVADFGLSRLM 368 (495)
T ss_dssp EEEECCTTCBHHHHHHHS--CTTTSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECG-GGCEEECCTTCEECC
T ss_pred EEEEccCCCCHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCChhhEEECC-CCcEEEeecccceec
Confidence 9999998 5787777642 23569999999999999999999999 89999999999999988 789999999999865
Q ss_pred ccCCc--cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCHHHHhcc
Q 021306 192 IAGEA--NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 268 (314)
Q Consensus 192 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 268 (314)
..... .....+++.|+|||.+.+.. ++.++||||||+++|+|++ |..||.+.+..+....+.+....+
T Consensus 369 ~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~-------- 439 (495)
T 1opk_A 369 TGDTYTAHAGAKFPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRME-------- 439 (495)
T ss_dssp TTCCEECCTTCCCCGGGCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCC--------
T ss_pred cCCceeecCCCcCCcceeCHhHHhcCC-CCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC--------
Confidence 43221 12233467899999996554 8999999999999999999 999999888766555443322111
Q ss_pred CCCCCCCcccccccCChhhhhcccCChHHHHHhcchhh
Q 021306 269 NPNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGSHIN 306 (314)
Q Consensus 269 ~p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~~~~ 306 (314)
.|......+.+|+..||...+..++....+++.++.+.
T Consensus 440 ~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~ 477 (495)
T 1opk_A 440 RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 477 (495)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred CCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 11112334667777888888887777777777766553
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-38 Score=272.52 Aligned_cols=254 Identities=24% Similarity=0.311 Sum_probs=181.1
Q ss_pred ccCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCCc
Q 021306 35 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 108 (314)
Q Consensus 35 ~~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 108 (314)
...++|++.+.||+|+||.||++++. ..+++|.++... ....+|+.++++++|+||++++++. ...
T Consensus 21 i~~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~---- 92 (289)
T 3og7_A 21 IPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAP---- 92 (289)
T ss_dssp CCTTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSS----
T ss_pred cCccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCC----
Confidence 33568999999999999999999853 359999886432 2345899999999999999998854 211
Q ss_pred eeEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCc
Q 021306 109 LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 187 (314)
Q Consensus 109 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~ 187 (314)
..++||||+.+ +|.+.+.. ....+++..++.++.|++.||.|||+ +|++|+||||+||+++. ++.++|+|||+
T Consensus 93 -~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~lH~-~~i~H~Dlkp~Nil~~~-~~~~kl~Dfg~ 166 (289)
T 3og7_A 93 -QLAIVTQWCEGSSLYHHLHA---SETKFEMKKLIDIARQTARGMDYLHA-KSIIHRDLKSNNIFLHE-DNTVKIGDFGL 166 (289)
T ss_dssp -SCEEEEECCCEEEHHHHHTT---C---CCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEET-TTEEEECCCC-
T ss_pred -ccEEEEEecCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHh-CCcccccCccceEEECC-CCCEEEcccee
Confidence 26799999985 66665543 34679999999999999999999999 89999999999999998 78999999999
Q ss_pred ccccccC---CccccccccccccccccccC--CCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCH
Q 021306 188 AKQLIAG---EANISYICSRFYRAPELIFG--ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 262 (314)
Q Consensus 188 ~~~~~~~---~~~~~~~~~~~y~aPE~~~~--~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~ 262 (314)
+...... .......+++.|+|||.+.. ...++.++||||||+++|+|++|+.||.+....+.+...+........
T Consensus 167 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 246 (289)
T 3og7_A 167 ATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPD 246 (289)
T ss_dssp -----------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCC
T ss_pred ccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcc
Confidence 8754321 12233567999999999852 334788999999999999999999999987776666666554322211
Q ss_pred HHHhccCCCCCCCcccccccCChhhhhcccCChHHHHHhcchh
Q 021306 263 EEIRCMNPNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGSHI 305 (314)
Q Consensus 263 ~~~~~~~p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~~~ 305 (314)
+..+.+. ....+.+++..+|...+..++....+++.++.+
T Consensus 247 --~~~~~~~-~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l 286 (289)
T 3og7_A 247 --LSKVRSN-CPKRMKRLMAECLKKKRDERPSFPRILAEIEEL 286 (289)
T ss_dssp --TTSSCTT-SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred --hhhcccc-CCHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence 0111111 112355666666666666666677777766544
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=281.71 Aligned_cols=200 Identities=15% Similarity=0.236 Sum_probs=164.0
Q ss_pred CCCceeeeeEeecCceEEEEE-----EECCCCcEEEEEEeeccc-cchHHHHHHHHhCC---CCceeeeceeeeecCCCC
Q 021306 37 TISYMAERVVGTGSFGIVFQA-----KCLETGETVAIKKVLQDR-RYKNRELQLMRVMD---HPNVISLKHCFFSTTSKN 107 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~-----~~~~~~~~~~vK~~~~~~-~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~ 107 (314)
.++|++.+.||+|+||.||+| .+..+++.||+|.+.... ....+|..+++.+. |+||+++++++.....
T Consensus 64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~-- 141 (365)
T 3e7e_A 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNG-- 141 (365)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSC--
T ss_pred CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCC--
Confidence 468999999999999999999 466789999999987543 33457788888886 8999999998854433
Q ss_pred ceeEEEEeecccc-cHHHHHHhhhh-cCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCC---------
Q 021306 108 ELFLNLVMEYVPE-SMYRVLKHYSS-ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPL--------- 176 (314)
Q Consensus 108 ~~~~~lv~e~~~~-~l~~~l~~~~~-~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~--------- 176 (314)
.++||||+++ +|.+.+..... ....+++.+++.++.||+.||.|||+ +||+||||||+||+++..
T Consensus 142 ---~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~-~~ivHrDiKp~NIll~~~~~~~~~~~~ 217 (365)
T 3e7e_A 142 ---SVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD-CEIIHGDIKPDNFILGNGFLEQDDEDD 217 (365)
T ss_dssp ---EEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCSGGGEEECGGGTCC-----
T ss_pred ---cEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhh-CCeecCCCCHHHEEecccccCcccccc
Confidence 7899999984 78877765433 35679999999999999999999999 899999999999999752
Q ss_pred -CCcEEEeecCccccccc---CCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 021306 177 -THQVKICDFGSAKQLIA---GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 243 (314)
Q Consensus 177 -~~~~~l~dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~ 243 (314)
++.++|+|||++..... ........+|+.|+|||.+.+.. ++.++||||||+++|+|+||+.||..
T Consensus 218 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~pf~~ 287 (365)
T 3e7e_A 218 LSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKP-WNYQIDYFGVAATVYCMLFGTYMKVK 287 (365)
T ss_dssp -CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCC-BSTHHHHHHHHHHHHHHHHSSCCCEE
T ss_pred ccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCC-CCccccHHHHHHHHHHHHhCCCcccc
Confidence 57899999999965432 22233456899999999997655 89999999999999999999999854
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-38 Score=277.66 Aligned_cols=251 Identities=20% Similarity=0.264 Sum_probs=183.5
Q ss_pred CccCCCceeeeeEeecCceEEEEEEECCCC----cEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecC
Q 021306 34 PKQTISYMAERVVGTGSFGIVFQAKCLETG----ETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTT 104 (314)
Q Consensus 34 ~~~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~----~~~~vK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 104 (314)
....++|++.+.||+|+||.||+|.+..++ ..|++|.+.... ....+|+.++++++||||+++++++..
T Consensus 40 ~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-- 117 (333)
T 1mqb_A 40 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK-- 117 (333)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS--
T ss_pred cCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEec--
Confidence 344568999999999999999999987553 459999986532 234579999999999999999998843
Q ss_pred CCCceeEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEe
Q 021306 105 SKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKIC 183 (314)
Q Consensus 105 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~ 183 (314)
....++||||+++ +|.+.+.. ....+++.+++.++.||+.||.+||+ +||+|+||||+||+++. ++.++|+
T Consensus 118 ---~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dikp~NIl~~~-~~~~kl~ 189 (333)
T 1mqb_A 118 ---YKPMMIITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYLAN-MNYVHRDLAARNILVNS-NLVCKVS 189 (333)
T ss_dssp ---SSSEEEEEECCTTEEHHHHHHH---TTTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECT-TCCEEEC
T ss_pred ---CCCcEEEEeCCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCChheEEECC-CCcEEEC
Confidence 3348899999987 77766653 34679999999999999999999999 89999999999999998 8899999
Q ss_pred ecCcccccccCCc----cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcC
Q 021306 184 DFGSAKQLIAGEA----NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLG 258 (314)
Q Consensus 184 dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~t-g~~pf~~~~~~~~~~~i~~~~~ 258 (314)
|||++........ .....+++.|+|||.+.+.. ++.++||||||+++|+|++ |+.||.+.+..+....+.+...
T Consensus 190 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~ 268 (333)
T 1mqb_A 190 DFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRK-FTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFR 268 (333)
T ss_dssp CCCC-----------------CCCGGGSCHHHHHSCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC
T ss_pred CCCcchhhccccccccccCCCCccccccCchhcccCC-CCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCc
Confidence 9999976543221 11223467899999996554 8999999999999999999 9999998887766665544322
Q ss_pred CCCHHHHhccCCCCCCCcccccccCChhhhhcccCChHHHHHhcc
Q 021306 259 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGS 303 (314)
Q Consensus 259 ~~~~~~~~~~~p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~ 303 (314)
.+.+. . ....+.+++..+|...+..++....+++.++
T Consensus 269 ~~~~~---~-----~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~ 305 (333)
T 1mqb_A 269 LPTPM---D-----CPSAIYQLMMQCWQQERARRPKFADIVSILD 305 (333)
T ss_dssp CCCCT---T-----CBHHHHHHHHHHTCSSTTTSCCHHHHHHHHH
T ss_pred CCCcc---c-----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 22111 0 1223445555555555555555555555443
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-38 Score=269.53 Aligned_cols=251 Identities=17% Similarity=0.211 Sum_probs=194.4
Q ss_pred ccCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCCc
Q 021306 35 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 108 (314)
Q Consensus 35 ~~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 108 (314)
...++|++.+.||+|+||.||+|++ +++.+++|.+.... ....+|+.++++++||||+++++++.... .
T Consensus 7 i~~~~y~~~~~lg~G~~g~V~~~~~--~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---~ 81 (271)
T 3kmu_A 7 IDFKQLNFLTKLNENHSGELWKGRW--QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPP---A 81 (271)
T ss_dssp CCGGGCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTT---S
T ss_pred CCHHHhHHHHHhcCCCcceEEEEEE--CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCC---C
Confidence 3456899999999999999999998 48899999986542 23457888999999999999999885432 2
Q ss_pred eeEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCC--ceecCCCCCcEEEcCCCCcEEEeec
Q 021306 109 LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR--VCHRDLKPQNLLVDPLTHQVKICDF 185 (314)
Q Consensus 109 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~--i~h~dl~p~Nil~~~~~~~~~l~df 185 (314)
...+++|||+++ +|.+.+... ....+++.+++.++.|++.||.|||+ +| ++|+||||+||+++. ++.++++||
T Consensus 82 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~-~~~~i~H~dikp~Nil~~~-~~~~~l~~~ 157 (271)
T 3kmu_A 82 PHPTLITHWMPYGSLYNVLHEG--TNFVVDQSQAVKFALDMARGMAFLHT-LEPLIPRHALNSRSVMIDE-DMTARISMA 157 (271)
T ss_dssp SSCEEEEECCTTCBHHHHHHSC--SSCCCCHHHHHHHHHHHHHHHHHHTT-SSSCCTTCCCSGGGEEECT-TSCEEEEGG
T ss_pred CCeEeeecccCCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhc-CCCceecCCCccceEEEcC-CcceeEEec
Confidence 347899999986 887777641 22369999999999999999999999 89 999999999999998 788999988
Q ss_pred CcccccccCCccccccccccccccccccCCCC--CCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCHH
Q 021306 186 GSAKQLIAGEANISYICSRFYRAPELIFGATE--YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 263 (314)
Q Consensus 186 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~--~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~ 263 (314)
+++.... .....+|+.|+|||.+.+... ++.++||||||+++|+|++|+.||.+.+..+....+......+..
T Consensus 158 ~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~- 232 (271)
T 3kmu_A 158 DVKFSFQ----SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTI- 232 (271)
T ss_dssp GSCCTTS----CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCC-
T ss_pred cceeeec----ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCC-
Confidence 8875432 223467899999999976432 233899999999999999999999998887766666544322211
Q ss_pred HHhccCCCCCCCcccccccCChhhhhcccCChHHHHHhcchh
Q 021306 264 EIRCMNPNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGSHI 305 (314)
Q Consensus 264 ~~~~~~p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~~~ 305 (314)
++. ....+.+++..+|...+..+++...+++.++.+
T Consensus 233 -----~~~-~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l 268 (271)
T 3kmu_A 233 -----PPG-ISPHVSKLMKICMNEDPAKRPKFDMIVPILEKM 268 (271)
T ss_dssp -----CTT-CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----CCC-CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence 111 233456677777777777777777777776654
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=272.45 Aligned_cols=253 Identities=22% Similarity=0.264 Sum_probs=191.3
Q ss_pred CccCCCceeeeeEeecCceEEEEEEECC---CCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCC
Q 021306 34 PKQTISYMAERVVGTGSFGIVFQAKCLE---TGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTS 105 (314)
Q Consensus 34 ~~~~~~y~~~~~Lg~g~~g~Vy~~~~~~---~~~~~~vK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 105 (314)
+...++|++.+.||+|+||.||+|++.. ++..|++|.+.... ....+|+.++++++||||+++++++..
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--- 84 (281)
T 3cc6_A 8 GIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE--- 84 (281)
T ss_dssp SCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS---
T ss_pred eecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC---
Confidence 4456789999999999999999998654 34569999887542 334579999999999999999998632
Q ss_pred CCceeEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEee
Q 021306 106 KNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICD 184 (314)
Q Consensus 106 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~d 184 (314)
. ..+++|||+++ +|.+.+.. ....+++..++.++.|++.||.+||+ +|++|+||||+||+++. ++.++|+|
T Consensus 85 --~-~~~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~Nil~~~-~~~~kl~D 156 (281)
T 3cc6_A 85 --E-PTWIIMELYPYGELGHYLER---NKNSLKVLTLVLYSLQICKAMAYLES-INCVHRDIAVRNILVAS-PECVKLGD 156 (281)
T ss_dssp --S-SCEEEEECCTTCBHHHHHHH---HTTTCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCSGGGEEEEE-TTEEEECC
T ss_pred --C-CCEEEEecCCCCCHHHHHHh---ccccCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCccceEEECC-CCcEEeCc
Confidence 1 14699999995 77776654 24669999999999999999999999 89999999999999998 78999999
Q ss_pred cCcccccccCCc--cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCC
Q 021306 185 FGSAKQLIAGEA--NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPT 261 (314)
Q Consensus 185 fg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~ 261 (314)
||.+........ .....+++.|+|||.+.+.. ++.++||||||+++|+|++ |+.||......+....+......+.
T Consensus 157 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~~ 235 (281)
T 3cc6_A 157 FGLSRYIEDEDYYKASVTRLPIKWMSPESINFRR-FTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPK 235 (281)
T ss_dssp CCGGGCC---------CCCCCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCCC
T ss_pred cCCCcccccccccccccCCCCcceeCchhhccCC-CCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCCC
Confidence 999876543221 12234577899999986544 8999999999999999998 9999988777665555544322221
Q ss_pred HHHHhccCCCCCCCcccccccCChhhhhcccCChHHHHHhcchhh
Q 021306 262 REEIRCMNPNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGSHIN 306 (314)
Q Consensus 262 ~~~~~~~~p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~~~~ 306 (314)
+ ......+.+++..+|...+..++....+++.++.+.
T Consensus 236 ~--------~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 272 (281)
T 3cc6_A 236 P--------DLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVY 272 (281)
T ss_dssp C--------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred C--------CCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHH
Confidence 1 112234556667777777777777777776665543
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-38 Score=273.35 Aligned_cols=252 Identities=27% Similarity=0.349 Sum_probs=189.3
Q ss_pred CCceeeeeEeecCceEEEEEE----ECCCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCc
Q 021306 38 ISYMAERVVGTGSFGIVFQAK----CLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 108 (314)
Q Consensus 38 ~~y~~~~~Lg~g~~g~Vy~~~----~~~~~~~~~vK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 108 (314)
..|++.+.||+|+||.||+|+ +..+++.||+|.+.... ....+|+.++++++|+||+++++++.... .
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~---~ 97 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDG---G 97 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC------
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCC---C
Confidence 469999999999999999999 56789999999986442 33468999999999999999999886432 2
Q ss_pred eeEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCc
Q 021306 109 LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 187 (314)
Q Consensus 109 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~ 187 (314)
..+++||||+++ +|.+.+.. ....+++.+++.++.|++.||.+||+ +|++|+||||+||+++. ++.++|+|||+
T Consensus 98 ~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dikp~Nil~~~-~~~~kl~Dfg~ 172 (302)
T 4e5w_A 98 NGIKLIMEFLPSGSLKEYLPK---NKNKINLKQQLKYAVQICKGMDYLGS-RQYVHRDLAARNVLVES-EHQVKIGDFGL 172 (302)
T ss_dssp CCEEEEEECCTTCBHHHHHHH---HTTTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEEE-TTEEEECCCTT
T ss_pred ceEEEEEEeCCCCcHHHHHHh---ccccCCHHHHHHHHHHHHHHHHHhhc-CCcccCCCchheEEEcC-CCCEEECcccc
Confidence 347899999986 77777643 24679999999999999999999999 89999999999999998 78999999999
Q ss_pred ccccccCCc----cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCh--------------HHH
Q 021306 188 AKQLIAGEA----NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA--------------VDQ 249 (314)
Q Consensus 188 ~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~--------------~~~ 249 (314)
+........ .....++..|+|||.+.+.. ++.++||||||+++|+|++|..|+..... ...
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 251 (302)
T 4e5w_A 173 TKAIETDKEYYTVKDDRDSPVFWYAPECLMQSK-FYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTR 251 (302)
T ss_dssp CEECCTTCCEEECCCCTTCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHH
T ss_pred cccccCCCcceeccCCCCCCccccCCeeecCCC-CCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHH
Confidence 976544322 22345677799999986654 78999999999999999999988643211 111
Q ss_pred HHHHHHHcCCCCHHHHhccCCCCCCCcccccccCChhhhhcccCChHHHHHhcchh
Q 021306 250 LVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGSHI 305 (314)
Q Consensus 250 ~~~i~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~~~ 305 (314)
+...+...... ..++. ....+.+++..+|...+..+++...+++.++.+
T Consensus 252 ~~~~~~~~~~~------~~~~~-~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 300 (302)
T 4e5w_A 252 LVNTLKEGKRL------PCPPN-CPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL 300 (302)
T ss_dssp HHHHHHTTCCC------CCCTT-CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHhccCCC------CCCCC-CCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH
Confidence 11111110000 01111 233466788888888888888888888776654
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=275.16 Aligned_cols=249 Identities=21% Similarity=0.229 Sum_probs=189.8
Q ss_pred CCCceeee-eEeecCceEEEEEEE--CCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCC
Q 021306 37 TISYMAER-VVGTGSFGIVFQAKC--LETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKN 107 (314)
Q Consensus 37 ~~~y~~~~-~Lg~g~~g~Vy~~~~--~~~~~~~~vK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 107 (314)
.++|++.+ .||+|+||.||+|.+ ..+++.|++|.++... ....+|+.++++++||||+++++++ ...
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~--- 90 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAE--- 90 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESS---
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCC---
Confidence 35799999 999999999999954 5668899999986542 3345899999999999999999987 222
Q ss_pred ceeEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecC
Q 021306 108 ELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 186 (314)
Q Consensus 108 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg 186 (314)
..++||||+++ +|.+.+.. ...+++.+++.++.|++.||.+||+ +|++|+||||+||+++. ++.++|+|||
T Consensus 91 --~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~-~~i~H~dikp~Nil~~~-~~~~kl~Dfg 162 (291)
T 1xbb_A 91 --SWMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEE-SNFVHRDLAARNVLLVT-QHYAKISDFG 162 (291)
T ss_dssp --SEEEEEECCTTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEEE-TTEEEECCCT
T ss_pred --CcEEEEEeCCCCCHHHHHHh----CcCCCHHHHHHHHHHHHHHHHHHHh-CCeEcCCCCcceEEEeC-CCcEEEccCC
Confidence 26799999985 67666653 4679999999999999999999999 89999999999999998 7899999999
Q ss_pred cccccccCCcc----ccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCC
Q 021306 187 SAKQLIAGEAN----ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPT 261 (314)
Q Consensus 187 ~~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~ 261 (314)
++......... ....+++.|+|||.+.+.. ++.++||||||+++|+|++ |+.||.+.+..+....+........
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~ 241 (291)
T 1xbb_A 163 LSKALRADENYYKAQTHGKWPVKWYAPECINYYK-FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGC 241 (291)
T ss_dssp TCEECCTTCSEEEC----CCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCC
T ss_pred cceeeccCCCcccccccCCCCceeeChHHhccCC-CChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence 98765433221 1223467899999996544 7899999999999999999 9999998887665554443221111
Q ss_pred HHHHhccCCCCCCCcccccccCChhhhhcccCChHHHHHhcchhh
Q 021306 262 REEIRCMNPNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGSHIN 306 (314)
Q Consensus 262 ~~~~~~~~p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~~~~ 306 (314)
.+. ....+.+++..+|...+..++....+++.++.+.
T Consensus 242 -------~~~-~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 278 (291)
T 1xbb_A 242 -------PAG-CPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 278 (291)
T ss_dssp -------CTT-CCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred -------CCC-CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 111 2234566777777777777767777776665543
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=291.45 Aligned_cols=254 Identities=24% Similarity=0.310 Sum_probs=198.0
Q ss_pred CCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeEEE
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 113 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 113 (314)
.++|++.+.||+|+||.||+|.+.. +..||+|.++... ....+|+.++++++||||+++++++.. ...++
T Consensus 183 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~------~~~~i 255 (452)
T 1fmk_A 183 RESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EPIYI 255 (452)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS------SSCEE
T ss_pred hhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC------CceEE
Confidence 4689999999999999999999764 4679999987543 345689999999999999999988732 12679
Q ss_pred Eeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcccccc
Q 021306 114 VMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 192 (314)
Q Consensus 114 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~ 192 (314)
||||+++ +|.+.+... .+..+++.+++.++.|++.||.|||+ +||+||||||+||+++. ++.++|+|||+++...
T Consensus 256 v~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~-~~ivHrDlkp~Nill~~-~~~~kl~DfG~a~~~~ 331 (452)
T 1fmk_A 256 VTEYMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVER-MNYVHRDLRAANILVGE-NLVCKVADFGLARLIE 331 (452)
T ss_dssp EECCCTTCBHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECG-GGCEEECCCCTTC---
T ss_pred EehhhcCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCChhhEEECC-CCCEEECCCccceecC
Confidence 9999985 787777532 23569999999999999999999999 89999999999999997 7889999999997654
Q ss_pred cCCc--cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCHHHHhccC
Q 021306 193 AGEA--NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 269 (314)
Q Consensus 193 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 269 (314)
.... .....++..|+|||.+.+.. ++.++||||||+++|+|++ |+.||.+....+....+.+....+.
T Consensus 332 ~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~-------- 402 (452)
T 1fmk_A 332 DNEYTARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC-------- 402 (452)
T ss_dssp -----------CCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCC--------
T ss_pred CCceecccCCcccccccCHhHHhcCC-CCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC--------
Confidence 3221 12334567899999986554 8999999999999999999 9999999888776666554322221
Q ss_pred CCCCCCcccccccCChhhhhcccCChHHHHHhcchhhhcCC
Q 021306 270 PNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGSHINAISP 310 (314)
Q Consensus 270 p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (314)
|......+.+|+..||...+..+++...+.+.++.+.....
T Consensus 403 ~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~ 443 (452)
T 1fmk_A 403 PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 443 (452)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCC
Confidence 11123346788888998888888888888888887765443
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=280.25 Aligned_cols=198 Identities=25% Similarity=0.405 Sum_probs=167.4
Q ss_pred cCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCcee
Q 021306 36 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 110 (314)
Q Consensus 36 ~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 110 (314)
..++|++.+.||+|+||.||+|++ .+++.||+|.+.... ....+|+.++++++|+||+++++++.... .
T Consensus 28 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~ 101 (326)
T 3uim_A 28 ASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT-----E 101 (326)
T ss_dssp TTTSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECCSS-----C
T ss_pred HhhccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEecCC-----c
Confidence 356899999999999999999984 578999999986542 23568999999999999999999885433 3
Q ss_pred EEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCC---CceecCCCCCcEEEcCCCCcEEEeecC
Q 021306 111 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP---RVCHRDLKPQNLLVDPLTHQVKICDFG 186 (314)
Q Consensus 111 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~---~i~h~dl~p~Nil~~~~~~~~~l~dfg 186 (314)
.++||||+.+ +|.+.+........++++..++.++.|++.||.|||+ + ||+|+||||+||+++. ++.++|+|||
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~~~~ivH~Dlkp~Nil~~~-~~~~kl~Dfg 179 (326)
T 3uim_A 102 RLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHD-HCDPKIIHRDVKAANILLDE-EFEAVVGDFG 179 (326)
T ss_dssp CEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHH-SSSSCEECCCCSGGGEEECT-TCCEEECCCS
T ss_pred eEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeCCCchhhEEECC-CCCEEeccCc
Confidence 6799999986 7888777655455679999999999999999999999 8 9999999999999998 7899999999
Q ss_pred cccccccCCc--cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 021306 187 SAKQLIAGEA--NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFP 242 (314)
Q Consensus 187 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~ 242 (314)
++........ .....+|+.|+|||.+.+.. ++.++||||||+++|+|++|+.||.
T Consensus 180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~ 236 (326)
T 3uim_A 180 LAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK-SSEKTDVFGYGVMLLELITGQRAFD 236 (326)
T ss_dssp SCEECCSSSSCEECCCCSCGGGCCHHHHHHSE-ECHHHHHHHHHHHHHHHHHCCCSBC
T ss_pred cccccCcccccccccccCCcCccCHHHhccCC-CCccccchhHHHHHHHHHhCCCccc
Confidence 9976543322 22345799999999986655 7999999999999999999999995
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=279.30 Aligned_cols=249 Identities=26% Similarity=0.353 Sum_probs=182.8
Q ss_pred CCCceeeeeEeecCceEEEEEEECCCCcEE----EEEEeecc-----ccchHHHHHHHHhCCCCceeeeceeeeecCCCC
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCLETGETV----AIKKVLQD-----RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKN 107 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~----~vK~~~~~-----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 107 (314)
.++|++.+.||+|+||.||+|++..+++.+ ++|.+... .....+|+.++++++||||+++++++....
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~--- 90 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST--- 90 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS---
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC---
Confidence 468999999999999999999998887765 66665432 233468999999999999999999885321
Q ss_pred ceeEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecC
Q 021306 108 ELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 186 (314)
Q Consensus 108 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg 186 (314)
.+++++|+.+ +|.+.+.. ....+++..++.++.||+.||.|||+ +||+||||||+||+++. ++.++|+|||
T Consensus 91 ---~~~v~~~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dikp~NIl~~~-~~~~kL~DfG 162 (327)
T 3lzb_A 91 ---VQLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLED-RRLVHRDLAARNVLVKT-PQHVKITDFG 162 (327)
T ss_dssp ---EEEEECCCSSCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEEE-TTEEEECCTT
T ss_pred ---ceEEEEecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHhh-CCCcCCCCCHHHEEEcC-CCCEEEccCc
Confidence 5688888885 77776654 34679999999999999999999999 89999999999999988 7899999999
Q ss_pred cccccccCCcc---ccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCH
Q 021306 187 SAKQLIAGEAN---ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTR 262 (314)
Q Consensus 187 ~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~ 262 (314)
++......... ....+++.|+|||.+.+.. ++.++||||||+++|+|++ |..||.+....+....+......+.+
T Consensus 163 ~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 241 (327)
T 3lzb_A 163 LAKLLGAEEKEYHAEGGKVPIKWMALESILHRI-YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQP 241 (327)
T ss_dssp C----------------CCCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCC
T ss_pred ceeEccCccccccccCCCccccccCHHHHcCCC-CChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence 99765433222 2234467899999997654 8999999999999999999 99999988776655544433222211
Q ss_pred HHHhccCCCCCCCcccccccCChhhhhcccCChHHHHHhcchh
Q 021306 263 EEIRCMNPNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGSHI 305 (314)
Q Consensus 263 ~~~~~~~p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~~~ 305 (314)
......+.++++.+|...+..++....+++.++.+
T Consensus 242 --------~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 276 (327)
T 3lzb_A 242 --------PICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKM 276 (327)
T ss_dssp --------TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --------ccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 11222355566666666666666666666655443
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-38 Score=271.27 Aligned_cols=249 Identities=24% Similarity=0.263 Sum_probs=189.0
Q ss_pred CCCceeee-eEeecCceEEEEEEEC--CCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCc
Q 021306 37 TISYMAER-VVGTGSFGIVFQAKCL--ETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 108 (314)
Q Consensus 37 ~~~y~~~~-~Lg~g~~g~Vy~~~~~--~~~~~~~vK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 108 (314)
.++|.+.+ .||+|+||.||+|.+. .++..|++|.++... ....+|+.++++++||||+++++++ ...
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~---- 82 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAE---- 82 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESS----
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCC----
Confidence 45788887 9999999999999864 467889999987532 2345899999999999999999987 222
Q ss_pred eeEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCc
Q 021306 109 LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 187 (314)
Q Consensus 109 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~ 187 (314)
..++||||+++ +|.+.+.. ....+++..++.++.|++.||.+||+ +|++|+||+|+||+++. ++.++|+|||+
T Consensus 83 -~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nili~~-~~~~kl~Dfg~ 156 (287)
T 1u59_A 83 -ALMLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEE-KNFVHRDLAARNVLLVN-RHYAKISDFGL 156 (287)
T ss_dssp -SEEEEEECCTTEEHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEEE-TTEEEECCCTT
T ss_pred -CcEEEEEeCCCCCHHHHHHh---CCccCCHHHHHHHHHHHHHHHHHHHH-CCEeeCCCchheEEEcC-CCCEEECcccc
Confidence 27899999997 66665542 34679999999999999999999999 89999999999999997 78999999999
Q ss_pred ccccccCCcc----ccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCH
Q 021306 188 AKQLIAGEAN----ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTR 262 (314)
Q Consensus 188 ~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~ 262 (314)
+......... ....+++.|+|||.+.+.. ++.++||||||+++|+|++ |+.||.+.+..+....+.+......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~~~- 234 (287)
T 1u59_A 157 SKALGADDSYYTARSAGKWPLKWYAPECINFRK-FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMEC- 234 (287)
T ss_dssp CEECTTCSCEECCCCSSCCCGGGCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCC-
T ss_pred eeeeccCcceeeccccccccccccCHHHhccCC-CCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcCCC-
Confidence 9765433221 1233478899999986544 7899999999999999998 9999998887666555544321111
Q ss_pred HHHhccCCCCCCCcccccccCChhhhhcccCChHHHHHhcchh
Q 021306 263 EEIRCMNPNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGSHI 305 (314)
Q Consensus 263 ~~~~~~~p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~~~ 305 (314)
++. ....+.+++..+|...+..++....+++.++.+
T Consensus 235 ------~~~-~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 270 (287)
T 1u59_A 235 ------PPE-CPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 270 (287)
T ss_dssp ------CTT-CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred ------CCC-cCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 111 223355566666666666666666666655443
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=276.01 Aligned_cols=257 Identities=22% Similarity=0.292 Sum_probs=192.1
Q ss_pred CceeeeeEeecCceEEEEEEECCCCcEEEEEEeecc--------ccchHHHHHHHHhCCCCceeeeceeeeecCCCCcee
Q 021306 39 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD--------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 110 (314)
Q Consensus 39 ~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~--------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 110 (314)
.|...+.||+|+||.||+|++ +++.+++|.+... .....+|+.++++++||||+++++++.... .
T Consensus 32 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-----~ 104 (307)
T 2nru_A 32 ISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGD-----D 104 (307)
T ss_dssp TTTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-----S
T ss_pred ccccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCC-----c
Confidence 355669999999999999986 6889999998642 123458999999999999999999884433 3
Q ss_pred EEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCccc
Q 021306 111 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 189 (314)
Q Consensus 111 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~ 189 (314)
.+++|||+++ +|.+.+.. .....++++..++.++.|++.||.|||+ +|++|+||+|+||+++. ++.++|+|||++.
T Consensus 105 ~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~i~H~dlkp~Nili~~-~~~~kl~Dfg~~~ 181 (307)
T 2nru_A 105 LCLVYVYMPNGSLLDRLSC-LDGTPPLSWHMRCKIAQGAANGINFLHE-NHHIHRDIKSANILLDE-AFTAKISDFGLAR 181 (307)
T ss_dssp CEEEEECCTTCBHHHHHHT-GGGCCCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEECT-TCCEEECCCTTCE
T ss_pred eEEEEEecCCCcHHHHHHh-ccCCCCCCHHHHHHHHHHHHHHHHHHhc-CCeecCCCCHHHEEEcC-CCcEEEeeccccc
Confidence 7899999975 77776654 2335679999999999999999999999 89999999999999998 8899999999987
Q ss_pred ccccCCc---cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCHHHHh
Q 021306 190 QLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 266 (314)
Q Consensus 190 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 266 (314)
....... .....+++.|+|||.+.+ . ++.++||||||+++|+|++|..||........+..+.+...........
T Consensus 182 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (307)
T 2nru_A 182 ASEKFAQTVMTSRIVGTTAYMAPEALRG-E-ITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIED 259 (307)
T ss_dssp ECCSCSSCEECSSCCSCGGGCCHHHHTT-E-ECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHH
T ss_pred ccccccccccccccCCCcCcCChHHhcC-C-CCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhh
Confidence 5543222 223467899999999854 3 7899999999999999999999998765443333333322111111111
Q ss_pred ccCCCCC------CCcccccccCChhhhhcccCChHHHHHhcchhhh
Q 021306 267 CMNPNYT------DFRFPQIKAHPWHKVCIFHFPKHWLLEYGSHINA 307 (314)
Q Consensus 267 ~~~p~~~------~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~~~~~ 307 (314)
.+++.+. ...+.+++..||...+..+++...+++.++.+.+
T Consensus 260 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 260 YIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp HSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred hccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 1111111 1124567888888888888888888888776643
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-38 Score=275.66 Aligned_cols=256 Identities=25% Similarity=0.370 Sum_probs=192.7
Q ss_pred CCCceeeeeEeecCceEEEEEEE-----CCCCcEEEEEEeeccc-----cchHHHHHHHHhC-CCCceeeeceeeeecCC
Q 021306 37 TISYMAERVVGTGSFGIVFQAKC-----LETGETVAIKKVLQDR-----RYKNRELQLMRVM-DHPNVISLKHCFFSTTS 105 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~-----~~~~~~~~vK~~~~~~-----~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~ 105 (314)
.++|++.+.||+|+||.||+|++ ..+++.|++|.+.... ....+|+.+++++ .||||+++++++....
T Consensus 26 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~- 104 (316)
T 2xir_A 26 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG- 104 (316)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTT-
T ss_pred hhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCC-
Confidence 46899999999999999999985 3567899999987543 2345789999999 7899999999875322
Q ss_pred CCceeEEEEeecccc-cHHHHHHhhhhc------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEE
Q 021306 106 KNELFLNLVMEYVPE-SMYRVLKHYSSA------------NQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLL 172 (314)
Q Consensus 106 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~------------~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil 172 (314)
..++++|||+++ +|.+.+...... ...+++..++.++.|++.||.|||+ +|++|+||||+||+
T Consensus 105 ---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~i~H~dikp~Nil 180 (316)
T 2xir_A 105 ---GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS-RKCIHRDLAARNIL 180 (316)
T ss_dssp ---SCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEE
T ss_pred ---CceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHh-CCcccccCccceEE
Confidence 237799999986 777777643211 1238999999999999999999999 89999999999999
Q ss_pred EcCCCCcEEEeecCcccccccCCc---cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHH
Q 021306 173 VDPLTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVD 248 (314)
Q Consensus 173 ~~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~t-g~~pf~~~~~~~ 248 (314)
++. ++.++|+|||++........ .....+++.|+|||.+.+.. ++.++||||||+++|+|++ |..||.+....+
T Consensus 181 ~~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~ 258 (316)
T 2xir_A 181 LSE-KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 258 (316)
T ss_dssp ECG-GGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH
T ss_pred ECC-CCCEEECCCccccccccCccceeccCCCcceeecCchhhcccc-ccchhHHHHHHHHHHHHHhCCCCCCcccchhH
Confidence 987 78899999999976543322 22345678899999986654 8999999999999999998 999998877555
Q ss_pred HHHHHHHHcCCCCHHHHhccCCCCCCCcccccccCChhhhhcccCChHHHHHhcchhh
Q 021306 249 QLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGSHIN 306 (314)
Q Consensus 249 ~~~~i~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~~~~ 306 (314)
.+...+....... .|......+.+++..+|...+..++....+++.++.+.
T Consensus 259 ~~~~~~~~~~~~~-------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 309 (316)
T 2xir_A 259 EFCRRLKEGTRMR-------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 309 (316)
T ss_dssp HHHHHHHHTCCCC-------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHhccCccCC-------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 5555544332211 11112233555666666666666666666766665543
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-39 Score=281.02 Aligned_cols=205 Identities=24% Similarity=0.318 Sum_probs=167.9
Q ss_pred CCccCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc----cchHHHHHHHHhCCCCceeeeceeeeecCCCCc
Q 021306 33 EPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 108 (314)
Q Consensus 33 ~~~~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 108 (314)
.....++|++.+.||+|+||.||+|++ .+++.|++|.+.... ....+|+.++++++||||+++++++...
T Consensus 34 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~----- 107 (321)
T 2qkw_B 34 LEEATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDER----- 107 (321)
T ss_dssp CCCCCCCCSCCCCSCBCSSSEEEEEEC-TTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCT-----
T ss_pred HHHHHhccCccceeecCCCeeEEEEEE-CCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC-----
Confidence 344668999999999999999999995 478999999886543 2346899999999999999999988433
Q ss_pred eeEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCc
Q 021306 109 LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 187 (314)
Q Consensus 109 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~ 187 (314)
...++||||+++ +|.+.+.........+++.+++.++.|++.||.|||+ +|++|+||||+||+++. ++.++|+|||+
T Consensus 108 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~ivH~dlkp~Nil~~~-~~~~kl~Dfg~ 185 (321)
T 2qkw_B 108 NEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHT-RAIIHRDVKSINILLDE-NFVPKITDFGI 185 (321)
T ss_dssp TCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCSTTEEECT-TCCEEECCCTT
T ss_pred CeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcC-CCeecCCCCHHHEEECC-CCCEEEeeccc
Confidence 337899999986 6655544322223469999999999999999999999 89999999999999998 88999999999
Q ss_pred ccccccCC---ccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCh
Q 021306 188 AKQLIAGE---ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA 246 (314)
Q Consensus 188 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~ 246 (314)
+....... ......+++.|+|||.+.+.. ++.++||||||+++|+|++|+.||.+..+
T Consensus 186 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~g~~p~~~~~~ 246 (321)
T 2qkw_B 186 SKKGTELDQTHLSTVVKGTLGYIDPEYFIKGR-LTEKSDVYSFGVVLFEVLCARSAIVQSLP 246 (321)
T ss_dssp CEECSSSSCCCCBCCCEEETTTCCHHHHHHCB-CCTHHHHHHHHHHHHHHHHCCTTCSCSSS
T ss_pred ccccccccccccccccCCCccccCHHHhcCCC-CCcccchHhHHHHHHHHHhCCCcccccCc
Confidence 87543221 122345789999999986654 89999999999999999999999976543
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-38 Score=286.49 Aligned_cols=242 Identities=28% Similarity=0.364 Sum_probs=175.9
Q ss_pred CCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc-cchHHHHHHHHhC-CCCceeeeceeeeecCCCCceeEEEEe
Q 021306 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-RYKNRELQLMRVM-DHPNVISLKHCFFSTTSKNELFLNLVM 115 (314)
Q Consensus 38 ~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~-~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv~ 115 (314)
+.|.+.+.||+|+||+||.+. ..+|+.||+|.+..+. ....+|+.+++++ +||||+++++++.. ...+++||
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~-----~~~~~lv~ 88 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRYYCSETT-----DRFLYIAL 88 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGGGHHHHHHHHHHHHHHTTSTTBCCEEEEEEC-----SSEEEEEE
T ss_pred heeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHHHHHHHHHHHHHHHhccCCCCcCeEEEEEec-----CCeEEEEE
Confidence 456778899999999998754 5689999999987553 3346888888876 89999999988743 34488999
Q ss_pred ecccccHHHHHHhhhhcCCC---CCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCC------------CCcE
Q 021306 116 EYVPESMYRVLKHYSSANQR---MPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPL------------THQV 180 (314)
Q Consensus 116 e~~~~~l~~~l~~~~~~~~~---l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~------------~~~~ 180 (314)
||++|+|.+.+......... .++..++.++.||+.||.|||+ +||+||||||+||+++.. +..+
T Consensus 89 E~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~ 167 (434)
T 2rio_A 89 ELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS-LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRI 167 (434)
T ss_dssp CCCSEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred ecCCCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHH-CCccccCCChHhEEEecCcccccccccCCCceEE
Confidence 99999988888753221111 1333467899999999999999 899999999999999752 3489
Q ss_pred EEeecCcccccccCCc-----cccccccccccccccccC------CCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHH
Q 021306 181 KICDFGSAKQLIAGEA-----NISYICSRFYRAPELIFG------ATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVD 248 (314)
Q Consensus 181 ~l~dfg~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~------~~~~~~~~Dv~slG~il~el~t-g~~pf~~~~~~~ 248 (314)
+|+|||++........ .....+|+.|+|||.+.+ ...++.++|||||||++|+|++ |..||.+....+
T Consensus 168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~ 247 (434)
T 2rio_A 168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE 247 (434)
T ss_dssp EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH
T ss_pred EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH
Confidence 9999999986644322 123568999999999865 2447899999999999999999 999997765433
Q ss_pred HHHHHHHHcCCC--------------CHHHHh---ccCCCCCCCcccccccCChhhhh
Q 021306 249 QLVEIIKVLGTP--------------TREEIR---CMNPNYTDFRFPQIKAHPWHKVC 289 (314)
Q Consensus 249 ~~~~i~~~~~~~--------------~~~~~~---~~~p~~~~~~~~~l~~~p~~~~~ 289 (314)
..+++..... ..+.+. ..+|. +|+++.++++|||+...
T Consensus 248 --~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~-~Rps~~eil~hp~f~~~ 302 (434)
T 2rio_A 248 --SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPL-KRPTAMKVLRHPLFWPK 302 (434)
T ss_dssp --HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGG-GSCCHHHHHTSGGGSCH
T ss_pred --HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChh-hCCCHHHHHhCCccCCc
Confidence 2333322111 011122 23666 89999999999999754
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=270.41 Aligned_cols=255 Identities=23% Similarity=0.347 Sum_probs=192.6
Q ss_pred ccCCCceeeeeEeecCceEEEEEEECCC---CcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCC
Q 021306 35 KQTISYMAERVVGTGSFGIVFQAKCLET---GETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSK 106 (314)
Q Consensus 35 ~~~~~y~~~~~Lg~g~~g~Vy~~~~~~~---~~~~~vK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 106 (314)
....+|++.+.||+|+||.||+|++..+ ...+++|.+.... ....+|+.++++++||||+++++++....
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-- 99 (298)
T 3f66_A 22 PSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE-- 99 (298)
T ss_dssp GGGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSS--
T ss_pred ccceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCC--
Confidence 3445799999999999999999997643 3468899876432 23458999999999999999999864322
Q ss_pred CceeEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeec
Q 021306 107 NELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF 185 (314)
Q Consensus 107 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~df 185 (314)
...+++|||+++ +|.+.+.. ....+++..++.++.|++.||.+||+ +|++|+||||+||+++. ++.++|+||
T Consensus 100 --~~~~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~ql~~~l~~lH~-~~i~H~dikp~Nil~~~-~~~~kl~Df 172 (298)
T 3f66_A 100 --GSPLVVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKYLAS-KKFVHRDLAARNCMLDE-KFTVKVADF 172 (298)
T ss_dssp --SCCEEEEECCTTCBHHHHHHC---TTCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECT-TCCEEECSC
T ss_pred --CceEEEEeCCCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCchheEEECC-CCCEEECcc
Confidence 236799999997 77776653 34678999999999999999999999 89999999999999998 889999999
Q ss_pred CcccccccCC-----ccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCC
Q 021306 186 GSAKQLIAGE-----ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGT 259 (314)
Q Consensus 186 g~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~t-g~~pf~~~~~~~~~~~i~~~~~~ 259 (314)
|.+....... ......+++.|+|||.+.+.. ++.++||||||+++|+|++ |.+||.+.+..+....+.+....
T Consensus 173 g~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (298)
T 3f66_A 173 GLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQK-FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRL 251 (298)
T ss_dssp GGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCC
T ss_pred cccccccccchhccccccCCCCCccccChHHhcCCC-CChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCC
Confidence 9997553322 122344577899999996654 8999999999999999999 66788777766655555443222
Q ss_pred CCHHHHhccCCCCCCCcccccccCChhhhhcccCChHHHHHhcchhhh
Q 021306 260 PTREEIRCMNPNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGSHINA 307 (314)
Q Consensus 260 ~~~~~~~~~~p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~~~~~ 307 (314)
.. |......+.+++..+|...+..++....+++.++.+..
T Consensus 252 ~~--------~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 291 (298)
T 3f66_A 252 LQ--------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 291 (298)
T ss_dssp CC--------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CC--------CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 21 11122345667777777777777777777777766544
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-38 Score=276.58 Aligned_cols=263 Identities=22% Similarity=0.319 Sum_probs=185.3
Q ss_pred ccCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccccc-hHHHHHH--HHhCCCCceeeeceeeeecCCCCceeE
Q 021306 35 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY-KNRELQL--MRVMDHPNVISLKHCFFSTTSKNELFL 111 (314)
Q Consensus 35 ~~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~~~-~~~e~~~--l~~l~h~~iv~~~~~~~~~~~~~~~~~ 111 (314)
...++|++.+.||+|+||.||+|++ +++.||+|.+...... ...|.++ +..++|+||+++++.+..........+
T Consensus 10 ~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 87 (336)
T 3g2f_A 10 LDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY 87 (336)
T ss_dssp CCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred cChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccchhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence 4467999999999999999999986 7899999998754332 2334444 445899999999887655555556668
Q ss_pred EEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCC---------CceecCCCCCcEEEcCCCCcEE
Q 021306 112 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP---------RVCHRDLKPQNLLVDPLTHQVK 181 (314)
Q Consensus 112 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~---------~i~h~dl~p~Nil~~~~~~~~~ 181 (314)
++||||+++ +|.+.+.. ...++..++.++.||+.||.|||+ + ||+||||||+||+++. ++.++
T Consensus 88 ~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~~L~~LH~-~~~~~~~~~~~ivH~Dikp~Nill~~-~~~~k 160 (336)
T 3g2f_A 88 LLVMEYYPNGSLXKYLSL-----HTSDWVSSCRLAHSVTRGLAYLHT-ELPRGDHYKPAISHRDLNSRNVLVKN-DGTCV 160 (336)
T ss_dssp EEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHC-CBCCGGGCBCCEECSSCSGGGEEECT-TSCEE
T ss_pred EEEEecCCCCcHHHHHhh-----cccchhHHHHHHHHHHHHHHHHHh-hhccccccccceeecccccceEEEcC-CCcEE
Confidence 899999975 77777753 456899999999999999999999 8 9999999999999998 78999
Q ss_pred EeecCcccccccCC---------ccccccccccccccccccCC------CCCCcchhHHHHHHHHHHHHhCCCCCCCCCh
Q 021306 182 ICDFGSAKQLIAGE---------ANISYICSRFYRAPELIFGA------TEYTTSIDIWSAGCVLAELLLGQPLFPGENA 246 (314)
Q Consensus 182 l~dfg~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~~------~~~~~~~Dv~slG~il~el~tg~~pf~~~~~ 246 (314)
|+|||++....... ......+|+.|+|||.+.+. ..++.++||||||+++|+|++|..||.....
T Consensus 161 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~ 240 (336)
T 3g2f_A 161 ISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES 240 (336)
T ss_dssp ECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSC
T ss_pred EeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccc
Confidence 99999997654321 11234579999999998652 2356789999999999999999766533221
Q ss_pred -HHHHHHHHH-HcCCCCHHHHh------ccCCCC----CC-----CcccccccCChhhhhcccCChHHHHHhcchhh
Q 021306 247 -VDQLVEIIK-VLGTPTREEIR------CMNPNY----TD-----FRFPQIKAHPWHKVCIFHFPKHWLLEYGSHIN 306 (314)
Q Consensus 247 -~~~~~~i~~-~~~~~~~~~~~------~~~p~~----~~-----~~~~~l~~~p~~~~~~~~~~~~~~~~~~~~~~ 306 (314)
.+....... ....+....+. ...|.+ .. ..+.+++..+|...+..+++...+++.++.+.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll 317 (336)
T 3g2f_A 241 VPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELM 317 (336)
T ss_dssp CCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred hhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHH
Confidence 110000000 11111111111 001110 00 12566777777777777777777777665543
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=298.89 Aligned_cols=206 Identities=31% Similarity=0.445 Sum_probs=166.9
Q ss_pred CCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeecc-----ccchHHHHHHHHhCCCCceeeeceeeeecCC-CCcee
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-----RRYKNRELQLMRVMDHPNVISLKHCFFSTTS-KNELF 110 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~-----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~~~~~ 110 (314)
.++|++.+.||+|+||.||+|.+..+|+.||+|.+... .....+|+.++++++||||+++++++..... .....
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 36899999999999999999999999999999988654 2234579999999999999999887643111 12344
Q ss_pred EEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCC--CcEEEeecCc
Q 021306 111 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLT--HQVKICDFGS 187 (314)
Q Consensus 111 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~--~~~~l~dfg~ 187 (314)
.++||||++| +|.+.+... .....+++..++.++.|++.||.|||+ .||+|+||+|+||+++..+ ..++|+|||.
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~-~~~~~lse~~i~~I~~QLl~aL~yLHs-~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~ 170 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQF-ENCCGLKEGPIRTLLSDISSALRYLHE-NRIIHRDLKPENIVLQPGPQRLIHKIIDLGY 170 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSS-SCTTCCCSSHHHHHHHHHHHHHHHHHH-TTBCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred EEEEEEeCCCCCHHHHHHhc-ccCCCCCHHHHHHHHHHHHHHHHHHHH-CCCccCCCCHHHeEeecCCCceeEEEccccc
Confidence 6799999975 777666542 223469999999999999999999999 8999999999999998632 2499999999
Q ss_pred ccccccCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 021306 188 AKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 245 (314)
Q Consensus 188 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~ 245 (314)
+.............+++.|+|||.+.+.. ++.++||||||+++|+|++|..||.+..
T Consensus 171 a~~~~~~~~~~~~~gt~~Y~APE~l~~~~-~s~ksDIwSLGviLyeLltG~~Pf~~~~ 227 (676)
T 3qa8_A 171 AKELDQGELCTEFVGTLQYLAPELLEQKK-YTVTVDYWSFGTLAFECITGFRPFLPNW 227 (676)
T ss_dssp CCBTTSCCCCCCCCSCCTTCSSCSSCCSC-CSTTHHHHHHHHHHHHHHSSCSSCCSSC
T ss_pred ccccccccccccccCCcccCChHHhccCC-CCchhHHHHHHHHHHHHHHCCCCCCccc
Confidence 98765555555567899999999996554 8999999999999999999999997654
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-37 Score=266.99 Aligned_cols=254 Identities=23% Similarity=0.394 Sum_probs=189.3
Q ss_pred CccCCCceeeeeEeecCceEEEEEEECCCCc---EEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCC
Q 021306 34 PKQTISYMAERVVGTGSFGIVFQAKCLETGE---TVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTS 105 (314)
Q Consensus 34 ~~~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~---~~~vK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 105 (314)
|.....|++.+.||+|+||.||+|++..+++ .+++|.+.... ....+|+.++++++||||+++++++.....
T Consensus 17 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 96 (298)
T 3pls_A 17 PHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEG 96 (298)
T ss_dssp CGGGEEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSS
T ss_pred cccceEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCC
Confidence 3344468888999999999999999765544 79999886432 233589999999999999999998854332
Q ss_pred CCceeEEEEeeccc-ccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEee
Q 021306 106 KNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICD 184 (314)
Q Consensus 106 ~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~d 184 (314)
..++++||+. ++|.+.+.. ....+++.+++.++.|++.||.|||+ +|++|+||||+||+++. ++.++|+|
T Consensus 97 ----~~~~v~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~-~~i~H~dikp~Nili~~-~~~~kl~D 167 (298)
T 3pls_A 97 ----LPHVLLPYMCHGDLLQFIRS---PQRNPTVKDLISFGLQVARGMEYLAE-QKFVHRDLAARNCMLDE-SFTVKVAD 167 (298)
T ss_dssp ----CCEEEECCCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECT-TCCEEECC
T ss_pred ----CcEEEEecccCCCHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCcceEEEcC-CCcEEeCc
Confidence 2479999997 477776653 35678999999999999999999999 89999999999999998 78999999
Q ss_pred cCcccccccC-----CccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHHHcC
Q 021306 185 FGSAKQLIAG-----EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLG-QPLFPGENAVDQLVEIIKVLG 258 (314)
Q Consensus 185 fg~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg-~~pf~~~~~~~~~~~i~~~~~ 258 (314)
||++...... .......+++.|+|||.+.+.. ++.++||||||+++|+|++| .+||...+..+....+.+...
T Consensus 168 fg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~ 246 (298)
T 3pls_A 168 FGLARDILDREYYSVQQHRHARLPVKWTALESLQTYR-FTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRR 246 (298)
T ss_dssp TTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCC-CCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCC
T ss_pred CCCcccccCCcccccccCcCCCCCccccChhhhccCC-CChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCC
Confidence 9999754322 1222345678899999996554 89999999999999999995 555666666554444443322
Q ss_pred CCCHHHHhccCCCCCCCcccccccCChhhhhcccCChHHHHHhcchh
Q 021306 259 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGSHI 305 (314)
Q Consensus 259 ~~~~~~~~~~~p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~~~ 305 (314)
.+. |......+.+++..+|...+..+++...+++.++.+
T Consensus 247 ~~~--------~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~ 285 (298)
T 3pls_A 247 LPQ--------PEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQI 285 (298)
T ss_dssp CCC--------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCC--------CccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 221 111122355666667776666666777777666544
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=277.87 Aligned_cols=255 Identities=25% Similarity=0.322 Sum_probs=189.9
Q ss_pred cCCCceeeeeEeecCceEEEEEE----ECCCCcEEEEEEeeccc----cchHHHHHHHHhCCCCceeeeceeeeecCCCC
Q 021306 36 QTISYMAERVVGTGSFGIVFQAK----CLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKN 107 (314)
Q Consensus 36 ~~~~y~~~~~Lg~g~~g~Vy~~~----~~~~~~~~~vK~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 107 (314)
..++|++.+.||+|+||.||+|+ +..+++.|++|.+.... ....+|+.++++++|+||+++++++... .
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~ 97 (327)
T 3lxl_A 21 EERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGP---G 97 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS---S
T ss_pred chhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecC---C
Confidence 34689999999999999999999 46789999999986543 2346899999999999999999987542 3
Q ss_pred ceeEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecC
Q 021306 108 ELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 186 (314)
Q Consensus 108 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg 186 (314)
....++||||+++ +|.+.+... ...+++.+++.++.|++.||.|||+ +|++|+||||+||+++. ++.++|+|||
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~Dikp~NIl~~~-~~~~kl~Dfg 172 (327)
T 3lxl_A 98 RQSLRLVMEYLPSGCLRDFLQRH---RARLDASRLLLYSSQICKGMEYLGS-RRCVHRDLAARNILVES-EAHVKIADFG 172 (327)
T ss_dssp SCEEEEEEECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEEE-TTEEEECCGG
T ss_pred CceEEEEEeecCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCChhhEEECC-CCCEEEcccc
Confidence 3457899999965 777766542 3469999999999999999999999 89999999999999998 8899999999
Q ss_pred cccccccCCc----cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHH-------------
Q 021306 187 SAKQLIAGEA----NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQ------------- 249 (314)
Q Consensus 187 ~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~------------- 249 (314)
.+........ .....+++.|+|||.+.+.. ++.++||||||+++|+|++|..||........
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~ 251 (327)
T 3lxl_A 173 LAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNI-FSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALS 251 (327)
T ss_dssp GCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHH
T ss_pred cceecccCCccceeeccCCccccccCHHHhccCC-CChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHH
Confidence 9976543322 12234577799999986654 78999999999999999999999965443211
Q ss_pred -HHHHHHHcCCCCHHHHhccCCCCCCCcccccccCChhhhhcccCChHHHHHhcchhh
Q 021306 250 -LVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGSHIN 306 (314)
Q Consensus 250 -~~~i~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~~~~ 306 (314)
....+...... ..|......+.+++..+|...+..+++...+++.++.+.
T Consensus 252 ~~~~~~~~~~~~-------~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 302 (327)
T 3lxl_A 252 RLLELLEEGQRL-------PAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLW 302 (327)
T ss_dssp HHHHHHHTTCCC-------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-
T ss_pred HHHHHhhcccCC-------CCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 11111110000 001112233556666666666666666666666655443
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-38 Score=280.01 Aligned_cols=253 Identities=23% Similarity=0.345 Sum_probs=185.5
Q ss_pred CCCceeeeeEeecCceEEEEEEECCC---CcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCc
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCLET---GETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 108 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~~~---~~~~~vK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 108 (314)
...|++.+.||+|+||.||+|++..+ +..+++|.++... ....+|+.++++++||||+++++++....
T Consensus 88 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~---- 163 (373)
T 3c1x_A 88 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE---- 163 (373)
T ss_dssp TEEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCS----
T ss_pred hceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCC----
Confidence 34688999999999999999987543 2468999876432 23457899999999999999999764322
Q ss_pred eeEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCc
Q 021306 109 LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 187 (314)
Q Consensus 109 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~ 187 (314)
...++||||+++ +|.+.+.. ....+++.+++.++.|++.||.|||+ +||+||||||+||+++. ++.++|+|||+
T Consensus 164 ~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~-~~~~kL~DFG~ 238 (373)
T 3c1x_A 164 GSPLVVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFLAS-KKFVHRDLAARNCMLDE-KFTVKVADFGL 238 (373)
T ss_dssp SCCEEEEECCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECT-TCCEEECCC--
T ss_pred CCeEEEEECCCCCCHHHHHhh---cccCCCHHHHHHHHHHHHHHHHHHHH-CCEecCccchheEEECC-CCCEEEeeccc
Confidence 236799999986 77776653 34568999999999999999999999 89999999999999998 78999999999
Q ss_pred ccccccCCc-----cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCC
Q 021306 188 AKQLIAGEA-----NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPT 261 (314)
Q Consensus 188 ~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~ 261 (314)
++....... .....+++.|+|||.+.+.. ++.++||||||+++|+|++ |..||.+.+..+....+.+.....
T Consensus 239 a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~- 316 (373)
T 3c1x_A 239 ARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQK-FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLL- 316 (373)
T ss_dssp -------------------CCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCCC-
T ss_pred cccccccccccccccCCCCCcccccChHHhcCCC-CCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCCC-
Confidence 975533221 12344577899999996554 8999999999999999999 788898776655555444332111
Q ss_pred HHHHhccCCCCCCCcccccccCChhhhhcccCChHHHHHhcchhhh
Q 021306 262 REEIRCMNPNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGSHINA 307 (314)
Q Consensus 262 ~~~~~~~~p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~~~~~ 307 (314)
.|......+.+++..||...+..++....+++.++.+..
T Consensus 317 -------~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~ 355 (373)
T 3c1x_A 317 -------QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 355 (373)
T ss_dssp -------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 122223346677888888888888888888777765543
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=274.48 Aligned_cols=215 Identities=19% Similarity=0.266 Sum_probs=167.7
Q ss_pred ccCCCceeeeeEeecCceEEEEEE-----ECCCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecC
Q 021306 35 KQTISYMAERVVGTGSFGIVFQAK-----CLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTT 104 (314)
Q Consensus 35 ~~~~~y~~~~~Lg~g~~g~Vy~~~-----~~~~~~~~~vK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 104 (314)
...++|++.+.||+|+||.||+|+ +..+++.||+|.+.... ....+|+.++++++||||+++++++....
T Consensus 27 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 106 (327)
T 2yfx_A 27 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL 106 (327)
T ss_dssp CCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCC
Confidence 345789999999999999999999 55678899999986432 23457999999999999999999884432
Q ss_pred CCCceeEEEEeecccc-cHHHHHHhhhhc---CCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcC--CCC
Q 021306 105 SKNELFLNLVMEYVPE-SMYRVLKHYSSA---NQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP--LTH 178 (314)
Q Consensus 105 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~---~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~--~~~ 178 (314)
..++||||+++ +|.+.+...... ...+++.+++.++.|++.||.|||+ +|++|+||||+||+++. .+.
T Consensus 107 -----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~-~~i~H~dlkp~NIli~~~~~~~ 180 (327)
T 2yfx_A 107 -----PRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE-NHFIHRDIAARNCLLTCPGPGR 180 (327)
T ss_dssp -----SCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEESCSSTTC
T ss_pred -----CcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhh-CCeecCcCCHhHEEEecCCCcc
Confidence 36899999964 787777653211 2459999999999999999999999 89999999999999984 145
Q ss_pred cEEEeecCcccccccCC---ccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 021306 179 QVKICDFGSAKQLIAGE---ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEII 254 (314)
Q Consensus 179 ~~~l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~t-g~~pf~~~~~~~~~~~i~ 254 (314)
.++|+|||++....... ......+++.|+|||.+.+.. ++.++||||||+++|+|++ |..||.+....+....+.
T Consensus 181 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~ 259 (327)
T 2yfx_A 181 VAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGI-FTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT 259 (327)
T ss_dssp CEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH
T ss_pred eEEECccccccccccccccccCCCcCCCcceeCHhHhcCCC-CCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHh
Confidence 69999999987543222 122345688899999986554 8999999999999999998 999999888776665555
Q ss_pred HH
Q 021306 255 KV 256 (314)
Q Consensus 255 ~~ 256 (314)
..
T Consensus 260 ~~ 261 (327)
T 2yfx_A 260 SG 261 (327)
T ss_dssp TT
T ss_pred cC
Confidence 43
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-38 Score=293.26 Aligned_cols=253 Identities=25% Similarity=0.315 Sum_probs=200.4
Q ss_pred cCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeEE
Q 021306 36 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 112 (314)
Q Consensus 36 ~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 112 (314)
..++|++.+.||+|+||.||++.+.. +..||+|.++... ..+.+|+.++++++|+||+++++++.. ..++
T Consensus 265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~------~~~~ 337 (535)
T 2h8h_A 265 PRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EPIY 337 (535)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS------SSCE
T ss_pred chhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEee------ccce
Confidence 34689999999999999999999764 4679999987543 345689999999999999999988732 1267
Q ss_pred EEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCccccc
Q 021306 113 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 191 (314)
Q Consensus 113 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~ 191 (314)
+||||+.+ +|.+.+... .+..+++.+++.++.||+.||.|||+ +||+||||||+|||++. ++.++|+|||+++..
T Consensus 338 lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivHrDlkp~NIll~~-~~~~kl~DFG~a~~~ 413 (535)
T 2h8h_A 338 IVTEYMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVER-MNYVHRDLRAANILVGE-NLVCKVADFGLARLI 413 (535)
T ss_dssp EEECCCTTEEHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECG-GGCEEECCTTSTTTC
T ss_pred EeeehhcCCcHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCCHhhEEEcC-CCcEEEcccccceec
Confidence 99999986 787777542 23568999999999999999999999 89999999999999987 788999999999765
Q ss_pred ccCC--ccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCHHHHhcc
Q 021306 192 IAGE--ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 268 (314)
Q Consensus 192 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 268 (314)
.... ......++..|+|||.+.+.. ++.++||||||+++|+|++ |+.||.+....+.+..+.+....+.
T Consensus 414 ~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~------- 485 (535)
T 2h8h_A 414 EDNEYTARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC------- 485 (535)
T ss_dssp CCHHHHTTCSTTSCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCCCC-------
T ss_pred CCCceecccCCcCcccccCHHHhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC-------
Confidence 3221 112234567899999986554 8999999999999999999 9999999887776665544322211
Q ss_pred CCCCCCCcccccccCChhhhhcccCChHHHHHhcchhhhc
Q 021306 269 NPNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGSHINAI 308 (314)
Q Consensus 269 ~p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 308 (314)
|......+.+|+..||...+..+.+...+.+.++.+...
T Consensus 486 -~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~ 524 (535)
T 2h8h_A 486 -PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 524 (535)
T ss_dssp -CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCC
T ss_pred -CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhc
Confidence 111233467788889988888888888888888776543
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=268.09 Aligned_cols=251 Identities=23% Similarity=0.301 Sum_probs=192.6
Q ss_pred CCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeEEE
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 113 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 113 (314)
.++|++.+.||+|+||.||+|.+. ++..|++|.+.... ....+|+.++++++|+||+++++++.. . ..++
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~-----~~~~ 84 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-E-----PIYI 84 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-S-----SCEE
T ss_pred HHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEcC-C-----CcEE
Confidence 468999999999999999999964 67789999987543 334689999999999999999988631 1 2679
Q ss_pred Eeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcccccc
Q 021306 114 VMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 192 (314)
Q Consensus 114 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~ 192 (314)
||||+.+ +|.+.+... .+..+++.+++.++.|++.||.+||+ +|++|+||+|+||+++. ++.++|+|||.+....
T Consensus 85 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dikp~Nil~~~-~~~~kl~Dfg~~~~~~ 160 (279)
T 1qpc_A 85 ITEYMENGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEE-RNYIHRDLRAANILVSD-TLSCKIADFGLARLIE 160 (279)
T ss_dssp EEECCTTCBHHHHTTSH--HHHTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECT-TSCEEECCCTTCEECS
T ss_pred EEecCCCCCHHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHhhEEEcC-CCCEEECCCccccccc
Confidence 9999975 776665431 12369999999999999999999999 89999999999999997 8899999999997654
Q ss_pred cCCc--cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCHHHHhccC
Q 021306 193 AGEA--NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 269 (314)
Q Consensus 193 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 269 (314)
.... .....+++.|+|||.+.+.. ++.++||||||+++|+|++ |+.||.+.+..+....+.+......
T Consensus 161 ~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~-------- 231 (279)
T 1qpc_A 161 DNEYTAREGAKFPIKWTAPEAINYGT-FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR-------- 231 (279)
T ss_dssp SSCEECCTTCCCCTTTSCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCC--------
T ss_pred CcccccccCCCCccCccChhhhccCC-CCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCCCC--------
Confidence 3322 12234567899999986544 7899999999999999999 9999998887766655544322111
Q ss_pred CCCCCCcccccccCChhhhhcccCChHHHHHhcchhhh
Q 021306 270 PNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGSHINA 307 (314)
Q Consensus 270 p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~~~~~ 307 (314)
|......+.+++..+|...+..++....+.+.++.+..
T Consensus 232 ~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 269 (279)
T 1qpc_A 232 PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (279)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHH
Confidence 11122245566666777667777777777777665543
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=287.47 Aligned_cols=249 Identities=16% Similarity=0.099 Sum_probs=181.8
Q ss_pred CCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhCCC-Cceeee---------cee
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDH-PNVISL---------KHC 99 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~-------~~~~~e~~~l~~l~h-~~iv~~---------~~~ 99 (314)
..+|++.+.||+|+||.||+|++..+|+.||||++.... ....+|+.+++.++| ++.... .+.
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence 346899999999999999999999999999999886322 234588888888876 221111 011
Q ss_pred ------------eeecCCCCceeEEEEeecccccHHHHHHhh---hhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceec
Q 021306 100 ------------FFSTTSKNELFLNLVMEYVPESMYRVLKHY---SSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 164 (314)
Q Consensus 100 ------------~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~---~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~ 164 (314)
+..........++++|+++.++|.+.+... ...+..+++..++.++.||+.||.|||+ +||+||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~iiHr 235 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH-YGLVHT 235 (413)
T ss_dssp EECCC---------------CCSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH-TTEECS
T ss_pred cccCCCCccccccCCCccccccceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccC
Confidence 111000112236788999999888777533 2234568888999999999999999999 899999
Q ss_pred CCCCCcEEEcCCCCcEEEeecCcccccccCCcccccccccccccccccc---------CCCCCCcchhHHHHHHHHHHHH
Q 021306 165 DLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIF---------GATEYTTSIDIWSAGCVLAELL 235 (314)
Q Consensus 165 dl~p~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~---------~~~~~~~~~Dv~slG~il~el~ 235 (314)
||||+||+++. ++.+||+|||+++..... .....+ +.|+|||.+. ....++.++||||||+++|+|+
T Consensus 236 DiKp~NILl~~-~~~~kL~DFG~a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ell 311 (413)
T 3dzo_A 236 YLRPVDIVLDQ-RGGVFLTGFEHLVRDGAS--AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIW 311 (413)
T ss_dssp CCCGGGEEECT-TCCEEECCGGGCEETTEE--ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHH
T ss_pred CcccceEEEec-CCeEEEEeccceeecCCc--cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHH
Confidence 99999999998 778999999998754332 333455 8999999983 3334788999999999999999
Q ss_pred hCCCCCCCCChHHHHHHHHHHcCCCCHH---HH---hccCCCCCCCcccccccCChhhhhcc
Q 021306 236 LGQPLFPGENAVDQLVEIIKVLGTPTRE---EI---RCMNPNYTDFRFPQIKAHPWHKVCIF 291 (314)
Q Consensus 236 tg~~pf~~~~~~~~~~~i~~~~~~~~~~---~~---~~~~p~~~~~~~~~l~~~p~~~~~~~ 291 (314)
+|+.||.+.+..+....+.......+.. .+ ...+|. +|+++.++++|||++....
T Consensus 312 tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~-~Rpt~~~~l~~~~~~~~~~ 372 (413)
T 3dzo_A 312 CADLPNTDDAALGGSEWIFRSCKNIPQPVRALLEGFLRYPKE-DRLLPLQAMETPEYEQLRT 372 (413)
T ss_dssp HSSCCCCTTGGGSCSGGGGSSCCCCCHHHHHHHHHHTCSSGG-GSCCHHHHTTSHHHHHHHH
T ss_pred HCCCCCCCcchhhhHHHHHhhcccCCHHHHHHHHHHccCChh-hCcCHHHHHhCHHHHHHHH
Confidence 9999998876544444333322222222 12 233666 8999999999999987643
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-37 Score=268.32 Aligned_cols=250 Identities=27% Similarity=0.390 Sum_probs=177.9
Q ss_pred cCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc--cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeEEE
Q 021306 36 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR--RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 113 (314)
Q Consensus 36 ~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~--~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 113 (314)
..++|++.+.||+|+||.||++++ .++.|++|.+.... ....+|+.++++++||||+++++++. +. .++
T Consensus 6 ~~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~--~~l 76 (307)
T 2eva_A 6 DYKEIEVEEVVGRGAFGVVCKAKW--RAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGACL-----NP--VCL 76 (307)
T ss_dssp CGGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEECSSTTHHHHHHHHHHHHHHCCCTTBCCEEEBCT-----TT--TEE
T ss_pred CHhHeeeeeEeecCCCceEEEEEE--CCeeEEEEEecChhHHHHHHHHHHHHhcCCCCCcCeEEEEEc-----CC--cEE
Confidence 456899999999999999999987 57899999986543 33468999999999999999998773 22 569
Q ss_pred Eeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcC--CCceecCCCCCcEEEcCCCCcEEEeecCcccc
Q 021306 114 VMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV--PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 190 (314)
Q Consensus 114 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~--~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~ 190 (314)
||||+++ +|.+.+... .....+++..++.++.|++.||.|||+. +||+|+||||+||+++.++..++|+|||++..
T Consensus 77 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~ 155 (307)
T 2eva_A 77 VMEYAEGGSLYNVLHGA-EPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD 155 (307)
T ss_dssp EEECCTTCBHHHHHHCS-SSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---
T ss_pred EEEcCCCCCHHHHHhcc-CCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccc
Confidence 9999986 777766532 1123478999999999999999999983 48999999999999987444589999999875
Q ss_pred cccCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHcCCCCHHHHhccC
Q 021306 191 LIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQ-LVEIIKVLGTPTREEIRCMN 269 (314)
Q Consensus 191 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~ 269 (314)
.... .....+++.|+|||.+.+.. ++.++||||||+++|+|++|+.||........ ..........+ .....+
T Consensus 156 ~~~~--~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~- 229 (307)
T 2eva_A 156 IQTH--MTNNKGSAAWMAPEVFEGSN-YSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRP--PLIKNL- 229 (307)
T ss_dssp -----------CCTTSSCHHHHTCCC-CCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCC--CCBTTC-
T ss_pred cccc--cccCCCCCceEChhhhCCCC-CCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCC--Cccccc-
Confidence 4322 22346799999999996644 89999999999999999999999986543221 11111111111 011111
Q ss_pred CCCCCCcccccccCChhhhhcccCChHHHHHhcchh
Q 021306 270 PNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGSHI 305 (314)
Q Consensus 270 p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~~~ 305 (314)
...+.+++..+|...+..+++...+++.++.+
T Consensus 230 ----~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 261 (307)
T 2eva_A 230 ----PKPIESLMTRCWSKDPSQRPSMEEIVKIMTHL 261 (307)
T ss_dssp ----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----CHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 12345566666666666666666666665544
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=293.69 Aligned_cols=249 Identities=23% Similarity=0.250 Sum_probs=191.3
Q ss_pred CCceeee-eEeecCceEEEEEEEC--CCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCce
Q 021306 38 ISYMAER-VVGTGSFGIVFQAKCL--ETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL 109 (314)
Q Consensus 38 ~~y~~~~-~Lg~g~~g~Vy~~~~~--~~~~~~~vK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 109 (314)
+++.+.+ .||+|+||.||+|.++ .++..||+|.++... ....+|+.++++++||||+++++++.. .
T Consensus 335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~----- 408 (613)
T 2ozo_A 335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-E----- 408 (613)
T ss_dssp TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-S-----
T ss_pred cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-C-----
Confidence 3455666 8999999999999875 356779999987532 334689999999999999999998742 1
Q ss_pred eEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcc
Q 021306 110 FLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 188 (314)
Q Consensus 110 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~ 188 (314)
.+++||||+.+ +|.+.+.. ....+++.+++.++.||+.||.|||+ +||+||||||+||+++. ++.++|+|||++
T Consensus 409 ~~~lv~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~LH~-~~iiHrDlkp~NILl~~-~~~vkL~DFGla 483 (613)
T 2ozo_A 409 ALMLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEE-KNFVHRNLAARNVLLVN-RHYAKISDFGLS 483 (613)
T ss_dssp SEEEEEECCTTCBHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEEE-TTEEEECCCSTT
T ss_pred CeEEEEEeCCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHH-CCEEcCcCCHHHEEEcC-CCcEEEeeccCc
Confidence 27899999986 66666543 34679999999999999999999999 89999999999999998 889999999999
Q ss_pred cccccCCcc----ccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCHH
Q 021306 189 KQLIAGEAN----ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTRE 263 (314)
Q Consensus 189 ~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~ 263 (314)
+........ ....+++.|+|||.+.+.. ++.++||||||+++|||++ |+.||.+.+..+....+.+....+.
T Consensus 484 ~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~-~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~-- 560 (613)
T 2ozo_A 484 KALGADDSYYTARSAGKWPLKWYAPECINFRK-FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMEC-- 560 (613)
T ss_dssp TTCC--------------CCTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCCCC--
T ss_pred ccccCCCceeeeccCCCCccceeCHhhhcCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCC--
Confidence 765432211 1223457899999996544 8999999999999999998 9999999888776665554322111
Q ss_pred HHhccCCCCCCCcccccccCChhhhhcccCChHHHHHhcchhh
Q 021306 264 EIRCMNPNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGSHIN 306 (314)
Q Consensus 264 ~~~~~~p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~~~~ 306 (314)
|......+.+|+..||...+..++....+.+.++.+.
T Consensus 561 ------p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~ 597 (613)
T 2ozo_A 561 ------PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY 597 (613)
T ss_dssp ------CTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHH
T ss_pred ------CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 1112345677888888888888888887777766543
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-37 Score=266.41 Aligned_cols=231 Identities=23% Similarity=0.358 Sum_probs=174.2
Q ss_pred CCccCCCceee-eeEeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHH-HhCCCCceeeeceeeeecCCCCcee
Q 021306 33 EPKQTISYMAE-RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLM-RVMDHPNVISLKHCFFSTTSKNELF 110 (314)
Q Consensus 33 ~~~~~~~y~~~-~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~~~~~~e~~~l-~~l~h~~iv~~~~~~~~~~~~~~~~ 110 (314)
.....++|.+. +.||+|+||.||++.+..+++.||+|.+.... ...+|+.++ +.++||||+++++++.... .....
T Consensus 12 ~~~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~e~~~~~~~~~h~~i~~~~~~~~~~~-~~~~~ 89 (299)
T 3m2w_A 12 KNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP-KARREVELHWRASQCPHIVRIVDVYENLY-AGRKC 89 (299)
T ss_dssp CSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSH-HHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEEE
T ss_pred ccccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecccH-HHHHHHHHHHHhccCCCchhHHhhhhhhc-CCCce
Confidence 34456789998 78999999999999999999999999987543 455677776 6679999999999875422 23456
Q ss_pred EEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCC--CCcEEEeecCc
Q 021306 111 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPL--THQVKICDFGS 187 (314)
Q Consensus 111 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~--~~~~~l~dfg~ 187 (314)
+++||||+++ +|.+.+... .+..+++.+++.++.|++.||.|||+ +|++|+||||+||+++.. ++.++|+|||+
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~ 166 (299)
T 3m2w_A 90 LLIVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHS-INIAHRDVKPENLLYTSKRPNAILKLTDFGF 166 (299)
T ss_dssp EEEEECCCCSCBHHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEESSSSTTCCEEECCCTT
T ss_pred EEEEEeecCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEEecCCCCCcEEEecccc
Confidence 8899999986 887777652 23579999999999999999999999 899999999999999874 46799999998
Q ss_pred ccccccCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHc----------
Q 021306 188 AKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVL---------- 257 (314)
Q Consensus 188 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~---------- 257 (314)
+.... ...++.++||||||+++|+|++|+.||.+.+............
T Consensus 167 a~~~~----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (299)
T 3m2w_A 167 AKETT----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNP 224 (299)
T ss_dssp CEECT----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSCHH
T ss_pred ccccc----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCCch
Confidence 85321 1236789999999999999999999997765433211111100
Q ss_pred -----CCCCHHHH---hccCCCCCCCcccccccCChhhhhcc
Q 021306 258 -----GTPTREEI---RCMNPNYTDFRFPQIKAHPWHKVCIF 291 (314)
Q Consensus 258 -----~~~~~~~~---~~~~p~~~~~~~~~l~~~p~~~~~~~ 291 (314)
.....+.+ ...+|. +|+++.++++|||++....
T Consensus 225 ~~~~~~~~~~~li~~~l~~dP~-~Rps~~e~l~hp~~~~~~~ 265 (299)
T 3m2w_A 225 EWSEVSEEVKMLIRNLLKTEPT-QRMTITEFMNHPWIMQSTK 265 (299)
T ss_dssp HHTTSCHHHHHHHHHHTCSSTT-TSCCHHHHHTSHHHHTGGG
T ss_pred hcccCCHHHHHHHHHHcccChh-hCCCHHHHhcChhhccccc
Confidence 00011122 234677 8999999999999976654
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-37 Score=270.06 Aligned_cols=258 Identities=20% Similarity=0.288 Sum_probs=185.5
Q ss_pred CCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccccc-hHHHHHHHHhC--CCCceeeeceeeeecCCCCceeEEE
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY-KNRELQLMRVM--DHPNVISLKHCFFSTTSKNELFLNL 113 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~~~-~~~e~~~l~~l--~h~~iv~~~~~~~~~~~~~~~~~~l 113 (314)
.++|++.+.||+|+||.||+|++ +++.||+|.+...... ..+|.+++..+ +|+||+++++++..... ....+++
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~-~~~~~~l 112 (337)
T 3mdy_A 36 AKQIQMVKQIGKGRYGEVWMGKW--RGEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKGTG-SWTQLYL 112 (337)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCG-GGCEEEE
T ss_pred ccceEEEeEeecCCCeEEEEEEE--CCceEEEEEEeccccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCC-CCCceEE
Confidence 46899999999999999999997 4899999998654332 23555555554 99999999998765432 2245789
Q ss_pred Eeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCC--------CceecCCCCCcEEEcCCCCcEEEee
Q 021306 114 VMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP--------RVCHRDLKPQNLLVDPLTHQVKICD 184 (314)
Q Consensus 114 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~--------~i~h~dl~p~Nil~~~~~~~~~l~d 184 (314)
||||+++ +|.+.+.. ..+++..++.++.|++.||.|||+ + ||+|+||||+||+++. ++.++|+|
T Consensus 113 v~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~-~~~~~~~~~~ivH~Dikp~Nill~~-~~~~kl~D 185 (337)
T 3mdy_A 113 ITDYHENGSLYDYLKS-----TTLDAKSMLKLAYSSVSGLCHLHT-EIFSTQGKPAIAHRDLKSKNILVKK-NGTCCIAD 185 (337)
T ss_dssp EECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHS-CBCSTTCBCCEECSCCCGGGEEECT-TSCEEECC
T ss_pred EEeccCCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHH-hhhhhccCCCEEecccchHHEEECC-CCCEEEEe
Confidence 9999986 78777753 579999999999999999999999 8 9999999999999998 78999999
Q ss_pred cCcccccccCCcc-----ccccccccccccccccCCCCCCc------chhHHHHHHHHHHHHhC----------CCCCCC
Q 021306 185 FGSAKQLIAGEAN-----ISYICSRFYRAPELIFGATEYTT------SIDIWSAGCVLAELLLG----------QPLFPG 243 (314)
Q Consensus 185 fg~~~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~------~~Dv~slG~il~el~tg----------~~pf~~ 243 (314)
||++......... ....+|+.|+|||.+.+.. ... ++||||||+++|+|++| +.||..
T Consensus 186 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~ 264 (337)
T 3mdy_A 186 LGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESL-NRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHD 264 (337)
T ss_dssp CTTCEECC---------CCSSCSCGGGCCHHHHTTCC-CTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred CCCceeeccccccccCCCCCCccCcceeChhhccccc-CCccccCccccchHHHHHHHHHHHhccCcccccccccccHhh
Confidence 9999755433221 2346799999999996544 333 49999999999999999 777765
Q ss_pred CChH----HHHHHHHHHc--CCCCHHHHhccCCCCCCCcccccccCChhhhhcccCChHHHHHhcchhhhc
Q 021306 244 ENAV----DQLVEIIKVL--GTPTREEIRCMNPNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGSHINAI 308 (314)
Q Consensus 244 ~~~~----~~~~~i~~~~--~~~~~~~~~~~~p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 308 (314)
.... .......... ....+.. ..+......+.++++.||...+..+++...+++.++.+.-.
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~ 332 (337)
T 3mdy_A 265 LVPSDPSYEDMREIVCIKKLRPSFPNR---WSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSES 332 (337)
T ss_dssp TSCSSCCHHHHHHHHTTSCCCCCCCGG---GGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred hcCCCCchhhhHHHHhhhccCcccccc---chhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhh
Confidence 4221 2222221110 0000100 00000011255677888888888888888888877765543
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=273.39 Aligned_cols=254 Identities=28% Similarity=0.386 Sum_probs=186.8
Q ss_pred CCc-eeeeeEeecCceEEEEEEE----CCCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCC
Q 021306 38 ISY-MAERVVGTGSFGIVFQAKC----LETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKN 107 (314)
Q Consensus 38 ~~y-~~~~~Lg~g~~g~Vy~~~~----~~~~~~~~vK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 107 (314)
++| ++++.||+|+||.||++.. ..+++.||+|.++... ....+|+.++++++||||+++++++....
T Consensus 30 ~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--- 106 (318)
T 3lxp_A 30 KRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAG--- 106 (318)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT---
T ss_pred HHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCC---
Confidence 455 9999999999999988754 3578999999997543 23468999999999999999999886532
Q ss_pred ceeEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecC
Q 021306 108 ELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 186 (314)
Q Consensus 108 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg 186 (314)
...+++||||+++ +|.+.+.. ..+++.+++.++.||+.||.+||+ +||+|+||||+||+++. ++.++|+|||
T Consensus 107 ~~~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~i~~~l~~~l~~LH~-~~ivH~Dikp~Nil~~~-~~~~kl~Dfg 179 (318)
T 3lxp_A 107 AASLQLVMEYVPLGSLRDYLPR-----HSIGLAQLLLFAQQICEGMAYLHA-QHYIHRDLAARNVLLDN-DRLVKIGDFG 179 (318)
T ss_dssp TTEEEEEECCCTTCBHHHHGGG-----SCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECT-TCCEEECCGG
T ss_pred CceEEEEEecccCCcHHHHHhh-----CCCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCchheEEEcC-CCCEEECCcc
Confidence 2347899999986 76666543 459999999999999999999999 89999999999999998 7889999999
Q ss_pred cccccccCCc----cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHH-----------HHH
Q 021306 187 SAKQLIAGEA----NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVD-----------QLV 251 (314)
Q Consensus 187 ~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~-----------~~~ 251 (314)
++........ .....+++.|+|||.+.+.. ++.++||||||+++|+|++|..||....... ...
T Consensus 180 ~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~ 258 (318)
T 3lxp_A 180 LAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYK-FYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVL 258 (318)
T ss_dssp GCEECCTTCSEEEC---CCCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHH
T ss_pred ccccccccccccccccCCCCCceeeChHHhcCCC-CCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHH
Confidence 9986644322 22344577899999997654 7899999999999999999999996543211 011
Q ss_pred HHHHHcCCCCHHHHhccCCCCCCCcccccccCChhhhhcccCChHHHHHhcchhh
Q 021306 252 EIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGSHIN 306 (314)
Q Consensus 252 ~i~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~~~~ 306 (314)
.+.+...... ....|......+.++++.+|...+..+++...+++.++.+.
T Consensus 259 ~~~~~~~~~~----~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~ 309 (318)
T 3lxp_A 259 RLTELLERGE----RLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVH 309 (318)
T ss_dssp HHHHHHHTTC----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHhccc----CCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 1111100000 00011112334667777777777777777777777766543
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=271.91 Aligned_cols=266 Identities=27% Similarity=0.371 Sum_probs=192.9
Q ss_pred cCCCCCCccCCCceeeeeEeecCceEEEEEE----ECCCCcEEEEEEeeccc----cchHHHHHHHHhCCCCceeeecee
Q 021306 28 GGKNGEPKQTISYMAERVVGTGSFGIVFQAK----CLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHC 99 (314)
Q Consensus 28 ~~~~~~~~~~~~y~~~~~Lg~g~~g~Vy~~~----~~~~~~~~~vK~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~ 99 (314)
..........++|++.+.||+|+||.||+++ +..+++.|++|.+.... ....+|+.++++++|+||++++++
T Consensus 31 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 110 (326)
T 2w1i_A 31 EDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGV 110 (326)
T ss_dssp ------CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred cccCccccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEE
Confidence 3333444556789999999999999999998 45689999999986543 234689999999999999999998
Q ss_pred eeecCCCCceeEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCC
Q 021306 100 FFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH 178 (314)
Q Consensus 100 ~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~ 178 (314)
+.... ...+++||||+++ +|.+.+.. ....+++.+++.++.|++.||.+||+ +|++|+||||+||+++. ++
T Consensus 111 ~~~~~---~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~dikp~NIli~~-~~ 182 (326)
T 2w1i_A 111 CYSAG---RRNLKLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQICKGMEYLGT-KRYIHRDLATRNILVEN-EN 182 (326)
T ss_dssp ECC-------CCEEEECCCTTCBHHHHHHH---STTSSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEEEE-TT
T ss_pred EEecC---CCceEEEEECCCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHh-CCEeccCCCcceEEEcC-CC
Confidence 75432 2237799999986 77777764 23569999999999999999999999 89999999999999998 78
Q ss_pred cEEEeecCcccccccCCcc----ccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChH-------
Q 021306 179 QVKICDFGSAKQLIAGEAN----ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV------- 247 (314)
Q Consensus 179 ~~~l~dfg~~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~------- 247 (314)
.++|+|||++......... ....++..|+|||.+.+.. ++.++||||||+++|+|++|..||......
T Consensus 183 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~ 261 (326)
T 2w1i_A 183 RVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESK-FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGN 261 (326)
T ss_dssp EEEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCT
T ss_pred cEEEecCcchhhccccccccccccCCCCceeEECchhhcCCC-CCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhcc
Confidence 9999999999765443221 1234466799999986654 789999999999999999999998643211
Q ss_pred -----HHHHHHHHHcCCCCHHHHhccCCCCCCCcccccccCChhhhhcccCChHHHHHhcchhh
Q 021306 248 -----DQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGSHIN 306 (314)
Q Consensus 248 -----~~~~~i~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~~~~ 306 (314)
.....+.+...... ....|......+.++++.||...+..+++...+++.++.+.
T Consensus 262 ~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~ 321 (326)
T 2w1i_A 262 DKQGQMIVFHLIELLKNNG----RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 321 (326)
T ss_dssp TCCTHHHHHHHHHHHHTTC----CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred ccchhhhHHHHHHHhhcCC----CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 00011111100000 00011112334667888888888888888888887776654
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=270.95 Aligned_cols=254 Identities=19% Similarity=0.208 Sum_probs=189.4
Q ss_pred CCCccCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeecc------ccchHHHHHHHHhCCCCceeeeceeeeecCC
Q 021306 32 GEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRVMDHPNVISLKHCFFSTTS 105 (314)
Q Consensus 32 ~~~~~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 105 (314)
.-+...++|++.+.||+|+||.||+|++.. .+++|.+... .....+|+.++++++|+||+++++++....
T Consensus 27 ~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~- 102 (319)
T 2y4i_B 27 EWDIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPP- 102 (319)
T ss_dssp GSSSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSS-
T ss_pred cccCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC-
Confidence 334456789999999999999999999753 4899988643 233458999999999999999999885433
Q ss_pred CCceeEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEee
Q 021306 106 KNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICD 184 (314)
Q Consensus 106 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~d 184 (314)
.+++++||+.+ +|.+.+.. ....+++..++.++.|++.||.+||+ +|++|+||||+||+++ ++.++|+|
T Consensus 103 ----~~~iv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~-~~i~H~dlkp~NIl~~--~~~~~l~D 172 (319)
T 2y4i_B 103 ----HLAIITSLCKGRTLYSVVRD---AKIVLDVNKTRQIAQEIVKGMGYLHA-KGILHKDLKSKNVFYD--NGKVVITD 172 (319)
T ss_dssp ----CEEEECBCCCSEEHHHHTTS---SCCCCCSHHHHHHHHHHHHHHHHHHH-TTCCCCCCCSTTEEEC----CCEECC
T ss_pred ----ceEEEeecccCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCChhhEEEe--CCCEEEee
Confidence 38899999985 66665543 23579999999999999999999999 8999999999999998 46899999
Q ss_pred cCcccccccC------CccccccccccccccccccC--------CCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 021306 185 FGSAKQLIAG------EANISYICSRFYRAPELIFG--------ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQL 250 (314)
Q Consensus 185 fg~~~~~~~~------~~~~~~~~~~~y~aPE~~~~--------~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~ 250 (314)
||++...... .......+++.|+|||.+.+ ...++.++||||||+++|+|++|+.||.........
T Consensus 173 fg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~ 252 (319)
T 2y4i_B 173 FGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAII 252 (319)
T ss_dssp CSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHH
T ss_pred cCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 9987644211 11223457889999999864 234688999999999999999999999988876655
Q ss_pred HHHHHHcCCCCHHHHhccCCCCCCCcccccccCChhhhhcccCChHHHHHhcchhh
Q 021306 251 VEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGSHIN 306 (314)
Q Consensus 251 ~~i~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~~~~ 306 (314)
..+........ .+.-....+.+++..+|...+..+++...+++.++.+.
T Consensus 253 ~~~~~~~~~~~-------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~ 301 (319)
T 2y4i_B 253 WQMGTGMKPNL-------SQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLP 301 (319)
T ss_dssp HHHHTTCCCCC-------CCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC-
T ss_pred HHhccCCCCCC-------CcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence 55443321111 11001224567777777777777777777777766544
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=293.71 Aligned_cols=241 Identities=22% Similarity=0.247 Sum_probs=187.0
Q ss_pred eeEeecCceEEEEEEE--CCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeEEEEe
Q 021306 44 RVVGTGSFGIVFQAKC--LETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVM 115 (314)
Q Consensus 44 ~~Lg~g~~g~Vy~~~~--~~~~~~~~vK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 115 (314)
+.||+|+||.||+|.+ +.+++.||+|+++... ....+|+.++++++|+||+++++++. .. ..++||
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~-----~~~lv~ 448 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AE-----SWMLVM 448 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-SS-----SEEEEE
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cC-----CEEEEE
Confidence 4799999999999954 4567899999987542 23468999999999999999999873 21 167999
Q ss_pred ecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcccccccC
Q 021306 116 EYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG 194 (314)
Q Consensus 116 e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~~~ 194 (314)
||+.+ +|.+.+. ....+++.+++.++.||+.||.|||+ +||+||||||+||+++. ++.++|+|||+++.....
T Consensus 449 E~~~~g~L~~~l~----~~~~l~~~~~~~i~~qi~~~L~yLH~-~~iiHrDLkp~NILl~~-~~~~kL~DFGla~~~~~~ 522 (635)
T 4fl3_A 449 EMAELGPLNKYLQ----QNRHVKDKNIIELVHQVSMGMKYLEE-SNFVHRDLAARNVLLVT-QHYAKISDFGLSKALRAD 522 (635)
T ss_dssp ECCTTEEHHHHHH----HCTTCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEEE-TTEEEECCTTHHHHTTC-
T ss_pred EccCCCCHHHHHh----hCCCCCHHHHHHHHHHHHHHHHHHHH-CCEeCCCCChHhEEEeC-CCCEEEEEcCCccccccC
Confidence 99986 6766664 35789999999999999999999999 89999999999999998 789999999999765432
Q ss_pred Cc----cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCHHHHhccC
Q 021306 195 EA----NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 269 (314)
Q Consensus 195 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 269 (314)
.. .....+++.|+|||.+.+.. ++.++||||||+++|+|++ |+.||.+.+..+....+.+....+.
T Consensus 523 ~~~~~~~~~~~~t~~y~APE~~~~~~-~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~-------- 593 (635)
T 4fl3_A 523 ENYYKAQTHGKWPVKWYAPECINYYK-FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGC-------- 593 (635)
T ss_dssp ------------CGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCC--------
T ss_pred ccccccccCCCCceeeeChhhhcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC--------
Confidence 21 12234467899999996544 8999999999999999998 9999999888776665554322211
Q ss_pred CCCCCCcccccccCChhhhhcccCChHHHHHhcchh
Q 021306 270 PNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGSHI 305 (314)
Q Consensus 270 p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~~~ 305 (314)
|......+.+|++.+|...+..++....+.+.++.+
T Consensus 594 p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~ 629 (635)
T 4fl3_A 594 PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 629 (635)
T ss_dssp CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred CCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 111233466778888888888888888777776654
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=268.84 Aligned_cols=256 Identities=21% Similarity=0.261 Sum_probs=190.4
Q ss_pred CCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc-cchHHHHHHHHh--CCCCceeeeceeeeecCCCCceeEEEE
Q 021306 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-RYKNRELQLMRV--MDHPNVISLKHCFFSTTSKNELFLNLV 114 (314)
Q Consensus 38 ~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~-~~~~~e~~~l~~--l~h~~iv~~~~~~~~~~~~~~~~~~lv 114 (314)
++|++.+.||+|+||.||++++ +++.||+|.+.... ....+|.++++. ++||||+++++++..... .....++|
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~-~~~~~~lv 118 (342)
T 1b6c_B 42 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNG-TWTQLWLV 118 (342)
T ss_dssp HHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCS-SCCCEEEE
T ss_pred ccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCchhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCC-ccceeEEE
Confidence 6899999999999999999997 68999999986543 334578888877 799999999998754431 12247899
Q ss_pred eecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhh--------cCCCceecCCCCCcEEEcCCCCcEEEeec
Q 021306 115 MEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH--------TVPRVCHRDLKPQNLLVDPLTHQVKICDF 185 (314)
Q Consensus 115 ~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH--------~~~~i~h~dl~p~Nil~~~~~~~~~l~df 185 (314)
|||+++ +|.+.+.. ..+++.+++.++.|++.||.||| + +||+|+||||+||+++. ++.++|+||
T Consensus 119 ~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~-~~ivH~Dlkp~NIll~~-~~~~kL~Df 191 (342)
T 1b6c_B 119 SDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGK-PAIAHRDLKSKNILVKK-NGTCCIADL 191 (342)
T ss_dssp ECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCB-CEEECSCCSGGGEEECT-TSCEEECCC
T ss_pred EeecCCCcHHHHHhc-----cCccHHHHHHHHHHHHHHHHHHHHHHhhhccc-CCeeeCCCCHHHEEECC-CCCEEEEEC
Confidence 999996 88777754 57999999999999999999999 8 89999999999999998 789999999
Q ss_pred CcccccccCCc-----cccccccccccccccccCCCC-----CCcchhHHHHHHHHHHHHhC----------CCCCCCCC
Q 021306 186 GSAKQLIAGEA-----NISYICSRFYRAPELIFGATE-----YTTSIDIWSAGCVLAELLLG----------QPLFPGEN 245 (314)
Q Consensus 186 g~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~-----~~~~~Dv~slG~il~el~tg----------~~pf~~~~ 245 (314)
|++........ .....+++.|+|||.+.+... ++.++||||||+++|+|++| ..||....
T Consensus 192 g~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~ 271 (342)
T 1b6c_B 192 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV 271 (342)
T ss_dssp TTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred CCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccC
Confidence 99976544332 233467899999999865432 23689999999999999999 78987653
Q ss_pred h----HHHHHHHHH-HcC-CCCHHHHhccCCCCCCCcccccccCChhhhhcccCChHHHHHhcchhh
Q 021306 246 A----VDQLVEIIK-VLG-TPTREEIRCMNPNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGSHIN 306 (314)
Q Consensus 246 ~----~~~~~~i~~-~~~-~~~~~~~~~~~p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~~~~ 306 (314)
. .+.+...+. ... ...+..+. +.. ....+.+|+..||...+..+++...+++.++.+.
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~-~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~ 335 (342)
T 1b6c_B 272 PSDPSVEEMRKVVCEQKLRPNIPNRWQ--SCE-ALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 335 (342)
T ss_dssp CSSCCHHHHHHHHTTSCCCCCCCGGGG--TSH-HHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHH
T ss_pred cCcccHHHHHHHHHHHHhCCCCccccc--chh-HHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHH
Confidence 2 122222221 111 11111000 000 0113557888888888888888888888777654
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=290.34 Aligned_cols=250 Identities=26% Similarity=0.307 Sum_probs=193.2
Q ss_pred cCCCceeeeeEeecCceEEEEEEECCC---CcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCC
Q 021306 36 QTISYMAERVVGTGSFGIVFQAKCLET---GETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKN 107 (314)
Q Consensus 36 ~~~~y~~~~~Lg~g~~g~Vy~~~~~~~---~~~~~vK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 107 (314)
..++|++.+.||+|+||.||+|.+..+ +..+++|.++... ....+|+.++++++||||+++++++.. .
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~--- 463 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-N--- 463 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-S---
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-C---
Confidence 346899999999999999999998653 4679999876432 334589999999999999999998721 1
Q ss_pred ceeEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecC
Q 021306 108 ELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 186 (314)
Q Consensus 108 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg 186 (314)
..++||||+++ +|.+.+.. ....+++..++.++.|++.||.|||+ +||+||||||+||+++. ++.++|+|||
T Consensus 464 --~~~lv~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~-~givHrDikp~NILl~~-~~~vkL~DFG 536 (656)
T 2j0j_A 464 --PVWIIMELCTLGELRSFLQV---RKFSLDLASLILYAYQLSTALAYLES-KRFVHRDIAARNVLVSS-NDCVKLGDFG 536 (656)
T ss_dssp --SCEEEEECCTTCBHHHHHHH---TTTTCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEEE-TTEEEECCCC
T ss_pred --ceEEEEEcCCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHh-CCccccccchHhEEEeC-CCCEEEEecC
Confidence 26799999995 77776653 24579999999999999999999999 89999999999999998 8899999999
Q ss_pred cccccccCCcc--ccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCHH
Q 021306 187 SAKQLIAGEAN--ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTRE 263 (314)
Q Consensus 187 ~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~ 263 (314)
++......... ....+++.|+|||.+.+.. ++.++||||||+++|+|++ |..||.+.+..+....+......+.+
T Consensus 537 ~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~~- 614 (656)
T 2j0j_A 537 LSRYMEDSTYYKASKGKLPIKWMAPESINFRR-FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMP- 614 (656)
T ss_dssp CCCSCCC----------CCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCCCC-
T ss_pred CCeecCCCcceeccCCCCCcceeCHHHhcCCC-CCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCC-
Confidence 99765433221 1234467899999996554 8999999999999999997 99999998887776666554322211
Q ss_pred HHhccCCCCCCCcccccccCChhhhhcccCChHHHHHhcchh
Q 021306 264 EIRCMNPNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGSHI 305 (314)
Q Consensus 264 ~~~~~~p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~~~ 305 (314)
+. ....+.+++..+|...+..++....+.+.++.+
T Consensus 615 ------~~-~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~i 649 (656)
T 2j0j_A 615 ------PN-CPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 649 (656)
T ss_dssp ------TT-CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ------cc-ccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 11 233466777777777777777777777766554
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-37 Score=266.94 Aligned_cols=251 Identities=25% Similarity=0.324 Sum_probs=182.1
Q ss_pred CCCceeeeeEeecCceEEEEEEECC-CCc--EEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCC
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCLE-TGE--TVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSK 106 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~~-~~~--~~~vK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 106 (314)
.++|++.+.||+|+||.||+|++.. +++ .|++|.++... ....+|+.++++++|+||+++++++...
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--- 93 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP--- 93 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS---
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccC---
Confidence 3589999999999999999998643 333 68999876431 2345899999999999999999987432
Q ss_pred CceeEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeec
Q 021306 107 NELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF 185 (314)
Q Consensus 107 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~df 185 (314)
. .++++||+.+ +|.+.+... ...+++.+++.++.|++.||.+||+ +|++|+||||+||+++. ++.++|+||
T Consensus 94 --~-~~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dikp~Nili~~-~~~~kl~Df 165 (291)
T 1u46_A 94 --P-MKMVTELAPLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEGMGYLES-KRFIHRDLAARNLLLAT-RDLVKIGDF 165 (291)
T ss_dssp --S-CEEEEECCTTCBHHHHHHHH---GGGSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEEEE-TTEEEECCC
T ss_pred --C-ceeeEecccCCCHHHHHHhc---cCCcCHHHHHHHHHHHHHHHHHHHh-CCcccCCCchheEEEcC-CCCEEEccc
Confidence 1 5699999985 777777642 3569999999999999999999999 89999999999999998 789999999
Q ss_pred CcccccccCCcc----ccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCC
Q 021306 186 GSAKQLIAGEAN----ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTP 260 (314)
Q Consensus 186 g~~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~t-g~~pf~~~~~~~~~~~i~~~~~~~ 260 (314)
|++......... ....++..|+|||.+.+.. ++.++||||||+++|+|++ |+.||.+.+..+....+.......
T Consensus 166 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~ 244 (291)
T 1u46_A 166 GLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRT-FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERL 244 (291)
T ss_dssp TTCEECCC-CCEEEC-----CCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCC
T ss_pred cccccccccccchhhhccCCCCceeeCchhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCC
Confidence 998765433221 2234567899999986554 7899999999999999999 999999988776666554432211
Q ss_pred CHHHHhccCCCCCCCcccccccCChhhhhcccCChHHHHHhcchhh
Q 021306 261 TREEIRCMNPNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGSHIN 306 (314)
Q Consensus 261 ~~~~~~~~~p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~~~~ 306 (314)
+. +......+.+++..+|...+..+++...+++.++...
T Consensus 245 ~~-------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 283 (291)
T 1u46_A 245 PR-------PEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 283 (291)
T ss_dssp CC-------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred CC-------CcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhC
Confidence 10 1111223555666666666666666666666655443
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=282.40 Aligned_cols=192 Identities=22% Similarity=0.200 Sum_probs=152.6
Q ss_pred CCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc------------cchHHHHHHHHhCC---------CCceee
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------------RYKNRELQLMRVMD---------HPNVIS 95 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~------------~~~~~e~~~l~~l~---------h~~iv~ 95 (314)
.++|++.+.||+|+||.||+|++ +|+.||+|.+.... ....+|+.+++.++ |+||++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 36899999999999999999998 78999999997543 33468888888886 555555
Q ss_pred ecee-----------------eeecC--------CCCceeEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHH
Q 021306 96 LKHC-----------------FFSTT--------SKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIF 149 (314)
Q Consensus 96 ~~~~-----------------~~~~~--------~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~ 149 (314)
+.++ +.... ......+++||||+.+ ++++.+. ...+++.+++.++.||+
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~-----~~~~~~~~~~~i~~qi~ 171 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR-----TKLSSLATAKSILHQLT 171 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT-----TTCCCHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHH-----hcCCCHHHHHHHHHHHH
Confidence 5444 32210 0013458899999976 4544443 26789999999999999
Q ss_pred HHHHHhh-cCCCceecCCCCCcEEEcCCCC--------------------cEEEeecCcccccccCCccccccccccccc
Q 021306 150 RGLAYIH-TVPRVCHRDLKPQNLLVDPLTH--------------------QVKICDFGSAKQLIAGEANISYICSRFYRA 208 (314)
Q Consensus 150 ~~l~~LH-~~~~i~h~dl~p~Nil~~~~~~--------------------~~~l~dfg~~~~~~~~~~~~~~~~~~~y~a 208 (314)
.||.||| + +||+||||||+|||++. ++ .+||+|||+++..... ...+|+.|+|
T Consensus 172 ~aL~~lH~~-~~ivHrDlKp~NILl~~-~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~----~~~gt~~y~a 245 (336)
T 2vuw_A 172 ASLAVAEAS-LRFEHRDLHWGNVLLKK-TSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG----IVVFCDVSMD 245 (336)
T ss_dssp HHHHHHHHH-HCCBCSCCCGGGEEEEE-CSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT----EEECCCCTTC
T ss_pred HHHHHHHHh-CCEeECCCCHHHEEEec-cCCcceeeeccCccccccCCCceEEEeeccccEecCCC----cEEEeecccC
Confidence 9999999 8 89999999999999997 44 8999999999865432 3478999999
Q ss_pred cccccCCCCCCcchhHHHHHHH-HHHHHhCCCCCCC
Q 021306 209 PELIFGATEYTTSIDIWSAGCV-LAELLLGQPLFPG 243 (314)
Q Consensus 209 PE~~~~~~~~~~~~Dv~slG~i-l~el~tg~~pf~~ 243 (314)
||.+.+.. +.++|||||+++ .+++++|..||.+
T Consensus 246 PE~~~g~~--~~~~Diwsl~~~~~~~~~~g~~p~~~ 279 (336)
T 2vuw_A 246 EDLFTGDG--DYQFDIYRLMKKENNNRWGEYHPYSN 279 (336)
T ss_dssp SGGGCCCS--SHHHHHHHHHHHHHTTCTTSCCTHHH
T ss_pred hhhhcCCC--ccceehhhhhCCCCcccccccCCCcc
Confidence 99997654 889999998777 7778889999954
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-36 Score=260.54 Aligned_cols=229 Identities=14% Similarity=0.013 Sum_probs=168.4
Q ss_pred CCCccCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecC
Q 021306 32 GEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTT 104 (314)
Q Consensus 32 ~~~~~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 104 (314)
+.+...++|++.+.||+|+||.||+|++..+++.||+|.+.... ....+|+..+.+++|+||+++++++...
T Consensus 25 g~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~- 103 (286)
T 3uqc_A 25 GARIANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTR- 103 (286)
T ss_dssp TCEETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEET-
T ss_pred CCEEecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEEC-
Confidence 33344578999999999999999999999999999999987542 2346888999999999999999998543
Q ss_pred CCCceeEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEe
Q 021306 105 SKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKIC 183 (314)
Q Consensus 105 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~ 183 (314)
...|+||||++| +|.+.+.. + ....++..++.|++.||.|||+ +||+|+||||+||+++. ++.++|+
T Consensus 104 ----~~~~lv~e~~~g~~L~~~l~~-----~-~~~~~~~~i~~ql~~aL~~lH~-~givH~Dikp~NIll~~-~g~~kl~ 171 (286)
T 3uqc_A 104 ----AGGLVVAEWIRGGSLQEVADT-----S-PSPVGAIRAMQSLAAAADAAHR-AGVALSIDHPSRVRVSI-DGDVVLA 171 (286)
T ss_dssp ----TEEEEEEECCCEEEHHHHHTT-----C-CCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCSGGGEEEET-TSCEEEC
T ss_pred ----CcEEEEEEecCCCCHHHHHhc-----C-CChHHHHHHHHHHHHHHHHHHH-CCCccCCCCcccEEEcC-CCCEEEE
Confidence 338899999986 66665532 2 4666789999999999999999 89999999999999998 7888887
Q ss_pred ecCcccccccCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH---HHHHHcCCC
Q 021306 184 DFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLV---EIIKVLGTP 260 (314)
Q Consensus 184 dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~---~i~~~~~~~ 260 (314)
+++ |++| ++.++||||||+++|+|+||+.||.+.+....+. ........+
T Consensus 172 ~~~-------------------~~~~--------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 224 (286)
T 3uqc_A 172 YPA-------------------TMPD--------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIE 224 (286)
T ss_dssp SCC-------------------CCTT--------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCC
T ss_pred ecc-------------------ccCC--------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCC
Confidence 432 3332 6889999999999999999999998876533221 111111111
Q ss_pred CHHHHhccCCCCCCCcccccccCChhhhhcccCChHHHHHhcchhh
Q 021306 261 TREEIRCMNPNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGSHIN 306 (314)
Q Consensus 261 ~~~~~~~~~p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~~~~ 306 (314)
.......+++ .+.+++..+|...+..+ +...+++.++...
T Consensus 225 ~~~~~~~~~~-----~l~~li~~~l~~dP~~R-s~~el~~~L~~~~ 264 (286)
T 3uqc_A 225 PADIDRDIPF-----QISAVAARSVQGDGGIR-SASTLLNLMQQAT 264 (286)
T ss_dssp HHHHCTTSCH-----HHHHHHHHHHCTTSSCC-CHHHHHHHHHHHH
T ss_pred hhhcccCCCH-----HHHHHHHHHcccCCccC-CHHHHHHHHHHHh
Confidence 1111122233 34556666666666665 6666666655443
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=292.13 Aligned_cols=194 Identities=25% Similarity=0.395 Sum_probs=162.2
Q ss_pred cCCCceeeeeEeecCceEEEEEEECC-CCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCce
Q 021306 36 QTISYMAERVVGTGSFGIVFQAKCLE-TGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL 109 (314)
Q Consensus 36 ~~~~y~~~~~Lg~g~~g~Vy~~~~~~-~~~~~~vK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 109 (314)
..++|++.+.||+|+||.||++.+.. +++.|++|.+.... ....+|+.++++++||||+++++++......+..
T Consensus 78 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 157 (681)
T 2pzi_A 78 VAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDP 157 (681)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCE
T ss_pred eCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCc
Confidence 34799999999999999999999876 78999999886432 2335789999999999999999998766554445
Q ss_pred eEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcc
Q 021306 110 FLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 188 (314)
Q Consensus 110 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~ 188 (314)
..|+||||++| +|.+.+ ...+++.+++.++.||+.||.|||+ +||+||||||+||+++. + .++|+|||++
T Consensus 158 ~~~lv~E~~~g~~L~~~~------~~~l~~~~~~~~~~qi~~aL~~lH~-~giiHrDlkp~NIll~~-~-~~kl~DFG~a 228 (681)
T 2pzi_A 158 VGYIVMEYVGGQSLKRSK------GQKLPVAEAIAYLLEILPALSYLHS-IGLVYNDLKPENIMLTE-E-QLKLIDLGAV 228 (681)
T ss_dssp EEEEEEECCCCEECC----------CCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECS-S-CEEECCCTTC
T ss_pred eeEEEEEeCCCCcHHHHH------hCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecccChHHeEEeC-C-cEEEEecccc
Confidence 56899999997 443322 2379999999999999999999999 89999999999999986 3 8999999999
Q ss_pred cccccCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 021306 189 KQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 243 (314)
Q Consensus 189 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~ 243 (314)
...... ....+|+.|+|||.+.+. ++.++||||||+++|+|++|..||.+
T Consensus 229 ~~~~~~---~~~~gt~~y~aPE~~~~~--~~~~sDi~slG~~l~~l~~g~~~~~~ 278 (681)
T 2pzi_A 229 SRINSF---GYLYGTPGFQAPEIVRTG--PTVATDIYTVGRTLAALTLDLPTRNG 278 (681)
T ss_dssp EETTCC---SCCCCCTTTSCTTHHHHC--SCHHHHHHHHHHHHHHHHSCCCEETT
T ss_pred hhcccC---CccCCCccccCHHHHcCC--CCCceehhhhHHHHHHHHhCCCCCcc
Confidence 765433 345689999999998653 48899999999999999999998865
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.6e-29 Score=237.55 Aligned_cols=178 Identities=19% Similarity=0.082 Sum_probs=121.6
Q ss_pred eEeecCceEEEEEEECCCCcEEEEEEeeccc--------------cchHHHHHHHHhC-CCCceeeeceeeeecCCCCce
Q 021306 45 VVGTGSFGIVFQAKCLETGETVAIKKVLQDR--------------RYKNRELQLMRVM-DHPNVISLKHCFFSTTSKNEL 109 (314)
Q Consensus 45 ~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~--------------~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~ 109 (314)
..+.|+.|.+..++....|+.+++|.+.++. ..+.+|+++|+++ .|+||+++++++. +..
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~e-----d~~ 315 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGE-----NAQ 315 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEE-----CSS
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEE-----ECC
Confidence 4556677777777766789999999986431 2346899999999 7999999999884 334
Q ss_pred eEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcc
Q 021306 110 FLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 188 (314)
Q Consensus 110 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~ 188 (314)
.+||||||++| +|.+.+. .++++++. .|+.||+.||.|+|+ +||+||||||+|||++. ++.+||+|||++
T Consensus 316 ~~yLVMEyv~G~~L~d~i~----~~~~l~~~---~I~~QIl~AL~ylH~-~GIIHRDIKPeNILL~~-dg~vKL~DFGlA 386 (569)
T 4azs_A 316 SGWLVMEKLPGRLLSDMLA----AGEEIDRE---KILGSLLRSLAALEK-QGFWHDDVRPWNVMVDA-RQHARLIDFGSI 386 (569)
T ss_dssp EEEEEEECCCSEEHHHHHH----TTCCCCHH---HHHHHHHHHHHHHHH-TTCEESCCCGGGEEECT-TSCEEECCCTTE
T ss_pred EEEEEEecCCCCcHHHHHH----hCCCCCHH---HHHHHHHHHHHHHHH-CCceeccCchHhEEECC-CCCEEEeecccC
Confidence 48999999998 6666665 35778775 478999999999999 99999999999999998 889999999999
Q ss_pred cccccC-CccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCC
Q 021306 189 KQLIAG-EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQ 238 (314)
Q Consensus 189 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~ 238 (314)
+..... .......||+.|+|||.+.+. +..++|+||+|++++++.++.
T Consensus 387 r~~~~~~~~~~t~vGTp~YmAPE~l~g~--~~~~~d~~s~g~~~~~l~~~~ 435 (569)
T 4azs_A 387 VTTPQDCSWPTNLVQSFFVFVNELFAEN--KSWNGFWRSAPVHPFNLPQPW 435 (569)
T ss_dssp ESCC---CCSHHHHHHHHHHHHHHC-------------------CCCCTTH
T ss_pred eeCCCCCccccCceechhhccHHHhCCC--CCCcccccccccchhhhcccc
Confidence 865433 233456789999999999653 567899999999888765543
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=5.2e-26 Score=212.50 Aligned_cols=179 Identities=17% Similarity=0.210 Sum_probs=133.1
Q ss_pred eeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc------------cchHHHHHHHHhCCCCceeeeceeeeecCCCCc
Q 021306 41 MAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 108 (314)
Q Consensus 41 ~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~------------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 108 (314)
...+.||+|+||.||++.. .++.+++|...... ....+|+.++++++||||+++..+......
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~--~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~--- 413 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY--LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDN--- 413 (540)
T ss_dssp ---------CCEEEEEEEC--SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTT---
T ss_pred CCCCEEeeCCCEEEEEEEE--CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCc---
Confidence 3456899999999999953 67888999764321 124689999999999999965544443322
Q ss_pred eeEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCc
Q 021306 109 LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 187 (314)
Q Consensus 109 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~ 187 (314)
.++||||++| +|.+.+.. +..++.|++.+|.|||+ +||+||||||+||+++. .++|+|||+
T Consensus 414 --~~lVmE~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~-~gIiHrDiKp~NILl~~---~~kL~DFGl 475 (540)
T 3en9_A 414 --KRIMMSYINGKLAKDVIED------------NLDIAYKIGEIVGKLHK-NDVIHNDLTTSNFIFDK---DLYIIDFGL 475 (540)
T ss_dssp --TEEEEECCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHH-TTEECTTCCTTSEEESS---SEEECCCTT
T ss_pred --cEEEEECCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHH-CcCccCCCCHHHEEECC---eEEEEECcc
Confidence 5799999985 66655542 56889999999999999 89999999999999996 899999999
Q ss_pred ccccccCCc--------cccccccccccccccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCC
Q 021306 188 AKQLIAGEA--------NISYICSRFYRAPELIFGA-TEYTTSIDIWSAGCVLAELLLGQPLFP 242 (314)
Q Consensus 188 ~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~el~tg~~pf~ 242 (314)
++....... .....+|+.|+|||.+.+. ..|+..+|+||..+-..+.+.++.+|.
T Consensus 476 a~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 476 GKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp CEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred CEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 987644321 1245689999999999641 226778899999999999888888774
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=9.2e-23 Score=175.43 Aligned_cols=136 Identities=18% Similarity=0.229 Sum_probs=106.6
Q ss_pred eeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc----------------------cchHHHHHHHHhCCCCceeeece
Q 021306 41 MAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----------------------RYKNRELQLMRVMDHPNVISLKH 98 (314)
Q Consensus 41 ~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~----------------------~~~~~e~~~l~~l~h~~iv~~~~ 98 (314)
.+.+.||+|+||.||+|.+ .+|+.||+|.++... ....+|+.++++++ | +++.+
T Consensus 93 ~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~ 168 (282)
T 1zar_A 93 AIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPK 168 (282)
T ss_dssp EEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCC
T ss_pred EecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCe
Confidence 3449999999999999998 889999999986322 22458999999999 5 67766
Q ss_pred eeeecCCCCceeEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCC
Q 021306 99 CFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLT 177 (314)
Q Consensus 99 ~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~ 177 (314)
++.. ...++||||++| +|.+ +. ......++.|++.||.+||+ +||+||||||+||+++ +
T Consensus 169 ~~~~------~~~~lvmE~~~g~~L~~-l~----------~~~~~~i~~qi~~~l~~lH~-~giiHrDlkp~NILl~--~ 228 (282)
T 1zar_A 169 VYAW------EGNAVLMELIDAKELYR-VR----------VENPDEVLDMILEEVAKFYH-RGIVHGDLSQYNVLVS--E 228 (282)
T ss_dssp EEEE------ETTEEEEECCCCEEGGG-CC----------CSCHHHHHHHHHHHHHHHHH-TTEECSCCSTTSEEEE--T
T ss_pred EEec------cceEEEEEecCCCcHHH-cc----------hhhHHHHHHHHHHHHHHHHH-CCCEeCCCCHHHEEEE--C
Confidence 5422 125799999987 5443 21 12355799999999999999 8999999999999999 7
Q ss_pred CcEEEeecCcccccccCCccccccccccccccccc
Q 021306 178 HQVKICDFGSAKQLIAGEANISYICSRFYRAPELI 212 (314)
Q Consensus 178 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~ 212 (314)
+.++|+|||++... ..+.|||.+
T Consensus 229 ~~vkl~DFG~a~~~------------~~~~a~e~l 251 (282)
T 1zar_A 229 EGIWIIDFPQSVEV------------GEEGWREIL 251 (282)
T ss_dssp TEEEECCCTTCEET------------TSTTHHHHH
T ss_pred CcEEEEECCCCeEC------------CCCCHHHHH
Confidence 78999999998632 335678776
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.82 E-value=4.9e-20 Score=156.44 Aligned_cols=135 Identities=19% Similarity=0.226 Sum_probs=102.7
Q ss_pred CceeeeeEeecCceEEEEEEECCCCcE--EEEEEeeccc----------------------------cchHHHHHHHHhC
Q 021306 39 SYMAERVVGTGSFGIVFQAKCLETGET--VAIKKVLQDR----------------------------RYKNRELQLMRVM 88 (314)
Q Consensus 39 ~y~~~~~Lg~g~~g~Vy~~~~~~~~~~--~~vK~~~~~~----------------------------~~~~~e~~~l~~l 88 (314)
-|++.+.||+|+||.||+|.+..+|+. ||+|.++... ....+|+..++++
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 378999999999999999998778989 9999864321 1346789999999
Q ss_pred CCCceeeeceeeeecCCCCceeEEEEeecccc------cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhh-cCCCc
Q 021306 89 DHPNVISLKHCFFSTTSKNELFLNLVMEYVPE------SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH-TVPRV 161 (314)
Q Consensus 89 ~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~------~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH-~~~~i 161 (314)
.|+++... ..+.. . ..++||||+++ .|.+... ..++..+..++.|++.+|.+|| + .||
T Consensus 128 ~~~~i~~p-~~~~~-~-----~~~lVmE~~g~~g~~~~~L~~~~~-------~~~~~~~~~i~~qi~~~l~~lH~~-~gi 192 (258)
T 1zth_A 128 KEAGVSVP-QPYTY-M-----KNVLLMEFIGEDELPAPTLVELGR-------ELKELDVEGIFNDVVENVKRLYQE-AEL 192 (258)
T ss_dssp HHTTCCCC-CEEEE-E-----TTEEEEECCEETTEECCBHHHHGG-------GGGGSCHHHHHHHHHHHHHHHHHT-SCE
T ss_pred HhCCCCCC-eEEEc-C-----CCEEEEEecCCCCCccccHHHHhh-------ccChHHHHHHHHHHHHHHHHHHHH-CCE
Confidence 88764221 22211 1 15699999953 4443321 1234567889999999999999 8 899
Q ss_pred eecCCCCCcEEEcCCCCcEEEeecCccccc
Q 021306 162 CHRDLKPQNLLVDPLTHQVKICDFGSAKQL 191 (314)
Q Consensus 162 ~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~ 191 (314)
+||||||+||+++. .++|+|||++...
T Consensus 193 vHrDlkp~NILl~~---~~~liDFG~a~~~ 219 (258)
T 1zth_A 193 VHADLSEYNIMYID---KVYFIDMGQAVTL 219 (258)
T ss_dssp ECSSCSTTSEEESS---SEEECCCTTCEET
T ss_pred EeCCCCHHHEEEcC---cEEEEECcccccC
Confidence 99999999999986 7999999999653
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.68 E-value=8.1e-17 Score=142.56 Aligned_cols=140 Identities=14% Similarity=0.091 Sum_probs=90.7
Q ss_pred ceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccccc------------------hHHHHHHHHhCCCCceeeeceeee
Q 021306 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY------------------KNRELQLMRVMDHPNVISLKHCFF 101 (314)
Q Consensus 40 y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~~~------------------~~~e~~~l~~l~h~~iv~~~~~~~ 101 (314)
|++...||.|++|.||+|.+ .+|+.||||+++..... ...+..+.....|+|+.+++....
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d-~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVAD-EKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp SEEEEEEEECSSEEEEEEEC-TTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEecCEeeeCCceEEEEEEC-CCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 89999999999999999996 57999999987532100 011122222223334333322111
Q ss_pred ecCCC-CceeEEEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCC--
Q 021306 102 STTSK-NELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH-- 178 (314)
Q Consensus 102 ~~~~~-~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~-- 178 (314)
..... .....++||||++|..+ ... ........++.|++.+|.+||+ .||+||||||.|||++. ++
T Consensus 176 ~vp~p~~~~~~~LVME~i~G~~L---~~l------~~~~~~~~l~~qll~~l~~lH~-~gIVHrDLKp~NILl~~-dgd~ 244 (397)
T 4gyi_A 176 PVPEPIAQSRHTIVMSLVDALPM---RQV------SSVPDPASLYADLIALILRLAK-HGLIHGDFNEFNILIRE-EKDA 244 (397)
T ss_dssp SCCCEEEEETTEEEEECCSCEEG---GGC------CCCSCHHHHHHHHHHHHHHHHH-TTEECSCCSTTSEEEEE-EECS
T ss_pred CCCeeeeccCceEEEEecCCccH---hhh------cccHHHHHHHHHHHHHHHHHHH-CCCcCCCCCHHHEEEeC-CCCc
Confidence 00000 00013599999998522 211 1112356778999999999999 89999999999999986 33
Q ss_pred --------cEEEeecCccccc
Q 021306 179 --------QVKICDFGSAKQL 191 (314)
Q Consensus 179 --------~~~l~dfg~~~~~ 191 (314)
.+.+|||+.+...
T Consensus 245 ~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 245 EDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp SCTTSEEEEEEECCCTTCEET
T ss_pred ccccccccceEEEEeCCcccC
Confidence 3899999987654
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.23 E-value=5.2e-11 Score=100.74 Aligned_cols=136 Identities=15% Similarity=0.083 Sum_probs=98.3
Q ss_pred CCceeeeeEeecCceEEEEEEECCCCcEEEEEEeec----cccchHHHHHHHHhCC-CCceeeeceeeeecCCCCceeEE
Q 021306 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQ----DRRYKNRELQLMRVMD-HPNVISLKHCFFSTTSKNELFLN 112 (314)
Q Consensus 38 ~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~----~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~ 112 (314)
+.|++...++.|+.+.||++.. .+..+++|.... ......+|+.+++.+. +..+.+++++... ....|
T Consensus 14 ~~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~-----~~~~~ 86 (263)
T 3tm0_A 14 EKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERH-----DGWSN 86 (263)
T ss_dssp TTSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEE-----TTEEE
T ss_pred ccceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEec-----CCceE
Confidence 4699999999999999999974 468899998864 3345678999998884 4556666665532 22377
Q ss_pred EEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcC----------------------------------
Q 021306 113 LVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV---------------------------------- 158 (314)
Q Consensus 113 lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~---------------------------------- 158 (314)
+|||+++|..+.... .+......++.++..++..||+.
T Consensus 87 lv~e~i~G~~l~~~~--------~~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (263)
T 3tm0_A 87 LLMSEADGVLCSEEY--------EDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW 158 (263)
T ss_dssp EEEECCSSEEHHHHC--------CTTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGG
T ss_pred EEEEecCCeehhhcc--------CCcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccc
Confidence 999999994322210 01122346677888888888871
Q ss_pred ------------------------CCceecCCCCCcEEEcCCCCcEEEeecCccc
Q 021306 159 ------------------------PRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 189 (314)
Q Consensus 159 ------------------------~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~ 189 (314)
..++|+|++|.||++++ +..+.|+||+.+.
T Consensus 159 ~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~-~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKD-GKVSGFIDLGRSG 212 (263)
T ss_dssp STTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEET-TEEEEECCCTTCE
T ss_pred cccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEEC-CcEEEEEEchhcc
Confidence 24899999999999986 5556799999875
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.12 E-value=4.3e-10 Score=94.65 Aligned_cols=133 Identities=15% Similarity=0.067 Sum_probs=89.7
Q ss_pred CCceeeeeEeecCceEEEEEEECCCCcEEEEEEeecc-ccchHHHHHHHHhCCCCce--eeeceeeeecCCCCceeEEEE
Q 021306 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-RRYKNRELQLMRVMDHPNV--ISLKHCFFSTTSKNELFLNLV 114 (314)
Q Consensus 38 ~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~-~~~~~~e~~~l~~l~h~~i--v~~~~~~~~~~~~~~~~~~lv 114 (314)
..|.+....+.|..+.||++. ..+|..+++|..... .....+|+.+++.+.+.++ .+++.+.... ...++|
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~-~~~g~~~vlK~~~~~~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~-----~~~~~v 93 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLS-AQGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVTEA-----GRDWLL 93 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEE-CTTSCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEEECS-----SCEEEE
T ss_pred CCCceEecccCCCCceEEEEe-cCCCCeEEEEeCCcccchhhhHHHHHHHHHHhCCCCCCeEEEeccCC-----CCCEEE
Confidence 356665554556679999997 456788999987654 2345689998888865443 3455544221 236799
Q ss_pred eecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCC----------------------------------
Q 021306 115 MEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR---------------------------------- 160 (314)
Q Consensus 115 ~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~---------------------------------- 160 (314)
|||++|..+. . ...+. ..++.+++..+..||+ ..
T Consensus 94 ~e~i~G~~l~-~-------~~~~~---~~~~~~l~~~l~~lh~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (264)
T 1nd4_A 94 LGEVPGQDLL-S-------SHLAP---AEKVSIMADAMRRLHT-LDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEE 161 (264)
T ss_dssp EECCSSEETT-T-------SCCCH---HHHHHHHHHHHHHHTT-SCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGG
T ss_pred EEecCCcccC-c-------CcCCH---hHHHHHHHHHHHHHhC-CCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhh
Confidence 9999985222 1 11121 2455677777777776 32
Q ss_pred ------------------------ceecCCCCCcEEEcCCCCcEEEeecCccc
Q 021306 161 ------------------------VCHRDLKPQNLLVDPLTHQVKICDFGSAK 189 (314)
Q Consensus 161 ------------------------i~h~dl~p~Nil~~~~~~~~~l~dfg~~~ 189 (314)
++|+|++|.||++++ +..+.|+||+.+.
T Consensus 162 ~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~-~~~~~liD~~~a~ 213 (264)
T 1nd4_A 162 HQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVEN-GRFSGFIDCGRLG 213 (264)
T ss_dssp GTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEET-TEEEEECCCTTCE
T ss_pred ccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEEC-CcEEEEEcchhcc
Confidence 999999999999986 5556699999875
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.00 E-value=1.1e-09 Score=97.06 Aligned_cols=141 Identities=16% Similarity=0.174 Sum_probs=98.2
Q ss_pred eeeeeEeecCceEEEEEEECCCCcEEEEEEee--cc-----ccchHHHHHHHHhCCCC--ceeeeceeeeecCCCCceeE
Q 021306 41 MAERVVGTGSFGIVFQAKCLETGETVAIKKVL--QD-----RRYKNRELQLMRVMDHP--NVISLKHCFFSTTSKNELFL 111 (314)
Q Consensus 41 ~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~--~~-----~~~~~~e~~~l~~l~h~--~iv~~~~~~~~~~~~~~~~~ 111 (314)
..++.|+.|.++.||++.. .+..+++|+.. .. .....+|..+++.+... .+.+++...... ...+..
T Consensus 41 ~~~~~l~~G~sn~~y~v~~--~~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~--~~~g~~ 116 (359)
T 3dxp_A 41 LSVEQFKGGQSNPTFKLVT--PGQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDE--SVIGRA 116 (359)
T ss_dssp CEEEECCC-CCSCEEEEEC--SSCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCT--TTTSSC
T ss_pred ceEEEcCCcccceEEEEEE--CCceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCC--CccCCe
Confidence 3567889999999999985 34678899776 22 33557899999988743 345555544222 111335
Q ss_pred EEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcC---------------------------------
Q 021306 112 NLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV--------------------------------- 158 (314)
Q Consensus 112 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~--------------------------------- 158 (314)
|+||||++|... .. .....++..+...++.+++.+|..||+.
T Consensus 117 ~~vme~v~G~~l---~~--~~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (359)
T 3dxp_A 117 FYIMEFVSGRVL---WD--QSLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSET 191 (359)
T ss_dssp EEEEECCCCBCC---CC--TTCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCC
T ss_pred EEEEEecCCeec---CC--CccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCC
Confidence 699999998521 11 1123477888888999999999999961
Q ss_pred ------------------------CCceecCCCCCcEEEcCCCC-cEEEeecCcccc
Q 021306 159 ------------------------PRVCHRDLKPQNLLVDPLTH-QVKICDFGSAKQ 190 (314)
Q Consensus 159 ------------------------~~i~h~dl~p~Nil~~~~~~-~~~l~dfg~~~~ 190 (314)
..++|||++|.||+++.++. .+.++||+.+..
T Consensus 192 ~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 192 ESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp SCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred cCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 36899999999999987332 368999998863
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.91 E-value=1.7e-09 Score=93.53 Aligned_cols=187 Identities=14% Similarity=0.186 Sum_probs=109.7
Q ss_pred eeeEeecCceEEEEEEECCCCcEEEEEEeecc--ccchHHHHHHHHhCCCCceeeeceeeeec-CCCCceeEEEEeeccc
Q 021306 43 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQD--RRYKNRELQLMRVMDHPNVISLKHCFFST-TSKNELFLNLVMEYVP 119 (314)
Q Consensus 43 ~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~~~~~~lv~e~~~ 119 (314)
++.++.|....||++. ..+++|..... .....+|..+++.+....-++........ ........|+||++++
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~ 99 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKHSRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIK 99 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESSHHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCC
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCCcchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccC
Confidence 4558999999999874 46899976543 23456889998887432212222222111 1111123468899999
Q ss_pred cc-HHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcC----------------------------------------
Q 021306 120 ES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV---------------------------------------- 158 (314)
Q Consensus 120 ~~-l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~---------------------------------------- 158 (314)
|. +..... ..++.++...++.|++..+..||+.
T Consensus 100 G~~l~~~~~------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 173 (304)
T 3sg8_A 100 GVPLTPLLL------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV 173 (304)
T ss_dssp CEECCHHHH------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred CeECCcccc------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence 84 222111 2456666677777777777777640
Q ss_pred -----------------CCceecCCCCCcEEEcCC-CCcEEEeecCcccccccCCccccccccc-cccccccc----c--
Q 021306 159 -----------------PRVCHRDLKPQNLLVDPL-THQVKICDFGSAKQLIAGEANISYICSR-FYRAPELI----F-- 213 (314)
Q Consensus 159 -----------------~~i~h~dl~p~Nil~~~~-~~~~~l~dfg~~~~~~~~~~~~~~~~~~-~y~aPE~~----~-- 213 (314)
..++|+|++|.||+++.+ ...+.++||+.+..... .......... .-..|+.. .
T Consensus 174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~-~~Dl~~~~~~~~~~~~~~~~~~l~~Y 252 (304)
T 3sg8_A 174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDP-DNDFISLMEDDEEYGMEFVSKILNHY 252 (304)
T ss_dssp HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECT-THHHHTTCCTTTSCCHHHHHHHHHHH
T ss_pred HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCCh-HHHHHHHHhhccccCHHHHHHHHHHc
Confidence 247999999999999874 34578999998764311 1100000000 00111111 0
Q ss_pred CCC-------CCCcchhHHHHHHHHHHHHhCCCCC
Q 021306 214 GAT-------EYTTSIDIWSAGCVLAELLLGQPLF 241 (314)
Q Consensus 214 ~~~-------~~~~~~Dv~slG~il~el~tg~~pf 241 (314)
+.. ....-.+.|+++.++|.+.+|..+|
T Consensus 253 ~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 253 KHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp TCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred CCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 000 0122368999999999999998776
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.55 E-value=8.3e-07 Score=76.63 Aligned_cols=73 Identities=10% Similarity=0.054 Sum_probs=45.3
Q ss_pred eeeEeecCceEEEEEEECCCCcEEEEEEeecc--ccchHHHHHHHHhCCCCceeeeceeeeecCCCCceeEEEEeecccc
Q 021306 43 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQD--RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE 120 (314)
Q Consensus 43 ~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~ 120 (314)
++.++.|....||++ +..+++|+.... .....+|..+++.+.+..-+++........ ...+..+++||+++|
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~-~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPKSQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGK-RSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEESSHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEE-CTTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecCCchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecc-cCCCceEEEEeccCC
Confidence 456788888999988 467889975432 234568999999987532222222211111 112235699999998
Q ss_pred c
Q 021306 121 S 121 (314)
Q Consensus 121 ~ 121 (314)
.
T Consensus 98 ~ 98 (306)
T 3tdw_A 98 Q 98 (306)
T ss_dssp E
T ss_pred e
Confidence 4
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.22 E-value=1.3e-05 Score=67.49 Aligned_cols=131 Identities=15% Similarity=0.136 Sum_probs=79.4
Q ss_pred eEeecCce-EEEEEEECCCCcEEEEEEeeccc-cchHHHHHHHHhCCC-CceeeeceeeeecCCCCceeEEEEeeccccc
Q 021306 45 VVGTGSFG-IVFQAKCLETGETVAIKKVLQDR-RYKNRELQLMRVMDH-PNVISLKHCFFSTTSKNELFLNLVMEYVPES 121 (314)
Q Consensus 45 ~Lg~g~~g-~Vy~~~~~~~~~~~~vK~~~~~~-~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~~ 121 (314)
.+..|..+ .||+......+..+++|...... ....+|...++.+.. --+.+++.+.... ...++|||+++|.
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~-----~~~~lvme~l~G~ 105 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGSVANDVTDEMVRLNWLTAFMPLPTIKHFIRTP-----DDAWLLTTAIPGK 105 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETHHHHHHHHHHHHHHHHTTTSCCCCEEEEEEET-----TEEEEEEECCCSE
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCCCHhHHHHHHHHHHHhccCCCcCeEEEEEEEC-----CeEEEEEEeeCCc
Confidence 34445444 68999877778889999876432 334678888887742 1133343333222 2367999999983
Q ss_pred -HHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcC------------------------------------------
Q 021306 122 -MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV------------------------------------------ 158 (314)
Q Consensus 122 -l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~------------------------------------------ 158 (314)
+.+.... .......+..++...+..||..
T Consensus 106 ~~~~~~~~--------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (272)
T 4gkh_A 106 TAFQVLEE--------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVE 177 (272)
T ss_dssp EHHHHHHH--------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHH
T ss_pred cccccccC--------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHH
Confidence 3332211 0111223334444444444420
Q ss_pred ---------------CCceecCCCCCcEEEcCCCCcEEEeecCccc
Q 021306 159 ---------------PRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 189 (314)
Q Consensus 159 ---------------~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~ 189 (314)
..++|+|+++.||++++ ++.+-|+||+.+.
T Consensus 178 ~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~-~~~~~viDwe~a~ 222 (272)
T 4gkh_A 178 QVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDE-GKLIGCIDVGRVG 222 (272)
T ss_dssp HHHHHHHTTCCCCCCEEEECSCCCTTSEEEET-TEEEEECCCTTCE
T ss_pred HHHHHHHhcccccCCcEEEcCCCCCCeEEEEC-CeEEEEEECcccc
Confidence 12789999999999987 5666799999875
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.11 E-value=1e-05 Score=70.50 Aligned_cols=30 Identities=27% Similarity=0.589 Sum_probs=26.6
Q ss_pred CCceecCCCCCcEEEcCCCCcEEEeecCccc
Q 021306 159 PRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 189 (314)
Q Consensus 159 ~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~ 189 (314)
..++|||+++.||+++. ++.+.++||+.+.
T Consensus 222 ~~l~HgD~~~~Nil~~~-~~~~~lIDfe~a~ 251 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGE-NEQIWVIDLDTVS 251 (346)
T ss_dssp CCEECSSCSTTSEEECG-GGCEEECCCTTCE
T ss_pred CceecCCCCcccEEEeC-CCcEEEEehhhcc
Confidence 68999999999999976 5679999999874
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.11 E-value=9.9e-06 Score=71.23 Aligned_cols=78 Identities=12% Similarity=0.081 Sum_probs=48.0
Q ss_pred eeeeeE-eecCceEEEEEEEC--C----CCcEEEEEEeeccc-------cchHHHHHHHHhCCC---Cceeeeceeeeec
Q 021306 41 MAERVV-GTGSFGIVFQAKCL--E----TGETVAIKKVLQDR-------RYKNRELQLMRVMDH---PNVISLKHCFFST 103 (314)
Q Consensus 41 ~~~~~L-g~g~~g~Vy~~~~~--~----~~~~~~vK~~~~~~-------~~~~~e~~~l~~l~h---~~iv~~~~~~~~~ 103 (314)
...+.| +.|..+.+|++... . ++..+++|...... ....+|..+++.+.. -.+.+++......
T Consensus 23 ~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~ 102 (357)
T 3ats_A 23 TVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTG 102 (357)
T ss_dssp EEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSS
T ss_pred EEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCC
Confidence 345677 77888999998753 0 26789999775433 345788888887742 2344444433211
Q ss_pred CCCCceeEEEEeecccc
Q 021306 104 TSKNELFLNLVMEYVPE 120 (314)
Q Consensus 104 ~~~~~~~~~lv~e~~~~ 120 (314)
......++|||+++|
T Consensus 103 --~~~g~~~~v~e~l~G 117 (357)
T 3ats_A 103 --DVLGTPFFLMDYVEG 117 (357)
T ss_dssp --TTTSSCEEEEECCCC
T ss_pred --CccCCceEEEEecCC
Confidence 111234689999987
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.05 E-value=2.8e-05 Score=69.43 Aligned_cols=72 Identities=18% Similarity=0.192 Sum_probs=44.0
Q ss_pred eeeeEeecCceEEEEEEECCCCcEEEEEEeeccc-----------cchHHHHHHHHhCCC--Ccee-eeceeeeecCCCC
Q 021306 42 AERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----------RYKNRELQLMRVMDH--PNVI-SLKHCFFSTTSKN 107 (314)
Q Consensus 42 ~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~-----------~~~~~e~~~l~~l~h--~~iv-~~~~~~~~~~~~~ 107 (314)
-.+.||.|..+.||++....+++.+++|...... .....|..+++.+.. +..+ +++. .+...
T Consensus 34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~--~d~~~-- 109 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFY--SDTEM-- 109 (397)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEE--EETTT--
T ss_pred EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEE--EcCCc--
Confidence 4568899999999999765567889999754321 123568888877632 3333 3322 22211
Q ss_pred ceeEEEEeecccc
Q 021306 108 ELFLNLVMEYVPE 120 (314)
Q Consensus 108 ~~~~~lv~e~~~~ 120 (314)
.++|||+++|
T Consensus 110 ---~~lvmE~l~g 119 (397)
T 2olc_A 110 ---AVTVMEDLSH 119 (397)
T ss_dssp ---TEEEECCCTT
T ss_pred ---cEEEEEeCCC
Confidence 3589999986
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.71 E-value=0.00018 Score=61.65 Aligned_cols=65 Identities=15% Similarity=0.128 Sum_probs=40.7
Q ss_pred eeeEeecCceEEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHhCCCCcee-eeceeeeecCCCCceeEEEEeecc
Q 021306 43 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMDHPNVI-SLKHCFFSTTSKNELFLNLVMEYV 118 (314)
Q Consensus 43 ~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~---~~~~~e~~~l~~l~h~~iv-~~~~~~~~~~~~~~~~~~lv~e~~ 118 (314)
.+.|+.|....+|++ ..+++|...... ....+|..+++.+....+. +++.. . .+. -++++||+
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~--~---~~~--~~~v~e~i 89 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHV--D---PAT--GVMVTRYI 89 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEE--C---TTT--CCEEEECC
T ss_pred eeEcCCcccccccee------eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEE--E---CCC--CEEEEeec
Confidence 788888999999999 468999876432 2235788777776433333 33222 1 111 23889999
Q ss_pred -cc
Q 021306 119 -PE 120 (314)
Q Consensus 119 -~~ 120 (314)
+|
T Consensus 90 ~~g 92 (301)
T 3dxq_A 90 AGA 92 (301)
T ss_dssp TTC
T ss_pred CCC
Confidence 65
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.48 E-value=0.0026 Score=53.85 Aligned_cols=75 Identities=16% Similarity=0.101 Sum_probs=50.6
Q ss_pred CceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeEEEE
Q 021306 39 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLV 114 (314)
Q Consensus 39 ~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 114 (314)
+..-++.+|.|..+.||++. ..+|+.+++|...... .....|+..|+.|....-+++..++... . -+++
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~-l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~-~-----~~lv 88 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVE-LADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD-D-----RTLA 88 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEE-ETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE-T-----TEEE
T ss_pred CeEEEEecCCCCCeEEEEEE-ECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc-C-----ceEE
Confidence 45678889999999999998 5688999999765432 2357899988888533223332222211 1 2488
Q ss_pred eecccc
Q 021306 115 MEYVPE 120 (314)
Q Consensus 115 ~e~~~~ 120 (314)
|||+.+
T Consensus 89 ~e~l~~ 94 (288)
T 3f7w_A 89 MEWVDE 94 (288)
T ss_dssp EECCCC
T ss_pred EEeecc
Confidence 999874
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.34 E-value=0.0011 Score=59.44 Aligned_cols=79 Identities=13% Similarity=-0.041 Sum_probs=46.7
Q ss_pred hcCCCceecCCCCCcEEEcCCCCcEEEeecCcccccccCCcccccc--ccccccccccccCCC--CCCcchhHHHHHHHH
Q 021306 156 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYI--CSRFYRAPELIFGAT--EYTTSIDIWSAGCVL 231 (314)
Q Consensus 156 H~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~--~~~~y~aPE~~~~~~--~~~~~~Dv~slG~il 231 (314)
+. ..++|||++|.||+++. ++ +.++||+.+..-.......... ....|.+|+...... ......++.++...+
T Consensus 230 ~~-~~liHGDl~~~Nil~~~-~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (420)
T 2pyw_A 230 RA-QALIHGDLHTGSVMVTQ-DS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQT 306 (420)
T ss_dssp BC-CEEECSCCSGGGEEECS-SC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHH
T ss_pred CC-CeEEecCCCCCcEEEeC-CC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHH
Confidence 45 78999999999999987 44 9999999886432111000111 123355665542111 112334556777777
Q ss_pred HHHHhC
Q 021306 232 AELLLG 237 (314)
Q Consensus 232 ~el~tg 237 (314)
|+.+++
T Consensus 307 ~~~y~~ 312 (420)
T 2pyw_A 307 WNLFNK 312 (420)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 777654
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.33 E-value=0.0022 Score=55.11 Aligned_cols=142 Identities=12% Similarity=0.052 Sum_probs=72.5
Q ss_pred eeeeEeecCceEEEEEEECCCCcEEEEEEeec--cccchHHHHHHHHhCCCCce--eeeceeeeecCCC----CceeEEE
Q 021306 42 AERVVGTGSFGIVFQAKCLETGETVAIKKVLQ--DRRYKNRELQLMRVMDHPNV--ISLKHCFFSTTSK----NELFLNL 113 (314)
Q Consensus 42 ~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~--~~~~~~~e~~~l~~l~h~~i--v~~~~~~~~~~~~----~~~~~~l 113 (314)
-.+.|+.|....+|++... +| .+++|.... .......|..+++.+....+ .+++.. .+.. .....++
T Consensus 26 ~~~~i~~G~~n~~~~v~~~-~g-~~vlk~~~~~~~~~~l~~e~~~l~~L~~~g~~vP~~~~~---~~g~~~~~~~g~~~~ 100 (322)
T 2ppq_A 26 SYKGIAEGVENSNFLLHTT-KD-PLILTLYEKRVEKNDLPFFLGLMQHLAAKGLSCPLPLPR---KDGELLGELSGRPAA 100 (322)
T ss_dssp EEEEECC---EEEEEEEES-SC-CEEEEEECC---CCHHHHHHHHHHHHHHTTCCCCCBCCB---TTCCSCEEETTEEEE
T ss_pred EeeccCCCcccceEEEEeC-Cc-cEEEEEeCCCCCHHHHHHHHHHHHHHHHCCCCCCcccCC---CCCCEEEEECCEEEE
Confidence 4566777888899999853 33 688998875 33444567777766632222 222211 0000 0123578
Q ss_pred EeecccccH------------HHH---HHhhhhc-CCC----CCHHHHHHH---------------HHHHHHHHHHhhc-
Q 021306 114 VMEYVPESM------------YRV---LKHYSSA-NQR----MPLIYVKLY---------------TYQIFRGLAYIHT- 157 (314)
Q Consensus 114 v~e~~~~~l------------~~~---l~~~~~~-~~~----l~~~~~~~i---------------~~ql~~~l~~LH~- 157 (314)
++++++|.. ... +...... ..+ ......... ...+...+..+..
T Consensus 101 l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~ 180 (322)
T 2ppq_A 101 LISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAH 180 (322)
T ss_dssp EEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHH
T ss_pred EEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhh
Confidence 999998731 011 1111000 000 111110000 0012233334431
Q ss_pred -----CCCceecCCCCCcEEEcCCCCcEEEeecCccc
Q 021306 158 -----VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 189 (314)
Q Consensus 158 -----~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~ 189 (314)
..+++|+|+++.||+++. +..+.++||+.+.
T Consensus 181 ~~~~~~~~liHgDl~~~Nil~~~-~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 181 WPKDLPAGVIHADLFQDNVFFLG-DELSGLIDFYFAC 216 (322)
T ss_dssp CCCSSCEEEECSCCCGGGEEEET-TEEEEECCCTTCE
T ss_pred CcccCCcccCCCCCCccCEEEeC-CceEEEecchhcc
Confidence 147999999999999986 5445799999875
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.26 E-value=0.0054 Score=55.65 Aligned_cols=70 Identities=14% Similarity=0.236 Sum_probs=45.3
Q ss_pred eeeeEeecCceEEEEEEECCCCcEEEEEEeecccc---chHHHHHHHHhCCCCcee-eeceeeeecCCCCceeEEEEeec
Q 021306 42 AERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR---YKNRELQLMRVMDHPNVI-SLKHCFFSTTSKNELFLNLVMEY 117 (314)
Q Consensus 42 ~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~~---~~~~e~~~l~~l~h~~iv-~~~~~~~~~~~~~~~~~~lv~e~ 117 (314)
-.+.|+.|-...+|++.....+..+++|+...... ...+|..+++.+...++. ++++.+ .. +.|+||
T Consensus 112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~-----~~----G~v~e~ 182 (458)
T 2qg7_A 112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFF-----TN----GRIEEF 182 (458)
T ss_dssp EEEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEE-----TT----EEEEEC
T ss_pred EEEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEe-----CC----eEEEEe
Confidence 45677888889999998654357899998754322 225889989888755554 344433 11 258999
Q ss_pred ccc
Q 021306 118 VPE 120 (314)
Q Consensus 118 ~~~ 120 (314)
++|
T Consensus 183 I~G 185 (458)
T 2qg7_A 183 MDG 185 (458)
T ss_dssp CCS
T ss_pred eCC
Confidence 986
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.20 E-value=0.0024 Score=55.32 Aligned_cols=32 Identities=41% Similarity=0.476 Sum_probs=27.1
Q ss_pred CCceecCCCCCcEEEcCC---CCcEEEeecCcccc
Q 021306 159 PRVCHRDLKPQNLLVDPL---THQVKICDFGSAKQ 190 (314)
Q Consensus 159 ~~i~h~dl~p~Nil~~~~---~~~~~l~dfg~~~~ 190 (314)
..++|||+++.||+++.+ ...+.++||+.+..
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 589999999999999862 15799999998863
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.18 E-value=0.0024 Score=56.42 Aligned_cols=139 Identities=14% Similarity=0.192 Sum_probs=77.2
Q ss_pred eeeEeecCceEEEEEEECC-------CCcEEEEEEeecc---ccchHHHHHHHHhCCCCce-eeeceeeeecCCCCceeE
Q 021306 43 ERVVGTGSFGIVFQAKCLE-------TGETVAIKKVLQD---RRYKNRELQLMRVMDHPNV-ISLKHCFFSTTSKNELFL 111 (314)
Q Consensus 43 ~~~Lg~g~~g~Vy~~~~~~-------~~~~~~vK~~~~~---~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~~~~~ 111 (314)
++.|..|-...+|++.... +++.+++|..... .....+|..+++.+....+ .++++.+ .+
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~-----~~---- 125 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVF-----PE---- 125 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEE-----TT----
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEc-----CC----
Confidence 3566668888999998532 3578999986432 2333578888877743333 3343333 22
Q ss_pred EEEeecccccH---------------HHHHHhhhhc----CCCC--CHHHHHHHHHHHHH-------------------H
Q 021306 112 NLVMEYVPESM---------------YRVLKHYSSA----NQRM--PLIYVKLYTYQIFR-------------------G 151 (314)
Q Consensus 112 ~lv~e~~~~~l---------------~~~l~~~~~~----~~~l--~~~~~~~i~~ql~~-------------------~ 151 (314)
.+|+||++|.. .+.|...... .... -..++..|+.++-. .
T Consensus 126 g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~ 205 (379)
T 3feg_A 126 GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDE 205 (379)
T ss_dssp EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHH
T ss_pred ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHH
Confidence 28899998621 1111111111 1112 23556666655422 1
Q ss_pred HHH----hhc---CCCceecCCCCCcEEEcCC---CCcEEEeecCcccc
Q 021306 152 LAY----IHT---VPRVCHRDLKPQNLLVDPL---THQVKICDFGSAKQ 190 (314)
Q Consensus 152 l~~----LH~---~~~i~h~dl~p~Nil~~~~---~~~~~l~dfg~~~~ 190 (314)
+.. |.. ...++|+|+.+.||+++.+ .+.+.++||..+..
T Consensus 206 ~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 206 MGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 222 221 1368999999999999873 26799999998863
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.10 E-value=0.0036 Score=53.79 Aligned_cols=73 Identities=14% Similarity=0.031 Sum_probs=49.4
Q ss_pred eeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc-cchHHHHHHHHhCCC---CceeeeceeeeecCCCCceeEEEEee
Q 021306 41 MAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-RYKNRELQLMRVMDH---PNVISLKHCFFSTTSKNELFLNLVME 116 (314)
Q Consensus 41 ~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~-~~~~~e~~~l~~l~h---~~iv~~~~~~~~~~~~~~~~~~lv~e 116 (314)
.-.+.|+.|....+|++.. ++..+++|...... .....|+..++.+.. ..+.+++..... ....++|||
T Consensus 39 ~~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~-----~g~~~lvme 111 (312)
T 3jr1_A 39 KHKEKLYSGEMNEIWLIND--EVQTVFVKINERSYRSMFRAEADQLALLAKTNSINVPLVYGIGNS-----QGHSFLLLE 111 (312)
T ss_dssp CEEEEECCSSSSEEEEEES--SSCEEEEEEEEGGGHHHHHHHHHHHHHHHHTTSSBCCCEEEEEEC-----SSEEEEEEE
T ss_pred eeeEEeCCccceeeeEEEE--CCCeEEEEeCCcccHHHHHHHHHHHHHHHhhCCCCcceEEEEeec-----CCceEEEEE
Confidence 3457789999999999984 56788999876542 335678888877732 334444443321 123679999
Q ss_pred cccc
Q 021306 117 YVPE 120 (314)
Q Consensus 117 ~~~~ 120 (314)
+++|
T Consensus 112 ~l~G 115 (312)
T 3jr1_A 112 ALNK 115 (312)
T ss_dssp CCCC
T ss_pred eccC
Confidence 9986
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.10 E-value=0.0034 Score=56.50 Aligned_cols=70 Identities=14% Similarity=0.238 Sum_probs=45.4
Q ss_pred eeeeEeecCceEEEEEEECC-------CCcEEEEEEeec-cc-cchHHHHHHHHhCCCCce-eeeceeeeecCCCCceeE
Q 021306 42 AERVVGTGSFGIVFQAKCLE-------TGETVAIKKVLQ-DR-RYKNRELQLMRVMDHPNV-ISLKHCFFSTTSKNELFL 111 (314)
Q Consensus 42 ~~~~Lg~g~~g~Vy~~~~~~-------~~~~~~vK~~~~-~~-~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~~~~~ 111 (314)
-++.|+.|....+|++.... ++..+++|+... .. ....+|..+++.+...++ .++++.+ .+
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~~~~li~E~~~l~~L~~~g~~P~l~~~~-----~~---- 147 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIF-----SG---- 147 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEE-----TT----
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCcHHHHHHHHHHHHHHHhCCCCCcEEEEe-----CC----
Confidence 45677888889999998642 257899998844 22 334468888877744344 3444433 21
Q ss_pred EEEeecccc
Q 021306 112 NLVMEYVPE 120 (314)
Q Consensus 112 ~lv~e~~~~ 120 (314)
++|+||++|
T Consensus 148 g~v~e~l~G 156 (429)
T 1nw1_A 148 GRLEEYIPS 156 (429)
T ss_dssp EEEECCCCE
T ss_pred CEEEEEeCC
Confidence 278899876
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.03 E-value=0.0042 Score=53.51 Aligned_cols=73 Identities=14% Similarity=0.031 Sum_probs=42.1
Q ss_pred eeEeecCceEEEEEEECCCCcEEEEEEeecc---ccchHHHHHHHHhCCCCc--eeeeceeeeecCC--CCceeEEEEee
Q 021306 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQD---RRYKNRELQLMRVMDHPN--VISLKHCFFSTTS--KNELFLNLVME 116 (314)
Q Consensus 44 ~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~---~~~~~~e~~~l~~l~h~~--iv~~~~~~~~~~~--~~~~~~~lv~e 116 (314)
..|+ |....||++.. .+|+.+++|..... ......|..+++.+.... +++++.. .... ...+..+++++
T Consensus 32 ~~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~--~g~~~~~~~g~~~~l~~ 107 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQD-EDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAF--NGQTLLNHQGFYFAVFP 107 (328)
T ss_dssp EEEC-CSSSEEEEECC-TTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCB--TTBSCEEETTEEEEEEE
T ss_pred Eeec-CcccceEEEEc-CCCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceeec--CCcEEEEECCEEEEEEE
Confidence 4556 77889998863 45678999988633 233456777777664222 2233221 1000 01223568999
Q ss_pred cccc
Q 021306 117 YVPE 120 (314)
Q Consensus 117 ~~~~ 120 (314)
+++|
T Consensus 108 ~i~G 111 (328)
T 1zyl_A 108 SVGG 111 (328)
T ss_dssp CCCC
T ss_pred ecCC
Confidence 9987
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.97 E-value=0.0032 Score=54.79 Aligned_cols=31 Identities=26% Similarity=0.473 Sum_probs=26.7
Q ss_pred CCceecCCCCCcEEEcCCCCcEEEeecCcccc
Q 021306 159 PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 190 (314)
Q Consensus 159 ~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~ 190 (314)
..++|+|+.+.||+++. ++.+.++||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~-~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGN-EESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECG-GGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeC-CCeEEEEECCCCee
Confidence 47999999999999986 56799999987753
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.97 E-value=0.0067 Score=48.81 Aligned_cols=151 Identities=13% Similarity=0.012 Sum_probs=87.0
Q ss_pred cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcccccccCCccccc
Q 021306 121 SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISY 200 (314)
Q Consensus 121 ~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~ 200 (314)
+|.+.|..+ +.+++++++|.++.|.+.+|..+-..+.-...=+.|..|++.. +|.|.+.+ +.+.
T Consensus 34 SL~eIL~~~---~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~-dG~V~f~~-~~s~----------- 97 (229)
T 2yle_A 34 SLEEILRLY---NQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWR-DGAVTLAP-AADD----------- 97 (229)
T ss_dssp EHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEET-TSCEEECC-C--------------
T ss_pred cHHHHHHHc---CCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEec-CCceeccc-cccc-----------
Confidence 688888764 6899999999999999999888621011112334568888887 66666553 1110
Q ss_pred cccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCC-CCCCChHHHHHHHHHHcCCCCHH------HHh-------
Q 021306 201 ICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL-FPGENAVDQLVEIIKVLGTPTRE------EIR------- 266 (314)
Q Consensus 201 ~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~p-f~~~~~~~~~~~i~~~~~~~~~~------~~~------- 266 (314)
.....+.+||... ...+.+.-|||||+++|..+--..| -....-.+.+..++........+ -+.
T Consensus 98 ~~~~~~~~pe~~~--~~~te~~~IysLG~tLY~ALDygL~e~eE~eLS~~LE~LL~~Mt~~~~d~~~~DeG~~~~~eg~~ 175 (229)
T 2yle_A 98 AGEPPPVAGKLGY--SQCMETEVIESLGIIIYKALDYGLKENEERELSPPLEQLIDHMANTVEADGSNDEGYEAAEEGLG 175 (229)
T ss_dssp ---------CCSS--SSSCHHHHHHHHHHHHHHHHTTTCCTTEEECCCHHHHHHHHHHTTCCC-----------------
T ss_pred ccccCCCChhhcc--ccchHHHHHHHHHHHHHHHhhcCCCcccchhhCHHHHHHHHHHHhcccccccccccccccccccc
Confidence 1122366888763 3357888999999999999974433 33323233444444332211100 000
Q ss_pred ----ccCCCCCCCcccccccCChhhhhc
Q 021306 267 ----CMNPNYTDFRFPQIKAHPWHKVCI 290 (314)
Q Consensus 267 ----~~~p~~~~~~~~~l~~~p~~~~~~ 290 (314)
.-.+ ..+.+++++++.|-.+...
T Consensus 176 d~~~~~~~-~~~~sl~~Vi~~C~~hl~~ 202 (229)
T 2yle_A 176 DEDEKRKI-SAIRSYRDVMKLCAAHLPT 202 (229)
T ss_dssp ---CCSCC-CCCCSHHHHHHHHHTTSSS
T ss_pred cccccccc-cCcCCHHHHHHHHHhhccC
Confidence 0112 2577888888888776663
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.77 E-value=0.004 Score=54.77 Aligned_cols=70 Identities=13% Similarity=0.125 Sum_probs=40.7
Q ss_pred eeeeEeecCceEEEEEEECC--------CCcEEEEEEeeccccc---hHHHHHHHHhCCCCce-eeeceeeeecCCCCce
Q 021306 42 AERVVGTGSFGIVFQAKCLE--------TGETVAIKKVLQDRRY---KNRELQLMRVMDHPNV-ISLKHCFFSTTSKNEL 109 (314)
Q Consensus 42 ~~~~Lg~g~~g~Vy~~~~~~--------~~~~~~vK~~~~~~~~---~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~~~ 109 (314)
-.+.|+.|....+|++.... .+..+++|........ ...|..+++.+....+ .+++... .
T Consensus 37 ~~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~-----~--- 108 (369)
T 3c5i_A 37 RVKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKIAPQLLNTF-----N--- 108 (369)
T ss_dssp EEEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTSSCCEEEEE-----T---
T ss_pred EEEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCCCCceEEec-----C---
Confidence 34567778888999998642 1368899987543322 3578888777743333 2443322 1
Q ss_pred eEEEEeecccc
Q 021306 110 FLNLVMEYVPE 120 (314)
Q Consensus 110 ~~~lv~e~~~~ 120 (314)
-++|+||++|
T Consensus 109 -~~~v~e~i~G 118 (369)
T 3c5i_A 109 -GGRIEEWLYG 118 (369)
T ss_dssp -TEEEEECCCS
T ss_pred -CcEEEEEecC
Confidence 1478999986
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.97 E-value=0.057 Score=48.38 Aligned_cols=70 Identities=11% Similarity=0.162 Sum_probs=44.7
Q ss_pred eeeeEeecCceEEEEEEECCC-------CcEEEEEEeecccc---chHHHHHHHHhCCCCcee-eeceeeeecCCCCcee
Q 021306 42 AERVVGTGSFGIVFQAKCLET-------GETVAIKKVLQDRR---YKNRELQLMRVMDHPNVI-SLKHCFFSTTSKNELF 110 (314)
Q Consensus 42 ~~~~Lg~g~~g~Vy~~~~~~~-------~~~~~vK~~~~~~~---~~~~e~~~l~~l~h~~iv-~~~~~~~~~~~~~~~~ 110 (314)
-++.|..|-...+|++..... +..+++|....... ...+|..+++.+....++ ++++.+ .
T Consensus 74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi~P~l~~~~-----~---- 144 (424)
T 3mes_A 74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINIAPNIIADF-----P---- 144 (424)
T ss_dssp EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTSSCCEEEEE-----T----
T ss_pred EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCCCCCEEEEc-----C----
Confidence 445666688889999986421 57899998754322 235788888887533333 333322 1
Q ss_pred EEEEeecccc
Q 021306 111 LNLVMEYVPE 120 (314)
Q Consensus 111 ~~lv~e~~~~ 120 (314)
-+.|+||++|
T Consensus 145 ~~~I~efI~G 154 (424)
T 3mes_A 145 EGRIEEFIDG 154 (424)
T ss_dssp TEEEEECCCS
T ss_pred CCEEEEEeCC
Confidence 2478999987
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=83.09 E-value=0.56 Score=41.47 Aligned_cols=31 Identities=23% Similarity=0.405 Sum_probs=25.3
Q ss_pred CceecCCCCCcEEEcC-----CCCcEEEeecCcccc
Q 021306 160 RVCHRDLKPQNLLVDP-----LTHQVKICDFGSAKQ 190 (314)
Q Consensus 160 ~i~h~dl~p~Nil~~~-----~~~~~~l~dfg~~~~ 190 (314)
.++|+|+.+.||++.+ .+..+.++||..+..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 3679999999999932 356799999998863
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 314 | ||||
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 3e-88 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-57 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 4e-56 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 3e-55 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 6e-54 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 7e-54 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-53 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 4e-53 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 5e-53 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-52 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 9e-52 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-51 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 4e-51 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 5e-51 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-50 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 3e-50 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 3e-50 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-49 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-49 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 8e-49 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 8e-49 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 3e-48 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 8e-48 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 3e-47 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-46 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-46 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 9e-46 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-45 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-45 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 3e-45 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 5e-45 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-44 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 4e-43 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 5e-43 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-41 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 3e-41 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 3e-40 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 8e-40 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-39 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-37 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 7e-36 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 9e-36 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-35 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-35 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 3e-35 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 8e-35 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-34 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-34 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-34 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-34 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 3e-34 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 4e-34 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-33 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-32 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-31 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-31 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-31 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 3e-31 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 9e-31 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 6e-29 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 7e-29 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 4e-26 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-17 |
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 265 bits (679), Expect = 3e-88
Identities = 180/275 (65%), Positives = 227/275 (82%), Gaps = 3/275 (1%)
Query: 23 ISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNREL 82
+ T G P Q +SY +V+G GSFG+V+QAK ++GE VAIKKVLQD+R+KNREL
Sbjct: 6 VVATPGQGPDRP-QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNREL 64
Query: 83 QLMRVMDHPNVISLKHCFFST-TSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYV 141
Q+MR +DH N++ L++ F+S+ K+E++LNLV++YVPE++YRV +HYS A Q +P+IYV
Sbjct: 65 QIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYV 124
Query: 142 KLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYI 201
KLY YQ+FR LAYIH+ +CHRD+KPQNLL+DP T +K+CDFGSAKQL+ GE N+SYI
Sbjct: 125 KLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYI 183
Query: 202 CSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 261
CSR+YRAPELIFGAT+YT+SID+WSAGCVLAELLLGQP+FPG++ VDQLVEIIKVLGTPT
Sbjct: 184 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPT 243
Query: 262 REEIRCMNPNYTDFRFPQIKAHPWHKVCIFHFPKH 296
RE+IR MNPNYT+F+FPQIKAHPW KV P
Sbjct: 244 REQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPE 278
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (473), Expect = 1e-57
Identities = 65/264 (24%), Positives = 118/264 (44%), Gaps = 17/264 (6%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----RELQLMRVMDHPNVI 94
+ +G G+ G+VF+ +G +A K + + + RELQ++ + P ++
Sbjct: 8 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 67
Query: 95 SLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 154
F+S +++ ME++ L R+P + + + +GL Y
Sbjct: 68 GFYGAFYSDGE-----ISICMEHMD---GGSLDQVLKKAGRIPEQILGKVSIAVIKGLTY 119
Query: 155 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFG 214
+ ++ HRD+KP N+LV+ ++K+CDFG + QLI AN S++ +R Y +PE + G
Sbjct: 120 LREKHKIMHRDVKPSNILVNS-RGEIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG 177
Query: 215 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENA-VDQLVEIIKVLGTPTREEIRCMNPNYT 273
T Y+ DIWS G L E+ +G+ P +A +L+ +V G R P
Sbjct: 178 -THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 236
Query: 274 DFRFPQIKAHPWHKVCIFHFPKHW 297
+ P + + +
Sbjct: 237 LSSYGMDSRPPMAIFELLDYIVNE 260
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 183 bits (465), Expect = 4e-56
Identities = 64/264 (24%), Positives = 110/264 (41%), Gaps = 27/264 (10%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVL----QDRRYKNRELQLMRVMDHPNVIS 95
Y +GTG+FG+V + TG A K V+ D+ +E+Q M V+ HP +++
Sbjct: 28 YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVN 87
Query: 96 LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 155
L F NE+ + + E++ + + + + +M Y Q+ +GL ++
Sbjct: 88 LHDAF---EDDNEMVM--IYEFMSGGE--LFEKVADEHNKMSEDEAVEYMRQVCKGLCHM 140
Query: 156 HTVPRVCHRDLKPQNLLVDP-LTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFG 214
H H DLKP+N++ ++++K+ DFG L ++ + + APE+ G
Sbjct: 141 HE-NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEG 199
Query: 215 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 274
D+WS G + LL G F GEN + L + ++ + D
Sbjct: 200 -KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKD 258
Query: 275 F-----------R--FPQIKAHPW 285
F R Q HPW
Sbjct: 259 FIRKLLLADPNTRMTIHQALEHPW 282
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (453), Expect = 3e-55
Identities = 62/268 (23%), Positives = 106/268 (39%), Gaps = 27/268 (10%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVL------QDRRYKNRELQLMRVMDHPNV 93
Y +GTGS+G + + G+ + K++ +++ E+ L+R + HPN+
Sbjct: 6 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 65
Query: 94 ISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 152
+ T+ L +VMEY + V+ + Q + +V Q+ L
Sbjct: 66 VRYYDRIIDRTNTT---LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 122
Query: 153 AYIH----TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI-SYICSRFYR 207
H V HRDLKP N+ +D VK+ DFG A+ L + +++ + +Y
Sbjct: 123 KECHRRSDGGHTVLHRDLKPANVFLDG-KQNVKLGDFGLARILNHDTSFAKAFVGTPYYM 181
Query: 208 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI-- 265
+PE + Y DIWS GC+L EL P F + + +I +
Sbjct: 182 SPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSD 240
Query: 266 -------RCMNPNYTD-FRFPQIKAHPW 285
R +N +I +P
Sbjct: 241 ELNEIITRMLNLKDYHRPSVEEILENPL 268
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (446), Expect = 6e-54
Identities = 83/255 (32%), Positives = 130/255 (50%), Gaps = 20/255 (7%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---------RELQLMRVMDHPNVI 94
+G G F V++A+ T + VAIKK+ R + RE++L++ + HPN+I
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 95 SLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 154
L F ++ ++LV +++ + + + ++K Y +GL Y
Sbjct: 64 GLLDAFGHKSN-----ISLVFDFMETDL---EVIIKDNSLVLTPSHIKAYMLMTLQGLEY 115
Query: 155 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPELIF 213
+H + HRDLKP NLL+D +K+ DFG AK + ++ +R+YRAPEL+F
Sbjct: 116 LHQ-HWILHRDLKPNNLLLDE-NGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLF 173
Query: 214 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 273
GA Y +D+W+ GC+LAELLL P PG++ +DQL I + LGTPT E+ M
Sbjct: 174 GARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPD 233
Query: 274 DFRFPQIKAHPWHKV 288
F P H +
Sbjct: 234 YVTFKSFPGIPLHHI 248
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (444), Expect = 7e-54
Identities = 59/262 (22%), Positives = 112/262 (42%), Gaps = 26/262 (9%)
Query: 43 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISL 96
+ +G GSF V++ ET VA ++ + K+ E ++++ + HPN++
Sbjct: 14 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73
Query: 97 KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 156
+ + +T K + + LV E + LK Y + M + ++ + QI +GL ++H
Sbjct: 74 -YDSWESTVKGKKCIVLVTELMTSGT---LKTYLKRFKVMKIKVLRSWCRQILKGLQFLH 129
Query: 157 T-VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGA 215
T P + HRDLK N+ + T VKI D G A A A + I + + APE+
Sbjct: 130 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK-AVIGTPEFMAPEMYEE- 187
Query: 216 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI---------- 265
+Y S+D+++ G + E+ + + Q+ + P +
Sbjct: 188 -KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEII 246
Query: 266 -RCMNPNYTD-FRFPQIKAHPW 285
C+ N + + + H +
Sbjct: 247 EGCIRQNKDERYSIKDLLNHAF 268
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (447), Expect = 2e-53
Identities = 88/262 (33%), Positives = 142/262 (54%), Gaps = 19/262 (7%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV--LQDRRYKN---RELQLMRVMDHPNVI 94
Y +G G++G+V A VAIKK+ + + Y RE++++ H N+I
Sbjct: 10 YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 69
Query: 95 SLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 154
+ + T + + LV + +Y++LK Q + ++ + YQI RGL Y
Sbjct: 70 GINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKT-----QHLSNDHICYFLYQILRGLKY 124
Query: 155 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI----SYICSRFYRAPE 210
IH+ V HRDLKP NLL++ T +KICDFG A+ + Y+ +R+YRAPE
Sbjct: 125 IHS-ANVLHRDLKPSNLLLNT-TCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 182
Query: 211 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM-- 268
++ + YT SIDIWS GC+LAE+L +P+FPG++ +DQL I+ +LG+P++E++ C+
Sbjct: 183 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 242
Query: 269 -NPNYTDFRFPQIKAHPWHKVC 289
P PW+++
Sbjct: 243 LKARNYLLSLPHKNKVPWNRLF 264
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 175 bits (445), Expect = 4e-53
Identities = 61/264 (23%), Positives = 107/264 (40%), Gaps = 27/264 (10%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV----LQDRRYKNRELQLMRVMDHPNVIS 95
Y +G+G+FG+V + TG K + D+ E+ +M + HP +I+
Sbjct: 31 YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLIN 90
Query: 96 LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 155
L F K E+ L ++E++ + ++ + +M V Y Q GL ++
Sbjct: 91 LHDAF---EDKYEMVL--ILEFLSGG--ELFDRIAAEDYKMSEAEVINYMRQACEGLKHM 143
Query: 156 HTVPRVCHRDLKPQNLLVD-PLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFG 214
H + H D+KP+N++ + VKI DFG A +L E + + APE++
Sbjct: 144 HE-HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDR 202
Query: 215 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 274
D+W+ G + LL G F GE+ ++ L + + + ++P D
Sbjct: 203 -EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKD 261
Query: 275 F-------------RFPQIKAHPW 285
F HPW
Sbjct: 262 FIKNLLQKEPRKRLTVHDALEHPW 285
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (438), Expect = 5e-53
Identities = 61/266 (22%), Positives = 100/266 (37%), Gaps = 30/266 (11%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----RELQLMRVMDHPNVI 94
+ + +G G++G V A T E VA+K V R +E+ + ++++H NV+
Sbjct: 7 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 66
Query: 95 SLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 154
L +EY + MP + + +Q+ G+ Y
Sbjct: 67 KFYGHRREGN-----IQYLFLEYCSGGELF---DRIEPDIGMPEPDAQRFFHQLMAGVVY 118
Query: 155 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI---SYICSRFYRAPEL 211
+H + HRD+KP+NLL+D +KI DFG A + Y APEL
Sbjct: 119 LHG-IGITHRDIKPENLLLDE-RDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 176
Query: 212 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI------ 265
+ + +D+WS G VL +L G+ + + Q K T
Sbjct: 177 LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAP 236
Query: 266 -----RCMNPNYTD-FRFPQIKAHPW 285
+ + N + P IK W
Sbjct: 237 LALLHKILVENPSARITIPDIKKDRW 262
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (435), Expect = 2e-52
Identities = 58/269 (21%), Positives = 108/269 (40%), Gaps = 34/269 (12%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV----LQDRRYKNRELQLMRVMDHPNVIS 95
+ +G G+FG V++A+ ET A K + ++ E+ ++ DHPN++
Sbjct: 14 WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVK 73
Query: 96 LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 155
L F+ + L +++E+ + + +++ Q L Y+
Sbjct: 74 LLDAFYYENN-----LWILIEFCAGGAVD--AVMLELERPLTESQIQVVCKQTLDALNYL 126
Query: 156 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI-SYICSRFYRAPELIFG 214
H ++ HRDLK N+L +K+ DFG + + S+I + ++ APE++
Sbjct: 127 HD-NKIIHRDLKAGNILFTL-DGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMC 184
Query: 215 AT----EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI----- 265
T Y D+WS G L E+ +P N + L++I K P
Sbjct: 185 ETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAK--SEPPTLAQPSRWS 242
Query: 266 --------RCMNPNYTD-FRFPQIKAHPW 285
+C+ N + Q+ HP+
Sbjct: 243 SNFKDFLKKCLEKNVDARWTTSQLLQHPF 271
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 170 bits (433), Expect = 9e-52
Identities = 68/266 (25%), Positives = 112/266 (42%), Gaps = 33/266 (12%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-------RELQLMRVMDHPN 92
+ R +G GSFG V+ A+ + E VAIKK+ + N +E++ ++ + HPN
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 93 VISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 152
I + C+ E LVMEY S + + + + T+ +GL
Sbjct: 77 TIQYRGCYL-----REHTAWLVMEYCLGSA---SDLLEVHKKPLQEVEIAAVTHGALQGL 128
Query: 153 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELI 212
AY+H+ + HRD+K N+L+ VK+ DFGSA + S++ + ++ APE+I
Sbjct: 129 AYLHS-HNMIHRDVKAGNILLSE-PGLVKLGDFGSASIM---APANSFVGTPYWMAPEVI 183
Query: 213 FGATE--YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI----- 265
E Y +D+WS G EL +P NA+ L I + +
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYF 243
Query: 266 -----RCMNPNYTD-FRFPQIKAHPW 285
C+ D + H +
Sbjct: 244 RNFVDSCLQKIPQDRPTSEVLLKHRF 269
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (432), Expect = 2e-51
Identities = 60/264 (22%), Positives = 108/264 (40%), Gaps = 27/264 (10%)
Query: 43 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLM-RVMDHPNVISLKHCFF 101
+V+G G G V Q T E A+ K+LQD RE++L R P+++ + +
Sbjct: 17 SQVLGLGINGKVLQIFNKRTQEKFAL-KMLQDCPKARREVELHWRASQCPHIVRIVDVYE 75
Query: 102 STTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR 160
+ + + L +VME + ++ ++ +Q I + Y+H++
Sbjct: 76 NLYAGRK-CLLIVMECLDGGELFSRIQDRG--DQAFTEREASEIMKSIGEAIQYLHSI-N 131
Query: 161 VCHRDLKPQNLLVDPLTHQ--VKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEY 218
+ HRD+KP+NLL +K+ DFG AK+ + + + + +Y APE++ +Y
Sbjct: 132 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGP-EKY 190
Query: 219 TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI------------- 265
S D+WS G ++ LL G P F + + + + E
Sbjct: 191 DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKM 250
Query: 266 ---RCMNPNYTD-FRFPQIKAHPW 285
+ T + HPW
Sbjct: 251 LIRNLLKTEPTQRMTITEFMNHPW 274
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (428), Expect = 4e-51
Identities = 68/261 (26%), Positives = 125/261 (47%), Gaps = 19/261 (7%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNV 93
Y +G G+FG VF+A+ +TG+ VA+KKVL + + RE+++++++ H NV
Sbjct: 12 YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENV 71
Query: 94 ISLKHCFFSTTS---KNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 150
++L + S + + + LV ++ + S+ + L +K +
Sbjct: 72 VNLIEICRTKASPYNRCKGSIYLVFDFCEHDL---AGLLSNVLVKFTLSEIKRVMQMLLN 128
Query: 151 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI-----SYICSRF 205
GL YIH ++ HRD+K N+L+ +K+ DFG A+ + + + + + +
Sbjct: 129 GLYYIHR-NKILHRDMKAANVLITR-DGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLW 186
Query: 206 YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 265
YR PEL+ G +Y ID+W AGC++AE+ P+ G QL I ++ G+ T E
Sbjct: 187 YRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVW 246
Query: 266 RCMNPNYTDFRFPQIKAHPWH 286
++ + +K
Sbjct: 247 PNVDNYELYEKLELVKGQKRK 267
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (424), Expect = 5e-51
Identities = 63/262 (24%), Positives = 109/262 (41%), Gaps = 28/262 (10%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVL-------QDRRYKNRELQLMRVMDHPN 92
+ R +G G FG V+ A+ ++ +A+K + RE+++ + HPN
Sbjct: 8 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 67
Query: 93 VISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 152
++ L F T + L++EY P + + Y ++ L
Sbjct: 68 ILRLYGYFHDATR-----VYLILEYAPLGT---VYRELQKLSKFDEQRTATYITELANAL 119
Query: 153 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELI 212
+Y H+ RV HRD+KP+NLL+ ++KI DFG + + + + Y PE+I
Sbjct: 120 SYCHS-KRVIHRDIKPENLLLGS-AGELKIADFGWSVHAPSSRRT-TLCGTLDYLPPEMI 176
Query: 213 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR---EEI---- 265
G + +D+WS G + E L+G+P F + I +V T E
Sbjct: 177 EG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLI 235
Query: 266 -RCMNPNYTD-FRFPQIKAHPW 285
R + N + ++ HPW
Sbjct: 236 SRLLKHNPSQRPMLREVLEHPW 257
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (426), Expect = 1e-50
Identities = 59/264 (22%), Positives = 110/264 (41%), Gaps = 28/264 (10%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV---LQDRRYKNRELQLMRVMDHPNVISL 96
YM +G G FGIV + + +T K V D+ +E+ ++ + H N++ L
Sbjct: 7 YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHL 66
Query: 97 KHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 155
F S L ++ E++ ++ + ++ + + Y +Q+ L ++
Sbjct: 67 HESFESMEE-----LVMIFEFISGLDIFERIN---TSAFELNEREIVSYVHQVCEALQFL 118
Query: 156 HTVPRVCHRDLKPQNLLVDPLTH-QVKICDFGSAKQLIAGEANISYICSRFYRAPELIFG 214
H+ + H D++P+N++ +KI +FG A+QL G+ + Y APE+
Sbjct: 119 HS-HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQH 177
Query: 215 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 274
+T+ D+WS G ++ LL G F E + I+ T E + ++ D
Sbjct: 178 -DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMD 236
Query: 275 F-----------R--FPQIKAHPW 285
F R + HPW
Sbjct: 237 FVDRLLVKERKSRMTASEALQHPW 260
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 167 bits (424), Expect = 3e-50
Identities = 73/259 (28%), Positives = 125/259 (48%), Gaps = 13/259 (5%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-NRELQLM-RVMDHPNVISLK 97
Y R +G G + VF+A + E V +K + ++ K RE++++ + PN+I+L
Sbjct: 37 YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLA 96
Query: 98 HCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT 157
S+ LV E+V + ++ L Q + ++ Y Y+I + L Y H+
Sbjct: 97 DIVKDPVSRT---PALVFEHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHS 147
Query: 158 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATE 217
+ + HRD+KP N+++D ++++ D+G A+ G+ + SR+++ PEL+
Sbjct: 148 M-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQM 206
Query: 218 YTTSIDIWSAGCVLAELLLGQ-PLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR 276
Y S+D+WS GC+LA ++ + P F G + DQLV I KVLGT + D R
Sbjct: 207 YDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPR 266
Query: 277 FPQIKAHPWHKVCIFHFPK 295
F I K
Sbjct: 267 FNDILGRHSRKRWERFVHS 285
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (422), Expect = 3e-50
Identities = 65/276 (23%), Positives = 122/276 (44%), Gaps = 33/276 (11%)
Query: 32 GEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKV----LQDRRYKNRELQLMRV 87
G+PK+ Y +G G+ G V+ A + TG+ VAI+++ + E+ +MR
Sbjct: 16 GDPKK--KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 73
Query: 88 MDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQ 147
+PN+++ + +EL++ VMEY + M + +
Sbjct: 74 NKNPNIVNYLDSY---LVGDELWV--VMEY----LAGGSLTDVVTETCMDEGQIAAVCRE 124
Query: 148 IFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFY 206
+ L ++H+ +V HRD+K N+L+ VK+ DFG Q+ ++ S + + ++
Sbjct: 125 CLQALEFLHSN-QVIHRDIKSDNILLGM-DGSVKLTDFGFCAQITPEQSKRSTMVGTPYW 182
Query: 207 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 266
APE++ Y +DIWS G + E++ G+P + EN + L I GTP +
Sbjct: 183 MAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT-NGTPELQNPE 240
Query: 267 CMNPNYTDF-------------RFPQIKAHPWHKVC 289
++ + DF ++ H + K+
Sbjct: 241 KLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIA 276
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (417), Expect = 1e-49
Identities = 68/273 (24%), Positives = 112/273 (41%), Gaps = 36/273 (13%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVL-------QDRRYKNRELQLMRVMDHPN 92
+ +++G GSF V A+ L T AIK + Y RE +M +DHP
Sbjct: 10 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 69
Query: 93 VISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 152
+ L F +L+ + Y L Y + YT +I L
Sbjct: 70 FVKLYFTF---QDDEKLYF--GLSYAKNGE---LLKYIRKIGSFDETCTRFYTAEIVSAL 121
Query: 153 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI---SYICSRFYRAP 209
Y+H + HRDLKP+N+L++ ++I DFG+AK L S++ + Y +P
Sbjct: 122 EYLHG-KGIIHRDLKPENILLNE-DMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSP 179
Query: 210 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI---- 265
EL+ S D+W+ GC++ +L+ G P F N +IIK+ +
Sbjct: 180 ELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKAR 238
Query: 266 ----RCMNPNYTD-------FRFPQIKAHPWHK 287
+ + + T + +KAHP+ +
Sbjct: 239 DLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFE 271
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 165 bits (418), Expect = 1e-49
Identities = 67/266 (25%), Positives = 106/266 (39%), Gaps = 30/266 (11%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----RELQLMRVMDHPNVI 94
Y V+GTG+F V A+ T + VAIK + + E+ ++ + HPN++
Sbjct: 11 YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIV 70
Query: 95 SLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 154
+L + S L+L +M+ V L +Q+ + Y
Sbjct: 71 ALDDIY---ESGGHLYL--IMQLVS---GGELFDRIVEKGFYTERDASRLIFQVLDAVKY 122
Query: 155 IHTVPRVCHRDLKPQNLLVDPLTH--QVKICDFGSAKQLIAGEANISYICSRFYRAPELI 212
+H + HRDLKP+NLL L ++ I DFG +K G + + Y APE++
Sbjct: 123 LHD-LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVL 181
Query: 213 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 272
Y+ ++D WS G + LL G P F EN +I+K ++ +
Sbjct: 182 AQ-KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSA 240
Query: 273 TDF-------------RFPQIKAHPW 285
DF Q HPW
Sbjct: 241 KDFIRHLMEKDPEKRFTCEQALQHPW 266
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 162 bits (410), Expect = 8e-49
Identities = 62/278 (22%), Positives = 108/278 (38%), Gaps = 42/278 (15%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV-------------LQDRRYKNRELQLMR 86
Y + ++G G +V + T + A+K + + R +E+ ++R
Sbjct: 5 YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 64
Query: 87 -VMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYT 145
V HPN+I LK + + F LV + + + L Y + + +
Sbjct: 65 KVSGHPNIIQLKDTY-----ETNTFFFLVFDLMKKGE---LFDYLTEKVTLSEKETRKIM 116
Query: 146 YQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF 205
+ + +H + HRDLKP+N+L+D + +K+ DFG + QL GE +
Sbjct: 117 RALLEVICALHK-LNIVHRDLKPENILLDDDMN-IKLTDFGFSCQLDPGEKLREVCGTPS 174
Query: 206 YRAPELIFGATE-----YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 260
Y APE+I + Y +D+WS G ++ LL G P F + L I+
Sbjct: 175 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQF 234
Query: 261 TREEI------------RCMNPNYTD-FRFPQIKAHPW 285
E R + + + AHP+
Sbjct: 235 GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPF 272
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (415), Expect = 8e-49
Identities = 87/259 (33%), Positives = 142/259 (54%), Gaps = 19/259 (7%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNV 93
Y + VG+G++G V A TG VAIKK+ + + + REL+L++ M H NV
Sbjct: 20 YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENV 79
Query: 94 ISLKHCFFSTTSKNELF-LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 152
I L F + ++ LVM ++ + +++KH +++ ++ YQ+ +GL
Sbjct: 80 IGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKH-----EKLGEDRIQFLVYQMLKGL 134
Query: 153 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELI 212
YIH + HRDLKP NL V+ ++KI DFG A+Q Y+ +R+YRAPE+I
Sbjct: 135 RYIHA-AGIIHRDLKPGNLAVNE-DCELKILDFGLARQA--DSEMTGYVVTRWYRAPEVI 190
Query: 213 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 272
YT ++DIWS GC++AE++ G+ LF G + +DQL EI+KV GTP E ++ + +
Sbjct: 191 LNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDE 250
Query: 273 TDF---RFPQIKAHPWHKV 288
P+++ + +
Sbjct: 251 AKNYMKGLPELEKKDFASI 269
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (408), Expect = 3e-48
Identities = 85/258 (32%), Positives = 140/258 (54%), Gaps = 17/258 (6%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNV 93
+ +G G++G+V++A+ TGE VA+KK+ D + RE+ L++ ++HPN+
Sbjct: 4 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 94 ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 153
+ L E L LV E++ + + + + SA +PL +K Y +Q+ +GLA
Sbjct: 64 VKLLDVI-----HTENKLYLVFEFLHQDLKKFMDA--SALTGIPLPLIKSYLFQLLQGLA 116
Query: 154 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA-GEANISYICSRFYRAPELI 212
+ H+ RV HRDLKPQNLL++ +K+ DFG A+ + + +YRAPE++
Sbjct: 117 FCHS-HRVLHRDLKPQNLLINT-EGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEIL 174
Query: 213 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI-RCMNPN 271
G Y+T++DIWS GC+ AE++ + LFPG++ +DQL I + LGTP +
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMP 234
Query: 272 YTDFRFPQIKAHPWHKVC 289
FP+ + KV
Sbjct: 235 DYKPSFPKWARQDFSKVV 252
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (405), Expect = 8e-48
Identities = 86/259 (33%), Positives = 135/259 (52%), Gaps = 16/259 (6%)
Query: 40 YMAERVVGTGSFGIVFQAKCLET-GETVAIKKVLQDRRYKN------RELQLMRVM---D 89
Y +G G++G VF+A+ L+ G VA+K+V + RE+ ++R + +
Sbjct: 9 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFE 68
Query: 90 HPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIF 149
HPNV+ L + + E L LV E+V + + L +P +K +Q+
Sbjct: 69 HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVP--EPGVPTETIKDMMFQLL 126
Query: 150 RGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAP 209
RGL ++H+ RV HRDLKPQN+LV + Q+K+ DFG A+ A S + + +YRAP
Sbjct: 127 RGLDFLHS-HRVVHRDLKPQNILVTS-SGQIKLADFGLARIYSFQMALTSVVVTLWYRAP 184
Query: 210 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 269
E++ + Y T +D+WS GC+ AE+ +PLF G + VDQL +I+ V+G P E+ +
Sbjct: 185 EVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW-PRD 242
Query: 270 PNYTDFRFPQIKAHPWHKV 288
F A P K
Sbjct: 243 VALPRQAFHSKSAQPIEKF 261
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (404), Expect = 3e-47
Identities = 86/260 (33%), Positives = 134/260 (51%), Gaps = 17/260 (6%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV------LQDRRYKNRELQLMRVMDHPNV 93
Y VG+G++G V A +TG VA+KK+ + + REL+L++ M H NV
Sbjct: 20 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 79
Query: 94 ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 153
I L F S E ++ ++ + + Q++ +V+ YQI RGL
Sbjct: 80 IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK----CQKLTDDHVQFLIYQILRGLK 135
Query: 154 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIF 213
YIH+ + HRDLKP NL V+ KI DFG A+ + Y+ +R+YRAPE++
Sbjct: 136 YIHS-ADIIHRDLKPSNLAVNEDCEL-KILDFGLARHT--DDEMTGYVATRWYRAPEIML 191
Query: 214 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 273
Y ++DIWS GC++AELL G+ LFPG + +DQL I++++GTP E ++ ++
Sbjct: 192 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESA 251
Query: 274 DF---RFPQIKAHPWHKVCI 290
Q+ + V I
Sbjct: 252 RNYIQSLTQMPKMNFANVFI 271
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (397), Expect = 1e-46
Identities = 62/274 (22%), Positives = 111/274 (40%), Gaps = 36/274 (13%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN----------RELQLMRVMD 89
Y +G+G F +V + + TG A K + + R + RE+ +++ +
Sbjct: 12 YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71
Query: 90 HPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIF 149
HPNVI+L + +N+ + L++E V L + + + + + QI
Sbjct: 72 HPNVITLHEVY-----ENKTDVILILELVAGGE---LFDFLAEKESLTEEEATEFLKQIL 123
Query: 150 RGLAYIHTVPRVCHRDLKPQNLLVD---PLTHQVKICDFGSAKQLIAGEANISYICSRFY 206
G+ Y+H+ ++ H DLKP+N+++ ++KI DFG A ++ G + + +
Sbjct: 124 NGVYYLHS-LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEF 182
Query: 207 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 266
APE++ D+WS G + LL G F G+ + L + V E
Sbjct: 183 VAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFS 241
Query: 267 CMNPNYTDF-------------RFPQIKAHPWHK 287
+ DF HPW K
Sbjct: 242 NTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 275
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (398), Expect = 2e-46
Identities = 70/270 (25%), Positives = 120/270 (44%), Gaps = 36/270 (13%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ--------LMRVMDHP 91
++ +++G GSFG VF A+ +T + AIK + +D + +++ L +HP
Sbjct: 4 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 63
Query: 92 NVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 151
+ + F + + L VMEY+ L ++ + + L Y +I G
Sbjct: 64 FLTHMFCTF-----QTKENLFFVMEYLN---GGDLMYHIQSCHKFDLSRATFYAAEIILG 115
Query: 152 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPE 210
L ++H+ + +RDLK N+L+D H KI DFG K+ + G+A + C + Y APE
Sbjct: 116 LQFLHS-KGIVYRDLKLDNILLDKDGHI-KIADFGMCKENMLGDAKTNTFCGTPDYIAPE 173
Query: 211 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI----- 265
++ G +Y S+D WS G +L E+L+GQ F G++ + I P
Sbjct: 174 ILLGQ-KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRM--DNPFYPRWLEKEA 230
Query: 266 -----RCMNPNYTDFRF---PQIKAHPWHK 287
+ R I+ HP +
Sbjct: 231 KDLLVKLFVREPEK-RLGVRGDIRQHPLFR 259
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 154 bits (390), Expect = 9e-46
Identities = 82/257 (31%), Positives = 136/257 (52%), Gaps = 19/257 (7%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNV 93
Y +G G++G+V++A+ GET A+KK+ ++ + RE+ +++ + H N+
Sbjct: 4 YHGLEKIGEGTYGVVYKAQ-NNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNI 62
Query: 94 ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 153
+ L + L LV E++ + + ++L + + K + Q+ G+A
Sbjct: 63 VKLYDVIH-----TKKRLVLVFEHLDQDLKKLLDVC---EGGLESVTAKSFLLQLLNGIA 114
Query: 154 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL-IAGEANISYICSRFYRAPELI 212
Y H RV HRDLKPQNLL++ ++KI DFG A+ I I + +YRAP+++
Sbjct: 115 YCHD-RRVLHRDLKPQNLLINR-EGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVL 172
Query: 213 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI-RCMNPN 271
G+ +Y+T+IDIWS GC+ AE++ G PLFPG + DQL+ I ++LGTP +
Sbjct: 173 MGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELP 232
Query: 272 YTDFRFPQIKAHPWHKV 288
D F + PW
Sbjct: 233 KYDPNFTVYEPLPWESF 249
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 156 bits (395), Expect = 1e-45
Identities = 63/276 (22%), Positives = 114/276 (41%), Gaps = 40/276 (14%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----------RYKNRELQLMRVMD 89
+ R++G G FG V+ + +TG+ A+K + + R + L L+ D
Sbjct: 6 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 65
Query: 90 HPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIF 149
P ++ + + F + L+ +++ + L ++ S + ++ Y +I
Sbjct: 66 CPFIVCMSYAFHTPDK-----LSFILDLMNGGD---LHYHLSQHGVFSEADMRFYAAEII 117
Query: 150 RGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAP 209
GL ++H V +RDLKP N+L+D H V+I D G A + + S + Y AP
Sbjct: 118 LGLEHMHN-RFVVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPHASV-GTHGYMAP 174
Query: 210 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 269
E++ Y +S D +S GC+L +LL G F D+ EI ++ T E +
Sbjct: 175 EVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EIDRMTLTMAVELPDSFS 233
Query: 270 PNYTDF------------------RFPQIKAHPWHK 287
P ++K P+ +
Sbjct: 234 PELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFR 269
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (387), Expect = 2e-45
Identities = 88/264 (33%), Positives = 137/264 (51%), Gaps = 18/264 (6%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNV 93
Y +G G++G VF+AK ET E VA+K+V D + RE+ L++ + H N+
Sbjct: 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 63
Query: 94 ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 153
+ L ++ L LV E+ + K++ S N + VK + +Q+ +GL
Sbjct: 64 VRLHDVL-----HSDKKLTLVFEFC---DQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLG 115
Query: 154 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS-YICSRFYRAPELI 212
+ H+ V HRDLKPQNLL++ ++K+ +FG A+ S + + +YR P+++
Sbjct: 116 FCHS-RNVLHRDLKPQNLLINR-NGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVL 173
Query: 213 FGATEYTTSIDIWSAGCVLAELLLG-QPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 271
FGA Y+TSID+WSAGC+ AEL +PLFPG + DQL I ++LGTPT E+ M
Sbjct: 174 FGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL 233
Query: 272 YTDFRFPQIKAHPWHKVCIFHFPK 295
+P A +
Sbjct: 234 PDYKPYPMYPATTSLVNVVPKLNA 257
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 152 bits (386), Expect = 3e-45
Identities = 58/247 (23%), Positives = 100/247 (40%), Gaps = 18/247 (7%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-------RELQLMRVMDHPN 92
Y ++G G V A+ L VA+K + D RE Q ++HP
Sbjct: 9 YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 68
Query: 93 VISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 152
++++ + T L +VMEYV L+ M + L
Sbjct: 69 IVAVYDTGEAETPAGPLPY-IVMEYVDGVT---LRDIVHTEGPMTPKRAIEVIADACQAL 124
Query: 153 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI----SYICSRFYRA 208
+ H + HRD+KP N+++ T+ VK+ DFG A+ + ++ + I + Y +
Sbjct: 125 NFSHQ-NGIIHRDVKPANIMISA-TNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS 182
Query: 209 PELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 268
PE G D++S GCVL E+L G+P F G++ V + ++ P +
Sbjct: 183 PEQARGD-SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGL 241
Query: 269 NPNYTDF 275
+ +
Sbjct: 242 SADLDAV 248
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (384), Expect = 5e-45
Identities = 60/261 (22%), Positives = 108/261 (41%), Gaps = 24/261 (9%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN----------RELQLMRVMD 89
Y ++G+G FG V+ + VAIK V +DR E+ L++ +
Sbjct: 6 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65
Query: 90 --HPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQ 147
VI L F S L++E L + + + + + +Q
Sbjct: 66 SGFSGVIRLLDWFERPDS-----FVLILERPEPVQD--LFDFITERGALQEELARSFFWQ 118
Query: 148 IFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYR 207
+ + + H V HRD+K +N+L+D ++K+ DFGS L+ + +R Y
Sbjct: 119 VLEAVRHCHNCG-VLHRDIKDENILIDLNRGELKLIDFGSGA-LLKDTVYTDFDGTRVYS 176
Query: 208 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQL-VEIIKVLGTPTREEI- 265
PE I + S +WS G +L +++ G F + + + V + + + + I
Sbjct: 177 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIR 236
Query: 266 RCMNPNYTD-FRFPQIKAHPW 285
C+ +D F +I+ HPW
Sbjct: 237 WCLALRPSDRPTFEEIQNHPW 257
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 151 bits (383), Expect = 2e-44
Identities = 68/268 (25%), Positives = 118/268 (44%), Gaps = 36/268 (13%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV-------LQDRRYKNRELQLMRVMDHPN 92
+ R +GTGSFG V + G A+K + L+ + N E ++ ++ HP
Sbjct: 6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 65
Query: 93 VISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 152
+I + F ++ + ++M+Y+ L +QR P K Y ++ L
Sbjct: 66 IIRMWGTF-----QDAQQIFMIMDYIEGGELFSLLRK---SQRFPNPVAKFYAAEVCLAL 117
Query: 153 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELI 212
Y+H+ + +RDLKP+N+L+D H +KI DFG AK + + + + Y APE++
Sbjct: 118 EYLHS-KDIIYRDLKPENILLDKNGH-IKITDFGFAKYV--PDVTYTLCGTPDYIAPEVV 173
Query: 213 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK-------VLGTPTREEI 265
Y SID WS G ++ E+L G F N + +I+ ++ +
Sbjct: 174 ST-KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLL 232
Query: 266 -RCMNPNYTDFRFP-------QIKAHPW 285
R + + + R +K HPW
Sbjct: 233 SRLITRDLSQ-RLGNLQNGTEDVKNHPW 259
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 4e-43
Identities = 55/225 (24%), Positives = 95/225 (42%), Gaps = 26/225 (11%)
Query: 43 ERVVGTGSFGIVFQAKCLETGETVAIKKV------LQDRRYKNRELQLMRVMDHPNVISL 96
+ +G+GSFG V++ K VA+K + Q + E+ ++R H N++
Sbjct: 13 GQRIGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 69
Query: 97 KHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 155
L +V ++ S+Y L + +I + Q +G+ Y+
Sbjct: 70 MGYS------TAPQLAIVTQWCEGSSLYHHLH---IIETKFEMIKLIDIARQTAQGMDYL 120
Query: 156 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISY---ICSRFYRAPELI 212
H + HRDLK N+ + VKI DFG A + + S + APE+I
Sbjct: 121 HA-KSIIHRDLKSNNIFLHE-DLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 178
Query: 213 FG--ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 255
Y+ D+++ G VL EL+ GQ + N DQ++ ++
Sbjct: 179 RMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVG 223
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 5e-43
Identities = 85/296 (28%), Positives = 147/296 (49%), Gaps = 24/296 (8%)
Query: 30 KNGEPKQTIS--YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RE 81
+ G+ T+ Y + +G+G+ GIV A VAIKK+ + + + RE
Sbjct: 7 EVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRE 66
Query: 82 LQLMRVMDHPNVISLKHCFFSTTSKNEL-FLNLVMEYVPESMYRVLKHYSSANQRMPLIY 140
L LM+ ++H N+ISL + F + E + LVME + ++ +V++ +
Sbjct: 67 LVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHER------ 120
Query: 141 VKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISY 200
+ YQ+ G+ ++H+ + HRDLKP N++V +KI DFG A+ Y
Sbjct: 121 MSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKS-DCTLKILDFGLARTAGTSFMMTPY 178
Query: 201 ICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 260
+ +R+YRAPE+I G Y ++DIWS GC++ E++ + LFPG + +DQ ++I+ LGTP
Sbjct: 179 VVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP 237
Query: 261 TREEIRCMNPNYTDF--RFPQIKAHPWHKVCIFHFPKHWLLEYGSHINAISPRHCD 314
E ++ + P ++ P+ + K+ FP H + + D
Sbjct: 238 CPEFMKKLQPTVRNYVENRPKYAGLTFPKL----FPDSLFPADSEHNKLKASQARD 289
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 145 bits (366), Expect = 2e-41
Identities = 79/294 (26%), Positives = 135/294 (45%), Gaps = 36/294 (12%)
Query: 32 GEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRVM 88
GEP + Y+ R +G G F V+ AK + VA+K V D+ Y E++L++ +
Sbjct: 7 GEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRV 66
Query: 89 DHPNVISLKH----------CFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPL 138
+ + F+ N + + +V E + E++ ++K Y ++ +PL
Sbjct: 67 NDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYE--HRGIPL 124
Query: 139 IYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH-----QVKICDFGSAKQLIA 193
IYVK + Q+ GL Y+H + H D+KP+N+L++ + Q+KI D G+A
Sbjct: 125 IYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD- 183
Query: 194 GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA------V 247
E + I +R YR+PE++ GA + DIWS C++ EL+ G LF +
Sbjct: 184 -EHYTNSIQTREYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 241
Query: 248 DQLVEIIKVLGTPTREEIRCMNPNYTDF-------RFPQIKAHPWHKVCIFHFP 294
D + +II++LG +R T F ++K P V +
Sbjct: 242 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYK 295
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 143 bits (360), Expect = 3e-41
Identities = 46/247 (18%), Positives = 88/247 (35%), Gaps = 23/247 (9%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--RELQLMRVMDHPNVISLK 97
Y R +G GSFG++F+ L + VAIK + E + +++ I
Sbjct: 7 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNV 66
Query: 98 HCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT 157
+ F L LV++ + S+ +L ++ + V + Q+ + IH
Sbjct: 67 YYFGQE----GLHNVLVIDLLGPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIHE 119
Query: 158 VPRVCHRDLKPQNLLVD----PLTHQVKICDFGSAKQLIAGEANI--------SYICSRF 205
+ +RD+KP N L+ + + + DFG K + +
Sbjct: 120 -KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTAR 178
Query: 206 YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 265
Y + G E + D+ + G V L G + G A + ++ +
Sbjct: 179 YMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL 237
Query: 266 RCMNPNY 272
R + +
Sbjct: 238 RELCAGF 244
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (351), Expect = 3e-40
Identities = 52/254 (20%), Positives = 96/254 (37%), Gaps = 27/254 (10%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--RELQLMRVMDHPNVISLKHCFF 101
+ +G G FG V G VA+K + D + E +M + H N++ L
Sbjct: 13 QTIGKGEFGDVMLGD--YRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIV 70
Query: 102 STTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR 160
L +V EY+ + S+ L+ S + + ++ + + Y+
Sbjct: 71 EEKGG----LYIVTEYMAKGSLVDYLR--SRGRSVLGGDCLLKFSLDVCEAMEYLEG-NN 123
Query: 161 VCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTT 220
HRDL +N+LV + K+ DFG K+ + + APE + +++T
Sbjct: 124 FVHRDLAARNVLVSE-DNVAKVSDFGLTKEA--SSTQDTGKLPVKWTAPEALRE-KKFST 179
Query: 221 SIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLGTPTREEI---------RCMNP 270
D+WS G +L E+ G+ +P D + + K + C +
Sbjct: 180 KSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMKNCWHL 239
Query: 271 NYTD-FRFPQIKAH 283
+ F Q++
Sbjct: 240 DAAMRPSFLQLREQ 253
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 8e-40
Identities = 55/263 (20%), Positives = 105/263 (39%), Gaps = 31/263 (11%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-------RELQLMRVMDHPNVISL 96
+++G G+FG V + TG A+K + ++ E ++++ HP + +L
Sbjct: 11 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 97 KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 156
K+ F + L VMEY L + S + + Y +I L Y+H
Sbjct: 71 KYAFQT-----HDRLCFVMEYANGGE---LFFHLSRERVFTEERARFYGAEIVSALEYLH 122
Query: 157 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGAT 216
+ V +RD+K +NL++D +KI DFG K+ I+ A + C +
Sbjct: 123 S-RDVVYRDIKLENLMLDK-DGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDN 180
Query: 217 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV-------LGTPTREEIRCM- 268
+Y ++D W G V+ E++ G+ F ++ I+ L + + +
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLL 240
Query: 269 --NPN----YTDFRFPQIKAHPW 285
+P ++ H +
Sbjct: 241 KKDPKQRLGGGPSDAKEVMEHRF 263
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 138 bits (349), Expect = 1e-39
Identities = 55/247 (22%), Positives = 95/247 (38%), Gaps = 21/247 (8%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--RELQLMRVMDHPNVISLK 97
Y R +G+GSFG ++ + GE VAIK ++ E ++ ++M I
Sbjct: 9 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTI 68
Query: 98 HCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT 157
+ + +VME + S+ ++ +++ L V L Q+ + YIH+
Sbjct: 69 RWCGAEGD----YNVMVMELLGPSL---EDLFNFCSRKFSLKTVLLLADQMISRIEYIHS 121
Query: 158 VPRVCHRDLKPQNLLV--DPLTHQVKICDFGSAKQLIAGEANI--------SYICSRFYR 207
HRD+KP N L+ + V I DFG AK+ + + + Y
Sbjct: 122 -KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180
Query: 208 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 267
+ G E + D+ S G VL LG + G A + + ++ I
Sbjct: 181 SINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV 239
Query: 268 MNPNYTD 274
+ Y
Sbjct: 240 LCKGYPS 246
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 134 bits (339), Expect = 1e-37
Identities = 57/264 (21%), Positives = 107/264 (40%), Gaps = 36/264 (13%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIKKV-------LQDRRYKNRELQLMRVMDHPNVISL 96
+ +GTGSFG V K E+G A+K + L+ + E ++++ ++ P ++ L
Sbjct: 47 KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 97 KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 156
+ F + + + + + R + + Y QI Y+H
Sbjct: 107 EFSFKDN--------SNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 157 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGAT 216
++ + +RDLKP+NLL+D +++ DFG AK++ + + APE+I
Sbjct: 159 SL-DLIYRDLKPENLLIDQ-QGYIQVTDFGFAKRVK--GRTWTLCGTPEALAPEIILS-K 213
Query: 217 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE--------EIRCM 268
Y ++D W+ G ++ E+ G P F + + +I+ +
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLL 273
Query: 269 NPNYTDFRFP-------QIKAHPW 285
+ T RF IK H W
Sbjct: 274 QVDLTK-RFGNLKNGVNDIKNHKW 296
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (323), Expect = 7e-36
Identities = 58/244 (23%), Positives = 94/244 (38%), Gaps = 26/244 (10%)
Query: 43 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRVMDHPNVISLKHC 99
E +G G FG V+ T VAIK + +E Q+M+ + H ++ L
Sbjct: 22 EVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 80
Query: 100 FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 159
S+ +++ V EY+ + + + L + QI G+AY+
Sbjct: 81 V----SEEPIYI--VTEYMSKGSLL-DFLKGETGKYLRLPQLVDMAAQIASGMAYVER-M 132
Query: 160 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE--ANISYICSRFYRAPELIFGATE 217
HRDL+ N+LV K+ DFG A+ + E A + APE
Sbjct: 133 NYVHRDLRAANILVGE-NLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY-GR 190
Query: 218 YTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLGTPTREEI---------RC 267
+T D+WS G +L EL G+ +PG + L ++ + P E +C
Sbjct: 191 FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQC 250
Query: 268 MNPN 271
Sbjct: 251 WRKE 254
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (323), Expect = 9e-36
Identities = 57/249 (22%), Positives = 98/249 (39%), Gaps = 31/249 (12%)
Query: 39 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKV---LQDRRYKNRELQLMRVMDHPNVIS 95
+ + + +G G FG V++ K GE VA+K + ++ E+ ++ H N++
Sbjct: 4 TIVLQESIGKGRFGEVWRGK--WRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILG 61
Query: 96 LKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 154
+ + L LV +Y S++ L Y + + + GLA+
Sbjct: 62 F-IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAH 115
Query: 155 IHTV-------PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF-- 205
+H P + HRDLK +N+LV I D G A + + I +
Sbjct: 116 LHMEIVGTQGKPAIAHRDLKSKNILVKK-NGTCCIADLGLAVRHDSATDTIDIAPNHRVG 174
Query: 206 ---YRAPELIFGA-----TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVL 257
Y APE++ + E DI++ G V E+ + G + QL V
Sbjct: 175 TKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIG-GIHEDYQLPYYDLVP 233
Query: 258 GTPTREEIR 266
P+ EE+R
Sbjct: 234 SDPSVEEMR 242
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 128 bits (323), Expect = 1e-35
Identities = 58/257 (22%), Positives = 103/257 (40%), Gaps = 34/257 (13%)
Query: 39 SYMAERVVGTGSFGIVFQAKCLETGET---VAIKKVL-----QDRRYKNRELQLMRVMDH 90
E+V+G G FG V G+ VAIK + + RR E +M DH
Sbjct: 27 CVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDH 86
Query: 91 PNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 150
PNVI L+ +T + ++ E++ + + + +I + I
Sbjct: 87 PNVIHLEGVVTKST-----PVMIITEFMENGSLDSFLRQN--DGQFTVIQLVGMLRGIAA 139
Query: 151 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR------ 204
G+ Y+ HRDL +N+LV+ K+ DFG ++ L ++ +Y +
Sbjct: 140 GMKYLAD-MNYVHRDLAARNILVNS-NLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPI 197
Query: 205 FYRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLGTPTRE 263
+ APE I ++T++ D+WS G V+ E++ G+ + D + I + P
Sbjct: 198 RWTAPEAIQY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPM 256
Query: 264 EI---------RCMNPN 271
+ C +
Sbjct: 257 DCPSALHQLMLDCWQKD 273
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (319), Expect = 2e-35
Identities = 57/235 (24%), Positives = 90/235 (38%), Gaps = 24/235 (10%)
Query: 44 RVVGTGSFGIVFQAKCLET---GETVAIKKVLQDRRYKN-------RELQLMRVMDHPNV 93
+G GSFG+V + + +VA+K + D + RE+ M +DH N+
Sbjct: 14 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 94 ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 153
I L + + +V E P + +L L + Y Q+ G+
Sbjct: 74 IRLYGVVLTPP------MKMVTELAP--LGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMG 125
Query: 154 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI---SYICSRFYRAPE 210
Y+ + R HRDL +NLL+ VKI DFG + L + + + F
Sbjct: 126 YLES-KRFIHRDLAARNLLLAT-RDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 183
Query: 211 LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLGTPTREE 264
++ + D W G L E+ GQ + G N L +I K R E
Sbjct: 184 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPE 238
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (318), Expect = 3e-35
Identities = 51/247 (20%), Positives = 90/247 (36%), Gaps = 26/247 (10%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRVMDHPNVISL 96
+G G FG V+ VA+K + Q + E LM+ + H ++ L
Sbjct: 15 LKLVERLGAGQFGEVWMGY-YNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRL 73
Query: 97 KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 156
++ +++ + EY+ S ++ + + QI G+A+I
Sbjct: 74 YAVV----TQEPIYI--ITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIE 126
Query: 157 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC--SRFYRAPELIFG 214
HRDL+ N+LV KI DFG A+ + E + APE I
Sbjct: 127 E-RNYIHRDLRAANILVSDTLSC-KIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY 184
Query: 215 ATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLGTPTREEI-------- 265
+T D+WS G +L E++ G+ +PG + + + + +
Sbjct: 185 G-TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLM 243
Query: 266 -RCMNPN 271
C
Sbjct: 244 RLCWKER 250
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 125 bits (316), Expect = 8e-35
Identities = 44/218 (20%), Positives = 89/218 (40%), Gaps = 14/218 (6%)
Query: 43 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRVMDHPNVISLKHC 99
+ +G G +G V++ + TVA+K + +D +E +M+ + HPN++ L
Sbjct: 22 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 81
Query: 100 FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 159
++ E++ + Q + + + QI + Y+
Sbjct: 82 CTREPP-----FYIITEFMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEK-K 134
Query: 160 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE--ANISYICSRFYRAPELIFGATE 217
HRDL +N LV H VK+ DFG ++ + A+ + APE + +
Sbjct: 135 NFIHRDLAARNCLVGE-NHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY-NK 192
Query: 218 YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 255
++ D+W+ G +L E+ + Q+ E+++
Sbjct: 193 FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE 230
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (317), Expect = 1e-34
Identities = 63/225 (28%), Positives = 104/225 (46%), Gaps = 25/225 (11%)
Query: 44 RVVGTGSFGIVFQAKCLETGET----VAIKKVLQDRRYKN-----RELQLMRVMDHPNVI 94
+V+G+G+FG V++ + GE VAIK++ + K E +M +D+P+V
Sbjct: 15 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 74
Query: 95 SLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 154
L ++T + L+ + +P +L + + Y+ + QI +G+ Y
Sbjct: 75 RLLGICLTST------VQLITQLMPFGC--LLDYVREHKDNIGSQYLLNWCVQIAKGMNY 126
Query: 155 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR---FYRAPEL 211
+ R+ HRDL +N+LV H VKI DFG AK L A E + + A E
Sbjct: 127 LED-RRLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 184
Query: 212 IFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIK 255
I YT D+WS G + EL+ G + G A ++ I++
Sbjct: 185 ILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-SEISSILE 227
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (316), Expect = 1e-34
Identities = 60/278 (21%), Positives = 117/278 (42%), Gaps = 41/278 (14%)
Query: 40 YMAERVVGTGSFGIVFQAKCL---ETGETVAIKKV--------LQDRRYKNRELQLMRVM 88
+ +V+GTG++G VF + + +TG+ A+K + + + E Q++ +
Sbjct: 26 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 85
Query: 89 DHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQI 148
+ H F T +K L+L+++Y+ L + S +R V++Y +I
Sbjct: 86 RQSPFLVTLHYAFQTETK----LHLILDYI---NGGELFTHLSQRERFTEHEVQIYVGEI 138
Query: 149 FRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC---SRF 205
L ++H + +RD+K +N+L+D V + DFG +K+ +A E +Y +
Sbjct: 139 VLALEHLHK-LGIIYRDIKLENILLDS-NGHVVLTDFGLSKEFVADETERAYDFCGTIEY 196
Query: 206 YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 265
+ G + + ++D WS G ++ ELL G F + + EI + +
Sbjct: 197 MAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYP 256
Query: 266 RCMNPNYTDF-----------RFP-------QIKAHPW 285
+ M+ D R +IK H +
Sbjct: 257 QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLF 294
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (311), Expect = 2e-34
Identities = 44/217 (20%), Positives = 88/217 (40%), Gaps = 16/217 (7%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRVMDHPNVISLKHCF 100
+ +G+G FG+V + VAIK + + + E ++M + HP ++ L
Sbjct: 11 QEIGSGQFGLVHLGY-WLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 69
Query: 101 FSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR 160
+ LV E++ + + + + + G+AY+
Sbjct: 70 LEQA-----PICLVFEFMEHGC--LSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE-AC 121
Query: 161 VCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC--SRFYRAPELIFGATEY 218
V HRDL +N LV +K+ DFG + ++ + S + +PE+ + Y
Sbjct: 122 VIHRDLAARNCLVGE-NQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF-SRY 179
Query: 219 TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 255
++ D+WS G ++ E+ + + ++VE I
Sbjct: 180 SSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS 216
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (315), Expect = 2e-34
Identities = 58/248 (23%), Positives = 103/248 (41%), Gaps = 43/248 (17%)
Query: 43 ERVVGTGSFGIVFQAKCLETGET-----VAIKKVLQDRRYKN-----RELQLM-RVMDHP 91
+V+G+G+FG V A +T VA+K + + EL++M ++ H
Sbjct: 42 GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHE 101
Query: 92 NVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLK-------------------HYSS 131
N+++L T ++ L+ EY + L+
Sbjct: 102 NIVNLLGAC---TLSGPIY--LIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 132 ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 191
+ + + YQ+ +G+ ++ HRDL +N+LV VKICDFG A+ +
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEF-KSCVHRDLAARNVLVTH-GKVVKICDFGLARDI 214
Query: 192 IAGEANISYICSR---FYRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAV 247
++ + +R + APE +F YT D+WS G +L E+ LG +PG
Sbjct: 215 MSDSNYVVRGNARLPVKWMAPESLFE-GIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 273
Query: 248 DQLVEIIK 255
++I+
Sbjct: 274 ANFYKLIQ 281
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (310), Expect = 3e-34
Identities = 49/256 (19%), Positives = 102/256 (39%), Gaps = 27/256 (10%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRVMDHPNVISLKHCF 100
+ +GTG FG+V K VAIK + + ++ E ++M + H ++ L
Sbjct: 10 KELGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 68
Query: 101 FSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR 160
T + +F ++ EY+ +L + R + + + Y+ + +
Sbjct: 69 ---TKQRPIF--IITEYMANGC--LLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES-KQ 120
Query: 161 VCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS--YICSRFYRAPELIFGATEY 218
HRDL +N LV+ VK+ DFG ++ ++ E S + PE++ +++
Sbjct: 121 FLHRDLAARNCLVND-QGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY-SKF 178
Query: 219 TTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLGTPTREEI---------RCM 268
++ DIW+ G ++ E+ LG+ + + I + L C
Sbjct: 179 SSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCW 238
Query: 269 NPNYTD-FRFPQIKAH 283
+ + F + ++
Sbjct: 239 HEKADERPTFKILLSN 254
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (311), Expect = 4e-34
Identities = 56/272 (20%), Positives = 105/272 (38%), Gaps = 38/272 (13%)
Query: 43 ERVVGTGSFGIVFQAKC--LETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVI 94
++ +G+G+FG V + + +TVA+K + + E +M+ +D+P ++
Sbjct: 12 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 71
Query: 95 SLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 154
+ + + LVME L Y N+ + + +Q+ G+ Y
Sbjct: 72 RMIGICEAES------WMLVMEMAE---LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKY 122
Query: 155 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE----ANISYICSRFYRAPE 210
+ HRDL +N+L+ H KI DFG +K L A E A + APE
Sbjct: 123 LEE-SNFVHRDLAARNVLLVT-QHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 180
Query: 211 LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLGTPTREEI---- 265
I ++++ D+WS G ++ E GQ + G + + K
Sbjct: 181 CINY-YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREM 239
Query: 266 -----RCMNPNYTD-FRFPQIKA---HPWHKV 288
C + + F ++ + ++ V
Sbjct: 240 YDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 271
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (309), Expect = 1e-33
Identities = 53/227 (23%), Positives = 98/227 (43%), Gaps = 23/227 (10%)
Query: 43 ERVVGTGSFGIVFQAKCLE---TGETVAIKKV-----LQDRRYKNRELQLMRVMDHPNVI 94
V+G G FG V+ L+ A+K + + + E +M+ HPNV+
Sbjct: 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91
Query: 95 SLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 154
SL ++E +V+ Y+ R + + + Q+ +G+ +
Sbjct: 92 SLLGICL----RSEGSPLVVLPYMKHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKF 145
Query: 155 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR-----FYRAP 209
+ + + HRDL +N ++D VK+ DFG A+ + E + + + + A
Sbjct: 146 LAS-KKFVHRDLAARNCMLDE-KFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 203
Query: 210 ELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIK 255
E + ++TT D+WS G +L EL+ G P +P N D V +++
Sbjct: 204 ESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ 249
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (299), Expect = 2e-32
Identities = 60/253 (23%), Positives = 100/253 (39%), Gaps = 32/253 (12%)
Query: 43 ERVVGTGSFGIVFQAKCLETGE--TVAIKKVLQDRRYKN-----RELQLMRVMDHPNVIS 95
+ +G G+FG V Q + VAIK + Q + RE Q+M +D+P ++
Sbjct: 14 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 73
Query: 96 LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 155
L + L LVME + K + +P+ V +Q+ G+ Y+
Sbjct: 74 LIGVCQAEA------LMLVMEMAGGGP--LHKFLVGKREEIPVSNVAELLHQVSMGMKYL 125
Query: 156 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR----FYRAPEL 211
HRDL +N+L+ H KI DFG +K L A ++ + + + APE
Sbjct: 126 EE-KNFVHRDLAARNVLLVN-RHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPEC 183
Query: 212 IFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLGTPTREEI----- 265
I ++++ D+WS G + E L GQ + + + I + E
Sbjct: 184 INF-RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELY 242
Query: 266 ----RCMNPNYTD 274
C + D
Sbjct: 243 ALMSDCWIYKWED 255
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (295), Expect = 1e-31
Identities = 55/234 (23%), Positives = 99/234 (42%), Gaps = 29/234 (12%)
Query: 43 ERVVGTGSFGIVFQAKCLETGE--TVAIKKV-----LQDRRYKNRELQLM-RVMDHPNVI 94
+ V+G G+FG V +A+ + G AIK++ D R EL+++ ++ HPN+I
Sbjct: 15 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 74
Query: 95 SLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLK------------HYSSANQRMPLIYV 141
+L + +L L +EY P ++ L+ +S + +
Sbjct: 75 NLLGACE-----HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 142 KLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYI 201
+ + RG+ Y+ + HRDL +N+LV + KI DFG ++
Sbjct: 130 LHFAADVARGMDYLSQ-KQFIHRDLAARNILVGE-NYVAKIADFGLSRGQEVYVKKTMGR 187
Query: 202 CSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 255
+ A E + + YTT+ D+WS G +L E++ +L E +
Sbjct: 188 LPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP 240
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (293), Expect = 1e-31
Identities = 48/230 (20%), Positives = 85/230 (36%), Gaps = 23/230 (10%)
Query: 39 SYMAERVVGTGSFGIVFQAKCLETGE----TVAIKKVLQDRRYKN-----RELQLMRVMD 89
++V+G G FG V++ + VAIK + K E +M
Sbjct: 8 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFS 67
Query: 90 HPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIF 149
H N+I L+ + ++ EY+ K + ++ + I
Sbjct: 68 HHNIIRLEGVISKYKP-----MMIITEYMENGAL--DKFLREKDGEFSVLQLVGMLRGIA 120
Query: 150 RGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC----SRF 205
G+ Y+ HRDL +N+LV+ K+ DFG ++ L
Sbjct: 121 AGMKYLAN-MNYVHRDLAARNILVNS-NLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIR 178
Query: 206 YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 255
+ APE I + S D+WS G V+ E++ E + ++++ I
Sbjct: 179 WTAPEAISYRKFTSAS-DVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN 227
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (292), Expect = 2e-31
Identities = 64/265 (24%), Positives = 100/265 (37%), Gaps = 32/265 (12%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGET---VAIKKVL-----QDRRYKNRELQLMRVMDHP 91
R +G G FG V Q + VAIK R +E MR DHP
Sbjct: 9 IELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 68
Query: 92 NVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 151
+++ L E + ++ME R + L + LY YQ+
Sbjct: 69 HIVKLIGVI------TENPVWIIMELCTLGELR--SFLQVRKYSLDLASLILYAYQLSTA 120
Query: 152 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC--SRFYRAP 209
LAY+ + R HRD+ +N+LV VK+ DFG ++ + + + AP
Sbjct: 121 LAYLES-KRFVHRDIAARNVLVSS-NDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 178
Query: 210 ELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEI--- 265
E I +T++ D+W G + E+L+ G F G D + I P
Sbjct: 179 ESINF-RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPT 237
Query: 266 ------RCMNPNYTD-FRFPQIKAH 283
+C + + RF ++KA
Sbjct: 238 LYSLMTKCWAYDPSRRPRFTELKAQ 262
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (293), Expect = 3e-31
Identities = 60/243 (24%), Positives = 103/243 (42%), Gaps = 38/243 (15%)
Query: 43 ERVVGTGSFGIVFQAKCL-----ETGETVAIKKV-----LQDRRYKNRELQLM-RVMDHP 91
+ +G G+FG V +A + TVA+K + L +R EL+++ + +H
Sbjct: 28 GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHM 87
Query: 92 NVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHY--------------SSANQRM 136
N+++L T ++ EY + L+ +
Sbjct: 88 NIVNLLGAC---TIGGPTL--VITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 137 PLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA 196
L + ++YQ+ +G+A++ + HRDL +N+L+ KICDFG A+ +
Sbjct: 143 DLEDLLSFSYQVAKGMAFLAS-KNCIHRDLAARNILLTH-GRITKICDFGLARDIKNDSN 200
Query: 197 NISYICSR---FYRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVE 252
+ +R + APE IF YT D+WS G L EL LG +PG + +
Sbjct: 201 YVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK 259
Query: 253 IIK 255
+IK
Sbjct: 260 MIK 262
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 115 bits (288), Expect = 9e-31
Identities = 57/247 (23%), Positives = 93/247 (37%), Gaps = 43/247 (17%)
Query: 44 RVVGTGSFGIVFQAKC-----LETGETVAIKKVLQDRRYKN-----RELQLMRVMDHPNV 93
R +G G+FG VFQA+ E VA+K + ++ RE LM D+PN+
Sbjct: 19 RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 78
Query: 94 ISLKHCFFSTTSKNELFLNLVMEYVP---------------------ESMYRVLKHYSSA 132
+ + L + EY+ + + S
Sbjct: 79 V---KLLGVCAVGKPMCL--LFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPG 133
Query: 133 NQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 192
+ Q+ G+AY+ + HRDL +N LV VKI DFG ++ +
Sbjct: 134 PPPLSCAEQLCIARQVAAGMAYLSE-RKFVHRDLATRNCLVGE-NMVVKIADFGLSRNIY 191
Query: 193 AGE---ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVD 248
+ + A+ + + PE IF YTT D+W+ G VL E+ G + G +
Sbjct: 192 SADYYKADGNDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEE 250
Query: 249 QLVEIIK 255
+ +
Sbjct: 251 VIYYVRD 257
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (276), Expect = 6e-29
Identities = 54/244 (22%), Positives = 100/244 (40%), Gaps = 35/244 (14%)
Query: 40 YMAERVVGTGSFGIVFQAKC-----LETGETVAIKKVLQD------RRYKNRELQLMRVM 88
+ +G G+FG V +A T TVA+K + + R + L+ +
Sbjct: 15 LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG 74
Query: 89 DHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHY------------SSANQR 135
H NV++L L +++E+ ++ L+
Sbjct: 75 HHLNVVNLLGACTKPGGP----LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 130
Query: 136 MPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE 195
+ L ++ Y++Q+ +G+ ++ + + HRDL +N+L+ + VKICDFG A+ +
Sbjct: 131 LTLEHLICYSFQVAKGMEFLAS-RKCIHRDLAARNILLSE-KNVVKICDFGLARDIYKDP 188
Query: 196 ANI---SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLG-QPLFPGENAVDQLV 251
+ + APE IF YT D+WS G +L E+ +PG ++
Sbjct: 189 DYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 247
Query: 252 EIIK 255
+K
Sbjct: 248 RRLK 251
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (275), Expect = 7e-29
Identities = 55/246 (22%), Positives = 106/246 (43%), Gaps = 39/246 (15%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGE-------TVAIKKVLQD------RRYKNRELQLMR 86
+ + +G G+FG V A+ + + VA+K + D + +
Sbjct: 15 LVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKM 74
Query: 87 VMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHY------------SSAN 133
+ H N+I+L + L +++EY + ++ L+ +
Sbjct: 75 IGKHKNIINLLGACT-----QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPE 129
Query: 134 QRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA 193
+++ + YQ+ RG+ Y+ + + HRDL +N+LV + +KI DFG A+ +
Sbjct: 130 EQLSSKDLVSCAYQVARGMEYLAS-KKCIHRDLAARNVLVTE-DNVMKIADFGLARDIHH 187
Query: 194 GEAN---ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQ 249
+ + + APE +F YT D+WS G +L E+ LG +PG V++
Sbjct: 188 IDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP-VEE 245
Query: 250 LVEIIK 255
L +++K
Sbjct: 246 LFKLLK 251
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (256), Expect = 4e-26
Identities = 53/234 (22%), Positives = 95/234 (40%), Gaps = 29/234 (12%)
Query: 43 ERVVGTGSFGIVFQAKC-----LETGETVAIKKV-----LQDRRYKNRELQLMRVMDHPN 92
R +G GSFG+V++ E VAIK V +++R E +M+ + +
Sbjct: 25 SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 84
Query: 93 VISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLI------YVKLYT 145
V+ L ++ME + + L+ A P++ +
Sbjct: 85 VVRLLGVVSQGQP-----TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 146 YQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC--- 202
+I G+AY++ + HRDL +N +V VKI DFG + + +
Sbjct: 140 GEIADGMAYLNA-NKFVHRDLAARNCMVAE-DFTVKIGDFGMTRDIYETDYYRKGGKGLL 197
Query: 203 SRFYRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIK 255
+ +PE + +TT D+WS G VL E+ L + + G + L +++
Sbjct: 198 PVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME 250
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 77.5 bits (190), Expect = 1e-17
Identities = 31/200 (15%), Positives = 62/200 (31%), Gaps = 24/200 (12%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFST 103
+++G G VF E +K + ++++ R + L
Sbjct: 6 KLMGEGKESAVFNCYS-EKFGECVVK-FHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARN 63
Query: 104 TSKNELFL---NLVMEYVPESMYRVLKHYSSANQR-MPLIYVKLYTYQIFRGLAYIHTVP 159
+ L + Y E +++ + + + I +A +
Sbjct: 64 EFRALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYH-R 122
Query: 160 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA------NISYICSRFYRAPELIF 213
+ H DL N+LV + I DF + ++ ++ I + F R
Sbjct: 123 GIVHGDLSQYNVLVSE--EGIWIIDFPQSVEVGEEGWREILERDVRNIITYFSR------ 174
Query: 214 GATEYTTSIDIWSAGCVLAE 233
Y T DI SA + +
Sbjct: 175 ---TYRTEKDINSAIDRILQ 191
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 314 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.9 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.21 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.98 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.65 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.88 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.75 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.26 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-53 Score=361.36 Aligned_cols=242 Identities=26% Similarity=0.365 Sum_probs=195.0
Q ss_pred CCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeE
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 111 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 111 (314)
.++|++.+.||+|+||.||+|+++.+|+.||+|.+.... ....+|+.++++++||||+++++++.... .+
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~-----~~ 78 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGN-----IQ 78 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETT-----EE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCc-----ee
Confidence 468999999999999999999999999999999986432 34568999999999999999999985543 48
Q ss_pred EEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcccc
Q 021306 112 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 190 (314)
Q Consensus 112 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~ 190 (314)
++||||++| +|.+.+ .....+++.+++.++.||+.||.|||+ +||+||||||+||+++. ++.+||+|||+++.
T Consensus 79 ~ivmEy~~gg~L~~~l----~~~~~l~e~~~~~i~~qi~~al~ylH~-~~IiHrDiKp~NILl~~-~~~~KL~DFG~a~~ 152 (271)
T d1nvra_ 79 YLFLEYCSGGELFDRI----EPDIGMPEPDAQRFFHQLMAGVVYLHG-IGITHRDIKPENLLLDE-RDNLKISDFGLATV 152 (271)
T ss_dssp EEEEECCTTEEGGGGS----BTTTBCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEECT-TCCEEECCCTTCEE
T ss_pred EEEEeccCCCcHHHHH----hcCCCCCHHHHHHHHHHHHHHHHHHHH-cCCccCcccHHHEEECC-CCCEEEccchhhee
Confidence 899999997 554433 446789999999999999999999999 89999999999999998 78899999999986
Q ss_pred cccCC---ccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCC------
Q 021306 191 LIAGE---ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT------ 261 (314)
Q Consensus 191 ~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~------ 261 (314)
..... ......||+.|+|||.+.+...++.++|||||||++|+|+||+.||....................
T Consensus 153 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (271)
T d1nvra_ 153 FRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKI 232 (271)
T ss_dssp CEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGS
T ss_pred eccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccC
Confidence 54332 233467899999999997766457889999999999999999999987655444433333322111
Q ss_pred ----HHHHh---ccCCCCCCCcccccccCChhhhhc
Q 021306 262 ----REEIR---CMNPNYTDFRFPQIKAHPWHKVCI 290 (314)
Q Consensus 262 ----~~~~~---~~~p~~~~~~~~~l~~~p~~~~~~ 290 (314)
.+.+. ..+|. +|++++++++|||++.+.
T Consensus 233 s~~~~~li~~~L~~dP~-~R~t~~eil~hpwf~~~l 267 (271)
T d1nvra_ 233 DSAPLALLHKILVENPS-ARITIPDIKKDRWYNKPL 267 (271)
T ss_dssp CHHHHHHHHHHSCSSTT-TSCCHHHHTTCTTTTCCC
T ss_pred CHHHHHHHHHHcCCChh-HCcCHHHHhcCHhhCcCC
Confidence 12222 23677 899999999999997543
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-52 Score=360.60 Aligned_cols=239 Identities=24% Similarity=0.404 Sum_probs=200.1
Q ss_pred CCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeEEE
Q 021306 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 113 (314)
Q Consensus 38 ~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 113 (314)
++|++.+.||+|+||.||+|+++.+|+.||+|+++... ....+|+.++++++||||+++++++...+ .+++
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~-----~~~i 94 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGD-----ELWV 94 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETT-----EEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECC-----EEEE
Confidence 47999999999999999999999999999999986433 23468999999999999999999986543 3889
Q ss_pred Eeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcccccc
Q 021306 114 VMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 192 (314)
Q Consensus 114 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~ 192 (314)
|||||+| +|.+.+. .+.+++.+++.++.||+.||.|||+ +||+||||||+|||++. ++.+||+|||+++...
T Consensus 95 vmEy~~gg~L~~~~~-----~~~l~~~~~~~i~~qi~~aL~yLH~-~~iiHrDiKp~NILl~~-~~~vkl~DFG~a~~~~ 167 (293)
T d1yhwa1 95 VMEYLAGGSLTDVVT-----ETCMDEGQIAAVCRECLQALEFLHS-NQVIHRDIKSDNILLGM-DGSVKLTDFGFCAQIT 167 (293)
T ss_dssp EEECCTTCBHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECT-TCCEEECCCTTCEECC
T ss_pred EEEecCCCcHHHHhh-----ccCCCHHHHHHHHHHHHHHHHHHHH-CCCcccCCcHHHeEECC-CCcEeeccchhheeec
Confidence 9999997 5555443 2579999999999999999999999 89999999999999998 7899999999998764
Q ss_pred cCC-ccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCC--H-------
Q 021306 193 AGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT--R------- 262 (314)
Q Consensus 193 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~--~------- 262 (314)
... ......||+.|+|||.+.+.. ++.++|||||||++|+|+||+.||.+.+..+.+..+........ +
T Consensus 168 ~~~~~~~~~~gt~~Y~aPE~~~~~~-~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 246 (293)
T d1yhwa1 168 PEQSKRSTMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIF 246 (293)
T ss_dssp STTCCBCCCCSCGGGCCHHHHSSSC-BCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHH
T ss_pred cccccccccccCCCccChhhhcCCC-CCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCCHHH
Confidence 432 344567899999999997654 89999999999999999999999999988888877776643321 1
Q ss_pred -HHHh---ccCCCCCCCcccccccCChhhhhc
Q 021306 263 -EEIR---CMNPNYTDFRFPQIKAHPWHKVCI 290 (314)
Q Consensus 263 -~~~~---~~~p~~~~~~~~~l~~~p~~~~~~ 290 (314)
+.+. ..+|. +|+++.++++|||++...
T Consensus 247 ~~li~~~L~~dP~-~R~s~~eil~Hp~~~~~~ 277 (293)
T d1yhwa1 247 RDFLNRCLDMDVE-KRGSAKELLQHQFLKIAK 277 (293)
T ss_dssp HHHHHHHTCSSTT-TSCCHHHHTTCGGGGGCC
T ss_pred HHHHHHHccCChh-HCcCHHHHhcCHhhCCCC
Confidence 1122 23666 899999999999998654
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-53 Score=357.91 Aligned_cols=240 Identities=27% Similarity=0.463 Sum_probs=199.5
Q ss_pred CCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeecc-------ccchHHHHHHHHhCCCCceeeeceeeeecCCCCce
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL 109 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~-------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 109 (314)
.++|++.+.||+|+||.||+|+++.+++.||+|.+.+. .....+|+.++++++||||+++++++.+. .
T Consensus 5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~-----~ 79 (263)
T d2j4za1 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDA-----T 79 (263)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS-----S
T ss_pred hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEEC-----C
Confidence 46899999999999999999999999999999998642 22346899999999999999999998543 3
Q ss_pred eEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcc
Q 021306 110 FLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 188 (314)
Q Consensus 110 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~ 188 (314)
.+++|||||+| +|.+.+.. ..++++.+++.++.||+.||.|||+ +||+||||||+||+++. ++.+||+|||++
T Consensus 80 ~~~ivmEy~~~g~L~~~l~~----~~~l~e~~~~~i~~qi~~al~~lH~-~~ivHrDiKp~Nill~~-~~~~kl~DFG~a 153 (263)
T d2j4za1 80 RVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHS-KRVIHRDIKPENLLLGS-AGELKIADFGWS 153 (263)
T ss_dssp EEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECT-TSCEEECCCCSC
T ss_pred EEEEEEeecCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeeeeccccceecC-CCCEeeccccee
Confidence 48899999996 77666653 4689999999999999999999999 89999999999999998 788999999999
Q ss_pred cccccCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCC----H--
Q 021306 189 KQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT----R-- 262 (314)
Q Consensus 189 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~----~-- 262 (314)
...... ......||+.|+|||.+.+.. ++.++|||||||++|+|++|+.||.+.+..+.+..+.+.....+ .
T Consensus 154 ~~~~~~-~~~~~~Gt~~Y~APE~~~~~~-~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~ 231 (263)
T d2j4za1 154 VHAPSS-RRTTLCGTLDYLPPEMIEGRM-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA 231 (263)
T ss_dssp SCCCCC-CCEETTEEGGGCCHHHHTTCC-CCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHH
T ss_pred eecCCC-cccccCCCCcccCHHHHcCCC-CCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCccCCHHH
Confidence 765433 334567899999999997655 89999999999999999999999999888777776655432211 1
Q ss_pred -HHHh---ccCCCCCCCcccccccCChhhhhc
Q 021306 263 -EEIR---CMNPNYTDFRFPQIKAHPWHKVCI 290 (314)
Q Consensus 263 -~~~~---~~~p~~~~~~~~~l~~~p~~~~~~ 290 (314)
+.+. ..+|. +|++++++++|||++..+
T Consensus 232 ~~li~~~L~~dp~-~R~t~~eil~hp~~~~~s 262 (263)
T d2j4za1 232 RDLISRLLKHNPS-QRPMLREVLEHPWITANS 262 (263)
T ss_dssp HHHHHHHTCSSGG-GSCCHHHHHTCHHHHHHC
T ss_pred HHHHHHHccCCHh-HCcCHHHHHcCcCcCCcC
Confidence 1222 23666 899999999999997654
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-52 Score=355.31 Aligned_cols=243 Identities=26% Similarity=0.356 Sum_probs=190.5
Q ss_pred CCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCCcee
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 110 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 110 (314)
.++|++.+.||+|+||.||+|+++.+|+.||+|.+.... ....+|+.++++++||||+++++++.+.. ...
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~---~~~ 79 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRT---NTT 79 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC-------C
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCC---CCE
Confidence 368999999999999999999999999999999986542 22457999999999999999999885422 234
Q ss_pred EEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCC-----ceecCCCCCcEEEcCCCCcEEEee
Q 021306 111 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR-----VCHRDLKPQNLLVDPLTHQVKICD 184 (314)
Q Consensus 111 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~-----i~h~dl~p~Nil~~~~~~~~~l~d 184 (314)
+|+|||||+| +|.+.+......+..+++.+++.++.||+.||.|||+ +| |+||||||+|||++. ++.+||+|
T Consensus 80 ~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~-~~~~~~~IiHrDiKp~NIll~~-~~~vkl~D 157 (269)
T d2java1 80 LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR-RSDGGHTVLHRDLKPANVFLDG-KQNVKLGD 157 (269)
T ss_dssp EEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH-HCC---------CCGGGEEECT-TSCEEECC
T ss_pred EEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHH-hcCCCCCEEeCcCchhhcCcCC-CCcEEEee
Confidence 7899999985 7888777666667889999999999999999999998 66 999999999999998 78999999
Q ss_pred cCcccccccCC-ccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCH-
Q 021306 185 FGSAKQLIAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR- 262 (314)
Q Consensus 185 fg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~- 262 (314)
||+++...... ......+|+.|+|||.+.+.. ++.++|||||||++|+|+||+.||.+.+..+....+......+.+
T Consensus 158 FG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~-~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~~~~ 236 (269)
T d2java1 158 FGLARILNHDTSFAKAFVGTPYYMSPEQMNRMS-YNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPY 236 (269)
T ss_dssp HHHHHHC-----------CCCSCCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCT
T ss_pred ccceeecccCCCccccCCCCcccCCHHHHcCCC-CChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCc
Confidence 99998664432 233567899999999996554 899999999999999999999999998888777776654322211
Q ss_pred -------HHHh---ccCCCCCCCcccccccCChh
Q 021306 263 -------EEIR---CMNPNYTDFRFPQIKAHPWH 286 (314)
Q Consensus 263 -------~~~~---~~~p~~~~~~~~~l~~~p~~ 286 (314)
+.+. ..+|. +|+++.+|++|||.
T Consensus 237 ~~s~~l~~li~~~L~~dp~-~Rps~~ell~hp~i 269 (269)
T d2java1 237 RYSDELNEIITRMLNLKDY-HRPSVEEILENPLI 269 (269)
T ss_dssp TSCHHHHHHHHHHTCSSGG-GSCCHHHHHTSTTC
T ss_pred ccCHHHHHHHHHHcCCChh-HCcCHHHHHhCCcC
Confidence 1121 23666 89999999999994
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-51 Score=362.74 Aligned_cols=254 Identities=63% Similarity=1.093 Sum_probs=218.3
Q ss_pred CCccCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHhCCCCceeeeceeeeecCC-CCceeE
Q 021306 33 EPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTS-KNELFL 111 (314)
Q Consensus 33 ~~~~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~~~~~~ 111 (314)
.|.+. +|+..++||+|+||+||+|+++.+|+.||+|++.++.....+|+.++++++|+||+++++++..... .+..++
T Consensus 16 ~~~~~-~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~ 94 (350)
T d1q5ka_ 16 RPQEV-SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 94 (350)
T ss_dssp CCEEE-EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEE
T ss_pred CcccC-CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEE
Confidence 44334 6999999999999999999999999999999998888777899999999999999999999865433 445678
Q ss_pred EEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCccccc
Q 021306 112 NLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 191 (314)
Q Consensus 112 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~ 191 (314)
++||||+++++...+..+......+++.+++.++.||+.||+|||+ +||+||||||+|||++.++..+||+|||++...
T Consensus 95 ~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~-~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 95 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHh-cCCcccCCCcceEEEecCCCceeEecccchhhc
Confidence 8999999999888888777778899999999999999999999999 999999999999999975568999999999877
Q ss_pred ccCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCHHH-------
Q 021306 192 IAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE------- 264 (314)
Q Consensus 192 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~------- 264 (314)
..........+++.|+|||.+.+...++.++||||+||++|||++|+.||...+..+.+..+.+..+.+..+.
T Consensus 174 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~ 253 (350)
T d1q5ka_ 174 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPN 253 (350)
T ss_dssp CTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC-
T ss_pred cCCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccc
Confidence 6655566678899999999987776789999999999999999999999999998888888877654433211
Q ss_pred -----------------------------H---hccCCCCCCCcccccccCChhhhh
Q 021306 265 -----------------------------I---RCMNPNYTDFRFPQIKAHPWHKVC 289 (314)
Q Consensus 265 -----------------------------~---~~~~p~~~~~~~~~l~~~p~~~~~ 289 (314)
+ ...+|. +|+++.++++|||++..
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~-~R~ta~e~L~Hp~f~~~ 309 (350)
T d1q5ka_ 254 YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPT-ARLTPLEACAHSFFDEL 309 (350)
T ss_dssp --CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGG-GSCCHHHHHTSGGGGGG
T ss_pred hhhccccccccCchhhhcccCCCHHHHHHHHHHccCChh-HCcCHHHHhcCHhhccc
Confidence 1 233677 89999999999999765
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-51 Score=354.76 Aligned_cols=243 Identities=24% Similarity=0.388 Sum_probs=199.1
Q ss_pred CCceeeeeEeecCceEEEEEEECCCCcEEEEEEeecc----ccchHHHHHHHHhCCCCceeeeceeeeecCCCCceeEEE
Q 021306 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD----RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 113 (314)
Q Consensus 38 ~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 113 (314)
+.|++.+.||+|+||.||+|+++.+++.||+|.+... .....+|+.++++++||||+++++++.... .+++
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~-----~~~l 86 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYEN-----NLWI 86 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETT-----EEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC-----eEEE
Confidence 3699999999999999999999999999999998643 234568999999999999999999986543 3889
Q ss_pred Eeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcccccc
Q 021306 114 VMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 192 (314)
Q Consensus 114 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~ 192 (314)
|||||+| +|.+.+.. ...++++.+++.++.||+.||.|||+ +||+||||||+|||++. ++.+||+|||++....
T Consensus 87 vmEy~~~g~L~~~~~~---~~~~l~e~~~~~i~~qi~~gL~ylH~-~~ivHrDiKp~NIll~~-~~~~Kl~DFG~a~~~~ 161 (288)
T d2jfla1 87 LIEFCAGGAVDAVMLE---LERPLTESQIQVVCKQTLDALNYLHD-NKIIHRDLKAGNILFTL-DGDIKLADFGVSAKNT 161 (288)
T ss_dssp EEECCTTEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECT-TSCEEECCCTTCEECH
T ss_pred EEecCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCEEEeecChhheeECC-CCCEEEEechhhhccC
Confidence 9999996 55555443 34679999999999999999999999 89999999999999998 7899999999987553
Q ss_pred cCC-ccccccccccccccccccC----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCC------
Q 021306 193 AGE-ANISYICSRFYRAPELIFG----ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT------ 261 (314)
Q Consensus 193 ~~~-~~~~~~~~~~y~aPE~~~~----~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~------ 261 (314)
... ......||+.|+|||.+.. ...++.++|||||||++|+|+||+.||.+.+..+.+..+.+...+..
T Consensus 162 ~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 241 (288)
T d2jfla1 162 RTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRW 241 (288)
T ss_dssp HHHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSGGGS
T ss_pred CCcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCccccC
Confidence 322 2234678999999999842 33478999999999999999999999999988888887776532221
Q ss_pred -H---HHHh-c--cCCCCCCCcccccccCChhhhhcc
Q 021306 262 -R---EEIR-C--MNPNYTDFRFPQIKAHPWHKVCIF 291 (314)
Q Consensus 262 -~---~~~~-~--~~p~~~~~~~~~l~~~p~~~~~~~ 291 (314)
. +.+. + .+|. +|+++.++++|||++....
T Consensus 242 s~~~~~li~~~L~~dp~-~R~t~~ell~hp~~~~~~~ 277 (288)
T d2jfla1 242 SSNFKDFLKKCLEKNVD-ARWTTSQLLQHPFVTVDSN 277 (288)
T ss_dssp CHHHHHHHHHHSCSSTT-TSCCHHHHTTSGGGCCCCC
T ss_pred CHHHHHHHHHHccCChh-HCcCHHHHhcCcccCCCCC
Confidence 1 1222 2 3666 8999999999999986543
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-51 Score=349.79 Aligned_cols=238 Identities=24% Similarity=0.385 Sum_probs=191.6
Q ss_pred ceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeEEE
Q 021306 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 113 (314)
Q Consensus 40 y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 113 (314)
|++.+.||+|+||+||+|+++.+++.||+|.+.... ....+|++++++++||||+++++++.... .....+++
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~-~~~~~~~i 89 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGKKCIVL 89 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES-SSCEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeecc-ccCCEEEE
Confidence 478889999999999999999999999999986532 23458999999999999999999886543 23455789
Q ss_pred Eeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCC--ceecCCCCCcEEEcCCCCcEEEeecCcccc
Q 021306 114 VMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR--VCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 190 (314)
Q Consensus 114 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~--i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~ 190 (314)
||||+++ +|.+.+.. ...+++.+++.++.||+.||.|||+ ++ |+||||||+|||++..++.+||+|||+++.
T Consensus 90 vmE~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~gl~yLH~-~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~ 164 (270)
T d1t4ha_ 90 VTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHT-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 164 (270)
T ss_dssp EEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHT-SSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred EEeCCCCCcHHHHHhc----cccccHHHHHHHHHHHHHHHHHHHH-CCCCEEeCCcChhhceeeCCCCCEEEeecCccee
Confidence 9999996 66666653 4689999999999999999999999 78 999999999999976578899999999975
Q ss_pred cccCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCC-------H-
Q 021306 191 LIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT-------R- 262 (314)
Q Consensus 191 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~-------~- 262 (314)
... .......||+.|+|||.+.+ .++.++|||||||++|+|++|+.||.+......+...+.....+. +
T Consensus 165 ~~~-~~~~~~~GT~~Y~aPE~~~~--~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 241 (270)
T d1t4ha_ 165 KRA-SFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPE 241 (270)
T ss_dssp CCT-TSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHH
T ss_pred ccC-CccCCcccCccccCHHHhCC--CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCccCCHH
Confidence 432 33345678999999999854 389999999999999999999999988766555554443322221 1
Q ss_pred --HHHh-cc--CCCCCCCcccccccCChhh
Q 021306 263 --EEIR-CM--NPNYTDFRFPQIKAHPWHK 287 (314)
Q Consensus 263 --~~~~-~~--~p~~~~~~~~~l~~~p~~~ 287 (314)
+.+. ++ +|+ +|+++.+|++|||++
T Consensus 242 ~~~li~~~l~~dp~-~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 242 VKEIIEGCIRQNKD-ERYSIKDLLNHAFFQ 270 (270)
T ss_dssp HHHHHHHHSCSSGG-GSCCHHHHHTSGGGC
T ss_pred HHHHHHHHccCCHh-HCcCHHHHhCCcccC
Confidence 1122 23 566 899999999999986
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-51 Score=353.96 Aligned_cols=242 Identities=27% Similarity=0.485 Sum_probs=196.9
Q ss_pred CCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCCcee
Q 021306 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 110 (314)
Q Consensus 38 ~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 110 (314)
++|++.+.||+|+||+||+|+++.+|+.||+|.+.+.. ....+|+.++++++||||+++++++.+ ...
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-----~~~ 82 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQD-----DEK 82 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEEC-----SSE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEE-----CCE
Confidence 57999999999999999999999999999999986421 234689999999999999999999843 334
Q ss_pred EEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCccc
Q 021306 111 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 189 (314)
Q Consensus 111 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~ 189 (314)
+|+||||++| +|.+.+.. .+.+++.+++.++.|++.||.|||+ +||+||||||+||+++. ++.++|+|||+++
T Consensus 83 ~~ivmEy~~gg~L~~~~~~----~~~l~e~~~~~~~~qi~~al~ylH~-~~iiHrDiKp~NIll~~-~~~vkl~DFG~a~ 156 (288)
T d1uu3a_ 83 LYFGLSYAKNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYLHG-KGIIHRDLKPENILLNE-DMHIQITDFGTAK 156 (288)
T ss_dssp EEEEECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECT-TSCEEECCCTTCE
T ss_pred EEEEEEccCCCCHHHhhhc----cCCCCHHHHHHHHHHHHHHHHhhcc-ccEEcCcCCccccccCC-CceEEecccccce
Confidence 8899999996 66665553 4789999999999999999999999 89999999999999998 7889999999998
Q ss_pred ccccCC---ccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCC----H
Q 021306 190 QLIAGE---ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT----R 262 (314)
Q Consensus 190 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~----~ 262 (314)
...... ......||+.|+|||.+.+.. ++.++|||||||++|+|++|+.||.+.+..+.+.++.+.....+ +
T Consensus 157 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~-~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~ 235 (288)
T d1uu3a_ 157 VLSPESKQARANSFVGTAQYVSPELLTEKS-ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFP 235 (288)
T ss_dssp ECC----------CCCCGGGCCHHHHHTCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCTTCCH
T ss_pred ecccCCcccccccccCCccccCceeeccCC-CCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCCCCccCCH
Confidence 654322 223457899999999997655 89999999999999999999999999988887777765432211 1
Q ss_pred ---HHHh---ccCCCCCCCcccc------cccCChhhhhccc
Q 021306 263 ---EEIR---CMNPNYTDFRFPQ------IKAHPWHKVCIFH 292 (314)
Q Consensus 263 ---~~~~---~~~p~~~~~~~~~------l~~~p~~~~~~~~ 292 (314)
+.+. ..+|. +|+++++ |++|||++....+
T Consensus 236 ~~~~li~~~L~~dP~-~R~t~~e~~~~~~i~~Hpff~~i~w~ 276 (288)
T d1uu3a_ 236 KARDLVEKLLVLDAT-KRLGCEEMEGYGPLKAHPFFESVTWE 276 (288)
T ss_dssp HHHHHHHTTSCSSGG-GSTTSGGGTCHHHHHTSGGGTTCCCT
T ss_pred HHHHHHHHHccCCHh-HCcCHHHHcCCHHHHcCCccCCCCHH
Confidence 1222 23666 8999998 4788888766543
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.5e-52 Score=359.79 Aligned_cols=241 Identities=28% Similarity=0.405 Sum_probs=187.0
Q ss_pred CCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeE
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 111 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 111 (314)
.+.|++.+.||+|+||+||+|+++.+++.||+|.+.+.. ....+|+.++++++||||+++++++.+ ...+
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-----~~~~ 82 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYES-----GGHL 82 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEEC-----SSEE
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-----CCEE
Confidence 456999999999999999999999999999999986432 234589999999999999999999843 3348
Q ss_pred EEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcC--CCCcEEEeecCcc
Q 021306 112 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP--LTHQVKICDFGSA 188 (314)
Q Consensus 112 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~--~~~~~~l~dfg~~ 188 (314)
++|||||+| +|.+.+.. .+.+++.+++.++.||+.||.|||+ +||+||||||+||++.. .++.+||+|||++
T Consensus 83 ~lvmE~~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~-~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a 157 (307)
T d1a06a_ 83 YLIMQLVSGGELFDRIVE----KGFYTERDASRLIFQVLDAVKYLHD-LGIVHRDLKPENLLYYSLDEDSKIMISDFGLS 157 (307)
T ss_dssp EEEECCCCSCBHHHHHHT----CSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEESSSSTTCCEEECCC---
T ss_pred EEEEeccCCCcHHHhhhc----ccCCCHHHHHHHHHHHHHHHHhhhh-ceeeeEEecccceeecccCCCceEEEecccee
Confidence 899999995 77776653 5789999999999999999999999 89999999999999953 3678999999999
Q ss_pred cccccCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCH------
Q 021306 189 KQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR------ 262 (314)
Q Consensus 189 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~------ 262 (314)
+............||+.|+|||.+.+.. ++.++|||||||++|+|++|+.||.+.+..+....+.+.......
T Consensus 158 ~~~~~~~~~~~~~GT~~y~APE~~~~~~-~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 236 (307)
T d1a06a_ 158 KMEDPGSVLSTACGTPGYVAPEVLAQKP-YSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDI 236 (307)
T ss_dssp ---------------CTTSCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTS
T ss_pred EEccCCCeeeeeeeCccccCcHHHcCCC-CCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCC
Confidence 8765555555677999999999997654 899999999999999999999999999888877777765322211
Q ss_pred -----HHHh---ccCCCCCCCcccccccCChhhhh
Q 021306 263 -----EEIR---CMNPNYTDFRFPQIKAHPWHKVC 289 (314)
Q Consensus 263 -----~~~~---~~~p~~~~~~~~~l~~~p~~~~~ 289 (314)
+.+. ..+|. +|+++.++++|||++..
T Consensus 237 s~~~~~li~~~L~~dP~-~R~s~~eil~hp~~~~~ 270 (307)
T d1a06a_ 237 SDSAKDFIRHLMEKDPE-KRFTCEQALQHPWIAGD 270 (307)
T ss_dssp CHHHHHHHHHHSCSSGG-GSCCHHHHHHSTTTTSS
T ss_pred CHHHHHHHHHHccCCHh-HCcCHHHHhcCHhhCCC
Confidence 1222 23676 89999999999999753
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.9e-51 Score=352.97 Aligned_cols=238 Identities=28% Similarity=0.429 Sum_probs=198.6
Q ss_pred CceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeE
Q 021306 39 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 111 (314)
Q Consensus 39 ~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 111 (314)
.|++.+.||+|+||.||+|+++.+++.||||.+.... ....+|+.++++++||||+++++++.... .+
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~-----~~ 90 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH-----TA 90 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT-----EE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECC-----EE
Confidence 4999999999999999999999999999999986543 22457999999999999999999985543 38
Q ss_pred EEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCccccc
Q 021306 112 NLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 191 (314)
Q Consensus 112 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~ 191 (314)
++|||||.++++..+.. ...++++.+++.++.||+.||.|||+ +||+||||||+|||++. ++.+||+|||++...
T Consensus 91 ~iv~E~~~~g~l~~~~~---~~~~l~e~~~~~i~~qi~~aL~yLH~-~~iiHrDiKp~NILl~~-~~~~Kl~DFG~a~~~ 165 (309)
T d1u5ra_ 91 WLVMEYCLGSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHS-HNMIHRDVKAGNILLSE-PGLVKLGDFGSASIM 165 (309)
T ss_dssp EEEEECCSEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCSGGGEEEET-TTEEEECCCTTCBSS
T ss_pred EEEEEecCCCchHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHh-CCEeccCCCcceEEECC-CCCEEEeeccccccc
Confidence 89999999876554432 35789999999999999999999999 99999999999999998 889999999999764
Q ss_pred ccCCccccccccccccccccccCC--CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCC--------
Q 021306 192 IAGEANISYICSRFYRAPELIFGA--TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT-------- 261 (314)
Q Consensus 192 ~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~-------- 261 (314)
.. .....||+.|+|||.+.+. ..++.++|||||||++|+|++|+.||.+.+..+.+..+.+......
T Consensus 166 ~~---~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~ 242 (309)
T d1u5ra_ 166 AP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEY 242 (309)
T ss_dssp SS---BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSCHH
T ss_pred CC---CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCHH
Confidence 33 3346789999999998642 3478999999999999999999999999988888887776543221
Q ss_pred -HHHHh---ccCCCCCCCcccccccCChhhhhc
Q 021306 262 -REEIR---CMNPNYTDFRFPQIKAHPWHKVCI 290 (314)
Q Consensus 262 -~~~~~---~~~p~~~~~~~~~l~~~p~~~~~~ 290 (314)
.+.+. ..+|. +|+++.++++|||++...
T Consensus 243 ~~~li~~~L~~dP~-~Rpt~~ell~Hp~~~~~~ 274 (309)
T d1u5ra_ 243 FRNFVDSCLQKIPQ-DRPTSEVLLKHRFVLRER 274 (309)
T ss_dssp HHHHHHHHTCSSGG-GSCCHHHHTTCHHHHSCC
T ss_pred HHHHHHHHCcCChh-HCcCHHHHHhCHHhcCCC
Confidence 11222 23677 899999999999997644
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=3e-51 Score=361.32 Aligned_cols=243 Identities=24% Similarity=0.379 Sum_probs=203.2
Q ss_pred cCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeE
Q 021306 36 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 111 (314)
Q Consensus 36 ~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 111 (314)
..+.|++.+.||+|+||.||+|+++.+|+.||+|.++... ....+|+.++++++||||+++++++.. ...+
T Consensus 27 ~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~-----~~~~ 101 (352)
T d1koba_ 27 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFED-----KYEM 101 (352)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEEC-----SSEE
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-----CCEE
Confidence 4568999999999999999999999999999999986543 234589999999999999999999853 3348
Q ss_pred EEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcC-CCCcEEEeecCccc
Q 021306 112 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP-LTHQVKICDFGSAK 189 (314)
Q Consensus 112 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~-~~~~~~l~dfg~~~ 189 (314)
++|||||+| +|.+.+. ....++++.+++.++.||+.||.|||+ +||+||||||+|||++. .++.+||+|||++.
T Consensus 102 ~ivmE~~~gg~L~~~~~---~~~~~l~e~~~~~i~~qi~~aL~ylH~-~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~ 177 (352)
T d1koba_ 102 VLILEFLSGGELFDRIA---AEDYKMSEAEVINYMRQACEGLKHMHE-HSIVHLDIKPENIMCETKKASSVKIIDFGLAT 177 (352)
T ss_dssp EEEEECCCCCBHHHHTT---CTTCCBCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESSTTCCCEEECCCTTCE
T ss_pred EEEEEcCCCChHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecccccccccccccCCCeEEEeecccce
Confidence 899999996 5555443 234679999999999999999999999 99999999999999974 36789999999998
Q ss_pred ccccCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCH-------
Q 021306 190 QLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR------- 262 (314)
Q Consensus 190 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~------- 262 (314)
............+|+.|+|||.+.+.. ++.++|||||||++|+|+||+.||.+.+..+.+..+.+.....+.
T Consensus 178 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 256 (352)
T d1koba_ 178 KLNPDEIVKVTTATAEFAAPEIVDREP-VGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVS 256 (352)
T ss_dssp ECCTTSCEEEECSSGGGCCHHHHTTCC-BCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSC
T ss_pred ecCCCCceeeccCcccccCHHHHcCCC-CCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCC
Confidence 876666666678899999999997654 899999999999999999999999999988888877765432221
Q ss_pred ----HHHh---ccCCCCCCCcccccccCChhhhh
Q 021306 263 ----EEIR---CMNPNYTDFRFPQIKAHPWHKVC 289 (314)
Q Consensus 263 ----~~~~---~~~p~~~~~~~~~l~~~p~~~~~ 289 (314)
+.+. ..+|. +|+++.++++|||++..
T Consensus 257 ~~~~~li~~~L~~dp~-~R~s~~eil~Hp~~~~~ 289 (352)
T d1koba_ 257 PEAKDFIKNLLQKEPR-KRLTVHDALEHPWLKGD 289 (352)
T ss_dssp HHHHHHHHTTSCSSGG-GSCCHHHHHTSTTTSSC
T ss_pred HHHHHHHHHHccCChh-HCcCHHHHhcCHhhCCC
Confidence 1222 23566 89999999999999754
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-51 Score=353.81 Aligned_cols=244 Identities=25% Similarity=0.402 Sum_probs=201.5
Q ss_pred cCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc----------cchHHHHHHHHhCCCCceeeeceeeeecCC
Q 021306 36 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----------RYKNRELQLMRVMDHPNVISLKHCFFSTTS 105 (314)
Q Consensus 36 ~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~----------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 105 (314)
..+.|++.+.||+|+||+||+|+++.+|+.||+|.+++.. ....+|+.++++++||||+++++++.+.
T Consensus 8 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~-- 85 (293)
T d1jksa_ 8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENK-- 85 (293)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS--
T ss_pred cccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC--
Confidence 3467999999999999999999999999999999986431 2346899999999999999999998443
Q ss_pred CCceeEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCC---CcEE
Q 021306 106 KNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLT---HQVK 181 (314)
Q Consensus 106 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~---~~~~ 181 (314)
..+++|||||+| +|.+.+.. .+.+++.+++.++.|++.||.|||+ +||+||||||+||+++..+ ..+|
T Consensus 86 ---~~~~iv~E~~~gg~L~~~i~~----~~~l~~~~~~~~~~qi~~al~yLH~-~~ivHrDiKp~Nill~~~~~~~~~vk 157 (293)
T d1jksa_ 86 ---TDVILILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLHS-LQIAHFDLKPENIMLLDRNVPKPRIK 157 (293)
T ss_dssp ---SEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEESCSSSSSCCEE
T ss_pred ---CEEEEEEEcCCCccccchhcc----ccccchhHHHHHHHHHHHHHHhhhh-cceeecccccceEEEecCCCcccceE
Confidence 348899999996 67766654 4689999999999999999999999 8999999999999998733 2599
Q ss_pred EeecCcccccccCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCC
Q 021306 182 ICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 261 (314)
Q Consensus 182 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~ 261 (314)
++|||++.............+|+.|+|||.+.+.. ++.++|||||||++|+|++|+.||.+.+..+.+..+.+......
T Consensus 158 l~DfG~a~~~~~~~~~~~~~~t~~y~APE~~~~~~-~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~ 236 (293)
T d1jksa_ 158 IIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEP-LGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFE 236 (293)
T ss_dssp ECCCTTCEECTTSCBCSCCCCCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCC
T ss_pred ecchhhhhhcCCCccccccCCCCcccCHHHHcCCC-CCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCC
Confidence 99999998776555556677899999999997654 89999999999999999999999999998888777766533322
Q ss_pred H-----------HHHh-cc--CCCCCCCcccccccCChhhhhcc
Q 021306 262 R-----------EEIR-CM--NPNYTDFRFPQIKAHPWHKVCIF 291 (314)
Q Consensus 262 ~-----------~~~~-~~--~p~~~~~~~~~l~~~p~~~~~~~ 291 (314)
. +.+. ++ +|. +|++++++++|||++....
T Consensus 237 ~~~~~~~s~~~~~li~~~L~~dP~-~R~s~~eil~hp~~~~~~~ 279 (293)
T d1jksa_ 237 DEYFSNTSALAKDFIRRLLVKDPK-KRMTIQDSLQHPWIKPKDT 279 (293)
T ss_dssp HHHHTTSCHHHHHHHHTTSCSSGG-GSCCHHHHHHSTTTCC---
T ss_pred chhcCCCCHHHHHHHHHHccCChh-HCcCHHHHhcCcccCCCCh
Confidence 2 1222 22 566 8999999999999987654
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=4.8e-51 Score=359.71 Aligned_cols=244 Identities=26% Similarity=0.405 Sum_probs=205.0
Q ss_pred cCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeE
Q 021306 36 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 111 (314)
Q Consensus 36 ~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 111 (314)
..++|++++.||+|+||.||+|+++.+|+.||+|++.... ....+|+.++++++||||+++++++.... .+
T Consensus 24 il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~-----~~ 98 (350)
T d1koaa2 24 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDN-----EM 98 (350)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETT-----EE
T ss_pred CccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECC-----EE
Confidence 4578999999999999999999999999999999986543 23458999999999999999999985433 48
Q ss_pred EEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcC-CCCcEEEeecCccc
Q 021306 112 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP-LTHQVKICDFGSAK 189 (314)
Q Consensus 112 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~-~~~~~~l~dfg~~~ 189 (314)
++|||||+| +|.+.+.. ..+++++.+++.++.||+.||.|||+ +||+||||||+||+++. .++.+||+|||+++
T Consensus 99 ~ivmE~~~gg~L~~~l~~---~~~~l~e~~~~~i~~qi~~aL~ylH~-~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~ 174 (350)
T d1koaa2 99 VMIYEFMSGGELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHMHE-NNYVHLDLKPENIMFTTKRSNELKLIDFGLTA 174 (350)
T ss_dssp EEEECCCCSCBHHHHHTC---TTSCBCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESSTTSCCEEECCCTTCE
T ss_pred EEEEEcCCCCCHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHh-cCCeeeeechhHeeeccCCCCeEEEeecchhe
Confidence 899999986 76666643 34679999999999999999999999 99999999999999964 25789999999998
Q ss_pred ccccCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCH-------
Q 021306 190 QLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR------- 262 (314)
Q Consensus 190 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~------- 262 (314)
............||+.|+|||.+.+.. ++.++|||||||++|+|++|+.||.+.+..+.+..+.+.......
T Consensus 175 ~~~~~~~~~~~~gT~~Y~aPEv~~~~~-~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 253 (350)
T d1koaa2 175 HLDPKQSVKVTTGTAEFAAPEVAEGKP-VGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGIS 253 (350)
T ss_dssp ECCTTSCEEEECSCTTTCCHHHHHTCC-BCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCC
T ss_pred ecccccccceecCcccccCHHHHcCCC-CChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCC
Confidence 776666666678899999999997655 899999999999999999999999999888888887765432221
Q ss_pred ----HHHh---ccCCCCCCCcccccccCChhhhhc
Q 021306 263 ----EEIR---CMNPNYTDFRFPQIKAHPWHKVCI 290 (314)
Q Consensus 263 ----~~~~---~~~p~~~~~~~~~l~~~p~~~~~~ 290 (314)
+.+. ..+|. +|+++.++++|||++...
T Consensus 254 ~~~~~li~~~L~~dP~-~R~t~~eil~hp~~~~~~ 287 (350)
T d1koaa2 254 EDGKDFIRKLLLADPN-TRMTIHQALEHPWLTPGN 287 (350)
T ss_dssp HHHHHHHHHHCCSSGG-GSCCHHHHHHSTTTSCTT
T ss_pred HHHHHHHHHHccCChh-HCcCHHHHhcCcccCCCC
Confidence 1222 23666 899999999999998653
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=8e-51 Score=353.84 Aligned_cols=239 Identities=27% Similarity=0.472 Sum_probs=198.2
Q ss_pred CCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCCce
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL 109 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 109 (314)
.++|++.+.||+|+||+||+|+++.+|+.||+|++++.. ....+|+.++++++||||+++++++... .
T Consensus 3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~-----~ 77 (316)
T d1fota_ 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDA-----Q 77 (316)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECS-----S
T ss_pred hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeC-----C
Confidence 357999999999999999999999999999999986431 2345899999999999999999998543 3
Q ss_pred eEEEEeeccccc-HHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcc
Q 021306 110 FLNLVMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 188 (314)
Q Consensus 110 ~~~lv~e~~~~~-l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~ 188 (314)
.+++||||+.|+ +...+. ....+++..++.++.||+.||.|||+ +||+||||||+|||++. ++.+||+|||++
T Consensus 78 ~~~ivmE~~~gg~l~~~~~----~~~~~~~~~~~~~~~qi~~al~~lH~-~~iiHrDiKp~NILl~~-~g~vkL~DFG~a 151 (316)
T d1fota_ 78 QIFMIMDYIEGGELFSLLR----KSQRFPNPVAKFYAAEVCLALEYLHS-KDIIYRDLKPENILLDK-NGHIKITDFGFA 151 (316)
T ss_dssp EEEEEECCCCSCBHHHHHH----HTSSCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCCGGGEEECT-TSCEEECCCSSC
T ss_pred eeeeEeeecCCcccccccc----ccccccccHHHHHHHHHHHhhhhhcc-CcEEccccCchheeEcC-CCCEEEecCccc
Confidence 489999999975 444333 46789999999999999999999999 99999999999999998 889999999999
Q ss_pred cccccCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCC----H--
Q 021306 189 KQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT----R-- 262 (314)
Q Consensus 189 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~----~-- 262 (314)
+..... .....||+.|+|||.+.+.. ++.++|||||||++|+|+||+.||.+.+..+....+.+.....+ +
T Consensus 152 ~~~~~~--~~~~~Gt~~Y~APE~l~~~~-y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~ 228 (316)
T d1fota_ 152 KYVPDV--TYTLCGTPDYIAPEVVSTKP-YNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDV 228 (316)
T ss_dssp EECSSC--BCCCCSCTTTCCHHHHTTCC-BCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSCHHH
T ss_pred eEeccc--cccccCcccccCHHHHcCCC-CCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCCCCHHH
Confidence 865433 33567899999999996654 89999999999999999999999999998888887776533221 1
Q ss_pred -HHHh---ccCCCCCCC-----cccccccCChhhhhc
Q 021306 263 -EEIR---CMNPNYTDF-----RFPQIKAHPWHKVCI 290 (314)
Q Consensus 263 -~~~~---~~~p~~~~~-----~~~~l~~~p~~~~~~ 290 (314)
+.+. ..+|. +|+ ++++|++|||++...
T Consensus 229 ~~li~~~L~~dp~-~R~~~~r~t~~~il~Hp~f~~i~ 264 (316)
T d1fota_ 229 KDLLSRLITRDLS-QRLGNLQNGTEDVKNHPWFKEVV 264 (316)
T ss_dssp HHHHHHHTCSCTT-TCTTSSTTTTHHHHTSGGGSSCC
T ss_pred HHHHHHHhhhCHH-hccccchhhHHHHHcCcccccCC
Confidence 1222 23565 564 899999999998754
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-50 Score=354.63 Aligned_cols=240 Identities=23% Similarity=0.358 Sum_probs=199.1
Q ss_pred CCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCCce
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL 109 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 109 (314)
.++|++++.||+|+||.||+|+++.+|+.||+|.+++.. ....+|+.++++++||||+++++++.+ ..
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~-----~~ 78 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT-----HD 78 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEEC-----SS
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecc-----cc
Confidence 468999999999999999999999999999999986431 234589999999999999999999844 34
Q ss_pred eEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcc
Q 021306 110 FLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 188 (314)
Q Consensus 110 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~ 188 (314)
.+++||||++| +|...+. ....+++..++.++.||+.||.|||+ +||+||||||+||+++. ++.+||+|||++
T Consensus 79 ~~~iv~ey~~gg~L~~~~~----~~~~~~e~~~~~~~~qil~al~ylH~-~~iiHRDlKP~NILl~~-~g~vkl~DFG~a 152 (337)
T d1o6la_ 79 RLCFVMEYANGGELFFHLS----RERVFTEERARFYGAEIVSALEYLHS-RDVVYRDIKLENLMLDK-DGHIKITDFGLC 152 (337)
T ss_dssp EEEEEEECCTTCBHHHHHH----HHSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECT-TSCEEECCCTTC
T ss_pred ccccceeccCCCchhhhhh----cccCCcHHHHHHHHHHHhhhhhhhhh-cCccccccCHHHeEecC-CCCEEEeecccc
Confidence 48999999996 5555544 35789999999999999999999999 89999999999999998 789999999999
Q ss_pred cccccC-CccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCC------
Q 021306 189 KQLIAG-EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT------ 261 (314)
Q Consensus 189 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~------ 261 (314)
+..... .......||+.|+|||.+.+.. ++.++|||||||++|+|++|+.||.+.+..+....+.......+
T Consensus 153 ~~~~~~~~~~~~~~GT~~Y~aPE~~~~~~-y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~ 231 (337)
T d1o6la_ 153 KEGISDGATMKTFCGTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPE 231 (337)
T ss_dssp BCSCCTTCCBCCCEECGGGCCGGGGSSSC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHH
T ss_pred cccccCCcccccceeCHHHhhhhhccCCC-CChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCCCccCCHH
Confidence 865443 3344577899999999997655 89999999999999999999999999998777776665432221
Q ss_pred -HHHHh---ccCCCCCCC-----cccccccCChhhhh
Q 021306 262 -REEIR---CMNPNYTDF-----RFPQIKAHPWHKVC 289 (314)
Q Consensus 262 -~~~~~---~~~p~~~~~-----~~~~l~~~p~~~~~ 289 (314)
.+.+. ..+|. +|+ +++++++|||++..
T Consensus 232 ~~dli~~~L~~dP~-~R~~~~~~~~~eil~Hp~f~~i 267 (337)
T d1o6la_ 232 AKSLLAGLLKKDPK-QRLGGGPSDAKEVMEHRFFLSI 267 (337)
T ss_dssp HHHHHHHHTCSSTT-TSTTCSTTTHHHHHTSGGGTTC
T ss_pred HHHHHHhhccCCch-hhcccccccHHHHHcCcccccC
Confidence 12222 34677 777 48999999999754
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=9.8e-51 Score=346.89 Aligned_cols=241 Identities=24% Similarity=0.393 Sum_probs=201.7
Q ss_pred CCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc-------------cchHHHHHHHHhCC-CCceeeeceeeee
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------------RYKNRELQLMRVMD-HPNVISLKHCFFS 102 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~-------------~~~~~e~~~l~~l~-h~~iv~~~~~~~~ 102 (314)
.++|++.+.||+|+||+||+|++..+|+.||+|++++.. ....+|+.++++++ ||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 468999999999999999999999999999999986532 12357999999997 9999999999854
Q ss_pred cCCCCceeEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEE
Q 021306 103 TTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVK 181 (314)
Q Consensus 103 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~ 181 (314)
...+|+||||++| +|.+.+.. .+++++.+++.++.||+.||.|||+ +||+||||||+||+++. ++.+|
T Consensus 82 -----~~~~~ivmE~~~~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~~lH~-~~ivHrDlkp~Nill~~-~~~~k 150 (277)
T d1phka_ 82 -----NTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHK-LNIVHRDLKPENILLDD-DMNIK 150 (277)
T ss_dssp -----SSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECT-TCCEE
T ss_pred -----CcceEEEEEcCCCchHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-cCCcccccccceEEEcC-CCCeE
Confidence 3348999999985 77777654 4689999999999999999999999 89999999999999998 88999
Q ss_pred EeecCcccccccCCccccccccccccccccccC-----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q 021306 182 ICDFGSAKQLIAGEANISYICSRFYRAPELIFG-----ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 256 (314)
Q Consensus 182 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~ 256 (314)
|+|||++.............||+.|+|||.+.+ ...++.++||||+||++|+|++|+.||.+.+..+....+++.
T Consensus 151 l~DFG~a~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~ 230 (277)
T d1phka_ 151 LTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG 230 (277)
T ss_dssp ECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT
T ss_pred EccchheeEccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhC
Confidence 999999987765555556778999999999853 334688999999999999999999999999988888777765
Q ss_pred cCCCCH-----------HHHh-cc--CCCCCCCcccccccCChhhhh
Q 021306 257 LGTPTR-----------EEIR-CM--NPNYTDFRFPQIKAHPWHKVC 289 (314)
Q Consensus 257 ~~~~~~-----------~~~~-~~--~p~~~~~~~~~l~~~p~~~~~ 289 (314)
....+. +.+. ++ +|. +|++++++++|||++.+
T Consensus 231 ~~~~~~~~~~~~s~~~~~li~~~L~~~p~-~R~s~~eil~h~~~~~~ 276 (277)
T d1phka_ 231 NYQFGSPEWDDYSDTVKDLVSRFLVVQPQ-KRYTAEEALAHPFFQQY 276 (277)
T ss_dssp CCCCCTTTGGGSCHHHHHHHHHHCCSSGG-GSCCHHHHTTSGGGCTT
T ss_pred CCCCCCcccccCCHHHHHHHHHHccCChh-HCcCHHHHHcCHHHHHh
Confidence 332211 1122 33 455 89999999999999864
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-50 Score=345.84 Aligned_cols=243 Identities=35% Similarity=0.681 Sum_probs=202.8
Q ss_pred CCceeeeeEeecCceEEEEEEECCCCcEEEEEEeecc------ccchHHHHHHHHhCCCCceeeeceeeeecCCCCceeE
Q 021306 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 111 (314)
Q Consensus 38 ~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 111 (314)
++|++++.||+|+||.||+|+++.+|+.||+|+++.. .....+|+.++++++||||+++++++.... .+
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~-----~~ 76 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTEN-----KL 76 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETT-----EE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEecccccccc-----ce
Confidence 6899999999999999999999999999999998543 233458999999999999999999996543 38
Q ss_pred EEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCccccc
Q 021306 112 NLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 191 (314)
Q Consensus 112 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~ 191 (314)
++||||+.+++...+.. .....+++.+++.++.||+.||.|||+ +||+||||||+||+++. ++.++|+|||.++..
T Consensus 77 ~iv~e~~~~~~~~~~~~--~~~~~l~e~~~~~~~~qil~~L~yLH~-~~IiHrDiKpeNIl~~~-~~~~kl~DFG~a~~~ 152 (298)
T d1gz8a_ 77 YLVFEFLHQDLKKFMDA--SALTGIPLPLIKSYLFQLLQGLAFCHS-HRVLHRDLKPQNLLINT-EGAIKLADFGLARAF 152 (298)
T ss_dssp EEEEECCSEEHHHHHHH--TTTTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECT-TSCEEECSTTHHHHH
T ss_pred eEEEeecCCchhhhhhh--hcccCCCHHHHHHHHHHHHHHHHHhhc-CCEEccccCchheeecc-cCcceeccCCcceec
Confidence 89999999987766643 235679999999999999999999999 99999999999999998 789999999999766
Q ss_pred ccC-CccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCH--------
Q 021306 192 IAG-EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR-------- 262 (314)
Q Consensus 192 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~-------- 262 (314)
... .......+|+.|+|||.+.....++.++|+|||||++|+|++|+.||.+.+..+.+..+.+..+.+..
T Consensus 153 ~~~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 232 (298)
T d1gz8a_ 153 GVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 232 (298)
T ss_dssp CCCSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred cCCcccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccc
Confidence 443 23334578999999999877666789999999999999999999999999988888887765433221
Q ss_pred ----------------------------HHHh---ccCCCCCCCcccccccCChhhhhc
Q 021306 263 ----------------------------EEIR---CMNPNYTDFRFPQIKAHPWHKVCI 290 (314)
Q Consensus 263 ----------------------------~~~~---~~~p~~~~~~~~~l~~~p~~~~~~ 290 (314)
+.+. ..+|. +|+++++|++|||++...
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~-~R~t~~ell~H~ff~~~~ 290 (298)
T d1gz8a_ 233 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPN-KRISAKAALAHPFFQDVT 290 (298)
T ss_dssp STTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTT-TSCCHHHHHTSGGGTTCC
T ss_pred ccccccccccccccchhhhccCCCHHHHHHHHHHccCChh-HCcCHHHHhCCHhhccCC
Confidence 1122 33677 899999999999998654
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-51 Score=358.86 Aligned_cols=198 Identities=30% Similarity=0.534 Sum_probs=169.3
Q ss_pred CCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeE
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 111 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 111 (314)
.++|++.+.||+|+||+||+|+++.+|+.||+|.++... ....+|+.++++++||||+++++++.... .+
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-----~~ 79 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG-----EI 79 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSS-----EE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC-----EE
Confidence 568999999999999999999999999999999986542 23458999999999999999999995433 48
Q ss_pred EEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcccc
Q 021306 112 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 190 (314)
Q Consensus 112 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~ 190 (314)
++||||++| +|.+.+.. .+.+++..++.++.|++.||.|||+.+||+||||||+|||++. ++.+||+|||+|..
T Consensus 80 ~iVmEy~~gg~L~~~l~~----~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~-~~~vkl~DFGla~~ 154 (322)
T d1s9ja_ 80 SICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNS-RGEIKLCDFGVSGQ 154 (322)
T ss_dssp EEEEECCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECT-TCCEEECCCCCCHH
T ss_pred EEEEEcCCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECC-CCCEEEeeCCCccc
Confidence 899999996 66666653 4679999999999999999999996138999999999999998 88999999999986
Q ss_pred cccCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCh
Q 021306 191 LIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA 246 (314)
Q Consensus 191 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~ 246 (314)
.... ......||+.|+|||.+.+.. ++.++||||+||++|||++|+.||.+.+.
T Consensus 155 ~~~~-~~~~~~GT~~Y~APEvl~~~~-y~~~~DiWSlGvil~ell~G~~Pf~~~~~ 208 (322)
T d1s9ja_ 155 LIDS-MANSFVGTRSYMSPERLQGTH-YSVQSDIWSMGLSLVEMAVGRYPIPPPDA 208 (322)
T ss_dssp HHHH-TC---CCSSCCCCHHHHHCSC-CCTTHHHHHHHHHHHHHHHSSCCSSCCCT
T ss_pred cCCC-ccccccCCccccCchHHcCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCCCH
Confidence 5432 233568999999999998755 99999999999999999999999977654
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.3e-50 Score=354.54 Aligned_cols=242 Identities=26% Similarity=0.425 Sum_probs=200.5
Q ss_pred CccCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCC
Q 021306 34 PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSK 106 (314)
Q Consensus 34 ~~~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 106 (314)
+...++|++++.||+|+||.||+|+++.+|+.||+|.+.+.. ....+|+.+++.++||||+++++++...
T Consensus 37 ~~~ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~--- 113 (350)
T d1rdqe_ 37 TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDN--- 113 (350)
T ss_dssp CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS---
T ss_pred CCCccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccc---
Confidence 334589999999999999999999999999999999986432 2235899999999999999999998443
Q ss_pred CceeEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeec
Q 021306 107 NELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF 185 (314)
Q Consensus 107 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~df 185 (314)
..+++|+||+.| ++...+.. .+.+++.+++.++.||+.||.|||+ +||+||||||+|||++. ++.+||+||
T Consensus 114 --~~~~~v~e~~~~g~l~~~l~~----~~~l~e~~~~~i~~qi~~aL~yLH~-~~iiHRDIKP~NILl~~-~g~ikL~DF 185 (350)
T d1rdqe_ 114 --SNLYMVMEYVAGGEMFSHLRR----IGRFSEPHARFYAAQIVLTFEYLHS-LDLIYRDLKPENLLIDQ-QGYIQVTDF 185 (350)
T ss_dssp --SEEEEEEECCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECT-TSCEEECCC
T ss_pred --cccccccccccccchhhhHhh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCEecCcCCHHHcccCC-CCCEEeeec
Confidence 348899999996 55555543 4689999999999999999999999 89999999999999998 789999999
Q ss_pred CcccccccCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCH---
Q 021306 186 GSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR--- 262 (314)
Q Consensus 186 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~--- 262 (314)
|+++.... ......||+.|+|||.+.+.. ++.++|||||||++|+|+||+.||.+.+....+..+.+.....+.
T Consensus 186 G~a~~~~~--~~~~~~Gt~~Y~APE~~~~~~-~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s 262 (350)
T d1rdqe_ 186 GFAKRVKG--RTWTLCGTPEALAPEIILSKG-YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFS 262 (350)
T ss_dssp TTCEECSS--CBCCCEECGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTCC
T ss_pred eeeeeccc--ccccccCccccCCHHHHcCCC-CCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCCCccCC
Confidence 99986643 234567899999999997655 899999999999999999999999999888888877765433221
Q ss_pred ----HHHh---ccCCCCCC-----CcccccccCChhhhhc
Q 021306 263 ----EEIR---CMNPNYTD-----FRFPQIKAHPWHKVCI 290 (314)
Q Consensus 263 ----~~~~---~~~p~~~~-----~~~~~l~~~p~~~~~~ 290 (314)
+.+. ..+|. +| +++++|++|||++...
T Consensus 263 ~~~~~li~~~L~~dP~-kR~~~~r~t~~ell~Hp~f~~~~ 301 (350)
T d1rdqe_ 263 SDLKDLLRNLLQVDLT-KRFGNLKNGVNDIKNHKWFATTD 301 (350)
T ss_dssp HHHHHHHHHHSCSCTT-TCTTSSTTTTHHHHTSGGGTTCC
T ss_pred HHHHHHHHHHhhhCHH-hccccccccHHHHHcCccccCCC
Confidence 1222 33665 55 4899999999998754
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-50 Score=348.10 Aligned_cols=238 Identities=36% Similarity=0.625 Sum_probs=197.7
Q ss_pred eeeeEeecCceEEEEEEECCCCcEEEEEEeeccc---------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeEE
Q 021306 42 AERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 112 (314)
Q Consensus 42 ~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~---------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 112 (314)
..+.||+|+||+||+|+++.+|+.||+|+++... ....+|+.++++++||||+++++++.... .++
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~-----~~~ 76 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS-----NIS 76 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT-----CCE
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCC-----cee
Confidence 5689999999999999999999999999985432 23458999999999999999999985433 388
Q ss_pred EEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcccccc
Q 021306 113 LVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 192 (314)
Q Consensus 113 lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~ 192 (314)
+||||+.+++...+. ..+..+++.+++.++.||+.||+|||+ +||+||||||+||+++. ++.+||+|||++....
T Consensus 77 ivmE~~~~~~~~~~~---~~~~~l~~~~~~~~~~qil~aL~~lH~-~~iiHrDiKp~NIli~~-~~~~KL~DFG~a~~~~ 151 (299)
T d1ua2a_ 77 LVFDFMETDLEVIIK---DNSLVLTPSHIKAYMLMTLQGLEYLHQ-HWILHRDLKPNNLLLDE-NGVLKLADFGLAKSFG 151 (299)
T ss_dssp EEEECCSEEHHHHHT---TCCSSCCSSHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECT-TCCEEECCCGGGSTTT
T ss_pred ehhhhhcchHHhhhh---hcccCCCHHHHHHHHHHHHHHHHHhhc-cceecccCCcceEEecC-CCccccccCccccccC
Confidence 999999998665554 346789999999999999999999999 99999999999999998 8899999999997654
Q ss_pred cCC-ccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCHH--------
Q 021306 193 AGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE-------- 263 (314)
Q Consensus 193 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~-------- 263 (314)
... ......+|+.|+|||.+.+...++.++|||||||++|+|+||+.||.+.+..+.+..+.+..+.+...
T Consensus 152 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~ 231 (299)
T d1ua2a_ 152 SPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSL 231 (299)
T ss_dssp SCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSS
T ss_pred CCcccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhcc
Confidence 433 23345789999999998766668999999999999999999999999999999888888765443211
Q ss_pred ---------------------------HH---hccCCCCCCCcccccccCChhhhhc
Q 021306 264 ---------------------------EI---RCMNPNYTDFRFPQIKAHPWHKVCI 290 (314)
Q Consensus 264 ---------------------------~~---~~~~p~~~~~~~~~l~~~p~~~~~~ 290 (314)
.+ ...+|. +|+++.++++|||++..+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~-~R~sa~e~L~Hp~f~~~p 287 (299)
T d1ua2a_ 232 PDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPC-ARITATQALKMKYFSNRP 287 (299)
T ss_dssp TTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTT-TSCCHHHHHTSGGGTSSS
T ss_pred chhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChh-hCcCHHHHhCCHhhCCCC
Confidence 11 133677 899999999999998654
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-49 Score=344.58 Aligned_cols=247 Identities=34% Similarity=0.609 Sum_probs=205.7
Q ss_pred CCCceeeeeEeecCceEEEEEEECCC-CcEEEEEEeecc------ccchHHHHHHHHhC---CCCceeeeceeeeecCCC
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCLET-GETVAIKKVLQD------RRYKNRELQLMRVM---DHPNVISLKHCFFSTTSK 106 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~~~-~~~~~vK~~~~~------~~~~~~e~~~l~~l---~h~~iv~~~~~~~~~~~~ 106 (314)
.++|++++.||+|+||+||+|++..+ ++.||+|+++.. .....+|+.+++.+ +||||+++++++......
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 46899999999999999999999765 677999998543 12334777776665 799999999998766656
Q ss_pred CceeEEEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecC
Q 021306 107 NELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 186 (314)
Q Consensus 107 ~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg 186 (314)
...++++++||+.+++...... .....+++..++.++.|++.||.|||+ +||+||||||+|||++. .+.++|+|||
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~--~~~~~~~~~~~~~~~~qi~~aL~yLH~-~~ivHrDiKp~NILi~~-~~~~kl~dfg 161 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDK--VPEPGVPTETIKDMMFQLLRGLDFLHS-HRVVHRDLKPQNILVTS-SGQIKLADFG 161 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHH--SCTTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECT-TCCEEECSCC
T ss_pred cCceEEEEEEeccCCchhhhhh--ccCCCCCHHHHHHHHHHHHHHHHHHHh-CCEEecCCCccEEEEcC-CCCeeecchh
Confidence 6677899999999986655443 245679999999999999999999999 99999999999999998 7899999999
Q ss_pred cccccccCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCH----
Q 021306 187 SAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR---- 262 (314)
Q Consensus 187 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~---- 262 (314)
++.............||+.|+|||.+.+.. ++.++|||||||++|||++|+.||.+.+..+.+..+++..+.+..
T Consensus 162 ~~~~~~~~~~~~~~~gT~~Y~APE~~~~~~-y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 240 (305)
T d1blxa_ 162 LARIYSFQMALTSVVVTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 240 (305)
T ss_dssp SCCCCCGGGGGCCCCCCCTTCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSC
T ss_pred hhhhhcccccCCCcccChhhcCcchhcCCC-CChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhccc
Confidence 998766555566778899999999997654 899999999999999999999999999999888888876544321
Q ss_pred ------------------------------HHHh---ccCCCCCCCcccccccCChhhhh
Q 021306 263 ------------------------------EEIR---CMNPNYTDFRFPQIKAHPWHKVC 289 (314)
Q Consensus 263 ------------------------------~~~~---~~~p~~~~~~~~~l~~~p~~~~~ 289 (314)
+.+. ..+|. +|+++.++++|||++.-
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~-~R~sa~e~L~Hpff~~i 299 (305)
T d1blxa_ 241 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPA-KRISAYSALSHPYFQDL 299 (305)
T ss_dssp TTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTT-TSCCHHHHHTSGGGTTC
T ss_pred ccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChh-HCcCHHHHhcChhhcCc
Confidence 1222 34777 89999999999999854
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-49 Score=345.01 Aligned_cols=239 Identities=27% Similarity=0.476 Sum_probs=194.8
Q ss_pred CCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHH-HhCCCCceeeeceeeeecCCCCce
Q 021306 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLM-RVMDHPNVISLKHCFFSTTSKNEL 109 (314)
Q Consensus 38 ~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~-------~~~~~e~~~l-~~l~h~~iv~~~~~~~~~~~~~~~ 109 (314)
++|++.+.||+|+||+||+|+++.+++.||+|.+++.. ....+|..++ +.++||||+++++++... .
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~-----~ 76 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTK-----E 76 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECS-----S
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccC-----C
Confidence 68999999999999999999999999999999996432 1123455544 578999999999998543 3
Q ss_pred eEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcc
Q 021306 110 FLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 188 (314)
Q Consensus 110 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~ 188 (314)
.+|+||||++| +|.+.+.. ...+++.+++.++.||+.||.|||+ +||+||||||+|||++. ++.++|+|||++
T Consensus 77 ~~yivmEy~~~g~L~~~i~~----~~~~~e~~~~~~~~qi~~al~ylH~-~~iiHrDikp~NiL~~~-~~~~kl~DFG~a 150 (320)
T d1xjda_ 77 NLFFVMEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLHS-KGIVYRDLKLDNILLDK-DGHIKIADFGMC 150 (320)
T ss_dssp EEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECT-TSCEEECCCTTC
T ss_pred ceeEEEeecCCCcHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccCcccceeecC-CCceeccccchh
Confidence 48999999996 66665543 4789999999999999999999999 89999999999999998 889999999999
Q ss_pred cccccCC-ccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCC----H-
Q 021306 189 KQLIAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT----R- 262 (314)
Q Consensus 189 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~----~- 262 (314)
+...... ......||+.|+|||.+.+.. ++.++|||||||++|+|++|+.||.+.+..+....+.......+ .
T Consensus 151 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~ 229 (320)
T d1xjda_ 151 KENMLGDAKTNTFCGTPDYIAPEILLGQK-YNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKE 229 (320)
T ss_dssp BCCCCTTCCBCCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHH
T ss_pred hhcccccccccccCCCCCcCCHHHHcCCC-CCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccCCHH
Confidence 8654332 333467899999999997655 89999999999999999999999999988877777765432211 1
Q ss_pred --HHHh---ccCCCCCCCccc-ccccCChhhhh
Q 021306 263 --EEIR---CMNPNYTDFRFP-QIKAHPWHKVC 289 (314)
Q Consensus 263 --~~~~---~~~p~~~~~~~~-~l~~~p~~~~~ 289 (314)
+.+. ..+|. +|+++. +|++|||++..
T Consensus 230 ~~dli~~~L~~dP~-~R~s~~~~l~~hpff~~~ 261 (320)
T d1xjda_ 230 AKDLLVKLFVREPE-KRLGVRGDIRQHPLFREI 261 (320)
T ss_dssp HHHHHHHHSCSSGG-GSBTTBSCGGGSGGGTTC
T ss_pred HHHHHHHhcccCCC-CCcCHHHHHHhCchhccC
Confidence 1222 33676 899996 89999999764
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-49 Score=346.14 Aligned_cols=243 Identities=23% Similarity=0.379 Sum_probs=204.0
Q ss_pred cCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeecccc---chHHHHHHHHhCCCCceeeeceeeeecCCCCceeEE
Q 021306 36 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR---YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 112 (314)
Q Consensus 36 ~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~~---~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 112 (314)
..++|++.+.||+|+||+||+|+++.+++.||+|.++.... ...+|+.++++++||||+++++++.+.. .+|
T Consensus 3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~-----~~~ 77 (321)
T d1tkia_ 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESME-----ELV 77 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETT-----EEE
T ss_pred CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEEECC-----EEE
Confidence 46789999999999999999999999999999999975432 3458999999999999999999985433 489
Q ss_pred EEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCC-CCcEEEeecCcccc
Q 021306 113 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPL-THQVKICDFGSAKQ 190 (314)
Q Consensus 113 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~-~~~~~l~dfg~~~~ 190 (314)
+|||||+| +|.+.+.. .+..+++.+++.++.||+.||.|||+ +||+||||||+||+++.. ...++|+|||++..
T Consensus 78 lvmE~~~gg~L~~~i~~---~~~~l~e~~~~~i~~qi~~al~yLH~-~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~ 153 (321)
T d1tkia_ 78 MIFEFISGLDIFERINT---SAFELNEREIVSYVHQVCEALQFLHS-HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQ 153 (321)
T ss_dssp EEECCCCCCBHHHHHTS---SSCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESSSSCCCEEECCCTTCEE
T ss_pred EEEecCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-cCCCcccccccceeecCCCceEEEEcccchhhc
Confidence 99999996 67666643 23579999999999999999999999 899999999999999852 45799999999987
Q ss_pred cccCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCH--------
Q 021306 191 LIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR-------- 262 (314)
Q Consensus 191 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~-------- 262 (314)
...........+++.|+|||.+.+.. ++.++|||||||++|+|++|+.||.+.+..+.+..+++.....+.
T Consensus 154 ~~~~~~~~~~~~t~~y~ape~~~~~~-~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 232 (321)
T d1tkia_ 154 LKPGDNFRLLFTAPEYYAPEVHQHDV-VSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISI 232 (321)
T ss_dssp CCTTCEEEEEESCGGGSCHHHHTTCE-ECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCH
T ss_pred cccCCcccccccccccccchhccCCC-CCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCH
Confidence 65555555667899999999986654 899999999999999999999999999988888888775433332
Q ss_pred ---HHHh-c--cCCCCCCCcccccccCChhhhh
Q 021306 263 ---EEIR-C--MNPNYTDFRFPQIKAHPWHKVC 289 (314)
Q Consensus 263 ---~~~~-~--~~p~~~~~~~~~l~~~p~~~~~ 289 (314)
+.+. + .+|. +|++++++++|||++..
T Consensus 233 ~~~~li~~~L~~dp~-~R~s~~eil~hp~~~~~ 264 (321)
T d1tkia_ 233 EAMDFVDRLLVKERK-SRMTASEALQHPWLKQK 264 (321)
T ss_dssp HHHHHHHTTSCSSGG-GSCCHHHHHHSHHHHSC
T ss_pred HHHHHHHHHccCChh-HCcCHHHHhcCHhhccC
Confidence 2222 2 2566 89999999999999754
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=9.8e-49 Score=336.98 Aligned_cols=239 Identities=34% Similarity=0.654 Sum_probs=197.9
Q ss_pred CCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeE
Q 021306 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 111 (314)
Q Consensus 38 ~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 111 (314)
++|++.+.||+|+||+||+|+++ +|+.||+|+++... ....+|+.++++++||||+++++++..... .
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~-----~ 75 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKR-----L 75 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSC-----E
T ss_pred CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCc-----e
Confidence 68999999999999999999975 78999999986532 234589999999999999999999865443 8
Q ss_pred EEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCccccc
Q 021306 112 NLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 191 (314)
Q Consensus 112 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~ 191 (314)
++++|++.+++...+.. ..+.+++.+++.++.||+.||+|||+ .||+||||||+||+++. ++.+|++|||.+...
T Consensus 76 ~i~~e~~~~~~~~~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~-~~IvHrDiKp~NIll~~-~~~~kl~DfG~a~~~ 150 (286)
T d1ob3a_ 76 VLVFEHLDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHD-RRVLHRDLKPQNLLINR-EGELKIADFGLARAF 150 (286)
T ss_dssp EEEEECCSEEHHHHHHT---STTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECT-TSCEEECCTTHHHHH
T ss_pred eEEEEeehhhhHHHHHh---hcCCcchhhhHHHHHHHHHHHHHhcc-CcEEecCCCCceeeEcC-CCCEEecccccceec
Confidence 89999999987766653 45789999999999999999999999 89999999999999998 889999999999765
Q ss_pred ccCCc-cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCH--------
Q 021306 192 IAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR-------- 262 (314)
Q Consensus 192 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~-------- 262 (314)
..... .....+++.|+|||.+.+...++.++|||||||++|+|++|+.||.+.+..+.+.++.+..+.+..
T Consensus 151 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 230 (286)
T d1ob3a_ 151 GIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTE 230 (286)
T ss_dssp CC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred ccCccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhh
Confidence 44322 334567889999999987776899999999999999999999999999888888887765443321
Q ss_pred ----------------------------HHH---hccCCCCCCCcccccccCChhhh
Q 021306 263 ----------------------------EEI---RCMNPNYTDFRFPQIKAHPWHKV 288 (314)
Q Consensus 263 ----------------------------~~~---~~~~p~~~~~~~~~l~~~p~~~~ 288 (314)
+.+ ...+|. +|+++.++++|||++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~-~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPN-QRITAKQALEHAYFKE 286 (286)
T ss_dssp STTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTT-TSCCHHHHHTSGGGGC
T ss_pred hhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChh-HCcCHHHHhcCcccCc
Confidence 112 234677 8999999999999973
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=2.5e-49 Score=350.69 Aligned_cols=240 Identities=24% Similarity=0.390 Sum_probs=190.9
Q ss_pred CCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc-------cchH---HHHHHHHhCCCCceeeeceeeeecCCC
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKN---RELQLMRVMDHPNVISLKHCFFSTTSK 106 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~-------~~~~---~e~~~l~~l~h~~iv~~~~~~~~~~~~ 106 (314)
.++|++.+.||+|+||.||+|+++.+|+.||+|.+.+.. .... +++.+++.++||||+++++++...
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~--- 79 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP--- 79 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECS---
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEEC---
Confidence 578999999999999999999999999999999986432 1112 346677778999999999998543
Q ss_pred CceeEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeec
Q 021306 107 NELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF 185 (314)
Q Consensus 107 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~df 185 (314)
..+++||||++| +|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++. ++.+||+||
T Consensus 80 --~~~~ivmE~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~ylH~-~~iiHrDlKP~NILl~~-~g~iKl~DF 151 (364)
T d1omwa3 80 --DKLSFILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMHN-RFVVYRDLKPANILLDE-HGHVRISDL 151 (364)
T ss_dssp --SEEEEEECCCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECS-SSCEEECCC
T ss_pred --CEEEEEEEecCCCcHHHHHHh----cccccHHHHHHHHHHHHHHHHHHHH-CCccceeeccceeEEcC-CCcEEEeee
Confidence 348899999995 66666653 4789999999999999999999999 99999999999999998 889999999
Q ss_pred CcccccccCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHc-CCC----
Q 021306 186 GSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVL-GTP---- 260 (314)
Q Consensus 186 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~-~~~---- 260 (314)
|+++..... ......||+.|+|||.+.+...++.++|||||||++|+|+||+.||.+.+..+... +.+.. ..+
T Consensus 152 Gla~~~~~~-~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~-~~~~~~~~~~~~~ 229 (364)
T d1omwa3 152 GLACDFSKK-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-IDRMTLTMAVELP 229 (364)
T ss_dssp TTCEECSSS-CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHH-HHHHSSSCCCCCC
T ss_pred ceeeecCCC-cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHhcccCCCCCC
Confidence 999865443 33456789999999999765568999999999999999999999998765433322 22221 111
Q ss_pred ---C---HHHHh---ccCCCCCCCc-----ccccccCChhhhhc
Q 021306 261 ---T---REEIR---CMNPNYTDFR-----FPQIKAHPWHKVCI 290 (314)
Q Consensus 261 ---~---~~~~~---~~~p~~~~~~-----~~~l~~~p~~~~~~ 290 (314)
. .+.+. ..+|. +|++ +++|++|||++...
T Consensus 230 ~~~s~~~~~li~~~L~~dP~-~R~t~~~~~a~eil~Hp~f~~i~ 272 (364)
T d1omwa3 230 DSFSPELRSLLEGLLQRDVN-RRLGCLGRGAQEVKESPFFRSLD 272 (364)
T ss_dssp SSSCHHHHHHHHHHTCSSTT-TSTTTSSSTHHHHHTSGGGTTCC
T ss_pred CCCCHHHHHHHHHHcccCHH-HhCCCcccCHHHHHcCccccCCC
Confidence 1 12222 34777 8988 69999999998653
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=3e-49 Score=338.53 Aligned_cols=255 Identities=23% Similarity=0.334 Sum_probs=197.1
Q ss_pred cCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCCc
Q 021306 36 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 108 (314)
Q Consensus 36 ~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 108 (314)
..++|++.+.||+|+||.||+|++..+|+.||+|.++... ....+|+.+++.++||||+++++++.... ...
T Consensus 5 l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~-~~~ 83 (277)
T d1o6ya_ 5 LSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET-PAG 83 (277)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEC-SSS
T ss_pred ccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeecc-CCC
Confidence 3467999999999999999999999999999999986432 12458999999999999999999886544 233
Q ss_pred eeEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCc
Q 021306 109 LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 187 (314)
Q Consensus 109 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~ 187 (314)
..+|+||||++| +|...+. ..+++++.+++.++.||+.||.|||+ +||+||||||+||+++. ++..+++|||.
T Consensus 84 ~~~~lvmE~~~g~~L~~~~~----~~~~l~~~~~~~i~~qi~~al~~lH~-~~iiHrDiKP~NIll~~-~~~~~l~d~~~ 157 (277)
T d1o6ya_ 84 PLPYIVMEYVDGVTLRDIVH----TEGPMTPKRAIEVIADACQALNFSHQ-NGIIHRDVKPANIMISA-TNAVKVMDFGI 157 (277)
T ss_dssp EEEEEEEECCCEEEHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEET-TSCEEECCCTT
T ss_pred ceEEEEEECCCCCEehhhhc----ccCCCCHHHHHHHHHHHHHHHHHHHh-CCccCccccCcccccCc-cccceeehhhh
Confidence 457899999997 5554443 34789999999999999999999999 89999999999999998 88899999998
Q ss_pred ccccccCC----ccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCHH
Q 021306 188 AKQLIAGE----ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 263 (314)
Q Consensus 188 ~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~ 263 (314)
+....... ......||+.|+|||.+.+.. ++.++|||||||++|+|+||+.||.+.+..+.+..+++....++..
T Consensus 158 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~-~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~ 236 (277)
T d1o6ya_ 158 ARAIADSGNSVTQTAAVIGTAQYLSPEQARGDS-VDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSA 236 (277)
T ss_dssp CEECC----------------TTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGG
T ss_pred hhhhccccccccccccccCcccccCHHHHcCCC-CCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCch
Confidence 86543222 233456899999999997654 8999999999999999999999999999888888887765554444
Q ss_pred HHhccCCCCCCCcccccccCChhhhhcccCChHHH
Q 021306 264 EIRCMNPNYTDFRFPQIKAHPWHKVCIFHFPKHWL 298 (314)
Q Consensus 264 ~~~~~~p~~~~~~~~~l~~~p~~~~~~~~~~~~~~ 298 (314)
....+++.++++...+|..+|-.|+...+...+.+
T Consensus 237 ~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l 271 (277)
T d1o6ya_ 237 RHEGLSADLDAVVLKALAKNPENRYQTAAEMRADL 271 (277)
T ss_dssp TSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHH
T ss_pred hccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHH
Confidence 44455666666666666666666664433333333
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-49 Score=345.29 Aligned_cols=248 Identities=23% Similarity=0.359 Sum_probs=194.3
Q ss_pred cCCCceeee-eEeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHH-hCCCCceeeeceeeeecCCCCceeEEE
Q 021306 36 QTISYMAER-VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMR-VMDHPNVISLKHCFFSTTSKNELFLNL 113 (314)
Q Consensus 36 ~~~~y~~~~-~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~~~~~~e~~~l~-~l~h~~iv~~~~~~~~~~~~~~~~~~l 113 (314)
..++|++.. .||+|+||.||+|+++.+++.||+|+++.. ....+|+.++. .++||||++++++|.... ....++|+
T Consensus 9 i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~-~~~~~~~i 86 (335)
T d2ozaa1 9 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-PKARREVELHWRASQCPHIVRIVDVYENLY-AGRKCLLI 86 (335)
T ss_dssp GGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEEEEEE
T ss_pred cccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-HHHHHHHHHHHHhcCCCCCCeEEEEEeecc-cCCCEEEE
Confidence 457899875 599999999999999999999999998654 44567888755 458999999999885432 23456899
Q ss_pred Eeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCC--CCcEEEeecCcccc
Q 021306 114 VMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPL--THQVKICDFGSAKQ 190 (314)
Q Consensus 114 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~--~~~~~l~dfg~~~~ 190 (314)
|||||+| +|.+.+.. .....+++.+++.++.||+.||.|||+ +||+||||||+||+++.. .+.+||+|||+++.
T Consensus 87 vmEy~~gg~L~~~i~~--~~~~~l~e~~~~~i~~qi~~al~ylH~-~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~ 163 (335)
T d2ozaa1 87 VMECLDGGELFSRIQD--RGDQAFTEREASEIMKSIGEAIQYLHS-INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE 163 (335)
T ss_dssp EEECCCSEEHHHHHHS--CSCCCEEHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred EEECCCCCcHHHHHHh--cCCCCcCHHHHHHHHHHHHHHHHHHHH-cCCccccccccccccccccccccccccccceeee
Confidence 9999985 78777764 123579999999999999999999999 899999999999999862 45799999999987
Q ss_pred cccCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcC------------
Q 021306 191 LIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLG------------ 258 (314)
Q Consensus 191 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~------------ 258 (314)
...........||+.|+|||.+.+.. ++.++|||||||++|+|+||+.||.+.+.......+.....
T Consensus 164 ~~~~~~~~~~~gt~~y~aPE~~~~~~-y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 242 (335)
T d2ozaa1 164 TTSHNSLTTPCYTPYYVAPEVLGPEK-YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWS 242 (335)
T ss_dssp CCCCCCCCCCSCCCSSCCCCCCCGGG-GSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCTTHHH
T ss_pred ccCCCccccccCCcccCCcHHHcCCC-CCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCcccc
Confidence 76666666778999999999996654 89999999999999999999999987765544444333211
Q ss_pred ---CCCHHHHh---ccCCCCCCCcccccccCChhhhhc
Q 021306 259 ---TPTREEIR---CMNPNYTDFRFPQIKAHPWHKVCI 290 (314)
Q Consensus 259 ---~~~~~~~~---~~~p~~~~~~~~~l~~~p~~~~~~ 290 (314)
+...+.+. ..+|. +|+++.++++|||+....
T Consensus 243 ~~s~~~~~li~~~L~~dP~-~R~s~~eil~hp~~~~~~ 279 (335)
T d2ozaa1 243 EVSEEVKMLIRNLLKTEPT-QRMTITEFMNHPWIMQST 279 (335)
T ss_dssp HSCHHHHHHHHHHSCSSTT-TSCCHHHHHHSHHHHTTT
T ss_pred cCCHHHHHHHHHHccCChh-HCcCHHHHHcCHHhhCCC
Confidence 11112222 34777 899999999999996543
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-48 Score=329.32 Aligned_cols=235 Identities=26% Similarity=0.420 Sum_probs=188.4
Q ss_pred CCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc----------cchHHHHHHHHhCC--CCceeeeceeeeecC
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----------RYKNRELQLMRVMD--HPNVISLKHCFFSTT 104 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~----------~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~ 104 (314)
.++|++.+.||+|+||.||+|+++.+|+.||+|.+.+.. ....+|+.++++++ ||||+++++++...
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~- 81 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP- 81 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS-
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeC-
Confidence 357999999999999999999999999999999986432 22458999999986 89999999998543
Q ss_pred CCCceeEEEEeecccc--cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEE
Q 021306 105 SKNELFLNLVMEYVPE--SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKI 182 (314)
Q Consensus 105 ~~~~~~~~lv~e~~~~--~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l 182 (314)
...++||||+.+ ++.+.+.. ...+++.+++.++.||+.||.|||+ +||+||||||+||+++.+++.++|
T Consensus 82 ----~~~~lv~e~~~~~~~l~~~~~~----~~~l~e~~~~~~~~qi~~al~~lH~-~~iiHrDiKp~NIll~~~~~~vkl 152 (273)
T d1xwsa_ 82 ----DSFVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHN-CGVLHRDIKDENILIDLNRGELKL 152 (273)
T ss_dssp ----SEEEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEETTTTEEEE
T ss_pred ----CeEEEEEEeccCcchHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCccccCcccceEEecCCCeEEE
Confidence 348899999975 45555443 4789999999999999999999999 999999999999999875679999
Q ss_pred eecCcccccccCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHc-----
Q 021306 183 CDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVL----- 257 (314)
Q Consensus 183 ~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~----- 257 (314)
+|||++...... ......||+.|+|||.+.+...++.++|||||||++|+|+||+.||.+.+ .+.+..
T Consensus 153 ~DFG~a~~~~~~-~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~~~~~~~~~ 225 (273)
T d1xwsa_ 153 IDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFRQ 225 (273)
T ss_dssp CCCTTCEECCSS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCCCCCSS
T ss_pred Cccccceecccc-cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------HHhhcccCCCC
Confidence 999999754332 33456789999999999776655778999999999999999999997632 122211
Q ss_pred --CCCCHHHHh---ccCCCCCCCcccccccCChhhhh
Q 021306 258 --GTPTREEIR---CMNPNYTDFRFPQIKAHPWHKVC 289 (314)
Q Consensus 258 --~~~~~~~~~---~~~p~~~~~~~~~l~~~p~~~~~ 289 (314)
+....+.+. ..+|. +|++++++++|||++..
T Consensus 226 ~~s~~~~~li~~~L~~dp~-~R~s~~eil~hp~~~~~ 261 (273)
T d1xwsa_ 226 RVSSECQHLIRWCLALRPS-DRPTFEEIQNHPWMQDV 261 (273)
T ss_dssp CCCHHHHHHHHHHTCSSGG-GSCCHHHHHTSGGGSSC
T ss_pred CCCHHHHHHHHHHccCCHh-HCcCHHHHhcCHhhCCC
Confidence 111112222 33666 89999999999999864
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-47 Score=333.72 Aligned_cols=246 Identities=28% Similarity=0.524 Sum_probs=198.7
Q ss_pred CCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCC---CC
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTS---KN 107 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~---~~ 107 (314)
.++|++++.||+|+||+||+|+++.+|+.||||++.... ....+|+.++++++|+||+++++++..... ..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 468999999999999999999999999999999885432 224589999999999999999998754321 12
Q ss_pred ceeEEEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCc
Q 021306 108 ELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 187 (314)
Q Consensus 108 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~ 187 (314)
...++++|||+.+++..... .....+++.+++.++.|++.||.|||+ +||+||||||+||+++. ++.++++|||+
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~---~~~~~~~~~~~~~i~~qil~~l~~lH~-~~ivHrDlKp~NILl~~-~~~~kl~dfg~ 163 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLS---NVLVKFTLSEIKRVMQMLLNGLYYIHR-NKILHRDMKAANVLITR-DGVLKLADFGL 163 (318)
T ss_dssp --CEEEEEECCCEEHHHHHT---CTTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECT-TSCEEECCCTT
T ss_pred CceEEEEEeccCCCccchhh---hcccccccHHHHHHHHHHHHHHHHhcc-CCEEecCcCchheeecC-CCcEEeeecce
Confidence 34578999999988766544 345789999999999999999999999 89999999999999998 88999999999
Q ss_pred ccccccCC-----ccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCH
Q 021306 188 AKQLIAGE-----ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 262 (314)
Q Consensus 188 ~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~ 262 (314)
+....... ......+|+.|+|||.+.+...++.++|||||||++|+|++|+.||.+.+..+....+.+..+.+..
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 243 (318)
T d3blha1 164 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 243 (318)
T ss_dssp CEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred eeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence 97554222 2233568999999999987766899999999999999999999999998888887777765543321
Q ss_pred H---------------------------------------HHh---ccCCCCCCCcccccccCChhhh
Q 021306 263 E---------------------------------------EIR---CMNPNYTDFRFPQIKAHPWHKV 288 (314)
Q Consensus 263 ~---------------------------------------~~~---~~~p~~~~~~~~~l~~~p~~~~ 288 (314)
+ .+. ..+|+ +|++++++++||||+.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~-~R~sa~elL~Hpff~~ 310 (318)
T d3blha1 244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPA-QRIDSDDALNHDFFWS 310 (318)
T ss_dssp TTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTT-TSCCHHHHHHSGGGSS
T ss_pred hhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChh-HCcCHHHHHcChhhcc
Confidence 1 122 34787 8999999999999985
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-47 Score=337.23 Aligned_cols=243 Identities=37% Similarity=0.633 Sum_probs=196.5
Q ss_pred CCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCC-CCce
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTS-KNEL 109 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~~~~ 109 (314)
.++|++++.||+|+||+||+|.++.+|+.||+|++++.. ....+|+.++++++||||+++++++..... ....
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 468999999999999999999999999999999987532 223589999999999999999999865432 2234
Q ss_pred eEEEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCccc
Q 021306 110 FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 189 (314)
Q Consensus 110 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~ 189 (314)
.+++||||++.++...... ..+++..++.++.||+.||.|||+ +||+||||||+|||++. ++.++++|||++.
T Consensus 97 ~~~lv~e~~~~~l~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~-~~IiHrDiKp~NIL~~~-~~~~kl~Dfg~a~ 169 (346)
T d1cm8a_ 97 DFYLVMPFMGTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHA-AGIIHRDLKPGNLAVNE-DCELKILDFGLAR 169 (346)
T ss_dssp CCEEEEECCSEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECT-TCCEEECCCTTCE
T ss_pred eEEEEEecccccHHHHHHh-----ccccHHHHHHHHHHHHHHHHHHHh-CCCcccccCcchhhccc-cccccccccccee
Confidence 5789999998777666543 679999999999999999999999 99999999999999998 8899999999998
Q ss_pred ccccCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCHH------
Q 021306 190 QLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE------ 263 (314)
Q Consensus 190 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~------ 263 (314)
..... .....+|+.|+|||.+.+...++.++||||+||++|+|++|+.||.+.+..+.+..+.+..+.++..
T Consensus 170 ~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (346)
T d1cm8a_ 170 QADSE--MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQ 247 (346)
T ss_dssp ECCSS--CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCS
T ss_pred ccCCc--cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhc
Confidence 65433 3346789999999999876667999999999999999999999999998887777766654443221
Q ss_pred --------------------------------HH---hccCCCCCCCcccccccCChhhhh
Q 021306 264 --------------------------------EI---RCMNPNYTDFRFPQIKAHPWHKVC 289 (314)
Q Consensus 264 --------------------------------~~---~~~~p~~~~~~~~~l~~~p~~~~~ 289 (314)
.+ ...+|. +|+++.++++|||++..
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~-~R~ta~eiL~Hp~f~~~ 307 (346)
T d1cm8a_ 248 SDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAE-QRVTAGEALAHPYFESL 307 (346)
T ss_dssp CHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTT-TSCCHHHHHHSGGGTTT
T ss_pred chhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChh-HCcCHHHHhcChhhCcC
Confidence 12 234777 89999999999999863
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-47 Score=334.85 Aligned_cols=246 Identities=36% Similarity=0.629 Sum_probs=197.9
Q ss_pred cCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeecccc-----chHHHHHHHHhCCCCceeeeceeeeecCCCCcee
Q 021306 36 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 110 (314)
Q Consensus 36 ~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~~-----~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 110 (314)
.+++|++++.||+|+||+||+|+++.+|+.||||++.+... ...+|+.++++++||||+++++++.........+
T Consensus 6 i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~ 85 (345)
T d1pmea_ 6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 85 (345)
T ss_dssp CCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred cCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence 34689999999999999999999999999999999865332 3358999999999999999999986655444455
Q ss_pred EEEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcccc
Q 021306 111 LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 190 (314)
Q Consensus 111 ~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~ 190 (314)
+++++++++|+|.+.+.. ..+++.+++.++.||+.||.|||+ +||+||||||+|||++. ++.+||+|||++..
T Consensus 86 ~~l~~~~~~g~L~~~l~~-----~~l~~~~i~~i~~qil~al~yLH~-~~iiHRDIKp~NILl~~-~~~~kl~DfG~a~~ 158 (345)
T d1pmea_ 86 VYLVTHLMGADLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHS-ANVLHRDLKPSNLLLNT-TCDLKICDFGLARV 158 (345)
T ss_dssp EEEEEECCCEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECT-TCCEEECCCTTCEE
T ss_pred EEEEEeecCCchhhhhhc-----CCCCHHHHHHHHHHHHHHHHHHHH-CCCcCCCCCcceEEECC-CCCEEEcccCceee
Confidence 677777777888887764 579999999999999999999999 89999999999999998 78999999999976
Q ss_pred cccCCc----cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCC-----
Q 021306 191 LIAGEA----NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT----- 261 (314)
Q Consensus 191 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~----- 261 (314)
...... .....+++.|+|||.+.....++.++||||+||++|+|++|+.||.+.+..+...........+.
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (345)
T d1pmea_ 159 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN 238 (345)
T ss_dssp CCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHH
T ss_pred ccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhh
Confidence 543222 23456789999999986666688999999999999999999999998887766666554332221
Q ss_pred ---------------------------------HHHHh---ccCCCCCCCcccccccCChhhhh
Q 021306 262 ---------------------------------REEIR---CMNPNYTDFRFPQIKAHPWHKVC 289 (314)
Q Consensus 262 ---------------------------------~~~~~---~~~p~~~~~~~~~l~~~p~~~~~ 289 (314)
.+.+. ..+|. +|+++.++++|||++..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~-~R~ta~e~L~hpf~~~~ 301 (345)
T d1pmea_ 239 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPH-KRIEVEQALAHPYLEQY 301 (345)
T ss_dssp TCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTT-TSCCHHHHHTSGGGTTT
T ss_pred hhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChh-HCcCHHHHhcCHhhccC
Confidence 11222 33677 89999999999998843
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-47 Score=335.05 Aligned_cols=241 Identities=33% Similarity=0.575 Sum_probs=192.4
Q ss_pred CCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCC-CCcee
Q 021306 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTS-KNELF 110 (314)
Q Consensus 38 ~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~~~~~ 110 (314)
++|++++.||+|+||+||+|+++.+|+.||||+++... ....+|+.++++++||||++++++|..... +...+
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 68999999999999999999999999999999997542 224589999999999999999999854332 24567
Q ss_pred EEEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcccc
Q 021306 111 LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 190 (314)
Q Consensus 111 ~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~ 190 (314)
+|+||||+.+++++.+. ..+++..++.++.||+.||.|||+ +||+||||||+||+++. ++.++++|||+++.
T Consensus 97 ~~iv~Ey~~~~l~~~~~------~~~~~~~i~~~~~qil~gl~~LH~-~giiHrDlKP~Nil~~~-~~~~kl~df~~~~~ 168 (355)
T d2b1pa1 97 VYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKS-DCTLKILDFGLART 168 (355)
T ss_dssp EEEEEECCSEEHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECT-TCCEEECCCCC---
T ss_pred eEEEEeccchHHHHhhh------cCCCHHHHHHHHHHHHHHHHHhhh-cccccccCCcccccccc-ccceeeechhhhhc
Confidence 89999999999877653 578999999999999999999999 89999999999999998 78899999999887
Q ss_pred cccCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCHH-------
Q 021306 191 LIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE------- 263 (314)
Q Consensus 191 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~------- 263 (314)
...........+|+.|+|||.+.+.. ++.++||||+||++|+|++|+.||.+.+.......++.....+.++
T Consensus 169 ~~~~~~~~~~~~t~~y~aPE~l~~~~-~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 247 (355)
T d2b1pa1 169 AGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 247 (355)
T ss_dssp ------------CCTTCCHHHHTTCC-CCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCH
T ss_pred cccccccccccccccccChhhhcCCC-CCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhh
Confidence 76666666677899999999997754 8999999999999999999999999998887777776554433221
Q ss_pred ------------------------------------------H---HhccCCCCCCCcccccccCChhhh
Q 021306 264 ------------------------------------------E---IRCMNPNYTDFRFPQIKAHPWHKV 288 (314)
Q Consensus 264 ------------------------------------------~---~~~~~p~~~~~~~~~l~~~p~~~~ 288 (314)
. +...+|. +|++++++++|||++.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~-~R~ta~elL~Hpw~~~ 316 (355)
T d2b1pa1 248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPA-KRISVDDALQHPYINV 316 (355)
T ss_dssp HHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTT-TSCCHHHHHTSTTTGG
T ss_pred hHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChh-HCcCHHHHhcCcccCC
Confidence 1 2234787 8999999999999986
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.9e-47 Score=335.15 Aligned_cols=245 Identities=27% Similarity=0.490 Sum_probs=196.6
Q ss_pred cCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc-cchHHHHHHHHhCC-CCceeeeceeeeecCCCCceeEEE
Q 021306 36 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-RYKNRELQLMRVMD-HPNVISLKHCFFSTTSKNELFLNL 113 (314)
Q Consensus 36 ~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~-~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~l 113 (314)
..++|++++.||+|+||+||+|+++.+|+.||+|+++... ....+|+.++++++ ||||+++++++.... ...+++
T Consensus 33 ~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~---~~~~~~ 109 (328)
T d3bqca1 33 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPV---SRTPAL 109 (328)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTT---TCSEEE
T ss_pred CCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHHHHhccCCCCCcEEEEEEEecC---CCceeE
Confidence 3478999999999999999999999999999999987543 44568999999985 999999999885432 234889
Q ss_pred EeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCccccccc
Q 021306 114 VMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA 193 (314)
Q Consensus 114 v~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~~ 193 (314)
||||++++.+. . ..+.+++.+++.++.||+.||.|||+ +||+||||||+|||++.++..++|+|||++.....
T Consensus 110 v~e~~~~~~L~---~---~~~~l~e~~i~~i~~qil~aL~~LH~-~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~ 182 (328)
T d3bqca1 110 VFEHVNNTDFK---Q---LYQTLTDYDIRFYMYEILKALDYCHS-MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182 (328)
T ss_dssp EEECCCSCBGG---G---TTTSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred EEeecCCCcHH---H---HhcCCCHHHHHHHHHHHHHHHHHHhh-cccccccccccceEEcCCCCeeeecccccceeccC
Confidence 99999975322 2 13679999999999999999999999 99999999999999997566799999999987766
Q ss_pred CCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHcCCC------------
Q 021306 194 GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA-VDQLVEIIKVLGTP------------ 260 (314)
Q Consensus 194 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~-~~~~~~i~~~~~~~------------ 260 (314)
........+|+.|+|||.+.+...++.++|+||+||++|+|++|+.||..... .+....+.+.++.+
T Consensus 183 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 262 (328)
T d3bqca1 183 GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE 262 (328)
T ss_dssp TCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCC
T ss_pred CCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccc
Confidence 55566677899999999987776689999999999999999999999976543 33333333221100
Q ss_pred --------------------------------CHHHH---hccCCCCCCCcccccccCChhhhhcc
Q 021306 261 --------------------------------TREEI---RCMNPNYTDFRFPQIKAHPWHKVCIF 291 (314)
Q Consensus 261 --------------------------------~~~~~---~~~~p~~~~~~~~~l~~~p~~~~~~~ 291 (314)
..+.+ ...+|. +|++++++++||||+....
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~-~R~ta~e~L~Hp~F~~v~~ 327 (328)
T d3bqca1 263 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQ-SRLTAREAMEHPYFYTVVK 327 (328)
T ss_dssp CCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGG-GSCCHHHHHTSGGGTTSCC
T ss_pred cCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChh-HCcCHHHHhcCcccCCCCC
Confidence 01112 234677 8999999999999987543
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-47 Score=325.70 Aligned_cols=256 Identities=23% Similarity=0.280 Sum_probs=198.4
Q ss_pred CCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCCcee
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 110 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 110 (314)
.++|++.+.||+|+||.||+|+.+ ..||||.++... ..+.+|+.++++++||||++++++... . .
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~-----~ 77 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-P-----Q 77 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-S-----S
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-c-----E
Confidence 468999999999999999999853 359999985432 234589999999999999999987521 1 2
Q ss_pred EEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCccc
Q 021306 111 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 189 (314)
Q Consensus 111 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~ 189 (314)
+++||||+++ +|.+.+.. .+.++++.++..++.|++.||.|||+ ++|+||||||+|||++. ++.+||+|||+++
T Consensus 78 ~~lv~Ey~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~gl~yLH~-~~ivHrDlKp~NiLl~~-~~~~Kl~DFGla~ 152 (276)
T d1uwha_ 78 LAIVTQWCEGSSLYHHLHI---IETKFEMIKLIDIARQTAQGMDYLHA-KSIIHRDLKSNNIFLHE-DLTVKIGDFGLAT 152 (276)
T ss_dssp CEEEEECCCEEEHHHHHHT---SCCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEET-TSSEEECCCCCSC
T ss_pred EEEEEecCCCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHhc-CCEeccccCHHHEEEcC-CCCEEEcccccee
Confidence 6799999995 77766653 34679999999999999999999999 89999999999999998 8899999999997
Q ss_pred ccccCC---ccccccccccccccccccCC--CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCC-CCHH
Q 021306 190 QLIAGE---ANISYICSRFYRAPELIFGA--TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT-PTRE 263 (314)
Q Consensus 190 ~~~~~~---~~~~~~~~~~y~aPE~~~~~--~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~-~~~~ 263 (314)
...... ......+|+.|+|||.+.+. ..++.++|||||||++|||+||+.||.+.+....+..++..... +...
T Consensus 153 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~ 232 (276)
T d1uwha_ 153 VKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLS 232 (276)
T ss_dssp C------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGG
T ss_pred eccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcch
Confidence 654322 22345679999999998643 34789999999999999999999999998877666666654332 2222
Q ss_pred HHhccCCCCCCCcccccccCChhhhhcccCChHHHHHhcchhhhcCC
Q 021306 264 EIRCMNPNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGSHINAISP 310 (314)
Q Consensus 264 ~~~~~~p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (314)
. +.+. ....+.+|+..||...+..+++...+++.++.+.-..|
T Consensus 233 ~---~~~~-~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~P 275 (276)
T d1uwha_ 233 K---VRSN-CPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLP 275 (276)
T ss_dssp G---SCTT-CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred h---cccc-chHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcCC
Confidence 1 1221 22347788888999888888888888888877765544
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.1e-47 Score=329.88 Aligned_cols=252 Identities=19% Similarity=0.247 Sum_probs=194.0
Q ss_pred CCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeEEE
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 113 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 113 (314)
.++|++.+.||+|+||.||+|+++.+++.||+|+++.+. ..+.+|+.++++++||||+++++++.... .+++
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~-----~~~i 90 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP-----PFYI 90 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-----SCEE
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEeeCC-----eeEE
Confidence 458999999999999999999999999999999987553 33468999999999999999999985433 3789
Q ss_pred Eeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcccccc
Q 021306 114 VMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 192 (314)
Q Consensus 114 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~ 192 (314)
+|||+++ ++...+.. .....+++..++.++.|++.||.|||+ +||+||||||+|||++. ++.+||+|||+++...
T Consensus 91 v~E~~~~g~l~~~l~~--~~~~~~~~~~~~~i~~qi~~gL~yLH~-~~iiHrDlKp~NILl~~-~~~~Kl~DFG~a~~~~ 166 (287)
T d1opja_ 91 ITEFMTYGNLLDYLRE--CNRQEVSAVVLLYMATQISSAMEYLEK-KNFIHRDLAARNCLVGE-NHLVKVADFGLSRLMT 166 (287)
T ss_dssp EEECCTTCBHHHHHHH--SCTTTSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECG-GGCEEECCCCCTTTCC
T ss_pred EeecccCcchHHHhhh--ccccchHHHHHHHHHHHHHHHHHHHHH-CCcccCccccCeEEECC-CCcEEEccccceeecC
Confidence 9999995 67666653 234689999999999999999999999 89999999999999998 7899999999998654
Q ss_pred cCCc--cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCHHHHhccCC
Q 021306 193 AGEA--NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 270 (314)
Q Consensus 193 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~p 270 (314)
.... .....+++.|+|||.+.+.. ++.++||||||+++|||++|..||........+..++.....+.. |
T Consensus 167 ~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~~-------~ 238 (287)
T d1opja_ 167 GDTYTAHAGAKFPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMER-------P 238 (287)
T ss_dssp SSSSEEETTEEECGGGCCHHHHHHCC-CSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCC-------C
T ss_pred CCCceeeccccccccccChHHHcCCC-CCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCCCC-------C
Confidence 4322 22345688899999987655 899999999999999999977665554444445445443221110 1
Q ss_pred CCCCCcccccccCChhhhhcccCChHHHHHhcchh
Q 021306 271 NYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGSHI 305 (314)
Q Consensus 271 ~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~~~ 305 (314)
......+.+|++.||...+..+++...+++.++++
T Consensus 239 ~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~ 273 (287)
T d1opja_ 239 EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 273 (287)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred ccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 11122355666667766666666666666655543
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-47 Score=321.34 Aligned_cols=249 Identities=21% Similarity=0.324 Sum_probs=190.8
Q ss_pred CCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeEEE
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 113 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 113 (314)
.++|++.+.||+|+||.||+|++. +++.||||+++... ..+.+|+.++++++||||+++++++.... .+++
T Consensus 4 p~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~-----~~~l 77 (263)
T d1sm2a_ 4 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQA-----PICL 77 (263)
T ss_dssp CSCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-----SCEE
T ss_pred hHHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccCC-----ceEE
Confidence 357999999999999999999975 67789999987543 33468999999999999999999985433 3789
Q ss_pred Eeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcccccc
Q 021306 114 VMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 192 (314)
Q Consensus 114 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~ 192 (314)
||||+++ +|.+.+.. ....+++..++.++.|++.||.|||+ ++|+||||||+||+++. ++.+||+|||+++...
T Consensus 78 v~E~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qia~gl~~lH~-~~iiHrDlKp~Nill~~-~~~~Kl~DFGla~~~~ 152 (263)
T d1sm2a_ 78 VFEFMEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEE-ACVIHRDLAARNCLVGE-NQVIKVSDFGMTRFVL 152 (263)
T ss_dssp EEECCTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCTTCSGGGEEECG-GGCEEECSCC------
T ss_pred EEEecCCCcHHHHhhc---cccCCCHHHHHHHHHHHHHHHHhhhc-cceeecccchhheeecC-CCCeEecccchheecc
Confidence 9999985 66665543 34678999999999999999999999 89999999999999998 8899999999997654
Q ss_pred cCCc--cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCHHHHhccC
Q 021306 193 AGEA--NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 269 (314)
Q Consensus 193 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 269 (314)
.... .....+|+.|+|||.+.+.. ++.++||||||+++|||+| |.+||...+..+.+..+....... .
T Consensus 153 ~~~~~~~~~~~gt~~y~aPE~l~~~~-~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~--------~ 223 (263)
T d1sm2a_ 153 DDQYTSSTGTKFPVKWASPEVFSFSR-YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLY--------K 223 (263)
T ss_dssp ------------CTTSCCHHHHTTCC-CCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCC--------C
T ss_pred CCCceeecceecCcccCChHHhcCCC-CCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCC--------C
Confidence 4322 22356788999999997655 8999999999999999999 566677667666565554432222 2
Q ss_pred CCCCCCcccccccCChhhhhcccCChHHHHHhcchh
Q 021306 270 PNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGSHI 305 (314)
Q Consensus 270 p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~~~ 305 (314)
|......+.+|++.||...+..+++...+++.++.+
T Consensus 224 p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i 259 (263)
T d1sm2a_ 224 PRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEI 259 (263)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 222344567888888888888888888888877655
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.6e-47 Score=327.80 Aligned_cols=250 Identities=24% Similarity=0.334 Sum_probs=185.9
Q ss_pred CCCceeeeeEeecCceEEEEEEECCCCc---EEEEEEeecc-----ccchHHHHHHHHhCCCCceeeeceeeeecCCCCc
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCLETGE---TVAIKKVLQD-----RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 108 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~---~~~vK~~~~~-----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 108 (314)
.++|++.+.||+|+||.||+|+++.+++ .|++|.+... ...+.+|+.++++++|||||++++++....
T Consensus 25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~---- 100 (299)
T d1jpaa_ 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKST---- 100 (299)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS----
T ss_pred hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC----
Confidence 4679999999999999999999887664 5888887543 223468999999999999999999984433
Q ss_pred eeEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCc
Q 021306 109 LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 187 (314)
Q Consensus 109 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~ 187 (314)
.+++|||||++ +|.+.+.. ....+++.++..++.|++.||.|||+ ++|+||||||+|||++. ++.+||+|||+
T Consensus 101 -~~~iv~Ey~~~g~L~~~~~~---~~~~l~~~~~~~i~~qia~gl~yLH~-~~iiHrDlKp~NILl~~-~~~~Kl~DFGl 174 (299)
T d1jpaa_ 101 -PVMIITEFMENGSLDSFLRQ---NDGQFTVIQLVGMLRGIAAGMKYLAD-MNYVHRDLAARNILVNS-NLVCKVSDFGL 174 (299)
T ss_dssp -SCEEEEECCTTEEHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECT-TCCEEECCC--
T ss_pred -EEEEEEEecCCCcceeeecc---ccCCCCHHHHHHHHHHHHHHHHHHhh-CCCccCccccceEEECC-CCcEEECCccc
Confidence 37899999997 55554442 34679999999999999999999999 89999999999999998 88999999999
Q ss_pred ccccccCCcc------ccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCC
Q 021306 188 AKQLIAGEAN------ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTP 260 (314)
Q Consensus 188 ~~~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~t-g~~pf~~~~~~~~~~~i~~~~~~~ 260 (314)
++........ ....+|+.|+|||.+.+.. ++.++|||||||++|||+| |+.||.+.+..+.+..+.+....+
T Consensus 175 a~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~ 253 (299)
T d1jpaa_ 175 SRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRK-FTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLP 253 (299)
T ss_dssp ---------------------CGGGSCHHHHHSCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCC
T ss_pred ceEccCCCCcceeeecccccCCccccCHHHHhcCC-CCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 9865433221 1234688899999997654 8999999999999999998 899999988877666665543322
Q ss_pred CHHHHhccCCCCCCCcccccccCChhhhhcccCChHHHHHhcchh
Q 021306 261 TREEIRCMNPNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGSHI 305 (314)
Q Consensus 261 ~~~~~~~~~p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~~~ 305 (314)
.+. . ....+.+|+..||...+..+++...+++.++.+
T Consensus 254 ~~~-------~-~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~ 290 (299)
T d1jpaa_ 254 PPM-------D-CPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKM 290 (299)
T ss_dssp CCT-------T-CCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred CCc-------c-chHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 211 1 223456677777777777777777777666544
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-47 Score=319.31 Aligned_cols=247 Identities=20% Similarity=0.288 Sum_probs=199.5
Q ss_pred CCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeEEE
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 113 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 113 (314)
.++|++++.||+|+||+||+|+++ +++.||||.+++.. ..+.+|+.++++++||||+++++++.... .+++
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~-----~~~i 76 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQR-----PIFI 76 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSS-----SEEE
T ss_pred hHHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCC-----ceEE
Confidence 468999999999999999999974 78899999987643 34568999999999999999999885433 3889
Q ss_pred Eeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcccccc
Q 021306 114 VMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 192 (314)
Q Consensus 114 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~ 192 (314)
||||+++ ++...+.. ....+++..++.++.|++.||.|||+ +||+||||||+||+++. ++.+||+|||+++...
T Consensus 77 v~Ey~~~g~l~~~~~~---~~~~~~~~~~~~i~~qi~~gl~~LH~-~~iiH~dlk~~Nill~~-~~~~kl~DfG~a~~~~ 151 (258)
T d1k2pa_ 77 ITEYMANGCLLNYLRE---MRHRFQTQQLLEMCKDVCEAMEYLES-KQFLHRDLAARNCLVND-QGVVKVSDFGLSRYVL 151 (258)
T ss_dssp EEECCTTEEHHHHHHS---GGGCCCHHHHHHHHHHHHHHHHHHHH-TTBCCSCCSGGGEEECT-TCCEEECCCSSCCBCS
T ss_pred EEEccCCCcHHHhhhc---cccCCcHHHHHHHHHHHHHHHHHHhh-cCcccccccceeEEEcC-CCcEEECcchhheecc
Confidence 9999985 55554432 34678999999999999999999999 89999999999999998 8899999999997554
Q ss_pred cCCc--cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCHHHHhccC
Q 021306 193 AGEA--NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 269 (314)
Q Consensus 193 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 269 (314)
.... .....+|+.|+|||.+.+.. ++.++||||||+++|||+| |+.||.+.+..+....+.+....+.
T Consensus 152 ~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~-------- 222 (258)
T d1k2pa_ 152 DDEYTSSVGSKFPVRWSPPEVLMYSK-FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYR-------- 222 (258)
T ss_dssp SSSCCCCCCSCCCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCC--------
T ss_pred CCCceeecccCCCCCcCCcHHhcCCC-CCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCCC--------
Confidence 3322 22356788999999997655 8999999999999999998 8999999988776666654332222
Q ss_pred CCCCCCcccccccCChhhhhcccCChHHHHHhcc
Q 021306 270 PNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGS 303 (314)
Q Consensus 270 p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~ 303 (314)
|......+.++++.||...+..+++...+++.+.
T Consensus 223 p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~ 256 (258)
T d1k2pa_ 223 PHLASEKVYTIMYSCWHEKADERPTFKILLSNIL 256 (258)
T ss_dssp CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred cccccHHHHHHHHHHccCCHhHCcCHHHHHHHhh
Confidence 2223345778888888888888888777776553
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-46 Score=319.48 Aligned_cols=241 Identities=35% Similarity=0.611 Sum_probs=195.9
Q ss_pred CCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeE
Q 021306 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 111 (314)
Q Consensus 38 ~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 111 (314)
++|++++.||+|+||+||+|++..+++.||||+++... ....+|+.+++.++|+||+++++++.... ..
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~-----~~ 76 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDK-----KL 76 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSS-----EE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeecccccccc-----ce
Confidence 68999999999999999999999999999999986443 23358999999999999999999985433 47
Q ss_pred EEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCccccc
Q 021306 112 NLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 191 (314)
Q Consensus 112 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~ 191 (314)
+++++++.++.+..+. ...+.+++..++.++.|++.||+|||+ +||+||||||+||+++. ++.++|+|||.+...
T Consensus 77 ~iv~~~~~~~~l~~~~---~~~~~~~~~~~~~~~~q~~~aL~~lH~-~~IvHrDiKP~NIli~~-~~~~kl~DFG~a~~~ 151 (292)
T d1unla_ 77 TLVFEFCDQDLKKYFD---SCNGDLDPEIVKSFLFQLLKGLGFCHS-RNVLHRDLKPQNLLINR-NGELKLANFGLARAF 151 (292)
T ss_dssp EEEEECCSEEHHHHHH---HTTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECT-TCCEEECCCTTCEEC
T ss_pred eEEeeecccccccccc---ccccccchhHHHHHHHHHHHHHHHhhc-CCEeeecccCccccccc-CCceeeeecchhhcc
Confidence 8999999987655444 356789999999999999999999999 89999999999999998 788999999999876
Q ss_pred ccCCc-cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCC-CCCChHHHHHHHHHHcCCCCH-------
Q 021306 192 IAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLF-PGENAVDQLVEIIKVLGTPTR------- 262 (314)
Q Consensus 192 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf-~~~~~~~~~~~i~~~~~~~~~------- 262 (314)
..... .....+++.|+|||.+.+...++.++|||||||++|+|++|+.|| .+.+..+.+..+....+.+..
T Consensus 152 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (292)
T d1unla_ 152 GIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMT 231 (292)
T ss_dssp CSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGG
T ss_pred cCCCccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhh
Confidence 54332 233455778999999877666799999999999999999999885 555666666666554433211
Q ss_pred -----------------------------HHHh---ccCCCCCCCcccccccCChhhhh
Q 021306 263 -----------------------------EEIR---CMNPNYTDFRFPQIKAHPWHKVC 289 (314)
Q Consensus 263 -----------------------------~~~~---~~~p~~~~~~~~~l~~~p~~~~~ 289 (314)
+.+. ..+|. +|++++++++|||++..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~-~R~sa~e~L~Hp~f~~~ 289 (292)
T d1unla_ 232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPV-QRISAEEALQHPYFSDF 289 (292)
T ss_dssp GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGG-GSCCHHHHTTSGGGSSC
T ss_pred hcccccccccccccchhhhccccCCHHHHHHHHHHccCChh-HCcCHHHHhcChhhcCC
Confidence 1122 33677 89999999999999753
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-46 Score=319.38 Aligned_cols=251 Identities=22% Similarity=0.279 Sum_probs=195.5
Q ss_pred CCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeEEE
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 113 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 113 (314)
.++|++.+.||+|+||.||+|+++ +++.||||.++... ..+.+|+.++++++||||+++++++.. . .+++
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~-----~~~i 84 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-E-----PIYI 84 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-S-----SCEE
T ss_pred HHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-C-----CeEE
Confidence 358999999999999999999965 67889999987543 334689999999999999999997632 1 1579
Q ss_pred Eeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcccccc
Q 021306 114 VMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 192 (314)
Q Consensus 114 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~ 192 (314)
||||+++ +|.+.+... ...++++.++..++.||+.||.|||+ ++|+||||||+||+++. ++.+||+|||+++...
T Consensus 85 v~Ey~~~g~L~~~~~~~--~~~~l~~~~~~~i~~qi~~gl~~lH~-~~ivHrDiKp~NIll~~-~~~~Kl~DFGla~~~~ 160 (272)
T d1qpca_ 85 ITEYMENGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEE-RNYIHRDLRAANILVSD-TLSCKIADFGLARLIE 160 (272)
T ss_dssp EEECCTTCBHHHHTTSH--HHHTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECT-TSCEEECCCTTCEECS
T ss_pred EEEeCCCCcHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCccchhheeeec-ccceeeccccceEEcc
Confidence 9999996 555544322 23469999999999999999999999 89999999999999998 8899999999998664
Q ss_pred cCCc--cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHHHcCCCCHHHHhccC
Q 021306 193 AGEA--NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLG-QPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 269 (314)
Q Consensus 193 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 269 (314)
.... .....+++.|+|||.+.+.. ++.++||||||+++|||+|| .+||...+..+.+..+.+....+.+
T Consensus 161 ~~~~~~~~~~~gt~~y~APE~~~~~~-~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~~p------- 232 (272)
T d1qpca_ 161 DNEYTAREGAKFPIKWTAPEAINYGT-FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRP------- 232 (272)
T ss_dssp SSCEECCTTCCCCTTTSCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCC-------
T ss_pred CCccccccccCCcccccChHHHhCCC-CCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCc-------
Confidence 3322 23356788999999997554 89999999999999999995 4556666666555555443222211
Q ss_pred CCCCCCcccccccCChhhhhcccCChHHHHHhcchhhh
Q 021306 270 PNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGSHINA 307 (314)
Q Consensus 270 p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~~~~~ 307 (314)
......+.+|++.||...+..+++...+.+.++.+++
T Consensus 233 -~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 233 -DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp -TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -ccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 1122346778888888888888888888888777664
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-46 Score=325.83 Aligned_cols=250 Identities=24% Similarity=0.360 Sum_probs=195.3
Q ss_pred CCceeeeeEeecCceEEEEEEECCCCc-----EEEEEEeecc-----ccchHHHHHHHHhC-CCCceeeeceeeeecCCC
Q 021306 38 ISYMAERVVGTGSFGIVFQAKCLETGE-----TVAIKKVLQD-----RRYKNRELQLMRVM-DHPNVISLKHCFFSTTSK 106 (314)
Q Consensus 38 ~~y~~~~~Lg~g~~g~Vy~~~~~~~~~-----~~~vK~~~~~-----~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~ 106 (314)
++|++.+.||+|+||.||+|++..+++ .||+|.+... .....+|+.+++++ +|||||++++++....
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~-- 114 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG-- 114 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS--
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCC--
Confidence 589999999999999999999876543 6899987543 22345789999887 8999999999985433
Q ss_pred CceeEEEEeecccc-cHHHHHHhhhh-------------------cCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCC
Q 021306 107 NELFLNLVMEYVPE-SMYRVLKHYSS-------------------ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDL 166 (314)
Q Consensus 107 ~~~~~~lv~e~~~~-~l~~~l~~~~~-------------------~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl 166 (314)
.+++|||||++ +|.+.+..... ....+++..++.++.|++.||.|||+ ++|+||||
T Consensus 115 ---~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~-~~IiHRDl 190 (325)
T d1rjba_ 115 ---PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF-KSCVHRDL 190 (325)
T ss_dssp ---SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH-TTEEETTC
T ss_pred ---eEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccC
Confidence 37899999985 77777754221 12458999999999999999999999 89999999
Q ss_pred CCCcEEEcCCCCcEEEeecCcccccccCCcc---ccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCC
Q 021306 167 KPQNLLVDPLTHQVKICDFGSAKQLIAGEAN---ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFP 242 (314)
Q Consensus 167 ~p~Nil~~~~~~~~~l~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~t-g~~pf~ 242 (314)
||+||+++. ++.+||+|||+++........ ....+|+.|+|||.+.+.. ++.++|||||||++|||+| |+.||.
T Consensus 191 Kp~Nill~~-~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~~~~DiwS~Gvil~emlt~g~~Pf~ 268 (325)
T d1rjba_ 191 AARNVLVTH-GKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGI-YTIKSDVWSYGILLWEIFSLGVNPYP 268 (325)
T ss_dssp SGGGEEEET-TTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred chhcccccc-CCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCC-CCcceeccchhHHHHHHHhCCCCCCC
Confidence 999999998 889999999999865543322 2355689999999997655 8999999999999999998 899999
Q ss_pred CCChHHHHHHHHHHcCCCCHHHHhccCCCCCCCcccccccCChhhhhcccCChHHHHHhc
Q 021306 243 GENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYG 302 (314)
Q Consensus 243 ~~~~~~~~~~i~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~ 302 (314)
+.+..+.+.++++....+.. |......+.+|+..||...+..+++...+++.+
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~-------p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L 321 (325)
T d1rjba_ 269 GIPVDANFYKLIQNGFKMDQ-------PFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL 321 (325)
T ss_dssp TCCCSHHHHHHHHTTCCCCC-------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCCHHHHHHHHHhcCCCCCC-------CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 88777777777664322211 111233467788888888888888777777665
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-46 Score=317.76 Aligned_cols=247 Identities=24% Similarity=0.270 Sum_probs=192.0
Q ss_pred CCceeeee-EeecCceEEEEEEECC--CCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCce
Q 021306 38 ISYMAERV-VGTGSFGIVFQAKCLE--TGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL 109 (314)
Q Consensus 38 ~~y~~~~~-Lg~g~~g~Vy~~~~~~--~~~~~~vK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 109 (314)
++|.+.+. ||+|+||.||+|.++. ++..||||.++... ..+.+|+.++++++||||+++++++.. ..
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~---- 82 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EA---- 82 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SS----
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-Ce----
Confidence 57888885 9999999999998764 45589999986432 234589999999999999999998732 21
Q ss_pred eEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcc
Q 021306 110 FLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 188 (314)
Q Consensus 110 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~ 188 (314)
+++||||+++ +|.+.+.. ....+++.++..++.|++.||.|||+ +||+||||||+||+++. ++.+||+|||++
T Consensus 83 -~~lvmE~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~gL~ylH~-~~iiHrDlKp~Nill~~-~~~~Kl~DFGla 156 (285)
T d1u59a_ 83 -LMLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEE-KNFVHRDLAARNVLLVN-RHYAKISDFGLS 156 (285)
T ss_dssp -EEEEEECCTTEEHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEEE-TTEEEECCCTTC
T ss_pred -EEEEEEeCCCCcHHHHhhc---cccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCcCchhheeecc-CCceeeccchhh
Confidence 6799999996 66555432 34679999999999999999999999 99999999999999998 889999999999
Q ss_pred cccccCCcc----ccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCHH
Q 021306 189 KQLIAGEAN----ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTRE 263 (314)
Q Consensus 189 ~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~ 263 (314)
+........ ....+|+.|+|||.+.+.. ++.++|||||||++|||+| |+.||.+.+..+....+.++...+.+
T Consensus 157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~~~p- 234 (285)
T d1u59a_ 157 KALGADDSYYTARSAGKWPLKWYAPECINFRK-FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECP- 234 (285)
T ss_dssp EECTTCSCEECCCCSSCCCGGGCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCC-
T ss_pred hcccccccccccccccccCccccChHHHhCCC-CCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC-
Confidence 865433221 2345688999999997654 8999999999999999998 99999998877666655543322211
Q ss_pred HHhccCCCCCCCcccccccCChhhhhcccCChHHHHHhcch
Q 021306 264 EIRCMNPNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGSH 304 (314)
Q Consensus 264 ~~~~~~p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~~ 304 (314)
+. ....+.+|++.||...+..+++...+.+.++.
T Consensus 235 ------~~-~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~ 268 (285)
T d1u59a_ 235 ------PE-CPPELYALMSDCWIYKWEDRPDFLTVEQRMRA 268 (285)
T ss_dssp ------TT-CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred ------Cc-CCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 11 22346677778888777777777666665553
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-45 Score=326.66 Aligned_cols=243 Identities=36% Similarity=0.606 Sum_probs=195.1
Q ss_pred CCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeecccc------chHHHHHHHHhCCCCceeeeceeeeecCCC-Cce
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR------YKNRELQLMRVMDHPNVISLKHCFFSTTSK-NEL 109 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~~------~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~-~~~ 109 (314)
.++|++.+.||+|+||+||+|+++.+|+.||||++++... ...+|+.++++++|+|++++++++...... ...
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 4689999999999999999999999999999999865432 235899999999999999999988544332 233
Q ss_pred eEEEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCccc
Q 021306 110 FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 189 (314)
Q Consensus 110 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~ 189 (314)
.+++++++.+|+|.+.+. .+++++.+++.++.||+.||.|||+ +||+||||||+||+++. ++.++++|||.+.
T Consensus 97 ~~~i~~~~~gg~L~~~~~-----~~~l~e~~~~~i~~qil~aL~~LH~-~giiHrDiKp~NILi~~-~~~~kl~dfg~a~ 169 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHS-ADIIHRDLKPSNLAVNE-DCELKILDFGLAR 169 (348)
T ss_dssp CCEEEEECCSEEHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECT-TCCEEECCC----
T ss_pred eEEEEEeecCCchhhhcc-----cccccHHHHHHHHHHHHHHHHHHHh-CCCcccccCCccccccc-cccccccccchhc
Confidence 344555555567776654 3679999999999999999999999 89999999999999998 8899999999987
Q ss_pred ccccCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCHH------
Q 021306 190 QLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE------ 263 (314)
Q Consensus 190 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~------ 263 (314)
.... ......+++.|+|||.+.+...++.++|||||||++|+|++|+.||.+.+.......+.+....+..+
T Consensus 170 ~~~~--~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 247 (348)
T d2gfsa1 170 HTDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 247 (348)
T ss_dssp CCTG--GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCC
T ss_pred ccCc--ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhcc
Confidence 5433 33446778999999998777667899999999999999999999999998888877777665443221
Q ss_pred --------------------------------HHh---ccCCCCCCCcccccccCChhhhh
Q 021306 264 --------------------------------EIR---CMNPNYTDFRFPQIKAHPWHKVC 289 (314)
Q Consensus 264 --------------------------------~~~---~~~p~~~~~~~~~l~~~p~~~~~ 289 (314)
.+. ..+|. +|+++.++++|||++..
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~-~R~ta~elL~Hp~f~~~ 307 (348)
T d2gfsa1 248 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSD-KRITAAQALAHAYFAQY 307 (348)
T ss_dssp CHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGG-GSCCHHHHHTSGGGTTT
T ss_pred chhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChh-hCcCHHHHhcCHhhCCC
Confidence 122 34677 89999999999999854
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-46 Score=317.04 Aligned_cols=239 Identities=22% Similarity=0.247 Sum_probs=180.6
Q ss_pred eeEeecCceEEEEEEEC--CCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeEEEEe
Q 021306 44 RVVGTGSFGIVFQAKCL--ETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVM 115 (314)
Q Consensus 44 ~~Lg~g~~g~Vy~~~~~--~~~~~~~vK~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 115 (314)
++||+|+||.||+|.+. .+++.||+|.++... ..+.+|+.++++++||||+++++++. ... .++||
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~-~~~-----~~lvm 86 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AES-----WMLVM 86 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-SSS-----EEEEE
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEec-cCC-----EEEEE
Confidence 46999999999999864 356789999986432 23468999999999999999999873 221 57999
Q ss_pred ecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcccccccC
Q 021306 116 EYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG 194 (314)
Q Consensus 116 e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~~~ 194 (314)
||+++ +|.+.+. ...++++.++..++.||+.||.|||+ ++|+||||||+||+++. ++.++|+|||+++.....
T Consensus 87 E~~~~g~L~~~l~----~~~~l~~~~~~~i~~qi~~gl~ylH~-~~iiHrDlKp~Nill~~-~~~~kl~DFGla~~~~~~ 160 (277)
T d1xbba_ 87 EMAELGPLNKYLQ----QNRHVKDKNIIELVHQVSMGMKYLEE-SNFVHRDLAARNVLLVT-QHYAKISDFGLSKALRAD 160 (277)
T ss_dssp ECCTTEEHHHHHH----HCTTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEEE-TTEEEECCCTTCEECCTT
T ss_pred EcCCCCcHHHHHh----hccCCCHHHHHHHHHHHHHHHhhHHh-CCcccCCCcchhhcccc-cCcccccchhhhhhcccc
Confidence 99996 5665554 35789999999999999999999999 89999999999999998 889999999999865433
Q ss_pred Cc----cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCHHHHhccC
Q 021306 195 EA----NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 269 (314)
Q Consensus 195 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 269 (314)
.. .....+|+.|+|||.+.+.. ++.++||||||+++|||+| |+.||.+.+..+....+.++...+.+. .+
T Consensus 161 ~~~~~~~~~~~gt~~y~APE~l~~~~-~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~p~---~~- 235 (277)
T d1xbba_ 161 ENYYKAQTHGKWPVKWYAPECINYYK-FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPA---GC- 235 (277)
T ss_dssp CSEEEC----CCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCT---TC-
T ss_pred ccccccccccCCCceecCchhhcCCC-CCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCc---cc-
Confidence 22 22345788999999997654 8999999999999999998 899999988776665555432222111 11
Q ss_pred CCCCCCcccccccCChhhhhcccCChHHHHHhcc
Q 021306 270 PNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGS 303 (314)
Q Consensus 270 p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~ 303 (314)
...+.+|++.||...+..+++...+.+.++
T Consensus 236 ----~~~~~~li~~cl~~dp~~RPs~~~i~~~L~ 265 (277)
T d1xbba_ 236 ----PREMYDLMNLCWTYDVENRPGFAAVELRLR 265 (277)
T ss_dssp ----CHHHHHHHHHHTCSSTTTSCCHHHHHHHHH
T ss_pred ----CHHHHHHHHHHcCCCHhHCcCHHHHHHHhh
Confidence 223455666666666666655555554444
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-45 Score=313.26 Aligned_cols=249 Identities=20% Similarity=0.259 Sum_probs=183.3
Q ss_pred CCceeeeeEeecCceEEEEEEECCCC----cEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCc
Q 021306 38 ISYMAERVVGTGSFGIVFQAKCLETG----ETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 108 (314)
Q Consensus 38 ~~y~~~~~Lg~g~~g~Vy~~~~~~~~----~~~~vK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 108 (314)
..|++.+.||+|+||.||+|+++.++ ..||||.++... ..+.+|+.++++++|||||++++++....
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~---- 82 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYK---- 82 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS----
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCC----
Confidence 56999999999999999999987654 479999986432 23458999999999999999999985433
Q ss_pred eeEEEEeeccccc-HHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCc
Q 021306 109 LFLNLVMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 187 (314)
Q Consensus 109 ~~~~lv~e~~~~~-l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~ 187 (314)
..++++||+.++ +.+.+.. ....+++.++..++.|++.||.|||+ ++|+||||||+|||++. ++.+||+|||+
T Consensus 83 -~~~~v~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~~i~~gl~~lH~-~~iiHrDlKp~NILl~~-~~~~Kl~DFGl 156 (283)
T d1mqba_ 83 -PMMIITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYLAN-MNYVHRDLAARNILVNS-NLVCKVSDFGL 156 (283)
T ss_dssp -SEEEEEECCTTEEHHHHHHH---TTTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECT-TCCEEECCCCC
T ss_pred -ceEEEEEecccCcchhhhhc---ccccccHHHHHHHHHHHHHhhhhccc-cccccCccccceEEECC-CCeEEEcccch
Confidence 378999999975 4444332 35789999999999999999999999 89999999999999998 88999999999
Q ss_pred ccccccCCc----cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCC-CCCCChHHHHHHHHHHcCCCCH
Q 021306 188 AKQLIAGEA----NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL-FPGENAVDQLVEIIKVLGTPTR 262 (314)
Q Consensus 188 ~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~p-f~~~~~~~~~~~i~~~~~~~~~ 262 (314)
++....... .....+|+.|+|||.+.+.. ++.++||||||+++|||++|..| |.+.+..+.+..+.++...+.+
T Consensus 157 a~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~-~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~~ 235 (283)
T d1mqba_ 157 SRVLEDDPEATYTTSGGKIPIRWTAPEAISYRK-FTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTP 235 (283)
T ss_dssp -----------------CCCGGGSCHHHHHSCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCC
T ss_pred hhcccCCCccceEeccCCCCccccCHHHHccCC-CCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCCCCc
Confidence 986543321 22345688999999997654 89999999999999999996555 5555555544444333222211
Q ss_pred HHHhccCCCCCCCcccccccCChhhhhcccCChHHHHHhcchh
Q 021306 263 EEIRCMNPNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGSHI 305 (314)
Q Consensus 263 ~~~~~~~p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~~~ 305 (314)
. -....+.+|++.||...+..+++...+++.++.+
T Consensus 236 ~--------~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l 270 (283)
T d1mqba_ 236 M--------DCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 270 (283)
T ss_dssp T--------TCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred h--------hhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHH
Confidence 1 1122366777778877777777777776665543
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-45 Score=313.82 Aligned_cols=253 Identities=24% Similarity=0.316 Sum_probs=189.8
Q ss_pred CCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeEEE
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 113 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 113 (314)
.++|++.+.||+|+||.||+|+++.+ +.||+|.++... ..+.+|+.++++++|+|||++++++.. .. +++
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~-----~~l 88 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EP-----IYI 88 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SS-----CEE
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CC-----eEE
Confidence 46899999999999999999997644 679999987543 345689999999999999999998732 11 579
Q ss_pred Eeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcccccc
Q 021306 114 VMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 192 (314)
Q Consensus 114 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~ 192 (314)
||||+++ ++...+.. .....+++.+++.++.||+.||.|||+ +||+||||||+||+++. ++.+||+|||+++...
T Consensus 89 v~Ey~~~g~l~~~~~~--~~~~~l~~~~~~~i~~~i~~gl~~LH~-~~ivH~DlKp~NIll~~-~~~~kl~DfGla~~~~ 164 (285)
T d1fmka3 89 VTEYMSKGSLLDFLKG--ETGKYLRLPQLVDMAAQIASGMAYVER-MNYVHRDLRAANILVGE-NLVCKVADFGLARLIE 164 (285)
T ss_dssp EECCCTTCBHHHHHSH--HHHTTCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECG-GGCEEECCCCTTC---
T ss_pred EEEecCCCchhhhhhh--cccccchHHHHHHHHHHHHHHHHHHhh-hheecccccceEEEECC-CCcEEEcccchhhhcc
Confidence 9999996 45555443 233579999999999999999999999 89999999999999998 7899999999997654
Q ss_pred cCC--ccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCC-CCCCCCChHHHHHHHHHHcCCCCHHHHhccC
Q 021306 193 AGE--ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQ-PLFPGENAVDQLVEIIKVLGTPTREEIRCMN 269 (314)
Q Consensus 193 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~-~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 269 (314)
... ......+|+.|+|||.+.+.. ++.++||||||+++|||++|. +|+.+....+.+..+.+....+.+.
T Consensus 165 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~~~~------ 237 (285)
T d1fmka3 165 DNEYTARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPP------ 237 (285)
T ss_dssp -----------CCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCT------
T ss_pred CCCceeeccccccccccChHHHhCCC-CCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCc------
Confidence 332 223356789999999997655 899999999999999999965 4555566655555555433322221
Q ss_pred CCCCCCcccccccCChhhhhcccCChHHHHHhcchhhhcC
Q 021306 270 PNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGSHINAIS 309 (314)
Q Consensus 270 p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (314)
. ....+.+++..||...+..++..+.+.+.++......
T Consensus 238 -~-~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 238 -E-CPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp -T-SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred -c-cCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence 1 1224567777888888887777777777666555433
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-45 Score=311.85 Aligned_cols=252 Identities=21% Similarity=0.287 Sum_probs=199.1
Q ss_pred CCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc--cchHHHHHHHHhCCCCceeeeceeeeecCCCCceeEEEE
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR--RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLV 114 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~--~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 114 (314)
.++|++.+.||+|+||.||+|++ +|+.||+|.++.+. ....+|++++++++||||+++++++.+.. ..+++|
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~----~~~~lv 79 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEK----GGLYIV 79 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC------CCEEE
T ss_pred HHHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEecC----CcEEEE
Confidence 46899999999999999999997 57899999997653 44568999999999999999999875432 226899
Q ss_pred eecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCccccccc
Q 021306 115 MEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA 193 (314)
Q Consensus 115 ~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~~~~ 193 (314)
|||+++ +|.+.+... ....+++..++.++.|++.||.|||+ ++|+||||||+||+++. ++.++++|||+++....
T Consensus 80 ~ey~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~al~ylH~-~~ivH~dlkp~Nil~~~-~~~~kl~dfg~s~~~~~ 155 (262)
T d1byga_ 80 TEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEG-NNFVHRDLAARNVLVSE-DNVAKVSDFGLTKEASS 155 (262)
T ss_dssp ECCCTTEEHHHHHHHH--HHHHCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECT-TSCEEECCCCC------
T ss_pred EeccCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHhhcccccc-CceeccccchHhheecC-CCCEeecccccceecCC
Confidence 999986 677766542 22468999999999999999999999 89999999999999998 88899999999986543
Q ss_pred CCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCHHHHhccCCCC
Q 021306 194 GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 272 (314)
Q Consensus 194 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~p~~ 272 (314)
. .....+++.|+|||.+.+.. ++.++||||||+++|||+| |+.||...+..+....+.+....+. ++.
T Consensus 156 ~--~~~~~~~~~y~aPE~l~~~~-~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~~~-------~~~- 224 (262)
T d1byga_ 156 T--QDTGKLPVKWTAPEALREKK-FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDA-------PDG- 224 (262)
T ss_dssp --------CCTTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCC-------CTT-
T ss_pred C--CccccccccCCChHHHhCCC-CChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCC-------Ccc-
Confidence 2 23345688899999997654 8999999999999999998 7899988887776666644332221 111
Q ss_pred CCCcccccccCChhhhhcccCChHHHHHhcchhhhcC
Q 021306 273 TDFRFPQIKAHPWHKVCIFHFPKHWLLEYGSHINAIS 309 (314)
Q Consensus 273 ~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (314)
....+.+|++.||...+..+++...+++.++.+++++
T Consensus 225 ~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~~~ 261 (262)
T d1byga_ 225 CPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHE 261 (262)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred CCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHhCC
Confidence 2345778999999999999999999999998887653
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1e-44 Score=313.74 Aligned_cols=208 Identities=25% Similarity=0.320 Sum_probs=168.6
Q ss_pred CccCCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeecc--ccchHHHHHHHHhCCCCceeeeceeeeecCCCCceeE
Q 021306 34 PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD--RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 111 (314)
Q Consensus 34 ~~~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 111 (314)
-+.+++|++.+.||+|+||.||+|++..+|+.||||.+... .....+|++++++++|++++..+..+... ....
T Consensus 3 ~~vg~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~----~~~~ 78 (299)
T d1ckia_ 3 LRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAE----GDYN 78 (299)
T ss_dssp CEETTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTSCCHHHHHHHHHHSTTSTTCCCEEEEEEE----TTEE
T ss_pred CeECCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccCHHHHHHHHHHHHccCCCcccEEEEEEec----CCEE
Confidence 34567899999999999999999999999999999987643 34557899999999888766665544332 2247
Q ss_pred EEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcC--CCCcEEEeecCccc
Q 021306 112 NLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP--LTHQVKICDFGSAK 189 (314)
Q Consensus 112 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~--~~~~~~l~dfg~~~ 189 (314)
++||||+++++...+.. ....+++..+..++.|++.||.|||+ +||+||||||+||+++. .+..++++|||+++
T Consensus 79 ~ivme~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~-~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~ 154 (299)
T d1ckia_ 79 VMVMELLGPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHS-KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 154 (299)
T ss_dssp EEEEECCCCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEECCGGGTTCEEECCCSSCE
T ss_pred EEEEEEcCCchhhhhhh---ccCCCcHHHHHHHHHHHHHHHHHHHH-CCeeeccCCHhhccccccCCCceeeeeccCcce
Confidence 89999999988776653 45789999999999999999999999 99999999999999864 24579999999998
Q ss_pred ccccCCc--------cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 021306 190 QLIAGEA--------NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQL 250 (314)
Q Consensus 190 ~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~ 250 (314)
....... .....||+.|+|||.+.+.. ++.++|||||||++|||+||+.||.........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~ 222 (299)
T d1ckia_ 155 KYRDARTHQHIPYRENKNLTGTARYASINTHLGIE-QSRRDDLESLGYVLMYFNLGSLPWQGLKAATKR 222 (299)
T ss_dssp ECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBC-CCHHHHHHHHHHHHHHHHHSSCTTCCCC-----
T ss_pred eccccccccceeccccCCcCCCccccCHHHHhCCC-CCChhhEEecCHHHHHHHhCCCcccccchHHHH
Confidence 6643321 22456899999999997655 899999999999999999999999876554433
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-45 Score=316.76 Aligned_cols=208 Identities=29% Similarity=0.440 Sum_probs=166.4
Q ss_pred CCceeeeeEeecCceEEEEEEECCCCc----EEEEEEeecc-----ccchHHHHHHHHhCCCCceeeeceeeeecCCCCc
Q 021306 38 ISYMAERVVGTGSFGIVFQAKCLETGE----TVAIKKVLQD-----RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 108 (314)
Q Consensus 38 ~~y~~~~~Lg~g~~g~Vy~~~~~~~~~----~~~vK~~~~~-----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 108 (314)
++|++.+.||+|+||.||+|++..+|+ .||+|.++.. .....+|+.++++++||||+++++++....
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~---- 84 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST---- 84 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESSS----
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC----
Confidence 469999999999999999999988876 5888877532 233568999999999999999999885321
Q ss_pred eeEEEEeeccc-ccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCc
Q 021306 109 LFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 187 (314)
Q Consensus 109 ~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~ 187 (314)
.++++|++. |+|.+.+.. ....+++..++.++.||+.||.|||+ +||+||||||+||+++. ++.+||+|||+
T Consensus 85 --~~~v~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~qi~~gl~yLH~-~~iiHrDlKp~NIll~~-~~~~kl~DFGl 157 (317)
T d1xkka_ 85 --VQLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLED-RRLVHRDLAARNVLVKT-PQHVKITDFGL 157 (317)
T ss_dssp --EEEEEECCTTCBHHHHHHH---TSSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEEE-TTEEEECCCSH
T ss_pred --eeEEEEeccCCcccccccc---cccCCCHHHHHHHHHHHHHHHHHHHH-cCcccCcchhhcceeCC-CCCeEeecccc
Confidence 456677776 577766553 45789999999999999999999999 89999999999999998 88999999999
Q ss_pred ccccccCCc---cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHc
Q 021306 188 AKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVL 257 (314)
Q Consensus 188 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~t-g~~pf~~~~~~~~~~~i~~~~ 257 (314)
++....... .....+|+.|+|||.+.+.. ++.++||||||+++|||+| |..||.+.+..+....+.++.
T Consensus 158 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~-~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~ 230 (317)
T d1xkka_ 158 AKLLGAEEKEYHAEGGKVPIKWMALESILHRI-YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE 230 (317)
T ss_dssp HHHTTTTCC--------CCTTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTC
T ss_pred ceecccccccccccccccCccccChHHHhcCC-CChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC
Confidence 986543322 22345789999999997655 8999999999999999998 899998888776555554443
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-45 Score=319.07 Aligned_cols=241 Identities=25% Similarity=0.466 Sum_probs=189.0
Q ss_pred CCCceeeeeEeecCceEEEEEEEC---CCCcEEEEEEeecc--------ccchHHHHHHHHhCCC-CceeeeceeeeecC
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCL---ETGETVAIKKVLQD--------RRYKNRELQLMRVMDH-PNVISLKHCFFSTT 104 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~---~~~~~~~vK~~~~~--------~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~ 104 (314)
.++|++++.||+|+||.||+|++. .+|+.||+|.+++. .....+|+.++++++| |||+++++++....
T Consensus 23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~ 102 (322)
T d1vzoa_ 23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 102 (322)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCC
Confidence 478999999999999999999874 46899999988542 2234589999999977 79999999885443
Q ss_pred CCCceeEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEe
Q 021306 105 SKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKIC 183 (314)
Q Consensus 105 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~ 183 (314)
.+++++||+.+ +|.+.+.. .+.+++..++.++.||+.||.|||+ +||+||||||+||+++. ++.++|+
T Consensus 103 -----~~~~v~e~~~~~~L~~~i~~----~~~~~e~~~~~~~~Qi~~al~~lH~-~~ivHrDiKp~Nill~~-~~~vkL~ 171 (322)
T d1vzoa_ 103 -----KLHLILDYINGGELFTHLSQ----RERFTEHEVQIYVGEIVLALEHLHK-LGIIYRDIKLENILLDS-NGHVVLT 171 (322)
T ss_dssp -----EEEEEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECT-TSCEEES
T ss_pred -----ceeeeeecccccHHHHHHHh----cccccHHHHHHHHHHHHHHHHHhhc-CCEEeccCCccceeecC-CCCEEEe
Confidence 48899999996 66666554 4678899999999999999999999 89999999999999998 7899999
Q ss_pred ecCcccccccCC--ccccccccccccccccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH---c
Q 021306 184 DFGSAKQLIAGE--ANISYICSRFYRAPELIFGAT-EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV---L 257 (314)
Q Consensus 184 dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~-~~~~~~Dv~slG~il~el~tg~~pf~~~~~~~~~~~i~~~---~ 257 (314)
|||+++...... ......+++.|+|||.+.+.. .++.++|||||||++|+|++|+.||.+.+..+....+.+. .
T Consensus 172 DFG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~ 251 (322)
T d1vzoa_ 172 DFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS 251 (322)
T ss_dssp CSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHC
T ss_pred eccchhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccC
Confidence 999997654322 234567899999999997543 3678999999999999999999999876554444444432 1
Q ss_pred CCCC--------HHHHh-cc--CCCCCCC-----cccccccCChhhhh
Q 021306 258 GTPT--------REEIR-CM--NPNYTDF-----RFPQIKAHPWHKVC 289 (314)
Q Consensus 258 ~~~~--------~~~~~-~~--~p~~~~~-----~~~~l~~~p~~~~~ 289 (314)
..+. .+.+. ++ +|. +|+ +++++++|||++..
T Consensus 252 ~~~~~~~~s~~~~~li~~~l~~dP~-~R~s~~~~t~~eil~Hpff~~i 298 (322)
T d1vzoa_ 252 EPPYPQEMSALAKDLIQRLLMKDPK-KRLGCGPRDADEIKEHLFFQKI 298 (322)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGG-GSTTSSTTTHHHHHTSGGGTTC
T ss_pred CCCCcccCCHHHHHHHHHHcccCHH-HcCCCCcccHHHHHcCHhhcCC
Confidence 2111 12222 23 566 787 57899999999864
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-45 Score=310.97 Aligned_cols=248 Identities=25% Similarity=0.288 Sum_probs=184.1
Q ss_pred CCceeeeeEeecCceEEEEEEECCC---CcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCce
Q 021306 38 ISYMAERVVGTGSFGIVFQAKCLET---GETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL 109 (314)
Q Consensus 38 ~~y~~~~~Lg~g~~g~Vy~~~~~~~---~~~~~vK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 109 (314)
++|++++.||+|+||.||+|++..+ +..|++|.++... ....+|+.++++++||||+++++++.. .
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~----- 80 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-N----- 80 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-S-----
T ss_pred HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-C-----
Confidence 5899999999999999999998754 3568888875322 234589999999999999999998732 1
Q ss_pred eEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcc
Q 021306 110 FLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 188 (314)
Q Consensus 110 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~ 188 (314)
.+++||||+++ ++...+.. ....+++.+++.++.||+.||.|||+ ++++||||||+||+++. ++.+||+|||++
T Consensus 81 ~~~iv~E~~~~g~l~~~~~~---~~~~l~~~~~~~~~~qi~~gl~ylH~-~~iiHrDlKp~NIll~~-~~~~Kl~DfG~a 155 (273)
T d1mp8a_ 81 PVWIIMELCTLGELRSFLQV---RKYSLDLASLILYAYQLSTALAYLES-KRFVHRDIAARNVLVSS-NDCVKLGDFGLS 155 (273)
T ss_dssp SCEEEEECCTTEEHHHHHHH---TTTTSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEEE-TTEEEECC----
T ss_pred eEEEEEEeccCCcHHhhhhc---cCCCCCHHHHHHHHHHHHHHhhhhcc-cCeeccccchhheeecC-CCcEEEccchhh
Confidence 26799999996 55544432 35689999999999999999999999 89999999999999998 889999999999
Q ss_pred cccccCCc--cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCCHHHH
Q 021306 189 KQLIAGEA--NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEI 265 (314)
Q Consensus 189 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 265 (314)
+....... .....+|+.|+|||.+.+.. ++.++|||||||++|||+| |..||.+.+..+....+.+....+.+.
T Consensus 156 ~~~~~~~~~~~~~~~gt~~y~apE~l~~~~-~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~~~~~-- 232 (273)
T d1mp8a_ 156 RYMEDSTYYKASKGKLPIKWMAPESINFRR-FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPP-- 232 (273)
T ss_dssp ---------------CCGGGCCHHHHHHCC-CSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCT--
T ss_pred eeccCCcceeccceecCcccchhhHhccCC-CCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCC--
Confidence 76543322 23345688999999996554 8999999999999999998 899999988887777666543222211
Q ss_pred hccCCCCCCCcccccccCChhhhhcccCChHHHHHhcchh
Q 021306 266 RCMNPNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGSHI 305 (314)
Q Consensus 266 ~~~~p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~~~ 305 (314)
.+ ...+.+|++.||...+..+++...+++.++++
T Consensus 233 -~~-----~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i 266 (273)
T d1mp8a_ 233 -NC-----PPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 266 (273)
T ss_dssp -TC-----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -CC-----CHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 12 23466677777777777777777676666544
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.8e-43 Score=304.68 Aligned_cols=250 Identities=18% Similarity=0.220 Sum_probs=190.9
Q ss_pred CCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeecc--ccchHHHHHHHHhCCC-CceeeeceeeeecCCCCceeEEE
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD--RRYKNRELQLMRVMDH-PNVISLKHCFFSTTSKNELFLNL 113 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~--~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~~~~~~l 113 (314)
+++|++.+.||+|+||.||+|++..+|+.||+|.++.. .....+|.+.++.++| +|++.+++++... ...++
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~-----~~~~~ 78 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEG-----LHNVL 78 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEET-----TEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCcHHHHHHHHHHHHhcCCCCCCEEEEEeecC-----CccEE
Confidence 57899999999999999999999999999999987543 3445789999999976 8998888877433 34789
Q ss_pred EeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcC----CCCcEEEeecCccc
Q 021306 114 VMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP----LTHQVKICDFGSAK 189 (314)
Q Consensus 114 v~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~----~~~~~~l~dfg~~~ 189 (314)
||||++++|.+.+.. .+..+++..+..++.|++.||.|||+ +||+||||||+||+++. ..+.++|+|||+++
T Consensus 79 vme~~~~~l~~~~~~---~~~~~~~~~~~~i~~q~~~~l~~lH~-~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~ 154 (293)
T d1csna_ 79 VIDLLGPSLEDLLDL---CGRKFSVKTVAMAAKQMLARVQSIHE-KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 154 (293)
T ss_dssp EEECCCCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred EEEecCCCHHHHHHh---hccchhhHHHHHHHHHHHHHHHHHHH-CCceeccCCccceeecCcccccCCceEEcccceeE
Confidence 999999998887754 35679999999999999999999999 89999999999999974 24679999999998
Q ss_pred ccccCC--------ccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHHcC
Q 021306 190 QLIAGE--------ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA---VDQLVEIIKVLG 258 (314)
Q Consensus 190 ~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~~---~~~~~~i~~~~~ 258 (314)
...... ......||+.|+|||.+.+.. ++.++||||||+++|+|+||+.||.+... ......+.....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~-~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~ 233 (293)
T d1csna_ 155 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGRE-QSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ 233 (293)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHH
T ss_pred EcccCccccceeecccCceEEchhhcCHHHhcCCC-CChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccC
Confidence 654321 122456899999999997654 89999999999999999999999976543 233333333222
Q ss_pred CCCHHHH-hccCCCCCCCcccccccCChhhhhcccCChHHHHHh
Q 021306 259 TPTREEI-RCMNPNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEY 301 (314)
Q Consensus 259 ~~~~~~~-~~~~p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~ 301 (314)
..+...+ ..+++ .+.++++.+|...+..++..+.+.+.
T Consensus 234 ~~~~~~l~~~~p~-----~l~~ii~~~~~~~~~~rP~y~~l~~~ 272 (293)
T d1csna_ 234 STPLRELCAGFPE-----EFYKYMHYARNLAFDATPDYDYLQGL 272 (293)
T ss_dssp HSCHHHHTTTSCH-----HHHHHHHHHHHCCTTCCCCHHHHHHH
T ss_pred CCChHHhcCCCCH-----HHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 2222222 22333 35666777776666555555544444
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.7e-44 Score=312.32 Aligned_cols=254 Identities=24% Similarity=0.292 Sum_probs=199.9
Q ss_pred CCCceeeeeEeecCceEEEEEEECC-----CCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCC
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCLE-----TGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSK 106 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~~-----~~~~~~vK~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 106 (314)
.++|++.+.||+|+||.||+|+.+. +++.||||+++... ....+|+.++++++||||+++++++....
T Consensus 12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~-- 89 (301)
T d1lufa_ 12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGK-- 89 (301)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS--
T ss_pred HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCC--
Confidence 3579999999999999999999753 56789999986432 33568999999999999999999885433
Q ss_pred CceeEEEEeecccc-cHHHHHHhhh--------------------hcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecC
Q 021306 107 NELFLNLVMEYVPE-SMYRVLKHYS--------------------SANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRD 165 (314)
Q Consensus 107 ~~~~~~lv~e~~~~-~l~~~l~~~~--------------------~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~d 165 (314)
..++++||+++ +|.+.+.... .....+++..+..++.|++.||.|||+ ++++|||
T Consensus 90 ---~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~-~~ivHrD 165 (301)
T d1lufa_ 90 ---PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE-RKFVHRD 165 (301)
T ss_dssp ---SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSC
T ss_pred ---ceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhccc-CCeEeeE
Confidence 37899999985 7777665321 113458999999999999999999999 8999999
Q ss_pred CCCCcEEEcCCCCcEEEeecCcccccccCC---ccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCC-CCC
Q 021306 166 LKPQNLLVDPLTHQVKICDFGSAKQLIAGE---ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQ-PLF 241 (314)
Q Consensus 166 l~p~Nil~~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~-~pf 241 (314)
|||+||+++. ++.+||+|||+++...... ......+++.|+|||.+.+.. ++.++|||||||++|||++|. .||
T Consensus 166 lKp~NILld~-~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~t~ksDVwS~Gvvl~ell~~~~~p~ 243 (301)
T d1lufa_ 166 LATRNCLVGE-NMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNR-YTTESDVWAYGVVLWEIFSYGLQPY 243 (301)
T ss_dssp CSGGGEEECG-GGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred EcccceEECC-CCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCC-CChhhhhccchhhHHHHHccCCCCC
Confidence 9999999998 8899999999997553322 222355788999999997655 899999999999999999985 688
Q ss_pred CCCChHHHHHHHHHHcCCCCHHHHhccCCCCCCCcccccccCChhhhhcccCChHHHHHhcchhh
Q 021306 242 PGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGSHIN 306 (314)
Q Consensus 242 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~~~~ 306 (314)
.+.+..+....+.+....+. ++. ....+.+|+..||...+..+++...+.+.++.++
T Consensus 244 ~~~~~~e~~~~v~~~~~~~~-------p~~-~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 244 YGMAHEEVIYYVRDGNILAC-------PEN-CPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp TTSCHHHHHHHHHTTCCCCC-------CTT-CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCCCHHHHHHHHHcCCCCCC-------Ccc-chHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 88888776666544322111 111 2335778999999999999999998888887663
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-44 Score=312.61 Aligned_cols=254 Identities=22% Similarity=0.279 Sum_probs=196.0
Q ss_pred cCCCceeeeeEeecCceEEEEEEECCCCcE--EEEEEeecc-----ccchHHHHHHHHhC-CCCceeeeceeeeecCCCC
Q 021306 36 QTISYMAERVVGTGSFGIVFQAKCLETGET--VAIKKVLQD-----RRYKNRELQLMRVM-DHPNVISLKHCFFSTTSKN 107 (314)
Q Consensus 36 ~~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~--~~vK~~~~~-----~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~ 107 (314)
..++|++.+.||+|+||.||+|+++.++.. |+||.++.. .....+|++++.++ +||||+++++++.....
T Consensus 8 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~-- 85 (309)
T d1fvra_ 8 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY-- 85 (309)
T ss_dssp CGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTE--
T ss_pred CHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCe--
Confidence 457999999999999999999999888764 667776432 23456899999998 79999999999865433
Q ss_pred ceeEEEEeecccc-cHHHHHHhh------------hhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEc
Q 021306 108 ELFLNLVMEYVPE-SMYRVLKHY------------SSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVD 174 (314)
Q Consensus 108 ~~~~~lv~e~~~~-~l~~~l~~~------------~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~ 174 (314)
+++||||+++ +|.+.+... ......+++.++..++.||+.||.|||+ ++|+||||||+|||++
T Consensus 86 ---~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~-~~iiHrDlkp~NIL~~ 161 (309)
T d1fvra_ 86 ---LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ-KQFIHRDLAARNILVG 161 (309)
T ss_dssp ---EEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEC
T ss_pred ---eEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhc-CCccccccccceEEEc
Confidence 8899999995 777776542 1234679999999999999999999999 8999999999999999
Q ss_pred CCCCcEEEeecCcccccccCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCC-CCCCCCChHHHHHHH
Q 021306 175 PLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQ-PLFPGENAVDQLVEI 253 (314)
Q Consensus 175 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~-~pf~~~~~~~~~~~i 253 (314)
. ++.+||+|||+++............+|..|+|||.+.+.. ++.++||||||+++|||++|. .||.+.+..+....+
T Consensus 162 ~-~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i 239 (309)
T d1fvra_ 162 E-NYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSV-YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL 239 (309)
T ss_dssp G-GGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHG
T ss_pred C-CCceEEccccccccccccccccceecCCcccchHHhccCC-CCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHH
Confidence 8 7899999999998665544444566789999999997655 899999999999999999965 678888877766655
Q ss_pred HHHcCCCCHHHHhccCCCCCCCcccccccCChhhhhcccCChHHHHHhcchh
Q 021306 254 IKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGSHI 305 (314)
Q Consensus 254 ~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~~~ 305 (314)
.++...+.+ ..++ ..+..|++.||...+..++....+++.++.+
T Consensus 240 ~~~~~~~~~---~~~~-----~~~~~li~~cl~~dP~~RPs~~eil~~L~~i 283 (309)
T d1fvra_ 240 PQGYRLEKP---LNCD-----DEVYDLMRQCWREKPYERPSFAQILVSLNRM 283 (309)
T ss_dssp GGTCCCCCC---TTBC-----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HhcCCCCCC---ccCC-----HHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 443222211 1122 2356677777777777777777666665544
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-44 Score=308.09 Aligned_cols=248 Identities=25% Similarity=0.307 Sum_probs=188.4
Q ss_pred CCceeeeeEeecCceEEEEEEECCC-C--cEEEEEEeecc-------ccchHHHHHHHHhCCCCceeeeceeeeecCCCC
Q 021306 38 ISYMAERVVGTGSFGIVFQAKCLET-G--ETVAIKKVLQD-------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKN 107 (314)
Q Consensus 38 ~~y~~~~~Lg~g~~g~Vy~~~~~~~-~--~~~~vK~~~~~-------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 107 (314)
++|++.+.||+|+||.||+|+...+ + ..||+|+++++ ...+.+|+.++++++||||+++++++...
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~---- 83 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP---- 83 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS----
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec----
Confidence 5799999999999999999986543 3 36899987543 12346899999999999999999988421
Q ss_pred ceeEEEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecC
Q 021306 108 ELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 186 (314)
Q Consensus 108 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg 186 (314)
.+++||||+++ ++.+.+.. ....+++..++.++.||+.||.|||+ +||+||||||+||+++. ++.+||+|||
T Consensus 84 --~~~lv~e~~~~~~l~~~~~~---~~~~l~~~~~~~~~~qi~~gl~ylH~-~~iiHrDikp~NIll~~-~~~vkl~DfG 156 (273)
T d1u46a_ 84 --PMKMVTELAPLGSLLDRLRK---HQGHFLLGTLSRYAVQVAEGMGYLES-KRFIHRDLAARNLLLAT-RDLVKIGDFG 156 (273)
T ss_dssp --SCEEEEECCTTCBHHHHHHH---HGGGSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEEEE-TTEEEECCCT
T ss_pred --chheeeeeecCcchhhhhhc---ccCCCCHHHHHHHHHHHHHHHHHhhh-CCEeeeeecHHHhcccc-ccceeeccch
Confidence 15699999985 66655543 34679999999999999999999999 99999999999999998 8899999999
Q ss_pred cccccccCCcc----ccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHcCCCC
Q 021306 187 SAKQLIAGEAN----ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPT 261 (314)
Q Consensus 187 ~~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~ 261 (314)
+++........ ....++..|+|||.+.+.. ++.++||||||+++|||+| |+.||.+.+..+....+.+....++
T Consensus 157 l~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~ 235 (273)
T d1u46a_ 157 LMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRT-FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP 235 (273)
T ss_dssp TCEECCC-CCEEEC-----CCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCC
T ss_pred hhhhcccCCCcceecCccccCcccCCHHHHhCCC-CCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCC
Confidence 99866443221 2234577899999997654 8999999999999999998 8999999998887776655432221
Q ss_pred HHHHhccCCCCCCCcccccccCChhhhhcccCChHHHHHhcch
Q 021306 262 REEIRCMNPNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGSH 304 (314)
Q Consensus 262 ~~~~~~~~p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~~ 304 (314)
. ...+ ...+.+|++.||...+..+++...+.+.++.
T Consensus 236 ~--~~~~-----~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~ 271 (273)
T d1u46a_ 236 R--PEDC-----PQDIYNVMVQCWAHKPEDRPTFVALRDFLLE 271 (273)
T ss_dssp C--CTTC-----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred C--cccc-----cHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 1 1112 2346788888998888888888888877654
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-43 Score=305.75 Aligned_cols=254 Identities=25% Similarity=0.363 Sum_probs=184.7
Q ss_pred CCceeeeeEeecCceEEEEEEECC-----CCcEEEEEEeeccc-----cchHHHHHHHHhC-CCCceeeeceeeeecCCC
Q 021306 38 ISYMAERVVGTGSFGIVFQAKCLE-----TGETVAIKKVLQDR-----RYKNRELQLMRVM-DHPNVISLKHCFFSTTSK 106 (314)
Q Consensus 38 ~~y~~~~~Lg~g~~g~Vy~~~~~~-----~~~~~~vK~~~~~~-----~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~ 106 (314)
++|++.+.||+|+||.||+|++.. +++.||+|.++... ....+|...+.++ .|+||+.+++++....
T Consensus 13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~-- 90 (299)
T d1ywna1 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG-- 90 (299)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT--
T ss_pred HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCC--
Confidence 579999999999999999999754 45789999986432 2233555556555 6899999988764332
Q ss_pred CceeEEEEeecccc-cHHHHHHhhhh------------cCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEE
Q 021306 107 NELFLNLVMEYVPE-SMYRVLKHYSS------------ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLV 173 (314)
Q Consensus 107 ~~~~~~lv~e~~~~-~l~~~l~~~~~------------~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~ 173 (314)
..+++|||||++ +|.+.+..... ....+++.+++.++.|++.||.|||+ ++|+||||||+|||+
T Consensus 91 --~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~-~~ivHrDlKp~NILl 167 (299)
T d1ywna1 91 --GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS-RKCIHRDLAARNILL 167 (299)
T ss_dssp --SCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEE
T ss_pred --CeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHh-CCCcCCcCCccceeE
Confidence 237899999995 77777654322 13458999999999999999999999 999999999999999
Q ss_pred cCCCCcEEEeecCcccccccCCc---cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhC-CCCCCCCChHHH
Q 021306 174 DPLTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLG-QPLFPGENAVDQ 249 (314)
Q Consensus 174 ~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg-~~pf~~~~~~~~ 249 (314)
+. ++.+||+|||+++....... .....||+.|+|||.+.+.. ++.++|||||||++|||+|| ..||.+....+.
T Consensus 168 ~~-~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~-~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~ 245 (299)
T d1ywna1 168 SE-KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 245 (299)
T ss_dssp CG-GGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH
T ss_pred CC-CCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCC-CCcccceeehHHHHHHHHhCCCCCCCCCCHHHH
Confidence 98 88999999999975543322 22356799999999997654 89999999999999999996 578988776666
Q ss_pred HHHHHHHcCCCCHHHHhccCCCCCCCcccccccCChhhhhcccCChHHHHHhcchh
Q 021306 250 LVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGSHI 305 (314)
Q Consensus 250 ~~~i~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~~~ 305 (314)
+..++.....+.. |......+.+++..||...+..+++...+++.++++
T Consensus 246 ~~~~~~~~~~~~~-------~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~i 294 (299)
T d1ywna1 246 FCRRLKEGTRMRA-------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294 (299)
T ss_dssp HHHHHHHTCCCCC-------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHhcCCCCCC-------CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 6666554332211 111223466777888888888888888887776654
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-43 Score=306.33 Aligned_cols=256 Identities=23% Similarity=0.349 Sum_probs=194.4
Q ss_pred CCCceeeeeEeecCceEEEEEEECCCC-------cEEEEEEeecccc-----chHHHHHHHHhC-CCCceeeeceeeeec
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCLETG-------ETVAIKKVLQDRR-----YKNRELQLMRVM-DHPNVISLKHCFFST 103 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~~~~-------~~~~vK~~~~~~~-----~~~~e~~~l~~l-~h~~iv~~~~~~~~~ 103 (314)
.++|++++.||+|+||.||+|++..++ ..||+|+++++.. ...+|...+.++ +||||+++++++.+.
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence 468999999999999999999976554 4799999865432 234677777777 899999999998543
Q ss_pred CCCCceeEEEEeecccc-cHHHHHHhhh------------hcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCc
Q 021306 104 TSKNELFLNLVMEYVPE-SMYRVLKHYS------------SANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQN 170 (314)
Q Consensus 104 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~------------~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~N 170 (314)
...++||||+.+ ++.+.+.... .....+++.+++.++.||+.||.|||+ ++|+||||||+|
T Consensus 92 -----~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~-~~ivHrDiKp~N 165 (299)
T d1fgka_ 92 -----GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS-KKCIHRDLAARN 165 (299)
T ss_dssp -----SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGG
T ss_pred -----CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhh-CCEEeeeecccc
Confidence 347899999995 6777665432 123569999999999999999999999 999999999999
Q ss_pred EEEcCCCCcEEEeecCcccccccCCc---cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCh
Q 021306 171 LLVDPLTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENA 246 (314)
Q Consensus 171 il~~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~t-g~~pf~~~~~ 246 (314)
||++. ++.+||+|||+++....... .....+++.|+|||.+.+.. ++.++||||||+++|||++ |..||.+.+.
T Consensus 166 iLl~~-~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~-y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~ 243 (299)
T d1fgka_ 166 VLVTE-DNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 243 (299)
T ss_dssp EEECT-TCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred eeecC-CCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCC-CCchhhhHHhHHHHHHhccCCCCCCCCCCH
Confidence 99998 78999999999986644332 23356788999999997654 8999999999999999998 7899988887
Q ss_pred HHHHHHHHHHcCCCCHHHHhccCCCCCCCcccccccCChhhhhcccCChHHHHHhcchhhhc
Q 021306 247 VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGSHINAI 308 (314)
Q Consensus 247 ~~~~~~i~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 308 (314)
.+....+.++...+.+ ..+ ...+.+|+..||...+..++....+++.++.+.+.
T Consensus 244 ~~~~~~i~~~~~~~~p---~~~-----~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a~ 297 (299)
T d1fgka_ 244 EELFKLLKEGHRMDKP---SNC-----TNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 297 (299)
T ss_dssp HHHHHHHHTTCCCCCC---SSC-----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHcCCCCCCC---ccc-----hHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhhc
Confidence 6655544333222211 111 22467888889999888888888898888877543
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-42 Score=302.02 Aligned_cols=254 Identities=23% Similarity=0.340 Sum_probs=199.8
Q ss_pred CCCceeeeeEeecCceEEEEEEEC-----CCCcEEEEEEeecccc-----chHHHHHHHHhC-CCCceeeeceeeeecCC
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCL-----ETGETVAIKKVLQDRR-----YKNRELQLMRVM-DHPNVISLKHCFFSTTS 105 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~-----~~~~~~~vK~~~~~~~-----~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~ 105 (314)
.++|++++.||+|+||.||+|++. .+++.||||+++.... .+.+|+.+++++ +||||+++++++....
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~- 100 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG- 100 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCC-
Confidence 368999999999999999999863 4678999999875432 235788889988 6999999999985433
Q ss_pred CCceeEEEEeecccc-cHHHHHHhhh--------------hcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCc
Q 021306 106 KNELFLNLVMEYVPE-SMYRVLKHYS--------------SANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQN 170 (314)
Q Consensus 106 ~~~~~~~lv~e~~~~-~l~~~l~~~~--------------~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~N 170 (314)
.++++||||++ ++.+.+.... .....+++.++..++.||+.||.|||+ ++++||||||+|
T Consensus 101 ----~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~-~~ivHrDLKp~N 175 (311)
T d1t46a_ 101 ----PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS-KNCIHRDLAARN 175 (311)
T ss_dssp ----SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGG
T ss_pred ----EEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccccccc
Confidence 37899999996 6666665422 123469999999999999999999999 899999999999
Q ss_pred EEEcCCCCcEEEeecCcccccccCCc---cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCh
Q 021306 171 LLVDPLTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENA 246 (314)
Q Consensus 171 il~~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~t-g~~pf~~~~~ 246 (314)
|+++. ++.++++|||.++....... .....+|+.|+|||.+.+.. ++.++||||||+++|||+| |.+||.+.+.
T Consensus 176 Il~~~-~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DIwS~G~~l~ellt~g~p~~~~~~~ 253 (311)
T d1t46a_ 176 ILLTH-GRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGIFLWELFSLGSSPYPGMPV 253 (311)
T ss_dssp EEEET-TTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred ccccc-cCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCC-CCCcccccchHHHHHHHHhCCCCCCCCCCH
Confidence 99998 88999999999986644322 22356789999999997654 8999999999999999999 6677777777
Q ss_pred HHHHHHHHHHcCCCCHHHHhccCCCCCCCcccccccCChhhhhcccCChHHHHHhcchh
Q 021306 247 VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGSHI 305 (314)
Q Consensus 247 ~~~~~~i~~~~~~~~~~~~~~~~p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~~~ 305 (314)
.+.+.++++....+. .|......+.+|+..||...+..+++...+++.++++
T Consensus 254 ~~~~~~~i~~~~~~~-------~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~ 305 (311)
T d1t46a_ 254 DSKFYKMIKEGFRML-------SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305 (311)
T ss_dssp SHHHHHHHHHTCCCC-------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHHhcCCCCC-------CcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 677777765432221 1221233577888889988888888888888887754
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-42 Score=300.64 Aligned_cols=251 Identities=20% Similarity=0.227 Sum_probs=194.7
Q ss_pred CCceeeeeEeecCceEEEEEEECC-----CCcEEEEEEeecccc-----chHHHHHHHHhCCCCceeeeceeeeecCCCC
Q 021306 38 ISYMAERVVGTGSFGIVFQAKCLE-----TGETVAIKKVLQDRR-----YKNRELQLMRVMDHPNVISLKHCFFSTTSKN 107 (314)
Q Consensus 38 ~~y~~~~~Lg~g~~g~Vy~~~~~~-----~~~~~~vK~~~~~~~-----~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 107 (314)
++|++.+.||+|+||.||+|.++. +++.||||+++.... ...+|+.++++++||||+++++++....
T Consensus 20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~--- 96 (308)
T d1p4oa_ 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ--- 96 (308)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSS---
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCC---
Confidence 789999999999999999998752 357899999865322 2458999999999999999999884333
Q ss_pred ceeEEEEeecccc-cHHHHHHhhh------hcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcE
Q 021306 108 ELFLNLVMEYVPE-SMYRVLKHYS------SANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQV 180 (314)
Q Consensus 108 ~~~~~lv~e~~~~-~l~~~l~~~~------~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~ 180 (314)
..++||||+.+ ++.+.+.... .....+++..+..++.|++.||.|||+ ++|+||||||+|||++. ++.+
T Consensus 97 --~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~-~~ivHrDlk~~NiLld~-~~~~ 172 (308)
T d1p4oa_ 97 --PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA-NKFVHRDLAARNCMVAE-DFTV 172 (308)
T ss_dssp --SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH-TTCBCSCCSGGGEEECT-TCCE
T ss_pred --ceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhh-CCeeeceEcCCceeecC-CceE
Confidence 37899999985 6666554321 112457999999999999999999999 89999999999999998 8899
Q ss_pred EEeecCcccccccCCc---cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHHH
Q 021306 181 KICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLG-QPLFPGENAVDQLVEIIKV 256 (314)
Q Consensus 181 ~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg-~~pf~~~~~~~~~~~i~~~ 256 (314)
||+|||+++....... .....+++.|+|||.+.+.. ++.++||||||+++|||+|| ..||.+.+..+.+..+.+.
T Consensus 173 Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~-~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~ 251 (308)
T d1p4oa_ 173 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEG 251 (308)
T ss_dssp EECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTT
T ss_pred EEeecccceeccCCcceeeccceecccccCCHHHHccCC-CCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhC
Confidence 9999999976543322 22345789999999997655 88999999999999999997 5889888888777766653
Q ss_pred cCCCCHHHHhccCCCCCCCcccccccCChhhhhcccCChHHHHHhcch
Q 021306 257 LGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGSH 304 (314)
Q Consensus 257 ~~~~~~~~~~~~~p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~~ 304 (314)
...+.+. .....+.+|+..||...+..+++...+++.+++
T Consensus 252 ~~~~~p~--------~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~ 291 (308)
T d1p4oa_ 252 GLLDKPD--------NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 291 (308)
T ss_dssp CCCCCCT--------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGG
T ss_pred CCCCCcc--------cchHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 3222111 122346667777777777777777666666543
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-42 Score=297.34 Aligned_cols=251 Identities=22% Similarity=0.292 Sum_probs=188.0
Q ss_pred ceeeeeEeecCceEEEEEEECCCC---cEEEEEEeecc-----ccchHHHHHHHHhCCCCceeeeceeeeecCCCCceeE
Q 021306 40 YMAERVVGTGSFGIVFQAKCLETG---ETVAIKKVLQD-----RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 111 (314)
Q Consensus 40 y~~~~~Lg~g~~g~Vy~~~~~~~~---~~~~vK~~~~~-----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 111 (314)
+...++||+|+||+||+|.+..++ ..||||.++.. ...+.+|++++++++||||+++++++.... ...
T Consensus 29 ~~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~----~~~ 104 (311)
T d1r0pa_ 29 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE----GSP 104 (311)
T ss_dssp EEEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETT----TEE
T ss_pred eccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecC----Cce
Confidence 344689999999999999986543 36899988642 233568999999999999999999875432 237
Q ss_pred EEEeecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCCcEEEeecCcccc
Q 021306 112 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 190 (314)
Q Consensus 112 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~~ 190 (314)
++|||||++ ++.+.+.. ....+++.++..++.|++.||.|||+ .+|+||||||+|||++. ++.+||+|||+++.
T Consensus 105 ~lv~E~~~~g~l~~~~~~---~~~~~~~~~~~~i~~qia~gL~~lH~-~~iiHrDLK~~NILl~~-~~~~kL~DFG~~~~ 179 (311)
T d1r0pa_ 105 LVVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFLAS-KKFVHRDLAARNCMLDE-KFTVKVADFGLARD 179 (311)
T ss_dssp EEEEECCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECT-TCCEEECSSGGGCC
T ss_pred EEEEEEeecCchhhhhcc---ccccchHHHHHHHHHHHHHhhhhhcc-cCcccCCccHHhEeECC-CCCEEEecccchhh
Confidence 899999996 55544442 34678889999999999999999999 89999999999999998 88999999999986
Q ss_pred cccCCc-----cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHHcCCCCHHH
Q 021306 191 LIAGEA-----NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN-AVDQLVEIIKVLGTPTREE 264 (314)
Q Consensus 191 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~~-~~~~~~~i~~~~~~~~~~~ 264 (314)
...... .....+|+.|+|||.+.+.. ++.++||||||+++|||+||+.||.... ..+....+.++....
T Consensus 180 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~---- 254 (311)
T d1r0pa_ 180 MYDKEFDSVHNKTGAKLPVKWMALESLQTQK-FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLL---- 254 (311)
T ss_dssp TTTTTCCCTTCTTCSSCCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCC----
T ss_pred ccccccccceecccccccccccChHHHhcCC-CCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCC----
Confidence 543322 22345788999999987655 8999999999999999999877776543 333334333322111
Q ss_pred HhccCCCCCCCcccccccCChhhhhcccCChHHHHHhcchhhhc
Q 021306 265 IRCMNPNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGSHINAI 308 (314)
Q Consensus 265 ~~~~~p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 308 (314)
.|......+.+|+..||...+..++....+++.++++...
T Consensus 255 ----~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~ 294 (311)
T d1r0pa_ 255 ----QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294 (311)
T ss_dssp ----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred ----CcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 1222233577888888888888888888888887766543
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-42 Score=300.79 Aligned_cols=257 Identities=20% Similarity=0.241 Sum_probs=186.4
Q ss_pred CCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccccc-h--HHHHHHHHhCCCCceeeeceeeeecCCCCceeEEEE
Q 021306 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY-K--NRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLV 114 (314)
Q Consensus 38 ~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~~~-~--~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 114 (314)
..|.+.+.||+|+||.||+|+. +|+.||||+++..... . +.|+..+.+++||||+++++++.... .....+++|
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~-~~~~~~~lv 79 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDN-GTWTQLWLV 79 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCC-CcceEEEEE
Confidence 4689999999999999999986 7899999998654332 2 23444456789999999999886554 233457899
Q ss_pred eecccc-cHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcC-------CCceecCCCCCcEEEcCCCCcEEEeecC
Q 021306 115 MEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV-------PRVCHRDLKPQNLLVDPLTHQVKICDFG 186 (314)
Q Consensus 115 ~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~-------~~i~h~dl~p~Nil~~~~~~~~~l~dfg 186 (314)
|||+++ +|.+.+.. .++++.+.+.++.|++.||.|||+. +||+||||||+||+++. ++.+||+|||
T Consensus 80 ~Ey~~~g~L~~~l~~-----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~-~~~~Kl~DFG 153 (303)
T d1vjya_ 80 SDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKK-NGTCCIADLG 153 (303)
T ss_dssp EECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECT-TSCEEECCCT
T ss_pred EecccCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcC-CCCeEEEecC
Confidence 999985 77777764 5799999999999999999999961 59999999999999998 8899999999
Q ss_pred cccccccCCc-----cccccccccccccccccCCC-----CCCcchhHHHHHHHHHHHHhCCCCCCCCChH---------
Q 021306 187 SAKQLIAGEA-----NISYICSRFYRAPELIFGAT-----EYTTSIDIWSAGCVLAELLLGQPLFPGENAV--------- 247 (314)
Q Consensus 187 ~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~-----~~~~~~Dv~slG~il~el~tg~~pf~~~~~~--------- 247 (314)
+++....... .....||+.|+|||.+.+.. .++.++|||||||++|||+||..||......
T Consensus 154 l~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~ 233 (303)
T d1vjya_ 154 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP 233 (303)
T ss_dssp TCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSC
T ss_pred ccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccc
Confidence 9986644332 22456899999999986432 1466899999999999999999887432211
Q ss_pred -----HHHHHHHHH-cCCC-CHHHHhccCCCCCCCcccccccCChhhhhcccCChHHHHHhcchhh
Q 021306 248 -----DQLVEIIKV-LGTP-TREEIRCMNPNYTDFRFPQIKAHPWHKVCIFHFPKHWLLEYGSHIN 306 (314)
Q Consensus 248 -----~~~~~i~~~-~~~~-~~~~~~~~~p~~~~~~~~~l~~~p~~~~~~~~~~~~~~~~~~~~~~ 306 (314)
+........ ...+ .+.... +++ ..-.+..|+..||...+..+++...+++.++.+.
T Consensus 234 ~~~~~~~~~~~~~~~~~~p~~~~~~~--~~~-~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~ 296 (303)
T d1vjya_ 234 SDPSVEEMRKVVCEQKLRPNIPNRWQ--SCE-ALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296 (303)
T ss_dssp SSCCHHHHHHHHTTSCCCCCCCGGGG--GCH-HHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred ccchHHHHHHHHhccccCCCCCcccC--ChH-HHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 111111110 0000 000000 000 0012567889999999999998888888776554
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.1e-39 Score=287.53 Aligned_cols=200 Identities=32% Similarity=0.546 Sum_probs=155.5
Q ss_pred CCCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHhCC-----------CCceeeeceeeee
Q 021306 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMD-----------HPNVISLKHCFFS 102 (314)
Q Consensus 37 ~~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~---~~~~~e~~~l~~l~-----------h~~iv~~~~~~~~ 102 (314)
.++|++++.||+|+||+||+|+++.+|+.||||+++++. ....+|+.+++.+. |+||+++++++..
T Consensus 12 ~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 12 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 356999999999999999999999999999999997653 23357888887774 5789999888754
Q ss_pred cCCCCceeEEEEeeccc--ccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCCC--
Q 021306 103 TTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH-- 178 (314)
Q Consensus 103 ~~~~~~~~~~lv~e~~~--~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~~-- 178 (314)
.. .. ..+++++++. ++...... ......+++..++.++.|++.|+.|||+..||+||||||+||+++..+.
T Consensus 92 ~~-~~--~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~ 166 (362)
T d1q8ya_ 92 KG-PN--GVHVVMVFEVLGENLLALIK--KYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPE 166 (362)
T ss_dssp EE-TT--EEEEEEEECCCCEEHHHHHH--HTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTT
T ss_pred cc-cc--ceeeeeeecccccccccccc--cccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCccc
Confidence 22 12 2344444443 44333332 2345789999999999999999999996478999999999999976222
Q ss_pred ---cEEEeecCcccccccCCccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 021306 179 ---QVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE 244 (314)
Q Consensus 179 ---~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~pf~~~ 244 (314)
.++++|||.+..... ......+|+.|+|||.+.+.. ++.++|+||+|+++++|++|+.||...
T Consensus 167 ~~~~~kl~dfg~s~~~~~--~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~el~~g~~pF~~~ 232 (362)
T d1q8ya_ 167 NLIQIKIADLGNACWYDE--HYTNSIQTREYRSPEVLLGAP-WGCGADIWSTACLIFELITGDFLFEPD 232 (362)
T ss_dssp TEEEEEECCCTTCEETTB--CCCSCCSCGGGCCHHHHHTCC-CCTHHHHHHHHHHHHHHHHSSCCC---
T ss_pred ccceeeEeeccccccccc--ccccccccccccChhhccccC-CCccccccchHHHHHHHHHCCCCCCCC
Confidence 499999999875433 334567899999999997655 899999999999999999999999754
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.90 E-value=3e-24 Score=172.33 Aligned_cols=164 Identities=18% Similarity=0.105 Sum_probs=115.1
Q ss_pred ceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc----------------------cchHHHHHHHHhCCCCceeeec
Q 021306 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----------------------RYKNRELQLMRVMDHPNVISLK 97 (314)
Q Consensus 40 y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~----------------------~~~~~e~~~l~~l~h~~iv~~~ 97 (314)
+.+++.||+|+||.||+|++ .+|+.||+|.++... ....+|...+.++.|.+++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~-~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred chhCCEeeeCcceEEEEEEC-CCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 56899999999999999997 478999999764211 0112567788889999888775
Q ss_pred eeeeecCCCCceeEEEEeecccccHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCCceecCCCCCcEEEcCCC
Q 021306 98 HCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLT 177 (314)
Q Consensus 98 ~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~i~h~dl~p~Nil~~~~~ 177 (314)
+.. . .+++|||+++... ..++...+..++.|++.++.+||+ +||+||||||+||++++
T Consensus 81 ~~~-----~----~~lvme~~~~~~~----------~~l~~~~~~~i~~ql~~~l~~lH~-~giiHrDiKP~NILv~~-- 138 (191)
T d1zara2 81 AWE-----G----NAVLMELIDAKEL----------YRVRVENPDEVLDMILEEVAKFYH-RGIVHGDLSQYNVLVSE-- 138 (191)
T ss_dssp EEE-----T----TEEEEECCCCEEG----------GGCCCSCHHHHHHHHHHHHHHHHH-TTEECSCCSTTSEEEET--
T ss_pred Eec-----C----CEEEEEeeccccc----------cchhhHHHHHHHHHHHHHHHHHhh-CCEEEccCChhheeeeC--
Confidence 542 2 2589999998521 224455577899999999999999 89999999999999985
Q ss_pred CcEEEeecCcccccccCCccccccccccccccccccCCCCCCcchhHHHHHH
Q 021306 178 HQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGC 229 (314)
Q Consensus 178 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~ 229 (314)
..++|+|||.+.....+............ -.+.+ . ..++.++|+||+.-
T Consensus 139 ~~~~liDFG~a~~~~~~~~~~~l~rd~~~-~~~~f-~-r~y~~~~d~~s~~~ 187 (191)
T d1zara2 139 EGIWIIDFPQSVEVGEEGWREILERDVRN-IITYF-S-RTYRTEKDINSAID 187 (191)
T ss_dssp TEEEECCCTTCEETTSTTHHHHHHHHHHH-HHHHH-H-HHHCCCCCHHHHHH
T ss_pred CCEEEEECCCcccCCCCCcHHHHHHHHHH-HHHHH-c-CCCCCcccHHHHHH
Confidence 45999999998755332221100000000 01222 1 23788899999753
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.21 E-value=5e-06 Score=67.72 Aligned_cols=77 Identities=17% Similarity=0.060 Sum_probs=47.6
Q ss_pred CCceeeeeEeecCceEEEEEEECCCCcEEEEEEeeccc----cchHHHHHHHHhCCC-CceeeeceeeeecCCCCceeEE
Q 021306 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDH-PNVISLKHCFFSTTSKNELFLN 112 (314)
Q Consensus 38 ~~y~~~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~~----~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~~~~~~ 112 (314)
.+|++++..+.++.+.||++.. +++.+++|...... ....+|...+..+.- --+.+++..... ....+
T Consensus 14 ~~~~~~~~~~G~s~~~v~rv~~--~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~-----~~~~~ 86 (263)
T d1j7la_ 14 EKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERH-----DGWSN 86 (263)
T ss_dssp TTSEEEECSCCCSSSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEE-----TTEEE
T ss_pred hceEEEEcCCCCCCCcEEEEEe--CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEec-----CCceE
Confidence 4677777765555678998863 56678888775432 234678887776642 112333333311 12367
Q ss_pred EEeeccccc
Q 021306 113 LVMEYVPES 121 (314)
Q Consensus 113 lv~e~~~~~ 121 (314)
+||++++|.
T Consensus 87 lv~~~l~G~ 95 (263)
T d1j7la_ 87 LLMSEADGV 95 (263)
T ss_dssp EEEECCSSE
T ss_pred EEEEecccc
Confidence 999999984
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.98 E-value=3.4e-05 Score=66.71 Aligned_cols=71 Identities=21% Similarity=0.191 Sum_probs=42.1
Q ss_pred eeeEeecCceEEEEEEECCCCcEEEEEEeecc-----------ccchHHHHHHHHhCC-C-Cc-eeeeceeeeecCCCCc
Q 021306 43 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-----------RRYKNRELQLMRVMD-H-PN-VISLKHCFFSTTSKNE 108 (314)
Q Consensus 43 ~~~Lg~g~~g~Vy~~~~~~~~~~~~vK~~~~~-----------~~~~~~e~~~l~~l~-h-~~-iv~~~~~~~~~~~~~~ 108 (314)
.+.||.|....||++.+..+++.+++|.-... ......|.+.++.+. + |. +.+++. ++...
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~--~d~~~--- 105 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFY--SDTEM--- 105 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEE--EETTT---
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEE--EcCCC---
Confidence 55789999999999997777889999965321 112245777777652 2 22 333322 22222
Q ss_pred eeEEEEeecccc
Q 021306 109 LFLNLVMEYVPE 120 (314)
Q Consensus 109 ~~~~lv~e~~~~ 120 (314)
.++|||++++
T Consensus 106 --~~lvmE~L~~ 115 (392)
T d2pula1 106 --AVTVMEDLSH 115 (392)
T ss_dssp --TEEEECCCTT
T ss_pred --CEEEEeccCC
Confidence 3589999975
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.65 E-value=0.00022 Score=57.24 Aligned_cols=69 Identities=14% Similarity=0.073 Sum_probs=42.5
Q ss_pred EeecC-ceEEEEEEECCCCcEEEEEEeeccc-cchHHHHHHHHhCCCCce--eeeceeeeecCCCCceeEEEEeecccc
Q 021306 46 VGTGS-FGIVFQAKCLETGETVAIKKVLQDR-RYKNRELQLMRVMDHPNV--ISLKHCFFSTTSKNELFLNLVMEYVPE 120 (314)
Q Consensus 46 Lg~g~-~g~Vy~~~~~~~~~~~~vK~~~~~~-~~~~~e~~~l~~l~h~~i--v~~~~~~~~~~~~~~~~~~lv~e~~~~ 120 (314)
+..|. .+.||++. ..++..+++|...... .....|...++.+....+ .+++.+..+ ....+++|++++|
T Consensus 18 ~~~G~s~~~v~r~~-~~~~~~~vlK~~~~~~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~-----~~~~~~v~~~i~G 90 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLS-AQGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVTE-----AGRDWLLLGEVPG 90 (255)
T ss_dssp CSCTTSSCEEEEEE-CTTSCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEEEC-----SSCEEEEEECCSS
T ss_pred cCCcccCCeEEEEE-eCCCCEEEEEeCCccCHhHHHHHHHHHHHHHhcCCCCCceeeeccc-----ccceEEEEEeeec
Confidence 34444 36789998 4567778999776543 335678888877744333 334433322 1236799999986
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.88 E-value=0.0034 Score=53.67 Aligned_cols=70 Identities=14% Similarity=0.216 Sum_probs=45.1
Q ss_pred eeeeEeecCceEEEEEEECC-------CCcEEEEEEeeccc--cchHHHHHHHHhCCCCcee-eeceeeeecCCCCceeE
Q 021306 42 AERVVGTGSFGIVFQAKCLE-------TGETVAIKKVLQDR--RYKNRELQLMRVMDHPNVI-SLKHCFFSTTSKNELFL 111 (314)
Q Consensus 42 ~~~~Lg~g~~g~Vy~~~~~~-------~~~~~~vK~~~~~~--~~~~~e~~~l~~l~h~~iv-~~~~~~~~~~~~~~~~~ 111 (314)
.++.|+.|-.-.+|++.... ..+.+++++..... ....+|..+++.+.-.++. +++.++ ++
T Consensus 46 ~v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~~idr~~E~~i~~~ls~~gl~Pkll~~~-----~~---- 116 (395)
T d1nw1a_ 46 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIF-----SG---- 116 (395)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEE-----TT----
T ss_pred EEEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcchhhHHHHHHHHHHHHHhCCCCCeEEEEc-----CC----
Confidence 34677878889999998653 24568888765322 2235788888877544444 444444 22
Q ss_pred EEEeecccc
Q 021306 112 NLVMEYVPE 120 (314)
Q Consensus 112 ~lv~e~~~~ 120 (314)
++|+||++|
T Consensus 117 g~I~efi~g 125 (395)
T d1nw1a_ 117 GRLEEYIPS 125 (395)
T ss_dssp EEEECCCCE
T ss_pred ceEEEEecc
Confidence 478899886
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.75 E-value=0.0049 Score=51.15 Aligned_cols=69 Identities=17% Similarity=0.002 Sum_probs=39.0
Q ss_pred ceEEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHhCCCCcee--eeceeeeecCCCCceeEEEEeecccc
Q 021306 51 FGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMDHPNVI--SLKHCFFSTTSKNELFLNLVMEYVPE 120 (314)
Q Consensus 51 ~g~Vy~~~~~~~~~~~~vK~~~~~~---~~~~~e~~~l~~l~h~~iv--~~~~~~~~~~~~~~~~~~lv~e~~~~ 120 (314)
-..||++. ..+|..|++|+..... .....|..++..|....+. .....--........+.+.++++++|
T Consensus 35 EN~vy~v~-~~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G 108 (325)
T d1zyla1 35 ENRVYQFQ-DEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG 108 (325)
T ss_dssp SSEEEEEC-CTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred cceeEEEE-cCCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCC
Confidence 46899998 4688999999876543 3345677777776422221 11100000000123346788888875
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.26 E-value=0.012 Score=48.33 Aligned_cols=30 Identities=27% Similarity=0.203 Sum_probs=26.4
Q ss_pred CCceecCCCCCcEEEcCCCCcEEEeecCccc
Q 021306 159 PRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 189 (314)
Q Consensus 159 ~~i~h~dl~p~Nil~~~~~~~~~l~dfg~~~ 189 (314)
.|++|+|+.++||+++. +...-++||+.+.
T Consensus 183 ~giIHgDl~~dNvl~~~-~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLG-DELSGLIDFYFAC 212 (316)
T ss_dssp EEEECSCCCGGGEEEET-TEEEEECCCTTCE
T ss_pred cccccCCcchhhhhccc-ccceeEecccccc
Confidence 58999999999999997 6666899999875
|